018636330	O
DH	O

5425710	O

123524	O

0144918	O

6/2/2005	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

KOTE	O
,	O
OA	O

UNIT	O
NUMBER	O
:	O

509-22-30	O

ADMISSION	O
DATE	O
:	O

06/02/2005	O

DISCHARGE	O
DATE	O
:	O

06/05/2005	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

C5-6	B-problem
disc	I-problem
herniation	I-problem
with	O
cord	B-problem
compression	I-problem
and	O
myelopathy	B-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Microscopic	B-treatment
anterior	I-treatment
cervical	I-treatment
diskectomy	I-treatment
at	I-treatment
C5-6	I-treatment
and	O
fusion	B-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
63-year-old	O
female	O
with	O
a	O
three-year	O
history	O
of	O
bilateral	B-problem
hand	I-problem
numbness	I-problem
and	O
occasional	B-problem
weakness	I-problem
.	O

Within	O
the	O
past	O
year	O
,	O
these	B-problem
symptoms	I-problem
have	O
progressively	O
gotten	O
worse	O
,	O
to	O
encompass	O
also	O
her	O
feet	O
.	O

She	O
had	O
a	B-test
workup	I-test
by	O
her	O
neurologist	O
and	O
an	B-test
MRI	I-test
revealed	O
a	B-problem
C5-6	I-problem
disc	I-problem
herniation	I-problem
with	O
cord	B-problem
compression	I-problem
and	O
a	B-problem
T2	I-problem
signal	I-problem
change	I-problem
at	O
that	O
level	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
for	O
hypertension	B-problem
,	O
hyperlipidemia	B-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Lipitor	B-treatment
,	O
Flexeril	B-treatment
,	O
hydrochlorothiazide	B-treatment
and	O
Norvasc	B-treatment
.	O

ALLERGIES	O
:	O

She	O
has	O
no	O
known	B-problem
drug	I-problem
allergy	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

She	O
smokes	O
one	O
pack	O
per	O
day	O
x45	O
years	O
.	O

She	O
occasionally	O
drinks	O
alcohol	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

She	O
had	O
5/5	O
strength	O
in	O
bilateral	O
upper	O
and	O
lower	O
extremities	O
.	O

She	O
had	O
a	B-test
Hoffman	I-test
&apos;s	I-test
sign	I-test
greater	O
on	O
the	O
right	O
than	O
the	O
left	O
and	O
she	O
had	O
10	B-problem
beats	I-problem
of	I-problem
clonus	I-problem
in	O
the	O
right	O
foot	O
and	O
3-5	B-problem
beats	I-problem
in	I-problem
the	I-problem
left	I-problem
foot	I-problem
.	O

She	O
had	O
hyperreflexia	B-problem
in	O
both	O
the	O
bilateral	O
upper	O
and	O
lower	O
extremities	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
tolerated	O
a	B-treatment
C5-6	I-treatment
ACDF	I-treatment
by	O
Dr.	O
Miezetri	O
Gach	O
quite	O
well	O
.	O

She	O
had	O
a	B-test
postoperative	I-test
CT	I-test
scan	I-test
that	O
revealed	O
partial	B-problem
decompression	I-problem
of	I-problem
the	I-problem
spinal	I-problem
canal	I-problem
and	O
good	O
placement	O
of	O
her	B-treatment
hardware	I-treatment
.	O

Immediately	O
postop	O
,	O
her	B-test
exam	I-test
only	O
improved	O
slightly	O
in	O
her	B-problem
hyperreflexia	I-problem
.	O

She	O
was	O
ambulating	O
by	O
postoperative	O
day	O
number	O
two	O
.	O

She	O
tolerated	O
a	O
regular	O
diet	O
.	O

Her	B-problem
pain	I-problem
was	O
under	O
good	O
control	O
with	O
PO	B-treatment
pain	I-treatment
medications	I-treatment
and	O
she	O
was	O
deemed	O
suitable	O
for	O
discharge	O
.	O

DISCHARGE	O
ORDERS	O
:	O

The	O
patient	O
was	O
asked	O
to	O
call	O
Dr.	O
Miezetri	O
Gach	O
&apos;s	O
office	O
for	O
a	O
follow-up	O
appointment	O
and	O
wound	B-test
check	I-test
.	O

She	O
is	O
asked	O
to	O
call	O
with	O
any	O
fevers	B-problem
,	O
chills	B-problem
,	O
increasing	B-problem
weakness	I-problem
or	O
numbness	B-problem
or	O
any	O
bowel	B-problem
and	I-problem
bladder	I-problem
disruption	I-problem
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

She	O
was	O
discharged	O
on	O
the	O
following	O
medications	O
.	O

1.	O
Colace	B-treatment
,	O
100	O
mg	O
PO	O
bid	O
.	O

2.	O
Zantac	B-treatment
,	O
150	O
mg	O
PO	O
bid	O
.	O

3.	O
Percocet	B-treatment
,	O
5/325	O
,	O
1-2	O
tabs	O
PO	O
q4-6h	O
prn	O
pain	B-problem
.	O

4.	O
Lipitor	B-treatment
,	O
10	O
mg	O
PO	O
daily	O
.	O

5.	O
Hydrochlorothiazide	B-treatment
,	O
25	O
mg	O
PO	O
daily	O
.	O

6.	O
Norvasc	B-treatment
,	O
5	O
mg	O
PO	O
daily	O
.	O

LALIND	O
KOTE	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

Electronically	O
Signed	O
MIEZETRI	O
NIMIRY	O
POP	O
,	O
M.D.	O
08/01/2005	O
18:50	O

_____________________________	O
MIEZETRI	O
NIMIRY	O
POP	O
,	O
M.D.	O

TR	O
:	O

qg	O

DD	O
:	O

07/30/2005	O

TD	O
:	O

07/31/2005	O
9:43	O
A	O
123524	O

cc	O
:	O

MIEZETRI	O
NIMIRY	O
POP	O
,	O
M.D.	O

026350193	O
RWH	O

7093319	O

549304	O

8417371	O

6/5/2002	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

AASCOLESLENT	O
,	O
DIROD	O

MRN	O
:	O

7093319	O

Age	O
:	O

50y	O

REGISTRATION	O
DATE	O
:	O

06/05/2002	O
02:46	O
PM	O

Provider	O
:	O

RYBAM	O
SHOULDER	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O
MD	O
:	O

Left	O
message	O
with	O
answering	O
service	O
or	O
PCP	O
office	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Date	O
/	O
Time	O
:	O

06/05/2002	O
16:17	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

L	B-problem
SHOULDER	I-problem
INJ	I-problem

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
neck	B-problem
strains	I-problem
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

Left	B-problem
Shoulder	I-problem
/	I-problem
Neck	I-problem
strain	I-problem
/	I-problem
sprain	I-problem
.	O

Treatment	O
Rendered	O
:	O

Dilaudid	B-treatment
2mg	O
PO	O
x	O
1	O
Flexeril	B-treatment
10	O
mg	O
x	O
1	O

Discharge	O
Medications	O
:	O

Flexeril	B-treatment
10mg	O
TID	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Please	O
follow-up	O
with	O
your	O
Orthopaedic	O
physician	O
on	O
Wednesday	O
6/9/02	O
as	O
previously	O
arranged	O
by	O
patient	O
.	O

Please	O
follow-up	O
with	O
PCP	O
.	O

Take	O
codeine	B-treatment
prescribed	O
by	O
PCP	O
with	O
food	O
and	O
water	O
to	O
prevent	O
nausea	B-problem
and	O
constipation	B-problem
.	O

Do	O
not	O
drive	O
if	O
taking	O
flexeril	B-treatment
and	O
codeine	B-treatment
.	O

PCP	O
Name	O
:	O

DOUET	O
,	O
LAH	O

Provider	O
Number	O
:	O

19061	O

This	O
report	O
was	O
created	O
by	O
SHOULDER	O
,	O
RYBAM	O
06/05/2002	O
04:26	O
PM	O

037945397	O
RWH	O

2690633	O

194867	O

151887	O

10/17/2001	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

FYFEVAIA	O
,	O
LORERINDIL	O

MRN	O
:	O

2690633	O

Age	O
:	O

77y	O

REGISTRATION	O
DATE	O
:	O

10/17/2001	O
01:36	O
PM	O

Provider	O
:	O

CH	O
KOTEKOLL	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O

MD	O
:	O

Yes	O
-	O
Direct	O
contact	O
with	O
PCP	O

Benefits	O
Assigned	O
:	O

N	O

Discharge	O
Date	O
/	O
Time	O
:	O

10/17/2001	O
16:28	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

NEAR	B-problem
SYNCOPE	I-problem
Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
dizziness	B-problem
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

near	B-problem
syncope	I-problem
,	O
dehydration	B-problem
vs	O
cardiogenic	B-problem

Treatment	O
Rendered	O
:	O

IVF	B-treatment
,	O
cbc	B-test
(	O
hct	B-test
36	O
)	O
,	O
normal	O
chem	O
7	O
,	O
negative	O
cardiac	O
enzymes	O
,	O
negative	O
stool	O
guaiac	O
,	O
normal	O
CXR	O

Discharge	O
Medications	O
:	O

none	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Patient	O
will	O
follow-up	O
with	O
his	O
PCP	O
,	O
Dr.	O
Foutchner	O
,	O
on	O
Monday	O
.	O

Dr.	O
Foutchner	O
will	O
arrange	O
for	O
an	B-test
outpatient	I-test
Holter	I-test
monitor	I-test
.	O

The	O
patient	O
is	O
to	O
return	O
to	O
the	O
ED	O
for	O
recurrent	B-problem
dizziness	I-problem
,	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
or	O
weakness	B-problem
.	O

PCP	O
Name	O
:	O

SUMCHIRDKAYSMAVVEINDREPS	O
,	O
YERTREY	O

Provider	O
Number	O
:	O

12298	O

This	O
report	O
was	O
created	O
by	O
KOTEKOLL	O
,	O
CH	O
10/17/2001	O
07:08	O
PM	O

044687343	O
ELMVH	O

01719921	O

1626859	O

3/13/2006	O
12:00:00	O
AM	O

COPD	B-problem
flare	I-problem

DIS	O

Admission	O
Date	O
:	O

03/13/2006	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

03/19/2006	O

******	O
FINAL	O
DISCHARGE	O
ORDERS	O
******	O

FREIERMLINKENEIGHCAABLINFARST	O
,	O
ANEA	O

770-09-54-2	O
O32	O

Room	O
:	O

39K-128	O

Service	O
:	O

MED	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

03/19/06	O
AT	O
01:00	O
PM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

ALBFYFEAYLES	O
,	O
LORRE	O
EZO	O
,	O
M.D.	O

CODE	O
STATUS	O
:	O

Full	O
code	O

DISPOSITION	O
:	O

Villeflardsbroo	O
Ands	O
Tho	O
Cardhako	O
General	O
Hospital	O

DISCHARGE	O
MEDICATIONS	O
:	O

ACETYLSALICYLIC	B-treatment
ACID	I-treatment
81	O
MG	O
PO	O
DAILY	O
ALBUTEROL	B-treatment
NEBULIZER	I-treatment
2.5	O
MG	O
NEB	O
Q4H	O
Starting	O
Today	O
(	O
03/17	O
)	O
PRN	O
Shortness	B-problem
of	I-problem
Breath	I-problem
LISINOPRIL	B-treatment
10	O
MG	O
PO	O
DAILY	O
NIFEREX-150	B-treatment
150	O
MG	O
PO	O
BID	O
PREDNISONE	B-treatment
Taper	I-treatment
PO	I-treatment
Give	O
50	O
mg	O
q	O
24	O
h	O
X	O
1	O
dose	O
(	O
s	O
)	O
,	O
then	O
Give	O
40	O
mg	O
q	O
24	O
h	O
X	O
1	O
dose	O
(	O
s	O
)	O
,	O
then	O
Give	O
30	O
mg	O
q	O
24	O
h	O
X	O
1	O
dose	O
(	O
s	O
)	O
,	O
then	O
Give	O
20	O
mg	O
q	O
24	O
h	O
X	O
1	O
dose	O
(	O
s	O
)	O
,	O
then	O
Give	O
10	O
mg	O
q	O
24	O
h	O
X	O
1	O
dose	O
(	O
s	O
)	O
,	O
then	O
Starting	O
Today	O
(	O
03/17	O
)	O
CLARITIN	B-treatment
(	I-treatment
LORATADINE	I-treatment
)	I-treatment
10	O
MG	O
PO	O
DAILY	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Avoid	O
grapefruit	O
unless	O
MD	O
instructs	O
otherwise	O
.	O

Give	O
on	O
an	O
empty	O
stomach	O
(	O
give	O
1hr	O
before	O
or	O
2hr	O
after	O
food	O
)	O
SINGULAIR	B-treatment
(	I-treatment
MONTELUKAST	I-treatment
)	I-treatment
10	O
MG	O
PO	O
BEDTIME	O
ADVAIR	B-treatment
DISKUS	I-treatment
500/50	I-treatment
(	I-treatment
FLUTICASONE	I-treatment
PROPIONATE/...	I-treatment
)	I-treatment
1	O
PUFF	O
INH	O
BID	O
CALTRATE	B-treatment
+	I-treatment
D	I-treatment
1	O
TAB	O
PO	O
BID	O
LANTUS	B-treatment
(	I-treatment
INSULIN	I-treatment
GLARGINE	I-treatment
)	I-treatment
35	O
UNITS	O
SC	O
QAM	O
DUONEB	B-treatment
(	I-treatment
ALBUTEROL	I-treatment
AND	I-treatment
IPRATROPIUM	I-treatment
NEBULIZER	I-treatment
)	I-treatment
3/0.5	O
MG	O
NEB	O
Q6H	O
Starting	O
Today	O
(	O
03/17	O
)	O
PRN	O
Shortness	B-problem
of	I-problem
Breath	I-problem
,	O
Wheezing	B-problem
NOVOLOG	B-treatment
(	I-treatment
INSULIN	I-treatment
ASPART	I-treatment
)	I-treatment
4	O
UNITS	O
SC	O
AC	O

Instructions	O
:	O

standing	B-treatment
pre-meal	I-treatment
novolog	I-treatment
.	O

give	O
when	O
patient	O
will	O
eat	O
and	O
food	O
is	O
in	O
the	O
room	O
.	O

NOVOLOG	B-treatment
(	I-treatment
INSULIN	I-treatment
ASPART	I-treatment
)	I-treatment
Sliding	O
Scale	O
(	O
subcutaneously	O
)	O
SC	O
AC	O

Instructions	O
:	O

pre-meal	O
correction	O
dose	O
.	O

give	O
in	O
addition	O
to	O
standing	B-treatment
pre-meal	I-treatment
novolog	I-treatment
when	O
patient	O
will	O
eat	O
and	O
food	O
is	O
in	O
the	O
room	O
.	O

If	O
BS	B-test
is	O
less	O
than	O
125	O
,	O
then	O
give	O
0	O
units	O
subcutaneously	O
If	O
BS	B-test
is	O
125-150	O
,	O
then	O
give	O
2	O
units	O
subcutaneously	O
If	O
BS	B-test
is	O
151-200	O
,	O
then	O
give	O
3	O
units	O
subcutaneously	O
If	O
BS	B-test
is	O
201-250	O
,	O
then	O
give	O
4	O
units	O
subcutaneously	O
If	O
BS	B-test
is	O
251-300	O
,	O
then	O
give	O
6	O
units	O
subcutaneously	O
If	O
BS	B-test
is	O
301-350	O
,	O
then	O
give	O
8	O
units	O
subcutaneously	O
If	O
BS	B-test
is	O
351-400	O
,	O
then	O
give	O
10	O
units	O
subcutaneously	O
and	O
call	O
HO	O
Call	O
HO	O
if	O
BS	B-test
is	O
greater	O
than	O
400	O
PROTONIX	B-treatment
(	I-treatment
PANTOPRAZOLE	I-treatment
)	I-treatment
40	O
MG	O
PO	O
DAILY	O
COMBIVENT	B-treatment
(	I-treatment
IPRATROPIUM	I-treatment
AND	I-treatment
ALBUTEROL	I-treatment
SULFATE	I-treatment
)	I-treatment
2	O
PUFF	O
INH	O
QID	O
FOSAMAX	B-treatment
(	I-treatment
ALENDRONATE	I-treatment
)	I-treatment
70	O
MG	O
PO	O
QWEEK	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Give	O
on	O
an	O
empty	O
stomach	O
(	O
give	O
1hr	O
before	O
or	O
2hr	O
after	O
food	O
)	O

Take	O
with	O
8	O
oz	O
of	O
plain	O
water	O
SPIRIVA	B-treatment
(	I-treatment
TIOTROPIUM	I-treatment
)	I-treatment
18	O

MCG	O
INH	O
DAILY	O
DIET	O
:	O

House	O
/	O
Low	O
chol	O
/	O
low	O
sat.	O
fat	O

DIET	O
:	O

House	O
/	O
ADA	O
1800	O
cals	O
/	O
dy	O

ACTIVITY	O
:	O

walk	O
with	O
assist	O
per	O
PT	B-test
eval	I-test

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Dr	O
Zuknocegrend	O
PCP	O
4/24	O
130	O
,	O

Dr.	O
Pump	O
3/25/05	O
1:30	O
,	O

ALLERGY	O
:	O

NKA	O
ADMIT	O
DIAGNOSIS	O
:	O

COPD	B-problem
flare	I-problem

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
COPD	B-problem
flare	I-problem

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O

COPD	B-problem
(	I-problem
chronic	I-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
)	I-problem
DM	B-problem
cervical	B-problem
DJD	I-problem
(	O
)	O
iron	B-problem
deficiency	I-problem
anemia	I-problem
(	I-problem
iron	I-problem
deficiency	I-problem
anemia	I-problem
)	I-problem
cervical	B-problem
and	I-problem
lumbar	I-problem
djd	I-problem
(	O
12	O
)	O
osa	B-problem
(	I-problem
sleep	I-problem
apnea	I-problem
)	I-problem
s	O
/	O
p	O
tb	B-treatment
treatment	I-treatment
(	O
5	O
)	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

na	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

CC	O
:	O

weakness	B-problem

HPI	O
:	O

75	O
y	O
/	O
o	O
F	O
with	O
DM	B-problem
,	O
COPD	B-problem
on	O
2L	B-treatment
NC	I-treatment
and	O
Bipap	B-treatment
at	O
night	O
p	O
/	O
w	O
generalized	B-problem
weakness	I-problem
and	O
fatigue	B-problem
,	O
urinary	B-problem
incontinence	I-problem
and	O
shaking	B-problem
as	O
well	O
as	O
increased	B-problem
sputum	I-problem
production	I-problem
.	O

Per	O
daughter	O
these	B-problem
symptoms	I-problem
are	O
typical	O
of	O
COPD	B-problem
flare	I-problem
.	O

ROS	O
otherwise	O
negative	O
.	O

Admission	O
Status	O
:	O

ED	O
:	O

REc&apos;d	O
duonebs	B-treatment
,	O
solumedrol	B-treatment
125	O

Vitals	O
:	O

t97.5	O
,	O
hr	B-test
117	O
,	O
bp156/81	O
,	O
rr28	O
,	O
o2	B-test
sats	I-test
87%	O
RA	O
;	O
95%	O
4L	O

Exam	O
:	O

NAD	B-problem
,	O
pleasant	O
,	O
speaking	O
in	O
complete	O
sentences	O
,	O
poor	B-problem
air	I-problem
movement	I-problem
bilaterally	I-problem
,	O
L	O
&gt;	O
R	O
,	O
no	O
wheezes	B-problem
or	O
rales	B-problem
,	O
rrr	O
,	O
distant	O
,	O
abd	O
benign	O
,	O
no	O
edema	B-problem
,	O
alert	O
and	O
oriented	O
times	O
three	O
,	O
no	O
focal	B-problem
deficits	I-problem
,	O
conversant	O
Studies	O
:	O

-	O
EKG	B-test
sinus	O
92	O
,	O
no	O
ST	B-problem
changes	I-problem

-	O
CXR	B-test
no	O
focal	B-problem
consolidation	I-problem
or	O
edema	B-problem
,	O
old	B-problem
biapical	I-problem
scarring	I-problem
ABG	B-test
7.34/79/74	O
U	B-test
/	I-test
A	I-test
negative	O

Daily	O
Status	O
:	O

improving	O
,	O
but	O
still	B-problem
poor	I-problem
air	I-problem
movement	I-problem
,	O
diffusely	B-problem
wheezy	I-problem
on	O
exam	B-test
,	O
at	O
baseline	O
2L	B-treatment
o2	I-treatment
requirement	I-treatment

A	O
/	O
P	O
:	O

75	O
y	O
/	O
o	O
F	O
with	O
h	O
/	O
o	O
COPD	B-problem
c	O
/	O
b	O
frequent	B-problem
exacerbations	I-problem
p	O
/	O
w	O
typical	B-problem
flare	I-problem
symptoms	I-problem
.	O

Problem	O
List	O
:	O

CV	O
-	O
Ischemia	B-problem
ASA	B-treatment
,	O
lisinopril	B-treatment
Pump	I-treatment
no	O
evidence	O
of	O
failure	B-problem

Rhythm	O
Resp	O
-	O
COPD	B-problem

flare	B-problem
-	O
steroids	B-treatment
,	O
cont	O
prednisone	B-treatment
60	O
,	O
taper	O
slowly	O
as	O
tolerated	O
,	O
duonebs	B-treatment
,	O
advair	B-treatment
,	O
singulair	B-treatment
,	O
spiriva	B-treatment
,	O
claritin	B-treatment
azithromycin	B-treatment
for	O
atypical	B-problem
bronchitis	I-problem
to	O
complete	O
a	O
5	O
day	O
course	O
,	O
keep	O
o2	B-test
sat	I-test
90-94	O
,	O
home	B-treatment
nocturnal	I-treatment
CPAP	I-treatment
not	O
tolerated	O
in	O
house	O
,	O
does	O
well	O
on	O
nc	B-treatment
,	O
appears	O
ato	O
be	O
at	O
baseline	O

Renal	O
-	O

Cr	B-test
0.8	O
,	O
stress	B-problem
incontinence	I-problem
by	O
symptoms	B-problem
with	O
increased	B-problem
cough	I-problem
,	O
no	O
evidence	O
of	O
uti	B-problem
,	O
cont	O
to	O
closely	O
monitor	O

GI	O
-	O
Bowel	B-treatment
regimen	I-treatment

Heme	O
-	O
Chronic	B-problem
Fe	I-problem
deficiency	I-problem
anemia	I-problem
,	O
cont	O
iron	B-treatment

Endo	O
-	O
DM	B-problem
on	O
insulin	B-treatment
with	O
steroids	B-treatment

ID	O
-	O
afebrile	B-problem
,	O
no	O
wbc	B-test
,	O
started	O
on	O
Azithromycin	B-treatment
for	O
COPD	B-problem
flare	I-problem

FEN	O
-	O
ADA	O
diet	O

PPx	O
-	O
Lovenox	B-treatment
,	O
PPI	B-treatment

Dispo	O
-	O
to	O
rehab	O
when	O
resp	B-problem
status	I-problem
improved	O
,	O
PT	O
consulted	O

Code	O
-	O
FC	O

ADDITIONAL	O
COMMENTS	O
:	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

f	O
/	O
u	O
with	O
PCP	O
and	O
Dr.	O
Pump	O
as	O
scheduled	O
,	O
return	O
to	O
ED	O
with	O
worsening	B-problem
sob	I-problem
or	O
increased	B-problem
cough	I-problem
or	O
sputum	B-problem
production	I-problem

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

TIKWELD	O
,	O
WILLAIDE	O
V.	O
,	O
M.D.	O
(	O
QT296	O
)	O
03/19/06	O
10:53	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

060376519	O
DH	O

0649031	O

323495	O

3838556	O

4/5/2003	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

SELCFARST	O
,	O
NAORLY	O

MRN	O
:	O

0649031	O

Age	O
:	O

49y	O

REGISTRATION	O
DATE	O
:	O

04/05/2003	O
11:47	O
AM	O

Provider	O
:	O

STIEGE	O
,	O
M.D.	O
TLANDJESC	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O
MD	O
:	O

E-mail	O
PCP	O

Discharge	O
Date	O
/	O
Time	O
:	O

04/05/2003	O
22:06	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

DIZZINESS	B-problem

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
dizziness	B-problem
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

Benign	B-problem
positional	I-problem
vertigo	I-problem
vs	O
labyrinthitis	B-problem

Treatment	O
Rendered	O
:	O

Head	B-test
CT	I-test
negative	O
.	O

Discharge	O
Medications	O
:	O

Meclizine	B-treatment
25	O
mg	O
po	O
bid	O
.	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Return	O
to	O
ED	O
or	O
call	O
PCP	O
if	O
symptoms	B-problem
worsen	O
or	O
if	O
fever	B-problem
with	O
headache	B-problem
.	O

Pt	O
d	O
/	O
c&apos;d	O
home	O
in	O
stable	O
condition	O
.	O

PCP	O
Name	O
:	O

GUYNLORDSMANTDOUET	O
,	O
RYLA	O
B	O

Provider	O
Number	O
:	O

26596	O

This	O
report	O
was	O
created	O
by	O
TLANDJESC	O
,	O
IECELANE	O
,	O
M.D.	O
04/05/2003	O
10:09	O
PM	O

095889687	O
WGH	O

9786774	O

224527	O

311732	O

10/24/2001	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

SOURS	O
,	O
NANONIFF	O
ELLMI	O

MRN	O
:	O

9786774	O

Age	O
:	O

31y	O

REGISTRATION	O
DATE	O
:	O

10/24/2001	O
07:57	O
AM	O

Provider	O
:	O

LICHEREANYVE	O
CHIRDKOTEKERTH	O

PRELIMINARY	O
REPORT	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Date	O
/	O
Time	O
:	O

10/24/2001	O
10:07	O

Discharge	O
Status	O
:	O

Discharged	O
Condition	O
on	O
Discharge	O
:	O

Stable	O
Patient	O
States	O
Complaint	O
:	O

SWOLLEN	B-problem
PAINFUL	I-problem
L	I-problem
SIDE	I-problem
FC	I-problem

Diagnosis	O
:	O

L	B-problem
upper	I-problem
lip	I-problem
/	I-problem
L	I-problem
nostril	I-problem
abscess	I-problem

Treatment	O
Rendered	O
:	O

5	O
cc	O
of	O
purulent	B-problem
material	I-problem
drained	O
by	O
needle	B-treatment
aspiration	I-treatment

Discharge	O
Medications	O
:	O

Augmentin	B-treatment
875	O
mg	O
twice	O
a	O
day	O
for	O
10	O
days	O
.	O

Follow	O
up	O
Service	O
:	O

Please	O
see	O
your	O
PCP	O
in	O
follow	O
up	O
.	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Return	O
immediately	O
for	O
worsening	O
signs	O
of	O
infection	B-problem
(	O
increased	B-problem
swelling	I-problem
,	O
pain	B-problem
,	O
redness	B-problem
)	O
or	O
for	O
any	B-problem
neurologic	I-problem
changes	I-problem
(	O
blurry	B-problem
or	I-problem
double	I-problem
vision	I-problem
,	O
headaches	B-problem
,	O
trouble	B-problem
walking	I-problem
,	O
etc	O
)	O
.	O

PCP	O
Name	O
:	O

CLEV	O
,	O
NISHA	O

Provider	O
Number	O
:	O

53476	O

This	O
report	O
was	O
created	O
by	O
CHIRDKOTEKERTH	O
,	O
LICHEREANYVE	O
10/24/2001	O
10:09	O
AM	O

101407944	O
PUMC	O

3925529	O

441763	O

2345939	O

4/30/2005	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

CAUGH	O
,	O
DI	O
K	O

UNIT	O
NUMBER	O
:	O

569-82-26	O

ADMISSION	O
DATE	O
:	O

04/30/2005	O

DISCHARGE	O
DATE	O
:	O

5/14/05	O
05/14/2005	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Right	B-problem
parietal	I-problem
occipital	I-problem
temporal	I-problem
tumor	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

5/5/05	O
right	B-treatment
parietal	I-treatment
occipital	I-treatment
craniotomy	I-treatment
and	O
debulking	B-treatment
of	I-treatment
tumor	I-treatment
using	O
stulz	B-treatment
neuro	I-treatment
navigation	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
pleasant	O
83-year-old	O
retired	O
psychiatrist	O
who	O
presents	O
with	O
a	O
chief	O
complaint	O
of	O
gait	B-problem
difficulty	I-problem
for	O
the	O
last	O
five	O
to	O
six	O
months	O
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
laryngeal	B-problem
cancer	I-problem
in	O
2000	O
and	O
2001	O
,	O
CVA	B-problem
in	O
2001	O
to	O
2002	O
and	O
hypertension	B-problem
,	O
who	O
has	O
a	O
six	O
month	O
history	O
of	O
progressive	B-problem
difficulty	I-problem
in	I-problem
ambulation	I-problem
.	O

The	O
patient	O
was	O
in	O
previously	O
good	O
health	O
when	O
he	O
reports	O
starting	O
to	O
notice	O
problems	B-problem
ambulating	I-problem
about	O
six	O
months	O
ago	O
.	O

His	O
partner	O
also	O
reports	O
that	O
he	O
has	O
been	O
having	O
more	B-problem
difficulty	I-problem
with	I-problem
ADLs	I-problem
.	O

He	O
reported	O
that	O
he	O
began	O
with	O
difficulty	B-problem
buttoning	I-problem
his	I-problem
shirt	I-problem
for	O
many	O
years	O
since	O
after	O
a	B-problem
stroke	I-problem
but	O
now	O
reports	O
that	O
on	O
occasion	O
she	O
would	O
ask	O
him	O
why	O
he	O
was	O
doing	O
certain	O
things	O
and	O
he	O
could	O
not	O
give	O
a	O
concrete	O
example	O
.	O

The	O
patient	O
was	O
having	O
a	B-problem
hard	I-problem
time	I-problem
walking	I-problem
and	O
reports	O
that	O
he	O
has	O
felt	O
weaker	O
.	O

He	O
has	O
had	O
uncoordination	B-problem
of	I-problem
his	I-problem
feet	I-problem
and	O
began	O
having	O
a	B-treatment
cane	I-treatment
four	O
to	O
five	O
months	O
ago	O
with	O
the	B-problem
increasing	I-problem
weakness	I-problem
.	O

This	O
was	O
especially	O
bad	O
when	O
trying	O
to	O
arise	O
.	O

The	O
patient	O
has	O
seen	O
his	O
primary	O
care	O
physician	O
who	O
referred	O
him	O
to	O
physical	O
therapy	O
for	O
his	B-problem
gait	I-problem
weakness	I-problem
but	O
his	B-problem
symptoms	I-problem
failed	O
to	O
improve	O
.	O

He	O
continued	O
to	O
progress	O
until	O
two	O
weeks	O
prior	O
to	O
admission	O
when	O
he	O
was	O
found	O
in	O
the	O
bathtub	O
,	O
unsteady	B-problem
and	O
fell	O
trying	O
to	O
steady	O
himself	O
.	O

The	O
patient	O
could	O
not	O
be	O
moved	O
and	O
had	O
to	O
have	O
911	O
called	O
for	O
help	O
.	O

Since	O
that	O
time	O
he	O
had	O
been	O
ambulating	O
with	O
a	B-treatment
walker	I-treatment
and	O
has	O
had	O
increasing	B-problem
difficulty	I-problem
with	I-problem
falls	I-problem
in	O
the	O
last	O
two	O
weeks	O
.	O

The	O
patient	O
was	O
again	O
seen	O
by	O
his	O
primary	O
care	O
physician	O
and	O
a	B-test
CG	I-test
scan	I-test
revealed	O
a	B-problem
mass	I-problem
in	I-problem
the	I-problem
right	I-problem
parietal	I-problem
lobe	I-problem
.	O

The	O
patient	O
was	O
referred	O
to	O
the	O
Neurology	O
Service	O
for	O
further	B-test
workup	I-test
of	O
the	B-problem
mass	I-problem
.	O

The	O
patient	O
denied	O
blurry	B-problem
vision	I-problem
,	O
headache	B-problem
,	O
nausea	B-problem
,	O
vomiting	B-problem
,	O
paresthesias	B-problem
,	O
pain	B-problem
in	I-problem
mental	I-problem
status	I-problem
,	O
confusion	B-problem
or	O
seizures	B-problem
.	O

The	O
patient	O
is	O
status	O
post	O
radiation	B-treatment
therapy	I-treatment
and	O
resection	B-treatment
and	O
reconstruction	B-treatment
for	O
his	B-problem
laryngeal	I-problem
cancer	I-problem
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Positive	B-problem
weakness	I-problem
,	O
otherwise	O
negative	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Hypertension	B-problem
,	O
CVA	B-problem
2001	O
,	O
2002	O
diabetes	B-problem
,	O
laryngeal	B-problem
cancer	I-problem
,	O
right	B-treatment
CEA	I-treatment
,	O
prostatectomy	B-treatment
for	O
BPH	B-problem
,	O
total	B-treatment
knee	I-treatment
replacement	I-treatment
,	O
status	O
post	O
appendectomy	B-treatment
.	O

MEDICATIONS	O
PRIOR	O
TO	O
ADMISSION	O
:	O

Plavix	B-treatment
75	O
mg	O
every	O
day	O
,	O
Lipitor	B-treatment
40	O
mg	O
every	O
day	O
,	O
HCTZ	B-treatment
50	O
mg	O
,	O
Monopril	B-treatment
10	O
mg	O
every	O
day	O
,	O
Viagra	B-treatment
100	O
mg	O
prn	O
.	O

ALLERGIES	O
:	O

NKDA	B-problem
.	O

FAMILY	O
HISTORY	O
:	O

Father	O
with	O
CAD	B-problem
at	O
90	O
,	O
diabetes	B-problem
,	O
CVA	B-problem
,	O
hypercholesterolemia	B-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
has	O
one	O
to	O
two	O
pack	O
x20	O
year	O
history	O
of	O
smoking	O
that	O
was	O
30	O
years	O
ago	O
.	O

He	O
reports	O
occasional	O
alcohol	O
use	O
and	O
no	O
illicits	O
.	O

The	O
patient	O
is	O
a	O
retired	O
psychiatrist	O
who	O
lives	O
in	O
Ph	O
.	O

PHYSICAL	O
EXAM	O
:	O

Afebrile	B-problem
,	O
vital	B-test
signs	I-test
stable	O
but	O
notable	O
for	O
a	B-test
blood	I-test
pressure	I-test
of	O
164/80	O
.	O

Generally	O
a	O
well	O
developed	O
elderly	O
man	O
in	O
no	O
apparent	B-problem
distress	I-problem
sitting	O
in	O
bed	O
.	O

HEENT	O
;	O

extraocular	O
movements	O
intact	O
.	O

Pupils	O
equally	O
round	O
and	O
reactive	O
to	O
light	O
.	O

No	O
nystagmus	B-problem
.	O

No	O
retinal	B-problem
hemorrhages	I-problem
.	O

External	O
ears	O
normal	O
.	O

Moist	O
buccal	O
mucosa	O
,	O
poor	B-problem
dentition	I-problem
,	O
no	O
erythema	B-problem
or	I-problem
exudates	I-problem
in	I-problem
the	I-problem
posterior	I-problem
pharynx	I-problem
.	O

Neck	O
supple	O
.	O

Prominent	B-problem
salivary	I-problem
glands	I-problem
bilaterally	I-problem
.	O

No	O
other	B-problem
masses	I-problem
or	O
thyromegaly	B-problem
noted	O
.	O

No	O
cervical	B-problem
,	I-problem
para-auricular	I-problem
or	I-problem
clavicular	I-problem
lymphadenopathy	I-problem
.	O

Chest	O
:	O

Crackles	B-problem
in	I-problem
the	I-problem
right	I-problem
lung	I-problem
field	I-problem
.	O

No	O
egophony	B-problem
.	O

Heart	O
:	O

no	O
palpable	B-problem
thrill	I-problem
or	O
heave	B-problem
.	O

S1	O
,	O
S2	O
.	O

3/6	B-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
heard	O
best	O
at	O
the	O
apex	O
.	O

Pulses	O
2+	O
carotids	O
bilaterally	O
,	O
2+	O
radial	O
pulses	O
,	O
2+	O
DP	O
pulses	O
bilaterally	O
.	O

The	O
abdomen	O
was	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
,	O
positive	O
bowel	O
sounds	O
.	O

No	O
hepato	B-problem
or	O
splenomegaly	B-problem
.	O

Right	B-problem
lower	I-problem
quadrant	I-problem
scar	I-problem
and	O
inferior	B-problem
midline	I-problem
scar	I-problem
that	O
are	O
well	O
healed	O
.	O

Back	O
:	O

No	O
CVA	B-problem
tenderness	I-problem
.	O

Skin	O
:	O

No	O
petechiae	B-problem
.	O

Cranial	O
nerves	O
II	O
through	O
XII	O
grossly	O
intact	O
with	O
a	B-problem
slight	I-problem
deviation	I-problem
of	I-problem
the	I-problem
uvula	I-problem
and	I-problem
tongue	I-problem
to	O
the	O
right	O
.	O

There	O
is	O
increased	B-problem
tone	I-problem
in	I-problem
his	I-problem
right	I-problem
upper	I-problem
extremity	I-problem
with	O
a	B-problem
slight	I-problem
left	I-problem
pronator	I-problem
drift	I-problem
.	O

On	O
the	O
right	O
side	O
his	O
strength	O
was	O
5	O
out	O
5	O
.	O

On	O
the	O
left	O
side	O
it	O
is	O
4	O
out	O
of	O
5	O
in	O
the	O
lower	O
extremities	O
.	O

The	O
patient	O
has	O
an	B-problem
intention	I-problem
tremor	I-problem
with	I-problem
the	I-problem
left	I-problem
hand	I-problem
.	O

His	O
reflexes	O
were	O
symmetric	O
with	O
upgoing	O
toes	O
.	O

There	O
was	O
a	O
plantar	O
grasp	O
present	O
on	O
the	O
left	O
hand	O
.	O

Graphesthesia	O
was	O
poor	O
in	O
both	O
hands	O
.	O

His	O
gait	O
was	O
unsteady	O
and	O
he	O
was	O
unable	O
to	O
stand	O
on	O
his	O
own	O
.	O

Mental	O
status	O
:	O

he	O
was	O
alert	O
and	O
oriented	O
x3	O
.	O

RELEVANT	O
LABORATORY	O
DATA	O
:	O

White	B-test
blood	I-test
cell	I-test
count	I-test
on	O
admission	O
6.1	O
,	O
INR	B-test
on	O
admission	O
1.0	O
,	O
relevant	B-test
imaging	I-test
.	O

Echocardiogram	B-test
June	O
2004	O
showed	O
an	B-test
EF	I-test
of	O
77%	O
.	O

Chest	B-test
xray	I-test
reveals	O
no	O
consolidation	B-problem
or	O
signs	B-problem
of	I-problem
edema	I-problem
.	O

CT	B-test
shows	O
a	B-problem
right	I-problem
parietal	I-problem
hyperdense	I-problem
and	I-problem
heterogenously	I-problem
enhancing	I-problem
mass	I-problem
measuring	O
6.5	O
x	O
5	O
cm	O
with	O
the	B-problem
surrounding	I-problem
vasogenic	I-problem
edema	I-problem
in	O
effacement	O
of	O
the	O
right	O
lateral	O
ventricle	O
.	O

The	O
finding	O
was	O
most	O
consistent	O
with	O
metastatic	B-problem
disease	I-problem
and	O
less	O
likely	O
primary	B-problem
CNS	I-problem
neoplasm	I-problem
such	O
as	O
glioblastoma	B-problem
.	O

MRI	B-test
showed	O
a	B-problem
large	I-problem
heterogenous	I-problem
enhancing	I-problem
right	I-problem
parietal	I-problem
mass	I-problem
lesion	I-problem
with	O
a	O
possible	O
ependymal	B-problem
spread	I-problem
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Neurologic	O
Service	O
for	O
workup	B-test
of	O
his	B-problem
tumor	I-problem
.	O

The	O
neuro-oncologist	O
felt	O
that	O
because	O
of	O
the	B-problem
tremendous	I-problem
tumor	I-problem
burden	I-problem
that	O
was	O
likely	O
causing	O
his	B-problem
symptoms	I-problem
the	O
patient	O
will	O
require	O
open	B-treatment
debulking	I-treatment
as	O
well	O
as	O
obtaining	O
issue	O
for	O
a	B-test
pathologic	I-test
diagnosis	I-test
.	O

Thea	O
patient	O
was	O
referred	O
to	O
Dr.	O
Coma	O
of	O
the	O
Eragnes	O
Houseco	O
Ardbay	O
Memorial	O
Hospital	O
.	O

On	O
May	O
5	O
,	O
2005	O
the	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
for	O
a	B-treatment
right	I-treatment
parietal	I-treatment
occipital	I-treatment
craniotomy	I-treatment
and	O
debulking	B-treatment
of	O
the	B-problem
tumor	I-problem
using	O
stulz	B-treatment
neuro	I-treatment
navigation	I-treatment
.	O

Please	O
see	O
the	O
separately	O
dictated	O
operative	O
report	O
for	O
further	O
details	O
of	O
the	B-treatment
procedure	I-treatment
.	O

The	O
patient	O
was	O
taken	O
to	O
the	O
recovery	O
room	O
and	O
then	O
to	O
the	O
postoperative	O
floor	O
in	O
stable	O
condition	O
.	O

Of	O
note	O
the	O
patient	O
was	O
seen	O
by	O
cardiology	O
for	O
preoperative	B-test
assessment	I-test
.	O

The	O
patient	O
was	O
also	O
seen	O
by	O
physical	O
and	O
occupational	O
therapy	O
during	O
his	O
postoperative	O
course	O
and	O
they	O
recommended	O
that	O
he	O
go	O
to	O
a	O
rehabilitation	O
facility	O
for	O
his	O
recovery	O
.	O

A	B-test
postoperative	I-test
MRI	I-test
was	O
obtained	O
which	O
revealed	O
no	O
remarkable	B-problem
findings	I-problem
but	O
only	O
post	B-problem
surgical	I-problem
changes	I-problem
.	O

Transcranial	B-test
Dopplers	I-test
were	O
checked	O
following	O
surgery	B-treatment
and	O
the	O
patient	O
was	O
started	O
on	O
Decadron	B-treatment
4	O
mg	O
q6	O
to	O
prevent	O
swelling	B-problem
.	O

The	O
patient	O
was	O
started	O
on	O
Fragmin	B-treatment
for	O
DVT	B-treatment
prophylaxis	I-treatment
and	O
the	O
patient	O
was	O
also	O
started	O
on	O
Dilantin	B-test
levels	I-test
.	O

Of	O
note	O
on	O
5/9/05	O
the	O
patient	O
was	O
seen	O
by	O
Urology	O
due	O
to	O
an	B-problem
inability	I-problem
to	I-problem
void	I-problem
and	O
a	B-treatment
16	I-treatment
French	I-treatment
Coude	I-treatment
catheter	I-treatment
was	O
placed	O
.	O

The	O
patient	O
then	O
was	O
given	O
voiding	B-treatment
trials	I-treatment
but	O
eventually	O
he	O
needed	O
to	O
be	O
straight	O
cathed	O
prn	O
.	O

At	O
the	O
time	O
of	O
transfer	O
,	O
a	B-treatment
16	I-treatment
Coude	I-treatment
catheter	I-treatment
was	O
in	O
place	O
and	O
draining	O
well	O
.	O

The	O
patient	O
can	O
have	O
voiding	B-treatment
trials	I-treatment
at	O
rehab	O
and	O
he	O
is	O
being	O
maintained	O
on	O
Flomax	B-treatment
.	O

The	O
patient	O
had	O
a	O
relatively	O
unremarkable	O
course	O
and	O
his	O
neurologic	O
status	O
continued	O
to	O
improve	O
following	O
the	B-treatment
operation	I-treatment
.	O

At	O
the	O
time	O
of	O
discharge	O
the	O
patient	O
was	O
alert	O
and	O
oriented	O
x3	O
and	O
able	O
to	O
swallow	O
pureed	O
and	O
thick	O
diet	O
without	O
a	O
problem	O
.	O

On	O
5/11/05	O
repeat	B-test
imaging	I-test
revealed	O
some	B-problem
edema	I-problem
and	O
mass	B-problem
affect	I-problem
.	O

The	O
patient	O
was	O
given	O
an	B-treatment
IV	I-treatment
load	I-treatment
of	I-treatment
Decadron	I-treatment
and	O
restarted	O
on	O
IV	B-treatment
Decadron	I-treatment
which	O
was	O
eventually	O
transferred	O
to	O
po	B-treatment
Decadron	I-treatment
.	O

The	O
patient	O
was	O
also	O
started	O
on	O
Mannitol	B-treatment
.	O

His	B-test
pathology	I-test
came	O
back	O
as	O
a	B-problem
large	I-problem
grade	I-problem
IV	I-problem
glioma	I-problem
.	O

The	B-problem
patient	I-problem
&apos;s	I-problem
pain	I-problem
was	O
initially	O
controlled	O
with	O
IV	B-treatment
pain	I-treatment
medications	I-treatment
but	O
at	O
the	O
time	O
of	O
discharge	O
to	O
the	O
rehab	O
facility	O
he	O
was	O
able	O
to	O
control	O
his	B-problem
pain	I-problem
on	O
po	B-treatment
pain	I-treatment
medications	I-treatment
.	O

The	O
patient	O
did	O
have	O
a	B-test
postoperative	I-test
serum	I-test
sodium	I-test
in	O
the	O
120s	O
from	O
the	O
130s	O
three	O
days	O
postoperatively	O
.	O

An	O
endocrine	O
consult	O
was	O
obtained	O
to	O
help	O
manage	O
his	B-test
serum	I-test
electrolytes	I-test
.	O

The	O
patient	O
was	O
started	O
on	O
three	O
grams	O
of	O
sodium	B-treatment
,	O
3x	O
a	O
day	O
with	O
fluid	B-treatment
restriction	I-treatment
.	O

Over	O
the	O
next	O
several	O
days	O
his	B-test
sodium	I-test
levels	I-test
were	O
followed	O
and	O
by	O
5/12/05	O
his	B-test
plasma	I-test
sodium	I-test
was	O
back	O
to	O
136	O
.	O

The	O
patient	O
was	O
taken	O
off	O
fluid	B-treatment
restriction	I-treatment
.	O

On	O
5/14/05	O
Mannitol	B-treatment
was	O
tapered	O
and	O
then	O
d	O
/	O
c&apos;d.	O

At	O
the	O
time	O
of	O
transfer	O
the	O
patient	O
was	O
stable	O
and	O
needed	O
only	O
physical	B-treatment
and	I-treatment
occupational	I-treatment
therapy	I-treatment
.	O

The	O
patient	O
was	O
oriented	O
to	O
person	O
,	O
place	O
and	O
time	O
and	O
opened	O
eyes	O
appropriately	O
to	O
speech	O
when	O
asked	O
.	O

The	O
patient	O
is	O
hard	B-problem
of	I-problem
hearing	I-problem
.	O

The	O
patient	O
had	O
no	O
complaints	B-problem
of	I-problem
pain	I-problem
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Lipitor	B-treatment
40	O
mg	O
po	O
every	O
day	O
.	O

2.	O
Captopril	B-treatment
12.5	O
mg	O
po	O
tid	O
.	O

3.	O
Nexium	B-treatment
40	O
mg	O
po	O
every	O
day	O
.	O

4.	O
Colace	B-treatment
100	O
mg	O
po	O
bid	O
.	O

5.	O
Ativan	B-treatment
0.5	O
mg	O
po	O
q4	O
hours	O
prn	O
for	O
anxiety	B-problem
.	O

6.	O
Allegra	B-treatment
60	O
mg	O
po	O
bid	O
.	O

7.	O
Dilantin	B-treatment
100	O
mg	O
IV	O
tid	O
which	O
can	O
be	O
changed	O
to	O
a	B-treatment
po	I-treatment
regimen	I-treatment
in	O
seven	O
days	O
.	O

8.	O
Zinc	B-treatment
220	O
mg	O
po	O
every	O
day	O
.	O

9.	O
Vitamin	B-treatment
C	I-treatment
500	O
mg	O
po	O
bid	O
.	O

10.	O
Flomax	B-treatment
0.4	O
mg	O
po	O
every	O
day	O
.	O

11.	O
Fragmin	B-treatment
2500	O
units	O
subcut	O
every	O
day	O
.	O

12.	O
Levofloxacin	B-treatment
500	O
mg	O
po	O
q	O
daily	O
x10	O
days	O
.	O

13.	O
Dexamethasone	B-treatment
4	O
mg	O
po	O
q6	O
hours	O
.	O

14.	O
The	B-treatment
steroid	I-treatment
will	O
be	O
kept	O
for	O
now	O
and	O
tapered	O
at	O
a	O
later	O
date	O
on	O
follow	O
up	O
with	O
Dr.	O
Coma	O
.	O

15.	O
Regular	B-treatment
insulin	I-treatment
sliding	I-treatment
scale	I-treatment
with	O
finger	O
sticks	O
qac	O
and	O
qhs	O
.	O

16.	O
Neutra-Phos	B-treatment
1.25	O
grams	O
po	O
as	O
needed	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

The	O
patient	O
is	O
instructed	O
to	O
not	O
shower	O
or	O
bath	O
until	O
one	O
week	O
.	O

The	B-treatment
staples	I-treatment
were	O
removed	O
prior	O
to	O
discharge	O
.	O

The	O
patient	O
is	O
instructed	O
not	O
to	O
drive	O
.	O

The	O
patient	O
is	O
asked	O
to	O
see	O
a	O
physician	O
immediately	O
or	O
go	O
to	O
the	O
nearest	O
emergency	O
room	O
if	O
any	B-problem
bleeding	I-problem
,	O
wound	B-problem
infection	I-problem
,	O
fever	B-problem
greater	O
than	O
100.8	O
,	O
intractable	B-problem
nausea	I-problem
and	I-problem
vomiting	I-problem
,	O
headache	B-problem
,	O
dizziness	B-problem
,	O
numbness	B-problem
,	O
pain	B-problem
or	O
weakness	B-problem
occurs	O
.	O

The	O
patient	O
instructed	O
to	O
call	O
Dr.	O
Coma	O
&apos;s	O
office	O
at	O
496-260-3297	O
to	O
arrange	O
for	O
a	O
follow	O
up	O
appointment	O
in	O
the	O
Saintaelfoote	O
Hospital	O
at	O
the	O
first	O
available	O
time	O
,	O
one	O
to	O
two	O
months	O
after	O
surgery	B-treatment
.	O

The	O
patient	O
is	O
also	O
asked	O
to	O
call	O
the	O
Neuro	O
/	O
Oncology	O
Service	O
,	O
the	O
office	O
of	O
Dr.	O
Britts	O
at	O
430-884-2917	O
for	O
a	O
follow	O
up	O
appointment	O
in	O
three	O
weeks	O
.	O

The	O
patient	O
is	O
asked	O
to	O
take	O
a	O
course	O
of	O
Dilantin	B-treatment
for	O
ten	O
more	O
days	O
.	O

The	O
patient	O
is	O
instructed	O
not	O
to	O
undergo	O
any	O
heavy	O
lifting	O
until	O
seen	O
in	O
clinic	O
.	O

HOPETAMEMY	O
K.	O
THOREDUHEDREPS	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

Electronically	O
Signed	O
ERIN	O
KENGEKOTE	O
,	O
M.D.	O

05/14/2005	O
16:02	O

_____________________________	O
ERIN	O
KENGEKOTE	O
,	O
M.D.	O

TR	O
:	O

wy	O

DD	O
:	O

05/14/2005	O

TD	O
:	O

05/14/2005	O
1:10	O
P	O
441763	O

cc	O
:	O

ERIN	O
KENGEKOTE	O
,	O
M.D.	O

105732749	O

FIH	O

7017973	O

715894	O

55714	O

9/10/1999	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

STERPKOTENEISH	O
,	O
LYDELL	O
A	O

UNIT	O
NUMBER	O
:	O

712-67-96	O

ADMISSION	O
DATE	O
:	O

09/10/1999	O

DISCHARGE	O
DATE	O
:	O

09/14/1999	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Pancreatic	B-problem
carcinoma	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Laparoscopy	B-test
with	O
biopsy	B-test
for	O
diagnosis	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Ms.	O
Sterpkoteneish	O
is	O
a	O
69-year-old	O
woman	O
,	O
who	O
over	O
the	O
past	O
six	O
months	O
has	O
noted	O
increasing	B-problem
pain	I-problem
in	I-problem
her	I-problem
left	I-problem
upper	I-problem
quadrant	I-problem
radiating	O
to	O
the	O
back	O
.	O

She	O
described	O
the	B-problem
pain	I-problem
as	O
being	O
exacerbated	O
by	O
eating	O
and	O
described	O
an	B-problem
associated	I-problem
weight	I-problem
loss	I-problem
.	O

She	O
presented	O
to	O
her	O
primary	O
care	O
physician	O
,	O
Dr.	O
Tlandtaze	O
,	O
in	O
Aersing	O
Rocuch	O
Sun	O
,	O
who	O
obtained	O
a	B-test
CT	I-test
scan	I-test
,	O
which	O
demonstrated	O
a	B-problem
mass	I-problem
in	O
the	O
tail	O
of	O
the	O
pancreas	O
.	O

She	O
was	O
then	O
referred	O
to	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
under	O
the	O
El	O
Memorial	O
and	O
was	O
seen	O
by	O
Dr.	O
Blinjesc	O
,	O
who	O
scheduled	O
her	O
for	O
an	B-test
exploratory	I-test
laparoscopy	I-test
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Is	O
significant	O
for	O
spinal	B-problem
stenosis	I-problem
and	O
a	O
series	O
of	O
operations	B-treatment
including	O
repair	B-treatment
of	O
a	B-problem
ureteral	I-problem
stricture	I-problem
;	O
cataract	B-treatment
implants	I-treatment
;	O
two	B-treatment
partial	I-treatment
hysterectomies	I-treatment
;	O
and	O
an	B-treatment
appendectomy	I-treatment
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Oxycontin	B-treatment
10	O
mg	O
PO	O
q.day	O
.	O

Darvocet	B-treatment
.	O

Estratab	B-treatment
.	O

Aspirin	B-treatment
325	O
mg	O
PO	O
q.day	O
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	B-test
blood	I-test
pressure	I-test
was	O
150/86	O
;	O
pulse	B-test
82	O
;	O
respirations	B-test
16	O
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Heart	O
:	O

regular	O
S1	O
and	O
S2	O
;	O
no	O
murmurs	B-problem
.	O

Abdomen	O
:	O

soft	O
;	O
nontender	O
;	O
no	O
palpable	B-problem
masses	I-problem
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
was	O
admitted	O
through	O
same	O
day	O
surgery	O
and	O
taken	O
to	O
the	O
operating	O
room	O
where	O
Dr.	O
Blinjesc	O
,	O
assisted	O
by	O
Dr.	O
Zockbeathe	O
,	O
performed	O
a	B-test
diagnostic	I-test
laparoscopy	I-test
with	O
peritoneal	B-treatment
washings	I-treatment
.	O

Findings	O
included	O
no	B-problem
gross	I-problem
evidence	I-problem
seating	I-problem
in	I-problem
the	I-problem
abdominal	I-problem
wall	I-problem
;	O
one	B-problem
nodule	I-problem
on	O
the	O
posterior	O
surface	O
of	O
the	O
right	O
lobe	O
of	O
the	O
liver	O
;	O
one	B-problem
nodule	I-problem
in	O
the	O
inferior	O
edge	O
of	O
the	O
falciform	O
ligament	O
.	O

Specimens	B-test
sent	O
to	O
pathology	O
included	O
peritoneal	B-test
washings	I-test
and	O
permanent	B-test
specimens	I-test
from	I-test
the	I-test
liver	I-test
and	O
falciform	B-problem
nodules	I-problem
.	O

There	O
were	O
no	O
complications	B-problem
,	O
and	O
the	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
.	O

Postoperatively	O
,	O
the	O
patient	O
had	O
some	B-problem
abdominal	I-problem
bloating	I-problem
with	O
evidence	O
of	O
subcutaneous	B-problem
emphysema	I-problem
over	I-problem
the	I-problem
abdomen	I-problem
.	O

She	O
was	O
uncomfortable	B-problem
and	O
slow	O
to	O
have	O
bowel	O
movements	O
,	O
although	O
she	O
did	O
have	O
flatus	O
.	O

She	O
tolerated	O
a	O
full	O
diet	O
well	O
,	O
but	O
continued	O
to	O
have	O
abdominal	B-problem
cramping	I-problem
and	O
a	B-problem
mild	I-problem
ileus	I-problem
for	O
the	O
following	O
three	O
days	O
.	O

She	O
was	O
treated	O
with	O
repeated	B-treatment
Fleet	I-treatment
&apos;s	I-treatment
enemas	I-treatment
,	O
and	O
on	O
postoperative	O
day	O
three	O
,	O
she	O
had	O
a	O
number	O
of	O
bowel	O
movements	O
,	O
was	O
considerably	O
more	O
comfortable	O
,	O
and	O
deemed	O
ready	O
for	O
discharge	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Was	O
excellent	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Included	O
aspirin	B-treatment
325	O
mg	O
PO	O
q.day	O
.	O

Percocet	B-treatment
one	O
to	O
two	O
whenever	O
necessary	O
q.	O
four	O
to	O
six	O
hours	O
for	O
pain	B-problem
.	O

Estratab	B-treatment
one	O
PO	O
q.day	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
cytopathology	B-test
specimens	I-test
had	O
been	O
negative	O
,	O
and	O
surgical	B-test
pathology	I-test
specimens	I-test
were	O
still	O
pending	O
.	O

She	O
was	O
instructed	O
to	O
call	O
Dr.	O
Blinjesc	O
for	O
the	O
results	O
of	O
these	B-test
tests	I-test
and	O
to	O
follow	O
up	O
with	O
him	O
for	O
further	O
management	O
if	O
necessary	O
.	O

STA	O
BODEJOVE	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

______________________________	O
LONSHI	O
OCK	O
,	O
M.D.	O

TR	O
:	O

hjr	O

DD	O
:	O

09/14/1999	O

TD	O
:	O

09/17/1999	O
2:26	O
P	O

cc	O
:	O

LONSHI	O
OCK	O
,	O
M.D.	O

cc	O
:	O

Telshey	O
K.	O
Swatlleebtik	O
,	O
M.D.	O
Rinime	O
Hawnspantkote	O
Arkansas	O

115026438	O
SC	O

23754357	O

049885	O

8/25/2002	O
12:00:00	O
AM	O

s	O
/	O
p	O
NSVD	O

DIS	O

Admission	O
Date	O
:	O

08/25/2002	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

08/27/2002	O

******	O
DISCHARGE	O
ORDERS	O
******	O

HEMPWIERST	O
,	O
E	O

904-74-17-7	O
Z57	O

Room	O
:	O

FXP2-288	O

Service	O
:	O

OBS	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

08/27/02	O
AT	O
10:00	O
AM	O

CONTINGENT	O
UPON	O

HO	B-test
evaluation	I-test

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

BAWNREEF	O
,	O
CENTEKANEELD	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

DOCUSATE	B-treatment
SODIUM	I-treatment
100	O
MG	O
PO	O
BID	O
PRN	O
IBUPROFEN	B-treatment
200-600	O
MG	O
PO	O
Q4-6H	O
PRN	O
PAIN	B-problem

DIET	O
:	O

No	O
Restrictions	O

Activity	O
-	O
As	O
tolerated	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

OB	O
Clinic	O
2	O
weeks	O
and	O
6	O
weeks	O
,	O
No	O
Known	B-problem
Allergies	I-problem

ADMIT	O
DIAGNOSIS	O
:	O

postdates	B-problem
pregnancy	I-problem

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
s	O
/	O
p	O
NSVD	B-problem

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O

none	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

Primary	O
Anesthesia	O
:	O

Epidural	O
Secondary	O
Anesthesia	O
:	O

Local	O
Vaginal	O
delivery	O
:	O

Spontaneous	O
Episiotomy	O
:	O

Median	O
Placenta	O
:	O

Delivery	O
:	O

Manual	O
Condition	O
:	O

Normal	O
Delivering	O
Resident	O
/	O
Staff	O
:	O

GOINGNETHBUMPS	O
,	O
NANSO	O
R.	O
,	O
M.D.	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

G2	O
T0	O
P0	O
A1	O
L0	O
Estimated	O
EDC	O
:	O

02/03/02	O

Indications	O
for	O
induction	O
:	O

Post	B-problem
dates	I-problem

Maternal	O
transfer	O
:	O

No	O

Initial	B-test
newborn	I-test
exam	I-test
:	O

No	O
observed	B-problem
abnormalities	I-problem

Baby	O
1	O

MRN	O
:	O

70632019	O

Delivery	O
date	O
:	O

02/13/02	O
01:20	O
AM	O

Apgars	B-test
8,9	O

Weight	B-test
:	O

9lb	O
4	O
oz	O
4196	O
grams	O

Sex	O
:	O

Female	O

ADDITIONAL	O
COMMENTS	O
:	O

Nothing	O
in	O
the	O
vagina	O
for	O
6	O
weeks	O
-	O
no	O
tampons	B-treatment
,	O
no	O
douching	B-treatment
,	O
no	O
intercourse	O
.	O

If	O
you	O
experience	O
fever	B-problem
&gt;	O
100.4	O
,	O
bleeding	B-problem
&gt;	O
1	O
pad	O
/	O
hour	O
,	O
foul	B-problem
smelling	I-problem
discharge	I-problem
,	O
abdominal	B-problem
pain	I-problem
,	O
or	O
other	B-problem
worrisome	I-problem
symptoms	I-problem
,	O
please	O
call	O
your	O
doctor	O
or	O
return	O
to	O
the	O
hospital	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

GOINGNETHBUMPS	O
,	O
NANSO	O
R.	O
,	O
M.D.	O
(	O
HK18	O
)	O
02/14/02	O
08:39	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

130959255	O

FIH	O

1431063	O

10119/hy66	O

738478	O

6/15/1994	O
12:00:00	O
AM	O

RIGHT	B-problem
OCCIPITAL	I-problem
HEMORRHAGIC	I-problem
STROKE	I-problem
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

6-15-94	O

DISCHARGE	O
DATE	O
:	O

6-26-94	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Right	B-problem
occipital	I-problem
hemorrhagic	I-problem
stroke	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Ms.	O
Tlandkotesmitskote	O
is	O
a	O
patient	O
who	O
came	O
complaining	O
of	O
feeling	O
dizzy	B-problem
and	O
bumping	O
into	O
objects	O
on	O
her	O
left	O
side	O
.	O

She	O
is	O
a	O
seventy-one	O
year	O
old	O
female	O
with	O
a	O
history	O
of	O
hypertension	B-problem
who	O
is	O
in	O
otherwise	O
good	O
health	O
.	O

This	O
morning	O
while	O
on	O
a	O
cruise	O
ship	O
,	O
she	O
was	O
eating	O
breakfast	O
when	O
she	O
suddenly	O
noticed	O
she	O
could	O
not	O
see	O
a	O
roll	O
on	O
her	O
plate	O
although	O
she	O
knew	O
that	O
it	O
was	O
there	O
.	O

She	O
also	O
felt	O
dizzy	B-problem
and	O
the	O
room	O
was	O
spinning	O
.	O

While	O
walking	O
,	O
she	O
kept	O
bumping	O
into	O
object	O
on	O
her	O
left	O
side	O
.	O

She	O
also	O
complained	O
of	O
a	B-problem
dull	I-problem
,	I-problem
right	I-problem
sided	I-problem
headache	I-problem
over	I-problem
the	I-problem
right	I-problem
eyebrow	I-problem
.	O

Symptoms	B-problem
lasted	O
about	O
five	O
hours	O
and	O
then	O
gradually	O
resolved	O
except	O
for	O
the	B-problem
change	I-problem
in	I-problem
vision	I-problem
.	O

She	O
denied	O
having	O
any	O
weakness	B-problem
,	O
numbness	B-problem
,	O
or	O
pain	B-problem
.	O

She	O
also	O
denies	O
having	O
hoarseness	B-problem
,	O
difficulties	B-problem
in	I-problem
finding	I-problem
words	I-problem
,	O
speaking	O
,	O
hiccups	B-problem
,	O
or	O
diplopia	B-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

The	O
past	O
medical	O
history	O
is	O
significant	O
for	O
hypertension	B-problem
.	O

The	O
past	O
surgical	O
history	O
is	O
negative	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Atenolol	B-treatment
,	O
25	O
mg	O
PO	O
qd	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
has	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

On	O
review	O
of	O
systems	O
,	O
the	O
patient	O
denied	O
any	O
history	O
of	O
transient	B-problem
ischemic	I-problem
attacks	I-problem
.	O

FAMILY	O
HISTORY	O
:	O

Father	O
and	O
mother	O
died	O
in	O
their	O
eighties	O
of	O
heart	B-problem
disease	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
denied	O
using	O
tobacco	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
physical	B-test
examination	I-test
,	O
she	O
was	O
a	O
very	O
pleasant	O
,	O
moderately	O
obese	O
female	O
in	O
no	O
apparent	B-problem
distress	I-problem
.	O

She	O
was	O
afebrile	B-problem
and	O
her	B-test
vital	I-test
signs	I-test
were	O
stable	O
.	O

The	O
head	O
was	O
normocephalic	O
and	O
atraumatic	B-problem
.	O

The	O
pupils	O
were	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
.	O

The	O
tympanic	O
membranes	O
were	O
gray	O
.	O

The	O
fundi	O
were	O
sharp	O
.	O

The	O
neck	O
was	O
supple	O
with	O
full	O
range	O
of	O
movement	O
.	O

The	O
lungs	O
were	O
clear	O
to	O
auscultation	B-test
bilaterally	O
,	O
without	O
rales	B-problem
or	O
wheezes	B-problem
.	O

The	O
heart	O
had	O
a	O
recovery	O
regular	O
rate	O
and	O
rhythm	O
.	O

The	O
abdomen	O
was	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
.	O

Extremities	O
revealed	O
2+	B-problem
pitting	I-problem
edema	I-problem
in	I-problem
the	I-problem
knees	I-problem
bilaterally	I-problem
.	O

The	B-test
neurological	I-test
examination	I-test
revealed	O
that	O
the	O
patient	O
was	O
awake	O
,	O
alert	O
and	O
oriented	O
to	O
person	O
,	O
place	O
and	O
time	O
.	O

She	O
was	O
able	O
to	O
subtract	O
serial	O
sevens	O
,	O
remember	O
three	O
out	O
of	O
three	O
objects	O
after	O
five	O
minutes	O
,	O
and	O
there	O
was	O
notable	B-problem
aphasia	I-problem
or	O
word	B-problem
finding	I-problem
difficulty	I-problem
.	I-problem

The	O
cranial	O
nerves	O
showed	O
pupils	O
were	O
bilaterally	O
active	O
from	O
3	O
to	O
2	O
mm	O
.	O

There	O
was	O
a	B-problem
dense	I-problem
hemianopsia	I-problem
on	I-problem
the	I-problem
left	I-problem
side	I-problem
.	O

The	O
extra	O
ocular	O
muscles	O
were	O
intact	O
bilaterally	O
.	O

Corneals	O
were	O
present	O
bilaterally	O
.	O

Sensation	O
was	O
intact	O
to	O
light	B-test
touch	I-test
and	O
pin	B-test
prick	I-test
bilaterally	O
.	O

Face	O
was	O
symmetric	O
.	O

Eye	O
closing	O
was	O
tight	O
.	O

Hearing	O
was	O
intact	O
bilaterally	O
.	O

Palate	O
was	O
midline	O
.	O

Gag	O
was	O
intact	O
.	O

The	O
sternocleidomastoid	O
and	O
trapezius	O
had	O
good	O
strength	O
.	O

Tongue	O
was	O
midline	O
.	O

Strength	O
was	O
5/5	O
in	O
bilateral	O
upper	O
extremities	O
and	O
bilateral	O
lower	O
extremities	O
in	O
detail	O
.	O

There	O
was	O
no	O
pronator	B-problem
drift	I-problem
.	O

Sensation	O
was	O
intact	O
to	O
light	B-test
touch	I-test
,	O
pin	B-test
prick	I-test
,	O
and	O
proprioception	B-test
.	O

Cerebellar	B-test
examination	I-test
revealed	O
in	O
intention	B-problem
tremor	I-problem
on	I-problem
the	I-problem
right	I-problem
side	I-problem
.	O

The	O
patient	O
had	O
considerable	B-problem
difficulty	I-problem
with	I-problem
left	I-problem
finger-to-nose	I-problem
movement	I-problem
,	O
most	O
likely	O
secondary	O
to	O
hemianopsia	B-problem
.	O

There	O
was	O
no	O
nystagmus	B-problem
,	O
except	O
for	O
some	B-problem
fine	I-problem
fast	I-problem
beat	I-problem
nystagmus	I-problem
bilateral	I-problem
extremes	I-problem
of	I-problem
abduction	I-problem
.	O

Reflexes	O
were	O
symmetric	O
and	O
2+	O
bilaterally	O
at	O
the	O
biceps	O
tendon	O
,	O
2+	O
bilaterally	O
at	O
brachial	O
radialis	O
,	O
2+	O
bilaterally	O
at	O
the	O
patellar	O
tendon	O
,	O
1+	O
bilaterally	O
Achilles	O
tendon	O
.	O

The	O
toes	O
were	O
downgoing	O
bilaterally	O
.	O

Gait	O
:	O

patient	O
had	O
difficulty	B-problem
with	I-problem
tandem	I-problem
gait	I-problem
and	O
fell	O
forward	O
while	O
standing	O
on	O
his	O
his	O
toes	O
.	O

Otherwise	O
,	O
the	O
gait	O
was	O
normal	O
.	O

LABORATORY	O
DATA	O
:	O

Laboratory	O
studies	O
on	O
admission	O
demonstrated	O
a	B-test
sodium	I-test
of	O
144	O
,	O
potassium	B-test
4.1	O
,	O
chloride	B-test
106	O
,	O
bicarbonate	B-test
20.0	O
,	O
BUN	B-test
and	O
creatinine	B-test
12/0.7	O
,	O
glucose	B-test
99	O
,	O
white	B-test
blood	I-test
count	I-test
of	O
5.7	O
,	O
hematocrit	B-test
of	O
40.6	O
,	O
platelet	B-test
count	I-test
of	O
226	O
,	O
prothrombin	B-test
time	I-test
was	O
9.4	O
,	O
partial	B-test
thromboplastin	I-test
time	I-test
was	O
29	O
.	O

The	B-test
computerized	I-test
tomography	I-test
scan	I-test
was	O
performed	O
and	O
showed	O
a	B-problem
right	I-problem
occipital	I-problem
hemorrhage	I-problem
.	O

SUMMARY	O
:	O

The	O
patient	O
is	O
a	O
seventy-one	O
year	O
old	O
female	O
with	O
a	O
history	O
of	O
hypertension	B-problem
who	O
now	O
presents	O
with	O
a	B-problem
right	I-problem
occipital	I-problem
hemorrhagic	I-problem
stroke	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
hospital	O
for	O
further	B-test
evaluation	I-test
and	O
work	B-test
up	I-test
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Intermediate	O
Care	O
Unit	O
in	O
the	O
Neurology	O
Intensive	O
Care	O
Unit	O
.	O

However	O
,	O
she	O
was	O
soon	O
moved	O
out	O
of	O
there	O
as	O
her	B-test
examination	I-test
appeared	O
to	O
be	O
stable	O
.	O

A	O
Neurosurgery	O
Service	O
consultation	O
was	O
obtained	O
and	O
they	O
felt	O
that	O
no	O
surgical	B-treatment
intervention	I-treatment
was	O
required	O
.	O

The	O
patient	O
underwent	O
a	O
number	O
of	O
tests	B-test
.	O

She	O
had	O
a	B-test
magnetic	I-test
resonance	I-test
imaging	I-test
study	I-test
and	O
magnetic	B-test
resonance	I-test
imaging	I-test
angiogram	I-test
performed	O
which	O
showed	O
a	B-problem
large	I-problem
hemorrhagic	I-problem
lesion	I-problem
on	I-problem
the	I-problem
occipital	I-problem
lobe	I-problem
.	O

There	O
was	O
no	O
clear	B-problem
enhancing	I-problem
mass	I-problem
,	O
but	O
follow	O
up	O
was	O
suggested	O
.	O

So	O
an	B-test
magnetic	I-test
resonance	I-test
imaging	I-test
angiogram	I-test
was	O
obtained	O
and	O
showed	O
the	B-problem
right	I-problem
parietal	I-problem
occipital	I-problem
hemorrhage	I-problem
.	O

The	B-test
MRA	I-test
showed	O
mild	B-problem
narrowing	I-problem
of	I-problem
the	I-problem
left	I-problem
ICA	I-problem
just	O
distal	O
to	O
the	O
bifurcation	O
.	O

There	O
was	O
also	O
scattered	B-problem
T2	I-problem
hyperintense	I-problem
foci	I-problem
within	I-problem
the	I-problem
periventricular	I-problem
and	I-problem
left	I-problem
frontal	I-problem
white	I-problem
matter	I-problem
consistent	O
with	O
small	B-problem
vessel	I-problem
disease	I-problem
,	O
gliosis	B-problem
or	O
demyelination	B-problem
.	O

A	B-test
Holter	I-test
monitor	I-test
was	O
obtained	O
and	O
showed	O
that	O
the	O
patient	O
was	O
in	O
normal	O
sinus	O
rhythm	O
.	O

The	B-test
heart	I-test
rate	I-test
was	O
53	O
to	O
106	O
.	O

There	O
were	O
some	B-problem
very	I-problem
rare	I-problem
atrial	I-problem
premature	I-problem
contractions	I-problem
.	O

There	O
were	O
no	O
ventricular	B-problem
premature	I-problem
contractions	I-problem
.	O

An	B-test
echocardiogram	I-test
was	O
obtained	O
and	O
showed	O
that	O
the	B-test
ejection	I-test
fraction	I-test
was	O
60%	O
and	O
there	O
was	O
no	O
thrombus	B-problem
.	O

It	O
was	O
felt	O
to	O
be	O
within	O
normal	O
limits	O
.	O

Over	O
the	O
ensuing	O
days	O
,	O
the	O
patient	O
had	O
several	O
episodes	O
of	O
confusion	B-problem
at	O
night	O
.	O

However	O
,	O
these	O
gradually	O
resolved	O
.	O

She	O
also	O
developed	O
what	O
appeared	O
to	O
be	O
urinary	B-problem
tract	I-problem
infection	I-problem
and	O
was	O
placed	O
on	O
PO	B-treatment
Bactrim	I-treatment
.	O

By	O
6-26-94	O
,	O
the	O
patient	O
was	O
felt	O
to	O
be	O
ready	O
for	O
discharge	O
.	O

At	O
that	O
time	O
,	O
she	O
was	O
afebrile	B-problem
and	O
her	B-test
vital	I-test
signs	I-test
were	O
stable	O
.	O

She	O
was	O
tolerating	O
a	O
regular	O
diet	O
.	O

She	O
was	O
awake	O
,	O
alert	O
and	O
oriented	O
to	O
person	O
,	O
place	O
,	O
and	O
time	O
.	O

She	O
continued	O
to	O
have	O
a	B-problem
dense	I-problem
left	I-problem
hemianopsia	I-problem
,	O
but	O
otherwise	O
was	O
neurologically	O
intact	O
.	O

The	O
patient	O
was	O
discharged	O
home	O
with	O
Santea	O
Gehawhi	O
General	O
Hospital	O
care	O
and	O
instructed	O
to	O
follow	O
up	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

The	O
patient	O
was	O
discharged	O
on	O
Tenormin	B-treatment
,	O
25	O
mg	O
PO	O
qd	O
;	O
Bactrim	B-treatment
DS	I-treatment
,	O
one	O
PO	O
bid	O
x5	O
days	O
.	O

TATAJO	O
SEE	O
,	O
M.D.	O

TR	O
:	O

ba	O
/	O
bmot	O

DD	O
:	O

8-4-94	O

TD	O
:	O

08/06/94	O

CC	O
:	O

134300717	O

FIH	O

9099750	O

22777/5p0t	O

355178	O

2/23/1993	O
12:00:00	O
AM	O

DEEP	B-problem
VENOUS	I-problem
THROMBOSIS	I-problem
OF	I-problem
RIGHT	I-problem
LOWER	I-problem
EXTREMITY	I-problem
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

2-23-93	O

DISCHARGE	O
DATE	O
:	O

2-24-93	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Deep	B-problem
venous	I-problem
thrombosis	I-problem
of	I-problem
right	I-problem
lower	I-problem
extremity	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Metastatic	B-problem
melanoma	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
the	O
second	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
admission	O
for	O
Taroby	O
Patient	O
,	O
a	O
70	O
year	O
old	O
male	O
with	O
a	O
history	O
of	O
metastatic	B-problem
melanoma	I-problem
.	O

His	B-problem
melanoma	I-problem
was	O
originally	O
diagnosed	O
last	O
fall	O
when	O
he	O
presented	O
with	O
lesions	B-problem
in	I-problem
the	I-problem
liver	I-problem
and	I-problem
spleen	I-problem
,	O
and	O
a	B-test
chest	I-test
CT	I-test
showed	O
left	B-problem
upper	I-problem
lobe	I-problem
nodules	I-problem
.	O

A	B-test
head	I-test
CT	I-test
scan	I-test
was	O
negative	O
,	O
but	O
an	B-test
MRI	I-test
scan	I-test
of	I-test
the	I-test
spine	I-test
showed	O
an	O
L5	B-problem
metastasis	I-problem
with	O
a	B-problem
fracture	I-problem
and	O
had	O
with	O
epidural	B-problem
and	I-problem
paraspinal	I-problem
extension	I-problem
.	O

In	O
addition	O
,	O
there	O
was	O
a	B-problem
T11	I-problem
metastasis	I-problem
with	O
cord	B-problem
compression	I-problem
.	O

Approximately	O
one	O
week	O
ago	O
,	O
he	O
was	O
admitted	O
to	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
for	O
chemotherapy	B-treatment
with	O
DTIC	B-treatment
and	O
Tamoxifen	B-treatment
.	O

At	O
that	O
time	O
,	O
he	O
also	O
began	O
radiation	B-treatment
therapy	I-treatment
to	O
his	O
lumbosacral	O
spine	O
.	O

He	O
is	O
continuing	O
on	O
the	B-treatment
radiation	I-treatment
therapy	I-treatment
to	O
date	O
.	O

On	O
February	O
23	O
,	O
Mr.	O
Patient	O
presented	O
to	O
Dr.	O
Patient	O
&apos;s	O
office	O
with	O
two	B-problem
major	I-problem
symptoms	I-problem
.	O

First	O
,	O
he	O
had	O
right	B-problem
lower	I-problem
extremity	I-problem
swelling	I-problem
and	O
lower	B-test
extremity	I-test
noninvasives	I-test
confirmed	O
the	O
diagnosis	O
of	O
a	B-problem
femoral	I-problem
deep	I-problem
venous	I-problem
thrombosis	I-problem
.	O

Second	O
,	O
he	O
had	O
a	B-problem
witnessed	I-problem
episode	I-problem
in	O
which	O
his	O
eyes	O
rolled	O
to	O
the	O
back	O
of	O
his	O
head	O
and	O
there	O
was	O
a	O
question	O
of	O
some	B-problem
seizure	I-problem
activity	I-problem
.	O

In	O
the	O
past	O
,	O
he	O
has	O
not	O
been	O
known	O
to	O
have	O
a	O
history	O
of	O
CNS	B-problem
metastases	I-problem
.	O

The	O
episode	O
of	O
potential	B-problem
seizure	I-problem
activity	I-problem
occurred	O
in	O
the	O
setting	O
of	O
a	O
bowel	O
movement	O
and	O
may	O
have	O
been	O
associated	O
with	O
vasovagal	B-problem
activity	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

The	O
past	O
medical	O
history	O
is	O
as	O
above	O
.	O

FAMILY	O
HISTORY	O
:	O

Noncontributory	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

The	B-test
review	I-test
of	I-test
systems	I-test
is	O
negative	O
,	O
except	O
as	O
above	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
has	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	B-test
physical	I-test
examination	I-test
reveals	O
a	O
pleasant	O
70	O
year	O
old	O
male	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

The	B-test
blood	I-test
pressure	I-test
was	O
113/70	O
,	O
pulse	B-test
66	O
,	O
respirations	B-test
20	O
,	O
and	O
a	B-test
temperature	I-test
of	O
96.8	O
.	O

HEENT	B-test
showed	O
pupils	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
and	O
accommodation	O
,	O
and	O
extra	O
ocular	O
movements	O
intact	O
.	O

The	O
sclerae	O
were	O
anicteric	O
.	O

The	O
neck	O
was	O
supple	O
,	O
without	O
jugular	B-problem
venous	I-problem
distention	I-problem
or	O
increased	B-problem
thyroid	I-problem
.	O

Nodes	O
:	O

There	O
was	O
no	O
appreciable	B-problem
cervical	I-problem
,	I-problem
supraclavicular	I-problem
,	I-problem
axillary	I-problem
,	I-problem
or	I-problem
inguinal	I-problem
adenopathy	I-problem
.	O

The	O
chest	O
was	O
clear	O
to	O
auscultation	B-test
and	O
percussion	B-test
.	O

Cardiac	O
:	O

regular	O
rate	O
and	O
rhythm	O
,	O
with	O
a	B-problem
I	I-problem
/	I-problem
VI	I-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
.	O

The	O
abdomen	O
showed	O
a	O
10	O
cm	O
liver	O
with	O
the	O
edge	O
palpable	O
2	O
fingerbreadths	O
below	O
the	O
right	O
costal	O
margin	O
.	O

The	B-test
extremity	I-test
exam	I-test
was	O
notable	O
for	O
2+	B-problem
pitting	I-problem
edema	I-problem
in	I-problem
the	I-problem
right	I-problem
lower	I-problem
extremity	I-problem
extending	O
to	O
the	O
knee	O
.	O

The	B-test
neurological	I-test
examination	I-test
was	O
nonfocal	O
.	O

HOSPITAL	O
COURSE	O
:	O

Mr.	O
Patient	O
underwent	O
venogram	B-test
and	O
inferior	B-treatment
vena	I-treatment
cava	I-treatment
filter	I-treatment
placement	I-treatment
on	O
February	O
23	O
,	O
1993	O
and	O
was	O
then	O
he	O
was	O
admitted	O
to	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
for	O
postoperative	B-treatment
care	I-treatment
.	O

He	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
.	O

In	O
addition	O
,	O
the	O
second	O
major	O
event	O
that	O
had	O
occurred	O
yesterday	O
was	O
a	B-problem
neurologic	I-problem
event	I-problem
of	O
some	O
kind	O
.	O

Over	O
the	O
24	O
hours	O
of	O
in	O
house	O
hospitalization	O
,	O
he	O
did	O
not	O
have	O
any	B-problem
further	I-problem
neurologic	I-problem
activity	I-problem
and	O
was	O
able	O
to	O
ambulate	O
without	O
assistance	O
prior	O
to	O
discharge	O
.	O

He	O
will	O
be	O
scheduled	O
for	O
an	B-test
MRI	I-test
scan	I-test
,	O
Neurology	B-test
consult	I-test
,	O
and	O
an	B-test
EEG	I-test
next	O
week	O
as	O
an	O
out	O
patient	O
.	O

Mr.	O
Patient	O
was	O
a	O
poor	O
candidate	O
for	O
anticoagulation	B-treatment
because	O
of	O
his	O
history	O
of	O
metastatic	B-problem
melanoma	I-problem
and	O
the	O
question	O
of	O
CNS	B-problem
metastases	I-problem
.	O

An	B-treatment
IVC	I-treatment
filter	I-treatment
placement	I-treatment
was	O
accomplished	O
without	O
complication	B-problem
.	O

He	O
is	O
stable	O
on	O
February	O
24	O
and	O
ready	O
for	O
discharge	O
to	O
home	O
.	O

PROCEDURES	O
:	O

IVC	B-treatment
filter	I-treatment
placement	I-treatment
.	O

COMPLICATIONS	O
:	O

None	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Decadron	B-treatment
4	O
mg	O
PO	O
bid	O
,	O
Dilantin	B-treatment
100	O
mg	O
PO	O
tid	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DISPOSITION	O
:	O

Mr.	O
Patient	O
will	O
be	O
discharged	O
to	O
home	O
.	O

He	O
will	O
have	O
follow	O
up	O
arranged	O
with	O
Dr.	O
Guabenfranda	O
Patient	O
.	O

ESTIMATED	O
DISABILITY	O
AND	O
PROBABLE	O
DURATION	O
:	O

Permanent	O
.	O

CA	O
SHUFF	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

GUABENFRANDA	O
PATIENT	O
,	O
M.D.	O

TR	O
:	O

it	O
/	O
bmot	O

DD	O
:	O

2-24-93	O

TD	O
:	O

02/26/93	O

CC	O
:	O

143748600	O
SC	O

43243309	O

095342	O

09/30/2000	O
12:00:00	O
AM	O

atypical	B-problem
chest	I-problem
pain	I-problem

DIS	O

Admission	O
Date	O
:	O

09/30/2000	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

10/01/2000	O

******	O
DISCHARGE	O
ORDERS	O
******	O

FALC	O
,	O
COLL	O
891-57-52-0	O
T37	O

Room	O
:	O

53X-785	O

Service	O
:	O

CAR	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

10/01/00	O
AT	O
03:30	O
PM	O

CONTINGENT	O
UPON	O

ETT	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

KOTEZUSTLEEB	O
,	O
LIJO	O
LIFLE	O
,	O
M.D.	O

CODE	O
STATUS	O
:	O

Full	O
code	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

ALBUTEROL	B-treatment
INHALER	I-treatment
2	O
PUFF	O
INH	O
QID	O

Instructions	O
:	O

PLEASE	O
USE	O
WITH	O
SPACER	B-treatment
(	O
PLEASE	O
INSTRUCT	O
PATIENT	O
)	O
ECASA	B-treatment
(	I-treatment
ASPIRIN	I-treatment
ENTERIC	I-treatment
COATED	I-treatment
)	I-treatment
325	O
MG	O
PO	O
QD	O
WELLBUTRIN	B-treatment
(	I-treatment
BUPROPION	I-treatment
HCL	I-treatment
)	I-treatment
150	O
MG	O
PO	O
BID	O
GEMFIBROZIL	B-treatment
600	O
MG	O
PO	O
BID	O
ZESTRIL	B-treatment
(	I-treatment
LISINOPRIL	I-treatment
)	I-treatment
20	O
MG	O
PO	O
QD	O
ZANTAC	B-treatment
(	I-treatment
RANITIDINE	I-treatment
HCL	I-treatment
)	I-treatment
150	O
MG	O
PO	O
BID	O
SERZONE	B-treatment
(	I-treatment
NEFAZODONE	I-treatment
)	I-treatment
300	O
MG	O
PO	O
QHS	O
ZYPREXA	B-treatment
(	I-treatment
OLANZAPINE	I-treatment
)	I-treatment
5	O
MG	O
PO	O
QHS	O

Number	O
of	O
Doses	O
Required	O
(	O
approximate	O
)	O
:	O

4	O

GLUCOPHAGE	B-treatment
(	I-treatment
METFORMIN	I-treatment
)	I-treatment
850	O
MG	O
PO	O
TID	O
Starting	O
ON	O
10/03/00	O
(	O
10/03	O
)	O
ACTOS	B-treatment
30	O
MG	O
PO	O
QD	O

DIET	O
:	O

House	O
/	O
ADA	O
2100	O
cals	O
/	O
dy	O

RETURN	O
TO	O
WORK	O
:	O

Immediately	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Dr.	O
Rotrysbreunkorc	O
1-2	O
weeks	O
,	O

ALLERGY	O
:	O

Penicillins	B-treatment

ADMIT	O
DIAGNOSIS	O
:	O

atypical	B-problem
cp	I-problem

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O
Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
atypical	B-problem
chest	I-problem
pain	I-problem

OTHER	O
DIAGNOSIS	O
;	O
Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
dm	B-problem
(	I-problem
diabetes	I-problem
mellitus	I-problem
)	I-problem
anxiety	B-problem
(	I-problem
anxiety	I-problem
)	I-problem
htn	B-problem
(	I-problem
hypertension	I-problem
)	I-problem
gerd	B-problem
(	I-problem
esophageal	I-problem
reflux	I-problem
)	I-problem

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

41	O
yo	O
man	O
with	O
CRFs	B-problem
of	O
DM	B-problem
Type	I-problem
II	I-problem
,	O
high	B-problem
cholesterol	I-problem
,	O
smoking	O
history	O
,	O
family	O
hx	O
,	O
HTN	B-problem
p	O
/	O
w	O
episodes	B-problem
of	I-problem
atypical	I-problem
CP	I-problem
x	I-problem
1	I-problem
week	I-problem
,	O
with	O
rest	O
and	O
exertion	O
.	O

also	O
has	O
h	O
/	O
o	O
anxiety	B-problem
and	O
GERD	B-problem
.	O

No	O
assoicated	B-problem
Sx	I-problem
.	O

Here	O
,	O
had	O
T	B-problem
wave	I-problem
flattening	I-problem
laterally	I-problem
and	I-problem
inferiorly	I-problem
with	O
pain	B-problem
that	O
resolved	O
pain	B-problem
free	O
,	O
but	O
not	O
clear	O
that	O
lead	B-test
placement	I-test
is	O
the	O
same	O
.	O

Had	O
Chest	B-test
CT	I-test
to	O
r	O
/	O
o	O
dissection	B-problem
(	O
due	O
to	O
back	B-problem
pain	I-problem
)	O
which	O
was	O
neg.	O

Ruled	O
out	O
for	O
MI	B-problem
.	O

Will	O
plan	O
on	O
ETT	B-test
.	O

Holding	O
Metformin	B-treatment
until	O
Friday	O
due	O
to	O
CT	B-test
with	I-test
contrast	I-test
.	O

ADDITIONAL	O
COMMENTS	O
:	O

smoking	O
cessation	O
group	O
will	O
contact	O
you	O
at	O
home	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

you	O
will	O
be	O
contacted	O
at	O
home	O
by	O
the	O
smoking	O
cessation	O
program	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

WIERST	O
,	O
STO	O
L.	O
,	O
M.D.	O
(	O
RR86	O
)	O
10/01/00	O
02:33	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

145980160	O

FIH	O

6382196	O

94916/ly7e	O

289653	O

06/30/1993	O
12:00:00	O
AM	O

PROSTATE	B-problem
CANCER	I-problem
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

06-30-93	O

DISCHARGE	O
DATE	O
:	O

07-06-93	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Prostate	B-problem
cancer	I-problem
.	O

SPECIAL	O
PROCEDURES	O
AND	O
OPERATIONS	O
:	O

Radical	B-treatment
retropubic	I-treatment
prostatectomy	I-treatment
,	O
bilateral	B-treatment
lymph	I-treatment
node	I-treatment
dissection	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
67	O
year	O
old	O
white	O
male	O
with	O
a	O
recent	O
history	O
of	O
urinary	B-problem
frequency	I-problem
Q2-3H	O
,	O
stranguria	B-problem
,	O
nocturia	B-problem
x	O
3-4	O
per	O
night	O
.	O

He	O
was	O
found	O
on	O
physical	B-test
exam	I-test
to	O
have	O
an	B-problem
asymmetric	I-problem
prostate	I-problem
with	O
prominence	B-problem
on	I-problem
the	I-problem
left	I-problem
and	O
a	O
question	O
of	O
a	B-problem
nodule	I-problem
.	O

Repeat	B-test
exam	I-test
one	O
month	O
later	O
showed	O
a	B-problem
firm	I-problem
left-sided	I-problem
lobe	I-problem
.	O

Transrectal	B-test
ultrasound	I-test
showed	O
a	B-problem
hypoechoic	I-problem
left-sided	I-problem
mass	I-problem
in	I-problem
the	I-problem
peripheral	I-problem
zone	I-problem
.	O

A	B-test
biopsy	I-test
showed	O
moderately	B-problem
to	I-problem
poorly	I-problem
differentiated	I-problem
Grade	I-problem
III-IV	I-problem
adenocarcinoma	I-problem
on	I-problem
the	I-problem
left	I-problem
.	O

The	O
right	O
lobe	O
was	O
within	O
normal	O
limits	O
.	O

This	O
was	O
done	O
on	O
05/05/93	O
at	O
FIH	O
.	O

He	O
also	O
had	O
a	O
3-4	O
year	O
history	O
of	O
impotence	B-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
for	O
non-insulin	B-problem
diabetes	I-problem
mellitus	I-problem
,	O
for	O
which	O
he	O
takes	O
Diabeta	B-treatment
,	O
one	O
QD	O
;	O
right	B-problem
eye	I-problem
cataract	I-problem
,	O
operated	O
on	O
three	O
years	O
ago	O
.	O

ALLERGIES	O
:	O

He	O
is	O
allergic	B-problem
to	O
Motrin	B-treatment
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Diabeta	B-treatment
,	O
one	O
QD	O
.	O

SOCIAL	O
HISTORY	O
:	O

No	O
smoking	O
history	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

He	O
was	O
a	O
well	O
developed	O
,	O
well	O
nourished	O
white	O
male	O
.	O

HEENT	O
:	O

within	O
normal	O
limits	O
.	O

His	O
neck	O
was	O
supple	O
with	O
no	O
jugular	B-problem
venous	I-problem
distention	I-problem
or	O
thyromegaly	B-problem
.	O

Chest	O
was	O
clear	O
to	O
percussion	B-test
and	O
auscultation	B-test
.	O

Heart	O
:	O

regular	O
rate	O
and	O
rhythm	O
with	O
normal	O
S1	O
and	O
S2	O
,	O
no	O
murmurs	B-problem
.	I-problem

The	O
abdomen	O
was	O
soft	O
and	O
non-tender	B-problem
with	O
no	O
masses	B-problem
or	O
organomegaly	B-problem
.	O

No	O
costovertebral	B-problem
angle	I-problem
tenderness	I-problem
.	O

His	B-test
genitourinary	I-test
exam	I-test
showed	O
an	O
uncircumcised	O
male	O
with	O
normal	O
scrotal	O
contents	O
.	O

Rectal	O
:	O

There	O
was	O
a	B-problem
firm	I-problem
nodule	I-problem
in	O
the	O
left	O
lobe	O
of	O
the	O
prostate	O
in	O
the	O
lateral	O
aspect	O
.	O

Extremities	O
:	O

No	O
clubbing	B-problem
,	I-problem
cyanosis	B-problem
or	O
edema	B-problem
.	O

Pulses	B-test
2+	O
.	O

Neurological	O
:	O

Nonfocal	O
.	O

LABORATORY	O
DATA	O
:	O

Sodium	B-test
141	O
,	O
potassium	B-test
4.1	O
,	O
chloride	B-test
104	O
,	O
bicarbonate	B-test
28.8	O
,	O
BUN	B-test
17	O
,	O
creatinine	B-test
0.9	O
,	O
glucose	B-test
118	O
.	O

His	B-test
white	I-test
blood	I-test
count	I-test
was	O
7100	O
,	O
hematocrit	B-test
35.9	O
,	O
platelet	B-test
count	I-test
258,000	O
.	O

PT	B-test
9.4/10.3	O
,	O
PTT	B-test
27	O
.	O

His	B-test
urinalysis	I-test
showed	O
marked	B-problem
occult	I-problem
blood	I-problem
and	O
positive	B-problem
white	I-problem
blood	I-problem
cell	I-problem
screen	I-problem
but	O
was	O
otherwise	O
negative	O
.	O

His	B-test
chest	I-test
X-ray	I-test
was	O
normal	O
.	O

EKG	B-test
:	O

normal	O
sinus	O
rhythm	O
at	O
73	O
beats	O
per	O
minute	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
brought	O
to	O
the	O
operating	O
room	O
on	O
06/30/93	O
after	O
informed	O
consent	O
was	O
obtained	O
.	O

A	B-treatment
radical	I-treatment
retropubic	I-treatment
prostatectomy	I-treatment
with	O
bilateral	B-treatment
lymph	I-treatment
node	I-treatment
dissection	I-treatment
was	O
done	O
.	O

He	O
was	O
afebrile	B-problem
postoperatively	O
with	O
vital	B-test
signs	I-test
stable	O
.	O

His	B-test
potassium	I-test
was	O
3.7	O
and	O
his	B-test
hematocrit	I-test
33	O
.	O

His	O
postoperative	O
course	O
was	O
remarkable	O
for	O
a	B-problem
low	I-problem
grade	I-problem
temperature	I-problem
to	O
101.7	O
.	O

His	B-test
blood	I-test
cultures	I-test
and	O
chest	B-test
X-ray	I-test
were	O
negative	O
.	O

He	O
had	O
flatus	O
on	O
postoperative	O
day	O
#	O
3	O
.	O

His	B-treatment
Jackson-Pratt	I-treatment
drained	O
about	O
35-40	O
cc	O
per	O
day	O
and	O
was	O
discontinued	O
on	O
postoperative	O
day	O
#	O
3	O
.	O

His	B-test
hematocrit	I-test
on	O
07/03	O
was	O
28.1	O
.	O

On	O
that	O
day	O
he	O
was	O
slightly	B-problem
diaphoretic	I-problem
with	O
some	B-problem
tachycardia	I-problem
to	O
100	O
.	O

The	O
remaining	O
unit	O
of	O
autologous	B-treatment
packed	I-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
was	O
transfused	O
.	O

A	B-test
cardiology	I-test
consult	I-test
was	O
obtained	O
for	O
this	O
episode	O
of	O
diaphoresis	B-problem
with	O
tachycardia	B-problem
,	O
as	O
well	O
as	O
for	O
an	B-test
EKG	I-test
being	O
read	O
as	O
having	O
anterolateral	B-problem
changes	I-problem
.	O

He	O
had	O
no	O
symptoms	B-problem
of	O
chest	B-problem
pain	I-problem
or	O
myocardial	B-problem
ischemia	I-problem
.	O

A	B-test
repeat	I-test
EKG	I-test
showed	O
no	O
changes	B-problem
.	O

He	O
subsequently	O
did	O
well	O
,	O
with	O
a	B-test
repeat	I-test
hematocrit	I-test
of	O
34.3	O
after	O
the	B-test
transfusion	I-test
.	O

His	B-test
creatinine	I-test
was	O
1.2	O
on	O
postoperative	O
day	O
#	O
5	O
.	O

On	O
postoperative	O
day	O
#	O
6	O
his	B-problem
low	I-problem
grade	I-problem
temperature	I-problem
resolved	O
.	O

His	B-test
vital	I-test
signs	I-test
were	O
stable	O
.	O

He	O
was	O
discharged	O
home	O
on	O
Percocet	B-treatment
and	O
Keflex	B-treatment
.	O

He	O
was	O
discharged	O
in	O
good	O
condition	O
.	O

He	O
will	O
follow	O
up	O
with	O
Dr.	O
Iechalette	O
Cancer	O
in	O
his	O
office	O
.	O

SIE	O
ROOM	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

IECHALETTE	O
ROOM	O
,	O
M.D.	O

TR	O
:	O

btt	O
/	O
bmot	O

DD	O
:	O

07-07-93	O

TD	O
:	O

07/08/93	O

CC	O
:	O

Dr.	O
Na	O
Dussmum	O

156406283	O

HLGMC	O

7213645	O

64723/51cy	O

5/28/1993	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

5-28-93	O

DISCHARGE	O
DATE	O
:	O

6-4-93	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
58	O
year	O
old	O
right	O
hand	O
dominant	O
white	O
male	O
with	O
a	O
long	O
history	O
of	O
hypertension	B-problem
,	O
changed	O
his	B-treatment
medications	I-treatment
from	O
Aldomet	B-treatment
to	O
Clonidine	B-treatment
six	O
weeks	O
ago	O
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
adult	B-problem
onset	I-problem
diabetes	I-problem
mellitus	I-problem
,	O
ankylosing	B-problem
spondylitis	I-problem
,	O
status	O
post	O
myocardial	B-problem
infarction	I-problem
in	O
&apos;96	O
(	O
?	O
)	O
now	O
with	O
acute	O
onset	O
of	O
left	B-problem
face	I-problem
and	I-problem
arm	I-problem
greater	I-problem
than	I-problem
leg	I-problem
hemiplegia	I-problem
and	O
primary	B-problem
hemisensory	I-problem
loss	I-problem
on	I-problem
the	I-problem
left	I-problem
.	O

Briefly	O
,	O
he	O
was	O
talking	O
to	O
a	O
friend	O
at	O
5:30	O
p.m.	O
the	O
day	O
prior	O
to	O
admission	O
,	O
when	O
he	O
had	O
to	O
grab	O
his	O
locker	O
and	O
sit	O
down	O
.	O

His	O
voice	O
became	O
slurred	B-problem
and	O
he	O
had	O
a	B-problem
mild	I-problem
central	I-problem
dull	I-problem
headache	I-problem
.	O

He	O
was	O
unable	O
to	O
move	O
the	O
left	O
side	O
of	O
his	O
body	O
and	O
felt	O
numb	B-problem
on	I-problem
that	I-problem
side	I-problem
.	O

He	O
was	O
taken	O
to	O
Wayskemedcalltown	O
Talmi	O
and	O
transferred	O
to	O
Heaonboburg	O
Linpack	O
Grant	O
Medical	O
Center	O
with	O
a	B-test
computerized	I-test
tomography	I-test
scan	I-test
showing	O
a	B-problem
1x2	I-problem
thalamic	I-problem
capsular	I-problem
hemorrhage	I-problem
without	O
superficial	B-problem
mass	I-problem
effect	I-problem
.	O

His	B-test
blood	I-test
pressure	I-test
was	O
220/110	O
there	O
.	O

He	O
denies	O
any	O
visual	B-problem
symptoms	I-problem
or	O
cortical-type	B-problem
symptoms	I-problem
.	O

He	O
is	O
a	O
heavy	O
smoker	O
and	O
drinks	O
2-3	O
shots	O
per	O
day	O
at	O
times	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Vasotec	B-treatment
40	O
mg	O
q.day	O
,	O
Soma	B-treatment
1	O
tablet	O
q.day	O
,	O
Demerolprn	B-treatment
,	O
Clonidine	B-treatment
.	O

ALLERGIES	O
:	O

The	O
patient	O
has	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

As	O
described	O
above	O
.	O

FAMILY	O
HISTORY	O
:	O

The	O
family	O
history	O
is	O
positive	O
for	O
diabetes	B-problem
mellitus	I-problem
,	O
positive	O
for	O
cancer	B-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
with	O
two	O
people	O
in	O
Cinglendda	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	B-test
physical	I-test
examination	I-test
,	O
patient	O
is	O
in	O
no	O
acute	B-problem
distress	I-problem
,	O
afebrile	B-problem
,	O
blood	B-test
pressure	I-test
134/80	O
,	O
heart	B-test
rate	I-test
80	O
and	O
regular	O
,	O
no	O
bruits	B-problem
.	O

Cardiovascular	B-test
exam	I-test
:	O

regular	O
rate	O
and	O
rhythm	O
with	O
a	B-problem
I/VI	I-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
.	O

His	O
lungs	O
were	O
clear	O
to	O
auscultation	B-test
and	O
percussion	B-test
.	O

The	O
abdomen	O
was	O
soft	O
and	O
non-tender	B-problem
,	O
obese	B-problem
,	O
with	O
normal	O
bowel	O
sounds	O
.	O

Back	O
and	O
neck	O
were	O
stiff	B-problem
and	O
sore	B-problem
,	O
without	O
localizing	B-problem
tenderness	I-problem
.	O

On	O
neurological	B-test
examination	I-test
,	O
mental	O
status	O
alert	O
and	O
oriented	O
x	O
three	O
,	O
good	O
memory	O
,	O
fluent	O
speech	O
,	O
good	O
repetition	O
and	O
naming	O
.	O

Able	O
to	O
describe	O
two	O
routes	O
from	O
house	O
to	O
the	O
CMH	O
.	O

The	O
cranial	O
nerves	O
showed	O
full	O
visual	O
fields	O
without	O
extinction	B-problem
,	O
pupils	O
5	O
to	O
3	O
bilaterally	O
and	O
equal	O
,	O
disks	O
flat	O
,	O
lower	B-problem
left	I-problem
facial	I-problem
decreased	I-problem
sensation	I-problem
to	I-problem
temperature	I-problem
,	O
pin	B-test
prick	I-test
on	O
the	O
left	O
V1	O
through	O
V3	O
,	O
tongue	O
deviates	O
to	O
the	O
left	O
,	O
good	O
gag	O
,	O
decreased	B-problem
shrug	I-problem
on	I-problem
the	I-problem
left	I-problem
.	O

Motor	B-test
examination	I-test
showed	O
full	O
power	O
on	O
the	O
right	O
arm	O
and	O
leg	O
,	O
could	O
barely	O
flex	O
fingers	O
of	O
the	O
left	O
hand	O
,	O
pulls	O
left	O
arm	O
medially	O
only	O
.	O

Left	O
leg	O
could	O
flex	O
2/5	O
and	O
wiggle	O
toes	O
.	O

On	O
sensory	B-test
examination	I-test
,	O
had	O
decreased	O
pin	O
prick	O
,	O
temperature	O
,	O
vibration	O
in	O
the	O
left	O
side	O
of	O
the	O
body	O
.	O

The	B-test
finger-to-nose	I-test
was	O
okay	O
on	O
the	O
right	O
.	O

On	O
reflex	B-test
examination	I-test
,	O
2	O
on	O
the	O
right	O
upper	O
extremity	O
,	O
2+	O
on	O
the	O
left	O
upper	O
extremity	O
,	O
2	O
on	O
the	O
right	O
knee	O
,	O
0	O
on	O
the	O
right	O
ankle	O
,	O
with	O
down	O
going	O
toe	O
on	O
the	O
right	O
.	O

Three	O
on	O
the	O
left	O
knee	O
,	O
4	O
on	O
the	O
left	O
ankle	O
with	O
upgoing	O
toe	O
and	O
clonus	B-problem
on	O
the	O
left	O
.	O

LABORATORY	O
DATA	O
:	O

Electrolytes	B-test
were	O
within	O
normal	O
limits	O
,	O
glucose	B-test
192	O
,	O
BUN	B-test
and	O
creatinine	B-test
9/0.7	O
,	O
hematocrit	B-test
49.5	O
,	O
white	B-test
blood	I-test
count	I-test
7.9	O
,	O
platelet	B-test
count	I-test
166,000	O
,	O
65%	O
polys	B-test
,	O
3	O
bands	B-test
,	O
24%	O
lymphs	B-test
.	O

The	B-test
electrocardiogram	I-test
showed	O
normal	O
sinus	O
rhythm	O
with	O
old	B-problem
Q	I-problem
wave	I-problem
inferior	I-problem
myocardial	I-problem
infarction	I-problem
.	O

Head	B-test
computerized	I-test
tomography	I-test
scan	I-test
showed	O
1.5	B-problem
to	I-problem
2	I-problem
centimeter	I-problem
bleed	I-problem
in	I-problem
the	I-problem
right	I-problem
thalamus	I-problem
extending	O
to	O
the	O
internal	O
capsule	O
with	O
mild	B-problem
distortion	I-problem
only	O
,	O
no	O
shift	B-problem
.	O

The	B-test
chest	I-test
X-ray	I-test
was	O
clear	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
floor	O
for	O
observation	O
.	O

The	B-test
neurological	I-test
examination	I-test
on	O
discharge	O
was	O
no	O
movement	B-problem
in	I-problem
the	I-problem
hand	I-problem
on	O
the	O
left	O
or	O
arm	O
.	O

Slight	O
abductive	O
and	O
adductive	O
movement	O
on	O
the	O
left	O
only	O
in	O
the	O
upper	O
extremity	O
.	O

On	O
the	O
lower	O
extremity	O
,	O
could	O
wiggle	B-test
toes	I-test
,	O
flexor	B-test
and	O
plantar	B-test
,	O
3+/5	O
,	O
quadriceps	O
4/5	O
on	O
the	O
left	O
.	O

2.	O
hypertension	B-problem
.	O

The	O
patient	O
was	O
managed	O
with	O
Vasotec	B-treatment
,	O
Nifedipine	B-treatment
and	O
Clonidine	B-treatment
with	O
blood	B-test
pressure	I-test
under	O
good	O
control	O
at	O
the	O
time	O
of	O
discharge	O
,	O
average	O
125	O
systolic	B-test
,	O
70	O
diastolic	B-test
,	O
heart	B-test
rate	I-test
of	O
72	O
.	O

Also	O
managed	O
with	O
Valium	B-treatment
5	O
mg	O
PO	O
t.i.d.	O

Muscle	B-problem
spasms	I-problem
were	O
managed	O
with	O
Flexeril	B-treatment
10	O
PO	O
t.i.d.	O

3.	O
diabetes	B-problem
mellitus	I-problem
.	O

The	O
patient	O
was	O
started	O
on	O
2.5	O
of	O
Micronase	B-treatment
with	O
resulting	B-test
sugars	I-test
as	O
low	O
as	O
63	O
,	O
decreased	O
to	O
1.25	O
mg	O
q.day	O
.	O

The	O
patient	O
is	O
discharged	O
in	O
fair	O
condition	O
with	O
medical	O
approval	O
to	O
the	O
Pasi	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Vasotec	B-treatment
20	O
mg	O
PO	O
b.i.d.	O
,	O
Clonidine	B-treatment
0.2	O
mg	O
PO	O
b.i.d.	O
,	O
Nifedipine	B-treatment
20	O
mg	O
PO	O
t.i.d.	O
,	O
Flexeril	B-treatment
10	O
mg	O
PO	O
t.i.d.	O
,	O
Valium	B-treatment
5	O
mg	O
PO	O
t.i.d.	O
,	O
Micronase	B-treatment
1.25	O
mg	O
q.day	O
.	O

ADVERSE	O
DRUG	O
REACTIONS	O
:	O

The	O
patient	O
was	O
found	O
to	O
be	O
allergic	B-problem
to	O
Percocet	B-treatment
and	O
Percodan	B-treatment
during	O
his	O
hospital	O
course	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Right	B-problem
thalamic	I-problem
hemorrhage	I-problem
,	O
hypertension	B-problem
,	O
diabetes	B-problem
mellitus	I-problem
.	O

ROBTHER	O
TIMES	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

SHAA	O
LEFT	O
,	O
M.D.	O

TR	O
:	O

nj	O
/	O
bmot	O

DD	O
:	O

6-4-93	O

TD	O
:	O

06/04/93	O

CC	O
:	O

Dr.	O
Namarce	O
Aldridge	O
Pasi	O
STAT	O

176318078_a	O

FIH	O

4189699	O

28872/d70h	O

094756	O

11/03/1993	O
12:00:00	O
AM	O

MITRAL	B-problem
STENOSIS	I-problem

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

11-03-93	O

DISCHARGE	O
DATE	O
:	O

11-06-93	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Mitral	B-problem
stenosis	I-problem

ASSOCIATED	O
DIAGNOSIS	O
:	O

Tricuspid	B-problem
regurgitation	I-problem
,	O
heart	B-problem
failure	I-problem
,	O
chronic	B-problem
atrial	I-problem
fibrillation	I-problem
,	O
chronic	B-problem
ventricular	I-problem
ectopy	I-problem
,	O
chronic	B-problem
obstructive	I-problem
lung	I-problem
disease	I-problem
.	O

ADVERSE	O
DRUG	O
REACTIONS	O
:	O

Epistaxis	B-problem
to	O
Coumadin	B-treatment
in	O
the	O
past	O
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Cardiac	B-test
catheterization	I-test
11/03	O
.	O

OTHER	O
PROCEDURE	O
:	O

Pulmonary	B-test
function	I-test
test	I-test
11/04	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
68-year-old	O
patient	O
of	O
Dr.	O
Naka	O
Jesc	O
had	O
two	O
episodes	O
of	O
rheumatic	B-problem
fever	I-problem
as	O
a	O
teenager	O
.	O

She	O
has	O
had	O
chronic	B-problem
atrial	I-problem
fibrillation	I-problem
.	O

Coumadin	B-treatment
has	O
caused	O
bleeding	B-problem
from	I-problem
the	I-problem
mouth	I-problem
and	I-problem
nose	I-problem
on	O
two	O
occasions	O
,	O
on	O
one	O
occasion	O
with	O
prothrombin	B-test
time	I-test
13	O
,	O
and	O
has	O
been	O
replaced	O
by	O
anti-platelet	B-treatment
agents	I-treatment
.	O

She	O
has	O
had	O
recurrent	B-problem
syncope	I-problem
since	O
age	O
6	O
.	O

She	O
has	O
now	O
had	O
progressive	B-problem
heart	I-problem
failure	I-problem
.	O

A	B-test
Holter	I-test
showed	O
atrial	B-problem
fibrillation	I-problem
with	O
period	O
of	O
ventricular	B-problem
bigemini	I-problem
.	O

She	O
cut	O
down	O
dramatically	O
on	O
smoking	O
two	O
years	O
ago	O
,	O
but	O
has	O
continued	O
to	O
smoke	O
,	O
although	O
,	O
very	O
recently	O
,	O
she	O
admits	O
to	O
only	O
&quot;	O
two	O
puffs	O
&quot;	O
per	O
day	O
.	O

She	O
has	O
not	O
had	O
hypertension	B-problem
or	O
diabetes	B-problem
,	O
and	O
says	O
he	O
has	O
lowered	O
her	B-test
cholesterol	I-test
from	O
333	O
to	O
197	O
by	O
changing	O
her	O
diet	O
.	O

There	O
is	O
no	O
family	O
history	O
of	O
heart	B-problem
disease	I-problem
.	O

She	O
has	O
been	O
treated	O
with	O
Vanceril	B-treatment
for	O
chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
.	O

She	O
has	O
had	O
one	O
gram	O
per	O
day	O
proteinuria	B-treatment
with	O
normal	O
creatinine	O
.	O

She	O
had	O
a	B-treatment
partial	I-treatment
gastrectomy	I-treatment
in	O
1972	O
for	O
a	B-problem
&quot;	I-problem
tumor	I-problem
&quot;	I-problem
.	O

She	O
has	O
had	O
an	B-treatment
appendectomy	I-treatment
and	O
cholecystectomy	B-treatment
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Digoxin	B-treatment
0.125	O
mg	O
po	O
q.d.	O
,	O
Lasix	B-treatment
40	O
mg	O
b.i.d.	O
,	O
aspirin	B-treatment
held	O
,	O
and	O
Vanceril	B-treatment
three	O
puffs	O
b.i.d.	O

ALLERGIES	O
:	O

Transdermal	B-treatment
nitroglycerin	I-treatment
caused	O
headache	B-problem
.	O

SOCIAL	O
HISTORY	O
:	O

She	O
does	O
not	O
drink	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Heart	B-test
rate	I-test
86	O
,	O
irregularly	O
irregular	O
,	O
blood	B-test
pressure	I-test
142/86	O
.	O

Neck	B-problem
veins	I-problem
distended	I-problem
.	O

Carotids	O
normal	O
.	O

Chest	O
clear	O
.	O

Apical	B-test
impulse	I-test
not	O
palpable	O
.	O

Right	B-problem
ventricular	I-problem
heave	I-problem
.	O

S1	O
normal	O
.	O

S2	O
narrowly	B-problem
physiologically	I-problem
split	I-problem
with	O
accentuation	B-problem
of	O
P2	O
.	O

No	O
S3	B-problem
or	O
opening	B-problem
snap	I-problem
.	O

Grade	B-problem
II	I-problem
systolic	I-problem
murmur	I-problem
at	I-problem
the	I-problem
left	I-problem
lower	I-problem
sternal	I-problem
border	I-problem
.	O

Grade	B-problem
II	I-problem
decrescendo	I-problem
diastolic	I-problem
murmur	I-problem
at	I-problem
the	I-problem
left	I-problem
lower	I-problem
sternal	I-problem
border	I-problem
.	O

Diastolic	B-problem
rumble	I-problem
at	I-problem
the	I-problem
apex	I-problem
.	O

Liver	B-problem
slightly	I-problem
pulsatile	I-problem
but	O
no	O
enlarged	B-problem
.	O

Pulses	B-test
normal	O
to	O
the	O
femorals	O
with	O
weak	B-problem
dorsalis	I-problem
pedis	I-problem
pulses	I-problem
.	O

Superficial	B-problem
varicose	I-problem
veins	I-problem
.	O

No	O
edema	B-problem
.	O

LABORATORY	O
DATA	O
:	O

Hematocrit	B-test
44	O
,	O
potassium	B-test
4.0	O
,	O
BUN	B-test
23	O
,	O
creatinine	B-test
1.2	O
,	O
blood	B-test
sugar	I-test
115	O
,	O
Digoxin	B-test
1.4	O
.	O

Electrocardiogram	B-test
showed	O
atrial	B-problem
fibrillation	I-problem
,	O
moderate	B-problem
ventricular	I-problem
response	I-problem
,	O
incomplete	B-problem
right	I-problem
bundle	I-problem
branch	I-problem
block	I-problem
,	O
right	B-problem
axis	I-problem
deviation	I-problem
,	O
right	B-problem
ventricular	I-problem
hypertrophy	I-problem
and	O
possible	O
apical	B-problem
infarction	I-problem
.	O

Chest	B-test
x-ray	I-test
showed	O
left	B-problem
atrial	I-problem
,	I-problem
right	I-problem
ventricular	I-problem
and	I-problem
pulmonary	I-problem
arterial	I-problem
enlargement	I-problem
and	O
interstitial	B-problem
edema	I-problem
with	O
small	B-problem
,	I-problem
bilateral	I-problem
effusions	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

Cardiac	B-treatment
catheterization	I-treatment
was	O
performed	O
without	O
complication	B-problem
from	O
the	O
right	O
neck	O
and	O
right	O
groin	O
on	O
the	O
day	O
of	O
admission	O
.	O

Right	B-test
atrial	I-test
pressure	I-test
was	O
12	O
with	O
a	O
wave	O
form	O
consistent	O
with	O
tricuspid	B-problem
regurgitation	I-problem
.	O

There	O
was	O
no	O
tricuspid	B-problem
valve	I-problem
gradient	I-problem
.	O

Pulmonary	B-test
artery	I-test
pressure	I-test
was	O
markedly	B-problem
elevated	I-problem
at	O
120/60	O
.	O

Pulmonary	B-test
capillary	I-test
wedge	I-test
pressure	I-test
was	O
markedly	B-problem
elevated	I-problem
at	O
38	O
,	O
with	O
a	B-problem
very	I-problem
large	I-problem
mitral	I-problem
valve	I-problem
gradient	I-problem
.	O

There	O
was	O
little	O
or	O
no	O
aortic	B-problem
valve	I-problem
gradient	I-problem
.	O

Fich	B-test
cardiac	I-test
output	I-test
was	O
3.0	O
and	O
indexed	O
2.0	O
.	O

Arterial	B-test
oxygen	I-test
saturation	I-test
was	O
85	O
percent	O
.	O

There	O
was	O
minimal	B-problem
mitral	I-problem
valve	I-problem
calcification	I-problem
,	O
normal	O
left	O
ventricular	O
contraction	O
,	O
and	O
2+	B-problem
mitral	I-problem
regurgitation	I-problem
into	I-problem
a	I-problem
large	I-problem
left	I-problem
atrium	I-problem
.	O

There	O
was	O
minimal	B-problem
aortic	I-problem
valve	I-problem
calcification	I-problem
,	O
mild	B-problem
______________	I-problem
thickening	I-problem
,	O
normal	O
open	O
,	O
and	O
mild	B-problem
aortic	I-problem
regurgitation	I-problem
.	O

There	O
was	O
mild	B-problem
atherosclerosis	I-problem
of	I-problem
the	I-problem
mid	I-problem
left	I-problem
anterior	I-problem
descending	I-problem
.	O

FVC	B-test
was	O
1.6	O
or	O
58	O
percent	O
of	O
predicted	O
and	O
FEV1	B-test
0.95	O
or	O
45	O
percent	O
of	O
predicted	O
.	O

Room	B-test
air	I-test
arterial	I-test
blood	I-test
gas	I-test
was	O
56/40/7.45	O
.	O

Because	O
it	O
would	O
be	O
ideal	O
to	O
place	O
a	B-treatment
mechanical	I-treatment
valve	I-treatment
if	O
valve	B-treatment
replacement	I-treatment
rather	O
that	O
commissurotomy	B-treatment
is	O
needed	O
,	O
she	O
was	O
seen	O
by	O
Dr.	O
Ca	O
Shuff	O
of	O
ENT	O
for	O
her	O
history	O
of	O
epistaxis	B-problem
.	O

He	O
identified	O
no	O
bleeding	B-problem
source	I-problem
,	O
but	O
felt	O
that	O
the	O
risk	O
of	O
nasal	B-problem
hemorrhage	I-problem
on	O
Coumadin	B-treatment
could	O
be	O
minimized	O
interventional	B-treatment
neuroradiology	I-treatment
occlusion	I-treatment
of	O
the	O
arteries	O
to	O
the	O
nose	O
bilaterally	O
.	O

The	O
patient	O
was	O
therefore	O
referred	O
to	O
the	O
Dr.	O
A	O
Eu	O
Wave	O
.	O

The	B-treatment
procedure	I-treatment
could	O
not	O
be	O
scheduled	O
during	O
this	O
admission	O
.	O

The	O
patient	O
is	O
,	O
therefore	O
,	O
discharged	O
after	O
a	O
three	O
day	O
hospitalization	O
,	O
with	O
plans	O
for	O
re-admission	O
for	O
the	B-treatment
neuroradiology	I-treatment
procedure	I-treatment
.	O

This	O
will	O
be	O
followed	O
by	O
a	O
trial	O
of	O
Coumadin	B-treatment
,	O
and	O
then	O
by	O
mitral	B-treatment
commissurotomy	I-treatment
or	O
replacement	B-treatment
and	O
probable	O
tricuspid	B-treatment
annuloplasty	I-treatment
by	O
Dr.	O
Riemund	O
C.	O
Wave	O
.	O

In	O
the	O
meantime	O
,	O
Lasix	B-treatment
dosage	O
is	O
increased	O
.	O

Potassium	B-treatment
replacement	I-treatment
has	O
caused	O
,	O
according	O
to	O
the	O
patient	O
,	O
marked	B-problem
hyperkalemia	I-problem
in	O
the	O
past	O
.	O

DISCHARGE	O
REGIMEN	O
:	O

Digoxin	B-treatment
0.125	O
mg	O
q.d.	O
,	O
Lasix	B-treatment
80	O
mg	O
q.a.m.	O
and	O
40	O
mg	O
q.p.m.	O
aspirin	B-treatment
1	O
q.d.	O
,	O
and	O
Vanceril	B-treatment
three	O
puffs	O
b.i.d.	O

CA	O
SHUFF	O
,	O
M.D.	O

TR	O
:	O

vw	O
/	O
bmot	O

DD	O
:	O

11-06-93	O

TD	O
:	O

11/07/93	O

CC	O
:	O

Copies	O
to	O
Dr.	O
Bodejove	O
at	O
Valtawnprinceel	O
Community	O
Memorial	O
Hospital	O
,	O
Dr.	O
A	O
Eu	O
Wave	O
,	O
Dr.	O
Riemund	O
C.	O
Wave	O
,	O
and	O
three	O
copies	O
to	O
Dr.	O
Ca	O
Shuff	O
edited	O
12/31/93	O
qm	O

176746010	O
WGH	O

0014633	O

546385	O

8603421	O

12/7/2004	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

GLOTZASRHALT	O
,	O
SHIRLH	O

MRN	O
:	O

0014633	O

Age	O
:	O

25y	O

REGISTRATION	O
DATE	O
:	O

12/07/2004	O
10:08	O
PM	O

Provider	O
:	O

Gram	O
Meedner	O

PRELIMINARY	O
REPORT	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Date	O
/	O
Time	O
:	O

12/07/2004	O
22:57	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

FLANK	B-problem
PAIN	I-problem
URI	B-problem
?	O

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
urinary	B-problem
tract	I-problem
infection	I-problem
(	O
Portugese	O
)	O
.	O

Diagnosis	O
:	O

Urinary	B-problem
Tract	I-problem
Infection	I-problem

Treatment	O
Rendered	O
:	O

Exam	B-test
,	O
urinalysis	B-test
,	O
medication	B-treatment

Discharge	O
Medications	O
:	O

Levofloxacin	B-treatment
500	O
mg	O
every	O
day	O
for	O
7	O
days	O

Follow	O
up	O
Service	O
:	O

If	O
you	O
do	O
not	O
have	O
a	O
primary	O
care	O
physician	O
,	O
it	O
is	O
recommended	O
that	O
you	O
select	O
one	O
.	O

If	O
you	O
would	O
like	O
an	O
WGH	O
primary	O
care	O
physician	O
,	O
please	O
call	O
the	O
Eghelas	O
Medical	O
Centers	O
at	O
265-573-2272	O
.	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Return	O
to	O
the	O
ER	O
for	O
high	B-problem
fevers	I-problem
,	O
vomiting	B-problem
,	O
uncontrolled	B-problem
pains	I-problem
or	O
other	B-problem
concerns	I-problem
as	O
needed	O
.	O

PCP	O
Name	O
:	O

NONE	O
,	O
PHYSICIAN	O

Provider	O
Number	O
:	O

51669	O

This	O
report	O
was	O
created	O
by	O
Meedner	O
,	O
Shaza	O
12/07/2004	O
10:59	O
PM	O

188543380	O

NVH	O

24217709	O

06/07/2000	O
12:00:00	O
AM	O

CHRONIC	B-problem
MYELOGENOUS	I-problem
LEUKEMIA	I-problem

Signed	O

DIS	O

Admission	O
Date	O
:	O

06/07/2000	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

07/02/2000	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

CML	B-problem
.	O

OTHER	O
DIAGNOSES	O
:	O

1.	O
STATUS	O
POST	O
BONE	B-treatment
MARROW	I-treatment
TRANSPLANT	I-treatment
.	O

2.	O
INTRAPARENCHYMAL	B-problem
BLEED	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Larsen	O
was	O
a	O
50-year-old	O
salesman	O
who	O
in	O
12/26	O
was	O
noted	O
to	O
have	O
an	B-problem
elevated	I-problem
platelet	I-problem
count	I-problem
of	O
778,000	O
.	O

He	O
was	O
found	O
to	O
have	O
CML	B-problem
.	O

He	O
was	O
admitted	O
on	O
06/07/00	O
for	O
a	B-treatment
matched	I-treatment
,	I-treatment
unrelated	I-treatment
donor	I-treatment
bone	I-treatment
marrow	I-treatment
transplant	I-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Unremarkable	O
.	O

LABORATORY	O
DATA	O
:	O

White	B-test
blood	I-test
cell	I-test
count	I-test
of	O
24.409	O
and	O
platelets	B-test
of	O
956,000	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
received	O
his	B-treatment
bone	I-treatment
marrow	I-treatment
transplant	I-treatment
on	O
06/12/00	O
.	O

His	O
course	O
was	O
then	O
complicated	O
by	O
fevers	B-problem
and	O
neutropenia	B-problem
which	O
were	O
treated	O
with	O
antibiotics	B-treatment
and	O
a	B-problem
diffuse	I-problem
erythroderm	I-problem
felt	O
to	O
be	O
a	B-problem
drug	I-problem
reaction	I-problem
.	O

On	O
06/24/00	O
the	O
patient	O
was	O
found	O
to	O
have	O
pulmonary	B-problem
infiltrates	I-problem
and	O
some	B-problem
hemoptysis	I-problem
.	O

A	B-test
bronchoscopy	I-test
was	O
done	O
and	O
there	O
was	O
blood	B-problem
found	O
in	O
the	O
upper	O
airways	O
but	O
no	O
evidence	O
of	O
blood	B-problem
in	I-problem
alveoli	I-problem
so	O
it	O
was	O
not	O
felt	O
to	O
be	O
DAH	B-problem
.	O

On	O
06/26/00	O
due	O
to	O
agitation	B-problem
,	O
change	B-problem
in	I-problem
mental	I-problem
status	I-problem
and	O
increased	B-problem
respiratory	I-problem
distress	I-problem
,	O
the	O
patient	O
was	O
intubated	B-treatment
.	O

It	O
was	O
felt	O
at	O
that	O
time	O
that	O
the	B-problem
changing	I-problem
mental	I-problem
status	I-problem
and	O
respiratory	B-problem
distress	I-problem
might	O
be	O
due	O
to	O
a	O
combination	O
of	O
medication	B-treatment
and	O
worsening	B-problem
mucositis	I-problem
.	O

Although	O
the	B-treatment
patient	I-treatment
&apos;s	I-treatment
pain	I-treatment
and	I-treatment
sedation	I-treatment
meds	I-treatment
were	O
adjusted	O
he	O
continued	O
to	O
be	O
agitated	B-problem
and	O
there	O
was	O
difficulty	O
weaning	O
him	O
off	O
the	B-treatment
vent	I-treatment
.	O

Because	O
of	O
this	B-problem
continued	I-problem
agitation	I-problem
,	O
a	B-test
head	I-test
CT	I-test
was	O
performed	O
on	O
07/01/00	O
and	O
it	O
revealed	O
an	B-problem
intraparenchymal	I-problem
hemorrhage	I-problem
.	O

Neurosurgery	O
was	O
consulted	O
but	O
due	O
to	O
the	B-problem
severity	I-problem
of	I-problem
the	I-problem
bleed	I-problem
surgery	B-treatment
was	O
not	O
considered	O
an	O
option	O
.	O

The	O
patient	O
gradually	O
lost	O
brain	O
systolic	O
ejection	O
murmur	O
function	O
and	O
was	O
pronounced	O
dead	B-problem
on	O
07/02/00	O
.	O

Dictated	O
By	O
:	O

LAYMIE	O
LARSEN	O
,	O
M.D.	O
EM08	O

Attending	O
:	O

ANA	O
V.	O
A	O
,	O
M.D.	O
ZM0	O
LB414/6537	O

Batch	O
:	O

67043	O

Index	O
No.	O

EZCDQ560N8	O

D	O
:	O

07/19/00	O

T	O
:	O

07/20/00	O

194442600	O
RWH	O

1642008	O

83328/rh01	O

61509	O

10/19/1993	O
12:00:00	O
AM	O

RIGHT	B-problem
CAPSULAR	I-problem
PUTAMENAL	I-problem
HEMORRHAGE	I-problem
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

10/19/93	O

DISCHARGE	O
DATE	O
:	O

10/25/93	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Right	B-problem
capsular	I-problem
putamenal	I-problem
hemorrhage	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

hypertension	B-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mrs.	O
Dua	O
is	O
a	O
34	O
year	O
old	O
white	O
female	O
with	O
an	O
unclear	O
history	O
of	O
hypertension	B-problem
for	O
at	O
least	O
five	O
years	O
.	O

She	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
around	O
12:40	O
on	O
October	O
19	O
,	O
when	O
while	O
on	O
the	O
phone	O
,	O
started	O
to	O
have	O
difficulty	B-problem
in	I-problem
talking	I-problem
.	O

Her	O
speech	O
became	O
slurred	B-problem
,	O
this	O
was	O
followed	O
a	O
few	O
seconds	O
after	O
by	O
weakness	B-problem
and	I-problem
numbness	I-problem
of	I-problem
her	I-problem
arm	I-problem
and	I-problem
leg	I-problem
.	O

She	O
did	O
not	O
complain	O
of	O
headache	B-problem
,	O
diplopia	B-problem
,	O
or	O
any	B-problem
other	I-problem
neurological	I-problem
symptoms	I-problem
.	O

She	O
was	O
seen	O
at	O
A	O
Memorial	O
Hospital	O
where	O
her	B-test
blood	I-test
pressure	I-test
was	O
measured	O
at	O
240/120	O
and	O
was	O
found	O
to	O
have	O
a	B-problem
mild	I-problem
left	I-problem
hemiparesis	I-problem
.	O

She	O
was	O
then	O
transferred	O
to	O
Ro	O
Woodma	O
Healthcare	O
for	O
further	B-treatment
management	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

negative	O
.	O

HABITS	O
:	O

She	O
does	O
not	O
smoke	O
,	O
does	O
not	O
use	O
birth	B-treatment
control	I-treatment
pills	I-treatment
,	O
does	O
not	O
use	O
drugs	O
.	O

Denies	O
any	O
abuse	O
of	O
alcohol	O
.	O

FAMILY	O
HISTORY	O
:	O

Father	O
and	O
brother	O
died	O
of	O
PE	B-problem
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

negative	O
.	O

SOCIAL	O
HISTORY	O
:	O

She	O
works	O
at	O
TackyMart	O
,	O
is	O
single	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

A	O
34	O
year	O
old	O
white	O
female	O
lying	O
in	O
bed	O
,	O
anxious	B-problem
;	O
blood	B-test
pressure	I-test
of	O
220/120	O
,	O
afebrile	B-problem
.	O

Skin	O
:	O

no	O
lesions	B-problem
.	O

HEENT	O
:	O

normocephalic	O
,	O
atraumatic	B-problem
,	O
anicteric	B-problem
.	O

Neck	O
:	O

supple	O
,	O
no	O
bruits	B-problem
.	O

Heart	O
:	O

regular	O
rhythm	O
with	O
no	O
murmur	B-problem
,	O
rub	B-problem
or	O
gallop	B-problem
.	O

Lungs	O
:	O

clear	O
to	O
auscultation	B-test
.	O

Abdomen	O
:	O

bowel	O
sounds	O
present	O
,	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
,	O
guaiac	O
negative	O
,	O
no	O
hepatosplenomegaly	B-problem
.	O

Extremities	O
:	O

no	O
clubbing	B-problem
,	I-problem
cyanosis	B-problem
or	O
edema	B-problem
.	O

Neurological	O
:	O

she	O
was	O
alert	O
and	O
oriented	O
times	O
three	O
.	O

Her	O
speech	O
was	O
fluent	O
with	O
no	O
phasic	B-problem
or	I-problem
praxic	I-problem
problems	I-problem
,	O
dysarthric	B-problem
.	O

Memory	O
and	O
attention	O
span	O
good	O
.	O

Visual	O
fields	O
were	O
full	O
to	O
confrontation	B-test
.	O

Fundi	O
were	O
flat	O
.	O

Pupils	O
were	O
2	O
millimeters	O
down	O
to	O
1	O
millimeter	O
by	O
direct	B-test
and	I-test
consensual	I-test
stimuli	I-test
.	O

Extra	O
ocular	O
movements	O
were	O
full	O
.	O

Corneals	O
diminished	O
on	O
the	O
left	O
side	O
.	O

V1	O
through	O
V3	O
,	O
diminished	O
light	B-test
touch	I-test
and	O
pinprick	B-test
in	O
the	O
left	O
side	O
.	O

There	O
was	O
a	B-problem
left	I-problem
central	I-problem
facial	I-problem
paresis	I-problem
.	O

Gag	B-test
was	O
symmetric	O
.	O

Tongue	O
deviated	O
to	O
the	O
left	O
.	O

There	O
was	O
a	B-problem
left	I-problem
arm	I-problem
pronator	I-problem
.	O

The	O
______________	O
was	O
normal	O
.	O

Strength	O
was	O
5/5	O
on	O
the	O
right	O
side	O
,	O
4/5	O
on	O
the	O
left	O
side	O
.	O

The	B-test
deep	I-test
tendon	I-test
reflexes	I-test
were	O
2+	O
on	O
the	O
left	O
side	O
,	O
1+	O
on	O
the	O
right	O
side	O
.	O

The	O
plantar	O
was	O
upgoing	O
on	O
the	O
left	O
side	O
.	O

On	O
sensory	B-test
exam	I-test
there	O
was	O
a	B-problem
mild	I-problem
diminution	I-problem
of	I-problem
light	I-problem
touch	I-problem
,	I-problem
pinprick	I-problem
,	I-problem
position	I-problem
,	I-problem
and	I-problem
vibration	I-problem
sense	I-problem
in	I-problem
the	I-problem
left	I-problem
side	I-problem
.	O

Cerebella	O
:	O

the	O
fine	O
motor	O
movements	O
of	O
the	O
left	O
hand	O
were	O
diminished	B-problem
,	O
there	O
was	O
a	B-problem
mild	I-problem
dysmetria	I-problem
on	I-problem
the	I-problem
left	I-problem
side	I-problem
to	O
finger	B-test
/	I-test
nose	I-test
and	O
heel	B-test
/	I-test
shin	I-test
.	O

The	B-problem
walk	I-problem
was	I-problem
paretic	I-problem
in	I-problem
the	I-problem
left	I-problem
side	I-problem
.	O

LABORATORY	O
DATA	O
:	O

sodium	B-test
140	O
,	O
potassium	B-test
4	O
,	O
chloride	B-test
107	O
,	O
CO2	B-test
25.4	O
,	O
BUN	B-test
9	O
,	O
creatinine	B-test
.8	O
,	O
blood	B-test
sugar	I-test
130	O
.	O

Uric	B-test
acid	I-test
4.7	O
,	O
cholesterol	B-test
150	O
,	O
triglycerides	B-test
74	O
,	O
HDL	B-test
44	O
,	O
LDL	B-test
91	O
.	O

Normal	O
liver	O
function	O
tests	O
.	O

Urine	B-test
and	I-test
serum	I-test
toxicology	I-test
screen	I-test
negative	O
.	O

Thyroid	B-test
stimulation	I-test
hormone	I-test
1.9	O
.	O

Dexamethasone	B-test
suppression	I-test
test	I-test
negative	O
with	O
a	B-test
cortisol	I-test
level	I-test
at	O
8	O
a.m.	O
of	O
1.7	O
.	O

Twenty-four	B-test
urine	I-test
for	O
catecholamine	B-test
,	O
metanephrines	B-test
,	O
and	O
VMA	B-test
pending	O
at	O
the	O
time	O
of	O
discharge	O
.	O

White	B-test
blood	I-test
cell	I-test
count	I-test
9.8	O
,	O
hematocrit	B-test
44.1	O
,	O
platelets	B-test
262	O
,	O
prothrombin	B-test
time	I-test
10.4/	O
10.3	O
,	O
partial	B-test
thromboplastin	I-test
time	I-test
25.9	O
.	O

urinalysis	B-test
:	O

specific	B-test
gravity	I-test
125	O
,	O
PH	O
6	O
.	O

Urine	B-test
culture	I-test
negative	O
.	O

Sedimentation	B-test
rate	I-test
2	O
,	O
antithrombin	B-test
3	O
.	O

Protein	B-test
C	I-test
,	O
protein	B-test
S	I-test
and	O
plasminogen	B-test
level	I-test
within	O
normal	O
limits	O
.	O

Electrocardiogram	B-test
:	O

sinus	B-test
rhythm	I-test
at	O
116	O
,	O
axis	B-test
of	O
23	O
,	O
intervals	B-test
of	O
.14/	O
.07/	O
.42	O
,	O
no	O
ST-segment	B-problem
abnormalities	I-problem
.	O

Chest	B-test
x-ray	I-test
negative	O
.	O

Head	B-test
computerized	I-test
tomography	I-test
scan	I-test
on	O
10/19	O
:	O
3	B-problem
centimeter	I-problem
hyperdensity	I-problem
within	O
the	O
right	O
putamenal	O
area	O
in	O
the	O
right	O
external	O
capsusle	O
consistent	O
with	O
intra-parenchymal	B-problem
hematoma	I-problem
with	O
mild	B-problem
local	I-problem
mass	I-problem
effect	I-problem
and	O
surrounding	B-problem
edema	I-problem
.	O

No	O
other	O
areas	O
of	O
hemorrhage	B-problem
identified	O
.	O

Head	B-test
computerized	I-test
tomography	I-test
scan	I-test
of	O
10/23	O
:	O

the	O
area	O
of	O
hemorrhage	B-problem
the	O
same	O
,	O
slightly	B-problem
more	I-problem
edema	I-problem
and	I-problem
mass	I-problem
effect	I-problem
.	O

Pulmonary	B-test
angiogram	I-test
:	O

no	O
evidence	O
of	O
pulmonary	B-problem
emboli	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

Given	O
the	O
localization	O
of	O
the	B-problem
hematoma	I-problem
and	O
the	O
history	O
of	O
hypertension	B-problem
,	O
the	O
most	O
likely	O
cause	O
for	O
Mrs.	O
Dua	O
&apos;s	O
cerebellar	B-problem
hemorrhage	I-problem
is	O
hypertension	B-problem
.	O

A	B-test
magnetic	I-test
resonance	I-test
imaging	I-test
study	I-test
will	O
be	O
scheduled	O
as	O
an	O
outpatient	O
in	O
three	O
months	O
to	O
rule	O
out	O
a	B-problem
small	I-problem
vascular	I-problem
malformation	I-problem
if	O
responsible	O
for	O
the	B-problem
hemorrhage	I-problem
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
Mrs.	O
Dua	O
has	O
had	O
a	O
remarkable	O
recovery	O
.	O

She	O
is	O
now	O
able	O
to	O
walk	O
fitfully	O
and	O
use	O
her	O
left	O
hand	O
with	O
no	O
problem	B-problem
.	O

The	B-test
exam	I-test
is	O
remarkable	O
for	O
a	B-problem
mild	I-problem
leftsided	I-problem
face	I-problem
,	O
arm	B-problem
and	I-problem
leg	I-problem
weakness	I-problem
and	O
sensory	B-problem
deficit	I-problem
that	O
should	O
further	O
improve	O
with	O
physical	B-treatment
therapy	I-treatment
and	O
occupational	B-treatment
therapy	I-treatment
help	O
.	O

She	O
will	O
be	O
followed	O
by	O
the	O
OT	O
/	O
PT	O
dept.	O
for	O
that	O
.	O

Her	B-problem
hypertension	I-problem
was	O
difficult	O
to	O
manage	O
initially	O
and	O
required	O
three	O
days	O
of	O
Intensive	O
Care	O
Unit	O
with	O
A-line	B-treatment
and	O
Nipride	B-treatment
intravenously	I-treatment
.	O

It	O
was	O
finally	O
under	O
control	O
with	O
high	O
doses	O
of	O
Captopril	B-treatment
,	O
Nifedipine	B-treatment
,	O
and	O
hydrochlorothiazide	B-treatment
.	O

The	B-test
workup	I-test
to	O
rule	O
out	O
secondary	B-problem
cause	I-problem
of	O
hypertension	B-problem
given	O
the	O
patient	O
&apos;s	O
young	O
age	O
and	O
the	O
difficulty	O
controlling	O
the	O
blood	O
pressure	O
was	O
started	O
as	O
an	O
inpatient	O
and	O
will	O
be	O
completed	O
by	O
Dr.	O
______________as	O
an	O
outpatient	O
.	O

So	O
far	O
no	O
secondary	B-problem
causes	I-problem
of	O
hypertension	B-problem
were	O
identified	O
but	O
causes	O
like	O
lymphocytic	B-problem
?	I-problem
chromocytoma	I-problem
or	O
renal	B-problem
artery	I-problem
stenosis	I-problem
have	O
not	O
been	O
ruled	O
out	O
yet	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

hydrochlorothiazide	B-treatment
25	O
mg.	O
po	O
q.day	O
,	O
Captopril	B-treatment
75	O
mg.	O
po	O
three	O
times	O
a	O
day	O
,	O
Nifedipine	B-treatment
40	O
mg.	O
po	O
three	O
times	O
a	O
day	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

FOLLOWUP	O
:	O

The	O
patient	O
will	O
followup	O
with	O
Dr.	O
______________at	O
Omend	O
Hospital	O
and	O
with	O
Dr.	O
Deep	O
at	O
the	O
Barb	O
Memorial	O
Hospital	O
.	O

DISABILITY	O
:	O

100%	O
for	O
now	O
.	O

Will	O
be	O
reassessed	O
after	O
a	O
month	O
of	O
intensive	B-treatment
physical	I-treatment
therapy	I-treatment
and	O
occupational	B-treatment
therapy	I-treatment
.	O

MATAANRE	O
TAG	O
,	O
M.D.	O

TR	O
:	O

ee	O
/	O
bihn	O

DD	O
:	O

10/25/93	O

TD	O
:	O

10/27/93	O

CC	O
:	O

212512774	O
WGH	O

6218589	O

29021	O

9923207	O

10/31/2004	O
12:00:00	O
AM	O

OB	O
Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O
OB	O
EMR	O
L	O
and	O
D	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

RIASHWAN	O
BERLNI	O
VALLEY	O

UNIT	O
NUMBER	O
:	O

130-93-91	O

ADMISSION	O
DATE	O
:	O

20041031	O

DISCHARGE	O
DATE	O
:	O

20041103	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
:	O

Vaginal	B-treatment
Delivery	I-treatment
With	O
Second	B-problem
Degree	I-problem
Laceration	I-problem

ASSOCIATED	O
DIAGNOSES	O
:	O

Abnormal	B-problem
Laboratory	I-problem
Result	I-problem
;	O
Abnormal	B-problem
Pap	I-problem
Test	I-problem
;	O
Monilial	B-problem
Vaginitis	I-problem

PRINCIPAL	O
PROCEDURE	O
OR	O
OPERATION	O
:	O

Spontaneous	B-treatment
Vertex	I-treatment
Vaginal	I-treatment
Delivery	I-treatment

ASSOCIATED	O
PROCEDURES	O
OR	O
OPERATIONS	O
:	O

POSTPARTUM	O
DIAGNOSTIC	O
PROCEDURES	O
:	O

None	O

POSTPARTUM	O
THERAPEUTIC	O
PROCEDURES	O
:	O

None	O

OTHER	O
POSTPARTUM	O
THERAPIES	O
:	O

Routine	B-treatment
Post	I-treatment
Partum	I-treatment
Care	I-treatment

HISTORY	O
AND	O
REASON	O
FOR	O
HOSPITALIZATION	O
:	O

Premature	B-problem
Rupture	I-problem
Of	I-problem
Membranes	I-problem

PHYSICAL	O
EXAMINATION	O
:	O

HEIGHT	O
63	O
HEENT	B-test
NORMAL	O
MOUTH	O
NORMAL	O
NECK	O
NORMAL	O
BREASTS	O
NORMAL	O
No	O
masses	B-problem
NIPPLES	O
NORMAL	O
CHEST	O
NORMAL	O
CTA	B-test
bilat	O
,	O
neg	O
wheezing	B-problem
COR	O
NORMAL	O
NSR	O
,	O
no	O
murmur	B-problem
ABDOMEN	O
Gravid	B-problem
,	O
vtx	O
.	O

EFW	B-test
=	O
7#	O
.	O

FHTs	B-test
140s	O
w/	O
reactivity	O
.	O

Mild	B-problem
irreg.	I-problem
ctx	I-problem
.	O

EXTREM	B-test
NORMAL	O
SKIN	O
NORMAL	O
NODES	O
NORMAL	O
VULVA	O
NORMAL	O
VAGINA	O
Leaking	O
copious	B-problem
amounts	I-problem
clear	I-problem
fluid	I-problem
.	O

Fluid	B-test
amnioswab	I-test
and	O
fern	B-problem
positive	I-problem
.	O

SSE	B-test
and	O
digital	B-test
exam	I-test
deferred	O
CERVIX	B-test
digital	I-test
exam	I-test
deferred	O
at	O
time	O
of	O
admission	O
OS	B-test
NORMAL	O
see	O
above	O
ADNEXAE	B-test
NORMAL	O
non-palp	O
d	O
/	O
t	O
advanced	B-problem
gest	I-problem
UTERUS	I-problem
Gravid	I-problem
,	O
vtx	O
.	O

EFW	B-test
=	O
7#	O
.	O

FHTs	B-test
140s	O
w/	O
reactivity	O
.	O

Ctx	B-test
q	O
6	O
&apos;	O
.	O

UTERINE	B-test
SIZE	I-test
IN	O
WEEKS	O
38	O

HOSPITAL	O
COURSE	O
(	O
include	O
complications	O
if	O
any	O
)	O
:	O

This	O
27	O
year	O
old	O
Gravida	O
1	O
Para	O
0000	O
was	O
admitted	O
to	O
the	O
Life	O
Valley	O
Medical	O
Center	O
Obstetrical	O
service	O
on	O
10/31/2004	O
at	O
08:45	O
pm	O
for	O
the	O
indication	O
(	O
s	O
)	O
:	O

premature	B-problem
rupture	I-problem
of	I-problem
membranes	I-problem
.	O

She	O
delivered	O
a	O
3235	O
gram	O
male	O
infant	O
on	O
11/01/2004	O
at	O
09:31	O
am	O
with	O
apgar	B-test
scores	I-test
of	O
9	O
and	O
9	O
at	O
one	O
and	O
five	O
minutes	O
respectively	O
at	O
39.0	O
weeks	O
gestation	O
via	O
spontaneous	B-treatment
vertex	I-treatment
vaginal	I-treatment
delivery	I-treatment
.	O

During	O
her	O
labor	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

none	O
.	O

During	O
her	O
delivery	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

none	O
.	O

Postpartum	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

none	O
.	O

She	O
was	O
discharged	O
on	O
11/03/2004	O
at	O
11:18	O
am	O
in	O
good	O
condition	O
.	O

DISCHARGE	O
ORDERS	O
(	O
medications	O
instructions	O
to	O
patient	O
,	O
follow-up	O
care	O
)	O
:	O

DISCHARGE	O
ACTIVITY	O
:	O

No	O
Restrictions	O

DISCHARGE	O
DIET	O
:	O

No	O
Restrictions	O

POSTPARTUM	O
DISPOSITION	O
:	O

Home	O
With	O
Self-Care	O
(	O
Routine	O
Discharge	O
)	O

POSTPARTUM	O
CARE	O
SITE	O
:	O

La	O
Community	O
Hospital	O

POSTPARTUM	O
RETURN	O
APPOINTMENT	O
(	O
DAYS	O
)	O
:	O

42	O

BREAST	O
FEEDING	O
AT	O
DISCHARGE	O
:	O

Yes	O

POSTPARTUM	O
RH	O
IMMUNE	O
GLOBULIN	O
:	O

Not	O
Indicated	O

POSTPARTUM	O
MEASLES	O
/	O
MUMPS	O
/	O
RUBELLA	O
VACCINE	O
:	O

Not	O
Indicated	O

MEDICATION	O
(	O
S	O
)	O
ON	O
DISCHARGE	O
:	O

Multivitamins	B-treatment
And	O
Folate	B-treatment

Electronically	O
Signed	O
:	O

Fyfe	O
,	O
Lan	O
S	O
11/03/2004	O
11:19:27	O
AM	O

223159990	O

PUOMC	O

3546292	O

181083	O

366324	O

7/31/2000	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

AKOTEBONTKAYS	O
,	O
JUANQUINTLEO	O

MRN	O
:	O

3546292	O

Age	O
:	O

37y	O

REGISTRATION	O
DATE	O
:	O

07/31/2000	O
07:36	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
AKOTEBONTKAYS	O
,	O
JUANQUINTLEO	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Ph	O
University	O
Of	O
Medical	O
Center	O
on	O
07/31/2000	O
07:36	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
FEVER	B-problem
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
PH	O
UNIVERSITY	O
OF	O
MEDICAL	O
CENTER	O
.	O

Your	O
patient	O
was	O
admitted	O
under	O
the	O
care	O
of	O
ANER	O
,	O
AEA	O
M	O
with	O
a	O
preliminary	O
diagnosis	O
of	O
LINE	B-problem
SEPSIS	I-problem
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
639-873-2993	O
.	O

245096078	O

FIH	O

9174858	O

12/February	O

997359	O

11/3/1992	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

11/3/92	O

DISCHARGE	O
DATE	O
:	O

12/6/92	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
68	O
year	O
old	O
,	O
right	O
handed	O
caucasian	O
female	O
,	O
former	O
R.N.	O
who	O
complained	O
of	O
several	O
days	O
of	O
vertigo	B-problem
,	O
one	O
day	O
of	O
double	B-problem
vision	I-problem
,	O
dysarthria	B-problem
and	O
worsening	O
of	O
vertigo	B-problem
.	O

She	O
was	O
seen	O
at	O
the	O
outside	O
hospital	O
and	O
put	O
on	O
aspirin	B-treatment
for	O
two	O
days	O
.	O

An	B-test
magnetic	I-test
resonance	I-test
imaging	I-test
study	I-test
showed	O
basilar	B-problem
artery	I-problem
disease	I-problem
,	O
questionable	O
aneurysm	B-problem
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
.	O

An	B-test
angiogram	I-test
on	O
11/3	O
was	O
consistent	O
with	O
thrombosis	B-problem
at	I-problem
the	I-problem
mid	I-problem
basilar	I-problem
artery	I-problem
.	O

The	O
patient	O
was	O
put	O
on	O
heparin	B-treatment
and	O
was	O
stable	O
since	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Hypertension	B-problem
for	O
20	O
years	O
,	O
high	B-problem
cholesterol	I-problem
,	O
coronary	B-problem
artery	I-problem
disease	I-problem
with	O
episodes	O
of	O
angina	B-problem
,	O
no	O
history	O
of	O
myocardial	B-problem
infarction	I-problem
,	O
exercise	B-test
treadmill	I-test
or	O
evaluation	B-test
.	O

She	O
has	O
had	O
an	B-treatment
inguinal	I-treatment
hernia	I-treatment
repair	I-treatment
.	O

A	B-treatment
left	I-treatment
breast	I-treatment
lumpectomy	I-treatment
was	O
reportedly	O
benign	B-test
.	O

ALLERGIES	O
:	O

The	O
patient	O
has	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Mevicor	B-treatment
60	O
mg.	O
PO	O
q.d.	O
,	O
Cardizem	B-treatment
90	O
mg.	O
w	O
release	O
PO	O
q.d.	O
,	O
Questran	B-treatment
one	O
pack	O
q.i.d.	O
,	O
Niacin	B-treatment
500	O
mg.	O
PO	O
b.i.d.	O

SOCIAL	O
HISTORY	O
:	O

She	O
is	O
a	O
one	O
pack	O
per	O
day	O
smoker	O
for	O
the	O
last	O
forty	O
years	O
,	O
denies	O
alcohol	O
,	O
is	O
a	O
former	O
nurse	O
with	O
the	O
Storm	O
Mor	O
Hospital	O
And	O
Medical	O
Center	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Her	B-test
blood	I-test
pressure	I-test
was	O
190/90	O
when	O
I	O
first	O
saw	O
her	O
on	O
her	O
second	O
hospital	O
day	O
.	O

She	O
was	O
afebrile	B-problem
,	O
in	O
sinus	O
rhythm	O
,	O
pulse	O
60	O
.	O

Neck	O
supple	O
.	O

Lungs	O
clear	O
.	O

Heart	O
:	O

regular	O
rate	O
and	O
rhythm	O
,	O
without	O
ectopy	B-problem
.	O

A	B-problem
II	I-problem
/	I-problem
VI	I-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
is	O
at	O
the	O
base	O
,	O
minimal	B-problem
radiation	I-problem
to	I-problem
the	I-problem
carotids	I-problem
.	O

Abdomen	O
:	O

soft	O
,	O
without	O
hepatosplenomegaly	B-problem
.	O

Extremities	O
:	O

normal	O
pulses	O
,	O
no	O
clubbing	B-problem
,	O
cyanosis	B-problem
or	O
edema	B-problem
.	O

The	B-test
neurological	I-test
examination	I-test
:	O

post	O
angiogram	B-test
her	O
eyes	O
were	O
closed	O
.	O

She	O
was	O
very	O
responsive	O
,	O
somewhat	O
sleepy	O
,	O
she	O
complained	O
of	O
chest	B-problem
pain	I-problem
,	O
which	O
was	O
diffuse	O
,	O
non-localizing	O
without	O
electrocardiogram	O
changes	O
and	O
persisted	O
for	O
several	O
days	O
and	O
then	O
went	O
away	O
completely	O
.	O

She	O
was	O
oriented	O
to	O
person	O
,	O
place	O
,	O
time	O
and	O
purpose	O
,	O
she	O
recalled	O
three	O
out	O
of	O
three	O
objects	O
at	O
five	O
minutes	O
,	O
she	O
is	O
able	O
to	O
do	O
calculations	O
.	O

She	O
maintained	O
her	O
fixation	O
on	O
the	O
conversation	O
well	O
.	O

The	B-test
cranial	I-test
nerve	I-test
exam	I-test
:	O

pupils	O
reactive	O
to	O
light	O
,	O
extra	B-test
ocular	I-test
movements	I-test
show	O
good	O
upgaze	O
up	O
to	O
3	O
mm.	O
,	O
good	O
down	O
gaze	O
.	O

Right	B-test
lateral	I-test
gaze	I-test
,	O
the	O
right	O
eye	O
had	O
2	O
mm.	O
of	O
sclera	O
showing	O
,	O
the	O
left	O
eye	O
was	O
normal	O
,	O
and	O
there	O
are	O
a	O
few	O
beats	O
of	O
right	B-problem
beading	I-problem
nystagmus	I-problem
.	O

The	B-test
left	I-test
lateral	I-test
gaze	I-test
,	O
the	O
left	O
eye	O
had	O
1	O
mm.	O
of	O
lateral	O
sclera	O
showing	O
.	O

Disks	O
were	O
flat	O
.	O

Sensory	O
limb	O
of	O
the	O
right	O
eye	O
corneal	B-test
reflex	I-test
is	O
slowed	O
,	O
otherwise	O
normal	O
.	O

Seventh	B-problem
nerve	I-problem
weakness	I-problem
on	O
the	O
right	O
in	O
a	O
central	O
pattern	O
is	O
present	O
.	O

Soft	O
palate	O
was	O
in	O
the	O
midline	O
and	O
moved	O
upward	O
nicely	O
,	O
but	O
did	O
not	O
respond	O
to	O
gag	O
.	O

Tongue	O
protrudes	O
2	O
cm.	O
with	O
slight	O
deviation	O
to	O
the	O
right	O
.	O

Sensory	B-test
exam	I-test
was	O
not	O
remarkable	O
,	O
cerebellar	B-test
exam	I-test
was	O
not	O
possible	O
.	O

Motor	B-test
exam	I-test
showed	O
greater	O
than	O
4+	O
strength	O
bilateral	O
upper	O
extremities	O
and	O
psoas	O
unable	O
to	O
lift	O
off	O
bed	O
.	O

Quadraceps	B-test
2+	O
on	O
the	O
left	O
and	O
3+	O
on	O
the	O
right	O
.	O

Gastroc.	B-test
3	O
on	O
the	O
left	O
and	O
4+	O
on	O
the	O
right	O
.	O

Tibialis	B-test
3	O
on	O
the	O
left	O
,	O
5+	O
on	O
the	O
right	O
.	O

Reflexes	B-test
were	O
diffuse	O
3+	O
,	O
toes	O
upgoing	O
bilaterally	O
.	O

LABORATORY	O
DATA	O
:	O

On	O
admission	O
,	O
electrocardiogram	B-test
showed	O
less	O
than	O
1	O
mm.	O
of	O
ST	B-problem
depression	I-problem
in	I-problem
V4	I-problem
to	I-problem
V6	I-problem
,	O
which	O
is	O
likely	O
the	O
patient	O
&apos;s	O
baseline	O
.	O

CK	B-test
&apos;s	I-test
were	O
mildly	B-problem
elevated	I-problem
but	O
the	B-test
MB	I-test
fractions	I-test
were	O
not	O
remarkable	O
.	O

A	B-test
chest	I-test
X-ray	I-test
showed	O
some	B-problem
left	I-problem
lower	I-problem
lobe	I-problem
atelectasis	I-problem
.	O

Admitting	B-test
creatinine	I-test
was	O
.7	O
,	O
glucose	B-test
131	O
,	O
white	B-test
blood	I-test
count	I-test
was	O
10,000	O
,	O
hematocrit	B-test
was	O
40	O
,	O
liver	B-test
enzymes	I-test
normal	O
range	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
taken	O
to	O
the	O
Intensive	O
Care	O
Unit	O
after	O
her	B-test
angiogram	I-test
.	O

She	O
was	O
aggressively	O
anticoagulated	O
with	O
heparin	B-treatment
.	O

A	B-problem
small	I-problem
intimal	I-problem
tear	I-problem
in	O
the	O
arch	O
of	O
the	O
aorta	O
during	O
the	B-test
angiogram	I-test
,	O
was	O
without	O
sequelae	B-problem
.	O

She	O
was	O
doing	O
well	O
with	O
at	O
least	O
4+	O
strength	O
in	O
all	O
of	O
her	O
extremities	O
,	O
when	O
on	O
11/13	O
,	O
she	O
had	O
an	B-problem
acute	I-problem
drop	I-problem
in	O
her	B-test
systolic	I-test
blood	I-test
pressure	I-test
to	O
70	O
for	O
unclear	O
reasons	O
and	O
without	O
evidence	O
of	O
acute	B-problem
sepsis	I-problem
.	O

This	O
was	O
accompanied	O
by	O
substantial	B-problem
decrement	I-problem
in	I-problem
neurologic	I-problem
function	I-problem
.	O

For	O
a	O
short	O
time	O
,	O
she	O
seemed	O
&quot;	B-problem
locked	I-problem
in	I-problem
&quot;	I-problem
.	O

She	O
has	O
made	O
slow	O
progress	O
since	O
then	O
and	O
at	O
the	O
time	O
of	O
discharge	O
has	O
4-strength	O
at	O
the	O
left	O
elbow	O
and	O
4+	O
in	O
the	O
left	O
wrist	O
and	O
hand	O
.	O

Trace	O
movement	O
of	O
the	O
right	O
elbow	O
and	O
4-strength	O
of	O
the	O
right	O
wrist	O
and	O
hand	O
.	O

4-to	O
4+	O
strength	O
at	O
the	O
left	O
ankle	O
,	O
4+	O
strength	O
at	O
the	O
right	O
knee	O
and	O
right	O
ankle	O
.	O

She	O
is	O
unable	O
to	O
lift	O
either	O
foot	O
off	O
the	O
bed	O
.	O

The	O
extra	O
ocular	O
movements	O
are	O
full	O
.	O

Tongue	O
protrudes	O
4	O
cm	O
.	O

She	O
is	O
drowsy	B-problem
at	O
times	O
,	O
but	O
generally	O
alert	O
,	O
responsive	O
,	O
interactive	O
,	O
able	O
to	O
talk	O
in	O
two	O
to	O
three	O
word	O
sentences	O
when	O
she	O
wants	O
to	O
.	O

She	O
has	O
severe	B-problem
memory	I-problem
deficits	I-problem
,	O
but	O
nevertheless	O
,	O
is	O
able	O
to	O
engage	O
in	O
conversation	O
,	O
answers	O
questions	O
,	O
names	O
things	O
well	O
,	O
does	O
calculations	O
and	O
recognizes	O
family	O
members	O
and	O
states	O
preferences	O
.	O

She	O
has	O
been	O
working	O
with	O
Speech	B-treatment
Therapy	I-treatment
,	O
occupational	B-treatment
therapy	I-treatment
and	O
physical	B-treatment
therapy	I-treatment
closely	O
and	O
should	O
continue	O
to	O
show	O
improvement	O
.	O

She	O
is	O
anticoagulated	O
on	O
Coumadin	B-treatment
and	O
this	O
has	O
been	O
stable	O
.	O

She	O
is	O
do	O
not	O
resuscitate	O
in	O
agreement	O
with	O
the	O
wishes	O
of	O
her	O
multiple	O
family	O
members	O
.	O

Follow	O
up	O
computerized	B-test
tomography	I-test
scans	I-test
and	O
magnetic	B-test
resonance	I-test
imaging	I-test
studies	I-test
have	O
shown	O
infarction	B-problem
in	I-problem
bilateral	I-problem
basis	I-problem
pontis	I-problem
,	I-problem
mid	I-problem
brain	I-problem
,	I-problem
the	I-problem
superior	I-problem
cerebellar	I-problem
areas	I-problem
,	I-problem
left	I-problem
thalamus	I-problem
,	I-problem
bilateral	I-problem
temporal	I-problem
lobes	I-problem
medially	I-problem
and	I-problem
inferiorly	I-problem
and	I-problem
left	I-problem
posterior	I-problem
communicating	I-problem
artery	I-problem
.	O

The	O
patient	O
had	O
fevers	B-problem
sporadically	O
during	O
this	O
hospitalization	O
with	O
rising	B-problem
white	I-problem
blood	I-problem
counts	I-problem
.	O

A	B-test
chest	I-test
X-ray	I-test
documented	O
a	B-problem
progressing	I-problem
left	I-problem
lower	I-problem
lobe	I-problem
infiltrate	I-problem
.	O

Initially	O
this	O
improved	O
on	O
Clindamycin	B-treatment
and	O
Cefotetan	B-treatment
,	O
but	O
fevers	B-problem
recurred	O
on	O
this	B-treatment
antibiotic	I-treatment
regimen	I-treatment
.	O

Sputum	B-test
grew	O
out	O
Klebsiella	B-problem
pneumoniae	I-problem
,	O
and	O
she	O
was	O
treated	O
with	O
Gentamicin	B-treatment
and	O
Ancef	B-treatment
for	O
14	O
days	O
intravenous	O
(	O
bug	B-problem
being	O
sensitive	O
to	O
these	B-treatment
two	I-treatment
drugs	I-treatment
)	O
.	O

A	B-problem
left	I-problem
pleural	I-problem
effusion	I-problem
developed	O
and	O
this	O
was	O
tapped	O
with	O
ultrasound	B-test
guidance	I-test
,	O
and	O
found	O
to	O
be	O
sterile	O
,	O
and	O
without	O
evidence	O
of	O
empyema	B-problem
.	O

The	O
patient	O
is	O
on	O
Ciprofloxacin	B-treatment
.	O

The	O
day	O
of	O
discharge	O
is	O
day	O
#3	O
of	O
7	O
,	O
after	O
which	O
antibiotics	B-treatment
should	O
be	O
totally	O
discontinued	O
.	O

She	O
has	O
developed	O
bad	B-problem
thrush	I-problem
in	O
this	O
setting	O
,	O
she	O
is	O
not	O
yet	O
able	O
to	O
swallow	O
and	O
so	O
she	O
is	O
on	O
Nystatin	B-treatment
swish	I-treatment
and	I-treatment
spit	I-treatment
five	O
times	O
a	O
day	O
.	O

She	O
also	O
gets	O
Peridex	B-treatment
to	O
clean	O
out	O
her	O
mouth	O
.	O

Once	O
her	B-test
liver	I-test
enzymes	I-test
are	O
completely	O
normal	O
,	O
a	O
seven	O
day	O
course	O
of	O
Fluconazol	B-treatment
may	O
be	O
helpful	O
if	O
the	B-problem
thrush	I-problem
is	O
not	O
spontaneously	O
resolving	O
off	O
of	O
antibiotics	B-treatment
.	O

She	O
has	O
been	O
afebrile	B-problem
for	O
greater	O
than	O
10	O
days	O
,	O
including	O
several	O
days	O
on	O
oral	B-treatment
antibiotics	I-treatment
.	O

The	B-test
patient	I-test
&apos;s	I-test
liver	I-test
enzymes	I-test
were	O
noted	O
to	O
be	O
elevated	O
mid	O
way	O
through	O
her	B-treatment
hospital	I-treatment
course	I-treatment
,	O
to	O
about	O
three	O
times	O
normal	O
,	O
especially	O
the	O
SGOT	B-test
and	O
SGPT	B-test
.	O

These	O
have	O
spontaneously	O
reversed	O
,	O
and	O
are	O
nearly	O
normal	O
at	O
the	O
time	O
of	O
discharge	O
.	O

A	B-test
right	I-test
upper	I-test
quadrant	I-test
ultrasound	I-test
documented	O
gallstones	B-problem
,	O
without	O
evidence	O
of	O
common	B-problem
bile	I-problem
duct	I-problem
dilatation	I-problem
or	O
active	B-problem
cholecystitis	I-problem
.	O

The	O
exact	O
cause	O
of	O
her	B-problem
liver	I-problem
enzyme	I-problem
elevation	I-problem
is	O
unclear	O
,	O
but	O
we	O
are	O
being	O
careful	O
about	O
administering	O
drugs	B-treatment
,	O
which	O
might	O
irritate	O
the	O
liver	O
.	O

The	O
patient	O
had	O
a	B-problem
steady	I-problem
decline	I-problem
in	O
her	B-test
hematocrit	I-test
during	O
this	B-treatment
hospitalization	I-treatment
.	O

Iron	B-test
studies	I-test
are	O
all	O
entirely	O
normal	O
,	O
her	B-problem
anemia	I-problem
is	O
attributed	O
to	O
anemia	B-problem
or	O
chronic	B-problem
disease	I-problem
with	O
hypoproliferation	B-problem
as	O
well	O
as	O
multiple	B-test
phlebotomies	I-test
.	O

The	O
plan	O
is	O
to	O
give	O
her	O
folic	B-treatment
acid	I-treatment
,	O
but	O
not	O
iron	B-treatment
.	O

The	B-test
patient	I-test
&apos;s	I-test
potassiums	I-test
have	O
been	O
repeatedly	O
low	O
and	O
require	O
daily	B-test
checks	I-test
and	O
repletion	B-treatment
.	O

This	O
is	O
thought	O
due	O
to	O
the	O
extensive	O
course	O
of	O
Gentamicin	B-treatment
which	O
she	O
received	O
.	O

This	O
must	O
be	O
carefully	O
checked	O
despite	O
the	O
standing	O
order	O
for	O
potassium	B-treatment
.	O

The	O
patient	O
has	O
had	O
low	B-problem
sodiums	I-problem
during	O
this	B-treatment
hospitalization	I-treatment
.	O

This	O
may	O
due	O
to	O
her	B-problem
central	I-problem
nervous	I-problem
system	I-problem
process	I-problem
or	O
her	B-problem
pulmonary	I-problem
process	I-problem
,	O
with	O
fluids	B-treatment
administered	I-treatment
as	O
described	O
,	O
she	O
should	O
not	O
have	O
any	B-problem
problems	I-problem
from	O
this	O
.	O

Her	B-test
sodiums	I-test
were	O
never	O
below	O
130	O
.	O

She	O
does	O
well	O
with	O
tube	B-treatment
feeds	I-treatment
.	O

Her	B-treatment
tube	I-treatment
feeds	I-treatment
orders	O
are	O
as	O
follow	O
:	O

full	O
strength	O
Replete	O
with	O
fiber	B-treatment
at	O
70	O
cc.	O
per	O
hour	O
.	O

In	O
addition	O
,	O
the	O
patient	O
gets	O
250	O
cc.	O
of	O
juice	B-treatment
(	O
not	O
water	O
)	O
three	O
times	O
a	O
day	O
.	O

She	O
also	O
gets	O
Lactinex	B-treatment
granules	I-treatment
three	O
packages	O
in	O
each	O
bottle	O
of	O
tube	B-treatment
feeds	I-treatment
.	O

She	O
also	O
gets	O
Metamucil	B-treatment
one	O
teaspoon	O
with	O
the	O
first	O
bolus	O
of	O
juice	B-treatment
each	O
day	O
.	O

Please	O
note	O
that	O
evaluation	B-test
by	I-test
the	I-test
swallowing	I-test
therapist	I-test
,	O
showed	O
that	O
the	O
patient	O
is	O
aspirating	O
at	O
this	O
time	O
,	O
but	O
there	O
is	O
great	O
hope	O
from	O
the	O
nature	O
of	O
her	B-problem
deficit	I-problem
and	O
the	O
good	O
movements	O
of	O
her	O
tongue	O
that	O
normal	O
swallowing	O
should	O
return	O
soon	O
.	O

It	O
is	O
for	O
this	O
reason	O
that	O
she	O
is	O
discharged	O
with	O
an	B-treatment
nasogastric	I-treatment
tube	I-treatment
and	O
that	O
no	O
plans	O
for	O
G	B-treatment
tube	I-treatment
placement	I-treatment
are	O
made	O
at	O
this	O
time	O
.	O

She	O
has	O
a	O
history	O
of	O
of	O
angina	B-problem
without	O
myocardial	B-problem
infarction	I-problem
that	O
has	O
not	O
been	O
worked	O
up	O
.	O

She	O
did	O
have	O
brief	B-problem
chest	I-problem
pain	I-problem
twice	O
during	O
this	O
admission	O
that	O
did	O
not	O
correlate	O
with	O
electrocardiogram	O
changes	O
.	O

In	O
the	O
first	O
week	O
of	O
November	O
,	O
her	B-test
electrocardiogram	I-test
showed	O
T	B-problem
wave	I-problem
inversions	I-problem
in	I-problem
the	I-problem
lateral	I-problem
leads	I-problem
,	O
correlating	O
with	O
an	B-problem
increase	I-problem
in	O
the	B-test
LDH	I-test
,	O
but	O
not	O
CK	B-test
.	O

This	O
did	O
not	O
normalize	O
with	O
administration	O
of	O
Isordil	B-treatment
and	O
the	O
patient	O
denied	O
chest	B-problem
pain	I-problem
at	O
this	O
time	O
.	O

As	O
of	O
4/7	O
,	O
her	B-test
electrocardiogram	I-test
had	O
reverted	O
back	O
to	O
normal	O
and	O
there	O
is	O
no	O
evidence	O
of	O
congestive	B-problem
heart	I-problem
failure	I-problem
or	O
continued	O
electrocardiogram	O
changes	O
,	O
and	O
chest	B-problem
pain	I-problem
is	O
absent	O
.	O

Her	B-test
cholesterol	I-test
was	O
350	O
here	O
.	O

She	O
has	O
been	O
off	O
of	O
her	B-treatment
hypercholesterol	I-treatment
medicines	I-treatment
.	O

These	O
can	O
be	O
restarted	O
when	O
it	O
is	O
deemed	O
reasonable	O
,	O
in	O
view	O
of	O
her	B-problem
acute	I-problem
disease	I-problem
and	O
recently	B-problem
elevated	I-problem
liver	I-problem
enzymes	I-problem
.	O

Note	O
that	O
the	B-test
liver	I-test
enzymes	I-test
were	O
normal	O
on	O
admission	O
,	O
at	O
which	O
time	O
she	O
was	O
taking	O
all	O
of	O
the	B-treatment
above	I-treatment
cholesterol	I-treatment
medicines	I-treatment
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Metamucil	B-treatment
1	O
teaspoon	O
q.d.	O
,	O
with	O
first	O
bolus	O
of	O
juice	B-treatment
,	O
juice	B-treatment
250	O
cc.	O
down	O
nasogastric	B-treatment
tube	I-treatment
t.i.d.	O
,	O
tube	B-treatment
feeds	I-treatment
as	O
above	O
,	O
Lactinex	B-treatment
as	O
above	O
,	O
Tagamet	B-treatment
800	O
mg.	O
nasogastric	B-treatment
tube	I-treatment
qhs	O
,	O
Nystatin	B-treatment
swish	I-treatment
and	I-treatment
spit	I-treatment
10	O
cc.	O
five	O
times	O
a	O
day	O
,	O
Cardizem	B-treatment
slow	I-treatment
release	I-treatment
90	O
mg.	O
PO	O
q.d.	O
,	O
Folic	B-treatment
Acid	I-treatment
1	O
mg.	O
PO	O
q.d.	O
,	O
Ciprofloxacin	B-treatment
500	O
mg.	O
PO	O
b.i.d.	O
,	O
discontinue	O
on	O
12/10/92	O
KayCiel	B-treatment
30	O
mEq.	O
down	O
nasogastric	B-treatment
tube	I-treatment
q.d.	O
,	O
Peridex	B-treatment
10	O
cc.	O
swish	O
and	O
spit	O
q.i.d.	O
,	O
Coumadin	B-treatment
4	O
mg.	O
nasogastric	O
tube	O
on	O
odd	O
days	O
,	O
alternating	O
with	O
5	O
mg.	O
nasogastric	O
tube	O
on	O
even	O
days	O
,	O
once	O
daily	O
,	O
Tylenol	B-treatment
650	O
mg.	O
PO	O
and	O
PR	O
q6hours	O
PRN	O
pain	B-problem
,	O
Nystatin	B-treatment
powder	I-treatment
to	O
axilla	O
and	O
groin	O
as	O
needed	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Basilar	B-problem
artery	I-problem
stenosis	I-problem
with	O
basilar	B-problem
thrombosis	I-problem
and	O
&quot;	B-problem
top	I-problem
of	I-problem
the	I-problem
basilar	I-problem
&quot;	I-problem
syndrome	I-problem
.	O

Includes	O
recent	B-problem
infarct	I-problem
to	I-problem
pons	I-problem
,	I-problem
mid	I-problem
brain	I-problem
,	I-problem
left	I-problem
thalamus	I-problem
,	I-problem
bilateral	I-problem
temporal	I-problem
lobes	I-problem
and	I-problem
left	I-problem
visual	I-problem
cortex	I-problem
,	O
on	O
Coumadin	B-treatment
.	O

The	O
patient	O
is	O
do	O
not	O
resuscitate	O
at	O
family	O
&apos;s	O
request	O
.	O

Left	B-problem
lower	I-problem
lobe	I-problem
pneumonia	I-problem
,	O
resolving	O
now	O
on	O
oral	B-treatment
antibiotics	I-treatment
.	O

Gallstones	B-problem
,	O
thought	O
to	O
be	O
inactive	O
.	O

Improving	O
liver	B-problem
enzyme	I-problem
elevation	I-problem
.	O

Anemia	B-problem
,	O
discharge	B-test
hematocrit	I-test
28	O
,	O
not	O
iron	B-problem
deficient	I-problem
.	O

Low	B-problem
potassium	I-problem
,	O
thought	O
due	O
to	O
Gentamicin	B-treatment
.	O

Low	B-problem
sodium	I-problem
,	O
responsive	O
to	O
fluid	B-treatment
restriction	I-treatment
.	O

History	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
.	O

Thrush	B-problem
.	O

High	B-problem
cholesterol	I-problem
.	O

The	O
patient	O
needs	O
prothrombin	B-test
time	I-test
checked	O
daily	O
,	O
patient	O
needs	O
potassium	B-test
checked	O
daily	O
,	O
patient	O
needs	O
sodium	B-test
checked	O
at	O
least	O
every	O
other	O
day	O
.	O

DO	O
JOASSCCHIRD	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

NAREA	O
SWALLOW	O
,	O
M.D.	O

TR	O
:	O

sw	O
/	O
bmot	O

DD	O
:	O

12/6/92	O

TD	O
:	O

12/06/92	O

CC	O
:	O

Dr.	O
Namarce	O
May	O
STAT	O

245317863	O
WGH	O

9156109	O

780576	O

0720567	O

04/20/2005	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

KOORSKOTE	O
,	O
RETCO	O

MRN	O
:	O

9156109	O

Age	O
:	O

26y	O

REGISTRATION	O
DATE	O
:	O

04/20/2005	O
10:30	O
PM	O

Provider	O
:	O

HE	O
HERDES	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O
MD	O
:	O

E-mail	O
PCP	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Note	O
Date	O
/	O
Time	O
:	O

04/21/2005	O
05:25	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

RLQ	B-problem
PAIN	I-problem

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
kidney	B-problem
stones	I-problem
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

likely	O
recently	B-problem
passed	I-problem
kidney	I-problem
stone	I-problem

Treatment	O
Rendered	O
:	O

history	O
,	O
physical	B-test
,	O
lab	B-test
,	O
Abdominal	B-test
CT	I-test
scan	I-test

Discharge	O
Medications	O
:	O

Motrin	B-treatment
as	O
needed	O

Follow	O
up	O
Service	O
:	O

Please	O
follow	O
up	O
with	O
your	O
primary	O
care	O
physician	O
within	O
the	O
next	O
week	O
.	O

Also	O
please	O
follow	O
up	O
with	O
urology	O
regarding	O
management	B-treatment
of	O
your	B-problem
kidney	I-problem
stones	I-problem
.	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Please	O
return	O
if	O
your	B-problem
symptoms	I-problem
return	O
,	O
you	O
develop	O
a	B-problem
fever	I-problem
.	O

PCP	O
Name	O
:	O

KOTEKOTEPRUESS	O
,	O
SUSNUM	O

Provider	O
Number	O
:	O

43264	O

This	O
report	O
was	O
created	O
by	O
HERDES	O
,	O
NEWSHALIE	O
04/21/2005	O
06:47	O
AM	O

262182942	O

BH	O

2513486	O

923091	O

05/08/2000	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

JEM	O
,	O
ON	O

MRN	O
:	O

2513486	O

Age	O
:	O

74y	O

REGISTRATION	O
DATE	O
:	O

05/08/2000	O
07:57	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
JEM	O
,	O
ON	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Bri	O
Health	O
on	O
05/08/2000	O
07:57	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
IV	B-treatment
FLUIDS	I-treatment
.	O

Following	O
triage	B-test
,	O
the	O
patient	O
LEFT	O
WITHOUT	O
TREATMENT	B-treatment
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
442-025-0303	O
.	O

PCP	O
Name	O
:	O

ACKCA	O
,	O
SLAINEAEE	O
L	O

Provider	O
Number	O
:	O

78369	O

262912613	O

CTMC	O

43279523	O

551881	O

6/25/1990	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

06/25/1990	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

07/05/1990	O

PRINCIPLE	O
DIAGNOSIS	O
:	O

LEFT	B-problem
KNEE	I-problem
OSTEOARTHRITIS	I-problem
.	O

PROCEDURE	O
:	O

LEFT	B-treatment
TOTAL	I-treatment
KNEE	I-treatment
ARTHROPLASTY	I-treatment
ON	O
6/26/90	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
78-year-old	O
female	O
who	O
has	O
had	O
osteoarthritis	B-problem
and	O
noted	O
the	O
sudden	O
onset	O
of	O
left	B-problem
knee	I-problem
pain	I-problem
in	O
09/89	O
.	O

Since	O
that	O
time	O
,	O
she	O
has	O
used	O
a	B-treatment
cane	I-treatment
and	O
she	O
was	O
referred	O
to	O
Dr.	O
Koors	O
.	O

MRI	B-test
demonstrated	O
a	B-problem
left	I-problem
femoral	I-problem
condyle	I-problem
osteonecrotic	I-problem
defect	I-problem
and	O
degenerative	B-problem
meniscus	I-problem
.	O

She	O
climbs	O
stairs	O
one	O
at	O
a	O
time	O
and	O
denied	O
rest	B-problem
pain	I-problem
.	O

She	O
can	O
one	O
walk	O
without	O
difficulties	B-problem
.	O

She	O
presented	O
for	O
an	B-treatment
elective	I-treatment
left	I-treatment
total	I-treatment
knee	I-treatment
arthroplasty	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Pneumonia	B-problem
one	O
and	O
a	O
half	O
years	O
ago	O
.	O

Hepatitis	B-problem
35	O
years	O
ago	O
.	O

Anxiety	B-problem
neurosis	I-problem
for	O
which	O
she	O
has	O
received	O
shock	B-treatment
therapy	I-treatment
in	O
the	O
past	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Total	B-treatment
abdominal	I-treatment
hysterectomy	I-treatment
.	O

MEDICATIONS	O
:	O

On	O
admission	O
included	O
Tylenol	B-treatment
.	O

ALLERGIES	O
:	O

DOXEPIN	B-treatment
CAUSES	O
ITCHING	B-problem
.	O

HABITS	O
:	O

The	O
patient	O
does	O
not	O
smoke	O
.	O

She	O
drinks	O
one	O
to	O
two	O
glasses	O
of	O
scotch	O
per	O
day	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
was	O
only	O
significant	O
for	O
her	B-test
orthopaedic	I-test
exam	I-test
.	O

Her	O
left	O
knee	O
had	O
5	O
degrees	O
of	O
valgus	B-problem
,	O
120	O
degrees	O
of	O
flexion	O
,	O
full	O
extension	O
and	O
slight	B-problem
valgus	I-problem
instability	I-problem
.	O

She	O
had	O
no	O
Lachmann	O
or	O
anterior	O
drawer	O
,	O
she	O
did	O
have	O
a	B-problem
mild	I-problem
effusion	I-problem
.	O

She	O
had	O
normal	O
sensation	O
and	O
pulses	O
in	O
both	O
legs	O
.	O

LABORATORY	O
DATA	O
:	O

On	O
admission	O
included	O
a	B-test
hematocrit	I-test
of	O
34.2	O
.	O

Potassium	B-test
4.4	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
cleared	O
for	O
surgery	B-treatment
by	O
Dr.	O
Lupevickette	O
Ca	O
.	O

Her	B-test
EKG	I-test
was	O
normal	O
.	O

She	O
was	O
therefore	O
taken	O
to	O
the	O
Operating	O
Room	O
on	O
6/26	O
and	O
underwent	O
a	B-treatment
left	I-treatment
total	I-treatment
knee	I-treatment
arthroplasty	I-treatment
losing	O
200	O
cc	O
of	O
blood	O
in	O
the	B-treatment
procedure	I-treatment
with	O
two	B-treatment
drains	I-treatment
left	O
in	O
which	O
were	O
removed	O
on	O
the	O
first	O
postoperative	O
day	O
.	O

She	O
was	O
slightly	B-problem
agitated	I-problem
on	O
the	O
first	O
postoperative	O
day	O
but	O
this	O
resolved	O
by	O
the	O
second	O
postoperative	O
day	O
.	O

Her	B-treatment
epidural	I-treatment
catheter	I-treatment
was	O
removed	O
on	O
6/29	O
.	O

The	B-treatment
Foley	I-treatment
catheter	I-treatment
was	O
removed	O
on	O
6/29	O
and	O
she	O
had	O
no	O
difficulties	B-problem
voiding	I-problem
.	O

Psychiatry	O
Service	O
saw	O
her	O
on	O
6/28	O
and	O
recommended	O
avoiding	O
benzodiazepines	B-treatment
and	O
Haldol	B-treatment
for	O
agitation	B-problem
.	O

She	O
was	O
prophylaxed	O
with	O
Kefzol	B-treatment
perioperatively	O
and	O
with	O
Coumadin	B-treatment
postoperatively	O
.	O

She	O
was	O
also	O
given	O
whiskey	B-treatment
spirits	I-treatment
because	O
of	O
the	O
fact	O
that	O
she	O
drank	O
one	O
to	O
two	O
drinks	O
of	O
scotch	O
per	O
day	O
.	O

Her	B-test
hematocrit	I-test
was	O
31.4	O
on	O
6/29	O
with	O
a	B-test
PT	I-test
of	O
18.2	O

Her	B-test
PT	I-test
drifted	O
down	O
to	O
a	O
level	O
of	O
12.9	O
by	O
7/3	O
and	O
therefore	O
she	O
will	O
be	O
discharged	O
with	O
4	O
mg	O
of	O
Coumadin	B-treatment
per	O
day	O
to	O
be	O
followed	O
by	O
the	O
Coumadin	O
Clinic	O
at	O
Cowerin	O
Tonli	O
Medical	O
Center	O
.	O

She	O
was	O
discharged	O
with	O
a	O
prescription	O
for	O
Tylenol	B-treatment
#3	I-treatment
with	O
Physical	B-treatment
Therapy	I-treatment
.	O

She	O
did	O
quite	O
well	O
with	O
Physical	B-treatment
Therapy	I-treatment
and	O
was	O
ambulating	O
with	O
a	B-treatment
walker	I-treatment
and	O
crutches	B-treatment
by	O
7/3/90	O
.	O

She	O
was	O
able	O
to	O
flex	O
her	O
knees	O
to	O
90	O
degrees	O
by	O
that	O
time	O
.	O

She	O
developed	O
no	O
problems	O
with	O
edema	B-problem
or	O
with	O
her	B-problem
wound	I-problem
during	O
her	O
hospital	O
stay	O
.	O

She	O
will	O
follow-up	O
with	O
Dr.	O
Koors	O
in	O
approximately	O
five	O
weeks	O
.	O

________________________________	O

IA605/6041	O
DE	O
KOORS	O
,	O
M.D.	O
CU2	O

D	O
:	O

07/03/90	O

Batch	O
:	O

1726	O

Report	O
:	O

J0929X49	O

T	O
:	O

07/04/90	O

Dicatated	O
By	O
:	O

LENTNY	O
FARSTNAPPSSHEE	O
,	O
M.D.	O

270045381	O

BH	O

6676757	O

650129	O

10/10/1997	O
12:00:00	O
AM	O

LEFT	B-problem
PROXIMAL	I-problem
HUMERUS	I-problem
FRACTURE	I-problem
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

JUNK	O
,	O
KACHOLERA	O

UNIT	O
NUMBER	O
:	O

482-31-51	O

ADMISSION	O
DATE	O
:	O

10/10/97	O

DISCHARGE	O
DATE	O
:	O

10/23/97	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Left	B-problem
proximal	I-problem
humerus	I-problem
fracture	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Adult-onset	B-problem
diabetes	I-problem
mellitus	I-problem
x	O
40	O
years	O
,	O
history	O
of	O
silent	B-problem
myocardial	I-problem
infarction	I-problem
,	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
(	O
three	O
vessels	O
in	O
1987	O
)	O
,	O
history	O
of	O
chronic	B-problem
,	I-problem
stable	I-problem
angina	I-problem
pectoris	I-problem
,	O
Fournier	B-problem
&apos;s	I-problem
gangrene	I-problem
versus	O
necrotizing	B-problem
fasciitis	I-problem
,	O
congestive	B-problem
heart	I-problem
failure	I-problem
in	O
03/97	O
while	O
in	O
the	O
hospital	O
for	O
a	B-problem
rib	I-problem
fracture	I-problem
,	O
glaucoma	B-problem
,	O
diabetic	B-problem
retinopathy	I-problem
with	O
blindness	B-problem
in	I-problem
the	I-problem
right	I-problem
eye	I-problem
,	O
history	O
of	O
gastric	B-treatment
stapling	I-treatment
,	O
left	B-problem
rib	I-problem
fracture	I-problem
,	O
right	B-treatment
femur	I-treatment
surgery	I-treatment
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Left	B-treatment
shoulder	I-treatment
hemiarthroplasty	I-treatment
.	O

OTHER	O
PROCEDURES	O
:	O

Upper	B-treatment
endoscopy	I-treatment
x	O
2	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
65-year-old	O
male	O
with	O
a	O
past	O
medical	O
history	O
of	O
diabetes	B-problem
mellitus	I-problem
,	O
three-vessel	B-treatment
coronary	I-treatment
artery	I-treatment
bypassgraft	I-treatment
,	O
congestive	B-problem
heart	I-problem
failure	I-problem
,	O
who	O
presents	O
with	O
a	B-problem
humeral	I-problem
fracture	I-problem
.	O

The	O
patient	O
is	O
admitted	O
for	O
preoperative	B-test
and	I-test
orthopedic	I-test
evaluations	I-test
.	O

The	O
patient	O
presented	O
with	O
a	B-problem
comminuted	I-problem
fracture	I-problem
of	I-problem
the	I-problem
proximal	I-problem
left	I-problem
humerus	I-problem
when	O
he	O
slipped	O
over	O
the	O
stairs	O
,	O
about	O
to	O
board	O
an	O
airplane	O
back	O
to	O
Jeglas	O
Blvd.	O
,	O
Jolouisrowarlihis	O
,	O
Alabama	O
86071	O
.	O

The	B-problem
fracture	I-problem
was	O
seen	O
by	O
Orthopedics	O
and	O
was	O
reduced	O
.	O

During	O
conscious	B-treatment
sedation	I-treatment
,	O
the	O
patient	O
developed	O
bigeminy	B-problem
(	O
the	O
patient	O
was	O
sedated	O
,	O
did	O
not	O
feel	O
chest	B-problem
pain	I-problem
or	O
shortness	B-problem
of	I-problem
breath	I-problem
)	O
.	O

The	O
patient	O
presented	O
to	O
Bri	O
Health	O
in	O
order	O
to	O
be	O
evaluated	O
for	O
preoperative	B-test
clearance	I-test
.	O

He	O
was	O
reported	O
to	O
have	O
had	O
a	B-problem
myocardial	I-problem
infarction	I-problem
in	O
the	O
past	O
(	O
EKG	B-test
positive	O
for	O
ischemia	B-problem
,	O
exercise	B-test
tolerance	I-test
test	I-test
positive	O
,	O
cardiac	B-test
catheterization	I-test
positive	O
,	O
the	O
patient	O
is	O
now	O
status	O
posta	O
three-vessel	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
in	O
1987	O
)	O
.	O

The	O
patient	O
also	O
hada	O
history	O
of	O
arrhythmia	B-problem
,	O
found	O
approximately	O
ten	O
years	O
ago	O
,	O
unknown	O
what	O
type	O
.	O

The	O
patient	O
was	O
on	O
coumadin	B-treatment
recently	O
,	O
?	O
whether	O
for	O
the	O
arrhythmia	B-problem
.	O

Coumadin	B-treatment
was	O
reportedly	O
discontinued	O
approximately	O
six	O
months	O
ago	O
secondary	O
to	O
planned	O
surgery	B-treatment
for	O
diabetic	B-problem
retinopathy	I-problem
and	O
glaucoma	B-problem
.	O

The	O
patient	O
did	O
not	O
have	O
chest	B-problem
pain	I-problem
until	O
approximately	O
1-1/2	O
years	O
ago	O
,	O
when	O
he	O
began	O
to	O
have	O
chest	B-problem
tightness	I-problem
(	I-problem
pressure	I-problem
)	I-problem
approximately	O
every	O
three	O
months	O
with	O
stress	B-problem
.	O

The	O
patient	O
has	O
no	O
chest	B-problem
pain	I-problem
when	O
walking	O
slowly	O
and	O
can	O
walk	O
approximately	O
1.5	O
miles	O
.	O

He	O
can	O
climb	O
approximately	O
three	O
flights	O
of	O
stairs	O
before	O
becoming	O
short	B-problem
of	I-problem
breath	I-problem
.	O

He	O
does	O
become	O
slightly	B-problem
short	I-problem
of	I-problem
breath	I-problem
when	O
lifting	O
furniture	O
.	O

On	O
the	O
day	O
of	O
admission	O
,	O
when	O
he	O
fell	O
,	O
the	O
patient	O
was	O
experiencing	O
no	O
chest	B-problem
pain	I-problem
,	O
no	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
and	O
had	O
no	O
loss	B-problem
of	I-problem
consciousness	I-problem
,	O
no	O
head	B-problem
trauma	I-problem
with	I-problem
fall	I-problem
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

No	O
fevers	B-problem
or	O
chills	B-problem
,	O
no	O
chest	B-problem
pain	I-problem
,	O
no	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

The	O
patient	O
has	O
stable	B-problem
three-pillow	I-problem
orthopnea	I-problem
and	O
occasional	B-problem
paroxysmal	I-problem
nocturnal	I-problem
dyspnea	I-problem
.	O

He	O
has	O
a	B-problem
chronic	I-problem
cough	I-problem
with	O
clear	B-problem
sputum	I-problem
.	O

No	O
hemoptysis	B-problem
,	O
hematemesis	B-problem
,	O
abdominal	B-problem
pain	I-problem
,	O
black	B-problem
or	I-problem
tarry	I-problem
stools	I-problem
,	O
dysuria	B-problem
/	O
frequency/urgency	B-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Some	O
type	O
of	O
cardiac	B-problem
arrhythmia	I-problem
,	O
diagnosed	O
approximately	O
ten	O
years	O
ago	O
.	O

History	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
status	O
post	O
silent	B-problem
myocardial	I-problem
infarction	I-problem
in	O
the	O
past	O
and	O
three-vessel	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
in	O
1987	O
.	O

The	O
patient	O
has	O
been	O
experiencing	O
chronic	B-problem
,	I-problem
stable	I-problem
angina	I-problem
pectoris	I-problem
over	O
the	O
past	O
one	O
to	O
one	O
and	O
a	O
half	O
years	O
approximately	O
once	O
every	O
three	O
months	O
.	O

History	O
of	O
congestive	B-problem
heart	I-problem
failure	I-problem
,	O
diagnosed	O
approximately	O
eight	O
years	O
ago	O
.	O

Diabetes	B-problem
mellitus	I-problem
for	O
approximately	O
40	O
years	O
.	O

Fournier	B-problem
&apos;s	I-problem
gangrene	I-problem
versus	O
necrotizing	B-problem
fasciitis	I-problem
.	O

Glaucoma	B-problem
.	O

Diabetic	B-problem
retinopathy	I-problem
with	O
the	O
patient	O
blind	B-problem
in	I-problem
right	I-problem
eye	I-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Cholecystectomy	B-treatment
.	O

Status	O
post	O
gastric	B-treatment
stapling	I-treatment
.	O

Left	B-problem
rib	I-problem
fracture	I-problem
.	O

Right	B-treatment
femur	I-treatment
surgery	I-treatment
approximately	O
two	O
years	O
ago	O
.	O

Righteye	B-treatment
surgery	I-treatment
for	O
glaucoma	B-problem
in	O
05/97	O
.	O

Laser	B-treatment
surgery	I-treatment
for	O
retinopathy	B-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Humulin	B-treatment
70/30	O
with	O
30	O
units	O
subq.q.a.m.	O
and	O
20	O
units	O
subq.q.p.m.	O
Vasotec	B-treatment
20	O
mg.	O
q.	O
a.m.	O
Prozac	B-treatment
40	O
mg.	O
q.d.	O
Lasix	B-treatment
40	O
mg.	O
q.d.	O
K-Dur	B-treatment
approximately	O
28	O
?	O
mEq	O
q.d.	O
Atropine	B-treatment
1%	O
1	O
GTT	O
OD	O
b.i.d.	O
Ocufen	B-treatment
0.03%	O
1	O
GTT	O
OD	O
t.i.d.	O
Ventolin	B-treatment
metered-dose	O
inhaler	O
.	O

ALLERGIES	O
:	O

no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

TOBACCO	O
:	O

Formerly	O
smoked	O
3	O
packs	O
per	O
day	O
x	O
25	O
years	O
;	O
2	O
cigars	O
per	O
day	O
x	O
approximately	O
6	O
months	O
.	O

He	O
quit	O
all	O
tobacco	O
approximately	O
27	O
years	O
ago	O
.	O

ETOH	O
:	O

Rare	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
retired	O
,	O
lives	O
with	O
his	O
wife	O
and	O
one	O
son	O
,	O
who	O
is	O
47	O
years	O
old	O
and	O
had	O
multiple	B-problem
myeloma	I-problem
and	O
renal	B-problem
failure	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
is	O
alert	O
and	O
oriented	O
and	O
has	O
a	B-treatment
sling	I-treatment
for	O
his	B-problem
left	I-problem
humeral	I-problem
fracture	I-problem
.	O

Blood	B-test
pressure	I-test
120/70	O
,	O
temperature	B-test
97.8	O
F	O
,	O
pulse	B-test
68	O
,	O
respirations	B-test
22	O
,	O
Sa02	B-test
on	O
2	O
L	O
94%	O
.	O

HEENT	O
:	O

Right-sided	B-problem
ptosis	I-problem
,	O
right	O
eye	O
not	O
reactive	O
to	O
light	O
,	O
cataract	B-problem
present	O
,	O
patient	O
blind	B-problem
in	I-problem
that	I-problem
eye	I-problem
,	O
left	O
eye	O
reactive	O
to	O
light	O
,	O
cataract	B-problem
also	O
present	O
in	O
that	O
eye	O
.	O

Extraocular	B-test
movements	I-test
-	O
conjugated	O
eye	O
movement	O
intact	O
.	O

Oropharynx	O
moist	O
,	O
without	O
lesions	B-problem
.	O

Mild	B-problem
right	I-problem
facial	I-problem
droop	I-problem
.	O

Sensation	O
intact	O
.	O

No	O
slurred	B-problem
speech	I-problem
.	O

Cardiac	O
:	O

regular	O
rate	O
and	O
rhythm	O
,	O
no	O
murmur	B-problem
appreciated	O
,	O
normal	O
S1	O
and	O
S2	O
.	O

Chest	O
/	O
lungs	O
:	O

The	O
patient	O
is	O
diffusely	B-problem
wheezy	I-problem
upon	O
presentation	O
.	O

Abdomen	B-problem
distended	I-problem
,	O
mild	B-problem
tenderness	I-problem
on	I-problem
the	I-problem
left	I-problem
,	O
bowel	B-test
sounds	I-test
present	O
,	O
nohepatosplenomegaly	B-problem
.	O

Extremities	O
:	O

1+	B-problem
edema	I-problem
of	I-problem
the	I-problem
ankles	I-problem
,	O
pulses	B-test
present	O
bilaterally	O
.	O

No	O
calf	B-problem
tenderness	I-problem
.	O

Rectal	O
:	O

Guaiac	B-test
negative	O
.	O

Neurological	O
:	O

Non-focal	O
,	O
except	O
unable	O
to	O
assess	O
left	O
upper	O
extremity	O
secondary	O
to	O
the	B-problem
patient	I-problem
&apos;s	I-problem
broken	I-problem
humeral	I-problem
fracture	I-problem
.	O

LABORATORY	O
DATA	O
:	O

sodium	B-test
135	O
,	O
potassium	B-test
4.1	O
,	O
chloride	B-test
101	O
,	O
C02	B-test
28.4	O
,	O
BUN	B-test
17	O
,	O
creatinine	B-test
1.0	O
,	O
glucose	B-test
302	O
,	O
calcium	B-test
8.6	O
,	O
phosphorus	B-test
2.5	O
,	O
magnesium	B-test
1.6	O
,	O
total	B-test
protein	I-test
6.7	O
,	O
albumin	B-test
3.3	O
,	O
globulin	B-test
3.4	O
,	O
uric	B-test
acid	I-test
6.3	O
,	O
totalbilirubin	B-test
.7	O
,	O
alkaline	B-test
phosphatase	I-test
93	O
,	O
SGOT	B-test
20	O
,	O
LDH	B-test
258	O
,	O
CPK	B-test
95	O
,	O
whiteblood	B-test
count	I-test
15.3	O
,	O
hematocrit	B-test
49.7	O
,	O
platelet	B-test
count	I-test
159	O
,	O
MCV	B-test
98	O
.	O

RADIOLOGIC	O
STUDIES	O
:	O

Chest	B-test
x-ray	I-test
10/10/97	O
:	O

Elevated	B-problem
left	I-problem
hemidiaphragm	I-problem
of	O
uncertain	O
etiology	O
or	O
duration	O
.	O

Postoperative	B-problem
changes	I-problem
of	I-problem
the	I-problem
sternum	I-problem
and	I-problem
media	I-problem
stinum	I-problem
were	O
seen	O
and	O
no	O
acute	B-problem
pulmonary	I-problem
disease	I-problem
was	O
visualized	O
.	O

The	O
patient	O
also	O
had	O
a	B-test
shoulder	I-test
film	I-test
done	O
on	O
10/10/97	O
that	O
showed	O
a	B-problem
severely	I-problem
comminuted	I-problem
fracture	I-problem
of	I-problem
the	I-problem
proximal	I-problem
left	I-problem
humerus	I-problem
with	O
proximal	B-problem
distraction	I-problem
.	O

A	B-problem
lucency	I-problem
and	I-problem
irregularity	I-problem
of	I-problem
the	I-problem
glenoid	I-problem
,	O
possibly	O
representing	O
a	B-problem
fracture	I-problem
,	O
was	O
also	O
seen	O
,	O
and	O
a	B-test
CT	I-test
scan	I-test
was	O
therefore	O
obtained	O
in	O
order	O
to	O
evaluate	O
this	O
area	O
.	O

This	B-test
CT	I-test
scan	I-test
,	O
done	O
also	O
on	O
10/10/97	O
,	O
again	O
showed	O
the	B-problem
severely	I-problem
comminuted	I-problem
fracture	I-problem
of	I-problem
the	I-problem
proximal	I-problem
left	I-problem
humerus	I-problem
.	O

Two	B-problem
major	I-problem
fracture	I-problem
fragments	I-problem
were	O
seen	O
at	O
the	O
humeral	O
head	O
,	O
articulating	O
with	O
the	O
glenoid	O
fossa	O
.	O

The	B-problem
fracture	I-problem
fragments	I-problem
retained	O
their	O
proper	O
site	O
of	O
articulation	O
with	O
the	O
glenoid	O
fossa	O
.	O

Innumerable	B-problem
smaller	I-problem
fracture	I-problem
fragments	I-problem
were	O
interposed	O
between	O
the	B-problem
fracture	I-problem
fragment	I-problem
and	O
the	O
distal	O
humeral	O
shaft	O
.	O

The	O
glenoid	O
fossa	O
was	O
intact	O
.	O

No	O
scapular	B-problem
fractures	I-problem
were	O
present	O
.	O

EKG	B-test
:	O

normal	O
sinus	O
rhythm	O
at	O
72	O
beats	B-test
/	I-test
minute	I-test
,	O
intraventricular	B-problem
conduction	I-problem
delay	I-problem
,	O
Q	O
-	O
waves	O
seen	O
in	O
II	O
,	O
III	O
,	O
and	O
AVF	O
with	O
probable	O
old	B-problem
inferior	I-problem
myocardial	I-problem
infarction	I-problem
.	O

T	O
-	O
waves	O
were	O
also	O
noted	O
to	O
be	O
inverted	O
in	O
I	O
and	O
AVL	O
.	O

Ventricular	B-problem
bigeminy	I-problem
was	O
also	O
seen	O
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

1.	O
ORTHOPEDICS	O
:	O

The	O
patient	O
has	O
a	B-problem
severely	I-problem
comminuted	I-problem
fracture	I-problem
of	I-problem
the	I-problem
proximal	I-problem
left	I-problem
humerus	I-problem
.	O

He	O
is	O
status	O
post	O
a	B-treatment
hemiarthroplasty	I-treatment
on	O
10/17/97	O
.	O

He	O
received	O
Ancef	B-treatment
preoperatively	O
.	O

Physical	O
Therapy	O
has	O
been	O
seeing	O
the	O
patient	O
and	O
putting	O
him	O
through	O
passive	B-treatment
external	I-treatment
rotation	I-treatment
to	O
the	O
neutral	O
position	O
of	O
the	O
left	O
shoulder	O
and	O
forward	O
flexion	O
with	O
physical	B-treatment
therapy	I-treatment
assistance	I-treatment
.	O

Brittle	B-problem
bones	I-problem
were	O
noted	O
during	O
the	B-treatment
operation	I-treatment
.	O

A	B-test
bone	I-test
density	I-test
scan	I-test
would	O
be	O
recommended	O
as	O
an	O
outpatient	O
,	O
in	O
order	O
to	O
evaluate	O
this	O
.	O

2.	O
NEUROLOGICAL	O
:	O

The	O
patient	O
has	O
right	B-problem
facial	I-problem
droop	I-problem
,	O
right	B-problem
ptosis	I-problem
,	O
stable	O
and	O
present	O
for	O
greater	O
than	O
one	O
year	O
.	O

3.	O
CARDIOVASCULAR	O
:	O

No	O
chest	B-problem
pain	I-problem
,	O
no	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
1+	B-problem
ankle	I-problem
edema	I-problem
.	O

The	O
patient	O
was	O
ruled	O
out	O
for	O
a	B-problem
myocardial	I-problem
infarction	I-problem
,	O
given	O
his	B-problem
fall	I-problem
at	O
the	O
airport	O
and	O
bigeminy	B-problem
seen	O
on	O
electrocardiogram	B-test
that	O
he	O
developed	O
during	O
conscious	B-treatment
sedation	I-treatment
during	O
reduction	B-treatment
of	I-treatment
the	I-treatment
fracture	I-treatment
.	O

Cardiology	O
was	O
consulted	O
and	O
aspirin	B-treatment
and	O
beta	B-treatment
blocker	I-treatment
added	O
to	O
his	B-treatment
regimen	I-treatment
,	O
as	O
well	O
as	O
chest	B-treatment
wall	I-treatment
nitroglycerin	I-treatment
around	O
the	O
time	O
of	O
surgery	B-treatment
,	O
which	O
was	O
subsequently	O
discontinued	O
.	O

An	B-test
adenosine	I-test
SESTAMIBI	I-test
was	O
performed	O
on	O
10/12/97	O
,	O
which	O
showed	O
a	O
negative	O
electrocardiogram	O
for	O
ischemia	B-problem
and	O
cardiac	B-test
perfusion	I-test
scans	I-test
,	O
with	O
a	B-problem
moderate-sized	I-problem
,	I-problem
dense	I-problem
,	I-problem
fixed	I-problem
inferior	I-problem
defect	I-problem
indicative	O
of	O
scar	B-problem
.	O

A	B-problem
small	I-problem
/	I-problem
moderate-sized	I-problem
,	I-problem
mild-intensity	I-problem
,	I-problem
reversible	I-problem
posterior	I-problem
lateral	I-problem
defect	I-problem
was	O
also	O
seen	O
,	O
indicative	O
of	O
mild	B-problem
/	I-problem
moderate	I-problem
ischemia	I-problem
.	O

An	B-test
echocardiogram	I-test
was	O
performed	O
on	O
Columbus	O
Day	O
which	O
showed	O
an	B-test
ejection	I-test
fraction	I-test
of	O
50%	O
,	O
left	B-problem
atrial	I-problem
enlargement	I-problem
,	O
thickening	B-problem
of	I-problem
the	I-problem
aortic	I-problem
wall	I-problem
consistent	O
with	O
atherosclerotic	B-problem
changes	I-problem
,	O
left	O
ventricle	O
size	O
,	O
and	O
systolic	O
function	O
within	O
normal	O
limits	O
.	O

Cardiac	B-test
monitor	I-test
was	O
placed	O
on	O
the	O
patient	O
,	O
given	O
the	B-problem
bigeminy	I-problem
,	O
and	O
he	O
did	O
rule	O
out	O
for	O
myocardial	B-problem
infarction	I-problem
.	O

Cardiology	O
recommended	O
that	O
in	O
addition	O
to	O
the	B-treatment
medications	I-treatment
already	O
stated	O
above	O
,	O
his	B-test
hematocrit	I-test
be	O
kept	O
greater	O
than	O
30	O
.	O

After	O
his	B-treatment
procedure	I-treatment
on	O
10/17/97	O
,	O
elevated	B-problem
CPKs	I-problem
were	O
noted	O
on	O
10/19/97	O
to	O
10/20/97	O
,	O
and	O
the	O
first	O
level	O
was	O
744	O
,	O
CPK	B-test
#	O
2	O
635	O
,	O
and	O
CPK	B-test
#	O
3	O
461	O
.	O

MB	B-problem
fractionations	I-problem
of	O
the	B-test
CPKs	I-test
were	O
all	O
negative	O
and	O
were	O
thought	O
to	O
be	O
secondary	O
to	O
the	O
patient	O
&apos;s	O
beginning	O
physical	O
therapy	O
on	O
10/19/97	O
,	O
and	O
all	O
muscular	O
in	O
origin	O
.	O

4.	O
GASTROENTEROLOGY	O
:	O

GI	O
was	O
consulted	O
on	O
10/15/97	O
for	O
melena	B-problem
,	O
decreased	B-problem
hematocrit	I-problem
prior	O
to	O
his	B-treatment
humeral	I-treatment
fixation	I-treatment
surgery	I-treatment
.	O

Upper	B-test
endoscopy	I-test
x	I-test
2	I-test
were	O
done	O
.	O

The	O
first	O
was	O
on	O
10/15/97	O
,	O
which	O
showed	O
clotted	B-problem
blood	I-problem
in	I-problem
the	I-problem
esophagus	I-problem
.	O

The	O
stomach	O
had	O
evidence	O
of	O
prior	B-treatment
surgery	I-treatment
and	O
old	B-problem
blood	I-problem
in	I-problem
the	I-problem
stomach	I-problem
.	O

It	O
was	O
thought	O
that	O
the	B-problem
blood	I-problem
in	I-problem
the	I-problem
esophagus	I-problem
was	O
secondary	O
to	O
a	O
possible	O
Mallory-Weiss	B-problem
tear	I-problem
.	O

A	B-test
second	I-test
endoscopy	I-test
was	O
also	O
performed	O
several	O
days	O
later	O
,	O
in	O
order	O
to	O
rule	O
out	O
a	B-problem
gastric	I-problem
ulcer	I-problem
,	O
and	O
also	O
because	O
the	O
patient	O
had	O
had	O
another	O
episode	O
of	O
melena	B-problem
.	O

A	B-problem
gastric	I-problem
ulcer	I-problem
was	O
found	O
and	O
this	O
was	O
biopsied	O
and	O
pathology	B-test
is	O
pending	O
at	O
this	O
time	O
.	O

This	O
report	O
needs	O
to	O
be	O
followed	O
up	O
,	O
and	O
will	O
be	O
available	O
at	O
Bri	O
Health	O
in	O
the	O
Pathology	O
Department	O
some	O
time	O
within	O
the	O
next	O
three	O
to	O
seven	O
days	O
.	O

The	O
patient	O
also	O
needs	O
a	B-test
repeat	I-test
endoscopy	I-test
and	O
a	B-test
GI	I-test
follow-up	I-test
appointment	O
inapproximately	O
two	O
months	O
.	O

I	O
have	O
spoken	O
with	O
the	O
patient	O
in	O
detail	O
,	O
and	O
he	O
will	O
be	O
getting	O
in	O
touch	O
with	O
his	O
primary-care	O
physician	O
,	O
Dr.	O
Fordwoodall	O
Stick	O
,	O
in	O
Ranegei	O
Pkwy	O
,	O
Verertliet	O
,	O
South	O
Carolina	O
62156	O
.	O

The	O
patient	O
is	O
to	O
arrange	O
follow	O
up	O
with	O
a	O
GI	O
doctor	O
in	O
Jotar	O
Boulevard	O
,	O
Cunahtampfordama	O
,	O
South	O
Dakota	O
62848	O
through	O
his	O
primary-care	O
physician	O
.	O

The	O
patient	O
was	O
initially	O
on	O
Cimetidine	B-treatment
and	O
Carafate	B-treatment
here	O
at	O
Bri	O
Health	O
,	O
and	O
then	O
switched	O
to	O
Prilosec	B-treatment
20	O
mg	O
bid	O
.	O

5.	O
PULMONARY	O
:	O

The	B-test
patient	I-test
&apos;s	I-test
admitting	I-test
chest	I-test
x-ray	I-test
showed	O
an	B-problem
elevated	I-problem
left	I-problem
hemidiaphragm	I-problem
consistent	O
with	O
atelectasis	B-problem
versus	O
splinting	B-problem
on	I-problem
that	I-problem
side	I-problem
.	O

Incentive	B-treatment
spirometry	I-treatment
was	O
started	O
.	O

Albuterol	B-treatment
and	I-treatment
Atrovent	I-treatment
nebulizers	I-treatment
were	O
done	O
.	O

The	O
patient	O
received	O
chest	B-treatment
physical	I-treatment
therapy	I-treatment
bid	O
.	O

6.	O
ENDOCRINE	O
:	O

The	O
patient	O
needs	O
still	O
better	O
diabetes	B-treatment
control	I-treatment
.	O

He	O
has	O
been	O
somewhat	O
noncompliant	O
with	O
his	O
diet	O
(	O
eating	O
Pringle	O
&apos;s	O
in	O
the	O
room	O
)	O
.	O

His	B-treatment
NPH	I-treatment
was	O
recently	O
increased	O
today	O
(	O
10/23/97	O
)	O
to	O
24	O
units	O
in	O
the	O
a.m.	O
and	O
14	O
units	O
in	O
the	O
p.m.	O
with	O
CZI	B-treatment
sliding-scale	I-treatment
coverage	I-treatment
.	O

7.	O
INFECTIOUS	O
DISEASE	O
:	O

The	B-test
patient	I-test
urinalysis	I-test
on	O
10/19/97	O
showed	O
moderate	B-problem
occult	I-problem
blood	I-problem
,	O
pH	B-test
5	O
,	O
albumin	B-test
1+	O
,	O
white	B-test
blood	I-test
cells	I-test
present	O
,	O
2-50	O
red	B-test
blood	I-test
cell	I-test
,	O
10-20	O
white	B-test
blood	I-test
cells	I-test
,	O
few	B-problem
bacteria	I-problem
,	O
and	O
moderate	B-problem
bladder	I-problem
epithelial	I-problem
cells	I-problem
.	O

Floxin	B-treatment
200	O
mg	O
po	O
bid	O
was	O
begun	O
.	O

However	O
,	O
his	B-test
urine	I-test
culture	I-test
from	O
the	O
same	O
day	O
remained	O
negative	O
,	O
and	O
this	O
was	O
discontinued	O
two	O
days	O
later	O
.	O

A	B-test
repeat	I-test
urinalysis	I-test
on	O
10/22/97	O
was	O
negative	O
.	O

8.	O
RENAL	O
:	O

After	O
the	B-treatment
patient	I-treatment
&apos;s	I-treatment
procedure	I-treatment
,	O
he	O
was	O
felt	O
to	O
be	O
volume	B-problem
overloaded	I-problem
.	O

He	O
was	O
given	O
Lasix	B-treatment
40	O
mg	O
IV	O
x	O
1	O
and	O
also	O
had	O
Nitro	B-treatment
paste	I-treatment
around	O
the	O
time	O
of	O
his	B-treatment
surgery	I-treatment
and	O
beta	B-treatment
blocker	I-treatment
.	O

The	O
patient	O
became	O
slightly	B-problem
hypotensive	I-problem
on	O
the	O
night	O
of	O
10/18/97	O
with	O
systolic	B-test
blood	I-test
pressures	I-test
in	O
the	O
80s	O
to	O
90s.	O

His	B-test
BUN/	I-test
creatinine	I-test
rose	O
from	O
16/1.2	O
on	O
10/18/97	O
to	O
25/1.9	O
on	O
10/18/97	O
to	O
22/9.1	O
to	O
today	O
&apos;s	O
labs	O
,	O
which	O
are	O
15/0.7	O
on	O
10/23/97	O
.	O

9.	O
HEMATOLOGY	O
:	O

The	O
patient	O
transfused	O
2	O
units	O
on	O
10/15/97	O
for	O
a	B-test
hematocrit	I-test
of	O
27.6	O
.	O

The	O
patient	O
transfused	O
2	O
units	O
of	O
10/16/97	O
for	O
a	B-test
hematocrit	I-test
of	O
30.03	O
.	O

The	O
patient	O
transfused	O
1	O
unit	O
on	O
10/18/97	O
for	O
a	B-test
hematocrit	I-test
of	O
29.4	O
.	O

The	O
patient	O
transfused	O
1	O
unit	O
on	O
10/19/97	O
for	O
a	B-test
hematocrit	I-test
of	O
27.9	O
.	O

The	O
patient	O
transfused	O
2	O
units	O
on	O
10/20/97	O
for	O
a	B-test
hematocrit	I-test
of	O
28.2.10	O
.	O

FEN	O
:	O

Repleting	O
potassium	B-treatment
,	O
magnesium	B-treatment
,	O
phosphorus	B-treatment
as	O
needed	O
.	O

The	O
patient	O
was	O
noted	O
to	O
be	O
slightly	B-problem
hyponatremic	I-problem
over	O
the	O
past	O
few	O
days	O
,	O
with	O
sodiums	B-test
in	O
the	O
128-132	O
range	O
,	O
but	O
this	O
was	O
secondary	O
to	O
elevated	B-problem
glucose	I-problem
fingerstick	I-problem
blood	I-problem
sugars	I-problem
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
,	O
good	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

NPH	B-treatment
insulin	I-treatment
24	O
units	O
subq.	O
q.	O
a.m.	O
NPH	B-treatment
insulin	I-treatment
14	O
units	O
subq.	O
q.	O
p.m.	O
CZI	B-treatment
sliding	O
scale	O
on	O
a	O
q.	O
a.c.	O
and	O
q.	O
h.s.	O
fingerstick	O
basis	O
with	O
the	O
following	O
scale	O
:	O

FBS	B-test
less	O
than	O
200	O
=	O
0	O
units	O
of	O
CZI	B-treatment
FBS	B-test
201-250	O
=	O
2	O
units	O
of	O
CZI	B-treatment
FBS	B-test
251-300	O
=	O
4	O
units	O
of	O
CZI	B-treatment
FBS	B-test
301-350	O
=	O
6	O
units	O
of	O
CZI	B-treatment
FBS	B-test
351-400	O
=	O
8	O
units	O
of	O
CZI	B-treatment
FBS	B-test
greater	O
than	O
400	O
=	O
10	O
units	O
of	O
CZI	B-treatment
.	O

Atropine	B-treatment
sulfate	I-treatment
1	O
GTT	O
1%	O
OD	O
b.i.d.	O

Ocufen	B-treatment
0.03%	O
1	O
GTT	O
OD	O
t.i.d.	O
Vasotec	B-treatment
20	O
mg.	O
p.o.q.	O
a.m.	O
Prozac	B-treatment
40	O
mg.p.o.q.	O
a.m.	O

Oxygen	B-treatment
2-4	O
L	O
to	O
keep	O
Sa02	B-test
greater	O
than	O
or	O
equal	O
to	O
94-95%	O
and	O
wean	O
as	O
tolerated	O
.	O

Colace	B-treatment
100	O
mg.	O
p.o.	O
t.i.d.	O
Senokot	B-treatment
1	O
p.o.	O
q.	O
h.s.	O
Nystatin	B-treatment
powder	O
to	O
affected	B-problem
area	I-problem
t.i.d.	O
Lopressor	B-treatment
25	O
mg.	O
p.o.	O
b.i.d.	O
Atrovent	B-treatment
0.8/2.5	O
c.c.	O
normal	B-treatment
saline	I-treatment
nebulizers	I-treatment
q.	O
8	O
h.	O
Albuterol	B-treatment
2.5/5	O
c.c.	O
normal	B-treatment
saline	I-treatment
nebulizers	I-treatment
q.	O
4	O
h.	O
with	O
q.	O
2	O
h.	O
p.r.n.	O
Percocet	B-treatment
1-2	O
p.o.	O
q.	O
4	O
h.	O
p.r.n.	O
pain	B-problem
.	O

Prilosec	B-treatment
20	O
mg.	O
p.o.	O
b.i.d.	O
Vexol	B-treatment
1%	O
1	O
GTT	O
OD	O
b.i.d.	O
Lasix	B-treatment
40	O
mg.	O
p.o.	O
q.d.	O
KCl	B-treatment
20	O
mEq	O
p.o.	O
q.d.	O
Tylenol	B-treatment
650	O
mg.	O
p.o.	O
q.	O
12	O
h.	O
p.r.n.	O
Ativan	B-treatment
1	O
mg.	O
p.o.	O
q.	O
h.s.	O
p.r.n.	O

SAY	O
REKE	O
,	O
M.D.	O

TR	O
:	O

vr	O

DD	O
:	O

TD	O
:	O

10/23/97	O
3:05	O

Pcc	O
:	O

NABETH	O
NA	O
GLYNCRED	O
,	O
M.D.	O
MI	O
T	O
THULRO	O
,	O
M.D.	O
/	O
Fordwoodall	O
Stick	O
,	O
M.D.	O
7922	O

Fordknoxtall	O
Illinois	O

274230067	O
EH	O

11456974	O

175762	O

02/04/1990	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

02/04/1990	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

02/13/1990	O

PRINCIPLE	O
DIAGNOSIS	O
:	O

LEFT	B-problem
ROTATOR	I-problem
CUFF	I-problem
TEAR	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
52-year-old	O
right	O
handed	O
male	O
with	O
a	O
many	O
year	O
history	O
of	O
bilateral	B-problem
shoulder	I-problem
pain	I-problem
,	O
right	O
greater	O
than	O
left	O
.	O

He	O
has	O
steroid	B-treatment
injections	I-treatment
in	O
the	O
right	O
and	O
in	O
the	O
left	O
four	O
times	O
.	O

Arthrogram	B-test
in	O
the	O
distant	O
past	O
showed	O
a	B-problem
right	I-problem
rotator	I-problem
cuff	I-problem
tear	I-problem
and	O
he	O
now	O
has	O
increased	B-problem
pain	I-problem
in	I-problem
his	I-problem
left	I-problem
shoulder	I-problem
.	O

MRI	B-test
by	O
report	O
showed	O
bilateral	B-treatment
rotator	I-treatment
cuff	I-treatment
repairs	I-treatment
and	O
he	O
was	O
admitted	O
for	O
repair	B-treatment
of	I-treatment
the	I-treatment
left	I-treatment
rotator	I-treatment
cuff	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Back	B-problem
pain	I-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Ankle	B-treatment
surgery	I-treatment
times	O
two	O
on	O
the	O
right	O
.	O

Pilonidal	B-treatment
cyst	I-treatment
removal	I-treatment
.	O

MEDICATIONS	O
:	O

On	O
admission	O
included	O
Naprosyn	B-treatment
.	O

ALLERGIES	O
:	O

NO	O
KNOWN	B-problem
DRUG	I-problem
ALLERGIES	I-problem
.	O

HABITS	O
:	O

The	O
patient	O
smokes	O
two	O
packs	O
per	O
day	O
and	O
has	O
an	O
approximately	O
a	O
75-pack-year	O
history	O
of	O
smoking	O
.	O

He	O
has	O
a	O
history	O
of	O
drinking	O
which	O
he	O
discontinued	O
in	O
May	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
revealed	O
a	O
white	O
male	O
with	O
no	O
palpable	B-problem
adenopathy	I-problem
.	O

HEENT	B-test
exam	I-test
was	O
within	O
normal	O
limits	O
.	O

Lungs	O
revealed	O
occasional	B-problem
wheezing	I-problem
bilaterally	I-problem
at	O
both	O
bases	O
.	O

Heart	O
was	O
regular	O
with	O
a	B-problem
I	I-problem
/	I-problem
VI	I-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
without	O
jugular	B-problem
venous	I-problem
distention	I-problem
.	O

Pulses	B-test
were	O
2+	O
bilaterally	O
.	O

Abdomen	O
was	O
obese	B-problem
with	O
positive	O
bowel	O
sounds	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
.	O

Examination	B-test
of	I-test
his	I-test
shoulder	I-test
revealed	O
the	O
patient	O
to	O
be	O
able	O
to	O
flex	O
his	O
right	O
arm	O
to	O
170	O
degrees	O
,	O
internally	O
rotate	O
to	O
10	O
degrees	O
and	O
externally	O
rotate	O
to	O
40	O
degrees	O
with	O
positive	B-problem
joint	I-problem
tenderness	I-problem
.	O

All	O
range	O
of	O
motion	O
with	O
his	O
right	O
shoulder	O
was	O
painful	O
.	O

The	O
left	O
shoulder	O
was	O
identical	O
in	O
range	O
of	O
motion	O
and	O
was	O
also	O
painful	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
with	O
the	B-test
assessment	I-test
of	O
left	B-treatment
rotator	I-treatment
cuff	I-treatment
repair	I-treatment
and	O
he	O
was	O
taken	O
to	O
the	O
Operating	O
Room	O
on	O
the	O
day	O
of	O
admission	O
where	O
he	O
underwent	O
left	B-treatment
rotator	I-treatment
cuff	I-treatment
repair	I-treatment
under	O
general	B-treatment
endotracheal	I-treatment
tube	I-treatment
anesthesia	I-treatment
.	O

There	O
were	O
no	O
intraoperative	B-problem
complications	I-problem
.	O

His	O
postoperative	O
course	O
was	O
generally	O
unremarkable	O
except	O
for	O
a	O
prolonged	O
course	O
of	O
advancement	O
with	O
range	O
of	O
motion	O
of	O
his	O
left	O
shoulder	O
.	O

Occupational	O
therapy	O
became	O
involved	O
initially	O
and	O
he	O
remained	O
on	O
patient	B-treatment
controlled	I-treatment
analgesia	I-treatment
secondary	O
to	O
problems	O
with	O
left	B-problem
shoulder	I-problem
pain	I-problem
.	O

He	O
was	O
kept	O
in	O
the	O
hospital	O
for	O
an	O
extended	O
period	O
to	O
improve	O
his	O
postoperative	O
range	O
of	O
motion	O
.	O

However	O
,	O
he	O
was	O
eventually	O
able	O
to	O
achieve	O
forward	O
flexion	O
of	O
135	O
degrees	O
and	O
external	O
rotation	O
of	O
30	O
degrees	O
by	O
postoperative	O
day	O
number	O
eight	O
.	O

His	B-problem
wound	I-problem
remained	O
clean	O
and	O
dry	O
and	O
showed	O
no	O
signs	B-problem
of	I-problem
infection	I-problem
and	O
healed	O
well	O
.	O

However	O
,	O
his	O
course	O
was	O
otherwise	O
complicated	O
by	O
discovery	O
of	O
persistently	B-problem
elevated	I-problem
blood	I-problem
sugars	I-problem
and	O
Endocrinology	O
was	O
consulted	O
to	O
rule	O
out	O
possible	O
newly	B-problem
diagnosed	I-problem
diabetes	I-problem
.	O

His	B-test
hemoglobin	I-test
A1C	I-test
levels	I-test
actually	O
came	O
back	O
within	O
normal	O
limits	O
,	O
however	O
,	O
the	B-problem
wide	I-problem
excursions	I-problem
of	O
his	B-test
sugars	I-test
were	O
consistent	O
with	O
possible	O
diabetes	B-problem
.	O

He	O
was	O
placed	O
on	O
a	B-treatment
diabetic	I-treatment
diet	I-treatment
and	O
his	B-test
sugars	I-test
did	O
show	O
some	O
improvement	O
.	O

It	O
was	O
not	O
necessary	O
to	O
start	O
him	O
on	O
oral	B-treatment
hypoglycemics	I-treatment
or	O
insulin	B-treatment
.	O

He	O
also	O
complained	O
of	O
occasional	B-problem
spells	I-problem
and	O
jitteriness	B-problem
and	O
some	B-problem
orthostatic	I-problem
dizziness	I-problem
and	O
thus	O
Neurology	O
was	O
consulted	O
and	O
EMG	B-test
&apos;s	I-test
were	O
performed	O
which	O
were	O
normal	O
.	O

His	O
neurologist	O
was	O
contacted	O
,	O
Dr.	O
Cap	O
,	O
and	O
the	O
exact	O
of	O
his	O
problems	O
was	O
not	O
demonstrated	O
during	O
this	O
hospitalization	O
,	O
however	O
,	O
they	O
felt	O
that	O
this	O
could	O
possibly	O
be	O
an	B-problem
autonomic	I-problem
type	I-problem
neuropathy	I-problem
maybe	O
secondary	O
to	O
some	B-problem
underlying	I-problem
diabetic	I-problem
process	I-problem
.	O

Further	B-test
work-up	I-test
of	O
his	B-problem
neurologic	I-problem
conditions	I-problem
were	O
planned	O
as	O
an	O
outpatient	O
.	O

Thus	O
,	O
he	O
was	O
discharged	O
on	O
postoperative	O
day	O
number	O
eight	O
in	O
good	O
condition	O
with	O
a	B-problem
well	I-problem
healed	I-problem
left	I-problem
shoulder	I-problem
wound	I-problem
and	O
doing	O
well	O
with	O
occupational	B-treatment
therapy	I-treatment
with	O
plans	O
for	O
him	O
to	O
follow-up	O
with	O
Dr.	O
Necessary	O
.	O

DISPOSITION	O
:	O

MEDICATIONS	O
:	O

On	O
discharge	O
included	O
Valium	B-treatment
,	O
2	O
mg	O
po	O
t.i.d.;	O
Naprosyn	B-treatment
,	O
500	O
mg	O
po	O
b.i.d.	O
________________________________	O
ZV061/6138	O
TICENA	O
NECESSARY	O
,	O
M.D.	O
WO00	O

D	O
:	O

03/12/90	O

Batch	O
:	O

2280	O

Report	O
:	O

V1412C43	O

T	O
:	O

03/14/89	O

Dictated	O
By	O
:	O

VITA	O
THOSTERWEN	O
LINKEKOTEMONES	O
,	O
M.D.	O

284487129	O

CTMC	O

42669672	O

466333	O

01/16/1996	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

01/16/1996	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

01/20/1996	O

PROBLEM	O
LIST	O
:	O

1.	O
INSULIN	B-problem
DEPENDENT	I-problem
DIABETES	I-problem
MELLITUS	I-problem

2.	O
PRIOR	O
HISTORY	O
OF	O
ANTERIOR	B-problem
MYOCARDIAL	I-problem
INFARCTION	I-problem

3.	O
EPISODE	O
OF	O
PULMONARY	B-problem
EDEMA	I-problem

4.	O
HYPERCHOLESTEROLEMIA	B-problem

CHIEF	O
COMPLAINT	O
:	O

The	O
patient	O
is	O
a	O
40	O
year	O
old	O
male	O
with	O
a	O
history	O
of	O
prior	B-problem
anterior	I-problem
myocardial	I-problem
infarction	I-problem
and	O
insulin	B-problem
dependent	I-problem
diabetes	I-problem
mellitus	I-problem
who	O
was	O
transferred	O
from	O
an	O
outside	O
hospital	O
after	O
an	O
episode	O
of	O
acute	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
and	O
pulmonary	B-problem
edema	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
has	O
a	O
history	O
four	O
years	O
ago	O
of	O
being	O
admitted	O
to	O
the	O
Etearal	O
Etsystems/	O
Hospital	O
after	O
suffering	O
an	B-problem
acute	I-problem
anterior	I-problem
myocardial	I-problem
infarction	I-problem
.	O

The	O
course	O
had	O
multiple	B-problem
complications	I-problem
requiring	O
pressors	B-treatment
.	O

He	O
had	O
a	B-test
cardiac	I-test
catheterization	I-test
performed	O
which	O
revealed	O
a	B-problem
three	I-problem
vessel	I-problem
coronary	I-problem
artery	I-problem
disease	I-problem
with	O
an	B-problem
occluded	I-problem
RCA	I-problem
,	O
70%-80%	B-problem
proximal	I-problem
LAD	I-problem
,	O
and	O
a	B-problem
high	I-problem
grade	I-problem
left	I-problem
circumflex	I-problem
lesion	I-problem
after	I-problem
the	I-problem
OM	I-problem
with	O
distal	B-problem
left	I-problem
circumflex	I-problem
occlusion	I-problem
.	O

The	O
patient	O
was	O
subsequently	O
medically	O
management	O
after	O
this	B-treatment
hospitalization	I-treatment
and	O
has	O
done	O
very	O
well	O
.	O

His	B-test
most	I-test
recent	I-test
echocardiogram	I-test
in	O
April	O
of	O
1996	O
showed	O
an	B-test
ejection	I-test
fraction	I-test
of	O
20%	O
with	O
a	B-problem
thin	I-problem
fibrotic	I-problem
septum	I-problem
with	O
akinesis	B-problem
and	O
moderately	B-problem
severe	I-problem
hypokinesis	I-problem
in	I-problem
all	I-problem
other	I-problem
regions	I-problem
except	O
for	O
the	O
lateral	O
wall	O
.	O

The	O
patient	O
also	O
had	O
an	B-test
electrocardiogram	I-test
in	O
April	O
of	O
1996	O
which	O
was	O
negative	O
following	O
,	O
however	O
was	O
at	O
a	O
low	O
workload	O
.	O

The	O
patient	O
&apos;s	O
was	O
most	O
recently	O
admitted	O
to	O
Centdick	O
Naco	O
Hospital	O
Medical	O
Center	O
on	O
Martin	O
Luther	O
King	O
Day	O
after	O
becoming	O
acutely	B-problem
short	I-problem
of	I-problem
breath	I-problem
after	O
a	O
five	O
minute	O
walk	O
.	O

He	O
had	O
no	O
chest	B-problem
pain	I-problem
,	O
palpitations	B-problem
,	O
diaphoresis	B-problem
,	O
or	O
nausea	B-problem
.	O

He	O
called	O
the	O
EMT	O
&apos;s	O
and	O
was	O
found	O
to	O
be	O
in	O
pulmonary	B-problem
edema	I-problem
by	O
chest	B-test
x-ray	I-test
at	O
Centdick	O
Naco	O
Hospital	O
Medical	O
Center	O
.	O

He	O
was	O
diuresed	B-treatment
and	O
ruled	O
out	O
for	O
myocardial	B-problem
infarction	I-problem
.	O

His	B-test
ECG	I-test
showed	O
no	O
ischemic	B-problem
changes	I-problem
.	O

He	O
was	O
then	O
transferred	O
to	O
the	O
Retelk	O
County	O
Medical	O
Center	O
for	O
further	B-treatment
management	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

(1)	O
Insulin	B-problem
dependent	I-problem
diabetes	I-problem
mellitus	I-problem
x	O
15	O
years	O
with	O
no	O
retinopathy	B-problem
or	O
foot	B-problem
lesions	I-problem
.	O

(2)	O
Bilateral	B-problem
cataracts	I-problem
.	O

(3)	O
In	O
1967	O
he	O
had	O
an	B-treatment
orchiopexy	I-treatment
for	O
undescended	B-problem
testicle	I-problem
.	O

(4)	O
Coronary	B-problem
artery	I-problem
disease	I-problem
as	O
above	O
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Aspirin	B-treatment
325	O
mg	O
p.o.	O
q.	O
day	O
,	O
Capoten	B-treatment
25	O
mg	O
p.o.	O
q.8h.	O
,	O
NPH	B-treatment
insulin	I-treatment
28	O
units	O
q.a.m.	O
and	O
10	O
units	O
q.p.m.	O
,	O
Regular	B-treatment
insulin	I-treatment
4	O
units	O
q.a.m.	O
and	O
4	O
units	O
q.p.m.	O
,	O
simvastatin	B-treatment
20	O
mg	O
p.o.	O
q.	O
day	O
,	O
digoxin	B-treatment
0.25	O
mg.	O

SOCIAL	O
HISTORY	O
:	O

He	O
lives	O
with	O
his	O
two	O
brothers	O
and	O
is	O
on	O
disability	O
.	O

He	O
has	O
a	O
ten	O
pack	O
year	O
history	O
of	O
smoking	O
,	O
quit	O
in	O
1990	O
.	O

He	O
does	O
not	O
drink	O
alcohol	O
.	O

FAMILY	O
HISTORY	O
:	O

His	O
mother	O
and	O
father	O
both	O
died	O
secondary	O
to	O
myocardial	B-problem
infarction	I-problem
.	O

One	O
of	O
his	O
brothers	O
has	O
had	O
a	B-problem
myocardial	I-problem
infarction	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Temperature	B-test
100.3	O
,	O
heart	B-test
rate	I-test
76	O
,	O
blood	B-test
pressure	I-test
100/78	O
,	O
respiratory	B-test
rate	I-test
16	O
,	O
and	O
an	B-test
oxygen	I-test
saturation	I-test
of	O
96%	O
on	O
two	O
liters	O
.	O

NECK	O
:	O

No	O
jugular	B-problem
venous	I-problem
distention	I-problem
.	O

CHEST	O
:	O

Clear	O
to	O
auscultation	B-test
with	O
no	O
wheezes	B-problem
or	O
rales	B-problem
.	O

CARDIOVASCULAR	O
:	O

Regular	O
rate	O
and	O
rhythm	O
with	O
no	O
extra	B-problem
heart	I-problem
sounds	I-problem
and	O
no	O
murmurs	B-problem
.	O

ABDOMEN	O
:	O

Benign	O
.	O

EXTREMITIES	O
:	O

No	O
edema	B-problem
with	O
2+	O
pulses	O
.	O

LABORATORY	O
DATA	O
:	O

BUN	B-test
25	O
and	O
creatinine	B-test
1.4	O
.	O

White	B-test
count	I-test
6	O
and	O
hematocrit	B-test
41.5	O
.	O

PT	B-test
14.1	O
with	O
an	B-test
INR	I-test
of	O
1.4	O
,	O
PTT	B-test
36.7	O
.	O

Chest	B-test
x-ray	I-test
showed	O
no	O
infiltrates	B-problem
and	O
no	O
pulmonary	B-problem
edema	I-problem
.	O

Urinalysis	B-test
was	O
negative	O
.	O

Electrocardiogram	B-test
showed	O
normal	O
sinus	O
rhythm	O
at	O
63	O
with	O
normal	O
intervals	O
.	O

He	O
had	O
flat	B-problem
T	I-problem
waves	I-problem
in	I-problem
I	I-problem
and	I-problem
aVL	I-problem
,	O
which	O
were	O
unchanged	O
from	O
previous	B-test
ECG	I-test
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
for	O
further	B-treatment
management	I-treatment
of	O
his	B-problem
pulmonary	I-problem
edema	I-problem
.	O

It	O
was	O
felt	O
that	O
the	O
patient	O
possibly	O
had	O
a	O
worsening	O
of	O
his	B-problem
coronary	I-problem
artery	I-problem
disease	I-problem
and	O
therefore	O
underwent	O
cardiac	B-test
catheterization	I-test
on	O
01/17/96	O
.	O

At	O
cardiac	B-test
catheterization	I-test
he	O
had	O
an	B-test
RA	I-test
pressure	I-test
of	O
8	O
,	O
an	B-test
RV	I-test
pressure	I-test
of	O
52/10	O
,	O
PA	B-test
pressure	I-test
of	O
60/25	O
,	O
and	O
wedge	B-test
of	O
26	O
.	O

His	O
coronary	O
arteries	O
revealed	O
an	B-problem
80%	I-problem
stenosis	I-problem
and	O
a	B-problem
large	I-problem
OM	I-problem
.	O

The	O
dominant	O
left	O
circumflex	O
was	O
occluded	B-problem
with	O
left-to-left	B-problem
filling	I-problem
.	O

He	O
also	O
had	O
a	B-problem
50%	I-problem
LAD	I-problem
stenosis	I-problem
,	O
a	B-problem
100%	I-problem
large	I-problem
DT	I-problem
stenosis	I-problem
and	O
a	O
nondominant	O
RCA	O
with	O
left	O
RCA	O
collaterals	O
.	O

It	O
was	O
felt	O
that	O
this	B-test
cardiac	I-test
catheterization	I-test
was	O
not	O
significantly	O
changed	O
from	O
his	B-test
previous	I-test
catheterization	I-test
.	O

Given	O
his	B-problem
high	I-problem
right-sided	I-problem
filling	I-problem
pressure	I-problem
,	O
he	O
was	O
started	O
on	O
Lasix	B-treatment
for	O
diuresis	B-treatment
and	O
his	B-treatment
Captopril	I-treatment
was	O
increased	O
for	O
greater	B-treatment
afterload	I-treatment
reduction	I-treatment
.	O

It	O
was	O
felt	O
that	O
the	O
patient	O
should	O
have	O
an	B-treatment
augmented	I-treatment
medical	I-treatment
regimen	I-treatment
and	O
as	O
an	O
outpatient	O
undergo	O
an	B-test
exercise	I-test
tolerance	I-test
test	I-test
with	O
viability	B-test
evaluation	I-test
to	O
determine	O
whether	O
he	O
would	O
benefit	O
from	O
revascularization	B-treatment
.	O

He	O
was	O
restarted	O
on	O
Coumadin	B-treatment
for	O
his	B-problem
low	I-problem
ejection	I-problem
fraction	I-problem
and	O
started	O
on	O
diuresis	B-treatment
with	O
IV	B-treatment
Lasix	I-treatment
for	O
two	O
days	O
and	O
then	O
switched	O
to	O
an	B-treatment
oral	I-treatment
Lasix	I-treatment
regimen	I-treatment
.	O

DISPOSITION	O
:	O

He	O
was	O
discharged	O
to	O
home	O
in	O
stable	O
condition	O
and	O
feeling	O
well	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Insulin	B-treatment
NPH	I-treatment
10	O
units	O
q.p.m.	O
and	O
28	O
units	O
q.a.m.	O
,	O
insulin	B-treatment
Regular	I-treatment
4	O
units	O
q.a.m.	O
and	O
4	O
units	O
q.p.m.	O
,	O
aspirin	B-treatment
325	O
mg	O
p.o.	O
q.	O
day	O
,	O
digoxin	B-treatment
0.25	O
mg	O
p.o.	O
q.	O
day	O
,	O
simvastatin	B-treatment
20	O
mg	O
p.o.	O
q.	O
day	O
,	O
captopril	B-treatment
37.5	O
mg	O
p.o.	O
t.i.d.	O
,	O
Coumadin	B-treatment
5	O
mg	O
p.o.	O
q.h.s.	O
,	O
Lasix	B-treatment
20	O
mg	O
p.o.	O
q.	O
day	O
.	O

FOLLOW-UP	O
:	O

He	O
is	O
to	O
see	O
Dr.	O
Ench	O
in	O
two	O
weeks	O
to	O
check	O
his	B-test
PT	I-test
and	O
INR	B-test
,	O
also	O
to	O
check	O
for	O
potassium	B-test
.	O

Dictated	O
By	O
:	O

CA	O
X.	O
SCGACH	O
,	O
M.D.	O
YG59	O

Attending	O
:	O

JEMALKYLE	O
J.	O
EHKOTE	O
,	O
M.D.	O
BI7	O
PJ387/3762	O

Batch	O
:	O

37377	O

Index	O
No.	O
WDXZUZ7Y9B	O

D	O
:	O

01/20/96	O

T	O
:	O

01/20/96	O

289811204	O

FIH	O

2696998	O

22684/ukjj	O

819579	O

4/16/1993	O
12:00:00	O
AM	O

RIGHT	B-problem
HIP	I-problem
,	I-problem
OSTEOARTHRITIS	I-problem
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

4/16/93	O

DISCHARGE	O
DATE	O
:	O

4/23/93	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Right	B-problem
hip	I-problem
,	I-problem
osteoarthritis	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
generally	O
healthy	O
85	O
year	O
old	O
female	O
,	O
who	O
has	O
had	O
a	O
five	O
year	O
history	O
of	O
right	B-problem
hip	I-problem
pain	I-problem
,	O
worsening	O
over	O
the	O
past	O
several	O
months	O
.	O

Her	B-problem
pain	I-problem
is	O
located	O
in	O
the	O
groin	O
and	O
thigh	O
.	O

It	O
is	O
aggravated	O
by	O
activity	O
and	O
improved	O
by	O
sitting	O
or	O
lying	O
down	O
.	O

It	O
is	O
associated	O
with	O
rest	B-problem
pain	I-problem
as	O
well	O
.	O

She	O
uses	O
a	B-treatment
cane	I-treatment
or	O
walker	B-treatment
for	O
ambulation	O
,	O
and	O
is	O
limited	O
to	O
one	O
to	O
two	O
blocks	O
.	O

She	O
does	O
stairs	O
one	O
at	O
a	O
time	O
and	O
only	O
with	O
help	O
.	O

She	O
has	O
difficulty	B-problem
with	I-problem
shoes	I-problem
and	I-problem
socks	I-problem
and	I-problem
foot	I-problem
care	I-problem
.	O

The	B-problem
patient	I-problem
&apos;s	I-problem
pain	I-problem
has	O
not	O
been	O
relieved	O
by	O
Darvocet	B-treatment
and	O
Advil	B-treatment
.	O

Radiographs	B-test
demonstrate	O
right	B-problem
hip	I-problem
osteoarthritis	I-problem
.	O

Having	O
failed	O
conservative	B-treatment
management	I-treatment
,	O
the	O
patient	O
presented	O
for	O
elective	B-treatment
right	I-treatment
total	I-treatment
hip	I-treatment
replacement	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Hypertension	B-problem
,	O
possible	O
peptic	B-problem
ulcer	I-problem
disease	I-problem
1959	O
,	O
history	O
of	O
left	B-problem
ankle	I-problem
and	I-problem
knee	I-problem
fractures	I-problem
,	O
1980	O
.	O

Recent	B-problem
urinary	I-problem
tract	I-problem
infection	I-problem
,	O
E.	B-problem
coli	I-problem
03/93	O
.	O

Recent	B-problem
herpes	I-problem
zoster	I-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

cholecystectomy	B-treatment
,	O
total	B-treatment
abdominal	I-treatment
hysterectomy	I-treatment
,	O
cataract	B-treatment
excision	I-treatment
.	O

MEDICATIONS	B-treatment
ON	I-treatment
ADMISSION	I-treatment
:	O

hydrochlorothiazide	B-treatment
50	O
mg.	O
PO	O
qday	O
,	O
KayCiel	B-treatment
.	O

ALLERGIES	O
:	O

The	O
patient	O
has	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

HABITS	O
:	O

The	O
patient	O
does	O
not	O
smoke	O
or	O
drink	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Negative	O
in	O
detail	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
was	O
an	O
elderly	O
woman	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

The	B-test
head	I-test
and	I-test
neck	I-test
exam	I-test
was	O
within	O
normal	O
limits	O
.	O

The	O
lungs	O
were	O
clear	O
to	O
auscultation	B-test
.	O

Cardiac	O
:	O

regular	O
rate	O
and	O
rhythm	O
without	O
murmur	B-problem
.	O

The	O
abdomen	O
was	O
soft	O
,	O
nontender	O
,	O
nondistended	O
,	O
with	O
normal	O
active	O
bowel	O
sounds	O
.	O

Extremities	O
:	O

left	O
hip	O
110	O
degrees	O
of	O
flexion	B-test
,	O
0	O
degrees	O
of	O
extension	B-test
,	O
30	O
degrees	O
of	O
abduction	B-test
,	O
45	O
degrees	O
of	O
adduction	B-test
,	O
10	O
degrees	O
of	O
internal	B-test
rotation	I-test
and	I-test
flexion	I-test
,	O
45	O
degrees	O
of	O
external	B-test
rotation	I-test
and	I-test
flexion	I-test
.	O

Right	O
hip	O
90	O
degrees	O
of	O
flexion	B-test
,	O
minus	O
30	O
degrees	O
of	O
extension	B-test
,	O
20	O
degrees	O
of	O
abduction	B-test
,	O
30	O
degrees	O
of	O
adduction	B-test
,	O
less	O
than	O
5	O
degrees	O
of	O
internal	B-test
rotation	I-test
and	I-test
flexion	I-test
and	O
less	O
than	O
5	O
degrees	O
of	O
external	B-test
rotation	I-test
and	I-test
flexion	I-test
.	O

There	O
was	O
no	O
leg	B-problem
length	I-problem
discrepancy	I-problem
.	O

The	O
patient	O
&apos;s	O
gait	O
was	O
halting	O
,	O
stooped	O
and	O
slow	O
.	O

The	O
patient	O
used	O
the	B-treatment
cane	I-treatment
in	O
her	O
left	O
hand	O
.	O

The	B-test
patient	I-test
&apos;s	I-test
neurovascular	I-test
examination	I-test
was	O
intact	O
.	O

LABORATORY	O
DATA	O
:	O

the	B-test
sodium	I-test
was	O
140	O
,	O
potassium	B-test
3.7	O
,	O
chloride	B-test
96	O
,	O
bicarbonate	B-test
30	O
,	O
BUN	B-test
and	O
creatinine	B-test
14/0.9	O
,	O
glucose	B-test
105	O
,	O
hematocrit	B-test
42	O
,	O
white	B-test
blood	I-test
count	I-test
8.6	O
,	O
platelet	B-test
count	I-test
644,000	O
,	O
prothrombin	B-test
time	I-test
10.4	O
,	O
partial	B-test
thromboplastin	I-test
time	I-test
28.7	O
,	O
urinalysis	B-test
trace	B-problem
white	I-problem
blood	I-problem
cells	I-problem
,	O
slight	B-problem
occult	I-problem
red	I-problem
blood	I-problem
cells	I-problem
.	O

The	B-test
electrocardiogram	I-test
showed	O
normal	O
sinus	O
rhythm	O
at	O
a	B-test
rate	I-test
of	O
80	O
with	O
intraventricular	B-problem
conduction	I-problem
delay	I-problem
and	O
poor	B-problem
R	I-problem
wave	I-problem
progression	I-problem
.	O

There	O
were	O
no	O
acute	B-problem
ischemic	I-problem
changes	I-problem
.	O

The	B-test
chest	I-test
X-ray	I-test
showed	O
borderline	B-problem
cardiomegaly	I-problem
but	O
no	O
acute	B-problem
cardiac	I-problem
or	I-problem
pulmonary	I-problem
disease	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Orthopedic	O
Service	O
on	O
4/16/93	O
.	O

On	O
that	O
day	O
she	O
underwent	O
clearance	O
from	O
the	O
Cardiology	O
Service	O
,	O
Dr.	O
Shuff	O
.	O

It	O
was	O
his	O
impression	O
that	O
the	B-problem
patient	I-problem
&apos;s	I-problem
hypertension	I-problem
was	O
controlled	O
on	O
hydrochlorothiazide	B-treatment
.	O

Given	O
the	B-problem
patient	I-problem
&apos;s	I-problem
low	I-problem
potassium	I-problem
level	I-problem
of	O
2.4	O
on	O
the	O
day	O
of	O
admission	O
,	O
he	O
suggested	O
supplementation	O
with	O
potassium	B-treatment
.	O

The	O
patient	O
was	O
cleared	O
from	O
surgery	O
from	O
a	O
cardiology	O
standpoint	O
.	O

On	O
the	O
following	O
morning	O
4/17/93	O
,	O
the	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
where	O
she	O
underwent	O
a	B-treatment
right	I-treatment
total	I-treatment
hip	I-treatment
replacement	I-treatment
,	O
using	O
a	B-treatment
hybrid	I-treatment
S-ROM	I-treatment
system	I-treatment
.	O

Postoperatively	O
,	O
the	O
patient	O
did	O
extremely	O
well	O
.	O

The	O
patient	O
was	O
seen	O
in	O
consultation	O
with	O
the	O
physical	O
therapy	O
service	O
initially	O
for	O
routine	B-treatment
rehabilitation	I-treatment
after	O
a	B-treatment
total	I-treatment
hip	I-treatment
replacement	I-treatment
.	O

Her	B-treatment
hemovac	I-treatment
drains	I-treatment
were	O
removed	O
on	O
postoperative	O
day	O
#	O
2	O
as	O
was	O
her	B-treatment
Foley	I-treatment
catheter	I-treatment
.	O

Her	B-test
hematocrit	I-test
remained	O
stable	O
in	O
the	O
low	O
to	O
mid	O
30	O
&apos;s	O
and	O
she	O
did	O
not	O
require	O
a	B-treatment
transfusion	I-treatment
.	O

The	O
patient	O
did	O
have	O
postoperatively	B-problem
hypokalemia	I-problem
to	O
a	O
level	O
of	O
2.7	O
and	O
subsequently	O
was	O
corrected	O
with	O
oral	B-treatment
and	I-treatment
intravenous	I-treatment
potassium	I-treatment
on	O
4/22/93	O
,	O
the	O
patient	O
underwent	O
a	B-test
duplex	I-test
ultrasound	I-test
examination	I-test
,	O
which	O
showed	O
no	O
evidence	O
of	O
of	O
deep	B-problem
venous	I-problem
thrombosis	I-problem
.	O

The	B-treatment
patient	I-treatment
&apos;s	I-treatment
Coumadin	I-treatment
was	O
thus	O
stopped	O
and	O
she	O
was	O
switched	O
to	O
Bufferin	B-treatment
.	O

The	O
patient	O
&apos;s	O
hospitalization	O
was	O
uncomplicated	O
.	O

She	O
was	O
discharged	O
to	O
the	O
Encharlea	O
Il	O
Medical	O
Center	O
in	O
New	O
Hampshire	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Right	B-problem
hip	I-problem
osteoarthritis	I-problem
,	O
status	O
post	O
right	B-treatment
total	I-treatment
hip	I-treatment
replacement	I-treatment
on	O
4/17/93	O
.	O

Hypertension	B-problem
.	O

Postoperative	B-problem
hypokalemia	I-problem
,	O
resolved	O
.	O

Postoperative	B-problem
confusion	I-problem
,	O
transient	O
and	O
resolved	O
spontaneously	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Satisfactory	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

hydrochlorothiazide	B-treatment
50	O
mg.	O
PO	O
qday	O
,	O
KayCiel	B-treatment
40	O
mEq.	O
b.i.d.	O
,	O
Ecotrin	B-treatment
1	O
tablet	O
qday	O
,	O
Ferrous	B-treatment
sulfate	I-treatment
325	O
mg.	O
PO	O
b.i.d.	O
,	O
Folate	B-treatment
1	O
mg.	O
PO	O
qday	O
,	O
multivitamins	B-treatment
one	O
tablet	O
qday	O
,	O
Tylenol	B-treatment
#	I-treatment
3	I-treatment
1	O
to	O
2	O
PO	O
q3hours	O
PRN	O
.	O

DISPOSITION	O
/	O
PLAN	O
ON	O
DISCHARGE	O
:	O

The	O
patient	O
is	O
discharged	O
to	O
the	O
Encharlea	O
Il	O
Medical	O
Center	O
.	O

There	O
she	O
should	O
received	O
physical	B-treatment
therapy	I-treatment
to	O
consist	O
of	O
a	B-treatment
routine	I-treatment
post	I-treatment
total	I-treatment
hip	I-treatment
replacement	I-treatment
rehabilitation	I-treatment
protocol	I-treatment
,	O
with	O
emphasis	O
on	O
gait	B-treatment
training	I-treatment
,	O
partial	O
weight	O
bearing	O
on	O
the	O
right	O
lower	O
extremity	O
,	O
using	O
a	O
walker	B-treatment
or	O
crutches	B-treatment
.	O

The	O
patient	O
should	O
also	O
have	O
her	B-test
potassium	I-test
levels	I-test
checked	O
two	O
times	O
per	O
week	O
to	O
insure	O
that	O
she	O
is	O
not	O
becoming	O
hypokalemic	B-problem
.	O

The	O
patient	O
should	O
have	O
a	O
follow	O
up	O
appointment	O
arranged	O
with	O
Dr.	O
Level	O
.	O

LAYMIE	O
M	O
HE	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

LILLBI	O
SERVICE	O
,	O
M.D.	O

TR	O
:	O

il	O
/	O
bmot	O

DD	O
:	O

4/22/93	O

TD	O
:	O

04/22/93	O

CC	O
:	O

Dr.	O
Lako	O
Service	O
STAT	O

297228405	O
DH	O

0595721	O

777098	O

4177257	O

2/3/2004	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

CHIRDVOLN	O
,	O
IENA	O

MRN	O
:	O

0595721	O

Age	O
:	O

46y	O

REGISTRATION	O
DATE	O
:	O

02/03/2004	O
11:14	O
AM	O

Provider	O
:	O

AGE	O
SHUFF	O

PRELIMINARY	O
REPORT	O

Discharge	O
Date	O
/	O
Time	O
:	O

02/03/2004	O
19:12	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

VAG	B-problem
BLEEDING	I-problem

Diagnosis	O
:	O

dysfunctional	B-problem
uterine	I-problem
bleeding	I-problem

Treatment	O
Rendered	O
:	O

pelvic	B-test
ultrasound	I-test
-	O
normal	O
ovaries	O
,	O
thickened	B-problem
endometrium	I-problem
hematocrit	B-test
-	O
33	O

Discharge	O
Medications	O
:	O

percocet	B-treatment
as	O
directed	O
for	O
pain	B-problem

Follow	O
up	O
Service	O
:	O

Please	O
follow	O
up	O
with	O
gynecology	O
-	O
you	O
will	O
need	O
to	O
have	O
your	B-problem
uterine	I-problem
bleeding	I-problem
evaluted	O

Please	O
call	O
gynecology	O
clinic	O
at	O
150-5825	O
to	O
arrange	O
for	O
follow	O
up	O
.	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Please	O
return	O
to	O
the	O
ED	O
if	O
you	O
develop	O
any	B-problem
worsening	I-problem
pain	I-problem
,	O
vomiting	B-problem
or	O
fevers	B-problem
&gt;	O
101	O
.	O

If	O
you	O
are	O
unable	O
to	O
keep	O
down	O
liquids	O
or	O
have	O
any	B-problem
fainting	I-problem
episodes	I-problem
we	O
should	O
see	O
you	O
again	O
as	O
well	O
.	O

Otherwise	O
you	O
need	O
to	O
see	O
a	O
gynecologist	O
to	O
evaluate	O
this	B-problem
bleeding	I-problem
.	O

PCP	O
Name	O
:	O

REKE	O
,	O
ATOTA	O
S	O

Provider	O
Number	O
:	O

26024	O

This	O
report	O
was	O
created	O
by	O
SHUFF	O
,	O
RONRIN	O
02/03/2004	O
07:23	O
PM	O

306968218	O
YC	O

24803748	O

3232251	O

1/20/2003	O
12:00:00	O
AM	O

IUP	O
at	O
36	O
weeks	O
,	O
delivered	O

DIS	O

Admission	O
Date	O
:	O

01/20/2003	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

01/24/2003	O

******	O
DISCHARGE	O
ORDERS	O
******	O

KOTEROSTREUKOTE	O
,	O
ARO	O
MA	O
O.	O
965-81-64-6	O
U94	O

Room	O
:	O

HSN28-1050	O

Service	O
:	O

OBS	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

01/24/03	O
AT	O
10:00	O
AM	O

CONTINGENT	O
UPON	O

Attending	B-test
evaluation	I-test

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

HOUGHTBREUN	O
,	O
TESANT	O
E.	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

TYLENOL	B-treatment
(	I-treatment
ACETAMINOPHEN	I-treatment
)	I-treatment
650	O
MG	O
PO	O
Q4H	O
PRN	O
PAIN	B-problem
COLACE	B-treatment
(	I-treatment
DOCUSATE	I-treatment
SODIUM	I-treatment
)	I-treatment
100	O
MG	O
PO	O
BID	O
PRN	O
Constipation	B-problem
IBUPROFEN	B-treatment
600	O
MG	O
PO	O
Q4-6H	O
PRN	O
PAIN	B-problem
MILK	B-treatment
OF	I-treatment
MAGNESIA	I-treatment
(	I-treatment
MAGNESIUM	I-treatment
HYDROXIDE	I-treatment
)	I-treatment
30	O
MILLILITERS	O
PO	O
QD	O
PRN	O
Constipation	B-problem
PERCOCET	B-treatment
1-2	O
TAB	O
PO	O
Q4H	O
PRN	O
PAIN	B-problem

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Walking	O
as	O
tolerated	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Houghtbreun	O
6	O
weeks	O
,	O
No	O
Known	B-problem
Allergies	I-problem

ADMIT	O
DIAGNOSIS	O
:	O

Repeat	B-problem
C	I-problem
/	I-problem
S	I-problem
PPS	I-problem

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
IUP	B-problem
at	O
36	O
weeks	O
,	O
delivered	O

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
IUP	B-problem
at	O
36	O
weeks	O
.	O

insulin	B-problem
dependent	I-problem
gestational	I-problem
diabetic	I-problem
,	O
prior	B-problem
C	I-problem
/	I-problem
S	I-problem
,	O
RSAP	B-problem

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

Primary	O

Anesthesia	O
:	O

Spinal	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

NONE	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

G4	O
T2	O
P0	O
A1	O
L2	O
Estimated	O

EDC	O
:	O

Maternal	O
transfer	O
:	O

No	O

Baby	O
1	O

MRN	O
:	O

23548875	O

Delivery	O
date	O
:	O

01/20/03	O
10:49	O
AM	O

Apgars	B-test
9,9	O

Weight	B-test
:	O

6lb	O
5	O
oz	O
2863	O
grams	O

Sex	O
:	O

Female	O

ADDITIONAL	O
COMMENTS	O
:	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

HOUGHTBREUN	O
,	O
TESANT	O
E.	O
,	O
M.D.	O
(	O
EV89	O
)	O
01/20/03	O
12:26	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

320422564	O

CTMC	O

09300549	O

340424	O

06/16/1997	O
12:00:00	O
AM	O

BILIARY	B-problem
OBSTRUCTION	I-problem

Signed	O

DIS	O

Admission	O
Date	O
:	O

06/16/1997	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

06/18/1997	O

PROBLEM	O
LIST	O
:	O

1.	O
RECTAL	B-problem
CARCINOMA	I-problem
,	O
STATUS	O
POST	O
PARTIAL	B-treatment
COLECTOMY	I-treatment
.	O

2.	O
METASTATIC	B-problem
COLON	I-problem
CARCINOMA	I-problem
.	O

3.	O
HYPERTENSION	B-problem
.	O

4.	O
AORTIC	B-problem
STENOSIS	I-problem
WITH	O
PORCINE	B-treatment
VALVE	I-treatment
.	O

5.	O
URINARY	B-problem
TRACT	I-problem
INFECTION	I-problem
.	O

6.	O
CHOLANGITIS	B-problem
.	O

7.	O
ANEMIA	B-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
70	O
year	O
old	O
gentleman	O
with	O
metastatic	B-problem
rectal	I-problem
cancer	I-problem
who	O
presented	O
with	O
biliary	B-problem
obstruction	I-problem
.	O

In	O
the	O
past	O
,	O
he	O
had	O
biliary	B-treatment
stents	I-treatment
placed	O
which	O
clotted	O
off	O
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Short	O
Stay	O
Unit	O
for	O
further	B-test
evaluation	I-test
.	O

The	O
day	O
prior	O
,	O
the	O
patient	O
had	O
endoscopic	B-test
retrograde	I-test
cholangiopancreatography	I-test
done	O
with	O
dilated	B-problem
ducts	I-problem
times	O
two	O
and	O
eventually	O
had	O
interventional	B-treatment
radiology	I-treatment
attempt	O
to	O
place	O
percutaneous	B-treatment
drains	I-treatment
to	O
decompress	O
his	B-problem
biliary	I-problem
tree	I-problem
.	O

The	O
patient	O
had	O
two	B-treatment
drains	I-treatment
placed	O
after	O
a	B-treatment
prolonged	I-treatment
course	I-treatment
and	O
difficult	B-treatment
procedure	I-treatment
.	O

After	O
being	O
transferred	O
from	O
the	O
interventional	O
radiology	O
table	O
to	O
the	O
stretcher	O
,	O
one	O
of	O
his	B-treatment
lateral	I-treatment
percutaneous	I-treatment
drains	I-treatment
had	O
been	O
pulled	O
out	O
inadvertently	O
.	O

He	O
was	O
admitted	O
to	O
the	O
Short	O
Stay	O
Unit	O
,	O
given	O
Ancef	B-treatment
and	O
Gentamicin	B-treatment
per	O
the	O
team	O
for	O
antibiotic	B-treatment
prophylaxis	I-treatment
and	O
observed	O
overnight	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

As	O
above	O
.	O

ALLERGIES	O
:	O

None	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Cipro	B-treatment
500	O
mg	O
p.o.	O
b.i.d.	O
,	O
Vasotec	B-treatment
10	O
mg	O
q.d.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
denies	O
any	O
alcohol	O
or	O
tobacco	O
.	O

FAMILY	O
HISTORY	O
:	O

Significant	O
for	O
colon	B-problem
carcinoma	I-problem
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Unremarkable	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Temperature	B-test
was	O
99.1	O
,	O
blood	B-test
pressure	I-test
132/74	O
,	O
heart	B-test
rate	I-test
80	O
,	O
respirations	B-test
18	O
,	O
02	B-test
sat	I-test
99%	O
on	O
room	O
air	O
.	O

The	O
patient	O
was	O
an	O
alert	O
,	O
jaundiced	O
gentleman	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

LUNGS	O
:	O

were	O
clear	O
to	O
auscultation	B-test
.	O

HEART	O
:	O

had	O
a	O
regular	O
rate	O
and	O
rhythm	O
with	O
a	B-problem
II	I-problem
/	I-problem
VI	I-problem
systolic	I-problem
murmur	I-problem
at	I-problem
the	I-problem
right	I-problem
sternal	I-problem
border	I-problem
.	O

ABDOMEN	O
:	O

was	O
soft	O
,	O
nontender	B-problem
,	O
with	O
good	O
bowel	O
sounds	O
.	O

He	O
had	O
midline	B-treatment
catheter	I-treatment
that	O
was	O
still	O
in	O
place	O
and	O
was	O
draining	O
bile	O
.	O

EXTREMITIES	O
:	O

were	O
without	O
edema	B-problem
.	O

NEUROLOGICAL	O
:	O

exam	B-test
within	O
normal	O
limits	O
.	O

LABORATORY	O
:	O

White	B-test
count	I-test
was	O
8.2	O
,	O
hematocrit	B-test
35	O
.	O

AST	B-test
was	O
175	O
,	O
ALT	B-test
76	O
,	O
LDH	B-test
454	O
.	O

Total	B-test
bilirubin	I-test
was	O
12	O
and	O
direct	B-test
bilirubin	I-test
8	O
.	O

Alkaline	B-test
phosphatase	I-test
was	O
372	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Short	O
Stay	O
Unit	O
and	O
continued	O
to	O
receive	O
antibiotics	B-treatment
overnight	O
.	O

The	O
next	O
morning	O
,	O
he	O
was	O
doing	O
well	O
with	O
the	B-treatment
intact	I-treatment
drain	I-treatment
draining	O
bilious	B-problem
material	I-problem
without	O
any	O
difficulty	O
.	O

The	O
patient	O
was	O
doing	O
well	O
with	O
minimal	O
to	O
no	O
belly	B-problem
pain	I-problem
and	O
no	O
nausea	B-problem
or	O
vomiting	B-problem
.	O

The	O
patient	O
was	O
taken	O
back	O
to	O
surgery	O
by	O
the	O
interventional	O
radiology	O
team	O
and	O
had	O
a	B-treatment
second	I-treatment
drain	I-treatment
placed	O
without	O
any	O
difficulty	O
and	O
was	O
transferred	O
back	O
to	O
the	O
Short	O
Stay	O
Unit	O
.	O

The	O
patient	O
was	O
observed	O
overnight	O
without	O
any	B-problem
problems	I-problem
.	O

He	O
was	O
tolerating	O
p.o.	O
and	O
feeling	O
back	O
to	O
his	O
baseline	O
.	O

He	O
was	O
discharged	O
in	O
stable	O
condition	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Same	O
as	O
admission	O
.	O

He	O
will	O
continue	O
Cipro	B-treatment
p.o.	I-treatment
for	O
prophylaxis	B-treatment
.	O

FOLLOW-UP	O
:	O

Follow-up	O
with	O
Dr.	O
Loydsadd	O
in	O
one	O
to	O
two	O
weeks	O
.	O

He	O
is	O
also	O
to	O
have	O
AH	B-treatment
for	O
his	B-treatment
home	I-treatment
stent	I-treatment
care	I-treatment
.	O

Dictated	O
By	O
:	O

Attending	O
:	O

LILLBI	O
FYFEBREUN	O
,	O
M.D.	O
KE15	O
TB326/0625	O

Batch	O
:	O

56777	O

Index	O
No.	O
M2ZRS51Y3Q	O

D	O
:	O

06/18/97	O

T	O
:	O

06/21/97	O

332803550	O

PUOMC	O

6548851	O

97371/52b3	O

854510	O

6/22/1993	O
12:00:00	O
AM	O

CHRONIC	B-problem
OBSTRUCTIVE	I-problem
PULMONARY	I-problem
DISEASE	I-problem

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

06-22-93	O

DISCHARGE	O
DATE	O
:	O

06-27-93	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem

ASSOCIATED	O
DIAGNOSES	O
:	O

Steroid	B-problem
complications	I-problem
,	O
including	O
cataract	B-problem
,	O
osteoporosis	B-problem
,	O
diffuse	B-problem
fibrocystic	I-problem
breast	I-problem
disease	I-problem
,	O
trigeminal	B-problem
neuralgia	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mrs.	O
Cast	O
is	O
a	O
50	O
year	O
old	O
white	O
female	O
with	O
a	O
history	O
of	O
chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
and	O
evidence	O
of	O
severe	B-problem
lobular	I-problem
emphysema	I-problem
,	O
who	O
has	O
progressive	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
and	O
inability	O
to	O
carry	O
on	O
with	O
activities	O
of	O
daily	O
living	O
without	O
assistance	O
.	O

She	O
was	O
admitted	O
to	O
the	O
hospital	O
for	O
a	B-test
pre	I-test
lung	I-test
transplant	I-test
evaluation	I-test
.	O

The	O
patient	O
has	O
been	O
steroid	B-problem
dependent	I-problem
for	O
two	O
years	O
and	O
has	O
been	O
intubated	B-treatment
in	O
the	O
past	O
only	O
once	O
for	O
a	B-treatment
surgical	I-treatment
repair	I-treatment
of	I-treatment
trigeminal	I-treatment
neuralgia	I-treatment
.	O

Her	O
previous	O
occupation	O
was	O
an	O
executive	O
secretary	O
,	O
home	O
trainer	O
/	O
nurse	O
,	O
rental	O
aide	O
.	O

She	O
has	O
no	O
history	O
of	O
asbestos	B-problem
exposure	I-problem
or	O
tuberculosis	B-problem
exposure	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Notable	O
for	O
a	O
history	O
of	O
trigeminal	B-problem
neuralgia	I-problem
,	O
left	B-treatment
shoulder	I-treatment
surgery	I-treatment
,	O
fibrocystic	B-problem
breast	I-problem
disease	I-problem
,	O
endometriosis	B-problem
and	O
status	O
post	O
total	B-problem
abdominal	I-problem
hysterectomy	I-problem
.	O

ALLERGIES	O
:	O

History	O
of	O
gastrointestinal	B-problem
intolerance	I-problem
to	O
Tetracycline	B-treatment
,	O
Erythromycin	B-treatment
,	O
declomycin	B-treatment
associated	O
with	O
edema	B-problem
and	O
rash	B-problem
,	O
Talwin	B-treatment
associated	O
with	O
disorientation	B-problem
and	O
gastrointestinal	B-problem
symptoms	I-problem
,	O
Dilantin	B-treatment
has	O
caused	O
rash	B-problem
and	O
edema	B-problem
,	O
morphine	B-treatment
associated	O
with	O
itching	B-problem
and	O
gastrointestinal	B-problem
symptoms	I-problem
,	O
Demerol	B-treatment
unclear	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
a	O
divorced	O
mother	O
of	O
two	O
on	O
Medicaid	O
.	O

FAMILY	O
HISTORY	O
:	O

Non	O
contributory	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Notable	O
for	O
her	B-problem
diffuse	I-problem
expiratory	I-problem
wheezes	I-problem
and	O
scattered	B-problem
expiratory	I-problem
crackles	I-problem
.	O

Cranial	O
nerves	O
were	O
intact	O
except	O
for	O
paresthesias	B-problem
on	O
the	O
left	O
in	O
the	O
VII	O
and	O
VIII	O
distribution	O
.	O

The	O
breasts	O
were	O
notable	O
for	O
fibrocystic	B-problem
changes	I-problem
.	O

LABORATORY	O
DATA	O
:	O

Serum	B-test
sodium	I-test
141	O
,	O
potassium	B-test
4.0	O
,	O
chloride	B-test
106	O
,	O
C02	B-test
29.6	O
,	O
calcium	B-test
9.2	O
,	O
phosphorus	B-test
3.6	O
.	O

Magnesium	B-test
1.7	O
.	O

BUN	B-test
12	O
,	O
creatinine	B-test
0.6	O
,	O
glucose	B-test
92	O
,	O
uric	B-test
acid	I-test
3.3.	O
Cholesterol	B-test
236	O
,	O
triglycerides	B-test
115	O
,	O
HDL	B-test
99	O
,	O
LDL	B-test
114	O
,	O
total	B-test
protein	I-test
6.2	O
,	O
globulin	B-test
2.6	O
,	O
direct	B-test
bilirubin	I-test
0	O
,	O
total	B-test
bilirubin	I-test
0.2	O
,	O
alkaline	B-test
phosphatase	I-test
59	O
,	O
amylase	B-test
64	O
,	O
SGOT	B-test
16	I-test
,	O
LDH	B-test
141	I-test
,	O
CPK	B-test
57	O
.	O

The	B-test
LH	I-test
was	O
4.9	O
,	O
FSH	B-test
3.3	O
.	O

TSH	B-test
was	O
124	O
,	O
cortisol	B-test
2.1	O
,	O
25	B-test
hydroxy	I-test
vitamin	I-test
D	I-test
,	I-test
and	I-test
125	I-test
dihydroxy	I-test
vitamin	I-test
D	I-test
levels	I-test
were	O
pending	O
.	O

Urine	B-test
cotenine	I-test
level	O
none	O
detected	O
.	O

Estradialol	B-test
pending	O
.	O

White	B-test
blood	I-test
count	I-test
9.6	O
,	O
hematocrit	B-test
38.8	O
,	O
platelet	B-test
348,000	O
,	O
mean	B-test
corpuscular	I-test
volume	I-test
85	O
and	O
86	O
,	O
MCH	B-test
29	O
,	O
MCHC	B-test
34	O
.	O

PT	B-test
9.5/10.0	O
,	O
PTT	B-test
23.9	O
.	O

Urinalysis	B-test
was	O
normal	O
.	O

Sed	B-test
rate	I-test
6	O
.	O

Varicella	B-test
antibody	I-test
positive	O
,	O
CMV	B-test
antibody	I-test
positive	O
,	O
toxo	B-test
negative	O
,	O
RPR	B-test
non	O
reactive	O
.	O

The	O
patient	O
was	O
A+	O
.	O

FEV1	B-test
0.78	O
liters	O
,	O
vital	B-test
capacity	I-test
2.12	O
liters	O
,	O
total	B-test
lung	I-test
capacity	I-test
5.51	O
liters	O
,	O
single	B-test
breath	I-test
DLCO	I-test
5.3	O
(	O
25%	O
predicted	O
)	O
.	O

Cardiopulmonary	B-test
exercise	I-test
study	I-test
results	O
are	O
pending	O
.	O

Echocardiogram	B-test
showed	O
normal	O
right	O
ventricular	O
and	O
left	O
ventricular	O
size	O
and	O
systolic	O
function	O
.	O

A	B-test
left	I-test
and	I-test
right	I-test
heart	I-test
catheterization	I-test
and	O
coronary	B-test
angiogram	I-test
revealed	O
aortic	B-test
120/70	O
,	O
mean	B-test
95	O
,	O
PA	B-test
26/10	O
,	O
mean	B-test
17	O
,	O
PC	B-test
7	O
,	O
RV	B-test
26/6	O
,	O
RA	B-test
4	O
,	O
cardiac	B-test
output	I-test
5.7	O
,	O
index	B-test
3.8	O
.	O

Systemic	B-test
arterial	I-test
resistance	I-test
12/81	O
.	O

The	B-test
electrocardiogram	I-test
showed	O
a	B-problem
short	I-problem
PR	I-problem
interval	I-problem
with	O
no	O
delta	B-problem
wave	I-problem
,	O
clockwise	B-problem
rotation	I-problem
present	I-problem
.	O

A	B-test
quantitative	I-test
VQ	I-test
scan	I-test
of	O
the	O
lung	O
showed	O
42%	O
ventilation	B-test
to	I-test
the	I-test
left	I-test
,	O
57%	O
ventilation	B-test
to	I-test
the	I-test
right	I-test
,	O
42%	O
perfusion	B-test
to	I-test
the	I-test
left	I-test
,	O
57%	O
perfusion	B-test
to	I-test
the	I-test
right	I-test
.	O

Abdominal	B-test
ultrasound	I-test
was	O
unremarkable	O
.	O

HIV	B-test
testing	I-test
results	O
pending	O
.	O

Hepatitis	B-test
serologies	I-test
pending	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
seen	O
in	O
consultation	O
by	O
a	O
variety	O
of	O
consultants	O
including	O
Infectious	O
Disease	O
,	O
Cardiology	O
,	O
Endocrine	O
,	O
Psychiatry	O
,	O
ENT	O
,	O
and	O
Neuro-ophthalmology	O
.	O

She	O
was	O
noted	O
to	O
have	O
mild	B-problem
cataracts	I-problem
,	O
possibly	O
due	O
to	O
chronic	B-treatment
steroids	I-treatment
,	O
as	O
well	O
as	O
a	B-problem
subtle	I-problem
temporal	I-problem
disc	I-problem
pallor	I-problem
OD	I-problem
,	O
possibly	O
due	O
to	O
previous	O
episode	O
of	O
optic	B-problem
neuritis	I-problem
.	O

No	O
acute	B-problem
pathology	I-problem
was	O
noted	O
and	O
no	O
treatment	B-problem
was	O
necessary	O
at	O
this	O
time	O
.	O

Dr.	O
Koteelks	O
indicated	O
that	O
the	O
patient	O
did	O
not	O
have	O
sinus	B-problem
problems	I-problem
currently	O
but	O
thought	O
that	O
the	B-problem
trigeminal	I-problem
pain	I-problem
might	O
be	O
investigated	O
further	O
and	O
that	O
the	B-problem
sphenoid	I-problem
might	O
account	O
for	O
some	O
of	O
the	B-problem
patient	I-problem
&apos;s	I-problem
discomfort	I-problem
.	O

If	O
so	O
,	O
he	O
considers	O
the	O
possibility	O
that	O
this	O
could	O
be	O
opened	O
.	O

This	O
is	O
left	O
for	O
further	O
follow	O
up	O
as	O
an	O
outpatient	O
.	O

Dr.	O
Tikkerth	O
felt	O
that	O
the	O
patient	O
had	O
mild	B-problem
adjustment	I-problem
related	I-problem
anxiety	I-problem
under	O
good	O
control	O
with	O
a	O
history	O
of	O
tobacco	O
abuse	O
in	O
the	O
past	O
.	O

The	O
patient	O
completed	O
the	B-test
studies	I-test
and	O
to	O
be	O
informed	O
of	O
the	O
results	O
as	O
an	O
outpatient	O
.	O

She	O
knows	O
to	O
return	O
to	O
her	O
local	O
physician	O
for	O
her	B-treatment
routine	I-treatment
care	I-treatment
with	O
her	B-problem
condition	I-problem
unchanged	O
at	O
the	O
time	O
of	O
discharge	O
.	O

I	O
L.	O
STERPSKOLK	O
,	O
M.D.	O

TR	O
:	O

bg	O
/	O
bmot	O

DD	O
:	O

09-08-93	O

TD	O
:	O

09/09/93	O

CC	O
:	O

333521954	O

FIH	O

9558642	O

616751	O

7916543	O

2/23/2005	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

WIEGNEIGH	O
,	O
YLA	O

MRN	O
:	O

9558642	O

Age	O
:	O

53y	O

REGISTRATION	O
DATE	O
:	O

02/23/2005	O
05:41	O
AM	O

Provider	O
:	O

GETZSIEH	O
,	O
M.D.	O
WORK	O

PRELIMINARY	O
REPORT	O
PCP	O
notified	O
by	O

MD	O
:	O

Yes-Direct	O
contact	O
with	O
PCP	O

Discharge	O
Date	O
/	O
Time	O
:	O

02/23/2005	O
13:38	O

Discharge	O
Status	O
:	O

Discharged	O
Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

CHEST	B-problem
PAIN	I-problem
/	O
SOB	B-problem

Diagnosis	O
:	O

R	B-problem
Lung	I-problem
Mass	I-problem
,	O
likely	O
cancer	B-problem

Treatment	O
Rendered	O
:	O

Physical	B-test
Examination	I-test
,	O
Laboratory	B-test
Evaluation	I-test
,	O
CXR	B-test
,	O
Chest	B-test
CT	I-test

Discharge	O
Medications	O
:	O

Vicodin	B-treatment
1-2	O
TABS	O
PO	O
Q6H	O
PRN	O
pain	B-problem
,	O
#	O
50	O
,	O
no	O
refills	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Oncologist	O
,	O
Dr.	O
Ala	O
Aixknoleskaysneighslemteelenortkote	O
,	O
will	O
call	O
you	O
will	O
your	O
appt	O
.	O

You	O
can	O
call	O
576-598-7570	O
if	O
you	O
need	O
to	O
reschedule	O
.	O

We	O
are	O
scheduling	O
you	O
for	O
a	B-test
needle	I-test
biopsy	I-test
by	O
interventional	O
radiology	O
for	O
some	O
time	O
in	O
the	O
next	O
week	O
.	O

they	O
will	O
call	O
you	O
to	O
set	O
up	O
appt	O
.	O

PCP	O
Name	O
:	O

NIQUE	O
,	O
TOYA	O
N	O

Provider	O
Number	O
:	O

21636	O

This	O
report	O
was	O
created	O
by	O
WORK	O
,	O
SHELLBETHA	O
,	O
M.D.	O
02/23/2005	O
01:59	O
PM	O

337702516	O
WGH	O

9387380	O

310695	O

271735	O

9/15/2000	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

FREIERMLINKENEIGHCAABLINFARST	O
,	O
ANEA	O

UNIT	O
NUMBER	O
:	O

008-08-33	O

ADMISSION	O
DATE	O
:	O

09/15/2000	O

DISCHARGE	O
DATE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
hospital	O
on	O
July	O
12th	O
for	O
a	B-treatment
chole	I-treatment
with	O
a	O
principle	O
diagnosis	O
of	O
recurrent	B-problem
biliary	I-problem
colic	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
42	O
year	O
old	O
with	O
recurrent	B-problem
biliary	I-problem
colic	I-problem
.	O

She	O
has	O
had	O
ultrasound	B-problem
proven	I-problem
gallstones	I-problem
for	O
ten	O
years	O
,	O
seen	O
on	O
an	B-test
earlier	I-test
obstetric	I-test
ultrasound	I-test
.	O

The	O
patient	O
has	O
had	O
no	O
symptoms	B-problem
until	O
approximately	O
two	O
years	O
ago	O
when	O
she	O
began	O
having	O
classic	B-problem
biliary	I-problem
colic	I-problem
pain	I-problem
with	O
right	B-problem
upper	I-problem
quadrant	I-problem
epigastric	I-problem
pain	I-problem
radiating	O
to	O
midback	O
with	O
nausea	B-problem
,	O
but	O
without	O
vomiting	B-problem
.	O

Onset	O
was	O
an	O
hour	O
to	O
1	O
hour	O
after	O
meals	O
,	O
worse	O
with	O
greasy	O
meals	O
,	O
lasting	O
five	O
minutes	O
to	O
two	O
hours	O
.	O

Episodes	B-problem
have	O
been	O
increasing	O
in	O
frequency	O
over	O
the	O
last	O
few	O
months	O
.	O

She	O
has	O
had	O
no	O
fevers	B-problem
,	O
chills	B-problem
,	O
respiratory	B-problem
symptoms	I-problem
,	O
diarrhea	B-problem
,	O
bright	B-problem
red	I-problem
blood	I-problem
per	I-problem
rectum	I-problem
or	O
melena	B-problem
.	O

She	O
has	O
not	O
found	O
any	O
relieve	O
with	O
any	O
over	B-treatment
the	I-treatment
counter	I-treatment
medications	I-treatment
.	O

She	O
has	O
no	O
family	O
history	O
of	O
gallbladder	B-problem
or	O
pancreatic	B-problem
disease	I-problem
.	O

She	O
has	O
had	O
no	O
significant	O
weight	B-problem
loss	I-problem
.	O

No	O
anorexia	B-problem
.	O

An	B-test
ultrasound	I-test
on	O
1/25/00	O
showed	O
six	B-problem
gallstones	I-problem
without	O
cholecystitis	B-problem
.	O

She	O
has	O
no	O
history	O
of	O
liver	B-problem
disease	I-problem
,	O
hepatitis	B-problem
.	O

The	O
patient	O
is	O
from	O
45	O
Sidewonly	O
Blvd	O
,	O
Fresa	O
Loharanleah	O
,	O
Maryland	O
.	O

Has	O
lived	O
in	O
896	O
Lokatspur	O
Pkwy	O
,	O
Ingrich	O
Vepobuffh	O
,	O
Indiana	O
for	O
25	O
years	O
and	O
works	O
as	O
a	O
teaching	O
assistant	O
in	O
a	O
second	O
grade	O
in	O
Satlnonew	O
Rollglend	O
Pabridrham	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
for	O
a	B-treatment
left	I-treatment
ear	I-treatment
operation	I-treatment
approximately	O
30	O
years	O
ago	O
with	O
left	B-treatment
TM	I-treatment
reconstruction	I-treatment
in	O
December	O
1999	O
at	O
Hitch	O
Hospital	O
.	O

MEDS	O
ON	O
ADMISSION	O
:	O

Only	O
multivitamins	B-treatment
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
denies	O
tobacco	O
and	O
/	O
or	O
alcohol	O
use	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Noncontributory	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
is	O
a	O
healthy	O
appearing	O
female	O
looking	O
her	O
stated	O
age	O
in	O
no	O
apparent	B-problem
distress	I-problem
.	O

She	O
is	O
anicteric	B-problem
without	O
rash	B-problem
or	O
HEENT	O
.	O

Significant	O
for	O
left	B-problem
TM	I-problem
scarring	I-problem
without	O
acute	B-problem
inflammation	I-problem
or	O
drainage	B-problem
.	O

Oropharynx	O
is	O
moist	O
.	O

No	O
lymphadenopathy	B-problem
is	O
noted	O
.	O

Thyroid	O
is	O
nonpalpable	O
.	O

She	O
is	O
without	O
bruits	B-problem
or	O
JVD	B-problem
.	O

Lungs	O
are	O
bilaterally	O
clear	O
to	O
auscultation	B-test
.	O

Cardiac	B-test
exam	I-test
;	O
she	O
has	O
positive	O
S1	O
,	O
S2	O
without	O
murmur	B-problem
,	O
rub	B-problem
or	O
gallop	B-problem
.	O

Rate	B-test
was	O
75	O
.	O

Abdomen	O
is	O
soft	O
and	O
nontender	B-problem
without	O
hepatosplenomegaly	B-problem
or	O
mass	B-problem
.	O

She	O
has	O
no	O
rebound	B-problem
or	O
guarding	B-problem
.	O

Her	B-test
rectal	I-test
exam	I-test
is	O
guaiac	O
negative	O
.	O

Her	O
extremities	O
are	O
without	O
normal	O
limits	O
with	O
+2	O
pulses	O
throughout	O
.	O

She	O
is	O
neurologically	O
intact	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
for	O
the	B-treatment
lap	I-treatment
coli	I-treatment
with	O
an	B-test
intraoperative	I-test
cholangiogram	I-test
by	O
Dr.	O
Sterp	O
under	O
general	B-treatment
anesthesia	I-treatment
.	O

A	O
separate	O
operative	O
note	O
has	O
been	O
dictated	O
.	O

Operative	O
course	O
and	O
recovery	O
were	O
without	O
complication	B-problem
.	O

The	O
patient	O
was	O
admitted	O
to	O
floor	O
.	O

The	O
patient	O
was	O
afebrile	B-problem
,	O
vital	B-test
signs	I-test
were	O
stable	O
.	O

She	O
is	O
taking	O
po	O
&apos;s	O
.	O

She	O
is	O
ambulatory	O
.	O

The	O
patient	O
will	O
be	O
discharged	O
to	O
home	O
in	O
stable	O
condition	O
with	O
a	O
follow	O
up	O
appointment	O
with	O
Dr.	O
Sterp	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Percocet	B-treatment
5	O
mg	O
in	O
325	O
mg	O
one	O
to	O
two	O
tabs	O
po	O
q4	O
to	O
6	O
prn	O
pain	B-problem
.	O

The	O
patient	O
will	O
be	O
discharged	O
in	O
stable	O
condition	O
.	O

Follow	O
up	O
as	O
mentioned	O
will	O
be	O
with	O
Dr.	O
Sterp	O
.	O

______________________	O
SANTDEL	O
GLOTZRHALT	O
,	O
M.D.	O

TR	O
:	O

sxu	O

DD	O
:	O

09/15/2000	O

TD	O
:	O

09/21/2000	O
10:58	O
P	O

cc	O
:	O

MINAQUEENALT	O
MASHINEUSSHA	O
STERP	O
,	O
M.D.	O

346176858	O
SC	O

29574503	O

4164300	O

12/9/2005	O
12:00:00	O
AM	O

SVD	O

DIS	O

Admission	O
Date	O
:	O

12/09/2005	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

12/12/2005	O

******	O
DISCHARGE	O
ORDERS	O
******	O

CHAFFBITZ	O
,	O
LI	O
183-67-53-0	O
U69	O

Room	O
:	O

DEALPERSANDERSWAUKE	O
MISSJEANES	O
MACOMTOMA	O
GLANDSTATE	O
MEDICAL	O
CENTER	O

Service	O
:	O

OBS	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

12/12/05	O
AT	O
10:00	O
AM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

GRENDZISKLEEB	O
,	O
DELMRU	O
CENI	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

DERMOPLAST	B-treatment
TOPICAL	I-treatment
TP	O
Q12H	O
PRN	O
Pain	B-problem
DOCUSATE	B-treatment
SODIUM	I-treatment
100	O
MG	O
PO	O
BID	O
PRN	O
Constipation	B-problem
IBUPROFEN	B-treatment
400-600	O
MG	O
PO	O
Q6H	O
PRN	O
Pain	B-problem

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Take	O
with	O
food	O
PRENATAL	B-treatment
MULTIVITAMINS	I-treatment
(	I-treatment
STUARTNATAL	I-treatment
1+1	I-treatment
)	I-treatment
1	O
TAB	O
PO	O
QD	O
TUCKS	B-treatment
(	I-treatment
WITCH	I-treatment
HAZEL	I-treatment
)	I-treatment
TOPICAL	O
TP	O
Q4H	O
PRN	O
Pain	B-problem

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Walking	O
as	O
tolerated	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Dr	O
Grendziskleeb	O
6	O
weeks	O
,	O

ALLERGY	O
:	O

NKA	B-problem

ADMIT	O
DIAGNOSIS	O
:	O

labor	B-problem
at	I-problem
term	I-problem

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O
Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O

SVD	O
OTHER	O
DIAGNOSIS	O
;	O
Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O

SVD	O
OPERATIONS	O
AND	O
PROCEDURES	O
:	O

Primary	O
Anesthesia	O
:	O

Epidural	O
Vaginal	O
delivery	O
:	O

Spontaneous	O
Episiotomy	O
:	O

Median	O
Placenta	O
:	O

Delivery	O
:	O

Spontaneous	O
Condition	O
:	O

Normal	O

Staff	O
Obstetrician	O
(	O
supervising	O
)	O
:	O

BOORMKAYSSCAJE	O
,	O
PA	O
A.	O
,	O
M.D.	O
Delivery	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

none	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

G3	O
T1	O
P0	O
A1	O
L1	O

Estimated	O
EDC	O
:	O

12/09/05	O

Maternal	O
transfer	O
:	O

No	O

Initial	B-test
newborn	I-test
exam	I-test
:	O

No	O
observed	B-problem
abnormalities	I-problem

ADDITIONAL	O
COMMENTS	O
:	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

BOORMKAYSSCAJE	O
,	O
PA	O
A.	O
,	O
M.D.	O
(	O
TI84	O
)	O
12/10/05	O
02:58	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

348301810	O

CTMC	O

65055310	O

421501	O

2/19/1991	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O

DIS	O

Admission	O
Date	O
:	O

02/19/1991	O

Report	O
Status	O
:	O

Unsigned	O

Discharge	O
Date	O
:	O

02/25/1991	O

ADMISSION	O
DIAGNOSIS	O
:	O

ENDOMETRIAL	B-problem
CANCER	I-problem
.	O

OPERATION	O
:	O

Total	B-treatment
abdominal	I-treatment
hysterectomy	I-treatment
,	O
bilateral	B-treatment
salpingo	I-treatment
oophorectomy	I-treatment
2-19-91	O
by	O
Dr.	O
Lako	O
Coma	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
an	O
81-year-old	O
who	O
presented	O
with	O
postmenopausal	B-problem
spotting	I-problem
and	O
had	O
an	B-test
endometrial	I-test
biopsy	I-test
which	O
was	O
read	O
at	O
the	O
Etearal	O
Etsystems/	O
Hospital	O
as	O
showing	O
grade	B-problem
I	I-problem
adenocarcinoma	I-problem
.	O

Accordingly	O
she	O
presents	O
for	O
operative	B-treatment
therapy	I-treatment
at	O
this	O
time	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Negative	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

None	O
.	O

MEDICATIONS	O
:	O

None	O
.	O

ALLERGIES	O
:	O

None	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

She	O
is	O
somewhat	O
obese	O
elderly	O
female	O
.	O

HEENT	O
unremarkable	O
.	O

Lungs	O
clear	O
.	O

Abdomen	B-problem
obese	I-problem
,	O
no	O
scars	B-problem
.	O

Pelvic	B-test
exam	I-test
showed	O
a	O
small	O
mobile	O
uterus	O
.	O

Extremities	O
show	O
no	O
edema	B-problem
.	O

LABORATORY	O
DATA	O
:	O

All	O
within	O
normal	O
limits	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
brought	O
to	O
the	O
Operating	O
Room	O
on	O
2-19-91	O
where	O
she	O
had	O
an	B-test
exploratory	I-test
laparotomy	I-test
,	O
TAH	B-treatment
/	I-treatment
BSO	I-treatment
,	O
and	O
omental	B-test
biopsy	I-test
.	O

She	O
had	O
a	B-test
normal	I-test
abdominal	I-test
exploration	I-test
of	O
a	O
small	O
uterus	O
with	O
superficial	B-problem
invasion	I-problem
on	O
gross	B-test
examination	I-test
,	O
normal	O
ovaries	O
.	O

Washings	B-test
were	O
sent	O
.	O

A	B-treatment
subfascial	I-treatment
J-P	I-treatment
was	O
left	O
.	O

The	O
patient	O
did	O
well	O
postoperatively	O
and	O
had	O
a	O
regular	O
diet	O
by	O
the	O
third	O
postoperative	O
day	O
.	O

Subfascia	B-treatment
drain	I-treatment
was	O
discontinued	O
.	O

The	O
patient	O
&apos;s	O
postoperative	B-test
Hct	I-test
was	O
34	O
.	O

DISPOSITION	O
:	O

She	O
will	O
have	O
follow-up	O
with	O
Dr.	O
Lako	O
Coma	O
.	O

YM263/3597	O
LAKO	O
C.	O
COMA	O
,	O
M.D.	O
TH0	O

D	O
:	O

02/25/91	O

Batch	O
:	O

4620	O

Report	O
:	O

A5427C65	O

T	O
:	O

02/27/91	O

Dicatated	O
By	O
:	O

TA	O
K.	O
JESC	O
,	O
M.D.	O

351853846	O
WGH	O

8921553	O

92855	O

715722	O

3/24/1997	O
12:00:00	O
AM	O

GAIT	B-problem
DISORDER	I-problem
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

PREHEPRIOR	O
,	O
NIENEMILEISELE	O

UNIT	O
NUMBER	O
:	O

372-41-54	O

ADMISSION	O
DATE	O
:	O

03/24/97	O

DISCHARGE	O
DATE	O
:	O

03/28/97	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Gait	B-problem
disorder	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
31-year-old	O
right-handed	O
female	O
with	O
right-sided	B-problem
greater	I-problem
than	I-problem
left-sided	I-problem
weakness	I-problem
and	O
difficulty	B-problem
walking	I-problem
for	O
several	O
days	O
.	O

She	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
3/20/97	O
when	O
she	O
experienced	O
the	O
fairly	O
sudden	O
onset	O
of	O
predominantly	O
right-sided	B-problem
arm	I-problem
and	I-problem
leg	I-problem
weakness	I-problem
and	O
ataxia	B-problem
.	O

She	O
was	O
standing	O
and	O
walking	O
with	O
her	O
friend	O
,	O
who	O
&quot;	O
had	O
to	O
catch	O
her	O
from	O
falling	O
down	O
&quot;	O
as	O
she	O
toppled	O
towards	O
the	O
right	O
.	O

She	O
evidently	O
recovered	O
from	O
the	B-problem
episode	I-problem
after	O
a	O
number	O
of	O
minutes	O
.	O

The	O
following	O
day	O
,	O
she	O
remained	O
in	O
bed	O
through	O
essentially	O
all	O
of	O
the	O
day	O
due	O
to	O
malaise	B-problem
with	O
no	O
specific	B-problem
deficits	I-problem
being	O
noted	O
.	O

In	O
the	O
subsequent	O
two	O
days	O
,	O
she	O
had	O
several	O
small	B-problem
spells	I-problem
of	I-problem
&quot;	I-problem
imbalance	I-problem
&quot;	O
,	O
particularly	O
towards	O
the	O
right	O
,	O
and	O
other	B-problem
symptoms	I-problem
included	O
diffuse	B-problem
and	I-problem
mainly	I-problem
frontal	I-problem
headaches	I-problem
and	O
mild	B-problem
neck	I-problem
soreness	I-problem
.	O

There	O
was	O
no	O
diplopia	B-problem
,	O
visual	B-problem
loss	I-problem
,	O
speech	B-problem
abnormality	I-problem
or	O
sensory	B-problem
change	I-problem
in	O
her	O
history	O
.	O

She	O
was	O
initially	O
evaluated	O
at	O
an	O
outside	O
hospital	O
emergency	O
room	O
,	O
and	O
then	O
transferred	O
to	O
Well	O
General	O
Hospital	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Is	O
notable	O
for	O
depression	B-problem
,	O
and	O
she	O
has	O
been	O
followed	O
regularly	O
by	O
Dr.	O
Freiermchird	O
of	O
Nash	O
Health	O
for	O
several	O
months	O
with	O
pharmacologic	B-treatment
treatment	I-treatment
,	O
which	O
is	O
apparently	O
working	O
well	O
.	O

Her	B-treatment
Doxepin	I-treatment
has	O
recently	O
been	O
increased	O
.	O

She	O
is	O
status	O
post	O
appendectomy	B-treatment
and	O
otherwise	O
has	O
no	O
remarkable	O
past	O
medical	O
history	O
.	O

ALLERGIES	O
:	O

Quinine	B-treatment
gives	O
her	O
a	B-problem
rash	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

The	O
only	O
medications	B-treatment
she	O
is	O
on	O
are	O
Paxil	B-treatment
30	O
mg	O
p.o.	O
q.day	O
,	O
Doxepin	B-treatment
25	O
mg	O
p.o.	O
q.day	O
,	O
and	O
Klonopin	B-treatment
2	O
mg	O
p.o.	O
q.h.s.	O

SOCIAL	O
HISTORY	O
:	O

She	O
is	O
currently	O
unemployed	O
,	O
but	O
until	O
recently	O
,	O
she	O
was	O
employed	O
at	O
a	O
bank	O
.	O

She	O
was	O
born	O
and	O
raised	O
in	O
Atonlaremont	O
Rockpo	O
.	O

There	O
is	O
a	O
history	O
of	O
childhood	O
abuse	O
.	O

She	O
does	O
not	O
drink	O
.	O

She	O
is	O
a	O
former	O
tobacco	O
user	O
and	O
takes	O
no	O
illicit	O
drugs	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

She	O
was	O
pleasant	O
,	O
in	O
no	O
acute	B-problem
distress	I-problem
;	O
blood	B-test
pressure	I-test
130/60	O
;	O
heart	B-test
rate	I-test
66	O
;	O
respirations	B-test
18	O
;	O
temperature	B-test
98	O
.	O

Her	O
thyroid	O
was	O
within	O
normal	O
limits	O
.	O

There	O
were	O
no	O
carotid	B-problem
or	I-problem
cervical	I-problem
bruits	I-problem
.	O

She	O
had	O
a	O
normal	O
S1	O
and	O
S2	O
and	O
regular	O
rate	O
and	O
rhythm	O
with	O
no	O
murmurs	B-problem
.	O

Her	O
lungs	O
were	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Her	O
abdomen	O
was	O
benign	O
.	O

Her	O
extremities	O
were	O
without	O
clubbing	B-problem
,	O
cyanosis	B-problem
,	O
edema	B-problem
,	O
or	O
rash	B-problem
;	O
there	O
were	O
some	O
older	O
hematomas	B-problem
in	I-problem
the	I-problem
bilaterally	I-problem
shins	I-problem
.	O

Mental	O
status	O
-	O
her	O
speech	O
was	O
fluent	O
without	O
errors	O
.	O

Her	O
affect	O
was	O
slightly	B-problem
inappropriate	I-problem
at	O
times	O
;	O
for	O
example	O
,	O
singing	B-problem
or	I-problem
humming	I-problem
along	I-problem
while	O
performing	O
some	O
of	O
the	B-test
motor	I-test
tasks	I-test
and	O
giving	O
the	O
impression	O
of	O
indifference	B-problem
to	O
the	B-problem
deficits	I-problem
that	O
were	O
demonstrated	O
on	O
the	B-test
examination	I-test
.	O

Her	O
memory	O
was	O
fully	O
intact	O
for	O
short-term	O
recollection	O
of	O
three	O
out	O
of	O
three	O
objects	O
at	O
five	O
minutes	O
with	O
excellent	O
naming	O
,	O
repetition	O
,	O
proverb	O
interpretation	O
,	O
and	O
ability	O
to	O
follow	O
commands	O
.	O

Visual	O
fields	O
were	O
full	O
to	O
confrontation	O
.	O

Her	O
left	O
pupil	O
was	O
7	O
mm	O
reacting	O
to	O
5	O
mm	O
.	O

Her	O
right	O
pupil	O
was	O
5.5	O
mm	O
reacting	O
to	O
4	O
mm	O
.	O

Her	O
extraocular	O
movements	O
were	O
intact	O
for	O
horizontal	O
and	O
vertical	O
pursuits	O
.	O

There	O
was	O
no	O
nystagmus	B-problem
and	O
no	O
ptosis	B-problem
.	O

Her	O
saccades	O
were	O
normal	O
.	O

Facial	O
strength	O
and	O
sensation	O
were	O
full	O
and	O
symmetric	O
.	O

Her	O
tongue	O
,	O
uvula	O
and	O
palate	O
were	O
midline	O
.	O

Shoulder	O
shrug	O
was	O
5/5	O
power	O
.	O

Motor	B-test
examination	I-test
revealed	O
5/5	O
power	O
in	O
all	O
groups	O
in	O
the	O
proximal	O
and	O
distal	O
upper	O
and	O
lower	O
extremities	O
.	O

There	O
was	O
no	O
drift	B-problem
.	O

There	O
was	O
normal	O
bulk	O
and	O
tone	O
.	O

She	O
had	O
slightly	B-problem
slow	I-problem
fine	I-problem
finger	I-problem
motility	I-problem
approximately	O
equal	O
bilaterally	O
,	O
although	O
this	O
was	O
extremely	O
difficult	O
to	O
reproduce	O
.	O

Sensory	O
-	O
intact	O
light	O
touch	O
,	O
temperature	O
,	O
and	O
vibration	O
overall	O
.	O

Reflexes	B-test
were	O
2+	O
throughout	O
in	O
the	O
upper	O
and	O
lower	O
extremities	O
,	O
and	O
toes	O
were	O
downgoing	O
.	O

There	O
was	O
no	O
jaw	B-problem
jerk	I-problem
and	O
no	O
Hoffman	O
&apos;s	O
sign	O
.	O

Coordination	O
-	O
toe	B-test
tap	I-test
was	O
slow	B-problem
bilaterally	I-problem
,	O
although	O
difficult	O
to	O
reproduce	O
,	O
and	O
at	O
best	O
,	O
was	O
essentially	O
within	O
normal	O
limits	O
.	O

On	O
standing	O
,	O
she	O
tended	O
to	O
fall	O
to	O
the	O
front	O
,	O
back	O
or	O
sides	O
without	O
trying	O
to	O
stop	O
her	O
fall	O
initially	O
,	O
and	O
extensive	B-test
gait	I-test
testing	I-test
was	O
deferred	O
due	O
to	O
concerns	O
for	O
safety	O
.	O

Her	B-test
heel-to-shin	I-test
and	I-test
finger-to-nose	I-test
testing	I-test
was	O
fully	O
intact	O
bilaterally	O
without	O
ataxia	B-problem
or	O
tremor	B-problem
.	O

LABORATORY	O
DATA	O
:	O

Were	O
unremarkable	O
with	O
normal	O
electrolytes	B-test
and	O
complete	B-test
blood	I-test
count	I-test
parameters	I-test
.	O

Her	B-test
erythrocyte	I-test
sedimentation	I-test
rate	I-test
was	O
12	O
.	O

Her	B-test
coagulation	I-test
parameters	I-test
were	O
normal	O
.	O

Head	B-test
CT	I-test
scan	I-test
without	I-test
contrast	I-test
showed	O
normal	O
brain	O
parenchyma	O
and	O
no	O
intracranial	B-problem
process	I-problem
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
was	O
admitted	O
for	O
her	B-problem
gait	I-problem
disorder	I-problem
with	O
other	O
notable	B-problem
findings	I-problem
on	O
examination	B-test
including	O
anisocoria	B-problem
,	O
which	O
,	O
by	O
the	O
patient	O
&apos;s	O
report	O
,	O
had	O
been	O
noted	O
several	O
months	O
earlier	O
.	O

A	B-test
magnetic	I-test
resonance	I-test
imaging	I-test
and	O
magnetic	B-test
resonance	I-test
angiogram	I-test
study	I-test
was	O
obtained	O
,	O
which	O
showed	O
no	O
clear	O
evidence	O
of	O
arterial	B-problem
dissections	I-problem
or	O
infarction	B-problem
or	O
other	B-problem
pathologic	I-problem
processes	I-problem
.	O

She	O
had	O
been	O
placed	O
on	O
heparin	B-treatment
initially	O
,	O
but	O
this	O
was	O
discontinued	O
after	O
the	B-test
magnetic	I-test
resonance	I-test
imaging	I-test
results	O
were	O
obtained	O
.	O

Posterior	B-test
transcranial	I-test
Doppler	I-test
studies	I-test
showed	O
normal	O
studies	O
of	O
both	O
vertebral	O
arteries	O
,	O
and	O
carotid	B-test
non-invasive	I-test
studies	I-test
showed	O
normal	O
right	O
and	O
left	O
carotid	O
bifurcations	O
.	O

On	O
the	O
second	O
hospital	O
day	O
,	O
her	B-problem
gait	I-problem
continued	O
to	O
be	O
markedly	B-problem
unstable	I-problem
,	O
although	O
with	O
no	O
consistent	O
pattern	O
in	O
terms	O
of	O
weakness	B-problem
or	O
directionality	O
of	O
falling	O
,	O
and	O
she	O
continued	O
to	O
have	O
no	O
reproducible	B-problem
upper	I-problem
extremity	I-problem
or	I-problem
lower	I-problem
extremity	I-problem
ataxia	I-problem
or	O
dysmetria	B-problem
.	O

She	O
was	O
seen	O
by	O
the	O
Psychiatry	B-treatment
Service	I-treatment
.	O

She	O
was	O
not	O
felt	O
to	O
be	O
acutely	B-problem
suicidal	I-problem
or	O
otherwise	O
in	O
need	O
of	O
acute	B-treatment
psychiatric	I-treatment
treatment	I-treatment
.	O

The	O
psychiatrist	O
also	O
noted	O
the	O
indifference	O
the	O
patient	O
evinced	O
regarding	O
her	B-problem
own	I-problem
symptomatology	I-problem
.	O

The	O
patient	O
was	O
evaluated	O
in	O
one	O
of	O
the	O
neurology	O
conferences	O
for	O
several	O
hours	O
,	O
and	O
during	O
this	O
time	O
,	O
showed	O
significant	O
improvement	O
while	O
receiving	O
gait	B-treatment
training	I-treatment
as	O
well	O
as	O
evaluation	B-test
;	O
in	O
particular	O
,	O
she	O
became	O
more	O
stable	O
with	O
counter-balancing	B-treatment
methods	I-treatment
.	O

This	O
trend	O
of	O
improvement	O
continued	O
,	O
and	O
she	O
was	O
discharged	O
in	O
stable	O
condition	O
.	O

She	O
will	O
follow	O
up	O
with	O
her	O
psychiatrist	O
,	O
Dr.	O
Freiermchird	O
(	O
Sone	O
Memorial	O
Hospital	O
)	O
on	O
a	O
regular	O
basis	O
,	O
and	O
she	O
can	O
follow	O
up	O
with	O
the	O
Neurology	O
Service	O
on	O
a	O
p.r.n.	O
basis	O
if	O
needed	O
.	O

She	O
will	O
continue	O
on	O
her	B-treatment
previous	I-treatment
outpatient	I-treatment
medical	I-treatment
regimen	I-treatment
.	O

NIREGE	O
MEMORY	O
,	O
M.D.	O

TR	O
:	O

bzo	O

DD	O
:	O

03/29/97	O

TD	O
:	O

03/31/97	O
12:36	O
P	O

cc	O
:	O

NYRI	O
A	O
MEMORY	O
,	O
M.D.	O

ASHELLRIETTE	O
NESSASU	O
THREATSVOT	O
,	O
M.D.	O

EJEAN	O
NADARC	O
FREIERMCHIRD	O
,	O
M.D.	O

373254497	O
PUMC	O

6211697	O

433913	O

209987	O

3/5/2002	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

SHUFFJESC	O
,	O
NANORA	O

MRN	O
:	O

6211697	O

Age	O
:	O

36y	O

REGISTRATION	O
DATE	O
:	O

03/05/2002	O
10:11	O
PM	O

Provider	O
:	O

QUELOISEVIER	O
DREWEILLTRIEVKEMME	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O
MD	O
:	O

E-mail	O
PCP	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Date	O
/	O
Time	O
:	O

03/06/2002	O
06:23	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

ABD	B-problem
PAIN/	I-problem
PELVIC	B-problem
PAIN	I-problem

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
abdominal	B-problem
pain	I-problem
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

Abdominal	B-problem
pain	I-problem
Treatment	O
Rendered	O
:	O

Ct	B-test
scan	I-test
shows	O
ovarian	B-problem
cyst	I-problem

Discharge	O
Medications	O
:	O

Vicodin	B-treatment

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Please	O
follow	O
up	O
with	O
Dr.	O
Wires	O
on	O
Monday	O
.	O

If	O
you	O
have	O
continued	O
fevers	B-problem
,	O
worsening	B-problem
abdominal	I-problem
pain	I-problem
,	O
discharge	B-problem
or	O
other	B-problem
worrisome	I-problem
symptoms	I-problem
,	O
please	O
return	O
to	O
the	O
emergency	O
department	O
.	O

PCP	O
Name	O
:	O

WIRES	O
,	O
PEANTSALL	O
A	O

Provider	O
Number	O
:	O

16986	O

This	O
report	O
was	O
created	O
by	O
DREWEILLTRIEVKEMME	O
,	O
QUELOISEVIER	O
03/06/2002	O
06:28	O
AM	O

384729825	O

FIH	O

0670582	O

899158	O

790156	O

11/20/2002	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

BREUNDAIL	O
,	O
NETFA	O

MRN	O
:	O

0670582	O

Age	O
:	O

91y	O

REGISTRATION	O
DATE	O
:	O

11/20/2002	O
02:02	O
AM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
BREUNDAIL	O
,	O
NETFA	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
on	O
11/20/2002	O
02:02	O
AM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
SDH	B-problem
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
FAIRM	O
OF	O
IJORDCOMPMAC	O
HOSPITAL	O
.	O

The	O
patient	O
&apos;s	O
preliminary	O
admitting	O
physician	O
is	O
GLYNCRED	O
,	O
NABETH	O
N	O
and	O
the	O
preliminary	O
diagnosis	O
is	O
SDH	B-problem
.	O

Please	O
note	O
this	O
information	O
may	O
have	O
been	O
updated	O
on	O
the	O
inpatient	O
unit	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
834-226-3369	O
.	O

PCP	O
Name	O
:	O

TRIEVA	O
,	O
WINGENE	O
R	O

Provider	O
Number	O
:	O

03519	O

388755206	O
SC	O

28741969	O

9895112	O

12/1/2003	O
12:00:00	O
AM	O

s	O
/	O
p	O
cesarean	B-treatment

DIS	O

Admission	O
Date	O
:	O

12/01/2003	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

12/06/2003	O

******	O
DISCHARGE	O
ORDERS	O
******	O

STENOBE	O
,	O
LANDEM	O
847-02-84-0	O
J73	O

Room	O
:	O

GHA74-9086	O

Service	O
:	O

OBS	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

12/06/03	O
AT	O
10:00	O
AM	O

CONTINGENT	O
UPON	O

Attending	B-test
evaluation	I-test

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

CLOZPLU	O
,	O
A	O
A	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

COLACE	B-treatment
(	I-treatment
DOCUSATE	I-treatment
SODIUM	I-treatment
)	I-treatment
100	O
MG	O
PO	O
BID	O
IBUPROFEN	B-treatment
600	O
MG	O
PO	O
Q6H	O
PRN	O
PAIN	O
ALDOMET	B-treatment
(	I-treatment
METHYLDOPA	I-treatment
)	I-treatment
250	O
MG	O
PO	O
BID	O
PERCOCET	B-treatment
1-2	O
TAB	O
PO	O
Q4H	O
PRN	O
PAIN	B-problem

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Resume	O
regular	O
exercise	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Your	O
obstetrician	O
6	O
weeks	O
,	O
No	O
Known	B-problem
Allergies	I-problem

ADMIT	O
DIAGNOSIS	O
:	O

s	O
/	O
p	O
cesarean	B-treatment

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O
Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
s	O
/	O
p	O
cesarean	B-treatment

OTHER	O
DIAGNOSIS	O
;	O
Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
s	O
/	O
p	O
cesarean	B-treatment

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

Primary	O
Anesthesia	O
:	O

Epidural	B-treatment
Vaginal	O
delivery	O
:	O

Undelivered	O
Cesarean	O
Status	O
:	O

Primary	O
Urgency	O
:	O

Emergent	O
Indications	O
:	O

Non-reassuring	B-problem
fetal	I-problem
status	I-problem
,	O
Uterine	O

incision	O
type	O
:	O

Transverse	O

Placenta	O
:	O

Delivery	O
:	O

Manual	O
Condition	O
:	O

Normal	O
Staff	O
Obstetrician	O
(	O
supervising	O
)	O
:	O

CLOZPLU	O
,	O
A	O
A	O
,	O
M.D.	O
Delivery	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

IV	B-treatment
ABX	I-treatment

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

G9	O
T3	O
P0	O
A5	O
L3	O

Estimated	O
EDC	O
:	O

11/28/03	O

Indications	O
for	O
induction	O
:	O

Post	B-problem
dates	I-problem

Complications	O
of	O
labor	O
:	O

,	O
Other	O
-	O
bradycardia	B-problem

Maternal	O
transfer	O
:	O

No	O

Initial	O
newborn	O
exam	O
:	O

No	O
observed	B-problem
abnormalities	I-problem

Baby	O
1	O

MRN	O
:	O

32859272	O

Delivery	O
date	O
:	O

12/02/03	O
03:20	O
PM	O
Apgars	B-test
7,8	O

Weight	B-test
:	O

9lb	O
15	O
oz	O
4508	O
grams	O

Sex	O
:	O

Male	O

ADDITIONAL	O
COMMENTS	O
:	O

no	O
heavy	O
lifting	O
;	O
nothing	O
in	O
the	O
vagina	O
for	O
6	O
weeks	O
--	O
no	O
intercourse	O
,	O
no	O
douching	O
,	O
no	O
tampons	O
;	O
call	O
for	O
fever	B-problem
above	I-problem
100.5	I-problem
,	O
worsening	B-problem
abdominal	I-problem
pain	I-problem
,	O
heavy	B-problem
bleeding	I-problem
,	O
or	O
any	B-problem
other	I-problem
concern	I-problem
;	O
no	O
driving	O
while	O
taking	O
percocet	B-treatment

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

HAXKOTE	O
,	O
A	O
N.	O
,	O
M.D.	O
(	O
ZL69	O
)	O
12/06/03	O
09:04	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

402389409	O
WGH	O

2852246	O

946048	O

3205820	O

10/18/2005	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

SLENTPEASEBUMPS	O
,	O
LISSSOND	O

MRN	O
:	O

2852246	O

Age	O
:	O

52y	O

REGISTRATION	O
DATE	O
:	O

10/18/2005	O
02:43	O
PM	O

Provider	O
:	O

APT	O
SHUFF	O

PRELIMINARY	O
REPORT	O

Benefits	O
Assigned	O
:	O

N	O

Discharge	O
Note	O
Date	O
/	O
Time	O
:	O

10/18/2005	O
15:50	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

S	O
/	O
P	O
MVA	O

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
motor	O
vehicle	O
accident	O
-	O
trauma	B-problem
(	O
English	O
)	O
.	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
sprains	B-problem
,	O
fractures	B-problem
and	O
bruises	B-problem
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

s	O
/	O
p	O
motor	O
vehicle	O
accident	O
,	O
muscle	B-problem
contusions	I-problem

Treatment	O
Rendered	O
:	O

xray	B-test
-	O
no	O
evidence	O
of	O
fracture	B-problem

Discharge	O
Medications	O
:	O

motrin	B-treatment
600	O
mg	O
every	O
8	O
hours	O
for	O
pain	B-problem
-	O
please	O
take	O
with	O
food	O
in	O
your	O
stomach	O

Follow	O
up	O
Service	O
:	O

Please	O
call	O
your	O
primary	O
care	O
doctor	O
next	O
week	O
and	O
arrange	O
for	O
follow	O
up	O
next	O
week	O
.	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Please	O
use	O
ice	B-treatment
to	O
sore	B-problem
areas	I-problem
for	O
the	O
next	O
few	O
days	O
.	O

If	O
you	O
develop	O
trouble	B-problem
breathing	I-problem
,	O
worsening	B-problem
pain	I-problem
,	O
vomiting	B-problem
or	O
any	B-problem
other	I-problem
concerns	I-problem
please	O
return	O
to	O
the	O
ED	O
for	O
further	B-test
evaluation	I-test
.	O

Do	O
no	O
strenuous	O
activity	O
or	O
heavy	O
lifting	O
for	O
the	O
next	O
few	O
days	O
.	O

PCP	O
Name	O
:	O

CLOPKOORSFONGAYLES	O
,	O
NORBMADE	O

Provider	O
Number	O
:	O

26318	O

This	O
report	O
was	O
created	O
by	O
SHUFF	O
,	O
RONRIN	O
10/18/2005	O
03:53	O
PM	O

405507617	O

FIH	O

2887168	O

132052	O

543394	O

11/12/2002	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

SPALDFREIERMPLCA	O
,	O
IEOLY	O
E	O

UNIT	O
NUMBER	O
:	O

251-62-95	O

ADMISSION	O
DATE	O
:	O

11/12/2002	O

DISCHARGE	O
DATE	O
:	O

11/15/2002	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Alzheimer	B-problem
&apos;s	I-problem
disease	I-problem
secondary	O
to	O
Down	B-problem
&apos;s	I-problem
syndrome	I-problem
.	O

CHIEF	O
COMPLAINT	O
:	O

This	O
is	O
a	O
44	O
year-old	O
right	O
handed	O
woman	O
with	O
Down	B-problem
&apos;s	I-problem
syndrome	I-problem
who	O
presents	O
with	O
falling	B-problem
and	O
a	B-problem
decrease	I-problem
in	I-problem
her	I-problem
activities	I-problem
of	O
daily	O
living	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
44	O
year-old	O
right	O
handed	O
woman	O
with	O
Down	B-problem
&apos;s	I-problem
syndrome	I-problem
who	O
presents	O
with	O
increased	B-problem
falling	I-problem
and	O
gait	B-problem
unsteadiness	I-problem
and	O
an	B-problem
increased	I-problem
inability	I-problem
to	O
perform	O
her	O
activities	O
of	O
daily	O
living	O
over	O
the	O
past	O
three	O
years	O
.	O

The	O
diagnosis	O
of	O
Alzheimer	B-problem
&apos;s	I-problem
was	O
made	O
in	O
1998	O
.	O

The	O
patient	O
had	O
an	B-test
MRI	I-test
at	O
an	O
outside	O
hospital	O
which	O
showed	O
enlarged	B-problem
lateral	I-problem
ventricles	I-problem
and	O
the	O
possible	O
diagnosis	O
of	O
normal	B-problem
pressure	I-problem
hydrocephalus	I-problem
was	O
entertained	O
and	O
the	O
patient	O
was	O
admitted	O
for	O
diagnostic	B-test
lumbar	I-test
puncture	I-test
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Notable	O
for	O
Down	B-problem
&apos;s	I-problem
syndrome	I-problem
,	O
Altzheimer	B-problem
&apos;s	I-problem
disease	I-problem
secondary	O
to	O
Down	B-problem
&apos;s	I-problem
syndrome	I-problem
diagnosed	O
in	O
1998	O
,	O
status	O
post	O
multiple	B-problem
falls	I-problem
,	O
no	O
heart	B-problem
disease	I-problem
,	O
ankle	B-treatment
surgery	I-treatment
and	O
an	B-problem
abnormal	I-problem
EEG	I-problem
.	O

MEDICATIONS	O
:	O

Include	O
Lamictal	B-treatment
50	O
mgs	O
bid	O
,	O
Aricept	B-treatment
10	O
mgs	O
qhs	O
,	O
BuSpar	B-treatment
15	O
mgs	O
bid	O
,	O
Trazodone	B-treatment
100	O
mgs	O
qhs	O
.	O

ALLERGIES	O
:	O

There	O
are	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
at	O
home	O
with	O
her	O
family	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Notable	O
for	O
decreased	B-problem
ability	I-problem
to	O
do	O
her	O
activities	O
of	O
daily	O
living	O
,	O
a	B-problem
decrease	I-problem
in	I-problem
her	I-problem
language	I-problem
,	O
some	B-problem
urinary	I-problem
accidents	I-problem
,	O
increased	B-problem
falls	I-problem
and	O
a	B-problem
poor	I-problem
gait	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Noted	O
for	O
friendly	O
,	O
jovial	O
44	O
year-old	O
woman	O
with	O
Down	B-problem
&apos;s	I-problem
.	O

Vital	O
signs	O
:	O

Blood	B-test
pressure	I-test
150/82	O
,	O
heart	B-test
rate	I-test
88	O
,	O
respiratory	B-test
rate	I-test
18	O
.	O

HEENT	B-test
examination	I-test
is	O
notable	O
for	O
bilateral	B-problem
esotropia	I-problem
.	O

Chest	O
was	O
clear	O
to	O
auscultation	B-test
.	O

Cardiac	B-test
examination	I-test
was	O
regular	O
rate	O
and	O
rhythm	O
.	O

Abdominal	B-test
examination	I-test
was	O
soft	O
,	O
non-tender	B-problem
,	O
positive	O
bowel	O
sounds	O
.	O

Extremities	O
:	O

Left	O
ankle	O
was	O
notable	O
for	O
swelling	B-problem
secondary	O
to	O
status	O
post	O
left	B-treatment
ankle	I-treatment
surgery	I-treatment
.	O

Skin	O
:	O

The	O
patient	O
had	O
back	B-problem
folliculitis	I-problem
.	O

Neuro	B-test
examination	I-test
was	O
notable	O
for	O
a	O
patient	O
who	O
was	O
alert	O
and	O
oriented	O
x	O
1	O
.	O

She	O
could	O
identify	O
her	O
siblings	O
.	O

She	O
can	O
name	O
several	O
words	O
such	O
as	O
thumb	O
,	O
watch	O
and	O
knuckle	O
.	O

She	O
was	O
unable	O
to	O
name	O
glasses	O
.	O

Cranial	O
nerves	O
notable	O
for	O
bilateral	B-problem
esotropia	I-problem
.	O

Her	O
extraocular	O
motions	O
were	O
full	O
.	O

The	O
face	O
was	O
symmetrical	O
.	O

The	O
motor	O
tone	O
was	O
within	O
normal	O
limits	O
in	O
the	O
upper	O
and	O
lower	O
extremities	O
.	O

The	O
strength	O
was	O
5	O
out	O
of	O
5	O
.	O

Reflexes	B-test
were	O
2+	O
bilaterally	O
with	O
down	O
going	O
toes	O
.	O

Her	O
gait	O
was	O
notable	O
for	O
requiring	O
assist	O
.	O

The	O
patient	O
walked	O
with	O
her	B-problem
feet	I-problem
externally	I-problem
rotated	I-problem
with	O
a	B-problem
wide	I-problem
based	I-problem
gait	I-problem
with	O
shuffling	B-problem
short	I-problem
steps	I-problem
with	O
a	B-problem
tendency	I-problem
to	I-problem
fall	I-problem
back	I-problem
and	O
she	O
was	O
unable	O
to	O
walk	O
without	O
assist	O
.	O

MRI	B-test
,	O
as	O
discussed	O
,	O
was	O
done	O
at	O
outside	O
hospital	O
and	O
demonstrated	O
large	B-problem
ventricles	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Arkzie-	O
Memorial	O
for	O
lumbar	B-test
puncture	I-test
.	O

On	O
the	O
night	O
of	O
admission	O
lumbar	B-test
puncture	I-test
was	O
attempted	O
on	O
the	O
floor	O
,	O
but	O
we	O
were	O
unable	O
to	O
get	O
cerebral	O
spinal	O
fluid	O
due	O
to	O
difficulty	O
with	O
compliance	O
with	O
the	O
patient	O
who	O
was	O
severely	B-problem
agitated	I-problem
and	O
would	O
not	O
comply	O
with	O
the	B-test
examination	I-test
.	O

On	O
hospital	O
day	O
the	O
patient	O
underwent	O
conscious	B-treatment
sedation	I-treatment
in	O
the	O
operating	O
room	O
where	O
lumbar	B-test
puncture	I-test
was	O
performed	O
.	O

Opening	B-test
pressure	I-test
was	O
17	O
and	O
approximately	O
20-25	O
cc	O
of	O
CSF	O
was	O
removed	O
.	O

CSF	B-test
was	O
notable	O
for	O
sugar	B-test
level	I-test
of	O
65	O
and	O
total	B-test
protein	I-test
level	I-test
of	O
56	O
.	O

OTHER	O
LABORATORIES	O
THAT	O
WERE	O
NOTABLE	O
:	O

Vitamin	B-test
B12	I-test
of	O
855	O
,	O
folic	B-test
acid	I-test
of	O
15.4	O
.	O

Chem-7	B-test
was	O
within	O
normal	O
limits	O
.	O

Tube	O
and	O
requisition	O
of	O
the	O
CSF	B-test
labeled	I-test
tube	I-test
#	I-test
1	I-test
was	O
notable	O
for	O
color	B-test
pink	O
,	O
turbidity	B-test
slight	O
,	O
xanthochromia	B-test
yes	O
,	O
red	B-test
blood	I-test
cells	I-test
3,800	O
,	O
white	B-test
blood	I-test
cells	I-test
3	O
,	O
neutrophils	B-test
58	O
,	O
bands	B-test
4	O
,	O
lymphs	B-test
29	O
,	O
monos	B-test
6	O
,	O
eos	B-test
2	O
and	O
basos	B-test
1	O
.	O

CSF	B-test
tube	I-test
labeled	I-test
#	I-test
4	I-test
was	O
notable	O
for	O
CSF	B-test
color	I-test
pink	O
,	O
CSF	B-test
turbidity	I-test
slight	O
,	O
CSF	B-test
xanthochromia	I-test
yes	O
,	O
CSF	B-test
RBCs	I-test
3,900	O
,	O
CSF	B-test
white	I-test
blood	I-test
cells	I-test
3	O
,	O
CSF	B-test
neutrophils	I-test
61	O
,	O
CSF	B-test
bands	I-test
3	O
,	O
CSF	B-test
lymphs	I-test
31	O
,	O
CSF	B-test
monos	I-test
1	O
,	O
CSF	B-test
eos	I-test
3	O
,	O
CSF	B-test
basos	I-test
1	O
.	O

CSF	B-test
gram	I-test
stain	I-test
was	O
notable	O
for	O
no	O
polys	B-problem
and	O
no	O
organisms	B-problem
seen	O
.	O

The	B-test
fluid	I-test
culture	I-test
was	O
no	O
growth	O
to	O
date	O
.	O

One	O
day	O
prior	O
to	O
lumbar	B-test
puncture	I-test
,	O
an	B-test
aerobic	I-test
culture	I-test
was	O
similarly	O
pending	O
.	O

Lyme	B-test
capture	I-test
was	O
pending	O
and	O
at	O
the	O
time	O
of	O
discharge	O
.	O

Other	O
notable	O
tests	O
:	O

RPR	B-test
card	I-test
test	I-test
was	O
negative	O
.	O

Because	O
of	O
poor	O
compliance	O
with	O
the	B-test
gait	I-test
examination	I-test
it	O
was	O
very	O
difficult	O
to	O
assess	O
changing	B-problem
gait	I-problem
post	O
lumbar	B-test
puncture	I-test
.	O

The	O
patient	O
&apos;s	O
gait	O
remained	O
wide	O
based	O
and	O
shuffling	O
and	O
requiring	O
assist	O
.	O

Her	O
mental	O
status	O
remained	O
similarly	O
to	O
her	B-test
admission	I-test
examination	I-test
.	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
on	O
11/15/02	O
with	O
instructions	O
to	O
the	O
family	O
to	O
observe	O
her	O
gait	O
in	O
her	O
home	O
environment	O
and	O
to	O
observe	O
her	O
behavior	O
in	O
her	O
home	O
environment	O
over	O
the	O
next	O
day	O
and	O
to	O
report	O
back	O
to	O
the	O
primary	O
neurologist	O
,	O
Dr.	O
Flythegach	O
,	O
as	O
to	O
changes	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Were	O
as	O
they	O
were	O
on	O
admission	O
.	O

The	B-test
patient	I-test
&apos;s	I-test
neuro	I-test
examination	I-test
was	O
largely	O
unchanged	O
from	O
the	B-test
admission	I-test
neuro	I-test
examination	I-test
.	O

LATO	O
TIKFREIERM	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

_____________________________	O
LATO	O
TIKFREIERM	O
,	O
M.D.	O

TR	O
:	O

yh	O

DD	O
:	O

11/14/2002	O

TD	O
:	O

11/19/2002	O
3:35	O
P	O

cc	O
:	O

SIE	O
FLYTHEGACH	O
,	O
M.D.	O
TIFFILL	O
SAPNINS	O
,	O
M.D.	O
STA	O
THERNLIN	O
BALLOON	O
,	O
M.D.	O
LATO	O
TIKFREIERM	O
,	O
M.D.	O
/PCP	O
,	O
Jofredd	O
Mones	O
,	O
M.D.	O

405868244	O
YC	O

70449076	O

5586564	O

11/16/2005	O
12:00:00	O
AM	O

POSTPARTUM	O

DIS	O

Admission	O
Date	O
:	O

11/16/2005	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

11/19/2005	O

******	O
FINAL	O
DISCHARGE	O
ORDERS	O
******	O

WARESIN	O
,	O
SAGAY	O
702-84-43-7	O
L06	O

Room	O
:	O

DBM62-8758	O

Service	O
:	O

OBS	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

11/18/05	O
AT	O
02:00	O
PM	O

CONTINGENT	O
UPON	O

cnm	B-test
evaluation	I-test

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

OBSTETRICS	O
SERVICE	O
,	O
YC	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

DOCUSATE	B-treatment
SODIUM	I-treatment
100	O
MG	O
PO	O
BID	O
PRN	O
Constipation	B-problem
IBUPROFEN	B-treatment
400-600	O
MG	O
PO	O
Q6H	O
PRN	O
Pain	B-problem

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Take	O
with	O
food	O
PRENATAL	B-treatment
MULTIVITAMINS	I-treatment
(	I-treatment
STUARTNATAL	I-treatment
)	I-treatment
1	O
TAB	O
PO	O
QD	O
MAALOX-TABLETS	B-treatment
QUICK	I-treatment
DISSOLVE	I-treatment
/	I-treatment
CHEWABLE	I-treatment
1-2	O
TAB	O
PO	O
Q6H	O
PRN	O
Upset	B-problem
Stomach	I-problem

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Resume	O
regular	O
exercise	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

BROOKSIDE	O
2	O
wks	O
,	O

ALLERGY	O
:	O

NKA	O
ADMIT	O
DIAGNOSIS	O
:	O

pregnancy	B-problem
,	I-problem
term	I-problem

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O

POSTPARTUM	O
OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
postpartum	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

Vaginal	O
delivery	O
:	O

Spontaneous	O

Laceration	B-problem
:	O

Perineal	B-problem
,	I-problem
1st	I-problem
degree	I-problem

Placenta	O
:	O

Delivery	O
:	O

Spontaneous	O

Condition	O
:	O

Normal	O

Certified	O
Nurse	O
Midwife	O
:	O

NEAD	O
,	O
MANERTNY	O
,	O
CNM	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

repair	B-treatment
of	O
first	B-problem
degree	I-problem
perineal	I-problem
laceration	I-problem

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

G2	O
T1	O
P0	O
A0	O
L1	O
Estimated	O

EDC	O
:	O

12/02/05	O

Maternal	O
transfer	O
:	O

No	O

Initial	O
newborn	O
exam	O
:	O

No	O
observed	B-problem
abnormalities	I-problem

Baby	O
1	O

MRN	O
:	O

26793023	O

Delivery	O
date	O
:	O

11/16/05	O
02:21	O
PM	O

Apgars	B-test
9,9	O

Weight	B-test
:	O

7lb	O
4.8	O
oz	O
3311	O
grams	O

Sex	O
:	O

Female	O

ADDITIONAL	O
COMMENTS	O
:	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

JESCCOT	O
,	O
LA	O
P.	O
,	O
C.N.M	O
(	O
YW8	O
)	O

11/17/05	O
08:24	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

412141256	O

FIH	O

3833231	O

39626/6vf7	O

817292	O

10/3/1994	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

10-03-94	O

DISCHARGE	O
DATE	O
:	O

10-06-94	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
85	O
year	O
old	O
man	O
was	O
admitted	O
because	O
of	O
the	O
new	O
onset	O
of	O
focal	B-problem
left-sided	I-problem
seizure	I-problem
and	O
unresponsiveness	B-problem
.	O

He	O
had	O
a	O
past	O
history	O
of	O
ischemic	B-problem
cardiomyopathy	I-problem
with	O
an	B-test
ejection	I-test
fraction	I-test
of	O
10	O
,	O
mild	B-problem
aortic	I-problem
stenosis	I-problem
and	O
a	B-problem
right	I-problem
middle	I-problem
cerebral	I-problem
artery	I-problem
territory	I-problem
stroke	I-problem
in	O
07/94	O
.	O

He	O
was	O
at	O
Orlak	O
on	O
the	O
day	O
of	O
admission	O
and	O
was	O
found	O
unresponsive	B-problem
with	O
left	B-problem
tonic-clonic	I-problem
movements	I-problem
,	O
greater	O
in	O
the	O
arms	O
than	O
in	O
the	O
legs	O
.	O

He	O
was	O
transferred	O
to	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
,	O
where	O
seizures	B-problem
were	O
stopped	O
with	O
2	O
mg	O
of	O
Ativan	B-treatment
.	O

He	O
was	O
loaded	O
with	O
IV	B-treatment
Dilantin	I-treatment
.	O

He	O
remained	O
unresponsive	B-problem
with	O
poor	B-problem
airway	I-problem
protection	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Eyes	O
were	O
deviated	O
to	O
the	O
left	O
.	O

He	O
was	O
flaccid	B-problem
bilaterally	I-problem
.	O

He	O
had	O
no	O
oculocephalic	B-problem
reflexes	I-problem
.	O

After	O
one	O
hour	O
his	O
eyes	O
were	O
midline	O
and	O
he	O
remained	O
unresponsive	B-problem
.	O

HOSPITAL	O
COURSE	O
:	O

By	O
the	O
patient	O
and	O
his	O
family	O
&apos;s	O
prior	O
wishes	O
,	O
the	O
patient	O
was	O
extubated	O
.	O

An	B-test
electroencephalogram	I-test
revealed	O
generalized	B-problem
slowing	I-problem
without	I-problem
ictal	I-problem
events	I-problem
.	O

He	O
had	O
no	O
carotid	B-problem
bruits	I-problem
.	O

He	O
had	O
stertorous	B-problem
breathing	I-problem
,	O
positional	B-problem
tremors	I-problem
of	I-problem
the	I-problem
left	I-problem
upper	I-problem
extremity	I-problem
,	O
a	B-problem
spastic	I-problem
left	I-problem
hemiparesis	I-problem
in	I-problem
flexion	I-problem
.	O

He	O
withdrew	O
both	O
legs	O
to	O
painful	B-test
stimuli	I-test
.	O

The	O
right	O
upper	O
extremity	O
was	O
flaccid	B-problem
and	O
paresthetic	B-problem
.	O

Again	O
,	O
comfort	O
measures	O
only	O
were	O
undertaken	O
as	O
per	O
the	O
patient	O
&apos;s	O
previous	O
wishes	O
and	O
the	O
family	O
&apos;s	O
current	O
insistence	O
.	O

At	O
1:15	O
PM	O
on	O
10/06/94	O
,	O
the	O
patient	O
was	O
found	O
unresponsive	B-problem
with	O
no	O
heart	B-problem
sounds	I-problem
,	O
carotid	B-problem
pulse	I-problem
,	O
respiratory	B-problem
excursions	I-problem
,	O
or	O
pupillary	B-problem
reactions	I-problem
.	O

His	O
family	O
was	O
notified	O
.	O

Consent	O
for	O
autopsy	B-test
was	O
denied	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
Left	B-problem
middle	I-problem
cerebral	I-problem
artery	I-problem
territory	I-problem
cerebral	I-problem
infarction	I-problem
.	O

2.	O
Cardiomyopathy	B-problem
.	O

3.	O
Residual	O
of	O
previous	B-problem
right	I-problem
middle	I-problem
cerebral	I-problem
artery	I-problem
stroke	I-problem
.	O

RE	O
RHALTFETHFONGPOCE	O
,	O
M.D.	O

TR	O
:	O

cnm	O
/	O
bmot	O

DD	O
:	O

10-18-94	O

TD	O
:	O

10/19/94	O

CC	O
:	O

424729395	O
DH	O

0011649	O

07013	O

908447	O

6/14/2001	O
12:00:00	O
AM	O

OB	O
Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O
OB	O
EMR	O
L	O
and	O
D	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

XARAH	O
RATIA	O
SERVICE	O

UNIT	O
NUMBER	O
:	O

642-07-90	O

ADMISSION	O
DATE	O
:	O

20010614	O

DISCHARGE	O
DATE	O
:	O

20010616	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
:	O

Abnormal	B-problem
Fetal	I-problem
Heart	I-problem
Rate	I-problem
/	I-problem
Rhythm	I-problem
-	O
Delivered	O

ASSOCIATED	O
DIAGNOSES	O
:	O

Abnormal	B-problem
Pap	I-problem
Test	I-problem
,	O
history	O
of	O

PRINCIPAL	O
PROCEDURE	O
OR	O
OPERATION	O
:	O

Vacuum	B-treatment
Extraction	I-treatment

ASSOCIATED	O
PROCEDURES	O
OR	O
OPERATIONS	O
:	O

POSTPARTUM	O
DIAGNOSTIC	O
PROCEDURES	O
:	O

None	O

POSTPARTUM	O
THERAPEUTIC	O
PROCEDURES	O
:	O

None	O

OTHER	O
POSTPARTUM	O
THERAPIES	O
:	O

Routine	B-treatment
Post	I-treatment
Partum	I-treatment
Care	I-treatment

HISTORY	O
AND	O
REASON	O
FOR	O
HOSPITALIZATION	O
:	O

Active	B-problem
Labor	I-problem

PHYSICAL	O
EXAMINATION	O
:	O

HEIGHT	B-test
49	O
HEENT	B-test
NORMAL	O
MOUTH	O
NORMAL	O
NECK	O
NORMAL	O
BREASTS	O
NORMAL	O
NIPPLES	O
NORMAL	O
CHEST	O
NORMAL	O
COR	O
NORMAL	O
ABDOMEN	O
NORMAL	O
gravid	O
,	O
+	O
FHR	O
,	O
NT	O
EXTREM	O
NORMAL	O
SKIN	O
NORMAL	O
NODES	O
NORMAL	O
VULVA	O
NORMAL	O
VAGINA	O
NORMAL	O
CERVIX	O
NORMAL	O
4-5/100%	O
OS	O
NORMAL	O
closed	O
,	O
firm	O
,	O
-CMT	O
ADNEXAE	O
NORMAL	O
UTERUS	O
NORMAL	O
term	O
7-7.5	O
#	O
vtx	O
UTERINE	O
SIZE	O
IN	O
WEEKS	O
NORMAL	O
term	O

HOSPITAL	O
COURSE	O
(	O
include	O
complications	O
if	O
any	O
)	O
:	O

This	O
23	O
year	O
old	O
Gravida	O
2	O
Para	O
1001	O
was	O
admitted	O
to	O
the	O
Naliheall	O
County	O
Memorial	O
Hospital	O
Obstetrical	O
service	O
on	O
06/14/2001	O
at	O
01:29	O
pm	O
for	O
the	O
indication	O
(	O
s	O
)	O
:	O

active	B-problem
labor	I-problem
.	O

She	O
delivered	O
a	O
3263	O
gram	O
female	O
infant	O
at	O
06/14/2001	O
at	O
06:40	O
pm	O
with	O
apgar	B-test
scores	I-test
of	O
8	O
and	O
8	O
at	O
one	O
and	O
five	O
minutes	O
respectively	O
at	O
40.3	O
weeks	O
gestation	O
via	O
vacuum	B-treatment
extraction	I-treatment
.	O

During	O
her	O
labor	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

fetal	B-problem
bradycardia	I-problem
.	O

During	O
her	O
delivery	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

nuchal	B-problem
cord	I-problem
,	O
times	O
two	O
.	O

Postpartum	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

none	O
.	O

She	O
was	O
discharged	O
on	O
06/16/2001	O
at	O
12:00	O
pm	O
in	O
stable	O
condition	O
.	O

DISCHARGE	O
ACTIVITY	O
:	O

No	O
Restrictions	O

DISCHARGE	O
DIET	O
:	O

No	O
Restrictions	O

POSTPARTUM	O
DISPOSITION	O
:	O

Home	O
With	O
Self-Care	O
(	O
Routine	O
Discharge	O
)	O

POSTPARTUM	O
CARE	O
SITE	O
:	O

Burnrise	O
Memorial	O
Hospital	O

POSTPARTUM	O
RETURN	O
APPOINTMENT	O
(	O
DAYS	O
)	O
:	O

42	O

BREAST	O
FEEDING	O
AT	O
DISCHARGE	O
:	O

Yes	O

POSTPARTUM	O
MEASLES	O
/	O
MUMPS/RUBELLA	O
VACCINE	O
:	O

Not	O
Indicated	O

Electronically	O
Signed	O
:	O

American	O
,	O
06/16/2001	O
5:14:05	O
PM	O

425680098	O
SC	O

55925443	O

867222	O

8/7/1992	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O

DIS	O

Admission	O
Date	O
:	O

08/07/1992	O

Report	O
Status	O
:	O

Unsigned	O

Discharge	O
Date	O
:	O

08/10/1992	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
an	O
81	O
year	O
old	O
female	O
with	O
a	B-problem
right	I-problem
breast	I-problem
mass	I-problem
with	O
a	B-problem
discharge	I-problem
.	O

A	B-test
mammogram	I-test
of	I-test
the	I-test
right	I-test
breast	I-test
with	O
shadow	B-test
biopsy	I-test
was	O
negative	O
.	O

In	O
the	O
fall	O
of	O
1991	O
,	O
nipple	B-problem
changes	I-problem
and	O
discomfort	B-problem
was	O
again	O
noted	O
.	O

A	B-test
mmamogram	I-test
showed	O
no	O
change	O
on	O
right	O
,	O
but	O
new	B-test
biopsy	I-test
was	O
positive	O
.	O

On	O
the	O
left	O
,	O
there	O
was	O
a	B-problem
new	I-problem
shawdown	I-problem
but	O
the	B-test
biopsy	I-test
was	O
negative	O
.	O

The	O
patient	O
presents	O
now	O
for	O
right	B-treatment
modified	I-treatment
radical	I-treatment
mastectomy	I-treatment
with	O
impant	B-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Unremarkable	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

None	O
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

HABITS	O
:	O

Smoked	O
twenty	O
years	O
ago	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Clear	O
lungs	O
,	O
normal	O
heart	O
,	O
Pagett	B-test
&apos;s	I-test
type	O
changes	O
on	O
the	O
right	O
breast	O
and	O
left	O
breast	O
without	O
apparent	B-problem
masses	I-problem
with	O
scarring	B-problem
supra-areolar	I-problem
and	I-problem
infra-areolar	I-problem
.	O

A	B-problem
biopsy	I-problem
scar	I-problem
on	I-problem
the	I-problem
right	I-problem
breast	I-problem
from	O
1990	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
taken	O
to	O
the	O
Operting	O
Room	O
on	O
8/7/92	O
,	O
where	O
a	B-treatment
right	I-treatment
modified	I-treatment
radical	I-treatment
mastectomy	I-treatment
was	O
performed	O
.	O

Subsequently	O
a	B-treatment
saline-filled	I-treatment
right	I-treatment
breast	I-treatment
implant	I-treatment
was	O
performed	O
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
extremely	O
well	O
.	O

Two	B-treatment
drains	I-treatment
were	O
used	O
.	O

One	B-treatment
drain	I-treatment
was	O
removed	O
on	O
postoperative	O
day	O
number	O
two	O
,	O
and	O
the	B-treatment
second	I-treatment
drain	I-treatment
she	O
will	O
be	O
discharged	O
to	O
home	O
with	O
.	O

DISPOSITION	O
:	O

The	O
patient	O
is	O
discharged	O
to	O
home	O
in	O
good	O
condiiton	O
.	O

Discharge	B-treatment
medications	I-treatment
include	O
Percocet	B-treatment
and	O
Colace	B-treatment
.	O

Folloowup	O
is	O
in	O
one	O
week	O
with	O
Dr.	O
Ralekote	O
.	O

DP337/1857	O
DETIASAIRE	O
KAYSJARDUHE	O
,	O
M.D.	O
PQ01	O

D	O
:	O

08/08/92	O

Batch	O
:	O

9736	O

Report	O
:	O

J3725F1	O

T	O
:	O

08/10/92	O

Dictated	O
By	O
:	O

LA	O
JESCCOT	O
,	O
M.D.	O
KC44	O

433651389	O

CTMC	O

81247987	O

625670	O

08/16/1998	O
12:00:00	O
AM	O

MENTAL	B-problem
STATUS	I-problem
CHANGE	I-problem
,	O
CELLULITIS	B-problem

Signed	O

DIS	O

Admission	O
Date	O
:	O

08/16/1998	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

08/18/1998	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

MENTAL	B-problem
STATUS	I-problem
CHANGES	I-problem
.	O

OTHER	O
DIAGNOSES	O
:	O

1)	O
AORTIC	B-problem
STENOSIS	I-problem
.	O

2)	O
MITRAL	B-problem
REGURGITATION	I-problem
.	O

3)	O
STATUS	O
POST	O
FALL	B-problem
.	O

4)	O
HISTORY	O
OF	O
TRANSIENT	B-problem
ISCHEMIC	I-problem
ATTACK	I-problem
/	O
CEREBROVASCULAR	B-problem
ACCIDENT	I-problem
.	O

5)	O
RIGHT	B-problem
LOWER	I-problem
EXTREMITY	I-problem
WOUND	I-problem
.	O

6)	O
ATRIAL	B-problem
FIBRILLATION	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
an	O
88	O
year-old	O
woman	O
undergoing	O
treatment	B-treatment
for	O
a	B-problem
right	I-problem
lower	I-problem
extremity	I-problem
cellulitis	I-problem
who	O
was	O
transferred	O
from	O
Child	O
for	O
worsening	B-problem
cellulitis	I-problem
and	O
new	B-problem
confusion	I-problem
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
severe	B-problem
aortic	I-problem
stenosis	I-problem
and	O
was	O
recently	O
admitted	O
to	O
the	O
Retelk	O
County	O
Medical	O
Center	O
for	O
a	O
Nafcillin	B-problem
sensitive	I-problem
Staphylococcus	I-problem
aureus	I-problem
cellulitis	I-problem
of	I-problem
the	I-problem
right	I-problem
leg	I-problem
treated	O
with	O
a	B-treatment
course	I-treatment
of	I-treatment
Nafcillin	I-treatment
and	O
Levofloxacin	B-treatment
.	O

There	O
was	O
also	O
a	B-problem
right	I-problem
leg	I-problem
fluid	I-problem
collection	I-problem
that	O
was	O
incised	O
and	O
drained	O
on	O
August	O
1	O
,	O
1998	O
.	O

The	O
patient	O
was	O
sent	O
to	O
rehabilitation	B-treatment
on	O
Levofloxacin	B-treatment
orally	O
.	O

Although	O
details	O
were	O
not	O
available	O
at	O
the	O
time	O
of	O
admission	O
,	O
apparently	O
,	O
she	O
had	O
done	O
well	O
until	O
the	O
24	O
hours	O
proceeding	O
admission	O
when	O
the	B-problem
cellulitis	I-problem
was	O
felt	O
to	O
be	O
worsening	O
.	O

She	O
had	O
also	O
been	O
noted	O
to	O
be	O
confused	B-problem
and	O
combative	B-problem
during	O
that	O
24	O
hour	O
period	O
.	O

As	O
her	O
baseline	O
mental	O
status	O
is	O
completely	O
alert	O
and	O
oriented	O
,	O
this	O
caused	O
concern	O
amongst	O
the	O
staff	O
of	O
the	O
rehabilitation	O
center	O
and	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
Retelk	O
County	O
Medical	O
Center	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1)	O
Aortic	B-problem
stenosis	I-problem
,	I-problem
severe	I-problem
,	O
echocardiogram	B-test
in	O
July	O
of	O
1998	O
with	O
a	B-test
peak	I-test
gradient	I-test
of	O
6-8	O
mm	O
of	O
mercury	O
,	O
aortic	B-test
valve	I-test
area	I-test
calculated	O
to	O
be	O
0.5	O
cm	O
squared	O
by	O
the	O
continuity	B-test
equation	I-test
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
congestive	B-problem
heart	I-problem
failure	I-problem
.	O

Calculated	B-test
ejection	I-test
fraction	I-test
was	O
45-50%	O
.	O

2)	O
Mitral	B-problem
regurgitation	I-problem
,	O
2+	O
on	O
July	O
of	O
1998	O
echocardiogram	B-test
.	O

3)	O
History	O
of	O
atrial	B-problem
fibrillation	I-problem
.	O

4)	O
History	O
of	O
cerebrovascular	B-problem
disease	I-problem
.	O

5)	O
Hypertension	B-problem
.	O

6)	O
History	O
of	O
temporal	B-problem
arteritis	I-problem
on	O
chronic	B-treatment
steroids	I-treatment
.	O

7)	O
History	O
of	O
colitis	B-problem
.	O

8)	O
History	O
of	O
vertebral	B-problem
body	I-problem
fractures	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1)	O
Digoxin	B-treatment
0.125	O
mg	O
p.o.	O
q.	O
day	O
.	O

2)	O
Lasix	B-treatment
80	O
mg	O
p.o.	O
b.i.d.	O

3)	O
Aspirin	B-treatment
81	O
mg	O
p.o.	O
q.	O
day	O
.	O

4)	O
Coumadin	B-treatment
2	O
mg	O
p.o.	O
q.h.s.	O

5)	O
Zaroxolyn	B-treatment
2.5	O
mg	O
p.o.	O
q.	O
day	O
.	O

6)	O
Toprol	B-treatment
XL	I-treatment
50	O
mg	O
p.o.	O
q.	O
day	O
.	O

7)	O
Potassium	B-treatment
20	O
mEq	O
p.o.	O
q.	O
day	O
.	O

8)	O
Prednisone	B-treatment
5	O
mg	O
p.o.	O
q.o.d.	O

9)	O
Fosamax	B-treatment
10	O
mg	O
p.o.	O
q.	O
day	O
.	O

10)	O
Levofloxacin	B-treatment
250	O
mg	O
p.o.	O
q.	O
day	O
.	O

11)	O
Axid	B-treatment
150	O
mg	O
p.o.	O
b.i.d.	O

12)	O
Buspar	B-treatment
5	O
mg	O
p.o.	O
t.i.d.	O

13)	O
Zyrtec	B-treatment
10	O
mg	O
p.o.	O
q.	O
day	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
had	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
presently	O
staying	O
at	O
the	O
Gangistown	O
Hospital	O
Center	O
.	O

She	O
has	O
a	O
son	O
who	O
is	O
actively	O
involved	O
in	O
her	O
care	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Physical	B-test
examination	I-test
on	O
admission	O
revealed	O
an	O
elderly	O
woman	O
,	O
sleeping	O
,	O
responsive	O
only	O
to	O
noxious	B-test
stimuli	I-test
after	O
having	O
received	O
some	B-treatment
sedation	I-treatment
in	O
the	O
emergency	O
department	O
.	O

Vital	B-test
signs	I-test
:	O

Heart	B-test
rate	I-test
60	O
,	O
respiratory	B-test
rate	I-test
18	O
,	O
blood	B-test
pressure	I-test
116/80	O
,	O
temperature	B-test
97.1	O
degrees	O
,	O
oxygen	B-test
saturation	I-test
93%	O
on	O
room	O
air	O
.	O

Head	B-test
and	I-test
neck	I-test
examination	I-test
was	O
benign	O
.	O

Skin	B-test
examination	I-test
was	O
notable	O
for	O
a	B-problem
leg	I-problem
ulcer	I-problem
and	O
cellulitis	B-problem
to	O
be	O
delineated	O
below	O
.	O

There	O
were	O
no	O
spider	B-problem
angiomata	I-problem
.	O

Neck	O
was	O
supple	O
with	O
no	O
thyromegaly	B-problem
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	B-test
bilaterally	I-test
.	O

The	B-test
heart	I-test
examination	I-test
revealed	O
that	O
the	O
patient	O
had	O
a	B-problem
sustained	I-problem
PMI	I-problem
which	O
was	O
located	O
in	O
the	O
left	O
mid	O
clavicular	O
line	O
,	O
S1	O
,	O
near	B-problem
complete	I-problem
obliteration	I-problem
of	I-problem
the	I-problem
second	I-problem
heart	I-problem
sound	I-problem
by	O
a	B-problem
two	I-problem
out	I-problem
of	I-problem
six	I-problem
high	I-problem
pitched	I-problem
murmur	I-problem
peaking	O
at	O
mid	O
to	O
late	O
systole	O
and	O
heard	O
across	O
the	O
precordium	O
.	O

It	O
radiates	O
to	O
both	O
carotids	O
bilaterally	O
.	O

There	O
was	O
also	O
a	B-problem
blowing	I-problem
holosystolic	I-problem
murmur	I-problem
heard	O
at	O
the	O
patient	O
&apos;s	O
apex	O
to	O
axilla	O
.	O

There	O
was	O
no	O
S3	B-problem
appreciated	O
.	O

Vascular	B-test
examination	I-test
was	O
notable	O
for	O
1+	B-problem
carotid	I-problem
impulses	I-problem
which	O
were	O
diminished	O
and	O
delayed	O
and	O
the	O
above	O
mentioned	O
transmitted	B-problem
cardiac	I-problem
murmurs	I-problem
.	O

Abdominal	B-test
examination	I-test
revealed	O
that	O
the	O
abdomen	O
was	O
soft	O
,	O
non-tender	B-problem
,	O
non-distended	B-problem
,	O
no	O
organomegaly	B-problem
,	O
no	O
masses	B-problem
,	O
normal	O
active	O
bowel	O
sounds	O
.	O

The	B-test
patient	I-test
&apos;s	I-test
extremity	I-test
examination	I-test
was	O
notable	O
for	O
erythema	B-problem
of	I-problem
the	I-problem
right	I-problem
calf	I-problem
with	O
a	B-problem
small	I-problem
ulcer	I-problem
with	O
a	O
relatively	O
clean	O
base	O
.	O

Neurological	B-test
examination	I-test
revealed	O
that	O
the	O
patient	O
was	O
quite	B-problem
sedated	I-problem
at	O
this	O
time	O
having	O
received	O
some	O
medications	B-treatment
.	O

She	O
was	O
arousable	O
only	O
to	O
painful	B-test
stimuli	I-test
.	O

Her	O
pupils	O
were	O
reactive	O
bilaterally	O
.	O

Her	O
face	O
was	O
symmetric	O
.	O

She	O
had	O
an	O
intact	O
gag	O
reflex	O
.	O

She	O
was	O
able	O
to	O
move	O
all	O
four	O
of	O
her	O
extremities	O
in	O
response	O
to	O
pain	B-test
.	O

Her	B-test
deep	I-test
tendon	I-test
reflexes	I-test
were	O
slightly	O
diminished	O
at	O
1+	O
bilaterally	O
,	O
but	O
symmetric	O
.	O

LABORATORY	O
:	O

The	O
patient	O
&apos;s	O
laboratory	O
data	O
on	O
admission	O
is	O
as	O
follows	O
:	O

Sodium	B-test
was	O
142	O
,	O
potassium	B-test
3.3	O
,	O
chloride	B-test
99	O
,	O
BUN	B-test
23	O
,	O
creatinine	B-test
1.1	O
.	O

AST	B-test
was	O
25	O
,	O
alkaline	B-test
phosphatase	I-test
130	O
,	O
total	B-test
bilirubin	I-test
3.2	O
,	O
albumin	B-test
3.4	O
,	O
calcium	B-test
8.8	O
.	O

Digoxin	B-test
level	I-test
was	O
0.8	O
.	O

Hematocrit	B-test
was	O
33.0	O
,	O
platelet	B-test
count	I-test
627	O
,	O
white	B-test
blood	I-test
cell	I-test
count	I-test
10,000	O
,	O
MCV	B-test
79.8	O
.	O

Coagulation	B-test
studies	I-test
revealed	O
a	O
PT	B-test
of	O
17.4	O
seconds	O
with	O
an	B-test
INR	I-test
of	O
2.1	O
,	O
PTT	B-test
25.5	O
.	O

The	B-test
patient	I-test
&apos;s	I-test
admission	I-test
chest	I-test
x-ray	I-test
revealed	O
no	O
infiltrate	B-problem
,	O
no	O
congestive	B-problem
heart	I-problem
failure	I-problem
.	O

Head	B-test
CT	I-test
scan	I-test
performed	O
in	O
the	O
emergency	O
department	O
revealed	O
no	O
bleed	B-problem
.	O

Urinalysis	B-test
revealed	O
trace	B-problem
microscopic	I-problem
hematuria	I-problem
with	O
47	O
red	O
blood	O
cells	O
per	O
high	O
powered	O
field	O
,	O
1+	B-problem
bacteria	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

1)	O
Mental	O
status	O
changes	O
:	O

On	O
admission	O
to	O
the	O
emergency	O
room	O
,	O
the	O
patient	O
was	O
somewhat	O
argumentative	B-problem
and	O
confused	B-problem
as	O
well	O
as	O
uncooperative	B-problem
with	I-problem
procedures	I-problem
.	O

A	B-test
neurologic	I-test
work-up	I-test
was	O
undertaken	O
which	O
included	O
a	B-test
CT	I-test
scan	I-test
of	I-test
the	I-test
head	I-test
which	O
revealed	O
no	O
acute	B-problem
bleed	I-problem
and	O
a	B-test
lumbar	I-test
puncture	I-test
which	O
revealed	O
a	B-test
glucose	I-test
of	O
72	O
,	O
protein	B-test
65	O
,	O
white	B-test
blood	I-test
cell	I-test
count	I-test
19	O
,	O
red	B-test
blood	I-test
cell	I-test
count	I-test
11,500	O
with	O
no	O
evidence	O
of	O
xanthrochromasia	B-problem
.	O

The	O
Neurology	O
Service	O
evaluated	O
the	O
patient	O
who	O
felt	O
that	O
her	B-problem
agitation	I-problem
was	O
most	O
likely	O
due	O
to	O
infection	B-problem
,	O
her	B-treatment
multiple	I-treatment
medications	I-treatment
,	O
or	O
her	B-problem
metabolic	I-problem
condition	I-problem
.	O

The	O
patient	O
&apos;s	O
mental	O
status	O
slowly	O
began	O
to	O
recover	O
,	O
however	O
on	O
the	O
morning	O
of	O
the	O
first	O
day	O
of	O
admission	O
,	O
August	O
16	O
,	O
1998	O
,	O
the	O
patient	O
was	O
found	O
after	O
having	O
fallen	O
.	O

A	B-test
neurological	I-test
examination	I-test
was	O
performed	O
which	O
revealed	O
no	O
abnormality	B-problem
and	O
imaging	B-test
included	O
a	B-test
head	I-test
scan	I-test
which	O
revealed	O
no	O
bleed	B-problem
and	O
a	B-test
cervical	I-test
spine	I-test
series	I-test
which	O
revealed	O
degenerative	B-problem
joint	I-problem
disease	I-problem
but	O
no	O
obvious	B-problem
fracture	I-problem
.	O

The	O
patient	O
decided	O
not	O
to	O
pursue	O
further	B-test
testing	I-test
with	O
a	B-test
neck	I-test
CT	I-test
scan	I-test
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
the	O
patient	O
&apos;s	O
mental	O
status	O
is	O
back	O
to	O
its	O
baseline	O
.	O

2)	O
Right	B-problem
lower	I-problem
extremity	I-problem
cellulitis	I-problem
:	O

The	O
patient	O
was	O
evaluated	O
by	O
the	O
Surgical	O
Service	O
who	O
felt	O
that	O
the	B-problem
wound	I-problem
was	O
clean	O
with	O
some	B-problem
erythema	I-problem
but	O
without	O
evidence	O
of	O
true	B-problem
cellulitis	I-problem
.	O

The	O
patient	O
&apos;s	O
antibiotics	B-treatment
were	O
discontinued	O
with	O
the	O
thought	O
that	O
prolonged	B-treatment
antibiotics	I-treatment
only	O
put	O
her	O
at	O
more	O
risk	O
for	O
infection	B-problem
.	O

3)	O
Cardiac	O
:	O

The	O
patient	O
has	O
a	O
history	O
of	O
critical	B-problem
aortic	I-problem
stenosis	I-problem
and	O
mitral	B-problem
regurgitation	I-problem
.	O

Fortunately	O
,	O
these	O
issues	O
were	O
not	O
active	O
during	O
the	O
present	O
admission	O
.	O

4)	O
Status	O
post	O
fall	B-problem
:	O

The	O
patient	O
did	O
fall	O
while	O
inhouse	O
.	O

A	B-test
head	I-test
CT	I-test
scan	I-test
and	O
cervical	B-test
spine	I-test
series	I-test
were	O
negative	O
.	O

The	O
patient	O
appeared	O
to	O
have	O
no	O
deficits	B-problem
at	O
the	O
time	O
of	O
discharge	O
.	O

5)	O
Atrial	B-problem
fibrillation	I-problem
:	O

The	B-treatment
patient	I-treatment
&apos;s	I-treatment
Coumadin	I-treatment
was	O
continued	O
.	O

6)	O
Abnormal	B-problem
liver	I-problem
function	I-problem
tests	I-problem
:	O

On	O
admission	O
,	O
the	O
patient	O
was	O
noted	O
to	O
have	O
elevated	B-problem
bilirubins	I-problem
in	O
the	O
3	O
range	O
and	O
mildly	B-problem
elevated	I-problem
alkaline	I-problem
phosphatase	I-problem
consistent	O
with	O
a	O
cholestatic	B-problem
picture	I-problem
.	O

These	B-test
liver	I-test
function	I-test
tests	I-test
will	O
be	O
followed	O
closely	O
as	O
an	O
outpatient	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1)	O
Aspirin	B-treatment
81	O
mg	O
p.o.	O
q.	O
day	O
.	O

2)	O
Digoxin	B-treatment
0.125	O
mg	O
p.o.	O
q.	O
AM	O
.	O

3)	O
Lasix	B-treatment
40	O
mg	O
p.o.	O
b.i.d.	O

4)	O
Zaroxolyn	B-treatment
0.25	O
mg	O
p.o.	O
q.	O
day	O
.	O

5)	O
Prednisone	B-treatment
5	O
mg	O
p.o.	O
q.o.d.	O

6)	O
Coumadin	B-treatment
2	O
mg	O
p.o.	O
q.h.s.	O

7)	O
Kay	B-treatment
Ciel	I-treatment
20	O
mEq	O
p.o.	O
q.	O
day	O
.	O

8)	O
Fosamax	B-treatment
10	O
mg	O
p.o.	O
q.	O
day	O
.	O

9)	O
Amitriptyline	B-treatment
10	O
mg	O
p.o.	O
q.h.s.	O

10)	O
Buspar	B-treatment
5	O
mg	O
p.o.	O
t.i.d.	O

FOLLOW-UP	O
:	O

The	O
patient	O
will	O
be	O
followed	O
at	O
rehabilitation	B-treatment
by	O
her	O
primary	O
care	O
physician	O
,	O
Dr.	O
Both	O
.	O

Dictated	O
By	O
:	O

TIA	O
BREUNMULL	O
,	O
M.D.	O
OH29	O

Attending	O
:	O

RA	O
S.	O
BOTH	O
,	O
M.D.	O
YT79	O
WH234/2364	O

Batch	O
:	O

4025	O

Index	O
No.	O
FSYAMR79X6	O

D	O
:	O

08/18/98	O

T	O
:	O

08/18/98	O

455343475	O
PUMC	O

4322324	O

195078	O

781135	O

6/15/2000	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

KOTE	O
,	O
YGA	O

MRN	O
:	O

4322324	O

Age	O
:	O

43y	O

REGISTRATION	O
DATE	O
:	O

06/15/2000	O
01:09	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
KOTE	O
,	O
YGA	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Ponta,itri-	O
University	O
Medical	O
Center	O
on	O
06/15/2000	O
01:09	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
R	B-problem
THUMB	I-problem
INJURY	I-problem
.	O

Following	O
triage	B-test
,	O
the	O
patient	O
LEFT	O
WITHOUT	O
TREATMENT	B-treatment
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
937-599-6520	O
.	O

493597270	O

CMC	O

86164445	O

3/17/1998	O
12:00:00	O
AM	O

ACUTE	B-problem
LEUKEMIA	I-problem

Signed	O

DIS	O

Admission	O
Date	O
:	O

03/17/1998	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

04/12/1998	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
68	O
year	O
old	O
with	O
acute	B-problem
leukemia	I-problem
.	O

The	O
patient	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
about	O
three	O
weeks	O
prior	O
to	O
admission	O
when	O
she	O
began	O
to	O
notice	O
increased	B-problem
weakness	I-problem
and	O
bruising	B-problem
.	O

She	O
presented	O
to	O
a	O
Wood	O
Emergency	O
Department	O
six	O
days	O
prior	O
to	O
admission	O
.	O

Platelets	B-test
were	O
9,000	O
,	O
hemoglobin	B-test
9.5	O
,	O
temperature	B-test
was	O
100.4	O
.	O

The	O
patient	O
had	O
a	B-test
smear	I-test
there	O
consistent	O
with	O
ALL	B-problem
.	O

The	O
patient	O
was	O
transferred	O
to	O
Norri	O
Hospital	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

No	O
headache	B-problem
,	O
no	O
nausea	B-problem
,	O
vomiting	B-problem
or	O
diarrhea	B-problem
.	O

Some	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
with	O
allergies	B-problem
,	O
particularly	O
cats	O
.	O

No	O
chest	B-problem
pain	I-problem
.	O

The	O
patient	O
had	O
been	O
doing	O
aerobics	O
three	O
times	O
a	O
week	O
until	O
a	O
couple	O
of	O
weeks	O
before	O
admission	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

The	O
patient	O
&apos;s	O
past	O
medical	O
history	O
is	O
significant	O
for	O
allergies	B-problem
,	O
depression	B-problem
and	O
anxiety	B-problem
,	O
pleural	B-problem
thickening	I-problem
/	O
asbestosis	B-problem
,	O
chronic	B-problem
left	I-problem
bundle	I-problem
branch	I-problem
block	I-problem
,	O
tonsillectomy	B-treatment
,	O
adenoidectomy	B-treatment
,	O
vein	B-treatment
stripping	I-treatment
(	O
1968	O
)	O
,	O
left	B-problem
wrist	I-problem
fracture	I-problem
(	O
1994	O
)	O
,	O
and	O
hypercholesterolemia	B-problem
.	O

ALLERGIES	O
:	O

The	B-problem
patient	I-problem
&apos;s	I-problem
allergies	I-problem
include	O
a	O
questionable	O
penicillin	B-problem
reaction	I-problem
;	O
however	O
,	O
the	O
patient	O
tolerated	O
Ampicillin	B-treatment
well	O
.	O

The	O
patient	O
does	O
not	O
recollect	O
what	O
her	B-problem
reaction	I-problem
to	O
penicillin	B-treatment
was	O
.	O

The	O
patient	O
also	O
had	O
a	O
history	O
of	O
platelet	B-problem
reaction	I-problem
.	O

FAMILY	O
HISTORY	O
:	O

The	O
patient	O
&apos;s	O
family	O
history	O
was	O
significant	O
for	O
a	O
brother	O
with	O
colon	B-problem
cancer	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
with	O
her	O
husband	O
and	O
she	O
has	O
three	O
children	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	B-test
patient	I-test
&apos;s	I-test
physical	I-test
examination	I-test
revealed	O
a	O
well-developed	O
,	O
well-nourished	O
white	O
female	O
in	O
no	O
apparent	B-problem
distress	I-problem
.	O

Vital	O
signs	O
:	O

Temperature	B-test
98.2	O
,	O
blood	B-test
pressure	I-test
134/80	O
,	O
respiratory	B-test
rate	I-test
22	O
,	O
pulse	B-test
102	O
.	O

HEENT	B-test
examination	I-test
was	O
normocephalic	O
and	O
atraumatic	B-problem
.	O

Cranial	O
nerves	O
II-XII	O
were	O
grossly	O
intact	O
.	O

There	O
was	O
decreased	B-problem
hearing	I-problem
bilaterally	I-problem
.	O

The	O
oropharynx	O
was	O
within	O
normal	O
limits	O
with	O
fillings	O
and	O
a	B-problem
partial	I-problem
upper	I-problem
plate	I-problem
.	O

The	O
neck	O
had	O
a	O
full	O
range	O
of	O
motion	O
,	O
no	O
lymphadenopathy	B-problem
.	O

The	B-test
chest	I-test
exam	I-test
was	O
clear	O
to	O
auscultation	B-test
.	O

Cardiac	B-test
exam	I-test
revealed	O
an	O
S1	O
and	O
an	O
S2	O
and	O
a	B-problem
diffuse	I-problem
2/6	I-problem
systolic	I-problem
murmur	I-problem
.	O

The	O
abdomen	O
was	O
soft	O
,	O
nontender	B-problem
and	O
nondistended	B-problem
with	O
no	O
guarding	B-problem
and	O
no	O
hepatosplenomegaly	B-problem
.	O

Bowel	O
sounds	O
were	O
present	O
.	O

The	B-test
skin	I-test
examination	I-test
revealed	O
the	O
right	O
breast	O
had	O
a	B-problem
dark	I-problem
two	I-problem
centimeter	I-problem
ecchymosis	I-problem
and	O
the	O
left	O
medial	O
thigh	O
had	O
two	O
pale	B-problem
blue	I-problem
two	I-problem
centimeter	I-problem
macules	I-problem
.	O

LABORATORY	O
DATA	O
:	O

Admitting	B-test
labs	I-test
were	O
:	O

Sodium	B-test
138	O
,	O
potassium	B-test
4.2	O
,	O
chloride	B-test
98	O
,	O
BUN	B-test
21	O
,	O
creatinine	B-test
0.7	O
,	O
glucose	B-test
117	O
,	O
white	B-test
blood	I-test
cell	I-test
count	I-test
13,200	O
,	O
hematocrit	B-test
22.5	O
,	O
platelet	B-test
count	I-test
40,000	O
.	O

AST	B-test
29	O
,	O
ALK	B-test
151	O
,	O
total	B-test
bilirubin	I-test
0.2	O
,	O
total	B-test
protein	I-test
7.2	O
,	O
albumin	B-test
4.3	O
,	O
globulins	B-test
2.9	O
,	O
calcium	B-test
8.9	O
.	O

PT	B-test
12.8	O
,	O
PTT	B-test
19.1	O
.	O

Peripheral	B-test
smear	I-test
revealed	O
blasts	B-test
of	O
62%	O
.	O

HOSPITAL	O
COURSE	O
:	O

A	B-treatment
Hickman	I-treatment
catheter	I-treatment
was	O
placed	O
and	O
the	O
patient	O
was	O
begun	O
on	O
chemotherapy	B-treatment
.	O

The	B-treatment
regimen	I-treatment
included	O
cyclophosphamide	B-treatment
,	O
daunorubicin	B-treatment
,	O
prednisone	B-treatment
,	O
Vincristine	B-treatment
and	O
PEG-asparaginase	B-treatment
.	O

The	O
patient	O
tolerated	O
the	B-treatment
chemotherapy	I-treatment
regimen	I-treatment
well	O
.	O

The	O
patient	O
began	O
neutropenic	B-problem
on	O
day	O
five	O
of	O
induction	O
.	O

The	B-test
patient	I-test
&apos;s	I-test
liver	I-test
function	I-test
tests	I-test
began	O
to	O
rise	O
and	O
she	O
began	O
to	O
experience	O
pulmonary	B-problem
symptoms	I-problem
including	O
increased	B-problem
crackles	I-problem
.	O

The	O
patient	O
began	O
to	O
spike	O
and	O
a	B-test
blood	I-test
culture	I-test
grew	O
out	O
Staphylococcusaureus	B-problem
.	O

The	O
patient	O
was	O
begun	O
on	O
Gentamicin	B-treatment
,	O
Vancomycin	B-treatment
and	O
Piperacillin	B-treatment
,	O
which	O
was	O
changed	O
to	O
Gentamicin	B-treatment
and	O
Ceftazidime	B-treatment
.	O

The	O
patient	O
continued	O
to	O
spike	O
and	O
was	O
enrolled	O
in	O
a	O
randomized	O
trial	O
,	O
the	O
patient	O
was	O
randomized	O
to	O
AmBisome	B-treatment
antifungal	I-treatment
treatment	I-treatment
.	O

An	B-test
abdominal	I-test
MRI	I-test
was	O
performed	O
to	O
assess	O
continued	O
elevated	B-problem
liver	I-problem
enzymes	I-problem
;	O
however	O
,	O
the	B-test
MRI	I-test
was	O
negative	O
.	O

The	O
patient	O
was	O
begun	O
on	O
Nafcillin	B-treatment
due	O
to	O
continued	O
spiking	O
.	O

The	O
patient	O
began	O
to	O
experience	O
urinary	B-problem
retention	I-problem
and	O
was	O
straight	O
catheterized	O
.	O

Thepatient	O
developed	O
a	O
possible	O
drug	B-problem
rash	I-problem
and	O
Nafcillin	B-treatment
was	O
changed	O
to	O
Ancef	B-treatment
.	O

The	O
patient	O
became	O
constipated	B-problem
;	O
this	O
resolved	O
with	O
laxatives	B-treatment
.	O

The	O
patient	O
improved	O
significantly	O
and	O
was	O
thought	O
to	O
be	O
ready	O
for	O
discharge	O
by	O
the	O
11th	O
of	O
April	O
.	O

She	O
will	O
follow	O
up	O
with	O
her	O
primary	O
oncologists	O
,	O
Dr	O
A	O
and	O
Dr	O
Dark	O
,	O
at	O
IVMC	O
,	O
after	O
her	O
discharge	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

The	B-treatment
patient	I-treatment
&apos;s	I-treatment
discharge	I-treatment
medications	I-treatment
include	O
the	O
following	O
:	O

1)	O
Albuterol	B-treatment
inhaler	I-treatment
two	O
puffs	O
q.i.d.	O
p.r.n.	O
breathing	B-problem
difficulties	I-problem
.	O

2)	O
Calcium	B-treatment
gluconate	I-treatment
1000	O
mg	O
p.o.	O
q	O
day	O
.	O

3)	O
Cefazolin	B-treatment
one	O
gram	O
IV	O
q.8h.	O
x	O
13days	O
.	O

4)	O
Colace	B-treatment
100	O
mg	O
p.o.	O
b.i.d.	O

5)	O
Lasix	B-treatment
40	O
mg	O
p.o.	O
q	O
day	O
.	O

6)	O
Lactulose	B-treatment
30	O
milliliters	O
p.o.	O
q.2h.	O
p.r.n.	O
constipation	B-problem
.	O

7)	O
Magnesium	B-treatment
hydroxide	I-treatment
30	O
milliliters	O
p.o.	O
q	O
day	O
.	O

8)	O
Miracle	B-treatment
Creamtopical	I-treatment
q	O
day	O
p.r.n.	O
skin	B-problem
irritation	I-problem
.	O

9)	O
Sarna	B-treatment
topical	I-treatment
b.i.d.	O
p.r.n.	O
itching	B-problem
.	O

10)	O
Senna	B-treatment
tablets	I-treatment
,	O
two	O
tablets	O
p.o.	O
b.i.d.	O

11)	O
Simethicone	B-treatment
80	O
mg	O
p.o.	O
q.i.d.	O
p.r.n.	O
gas	B-problem
pain	I-problem
.	O

12)	O
Citrucel	B-treatment
one	O
tablespoon	O
p.o.	O
q	O
day	O
.	O

13)	O
K-Dur	B-treatment
10	O
mEq	O
x	O
three	O
,	O
p.o.	O
b.i.d.	O

14)	O
Zoloft	B-treatment
25	O
mg	O
p.o.	O
q	O
day	O
.	O

15)	O
Peridex	B-treatment
30	O
cc	O
p.o.	O
b.i.d.	O
x	O
14	O
days	O
.	O

16)	O
Robituss	B-treatment
in	I-treatment
AC	I-treatment
five	O
to	O
ten	O
milliliters	O
p.o.	O
q.h.s.	O
p.r.n.	O
cough	B-problem
.	O

Dictated	O
By	O
:	O

AZEL	O
HIBBSKAYS	O
,	O
M.D.	O
CF66	O

Attending	O
:	O

TELSHEY	O
K.	O
SWATLLEEBTIK	O
,	O
M.D.	O
NJ38	O
ME089/6922	O

Batch	O
:	O

43792	O

Index	O
No.	O
CHDNIR25	O
OK	O

D	O
:	O

05/13/98	O

T	O
:	O

05/13/98	O

498710998	O

CMC	O

14172445	O

04/29/1992	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

04/29/1992	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

05/28/1992	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Carotid	B-problem
stenosis	I-problem
.	O

2.	O
Aortic	B-problem
stenosis	I-problem
.	O

3.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
.	O

PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
76-year-old	O
female	O
who	O
was	O
admitted	O
to	O
the	O
medicine	O
service	O
on	O
04-29-92	O
with	O
a	O
past	O
history	O
significant	O
for	O
aortic	B-problem
stenosis	I-problem
and	O
chest	B-problem
pain	I-problem
who	O
presented	O
for	O
evaluation	B-test
for	O
aortic	B-treatment
valve	I-treatment
replace-ment	I-treatment
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
exertional	B-problem
angina	I-problem
and	O
chest	B-problem
pain	I-problem
associated	O
with	O
light-headedness	B-problem
for	O
nine	O
years	O
which	O
was	O
noted	O
to	O
increase	O
in	O
frequency	O
over	O
the	O
past	O
year	O
,	O
then	O
upon	O
admission	O
had	O
light-headedness	B-problem
and	O
chest	B-problem
pain	I-problem
with	O
a	B-problem
dull	I-problem
pressure	I-problem
in	I-problem
her	I-problem
neck	I-problem
to	O
her	O
substernal	O
area	O
,	O
with	O
only	O
minimal	O
exertion	O
such	O
as	O
&quot;	O
walking	O
across	O
the	O
room	O
&quot;	O
.	O

She	O
states	O
this	O
light-headedness	B-problem
is	O
often	O
associated	O
with	O
shortness	B-problem
of	I-problem
breath	I-problem
and	O
diaphoresis	B-problem
occasionally	O
with	O
nausea	B-problem
.	O

She	O
denies	O
any	O
vomiting	B-problem
,	O
states	O
that	O
the	B-problem
episodes	I-problem
usually	O
last	O
about	O
five	O
minutes	O
and	O
are	O
relieved	O
with	O
rest	O
.	O

The	B-problem
pain	I-problem
and	O
light-headedness	B-problem
is	O
now	O
severely	O
lifestyle	O
limiting	O
and	O
the	O
patient	O
requested	O
evaluation	B-test
for	O
possible	O
aortic	B-treatment
valve	I-treatment
replacement	I-treatment
.	O

Cardiac	O
risk	O
factors	O
hypercholesterolemia	B-problem
,	O
hypertension	B-problem
,	O
no	O
history	O
of	O
tobacco	O
use	O
,	O
diabetes	B-problem
or	O
family	O
history	O
.	O

Past	O
medical	O
history	O
is	O
as	O
stated	O
above	O
,	O
aortic	B-problem
stenosis	I-problem
,	O
found	O
to	O
be	O
critical	O
on	O
echocardiogram	B-test
on	O
4-13-92	O
,	O
done	O
in	O
Otte	O
A	O
,	O
New	O
Jersey	O
and	O
was	O
found	O
to	O
have	O
left	B-problem
ventricular	I-problem
hypertrophy	I-problem
and	O
ejection	B-test
fraction	I-test
of	O
58%	O
,	O
no	O
right	B-problem
heart	I-problem
wall	I-problem
motion	I-problem
abnormali-ties	I-problem
and	O
an	B-test
aortic	I-test
valve	I-test
gradient	I-test
of	O
greater	O
than	O
100	O
.	O

She	O
also	O
has	O
a	O
history	O
of	O
uterine	B-problem
fibroids	I-problem
,	O
status	O
post	O
total	B-treatment
abdominal	I-treatment
hysterectomy	I-treatment
.	O

She	O
has	O
known	B-problem
bilateral	I-problem
carotid	I-problem
disease	I-problem
,	O
stated	O
to	O
be	O
greater	O
than	O
70%	O
bilaterally	O
.	O

She	O
has	O
a	O
history	O
of	O
glaucoma	B-problem
and	O
a	O
questionable	O
history	O
of	O
claudication	B-problem
in	I-problem
her	I-problem
legs	I-problem
as	O
well	O
as	O
a	O
history	O
of	O
hypertension	B-problem
.	O

Medications	B-treatment
on	I-treatment
admission	I-treatment
were	O
only	O
aspirin	B-treatment
p.r.n.	O
and	O
Timoptic	B-treatment
solution	I-treatment
0.5%	I-treatment
to	O
the	O
left	O
eye	O
twice	O
a	O
day	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
physical	B-test
examination	I-test
she	O
was	O
afebrile	B-problem
with	O
a	O
blood	B-test
pressure	I-test
of	O
170/100	O
,	O
heart	B-test
rate	I-test
of	O
70	O
.	O

HEENT	B-test
examination	I-test
notable	O
for	O
bilateral	B-problem
arcussenilis	I-problem
but	O
otherwise	O
unremarkable	O
.	O

Her	O
neck	O
showed	O
no	O
JVD	B-problem
,	O
there	O
was	O
a	B-problem
slow	I-problem
carotid	I-problem
upstroke	I-problem
bilaterally	I-problem
,	O
there	O
were	O
bilateral	B-problem
carotid	I-problem
bruits	I-problem
versus	O
transmitted	B-problem
murmur	I-problem
.	O

Chest	O
was	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Cardiac	B-test
examination	I-test
revealed	O
a	O
regular	O
rate	O
and	O
rhythm	O
with	O
a	O
normal	O
S1	O
and	O
S2	O
,	O
3/6	O
systolic	B-problem
murmur	I-problem
at	I-problem
the	I-problem
right	I-problem
upper	I-problem
sternal	I-problem
border	I-problem
,	O
no	O
gallop	B-problem
was	O
detected	O
.	O

Her	O
abdomen	O
was	O
soft	O
,	O
nontender	B-problem
with	O
good	O
bowel	O
sounds	O
.	O

Extremi-ties	O
:	O

There	O
is	O
no	O
clubbing	B-problem
,	O
cyanosis	B-problem
or	O
edema	B-problem
and	O
her	B-test
peripheral	I-test
pulses	I-test
were	O
trace	O
palpable	O
.	O

LAB	O
/	O
X-RAY	O
DATA	O
:	O

Labs	O
on	O
admission	O
:	O

Sodium	B-test
141	O
,	O
potassium	B-test
5.0	O
,	O
BUN	B-test
18	O
,	O
creatinine	B-test
1.0	O
,	O
PT	B-test
12.3	O
,	O
PTT	B-test
24	O
,	O
WBC	B-test
7.6	O
,	O
hematocrit	B-test
41	O
,	O
platelets	B-test
278,000	O
.	O

EKG	B-test
revealed	O
a	O
normal	O
sinus	O
rhythm	O
with	O
a	O
rate	O
of	O
69	O
,	O
left	B-problem
ventricular	I-problem
hyper-trophy	I-problem
with	O
poor	B-problem
anterior	I-problem
progression	I-problem
of	I-problem
R-waves	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

She	O
was	O
admitted	O
and	O
evaluated	O
by	O
the	O
cardiac	O
surgery	O
service	O
after	O
having	O
undergone	O
cardiac	B-test
catheterization	I-test
which	O
revealed	O
a	O
70%	B-problem
stenosis	I-problem
of	I-problem
her	I-problem
left	I-problem
circumflex	I-problem
artery	I-problem
,	O
50%	B-problem
stenosis	I-problem
of	I-problem
the	I-problem
left	I-problem
anterior	I-problem
descending	I-problem
and	O
10%	B-problem
stenosis	I-problem
of	I-problem
the	I-problem
right	I-problem
coronary	I-problem
artery	I-problem
.	O

Carotid	B-test
angiography	I-test
revealed	O
left	B-problem
internal	I-problem
carotid	I-problem
stenosis	I-problem
of	I-problem
90%	I-problem
,	O
right	B-problem
internal	I-problem
carotid	I-problem
artery	I-problem
&quot;	I-problem
critical	I-problem
stenosis	I-problem
&quot;	I-problem
.	O

On	O
05-01-92	O
she	O
was	O
taken	O
to	O
the	O
operating	O
room	O
at	O
which	O
time	O
she	O
underwent	O
an	B-treatment
aortic	I-treatment
valve	I-treatment
replacement	I-treatment
with	O
a	O
#	B-treatment
19	I-treatment
St.	I-treatment
Jude	I-treatment
valve	I-treatment
,	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
times	O
one	O
with	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
from	O
the	O
posterior	O
descending	O
artery	O
to	O
the	O
obtuse	O
marginal	O
and	O
right	B-treatment
carotid	I-treatment
endarterectomy	I-treatment
.	O

This	O
was	O
performed	O
by	O
Dr.	O
Medicine	O
and	O
Dr.	O
Room	O
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
and	O
was	O
found	O
postoperatively	O
to	O
have	O
some	B-problem
left	I-problem
upper	I-problem
extremity	I-problem
weakness	I-problem
on	O
proximal	O
greater	O
than	O
distal	O
musculature	O
.	O

She	O
was	O
extubated	O
on	O
postoperative	O
day	O
number	O
one	O
and	O
otherwise	O
had	O
an	O
unremarkable	O
postoperative	O
course	O
with	O
the	O
exception	O
of	O
her	B-problem
left	I-problem
upper	I-problem
extremity	I-problem
weakness	I-problem
.	O

On	O
05-04-92	O
she	O
was	O
evaluated	O
by	O
the	O
neurology	O
service	O
,	O
who	O
recommended	O
a	B-test
CT	I-test
scan	I-test
,	O
however	O
no	O
evidence	O
of	O
infarction	B-problem
was	O
detected	O
.	O

There	O
was	O
only	O
diffuse	B-problem
small	I-problem
vessel	I-problem
disease	I-problem
noted	O
.	O

On	O
05-05-92	O
she	O
was	O
noted	O
to	O
convert	O
to	O
atrial	B-problem
fibrillation	I-problem
which	O
resolved	O
spontaneously	O
a	O
few	O
days	O
later	O
.	O

However	O
,	O
on	O
05-07-92	O
there	O
was	O
a	O
a	O
question	O
of	O
a	B-problem
new	I-problem
event	I-problem
with	O
addition	O
to	O
the	B-problem
left	I-problem
upper	I-problem
extremity	I-problem
weakness	I-problem
,	O
some	B-problem
noted	I-problem
right	I-problem
upper	I-problem
and	I-problem
right	I-problem
lower	I-problem
extremity	I-problem
discoordination	I-problem
.	O

She	O
was	O
begun	O
on	O
a	B-treatment
heparin	I-treatment
drip	I-treatment
.	O

On	O
5-9-92	O
the	B-problem
right-sided	I-problem
symptoms	I-problem
worsened	O
and	O
she	O
also	O
had	O
some	B-problem
elements	I-problem
of	I-problem
aphasia	I-problem
.	O

She	O
underwent	O
angiography	B-test
on	O
5-9-92	O
which	O
showed	O
the	O
right	O
internal	O
carotid	O
artery	O
to	O
be	O
patent	O
,	O
however	O
there	O
was	O
highly	O
significant	B-problem
stenosis	I-problem
of	I-problem
the	I-problem
left	I-problem
carotid	I-problem
artery	I-problem
and	O
she	O
was	O
taken	O
to	O
the	O
operating	O
room	O
later	O
that	O
day	O
for	O
a	B-treatment
left	I-treatment
carotid	I-treatment
endarterectomy	I-treatment
.	O

She	O
was	O
taken	O
postoperatively	O
the	O
ICU	O
where	O
she	O
was	O
extubated	O
on	O
postoperative	O
day	O
number	O
one	O
and	O
by	O
5-11-92	O
she	O
was	O
noted	O
to	O
have	O
markedly	O
increased	O
use	O
of	O
her	O
right	O
side	O
,	O
resolving	O
aphasia	B-problem
and	O
she	O
was	O
transferred	O
to	O
the	O
floor	O
with	O
the	B-problem
residual	I-problem
deficit	I-problem
only	O
noted	O
to	O
be	O
some	B-problem
left	I-problem
upper	I-problem
extremity	I-problem
weakness	I-problem
.	O

She	O
was	O
worked	O
up	O
aggressively	O
with	O
the	O
physical	O
therapy	O
and	O
occupational	O
services	O
,	O
made	O
good	O
progress	O
and	O
began	O
ambulating	O
with	O
assistance	O
with	O
a	B-treatment
walker	I-treatment
but	O
with	O
minimal	O
assistance	O
from	O
an	O
aid	O
.	O

She	O
was	O
feeding	O
herself	O
and	O
was	O
very	O
enthusiastic	O
and	O
energetic	O
in	O
her	O
participation	O
in	O
her	B-treatment
rehabilitation	I-treatment
activities	I-treatment
.	O

She	O
was	O
maintained	O
on	O
heparin	B-treatment
therapy	I-treatment
initially	O
but	O
this	O
was	O
quickly	O
switched	O
over	O
to	O
Coumadin	B-treatment
anticoagulation	I-treatment
therapy	I-treatment
which	O
she	O
will	O
need	O
to	O
be	O
on	O
long-term	O
for	O
her	B-treatment
aortic	I-treatment
valve	I-treatment
replacement	I-treatment
.	O

DISPOSITION	O
:	O

She	O
is	O
transferred	O
to	O
Rockdempbanri	O
Hospital	O
on	O
05-28-92	O
to	O
continue	O
her	B-treatment
rehabilitation	I-treatment
.	O

Discharge	O
medications	O
:	O

Lopressor	B-treatment
100	O
mg	O
p.o.	O
b.i.d.	O
;	O
Nifedipine	B-treatment
10	O
mg	O
p.o.	O
t.i.d.	O
;	O
Timoptic	B-treatment
solution	I-treatment
0.5%	O
OS	O
b.i.d.	O
;	O
Coumadin	B-treatment
1	O
mg	O
alternating	O
with	O
1.5	O
mg	O
q.o.d.	O
at	O
q.h.s.	O
and	O
Haldol	B-treatment
2	O
mg	O
p.o.	O
q.h.s.	O
p.r.n.	O
in	O
the	O
evening	O
,	O
only	O
for	O
agitation	B-problem
associated	O
with	O
confusion	B-problem
.	O

Upon	O
discharge	O
it	O
was	O
the	O
recommendation	O
of	O
the	O
cardiology	O
team	O
that	O
the	B-test
patient	I-test
&apos;s	I-test
prothrombin	I-test
time	I-test
be	O
monitored	O
weekly	O
and	O
be	O
kept	O
at	O
a	O
ratio	O
of	O
3-4	O
IU	O
.	O

Dictated	O
By	O
:	O

NIEIE	O
FREIERM	O
,	O
M.D.	O
ZX	O
681	O
/	O
0201	O
/	O
RISHAN	O
MISHON	O
ROOM	O
,	O
M.D.	O

BREUNTIK	O

D	O
:	O

05/26/92	O

T	O
:	O

05/27/92	O

Batch	O
:	O

U886	O

Report	O
:	O

LH486L9	O

500472963	O

PUOMC	O

9506800	O

464389	O

651486	O

9/20/2000	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

FYFEUARDFEL	O
,	O
TADE	O

MRN	O
:	O

9506800	O

Age	O
:	O

65y	O

REGISTRATION	O
DATE	O
:	O

09/20/2000	O
12:41	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
FYFEUARDFEL	O
,	O
TADE	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Ph	O
University	O
Of	O
Medical	O
Center	O
on	O
09/20/2000	O
12:41	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
ABD	B-problem
PAIN	I-problem
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
PH	O
UNIVERSITY	O
OF	O
MEDICAL	O
CENTER	O
.	O

Your	O
patient	O
was	O
admitted	O
under	O
the	O
care	O
of	O
FONG	O
,	O
CONEY	O
N	O
with	O
a	O
preliminary	O
diagnosis	O
of	O
PERFORATION	B-problem
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
639-873-2993	O
.	O

503651854	O
WGH	O

4959433	O

288418	O

2823104	O

7/31/2004	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

A	O
,	O
WALINA	O

MRN	O
:	O

4959433	O

Age	O
:	O

32y	O

REGISTRATION	O
DATE	O
:	O

07/31/2004	O
11:24	O
AM	O

Provider	O
:	O

PADA	O
MEEDHUANG	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O
MD	O
:	O

E-mail	O
PCP	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Date	O
/	O
Time	O
:	O

07/31/2004	O
12:58	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

S	O
/	O
P	O
MVA	O

Diagnosis	O
:	O

head	B-problem
trauma	I-problem
-	O
mva	O

Treatment	B-treatment
Rendered	O
:	O

history	O
,	O
physical	B-test
,	O
neuro	B-test
exam	I-test
normal	O

Discharge	O
Medications	O
:	O

tylenol	B-treatment
as	O
needed	O
.	O

refrain	O
from	O
motrin	B-treatment
at	O
this	O
time	O
.	O

Follow	O
up	O
Service	O
:	O

f	O
/	O
u	O
with	O
dr.	O
white	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

monitor	O
/	O
return	O
for	O
nausea	B-problem
/	O
vomiting	B-problem
,	O
headache	B-problem
,	O
visual	B-problem
/	I-problem
mental	I-problem
status	I-problem
changes	I-problem
or	O
other	B-problem
concerns	I-problem
.	O

PCP	O
Name	O
:	O

WHITE	O
,	O
ELVNO	O
R	O

Provider	O
Number	O
:	O

70468	O

This	O
report	O
was	O
created	O
by	O
MEEDHUANG	O
,	O
PADA	O
07/31/2004	O
12:59	O
PM	O

517414339	O

PUOMC	O

4351342	O

88500	O

099515	O

12/26/1996	O
12:00:00	O
AM	O

HYPERPARATHYROIDISM	B-problem
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

HOUGHTJESCSLEM	O
,	O
RIESHINJIN	O
R	O

UNIT	O
NUMBER	O
:	O

948-14-32	O

ADMISSION	O
DATE	O
:	O

12/26/96	O

DISCHARGE	O
DATE	O
:	O

01/01/97	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

hyperparathyroidism	B-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

1.	O
status	O
post	O
mitral	B-treatment
valve	I-treatment
replacement	I-treatment
,	O

2.	O
hypertension	B-problem
,	O

3.	O
atrial	B-problem
fibrillation	I-problem
,	O

4.	O
hypertrophic	B-problem
obstructive	I-problem
cardiomyopathy	I-problem
,	O

5.	O
osteoarthritis	B-problem
,	O

6.	O
right	B-problem
cheek	I-problem
basal	I-problem
cell	I-problem
carcinoma	I-problem
,	O

7.	O
glaucoma	B-problem
,	O

8.	O
non-insulin	B-problem
dependent	I-problem
diabetes	I-problem
mellitus	I-problem
,	O

9.	O
status	O
post	O
laparoscopic	B-treatment
cholecystectomy	I-treatment
,	O

10.	O
status	O
post	O
dilation	B-treatment
and	I-treatment
curettage	I-treatment
,	O

11.	O
status	O
post	O
cataract	B-treatment
surgery	I-treatment
,	O

12.	O
status	O
post	O
left	B-test
breast	I-test
biopsy	I-test
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Parathyroidectomy	B-treatment
on	O
12-27-96	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
an	O
83-year-old	O
female	O
who	O
presents	O
for	O
surgical	B-test
evaluation	I-test
for	O
her	B-problem
hyperparathyroidism	I-problem
.	O

This	O
is	O
an	O
83-year-old	O
female	O
with	O
a	O
history	O
of	O
hypertrophic	B-problem
obstructive	I-problem
cardiomyopathy	I-problem
,	O
status	O
post	O
mitral	B-treatment
valve	I-treatment
replacement	I-treatment
in	O
1988	O
,	O
chronic	B-problem
atrial	I-problem
fibrillation	I-problem
,	O
hypertension	B-problem
,	O
who	O
presents	O
for	O
parathyroidectomy	B-treatment
.	O

In	O
August	O
of	O
1996	O
while	O
the	O
patient	O
was	O
at	O
Retelk	O
County	O
Medical	O
Center	O
for	O
replacement	B-treatment
of	I-treatment
her	I-treatment
knees	I-treatment
bilaterally	I-treatment
,	O
and	O
on	O
preoperative	B-test
evaluation	I-test
she	O
was	O
noted	O
to	O
have	O
a	B-problem
high	I-problem
calcium	I-problem
and	O
therefore	O
the	B-treatment
surgery	I-treatment
was	O
canceled	O
.	O

Further	B-test
testing	I-test
revealed	O
hyperparathyroidism	B-problem
as	O
evidenced	O
by	O
an	B-problem
elevated	I-problem
PTH	I-problem
.	O

The	O
patient	O
reports	O
no	O
masses	B-problem
in	I-problem
her	I-problem
neck	I-problem
.	O

She	O
has	O
noticed	O
some	O
generalized	B-problem
hoarseness	I-problem
in	I-problem
her	I-problem
voice	I-problem
for	O
the	O
past	O
5-6	O
months	O
.	O

In	O
addition	O
,	O
she	O
has	O
some	B-problem
dysphagia	I-problem
,	O
particularly	O
has	O
had	O
some	B-problem
difficulties	I-problem
with	I-problem
swallowing	I-problem
.	O

She	O
has	O
been	O
seen	O
by	O
Dr.	O
Tokbelb	O
,	O
her	O
primary	O
care	O
physician	O
in	O
Itgreenredan	O
Hospital	O
,	O
and	O
also	O
Dr.	O
Kotefyfechird	O
,	O
her	O
cardiologist	O
,	O
and	O
also	O
an	O
endocrinologist	O
at	O
Retelk	O
County	O
Medical	O
Center	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
status	O
post	O
mitral	B-treatment
valve	I-treatment
replacement	I-treatment
in	O
1988	O
.	O

She	O
has	O
a	B-treatment
St.	I-treatment
Jude	I-treatment
&apos;s	I-treatment
mechanical	I-treatment
valve	I-treatment
and	O
has	O
been	O
on	O
Coumadin	B-treatment
since	O
then	O
,	O

2.	O
hypertension	B-problem
,	O
she	O
has	O
had	O
hypertension	B-problem
for	O
15	O
years	O
,	O

3.	O
atrial	B-problem
fibrillation	I-problem
,	O
she	O
is	O
status	O
post	O
cardioversion	B-treatment
3-25-94	O
,	O

4.	O
hypertrophic	B-problem
obstructive	I-problem
cardiomyopathy	I-problem
,	O

5.	O
osteoarthritis	B-problem
;	O
she	O
is	O
to	O
receive	O
bilateral	B-treatment
total	I-treatment
knee	I-treatment
replacements	I-treatment
at	O
some	O
time	O
in	O
the	O
near	O
future	O
,	O

6.	O
right	B-problem
cheek	I-problem
basal	I-problem
cell	I-problem
carcinoma	I-problem
to	O
be	O
removed	O
in	O
the	O
future	O
,	O

7.	O
history	O
of	O
glaucoma	B-problem
,	O

8.	O
non	B-problem
insulin	I-problem
dependent	I-problem
diabetes	I-problem
mellitus	I-problem
which	O
was	O
diagnosed	O
in	O
March	O
,	O
1995	O
,	O

9.	O
shingles	B-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

1.	O
laparoscopic	B-treatment
cholecystectomy	I-treatment
03/93	O
by	O
Dr.	O
Sapmal	O
,	O

2.	O
dilation	B-treatment
and	I-treatment
curettage	I-treatment
in	O
1992	O
for	O
polyps	B-problem
,	O

3.	O
left	B-test
breast	I-test
biopsy	I-test
which	O
was	O
benign	O
,	O

4.	O
cataract	B-treatment
surgery	I-treatment
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Lopid	B-treatment
600	O
mg	O
PO	O
b.i.d.	O
,	O

2.	O
K-Dur	B-treatment
20	O
mg	O
PO	O
q.day	O
,	O

3.	O
Lasix	B-treatment
40	O
mg	O
PO	O
q.day	O
,	O

4.	O
Coumadin	B-treatment
2.5	O
mg	O
PO	O
q.day	O
which	O
was	O
last	O
taken	O
two	O
days	O
prior	O
to	O
admission	O
,	O

5.	O
Norvasc	B-treatment
500	O
mg	O
PO	O
q.day	O
,	O

6.	O
Digoxin	B-treatment
.25	O
mg	O
PO	O
q.day	O
,	O

7.	O
Lopressor	B-treatment
50	O
mg	O
PO	O
b.i.d.	O
,	O

8.	O
Glucotrol	B-treatment
10	O
XL	O
qam	O
,	O

9.	O
Timoptic	B-treatment
0.5%	O
b.i.d.	O
to	O
both	O
eyes	O
,	O

10.	O
Pilocarpine	B-treatment
gel	I-treatment
qhs	O
to	O
both	O
eyes	O
.	O

FAMILY	O
HISTORY	O
:	O

There	O
is	O
no	O
family	O
history	O
of	O
parathyroid	B-problem
or	I-problem
thyroid	I-problem
diseases	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
widowed	O
.	O

She	O
lives	O
alone	O
but	O
is	O
completely	O
independent	O
.	O

She	O
visits	O
her	O
daughter	O
once	O
a	O
week	O
.	O

No	O
ethanol	O
or	O
tobacco	O
use	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

The	B-test
review	I-test
of	I-test
systems	I-test
is	O
significant	O
for	O
a	O
history	O
of	O
dyspnea	B-problem
on	I-problem
exertion	I-problem
.	O

At	O
present	O
,	O
she	O
can	O
walk	O
one	O
to	O
two	O
blocks	O
before	O
having	O
to	O
stop	O
because	O
of	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

When	O
walking	O
outside	O
,	O
she	O
stops	O
multiple	O
times	O
because	O
of	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

She	O
sleeps	O
with	O
two	O
pillows	O
at	O
night	O
.	O

She	O
gets	O
short	B-problem
of	I-problem
breath	I-problem
walking	O
up	O
steps	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
physical	B-test
examination	I-test
,	O
she	O
is	O
a	O
pleasant	O
woman	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Her	B-test
pulse	I-test
is	O
72	O
,	O
irregularly	O
irregular	O
,	O
blood	B-test
pressure	I-test
96/60	O
,	O
temperature	B-test
97.9	O
,	O
respirations	B-test
18	O
.	O

The	B-test
head	I-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
and	I-test
throat	I-test
examination	I-test
is	O
notable	O
for	O
pupils	O
which	O
have	O
irregular	B-problem
border	I-problem
and	O
are	O
very	B-problem
sluggishly	I-problem
reactive	I-problem
.	O

The	O
patient	O
reports	O
that	O
she	O
will	O
have	O
revision	B-treatment
of	I-treatment
cataract	I-treatment
surgery	I-treatment
.	O

Neck	O
and	O
lungs	O
are	O
unremarkable	O
.	O

Cardiovascular	B-test
exam	I-test
:	O

III	B-problem
/	I-problem
VI	I-problem
systolic	I-problem
click	I-problem
and	O
irregularly	B-problem
irregular	I-problem
rhythm	I-problem
.	O

The	O
abdomen	O
was	O
benign	O
.	O

She	O
is	O
guaiac	O
negative	O
on	O
rectal	B-test
examination	I-test
.	O

Extremities	O
:	O

unremarkable	O
.	O

LABORATORY	O
DATA	O
:	O

Admission	O
white	B-test
blood	I-test
count	I-test
4.3	O
,	O
hematocrit	B-test
31.0	O
,	O
electrolytes	B-test
were	O
all	O
within	O
normal	O
limits	O
,	O
glucose	B-test
218	O
,	O
prothrombin	B-test
time	I-test
on	O
admission	O
was	O
15.1	O
with	O
INR	B-test
of	O
1.5	O
,	O
partial	B-test
thromboplastin	I-test
time	I-test
23.3	O
.	O

The	B-test
electrocardiogram	I-test
showed	O
atrial	B-problem
fibrillation	I-problem
with	O
slow	B-problem
ventricular	I-problem
response	I-problem
and	O
digitalis	B-problem
effect	I-problem
as	O
well	O
as	O
left	B-problem
ventricular	I-problem
hypertrophy	I-problem
.	O

IMPRESSION	O
ON	O
ADMISSION	O
:	O

Impression	O
was	O
that	O
this	O
was	O
an	O
83-year-old	O
female	O
with	O
cardiac	B-problem
history	I-problem
,	O
dyspnea	B-problem
on	I-problem
exertion	I-problem
,	O
increased	B-problem
calcium	I-problem
and	O
hyperparathyroidism	B-problem
who	O
presents	O
for	O
parathyroidectomy	B-treatment
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

On	O
the	O
day	O
of	O
admission	O
,	O
the	O
patient	O
was	O
brought	O
to	O
the	O
operating	O
room	O
for	O
parathyroidectomy	B-treatment
.	O

The	O
right	O
superior	O
parathyroid	O
gland	O
was	O
found	O
to	O
be	O
markedly	B-problem
enlarged	I-problem
and	O
consistent	O
with	O
an	B-problem
adenoma	I-problem
.	O

Her	O
right	O
superior	O
parathyroid	O
gland	O
was	O
removed	O
and	O
the	O
rest	O
of	O
her	O
parathyroid	O
glands	O
were	O
left	O
in	O
place	O
.	O

Postoperatively	O
,	O
the	O
patient	O
did	O
well	O
and	O
was	O
able	O
to	O
cough	O
and	O
phonate	O
completely	O
with	O
no	O
changes	B-problem
from	O
preoperative	O
.	O

The	O
plan	O
was	O
to	O
start	O
her	O
on	O
heparin	B-treatment
and	O
Coumadin	B-treatment
and	O
discontinue	O
her	B-treatment
heparin	I-treatment
when	O
her	B-test
Coumadin	I-test
levels	I-test
became	O
therapeutic	O
as	O
judged	O
by	O
the	B-test
prothrombin	I-test
time	I-test
/	O
INR	B-test
.	O

However	O
,	O
on	O
postoperative	O
day	O
number	O
two	O
,	O
the	O
patient	O
in	O
the	O
afternoon	O
noticed	O
some	B-problem
tingling	I-problem
in	I-problem
her	I-problem
hands	I-problem
and	O
also	O
some	B-problem
tingling	I-problem
hear	I-problem
her	I-problem
perioral	I-problem
region	I-problem
.	O

She	O
had	O
a	O
negative	O
Chvostek	O
&apos;s	O
and	O
negative	O
Trousseau	O
&apos;s	O
sign	O
.	O

She	O
had	O
no	O
muscular	B-problem
weakness	I-problem
noted	O
.	O

An	B-test
ionized	I-test
calcium	I-test
was	O
drawn	O
which	O
was	O
low	O
at	O
1.0	O
.	O

As	O
a	O
result	O
,	O
the	O
patient	O
was	O
started	O
on	O
Os-Cal	B-treatment
250	O
mg	O
PO	O
q.i.d.	O
On	O
postoperative	O
day	O
number	O
three	O
,	O
her	B-test
ionized	I-test
calcium	I-test
was	O
1.06	O
and	O
her	B-treatment
Os-Cal	I-treatment
was	O
increased	O
to	O
500	O
q.i.d.	O

However	O
,	O
her	B-problem
ionized	I-problem
calcium	I-problem
decreased	I-problem
to	O
0.97	O
and	O
she	O
was	O
given	O
one	O
amp	O
of	O
calcium	B-treatment
gluconate	I-treatment
.	O

On	O
postoperative	O
day	O
number	O
five	O
,	O
the	O
patient	O
felt	O
fine	O
and	O
had	O
an	B-test
INR	I-test
of	O
1.9	O
with	O
a	B-test
prothrombin	I-test
time	I-test
of	O
16.6	O
.	O

Her	B-test
calcium	I-test
was	O
8.5	O
,	O
albumin	B-test
3.6	O
,	O
and	O
phosphate	B-test
4.5	O
.	O

She	O
had	O
had	O
no	O
further	O
episodes	O
of	O
tingling	B-problem
in	I-problem
her	I-problem
fingers	I-problem
after	O
the	O
initial	O
episode	O
which	O
had	O
prompted	O
us	O
originally	O
to	O
draw	O
the	B-test
ionized	I-test
calcium	I-test
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Good	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Coumadin	B-treatment
5	O
mg	O
PO	O
q.day	O
,	O
then	O
she	O
will	O
follow	O
up	O
with	O
her	O
primary	O
care	O
physician	O
and	O
decide	O
the	O
dosage	O
thereafter	O
,	O

2.	O
Lopid	B-treatment
600	O
mg	O
PO	O
b.i.d.	O
,	O

3.	O
K-Dur	B-treatment
20	O
mg	O
PO	O
q.day	O
,	O

4.	O
Os-Cal	B-treatment
500	O
mg	O
PO	O
q.i.d.	O
,	O

5.	O
Rocaltrol	B-treatment
0.25	O
mg	O
PO	O
b.i.d.	O
,	O

6.	O
Lasix	B-treatment
40	O
mg	O
PO	O
q.day	O
,	O

7.	O
Norvasc	B-treatment
5	O
mg	O
PO	O
q.day	O
,	O

8.	O
Digoxin	B-treatment
.25	O
mg	O
PO	O
q.day	O
,	O

9.	O
Lopressor	B-treatment
50	O
mg	O
PO	O
b.i.d.	O
,	O

10.	O
Glucotrol	B-treatment
10	O
mg	O
qam	O
.	O

FOLLOW	O
UP	O
:	O

For	O
follow	O
up	O
,	O
the	O
patient	O
is	O
to	O
call	O
for	O
an	O
appointment	O
with	O
Dr.	O
Sapmal	O
.	O

In	O
addition	O
,	O
she	O
is	O
to	O
follow	O
up	O
with	O
her	O
primary	O
care	O
physician	O
to	O
check	O
her	B-test
prothrombin	I-test
time	I-test
/	O
INR	B-test
as	O
well	O
as	O
calcium	B-test
,	I-test
albumin	I-test
and	I-test
phosphate	I-test
levels	I-test
.	O

She	O
will	O
be	O
sent	O
home	O
with	O
home	O
Arnsperni	O
Health	O
.	O

LENNI	O
BREUTZOLN	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

_____________________	O
RIEEA	O
SAPMAL	O
,	O
M.D.	O

TR	O
:	O

hzu	O

DD	O
:	O

New	O
Years	O
Day	O

TD	O
:	O

01/06/97	O
2:48	O
P	O

cc	O
:	O

RIEEA	O
ODEE	O
SAPMAL	O
,	O
M.D.	O
CEALME	O
LEOE	O
MARESSYTHE	O
Dr.	O
Tokbelb	O
Welle	O
Health	O
Sonsant	O
.	O

523704694	O

PRGH	O

67119280	O

480282	O

10/23/1999	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

10/23/1999	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

11/02/1999	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Left	B-problem
sided	I-problem
spastic	I-problem
hemiparesis	I-problem
,	O
status	O
post	O
surgical	B-treatment
correction	I-treatment
of	I-treatment
C-1	I-treatment
,	I-treatment
C-2	I-treatment
dural	I-treatment
AVM	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Ms.	O
Breunlinke	O
is	O
a	O
69	O
year-old	O
right	O
handed	O
woman	O
,	O
status	O
post	O
surgical	B-treatment
correction	I-treatment
of	I-treatment
a	I-treatment
C-1	I-treatment
to	I-treatment
C-2	I-treatment
dural	I-treatment
AVM	I-treatment
in	O
January	O
,	O
1998	O
,	O
now	O
presenting	O
with	O
a	O
one	O
month	O
history	O
of	O
increasing	B-problem
left	I-problem
sided	I-problem
weakness	I-problem
and	O
pain	B-problem
with	O
spasticity	B-problem
,	O
occasional	O
difficulty	B-problem
swallowing	I-problem
and	O
abdominal	B-problem
pain	I-problem
.	O

She	O
was	O
originally	O
admitted	O
to	O
the	O
Verg	O
Medical	O
Center	O
in	O
January	O
,	O
1998	O
,	O
because	O
of	O
a	O
one	O
year	O
history	O
of	O
left	B-problem
sided	I-problem
weakness	I-problem
and	O
spasticity	B-problem
.	O

She	O
was	O
found	O
to	O
have	O
intermedullary	B-problem
lesion	I-problem
at	I-problem
C1-2	I-problem
level	I-problem
which	O
on	O
biopsy	B-test
showed	O
abnormal	B-problem
vasculature	I-problem
,	O
hemosiderin	B-problem
deposit	I-problem
,	O
leading	O
in	O
turn	O
to	O
the	O
discovery	O
of	O
a	B-problem
dural	I-problem
arteriovenous	I-problem
malformation	I-problem
at	O
that	O
level	O
which	O
was	O
surgically	O
corrected	O
.	O

The	O
postoperative	O
period	O
was	O
complicated	O
by	O
transient	B-problem
swallowing	I-problem
difficulty	I-problem
,	O
increasing	B-problem
left	I-problem
sided	I-problem
weakness	I-problem
and	O
urinary	B-problem
retention	I-problem
.	O

She	O
was	O
discharged	O
to	O
inpatient	O
rehabilitation	O
where	O
she	O
made	O
significant	O
progress	O
toward	O
recovery	O
.	O

As	O
of	O
the	O
beginning	O
of	O
September	O
,	O
1999	O
,	O
she	O
was	O
able	O
to	O
swallow	O
without	O
difficulty	O
,	O
urinate	O
without	O
difficulty	O
(	O
although	O
bowel	O
movements	O
have	O
been	O
problematic	B-problem
)	O
.	O

Functionally	O
,	O
she	O
was	O
at	O
the	O
level	O
of	O
pre-gait	B-treatment
training	I-treatment
and	O
able	O
to	O
stand	O
and	O
take	O
several	O
steps	O
with	O
upper	B-treatment
body	I-treatment
support	I-treatment
.	O

Over	O
the	O
past	O
4-5	O
weeks	O
her	B-problem
functional	I-problem
level	I-problem
has	O
progressively	O
deteriorated	O
.	O

She	O
is	O
now	O
unable	O
to	O
stand	O
and	O
needs	O
assistance	O
to	O
sit	O
up	O
.	O

Her	O
left	O
arm	O
has	O
developed	O
a	B-problem
flexure	I-problem
contraction	I-problem
and	O
she	O
reports	O
intermitttent	B-problem
pain	I-problem
in	I-problem
the	I-problem
left	I-problem
arm	I-problem
and	I-problem
leg	I-problem
which	O
occurs	O
both	O
spontaneously	O
and	O
is	O
also	O
triggered	O
by	O
contact	O
.	O

She	O
has	O
developed	O
some	O
new	B-problem
swallowing	I-problem
difficulty	I-problem
and	O
since	O
her	O
transfer	O
to	O
a	O
long	O
term	O
inpatient	O
care	O
facility	O
,	O
she	O
has	O
lost	O
ten	O
pounds	O
.	O

She	O
denies	O
dysuria	B-problem
or	O
excessive	B-problem
urinary	I-problem
frequency	I-problem
.	O

Over	O
the	O
past	O
several	O
weeks	O
she	O
has	O
also	O
developed	O
severe	B-problem
intermittent	I-problem
abdominal	I-problem
pain	I-problem
,	O
localized	O
to	O
the	O
suprapubic	O
area	O
,	O
left	O
greater	O
than	O
right	O
,	O
occurring	O
intermittently	O
.	O

The	O
patient	O
feels	O
this	O
is	O
secondary	O
to	O
her	B-problem
hemorrhoids	I-problem
,	O
although	O
it	O
does	O
not	O
clearly	O
localize	O
to	O
the	O
rectum	O
.	O

This	B-problem
pain	I-problem
often	O
follows	O
bowel	O
movement	O
but	O
does	O
occur	O
spontaneously	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
for	O
Insulin	B-problem
dependent	I-problem
diabetes	I-problem
mellitus	I-problem
,	O
atrial	B-problem
fibrillation	I-problem
,	O
hypothyroidism	B-problem
,	O
hypertension	B-problem
,	O
depression	B-problem
,	O
frequent	B-problem
urinary	I-problem
tract	I-problem
infections	I-problem
,	O
neuropathic	B-problem
pain	I-problem
syndrome	I-problem
and	O
osteoporosis	B-problem
.	O

MEDICATION	O
:	O

On	O
admission	O
include	O
Cozaar	B-treatment
75	O
mg	O
q.d.	O
,	O
Coumadin	B-treatment
2	O
mg/1	O
mg	O
alternate	O
days	O
,	O
Synthroid	B-treatment
175	O
mcg	O
q.d.	O
,	O
Zoloft	B-treatment
50	O
mg	O
q.d.	O
,	O
Zantac	B-treatment
150	O
mg	O
b.i.d.	O
,	O
Diabeta	B-treatment
25	O
mg	O
q.d.	O
,	O
Proctofoam	B-treatment
1%	O
q.i.d.	O
,	O
Demerol	B-treatment
100	O
mg	O
q	O
6	O
p.r.n.	O
,	O
OsCal	B-treatment
2	O
tabs	O
t.i.d.	O
,	O
multivitamins	B-treatment
and	O
KCl	B-treatment
supplements	I-treatment
,	O
Dulcolax	B-treatment
5	O
mg	O
q.d.	O
,	O
Senokot	B-treatment
2	O
tabs	O
q	O
h.s.	O
,	O
Metamucil	B-treatment
1	O
tablespoon	O
b.i.d.	O
,	O
Detrol	B-treatment
2	O
mg	O
b.i.d.	O
,	O
Neurontin	B-treatment
200	O
mg	O
t.i.d.	O
,	O
HydroDIURIL	B-treatment
12.5	O
mg	O
q.d.	O
,	O
Valium	B-treatment
10	O
mg	O
q	O
8	O
p.r.n.	O
muscle	B-problem
spasm	I-problem
,	O
Insulin	B-treatment
by	O
sliding	O
scale	O
and	O
levofloxacin	B-treatment
500	O
mg	O
q.d.	O
beginning	O
October	O
23	O
,	O
1999	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
is	O
allergic	B-problem
to	O
Hydralazine	B-treatment
,	O
codeine	B-treatment
,	O
ace	B-treatment
inhibitors	I-treatment
,	O
Nifedipine	B-treatment
and	O
Percocet	B-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
,	O
heart	O
is	O
regular	O
rate	O
and	O
rhythm	O
without	O
murmur	B-problem
.	O

Lungs	O
are	O
clear	O
to	O
auscultation	B-test
bilaterally	I-test
.	O

Abdomen	O
is	O
soft	O
,	O
with	O
marked	B-problem
suprapubic	I-problem
tenderness	I-problem
and	O
reduced	B-problem
bowel	I-problem
sounds	I-problem
.	O

Anal	O
tone	O
is	O
reduced	B-problem
.	O

Rectal	B-test
examination	I-test
is	O
nontender	B-problem
and	O
stool	O
is	O
guaiac	O
negative	O
.	O

Neurologically	O
,	O
the	O
patient	O
is	O
alert	O
and	O
oriented	O
times	O
three	O
with	O
normal	O
speech	O
,	O
language	O
and	O
repetition	O
.	O

Cranial	O
nerves	O
:	O

pupils	O
are	O
4-6	O
mm	O
bilaterally	O
,	O
extraocular	O
movements	O
were	O
full	O
without	O
nystagmus	B-problem
.	O

Eye	O
closure	O
and	O
smile	O
are	O
symmetric	O
.	O

Tongue	O
is	O
midline	O
.	O

Facial	O
sensation	O
is	O
sensation	O
.	O

Strength	O
:	O

The	O
tone	O
is	O
markedly	B-problem
increased	I-problem
in	I-problem
bot	I-problem
legs	I-problem
with	O
left	O
greater	O
than	O
right	O
.	O

Left	O
arm	O
shows	O
a	B-problem
flexor	I-problem
contracture	I-problem
and	O
markedly	B-problem
increased	I-problem
tone	I-problem
.	O

The	O
right	O
arm	O
shows	O
moderate	B-problem
increased	I-problem
tone	I-problem
.	O

Power	O
:	O

The	O
left	O
upper	O
extremity	O
shows	O
reduction	B-problem
in	I-problem
motor	I-problem
power	I-problem
ranging	O
from	O
2/5	O
in	O
the	O
triceps	O
,	O
4/5	O
in	O
the	O
biceps	O
,	O
and	O
3-4/5	O
in	O
the	O
wrists	O
and	O
hand	O
intrinsics	O
.	O

The	O
right	O
upper	O
extremity	O
shows	O
generalized	B-problem
reduction	I-problem
in	I-problem
strength	I-problem
,	O
4/5	O
in	O
all	O
joints	O
.	O

In	O
the	O
lower	O
extremities	O
on	O
the	O
left	O
hip	O
flexor	O
is	O
1/5	O
,	O
knee	O
flexion	O
and	O
extension	O
is	O
3/5	O
and	O
4/5	O
respectively	O
and	O
plantar	O
and	O
dorsiflexion	O
is	O
4/5	O
.	O

The	O
right	O
lower	O
extremity	O
shows	O
a	O
3/5	O
on	O
hip	O
flexion	O
,	O
4/5	O
at	O
knee	O
flexion	O
and	O
extension	O
and	O
full	O
power	O
on	O
dorsi	O
and	O
plantar	O
flexion	O
.	O

Reflexes	O
:	O

Upper	O
extremities	O
are	O
very	O
brisk	O
bilaterally	O
and	O
symmetrical	O
3+.	O
There	O
is	O
positive	B-problem
tremor	I-problem
reflex	I-problem
on	I-problem
the	I-problem
left	I-problem
and	O
absent	B-problem
on	I-problem
the	I-problem
right	I-problem
.	O

Lower	O
extremities	O
show	O
patellar	B-test
reflexes	I-test
3+	O
left	O
,	O
4+	O
right	O
,	O
no	O
cross	B-test
deductor	I-test
reflexes	I-test
and	O
absent	O
ankle	O
jerks	O
.	O

There	O
is	O
no	O
clonus	B-problem
on	I-problem
the	I-problem
right	I-problem
but	O
sustained	B-problem
clonus	I-problem
(	I-problem
10-12	I-problem
beats	I-problem
)	I-problem
on	I-problem
the	I-problem
left	I-problem
.	O

Plantar	O
responses	O
:	O

toes	O
are	O
upgoing	O
on	O
the	O
left	O
,	O
down	O
going	O
on	O
the	O
right	O
.	O

Sensory	O
:	O

The	O
patient	O
has	O
diminished	B-problem
vibration	I-problem
and	I-problem
propioception	I-problem
in	I-problem
the	I-problem
left	I-problem
upper	I-problem
and	I-problem
lower	I-problem
extremity	I-problem
and	O
decreased	B-problem
temperature	I-problem
,	O
light	B-test
touch	I-test
and	O
pinprick	B-test
sensation	I-test
in	O
the	O
right	O
upper	O
and	O
lower	O
extremity	O
consistent	O
with	O
a	B-problem
high	I-problem
cervical	I-problem
spinal	I-problem
sensory	I-problem
level	I-problem
.	O

Cerebellar	O
;	O
The	O
patient	O
demonstrates	O
an	B-problem
intention	I-problem
tremor	I-problem
on	O
finger	B-test
to	I-test
nose	I-test
with	O
the	O
left	O
hand	O
.	O

Fine	O
motor	O
movements	O
are	O
slow	B-problem
but	O
accurate	O
in	O
the	O
left	O
and	O
right	O
hands	O
.	O

LABORATORY	O
DATA	O
:	O

Sodium	B-test
140	O
,	O
potassium	B-test
3.8	O
,	O
chloride	B-test
100	O
,	O
bicarbonate	B-test
of	O
30	O
,	O
BUN	B-test
of	O
13	O
,	O
creatinine	B-test
0.8	O
,	O
serum	B-test
glucose	I-test
228	O
.	O

White	B-test
blood	I-test
count	I-test
is	O
7,000	O
.	O

Hematocrit	B-test
is	O
37.6	O
,	O
platelet	B-test
count	I-test
is	O
148,000	O
.	O

Prothrombin	B-test
time	I-test
is	O
15.9	O
with	O
an	B-test
INR	I-test
of	O
1.7	O
.	O

PTT	B-test
is	O
24	O
.	O

Urinalysis	B-test
from	O
October	O
21	O
,	O
is	O
positive	O
for	O
Citrobacter	B-problem
susceptible	O
to	O
ciprofloxacin	B-treatment
,	O
gentamycin	B-treatment
,	O
nitrofurantoin	B-treatment
,	O
tetracycline	B-treatment
and	O
Bactrim	B-treatment
.	O

Electrocardiogram	B-test
shows	O
no	O
P-waves	B-problem
.	O

The	O
patient	O
is	O
fully	O
paced	O
.	O

HOSPITAL	O
COURSE	O
:	O

On	O
admission	O
,	O
a	B-test
CT	I-test
scan	I-test
of	I-test
the	I-test
head	I-test
with	O
and	O
without	O
contrast	O
was	O
performed	O
,	O
showing	O
a	B-problem
missing	I-problem
posterior	I-problem
arch	I-problem
at	I-problem
C-1	I-problem
and	O
metallic	B-treatment
clips	I-treatment
at	I-treatment
the	I-treatment
craniocervical	I-treatment
junction	I-treatment
consistent	O
with	O
prior	B-treatment
surgical	I-treatment
intervention	I-treatment
.	O

No	O
arteriovenous	B-problem
malformations	I-problem
are	O
identified	O
;	O
there	O
is	O
no	O
evidence	O
of	O
recurrence	B-problem
of	O
her	B-problem
former	I-problem
vascular	I-problem
malformation	I-problem
.	O

No	O
intraspinal	B-problem
lesions	I-problem
are	O
identified	O
.	O

Upon	O
further	O
review	O
of	O
Dr.	O
Laymie	O
Fields	O
,	O
Department	O
of	O
Neuroradiology	O
,	O
review	O
of	O
the	O
cervical	O
spine	O
on	O
CT	B-test
reveals	O
no	O
extrinsic	B-problem
compressive	I-problem
lesions	I-problem
impacting	O
the	O
spinal	O
cord	O
and	O
no	O
enhancing	B-problem
lesions	I-problem
of	I-problem
the	I-problem
spinal	I-problem
cord	I-problem
with	O
contrast	B-test
.	O

Angiography	B-test
performed	O
on	O
October	O
31	O
,	O
1999	O
,	O
showed	O
normal	B-problem
vascular	I-problem
distribution	I-problem
of	I-problem
the	I-problem
head	I-problem
and	I-problem
neck	I-problem
with	O
no	O
recurrence	B-problem
of	I-problem
arteriovenous	I-problem
malformation	I-problem
.	O

During	O
this	O
admission	O
,	O
the	O
patient	O
was	O
started	O
on	O
Baclofen	B-treatment
10	O
mg	O
p.o.	O
t.i.d.	O
for	O
spasticity	B-problem
.	O

Coumadin	B-treatment
was	O
discontinued	O
.	O

The	O
patient	O
was	O
given	O
aspirin	B-treatment
325	O
mg	O
p.o.	O
q.d.	O

The	O
patient	O
was	O
also	O
given	O
Valium	B-treatment
5-10	O
mg	O
p.o.	O
t.i.d.	O
for	O
muscle	B-problem
spasm	I-problem
.	O

She	O
was	O
continued	O
on	O
Demerol	B-treatment
50	O
mg	O
q	O
6-8	O
hours	O
p.r.n.	O
for	O
left	B-problem
arm	I-problem
and	I-problem
leg	I-problem
pain	I-problem
.	O

Upon	O
further	O
review	O
of	O
CT	B-test
and	O
angiography	B-test
results	O
with	O
Neuroradiology	O
and	O
Neurology	O
service	O
,	O
it	O
was	O
decided	O
that	O
CT	B-test
myelography	I-test
was	O
not	O
indicated	O
at	O
this	O
time	O
.	O

Note	O
,	O
the	O
patient	O
is	O
not	O
a	O
candidate	O
for	O
magnetic	B-test
resonance	I-test
imaging	I-test
secondary	O
to	O
ferromagnetic	B-treatment
intracardiac	I-treatment
pacing	I-treatment
device	I-treatment
.	O

DISPOSITION	O
:	O

The	O
patient	O
was	O
discharged	O
back	O
to	O
Raka	O
St	O
,	O
Mcape	O
Garl	O
,	O
long	O
term	O
facility	O
.	O

We	O
recommend	O
daily	O
physical	B-treatment
therapy	I-treatment
and	O
occupational	B-treatment
therapy	I-treatment
to	O
maximize	O
functional	B-problem
capacity	I-problem
with	O
optimization	O
of	O
pharmacological	B-treatment
regimen	I-treatment
for	O
spasticity	B-problem
including	O
Baclofen	B-treatment
,	O
Valium	B-treatment
and	O
adequate	B-treatment
analgesia	I-treatment
.	O

The	O
patient	O
is	O
to	O
followup	O
in	O
Neurology	O
clinic	O
,	O
Verg	O
Medical	O
Center	O
with	O
Dr.	O
Deida	O
K.	O
Areke	O
and	O
/	O
or	O
Dr.	O
Istranmuna	O
Cord	O
in	O
4-6	O
weeks	O
time	O
.	O

Dictated	O
By	O
:	O

DEIDA	O
K.	O
LONG	O
,	O
M.D.	O

Attending	O
:	O

ISTRANMUNA	O
B.	O
CORD	O
,	O
M.D.	O
VR52	O
PH501/3560	O

Batch	O
:	O

1445	O

Index	O
No.	O
MUZHFDOZK0	O

D	O
:	O

11/02/99	O

T	O
:	O

11/02/99	O
KE9	O

544907529	O
RWH	O

2746299	O

006349	O

700114	O

4/4/2002	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

JESCWIERST	O
,	O
MA	O

MRN	O
:	O

2746299	O

Age	O
:	O

55y	O

REGISTRATION	O
DATE	O
:	O

04/04/2002	O
01:09	O
AM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
JESCWIERST	O
,	O
MA	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Ro	O
Woodma	O
Healthcare	O
on	O
04/04/2002	O
01:09	O
AM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
EPIGASTRIC	B-problem
PAIN	I-problem
/	O
ABD	B-problem
PAIN	I-problem
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
RO	O
WOODMA	O
HEALTHCARE	O
.	O

The	O
patient	O
&apos;s	O
preliminary	O
admitting	O
physician	O
is	O
PRIESDOUET	O
,	O
CH	O
J	O
and	O
the	O
preliminary	O
diagnosis	O
is	O
CHOLECYSTITIS	B-problem
.	O

Please	O
note	O
this	O
information	O
may	O
have	O
been	O
updated	O
on	O
the	O
inpatient	O
unit	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
662-747-1199	O
.	O

PCP	O
Name	O
:	O

GRENDZISKLEEB	O
,	O
FACISA	O
T	O

Provider	O
Number	O
:	O

11181	O

555509347	O
PUMC	O

7264645	O

16649	O

8815716	O

8/31/2004	O
12:00:00	O
AM	O

OB	O
Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O
OB	O
EMR	O
L	O
and	O
D	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

THON	O
MERI	O
CINKGUAY	O

UNIT	O
NUMBER	O
:	O

069-81-00	O

ADMISSION	O
DATE	O
:	O

20040831	O

DISCHARGE	O
DATE	O
:	O

20040903	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
:	O

Vaginal	B-treatment
Delivery	I-treatment
With	O
Second	B-problem
Degree	I-problem
Laceration	I-problem

ASSOCIATED	O
DIAGNOSES	O
:	O

Low	B-problem
Lying	I-problem
Placenta	I-problem
;	O
Past	O
Medical	O
History	O
,	O
history	O
of	O
;	O
Urinary	B-problem
Tract	I-problem
Infection	I-problem
,	O
history	O
of	O

PRINCIPAL	O
PROCEDURE	O
OR	O
OPERATION	O
:	O

Spontaneous	B-treatment
Vertex	I-treatment
Vaginal	I-treatment
Delivery	I-treatment

ASSOCIATED	O
PROCEDURES	O
OR	O
OPERATIONS	O
:	O

POSTPARTUM	O
DIAGNOSTIC	O
PROCEDURES	O
:	O

None	O

POSTPARTUM	O
THERAPEUTIC	O
PROCEDURES	O
:	O

None	O

OTHER	O
POSTPARTUM	O
THERAPIES	O
:	O

Routine	B-treatment
Post	I-treatment
Partum	I-treatment
Care	I-treatment

HISTORY	O
AND	O
REASON	O
FOR	O
HOSPITALIZATION	O
:	O

Active	B-problem
Labor	I-problem

PHYSICAL	O
EXAMINATION	O
:	O

HEIGHT	B-test
66	O
HEENT	B-test
NORMAL	O
NECK	O
NORMAL	O
BREASTS	O
NORMAL	O
NIPPLES	O
NORMAL	O
CHEST	O
NORMAL	O
COR	O
NORMAL	O
ABDOMEN	O
NORMAL	O
EXTREM	O
NORMAL	O
SKIN	O
NORMAL	O
NODES	O
NORMAL	O
VULVA	O
NORMAL	O
VAGINA	O
NORMAL	O
CERVIX	O
NORMAL	O
OS	O
NORMAL	O
ADNEXAE	O
NORMAL	O
UTERUS	O
NORMAL	O
UTERINE	O
SIZE	O
IN	O
WEEKS	O
NORMAL	O
12	O

HOSPITAL	O
COURSE	O
(	O
include	O
complications	O
if	O
any	O
)	O
:	O

This	O
34	O
year	O
old	O
Gravida	O
1	O
Para	O
0000	O
was	O
admitted	O
to	O
the	O
Bap	O
Spald	O
Hospital	O
Obstetrical	O
service	O
on	O
08/31/2004	O
at	O
06:00	O
am	O
for	O
the	O
indication	O
(	O
s	O
)	O
:	O

active	B-problem
labor	I-problem
.	O

She	O
delivered	O
a	O
3550	O
gram	O
male	O
infant	O
on	O
08/31/2004	O
at	O
09:33	O
pm	O
with	O
apgar	B-test
scores	I-test
of	O
9	O
and	O
9	O
at	O
one	O
and	O
five	O
minutes	O
respectively	O
at	O
41.0	O
weeks	O
gestation	O
via	O
spontaneous	B-treatment
vertex	I-treatment
vaginal	I-treatment
delivery	I-treatment
.	O

During	O
her	O
labor	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

chorioamnionitis	B-problem
.	O

During	O
her	O
delivery	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

nuchal	B-problem
cord	I-problem
.	O

Postpartum	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

none	O
.	O

She	O
was	O
discharged	O
on	O
09/03/2004	O
at	O
12:07	O
pm	O
in	O
good	O
condition	O
.	O

DISCHARGE	O
ACTIVITY	O
:	O

No	O
Restrictions	O

DISCHARGE	O
DIET	O
:	O

No	O
Restrictions	O

POSTPARTUM	O
DISPOSITION	O
:	O

Home	O
With	O
Self-Care	O
(	O
Routine	O
Discharge	O
)	O

POSTPARTUM	O
CARE	O
SITE	O
:	O

Cinpipecoursspi	O
Hospital	O
Health	O
Center	O

POSTPARTUM	O
RETURN	O
APPOINTMENT	O
(	O
DAYS	O
)	O
:	O

42	O

BREAST	O
FEEDING	O
AT	O
DISCHARGE	O
:	O

Yes	O

POSTPARTUM	O
MEASLES	O
/	O
MUMPS/RUBELLA	O
VACCINE	O
:	O

Not	O
Indicated	O

MEDICATION	O
(	O
S	O
)	O
ON	O
DISCHARGE	O
:	O

Multivitamins	B-treatment
And	O
Folate	B-treatment
(	I-treatment
Fam	I-treatment
Pren	I-treatment
Forte	I-treatment
)	I-treatment

Electronically	O
Signed	O
:	O

Pada	O
Post	O
,	O
MD	O

09/03/2004	O
9:51:35	O
PM	O

574700124	O
RWH	O

0587585	O

896338	O

996098	O

11/26/2000	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

CHAFFBITZ	O
,	O
TESSMONDMARV	O

MRN	O
:	O

0587585	O

Age	O
:	O

26y	O

REGISTRATION	O
DATE	O
:	O

11/26/2000	O
06:47	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
CHAFFBITZ	O
,	O
TESSMONDMARV	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Ro	O
Woodma	O
Healthcare	O
on	O
11/26/2000	O
06:47	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
ABD	B-problem
PAIN	I-problem
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
TREATED	O
AND	O
RELEASED	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
662-747-1199	O
.	O

596437842	O

CTMC	O

63056604	O

547591	O

02/08/1991	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

02/08/1991	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

02/18/1991	O

DISCHARGE	O
DIAGNOSES	O
:	O

1)	O
ACQUIRED	B-problem
IMMUNODEFICIENCY	I-problem
SYNDROME	I-problem
.	O

2)	O
PNEUMOCYSTIS	B-problem
CARINII	I-problem
PNEUMONIA	I-problem
.	O

3)	O
ADULT	B-problem
RESPIRATORY	I-problem
DISTRESS	I-problem
SYNDROME	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Breutzfarstxei	O
is	O
a	O
30	O
year	O
old	O
man	O
with	O
recently	O
diagnosed	O
acquired	B-problem
immunodeficiency	I-problem
syndrome	I-problem
and	O
Pneumocystis	B-problem
carinii	I-problem
pneumonia	I-problem
who	O
presented	O
with	O
pneumonia	B-problem
,	O
developed	O
adult	B-problem
respiratory	I-problem
distress	I-problem
syndrome	I-problem
,	O
and	O
died	O
in	O
the	O
hospital	O
after	O
failed	O
efforts	O
of	O
ventilatory	B-treatment
support	I-treatment
.	O

Mr.	O
Breutzfarstxei	O
was	O
recently	O
diagnosed	O
with	O
acquired	B-problem
immunodeficiency	I-problem
syndrome	I-problem
when	O
he	O
had	O
Pneumocystis	B-problem
carinii	I-problem
pneumonia	I-problem
on	O
01/17/91	O
.	O

He	O
was	O
admitted	O
to	O
the	O
Retelk	O
County	O
Medical	O
Center	O
at	O
that	O
time	O
and	O
was	O
treated	O
with	O
Bactrim	B-treatment
and	O
steroids	B-treatment
.	O

He	O
was	O
actually	O
intubated	O
and	O
underwent	O
bronchoscopy	B-treatment
where	O
the	O
diagnosis	O
was	O
made	O
with	O
a	B-problem
positive	I-problem
toluidine	I-problem
blue	I-problem
study	I-problem
.	O

He	O
initially	O
did	O
well	O
after	O
extubation	B-treatment
and	O
completed	O
approximately	O
two	O
weeks	O
of	O
Bactrim	B-treatment
and	O
a	B-treatment
steroid	I-treatment
taper	I-treatment
.	O

At	O
discharge	O
after	O
about	O
two	O
weeks	O
post-extubation	O
,	O
he	O
had	O
an	O
O2	B-test
saturation	I-test
of	O
approximately	O
95%	O
on	O
room	O
air	O
.	O

He	O
was	O
seen	O
by	O
Dr.	O
Seen	O
and	O
Dr.	O
Seen	O
as	O
an	O
out-patient	O
.	O

On	O
02/06/91	O
,	O
he	O
was	O
seen	O
in	O
FLFDMC	O
and	O
at	O
that	O
point	O
,	O
his	B-test
temperature	I-test
was	O
noted	O
to	O
be	O
101.4	O
and	O
he	O
had	O
malaise	B-problem
and	O
diarrhea	B-problem
.	O

He	O
was	O
evaluated	O
in	O
the	O
Emergency	O
Room	O
.	O

At	O
that	O
time	O
,	O
his	B-test
oxygen	I-test
saturation	I-test
was	O
only	O
90%	O
on	O
room	O
air	O
and	O
his	B-test
chest	I-test
X-Ray	I-test
showed	O
no	O
change	O
.	O

Cultures	B-test
were	O
taken	O
and	O
he	O
was	O
sent	O
out	O
.	O

On	O
02/08/91	O
,	O
the	O
patient	O
called	O
Dr.	O
Seen	O
because	O
of	O
increased	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
and	O
malaise	B-problem
.	O

He	O
was	O
seen	O
in	O
FLFDMC	O
where	O
he	O
was	O
noted	O
to	O
have	O
jaundice	B-problem
and	O
newly	B-problem
palpable	I-problem
liver	I-problem
edge	I-problem
.	O

Review	O
of	O
liver	B-test
function	I-test
tests	I-test
revealed	O
a	B-problem
cholestatic	I-problem
picture	I-problem
which	O
was	O
not	O
previously	O
found	O
and	O
it	O
was	O
felt	O
that	O
this	O
was	O
secondary	O
to	O
the	B-treatment
Bactrim	I-treatment
which	O
had	O
been	O
recently	O
stopped	O
anyway	O
.	O

His	B-test
oxygen	I-test
saturation	I-test
at	O
that	O
time	O
was	O
only	O
86%	O
on	O
room	O
air	O
and	O
he	O
was	O
admitted	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1)	O
HIV	B-problem
positive	I-problem
with	O
a	B-test
CD4	I-test
count	I-test
of	O
74	O
.	O

2)	O
Recent	B-problem
PCP	I-problem
.	O

3)	O
Status	O
post	O
right	B-treatment
elbow	I-treatment
surgery	I-treatment
.	O

4)	O
Venereal	B-problem
disease	I-problem
history	I-problem
.	O

5)	O
PPD	B-problem
anergic	I-problem
.	O

The	O
patient	O
&apos;s	O
HIV	O
risk	O
factors	O
include	O
history	O
of	O
intravenous	O
drug	O
abuse	O
,	O
prostitution	O
,	O
and	O
a	O
former	O
prisoner	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
presentation	O
,	O
the	O
patient	O
was	O
a	O
young	O
appearing	O
Hispanic	O
male	O
in	O
mild	B-problem
respiratory	I-problem
distress	I-problem
with	O
a	B-test
blood	I-test
pressure	I-test
of	O
140/90	O
,	O
heart	B-test
rate	I-test
120	O
,	O
respirations	B-test
32	O
,	O
and	O
temperature	B-test
101	O
.	O

SKIN	O
:	O

Jaundiced	O
.	O

HEENT	O
:	O

Revealed	O
icteric	B-problem
sclerae	I-problem
,	O
the	B-problem
oropharynx	I-problem
with	I-problem
extensive	I-problem
thrush	I-problem
,	O
and	O
an	B-problem
ulcer	I-problem
under	I-problem
his	I-problem
tongue	I-problem
.	O

NECK	O
:	O

He	O
had	O
no	O
cervical	B-problem
adenopathy	I-problem
and	O
his	O
neck	O
was	O
supple	O
.	O

LUNGS	O
:	O

Had	O
tubular	B-problem
breath	I-problem
sounds	I-problem
especially	O
in	O
the	O
lower	O
lung	O
fields	O
.	O

CARDIAC	O
:	O

Showed	O
regular	O
rate	O
and	O
rhythm	O
without	O
murmurs	B-problem
,	O
rubs	B-problem
,	O
or	O
gallops	B-problem
.	O

There	O
was	O
no	O
costovertebral	B-problem
angle	I-problem
tenderness	I-problem
.	O

ABDOMEN	O
:	O

Soft	O
with	O
bowel	O
sounds	O
and	O
there	O
was	O
mid	B-problem
epigastric	I-problem
and	I-problem
right	I-problem
upper	I-problem
quadrant	I-problem
tenderness	I-problem
.	O

His	O
liver	O
was	O
10	O
cm	O
and	O
was	O
felt	O
three	O
finger	O
breadths	O
below	O
the	O
costal	O
margin	O
.	O

His	O
spleen	O
was	O
not	O
palpable	O
.	O

RECTAL	O
:	O

He	O
had	O
guaiac	B-problem
positive	I-problem
stools	I-problem
.	O

EXTREMITIES	O
:	O

Unremarkable	O
.	O

GENITOURINARY	O
:	O

His	O
penis	O
had	O
a	O
1/2	B-problem
cm	I-problem
ulcer	I-problem
with	O
yellowish	B-problem
discharge	I-problem
.	O

NEUROLOGICAL	O
:	O

Non-focal	O
.	O

LABORATORY	O
EXAMINATION	O
:	O

On	O
admission	O
,	O
white	B-test
count	I-test
was	O
7.2	O
with	O
57%	O
neutrophils	B-test
,	O
40%	O
lymphocytes	B-test
,	O
l	O
mononuclear	B-test
cell	I-test
,	O
and	O
1.6	O
eosinophils	B-test
.	O

PT	B-test
was	O
12.6	O
and	O
PTT	B-test
was	O
29	O
.	O

Sodium	B-test
was	O
133	O
,	O
potassium	B-test
was	O
4.2	O
,	O
chloride	B-test
100	O
,	O
CO2	B-test
19	O
,	O
BUN	B-test
21	O
,	O
creatinine	B-test
1.2	O
,	O
and	O
glucose	B-test
122	O
.	O

ALT	B-test
was	O
181	O
,	O
AST	B-test
was	O
156	O
,	O
LDH	B-test
was	O
336	O
,	O
alkaline	B-test
phosphatase	I-test
was	O
214	O
,	O
and	O
bilirubin	B-test
was	O
12.7	O
total	O
.	O

(	O
On	O
02/06	O
,	O
his	B-test
bilirubin	I-test
had	O
been	O
7.2	O
with	O
6	O
direct	O
)	O
.	O

His	B-test
arterial	I-test
blood	I-test
gas	I-test
on	O
50%	O
was	O
pO2	B-test
92	O
,	O
pCO2	B-test
24	O
,	O
and	O
pH	B-test
7.46	O
.	O

His	B-test
chest	I-test
X-Ray	I-test
showed	O
bilateral	B-problem
nodular	I-problem
infiltrates	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
for	O
work-up	B-test
of	O
his	B-problem
cholestatic	I-problem
jaundice	I-problem
picture	I-problem
along	O
with	O
work-up	B-test
for	O
his	B-problem
pulmonary	I-problem
process	I-problem
and	O
treatment	B-treatment
of	O
both	O
.	O

In	O
terms	O
of	O
pulmonary	O
function	O
,	O
it	O
was	O
felt	O
that	O
one	O
possibility	O
was	O
that	O
the	O
patient	O
was	O
a	B-problem
Bactrim	I-problem
failure	I-problem
for	O
PCP	B-problem
although	O
this	O
was	O
unusual	O
.	O

He	O
was	O
started	O
on	O
Pentamidine	B-treatment
,	O
especially	O
in	O
light	O
of	O
the	O
fact	O
that	O
it	O
was	O
felt	O
that	O
his	B-test
liver	I-test
function	I-test
tests	I-test
were	O
due	O
possibly	O
to	O
Bactrim	B-treatment
.	O

The	O
patient	O
was	O
also	O
covered	O
with	O
Erythromycin	B-treatment
and	O
Gentamicin	B-treatment
for	O
coverage	O
of	O
community	B-problem
acquired	I-problem
pneumonias	I-problem
and	O
gram	B-problem
negative	I-problem
rods	I-problem
.	O

He	O
was	O
given	O
supplemental	B-treatment
oxygen	I-treatment
.	O

In	O
terms	O
of	O
his	B-problem
liver	I-problem
abnormalities	I-problem
,	O
it	O
was	O
felt	O
that	O
viral	B-problem
hepatitis	I-problem
was	O
in	O
the	O
differential	O
as	O
well	O
as	O
several	B-problem
opportunistic	I-problem
infections	I-problem
of	I-problem
the	I-problem
liver	I-problem
but	O
also	O
was	O
felt	O
that	O
Bactrim	B-treatment
could	O
be	O
a	O
cause	O
of	O
these	B-problem
abnormalities	I-problem
.	O

Titers	B-test
for	O
CMV	B-problem
and	O
Epstein-Barr	B-problem
virus	I-problem
were	O
sent	O
and	O
a	B-test
titer	I-test
for	O
toxoplasma	B-problem
was	O
sent	O
.	O

Stool	B-test
was	O
sent	O
for	O
ova	B-problem
and	O
parasites	B-problem
.	O

Gastrointestinal	O
was	O
consulted	O
.	O

Initially	O
,	O
the	O
patient	O
did	O
well	O
in	O
terms	O
of	O
his	O
pre-status	O
and	O
required	O
less	O
oxygen	B-treatment
.	O

However	O
,	O
on	O
02/10/91	O
,	O
his	B-test
respiratory	I-test
rate	I-test
increased	O
and	O
his	B-test
oxygen	I-test
saturation	I-test
decreased	O
.	O

Actually	O
in	O
reviewing	O
the	O
records	O
at	O
this	O
point	O
,	O
it	O
appears	O
that	O
Pentamidine	B-treatment
was	O
not	O
started	O
initially	O
so	O
on	O
the	B-treatment
antibiotics	I-treatment
of	O
Erythromycin	B-treatment
and	O
Gentamicin	B-treatment
,	O
the	O
patient	O
&apos;s	O
respiratory	O
status	O
worsened	O
and	O
his	B-test
LDH	I-test
climbed	O
so	O
he	O
began	O
Pentamidine	B-treatment
on	O
02/10/91	O
.	O

On	O
02/11/91	O
,	O
the	O
patient	O
again	O
appeared	O
more	O
comfortable	O
this	O
time	O
with	O
50%	B-treatment
facemask	I-treatment
but	O
then	O
required	O
more	O
oxygen	B-treatment
,	O
dropped	O
his	B-test
O2	I-test
saturations	I-test
,	O
and	O
was	O
intubated	O
on	O
02/11/91	O
.	O

He	O
was	O
transferred	O
to	O
the	O
Intensive	O
Care	O
Unit	O
on	O
12/12/90	O
on	O
Gentamicin	B-treatment
,	O
Vancomycin	B-treatment
,	O
Pentamidine	B-treatment
,	O
and	O
Prednisone	B-treatment
.	O

Also	O
of	O
note	O
at	O
that	O
point	O
,	O
hepatitis	B-test
C	I-test
virus	I-test
serologies	I-test
had	O
come	O
back	O
positive	O
.	O

However	O
,	O
at	O
this	O
point	O
,	O
his	B-problem
liver	I-problem
function	I-problem
test	I-problem
abnormalities	I-problem
appeared	O
more	O
consistent	O
with	O
a	B-problem
cholestatic	I-problem
picture	I-problem
with	O
his	B-test
direct	I-test
bilirubin	I-test
being	O
12.1	O
and	O
total	B-test
being	O
14.1	O
.	O

The	B-test
patient	I-test
&apos;s	I-test
abdominal	I-test
CT	I-test
scan	I-test
showed	O
no	O
liver	B-problem
disease	I-problem
and	O
no	O
obstruction	B-problem
.	O

The	B-test
patient	I-test
&apos;s	I-test
liver	I-test
function	I-test
tests	I-test
appeared	O
to	O
improve	O
.	O

The	B-problem
patient	I-problem
&apos;s	I-problem
penile	I-problem
ulcer	I-problem
was	O
cultured	O
and	O
grew	O
positive	B-problem
herpes	I-problem
simplex	I-problem
virus	I-problem
and	O
the	O
patient	O
was	O
started	O
on	O
Acyclovir	B-treatment
.	O

On	O
02/13/91	O
,	O
the	O
patient	O
had	O
a	B-test
bronchoalveolar	I-test
lavage	I-test
performed	O
which	O
showed	O
a	B-problem
toluidine	I-problem
blue	I-problem
with	O
many	B-problem
pneumocysts	I-problem
noted	O
.	O

No	O
other	B-test
cultures	I-test
grew	O
out	O
and	O
the	O
patient	O
&apos;s	O
clinical	O
status	O
deteriorated	O
.	O

The	O
patient	O
required	O
100%	B-treatment
oxygen	I-treatment
to	O
maintain	O
adequate	O
oxygen	O
saturations	O
on	O
the	B-treatment
ventilator	I-treatment
.	O

He	O
required	O
elevated	B-treatment
ventilatory	I-treatment
pressures	I-treatment
with	O
PIPS	B-test
often	O
above	O
60	O
.	O

Fortunately	O
,	O
no	O
evidence	O
of	O
baratroma	B-problem
was	O
ever	O
discerned	O
.	O

However	O
,	O
the	O
patient	O
&apos;s	O
respiratory	O
status	O
continued	O
to	O
decline	O
and	O
we	O
were	O
unable	O
to	O
maintain	O
oxygen	B-test
saturations	I-test
above	O
80%	O
even	O
using	O
reverse	B-treatment
I	I-treatment
to	I-treatment
E	I-treatment
ventilation	I-treatment
,	O
paralysis	B-treatment
,	O
sedation	B-treatment
,	O
and	O
other	B-treatment
modes	I-treatment
of	I-treatment
ventilation	I-treatment
.	O

Patient	O
underwent	O
liver	B-test
biopsy	I-test
on	O
02/16/91	O
and	O
the	O
results	O
of	O
this	O
were	O
pending	O
when	O
the	O
patient	O
died	O
.	O

The	O
patient	O
actually	O
developed	O
decreasing	B-problem
counts	I-problem
with	O
white	B-test
count	I-test
as	O
low	O
as	O
1.75	O
,	O
hematocrit	B-test
as	O
low	O
as	O
26	O
,	O
and	O
platelets	B-test
as	O
low	O
as	O
68	O
noted	O
on	O
02/15/91	O
.	O

These	O
were	O
supported	O
with	O
blood	B-treatment
products	I-treatment
and	O
Hematology	O
was	O
consulted	O
.	O

They	O
felt	O
that	O
it	O
was	O
most	O
likely	O
secondary	O
to	O
Bactrim	B-treatment
and	O
these	O
actually	O
were	O
getting	O
better	O
when	O
the	O
patient	O
died	O
.	O

Bone	B-test
marrow	I-test
biopsy	I-test
was	O
not	O
attempted	O
.	O

Discussions	O
were	O
begun	O
with	O
the	O
family	O
regarding	O
limits	O
of	O
supportive	B-treatment
care	I-treatment
.	O

Due	O
to	O
continued	B-problem
worsening	I-problem
pulmonary	I-problem
status	I-problem
and	O
an	O
overall	O
grim	O
prognosis	O
,	O
the	O
family	O
decided	O
,	O
in	O
consultation	O
with	O
the	O
Medical	O
Team	O
,	O
to	O
withdraw	O
ventilatory	B-treatment
support	I-treatment
.	O

This	O
was	O
done	O
on	O
the	O
evening	O
of	O
02/18/91	O
.	O

Patient	O
expired	O
after	O
the	B-treatment
endotracheal	I-treatment
tube	I-treatment
was	O
withdrawn	O
at	O
6:40	O
p.m.	O

DISPOSITION	O
:	O

The	O
patient	O
died	O
in	O
hospital	O
.	O

An	B-test
autopsy	I-test
will	O
be	O
performed	O
.	O

An	B-test
autopsy	I-test
was	O
performed	O
as	O
per	O
the	O
family	O
&apos;s	O
wishes	O
.	O

WE221/9850	O
TAKO	O
C.	O
INSKE	O
,	O
M.D.	O
,	O
PH.	O
JT2	O
FF2	O

D	O
:	O

02/18/91	O

Batch	O
:	O

8600	O

Report	O
:	O

V7238B57	O

T	O
:	O

02/20/91	O

Dicatated	O
By	O
:	O

LATO	O
L.	O
TIKFREIERM	O
,	O
M.D.	O

cc	O
:	O

1.	O
LERMA	O
N.	O
WYNBRANTESXELL	O
,	O
M.D.	O

2.	O
ANA	O
V.	O
A	O
,	O
M.D.	O

3.	O
DALLI	O
A.	O
SEEN	O
,	O
M.D	O

4.	O
ARC	O
N.	O
SEEN	O
,	O
M.D.	O

598403789	O
DH	O

8993683	O

816711	O

963035	O

02/25/2001	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

GLYN	O
,	O
AEA	O

MRN	O
:	O

8993683	O

Age	O
:	O

67y	O

REGISTRATION	O
DATE	O
:	O

02/25/2001	O
12:20	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
GLYN	O
,	O
AEA	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Daughtersvillshamen&apos;s	O
Hospital	O
on	O
02/25/2001	O
12:20	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
HEMATURIA	B-problem
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
DAUGHTERSVILLSHAMEN&apos;S	O
HOSPITAL	O
.	O

The	O
patient	O
&apos;s	O
preliminary	O
admitting	O
physician	O
is	O
LINKETHORE	O
,	O
HANSVERLLEN	O
G	O
and	O
the	O
preliminary	O
diagnosis	O
is	O
HEMATURIA	B-problem
.	O

Please	O
note	O
this	O
information	O
may	O
have	O
been	O
updated	O
on	O
the	O
inpatient	O
unit	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
613-870-0699	O
.	O

PCP	O
Name	O
:	O

SWANKEMANDESSKIAIS	O
,	O
SANTCINET	O
E	O

Provider	O
Number	O
:	O

42283	O

614746156	O

CTMC	O

48720920	O

513332	O

7/3/1999	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

07/03/1999	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

EHC9	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
71-year-old	O
police	O
chief	O
who	O
presents	O
with	O
painless	B-problem
jaundice	I-problem
x1	O
day	O
.	O

The	O
patient	O
was	O
generally	O
in	O
excellent	O
health	O
with	O
a	O
past	O
medical	O
history	O
significant	O
only	O
for	O
noninsulin	B-problem
dependent	I-problem
diabetes	I-problem
mellitus	I-problem
who	O
was	O
presented	O
with	O
painless	B-problem
jaundice	I-problem
x2	O
days	O
.	O

He	O
also	O
noted	O
a	B-problem
23	I-problem
pound	I-problem
weight	I-problem
loss	I-problem
in	O
the	O
past	O
11	O
months	O
despite	O
having	O
an	B-problem
increased	I-problem
appetite	I-problem
.	O

The	O
patient	O
also	O
complained	O
of	O
fatigue	B-problem
and	O
&quot;	B-problem
feeling	I-problem
down	I-problem
&quot;	I-problem
.	O

His	O
wife	O
noted	O
personality	B-problem
changes	I-problem
with	O
increased	B-problem
irritability	I-problem
.	O

Patient	O
denies	O
night	B-problem
sweats	I-problem
in	O
the	O
past	O
month	O
.	O

The	O
patient	O
denies	O
melena	B-problem
,	O
hematochezia	B-problem
,	O
nausea	B-problem
,	O
and	O
abdominal	B-problem
pain	I-problem
.	O

The	O
patient	O
states	O
that	O
he	O
is	O
occasionally	B-problem
constipated	I-problem
.	O

Also	O
denies	O
tenesmus	B-problem
.	O

On	O
the	O
day	O
prior	O
to	O
admission	O
,	O
the	O
patient	O
&apos;s	O
family	O
noted	O
that	O
&quot;	O
he	O
looked	O
yellow	B-problem
&quot;	O
and	O
presented	O
to	O
the	O
Lorough	O
Medical	O
Center	O
&apos;s	O
Emergency	O
Department	O
this	O
after	O
noon	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Type	B-problem
II	I-problem
diabetes	I-problem
mellitus	I-problem
diagnosed	O
06/94	O
,	O
well-controlled	O
with	O
last	B-test
hemoglobin	I-test
A1C	I-test
6.2	O

2.	O
Vocal	B-problem
cord	I-problem
polyps	I-problem

3.	O
Question	O
of	O
history	O
of	O
AVN	B-problem
or	O
osseous	B-problem
necrosis	I-problem

4.	O
History	O
of	O
hyperkalemia	B-problem
.	O

Question	O
RTA	B-problem
type	I-problem
4	I-problem

MEDICATIONS	O
:	O

Glucotrol	B-treatment
10	O
q.a.m.	O
and	O
vitamins	B-treatment

ALLERGIES	O
:	O

The	O
patient	O
is	O
allergic	B-problem
to	O
MSG	O
from	O
which	O
he	O
gets	O
hives	B-problem
.	O

SOCIAL	O
HISTORY	O
:	O

No	O
ethanol	O
use	O
,	O
remote	O
pipe	O
smoking	O
use	O
which	O
he	O
discontinued	O
20	O
years	O
ago	O
,	O
no	O
illicit	O
drug	O
use	O
.	O

FAMILY	O
HISTORY	O
:	O

Noncontributory	O
.	O

The	O
patient	O
&apos;s	O
father	O
died	O
at	O
the	O
age	O
of	O
83	O
of	O
CHF	B-problem
.	O

The	O
patient	O
&apos;s	O
mother	O
is	O
alive	O
at	O
the	O
age	O
of	O
114y	O
.	O

The	O
patient	O
has	O
six	O
children	O
and	O
10	O
grandchildren	O
,	O
all	O
in	O
excellent	O
health	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
presented	O
to	O
the	O
Emergency	O
Department	O
with	O
a	O
complaint	O
of	O
painless	B-problem
jaundice	I-problem
,	O
weight	B-problem
loss	I-problem
,	O
and	O
fatigue	B-problem
.	O

Abdominal	B-test
CT	I-test
while	O
in	O
the	O
Emergency	O
Department	O
revealed	O
likely	O
primary	B-problem
colorectal	I-problem
adenocarcinoma	I-problem
with	O
multiple	B-problem
liver	I-problem
metastases	I-problem
.	O

Hematocrit	B-test
was	O
24	O
in	O
the	O
Emergency	O
Department	O
.	O

The	O
patient	O
received	O
two	O
units	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
and	O
the	B-test
hematocrit	I-test
rose	O
to	O
30	O
the	O
following	O
day	O
.	O

The	O
patient	O
was	O
seen	O
by	O
both	O
Gastroenterology	O
and	O
Oncology	O
.	O

Biopsy	B-test
was	O
taken	O
at	O
colonoscopy	B-test
on	O
7/5/99	O
.	O

Head	B-test
CT	I-test
was	O
done	O
with	O
final	O
results	O
pending	O
on	O
discharge	O
.	O

The	O
patient	O
was	O
to	O
follow-up	O
with	O
the	O
Petersly	O
Hospital	O
And	O
Medical	O
Center	O
as	O
an	O
outpatient	O
for	O
further	B-treatment
treatment	I-treatment
.	O

The	O
patient	O
is	O
discharged	O
to	O
home	O
.	O

His	O
condition	O
is	O
stable	O
and	O
he	O
was	O
discharged	O
with	O
the	B-treatment
following	I-treatment
medications	I-treatment
:	O

Iron	B-treatment
300	O
mg	O
p.o.	O
t.i.d.	O
,	O
Glucotrol	B-treatment
,	O
Acel	B-treatment
10	O
mg	O
p.o.	O
q.d.	O
,	O
and	O
Bactrim	B-treatment
SS	I-treatment
1	O
tablet	O
p.o.	O
b.i.d.	O

Dicatated	O
By	O
:	O

STEPH	O
ALEA	O
,	O
M.D.	O

Attending	O
:	O

BREANA	O
G.	O
CORNEA	O
,	O
M.D.	O
IS68	O
ON208/5303	O

Batch	O
:	O

31863	O

Index	O
No.	O
MIEQVK9Q4Z	O

D	O
:	O

07/05/99	O

T	O
:	O

07/05/99	O

CC	O
:	O

1.	O
BREANA	O
G.	O
CORNEA	O
,	O
M.D.*	O
CONFORD	O
GHACOLL	O
HEALTHCARE	O

622086964	O

BH	O

8245338	O

356492	O

05/16/2004	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

WIERSTUPH	O
,	O
NORNAME	O
H	O

UNIT	O
NUMBER	O
:	O

370-15-25	O

ADMISSION	O
DATE	O
:	O

05/16/2004	O

DISCHARGE	O
DATE	O
:	O

05/26/2004	O

PRIMARY	O
DIAGNOSIS	O
:	O

Ovarian	B-problem
cancer	I-problem
.	O

ASSOCIATED	O
DIAGNOSES	O
:	O

Hypertension	B-problem
,	O
asthma	B-problem
,	O
obesity	B-problem
,	O
history	O
of	O
heart	B-problem
murmur	I-problem
,	O
hemorrhoids	B-problem
,	O
whooping	B-problem
cough	I-problem
as	O
a	O
child	O
.	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

Total	B-treatment
abdominal	I-treatment
hysterectomy	I-treatment
,	O
bilateral	B-treatment
salpingooophorectomy	I-treatment
,	O
bilateral	B-treatment
lymph	I-treatment
node	I-treatment
dissection	I-treatment
,	O
omentectomy	B-treatment
,	O
lysis	B-treatment
of	O
adhesions	B-problem
,	O
removal	B-treatment
of	O
mass	B-problem
from	O
surface	O
of	O
transverse	O
colon	O
.	O

HISTORY	O
OF	O
THE	O
PRESENT	O
ILLNESS	O
AND	O
REASON	O
FOR	O
HOSPITALIZATION	O
:	O

64-year-old	O
G5P5	O
postmenopausal	O
for	O
10	O
years	O
with	O
a	O
history	O
of	O
two	O
months	O
of	O
progressive	B-problem
abdominal	I-problem
distention	I-problem
,	O
crampy	B-problem
abdominal	I-problem
pain	I-problem
,	O
urinary	B-problem
frequency	I-problem
and	O
diarrhea	B-problem
.	O

The	O
patient	O
has	O
not	O
obtained	O
gynecologic	B-treatment
care	I-treatment
for	O
32	O
years	O
until	O
April	O
2004	O
when	O
an	O
increase	O
in	O
abdominal	B-problem
GERD	I-problem
and	O
urinary	B-problem
symptoms	I-problem
lead	O
her	O
to	O
initial	O
consultation	O
with	O
Dr.	O
Lentny	O
Farstnappsshee	O
in	O
Gobrew	O
Street	O
,	O
Denlandcobridclevena	O
,	O
West	O
Virginia	O
28880	O
.	O

At	O
that	O
time	O
a	B-test
pelvic	I-test
ultrasound	I-test
was	O
performed	O
showing	O
extensive	B-problem
fluid	I-problem
and	O
clear	B-problem
mass	I-problem
within	O
the	O
pelvi-abdominal	O
cavity	O
.	O

MRI	B-test
showed	O
a	B-problem
large	I-problem
fluid	I-problem
filled	I-problem
abdomen	I-problem
with	O
a	B-problem
relatively	I-problem
small	I-problem
mass	I-problem
measuring	O
about	O
5	O
to	O
6	O
cm	O
in	O
the	O
right	O
pelvis	O
.	O

At	O
this	O
point	O
she	O
had	O
an	B-problem
elevated	I-problem
CA	I-problem
125	O
at	O
440	O
and	O
came	O
to	O
Dr.	O
Chabechird	O
for	O
further	O
consultation	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Hypertension	B-problem
,	O
asthma	B-problem
for	O
10	O
years	O
,	O
no	O
hospitalizations	B-treatment
,	O
obesity	B-problem
,	O
history	O
of	O
heart	B-problem
murmur	I-problem
,	O
hemorrhoids	B-problem
and	O
whooping	B-problem
cough	I-problem
as	O
a	O
child	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Tonsillectomy	B-treatment
in	O
1947	O
,	O
removal	B-treatment
of	O
a	B-problem
renal	I-problem
calculus	I-problem
in	O
1979	O
,	O
cholecystectomy	B-treatment
in	O
1986	O
.	O

OB-GYN	O
HISTORY	O
:	O

G5	O
,	O
P5	O
normal	O
Pap	O
smears	O
,	O
sexual	O
active	O
without	O
dyspareunia	B-problem
.	O

No	O
regular	B-test
breast	I-test
self	I-test
examination	I-test
,	O
has	O
not	O
had	O
a	B-test
mammogram	I-test
.	O

MEDICATIONS	O
AT	O
HOME	O
:	O

Included	O
Prinzide	B-treatment
12.5	O
mg	O
po	O
daily	O
,	O
albuterol	B-treatment
inhaler	I-treatment
prn	O

ALLERGIES	O
:	O

Demerol	B-treatment
.	O

The	O
patient	O
developed	O
ulceration	B-problem
after	O
IM	B-treatment
injection	I-treatment
.	O

She	O
also	O
has	O
food	B-problem
allergies	I-problem
to	O
raw	O
vegetables	O
as	O
well	O
as	O
some	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
and	O
throat	B-problem
constriction	I-problem
with	O
shrimp	O
.	O

FAMILY	O
HISTORY	O
:	O

Remarkable	O
for	O
colon	B-problem
cancer	I-problem
in	O
her	O
mother	O
and	O
maternal	O
grandfather	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
on	O
05/16/2004	O
for	O
bowel	B-treatment
preparation	I-treatment
before	O
the	B-treatment
surgery	I-treatment
.	O

On	O
05/17/2004	O
the	O
patient	O
underwent	O
atotal	B-treatment
abdominal	I-treatment
hysterectomy	I-treatment
,	O
bilateral	B-treatment
salpingooophorectomy	I-treatment
,	O
bilateral	B-treatment
node	I-treatment
dissection	I-treatment
,	O
omentectomy	B-treatment
,	O
lysis	B-treatment
of	O
adhesions	B-problem
,	O
removal	B-treatment
of	O
mass	B-problem
from	O
surface	O
of	O
transverse	O
colon	O
.	O

The	O
report	O
from	O
the	B-test
frozen	I-test
section	I-test
sent	O
in	O
the	B-treatment
surgery	I-treatment
came	O
back	O
with	O
poorly	B-problem
differentiated	I-problem
adenocarcinoma	I-problem
,	O
possibly	O
serous	B-problem
carcinoma	I-problem
of	I-problem
the	I-problem
ovary	I-problem
.	O

In	O
the	O
postoperative	O
recovery	O
room	O
the	O
patient	O
had	O
a	B-test
hematocrit	I-test
of	O
29.2	O
with	O
low	B-problem
urine	I-problem
output	I-problem
.	O

She	O
was	O
given	O
1	O
unit	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cell	I-treatment
.	O

Her	B-test
urine	I-test
output	I-test
subsequently	O
increased	O
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
floor	O
without	O
any	B-problem
complications	I-problem
.	O

She	O
had	O
an	O
uneventful	O
night	O
.	O

On	O
postoperative	O
day	O
one	O
,	O
the	B-test
patient	I-test
&apos;s	I-test
urine	I-test
culture	I-test
came	O
back	O
with	O
moderate	B-problem
E.	I-problem
coli	I-problem
.	O

She	O
was	O
started	O
on	O
Levofloxacin	B-treatment
500	O
mg	O
po	O
daily	O
.	O

The	O
patient	O
was	O
also	O
started	O
on	O
a	O
clear	O
diet	O
.	O

On	O
postoperative	O
day	O
two	O
,	O
her	B-treatment
Foley	I-treatment
was	O
discontinued	O
.	O

The	O
patient	O
was	O
out	O
of	O
bed	O
.	O

She	O
was	O
tolerating	O
liquids	O
.	O

On	O
postoperative	O
day	O
three	O
,	O
the	O
patient	O
had	O
a	B-treatment
port	I-treatment
placed	O
.	O

She	O
also	O
had	O
one	O
episode	O
of	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

Achest	B-test
x-ray	I-test
done	O
at	O
that	O
time	O
showed	O
left	B-problem
pleural	I-problem
effusion	I-problem
and	O
small	B-problem
right	I-problem
pleural	I-problem
effusion	I-problem
,	O
not	O
pulmonary	B-problem
edema	I-problem
and	O
left	B-problem
lower	I-problem
lobe	I-problem
consolidations	I-problem
.	O

The	O
patient	O
was	O
afebrile	B-problem
,	O
her	B-test
vital	I-test
signs	I-test
were	O
stable	O
and	O
she	O
maintained	O
a	O
good	O
urine	B-test
output	I-test
.	O

She	O
also	O
had	O
an	O
episode	O
of	O
nausea	B-problem
with	O
some	B-problem
emesis	I-problem
,	O
after	O
being	O
treated	O
with	O
Zofran	B-treatment
with	O
no	B-problem
relief	I-problem
,	O
a	B-treatment
nasogastric	I-treatment
tube	I-treatment
was	O
placed	O
which	O
drained	O
1200	O
cc	O
of	O
bilious	B-problem
fluid	I-problem
.	O

On	O
postoperative	O
day	O
four	O
,	O
the	O
patient	O
continued	O
to	O
have	O
nasogastric	B-treatment
tube	I-treatment
in	O
place	O
.	O

A	B-test
repeat	I-test
chest	I-test
x-ray	I-test
done	O
for	O
dyspnea	B-problem
showed	O
persistent	B-problem
pleural	I-problem
effusion	I-problem
with	O
atelectasis	B-problem
versus	O
pneumonia	B-problem
.	O

Her	B-treatment
levofloxacin	I-treatment
was	O
continued	O
.	O

The	O
patient	O
tolerated	O
nasogastric	B-test
tube	I-test
clamping	I-test
trials	I-test
with	O
high	B-problem
residuals	I-problem
in	O
the	O
600	O
cc	O
range	O
.	O

The	O
patient	O
did	O
well	O
on	O
postoperative	O
day	O
five	O
and	O
six	O
.	O

She	O
was	O
started	O
on	O
clear	O
fluids	O
with	O
a	B-treatment
nasogastric	I-treatment
clamped	O
.	O

On	O
postoperative	O
day	O
seven	O
the	O
patient	O
diet	O
was	O
slowly	O
advanced	O
as	O
tolerated	O
.	O

She	O
was	O
also	O
started	O
on	O
Decadron	B-treatment
in	O
preparation	O
for	O
her	B-treatment
chemotherapy	I-treatment
.	O

On	O
postoperative	O
day	O
eight	O
which	O
is	O
Memorial	O
Day	O
the	O
patient	O
was	O
started	O
on	O
Carboplatin-Taxolchemo	B-treatment
therapy	I-treatment
,	O
which	O
she	O
tolerated	O
without	O
complication	B-problem
.	O

On	O
postoperative	O
nine	O
,	O
her	B-treatment
JP	I-treatment
drain	I-treatment
was	O
discontinued	O
.	O

The	O
patient	O
was	O
discharged	O
home	O
that	O
afternoon	O
in	O
stable	O
condition	O
in	O
the	O
afternoon	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Dilaudid	B-treatment
2	O
to	O
4	O
mg	O
po	O
q3h	O
prn	O
pain	B-problem
,	O
Ativan	B-treatment
1	O
mg	O
po	O
q12h	O
prn	O
anxiety	B-problem
,	O
Zofran	B-treatment
8	O
mg	O
po	O
q8h	O
prn	O
nausea	B-problem
,	O
Compazine	B-treatment
10	O
mg	O
po	O
q6h	O
prn	O
nausea	B-problem
,	O
Decadron	B-treatment
20	O
mg	O
po	O
q6h	O
x	O
2	O
doses	O
.	O

The	O
patient	O
was	O
instructed	O
to	O
take	O
20	O
mg	O
at	O
11	O
pm	O
the	O
night	O
before	O
her	B-treatment
next	I-treatment
chemotherapy	I-treatment
and	O
8	O
am	O
on	O
the	O
morning	O
of	O
chemotherapy	B-treatment
.	O

Colace	B-treatment
100	O
mg	O
po	O
bid	O
,	O
Albuterol	B-treatment
inhalers	I-treatment
two	O
puffs	O
inhaled	O
qid	O
prn	O
wheezing	B-problem
and	O
asthma	B-problem
symptoms	I-problem
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

The	O
patient	O
was	O
instructed	O
to	O
follow	O
up	O
with	O
Dr.	O
Slaineaee	O
Chabechird	O
.	O

She	O
was	O
told	O
to	O
make	O
an	O
appointment	O
two	O
weeks	O
after	O
her	B-treatment
surgery	I-treatment
for	O
removal	B-treatment
of	O
her	B-treatment
retention	I-treatment
sutures	I-treatment
.	O

The	O
patient	O
was	O
discharged	O
home	O
in	O
stable	O
condition	O
.	O

NAUNGDAPHBERE	O
T.	O
BUMPSFOOKS	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

Electronically	O
Signed	O

SLAINEAEE	O
S	O
CHABECHIRD	O
,	O
JR	O
,	O
M.D.	O

06/04/2004	O
15:45	O

_____________________________	O
SLAINEAEE	O
S	O
CHABECHIRD	O
,	O
JR	O
,	O
M.D.	O

TR	O
:	O

fk	O

DD	O
:	O

05/26/2004	O

TD	O
:	O

05/27/2004	O
4:01	O
A	O
356492	O

cc	O
:	O

SLAINEAEE	O
S	O
CHABECHIRD	O
,	O
JR	O
,	O
M.D.	O

627258104	O

GH	O

56900479	O

1/8/2001	O
12:00:00	O
AM	O

PANCREATIC	B-problem
CANCER	I-problem

Signed	O

DIS	O

Admission	O
Date	O
:	O

01/08/2001	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

01/30/2001	O

CHIEF	O
COMPLAINT	O
:	O

The	O
patient	O
was	O
transferred	O
from	O
an	O
outside	O
hospital	O
for	O
a	O
second	O
opinion	O
regarding	O
workup	B-test
of	O
his	B-problem
pancreatic	I-problem
cancer	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
61	O
year	O
old	O
male	O
with	O
a	O
history	O
of	O
diabetes	B-problem
,	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
hepatitis	B-problem
C	I-problem
,	O
and	O
asthma	B-problem
who	O
was	O
diagnosed	O
recently	O
with	O
pancreatic	B-problem
cancer	I-problem
after	O
he	O
presented	O
to	O
Seph&apos;sju	O
Memorial	O
after	O
a	O
motor	O
vehicle	O
accident	O
.	O

Chest	B-test
CT	I-test
revealed	O
a	B-problem
pulmonary	I-problem
nodule	I-problem
.	O

Abdominal	B-test
CT	I-test
revealed	O
a	B-problem
3.0	I-problem
to	I-problem
4.0	I-problem
centimeter	I-problem
lesion	I-problem
in	I-problem
the	I-problem
pancreatic	I-problem
head	I-problem
.	O

An	B-test
ERCP	I-test
performed	O
there	O
showed	O
a	B-problem
long	I-problem
segment	I-problem
of	I-problem
distal	I-problem
narrowing	I-problem
of	I-problem
the	I-problem
common	I-problem
bileduct	I-problem
and	O
a	B-treatment
transhepatic	I-treatment
biliary	I-treatment
drain	I-treatment
was	O
placed	O
there	O
on	O
December	O
29	O
.	O

On	O
January	O
1	O
,	O
a	B-treatment
chest	I-treatment
tube	I-treatment
was	O
placed	O
for	O
a	B-problem
loculated	I-problem
pleural	I-problem
effusion	I-problem
.	O

On	O
January	O
2	O
,	O
pleurodesis	B-treatment
was	O
performed	O
.	O

On	O
January	O
4	O
,	O
he	O
had	O
a	B-problem
desaturation	I-problem
.	O

VQ	B-test
was	O
indeterminate	O
.	O

LENIs	B-test
were	O
negative	O
at	O
that	O
time	O
.	O

On	O
January	O
5	O
,	O
he	O
had	O
a	B-test
chest	I-test
xray	I-test
with	O
a	B-problem
left	I-problem
apicalpneumothorax	I-problem
but	O
was	O
stable	O
on	O
chest	B-test
xray	I-test
of	O
January	O
7	O
.	O

Brain	B-test
CT	I-test
was	O
negative	O
,	O
as	O
was	O
a	B-test
bronchoscopy	I-test
with	O
lavage	B-treatment
.	O

His	B-test
CA99	I-test
was	O
normal	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

The	O
patient	O
had	O
reported	O
an	O
approximately	O
30	B-problem
pound	I-problem
weight	I-problem
loss	I-problem
in	I-problem
six	I-problem
weeks	I-problem
.	O

He	O
had	O
experienced	O
some	B-problem
constipation	I-problem
for	O
the	O
few	O
months	O
prior	O
with	O
lighter	B-problem
colored	I-problem
stools	I-problem
,	O
darkened	B-problem
urine	I-problem
and	O
fatigue	B-problem
for	O
months	O
with	O
increased	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
,	O
orthopnea	B-problem
and	O
dyspnea	B-problem
on	O
exertion	O
.	O

He	O
denied	O
any	O
fevers	B-problem
,	O
chills	B-problem
or	O
night	B-problem
sweats	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
for	O
recently	B-problem
diagnosed	I-problem
pancreatic	I-problem
cancer	I-problem
.	O

Diabetes	B-problem
.	O

Hypertension	B-problem
.	O

Gout	B-problem
.	O

Hypercholesterolemia	B-problem
.	O

Coronary	B-problem
artery	I-problem
disease	I-problem
with	O
congestive	B-problem
heart	I-problem
failure	I-problem
.	O

Asthma	B-problem
.	O

Hepatitis	B-problem
C	I-problem
.	O

Psoriasis	B-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Lasix	B-treatment
,	O
80	O
;	O
Avandia	B-treatment
,	O
4	O
b.i.d.	O
;	O
Glipizide	B-treatment
,	O
10	O
b.i.d.;	O
Imdur	B-treatment
,	O
30	O
;	O
Allopurinol	B-treatment
;	O
Zocor	B-treatment
,	O
20	O
;	O
Prilosec	B-treatment
,	O
20	O
,	O
potassium	B-treatment
,	O
40	O
;	O
Oxycontin	B-treatment
,	O
30	O
b.i.d.;	O
subcutaneous	B-treatment
heparin	I-treatment
;	O
Unasyn	B-treatment
,	O
1.5	O
grams	O
q	O
6	O
;	O
Combivent	B-treatment
and	O
morphine	B-treatment
prn	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
a	O
hair	O
stylist	O
.	O

He	O
lives	O
by	O
himself	O
in	O
Tennessee	O
.	O

No	O
tobacco	O
.	O

Seldom	O
ETOH	O
.	O

No	O
drug	O
use	O
.	O

Heis	O
single	O
with	O
no	O
children	O
.	O

He	O
has	O
a	O
very	O
supportive	O
family	O
with	O
numerous	O
siblings	O
.	O

FAMILY	O
HISTORY	O
:	O

Mother	O
and	O
father	O
died	O
of	O
heart	B-problem
failure	I-problem
.	O

Theyalso	O
had	O
diabetes	B-problem
and	O
hypertension	B-problem
.	O

Sister	O
with	O
stomach	B-problem
cancer	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION	O
:	O

The	O
patient	O
was	O
afebrile	B-problem
.	O

Heart	B-test
rate	I-test
was	O
78	O
,	O
blood	B-test
pressure	I-test
98/50	O
,	O
respiratory	B-test
rate	I-test
of	O
32	O
,	O
satting	B-test
91%	O
on	O
four	B-treatment
liters	I-treatment
.	O

In	O
general	O
,	O
this	O
is	O
an	O
obese	O
male	O
in	O
mild	B-problem
respiratory	I-problem
distress	I-problem
.	O

Neck	O
was	O
supple	O
with	O
no	O
lymphadenopathy	B-problem
.	O

HEENT	O
-	O
normocephalic	O
/	O
atraumatic	B-problem
,	O
extraocular	O
movements	O
are	O
intact	O
,	O
pupils	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
and	O
accommodation	O
.	O

Chest	O
had	O
diffuse	B-problem
crackles	I-problem
bilaterally	I-problem
halfway	O
up	O
.	O

Coronary	O
-	O
irregular	B-problem
PVCs	I-problem
,	O
S1	O
,	O
S2	O
normal	O
,	O
positive	B-problem
systolic	I-problem
murmur	I-problem
at	I-problem
the	I-problem
left	I-problem
upper	I-problem
sternal	I-problem
border	I-problem
radiating	O
throughout	O
.	O

Abdomen	O
was	O
distended	B-problem
,	O
tympanitic	B-problem
,	O
mildly	B-problem
tender	I-problem
epigastrium	I-problem
and	I-problem
right	I-problem
lower	I-problem
quadrant	I-problem
.	O

No	O
rebound	B-problem
or	O
guarding	B-problem
.	O

Extremities	O
had	O
2+	B-problem
bilateral	I-problem
lower	I-problem
extremity	I-problem
edema	I-problem
to	I-problem
knees	I-problem
.	O

No	O
clubbing	B-problem
or	O
cyanosis	B-problem
.	O

Neurologic	B-test
examination	I-test
-	O
alert	O
and	O
oriented	O
x	O
3	O
,	O
slurred	B-problem
and	I-problem
slow	I-problem
speech	I-problem
,	O
distractable	B-problem
.	O

Cranial	O
nerves	O
II	O
through	O
XII	O
are	O
intact	O
.	O

Sensory	O
is	O
intact	O
to	O
soft	O
touch	O
throughout	O
.	O

Strength	O
is	O
5/5	O
throughout	O
.	O

LABORATORY	O
DATA	O
:	O

White	B-test
blood	I-test
count	I-test
4.36	O
,	O
hematocrit	B-test
26.1	O
with	O
platelets	B-test
of	O
107,000	O
,	O
MCV	B-test
81	O
.	O

Sodium	B-test
137	O
,	O
potassium	B-test
4.5	O
,	O
chloride97	B-test
,	O
bicarb	B-test
24	O
,	O
BUN	B-test
124	O
,	O
creatinine	B-test
4.1	O
,	O
glucose	B-test
144	O
,	O
AST	B-test
49	O
,	O
ALT33	B-test
,	O
alkaline	B-test
phosphatase	I-test
253	O
,	O
total	B-test
bili	I-test
1.6	O
,	O
calcium	B-test
9.2	O
,	O
magnesium	B-test
2.3	O
,	O
albumin	B-test
3.4	O
.	O

HOSPITAL	O
COURSE	O
:	O

1.	O
Gastrointestinal	O
.	O

The	O
patient	O
had	O
an	B-problem
elevated	I-problem
bilirubin	I-problem
on	O
admission	O
with	O
decreased	B-problem
output	I-problem
of	O
biliary	B-treatment
drain	I-treatment
.	O

The	B-treatment
drain	I-treatment
was	O
replaced	O
over	O
the	O
wire	O
,	O
8-10	O
by	O
IR	O
,	O
when	O
it	O
was	O
accidentally	O
removed	O
.	O

Increased	O
flow	O
again	O
.	O

The	O
patient	O
had	O
signs	B-problem
and	O
symptoms	B-problem
develop	O
of	O
SBP	B-problem
,	O
also	O
with	O
an	B-problem
elevated	I-problem
white	I-problem
count	I-problem
.	O

He	O
was	O
treated	O
broadly	O
with	O
amp	B-treatment
,	O
levo	B-treatment
and	O
Flagyl	B-treatment
.	O

Cultures	B-test
were	O
negative	O
and	O
onlyon	O
one	B-test
gram	I-test
stain	I-test
did	O
it	O
show	O
rare	B-problem
gram	I-problem
negative	I-problem
rods	I-problem
.	O

The	B-test
patient	I-test
&apos;s	I-test
abdominal	I-test
fluid	I-test
cell	I-test
counts	I-test
showed	O
2400	O
white	B-test
blood	I-test
cells	I-test
,	O
500	O
red	B-test
cells	I-test
with	O
82	O
polyps	B-test
,	O
11	O
lymphs	B-test
,	O
7	O
monos	B-test
.	O

Clinically	O
,	O
this	O
was	O
consistent	O
with	O
SBP	B-problem
,	O
although	O
unfortunately	O
,	O
fluid	O
was	O
never	O
sent	O
for	O
cytology	B-test
and	O
a	O
lot	O
of	O
those	B-problem
white	I-problem
cells	I-problem
are	O
most	O
likely	O
due	O
to	O
his	B-problem
cancer	I-problem
.	O

He	B-treatment
underwent	I-treatment
abdominal	I-treatment
paracentesis	I-treatment
approximately	O
two	O
times	O
a	O
week	O
for	O
therapeutic	O
.	O

This	O
had	O
to	O
be	O
performed	O
by	O
IR	O
because	O
the	B-problem
pocket	I-problem
was	O
too	O
deep	O
to	O
access	O
from	O
the	O
bedside	O
.	O

He	O
received	O
a	O
two	O
week	O
course	O
of	O
broad	B-treatment
spectrum	I-treatment
antibiotics	I-treatment
and	O
will	O
be	O
maintained	O
on	O
Levofloxacin	B-treatment
IV	I-treatment
for	O
prophylaxis	B-treatment
against	O
SBP	B-problem
.	O

2.	O
Pulmonary	O
.	O

From	O
a	O
pulmonary	O
standpoint	O
,	O
he	O
continued	O
to	O
complain	O
of	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

His	B-problem
apical	I-problem
pneumothorax	I-problem
from	O
the	O
outside	O
hospital	O
had	O
resolved	O
.	O

Chest	B-test
xray	I-test
was	O
consistent	O
with	O
pleurodesis	B-problem
.	O

However	O
,	O
with	O
persistent	B-problem
abdomen	I-problem
distention	I-problem
,	O
there	O
is	O
likely	O
restrictive	B-problem
deficit	I-problem
and	O
,	O
in	O
addition	O
,	O
after	O
each	O
tap	B-test
,	O
he	O
at	O
times	O
became	O
hypotensive	B-problem
and	O
with	O
some	B-treatment
mild	I-treatment
fluid	I-treatment
resuscitation	I-treatment
decompensated	O
with	O
pulmonary	B-problem
edema	I-problem
,	O
requiring	O
both	O
albumin	B-treatment
and	O
Lasix	B-treatment
to	O
try	O
to	O
mobilize	O
third	B-problem
space	I-problem
fluids	I-problem
.	O

On	O
the	O
day	O
of	O
discharge	O
,	O
he	O
is	O
stating	O
approximately	O
91	O
to	O
92%	O
on	O
three	O
to	O
four	O
liters	O
.	O

Chest	B-test
xray	I-test
is	O
still	O
consistent	O
with	O
volume	B-problem
overload	I-problem
.	O

The	O
plan	O
will	O
be	O
to	O
continue	O
to	O
try	O
to	O
alternate	O
albumin	B-treatment
and	O
Lasix	B-treatment
to	O
mobilize	O
his	B-problem
fluid	I-problem
.	O

3.	O
Cardiovascular	O
.	O

He	O
had	O
episodes	O
of	O
bradycardia	B-problem
without	O
subsequent	B-problem
fall	I-problem
in	I-problem
blood	I-problem
pressure	I-problem
at	O
the	O
beginning	O
of	O
his	O
admission	O
.	O

He	O
was	O
ruled	O
out	O
for	O
a	B-problem
myocardial	I-problem
infarction	I-problem
.	O

Echocardiogram	B-test
showed	O
50%	O
ejection	O
fraction	O
with	O
mild	B-problem
mitral	I-problem
regurgitation	I-problem
.	O

He	O
did	O
not	O
show	O
any	O
episodes	O
of	O
bradycardia	B-problem
throughout	O
the	O
remainder	O
of	O
his	B-treatment
hospital	I-treatment
course	I-treatment
.	O

4.	O
Endocrine	O
.	O

Diabetes	B-problem
.	O

His	B-treatment
Avandia	I-treatment
was	O
discontinued	O
secondary	O
to	O
the	B-problem
side	I-problem
effect	I-problem
profile	I-problem
.	O

He	O
is	O
being	O
maintained	O
on	O
glipizide	B-treatment
and	O
sliding	B-treatment
scale	I-treatment
insulin	I-treatment
.	O

5.	O
Heme	O
.	O

From	O
a	O
heme	O
standpoint	O
,	O
he	O
presented	O
anemic	B-problem
and	O
with	O
an	B-problem
elevated	I-problem
PT	I-problem
INR	I-problem
.	O

He	O
required	O
a	B-treatment
few	I-treatment
transfusions	I-treatment
during	O
his	B-treatment
hospital	I-treatment
course	I-treatment
.	O

He	O
also	O
required	O
FFP	B-treatment
initially	O
to	O
reverse	O
his	B-problem
coagulopathy	I-problem
.	O

However	O
,	O
this	O
resolved	O
on	O
its	O
own	O
over	O
the	B-treatment
hospital	I-treatment
course	I-treatment
.	O

His	B-test
INR	I-test
normalized	O
,	O
however	O
,	O
unfortunately	O
,	O
he	O
developed	O
bilateral	B-problem
deep	I-problem
venous	I-problem
thromboses	I-problem
during	O
his	B-treatment
hospital	I-treatment
course	I-treatment
and	O
will	O
be	O
maintained	O
on	O
Lovenox	B-treatment
.	O

6.	O
Renal	O
.	O

He	O
had	O
a	B-test
creatinine	I-test
of	O
4.0	O
on	O
admission	O
and	O
this	O
decreased	O
down	O
to	O
the	O
mid	O
ones	O
with	O
fluid	B-treatment
,	O
currently	O
at	O
1.7	O
on	O
discharge	O
.	O

From	O
his	B-test
urinalysis	I-test
,	O
he	O
has	O
mostly	O
a	B-problem
prerenal	I-problem
state	I-problem
.	O

However	O
,	O
he	O
does	O
require	O
diuresis	B-treatment
to	O
prevent	O
increased	B-problem
volume	I-problem
overload	I-problem
in	O
his	O
lungs	O
from	O
his	B-problem
hypoalbunemic	I-problem
state	I-problem
.	O

At	O
the	O
time	O
,	O
Nutrition	O
was	O
following	O
,	O
initially	O
with	O
a	O
low	O
fat	O
,	O
low	O
cholesterol	O
,	O
low	O
sugar	O
diet	O
.	O

His	O
appetite	O
is	O
decreasing	O
somewhat	O
as	O
his	B-problem
disease	I-problem
process	I-problem
progresses	O
,	O
therefore	O
,	O
we	O
have	O
liberalized	O
his	O
diet	O
for	O
him	O
to	O
take	O
what	O
he	O
wishes	O
.	O

7.	O
ID	O
.	O

Please	O
see	O
GI	O
.	O

He	O
was	O
treated	O
with	O
broad	B-treatment
spectrum	I-treatment
antibiotics	I-treatment
for	O
a	O
14	O
day	O
course	O
for	O
clinical	B-problem
SBP	I-problem
.	O

He	O
will	O
be	O
maintained	O
on	O
Levofloxacin	B-treatment
for	O
prophylaxis	B-treatment
against	O
SBP	B-problem
.	O

Given	O
that	O
he	O
will	O
need	O
continued	B-test
taps,	I-test

8.	O
Oncology	O
.	O

The	O
patient	O
initially	O
came	O
for	O
workup	B-test
of	O
pancreatic	B-problem
cancer	I-problem
with	O
a	O
questions	O
of	O
palliative	B-treatment
chemotherapy	I-treatment
.	O

However	O
,	O
given	O
his	B-problem
rapid	I-problem
clinical	I-problem
decline	I-problem
,	O
this	O
was	O
deferred	O
and	O
I	O
do	O
not	O
suspect	O
that	O
he	O
will	O
be	O
a	O
candidate	O
for	O
this	O
,	O
as	O
the	O
degree	O
of	O
his	B-problem
decline	I-problem
bodes	O
a	O
poor	O
prognosis	O
for	O
him	O
.	O

His	B-problem
pain	I-problem
here	O
has	O
been	O
controlled	O
,	O
initially	O
on	O
Oxycontin	B-treatment
with	O
morphine	B-treatment
for	O
breakthrough	B-problem
pain	I-problem
.	O

As	O
he	O
becomes	O
progressively	B-problem
more	I-problem
somnolent	I-problem
,	O
this	O
will	O
likely	O
need	O
to	O
be	O
switched	O
to	O
IV	B-treatment
pain	I-treatment
medications	I-treatment
only	O
.	O

Discussion	O
,	O
at	O
that	O
point	O
in	O
time	O
,	O
should	O
occur	O
with	O
the	O
family	O
about	O
comfort	B-treatment
measures	I-treatment
and	O
about	O
weaning	O
him	O
from	O
his	B-treatment
medications	I-treatment
to	O
make	O
him	O
more	O
comfortable	O
.	O

Code	O
status	O
-	O
the	O
patient	O
is	O
a	O
DNR	O
/	O
DNI	O
.	O

This	O
is	O
an	O
unfortunate	O
case	O
but	O
Mr.	O
Po	O
does	O
have	O
an	O
incredibly	O
supportive	O
family	O
who	O
have	O
been	O
here	O
consistently	O
to	O
visit	O
him	O
and	O
that	O
offers	O
him	O
an	O
important	O
source	O
of	O
comfort	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Tylenol	B-treatment
,	O
650	O
mg	O
p.o.	O
q	O
4	O
prn	O
;	O
Allopurinol	B-treatment
,	O
100	O
mg	O
p.o.	O
q.d.	O
;	O
Peridex	B-treatment
mouthwash	I-treatment
,	O
10	O
ml	O
b.i.d.;	O
cholysteramineresin	B-treatment
,	O
4	O
grams	O
p.o.	O
q.d.	O
;	O
clotrimazole	B-treatment
,	O
one	O
troche	O
p.o.	O
q.i.d.	O
;	O
Fentanyl	B-treatment
patch	I-treatment
,	O
100	O
mcg	O
per	O
hour	O
topical	O
q	O
72	O
hours	O
;	O
glipizide	B-treatment
,	O
10	O
mg	O
p.o.	O
q.d.;	O
Atarax	B-treatment
,	O
25	O
operating	O
table	O
50	O
mg	O
p.o.	O
q	O
6	O
to	O
8	O
hours	O
prn	O
itching	B-problem
;	O
regular	B-treatment
sliding	I-treatment
scale	I-treatment
insulin	I-treatment
;	O
KBL	B-treatment
mouthwash	I-treatment
,	O
15	O
ccp	O
.o.	O
q.d.	O
prn	O
mouth	B-problem
discomfort	I-problem
;	O
Lactulose	B-treatment
,	O
30	O
ml	O
p.o.	O
q.i.d.	O
that	O
was	O
started	O
on	O
January	O
30	O
,	O
for	O
no	O
bowel	B-problem
movements	I-problem
with	O
instructions	O
to	O
continue	O
until	O
bowel	O
movement	O
and	O
then	O
decrease	O
to	O
b.i.d.	O
or	O
q.d.	O
;	O
Lidocaine	B-treatment
,	O
2%	O
,	O
10	O
ml	O
UR	O
q	O
3	O
to	O
4	O
hours	O
prn	O
for	O
pain	B-problem
around	I-problem
Foley	I-problem
site	I-problem
;	O
Ativan	B-treatment
,	O
0.25	O
to	O
0.5	O
mg	O
IV	O
q	O
4	O
to	O
6	O
hours	O
prn	O
anxiety	B-problem
with	O
instructions	O
to	O
use	O
caution	O
.	O

The	O
patient	O
gets	O
very	B-problem
somnolent	I-problem
with	O
Ativan	B-treatment
.	O

Maalox	B-treatment
Plus	I-treatment
,	I-treatment
Extra	I-treatment
Strength	I-treatment
,	O
15	O
cc	O
p.o.	O
q	O
6	O
hours	O
prn	O
indigestion	B-problem
;	O
magnesium	B-treatment
sulfate	I-treatment
;	O
sliding	O
scale	O
IV	O
and	O
potassium	B-treatment
chloride	I-treatment
,	O
sliding	O
scale	O
IV	O
.	O

He	O
is	O
also	O
on	O
Reglan	B-treatment
,	O
10	O
mg	O
p.o.	O
q	O
h	O
;	O
Miracle	B-treatment
topical	I-treatment
cream	I-treatment
to	O
affected	B-problem
area	I-problem
;	O
also	O
Sarna	B-treatment
,	I-treatment
topical	I-treatment
cream	I-treatment
,	O
b.i.d.	O

He	O
has	O
Nystatin	B-treatment
suspension	I-treatment
mouthwash	I-treatment
,	O
10	O
cc	O
swish	O
and	O
swallow	O
q.i.d.	O
He	O
gets	O
Serax	B-treatment
,	O
15	O
to	O
30	O
mg	O
p.o.	O
q	O
h.s.	O
prni	O
nsomnia	B-problem
.	O

Ocean	B-treatment
Spray	I-treatment
q.i.d.	O
to	O
nares	O
prn	O
nasal	B-problem
dryness	I-problem
.	O

Multivitamin	B-treatment
,	O
one	O
tab	O
q.d.	O
Morphine	B-treatment
immediate	I-treatment
release	I-treatment
,	O
MSIR	B-treatment
,	O
15	O
to	O
30	O
mg	O
p.o.	O
q	O
2	O
to	O
3	O
hours	O
prn	O
pain	B-problem
.	O

He	O
is	O
also	O
on	O
a	B-treatment
Fentanyl	I-treatment
patch	I-treatment
,	O
100	O
mcg	O
q	O
72	O
hours	O
.	O

The	B-treatment
morphine	I-treatment
is	O
for	O
breakthrough	B-problem
pain	I-problem
.	O

Hydrocortisone	B-treatment
,	O
1%	O
topical	O
cream	O
q	O
6	O
to	O
8	O
hours	O
prn	O
itching	B-problem
.	O

Levofloxacin	B-treatment
,	O
250	O
mg	O
p.o.	O
q.d.	O
;	O
Albuterol	B-treatment
and	I-treatment
Atrovent	I-treatment
nebs	I-treatment
q	O
4	O
to6	O
hours	O
as	O
needed	O
prn	O
wheeze	B-problem
.	O

PLAN	O
FOR	O
FOLLOWUP	O
:	O

Follow	O
up	O
will	O
be	O
with	O
Dr.	O
A	O
Flow	O
from	O
Stromware	O
St.	O
,	O
Balt	O
who	O
is	O
the	O
patient	O
&apos;s	O
primary	O
oncologist	O
there	O
.	O

Dictated	O
By	O
:	O

JIMCHARL	O
B.	O
VERGEFLOW	O
,	O
M.D.	O
XX14	O

Attending	O
:	O

LUPEVICKETTE	O
FLOW	O
,	O
M.D.	O
YA80	O
QO567/192247	O

Batch	O
:	O

8798	O

Index	O
No.	O

QFQYRB7	O
AGG	O

D	O
:	O

01/30/01	O

T	O
:	O

01/30/01	O

638157550	O
SC	O

97308722	O

6261929	O

1/22/2005	O
12:00:00	O
AM	O

gastritis	B-problem

DIS	O

Admission	O
Date	O
:	O

01/22/2005	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

01/24/2005	O

******	O
DISCHARGE	O
ORDERS	O
******	O

AKOTE	O
,	O
NAO	O
630-65-64-5	O
Q39	O

Room	O
:	O

70B-157	O

Service	O
:	O

GGI	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

01/24/05	O
AT	O
07:00	O
PM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

GAETZFREIERM	O
,	O
DENA	O
DA	O
,	O
M.D.	O

CODE	O
STATUS	O
:	O

Full	O
code	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

AMOXICILLIN	B-treatment
1,000	O
MG	O
PO	O
BID	O
X	O
28	O
doses	O

Instructions	O
:	O

for	O
H.Pylori	B-problem
.	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

May	O
be	O
taken	O
without	O
regard	O
to	O
meals	O

CLARITHROMYCIN	B-treatment
500	O
MG	O
PO	O
BID	O
X	O
28	O
doses	O

Instructions	O
:	O

h.pylori	B-treatment
tx	I-treatment
.	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Take	O
with	O
food	O

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
01/23/05	O
by	O
DAINSAYLESNOORT	O
,	O
AGER	O
,	O
M.D.	O
,	O
PH.D.	O

SERIOUS	O
INTERACTION	O
:	O

SIMVASTATIN	B-treatment
and	O
CLARITHROMYCIN	B-treatment

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

SIMVASTATIN	B-treatment
and	O
CLARITHROMYCIN	B-treatment

Reason	O
for	O
override	O
:	O

will	O
monitor	O
.	O

HYDROCHLOROTHIAZIDE	B-treatment
25	O
MG	O
PO	O
QD	O
ZOCOR	B-treatment
(	I-treatment
SIMVASTATIN	I-treatment
)	I-treatment
40	O
MG	O
PO	O
QHS	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Avoid	O
grapefruit	O
unless	O
MD	O
instructs	O
otherwise	O
.	O

Override	O
Notice	O
:	O

Override	O
added	O
on	O
01/23/05	O
by	O
DAINSAYLESNOORT	O
,	O
AGER	O
,	O
M.D.	O
,	O
PH.D.	O
on	O
order	O
for	O
CLARITHROMYCIN	B-treatment
PO	I-treatment
(	O
ref	O
#	O
99052380	O
)	O

SERIOUS	O
INTERACTION	O
:	O

SIMVASTATIN	B-treatment
and	O
CLARITHROMYCIN	B-treatment

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

SIMVASTATIN	B-treatment
and	O
CLARITHROMYCIN	B-treatment

Reason	O
for	O
override	O
:	O

will	O
monitor	O
.	O

POTASSIUM	B-treatment
CHLORIDE	I-treatment
SLOW	I-treatment
REL.	I-treatment
(	I-treatment
KCL	I-treatment
SLOW	I-treatment
RELEASE	I-treatment
)	I-treatment
40	O
MEQ	O
PO	O
QD	O
As	O
per	O
SC	O

Potassium	O
Chloride	O
Policy	O
:	O

each	O
20	O
mEq	O
dose	O
to	O
be	O
given	O
with	O
4	O
oz	O
of	O
fluid	O
COZAAR	B-treatment
(	I-treatment
LOSARTAN	I-treatment
)	I-treatment
50	O
MG	O
PO	O
QD	O

Number	O
of	O
Doses	O
Required	O
(	O
approximate	O
)	O
:	O

2	O

LAMICTAL	B-treatment
(	I-treatment
LAMOTRIGINE	I-treatment
)	I-treatment
150	O
MG	O
PO	O
BID	O

Number	O
of	O
Doses	O
Required	O
(	O
approximate	O
)	O
:	O

5	O

WELLBUTRIN	B-treatment
SR	I-treatment
(	I-treatment
BUPROPION	I-treatment
HCL	I-treatment
SUSTAINED	I-treatment
RELEASE	I-treatment
)	I-treatment
200	O
MG	O
PO	O
BID	O

Number	O
of	O
Doses	O
Required	O
(	O
approximate	O
)	O
:	O

4	O

ESOMEPRAZOLE	B-treatment
20	O
MG	O
PO	O
BID	O
X	O
28	O
doses	O

Instructions	O
:	O

H.	B-treatment
Pylori	I-treatment
tx	I-treatment
.	O

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Resume	O
regular	O
exercise	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Dr.	O
Gaetzfreierm	O
1-2	O
weeks	O
,	O

ALLERGY	O
:	O

PERCOCET	B-treatment
,	O
IV	B-treatment
Contrast	I-treatment
,	O
LISINOPRIL	B-treatment
,	O
ATENOLOL	B-treatment

ADMIT	O
DIAGNOSIS	O
:	O

Gastritis	B-problem

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O
Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
gastritis	B-problem

OTHER	O
DIAGNOSIS	O
;	O
Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
Obesity	B-problem
HTN	B-problem
High	B-problem
Cholesterol	I-problem
Tobacco	O
Fhx	O
of	O
CAD	B-problem
ETT	B-treatment
12/94	O
(	O
-	O
)	O
ischemia	B-problem
ECHO	B-test
02/89	O
nl	B-test
ETT	I-test
03/89	O
,	O
07/90	O
c	O
/	O
w	O
ND	B-problem
ische	I-problem

Takes	O
hubby	O
&apos;s	O
sl	B-treatment
ntg	I-treatment
Barium	B-test
Swallow	I-test
04/89	O
(	O
-	O
)	O
UGI	B-test
06/91	O
(	O
-	O
)	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

MRI	B-test
HIDA	B-test
CT	B-test

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

The	O
pt	O
is	O
a	O
55yo	O
F	O
s	O
/	O
p	O
Roux	B-treatment
en	I-treatment
Y	I-treatment
GBP	I-treatment
in	O
12/20	O
presenting	O
to	O
the	O
ED	O
this	O
AM	O
c	O
/	O
o	O
mod	B-problem
severe	I-problem
midepigastric	I-problem
pain	I-problem
.	O

She	O
notes	O
that	O
she	O
has	O
had	O
this	B-problem
pain	I-problem
since	O
Thursday	O
,	O
and	O
that	O
it	O
becomes	O
much	O
worse	O
within	O
15	O
min	O
of	O
consuming	O
a	O
meal	O
.	O

She	O
has	O
also	O
had	O
intermittent	B-problem
post-prandial	I-problem
nausea	I-problem
/	I-problem
satiety	I-problem
for	O
which	O
she	O
had	O
been	O
scheduled	O
for	O
an	B-test
outpt	I-test
EGD	I-test
with	O
GI	B-test
on	O
2/8	O
.	O

She	O
describes	O
the	B-problem
pain	I-problem
as	O
band-like	O
/	O
radiating	O
to	O
both	O
sides	O
but	O
not	O
the	O
back	O
.	O

Her	B-problem
pain	I-problem
currently	O
is	O
5/10	O
.	O

ROS	O
(	O
-	O
)	O
emesis	B-problem
/	O
BRBPR/melena	B-problem
/	O
fever/chills	B-problem
/	O
sob	B-problem
.	O

Pt	O
was	O
seen	O
by	O
GI	O
on	O
13	O
EGD	B-test
was	O
performed	O
HD2	O
which	O
was	O
negative	O
for	O
gastritis	B-problem
,	O
stricture	B-problem
or	O
ulcer	B-problem
.	O

Pt	O
was	O
found	O
to	O
be	O
H.	B-problem
Pylori	I-problem
positive	I-problem
and	O
therefore	O
was	O
started	O
on	O
empiric	B-treatment
treatment	I-treatment
.	O

Afferent	O
limb	O
of	O
the	O
roux	B-treatment
en	I-treatment
y	I-treatment
anastamosis	I-treatment
was	O
visualized	O
however	O
the	O
efferent	O
limb	O
could	O
not	O
be	O
explored	O
.	O

Pt	O
had	O
HIDA	B-test
scan	I-test
which	O
was	O
negative	O
for	O
obstruction	B-problem
,	O
and	O
CT	B-test
was	O
unremarkable	O
.	O

Pt	O
was	O
tolerating	O
regular	O
diet	O
by	O
HD4	O
,	O
and	O
GI	O
felt	O
that	O
further	B-test
workup	I-test
could	O
be	O
continued	O
as	O
an	O
outpatient	O
.	O

Pt	O
was	O
therefore	O
discharged	O
home	O
in	O
stable	O
condition	O
,	O
voiding	O
,	O
ambulating	O
and	O
eating	O
without	O
difficulty	O
.	O

Plans	O
to	O
follow	O
up	O
with	O
outpatient	B-test
MRA	I-test
to	O
rule	O
out	O
ischemic	O
causes	O
of	O
post	B-problem
prandial	I-problem
pain	I-problem
,	O
as	O
well	O
as	O
HIDA	B-test
with	I-test
CK	I-test
challenge	I-test
to	O
evaluate	O
for	O
biliary	B-problem
dyskinesia	I-problem
without	O
stasis	O
.	O

Pt	O
will	O
finish	O
course	O
of	O
H.	B-treatment
pylori	I-treatment
treatment	I-treatment
as	O
well	O
.	O

ADDITIONAL	O
COMMENTS	O
:	O

If	O
fevers	B-problem
,	O
chills	B-problem
,	O
nausea	B-problem
,	O
vomiting	B-problem
,	O
diarrhea	B-problem
,	O
increasing	B-problem
pain	I-problem
with	I-problem
food	I-problem
please	O
call	O
Dr.	O
Gaetzfreierm	O
&apos;s	O
office	O
or	O
PCP	O
.	O

If	O
severe	O
,	O
then	O
proceed	O
to	O
ER	O
for	O
evaluation	B-test
.	O

Will	O
need	O
to	O
call	O
for	O
outpatient	O
MRA	B-test
and	O
HIDA	B-test
with	I-test
CCK	I-test
challenge	I-test
to	O
evaluate	O
biliary	O
system	O
and	O
mesenteric	O
vasculature	O
.	O

Please	O
continue	O
taking	O
the	B-treatment
antibiotics	I-treatment
for	O
H.	B-problem
Pylori	I-problem
for	O
full	O
course	O
(	O
26	O
more	O
days	O
)	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

DOUETSHUFF	O
,	O
DE	O
CLEEE	O
,	O
M.D.	O
(	O
CP85	O
)	O
01/24/05	O
06:53	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

641557794	O
WGH	O

1460214	O

715884	O

957382	O

5/29/2000	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

FREIERMPRATL	O
,	O
NI	O
L	O

UNIT	O
NUMBER	O
:	O

794-23-29	O

ADMISSION	O
DATE	O
:	O

05/29/2000	O

DISCHARGE	O
DATE	O
:	O

05/30/2000	O

PRINCIPAL	O
DIAGNOSIS	O
:	O
:	O

Non-toxic	B-problem
multinodular	I-problem
goiter	I-problem
.	O

ASSOCIATED	O
DIAGNOSES	O
;	O

Left	B-problem
thyroid	I-problem
occult	I-problem
papillary	I-problem
carcinoma	I-problem
.	O

Chronic	B-problem
lymphocytic	I-problem
thyroiditis	I-problem
,	O
status	O
post	O
right	B-treatment
total	I-treatment
and	I-treatment
left	I-treatment
subtotal	I-treatment
oophorectomy	I-treatment
,	O
asthma	B-problem
,	O
migraine	B-problem
,	O
history	O
of	O
Droperidol	B-problem
allergy	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O
:	O

5-29-00	O
:	O

Thyroidectomy	B-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
51	O
year-old	O
female	O
,	O
with	O
a	B-problem
non-toxic	I-problem
multinodular	I-problem
goiter	I-problem
.	O

She	O
has	O
developed	O
symptoms	B-problem
from	O
a	B-problem
right	I-problem
lower	I-problem
dominant	I-problem
nodule	I-problem
with	O
pressure	B-problem
discomfort	I-problem
in	I-problem
the	I-problem
neck	I-problem
.	O

She	O
has	O
no	O
dyspnea	B-problem
or	O
dysphagia	B-problem
.	O

She	O
is	O
euthyroid	O
.	O

There	O
is	O
no	O
family	O
history	O
of	O
thyroid	B-problem
cancer	I-problem
.	O

She	O
has	O
not	O
received	O
prior	B-treatment
radiation	I-treatment
exposure	I-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O
:	O

On	O
physical	B-test
exam	I-test
,	O
she	O
is	O
a	O
healthy-appearing	O
female	O
with	O
a	O
normal	O
voice	O
and	O
no	O
exophthalmos	B-problem
.	O

Vital	B-test
Signs	I-test
:	O

include	O
a	B-test
blood	I-test
pressure	I-test
of	O
174/84	O
,	O
respirations	B-test
14	O
,	O
pulse	B-test
89	O
,	O
temperature	B-test
98.9	O
,	O
O2	B-test
sat	I-test
98%	O
.	O

Pupils	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
and	O
accommodation	O
,	O
and	O
extraocular	O
movements	O
intact	O
.	O
,	O
with	O
a	O
benign	O
oropharynx	O
.	O

Palpation	B-test
of	O
the	O
neck	O
discloses	O
a	B-problem
multinodular	I-problem
goiter	I-problem
,	O
larger	O
on	O
the	O
right	O
side	O
,	O
with	O
no	O
associated	B-problem
cervical	I-problem
lymphadenopathy	I-problem
.	O

Carotid	O
pulsations	O
are	O
normal	O
without	O
bruit	B-problem
.	O

Lungs	O
:	O

clear	O
to	O
auscultation	B-test
and	O
percussion	B-test
.	O

Bilaterally	O
without	O
stridor	B-problem
.	O

Her	B-test
heart	I-test
rhythm	I-test
is	O
regular	O
with	O
a	O
normal	O
S1-S2	O
,	O
and	O
no	O
murmur	B-problem
.	O

Abdomen	O
is	O
soft	O
,	O
non-tender	B-problem
,	O
with	O
no	O
organomegaly	B-problem
or	O
masses	B-problem
.	O

Her	B-test
deep	I-test
tendon	I-test
reflexes	I-test
are	O
symmetric	O
.	O

HOSPITAL	O
COURSE	O
:	O

On	O
5-29-00	O
,	O
she	O
underwent	O
thyroidectomy	B-treatment
with	O
removal	B-treatment
of	O
a	B-problem
3.3	I-problem
centimeter	I-problem
right	I-problem
lobe	I-problem
microfollicular	I-problem
adenoma	I-problem
and	O
left	O
lobe	O
6	O
mm	O
.	O

papillary	B-problem
carcinoma	I-problem
.	O

There	O
was	O
no	O
evidence	O
of	O
any	B-problem
middle	I-problem
compartment	I-problem
lymphadenopathy	I-problem
or	O
spread	O
of	O
the	B-problem
tumor	I-problem
outside	O
the	O
thyroid	O
.	O

She	O
had	O
an	O
uncomplicated	O
postoperative	O
recovery	O
period	O
.	O

Her	B-treatment
sutures	I-treatment
were	O
removed	O
on	O
postoperative	O
day	O
#	O
one	O
,	O
at	O
which	O
time	O
she	O
went	O
home	O
in	O
satisfactory	O
condition	O
.	O

DOCTOR	O
&apos;S	O
DISCHARGE	O
ORDERS	O
:	O

1.	O
Synthroid	B-treatment
0.125	O
mg.	O
daily	O
.	O

2.	O
She	O
will	O
see	O
Dr.	O
Days	O
in	O
his	O
office	O
in	O
two	O
weeks	O
.	O

3.	O
She	O
will	O
remove	O
the	B-treatment
neck	I-treatment
suture	I-treatment
lines	I-treatment
Steri-Strips	I-treatment
in	O
10	O
days	O
.	O

STELLRISH	O
L.	O
LIGHT	O
,	O
M.D.	O

Cc	O
:	O

Stellrish	O
L.	O
Days	O
,	O
M.D.	O
(	O
3	O
copies	O
)	O

Electronically	O
Signed	O
STELLRISH	O
LOISRA	O
LIGHT	O
,	O
M.D.	O
09/06/2000	O
04:20	O

TR	O
:	O

jrn	O

DD	O
:	O

08/16/2000	O

TD	O
:	O

08/20/2000	O
9:25	O
A	O

cc	O
:	O

STELLRISH	O
LOISRA	O
LIGHT	O
,	O
M.D.	O

655358166	O
WGH	O

5367777	O

33714	O

8114836	O

10/12/2004	O
12:00:00	O
AM	O

OB	O
Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O
OB	O
EMR	O
L	O
and	O
D	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

JUARISY	O
DUHESMITRE	O

UNIT	O
NUMBER	O
:	O

683-54-33	O

ADMISSION	O
DATE	O
:	O

20041012	O

DISCHARGE	O
DATE	O
:	O

20041015	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
:	O

Vaginal	B-treatment
Delivery	I-treatment
With	O
Second	B-problem
Degree	I-problem
Laceration	I-problem

ASSOCIATED	O
DIAGNOSES	O
:	O

Abnormal	B-problem
Pap	I-problem
Test	I-problem
,	O
history	O
of	O
;	O
Bacterial	B-problem
Vaginitis	I-problem
;	O
Contraception	B-treatment
Management	I-treatment
;	O
Hiv	O
Counseled	O

PRINCIPAL	O
PROCEDURE	O
OR	O
OPERATION	O
:	O

Spontaneous	B-treatment
Vertex	I-treatment
Vaginal	I-treatment
Delivery	I-treatment

ASSOCIATED	O
PROCEDURES	O
OR	O
OPERATIONS	O
:	O

POSTPARTUM	O
DIAGNOSTIC	O
PROCEDURES	O
:	O

None	O

OTHER	O
POSTPARTUM	O
THERAPIES	O
:	O

Antimicrobial	B-treatment
Therapy	I-treatment

HISTORY	O
AND	O
REASON	O
FOR	O
HOSPITALIZATION	O
:	O

Srom	B-problem
In	O
Labor	B-problem

PHYSICAL	O
EXAMINATION	O
:	O

MOUTH	O
NORMAL	O
NECK	O
NORMAL	O
thyroid	O
wnl	O
BREASTS	O
NORMAL	O
no	O
distinct	B-problem
masses	I-problem
NIPPLES	O
NORMAL	O
inverted	B-problem
[	O
b	O
]	O
,	O
evert	B-treatment
w	I-treatment
/	I-treatment
stimulation	I-treatment
CHEST	O
NORMAL	O
LCTA	O
COR	O
NORMAL	O
RRR	O
ABDOMEN	O
NORMAL	O
gravid	O
EXTREM	O
NORMAL	O
SKIN	O
NORMAL	O
NODES	O
NORMAL	O
VULVA	O
NORMAL	O
no	O
lesions	B-problem
,	O
white	B-problem
d	I-problem
/	I-problem
c	I-problem
at	I-problem
introitus	I-problem
VAGINA	O
NORMAL	O
sml	B-problem
amt	I-problem
thin	I-problem
white	I-problem
d	I-problem
/	I-problem
c	I-problem
ph	B-test
4.5	O
,	O
koh	B-test
+amine	O
,	O
NS	B-test
+clue	O
,	O
neg	O
trich	O
CERVIX	O
NORMAL	O
1/100/0	O
srom	B-problem
clear	O
OS	O
NORMAL	O
closed	O
ADNEXAE	O
NORMAL	O
no	O
palp	B-problem
masses	I-problem
,	O
NT	O
UTERUS	O
NORMAL	O
gravid	O
UTERINE	O
SIZE	O
IN	O
WEEKS	O
NORMAL	O
term	O
RECTUM	O
NORMAL	O
no	O
ext	B-problem
lesions	I-problem

HOSPITAL	O
COURSE	O
(	O
include	O
complications	O
if	O
any	O
)	O
:	O

This	O
21	O
year	O
old	O
Gravida	O
2	O
Para	O
0010	O
was	O
admitted	O
to	O
the	O
Life	O
Valley	O
Medical	O
Center	O
Obstetrical	O
service	O
on	O
10/12/2004	O
at	O
08:41	O
am	O
for	O
the	O
indication	O
(	O
s	O
)	O
:	O

srom	B-problem
in	O
labor	B-problem
.	O

She	O
delivered	O
a	O
3680	O
gram	O
male	O
infant	O
on	O
10/12/2004	O
at	O
10:17	O
pm	O
with	O
apgar	B-test
scores	I-test
of	O
9	O
and	O
9	O
at	O
one	O
and	O
five	O
minutes	O
respectively	O
at	O
40.0	O
weeks	O
gestation	O
via	O
spontaneous	B-treatment
vertex	I-treatment
vaginal	I-treatment
delivery	I-treatment
.	O

During	O
her	O
labor	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

srom	B-problem
.	O

During	O
her	O
delivery	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

none	O
.	O

Postpartum	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

none	O
.	O

She	O
was	O
discharged	O
on	O
10/15/2004	O
at	O
01:52	O
pm	O
in	O
good	O
condition	O
.	O

DISCHARGE	O
ACTIVITY	O
:	O

No	O
Restrictions	O

DISCHARGE	O
DIET	O
:	O

No	O
Restrictions	O

POSTPARTUM	O
DISPOSITION	O
:	O

Home	O
Under	O
Care	O
Of	O
Home	O
Health	O
Agency	O

POSTPARTUM	O
CARE	O
SITE	O
:	O

Alle	O
Rehabilitation	O
Hospital	O

POSTPARTUM	O
RETURN	O
APPOINTMENT	O
(	O
DAYS	O
)	O
:	O

42	O

BREAST	O
FEEDING	O
AT	O
DISCHARGE	O
:	O

Yes	O

MEDICATION	O
(	O
S	O
)	O
ON	O
DISCHARGE	O
:	O

Metronidazole	B-treatment
Tablets	I-treatment
(	I-treatment
Flagyl	I-treatment
)	I-treatment
;	O
Multivitamins	B-treatment
And	I-treatment
Folate	I-treatment
Capsules	I-treatment
(	I-treatment
Stuart	I-treatment
Prenatal	I-treatment
With	I-treatment
Folate	I-treatment
)	I-treatment

Electronically	O
Signed	O
:	O

Thorerogodlethrelf	O
,	O
Cisperna	O
M	O
10/17/2004	O
6:01:02	O
PM	O

688127038	O
EH	O

47449520	O

204512	O

3/5/2002	O
12:00:00	O
AM	O

TCA	B-problem
overdose	I-problem

DIS	O

Admission	O
Date	O
:	O

03/05/2002	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

03/07/2002	O

******	O
DISCHARGE	O
ORDERS	O
******	O

HULLEKOTE	O
,	O
AU	O
329-72-53-3	O
Z23	O

Room	O
:	O

29Z-191	O

Service	O
:	O

MED	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

03/07/02	O
AT	O
11:00	O
AM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

UPHMADRE	O
,	O
CIOUSALE	O
N.	O
,	O
M.D.	O

CODE	O
STATUS	O
:	O

Full	O
code	O

DISPOSITION	O
:	O

Rehabilitation	B-treatment

DISCHARGE	O
MEDICATIONS	O
:	O

FOLATE	B-treatment
(	I-treatment
FOLIC	I-treatment
ACID	I-treatment
)	I-treatment
1	O
MG	O
PO	O
QD	O
ZANTAC	B-treatment
(	I-treatment
RANITIDINE	I-treatment
HCL	I-treatment
)	I-treatment
150	O
MG	O
PO	O
BID	O
MVI	B-treatment
THERAPEUTIC	I-treatment
W	I-treatment
/	I-treatment
MINERALS	I-treatment
(	I-treatment
THERAP	I-treatment
VITS	I-treatment
/	I-treatment
MINERALS	I-treatment
)	I-treatment
1	O
TAB	O
PO	O
QD	O
THIAMINE	B-treatment
HCL	I-treatment
100	O
MG	O
PO	O
QD	O

DIET	O
:	O

No	O
Restrictions	O
Activity	O
-	O
As	O
tolerated	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Dr.	O
Ee	O
,	O
patient	O
to	O
arrange	O
,	O
No	O
Known	B-problem
Allergies	I-problem

ADMIT	O
DIAGNOSIS	O
:	O

TCA	B-problem
overdose	I-problem

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O
Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
TCA	B-problem
overdose	I-problem

OTHER	O
DIAGNOSIS	O
;	O
Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
depression	B-problem
(	I-problem
depression	I-problem
)	I-problem

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

None	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

32	O
y	O
/	O
o	O
woman	O
with	O
h	O
/	O
o	O
anxiety	B-problem
and	O
depression	B-problem
and	O
prior	B-problem
suicide	I-problem
attempt	I-problem
presents	O
with	O
TCA	B-problem
and	I-problem
celexa	I-problem
overdose	I-problem
,	O
tremulous	B-problem
/	O
light-headed	B-problem
,	O
felt	O
better	O
post	O
charcoal	B-treatment
.	O

No	O
EKG	O
changes	O
,	O
marijuana	B-test
in	I-test
urine	I-test
,	O
HCO3	B-test
22	O
.	O

Transferred	O
to	O
floor	O
on	O
day	O
of	O
admission	O
with	O
no	O
acute	B-problem
medical	I-problem
issues	I-problem
;	O
awaiting	O
psych	B-test
eval	I-test
.	O

Not	O
actively	B-problem
suicidal	I-problem
.	O

3/7	O
--	O
repeat	B-test
HCO3	I-test
24	O
and	O
26	O
without	O
bicarb	B-treatment
drip	I-treatment
.	O

EKG	B-test
without	O
changes	O
.	O

Patient	O
felt	O
well	O
,	O
tolerating	O
POs	O
.	O

BEST	B-test
team	I-test
eval	I-test
found	O
bed	O
at	O
psych	O
rehab	O
facility	O
.	O

OF	O
NOTE	O
,	O
Nortriptyline	B-test
level	I-test
came	O
back	O
as	O
43	O
(	O
SUBTHERAPEUTIC	O
--	O
NORMAL	O
50-150	O
)	O
.	O

ADDITIONAL	O
COMMENTS	O
:	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

KOTEKEESECRANKBERF	O
,	O
LA	O
A.	O
,	O
M.D.	O
(	O
JG92	O
)	O
03/07/02	O
10:56	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

693008750	O

HLGMC	O

6001356	O

014235	O

9/18/2001	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

HUHTLAND	O
,	O
CIE	O

MRN	O
:	O

6001356	O

Age	O
:	O

82y	O

REGISTRATION	O
DATE	O
:	O

09/18/2001	O
10:52	O
AM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
HUHTLAND	O
,	O
CIE	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Heaonboburg	O
Linpack	O
Grant	O
Medical	O
Center	O
on	O
09/18/2001	O
10:52	O
AM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
WHEEZES	B-problem
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
HEAONBOBURG	O
LINPACK	O
GRANT	O
MEDICAL	O
CENTER	O
.	O

Your	O
patient	O
was	O
admitted	O
under	O
the	O
care	O
of	O
SAPSCLYSS	O
,	O
LEO	O
R	O
with	O
a	O
preliminary	O
diagnosis	O
of	O
PNEUMONIA	B-problem
,	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
605-304-8547	O
.	O

PCP	O
Name	O
:	O

SC	O
,	O
JUSONKIM	O
N	O

Provider	O
Number	O
:	O

96078	O

699905656	O
SC	O

06100044	O

921737	O

1/17/1993	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

01/17/1993	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

01/21/1993	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
RIGHT	B-treatment
SIDED	I-treatment
SCIATICA	I-treatment
PROCEDURE	I-treatment
:	O

Right	B-treatment
laminectomy	I-treatment
and	O
discectomy	B-treatment
by	O
Dr.	O
Small	O
,	O
Neurosurgery	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
42	O
year	O
old	O
gentleman	O
who	O
suffered	O
lower	B-problem
back	I-problem
pain	I-problem
during	O
an	O
accident	O
at	O
work	O
in	O
1990	O
.	O

This	O
gradually	O
increased	O
until	O
June	O
1992	O
where	O
he	O
had	O
recurrent	B-problem
severe	I-problem
right	I-problem
sided	I-problem
sciatica	I-problem
.	O

In	O
September	O
1992	O
CT	B-test
myelogram	I-test
showed	O
a	B-problem
lateral	I-problem
L-1	I-problem
S-1	I-problem
disc	I-problem
bulge	I-problem
and	O
small	B-problem
L-4-4	I-problem
bulge	I-problem
.	O

He	O
has	O
had	O
no	O
change	O
in	O
pain	B-problem
in	O
the	O
last	O
few	O
months	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Negative	O
.	O

ALLERGIES	O
:	O

None	O
.	O

MEDICATIONS	O
:	O

None	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

He	O
was	O
found	O
to	O
be	O
healthy	O
.	O

His	B-test
examination	I-test
was	O
completely	O
unremarkable	O
.	O

He	O
had	O
5	O
out	O
of	O
5	O
strength	O
diffusely	O
,	O
normal	O
deep	O
tendon	O
reflexes	O
and	O
normal	O
sensation	O
.	O

HOSPITAL	O
COURSE	O
:	O

He	O
was	O
admitted	O
,	O
taken	O
to	O
the	O
operating	O
room	O
where	O
he	O
underwent	O
L5-S1	B-treatment
right	I-treatment
hemilaminectomy	I-treatment
and	O
discectomy	B-treatment
.	O

He	O
tolerated	O
the	O
procedure	O
well	O
,	O
was	O
taken	O
to	O
the	O
floor	O
in	O
stable	O
condition	O
.	O

Over	O
the	O
next	O
three	O
days	O
he	O
increased	O
his	O
activity	O
gradually	O
,	O
was	O
able	O
to	O
do	O
stairs	O
with	O
Physical	B-treatment
Therapy	I-treatment
and	O
had	O
pain	B-problem
which	O
could	O
be	O
controlled	O
with	O
oral	B-treatment
analgesics	I-treatment
.	O

DISPOSITION	O
:	O

MEDICATIONS	O
:	O

He	O
is	O
discharged	O
on	O
Percocet	B-treatment
,	O
Colace	B-treatment
and	O
Motrin	B-treatment
.	O

Dictated	O
By	O
:	O

NASA	O
R.	O
SMALL	O
,	O
M.D.	O
IX97	O

Attending	O
:	O

VIENNIEZUTACHANT	O
WAVE	O
,	O
M.D.	O
NN08	O
QM838/6096	O

Batch	O
:	O

8704	O

Index	O
No.	O
AFUFB928WZ	O

D	O
:	O

01/20/93	O

T	O
:	O

01/22/93	O

708739405	O
DH	O

0606127	O

65761	O

4209641	O

10/29/2003	O
12:00:00	O
AM	O

OB	O
Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O
OB	O
EMR	O
L	O
and	O
D	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

SYSCO	O
TAMARCE	O
DOSE	O

UNIT	O
NUMBER	O
:	O

372-13-02	O

ADMISSION	O
DATE	O
:	O

20031029	O

DISCHARGE	O
DATE	O
:	O

20041101	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
:	O

Normal	B-treatment
Vaginal	I-treatment
Delivery	I-treatment

ASSOCIATED	O
DIAGNOSES	O
:	O

Current	O
Smoker	O
,	O
history	O
of	O
;	O
Depression	B-problem
,	O
history	O
of	O
;	O
Isoimmunization	B-problem
,	I-problem
Rh	I-problem
;	O
Undesired	B-problem
Fertility	I-problem

PRINCIPAL	O
PROCEDURE	O
OR	O
OPERATION	O
:	O

Spontaneous	B-treatment
Vertex	I-treatment
Vaginal	I-treatment
Delivery	I-treatment

ASSOCIATED	O
PROCEDURES	O
OR	O
OPERATIONS	O
:	O

POSTPARTUM	O
DIAGNOSTIC	O
PROCEDURES	O
:	O

None	O

POSTPARTUM	O
THERAPEUTIC	O
PROCEDURES	O
:	O

None	O

OTHER	O
POSTPARTUM	O
THERAPIES	O
:	O

Pp	B-treatment
Sterilization	I-treatment

HISTORY	O
AND	O
REASON	O
FOR	O
HOSPITALIZATION	O
:	O

Early	B-problem
Labor	I-problem
/	O
Rule	O
Out	O
Labor	B-problem

PHYSICAL	O
EXAMINATION	O
:	O

HEIGHT	O
HOSPITAL	O
COURSE	O
(	O
include	O
complications	O
if	O
any	O
)	O
:	O

This	O
22	O
year	O
old	O
Gravida	O
4	O
Para	O
2012	O
was	O
admitted	O
to	O
the	O
Naliheall	O
County	O
Memorial	O
Hospital	O
Obstetrical	O
service	O
on	O
10/29/2003	O
at	O
11:14	O
pm	O
for	O
the	O
indication	O
(	O
s	O
)	O
:	O
early	B-problem
labor	I-problem
/	O
rule	O
out	O
labor	B-problem
.	O

She	O
delivered	O
a	O
3263	O
gram	O
female	O
infant	O
on	O
10/30/2003	O
at	O
05:03	O
am	O
with	O
apgar	B-test
scores	I-test
of	O
8	O
and	O
9	O
at	O
one	O
and	O
five	O
minutes	O
respectively	O
at	O
40.1	O
weeks	O
gestation	O
via	O
spontaneous	B-treatment
vertex	I-treatment
vaginal	I-treatment
delivery	I-treatment
.	O

During	O
her	O
labor	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

none	O
.	O

During	O
her	O
delivery	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

nuchal	B-problem
cord	I-problem
,	O
x	O
1-	O
reduced	O
prior	O
to	O
delivery	B-treatment
.	O

Postpartum	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

none	O
.	O

She	O
was	O
discharged	O
on	O
11/01/2004	O
at	O
12:00	O
pm	O
in	O
good	O
condition	O
.	O

DISCHARGE	O
ORDERS	O
(	O
medications	B-treatment
instructions	O
to	O
patient	O
,	O
follow-up	O
care	O
)	O
:	O

DISCHARGE	O
ACTIVITY	O
:	O

No	O
Restrictions	O

DISCHARGE	O
DIET	O
:	O

No	O
Restrictions	O

POSTPARTUM	O
DISPOSITION	O
:	O

Home	O
With	O
Self-Care	B-treatment
(	O
Routine	O
Discharge	O
)	O

POSTPARTUM	O
CARE	O
SITE	O
:	O

Uval	O
General	O
Hospital	O

POSTPARTUM	O
RETURN	O
APPOINTMENT	O
(	O
DAYS	O
)	O
:	O

42	O

BREAST	O
FEEDING	O
AT	O
DISCHARGE	O
:	O

No	O

POSTPARTUM	O
RH	O
IMMUNE	O
GLOBULIN	O
:	O

Given	O

POSTPARTUM	O
MEASLES	O
/	O
MUMPS/RUBELLA	O
VACCINE	O
:	O

Not	O
Indicated	O

MEDICATION	O
(	O
S	O
)	O
ON	O
DISCHARGE	O
:	O

Multivitamins	B-treatment
And	O
Folate	B-treatment

Electronically	O
Signed	O
:	O

Ockgiernruss	O
,	O
Riret	O
R	O
12/18/2003	O
7:53:30	O
PM	O

723989226	O

OMH	O

6410178	O

996067	O

3/30/1999	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

NETSHUFFSCARVTRACE	O
,	O
RIRA	O

UNIT	O
NUMBER	O
:	O

005-27-20	O

ADMISSION	O
DATE	O
:	O

03/30/1999	O

DISCHARGE	O
DATE	O
:	O

09/16/2006	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Severe	B-problem
chronic	I-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
.	O

Respiratory	B-problem
failure	I-problem
.	O

Congestive	B-problem
heart	I-problem
failure	I-problem
.	O

Right	B-problem
lower	I-problem
lobe	I-problem
pneumonia	I-problem
.	O

Atonic	B-problem
bladder	I-problem
with	O
suprapubic	B-treatment
catheter	I-treatment
.	O

Anxiety	B-problem
.	O

Coronary	B-problem
artery	I-problem
disease	I-problem
.	O

History	O
of	O
colon	B-problem
cancer	I-problem
status	O
post	O
hemicolectomy	B-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
76	O
year	O
old	O
white	O
male	O
with	O
severe	B-problem
chronic	I-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
who	O
has	O
had	O
several	O
recent	O
admissions	O
to	O
Oaksgekesser/	O
Memorial	O
Hospital	O
for	O
respiratory	B-problem
insuffiencey	I-problem
most	O
often	O
secondary	O
to	O
pneumonia	B-problem
.	O

He	O
was	O
most	O
recently	O
discharged	O
from	O
Oaksgekesser/	O
Memorial	O
Hospital	O
on	O
03/06/99	O
and	O
was	O
then	O
transferred	O
to	O
Linghs	O
County	O
Medical	O
Center	O
from	O
which	O
he	O
was	O
discharged	O
on	O
03/20/99	O
.	O

The	O
patient	O
was	O
doing	O
relatively	O
at	O
home	O
until	O
one	O
day	O
prior	O
to	O
admission	O
he	O
complained	O
discomfort	B-problem
over	O
a	B-treatment
suprapubic	I-treatment
catheter	I-treatment
area	I-treatment
.	O

The	O
patient	O
had	O
missed	O
his	O
usual	O
monthly	O
change	O
of	O
his	B-treatment
suprapubic	I-treatment
catheter	I-treatment
and	O
felt	O
discomfort	B-problem
and	O
noticed	O
some	B-problem
blood	I-problem
at	I-problem
the	I-problem
site	I-problem
of	O
the	O
catheter	O
.	O

The	O
patient	O
was	O
brought	O
to	O
the	O
Emergency	O
Room	O
one	O
day	O
prior	O
to	O
admission	O
where	O
he	O
was	O
evaluated	O
by	O
Urology	O
and	O
had	O
his	B-treatment
catheter	I-treatment
changed	O
.	O

The	O
patient	O
at	O
that	O
time	O
noted	O
slight	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
but	O
was	O
sent	O
home	O
anyway	O
.	O

On	O
the	O
day	O
of	O
admission	O
the	O
patient	O
noticed	O
increasing	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
.	O

The	O
patient	O
was	O
noted	O
to	O
be	O
confused	B-problem
and	O
to	O
be	O
disoriented	B-problem
toward	O
the	O
end	O
of	O
the	O
day	O
after	O
complaining	O
of	O
shortness	B-problem
of	I-problem
breath	I-problem
for	O
most	O
of	O
the	O
day	O
.	O

The	O
patient	O
denies	O
any	O
recent	B-problem
upper	I-problem
respiratory	I-problem
infections	I-problem
,	O
no	O
fevers	B-problem
,	O
no	O
chills	B-problem
,	O
no	O
change	B-problem
in	I-problem
cough	I-problem
,	O
sputum	B-problem
.	O

He	O
also	O
denies	O
any	O
chest	B-problem
pain	I-problem
.	O

No	O
orthopnea	B-problem
.	O

No	O
paroxysmal	B-problem
nocturnal	I-problem
dyspnea	I-problem
.	O

The	O
patient	O
had	O
been	O
taking	O
his	B-treatment
usual	I-treatment
medications	I-treatment
and	O
using	O
his	B-treatment
nasal	I-treatment
oxygen	I-treatment
at	I-treatment
home	I-treatment
.	O

By	O
the	O
time	O
the	O
patient	O
arrived	O
at	O
the	O
Oaksgekesser/	O
Memorial	O
Hospital	O
Emergency	O
Room	O
he	O
was	O
in	O
moderate	B-problem
respiratory	I-problem
distress	I-problem
.	O

His	B-test
initial	I-test
blood	I-test
gases	I-test
on	O
40%	B-treatment
02	I-treatment
was	O
P02	B-test
102	O
,	O
PC02	B-test
115	O
,	O
PH	B-test
7.11	O
.	O

The	O
patient	O
was	O
given	O
respiratory	B-treatment
therapy	I-treatment
in	O
the	O
way	O
of	O
nebulizer	B-treatment
treatments	I-treatment
in	O
the	O
Oaksgekesser/	O
Memorial	O
Hospital	O
Emergency	O
Room	O
because	O
of	O
a	O
longstanding	O
desire	O
by	O
patient	O
and	O
family	O
to	O
refrain	O
from	O
intubation	B-treatment
to	O
be	O
considered	O
Do	O
Not	O
Resuscitate	O
.	O

The	O
patient	O
was	O
not	O
intubated	O
.	O

However	O
he	O
was	O
transferred	O
to	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
where	O
he	O
received	O
continuous	B-treatment
respiratory	I-treatment
therapy	I-treatment
in	O
theway	O
of	O
Albuterol	B-treatment
nebulizers	I-treatment
as	O
well	O
as	O
nasal	B-treatment
oxygen	I-treatment
,	O
intravenous	B-treatment
steroids	I-treatment
and	O
intravenous	B-treatment
antibiotics	I-treatment
.	O

A	B-test
chest	I-test
x-ray	I-test
in	O
the	O
Oaksgekesser/	O
Memorial	O
Hospital	O
Emergency	O
Room	O
showed	O
new	B-problem
changes	I-problem
on	O
his	B-test
chest	I-test
x-ray	I-test
on	O
top	O
of	O
his	B-problem
usual	I-problem
severe	I-problem
bilateral	I-problem
emphysema_____	I-problem
with	O
scarring	B-problem
in	I-problem
both	I-problem
lungs	I-problem
.	O

There	O
were	O
new	B-problem
air	I-problem
space	I-problem
opacifications	I-problem
in	I-problem
the	I-problem
left	I-problem
apex	I-problem
and	I-problem
the	I-problem
right	I-problem
lower	I-problem
lobe	I-problem
.	O

These	O
were	O
thought	O
to	O
be	O
consistent	O
either	O
with	O
pneumonia	B-problem
or	O
asymmetric	B-problem
pulmonary	I-problem
edema	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Associated	B-problem
medical	I-problem
problems	I-problem
include	O
:	O

1.	O
Atonic	B-problem
bladder	I-problem
with	O
a	B-treatment
suprapubic	I-treatment
tube	I-treatment
.	O

2.	O
Anxiety	B-problem
.	O

3.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
with	O
a	O
history	O
of	O
angina	B-problem
in	O
the	O
distant	O
past	O
.	O

4.	O
History	O
of	O
colon	B-problem
cancer	I-problem
with	O
a	B-treatment
colectomy	I-treatment
in	O
the	O
past	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Ativan	B-treatment
1	O
mg	O
po	O
twice	O
a	O
day	O
.	O

2.	O
Trusopt	B-treatment
1	O
gtt	O
left	O
eye	O
three	O
times	O
a	O
day	O
.	O

3.	O
Xalatan	B-treatment
0.005%	O
one	O
gtt	O
left	O
eye	O
qhs	O
.	O

4.	O
Brimonidine	B-treatment
1	O
gtt	O
left	O
eye	O
three	O
times	O
a	O
day	O
.	O

5.	O
Combivent	B-treatment
3	O
puffs	O
four	O
times	O
per	O
day	O
.	O

6.	O
Aerobid	B-treatment
three	O
puffs	O
twice	O
a	O
day	O
.	O

7.	O
Sorbitol	B-treatment
30	O
cc	O
every	O
other	O
day	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

He	O
was	O
an	O
elderly	O
frail	O
gentleman	O
in	O
moderate	B-problem
respiratory	I-problem
distress	I-problem
.	O

He	O
had	O
a	B-test
blood	I-test
pressure	I-test
110/70	O
,	O
heart	B-test
rate	I-test
110	O
beats	O
per	O
minute	O
and	O
regular	O
,	O
respiratory	B-test
rate	I-test
25	O
.	O

He	O
was	O
in	O
moderate	B-problem
respiratory	I-problem
distress	I-problem
.	O

His	B-test
temperature	I-test
was	O
98F	O
.	O

He	O
had	O
a	O
normal	O
head	B-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
and	I-test
throat	I-test
exam	I-test
.	O

Neck	B-test
exam	I-test
revealed	O
no	O
jugular	B-problem
venous	I-problem
distention	I-problem
and	O
no	O
masses	B-problem
.	O

Lung	B-test
exam	I-test
revealed	O
decreased	B-problem
breath	I-problem
sounds	I-problem
as	O
well	O
as	O
crackles	B-problem
in	I-problem
the	I-problem
bases	I-problem
.	O

There	O
were	O
no	O
wheezes	B-problem
or	O
rhonchi	B-problem
.	O

Heart	B-test
exam	I-test
revealed	O
a	O
soft	O
S1	O
and	O
S2	O
,	O
no	O
murmur	B-problem
was	O
heard	O
,	O
no	O
S3	B-problem
.	O

Abdomen	O
was	O
soft	O
,	O
nontender	B-problem
with	O
no	O
masses	B-problem
palpable	I-problem
.	O

Rectal	B-test
exam	I-test
was	O
unremarkable	O
with	O
stool	B-test
heme	I-test
negative	O
.	O

Neurological	B-test
exam	I-test
revealed	O
an	O
alert	O
and	O
oriented	O
x	O
3	O
elderly	O
male	O
.	O

He	O
moved	O
all	O
extremities	O
.	O

Deep	B-test
tendon	I-test
reflexes	I-test
were	O
symmetrical	O
in	O
all	O
extremities	O
.	O

LABORATORY	O
AND	O
RADIOLOGIC	O
DATA	O
:	O

Sodium	B-test
148	O
,	O
potassium	B-test
3.4	O
,	O
glucose	B-test
174	O
,	O
P02	B-test
102	O
,	O
PC02	B-test
115	O
,	O
PH	B-test
7.11	O
on	O
40%	B-treatment
02	I-treatment
.	O

Blood	B-test
urea	I-test
nitrogen	I-test
11	O
,	O
creatinine	B-test
.6	O
,	O
uric	B-test
acid	I-test
3.0	O
,	O
alkaline	B-test
phosphatase	I-test
78	O
,	O
creatinine	B-problem
phosphokinase	I-problem
isoenzymes	I-problem
too	I-problem
low	I-problem
,	O
hematocrit	B-test
41	O
,	O
white	B-test
blood	I-test
cell	I-test
count	I-test
11.6	O
.	O

Urine	B-test
analysis	I-test
showed	O
20-50	O
white	B-test
blood	I-test
cells	I-test
and	O
3-5	O
red	B-test
blood	I-test
cells	I-test
.	O

Electrocardiogram	B-test
showed	O
sinus	B-problem
tachycardia	I-problem
at	O
a	O
rate	O
of	O
123	O
beats	O
per	O
minute	O
compared	O
to	O
previous	B-test
electrocardiogram	I-test
of	O
1/29	O
there	O
were	O
no	O
significant	B-problem
changes	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
stabilized	O
in	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
.	O

He	O
stayed	O
in	O
the	O
unit	O
for	O
about	O
one	O
day	O
.	O

During	O
that	O
period	O
of	O
time	O
he	O
received	O
nebulizer	B-treatment
treatments	I-treatment
with	O
Albuterol	B-treatment
.	O

He	O
was	O
also	O
started	O
on	O
intravenous	B-treatment
Ticarcillin	I-treatment
for	O
possible	O
gram	B-problem
negative	I-problem
pneumonia	I-problem
.	O

He	O
was	O
diuresed	O
with	O
intravenous	B-treatment
Lasix	I-treatment
to	O
which	O
he	O
responded	O
with	O
at	O
lease	O
a	O
2L	O
urine	B-test
output	I-test
on	O
the	O
first	O
day	O
and	O
1.5L	O
the	O
second	O
day	O
.	O

After	O
one	O
day	O
in	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
the	O
patient	O
was	O
stable	O
enough	O
to	O
go	O
to	O
the	O
floor	O
where	O
he	O
continued	O
the	O
rest	O
of	O
his	B-treatment
treatment	I-treatment
.	O

This	O
consisted	O
of	O
continued	O
nebulizer	B-treatment
treatments	I-treatment
as	O
well	O
as	O
intravenous	B-treatment
antibiotics	I-treatment
and	O
intravenous	B-treatment
Solu-Medrol	I-treatment
.	O

As	O
the	B-treatment
patient	I-treatment
&apos;s	I-treatment
diuresis	I-treatment
continued	O
his	B-problem
respiratory	I-problem
status	I-problem
improved	O
.	O

A	B-test
chest	I-test
x-ray	I-test
showed	O
clearing	O
of	O
the	B-problem
opacities	I-problem
in	O
the	B-test
chest	I-test
x-ray	I-test
that	O
were	O
consistent	O
with	O
pulmonary	B-problem
edema	I-problem
because	O
he	O
continued	O
to	O
have	O
some	B-problem
abnormality	I-problem
in	I-problem
the	I-problem
right	I-problem
lower	I-problem
lobe	I-problem
.	O

The	O
patient	O
was	O
continued	O
on	O
antibiotics	B-treatment
for	O
possible	O
pneumonia	B-problem
.	O

The	B-treatment
antibiotic	I-treatment
chosen	O
was	O
Levaquin	B-treatment
500	O
mg	O
1	O
tab	O
per	O
day	O
.	O

This	O
was	O
started	O
on	O
4/2/99	O
and	O
should	O
be	O
continued	O
for	O
ten	O
days	O
.	O

The	B-treatment
Ticarcillin	I-treatment
was	O
stopped	O
after	O
two	O
days	O
when	O
it	O
was	O
felt	O
that	O
he	O
did	O
not	O
have	O
a	B-problem
serious	I-problem
pneumonia	I-problem
.	O

The	B-problem
patient	I-problem
&apos;s	I-problem
respiratory	I-problem
status	I-problem
continued	O
to	O
improve	O
but	O
towards	O
the	O
last	O
2-3	O
days	O
of	O
his	O
hospitalization	O
the	O
amount	O
of	O
improvement	O
was	O
minimal	O
.	O

It	O
was	O
felt	O
that	O
his	B-problem
respiratory	I-problem
status	I-problem
has	O
been	O
maximally	O
treated	O
by	O
then	O
.	O

The	O
patient	O
&apos;s	O
major	O
improvement	O
came	O
after	O
the	O
first	O
two	O
days	O
with	O
brisk	B-treatment
diuresis	I-treatment
with	O
Lasix	B-treatment
.	O

While	O
in	O
the	O
Oaksgekesser/	O
Memorial	O
Hospital	O
the	O
patient	O
on	O
4/4/99	O
complained	O
of	O
mild	B-problem
epigastric	I-problem
discomfort	I-problem
because	O
he	O
was	O
put	O
in	O
Cimetidine	B-treatment
while	O
in	O
the	O
Intensive	O
Care	O
Unit	O
for	O
prophylaxis	B-treatment
against	O
peptic	B-problem
ulcer	I-problem
disease	I-problem
.	O

The	O
patient	O
was	O
upgraded	O
to	O
Prilosec	B-treatment
20	O
mg	O
per	O
day	O
for	O
possible	O
treatment	O
of	O
gastritis	B-problem
or	O
gastroesophageal	B-problem
reflux	I-problem
disease	I-problem
.	O

The	O
patient	O
did	O
have	O
any	O
nausea	B-problem
,	O
vomiting	B-problem
or	O
evidence	O
of	O
gastrointestinal	B-problem
bleeding	I-problem
.	O

The	B-problem
patient	I-problem
&apos;s	I-problem
abdominal	I-problem
pain	I-problem
should	O
be	O
followed	O
over	O
the	O
next	O
week	O
or	O
so	O
in	O
case	O
it	O
does	O
not	O
respond	O
to	O
Prilosec	B-treatment
.	O

While	O
in	O
Oaksgekesser/	O
Memorial	O
Hospital	O
the	O
patient	O
was	O
never	O
able	O
to	O
get	O
out	O
of	O
bed	O
and	O
walk	O
independently	O
.	O

It	O
is	O
hoped	O
that	O
when	O
he	O
is	O
transferred	O
to	O
a	O
rehab	O
facility	O
that	O
he	O
will	O
continue	O
with	O
physical	B-treatment
therapy	I-treatment
to	O
regain	O
his	O
strength	O
and	O
regain	O
independence	O
in	O
activities	O
of	O
daily	O
living	O
.	O

Discussion	O
with	O
the	O
family	O
regarding	O
the	O
possibility	O
of	O
sending	O
him	O
to	O
a	O
nursing	O
home	O
was	O
entertained	O
however	O
the	O
family	O
strongly	O
refused	O
to	O
allow	O
him	O
to	O
go	O
a	O
nursing	O
home	O
.	O

They	O
wanted	O
the	O
patient	O
to	O
return	O
to	O
his	O
home	O
after	O
a	O
stay	O
at	O
a	B-treatment
rehab	I-treatment
facility	I-treatment
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

The	O
patient	O
&apos;s	O
respiratory	O
status	O
was	O
stable	O
.	O

I	O
think	O
his	O
breathing	O
was	O
as	O
good	O
as	O
to	O
be	O
expected	O
with	O
the	O
amount	O
of	O
severe	B-problem
chronic	I-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
he	O
had	O
.	O

He	O
needed	O
to	O
go	O
to	O
a	B-treatment
rehab	I-treatment
facility	I-treatment
for	O
continued	B-treatment
respiratory	I-treatment
therapy	I-treatment
and	O
for	O
Physical	B-treatment
Therapy	I-treatment
to	O
increase	O
his	O
muscle	O
strength	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Albuterol	B-treatment
2.5	O
mg	O
in	O
2.5	B-treatment
normal	I-treatment
saline	I-treatment
q4h	O
.	O

2.	O
Heparin	B-treatment
5000	O
units	O
subcutaneously	O
twice	O
a	O
day	O
.	O

3.	O
Ativan	B-treatment
.5	O
mg	O
twice	O
a	O
day	O
.	O

4.	O
Nasal	B-treatment
oxygen	I-treatment
3L	O
per	O
minute	O
.	O

5.	O
Levaquin	B-treatment
500	O
mg	O
per	O
day	O
to	O
be	O
continued	O
until	O
4/12/99	O
.	O

6.	O
Lasix	B-treatment
40	O
mg	O
per	O
day	O
.	O

7.	O
Prednisone	B-treatment
40	O
mg	O
per	O
day	O
to	O
be	O
tapered	O
over	O
two	O
weeks	O
.	O

8.	O
Xalatan	B-treatment
eyedrops	I-treatment
1	O
gtt	O
in	O
left	O
eye	O
per	O
day	O
.	O

9.	O
Alphagan	B-treatment
1	O
gtt	O
in	O
left	O
eye	O
three	O
times	O
a	O
day	O
.	O

10.	O
Trusopt	B-treatment
1gtt	O
in	O
left	O
eye	O
three	O
times	O
a	O
day	O
.	O

11.	O
Prilosec	B-treatment
20	O
mg	O
per	O
day	O
.	O

FOLLOWUP	O
:	O

The	O
patient	O
should	O
have	O
follow	O
up	O
with	O
his	O
primary	O
care	O
physician	O
Dr.	O
Rod	O
Linkeboltshieltrus	O
at	O
the	O
TRE	O
453	O
about	O
one	O
week	O
after	O
discharge	O
from	O
rehab	O
facility	O
.	O

The	O
telephone	O
number	O
at	O
his	O
office	O
is	O
236-4518	O
.	O

ROD	O
END	O
,	O
M.D.	O

TR	O
:	O

lh	O

DD	O
:	O

04/05/1999	O

TD	O
:	O

04/05/1999	O
3:06	O

Pcc	O
:	O

ROD	O
END	O
,	O
M.D.	O

C.R.TRYGLO	O
HOSPITAL	O
OF	O
STAT	O

745431641	O
WGH	O

2464448	O

333887	O

3473372	O

9/16/2004	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

KOTEA	O
,	O
TORTHEOA	O

MRN	O
:	O

2464448	O

Age	O
:	O

59y	O

REGISTRATION	O
DATE	O
:	O

09/16/2004	O
09:22	O
AM	O

Provider	O
:	O

YERTREY	O
SUMCHIRDKAYSMAVVEINDREPS	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O
MD	O
:	O

Yes	O
-	O
Direct	O
contact	O
with	O
PCP	O

Benefits	O
Assigned	O
:	O

N	O

Discharge	O
Date	O
/	O
Time	O
:	O

09/16/2004	O
17:48	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

CP	B-problem

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
chest	B-problem
pain	I-problem
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

Noncardiac	B-problem
chest	I-problem
pain	I-problem

Treatment	O
Rendered	O
:	O

Labs	B-test
stable	O
,	O
NTG	B-treatment
sublingual	I-treatment
,	O
stress	B-test
MIBI	I-test
was	O
negative	O
for	O
ischemia	B-problem
.	O

Discharge	O
Medications	O
:	O

Continue	O
current	B-treatment
medication	I-treatment

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Follow	O
up	O
as	O
scheduled	O
with	O
Dr.	O
Fyfechird	O
.	O

Return	O
to	O
the	O
ED	O
for	O
worsening	B-problem
chest	I-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
nausea	B-problem
/	O
vomiting	B-problem
,	O
fever	B-problem
/	O
chills	B-problem
,	O
weakness	B-problem
/	O
dizziness/numbness	B-problem
,	O
or	O
any	B-problem
other	I-problem
problems	I-problem
.	O

PCP	O
Name	O
:	O

SLANDTIF	O
,	O
ASTHEO	O
D	O

Provider	O
Number	O
:	O

49422	O

This	O
report	O
was	O
created	O
by	O
SUMCHIRDKAYSMAVVEINDREPS	O
,	O
YERTREY	O
09/16/2004	O
05:53	O
PM	O

745701560	O
WGH	O

2217927	O

991462	O

4257841	O

10/23/2005	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

SMANTVERGE	O
,	O
TAWNEN	O

MRN	O
:	O

2217927	O

Age	O
:	O

78y	O

REGISTRATION	O
DATE	O
:	O

10/23/2005	O
09:30	O
AM	O

Provider	O
:	O

VONNELIBRY	O
POUSSCROOKESSEILLE	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O
MD	O
:	O

E-mail	O
PCP	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Note	O

Date	O
/	O
Time	O
:	O

10/23/2005	O
10:35	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

APPT	O
VONNELIBRY	O
POUSSCROOKESSEILLE	O

Diagnosis	O
:	O

Anxiety	B-problem
NOS	I-problem

Treatment	O
Rendered	O
:	O

psychological	B-test
assessment	I-test
,	O
past	O
medication	O
responses	O
discussed	O
.	O

No	O
new	B-treatment
meds	I-treatment
for	O
now	O

Discharge	O
Medications	O
:	O

None	O
today	O
Disposition	O
,	O

Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Keep	O
follow-up	O
medical	O
appointments	O
with	O
Dr	O
Trosgaugh	O
.	O

Continuing	O
taking	O
meds	B-treatment
she	O
prescribed	O
.	O

PCP	O
Name	O
:	O

TROSGAUGH	O
,	O
NACOLE	O

Provider	O
Number	O
:	O

16660	O

This	O
report	O
was	O
created	O
by	O
POUSSCROOKESSEILLE	O
,	O
VONNELIBRY	O
10/23/2005	O
10:51	O
AM	O

767751445	O
ELMVH	O

45154940	O

6035801	O

12/6/2005	O
12:00:00	O
AM	O

COPD	B-problem
exacerbation	I-problem
with	O
NSTEMI	B-problem

DIS	O

Admission	O
Date	O
:	O

12/06/2005	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

12/10/2005	O

******	O
FINAL	O
DISCHARGE	O
ORDERS	O
******	O

SCHOELLSULLKOTEFONG	O
,	O
MAUSTINIE	O

161-66-98-5	O
W53	O

Room	O
:	O

66R-249	O

Service	O
:	O

MED	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

12/09/05	O
AT	O
08:00	O
PM	O

CONTINGENT	O
UPON	O

Attending	B-test
evaluation	I-test

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

FREIERMFUSC	O
,	O
SHAIGAYDONA	O
,	O
M.D.	O
,	O
M.DIV.	O

CODE	O
STATUS	O
:	O

Full	O
code	O

DISPOSITION	O
:	O

Home	O
w/	O
services	O

DISCHARGE	O
MEDICATIONS	O
:	O

VITAMIN	B-treatment
C	I-treatment
(	I-treatment
ASCORBIC	I-treatment
ACID	I-treatment
)	I-treatment
1,000	O
MG	O
PO	O
QD	O
ECASA	B-treatment
(	I-treatment
ASPIRIN	I-treatment
ENTERIC	I-treatment
COATED	I-treatment
)	I-treatment
81	O
MG	O
PO	O
QD	O
CALCIUM	B-treatment
CARBONATE	I-treatment
(	I-treatment
500	I-treatment
MG	I-treatment
ELEMENTAL	I-treatment
CA++	I-treatment
)	I-treatment
500	O
MG	O
PO	O
BID	O
PREDNISONE	B-treatment
20	O
MG	O
PO	O
QAM	O
Starting	O
Today	O
(	O
12/09	O
)	O

Instructions	O
:	O

taper	O
over	O
2	O
weeks	O
MULTIVITAMIN	B-treatment
THERAPEUTIC	I-treatment
(	I-treatment
THERAPEUTIC	I-treatment
MULTIVI	I-treatment
...	I-treatment
)	I-treatment
5	O
MILLILITERS	O
PO	O
QD	O

Override	O
Notice	O
:	O

Override	O
added	O
on	O
12/07/05	O
by	O
BELB	O
,	O
BRITHERL	O
,	O
M.D.	O
on	O
order	O
for	O
ATORVASTATIN	B-treatment
PO	I-treatment
(	O
ref	O
#	O
33823759	O
)	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

NIACIN	B-treatment
,	O
VIT	B-treatment
.	O

B-3	B-treatment
and	O
ATORVASTATIN	B-treatment
CALCIUM	I-treatment

Reason	O
for	O
override	O
:	O

md	O
aware	O

Previous	O
override	O
information	O
:	O

Override	O
added	O
on	O
12/06/05	O
by	O
BELB	O
,	O
BRITHERL	O
,	O
M.D.	O
on	O
order	O
for	O
ZOCOR	B-treatment
PO	I-treatment
(	O
ref	O
#	O
33033281	O
)	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

NIACIN	B-treatment
,	O
VIT	B-treatment
.	O

B-3	B-treatment
and	O
SIMVASTATIN	B-treatment

Reason	O
for	O
override	O
:	O

md	O
aware	O

FLOVENT	B-treatment
(	I-treatment
FLUTICASONE	I-treatment
PROPIONATE	I-treatment
)	I-treatment
44	O
MCG	O
INH	O
BID	O
Starting	O
Today	O
(	O
12/09	O
)	O
LEVAQUIN	B-treatment
(	I-treatment
LEVOFLOXACIN	I-treatment
)	I-treatment
500	O
MG	O
PO	O
QD	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Administer	O
iron	B-treatment
products	I-treatment
a	O
minimum	O
of	O
2	O
hours	O
before	O
or	O
after	O
a	O
levofloxacin	B-treatment
or	O
ciprofloxacin	B-treatment
dose	O
dose	O

If	O
on	O
tube	B-treatment
feeds	I-treatment
,	O
please	O
cycle	O
(	O
hold	O
1	O
hr	O
before	O
to	O
2	O
hr	O
after	O
)	O

Take	O
2	O
hours	O
before	O
or	O
2	O
hours	O
after	O
dairy	O
products	O
.	O

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
12/06/05	O
by	O
BELB	O
,	O
BRITHERL	O
,	O
M.D.	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

SALMETEROL	B-treatment
XINAFOATE	I-treatment
and	O
LEVOFLOXACIN	B-treatment

Reason	O
for	O
override	O
:	O

md	O
aware	O

SEREVENT	B-treatment
DISKUS	I-treatment
(	I-treatment
SALMETEROL	I-treatment
DISKUS	I-treatment
)	I-treatment
1	O
PUFF	O
INH	O
BID	O

Override	O
Notice	O
:	O

Override	O
added	O
on	O
12/06/05	O
by	O
BELB	O
,	O
BRITHERL	O
,	O
M.D.	O
on	O
order	O
for	O
LEVAQUIN	B-treatment
PO	I-treatment
(	O
ref	O
#	O
57095042	O
)	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

SALMETEROL	B-treatment
XINAFOATE	I-treatment
and	O
LEVOFLOXACIN	B-treatment

Reason	O
for	O
override	O
:	O

md	O
aware	O

LISINOPRIL	B-treatment
5	O
MG	O
PO	O
QD	O

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
12/08/05	O
by	O
:	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

POTASSIUM	B-treatment
CHLORIDE	I-treatment
and	O
LISINOPRIL	B-treatment

Reason	O
for	O
override	O
:	O

md	O
aware	O

TOPROL	B-treatment
XL	I-treatment
(	I-treatment
METOPROLOL	I-treatment
SUCCINATE	I-treatment
EXTENDED	I-treatment
RELEASE	I-treatment
)	I-treatment
25	O
MG	O
PO	O
QD	O
Starting	O
Today	O
(	O
12/09	O
)	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Take	O
consistently	O
with	O
meals	O
or	O
on	O
empty	O
stomach	O
.	O

ALENDRONATE	B-treatment
70	O
MG	O
PO	O
QWEEK	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Give	O
on	O
an	O
empty	O
stomach	O
(	O
give	O
1hr	O
before	O
or	O
2hr	O
after	O
food	O
)	O

Take	O
with	O
8	O
oz	O
of	O
plain	O
water	O
ALBUTEROL	B-treatment
INHALER	I-treatment
2	O
PUFF	O
INH	O
QID	O
Starting	O
Today	O
(	O
12/09	O
)	O
ATROVENT	B-treatment
INHALER	I-treatment
(	I-treatment
IPRATROPIUM	I-treatment
INHALER	I-treatment
)	I-treatment
2	O
PUFF	O
INH	O
QID	O
Starting	O
Today	O
(	O
12/09	O
)	O

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Resume	O
regular	O
exercise	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Gento	O
Yaneslaunt	O
03/17/06	O
scheduled	O
,	O

Arois	O
Maillliepslighsint	O
02/18/06	O
scheduled	O
,	O

ALLERGY	O
:	O

NKA	B-problem
ADMIT	O
DIAGNOSIS	O
:	O

COPD	B-problem
exacerbation	I-problem

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
COPD	B-problem
exacerbation	I-problem
with	O
NSTEMI	B-problem

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O

severe	B-problem
COPD	I-problem
Pneumonia	B-problem
recovering	O
alcoholic	O
recovering	O
barbituate	O
abuse	O
unexplained	B-problem
hct	I-problem
drop	I-problem
poor	B-problem
appetite	I-problem
x	O
1	O
week	O

STEROID	B-problem
PSYCHOSIS	I-problem
NO	O
BENZOS	B-treatment

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

none	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

Heparin	B-treatment
while	O
having	O
a	B-problem
demand	I-problem
ischemic	I-problem
episode	I-problem

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

*	O
CC	O
:	O

82F	O
with	O
COPD	B-problem
exacerpation	I-problem

*	O
DDx	O
:	O

COPD	B-problem
exacerpation	I-problem
with	O
troponin	B-problem
leak	I-problem
likely	O
NSTEMI	B-problem
secondary	O
to	O
demand	B-problem
ischemia	I-problem
.	O

*	O
HPI	O
:	O

4	O
days	O
of	O
worsening	B-problem
SOB	I-problem
with	O
sore	B-problem
throat	I-problem
and	O
cough	B-problem
productive	I-problem
of	I-problem
yellow	I-problem
/	I-problem
green	I-problem
sputum	I-problem
.	O

Fatigue	B-problem
secondary	O
to	O
worsening	B-problem
dyspnea	I-problem
.	O

took	O
Prednisone	B-treatment
40	I-treatment
at	O
home	O
and	O
presented	O
to	O
ED	O
where	O
found	O
to	O
have	O
1mm	B-problem
lateral	I-problem
ST	I-problem
depressions	I-problem
and	O
slight	B-problem
troponin	I-problem
and	I-problem
MB	I-problem
leak	I-problem
.	O

no	O
N	B-problem
/	O
V/HA	B-problem
/	O
D	B-problem
no	O
sweats	B-problem
,	O
no	O
chills	B-problem
,	O
of	O
abdominal	B-problem
pain	I-problem
,	O
no	O
chest	B-problem
pain	I-problem
,	O
no	O
pleuricy	B-problem
,	O
no	O
LEE	B-problem
,	O
no	O
paresthesias	B-problem
,	O
no	O
numbness	B-problem
,	O
no	O
shoulder	B-problem
pain	I-problem
,	O
no	O
jaw	B-problem
pain	I-problem
.	O

*	O
PMH	O
:	O

COPD	B-problem
(	O
s	O
/	O
p	O
lung	B-treatment
resection	I-treatment
FEV1	B-test
25%	O
)	O
,	O
chronic	B-problem
pericardial	I-problem
effusion	I-problem
,	O
PVD	B-problem
,	O
R	B-problem
renal	I-problem
artery	I-problem
stenosis	I-problem
,	O
osteoporosis	B-problem
,	O
presbylaryngis	B-problem

**************	O
PATIENT	O
STATUS	O
********************	O

98.4	O
,	O
94	O
,	O
22	O
,	O
120/96	O
,	O
98%	O
on	O
2L.	O
NAD	B-problem
,	O
using	O
scalenes	B-test
,	O
AT	O
/	O
NC	O
,	O
no	O
oral	B-problem
lesions	I-problem
,	O
Bibasilar	B-problem
rales	I-problem
otherwise	O
clear	O
,	O
good	O
air	O
movement	O
,	O
RRR	O
,	O
no	O
MRG	O
,	O
NTND	O
+BS	O
,	O
no	O
CCE	O
,	O
2+	O
DPs	O
.	O

Guiac	O
negative	O

***************	O
STUDIES	O
***********************	O

LABS	O
:	O

WBC	B-test
12.91	O

CXR	O
:	O

small	B-problem
pleural	I-problem
effusion	I-problem
,	O
flat	O
diaphrams	O
no	O
acute	B-problem
changes	I-problem

Echo	B-test
-	O

***********	O
HOSPITAL	O
COURSE	O
****************	O

1.	O
CV	O
:	O

likely	O
having	O
a	B-problem
NSTEMI	I-problem
secondary	O
to	O
demand	B-problem
.	O

Cardiac	B-test
enzymes	I-test
trending	O
down	O
on	O
12.7.05	O
,	O
anticoagulated	O
while	O
having	O
leak	B-test
.	O

I	O
-	O
heparin	B-treatment
for	O
PTT	B-problem
50-70	O
durin	O
enzyme	B-problem
leak	I-problem
.	O
metoprolol	B-treatment
12	O
QID	O
.	O

Cardiac	B-test
enzymes	I-test
BID	O
while	O
actively	O
having	O
leak	B-problem
,	O
ASA	B-treatment

R	O
-	O
monitor	O
on	O
telemetry	B-treatment

P	O
-	O
no	O
evidence	B-problem
of	I-problem
failure	I-problem

-	O
Echo	O
:	O

2.	O
COPD	O
:	O

likely	O
exacerbation	B-problem
possibly	O
from	O
URI	B-problem
/	O
pneumonia	B-problem
.	O

Aputum	B-test
cultures	I-test
pending	O
.	O

Treated	O
with	O
:	O

atrovent	B-treatment
NEB	I-treatment
QID	O
,	O
albuterol	B-treatment
Neb	I-treatment
QID	O
,	O
ipratropium	B-treatment
NEB	I-treatment
BID	O
,	O
flovent	B-treatment
INH	I-treatment
BID	O
,	O
Serevent	B-treatment
INH	I-treatment
BID	O
,	O
and	O
prednisone	B-treatment
30	O
QD	O
taper	O
.	O

Levaquin	B-treatment
500	O
QD	O
empirically	O

3.	O
GI	O
:	O

PPI	B-treatment
prophylaxis	I-treatment

4.	O
FEN	O
:	O

MVI	B-problem
,	O
Cardiac	O
diet	O

ADDITIONAL	O
COMMENTS	O
:	O

Please	O
make	O
an	O
appointment	O
to	O
see	O
dr.	O
Arois	O
Maillliepslighsint	O
within2-3	O
weeks	O
after	O
you	O
leave	O
the	O
hospital	O

Please	O
taper	O
off	O
your	O
prednisone	B-treatment
within	O
2	O
weeks	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

PT	O
:	O

please	O
evaluate	O
ambutlation	O
ability	O
and	O
O2	B-test
requirement	I-test

Please	O
evaluate	O
resolution	O
of	O
cardiac	B-problem
troponin	I-problem
leak	I-problem
and	O
stable	O
EKG	O
.	O

Please	O
evaluate	O
resolution	O
of	O
COPD	B-problem
exacerbation	I-problem
and	O
need	O
for	O
any	B-treatment
further	I-treatment
antibiocis	I-treatment

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

BELB	O
,	O
BRITHERL	O
,	O
M.D.	O
(	O
IL35	O
)	O
12/10/05	O
02:50	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

779878634	O

TGCHO	O

9260099	O

612765	O

12/11/2003	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

A	O
,	O
REBAY	O
J	O

UNIT	O
NUMBER	O
:	O

984-98-62	O

ADMISSION	O
DATE	O
:	O

12/11/2003	O

DISCHARGE	O
DATE	O
:	O

01/08/2004	O

The	O
patient	O
has	O
a	O
known	O
history	O
of	O
pancreatic	B-problem
adenocarcinoma	I-problem
.	O

He	O
is	O
admitted	O
at	O
this	O
time	O
because	O
of	O
significant	B-problem
GI	I-problem
bleeding	I-problem
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Significant	O
for	O
fatigue	B-problem
and	O
increased	B-problem
abdominal	I-problem
discomfort	I-problem
.	O

MEDICATIONS	O
AT	O
THE	O
TIME	O
OF	O
ADMISSION	O
:	O

Insulin	B-treatment
,	O
Celexa	B-treatment
,	O
Protonix	B-treatment
,	O
Ambien	B-treatment
and	O
Pancreas	B-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Vital	B-test
signs	I-test
showed	O
his	B-test
blood	I-test
pressure	I-test
to	O
be	O
slightly	B-problem
decreased	I-problem
at	O
120/60	O
,	O
pulse	B-test
64	O
,	O
respirations	B-test
16	O
,	O
temperature	B-test
98.8	O
,	O
O2	B-test
sat	I-test
95	O
.	O

HEENT	O
:	O

Evidence	B-problem
of	I-problem
anemia	I-problem
with	O
being	B-problem
pale	I-problem
,	O
but	O
anicteric	O
,	O
no	O
oral	B-problem
lesions	I-problem
.	O

Neck	O
supple	O
.	O

Lungs	O
clear	O
.	O

Back	O
without	O
CVA	B-problem
or	I-problem
spinal	I-problem
tenderness	I-problem
.	O

Heart	O
regular	O
rate	O
and	O
rhythm	O
.	O

Abdomen	O
:	O

Bowel	O
sounds	O
positive	O
,	O
soft	O
,	O
mildly	B-problem
tender	I-problem
in	I-problem
the	I-problem
epigastrium	I-problem
without	O
hepatosplenomegaly	B-problem
,	O
mass	B-problem
or	O
tenderness	B-problem
.	O

Extremities	O
:	O

Trace	B-problem
edema	I-problem
without	O
cyanosis	B-problem
or	O
clubbing	B-problem
.	O

His	B-test
hematocrit	I-test
at	O
the	O
time	O
of	O
admission	O
was	O
20.5	O
,	O
after	O
having	O
been	O
32	O
one	O
week	O
earlier	O
.	O

ASSESSMENT	O
:	O

The	B-test
assessment	I-test
was	O
that	O
he	O
had	O
a	B-problem
GI	I-problem
bleed	I-problem
.	O

He	O
was	O
transfused	O
and	O
then	O
evaluated	O
by	O
GI	O
.	O

Endoscopy	B-test
showed	O
multiple	B-problem
angio	I-problem
ectasias	I-problem
throughout	I-problem
the	I-problem
stomach	I-problem
.	O

He	O
received	O
multiple	B-treatment
treatments	I-treatment
for	O
this	O
over	O
the	O
succeeding	O
weeks	O
.	O

In	O
addition	O
,	O
he	O
was	O
transfused	O
.	O

His	B-test
platelet	I-test
count	I-test
was	O
maintained	O
with	O
platelet	B-treatment
transfusion	I-treatment
as	O
necessary	O
.	O

He	O
was	O
treated	O
with	O
Octreotide	B-treatment
to	O
try	O
to	O
slow	O
down	O
the	B-problem
bleeding	I-problem
.	O

Despite	O
all	O
these	O
measures	O
,	O
his	B-problem
bleeding	I-problem
was	O
never	O
totally	O
controlled	O
.	O

He	O
then	O
had	O
an	B-treatment
angiogram	I-treatment
with	I-treatment
Gel	I-treatment
foam	I-treatment
to	O
try	O
to	O
control	O
his	B-problem
GI	I-problem
bleed	I-problem
.	O

Again	O
,	O
this	O
was	O
unsuccessful	O
.	O

At	O
that	O
point	O
he	O
had	O
a	B-problem
change	I-problem
in	I-problem
mental	I-problem
status	I-problem
and	O
was	O
no	B-problem
longer	I-problem
responsive	I-problem
.	O

Given	O
this	O
,	O
the	O
decision	O
was	O
made	O
to	O
make	O
his	O
care	O
comfort	O
measures	O
only	O
.	O

At	O
this	O
point	O
,	O
he	O
was	O
made	O
comfort	O
measures	O
and	O
expired	O
comfortably	O
.	O

The	O
cause	O
of	O
death	B-problem
was	O
a	O
combination	O
of	O
GI	B-problem
bleeding	I-problem
felt	O
to	O
be	O
ultimately	O
related	O
to	O
his	B-problem
known	I-problem
metastatic	I-problem
pancreatic	I-problem
cancer	I-problem
.	O

TA	O
KO	O
FOSSA	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

Electronically	O
Signed	O
TA	O
KO	O
FOSSA	O
,	O
M.D.	O

02/05/2004	O
17:03	O

_____________________________	O
TA	O
KO	O
FOSSA	O
,	O
M.D.	O

TR	O
:	O

mb	O

DD	O
:	O

01/23/2004	O

TD	O
:	O

01/26/2004	O
2:16	O
A	O
612765	O

cc	O
:	O

TA	O
KO	O
FOSSA	O
,	O
M.D.	O

788268693	O
DH	O

7258512	O

020586	O

0831510	O

4/30/2005	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

FREIERMDREPS	O
,	O
RI	O

MRN	O
:	O

7258512	O

Age	O
:	O

44y	O

REGISTRATION	O
DATE	O
:	O

04/30/2005	O
02:55	O
PM	O

Provider	O
:	O

RONRIN	O
SHUFF	O

PRELIMINARY	O
REPORT	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Note	O
Date	O
/	O
Time	O
:	O

04/30/2005	O
15:49	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

R	B-problem
ELBOW	I-problem
INJURY	I-problem

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
sprains	B-problem
,	O
fractures	B-problem
and	O
bruises	B-problem
(	O
English	O
)	O
.	O

The	O
patient	O
was	O
given	O
a	O
work	O
note	O
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

R	B-problem
elbow	I-problem
strain	I-problem

Treatment	O
Rendered	O
:	O

xray	B-test
-	O
no	O
evidence	O
of	O
effusion	B-problem
or	O
fracture	B-problem

Discharge	O
Medications	O
:	O

motrin	B-treatment
400-600	O
mg	O
every	O
8	O
hours	O
as	O
needed	O
for	O
pain	B-problem

Follow	O
up	O
Service	O
:	O

It	O
is	O
recommended	O
that	O
you	O
receive	O
follow-up	O
care	O
with	O
the	O
Department	O
of	O
Orthopaedics	O
if	O
your	B-problem
symptoms	I-problem
are	O
not	O
improved	O
in	O
5-7	O
days	O
.	O

Please	O
call	O
(	O
890	O
)	O
541-3008	O
to	O
schedule	O
an	O
appointment	O
.	O

For	O
managed	O
care	O
plans	O
,	O
check	O
with	O
your	O
PCP	O
before	O
making	O
this	O
appointment	O
.	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Use	O
ice	B-treatment
to	O
sore	B-problem
areas	I-problem
for	O
the	O
next	O
few	O
days	O
.	O

Do	O
no	O
strenuous	O
activity	O
until	O
your	B-problem
symptoms	I-problem
are	O
improved	O
.	O

Do	O
gentle	B-treatment
range	I-treatment
of	I-treatment
motion	I-treatment
exercises	I-treatment
for	O
the	O
next	O
few	O
days	O
.	O

PCP	O
Name	O
:	O

CREDKOTE	O
,	O
ALEN	O

Provider	O
Number	O
:	O

18160	O

This	O
report	O
was	O
created	O
by	O
SHUFF	O
,	O
RONRIN	O
04/30/2005	O
03:52	O
PM	O

814743340	O
RWH	O

3393103	O

501370	O

9041109	O

5/13/2006	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

TRICHEPRAKEJESC	O
,	O
BETLA	O

UNIT	O
NUMBER	O
:	O

381-75-78	O

ADMISSION	O
DATE	O
:	O

05/13/2006	O

DISCHARGE	O
DATE	O
:	O

05/16/2006	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Chest	B-problem
pain	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Coronary	B-problem
artery	I-problem
disease	I-problem
;	O
hypertension	B-problem
;	O
hyperlipidemia	B-problem
;	O
sleep	B-problem
apnea	I-problem
;	O
diabetes	B-problem
type	I-problem
2	I-problem
.	O

PROCEDURES	O
:	O

Adenosine	B-test
stress	I-test
test	I-test
.	O

Part	B-test
1	I-test
of	I-test
a	I-test
sleep	I-test
study	I-test
.	O

Coronary	B-test
angiogram	I-test
.	O

Chest	B-test
CT	I-test
.	O

Chest	B-test
x-ray	I-test
.	O

HISTORY	O
AND	O
REASON	O
FOR	O
HOSPITALIZATION	O
:	O

The	O
patient	O
is	O
a	O
55-year-old	O
gentleman	O
with	O
a	O
history	O
of	O
CAD	B-problem
status	O
post	O
non	B-problem
ST	I-problem
elevation	I-problem
MI	I-problem
in	O
11/17	O
who	O
presents	O
with	O
chest	B-problem
pain	I-problem
X	O
48	O
hours	O
.	O

He	O
went	O
to	O
Padrugmoff	O
Hospital	O
Emergency	O
Room	O
.	O

He	O
has	O
a	O
history	O
of	O
hypertension	B-problem
,	O
diabetes	B-problem
,	O
and	O
high	B-problem
cholesterol	I-problem
.	O

In	O
2003	O
,	O
he	O
had	O
a	B-problem
non	I-problem
ST	I-problem
elevation	I-problem
MI	I-problem
,	O
came	O
to	O
the	O
RWH	O
,	O
and	O
had	O
a	B-test
cath	I-test
done	O
,	O
which	O
showed	O
a	B-problem
40%	I-problem
RCA	I-problem
,	O
which	O
was	O
hazy	B-problem
.	O

An	B-test
IVUS	I-test
was	O
done	O
,	O
and	O
it	O
was	O
felt	O
that	O
it	O
was	O
more	O
severe	O
.	O

He	O
underwent	O
a	B-treatment
PTC	I-treatment
stenting	I-treatment
of	I-treatment
an	I-treatment
RCA	I-treatment
with	O
a	B-treatment
Vision	I-treatment
stent	I-treatment
,	O
3	O
x	O
18	O
.	O

Diagonal	O
1	O
also	O
had	O
a	B-problem
99%	I-problem
stenosis	I-problem
.	O

There	O
was	O
no	O
other	B-problem
noted	I-problem
disease	I-problem
.	O

Since	O
then	O
,	O
the	O
patient	O
has	O
occasional	B-problem
chest	I-problem
pain	I-problem
with	O
emotional	B-problem
stress	I-problem
,	O
when	O
he	O
is	O
angry	O
or	O
upset	O
.	O

Yesterday	O
morning	O
,	O
he	O
developed	O
intermittent	B-problem
substernal	I-problem
chest	I-problem
pain	I-problem
with	O
radiation	B-problem
to	I-problem
the	I-problem
left	I-problem
shoulder	I-problem
that	O
worsened	O
with	O
any	O
activity	O
and	O
any	O
motion	O
of	O
his	O
shoulders	O
.	O

It	O
progressed	O
over	O
the	O
course	O
of	O
the	O
day	O
requiring	O
less	O
movement	O
.	O

He	O
also	O
became	O
short	B-problem
of	I-problem
breath	I-problem
with	O
climbing	O
a	O
flight	O
of	O
stairs	O
.	O

He	O
denies	O
diaphoresis	B-problem
or	O
nausea	B-problem
.	O

He	O
went	O
to	O
the	O
Padrugmoff	O
Hospital	O
Emergency	O
Room	O
after	O
trying	O
nitroglycerin	B-treatment
at	O
home	O
.	O

However	O
,	O
his	B-treatment
nitroglycerin	I-treatment
was	O
old	O
and	O
the	B-treatment
script	I-treatment
was	O
expired	O
.	O

In	O
the	O
ER	O
,	O
he	O
received	O
3	B-treatment
sublingual	I-treatment
nitroglycerins	I-treatment
and	O
1	O
mg	O
of	O
Dilaudid	B-treatment
.	O

After	O
that	O
,	O
he	O
was	O
pain-free	B-problem
.	O

Lopressor	B-treatment
IV	I-treatment
was	O
given	O
to	O
control	O
his	B-test
heart	I-test
rate	I-test
.	O

He	O
also	O
received	O
Lipitor	B-treatment
80	O
mg	O
,	O
Plavix	B-treatment
300	O
,	O
heparin	B-treatment
IV	I-treatment
,	O
integrelin	B-treatment
double	I-treatment
bolus	I-treatment
,	O
followed	O
by	O
a	B-treatment
drip	I-treatment
.	O

Apparently	O
once	O
his	B-problem
pain	I-problem
was	O
free	O
,	O
his	B-test
EKG	I-test
was	O
noted	O
to	O
have	O
hyperacute	B-problem
T-wave	I-problem
anteriorly	I-problem
without	O
progression	B-problem
.	O

He	O
was	O
transferred	O
to	O
the	O
Ro	O
Woodma	O
Healthcare	O
for	O
further	B-treatment
cardiac	I-treatment
care	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Diabetes	B-problem
;	O
hypertension	B-problem
;	O
hyperlipidemia	B-problem
.	O

MEDICATIONS	O
AT	O
HOME	O
:	O

Include	O
Lisinopril	B-treatment
5	O
mg	O
p.o.	O
every	O
day	O
;	O
nitroglycerin	B-treatment
sublingual	I-treatment
p.r.n.;	O
Toprol	B-treatment
XL	I-treatment
100	O
mg	O
p.o.	O
every	O
day	O
;	O
Plavix	B-treatment
75	O
mg	O
p.o.	O
every	O
day	O
;	O
Avandia	B-treatment
4	O
mg	O
p.o.	O
every	O
day	O
;	O
Lipitor	B-treatment
40	O
mg	O
p.o.	O
every	O
day	O
;	O
TriCor	B-treatment
145	O
mg	O
p.o.	O
every	O
day	O
.	O

SOCIAL	O
HISTORY	O
:	O

He	O
is	O
married	O
.	O

He	O
does	O
have	O
a	O
lot	O
of	O
anxiety	B-problem
.	O

Socially	O
he	O
drinks	O
alcohol	O
.	O

He	O
does	O
not	O
smoke	O
.	O

He	O
has	O
2	O
daughters	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
ruled	O
out	O
for	O
an	B-problem
MI	I-problem
with	O
negative	O
CK	O
X4	O
and	O
negative	O
troponin	O
X4	O
.	O

He	O
was	O
taken	O
to	O
the	O
Cardiac	O
Catheterization	O
Lab	O
where	O
cath	B-test
showed	O
top-normal	O
LVEDP	O
at	O
12	O
;	O
no	O
AF	B-problem
;	O
widely	B-problem
patent	I-problem
RCA	I-problem
stent	I-problem
;	O
mild	B-problem
CAD	I-problem
in	I-problem
the	I-problem
left	I-problem
coronary	I-problem
artery	I-problem
symptom	I-problem
;	O
widely	B-problem
patent	I-problem
diagonal	I-problem
1	I-problem
at	O
the	O
site	O
of	O
prior	B-treatment
PTCA	I-treatment
.	O

He	O
received	O
an	B-treatment
Angio-Seal	I-treatment
to	I-treatment
the	I-treatment
right	I-treatment
common	I-treatment
femoral	I-treatment
artery	I-treatment
.	O

He	O
then	O
underwent	O
a	B-test
CT	I-test
scan	I-test
to	O
rule	O
out	O
a	B-problem
PE	I-problem
.	O

That	O
test	O
was	O
negative	O
.	O

He	O
underwent	O
lower	B-test
extremity	I-test
study	I-test
to	O
rule	O
out	O
a	B-problem
DVT	I-problem
in	I-problem
both	I-problem
legs	I-problem
.	O

That	O
was	O
negative	O
.	O

He	O
was	O
noted	O
to	O
have	O
an	O
episode	O
of	O
desaturation	B-problem
into	I-problem
the	I-problem
80%	I-problem
range	I-problem
while	O
sleeping	O
.	O

Pulmonary	B-test
consult	I-test
was	O
done	O
,	O
and	O
it	O
was	O
felt	O
that	O
the	O
patient	O
should	O
undergo	O
a	B-test
formal	I-test
sleep	I-test
study	I-test
,	O
full	B-test
PFTs	I-test
,	O
and	O
a	B-test
repeat	I-test
CT	I-test
scan	I-test
in	O
1	O
year	O
to	O
assess	O
for	O
pulmonary	B-problem
nodule	I-problem
that	O
was	O
seen	O
.	O

However	O
,	O
please	O
note	O
that	O
this	B-problem
nodule	I-problem
has	O
been	O
stable	O
over	O
time	O
.	O

The	O
patient	O
also	O
complained	O
of	O
intermittent	B-problem
right	I-problem
neck	I-problem
swelling	I-problem
,	O
and	O
recommendations	O
are	O
to	O
consider	O
a	B-test
CT	I-test
scan	I-test
with	I-test
contrast	I-test
to	O
evaluate	O
nodes	B-problem
in	I-problem
his	I-problem
neck	I-problem
.	O

On	O
physical	B-test
exam	I-test
today	O
,	O
the	O
patient	O
did	O
not	O
have	O
any	B-problem
swelling	I-problem
,	O
and	O
he	O
states	O
that	O
he	O
did	O
not	O
feel	O
the	B-problem
swelling	I-problem
was	O
present	O
.	O

The	O
patient	O
underwent	O
an	B-test
adenosine	I-test
stress	I-test
test	I-test
,	O
where	O
he	O
exercised	O
for	O
4	O
minutes	O
,	O
reaching	O
65%	O
of	O
predicted	O
heart	O
rate	O
.	O

He	O
did	O
not	O
have	O
chest	B-problem
pain	I-problem
.	O

EKG	B-test
was	O
negative	O
for	O
ischemia	B-problem
.	O

The	B-test
myocardial	I-test
perfusion	I-test
images	I-test
show	O
no	O
definite	O
evidence	O
of	O
ischemia	B-problem
.	O

The	B-test
LV	I-test
contractile	I-test
function	I-test
was	O
normal	O
.	O

There	O
was	O
mild	B-problem
posterior	I-problem
vasal	I-problem
thinning	I-problem
.	O

It	O
is	O
not	O
clearly	O
outside	O
normal	O
limits	O
.	O

He	O
underwent	O
an	B-test
echocardiogram	I-test
,	O
which	O
showed	O
an	B-test
EF	I-test
of	O
60%	O
.	O

There	O
was	O
no	O
evidence	O
of	O
MVP	B-problem
.	O

There	O
was	O
trace	B-problem
mitral	I-problem
regurgitation	I-problem
.	O

There	O
was	O
no	O
evidence	O
of	O
LA	B-problem
dilatation	I-problem
.	O

There	O
was	O
no	O
aortic	B-problem
stenosis	I-problem
.	O

There	O
was	O
trace	B-problem
aortic	I-problem
insufficiency	I-problem
.	O

The	O
LV	O
cavity	O
size	O
was	O
normal	O
.	O

The	B-test
systolic	I-test
function	I-test
was	O
within	O
normal	O
limits	O
.	O

There	O
was	O
no	O
evidence	O
of	O
LV	B-problem
hypertrophy	I-problem
.	O

There	O
was	O
no	O
obvious	O
segmental	B-problem
wall-motion	I-problem
abnormality	I-problem
.	O

There	O
was	O
no	O
evidence	O
of	O
pericardial	B-problem
effusion	I-problem
.	O

The	O
right	O
ventricle	O
was	O
not	O
dilated	B-problem
.	O

The	B-test
systolic	I-test
function	I-test
was	O
within	O
normal	O
limits	O
.	O

The	O
patient	O
underwent	O
a	B-test
sleep	I-test
study	I-test
,	O
the	O
first	O
part	O
,	O
which	O
showed	O
that	O
he	O
had	O
75	B-problem
respiratory	I-problem
events	I-problem
observed	O
with	O
apnea	B-problem
,	O
hypopnea	B-test
index	I-test
of	O
11	O
an	O
hour	O
.	O

The	B-test
mean	I-test
heart	I-test
rate	I-test
was	O
68	O
.	O

They	O
felt	O
that	O
there	O
was	O
obstruction	B-problem
and	O
possible	O
obstruction	B-problem
to	I-problem
airflow	I-problem
generating	O
some	B-problem
obstructive	I-problem
apnea	I-problem
,	O
as	O
well	O
as	O
partial	B-problem
obstructive	I-problem
events	I-problem
.	O

They	O
recommended	O
that	O
the	O
patient	O
may	O
benefit	O
from	O
a	O
trial	O
of	O
continuous	B-treatment
positive	I-treatment
pressure	I-treatment
at	I-treatment
the	I-treatment
bedside	I-treatment
.	O

The	O
patient	O
has	O
been	O
scheduled	O
to	O
have	O
the	O
second	O
part	O
of	O
the	B-test
sleep	I-test
study	I-test
done	O
on	O
June	O
18	O
,	O
2006	O
,	O
at	O
8:30	O
p.m.	O
at	O
RWH	O
in	O
the	O
Esley	O
Community	O
Hospital	O
,	O
10th	O
floor	O
sleep	O
lab	O
,	O
phone	O
number	O
133-225-1257	O
.	O

Prior	O
to	O
discharge	O
today	O
,	O
he	O
underwent	O
PFTs	B-test
.	O

The	O
results	O
of	O
the	B-test
PFTs	I-test
are	O
unavailable	O
at	O
the	O
time	O
of	O
this	O
dictation	O
.	O

Based	O
on	O
all	B-test
the	I-test
tests	I-test
above	I-test
,	O
it	O
was	O
felt	O
that	O
the	O
patient	O
was	O
stable	O
for	O
discharge	O
home	O
.	O

His	B-test
blood	I-test
pressure	I-test
was	O
114	O
to	O
123/62	O
.	O

Heart	B-test
rate	I-test
69	O
to	O
80	O
.	O

Room	B-test
air	I-test
saturation	I-test
96%	O
.	O

Temperature	B-test
97.9	O
.	O

Lung	B-test
sounds	I-test
clear	O
bilaterally	O
.	O

Heart	O
sounds	O
:	O

Regular	O
rate	O
and	O
rhythm	O
;	O
S1-S2	O
;	O
positive	O
S4	O
;	O
no	O
murmur	B-problem
.	O

Abdomen	O
:	O

Soft	O
,	O
nontender	O
,	O
nondistended	O
;	O
no	O
guarding	B-problem
;	O
no	O
masses	B-problem
;	O
positive	O
bowel	B-test
sounds	I-test
X4	O
.	O

Right	O
groin	O
status	B-problem
post	I-problem
catheterization	I-problem
showed	O
no	O
hematoma	B-problem
or	O
bruit	B-problem
.	O

Lower	B-test
extremity	I-test
pulses	I-test
were	O
intact	O
without	O
any	O
edema	B-problem
.	O

Lab	O
values	O
:	O

Sodium	B-test
139	O
;	O
potassium	B-test
4.1	O
;	O
BUN	B-test
15	O
;	O
creatinine	B-test
1.1	O
;	O
magnesium	B-test
1.6	O
;	O
SGPT	B-test
19	O
;	O
SGOT	B-test
20	O
;	O
alkaline	B-test
phosphatase	I-test
66	O
;	O
total	B-test
bilirubin	I-test
0.6	O
;	O
direct	B-test
bilirubin	I-test
0.2	O
;	O
total	B-test
cholesterol	I-test
234	O
;	O
triglycerides	B-test
274	O
;	O
HDL	B-test
44	O
;	O
LDL	B-test
135	O
;	O
hemoglobin	B-test
A1c	B-test
6.7	O
;	O
white	B-test
cell	I-test
count	I-test
6.1	O
;	O
hematocrit	B-test
36.4	O
;	O
platelet	B-test
count	I-test
201	O
.	O

During	O
the	O
hospital	O
course	O
,	O
the	O
patient	O
was	O
started	O
on	O
a	B-treatment
PPI	I-treatment
,	O
Nexium	B-treatment
,	O
for	O
concerns	O
of	O
acid	B-problem
reflux	I-problem
.	O

Also	O
,	O
a	O
long	O
discussion	O
was	O
taken	O
with	O
the	O
patient	O
as	O
most	O
of	O
his	B-problem
chest	I-problem
discomfort	I-problem
happens	O
when	O
he	O
is	O
quite	O
anxious	B-problem
.	O

He	O
used	O
Ativan	B-treatment
in	O
the	O
hospital	O
,	O
which	O
helped	O
him	O
.	O

The	O
patient	O
was	O
advised	O
that	O
he	O
needs	O
to	O
speak	O
with	O
his	O
PCP	O
about	O
medication	B-treatment
for	I-treatment
antianxiety	I-treatment
and	O
/	O
or	O
further	B-test
testing	I-test
or	O
counseling	B-treatment
to	O
help	O
control	O
his	B-problem
anxiety	I-problem
level	I-problem
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Nitroglycerin	B-treatment
1	O
tablet	O
sublingual	O
q.	O
5	O
minutes	O
X3	O
p.r.n.	O
chest	B-problem
pain	I-problem
.	O

TriCor	B-treatment
145	O
mg	O
p.o.	O
every	O
day	O
.	O

Lipitor	B-treatment
40	O
mg	O
p.o.	O
every	O
day	O
.	O

Plavix	B-treatment
75	O
mg	O
p.o.	O
every	O
day	O
.	O

Aspirin	B-treatment
325	O
mg	O
p.o.	O
every	O
day	O
.	O

Lisinopril	B-treatment
5	O
mg	O
p.o.	O
every	O
day	O
.	O

Avandia	B-treatment
4	O
mg	O
p.o.	O
every	O
day	O
.	O

Toprol	B-treatment
XL	I-treatment
100	O
mg	O
p.o.	O
every	O
day	O
.	O

Prilosec	B-treatment
20	O
mg	O
p.o.	O
every	O
day	O
.	O

Ativan	B-treatment
0.5	O
mg	O
p.o.	O
b.i.d.	O
p.r.n.	O
anxiety	B-problem
.	O

The	O
patient	O
was	O
asked	O
to	O
follow	O
up	O
with	O
his	O
PCP	O
,	O
Dr.	O
Cora	O
Belbsnil	O
,	O
at	O
Necrestneysagiles	O
Medical	O
Center	O
in	O
a	O
period	O
of	O
1	O
to	O
2	O
weeks	O
.	O

He	O
was	O
asked	O
to	O
follow	O
up	O
with	O
Dr.	O
Riale	O
Tables	O
,	O
his	O
cardiologist	O
,	O
in	O
a	O
period	O
of	O
1	O
to	O
2	O
weeks	O
;	O
he	O
also	O
works	O
at	O
Necrestneysagiles	O
Medical	O
Center	O
.	O

The	O
patient	O
was	O
told	O
that	O
he	O
should	O
discus	O
with	O
his	O
PCP	O
further	B-test
GI	I-test
testing	I-test
,	O
as	O
well	O
as	O
medications	B-treatment
for	O
anxiety	B-problem
.	O

The	O
patient	O
will	O
need	O
to	O
have	O
a	B-test
followup	I-test
sleep	I-test
study	I-test
done	O
as	O
above	O
per	O
the	O
recommendations	O
based	O
on	O
the	O
results	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

RYROL	O
DALEDAE	O
,	O
NP	O

DICTATING	O
FOR	O
:	O

Unreviewed	O

_____________________________	O
NAA	O
NARICHA	O
EARLY	O
,	O
M.D.	O

TR	O
:	O

so	O

DD	O
:	O

05/16/2006	O

TD	O
:	O

05/17/2006	O
7:29	O
A	O
501370	O

cc	O
:	O

NAA	O
NARICHA	O
EARLY	O
,	O
M.D.	O

817406016	O
RWH	O

3154334	O

554691	O

3547577	O

7/6/2005	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

JEMSKOP	O
,	O
COT	O

MRN	O
:	O

3154334	O

Age	O
:	O

54y	O

REGISTRATION	O
DATE	O
:	O

07/06/2005	O
11:11	O
AM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
JEMSKOP	O
,	O
COT	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Ro	O
Woodma	O
Healthcare	O
on	O
07/06/2005	O
11:11	O
AM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
CP	B-problem
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
admitted	O
as	O
an	O
inpatient	O
to	O
Ro	O
Woodma	O
Healthcare	O
.	O

The	O
patient	O
&apos;s	O
preliminary	O
admitting	O
physician	O
is	O
KOTEDAIZREKE	O
,	O
LILA	O
and	O
the	O
preliminary	O
admitting	O
diagnosis	O
is	O
CP	B-problem
.	O

Please	O
note	O
this	O
information	O
may	O
have	O
been	O
updated	O
on	O
the	O
inpatient	O
unit	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
662-747-1199	O
.	O

PCP	O
Name	O
:	O

TITCHEAGNERO	O
,	O
TO	O

Provider	O
Number	O
:	O

98076	O

825330116	O

HLGMC	O

6051380	O

10615/2646	O

8/15/1993	O
12:00:00	O
AM	O

ACUTE	B-problem
MYOCARDIAL	I-problem
INFARCTION	I-problem
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

8-15-93	O

DISCHARGE	O
DATE	O
:	O

08-22-93	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Acute	B-problem
myocardial	I-problem
infarction	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

1.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
,	O

2.	O
unstable	B-problem
angina	I-problem
(	I-problem
postmyocardial	I-problem
infarction	I-problem
angina	I-problem
)	I-problem
,	O

3.	O
Parkinson	B-problem
&apos;s	I-problem
disease	I-problem
.	O

SPECIAL	O
PROCEDURES	O
AND	O
OPERATIONS	O
:	O

1.	O
Percutaneous	B-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
and	O
coronary	B-treatment
atherectomy	I-treatment
of	I-treatment
the	I-treatment
left	I-treatment
anterior	I-treatment
descending	I-treatment
,	O
8-17-93	O
,	O

2.	O
relook	O
coronary	B-test
angiogram	I-test
,	O
08-18-93	O
.	O

DOCTORS	O
DISCHARGE	O
ORDERS	O
AND	O
MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Ecotrin	B-treatment
1	O
tablet	O
PO	O
qd	O
,	O
Captopril	B-treatment
6.25	O
mg	O
PO	O
tid	O
,	O
K-Dur	B-treatment
20	O
mEq.	O
PO	O
qd	O
,	O
Lasix	B-treatment
20	O
mg	O
PO	O
qd	O
,	O
Isordil	B-treatment
10	O
mg	O
PO	O
tid	O
,	O
Sinemet	B-treatment
1/2	O
tablet	O
PO	O
bid	O
,	O
Symmetrel	B-treatment
100	O
mg	O
PO	O
bid	O
,	O
Parloder	B-treatment
2.5mg	O
PO	O
qd	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
58	O
year	O
old	O
female	O
with	O
a	O
history	O
of	O
Parkinson	B-problem
&apos;s	I-problem
disease	I-problem
for	O
more	O
than	O
twenty	O
years	O
who	O
presented	O
to	O
the	O
Gemenadentoolpai	O
Medical	O
Center	O
with	O
a	B-problem
revolving	I-problem
anterolateral	I-problem
wall	I-problem
myocardial	I-problem
infarction	I-problem
on	O
08-01-93	O
.	O

She	O
has	O
been	O
under	O
the	O
care	O
of	O
Dr.	O
Aalv	O
Manual	O
and	O
was	O
referred	O
here	O
for	O
further	B-treatment
therapy	I-treatment
.	O

She	O
had	O
no	O
prior	O
significant	O
cardiac	O
history	O
and	O
presented	O
to	O
her	O
local	O
medical	O
doctor	O
&apos;s	O
office	O
with	O
an	O
episode	O
of	O
severe	B-problem
retrosternal	I-problem
chest	I-problem
pain	I-problem
.	O

Her	B-test
electrocardiogram	I-test
showed	O
a	B-problem
new	I-problem
right	I-problem
bundle	I-problem
branch	I-problem
block	I-problem
and	O
left	B-problem
anterior	I-problem
hemiblock	I-problem
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
Gemenadentoolpai	O
Medical	O
Center	O
and	O
was	O
admitted	O
.	O

Her	B-treatment
hospital	I-treatment
course	I-treatment
was	O
remarkable	O
for	O
ruling	O
in	O
for	O
a	B-problem
myocardial	I-problem
infarction	I-problem
with	O
a	B-test
peak	I-test
CPK	I-test
of	O
9,379	O
units	O
with	O
a	O
5.9%	O
MB	O
fraction	O
.	O

In	O
addition	O
,	O
on	O
telemetry	B-test
she	O
developed	O
complete	B-problem
heart	I-problem
block	I-problem
and	O
hypotension	B-problem
requiring	O
temporary	B-treatment
pacing	I-treatment
wire	I-treatment
and	O
then	O
a	B-treatment
permanent	I-treatment
pacemaker	I-treatment
implantation	I-treatment
on	O
08-03-93	O
.	O

She	O
developed	O
congestive	B-problem
heart	I-problem
failure	I-problem
and	O
required	O
pressor	B-treatment
support	I-treatment
.	O

She	O
underwent	O
cardiac	B-test
catheterization	I-test
on	O
8-15-93	O
and	O
was	O
found	O
to	O
have	O
a	B-test
left	I-test
ventricular	I-test
end	I-test
diastolic	I-test
pressure	I-test
of	O
28	O
millimeters	O
of	O
mercury	O
.	O

She	O
had	O
a	B-problem
dominant	I-problem
right	I-problem
coronary	I-problem
artery	I-problem
with	O
minor	B-problem
disease	I-problem
.	O

The	O
main	O
left	O
coronary	O
artery	O
had	O
a	B-problem
20%	I-problem
stenosis	I-problem
.	O

The	O
left	O
anterior	O
descending	O
had	O
a	B-problem
severe	I-problem
80%	I-problem
proximal	I-problem
stenosis	I-problem
with	O
a	B-problem
filling	I-problem
defect	I-problem
consistent	O
with	O
intraluminal	B-problem
thrombus	I-problem
.	O

The	O
circumflex	O
artery	O
had	O
a	B-problem
minor	I-problem
40%	I-problem
stenosis	I-problem
.	O

Cine	B-test
left	I-test
ventriculogram	I-test
revealed	O
a	B-problem
dilated	I-problem
left	I-problem
ventricle	I-problem
with	O
an	B-problem
area	I-problem
of	I-problem
anterolateral	I-problem
,	I-problem
apical	I-problem
,	I-problem
and	I-problem
septal	I-problem
akinesis	I-problem
.	O

The	B-test
left	I-test
ventricular	I-test
ejection	I-test
fraction	I-test
was	O
estimated	O
to	O
38%	O
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
Heaonboburg	O
Linpack	O
Grant	O
Medical	O
Center	O
for	O
consideration	O
of	O
coronary	B-treatment
angioplasty	I-treatment
.	O

CARDIAC	O
RISK	O
FACTORS	O
:	O

Her	B-problem
risk	I-problem
factors	I-problem
for	O
coronary	B-problem
artery	I-problem
disease	I-problem
included	O
a	B-problem
positive	I-problem
family	I-problem
history	I-problem
and	O
an	B-problem
elevated	I-problem
cholesterol	I-problem
level	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Her	O
past	O
medical	O
history	O
is	O
remarkable	O
for	O
a	O
history	O
of	O
Parkinson	B-problem
&apos;s	I-problem
disease	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Her	B-test
physical	I-test
examination	I-test
at	O
the	O
time	O
of	O
admission	O
revealed	O
a	O
pleasant	O
lady	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

The	B-test
blood	I-test
pressure	I-test
was	O
120/70	O
millimeters	O
of	O
mercury	O
.	O

Her	B-test
pulse	I-test
was	O
regular	O
at	O
80	O
beats	O
per	O
minute	O
.	O

The	B-test
jugular	I-test
venous	I-test
pressure	I-test
was	O
elevated	O
at	O
6	O
cm	O
above	O
the	O
sternal	O
angle	O
.	O

The	O
carotids	O
were	O
normal	O
.	O

The	O
chest	O
was	O
clear	O
.	O

The	B-test
cardiac	I-test
examination	I-test
revealed	O
anapical	B-problem
impulse	I-problem
in	I-problem
the	I-problem
fifth	I-problem
left	I-problem
intercostal	I-problem
space	I-problem
,	O
left	O
to	O
mid	O
clavicular	O
line	O
.	O

The	O
first	O
sound	O
was	O
normal	O
.	O

The	O
second	O
sound	O
was	O
normally	O
split	O
.	O

She	O
had	O
no	O
murmurs	B-problem
and	O
no	O
gallops	B-problem
.	O

The	B-test
examination	I-test
the	I-test
abdomen	I-test
was	O
benign	O
.	O

The	B-test
examination	I-test
of	I-test
the	I-test
extremities	I-test
showed	O
no	O
edema	B-problem
.	O

She	O
had	O
good	O
pulses	O
bilaterally	O
.	O

LABORATORY	O
DATA	O
:	O

Her	B-test
electrocardiogram	I-test
revealed	O
normal	O
sinus	O
rhythm	O
,	O
left	B-problem
atrial	I-problem
enlargement	I-problem
,	O
left	B-problem
axis	I-problem
deviation	I-problem
,	O
poor	B-problem
R-wave	I-problem
progression	I-problem
in	O
V1	O
through	O
V4	O
,	O
consistent	O
with	O
marked	O
clockwise	O
rotation	O
,	O
cannot	O
rule	O
out	O
an	B-problem
old	I-problem
anteroseptal	I-problem
wall	I-problem
myocardial	I-problem
infarction	I-problem
.	O

There	O
were	O
prominent	B-problem
Q-waves	I-problem
in	I-problem
AVL	I-problem
,	O
consistent	O
with	O
lateral	B-problem
myocardial	I-problem
infarction	I-problem
.	O

There	O
were	O
non-specific	B-problem
ST-T	I-problem
wave	I-problem
abnormalities	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Medical	O
Service	O
.	O

The	O
patient	O
was	O
seen	O
in	O
consultation	O
by	O
the	O
Neurology	O
Department	O
because	O
of	O
the	O
history	O
of	O
Parkinson	B-problem
&apos;s	I-problem
disease	I-problem
.	O

The	O
patient	O
was	O
maintained	O
on	O
intravenous	B-treatment
heparin	I-treatment
.	O

On	O
8-17-93	O
,	O
she	O
was	O
taken	O
to	O
the	O
cardiac	O
catheterization	O
laboratory	O
where	O
she	O
underwent	O
percutaneous	B-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
of	I-treatment
the	I-treatment
proximal	I-treatment
left	I-treatment
anterior	I-treatment
descending	I-treatment
.	O

Following	O
balloon	B-treatment
angioplasty	I-treatment
,	O
there	O
was	O
a	B-treatment
local	I-treatment
dissection	I-treatment
with	O
evidence	O
of	O
intraluminal	B-problem
thrombus	I-problem
,	O
with	O
a	B-problem
greater	I-problem
than	I-problem
10%	I-problem
loss	I-problem
in	I-problem
the	I-problem
initial	I-problem
gain	I-problem
following	O
coronary	B-treatment
angioplasty	I-treatment
.	O

Therefore	O
,	O
directional	B-treatment
coronary	I-treatment
atherectomy	I-treatment
was	O
performed	O
with	O
an	O
excellent	O
angiographic	O
outcome	O
,	O
and	O
a	B-problem
less	I-problem
than	I-problem
10%	I-problem
residual	I-problem
narrowing	I-problem
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
.	O

She	O
was	O
maintained	O
on	O
intravenous	B-treatment
heparin	I-treatment
and	O
was	O
brought	O
back	O
to	O
the	B-test
cardiac	I-test
catheterization	I-test
laboratory	I-test
on	O
08-18-93	O
for	O
a	B-test
relook	I-test
coronary	I-test
angiography	I-test
.	O

Coronary	B-test
angiography	I-test
demonstrated	O
ongoing	O
benefit	O
of	O
the	B-treatment
initial	I-treatment
coronary	I-treatment
atherectomy	I-treatment
.	O

Specifically	O
,	O
there	O
was	O
no	O
decrease	O
in	O
the	O
initial	O
gain	O
that	O
she	O
achieved	O
after	O
directional	B-treatment
atherectomy	I-treatment
.	O

The	O
patient	O
remained	O
stable	O
during	O
the	O
rest	O
of	O
the	O
hospitalization	O
.	O

She	O
was	O
transferred	O
in	O
stable	O
condition	O
to	O
the	O
Pasi	O
for	O
further	B-treatment
rehabilitation	I-treatment
therapy	I-treatment
.	O

RENLAN	O
FYFEZEIS	O
,	O
M.D.	O

Dr.	O
Aalv	O
Lorjes	O
Salv	O
Manual	O
Pasi	O

TR	O
:	O

jb	O
/	O
bmot	O

DD	O
:	O

9-17-93	O

TD	O
:	O

09/19/93	O

CC	O
:	O

837898389	O

CTMC	O

88360969	O

394521	O

11/24/1994	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

11/24/1994	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

1)	O
RIGHT	B-problem
LOWER	I-problem
EXTREMITY	I-problem
PSEUDOMONAS	I-problem
CELLULITIS	I-problem
.	O

2)	O
PAROXYSMAL	B-problem
ATRIAL	I-problem
FIBRILLATION	I-problem
.	O

3)	O
CORD	B-problem
COMPRESSION	I-problem
.	O

4)	O
STEROID	B-problem
INDUCED	I-problem
DIABETES	I-problem
MELLITUS	I-problem
.	O

5)	O
PLASMACYTOMA	B-problem
.	O

6)	O
POOR	B-problem
NUTRITIONAL	I-problem
STATUS	I-problem
.	O

7)	O
THROMBOCYTOPENIA	B-problem
STATUS	O
POST	O
BONE	B-treatment
MARROW	I-treatment
TRANSPLANT	I-treatment
.	O

8)	O
MULTIPLE	B-problem
MYELOMA	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
59-year-old	O
white	O
male	O
.	O

The	O
patient	O
has	O
had	O
multiple	B-problem
myeloma	I-problem
since	O
1990	O
.	O

He	O
underwent	O
an	B-treatment
autologous	I-treatment
bone	I-treatment
marrow	I-treatment
transplant	I-treatment
in	O
10/92	O
at	O
Petersly	O
Hospital	O
And	O
Medical	O
Center	O
.	O

At	O
that	O
time	O
he	O
received	O
total	B-treatment
body	I-treatment
irradiation	I-treatment
of	O
1400	O
cGy	O
.	O

This	B-treatment
bone	I-treatment
marrow	I-treatment
transplant	I-treatment
did	O
not	O
produce	O
remission	O
and	O
then	O
he	O
was	O
treated	O
with	O
three	B-treatment
cycles	I-treatment
of	I-treatment
VAD	I-treatment
subsequently	O
.	O

In	O
08/94	O
,	O
the	O
patient	O
developed	O
lower	B-problem
back	I-problem
pain	I-problem
.	O

A	B-test
workup	I-test
done	O
in	O
DE	O
is	O
not	O
available	O
at	O
the	O
time	O
of	O
this	O
dictation	O
.	O

According	O
to	O
her	O
scanty	O
records	O
,	O
an	B-test
MRI	I-test
of	I-test
the	I-test
spine	I-test
showed	O
diffuse	B-problem
spinal	I-problem
column	I-problem
involvement	I-problem
with	O
lesions	B-problem
in	I-problem
T4	I-problem
and	I-problem
T8	I-problem
with	O
no	O
cord	B-problem
compression	I-problem
at	O
that	O
time	O
.	O

He	O
was	O
then	O
treated	O
with	O
radiation	B-treatment
therapy	I-treatment
from	O
T3	O
to	O
T9	O
receiving	O
2500	O
cGy	O
from	O
08/94	O
to	O
09/94	O
.	O

He	O
has	O
been	O
on	O
Decadron	B-treatment
since	O
08/94	O
.	O

About	O
two	O
weeks	O
prior	O
to	O
admission	O
the	O
patient	O
developed	O
mid	B-problem
back	I-problem
pain	I-problem
,	O
burning	O
in	O
nature	O
with	O
radiation	O
around	O
the	O
right	O
lower	O
ribs	O
.	O

He	O
also	O
began	O
to	O
develop	O
noticeably	B-problem
increasing	I-problem
bilateral	I-problem
lower	I-problem
extremity	I-problem
weakness	I-problem
and	O
possibly	O
numbness	B-problem
in	I-problem
the	I-problem
lower	I-problem
extremities	I-problem
.	O

He	O
stated	O
that	O
he	O
had	O
difficulty	B-problem
rising	I-problem
from	I-problem
a	I-problem
chair	I-problem
.	O

An	B-test
MRI	I-test
without	I-test
gadolinium	I-test
done	O
on	O
11/20/94	O
of	O
the	O
spine	O
showed	O
a	B-problem
right	I-problem
posterior	I-problem
lateral	I-problem
epidural	I-problem
mass	I-problem
extending	O
from	O
T9	O
to	O
T12	O
.	O

There	O
was	O
evidence	O
of	O
cord	B-problem
compression	I-problem
.	O

The	B-treatment
patient	I-treatment
&apos;s	I-treatment
Decadron	I-treatment
dose	I-treatment
was	O
increased	O
to	O
12	O
mg	O
q	O
day	O
and	O
he	O
was	O
also	O
started	O
on	O
MS	B-treatment
Contin	I-treatment
and	O
radiation	B-treatment
therapy	I-treatment
was	O
being	O
planned	O
and	O
arranged	O
at	O
the	O
Petersly	O
Hospital	O
And	O
Medical	O
Center	O
.	O

However	O
,	O
one	O
day	O
prior	O
to	O
admission	O
the	O
patient	O
developed	O
right	B-problem
lower	I-problem
extremity	I-problem
pain	I-problem
and	O
could	O
not	O
walk	O
secondary	O
to	O
the	B-problem
pain	I-problem
.	O

Over	O
the	O
next	O
12	O
hours	O
while	O
in	O
transit	O
to	O
the	O
hospital	O
,	O
the	O
patient	O
&apos;s	O
right	O
lower	O
extremity	O
became	O
red	B-problem
,	O
swollen	B-problem
,	O
and	O
increasingly	B-problem
painful	I-problem
.	O

He	O
has	O
had	O
chronic	B-problem
bilateral	I-problem
lower	I-problem
extremity	I-problem
swelling	I-problem
since	O
his	B-treatment
transplant	I-treatment
but	O
the	B-problem
right	I-problem
lower	I-problem
extremity	I-problem
swelling	I-problem
was	O
noticeably	O
increased	O
.	O

He	O
also	O
complained	O
of	O
some	B-problem
fecal	I-problem
incontinence	I-problem
the	O
day	O
prior	O
to	O
admission	O
without	O
urinary	B-problem
incontinence	I-problem
.	O

At	O
the	O
time	O
of	O
presentation	O
the	O
patient	O
denied	O
headache	B-problem
,	O
arm	B-problem
weakness	I-problem
,	O
changes	B-problem
in	I-problem
vision	I-problem
,	O
dysarthria	B-problem
,	O
abdominal	B-problem
pain	I-problem
,	O
nausea	B-problem
or	O
vomiting	B-problem
,	O
chest	B-problem
pain	I-problem
or	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

He	O
was	O
taken	O
to	O
Huyychestleme	O
Health	O
Of	O
in	O
Scoo	O
,	O
Utah	O
where	O
he	O
had	O
a	B-test
temperature	I-test
of	O
99.9	O
,	O
blood	B-test
pressure	I-test
90/50	O
,	O
heart	B-test
rate	I-test
128	O
,	O
and	O
O2	B-test
sat	I-test
of	O
91%	O
on	O
room	O
air	O
.	O

Blood	B-test
cultures	I-test
,	O
urine	B-test
culture	I-test
,	O
and	O
UA	B-test
were	O
all	O
done	O
.	O

Blood	B-test
cultures	I-test
drawn	O
on	O
admission	O
subsequently	O
grew	O
Pseudomonas	B-problem
aeruginosa	I-problem
.	O

He	O
was	O
treated	O
with	O
Ceftazidime	B-treatment
,	O
gentamicin	B-treatment
,	O
and	O
Vancomycin	B-treatment
and	O
also	O
was	O
started	O
on	O
a	B-treatment
Dopamine	I-treatment
drip	I-treatment
for	O
treatment	O
of	O
his	B-problem
sepsis	I-problem
.	O

A	B-test
Swan	I-test
was	O
placed	O
and	O
initial	O
readings	O
were	O
CVP	B-test
of	O
6	O
,	O
wedge	B-test
pressure	I-test
of	O
10	O
to	O
12	O
,	O
cardiac	B-test
index	I-test
of	O
4.7	O
,	O
and	O
SVR	B-test
of	O
438	O
all	O
consistent	O
with	O
a	B-problem
Pseudomonas	I-problem
sepsis	I-problem
picture	I-problem
.	O

He	O
was	O
given	O
stress	B-treatment
steroids	I-treatment
and	O
was	O
subsequently	O
transferred	O
to	O
Lorough	O
Medical	O
Center	O
&apos;s	O
Intensive	O
Care	O
Unit	O
for	O
further	B-treatment
management	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1)	O
Multiple	B-problem
myeloma	I-problem
.	O

2)	O
Paroxysmal	B-problem
atrial	I-problem
fibrillation	I-problem
.	O

3)	O
Plasmacytoma	B-problem
of	I-problem
T9	I-problem
through	I-problem
T12	I-problem
.	O

4)	O
Chronic	B-problem
renal	I-problem
insufficiency	I-problem
.	O

5)	O
Chronically	B-problem
low	I-problem
platelet	I-problem
count	I-problem
.	O

6)	O
Failed	B-treatment
autologous	I-treatment
bone	I-treatment
marrow	I-treatment
transplant	I-treatment
in	O
10/92	O
.	O

7)	O
Hypothyroidism	B-problem
.	O

FAMILY	O
HISTORY	O
:	O

Positive	O
for	O
diabetes	B-problem
mellitus	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

Married	O
to	O
a	O
very	O
supportive	O
wife	O
.	O

ALLERGIES	O
:	O

Question	O
of	O
penicillin	B-treatment
and	O
sulfa	B-treatment
drugs	I-treatment
leading	O
to	O
a	B-problem
rash	I-problem
.	O

MEDICATIONS	O
:	O

On	O
transfer	O
include	O
Vancomycin	B-treatment
,	O
Ceftazidime	B-treatment
,	O
gentamicin	B-treatment
,	O
Solu	B-treatment
Cortef	I-treatment
100	O
mg	O
q8h	O
,	O
Lasix	B-treatment
,	O
Synthroid	B-treatment
,	O
insulin	B-treatment
,	O
MS	B-treatment
Contin	I-treatment
60	O
mg	O
b.i.d.	O
,	O
MSO4	B-treatment
2	O
mg	O
p.r.n.	O
pain	B-problem
IV	O
,	O
Dopamine	B-treatment
12	O
mcg	O
per	O
minute	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
showed	O
a	O
non-toxic	O
appearing	O
male	O
with	O
temperature	B-test
99.5	O
,	O
blood	B-test
pressure	I-test
82/50	O
,	O
heart	B-test
rate	I-test
118	O
,	O
respiratory	B-test
rate	I-test
15	O
.	O

HEENT	B-test
exam	I-test
atraumatic	B-problem
,	O
no	O
oral	B-problem
lesions	I-problem
.	O

Neck	O
supple	O
,	O
carotids	O
without	O
bruits	B-problem
.	O

Cardiac	B-test
exam	I-test
was	O
regular	O
S1	O
and	O
S2	O
,	O
no	O
murmur	B-problem
.	O

Chest	O
clear	O
to	O
auscultation	B-test
with	O
a	B-problem
few	I-problem
fine	I-problem
crackles	I-problem
at	I-problem
the	I-problem
left	I-problem
base	I-problem
.	O

Abdomen	O
non-distended	B-problem
,	O
positive	O
bowel	O
sounds	O
,	O
soft	O
,	O
non-tender	B-problem
,	O
no	O
hepatosplenomegaly	B-problem
or	O
masses	B-problem
.	O

Rectal	O
normal	O
tone	O
,	O
guaiac	B-problem
positive	I-problem
brown	I-problem
stool	I-problem
,	O
no	O
perirectal	B-problem
lesions	I-problem
or	O
erythema	B-problem
.	O

Extremities	O
reveal	O
the	O
right	O
lower	O
extremity	O
was	O
tense	B-problem
,	O
purple-red	B-problem
,	O
swollen	B-problem
,	O
and	O
was	O
warm	O
from	O
the	O
knee	O
to	O
the	O
ankle	O
and	O
extremely	B-problem
tender	I-problem
.	O

There	O
was	O
pitting	B-problem
edema	I-problem
of	I-problem
both	I-problem
lower	I-problem
extremities	I-problem
but	O
no	O
evidence	O
of	O
cellulitis	B-problem
of	I-problem
the	I-problem
left	I-problem
lower	I-problem
extremity	I-problem
.	O

Neurological	B-test
exam	I-test
on	I-test
admission	I-test
revealed	O
he	O
was	O
drowsy	B-problem
but	O
easily	O
arousable	O
to	O
voice	O
,	O
oriented	O
to	O
person	O
,	O
Retelk	O
County	O
Medical	O
Center	O
,	O
and	O
date	O
,	O
able	O
to	O
say	O
no	O
but	O
mildly	B-problem
inattentive	I-problem
during	O
examination	B-test
.	O

Cranial	O
nerves	O
intact	O
.	O

Motor	B-test
exam	I-test
normal	O
tone	O
,	O
positive	B-problem
asterixis	I-problem
,	O
no	O
drift	O
.	O

Strength	O
was	O
decreased	O
in	O
both	O
lower	O
extremities	O
.	O

Coordination	O
was	O
normal	O
with	O
good	O
finger	O
to	O
nose	O
,	O
gait	O
was	O
not	O
tested	O
.	O

Deep	B-test
tendon	I-test
reflexes	I-test
were	O
2+	O
in	O
the	O
upper	O
extremities	O
,	O
1+	O
in	O
the	O
patella	B-test
reflexes	I-test
,	O
no	B-problem
reflexes	I-problem
at	I-problem
the	I-problem
ankles	I-problem
,	O
upgoing	O
Babinski	O
toes	O
bilaterally	O
.	O

LABORATORY	O
DATA	O
:	O

On	O
admission	O
revealed	O
white	B-test
blood	I-test
cell	I-test
count	I-test
4.2	O
,	O
Hct	B-test
27	O
,	O
platelet	B-test
count	I-test
28	O
.	O

Glucose	B-test
191	O
.	O

PT	B-test
17.6	O
,	O
PTT	B-test
48.7	O
,	O
fibrinogen	B-test
686	O
,	O
TT	B-test
39.2	O
.	O

Magnesium	B-test
1.7	O
.	O

UA	B-test
showed	O
no	O
white	O
blood	O
cells	O
,	O
positive	B-problem
granular	I-problem
casts	I-problem
.	O

Chest	B-test
x-ray	I-test
was	O
without	O
infiltrates	B-problem
,	O
wand	O
in	O
good	O
position	O
.	O

An	B-test
MRI	I-test
was	O
performed	O
upon	O
admission	O
and	O
showed	O
an	B-problem
epidural	I-problem
mass	I-problem
at	O
the	O
right	O
posterior	O
lateral	O
T9	O
to	O
T12	O
area	O
invading	O
the	O
neural	O
foramina	O
.	O

There	O
was	O
no	O
CSF	B-problem
density	I-problem
.	O

These	B-problem
findings	I-problem
were	O
consistent	O
with	O
the	B-problem
cord	I-problem
compression	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

By	O
problems	O
-	O

1)	O
INFECTIOUS	O
DISEASE	O
/	O
CELLULITIS	O
:	O

The	B-problem
patient	I-problem
&apos;s	I-problem
clinical	I-problem
situation	I-problem
was	O
most	O
consistent	O
with	O
a	B-problem
Pseudomonas	I-problem
cellulitis	I-problem
and	O
subsequent	B-problem
sepsis	I-problem
.	O

Blood	B-test
cultures	I-test
drawn	O
at	O
the	O
outside	O
hospital	O
grew	O
out	O
Pseudomonas	B-problem
that	O
was	O
sensitive	O
to	O
Imipenem	B-treatment
and	O
Tobramycin	B-treatment
.	O

There	O
were	O
cultures	B-test
obtained	O
seeping	O
from	O
the	B-problem
wound	I-problem
at	O
Retelk	O
County	O
Medical	O
Center	O
and	O
those	O
also	O
grew	O
out	O
Pseudomonas	B-problem
aeruginosa	I-problem
.	O

The	B-problem
organism	I-problem
grown	O
at	O
this	O
institution	O
was	O
sensitive	O
to	O
Imipenem	B-treatment
,	O
Ceftazidime	B-treatment
,	O
Amikacin	B-treatment
,	O
gentamicin	B-treatment
,	O
Ciprofloxacin	B-treatment
,	O
Tobramycin	B-treatment
but	O
was	O
resistant	O
to	O
Cefotetan	B-treatment
,	O
Ceftriaxone	B-treatment
,	O
Mezlocillin	B-treatment
,	O
Bactrim	B-treatment
,	O
Ampicillin	B-treatment
,	O
chloramphenicol	B-treatment
,	O
and	O
sulbactam	B-treatment
.	O

He	O
was	O
treated	O
initially	O
with	O
Ceftazidime	B-treatment
and	O
gentamicin	B-treatment
but	O
there	O
was	O
a	O
question	O
about	O
the	B-problem
organism	I-problem
&apos;s	I-problem
susceptibility	I-problem
from	O
lab	B-test
studies	I-test
done	O
at	O
the	O
outside	O
hospital	O
.	O

He	O
was	O
subsequently	O
switched	O
to	O
Imipenem	B-treatment
and	O
Tobramycin	B-treatment
and	O
was	O
maintained	O
on	O
those	B-treatment
medications	I-treatment
throughout	O
the	O
hospital	O
course	O
.	O

The	B-treatment
Tobramycin	I-treatment
and	O
Imipenem	B-treatment
were	O
started	O
on	O
11/25/94	O
.	O

In	O
addition	O
,	O
the	O
patient	O
received	O
a	O
five	O
day	O
course	O
of	O
intravenous	B-treatment
IgG	I-treatment
to	O
improve	O
infection	B-treatment
control	I-treatment
.	O

Vancomycin	B-treatment
was	O
also	O
added	O
to	O
his	B-treatment
regimen	I-treatment
on	O
11/28/94	O
and	O
this	O
was	O
primarily	O
to	O
provide	O
improved	B-treatment
MRSA	I-treatment
coverage	I-treatment
as	O
he	O
continued	O
to	O
have	O
erythema	B-problem
along	I-problem
the	I-problem
lateral	I-problem
right	I-problem
lower	I-problem
extremity	I-problem
.	O

He	O
was	O
evaluated	O
by	O
the	O
Surgery	O
Department	O
and	O
it	O
is	O
there	O
feeling	O
that	O
there	O
is	O
no	O
indication	O
for	O
surgical	B-treatment
intervention	I-treatment
/	O
amputation	B-treatment
at	O
this	O
time	O
.	O

He	O
is	O
being	O
maintained	O
with	O
twice	O
daily	O
Xeroform	B-treatment
with	O
Betadine	B-treatment
changes	O
.	O

These	B-treatment
dressing	I-treatment
changes	I-treatment
are	O
applied	O
by	O
applying	O
the	O
Xeroform	B-treatment
on	O
Betadine	B-treatment
initially	O
and	O
then	O
changing	O
it	O
with	O
sterile	B-treatment
dry	I-treatment
bandages	I-treatment
.	O

Of	O
note	O
,	O
the	O
patient	O
has	O
extreme	B-problem
pain	I-problem
with	O
these	B-treatment
dressing	I-treatment
changes	I-treatment
and	O
requires	O
parenteral	B-treatment
morphine	I-treatment
sulfate	I-treatment
for	O
pain	B-problem
control	I-problem
during	I-problem
dressing	I-problem
changes	I-problem
.	O

The	O
plan	O
is	O
to	O
complete	O
a	O
full	O
course	O
of	O
Imipenem	B-treatment
and	O
Tobramycin	B-treatment
for	O
his	B-problem
Pseudomonas	I-problem
cellulitis	I-problem
.	O

As	O
mentioned	O
earlier	O
he	O
continues	O
to	O
have	O
erythema	B-problem
tracking	O
up	O
his	O
leg	O
and	O
up	O
to	O
his	O
lateral	O
thigh	O
.	O

The	O
cause	O
of	O
this	B-problem
erythema	I-problem
is	O
not	O
know	O
at	O
this	O
time	O
but	O
has	O
not	O
shown	O
extensive	O
progression	O
.	O

2)	O
CARDIOVASCULAR	O
:	O

The	O
patient	O
was	O
initially	O
treated	O
with	O
Dopamine	B-treatment
which	O
was	O
subsequently	O
weaned	O
off	O
after	O
his	B-problem
sepsis	I-problem
improved	O
.	O

He	O
was	O
noted	O
to	O
be	O
in	O
rapid	B-problem
AF	I-problem
on	O
several	O
episodes	O
receiving	O
5	B-treatment
mg	I-treatment
IV	I-treatment
Lopressor	I-treatment
each	O
time	O
with	O
improvement	O
.	O

He	O
has	O
been	O
in	O
and	O
out	O
of	O
atrial	B-problem
fibrillation	I-problem
and	O
normal	O
sinus	O
rhythm	O
.	O

An	B-test
echocardiogram	I-test
performed	O
at	O
the	O
outside	O
hospital	O
while	O
he	O
was	O
septic	B-problem
showed	O
decreased	B-problem
global	I-problem
EF	I-problem
.	O

The	O
patient	O
is	O
being	O
maintained	O
on	O
Digoxin	B-treatment
for	O
his	B-problem
paroxysmal	I-problem
atrial	I-problem
fibrillation	I-problem
.	O

He	O
has	O
had	O
no	O
significant	O
episode	O
of	O
tachycardia	B-problem
or	O
blood	B-problem
pressure	I-problem
alteration	I-problem
during	O
the	O
final	O
days	O
of	O
hospitalization	O
.	O

The	O
plan	O
is	O
to	O
continue	O
the	B-treatment
Digoxin	I-treatment
and	O
to	O
recheck	O
an	B-test
echocardiogram	I-test
to	O
assess	O
his	B-test
ejection	I-test
fraction	I-test
when	O
he	O
is	O
clinically	O
better	O
.	O

3)	O
ONCOLOGY	O
:	O

The	O
patient	O
has	O
a	B-problem
plasmacytoma	I-problem
affecting	O
the	O
spine	O
.	O

He	O
has	O
been	O
receiving	O
radiation	B-treatment
therapy	I-treatment
to	O
that	O
area	O
during	O
the	O
hospital	O
stay	O
.	O

The	O
plan	O
is	O
to	O
complete	O
a	O
full	O
course	O
of	O
XRT	B-treatment
to	I-treatment
the	I-treatment
spinal	I-treatment
region	I-treatment
for	O
the	B-problem
plasmacytoma	I-problem
.	O

The	B-problem
patient	I-problem
&apos;s	I-problem
lesion	I-problem
compressing	O
his	O
thoracic	O
spine	O
was	O
never	O
biopsied	O
,	O
however	O
,	O
the	B-test
MRI	I-test
appearance	O
does	O
not	O
seem	O
to	O
be	O
infectious	B-problem
and	O
is	O
most	O
consistent	O
with	O
plasmacytoma	B-problem
for	O
which	O
he	O
is	O
receiving	O
the	B-treatment
radiation	I-treatment
therapy	I-treatment
.	O

4)	O
NEUROLOGIC	O
:	O

As	O
mentioned	O
above	O
he	O
has	O
a	B-problem
cord	I-problem
compression	I-problem
and	O
is	O
on	O
steroids	B-treatment
.	O

He	O
was	O
initially	O
treated	O
with	O
IV	B-treatment
Decadron	I-treatment
10	O
mg	O
up	O
front	O
and	O
then	O
6	O
mg	O
q6h.	O

His	B-test
neurological	I-test
exam	I-test
remained	O
stable	O
with	O
no	O
evidence	O
of	O
increasing	B-problem
lower	I-problem
extremity	I-problem
edema	I-problem
.	O

His	B-treatment
Decadron	I-treatment
dose	I-treatment
was	O
titrated	O
down	O
to	O
5	O
mg	O
IV	O
q6h	O
on	O
12/3/94	O
.	O

His	B-treatment
Decadron	I-treatment
dose	I-treatment
will	O
be	O
slowly	O
titrated	O
down	O
over	O
time	O
following	O
his	B-test
neurological	I-test
exam	I-test
closely	O
.	O

5)	O
BLOOD	O
SUGARS	O
:	O

The	O
patient	O
has	O
steroid	B-problem
induced	I-problem
diabetes	I-problem
mellitus	I-problem
.	O

He	O
has	O
been	O
on	O
increasing	B-treatment
doses	I-treatment
of	I-treatment
insulin	I-treatment
receiving	O
NPH	B-treatment
in	O
the	O
morning	O
and	O
night	O
in	O
addition	O
to	O
a	B-treatment
CZI	I-treatment
sliding	I-treatment
scale	I-treatment
on	O
a	O
q6h	O
basis	O
.	O

The	O
plan	O
is	O
to	O
continue	O
the	B-treatment
supplemental	I-treatment
insulin	I-treatment
while	O
he	O
is	O
on	O
steroids	B-treatment
and	O
while	O
his	B-test
sugars	I-test
remain	O
high	O
.	O

6)	O
RESPIRATORY	O
:	O

He	O
initially	O
required	O
a	B-treatment
face	I-treatment
mask	I-treatment
to	O
keep	O
his	B-test
saturation	I-test
above	O
90%	O
.	O

However	O
,	O
with	O
increasing	B-treatment
diuresis	I-treatment
and	O
improving	B-problem
septic	I-problem
pictures	I-problem
his	B-test
O2	I-test
saturations	I-test
have	O
improved	O
and	O
he	O
is	O
now	O
on	O
nasal	B-treatment
cannula	I-treatment
and	O
will	O
be	O
maintained	O
on	O
nasal	B-treatment
cannula	I-treatment
to	O
keep	O
his	B-test
sat	I-test
above	O
93%	O
.	O

He	O
can	O
be	O
given	O
intravenous	B-treatment
Lasix	I-treatment
as	O
needed	O
for	O
any	O
evidence	O
of	O
respiratory	B-problem
compromise	I-problem
or	O
increasing	B-problem
pulmonary	I-problem
edema	I-problem
.	O

7)	O
NUTRITION	O
:	O

The	O
patient	O
has	O
a	B-problem
poor	I-problem
nutritional	I-problem
status	I-problem
with	O
hypoalbuminemia	B-problem
.	O

He	O
has	O
been	O
maintained	O
on	O
tube	B-treatment
feeds	I-treatment
and	O
that	O
should	O
be	O
continued	O
.	O

He	O
should	O
also	O
be	O
encouraged	O
to	O
eat	O
as	O
much	O
as	O
possible	O
orally	O
in	O
addition	O
to	O
this	B-treatment
tube	I-treatment
feeds	I-treatment
and	O
aspiration	B-treatment
precaution	I-treatment
should	O
be	O
maintained	O
.	O

8)	O
ELEVATED	B-problem
PT	I-problem
and	I-problem
PTT	I-problem
:	O

Both	O
of	O
these	O
responded	O
to	O
three	O
day	O
course	O
of	O
vitamin	B-treatment
K	I-treatment
10	O
mg	O
each	O
day	O
.	O

His	B-test
PT	I-test
and	O
PTT	B-test
are	O
now	O
normal	O
,	O
however	O
,	O
he	O
continues	O
to	O
run	O
a	B-problem
low	I-problem
platelet	I-problem
count	I-problem
.	O

This	O
has	O
been	O
evident	O
since	O
the	O
time	O
of	O
his	B-treatment
bone	I-treatment
marrow	I-treatment
transplant	I-treatment
.	O

We	O
have	O
been	O
transfusing	O
him	O
with	O
platelets	B-treatment
to	O
keep	O
his	B-test
counts	I-test
above	O
20,000	O
to	O
reduce	O
his	B-problem
bleeding	I-problem
risk	I-problem
.	O

He	O
also	O
received	O
several	B-treatment
blood	I-treatment
transfusions	I-treatment
while	O
here	O
to	O
maintain	O
his	B-test
Hct	I-test
around	O
30	O
.	O

Thrombocytopenic	B-treatment
inducing	I-treatment
drugs	I-treatment
should	O
be	O
avoided	O
if	O
possible	O
on	O
this	O
patient	O
.	O

DISPOSITION	O
:	O

DISCHARGE	O
MEDICATIONS	O
:	O

Tylenol	B-treatment
650	O
mg	O
po	O
q4h	O
p.r.n.	O
,	O
Dulcolax	B-treatment
10	O
mg	O
per	O
rectum	O
b.i.d.	O
p.r.n.	O
,	O
Decadron	B-treatment
5	O
mg	O
IV	O
q6h	O
,	O
Digoxin	B-treatment
0.25	O
mg	O
po	O
q	O
day	O
,	O
Colace	B-treatment
100	O
mg	O
po	O
t.i.d.	O
,	O
Florinef	B-treatment
0.1	O
mg	O
po	O
q	O
day	O
for	O
presumed	O
adrenal	B-problem
insufficiency	I-problem
,	O
Imipenem	B-treatment
500	O
mg	O
IV	O
q6h	O
,	O
insulin	B-treatment
NPH	I-treatment
60	O
units	O
subcu	O
q	O
a.m.	O
,	O
insulin	B-treatment
NPH	I-treatment
20	O
units	O
subcu	O
q	O
p.m.	O
,	O
insulin	B-treatment
CZI	I-treatment
sliding	I-treatment
scale	I-treatment
regular	I-treatment
,	O
Synthroid	B-treatment
125	O
mcg	O
po	O
q	O
day	O
,	O
magnesium	B-treatment
sliding	I-treatment
scale	I-treatment
,	O
potassium	B-treatment
sliding	I-treatment
scale	I-treatment
today	O
,	O
morphine	B-treatment
sulfate	I-treatment
IV	I-treatment
p.r.n.	O
dressing	B-treatment
changes	I-treatment
and	O
breakthrough	B-problem
pain	I-problem
,	O
Carafate	B-treatment
1	O
gm	O
po	O
q.i.d.	O
,	O
Tobramycin	B-treatment
200	O
mg	O
IV	O
q30h	O
,	O
Vancomyin	B-treatment
1	O
mg	O
IV	O
q18h.	O

Dicatated	O
By	O
:	O

LAYMIE	O
WHITE	O
,	O
M.D.	O
WE01	O

Attending	O
:	O

TAMYRCLEO	O
N.	O
BACK	O
,	O
M.D.	O
GP0	O
EA855/4665	O

Batch	O
:	O

669	O

Index	O
No.	O
FXZQ7B8JJX	O

D	O
:	O

12/03/94	O

T	O
:	O

12/03/94	O

839999049	O
YC	O

59242403	O

431924	O

11/01/2000	O
12:00:00	O
AM	O

Obstructive	B-problem
Sleep	I-problem
Apnea	I-problem

DIS	O

Admission	O
Date	O
:	O

11/01/2000	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

11/04/2000	O

******	O
DISCHARGE	O
ORDERS	O
******	O

BREUNCLONTSTREAUAYLES	O
,	O
BINTRIREE	O

766-50-79-4	O
H55	O

Room	O
:	O

42Z-770	O

Service	O
:	O

MED	O

DISCHARGE	O
PATIENT	O
ON	O
:	O
11/04/00	O
AT	O
03:00	O
PM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

AISTAKEFLICHSKI	O
,	O
TAINE	O
D.	O
,	O
M.D.	O

CODE	O
STATUS	O
:	O

Full	O
code	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

WELLBUTRIN	B-treatment
(	I-treatment
BUPROPION	I-treatment
HCL	I-treatment
)	I-treatment
150	O
MG	O
PO	O
BID	O
FOLATE	B-treatment
(	I-treatment
FOLIC	I-treatment
ACID	I-treatment
)	I-treatment
1	O
MG	O
PO	O
QD	O
ATIVAN	B-treatment
(	I-treatment
LORAZEPAM	I-treatment
)	I-treatment
1	O
MG	O
PO	O
Q12H	O
X	O
1	O
Days	O
ATIVAN	B-treatment
(	I-treatment
LORAZEPAM	I-treatment
)	I-treatment
1	O
MG	O
PO	O
QHS	O
X	O
7	O
Days	O
Starting	O
on	O
11/5	O
MVI	B-treatment
THERAPEUTIC	I-treatment
W	I-treatment
/	I-treatment
MINERALS	I-treatment
(	I-treatment
THERAP	I-treatment
VITS	I-treatment
/	I-treatment
MINERALS	I-treatment
)	I-treatment
1	O
TAB	O
PO	O
QD	O

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
11/03/00	O
by	O
TWADA	O
,	O
STASTERL	O
ETHESHI	O
,	O
M.D.	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

SIMVASTATIN	B-treatment
and	O
NIACIN	B-treatment
,	O
VIT.	B-treatment

B-3	B-treatment
Reason	O
for	O
override	O
:	O

indicated	O
THIAMINE	B-treatment
(	I-treatment
THIAMINE	I-treatment
HCL	I-treatment
)	I-treatment
100	O
MG	O
PO	O
QD	O
SIMVASTATIN	B-treatment
40	O
MG	O
PO	O
QHS	O

Override	O
Notice	O
:	O

Override	O
added	O
on	O
11/03/00	O
by	O
TWADA	O
,	O
STASTERL	O
ETHESHI	O
,	O
M.D.	O
on	O
order	O
for	O
MVI	B-treatment
THERAPEUTIC	I-treatment
W	I-treatment
/	I-treatment
MINERALS	I-treatment
PO	I-treatment
(	O
ref	O
#	O
90299469	O
)	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

SIMVASTATIN	B-treatment
and	O
NIACIN	B-treatment
,	O
VIT.	B-treatment
B-3	I-treatment

Reason	O
for	O
override	O
:	O

indicated	O
LISINOPRIL	B-treatment
10	O
MG	O
PO	O
QD	O
NICOTINE	B-treatment
PATCH	I-treatment
(	I-treatment
NICOTINE	I-treatment
)	I-treatment
21	O
MG/DAY	O
TP	O
Q24H	O

DIET	O
:	O

House	O
/	O
NAS	O
/	O
Low	O
chol	O
/	O
low	O
sat.	O
fat	O
&lt;	O
FDI	O
&gt;	O

RETURN	O
TO	O
WORK	O
:	O

Immediately	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Firmert	O
Hospital	O
11/6	O
at	O
9am	O
scheduled	O
,	O
Cialneinsisters	O
Hospital	O
And	O
Medical	O
Center	O
11/16	O
at	O
8:15pm	O
scheduled	O
,	O
Dr.	O
Condnort	O
12/04	O
at	O
2pm	O
scheduled	O
,	O
Dr.	O
Lila	O
Spielbjaque	O
12/01	O
at	O
1:50pm	O
scheduled	O
,	O
No	O
Known	B-problem
Allergies	I-problem

ADMIT	O
DIAGNOSIS	O
:	O

r	O
/	O
o	O
MI	B-problem

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
Obstructive	B-problem
Sleep	I-problem
Apnea	I-problem

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
HTN	B-problem
tobacco	O
EtOh	O
abuse	O
sinus	B-problem
bradycardia	I-problem

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

50	O
yo	O
M	O
from	O
Taheimpromong	O
admitted	O
w	O
/	O
CP	B-problem
for	O
r	O
/	O
o	O
MI	B-problem
.	O

Has	O
significant	B-problem
cardiac	I-problem

RF	O
:	O

FH	O
,	O
HTN	B-problem
,	O
tobacco	O
.	O

Presented	O
w	O
/	O
epigastric	B-problem
pain	I-problem
,	O
SOB	B-problem
at	O
work	O
.	O

ETT	B-test
was	O
negative	O
for	O
ischemia	B-problem
.	O

Echo	B-test
showed	O
ef	B-test
45-50%	O
,	O
with	O
mild	B-problem
dilatation	I-problem
and	O
no	O
significant	B-problem
valvular	I-problem
disease	I-problem
,	O
and	O
nl	O
PAP	O
.	O

ACE	O
team	O
consulted	O
who	O
arranged	O
for	O
pt	O
to	O
have	O
outpt	O
follow	O
up	O
.	O

During	O
this	O
hospitalization	O
,	O
pt	O
was	O
noted	O
to	O
have	O
sinus	B-problem
bradycardia	I-problem
and	O
pauses	B-problem
,	O
associated	O
with	O
desaturations	B-problem
in	I-problem
the	I-problem
70	I-problem
&apos;s	I-problem
.	O

CPAP	B-treatment
at	O
5	O
was	O
attempted	O
,	O
but	O
pt	O
did	O
not	O
tolerate	O
this	O
.	O

He	O
will	O
have	O
outpt	B-treatment
fitting	I-treatment
at	O
the	O
sleep	O
center	O
in	O
Sabo	O
.	O

Pt	O
also	O
counselled	O
re	O
:	O

quitting	O
smoking	O
,	O
and	O
he	O
appears	O
motivated	O
to	O
do	O
so	O
,	O
as	O
well	O
as	O
to	O
cut	O
down	O
on	O
his	O
drinking	O
.	O

ADDITIONAL	O
COMMENTS	O
:	O

1.	O
llame	O
a	O
su	O
doctor	O
y	O
haga	O
cita	O
para	O
verlo	O
dentro	O
de	O
1	O
semana	O
.	O

2.	O
llame	O
a	O
la	O
clinica	O
the	O
Wake	O
Valley	O
Hospital	O
442/961-2446	O
,	O
si	O
tiene	O
que	O
cambiar	O
la	O
cita	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

LARDES	O
,	O
COLNKAY	O
,	O
M.D.	O
(	O
IP09	O
)	O
11/04/00	O
03:34	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

843566350	O
RWH	O

0025596	O

526208	O

0555812	O

1/12/2005	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

KOTEA	O
,	O
TORTHEOA	O

MRN	O
:	O

0025596	O

Age	O
:	O

47y	O

REGISTRATION	O
DATE	O
:	O

01/12/2005	O
06:07	O
AM	O

Provider	O
:	O

THAA	O
WAGES	O

PRELMINARY	O
REPORT	O

Benefits	O
Assigned	O
:	O

N	O

Discharge	O
Note	O

Date	O
/	O
Time	O
:	O

01/12/2005	O
09:17	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

MIGRAINES	B-problem
FOR	O
10	O
DAYS	O

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
headache	B-problem
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

Headache	B-problem

Treatment	O
Rendered	O
:	O

MD	B-treatment
evaluation	I-treatment
,	O
head	B-test
CT	I-test

Discharge	O
Medications	O
:	O

None	O

Follow	O
up	O
Service	O
:	O

Please	O
follow	O
up	O
with	O
Dr.	O
Ner	O

PCP	O
Name	O
:	O

ANERM	O
,	O
CHRETTA	O

Provider	O
Number	O
:	O

25911	O

This	O
report	O
was	O
created	O
by	O
WAGES	O
,	O
THAA	O
01/12/2005	O
09:18	O
AM	O

853262744	O

OMH	O

8223316	O

121051	O

7/10/2002	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

SCOBE	O
,	O
RYLALON	O

MRN	O
:	O

8223316	O

Age	O
:	O

87y	O

REGISTRATION	O
DATE	O
:	O

07/10/2002	O
11:45	O
AM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
SCOBE	O
,	O
RYLALON	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Oaksgekesser/	O
Memorial	O
Hospital	O
on	O
07/10/2002	O
11:45	O
AM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
SOB	B-problem
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
OAKSGEKESSER/	O
MEMORIAL	O
HOSPITAL	O
.	O

The	O
patient	O
&apos;s	O
preliminary	O
admitting	O
physician	O
is	O
BRITTSFYFEAST	O
,	O
SHER	O
T	O
and	O
the	O
preliminary	O
diagnosis	O
is	O
S	O
/	O
SOB	B-problem
.	O

Please	O
note	O
this	O
information	O
may	O
have	O
been	O
updated	O
on	O
the	O
inpatient	O
unit	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
187-715-4303.	O

PCP	O
Name	O
:	O

NEIGHROBLIN	O
,	O
RETTE	O
R	O

Provider	O
Number	O
:	O

74337	O

869436718	O
SC	O

64806295	O

6613471	O

10/1/2003	O
12:00:00	O
AM	O

post	O
partum	O

DIS	O

Admission	O
Date	O
:	O

10/01/2003	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

10/04/2003	O

******	O
DISCHARGE	O
ORDERS	O
******	O

KULRINNE	O
,	O
RYYELEGE	O
N	O

386-85-38-0	O
X32	O

Room	O
:	O

JQL5-545	O

Service	O
:	O

OBS	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

10/04/03	O
AT	O
10:00	O
AM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

KOTEJOASTHOREUPHKAYS	O
,	O
GAI	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

TYLENOL	B-treatment
(	I-treatment
ACETAMINOPHEN	I-treatment
)	I-treatment
650	O
MG	O
PO	O
Q4H	O
PRN	O
PAIN	B-problem

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
10/01/03	O
by	O
KOTEJOASTHOREUPHKAYS	O
,	O
GAI	O
,	O
M.D.	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

ACETAMINOPHEN	B-treatment
and	O
ACETAMINOPHEN	B-treatment

Reason	O
for	O
override	O
:	O

ok	O

COLACE	B-treatment
(	I-treatment
DOCUSATE	I-treatment
SODIUM	I-treatment
)	I-treatment
100	O
MG	O
PO	O
BID	O
IBUPROFEN	B-treatment
600	O
MG	O
PO	O
Q4H	O
PRN	O
PAIN	B-problem

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Take	O
with	O
food	O
MILK	B-treatment
OF	I-treatment
MAGNESIA	I-treatment
(	I-treatment
MAGNESIUM	I-treatment
HYDROXIDE	I-treatment
)	I-treatment
30	O
MILLILITERS	O
PO	O
BID	O
PRN	O
Constipation	B-problem
PERCOCET	B-treatment
1-2	O
TAB	O
PO	O
Q4H	O
PRN	O
PAIN	B-problem

Override	O
Notice	O
:	O

Override	O
added	O
on	O
10/01/03	O
by	O
KOTEJOASTHOREUPHKAYS	O
,	O
GAI	O
,	O
M.D.	O
on	O
order	O
for	O
TYLENOL	B-treatment
PO	O
650	O
MG	O
Q4H	O
(	O
ref	O
#	O
85225311	O
)	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

ACETAMINOPHEN	B-treatment
and	O
ACETAMINOPHEN	B-treatment

Reason	O
for	O
override	O
:	O

ok	O

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Resume	O
regular	O
exercise	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

kotejoasthoreuphkays	O
6	O
weeks	O
,	O

ALLERGY	O
:	O

Sulfa	B-treatment
,	O
Bactrim	B-treatment

ADMIT	O
DIAGNOSIS	O
:	O

Pregnancy	B-problem

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O

post	O
partum	O

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O

twins	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

Primary	O
Anesthesia	O
:	O

Spinal	O

Vaginal	O
delivery	O
:	O

Undelivered	B-problem

Cesarean	O
Status	O
:	O

Primary	O

Urgency	O
:	O

Scheduled	O

Indications	O
:	O

Breech	B-problem
,	O
Multiple	B-problem
gestation	I-problem
,	O

Uterine	O
incision	O
type	O
:	O

Transverse	O

Placenta	O
:	O

Delivery	O
:	O

Spontaneous	O

Condition	O
:	O

Normal	O

Staff	O
Obstetrician	O
(	O
supervising	O
)	O
:	O

KOTEJOASTHOREUPHKAYS	O
,	O
GAI	O
,	O
M.D.	O
Delivery	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

none	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

G3	O
T1	O
P0	O
A1	O
L1	O

Estimated	O
EDC	O
:	O

10/14/03	O

Maternal	O
transfer	O
:	O

No	O

Initial	O
newborn	O
exam	O
:	O

No	O
observed	B-problem
abnormalities	I-problem

Baby	O
1	O

MRN	O
:	O

76306248	O

Delivery	O
date	O
:	O

10/01/03	O
09:06	O
AM	O

Apgars	B-test
8,9	O

Weight	B-test
:	O

7lb	O
1	O
oz	O
3204	O
grams	O

Sex	O
:	O

Male	O

Baby	O
2	O

MRN	O
:	O

62685780	O

Delivery	O
date	O
:	O

10/01/03	O
09:08	O
AM	O

Apgars	B-test
8,8	O

Weight	B-test
:	O

7lb	O
0	O
oz	O
3175	O
grams	O

Sex	O
:	O

Female	O

ADDITIONAL	O
COMMENTS	O
:	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

KOTEJOASTHOREUPHKAYS	O
,	O
GAI	O
,	O
M.D.	O
(	O
CT17	O
)	O
10/04/03	O
07:11	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

879492218	O
YC	O

53470378	O

3210349	O

6/26/2004	O
12:00:00	O
AM	O

PNEUMONIA	B-problem

Signed	O

DIS	O

Admission	O
Date	O
:	O

06/26/2004	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

07/08/2004	O

ATTENDING	O
:	O

MALTA	O
FYFEZEISLEITZ	O
MD	O

CHIEF	O
COMPLAINT	O
:	O

Shortness	B-problem
of	I-problem
breath	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
38-year-old	O
gentleman	O
,	O
Spanish-speaking	O
,	O
from	O
the	O
Taheimpromong	O
,	O
with	O
no	O
significant	O
past	O
medical	O
history	O
,	O
who	O
presents	O
with	O
shortness	B-problem
of	I-problem
breath	I-problem
x	O
2	O
months	O
as	O
well	O
as	O
a	B-problem
dry	I-problem
cough	I-problem
x	O
1	O
month	O
.	O

The	O
patient	O
was	O
in	O
his	O
usual	O
state	O
of	O
health	O
until	O
two	O
months	O
prior	O
to	O
admission	O
when	O
he	O
began	O
to	O
notice	O
shortness	B-problem
of	I-problem
breath	I-problem
on	O
climbing	O
flights	O
of	O
stairs	O
.	O

He	O
stated	O
that	O
this	O
became	O
worse	O
over	O
the	O
last	O
month	O
until	O
he	O
was	O
noted	O
to	O
be	O
short	B-problem
of	I-problem
breath	I-problem
at	O
rest	O
.	O

He	O
also	O
states	O
that	O
he	O
has	O
had	O
a	B-problem
dry	I-problem
and	I-problem
nonproductive	I-problem
cough	I-problem
for	O
one	O
month	O
.	O

He	O
denied	O
any	O
fevers	B-problem
,	O
chills	B-problem
,	O
or	O
night	B-problem
sweats	I-problem
.	O

No	O
nausea	B-problem
,	O
vomiting	B-problem
,	O
or	O
diarrhea	B-problem
.	O

He	O
did	O
note	O
some	B-problem
weight	I-problem
loss	I-problem
over	O
the	O
past	O
several	O
months	O
,	O
though	O
the	O
amount	O
was	O
unknown	O
.	O

He	O
denied	O
any	O
contact	O
with	O
TB	O
positive	O
patients	O
.	O

He	O
describes	O
a	O
negative	O
PPD	O
one	O
year	O
prior	O
to	O
admission	O
when	O
he	O
was	O
in	O
prison	O
for	O
one	O
week	O
.	O

He	O
did	O
travel	O
to	O
the	O
Taheimpromong	O
,	O
last	O
in	O
01/2004	O
for	O
three	O
weeks	O
.	O

He	O
did	O
note	O
multiple	O
female	O
sexual	O
partners	O
,	O
although	O
described	O
using	O
condoms	O
except	O
with	O
his	O
wife	O
.	O

He	O
denies	O
any	O
IV	O
drug	O
use	O
,	O
did	O
describe	O
cocaine	O
use	O
last	O
two	O
months	O
ago	O
.	O

He	O
did	O
drink	O
alcohol	O
three	O
drinks	O
per	O
day	O
,	O
no	O
withdrawal	B-problem
symptoms	I-problem
.	O

In	O
emergency	O
room	O
,	O
he	O
was	O
noted	O
to	O
be	O
afebrile	O
with	O
stable	O
vital	O
signs	O
,	O
was	O
treated	O
with	O
IV	B-treatment
fluids	I-treatment
,	O
azithromycin	B-treatment
,	O
and	O
cefuroxime	B-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

None	O
.	O

MEDICATIONS	O
:	O

None	O
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
currently	O
with	O
a	O
friend	O
,	O
he	O
is	O
from	O
the	O
Taheimpromong	O
and	O
has	O
lived	O
here	O
for	O
13	O
years	O
,	O
he	O
does	O
note	O
multiple	O
sexual	O
partners	O
,	O
although	O
he	O
notes	O
using	O
condoms	O
with	O
everyone	O
except	O
his	O
wife	O
,	O
he	O
reportedly	O
had	O
a	O
negative	O
PPD	O
during	O
his	O
prison	O
stay	O
one	O
year	O
ago	O
for	O
one	O
week	O
.	O

He	O
traveled	O
to	O
the	O
Taheimpromong	O
last	O
in	O
01/2004	O
for	O
one	O
month	O
.	O

He	O
does	O
drink	O
alcohol	O
three	O
drinks	O
per	O
day	O
,	O
denies	O
any	O
current	O
tobacco	O
use	O
.	O

FAMILY	O
HISTORY	O
:	O

Sister	O
with	O
bone	B-problem
cancer	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
UPON	O
ADMISSION	O
:	O

Temperature	B-test
97.4	O
,	O
heart	B-test
rate	I-test
100	O
,	O
blood	B-test
pressure	I-test
142/89	O
,	O
and	O
O2	B-test
saturation	I-test
94%	O
on	O
room	O
air	O
.	O

General	B-test
exam	I-test
revealed	O
a	O
well-developed	O
,	O
well-nourished	O
gentleman	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

HEENT	B-test
exam	I-test
revealed	O
sclerae	B-problem
to	O
be	O
injected	O
.	O

Pupils	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

No	O
lymphadenopathy	B-problem
was	O
noted	O
in	O
the	O
neck	O
,	O
there	O
was	O
a	O
question	O
of	O
right	B-problem
axillary	I-problem
lymphadenopathy	I-problem
.	O

Chest	B-test
exam	I-test
reveals	O
coarse	B-problem
rhonchi	I-problem
with	O
some	B-problem
bibasilar	I-problem
crackles	I-problem
.	O

Abdominal	B-test
exam	I-test
revealed	O
soft	O
,	O
nontender	O
,	O
and	O
nondistended	O
abdomen	O
.	O

Heart	B-test
exam	I-test
was	O
regular	O
rate	O
and	O
rhythm	O
,	O
tachycardic	B-problem
,	O
with	O
a	B-problem
flat	I-problem
jugular	I-problem
venous	I-problem
pressure	I-problem
.	O

His	O
extremities	O
were	O
without	O
cyanosis	B-problem
,	O
clubbing	B-problem
,	O
or	O
edema	B-problem
.	O

His	O
skin	O
was	O
clear	O
,	O
without	O
rashes	B-problem
.	O

There	O
is	O
no	O
hepatosplenomegaly	B-problem
noted	O
on	O
abdominal	B-test
exam	I-test
.	O

Neuro	B-test
exam	I-test
was	O
alert	O
and	O
oriented	O
x	O
3	O
.	O

LABORATORY	O
DATA	O
UPON	O
ADMISSION	O
:	O

Sodium	B-test
139	O
,	O
potassium	B-test
3.5	O
,	O
chloride	B-test
103	O
,	O
bicarbonate	B-test
25	O
,	O
BUN	B-test
9	O
,	O
creatinine	B-test
0.9	O
,	O
and	O
glucose	B-test
83	O
.	O

White	B-test
blood	I-test
cell	I-test
count	I-test
11.2	O
,	O
hematocrit	B-test
43.2	O
,	O
and	O
platelets	B-test
447,000	O
.	O

EKG	O
upon	O
admission	O
:	O

Sinus	B-problem
tachycardia	I-problem
at	O
100	O
.	O

Chest	O
x-ray	O
upon	O
admission	O
:	O

Diffuse	B-problem
interstitial	I-problem
process	I-problem
/	O
consolidation	B-problem
.	O

HOSPITAL	O
COURSE	O
BY	O
SYSTEM	O
:	O

1.	O
Pulmonary	O
/	O
Infectious	O
Disease	O
:	O

The	O
patient	O
&apos;s	O
differential	O
diagnosis	O
included	O
initially	O
a	O
question	O
of	O
an	B-problem
atypical	I-problem
pneumonia	I-problem
or	O
PCP	B-problem
.	O

His	B-test
PPD	I-test
has	O
been	O
negative	O
one	O
year	O
prior	O
to	O
admission	O
,	O
PPD	B-test
was	O
rechecked	O
during	O
this	O
admission	O
and	O
was	O
negative	O
.	O

He	O
was	O
ruled	O
out	O
for	O
tuberculosis	B-problem
with	O
an	B-test
induced	I-test
sputum	I-test
x	O
3	O
,	O
which	O
showed	O
no	O
AFB	B-problem
.	O

Chest	B-test
CT	I-test
showed	O
bibasilar	B-problem
diffuse	I-problem
infiltrates	I-problem
,	O
PCP	B-test
was	O
negative	O
.	O

Thus	O
initially	O
he	O
had	O
been	O
started	O
on	O
prednisone	B-treatment
and	O
Bactrim	B-treatment
,	O
this	O
was	O
discontinued	O
.	O

He	O
was	O
continued	O
on	O
azithromycin	B-treatment
and	O
cefuroxime	B-treatment
until	O
bronchoscopy	O
results	O
were	O
known	O
,	O
negative	O
.	O

Thus	O
they	O
were	O
discontinued	O
.	O

He	O
initially	O
had	O
refused	O
HIV	B-test
testing	I-test
,	O
however	O
,	O
was	O
finally	O
consented	O
,	O
HIV	B-problem
was	O
noted	O
to	O
be	O
negative	O
.	O

Pulmonary	O
consult	O
was	O
invited	O
,	O
initially	O
the	O
patient	O
refused	O
bronchoscopy	B-test
,	O
however	O
,	O
did	O
agree	O
to	O
it	O
during	O
his	O
hospital	O
stay	O
.	O

The	O
results	O
were	O
negative	O
for	O
Micro	B-problem
,	O
most	O
likely	O
diagnosis	O
as	O
per	O
review	B-test
of	I-test
pathology	I-test
is	O
organizing	B-problem
pneumonia	I-problem
with	O
possible	O
diagnosis	O
of	O
BOOP	B-problem
and	O
chronic	B-problem
inhalational	I-problem
injury	I-problem
was	O
a	O
possibility	O
.	O

The	O
patient	O
required	O
supplemental	B-treatment
oxygen	I-treatment
to	O
keep	O
his	B-test
oxygen	I-test
saturation	I-test
greater	O
than	O
93%	O
.	O

Ambulatory	B-test
saturation	I-test
was	O
82%	O
on	O
room	O
air	O
.	O

He	O
was	O
treated	O
with	O
supportive	B-treatment
medical	I-treatment
therapy	I-treatment
for	O
his	B-problem
cough	I-problem
.	O

He	O
was	O
to	O
follow	O
up	O
with	O
pulmonary	O
as	O
an	O
outpatient	O
.	O

2.	O
Cardiovascular	O
:	O

Echocardiogram	B-test
was	O
checked	O
to	O
rule	O
out	O
CHF	B-problem
,	O
showed	O
LVH	B-problem
and	O
trace	B-problem
TR	I-problem
,	O
ejection	B-test
fraction	I-test
of	O
60%	O
without	O
any	O
pulmonary	B-problem
hypertension	I-problem
.	O

3.	O
Heme	O

/ID	O
:	O

Hepatitis	B-test
serologies	I-test
were	O
negative	O
.	O

4.	O
FEN	O
:	O

The	O
patient	O
was	O
kept	O
on	O
a	O
house	O
diet	O
.	O

His	B-test
electrolytes	I-test
were	O
repeated	O
p.r.n.	O

5.	O
Prophylaxis	O
:	O

Lovenox	B-treatment
.	O

6.	O
Code	O
status	O
:	O

Full	O
.	O

7.	O
Disposition	O
:	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
in	O
satisfactory	O
condition	O
with	O
home	B-treatment
oxygen	I-treatment
.	O

Multiple	O
conversations	O
were	O
had	O
with	O
the	O
patient	O
as	O
well	O
as	O
an	O
interpreter	O
stating	O
the	O
importance	O
of	O
not	O
smoking	O
and	O
keeping	O
flames	O
away	O
from	O
his	B-treatment
oxygen	I-treatment
tank	I-treatment
.	O

He	O
was	O
sent	O
home	O
with	O
LDAMC	O
services	O
to	O
help	O
with	O
his	B-treatment
medications	I-treatment
as	O
well	O
as	O
oxygen	O
education	O
.	O

He	O
was	O
told	O
to	O
call	O
a	O
doctor	O
or	O
come	O
to	O
the	O
emergency	O
room	O
should	O
he	O
have	O
any	B-problem
further	I-problem
troubles	I-problem
,	O
breathing	O
,	O
chest	B-problem
pain	I-problem
,	O
or	O
fevers	B-problem
.	O

He	O
was	O
to	O
follow	O
up	O
with	O
Dr.	O
Malta	O
at	O
Firmert	O
Hospital	O
on	O
07/23/04	O
at	O
3:00	O
p.m.	O
,	O
as	O
well	O
as	O
Dr.	O
Shawn	O
Leick	O
at	O
the	O
Stonho	O
Health	O
Care	O
pulmonary	O
division	O
as	O
directed	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Prednisone	B-treatment
60	O
mg	O
p.o.	O
q.a.m.	O

2.	O
Bactrim	B-treatment
double	I-treatment
strength	I-treatment
one	O
tablet	O
p.o.	O
q.d.	O
for	O
PCP	B-treatment
prophylaxis	I-treatment
during	O
his	B-treatment
steroid	I-treatment
course	I-treatment
.	O

eScription	O
document	O
:	O

0-3054851	O
WEBCtug	O
Tel	O

CC	O
:	O

Mata	O
Fyfezeisleitz	O
MD	O
Verla	O

Dictated	O
By	O
:	O

KOTEHARBE	O
,	O
THRYNE	O

Attending	O
:	O

FYFEZEISLEITZ	O
,	O
MATA	O
Dictation	O
ID	O
5149122	O

D	O
:	O

11/06/04	O

T	O
:	O

11/07/04	O

888428725	O
RWH	O

0712675	O

695770	O

6153969	O

11/4/2006	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

CRITCHE	O
,	O
NIFREDEDRHET	O

MRN	O
:	O

0712675	O

Age	O
:	O

40y	O

REGISTRATION	O
DATE	O
:	O

11/04/2006	O
12:17	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
CRITCHE	O
,	O
NIFREDEDRHET	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Ro	O
Woodma	O
Healthcare	O
on	O
11/04/2006	O
12:17	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
CP	B-problem
SOB	B-problem
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
admitted	O
as	O
an	O
inpatient	O
to	O
Ro	O
Woodma	O
Healthcare	O
.	O

The	O
patient	O
&apos;s	O
preliminary	O
admitting	O
physician	O
is	O
DREISSNEIGH	O
,	O
LIRU	O
and	O
the	O
preliminary	O
admitting	O
diagnosis	O
is	O
CP	B-problem
,	O
R	O
/	O
O	O
MI	B-problem
.	O

Please	O
note	O
this	O
information	O
may	O
have	O
been	O
updated	O
on	O
the	O
inpatient	O
unit	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
662-747-1199	O
.	O

PCP	O
Name	O
:	O

DREISSNEIGH	O
,	O
LIRU	O

Provider	O
Number	O
:	O

33616	O

891864133	O
RWH	O

4713221	O

093061	O

136986	O

3/17/2000	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

CUCHSPARDCAMPMOTTELAMN	O
,	O
LARIN	O

MRN	O
:	O

4713221	O

Age	O
:	O

47y	O

REGISTRATION	O
DATE	O
:	O

03/17/2000	O
01:25	O
PM	O

Provider	O
:	O

VA	O
LARDESPRABLEYL	O

PRELIMINARY	O
REPORT	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Date	O
/	O
Time	O
:	O

03/17/2000	O
16:31	O

Discharge	O
Status	O
:	O

Discharged	O

Patient	O
States	O
Complaint	O
:	O

R	O
/	O
O	O
HEMMOROIDS	B-problem

Diagnosis	O
:	O

perianal	B-problem
and	I-problem
perivaginal	I-problem
pruritis	I-problem

Treatment	O
Rendered	O
:	O

pelvic	B-test
exam	I-test

Discharge	O
Medications	O
:	O

none	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Please	O
call	O
(	O
994	O
)	O
944-4238	O
in	O
2-3	O
days	O
to	O
obtain	O
results	O
of	O
the	B-test
lab	I-test
tests	I-test
that	O
were	O
ordered	O
.	O

If	O
tests	O
are	O
positive	B-problem
,	O
follow	O
up	O
with	O
your	O
primary	O
care	O
doctor	O
of	O
gynecologist	O
.	O

This	O
report	O
was	O
created	O
by	O
LARDESPRABLEYL	O
,	O
VA	O
03/17/2000	O
04:33	O
PM	O

910458031	O

NVH	O

23238893	O

1/12/1991	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

01/12/1991	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

01/20/1991	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

METASTATIC	B-problem
ADENOCARCINOMA	I-problem
OF	I-problem
UNKNOWN	I-problem
PRIMARY	I-problem
.	O

SECONDARY	O
DIAGNOSIS	O
:	O

INTRAUTERINE	B-problem
PREGNANCY	I-problem
AT	I-problem
23	I-problem
WEEKS	I-problem
.	O

HYPERCALCEMIA	B-problem
.	O

INFERIOR	B-problem
VENA	I-problem
CAVA	I-problem
OBSTRUCTION	I-problem
.	O

IMPENDING	B-problem
SPINAL	I-problem
CORD	I-problem
COMPRESSION	I-problem
.	O

IDENTIFICATION	O
DATA	O
:	O

The	O
patient	O
is	O
a	O
34-year-old	O
female	O
with	O
a	B-problem
22	I-problem
week	I-problem
intrauterine	I-problem
pregnancy	I-problem
who	O
was	O
transferred	O
from	O
Bri	O
Health	O
with	O
diffuse	B-problem
metastatic	I-problem
adenocarcinoma	I-problem
of	I-problem
unknown	I-problem
primary	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
was	O
in	O
her	O
usual	O
state	O
of	O
excellent	O
health	O
until	O
July	O
of	O
1991	O
when	O
she	O
first	O
noted	O
a	B-problem
left	I-problem
clavicular	I-problem
mass	I-problem
.	O

Subsequently	O
,	O
the	B-problem
mass	I-problem
continued	O
to	O
increase	O
in	O
size	O
.	O

On	O
12/23	O
,	O
she	O
was	O
seen	O
by	O
Dr.	O
Stonge	O
at	O
Bri	O
Health	O
where	O
a	B-problem
3	I-problem
x	I-problem
7	I-problem
cm	I-problem
left	I-problem
mid	I-problem
clavicular	I-problem
mass	I-problem
was	O
noted	O
.	O

A	B-test
fine	I-test
needle	I-test
aspirate	I-test
of	O
this	B-problem
mass	I-problem
reportedly	O
revealed	O
giant	B-problem
cell	I-problem
tumor	I-problem
.	O

The	O
patient	O
was	O
initially	O
told	O
that	O
this	O
was	O
a	B-problem
benign	I-problem
tumor	I-problem
and	O
that	O
it	O
could	O
simply	O
be	O
watched	O
and	O
definitively	O
treated	O
after	O
the	B-treatment
delivery	I-treatment
of	I-treatment
her	I-treatment
baby	I-treatment
.	O

Subsequently	O
,	O
the	B-problem
mass	I-problem
progressively	O
increased	O
in	O
size	O
and	O
the	O
patient	O
had	O
developed	O
significant	B-problem
discomfort	I-problem
in	I-problem
this	I-problem
region	I-problem
.	O

On	O
1/5	O
,	O
the	O
patient	O
underwent	O
a	B-treatment
local	I-treatment
tumor	I-treatment
debulking	I-treatment
at	O
Bri	O
Health	O
under	O
local	B-treatment
anesthesia	I-treatment
.	O

The	B-test
pathology	I-test
,	O
unfortunately	O
,	O
revealed	O
an	B-problem
aggressive	I-problem
adenocarcinoma	I-problem
(	O
micropapillary	O
type	O
;	O
mucin	O
producing	O
)	O
.	O

This	O
prompted	O
further	B-test
staging	I-test
work-up	I-test
.	O

The	O
patient	O
subsequently	O
had	O
a	B-test
limited	I-test
chest	I-test
CT	I-test
at	O
Bri	O
Health	O
which	O
showed	O
diffuse	B-problem
bilateral	I-problem
pulmonary	I-problem
metastases	I-problem
,	O
metastases	B-problem
to	I-problem
the	I-problem
sternum	I-problem
,	I-problem
rib	I-problem
,	I-problem
multiple	I-problem
spinal	I-problem
levels	I-problem
;	O
internal	B-problem
mammary	I-problem
lymphadenopathy	I-problem
.	O

The	O
poor	O
prognosis	O
for	O
the	O
patient	O
and	O
child	O
were	O
discussed	O
and	O
after	O
the	O
patient	O
decided	O
to	O
have	O
an	B-treatment
elective	I-treatment
abortion	I-treatment
,	O
an	B-test
abdominal	I-test
CT	I-test
scan	I-test
was	O
obtained	O
which	O
revealed	O
diffuse	B-problem
metastatic	I-problem
lesions	I-problem
of	I-problem
the	I-problem
liverspine	I-problem
,	I-problem
ribs	I-problem
and	I-problem
most	I-problem
of	I-problem
the	I-problem
lymph	I-problem
nodes	I-problem
.	O

There	O
was	O
no	O
obvious	B-problem
GIor	I-problem
pancreatic	I-problem
tumor	I-problem
identified	O
.	O

The	O
patient	O
had	O
a	B-problem
very	I-problem
firm	I-problem
nodule	I-problem
at	O
the	O
vertex	O
of	O
her	O
calvarium	O
.	O

A	O
specimen	O
was	O
obtained	O
by	O
fine	B-test
needle	I-test
aspiration	I-test
and	O
the	B-test
pathology	I-test
of	O
this	O
was	O
consistent	O
with	O
adenocarcinoma	B-problem
.	O

The	O
patient	O
was	O
transferred	O
to	O
Nimaconwood	O
Valley	O
Hospital	O
for	O
management	B-treatment
of	O
her	B-problem
cancer	I-problem
and	O
termination	B-treatment
of	O
the	B-problem
pregnancy	I-problem
.	O

Over	O
the	O
past	O
four	O
weeks	O
,	O
the	O
patient	O
reported	O
progressive	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
and	O
mid	B-problem
thoracic	I-problem
back	I-problem
pain	I-problem
.	O

She	O
has	O
had	O
no	O
motor	B-problem
weakness	I-problem
,	O
abnormal	B-problem
sensation	I-problem
,	O
numbness	B-problem
,	O
tingling	B-problem
or	O
incontinence	B-problem
of	I-problem
bowel	I-problem
or	I-problem
bladder	I-problem
.	O

She	O
denied	O
fevers	B-problem
,	O
chills	B-problem
or	O
sweats	B-problem
.	O

There	O
has	O
been	O
no	O
GI	B-problem
or	I-problem
GU	I-problem
symptoms	I-problem
except	O
for	O
constipation	B-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Unremarkable	O
.	O

MEDICATIONS	O
:	O

On	O
admission	O
included	O
Percocet	B-treatment
for	O
pain	B-problem
and	O
multivitamins	B-treatment
.	O

ALLERGIES	O
:	O

NO	O
KNOWN	B-problem
DRUG	I-problem
ALLERGIES	I-problem
.	O

FAMILY	O
HISTORY	O
:	O

The	O
patient	O
&apos;s	O
father	O
died	O
at	O
age	O
69	O
with	O
metastatic	B-problem
prostate	I-problem
cancer	I-problem
.	O

The	O
patient	O
&apos;s	O
sister	O
has	O
a	O
history	O
of	O
cervical	B-problem
cancer	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
married	O
and	O
lives	O
with	O
her	O
husband	O
.	O

She	O
has	O
no	O
children	O
.	O

She	O
is	O
a	O
nonsmoker	O
.	O

She	O
drinks	O
socially	O
.	O

She	O
has	O
not	O
had	O
any	O
alcoholic	O
beverages	O
during	O
this	B-problem
pregnancy	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
revealed	O
a	O
pleasant	O
,	O
comfortable	O
,	O
tired	O
appearing	O
female	O
.	O

The	O
patient	O
was	O
afebrile	O
.	O

Blood	B-test
pressure	I-test
was	O
98/64	O
.	O

Pulse	B-test
82	O
.	O

Respiratory	B-test
rate	I-test
20	O
.	O

Skin	B-test
exam	I-test
revealed	O
a	B-problem
right	I-problem
posterior	I-problem
parietal	I-problem
scalp	I-problem
nodle	I-problem
measuring	O
2	O
x	O
3	O
cm	O
which	O
was	O
very	O
firm	O
.	O

There	O
was	O
a	B-problem
1	I-problem
cm	I-problem
firm	I-problem
nodule	I-problem
at	I-problem
the	I-problem
left	I-problem
upper	I-problem
thoracic	I-problem
region	I-problem
of	O
the	O
back	O
between	O
the	O
midline	O
and	O
the	O
scapula	O
.	O

There	O
was	O
a	B-problem
1	I-problem
cm	I-problem
firm	I-problem
nodule	I-problem
in	O
the	O
right	O
upper	O
quadrant	O
of	O
the	O
abdomen	O
.	O

HEENT	B-test
exam	I-test
was	O
unremarkable	O
.	O

Neck	O
was	O
supple	O
.	O

There	O
was	O
no	O
jugular	B-problem
venous	I-problem
distention	I-problem
.	O

There	O
was	O
no	O
lymphadenopathy	B-problem
.	O

Back	O
was	O
without	O
CVA	B-problem
tenderness	I-problem
.	O

There	O
was	O
no	O
scapular	B-problem
tenderness	I-problem
.	O

There	O
was	O
mild	B-problem
lower	I-problem
thoracic	I-problem
tenderness	I-problem
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	B-test
.	O

There	O
were	O
no	O
rales	B-problem
or	O
wheezes	B-problem
.	O

There	O
was	O
no	O
egophony	B-problem
.	O

Cardiac	B-test
exam	I-test
was	O
tachycardic	B-problem
and	O
regular	O
,	O
normal	O
S1	O
and	O
S2	O
.	O

There	O
was	O
a	B-problem
II	I-problem
/	I-problem
VI	I-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
loudest	O
at	O
the	O
left	O
upper	O
sternal	O
border	O
.	O

There	O
was	O
no	O
heave	B-problem
.	O

Abdomen	O
was	O
gravid	B-problem
.	O

Bowel	O
sounds	O
were	O
present	O
.	O

The	O
abdomen	O
was	O
tympanitic	O
and	O
nontender	B-problem
.	O

The	O
liver	O
was	O
11	O
cm	O
by	O
percussion	B-test
.	O

There	O
was	O
no	O
liver	O
edge	O
palpable	O
,	O
no	O
spleen	O
tip	O
palpable	O
.	O

Rectal	O
revealed	O
normal	O
muscle	O
tone	O
,	O
heme	O
negative	O
stool	O
.	O

Extremities	O
revealed	O
1+	B-problem
bipedal	I-problem
edema	I-problem
on	O
admission	O
.	O

Neurological	B-test
examination	I-test
revealed	O
the	O
patient	O
to	O
be	O
alert	O
and	O
oriented	O
times	O
three	O
.	O

Cranial	O
nerves	O
II	O
-	O
XII	O
were	O
intact	O
.	O

Motor	O
was	O
5/5	O
.	O

Sensation	O
was	O
intact	O
to	O
light	B-test
touch	I-test
.	O

Deep	B-test
tendon	I-test
reflexes	I-test
were	O
1-2+	O
and	O
symmetric	O
bilaterally	O
.	O

Toes	O
were	O
downgoing	O
.	O

LABORATORY	O
DATA	O
:	O

On	O
admission	O
included	O
an	B-test
ALT	I-test
of	O
108	O
,	O
AST	B-test
of	O
286	O
.	O

Total	B-test
bilirubin	I-test
3.0	O
,	O
direct	B-test
bilirubin	I-test
of	O
2.0	O
.	O

Alkaline	B-test
phosphatase	I-test
1148	O
.	O

LDH	B-test
806	O
.	O

Calcium	B-test
11.8	O
.	O

Albumin	B-test
2.3	O
.	O

Hematocrit	B-test
was	O
30.6	O
.	O

White	B-test
blood	I-test
cell	I-test
count	I-test
was	O
11.14	O
.	O

PT	B-test
was	O
13.2	O
.	O

PTT	B-test
was	O
29.8	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
had	O
an	B-treatment
elective	I-treatment
termination	I-treatment
of	O
her	B-problem
pregnancy	I-problem
on	O
1/13/91	O
.	O

The	B-test
work-up	I-test
for	O
the	O
extent	O
of	O
the	B-problem
patient	I-problem
&apos;s	I-problem
disease	I-problem
included	O
MRI	B-test
scan	I-test
of	I-test
the	I-test
cervical	I-test
and	I-test
thoracic	I-test
spine	I-test
which	O
revealed	O
multiple	B-problem
metastatic	I-problem
lesions	I-problem
in	I-problem
the	I-problem
vertebral	I-problem
bodies	I-problem
;	O
a	B-problem
T3	I-problem
lesion	I-problem
extending	O
from	O
the	O
body	O
to	O
the	O
right	O
neural	O
for	O
amina	O
with	O
foraminal	B-problem
obstruction	I-problem
.	O

An	B-problem
epidural	I-problem
mass	I-problem
was	O
present	O
at	O
T10	O
which	O
was	O
extending	O
from	O
the	O
lamina	O
or	O
spinous	O
process	O
anteriorly	O
and	O
almost	O
compressing	O
the	O
spinal	O
cord	O
.	O

An	B-test
abdominal	I-test
and	I-test
pelvic	I-test
CT	I-test
scan	I-test
with	I-test
IV	I-test
contrast	I-test
revealed	O
bilateral	B-problem
pulmonary	I-problem
nodules	I-problem
and	O
bilateral	B-problem
pleural	I-problem
effusions	I-problem
,	O
extensive	B-problem
liver	I-problem
metastases	I-problem
,	O
narrowing	B-problem
of	I-problem
the	I-problem
intra	I-problem
hepatic	I-problem
IVC	I-problem
and	O
distention	B-problem
of	I-problem
the	I-problem
azygous	I-problem
system	I-problem
suggestive	O
of	O
IVC	B-problem
obstruction	I-problem
by	O
liver	B-problem
metastases	I-problem
;	O
ascites	B-problem
;	O
multiple	B-problem
bony	I-problem
metastases	I-problem
;	O
and	O
an	B-problem
isolated	I-problem
splenic	I-problem
metastases	I-problem
.	O

A	B-test
bone	I-test
scan	I-test
revealed	O
increased	B-problem
uptake	I-problem
in	I-problem
the	I-problem
left	I-problem
chest	I-problem
wall	I-problem
,	I-problem
left	I-problem
anterior	I-problem
ribs	I-problem
four	I-problem
to	I-problem
six	I-problem
,	O
and	O
increased	B-problem
uptake	I-problem
in	I-problem
the	I-problem
left	I-problem
and	I-problem
right	I-problem
lateral	I-problem
skull	I-problem
in	O
the	O
area	O
of	O
the	O
parotids	O
.	O

Ahead	B-test
CT	I-test
scan	I-test
revealed	O
a	B-problem
metastatic	I-problem
lesion	I-problem
in	O
the	O
right	O
vertex	O
of	O
the	O
calvarium	O
but	O
no	O
intracranial	B-problem
abnormalities	I-problem
.	O

Work-up	B-test
for	O
the	O
source	O
of	O
the	B-problem
primary	I-problem
tumor	I-problem
which	O
is	O
still	O
unknown	O
included	O
a	B-test
mammogram	I-test
which	O
identified	O
no	O
suspicious	B-problem
microcalcifications	I-problem
and	O
no	O
dominant	B-problem
masses	I-problem
.	O

The	B-test
abdominal	I-test
and	I-test
pelvic	I-test
CT	I-test
scans	I-test
showed	O
no	O
suspicious	B-problem
GI	I-problem
masses	I-problem
,	O
no	O
pancreatic	B-problem
mass	I-problem
;	O
a	B-problem
2	I-problem
cm	I-problem
ovarian	I-problem
cyst	I-problem
.	O

The	O
review	O
of	O
the	B-test
pathology	I-test
from	O
Bri	O
Health	O
confirmed	O
a	B-problem
high	I-problem
grade	I-problem
adenocarcinoma	I-problem
.	O

Erica	B-test
and	I-test
basic	I-test
cystic	I-test
protein	I-test
stains	I-test
are	O
still	O
pending	O
.	O

Serum	B-test
markers	I-test
were	O
normal	O
.	O

The	B-test
CEA	I-test
was	O
less	O
than	O
0.7	O
.	O

The	B-test
hCG	I-test
on	I-test
admission	I-test
was	O
30,710	O
and	O
on	O
1/19	O
was	O
805	O
.	O

The	B-test
CA-125	I-test
was	O
still	O
pending	O
and	O
alphafeto	B-test
protein	I-test
is	O
still	O
pending	O
.	O

Hypercalcemia	B-problem
:	O

The	O
patient	O
presented	O
with	O
a	B-test
serum	I-test
calcium	I-test
of	O
11.8	O
and	O
an	B-test
albumin	I-test
of	O
2.3	O
on	O
admission	O
.	O

She	O
received	O
three	O
days	O
of	O
intravenous	B-treatment
etidronate	I-treatment
with	O
normal	B-treatment
saline	I-treatment
diuresis	I-treatment
and	O
the	B-test
serum	I-test
calcium	I-test
subsequently	O
decreased	O
to	O
9.0	O
.	O

The	O
patient	O
was	O
then	O
switched	O
to	O
po	B-treatment
etidronate	I-treatment
.	O

IVC	B-problem
obstruction	I-problem
:	O

The	O
patient	O
has	O
extensive	B-problem
hepatic	I-problem
metastases	I-problem
and	O
by	O
CT	B-test
scan	I-test
there	O
is	O
obstruction	B-problem
of	I-problem
the	I-problem
intrahepatic	I-problem
IVC	I-problem
.	O

This	O
has	O
resulted	O
in	O
marked	B-problem
bilateral	I-problem
lower	I-problem
extremity	I-problem
and	I-problem
presacral	I-problem
edema	I-problem
with	O
ascites	B-problem
.	O

The	B-problem
patient	I-problem
&apos;s	I-problem
low	I-problem
serum	I-problem
albumin	I-problem
is	O
also	O
contributing	O
to	O
her	B-problem
extensive	I-problem
edema	I-problem
.	O

Hypoxia	B-problem
and	O
shortness	B-problem
of	I-problem
breath	I-problem
:	O

Although	O
the	B-test
patient	I-test
&apos;s	I-test
room	I-test
air	I-test
saturation	I-test
was	O
96%	O
during	O
this	O
admission	O
,	O
she	O
subjectively	O
complained	O
of	O
increased	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
.	O

It	O
was	O
felt	O
that	O
the	B-problem
patient	I-problem
&apos;s	I-problem
extensive	I-problem
pulmonary	I-problem
metastases	I-problem
and	O
bilateral	B-problem
pleural	I-problem
effusions	I-problem
resulted	O
in	O
increased	B-problem
work	I-problem
of	I-problem
respiration	I-problem
and	O
a	O
sensation	O
of	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

Impending	B-problem
spinal	I-problem
cord	I-problem
compression	I-problem
:	O

The	O
patient	O
had	O
back	B-problem
pain	I-problem
on	O
admission	O
without	O
any	B-problem
focal	I-problem
neurological	I-problem
signs	I-problem
.	O

The	B-test
MRI	I-test
scan	I-test
on	I-test
admission	I-test
revealed	O
an	B-problem
impending	I-problem
cord	I-problem
compression	I-problem
at	O
the	O
level	O
of	O
T10	O
.	O

She	O
was	O
started	O
on	O
Decadron	B-treatment
and	O
on	O
1/17	O
began	O
the	O
first	O
of	O
ten	B-treatment
radiation	I-treatment
treatments	I-treatment
to	O
two	O
fields	O
(	O
T2	O
to	O
T5	O
and	O
T9	O
to	O
T11	O
)	O
.	O

Per	O
the	O
patient	O
&apos;s	O
wishes	O
,	O
Dr.	O
Dalywoo	O
Droreite	O
the	O
Windgo	O
Hospital	O
was	O
consulted	O
for	O
a	O
second	O
opinion	O
regarding	O
the	B-treatment
management	I-treatment
of	O
her	B-problem
malignancy	I-problem
.	O

Dr.	O
Linke	O
recommended	O
chemotherapy	B-treatment
with	I-treatment
PFL	I-treatment
.	O

Per	O
the	O
patient	O
&apos;s	O
wishes	O
,	O
she	O
was	O
transferred	O
to	O
the	O
Windgo	O
Hospital	O
for	O
chemotherapy	B-treatment
.	O

ALT	B-test
was	O
53	O
.	O

AST	B-test
was	O
89	O
.	O

Her	B-test
LDH	I-test
was	O
394	O
.	O

Her	B-test
alkaline	I-test
phosphatase	I-test
was	O
1514	O
.	O

Total	B-test
bilirubin	I-test
was	O
2.1	O
.	O

Direct	B-test
bilirubin	I-test
was	O
1.4	O
.	O

Albumin	B-test
was	O
2.3	O
.	O

Calcium	B-test
9.1	O
.	O

Hematocrit	B-test
was	O
32.5	O
.	O

White	B-test
blood	I-test
cell	I-test
count	I-test
was	O
16.89	O
.	O

PT	B-test
was	O
12.9	O
.	O

PTT	B-test
was	O
27.3	O
.	O

DISPOSITION	O
:	O

MEDICATIONS	O
:	O

On	O
discharge	O
included	O
etidronate	B-treatment
,	O
475	O
mg	O
IV	O
q	O
day	O
;	O
heparin	B-treatment
,	O
5000	O
units	O
subcutaneously	O
b.i.d.	O
;	O
Decadron	B-treatment
,	O
4	O
mg	O
po	O
q	O
six	O
hours	O
;	O
MS	B-treatment
Contin	I-treatment
,	O
45	O
mg	O
po	O
b.i.d.	O
;	O
Pepcid	B-treatment
,	O
20	O
mg	O
po	O
b.i.d.	O
;	O
Senekot	B-treatment
,	O
one	O
tablet	O
po	O
t.i.d.	O
;	O
Bronkosol	B-treatment
,	O
0.25	O
cc	O
q	O
four	O
hours	O
.	O

It	O
was	O
decided	O
to	O
have	O
the	B-problem
patient	I-problem
&apos;s	I-problem
medical	I-problem
and	I-problem
oncological	I-problem
issues	I-problem
managed	O
at	O
Windgo	O
Hospital	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
the	B-test
patient	I-test
&apos;s	I-test
electrolytes	I-test
were	O
within	O
normal	O
limits	O
.	O

BD452/5255	O

RUTHU	O
PAIN	O
,	O
M.D.	O
KW25	O

D	O
:	O

01/20/91	O

Batch	O
:	O

8050	O

Report	O
:	O

H7691U2	O

T	O
:	O

01/24/91	O

Dictated	O
By	O
:	O

CEALME	O
PAIN	O
,	O
M.D.	O

915093496	O
RWH	O

0802338	O

045989	O

2923113	O

12/13/2002	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

GIENGBEENEA	O
,	O
NAA	O

UNIT	O
NUMBER	O
:	O

799-54-08	O

ADMISSION	O
DATE	O
:	O

12/13/2002	O

DISCHARGE	O
DATE	O
:	O

12/14/2002	O

ADMITTING	O
DIAGNOSIS	O
:	O

1.	O
Undesired	B-problem
fertility	I-problem
.	O

2.	O
Undesired	B-problem
adiposity	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
30	O
-year-old	O
Gravida	O
III	O
,	O
Para	O
II	O
who	O
presented	O
desiring	O
definitive	B-treatment
surgical	I-treatment
sterilization	I-treatment
.	O

She	O
was	O
extensively	O
counseled	O
regarding	O
other	O
methods	O
of	O
birth	B-treatment
control	I-treatment
and	O
desired	O
to	O
proceed	O
with	O
definitive	B-treatment
surgical	I-treatment
therapy	I-treatment
.	O

In	O
addition	O
,	O
the	O
patient	O
desired	O
liposuction	B-treatment
of	I-treatment
varying	I-treatment
areas	I-treatment
as	O
well	O
.	O

The	O
patient	O
was	O
consented	O
for	O
both	B-treatment
procedures	I-treatment
and	O
brought	O
to	O
the	O
Operating	O
Room	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

None	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Appendectomy	B-treatment
at	O
the	O
age	O
of	O
14	O
,	O
open	O
.	O

PAST	O
OBSTETRIC	O
HISTORY	O
:	O

Spontaneous	B-problem
vaginal	I-problem
delivery	I-problem
x	O
2	O
.	O

PAST	O
GYN	O
HISTORY	O
:	O

Regular	O
menses	O
,	O
on	O
Ortho-Tri-Cyclen	B-treatment
.	O

No	O
history	O
of	O
sexually	B-problem
transmitted	I-problem
disease	I-problem
,	O
no	O
history	O
of	O
domestic	O
violence	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Ortho	B-treatment
Tri-Cyclen	I-treatment
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Height	B-test
5	O
&apos;	O
1	O
&quot;	O
,	O
weight	B-test
138	O
lb.	O

Blood	B-test
pressure	I-test
:	O

130/82	O
and	O
heart	B-test
rate	I-test
80	O
.	O

Breasts	O
:	O

no	O
masses	B-problem
.	O

Lungs	O
:	O

clear	O
to	O
auscultation	B-test
and	O
percussion	B-test
bilaterally	O
.	O

Heart	O
:	O

regular	O
rate	O
and	O
rhythm	O
,	O
S1-S2	O
.	O

Abdomen	O
:	O

soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
.	O

Extremities	O
:	O

within	O
normal	O
.	O

Pelvic	B-test
exam	I-test
revealed	O
normal	O
vulva	O
,	O
vagina	O
normal	O
,	O
cervix	O
normal	O
,	O
uterus	O
anteverted	O
,	O
small	O
,	O
nontender	B-problem
.	O

Adnexa	O
:	O

no	O
masses	B-problem
or	O
tenderness	B-problem
.	O

Rectal	O
:	O

deferred	O
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Operating	O
Room	O
where	O
she	O
underwent	O
an	B-treatment
unremarkable	I-treatment
laparoscopic	I-treatment
tubal	I-treatment
ligation	I-treatment
.	O

This	O
was	O
done	O
with	O
Falope	B-treatment
rings	I-treatment
.	O

The	B-problem
estimated	I-problem
blood	I-problem
loss	I-problem
was	O
minimal	O
and	O
the	O
patient	O
received	O
600	O
cc.	O
of	O
intravenous	B-treatment
fluid	I-treatment
.	O

Of	O
note	O
,	O
the	O
patient	O
had	O
a	O
negative	O
urine	O
pregnancy	O
test	O
prior	O
to	O
the	B-treatment
surgery	I-treatment
.	O

The	O
patient	O
then	O
underwent	O
liposuction	B-treatment
of	I-treatment
her	I-treatment
abdomen	I-treatment
,	I-treatment
inner	I-treatment
thighs	I-treatment
,	I-treatment
hips	I-treatment
,	I-treatment
flanks	I-treatment
,	I-treatment
chest	I-treatment
and	I-treatment
arms	I-treatment
with	O
Dr.	O
Chain	O
.	O

She	O
did	O
well	O
and	O
was	O
admitted	O
to	O
the	O
GYN	O
Service	O
postoperatively	O
because	O
the	O
patient	O
had	O
persistent	B-problem
pain	I-problem
.	O

On	O
postoperative	O
day	O
#one	O
,	O
she	O
was	O
then	O
stable	O
with	O
no	O
complaints	B-problem
.	O

She	O
remained	O
afebrile	B-problem
.	O

Her	B-treatment
Foley	I-treatment
was	O
removed	O
.	O

Her	O
diet	O
was	O
advanced	O
without	O
difficulty	O
and	O
the	O
patient	O
was	O
stable	O
for	O
discharge	O
.	O

The	O
patient	O
was	O
to	O
follow	O
up	O
in	O
several	O
days	O
time	O
with	O
Dr.	O
Chain	O
of	O
the	O
Plastics	O
Clinic	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Motrin	B-treatment
and	O
Percocet	B-treatment
as	O
needed	O
.	O

PADA	O
MARONNESSGRE	O
CHAIN	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

Electronically	O
Signed	O
PADA	O
MARONNESSGRE	O
CHAIN	O
,	O
M.D.	O
04/25/2003	O
09:50	O

_____________________________	O
PADA	O
MARONNESSGRE	O
CHAIN	O
,	O
M.D.	O

TR	O
:	O

wwi	O

DD	O
:	O

04/17/2003	O

TD	O
:	O

04/18/2003	O
8:28	O
A	O
045989	O

cc	O
:	O

PADA	O
MARONNESSGRE	O
CHAIN	O
,	O
M.D.	O

917989835	O
RWH	O

5427551	O

405831	O

9660879	O

01/09/2002	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

STERPMOONE	O
,	O
NY	O

MRN	O
:	O

5427551	O

Age	O
:	O

37y	O

REGISTRATION	O
DATE	O
:	O

01/09/2002	O
01:27	O
PM	O

Provider	O
:	O

NONOK	O
AYREKEMPE	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O
MD	O
:	O

Left	O
message	O
with	O
answering	O
service	O
or	O
PCP	O
office	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Date	O
/	O
Time	O
:	O

01/09/2002	O
17:02	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

EVAL	B-test

Standardized	O
Discharge	O
Instructions	O
:	O

Schedule	O
outpatient	O
psychiatry	O
appointment	O
Necrestneysagiles	O
Medical	O
Center	O
.	O

Contact	O
BRIDC	O
BRESCA	O
DENONE	O
HEALTH	O
CARE	O
(	O
558-927-7217	O
)	O
for	O
appointment	O
w/	O
therapist	O
.	O

Needs	O
to	O
speak	O
w/	O
PCP	O
in	O
order	O
to	O
switch	O
provider	O
Diagnosis	O
:	O

PTSD	B-problem

Discharge	O
Medications	O
:	O

.5	B-treatment
Risperdal	I-treatment

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Continue	O
w/	O
Risperdal	B-treatment
per	O
new	O
psychiatrist	O

B	B-treatment
and	I-treatment
W	I-treatment
and	O
work	O
w/	O
therapist	O
re:	O
historical	O
issues	O
.	O

If	O
symptoms	B-problem
continue	O
to	O
be	O
overwhelming	B-problem
return	O
to	O
V	O
or	O
call	O
1-903-263-5797	O

PCP	O
Name	O
:	O

SHUFFNEG	O
,	O
SOA	O
W	O

Provider	O
Number	O
:	O

80157	O

This	O
report	O
was	O
created	O
by	O
AYREKEMPE	O
,	O
NONOK	O
01/09/2002	O
05:09	O
PM	O

920798564	O

CTMC	O

70160673	O

840502	O

3/3/1999	O
12:00:00	O
AM	O

PROSTATE	B-problem
CANCER	I-problem
AND	O
RENAL	B-problem
FAILURE	I-problem

Signed	O

DIS	O

Admission	O
Date	O
:	O

03/03/1999	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

03/08/1999	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

ACUTE	B-problem
RENAL	I-problem
FAILURE	I-problem
.	O

SIGNIFICANT	B-problem
PROBLEMS	I-problem
:	O

1.	O
METASTATIC	B-problem
PROSTATE	I-problem
CA	I-problem
.	O

2.	O
OBSTRUCTIVE	B-problem
UROPATHY	I-problem
,	O
STATUS	B-problem
POST	I-problem
LEFT	I-problem
NEPHROSTOMY	I-problem
.	O

3.	O
HYPERTENSION	B-problem
.	O

4.	O
ANEMIA	B-problem
.	O

5.	O
GASTROESOPHAGEAL	B-problem
REFLUX	I-problem
DISEASE	I-problem
.	O

CHIEF	O
COMPLAINT	O
:	O

This	O
88-year-old	O
male	O
with	O
history	O
of	O
prostate	B-problem
CA	I-problem
was	O
admitted	O
from	O
an	O
outside	O
hospital	O
secondary	O
to	O
persistent	B-problem
hematuria	I-problem
status	O
post	O
nephrostomy	B-treatment
tube	I-treatment
placement	I-treatment
transferred	O
to	O
Retelk	O
County	O
Medical	O
Center	O
for	O
further	B-treatment
management	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	B-problem
ILLNESS	I-problem
:	O

Mr.	O
Prehekote	O
is	O
an	O
88-year-old	O
Portuguese	O
speaking	O
only	O
male	O
who	O
was	O
diagnosed	O
with	O
adenocarcinoma	B-problem
of	I-problem
the	I-problem
prostate	I-problem
in	O
1998	O
.	O

He	O
received	O
transurethral	B-treatment
resection	I-treatment
of	I-treatment
the	I-treatment
prostate	I-treatment
one	O
year	O
ago	O
because	O
of	O
persistent	B-problem
urinary	I-problem
retention	I-problem
.	O

After	O
that	O
,	O
he	O
was	O
on	O
Lupron	B-treatment
and	O
Nilandron	B-treatment
hormone	I-treatment
therapy	I-treatment
.	O

The	O
patient	O
was	O
admitted	O
on	O
February	O
23	O
,	O
1999	O
to	O
Eifro	O
Medical	O
Center	O
because	O
of	O
failure	B-problem
to	I-problem
thrive	I-problem
and	O
decreased	B-problem
hematocrit	I-problem
.	O

He	O
was	O
noted	O
to	O
have	O
elevated	B-problem
BUN	I-problem
and	O
creatinine	B-test
.	O

BUN	B-test
was	O
34	O
and	O
creatinine	B-test
was	O
2.6	O
,	O
up	O
from	O
his	O
baseline	O
of	O
1.0	O
.	O

Prostate	B-test
specific	I-test
antigen	I-test
increased	O
from	O
77.9	O
to	O
88	O
,	O
and	O
the	O
patient	O
also	O
had	O
urinary	B-problem
incontinence	I-problem
and	O
body	B-problem
weight	I-problem
loss	I-problem
.	O

Further	B-test
evaluation	I-test
of	O
his	B-problem
renal	I-problem
failure	I-problem
showed	O
that	O
the	O
patient	O
has	O
bilateral	B-problem
hydronephrosis	I-problem
,	O
most	O
likely	O
obstructive	B-problem
uropathy	I-problem
due	O
to	O
prostate	B-problem
CA	I-problem
in	I-problem
the	I-problem
pelvic	I-problem
area	I-problem
.	O

Because	O
of	O
the	B-problem
increasing	I-problem
creatinine	I-problem
to	O
8.0	O
on	O
February	O
28	O
,	O
1999	O
,	O
a	B-treatment
left	I-treatment
nephrostomy	I-treatment
tube	I-treatment
was	O
placed	O
.	O

However	O
after	O
the	B-treatment
procedure	I-treatment
,	O
the	B-problem
patient	I-problem
&apos;s	I-problem
hematocrit	I-problem
dropped	I-problem
to	O
24	O
and	O
he	O
was	O
transfused	O
two	B-treatment
units	I-treatment
of	I-treatment
packed	I-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
.	O

His	B-test
hematocrit	I-test
increased	O
to	O
about	O
30	O
,	O
but	O
he	O
continued	O
to	O
have	O
hematuria	B-problem
and	O
his	B-test
renal	I-test
function	I-test
only	O
improved	O
very	O
slowly	O
.	O

He	O
also	O
received	O
Kayexalate	B-treatment
for	O
hyperkalemia	B-problem
.	O

Due	O
to	O
the	B-problem
persistent	I-problem
blood	I-problem
in	I-problem
the	I-problem
urine	I-problem
,	O
he	O
was	O
transferred	O
from	O
Eifro	O
Medical	O
Center	O
to	O
the	O
Retelk	O
County	O
Medical	O
Center	O
for	O
angiographic	B-test
studies	I-test
to	O
rule	O
out	O
any	O
vascular	B-problem
injuries	I-problem
.	O

The	O
patient	O
was	O
transferred	O
to	O
Genearocktemp	O
Ry	O
Health	O
on	O
March	O
3	O
,	O
1999	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

The	O
patient	O
had	O
constipation	B-problem
with	O
dysuria	B-problem
,	O
but	O
no	O
fever	B-problem
or	O
chills	B-problem
.	O

No	O
cough	B-problem
.	O

No	O
chest	B-problem
pain	I-problem
.	O

No	O
palpitations	B-problem
,	O
history	O
of	O
epigastric	B-problem
pain	I-problem
and	O
body	B-problem
weight	I-problem
loss	I-problem
.	O

No	O
headache	B-problem
.	O

No	O
bone	B-problem
pain	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1)	O
Hypertension	B-problem
.	O

2)	O
Gastroesophageal	B-problem
reflux	I-problem
disease	I-problem
.	O

3)	O
Anemia	B-problem
.	O

4)	O
Prostate	B-problem
CA	I-problem
.	O

ALLERGIES	B-problem
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
:	O

Clonidine	B-treatment
2.5	O
milligrams	O
topical	O
q.	O
week	O
,	O
Nitropaste	B-treatment
2	O
inches	O
q.4h.	O
,	O
Nilandron	B-treatment
50	O
milligrams	O
p.o.	O
q.d.	O
,	O
Lupron	B-treatment
,	O
Dulcolax	B-treatment
p.r.n.	O
,	O
Colace	B-treatment
100	O
milligrams	O
p.o.	O
b.i.d.	O
,	O
Ferrous	B-treatment
sulfate	I-treatment
300	O
milligrams	O
p.o.	O
b.i.d.	O
,	O
Lansopiacole	B-treatment
15	O
milligrams	O
p.o.	O
q.d.	O
,	O
bethanechol	B-treatment
25	O
milligrams	O
p.o.	O
t.i.d.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
has	O
been	O
living	O
in	O
the	O
Kansas	O
for	O
more	O
than	O
20	O
years	O
.	O

He	O
was	O
originally	O
from	O
Wark	O
and	O
he	O
speaks	O
Portuguese	O
only	O
.	O

He	O
is	O
now	O
living	O
with	O
his	O
son	O
and	O
daughter	O
,	O
and	O
five	O
other	O
children	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
,	O
the	O
patient	O
was	O
a	O
frail	O
looking	O
elderly	O
male	O
lying	O
in	O
bed	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Temperature	B-test
95.4	O
,	O
pulse	B-test
120	O
,	O
blood	B-test
pressure	I-test
150/80	O
,	O
respiratory	B-test
rate	I-test
24	O
,	O
95%	O
on	O
room	O
air	O
.	O

Conjunctiva	O
were	O
not	O
pale	O
.	O

Sclera	O
nonicteric	O
.	O

Pupils	O
:	O

Isocoric	B-problem
cataract	I-problem
bilaterally	I-problem
.	O

Mouth	O
:	O

Mucous	B-problem
membranes	I-problem
slightly	I-problem
dry	I-problem
.	O

No	O
oral	B-problem
ulcers	I-problem
.	O

Neck	O
:	O

Supple	O
.	O

Jugular	O
vein	O
not	O
engorged	O
.	O

Carotid	O
pulses	O
bounding	O
very	O
strongly	O
.	O

No	O
thyromegaly	B-problem
.	O

Chest	B-test
examination	I-test
showed	O
some	B-problem
basilar	I-problem
crackles	I-problem
at	I-problem
the	I-problem
right	I-problem
lung	I-problem
base	I-problem
.	O

Heart	O
initially	O
tachycardia	B-problem
,	O
grade	B-problem
II	I-problem
/	I-problem
VI	I-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
at	I-problem
the	I-problem
left	I-problem
sternal	I-problem
border	I-problem
.	O

Abdomen	O
:	O

Soft	O
.	O

Liver	O
and	O
spleen	O
were	O
not	O
palpable	O
.	O

Bowel	O
sounds	O
normoactive	O
.	O

Extremities	O
:	O

Traced	B-problem
pitting	I-problem
edema	I-problem
.	O

No	O
cyanosis	B-problem
and	O
no	O
clubbing	B-problem
.	O

Peripheral	B-test
pulses	I-test
were	O
very	O
strong	O
and	O
bounding	O
.	O

No	O
calf	B-problem
tenderness	I-problem
.	O

Homan	B-test
&apos;s	I-test
sign	I-test
negative	O
.	O

Neurologic	O
:	O

Examination	B-test
was	O
limited	O
because	O
the	O
patient	O
speaks	O
only	O
Portuguese	O
.	O

LABORATORY	O
DATA	O
:	O

On	O
admission	O
the	O
patient	O
&apos;s	O
biochemistry	O
showed	O
sodium	B-test
of	O
140	O
,	O
potassium	B-test
4.0	O
,	O
chloride	B-test
107	O
,	O
bicarb	B-test
14	O
,	O
BUN	B-test
63	O
,	O
creatinine	B-test
5.8	O
,	O
blood	B-test
sugar	I-test
133	O
.	O

Liver	B-test
function	I-test
test	I-test
showed	O
AST	B-test
21	O
,	O
alkaline	B-test
phosphatase	I-test
70	O
,	O
total	B-test
bilirubin	I-test
0.3	O
,	O
total	B-test
protein	I-test
6.5	O
,	O
albumin	B-test
3.9	O
,	O
globulin	B-test
2.6	O
.	O

CBC	B-test
:	O

WBC	B-test
8.4	O
,	O
hematocrit	B-test
32.6	O
,	O
platelet	B-test
count	I-test
194,000	O
.	O

PT	B-test
11.9	O
,	O
INR	B-test
1.0	O
,	O
PTT	B-test
28.4	O
.	O

Chest	B-test
x-ray	I-test
showed	O
no	O
evidence	O
of	O
cardiomegaly	B-problem
.	O

No	O
lung	B-problem
infiltrate	I-problem
.	O

CT	B-test
scan	I-test
of	I-test
the	I-test
renal	I-test
area	I-test
showed	O
right	B-problem
hydronephrosis	I-problem
which	O
extends	O
to	O
an	B-problem
asymmetrically	I-problem
thickened	I-problem
urinary	I-problem
bladder	I-problem
wall	I-problem
.	O

A	B-problem
mass	I-problem
like	I-problem
thickening	I-problem
of	I-problem
the	I-problem
urinary	I-problem
bladder	I-problem
suggestive	O
of	O
either	O
detrusor	B-problem
hypertrophy	I-problem
or	O
possibly	O
tumor	B-problem
.	O

The	B-test
CT	I-test
scan	I-test
showed	O
a	B-problem
cavitary	I-problem
lung	I-problem
lesion	I-problem
in	I-problem
the	I-problem
right	I-problem
lower	I-problem
lobe	I-problem
compatible	O
with	O
metastatic	O
or	O
septic	B-problem
embolus	I-problem
.	O

EKG	B-test
showed	O
atrial	B-problem
fibrillation	I-problem
,	O
left	B-problem
axis	I-problem
deviation	I-problem
,	O
LVH	B-problem
,	O
nonspecific	B-problem
ST-T	I-problem
changes	I-problem
either	O
due	O
to	O
digitalis	B-problem
affect	I-problem
.	O

CK	B-test
enzymes	I-test
146	O
.	O

Repeated	O
three	O
times	O
and	O
remained	O
flat	O
.	O

Troponin	B-test
I	I-test
on	O
the	O
second	O
day	O
of	O
admission	O
was	O
1.18	O
.	O

HOSPITAL	O
COURSE	O
:	O

After	O
admission	O
,	O
urology	O
,	O
nephrology	O
as	O
well	O
as	O
interventional	O
radiology	O
was	O
consulted	O
about	O
the	O
management	O
of	O
this	O
patient	O
.	O

The	O
specialist	O
concluded	O
that	O
because	O
the	B-problem
patient	I-problem
&apos;s	I-problem
hematuria	I-problem
seemed	O
to	O
be	O
stable	O
and	O
hematocrit	B-test
to	O
maintain	O
at	O
about	O
29-30	O
,	O
there	O
is	O
no	O
urgent	O
need	O
to	O
do	O
an	B-test
arteriogram	I-test
which	O
may	O
cause	O
further	B-problem
damage	I-problem
to	I-problem
the	I-problem
patient	I-problem
&apos;s	I-problem
kidney	I-problem
.	O

Urology	B-test
consultation	I-test
thinks	O
that	O
cystoscopy	B-treatment
would	O
not	O
add	O
any	O
benefit	O
to	O
the	O
management	O
and	O
only	O
would	O
consider	O
a	B-treatment
right	I-treatment
nephrostomy	I-treatment
if	O
renal	B-problem
function	I-problem
failed	O
to	O
improve	O
.	O

After	O
admission	O
,	O
the	O
patient	O
was	O
treated	O
conservatively	O
to	O
correct	O
his	B-problem
electrolyte	I-problem
and	I-problem
metabolic	I-problem
acidosis	I-problem
.	O

He	O
was	O
given	O
blood	B-treatment
transfusion	I-treatment
,	O
two	O
units	O
when	O
his	B-test
hematocrit	I-test
dropped	O
to	O
29.4	O
.	O

After	O
transfusion	B-treatment
,	O
the	B-test
patient	I-test
&apos;s	I-test
hematocrit	I-test
rose	O
to	O
37.7	O
on	O
the	O
day	O
of	O
discharge	O
.	O

The	O
patient	O
was	O
also	O
given	O
sodium	B-treatment
bicarbonate	I-treatment
to	O
correct	O
his	B-problem
metabolic	I-problem
acidosis	I-problem
.	O

He	O
continued	O
to	O
pass	O
about	O
1500-2000	O
cc	O
of	O
urine	O
a	O
day	O
and	O
his	B-test
renal	I-test
function	I-test
improved	O
slowly	O
with	O
creatinine	B-test
decreased	O
to	O
4.2	O
on	O
the	O
day	O
of	O
discharge	O
.	O

During	O
this	O
admission	O
,	O
the	O
patient	O
also	O
developed	O
atrial	B-problem
fibrillation	I-problem
with	O
ventricular	B-test
rate	I-test
of	O
about	O
70-80	O
.	O

CPK	B-test
was	O
tracked	O
,	O
but	O
was	O
totally	O
normal	O
.	O

No	O
beta	B-treatment
blockers	I-treatment
were	O
given	O
.	O

A	O
long	O
discussion	O
amongst	O
the	O
specialist	O
,	O
nephrology	O
,	O
urology	O
,	O
interventional	O
radiology	O
,	O
primary	O
oncology	O
as	O
well	O
with	O
the	O
family	O
lead	O
to	O
the	O
conclusion	O
that	O
conservative	B-treatment
management	I-treatment
may	O
give	O
the	O
patient	O
more	O
comfort	O
than	O
crisis	B-treatment
treatment	I-treatment
in	O
this	B-problem
well	I-problem
advanced	I-problem
prostate	I-problem
CA	I-problem
.	O

Dr.	O
Lucreamull	O
discussed	O
the	O
patient	O
&apos;s	O
clinical	O
status	O
and	O
overall	O
situation	O
with	O
the	O
patient	O
&apos;s	O
family	O
and	O
the	O
family	O
decided	O
that	O
Mr.	O
Prehekote	O
could	O
return	O
home	O
with	O
hospice	B-treatment
.	O

The	O
patient	O
&apos;s	O
primary	O
care	O
physician	O
,	O
Dr.	O
Tomedankell	O
Flowayles	O
will	O
manage	O
the	B-treatment
hospice	I-treatment
issues	O
.	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
for	O
hospice	B-treatment
on	O
March	O
8	O
,	O
1999	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Bethanechol	B-treatment
25	O
milligrams	O
p.o.	O
t.i.d.	O
,	O
Clonidine	B-treatment
2.5	O
milligrams	O
topical	O
q.	O
week	O
,	O
apply	O
every	O
Sunday	O
,	O
Colace	B-treatment
100	O
milligrams	O
p.o.	O
b.i.d.	O
,	O
Haldol	B-treatment
0.5-1	O
milligrams	O
p.o.	O
q.6-8h.	O
p.r.n.	O
agitation	B-problem
,	O
Niferex	B-treatment
150	O
milligrams	O
p.o.	O
b.i.d.	O
,	O
nitroglycerin	B-treatment
paste	I-treatment
2%	O
,	O
2	O
inches	O
topical	O
q.8h.	O
,	O
Prilosec	B-treatment
20	O
milligrams	O
p.o.	O
q.d.	O
,	O
Senna	B-treatment
tablets	I-treatment
2	O
tablets	O
b.i.d.	O
,	O
sodium	B-treatment
bicarbonate	I-treatment
650	O
milligrams	O
p.o.	O
t.i.d.	O
for	O
five	O
days	O
,	O
Proscar	B-treatment
5	O
milligrams	O
p.o.	O
q.d.	O
,	O
Casodex	B-treatment
50	O
milligrams	O
p.o.	O
q.d.	O
,	O
Nephrocaps	B-treatment
1	O
tablets	O
p.o.	O
q.d.	O

COMPLICATIONS	O
:	O

None	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Fair	O
.	O

DISPOSITION	O
:	O

Home	O
with	O
hospice	B-treatment
.	O

Dictated	O
By	O
:	O

KYMBELL	O
SPARDJEB	O
,	O
M.D.	O
BJ43	O

Attending	O
:	O

LAGEORG	O
LUCREAMULL	O
,	O
M.D.	O
MR28	O
PN199/1242	O

Batch	O
:	O

14667	O

Index	O
No.	O
UDFTTQ73N9	O

D	O
:	O

03/08/99	O

T	O
:	O

03/09/99	O

932057504	O
DH	O

5898830	O

809200	O

356490	O

11/25/2000	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

AGACHBRAUCH	O
,	O
RENSIAANARC	O

MRN	O
:	O

5898830	O

Age	O
:	O

44y	O

REGISTRATION	O
DATE	O
:	O

11/25/2000	O
01:36	O
AM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
AGACHBRAUCH	O
,	O
RENSIAANARC	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Daughtersvillshamen&apos;s	O
Hospital	O
on	O
11/25/2000	O
01:36	O
AM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
AF-RESOLVED	B-problem
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
TREATED	O
AND	O
RELEASED	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
613-870-0699	O
.	O

950452368	O

CTMC	O

25445040	O

808386	O

5/9/1998	O
12:00:00	O
AM	O

EXTERNAL	B-problem
WOUND	I-problem
INFECTIONS	I-problem

Signed	O

DIS	O

Admission	O
Date	O
:	O

05/09/1998	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

05/25/1998	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

STERNAL	B-problem
WOUND	I-problem
INFECTION	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
74-year-old	O
woman	O
,	O
well	O
known	O
to	O
the	O
cardiac	O
surgery	O
service	O
,	O
readmitted	O
from	O
Glasmif/putdi	O
Health	O
Network	O
with	O
sternal	B-problem
wound	I-problem
infection	I-problem
.	O

She	O
has	O
been	O
previously	O
hospitalized	O
on	O
12	O
April	O
1998	O
for	O
the	B-problem
same	I-problem
diagnosis	I-problem
.	O

She	O
is	O
now	O
coming	O
for	O
surgical	B-treatment
treatment	I-treatment
,	O
wound	B-treatment
debridement	I-treatment
,	O
and	O
possible	O
wound	B-treatment
closure	I-treatment
with	I-treatment
bilateral	I-treatment
pectoralis	I-treatment
flap	I-treatment
.	O

She	O
underwent	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
times	O
two	O
with	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
on	O
29	O
March	O
1998	O
.	O

Of	O
note	O
,	O
the	O
patient	O
is	O
status	B-problem
post	I-problem
lymphoma	I-problem
with	O
treatment	O
of	O
chemotherapy	B-treatment
and	O
radiation	B-treatment
six	O
years	O
ago	O
,	O
and	O
is	O
an	B-problem
insulin-dependent	I-problem
diabetic	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Insulin-dependent	B-problem
diabetes	I-problem
mellitus	I-problem
,	O
lymphoma	B-problem
as	O
above	O
,	O
ulcerative	B-problem
colitis	I-problem
,	O
melanoma	B-problem
status	O
post	O
excision	B-treatment
in	I-treatment
right	I-treatment
upper	I-treatment
extremity	I-treatment
,	O
hypertension	B-problem
,	O
hypothyroidism	B-problem
,	O
congestive	B-problem
heart	I-problem
failure	I-problem
,	O
and	O
coronary	B-problem
artery	I-problem
disease	I-problem
with	O
bypass	B-treatment
grafting	I-treatment
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

She	O
is	O
status	O
post	O
left	B-treatment
knee	I-treatment
replacement	I-treatment
and	O
status	O
post	O
multiple	B-treatment
prior	I-treatment
surgeries	I-treatment
and	O
reconstruction	B-treatment
of	I-treatment
the	I-treatment
knee	I-treatment
.	O

Status	O
post	O
cholecystectomy	B-treatment
,	O
lumbar	B-treatment
diskectomy	I-treatment
,	O
and	O
tonsillectomy	B-treatment
with	O
adenoidectomy	B-treatment
.	O

ALLERGIES	O
:	O

Erythromycin	B-treatment
,	O
vancomycin	B-treatment
,	O
and	O
Bacitracin	B-treatment
.	O

ADMISSION	O
MEDICATIONS	O
:	O

Elavil	B-treatment
50	O
mg	O
p.o.	O
q.h.s.	O
,	O
coated	B-treatment
aspirin	I-treatment
325	O
mg	O
p.o.	O
p.day	O
,	O
Tegretol	B-treatment
100	O
mg	O
p.o.	O
b.i.d.	O
,	O
Ancef	B-treatment
1	O
gm	O
IV	O
q.12h.	O
times	O
seven	O
days	O
,	O
Vasotec	B-treatment
5	O
mg	O
p.o.	O
q.day	O
,	O
Synthroid	B-treatment
0.025	O
mg	O
p.o.	O
q.day	O
,	O
Asacol	B-treatment
400	O
mg	O
q.a.m.	O
and	O
800	O
mg	O
q.p.m.	O
,	O
Lopressor	B-treatment
25	O
mg	O
p.o.	O
b.i.d.	O
,	O
Prilosec	B-treatment
20	O
mg	O
p.o.	O
q.day	O
,	O
and	O
insulin	B-treatment
70/30	O
26	O
units	O
in	O
the	O
morning	O
and	O
12	O
units	O
at	O
night	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
was	O
admitted	O
with	O
a	O
blood	B-test
pressure	I-test
of	O
140/80	O
,	O
temperature	B-test
101.3	O
,	O
pulse	B-test
84	O
,	O
and	O
respiratory	B-test
rate	I-test
22	O
.	O

The	O
patient	O
is	O
obese	B-problem
with	O
unremarkable	O
physical	O
examination	O
except	O
for	O
a	B-problem
systolic	I-problem
murmur	I-problem
,	O
I	B-problem
/	I-problem
VI	I-problem
and	I-problem
erythema	I-problem
over	I-problem
the	I-problem
sternal	I-problem
wound	I-problem
and	O
upper	O
third	O
.	O

The	B-problem
wound	I-problem
had	O
a	B-problem
beefy	I-problem
red	I-problem
cellulitic	I-problem
area	I-problem
surrounding	O
an	O
open	O
area	O
,	O
blanching	O
to	O
touch	O
.	O

There	O
was	O
no	O
purulence	B-problem
or	O
discharge	B-problem
noted	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
placed	O
on	O
IV	B-treatment
antibiotics	I-treatment
,	O
Ancef	B-treatment
1	O
gm	O
q.8h.	O

On	O
10	O
May	O
1998	O
,	O
she	O
underwent	O
sternal	B-treatment
wound	I-treatment
debridement	I-treatment
and	I-treatment
closure	I-treatment
,	O
performed	O
by	O
Dr.	O
Falccouette	O
and	O
Dr.	O
Shuffzeln	O
.	O

The	O
patient	O
was	O
switched	O
to	O
ampicillin	B-treatment
,	O
gentamicin	B-treatment
,	O
and	O
clindamycin	B-treatment
,	O
according	O
to	O
the	B-test
culture	I-test
,	O
Enterococci	B-problem
and	O
Staphylococcus	B-problem
in	O
the	B-problem
wound	I-problem
.	O

Due	O
to	O
the	B-problem
persistent	I-problem
fevers	I-problem
,	O
the	O
patient	O
underwent	O
vancomycin	B-treatment
desensitization	I-treatment
in	O
the	O
surgical	O
Intensive	O
Care	O
Unit	O
followed	O
by	O
a	B-treatment
change	I-treatment
of	I-treatment
antibiotics	I-treatment
to	O
vancomycin	B-treatment
and	O
levofloxacin	B-treatment
.	O

Further	B-test
cultures	I-test
from	I-test
sputum	I-test
and	I-test
urine	I-test
revealed	O
yeast	B-problem
sensitive	O
to	O
Diflucan	B-treatment
,	O
which	O
was	O
administered	O
shortly	O
after	O
.	O

Because	O
of	O
expected	B-treatment
long	I-treatment
term	I-treatment
antibiotic	I-treatment
administration	I-treatment
,	O
a	B-treatment
PICC	I-treatment
line	I-treatment
was	O
placed	O
and	O
the	O
patient	O
was	O
prepared	O
for	O
transfer	O
back	O
to	O
Fo	O
Hospital	O
.	O

As	O
a	B-problem
small	I-problem
complication	I-problem
,	O
the	O
patient	O
opened	O
a	B-problem
left	I-problem
ankle	I-problem
wound	I-problem
post	O
saphenous	B-treatment
vein	I-treatment
harvest	I-treatment
,	O
which	O
persists	O
up	O
until	O
now	O
and	O
is	O
of	O
a	O
size	O
2	O
x	O
1	O
cm	O
.	O

Due	O
to	O
difficult	B-problem
ambulation	I-problem
,	O
the	O
patient	O
developed	O
a	B-problem
small	I-problem
ulcer	I-problem
in	I-problem
the	I-problem
sacral	I-problem
area	I-problem
,	O
which	O
was	O
treated	O
with	O
Duoderm	B-treatment
dressing	I-treatment
.	O

During	O
the	O
course	O
of	O
hospitalization	O
,	O
the	O
patient	O
was	O
followed	O
by	O
cardiac	O
surgery	O
,	O
cardiology	O
,	O
infectious	O
disease	O
,	O
allergy	O
,	O
and	O
medicine	O
,	O
including	O
GI	O
teams	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Elavil	B-treatment
by	O
mouth	O
15	O
mg	O
every	O
night	O
,	O
Dulcolax	B-treatment
rectally	O
10	O
mg	O
once	O
a	O
day	O
,	O
Tegretol	B-treatment
by	O
mouth	O
100	O
mg	O
twice	O
a	O
day	O
,	O
Benadryl	B-treatment
by	O
mouth	O
25	O
mg	O
three	O
times	O
a	O
day	O
,	O
Colace	B-treatment
by	O
mouth	O
200	O
mg	O
twice	O
a	O
day	O
,	O
Vasotec	B-treatment
by	O
mouth	O
10	O
mg	O
twice	O
a	O
day	O
,	O
EOC	B-treatment
/	I-treatment
LOC	I-treatment
p.r./p.o.	O
one	O
each	O
once	O
a	O
day	O
as	O
needed	O
for	O
constipation	B-problem
,	O
Lasix	B-treatment
by	O
mouth	O
80	O
mg	O
every	O
morning	O
,	O
insulin	B-treatment
regular	O
according	O
to	O
insulin	O
scale	O
,	O
Synthroid	B-treatment
by	O
mouth	O
25	O
mcg	O
once	O
a	O
day	O
,	O
Maalox	B-treatment
Plus	I-treatment
Extra	I-treatment
Strength	I-treatment
by	O
mouth	O
15	O
ml	O
every	O
six	O
hours	O
as	O
needed	O
for	O
indigestion	B-problem
,	O
Milk	O
of	O
Magnesia	B-treatment
by	O
mouth	O
30	O
ml	O
once	O
a	O
day	O
as	O
needed	O
for	O
constipation	B-problem
,	O
Asacol	B-treatment
by	O
mouth	O
400	O
mg	O
every	O
morning	O
,	O
Asacol	B-treatment
800	O
mg	O
every	O
night	O
,	O
Lopressor	B-treatment
by	O
mouth	O
25	O
mg	O
twice	O
a	O
day	O
,	O
Miracle	B-treatment
cream	I-treatment
topically	O
on	O
skin	O
once	O
a	O
day	O
,	O
nystatin	B-treatment
swish	I-treatment
and	I-treatment
swallow	I-treatment
by	O
mouth	O
5	O
ml	O
four	O
times	O
a	O
day	O
,	O
Percocet	B-treatment
by	O
mouth	O
one	O
tab	O
every	O
four	O
hours	O
as	O
needed	O
for	O
pain	B-problem
,	O
and	O
vancomycin	B-treatment
by	O
infusion	O
1	O
gm	O
every	O
18	O
hours	O
;	O
instructions	O
in	O
250	O
ml	O
slow	B-treatment
IV	I-treatment
infusion	I-treatment
over	O
one	O
hour	O
.	O

Note	O
,	O
please	O
draw	O
blood	O
for	O
vancomycin	B-test
levels	I-test
on	O
25	O
May	O
1998	O
,	O
before	O
the	O
next	O
dose	O
,	O
to	O
get	O
the	B-test
trough	I-test
level	I-test
.	O

Keep	O
vancomycin	B-test
trough	I-test
between	O
10-20	O
,	O
but	O
not	O
less	O
due	O
to	O
desensitization	B-problem
.	O

Vancomycin	B-test
levels	I-test
should	O
be	O
checked	O
every	O
third	O
day	O
for	O
four	O
to	O
six	O
weeks	O
,	O
according	O
to	O
IMD	O
.	O

Nizatidine	B-treatment
by	O
mouth	O
150	O
mg	O
twice	O
a	O
day	O
,	O
insulin	B-treatment
70/30	O
human	O
injection	O
under	O
skin	O
12	O
units	O
every	O
night	O
,	O
insulin	B-treatment
70/30	O
human	O
injection	O
subcutaneous	O
26	O
units	O
every	O
morning	O
,	O
Lovenox	B-treatment
injection	O
under	O
skin	O
40	O
mg	O
once	O
a	O
day	O
,	O
and	O
levofloxacin	B-treatment
by	O
mouth	O
250	O
mg	O
once	O
a	O
day	O
.	O

Dictated	O
By	O
:	O

NALA	O
BEST	O
,	O
M.D.	O
KJ76	O

Attending	O
:	O

JOFREDD	O
N.	O
FALCCOUETTE	O
,	O
M.D.	O
CA8	O
XX584/6088	O

Batch	O
:	O

3679	O

Index	O
No.	O
W9YYL76XV1	O

D	O
:	O

05/25/98	O

T	O
:	O

05/25/98	O

CC	O
:	O

1.	O
LAELK	O
MEMORIAL	O
HOSPITAL	O

959086752	O

PUOMC	O

6824024	O

094907	O

812890	O

2/1/2000	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

RATHELIFE	O
,	O
TIEANAKI	O
B	O

UNIT	O
NUMBER	O
:	O

342-07-28	O

ADMISSION	O
DATE	O
:	O

02/01/2000	O

DISCHARGE	O
DATE	O
:	O

02/08/2000	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Non-healing	B-problem
ulcer	I-problem
on	I-problem
the	I-problem
right	I-problem
leg	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Right	B-treatment
fem	I-treatment
to	I-treatment
below	I-treatment
knee	I-treatment
pop	I-treatment
bypass	I-treatment
graft	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
patient	O
is	O
an	O
seventy	O
eight	O
year	O
old	O
female	O
with	O
history	O
of	O
peripheral	B-problem
vascular	I-problem
disease	I-problem
who	O
is	O
status	O
post	O
above	B-treatment
knee	I-treatment
to	I-treatment
fem	I-treatment
pop	I-treatment
bypass	I-treatment
graft	I-treatment
with	O
6	B-treatment
millimeter	I-treatment
PTFE	I-treatment
.	O

This	B-treatment
operation	I-treatment
was	O
performed	O
for	O
two	O
months	O
of	O
increased	B-problem
rest	I-problem
pain	I-problem
.	O

Her	B-problem
pain	I-problem
resolved	O
after	O
surgery	B-treatment
and	O
she	O
has	O
been	O
doing	O
well	O
since	O
,	O
although	O
at	O
baseline	O
now	O
she	O
is	O
minimally	B-problem
ambulatory	I-problem
from	O
bed	O
to	O
commode	O
.	O

For	O
the	O
past	O
couple	O
of	O
months	O
the	O
patient	O
has	O
had	O
a	B-problem
non-healing	I-problem
right	I-problem
dorsal	I-problem
foot	I-problem
ulcer	I-problem
which	O
has	O
been	O
increasing	O
in	O
size	O
and	O
started	O
as	O
a	B-problem
pin	I-problem
hole	I-problem
and	O
she	O
does	O
not	O
recollect	O
any	B-problem
trauma	I-problem
,	O
as	O
similar	B-problem
small	I-problem
ulcers	I-problem
developed	O
on	O
the	O
left	O
foot	O
as	O
well	O
around	O
the	O
same	O
time	O
,	O
but	O
that	O
has	O
subsequently	O
healed	O
.	O

The	B-problem
ulcer	I-problem
was	O
managed	O
conservatively	O
at	O
Har	O
Hospital	O
by	O
Dr.	O
Holes	O
with	O
Silvadene	B-treatment
b.i.d.	O
lower	B-test
extremity	I-test
non-invasive	I-test
study	I-test
obtained	O
at	O
that	O
time	O
showed	O
poor	B-problem
distal	I-problem
right	I-problem
extremity	I-problem
perfusion	I-problem
.	O

The	O
patient	O
was	O
referred	O
back	O
to	O
Dr.	O
Pop	O
for	O
the	O
possibility	O
of	O
a	B-treatment
revascularization	I-treatment
procedure	I-treatment
.	O

She	O
is	O
status	O
post	O
angiography	B-test
today	O
.	O

She	O
has	O
just	O
finished	O
a	O
ten	O
day	O
course	O
of	O
Ciprofloxacin	B-treatment
.	O

She	O
denies	O
any	O
fevers	B-problem
or	O
chills	B-problem
.	O

She	O
does	O
have	O
rest	B-problem
pain	I-problem
in	I-problem
the	I-problem
right	I-problem
foot	I-problem
and	I-problem
ankle	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
for	O
Guillain-Barr	B-problem
syndrome	I-problem
,	O
Lupus	B-problem
,	O
status	O
post	O
multiple	B-problem
decubiti	I-problem
,	O
peripheral	B-problem
vascular	I-problem
disease	I-problem
,	O
status	O
post	O
right	B-treatment
total	I-treatment
knee	I-treatment
replacement	I-treatment
and	O
status	O
post	O
cholecystectomy	B-treatment
,	O
status	O
post	O
hysterectomy	B-treatment
,	O
status	O
post	O
goiter	B-problem
and	O
left	B-problem
lung	I-problem
fibrosis	I-problem
,	O
status	O
post	O
methicillin	B-problem
resistant	I-problem
Staphylococcus	I-problem
aureus	I-problem
pneumonia	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Prednisone	B-treatment
5	O
every	O
other	O
day	O
,	O
alternating	O
with	O
ten	O
every	O
other	O
day	O
.	O

Trental	B-treatment
400	O
milligrams	O
t.i.d.	O
,	O
Cytotec	B-treatment
100	O
milligrams	O
t.i.d.	O
,	O
Ativan	B-treatment
2	O
milligrams	O
q.h.s.	O
Darvon	B-treatment
65	O
milligrams	O
two	O
q.i.d	O
,	O
Relafen	B-treatment
500	O
milligrams	O
b.i.d	O
,	O
Vitamin	B-treatment
E	I-treatment
,	O
Prilosec	B-treatment
20	O
milligrams	O
once	O
a	O
day	O
,	O
Zantac	B-treatment
150	O
milligrams	O
b.i.d	O
,	O
Lasix	B-treatment
120	O
milligrams	O
every	O
other	O
day	O
PRN	O
edema	B-problem
.	O

Didronel	B-treatment
1	O
q	O
day	O
which	O
has	O
been	O
on	O
hold	O
.	O

Proventil	B-treatment
inhaler	I-treatment
via	I-treatment
nebulizers	I-treatment
0.5	O
milligrams	O
with	O
Atrovent	B-treatment
.	O

ALLERGIES	O
:	O

The	O
patient	O
is	O
allergic	B-problem
Ampicillin	B-treatment
,	O
Tylenol	B-treatment
,	O
Clinoril	B-treatment
,	O
Biaxin	B-treatment
,	O
Codeine	B-treatment
,	O
Sulfa	B-treatment
and	O
Aminophylline	B-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

She	O
is	O
afebrile	O
,	O
her	B-test
vital	I-test
signs	I-test
are	O
stable	O
.	O

Her	O
pupils	O
equal	O
round	O
reactive	O
to	O
light	O
and	O
accomodation	O
,	O
normocephalic	O
,	O
atraumatic	O
,	O
extraocular	O
muscles	O
intact	O
.	O

Neck	O
,	O
she	O
has	O
II+	O
bilateral	O
carotids	O
,	O
no	O
bruits	B-problem
,	O
no	O
jugular	B-problem
venous	I-problem
distention	I-problem
.	O

Lungs	O
decreased	B-problem
breath	I-problem
sounds	I-problem
at	I-problem
bilateral	I-problem
bases	I-problem
with	O
minimal	B-problem
expiratory	I-problem
crackles	I-problem
on	I-problem
the	I-problem
right	I-problem
.	O

Abdomen	O
,	O
soft	O
,	O
non-tender	B-problem
,	O
non-distended	B-problem
,	O
normal	O
active	O
bowel	O
sounds	O
.	O

Extremities	O
on	O
the	O
right	O
,	O
she	O
has	O
a	O
II+	O
femoral	O
,	O
no	O
distal	B-problem
pulses	I-problem
beyond	O
that	O
.	O

On	O
the	O
left	O
she	O
has	O
a	O
II+	O
femoral	O
and	O
II+	O
popliteal	O
,	O
no	O
distal	B-problem
pulses	I-problem
beyond	O
that	O
.	O

She	O
has	O
on	O
her	O
right	O
ankle	O
anteriorly	O
a	B-problem
four	I-problem
centimeter	I-problem
ulcer	I-problem
with	I-problem
necrotic	I-problem
base	I-problem
.	O

Minimal	B-problem
surrounding	I-problem
erythema	I-problem
.	O

She	O
is	O
able	O
to	O
wiggle	O
her	O
toes	O
bilaterally	O
.	O

Sensation	O
is	O
intact	O
bilaterally	O
.	O

Her	O
legs	O
are	O
tender	O
to	O
touch	O
bilaterally	O
.	O

Her	B-test
angiography	I-test
showed	O
a	B-problem
right	I-problem
proximal	I-problem
popliteal	I-problem
occlusion	I-problem
,	O
anterior	B-problem
tibial	I-problem
dominant	I-problem
foot	I-problem
vessel	I-problem
.	O

Small	B-problem
posterior	I-problem
tibial	I-problem
occlusion	I-problem
on	I-problem
the	I-problem
distal	I-problem
calf	I-problem
and	O
a	B-problem
small	I-problem
peroneal	I-problem
goes	O
down	O
to	O
the	O
ankle	O
.	O

On	O
a	B-test
rectal	I-test
examination	I-test
she	O
is	O
guaiac	O
negative	O
,	O
no	O
masses	B-problem
and	O
no	O
gluteal	B-problem
ulcers	I-problem
or	O
decubiti	B-problem
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
was	O
admitted	O
and	O
taken	O
to	O
the	O
operating	O
room	O
on	O
the	O
following	O
day	O
and	O
she	O
underwent	O
a	B-treatment
right	I-treatment
fem	I-treatment
to	I-treatment
below	I-treatment
knee	I-treatment
popliteal	I-treatment
bypass	I-treatment
graft	I-treatment
using	O
a	B-treatment
six	I-treatment
millimeter	I-treatment
ring	I-treatment
PTFE	I-treatment
.	O

She	O
had	O
a	O
strong	O
popliteal	O
doppler	O
pulse	O
intraoperatively	O
and	O
good	O
PVR	O
on	O
the	O
right	O
postoperatively	O
.	O

The	O
patient	O
did	O
well	O
in	O
the	O
postoperative	O
period	O
.	O

She	O
was	O
afebrile	O
,	O
her	B-test
vital	I-test
signs	I-test
were	O
stable	O
.	O

She	O
was	O
making	O
adequate	O
urine	O
output	O
anywhere	O
between	O
20	O
to	O
50	O
ccs	O
an	O
hour	O
.	O

Her	B-test
hematocrit	I-test
was	O
26.8	O
and	O
she	O
was	O
transfused	O
1	O
unit	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
.	O

Her	O
diet	O
was	O
advanced	O
from	O
clears	O
to	O
a	O
diet	O
as	O
tolerated	O
.	O

On	O
postoperative	O
day	O
two	O
the	O
patient	O
was	O
noted	O
to	O
have	O
some	B-problem
swelling	I-problem
in	I-problem
her	I-problem
left	I-problem
lower	I-problem
extremity	I-problem
and	O
this	O
was	O
felt	O
to	O
be	O
a	B-problem
hematoma	I-problem
secondary	O
to	O
her	B-test
PVR	I-test
cuff	I-test
.	O

There	O
is	O
mild	O
amount	O
of	O
surrounding	B-problem
erythema	I-problem
and	O
the	O
patient	O
was	O
started	O
on	O
Ancef	B-treatment
at	O
that	O
time	O
.	O

The	O
patient	O
was	O
seen	O
by	O
physical	O
therapy	O
.	O

The	O
area	O
of	O
erythema	B-problem
on	I-problem
her	I-problem
left	I-problem
leg	I-problem
enlarged	O
slightly	O
and	O
the	O
patient	O
was	O
placed	O
on	O
Vancomycin	B-treatment
for	O
several	O
days	O
after	O
which	O
time	O
her	B-problem
erythema	I-problem
again	O
began	O
to	O
decrease	O
.	O

Her	O
right	O
foot	O
remained	O
warm	O
.	O

She	O
had	O
wounds	B-problem
which	O
were	O
clean	O
,	O
dry	O
and	O
intact	O
and	O
the	O
patient	O
was	O
stable	O
from	O
a	O
respiratory	O
standpoint	O
using	O
her	B-treatment
respirator	I-treatment
at	O
night	O
.	O

The	O
patient	O
required	O
an	B-treatment
additional	I-treatment
blood	I-treatment
transfusion	I-treatment
during	O
her	O
hospital	O
stay	O
as	O
her	B-test
hematocrit	I-test
had	O
decreased	O
to	O
27	O
on	O
postoperative	O
day	O
three	O
.	O

The	O
patient	O
while	O
in	O
bed	O
had	O
her	O
legs	O
elevated	O
.	O

The	O
patient	O
was	O
tolerating	O
a	O
general	O
diet	O
,	O
she	O
was	O
voiding	O
on	O
her	O
own	O
and	O
the	O
patient	O
was	O
discharged	O
to	O
home	O
as	O
her	O
daughter	O
is	O
a	O
nurse	O
.	O

She	O
was	O
discharged	O
with	O
PO	B-treatment
Keflex	I-treatment
that	O
she	O
was	O
to	O
take	O
for	O
the	O
next	O
ten	O
days	O
.	O

The	O
patient	O
is	O
to	O
follow	O
up	O
with	O
Dr.	O
Pop	O
in	O
one	O
week	O
and	O
the	O
patient	O
was	O
afebrile	O
with	O
stable	O
vital	O
signs	O
at	O
the	O
time	O
of	O
discharge	O
.	O

LAYMIE	O
ASLINKE	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

Electronically	O
Signed	O
EDRY	O
R	O
YELLOW	O
,	O
M.D.	O

03/16/2000	O
13:21	O

_____________________________	O
EDRY	O
YELLOW	O
,	O
M.D.	O

TR	O
:	O

nw	O

DD	O
:	O

02/09/2000	O

TD	O
:	O

02/12/2000	O
1:41	O
P	O

cc	O
:	O

EDRY	O
R	O
YELLOW	O
,	O
M.D.	O

965367286	O
WGH	O

4025213	O

465655	O

9246470	O

12/19/2006	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

CIENNE	O
,	O
GUTAOI	O

MRN	O
:	O

4025213	O

Age	O
:	O

42y	O

REGISTRATION	O
DATE	O
:	O

12/19/2006	O
08:13	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
CIENNE	O
,	O
GUTAOI	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Well	O
General	O
Hospital	O
on	O
12/19/2006	O
08:13	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
SOB	B-problem
.	O

Following	O
triage	B-test
,	O
the	O
patient	O
left	O
without	O
being	O
seen	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
366-686-5449	O
.	O

PCP	O
Name	O
:	O

ELKSOBEBEUCH	O
,	O
IEVE	O

Provider	O
Number	O
:	O

66130	O

974381789	O

PUOMC	O

0520610	O

70648	O

390115	O

12/25/1996	O
12:00:00	O
AM	O

ATRIAL	B-problem
FIBRILLATION	I-problem
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

LENKPRUSKIHKOOGLEKIH	O
,	O
NIEKERO	O
C	O

UNIT	O
NUMBER	O
:	O

449-50-82	O

ADMISSION	O
DATE	O
:	O

12/25/96	O

DISCHARGE	O
DATE	O
:	O

12/29/96	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Atrial	B-problem
fibrillation	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

History	O
of	O
multinodular	B-problem
goiter	I-problem
;	O
history	O
of	O
hypertension	B-problem
;	O
history	O
of	O
subtotal	B-treatment
thyroidectomy	I-treatment
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Electrical	B-treatment
cardioversion	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Ms.	O
Lenkpruskihkooglekih	O
is	O
a	O
63-year-old	O
lady	O
with	O
a	O
history	O
of	O
frequent	B-problem
premature	I-problem
ventricular	I-problem
contractions	I-problem
and	O
infrequent	B-problem
short	I-problem
runs	I-problem
of	I-problem
non-sustained	I-problem
ventricular	I-problem
tachycardia	I-problem
(	O
one	O
four-beat	O
run	O
)	O
in	O
1991	O
,	O
for	O
which	O
several	O
antiarrhythmic	O
agents	O
including	O
Propranolol	B-treatment
,	O
Quinidine	B-treatment
,	O
Procainamide	B-treatment
,	O
Tenormin	B-treatment
,	O
Norpace	B-treatment
,	O
Corgard	B-treatment
,	O
and	O
Flecainide	B-treatment
were	O
used	O
,	O
but	O
were	O
stopped	O
because	O
of	O
intolerance	B-problem
.	O

At	O
that	O
time	O
,	O
she	O
had	O
clear	O
coronary	O
arteries	O
on	O
coronary	B-test
angiography	I-test
and	O
an	B-test
ejection	I-test
fraction	I-test
greater	O
than	O
50%	O
.	O

She	O
did	O
well	O
off	O
antiarrhythmic	B-treatment
agents	I-treatment
until	O
October	O
of	O
this	O
year	O
when	O
she	O
was	O
noted	O
to	O
have	O
atrial	B-problem
fibrillation	I-problem
with	O
a	B-problem
rapid	I-problem
ventricular	I-problem
rate	I-problem
after	O
several	O
days	O
of	O
decreased	B-problem
exercise	I-problem
tolerance	I-problem
.	O

She	O
was	O
started	O
on	O
Coumadin	B-treatment
and	O
had	O
a	O
failed	O
attempt	O
at	O
DC	B-treatment
electrical	I-treatment
cardioversion	I-treatment
on	O
11/16/96	O
.	O

She	O
has	O
been	O
on	O
Coumadin	B-treatment
since	O
and	O
has	O
continued	O
to	O
have	O
occasional	B-problem
palpitations	I-problem
and	O
mild	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Includes	O
a	O
history	O
of	O
hypertension	B-problem
;	O
multinodular	B-problem
goiter	I-problem
;	O
subtotal	B-treatment
thyroidectomy	I-treatment
.	O

MEDICATIONS	O
:	O

Include	O
Cardizem	B-treatment
CD	I-treatment
180	O
mg	O
daily	O
;	O
Monopril	B-treatment
10	O
mg	O
daily	O
;	O
Digoxin	B-treatment
.25	O
mg	O
daily	O
;	O
and	O
Lasix	B-treatment
40	O
mg	O
every	O
other	O
day	O
.	O

ALLERGIES	O
:	O

To	O
Quinidine	B-treatment
,	O
Procardia	B-treatment
,	O
and	O
sulfa	B-treatment
antibiotics	I-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
examination	B-test
,	O
blood	B-test
pressure	I-test
was	O
200/100	O
;	O
heart	B-test
rate	I-test
120	O
per	O
minute	O
(	O
atrial	B-problem
fibrillation	I-problem
)	O
.	O

The	O
patient	O
was	O
noted	O
to	O
be	O
anxious	B-problem
.	O

There	O
was	O
no	O
neck	B-problem
vein	I-problem
distension	I-problem
or	O
carotid	B-problem
bruits	I-problem
.	O

Heart	O
sounds	O
were	O
normal	O
.	O

The	O
lungs	O
were	O
clear	O
.	O

The	B-test
abdominal	I-test
examination	I-test
was	O
benign	O
.	O

There	O
was	O
no	O
peripheral	B-problem
edema	I-problem
.	O

Pulses	O
were	O
all	O
easily	O
palpable	O
.	O

LABORATORY	O
DATA	O
:	O

A	B-test
12-lead	I-test
electrocardiogram	I-test
showed	O
atrial	B-problem
fibrillation	I-problem
with	O
a	O
QT	O
interval	O
of	O
.46	O
seconds	O
.	O

There	O
were	O
diffuse	B-problem
ST	I-problem
segment	I-problem
and	I-problem
T-wave	I-problem
abnormalities	I-problem
,	O
which	O
were	O
nonspecific	O
.	O

A	B-test
complete	I-test
blood	I-test
count	I-test
,	O
electrolytes	B-test
,	O
BUN	B-test
and	O
creatinine	B-test
were	O
within	O
normal	O
limits	O
.	O

INR	B-test
was	O
elevated	O
at	O
2.5	O
.	O

An	B-test
echocardiogram	I-test
was	O
performed	O
,	O
which	O
showed	O
completely	O
normal	O
left	O
ventricular	O
systolic	O
function	O
with	O
an	O
ejection	O
fraction	O
calculated	O
at	O
.74	O
.	O

There	O
was	O
no	O
evidence	O
of	O
left	B-problem
ventricular	I-problem
hypertrophy	I-problem
or	O
asymmetric	B-problem
septal	I-problem
hypertrophy	I-problem
,	O
which	O
had	O
been	O
an	O
issue	O
that	O
had	O
been	O
raised	O
on	O
an	B-test
echocardiogram	I-test
in	O
Ownra	O
Cin	O
,	O
New	O
Mexico	O
on	O
12/06/96	O
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
was	O
started	O
on	O
Propafenone	B-treatment
300	O
mg	O
three	O
times	O
a	O
day	O
and	O
underwent	O
an	O
attempt	O
at	O
electrical	B-treatment
cardioversion	I-treatment
after	O
seven	O
doses	O
of	O
this	O
.	O

This	O
failed	O
,	O
despite	O
one	O
shock	O
at	O
300	O
joules	O
and	O
two	O
shocks	O
at	O
360	O
joules	O
.	O

The	O
Propafenone	B-treatment
was	O
stopped	O
,	O
and	O
the	O
patient	O
was	O
changed	O
to	O
Amiodarone	B-treatment
400	O
mg	O
t.i.d.	O
,	O
which	O
was	O
continued	O
for	O
two	O
days	O
.	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
on	O
Amiodarone	B-treatment
200	O
mg	O
daily	O
on	O
12/29/96	O
.	O

An	B-test
electrocardiogram	I-test
showed	O
no	O
evidence	O
of	O
QT	B-problem
prolongation	I-problem
prior	O
to	O
discharge	O
,	O
and	O
pulmonary	B-test
function	I-test
tests	I-test
will	O
be	O
performed	O
before	O
the	O
patient	O
goes	O
home	O
today	O
.	O

The	O
patient	O
will	O
follow	O
up	O
with	O
Dr.	O
Ther	O
Ludzjesc	O
at	O
Shiekeu	O
Hospital	O
Medical	O
Centers	O
in	O
Connecticut	O
.	O

In	O
addition	O
,	O
she	O
will	O
return	O
to	O
this	O
hospital	O
in	O
early	O
February	O
for	O
repeat	O
attempt	O
at	O
electrical	B-treatment
cardioversion	I-treatment
on	O
Amiodarone	B-treatment
.	O

She	O
will	O
continue	O
her	O
Coumadin	B-treatment
until	O
then	O
and	O
arrangements	O
for	O
her	O
readmission	O
can	O
be	O
made	O
through	O
Dr.	O
Iceca	O
Rhaltkaaispehbreun	O
's	O
office	O
here	O
.	O

MEDICATIONS	O
:	O

Other	O
than	O
the	O
addition	O
of	O
Amiodarone	B-treatment
200	O
mg	O
daily	O
,	O
will	O
be	O
the	O
same	O
as	O
her	B-treatment
admission	I-treatment
medications	I-treatment
.	O

STA	O
BODEJOVE	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

ICECA	O
RHALTKAAISPEHBREUN	O
,	O
M.D.	O

cc	O
:	O

Dr.	O
Ther	O
Ludzjesc	O
Director	O
,	O
Section	O
of	O
Cardiology	O
Shiekeu	O
Hospital	O
Medical	O
Centers	O
NC	O

TR	O
:	O

sip	O

DD	O
:	O

12/29/96	O

TD	O
:	O

12/29/96	O
10:03	O
A	O

cc	O
:	O

ICECA	O
RHALTKAAISPEHBREUN	O
,	O
M.D.	O

979440029	O
RWH	O

2027705	O

618070	O

3030191	O

06/11/2005	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

ELKSFALCBAINKIH	O
,	O
ON	O

MRN	O
:	O

2027705	O

Age	O
:	O

47y	O

REGISTRATION	O
DATE	O
:	O

06/11/2005	O
12:08	O
PM	O

Provider	O
:	O

BURLTIS	O
TROWELKS	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O
MD	O
:	O

E-mail	O

PCP	O
Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Note	O
Date	O
/	O
Time	O
:	O

06/11/2005	O
21:46	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

BODY	B-problem
SHAKING	I-problem

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
back	B-problem
pain	I-problem
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

back	B-problem
pain/	I-problem
mechanical	B-problem
fall	I-problem

Treatment	O
Rendered	O
:	O

Pt	B-test
&apos;s	I-test
labs	I-test
were	O
checked	O
,	O
he	O
was	O
seen	O
by	O
Neurology	O
,	O
and	O
he	O
received	O
a	B-test
spine	I-test
MRI	I-test
which	O
was	O
negative	O
.	O

He	O
received	O
Rx	B-treatment
for	O
potassium	B-treatment
to	O
help	O
with	O
cramps	B-problem
.	O

Advised	O
to	O
contact	O
Pain	O
service	O
for	O
repeat	B-treatment
injections	I-treatment
,	O
F	O
/	O
U	O
with	O
Neurology	O
,	O
explore	O
PT	B-treatment
,	O
massage	B-treatment
therapy	I-treatment
.	O

Discharge	O
Medications	O
:	O

K-Dur	B-treatment
20meq	O
PO	O
QD	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

F	O
/	O
U	O
with	O
Dr.	O
Wierstkotea	O
within	O
1	O
week	O
.	O

F	O
/	O
U	O
with	O
Neurology	O
,	O
pain	O
service	O
to	O
schedule	O
an	O
appt	O
.	O

PCP	O
Name	O
:	O

WIERSTKOTEA	O
,	O
JETA	O

Provider	O
Number	O
:	O

50927	O

This	O
report	O
was	O
created	O
by	O
TROWELKS	O
,	O
BURLTIS	O
06/11/2005	O
09:52	O
PM	O

989519730	O
WGH	O

4708487	O

265076	O

4927849	O

05/09/2004	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

GINSLENT	O
,	O
A	O
L	O

UNIT	O
NUMBER	O
:	O

537-43-35	O

ADMISSION	O
DATE	O
:	O

05/09/2004	O

DISCHARGE	O
DATE	O
:	O

05/16/2004	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Colon	B-problem
cancer	I-problem
.	O

ASSOCIATED	O
DIAGNOSES	O
:	O

History	O
of	O
diverticulitis	B-problem
,	O
status	O
post	O
cholecystectomy	B-treatment
,	O
status	O
post	O
appendectomy	B-treatment
,	O
and	O
hypertension	B-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Transverse	B-treatment
colectomy	I-treatment
for	O
tumor	B-problem
.	O

ASSOCIATED	O
PROCEDURES	O
:	O

None	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
an	O
84-year-old	O
woman	O
with	O
a	O
history	O
of	O
diverticulitis	B-problem
who	O
was	O
found	O
to	O
have	O
colon	B-problem
cancer	I-problem
on	O
colonoscopy	B-test
,	O
which	O
was	O
performed	O
in	O
March	O
of	O
2004	O
.	O

An	B-problem
invasive	I-problem
moderately	I-problem
differentiated	I-problem
adenocarcinoma	I-problem
was	O
noted	O
in	O
the	O
transverse	O
colon	O
at	O
80	O
cm	O
.	O

The	O
patient	O
reports	O
a	O
history	O
of	O
bloating	B-problem
and	O
flatulence	B-problem
as	O
well	O
as	O
increased	B-problem
fatigue	I-problem
.	O

She	O
has	O
also	O
had	O
some	B-problem
discomfort	I-problem
in	I-problem
her	I-problem
left	I-problem
lower	I-problem
abdomen	I-problem
and	O
notes	O
diarrhea	B-problem
every	O
4-5	O
days	O
.	O

She	O
says	O
that	O
her	O
appetite	O
is	O
good	O
and	O
has	O
noted	O
no	O
weight	B-problem
loss	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Cholecystectomy	B-treatment
in	O
1994	O
,	O
colonoscopy	B-treatment
2004	O
,	O
status	O
post	O
tonsillectomy	B-treatment
,	O
status	O
post	O
appendectomy	B-treatment
,	O
status	O
post	O
ORIF	B-treatment
of	I-treatment
left	I-treatment
wrist	I-treatment
,	O
status	O
post	O
left	B-treatment
ear	I-treatment
surgery	I-treatment
,	O
NSVD	B-treatment
x5	O
,	O
and	O
hypertension	B-problem
.	O

MEDICATIONS	O
:	O

Premarin	B-treatment
vaginal	I-treatment
once	O
a	O
month	O
,	O
enalapril	B-treatment
,	O
Tylenol	B-treatment
,	O
vitamins	B-treatment
,	O
and	O
Halcion	B-treatment
at	O
night	O
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

She	O
is	O
married	O
and	O
lives	O
in	O
an	O
assisted	O
living	O
facility	O
with	O
her	O
husband	O
.	O

She	O
has	O
five	O
grown	O
children	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
exam	B-test
she	O
is	O
afebrile	B-problem
.	O

Her	B-test
vital	I-test
signs	I-test
are	O
stable	O
.	O

Baseline	B-test
blood	I-test
pressure	I-test
of	O
144/61	O
,	O
heart	B-test
rate	I-test
of	O
73	O
,	O
and	O
oxygen	B-test
saturation	I-test
of	O
96%	O
on	O
room	O
air	O
.	O

She	O
is	O
a	O
pleasant	O
well	O
appearing	O
elderly	O
woman	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Lungs	O
are	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Heart	O
is	O
regular	O
without	O
murmurs	B-problem
,	O
rubs	B-problem
,	O
or	O
gallops	B-problem
.	O

Abdomen	O
is	O
soft	O
,	O
nontender	B-problem
,	O
and	O
nondistended	B-problem
.	O

Her	O
extremities	O
are	O
without	O
edema	B-problem
and	O
are	O
warm	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
consented	O
for	O
surgery	B-treatment
and	O
on	O
the	O
day	O
of	O
admission	O
was	O
taken	O
to	O
the	O
operating	O
room	O
for	O
transverse	B-treatment
colectomy	I-treatment
for	O
tumor	B-problem
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
and	O
there	O
are	O
no	O
complications	B-problem
.	O

Her	O
postoperative	O
course	O
was	O
unremarkable	O
.	O

She	O
was	O
maintained	O
on	O
an	B-treatment
epidural	I-treatment
and	O
PCA	B-treatment
for	O
pain	B-problem
control	I-problem
.	O

She	O
was	O
kept	O
NPO	B-treatment
initially	O
and	O
her	O
diet	O
was	O
slowly	O
advanced	O
as	O
tolerated	O
.	O

When	O
she	O
was	O
taking	O
clear	B-treatment
liquids	I-treatment
,	O
her	B-treatment
pain	I-treatment
medication	I-treatment
was	O
switched	O
to	O
p.o.	B-treatment
pain	I-treatment
regimen	I-treatment
with	O
good	O
affect	O
.	O

For	O
blood	B-treatment
pressure	I-treatment
control	I-treatment
she	O
was	O
maintained	O
on	O
metoprolol	B-treatment
at	O
the	O
request	O
of	O
her	O
primary	O
care	O
physician	O
and	O
enalapril	B-treatment
was	O
discontinued	O
.	O

With	O
the	O
help	O
of	O
physical	B-treatment
therapy	I-treatment
the	O
patient	O
was	O
ambulated	O
and	O
on	O
postoperative	O
seven	O
,	O
with	O
the	O
patient	O
tolerating	O
a	B-treatment
post	I-treatment
surgical	I-treatment
soft	I-treatment
diet	I-treatment
and	O
with	O
pain	B-problem
well	O
controlled	O
on	O
oral	B-treatment
pain	I-treatment
medications	I-treatment
,	O
she	O
was	O
discharged	O
to	O
rehabilitation	O
facility	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Tylenol	B-treatment
650	O
mg	O
p.o.	O
q.4.h.	O
p.r.n.	O
pain	B-problem
.	O

2.	O
Metoprolol	B-treatment
25	O
mg	O
p.o.	O
b.i.d.	O

3.	O
Motrin	B-treatment
400	O
mg	O
p.o.	O
b.i.d.	O
p.r.n.	O
pain	B-problem
.	O

4.	O
Halcion	B-treatment
0.25	O
mg	O
p.o.	O
at	O
night	O
.	O

5.	O
Dulcolax	B-treatment
10	O
to	O
20	O
mg	O
PR	O
b.i.d.	O
p.r.n.	O
constipation	B-problem
.	O

6.	O
Senna	B-treatment
2	O
tablets	O
p.o.	O
b.i.d.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

Consume	O
a	O
diet	O
as	O
tolerated	O
avoiding	O
carbonated	O
beverages	O
.	O

Her	O
activity	O
level	O
is	O
as	O
tolerated	O
.	O

She	O
is	O
to	O
contact	O
Dr.	O
Warm	O
&apos;s	O
office	O
to	O
schedule	O
a	O
follow	O
up	O
appointment	O
.	O

She	O
is	O
to	O
also	O
call	O
the	O
office	O
if	O
she	O
has	O
any	O
fever	B-problem
greater	I-problem
than	I-problem
101	I-problem
,	O
bleeding	B-problem
from	I-problem
the	I-problem
surgical	I-problem
wounds	I-problem
,	O
or	O
pus	B-problem
from	I-problem
the	I-problem
wounds	I-problem
.	O

She	O
is	O
to	O
be	O
maintained	O
on	O
metoprolol	B-treatment
for	O
blood	B-treatment
pressure	I-treatment
control	I-treatment
and	O
the	O
restarting	O
of	O
her	B-treatment
ACE	I-treatment
inhibitor	I-treatment
is	O
to	O
be	O
decided	O
by	O
her	O
primary	O
care	O
physician	O
.	O

ALEN	O
L	O
CREDKOTE	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

Electronically	O
Signed	O
OIE	O
LIMOR	O
WARM	O
,	O
M.D.	O
05/18/2004	O
11:28	O

_____________________________	O
OIE	O
LIMOR	O
WARM	O
,	O
M.D.	O

TR	O
:	O

ep	O

DD	O
:	O

05/16/2004	O

TD	O
:	O

05/16/2004	O
7:28	O
A	O
265076	O

cc	O
:	O

OIE	O
LIMOR	O
WARM	O
,	O
M.D.	O
CH	O
GILD	O
WARM	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2017-06-13	O

Discharge	O
Date	O
:	O

2017-06-17	O

Date	O
of	O
Birth	O
:	O

1956-02-17	O

Sex	O
:	O

M	O

Service	O
:	O

CARDIOTHORACIC	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending:Jordan	O
U	O
Kostohryz	O
,	O
M.D.	O

Chief	O
Complaint:	O
recent	B-problem
mild	I-problem
angina	I-problem
with	O
exertion	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

emergency	B-treatment
CABG	I-treatment
X	O
3	O
(	O
2017-06-13	O
)(	O
LIMA	B-treatment
to	I-treatment
LAD	I-treatment
,	O
SVG	B-treatment
to	I-treatment
ramus	I-treatment
,	O
SVG	B-treatment
to	I-treatment
OM	I-treatment
)	O

History	O
of	O
Present	O
Illness	O
:	O

61	O
yo	O
African-American-Hispanic	O
male	O
had	O
abnormal	B-problem
EKG	I-problem
found	O
as	O
part	O
of	O
pre-op	B-test
eval.	I-test
for	O
ventral	B-treatment
hernia	I-treatment
repair	I-treatment
.	O

Had	O
subsequent	O
abnormal	B-problem
stress	I-problem
test	I-problem
and	O
pefusion	B-test
imaging	I-test
showed	O
EF	B-test
38%	O
with	O
perfusion	B-problem
defects	I-problem
.	O

Echo	B-test
prior	O
to	O
scheduled	B-test
cath	I-test
showed	O
mild	B-problem
LVH	I-problem
,	O
inferior	B-problem
HK	I-problem
,	O
EF	B-test
40%	O
,	O
mild	B-problem
MR	I-problem
,	O
mild	B-problem
LAE	I-problem
.	O

Cath	B-test
at	O
Kindred/North	O
Shore	O
today	O
showed	O
80%	B-problem
LM	I-problem
lesion	I-problem
with	O
normal	O
LAD	O
,	O
CX	O
,	O
RCA	O
.	O

Severe	B-problem
systolic	I-problem
HTN	I-problem
also	O
noted	O
.	O

Transferred	O
in	O
urgently	O
for	O
cabg	B-treatment
with	O
Dr.	O
Howard	O
.	O

Past	O
Medical	O
History	O
:	O

ventral	B-problem
hernia	I-problem

HTN	B-problem
elev.	B-problem
chol.	I-problem
right	B-problem
facial	I-problem
droop	I-problem
with	O
metal	B-treatment
plate	I-treatment
secondary	O
to	O
GSW	B-problem
to	O
face	B-treatment
right	I-treatment
nephrectomy	I-treatment

Social	O
History	O
:	O

current	O
smoker	O

Family	O
History	O
:	O

not	O
given	O

Physical	O
Exam:	O

Not	O
done	O
,	O
taken	O
to	O
OR	O
direct	O
from	O
ambulance	O
transfer	O
.	O

Pertinent	O
Results:	O

2017-06-14	O
02:06AM	O
BLOOD	B-test

WBC	B-test
-	O
9.4	O
RBC	B-test
-	O
3.61*	O
Hgb	B-test
-	O
10.4*	O
Hct	B-test
-	O
29.9*	O
MCV	B-test
-	O
83	O
MCH	B-test
-	O
28.8	O
MCHC	B-test
-	O
34.8	O
RDW	B-test
-	O
14.3	O
Plt	B-test
Ct	I-test
-	O
154	O

2017-06-17	O
05:14AM	O
BLOOD	B-test

Hct	B-test
-	O
25.2*	O

2017-06-14	O
02:06AM	O
BLOOD	B-test

Plt	B-test
Ct	I-test
-	O
154	O

2017-06-13	O
08:05PM	O
BLOOD	B-test

PT	B-test
-	O
13.6*	O
PTT	B-test
-	O
33.3	O
INR	B-test
(	O
PT	B-test
)	O
-	O
1.2*	O

2017-06-17	O
05:14AM	O
BLOOD	B-test

UreaN	B-test
-	O
25*	O
Creat	B-test
-	O
1.0	O
K	B-test
-	O
3.9	O

2017-06-15	O
02:02PM	O
BLOOD	B-test

Mg	B-test
-	O
2.1	O

FINAL	O
REPORT	O

TWO	B-test
VIEW	I-test
CHEST	I-test
,	O
2017-06-17	O

COMPARISON	O
:	O

2017-06-14	O
.	O

INDICATION	O
:	O

Status	O
post	O
coronary	B-treatment
bypass	I-treatment
surgery	I-treatment
.	O

There	O
has	O
been	O
removal	O
of	O
a	B-treatment
Swan-Ganz	I-treatment
catheter	I-treatment
and	O
placement	O
of	O
a	B-treatment
right	I-treatment
internal	I-treatment
jugular	I-treatment
vascular	I-treatment
catheter	I-treatment
,	O
with	O
the	O
tip	O
terminating	O
in	O
the	O
proximal	O
right	O
atrium	O
just	O
below	O
the	O
junction	O
with	O
the	O
superior	O
vena	O
cava	O
.	O

Cardiac	O
and	O
mediastinal	O
contours	O
are	O
stable	O
in	O
the	O
postoperative	O
period	O
.	O

Previously	O
reported	O
interstitial	B-problem
edema	I-problem
has	O
resolved	O
.	O

There	O
has	O
been	O
interval	O
improvement	O
in	O
left	B-problem
basilar	I-problem
atelectasis	I-problem
.	O

Right	B-problem
basilar	I-problem
atelectasis	I-problem
has	O
slightly	O
worsened	O
.	O

Bilateral	B-problem
pleural	I-problem
effusions	I-problem
are	O
unchanged	O
.	O

IMPRESSION	O
:	O

1.	O
Vascular	B-treatment
catheter	I-treatment
tip	I-treatment
terminates	O
in	O
proximal	O
right	O
atrium	O
.	O

2.	O
Bibasilar	B-problem
minor	I-problem
atelectasis	I-problem
,	O
worse	O
on	O
the	O
right	O
and	O
improved	O
on	O
the	O
left	O
.	O

Persistent	B-problem
pleural	I-problem
effusions	I-problem
.	O

DR.	O
John	O
S.	O
Beauchamp	O

Approved	O
:	O

SAT	O
2017-06-17	O
8:20	O
PM	O

Procedure	O
Date:2017-06-17	O

PRE-CPB	O
:	O

The	O
left	O
atrium	O
is	O
mildly	B-problem
dilated	I-problem
.	O

No	O
spontaneous	B-problem
echo	I-problem
contrast	I-problem
is	O
seen	O
in	O
the	O
body	O
of	O
the	O
left	O
atrium	O
.	O

No	O
spontaneous	B-problem
echo	I-problem
contrast	I-problem
or	O
thrombus	B-problem
is	O
seen	O
in	O
the	O
body	O
of	O
the	O
left	O
atrium	O
or	O
left	O
atrial	O
appendage	O
.	O

No	O
mass/thrombus	B-problem
is	O
seen	O
in	O
the	O
left	O
atrium	O
or	O
left	O
atrial	O
appendage	O
.	O

No	O
atrial	B-problem
septal	I-problem
defect	I-problem
is	O
seen	O
by	O
2D	B-test
or	O
color	B-test
Doppler	I-test
.	O

There	O
is	O
mild	B-problem
symmetric	I-problem
left	I-problem
ventricular	I-problem
hypertrophy	I-problem
with	O
normal	O
cavity	O
size	O
.	O

There	O
is	O
mild	B-problem
symmetric	I-problem
left	I-problem
ventricular	I-problem
hypertrophy	I-problem
.	O

The	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

No	O
left	B-problem
ventricular	I-problem
aneurysm	I-problem
is	O
seen	O
.	O

There	O
is	O
mild	B-problem
regional	I-problem
left	I-problem
ventricular	I-problem
systolic	I-problem
dysfunction	I-problem
.	O

Overall	B-test
left	I-test
ventricular	I-test
systolic	I-test
function	I-test
is	O
mildly	B-problem
depressed	I-problem
.	O

There	O
is	O
no	O
ventricular	B-problem
septal	I-problem
defect	I-problem
.	O

Resting	B-problem
regional	I-problem
wall	I-problem
motion	I-problem
abnormalities	I-problem
include	O
mild	B-problem
inferior	I-problem
hypokinesis	I-problem
.	O

Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

The	O
right	O
ventricular	O
cavity	O
is	O
mildly	B-problem
dilated	I-problem
.	O

There	O
are	O
simple	B-problem
atheroma	I-problem
in	O
the	O
aortic	O
root	O
.	O

There	O
are	O
simple	B-problem
atheroma	I-problem
in	O
the	O
ascending	O
aorta	O
.	O

There	O
are	O
simple	B-problem
atheroma	I-problem
in	O
the	O
aortic	O
arch	O
.	O

There	O
are	O
simple	B-problem
atheroma	I-problem
in	O
the	O
descending	O
thoracic	O
aorta	O
.	O

There	O
are	O
three	O
aortic	O
valve	O
leaflets	O
.	O

The	O
aortic	O
valve	O
leaflets	O
are	O
mildly	B-problem
thickened	I-problem
.	O

No	O
masses	B-problem
or	O
vegetations	B-problem
are	O
seen	O
on	O
the	O
aortic	O
valve	O
.	O

There	O
is	O
no	O
aortic	B-problem
valve	I-problem
stenosis	I-problem
.	O

Trace	B-problem
aortic	I-problem
regurgitation	I-problem
is	O
seen	O
.	O

The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	B-problem
thickened	I-problem
.	O

No	O
mass	B-problem
or	O
vegetation	B-problem
is	O
seen	O
on	O
the	O
mitral	O
valve	O
.	O

Trivial	B-problem
mitral	I-problem
regurgitation	I-problem
is	O
seen	O
.	O

There	O
is	O
no	O
pericardial	B-problem
effusion	I-problem
.	O

POST-CPB	O
:	O

Preserved	O
LV	O
systolic	O
function	O
on	O
phenylephrine	B-treatment
.	O

LVEF	B-test
now	O
50%	O
.	O

Trace	B-problem
MR	I-problem
,	O
AI	B-problem
as	O
described	O
.	O

Normal	O
aortic	O
contours	O
.	O

I	O
certify	O
that	O
I	O
was	O
present	O
for	O
this	B-treatment
procedure	I-treatment
in	O
compliance	O
with	O
HCFA	O
regulations	O
.	O

Electronically	O
signed	O
by	O
Tracy	O
Kimball	O
,	O
MD	O
,	O
Interpreting	O
physician	O

Brief	O
Hospital	O
Course:	O

Admitted	O
directly	O
to	O
OR	O
from	O
ambulance	O
transfer	O
and	O
underwent	O
cabg	B-treatment
x3	O
with	O
Dr.	O
Howard	O
on	O
06-13	O
.	O

Transferred	O
to	O
the	O
CSRU	O
in	O
stable	O
condition	O
on	O
phenylephrine	B-treatment
and	O
propofol	B-treatment
drips	I-treatment
.	O

Extubated	O
early	O
the	O
next	O
morning	O
and	O
chest	B-treatment
tubes	I-treatment
removed	O
.	O

Gentle	B-treatment
diuresis	I-treatment
and	O
beta	B-treatment
blockade	I-treatment
started	O
,	O
and	O
he	O
was	O
transferred	O
to	O
the	O
floor	O
to	O
begin	O
increasing	O
his	O
activity	O
level	O
.	O

Foley	B-treatment
removed	O
on	O
POD	O
#2	O
and	O
had	O
scattered	B-problem
rales	I-problem
with	O
temp	B-test
101.2	O
.	O

Afebrile	B-problem
the	O
next	O
day	O
and	O
pacing	B-treatment
wires	I-treatment
removed	O
without	O
incident	O
.	O

He	O
made	O
excellent	O
progress	O
and	O
was	O
discharged	O
to	O
home	O
with	O
VNA	O
services	O
on	O
POD	O
#4	O
.	O

He	O
is	O
to	O
follow	O
up	O
with	O
providers	O
as	O
per	O
discharge	O
instructions	O
.	O

Medications	O
on	O
Admission	O
:	O

bisoprolol	B-treatment
5	O
mg	O
daily	O
crestor	B-treatment
20	O
mg	O
daily	O

HCTZ	B-treatment
25	O
mg	O
daily	O
lisinopril	B-treatment
40	O
mg	O
daily	O

Discharge	O
Medications:	O

1.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:	O
*60	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*2*	O

2.	O
Potassium	B-treatment
Chloride	I-treatment
10	O
mEq	O
Capsule	O
,	O
Sustained	O
Release	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Capsule	O
,	O
Sustained	O
Release	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
)	O
for	O
7	O
days	O
.	O

Disp	O
:	O
*28	O
Capsule	O
,	O
Sustained	O
Release(	O
s	O
)*	O

Refills	O
:	O
*0*	O

3.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:	O
*60	O
Capsule(	O
s	O
)*	O

Refills	O
:	O
*2*	O

4.	O
Ranitidine	B-treatment
HCl	I-treatment
150	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:	O
*60	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*2*	O

5.	O
Aspirin	B-treatment
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:	O
*30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(	O
s	O
)*	O

Refills	O
:	O
*2*	O

6.	O
Oxycodone-Acetaminophen	B-treatment
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
every	O
4-6	O
hours	O
as	O
needed	O
for	O
pain	B-problem
.	O

Disp	O
:	O
*50	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*0*	O

7.	O
Rosuvastatin	B-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:	O
*30	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*2*	O

8.	O
Furosemide	B-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
for	O
7	O
days	O
.	O

Disp	O
:	O
*14	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*0*	O

Discharge	O
Disposition:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis:	O

CAD	B-problem

HTN	B-problem
ventral	B-problem
hernia	I-problem
right	B-treatment
nephrectomy	I-treatment
s/p	O
right	B-treatment
facial	I-treatment
plating	I-treatment

Discharge	O
Condition	O
:	O
good	O

Discharge	O
Instructions	O
:	O
may	O
shower	O
,	O
no	O
bathing	O
or	O
swimming	O
for	O
1	O
month	O
no	O
creams	B-treatment
,	O
lotions	B-treatment
or	O
powders	B-treatment
to	O
any	B-problem
incisions	I-problem
no	O
driving	O
for	O
1	O
month	O
no	O
lifting	O
>	O
10	O
#	O
for	O
10	O
weeks	O

A.	O
Instructions	O
:	O
with	O
Dr.	O
Matthew	O
in	O
2-3	O
weeks	O
with	O
Dr.	O
Dellinger	O
in	O
2-3	O
weeks	O
with	O
Dr.	O
les	O
Gokey	O
in	O
4	O
weeks	O

Curtis	O
van	O
den	O
Moreno	O
MD	O
07-506	O

Completed	O
by	O
:	O

Scott	O
Robert	O
NP	O
80-AUM	O
2017-06-29	O
@	O
1121	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Barbara	O
van	O
de	O
Tate	O
on	O
:	O

FRI	O
2017-07-28	O
1:55	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2015-10-05	O

Discharge	O
Date	O
:	O

2015-10-08	O

Date	O
of	O
Birth	O
:	O

1815-10-05	O

Sex	O
:	O

F	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Shellfish	O

Attending	O
:	O

Jacob	O
U.	O
Rolland	O
,	O
M.D.	O

Chief	O
Complaint:	O

Chest	B-problem
pain	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O

None	O

History	O
of	O
Present	O
Illness:	O

The	O
patient	O
is	O
a	O
91	O
yo	O
woman	O
with	O
h/o	O
HTN	B-problem
who	O
came	O
from	O
Bridgewater	O
State	O
Hospital	O
Rehab	O
with	O
substernal	B-problem
chest	I-problem
pain	I-problem
after	O
exercise	O
.	O

Pt	O
had	O
been	O
in	O
her	O
usual	O
state	O
of	O
health	O
and	O
performed	O
here	O
regular	O
exercises	O
.	O

After	O
returning	O
to	O
her	O
room	O
she	O
w	O
noted	O
SSCP	B-problem
without	O
radiation	O
.	O

No	O
nausea	B-problem
,	O
vomiting	B-problem
,	O
diaphoresis	B-problem
.	O

They	O
did	O
an	B-test
ECG	I-test
at	O
Bridgewater	O
State	O
Hospital	O
rehab	O
which	O
demonstarted	O
new	B-problem
ST	I-problem
depressions	I-problem
in	I-problem
V1-V4	I-problem
.	O

She	O
received	O
ASA	B-treatment
81	O
mg	O
x	O
2	O
and	O
nitro	B-treatment
SL	I-treatment
x	O
2	O
with	O
partial	O
relief	O
at	O
nursing	O
home	O
.	O

On	O
presentation	O
to	O
Providence	O
Behavioral	O
Health	O
Hospital	O
Amanda	O
,	O
her	B-test
vitals	I-test
were	O
HR	B-test
68	O
,	O
BP	B-test
142/68	O
,	O
RR	B-test
28	O
,	O
O2	B-test
sat	I-test
100%	O
RA	O
.	O

Exam	B-test
was	O
notable	O
for	O
RRR	O
with	O
no	O
murmur	B-problem
,	O
bibasilar	B-problem
crackles	I-problem
,	O
guaiac	B-test
negative	O
.	O

EKG	B-test
showed	O
sinus	B-problem
brady	I-problem
,	O
with	O
old	B-problem
LAD	I-problem
and	I-problem
new	I-problem
ST	I-problem
depressions	I-problem
in	I-problem
V1-V4	I-problem
.	O

Troponin	B-test
was	O
0.07	O
.	O

She	O
received	O
ASA	B-treatment
,	O
nitro	B-treatment
SL	I-treatment
then	O
gtt	O
,	O
morphine	B-treatment
,	O
metoprolol	B-treatment
,	O
and	O
heparin	B-treatment
gtt	I-treatment
.	O

Cardiology	O
discussed	O
cath	B-test
however	O
,	O
patient	O
's	O
family	O
turned	O
down	O
.	O

Transferred	O
to	O
CCU	O
for	O
further	B-treatment
management	I-treatment
and	O
observation	O
.	O

Past	O
Medical	O
History:	O

HTN	B-problem

Hearing	B-problem
difficulty	I-problem

Blindness	B-problem
02-26	O
macular	B-problem
degeneration	I-problem

R	B-problem
ankle	I-problem
fx	I-problem
2002	O

S/p	O
hysterectomy	B-treatment

Social	O
History	O
:	O

currently	O
lives	O
at	O
Bridgewater	O
State	O
Hospital	O
Rehab;	O
no	O
tobacco	O
or	O
EtOH	O
use;	O
used	O
to	O
be	O
housewife	O

Family	O
History	O
:	O

n/c	O

Physical	O
Exam:	O

Vitals	O
:	O

T	B-test
97.8	O
,	O
HR	B-test
53	O
,	O
BP	B-test
156/58	O
,	O
RR	B-test
16	O
,	O
O2	B-test
sat	I-test
94%	O
on	O
2.5	O
L	O

Gen	O
:	O

NAD	B-problem
,	O
awake	O
,	O
alert	O
,	O
blind	B-problem
,	O
able	O
to	O
hear	O
loud	O
voices	O
at	O
L	O
ear	O

HEENT	O
:	O

MMM	O
,	O
OP	O
clear	O

Neck	O
:	O

JVP	B-test
11	O
cm	O

CV	O
:	O

Reg	O
rate	O
,	O
nl	O
S1	O
&	O
S2	O
,	O
no	O
m/r/g	B-problem

Pulm	O
:	O

Crackles	B-problem
at	I-problem
base	I-problem
and	I-problem
mid-lungs	I-problem
bilaterally	I-problem

Abd	O
:	O

Soft	O
,	O
NT	B-problem
,	O
ND	B-problem
,	O
BS	O
present	O
,	O
no	O
masses	B-problem

Ext	O
:	O

Trace	B-problem
ankle	I-problem
edema	I-problem
bilaterally	I-problem

Pertinent	O
Results:	O

LABS	O
on	O
admission:	O

WBC	B-test
-	O
11.4*	O
RBC	B-test
-	O
3.61*	O
Hgb	B-test
-	O
11.4*	O
Hct	B-test
-	O
32.6*	O
MCV	B-test
-	O
90	O
MCH	B-test
-	O
31.7	O

MCHC	B-test
-	O
35.1*	O
RDW	B-test
-	O
14.7	O
Plt	B-test
Ct	I-test
-	O
281	O

Glucose	B-test
-	O
124*	O
UreaN	B-test
-	O
30*	O
Creat	B-test
-	O
1.3*	O
Na	B-test
-	O
137	O
K	B-test
-	O
4.2	O
Cl	B-test
-	O
102	O
HCO3	B-test
-	O
27	O

AnGap	B-test
-	O
12	O

CK	B-test
(	O
CPK	B-test
)	O
-	O
42	O
cTropnT	B-test
-	O
0.07*	O

.	O

STUDIES:	O

EKG	B-test
:	O

sinus	B-problem
brady	I-problem
@	O
48	O
bpm	O
,	O
LAD	O
,	O
LVH	B-problem
,	O
RBBB	B-problem
,	O
Q	B-problem
wave	I-problem
in	I-problem
I	I-problem
,	O
ST	B-problem
depressions	I-problem
in	I-problem
V1-V4	I-problem
,	O
ST	B-problem
elevation	I-problem
in	I-problem
III	I-problem
,	O
aVF	B-problem
,	O
TWI	B-problem
in	I-problem
III	I-problem
,	O
V5	O
.	O

CXR	B-test
10-07	O
:	O

There	O
is	O
slight	B-problem
worsening	I-problem
of	O
the	B-problem
still	I-problem
mild	I-problem
pulmonary	I-problem
edema	I-problem
.	O

There	O
is	O
no	O
pneumothorax	B-problem
.	O

Small	B-problem
right	I-problem
pleural	I-problem
effusion	I-problem
is	O
stable	O
.	O

Cardiac	O
size	O
is	O
normal	O
.	O

Echo	B-test
:	O

LVEF	B-test
>70%	O
,	O
LA	B-test
6.1	O
cm	O
,	O
no	O
regional	B-problem
wall	I-problem
motion	I-problem
abnormality	I-problem
.	O

Cardiac	B-test
Enzymes	I-test

2015-10-05	O
09:00PM	O
BLOOD	B-test

CK	B-test
(	O
CPK	B-test
)	O
-	O
1471*	O
CK-MB	B-test
-	O
207*	O
MB	B-test
Indx	I-test
-	O
14.1*	O
cTropnT	B-test
-	O
6.00*	O

2015-10-06	O
04:47PM	O
BLOOD	B-test

CK	B-test
(	O
CPK	B-test
)	O
-	O
1288*	O
CK-MB	B-test
-	O
158*	O
MB	B-test
Indx	I-test
-	O
12.3*	O
cTropnT	B-test
-	O
6.88*	O

2015-10-07	O
07:30AM	O
BLOOD	B-test

CK	B-test
(	O
CPK	B-test
)	O
-	O
627*	O
CK-MB	B-test
-	O
55*	O
MB	B-test
Indx	I-test
-	O
8.8*	O
cTropnT	B-test
-	O
4.46*	O

.	O

Labs	B-test
on	O
Discharge	O
2015-10-08	O
08:35AM	O

WBC	B-test
-	O
13.8*	O
RBC	B-test
-	O
3.39*	O
Hgb	B-test
-	O
10.7*	O
Hct	B-test
-	O
30.2*	O
MCV	B-test
-	O
89	O
MCH	B-test
-	O
31.5	O

MCHC	B-test
-	O
35.3*	O
RDW	B-test
-	O
14.8	O
Plt	B-test
Ct	I-test
-	O
214	O

Glucose	B-test
-	O
120*	O
UreaN	B-test
-	O
30*	O
Creat	B-test
-	O
1.2*	O
Na	B-test
-	O
134	O
K	B-test
-	O
4.2	O
Cl	B-test
-	O
100	O
HCO3	B-test
-	O
25	O

AnGap	B-test
-	O
13	O

Calcium	B-test
-	O
8.7	O
Phos	B-test
-	O
2.5*	O
Mg	B-test
-	O
2.1	O

Brief	O
Hospital	O
Course:	O

INITIAL	O
IMPRESSION	O
:	O

90	O
year-old	O
woman	O
with	O
h/o	O
of	O
HTN	B-problem
p/w	O
substernal	B-problem
chest	I-problem
pain	I-problem
shortly	O
after	O
exercise	O
at	O
nursing	O
home	O
,	O
with	O
EKG	B-test
showing	O
ST	B-problem
depressions	I-problem
in	I-problem
V1-V4	I-problem
and	O
troponin	B-test
0.07.	O

Likely	O
NSTEMI	B-problem
.	O

.	O

HOSPITAL	O
COURSE	O
BY	O
SYSTEM	O
:	O

.	O

*	O
CV	O
:	O

The	O
patient	O
's	O
family	O
refused	O
coronary	B-treatment
artery	I-treatment
catheterization	I-treatment
.	O

The	O
patient	O
was	O
given	O
ASA	B-treatment
,	O
Plavix	B-treatment
,	O
heparin	B-treatment
drip	I-treatment
x	O
24	O
hours	O
,	O
nitro	B-treatment
drip	I-treatment
,	O
atorvastatin	B-treatment
,	O
metoprolol	B-treatment
,	O
and	O
lisinopril	B-treatment
.	O

Her	B-problem
chest	I-problem
pain	I-problem
was	O
controlled	O
with	O
morphine	B-treatment
.	O

Her	B-test
SBP	I-test
remained	O
in	O
the	O
160s-170s	O
on	O
hospital	O
day	O
1	O
and	O
she	O
was	O
gently	O
diuresed	O
.	O

On	O
hospital	O
day	O
2	O
she	O
experienced	O
atrial	B-problem
fibrillation	I-problem
with	O
HR	B-test
in	O
the	O
140s	O
.	O

Her	B-treatment
metoprolol	I-treatment
dose	I-treatment
was	O
increased	O
from	O
25	O
mg	O
PO	O
bid	O
to	O
50	O
mg	O
PO	O
bid	O
then	O
75	O
mg	O
PO	O
tid	O
.	O

Her	B-test
HR	I-test
decreased	O
to	O
70s-80s	O
.	O

Her	B-test
BP	I-test
remained	O
stable	O
.	O

An	B-test
ECHO	I-test
showed	O
that	O
she	O
had	O
preserved	O
EF	O
and	O
no	O
wall	B-problem
motion	I-problem
abnormalities	I-problem
.	O

We	O
decided	O
given	O
her	O
age	O
that	O
she	O
would	O
not	O
be	O
a	O
good	O
candidate	O
for	O
cardioversion	B-treatment
for	O
her	B-problem
afib	I-problem
nor	O
would	O
she	O
be	O
a	O
good	O
candidate	O
for	O
coumadin	B-treatment
.	O

Therefore	O
we	O
will	O
continue	O
rate	O
control	O
with	O
metoprolol	B-treatment
this	O
can	O
be	O
titrated	O
if	O
needed	O
,	O
and	O
aspirin	B-treatment
and	O
plavix	B-treatment
for	O
anti-coagulation	B-treatment
.	O

She	O
should	O
also	O
continue	O
on	O
lipitor	B-treatment
and	O
lisinopril	B-treatment
.	O

She	O
should	O
have	O
her	B-test
chem	I-test
7	I-test
checked	O
next	O
week	O
given	O
the	O
start	O
of	O
her	B-treatment
new	I-treatment
meds	I-treatment
.	O

Will	O
also	O
need	O
LFT	B-test
's	I-test
checked	O
in	O
3-6	O
months	O
.	O

.	O

*	O
Pulmonary	O
:	O

Bilateral	B-problem
crackles	I-problem
at	I-problem
bases	I-problem
and	I-problem
midlungs	I-problem
,	O
elevated	B-problem
JVP	I-problem
,	O
trace	B-problem
bilateral	I-problem
ankle	I-problem
edema	I-problem
,	O
and	O
CXR	B-test
with	O
diffuse	B-problem
opacities	I-problem
suggest	O
possible	O
pulmonary	B-problem
edema	I-problem
,	O
likely	O
secondary	O
to	O
acute	B-problem
MI	I-problem
.	O

Her	B-test
O2	I-test
sat	I-test
was	O
stable	O
at	O
94-97%	O
on	O
2.5L	O
of	O
supplemental	B-treatment
O2	I-treatment
.	O

She	O
experienced	O
no	O
respiratory	B-problem
difficulty	I-problem
during	O
the	O
hospital	O
stay	O
.	O

She	O
was	O
diuresed	O
small	O
amount	O
.	O

Her	B-test
CXR	I-test
prior	O
to	O
discharge	O
showed	O
mild	B-problem
pulm	I-problem
edema	I-problem
and	O
thus	O
was	O
given	O
40	O
of	O
lasix	B-treatment
prior	O
to	O
going	O
to	O
rehab	O
.	O

She	O
can	O
be	O
given	O
prn	O
lasix	B-treatment
for	O
weight	B-problem
gain	I-problem
or	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

.	O

*	O
Leukocytosis-	B-problem
She	O
developed	O
mild	B-problem
elevated	I-problem
WBC	I-problem
.	O

UA	B-test
had	O
12-14	O

WBC	B-test
's	I-test
,	O
few	B-problem
bacteria	I-problem
.	O

She	O
was	O
initially	O
started	O
on	O
Bactrim	B-treatment
,	O
but	O
this	O
was	O
stopped	O
as	O
she	O
was	O
afebrile	B-problem
.	O

SHe	O
has	O
a	B-test
culture	I-test
pending	O
which	O
needs	O
to	O
be	O
followed	O
up	O
at	O
the	O
nursing	O
home	O
and	O
treated	O
if	O
positive	B-problem
.	O

.	O

*	O
Code	O
:	O

DNR/DNI	O

Medications	O
on	O
Admission	O
:	O

tylenol	B-treatment
PRN	O
lisinopril	B-treatment
5	O
mg	O
PO	O
qd	O
protonix	B-treatment
20	O
mg	O
PO	O
qd	O
artifical	B-treatment
tears	I-treatment
bid	O
metoprolol	B-treatment
25	O
mg	O
PO	O
bid	O

Discharge	O
Medications:	O

1.	O
Senna	B-treatment
8.6	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

2.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
constipation	B-problem
.	O

3.	O
Aspirin	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

4.	O
Clopidogrel	B-treatment
75	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

5.	O
Atorvastatin	B-treatment
80	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

6.	O
Pantoprazole	B-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
0.5	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
.	O

7.	O
Polyvinyl	B-treatment
Alcohol	I-treatment
1.4	O
%	O
Drops	O
Sig	O
:	O
1-2	O
Drops	O
Ophthalmic	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

8.	O
Lisinopril	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

9.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

10.	O
Acetaminophen	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

11.	O
Maalox	B-treatment
225-200	O
mg/5	O
mL	O
Suspension	O
Sig	O
:	O
Five	O
(	O
5	O
)	O
mL	O
PO	O
every	O
six	O
(	O
6	O
)	O
hours	O
as	O
needed	O
for	O
indigestion	B-problem
.	O

12.	O
Lasix	B-treatment
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
as	O
needed	O
for	O
shortness	B-problem
of	I-problem
breath	I-problem
or	O
wheezing	B-problem
:	O

Can	O
give	O
40	O
lasix	B-treatment
PO	O
if	O
having	O
any	O
weight	B-problem
gain	I-problem
or	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

Discharge	O
Disposition:	O

Extended	O
Care	O

Discharge	O
Diagnosis:	O

NSTEMI	B-problem

Atrial	B-problem
Fibrillation	I-problem

HTN	B-problem

Discharge	O
Condition:	O

Patient	O
without	O
chest	B-problem
pain	I-problem
,	O
heart	B-test
rate	I-test
and	O
BP	B-test
stable	O
.	O

Discharge	O
Instructions:	O

Please	O
take	O
all	B-treatment
medications	I-treatment
as	O
instructed	O
.	O

She	O
has	O
been	O
started	O
on	O
several	B-treatment
new	I-treatment
medications	I-treatment
which	O
are	O
important	O
to	O
protect	O
her	O
heart	O
.	O

If	O
the	O
patient	O
experiences	O
any	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
nausea	B-problem
,	O
vomiting	B-problem
,	O
fevers	B-problem
,	O
chills	B-problem
,	O
please	O
return	O
to	O
the	O
emergency	O
room	O
.	O

Followup	O
Instructions:	O

Please	O
call	O
(	O
881-6997	O
to	O
set	O
up	O
follow	O
up	O
cardiology	O
appointment	O
in	O
2-3	O
months	O
.	O

Betty	O
Herbert	O
MD	O
43-075	O

Completed	O
by	O
:	O

Allison	O
Crystal	O
MD	O
52-741	O
2015-10-08	O
@	O
1510	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Dorothy	O
Z.	O
Alderman	O
on	O
:	O

SUN	O
2015-10-11	O
11:49	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2015-06-05	O

Discharge	O
Date	O
:	O

2015-06-10	O

Date	O
of	O
Birth	O
:	O

2015-06-05	O

Sex	O
:	O

M	O

Service	O
:	O

Neonatology	O

HISTORY	O
:	O

The	O
patient	O
is	O
a	O
1,770	O
gram	O
male	O
infant	O
born	O
by	O
stat	B-treatment
cesarean	I-treatment
section	I-treatment
for	O
fetal	B-problem
bradycardia	I-problem
at	O
30-6/7	O
weeks	O
gestation	O
to	O
a	O
29-year-old	O
gravida	O
3	O
,	O
para	O
0	O
now	O
1	O
mother	O
.	O

The	O
pregnancy	O
was	O
unremarkable	O
until	O
2015-06-01	O
when	O
the	O
mother	O
presented	O
to	O
Shriner	O
's	O
Hospital	O
for	O
Crippled	O
Children	O
for	O
increased	B-problem
blood	I-problem
pressure	I-problem
and	O
proteinuria	B-problem
.	O

She	O
was	O
transferred	O
to	O
Charles	O
River	O
Hospital	O
and	O
was	O
treated	O
with	O
magnesium	B-treatment
sulfate	I-treatment
and	O
betamethasone	B-treatment
.	O

The	O
morning	O
of	O
admission	O
the	O
mother	O
developed	O
vaginal	B-problem
bleeding	I-problem
and	O
fetal	B-problem
bradycardia	I-problem
was	O
noted	O
.	O

Therefore	O
,	O
a	B-treatment
stat	I-treatment
cesarean	I-treatment
section	I-treatment
was	O
performed	O
.	O

The	O
infant	O
emerged	O
limp	B-problem
and	O
without	O
spontaneous	B-problem
respiratory	I-problem
effort	I-problem
.	O

He	O
was	O
given	O
bag	B-treatment
mask	I-treatment
ventilation	I-treatment
with	O
good	O
response	O
.	O

Apgar	B-test
scores	I-test
were	O
6	O
at	O
one	O
minute	O
and	O
8	O
at	O
five	O
minutes	O
.	O

PRENATAL	O
SCREENS	O
:	O

O+	O
,	O
hepatitis	B-test
B	I-test
surface	I-test
antigen	I-test
negative	O
,	O

RPR	B-test
nonreactive	O
,	O
rubella	B-problem
immune	O
.	O

ADMISSION	O
PHYSICAL	O
EXAMINATION	O
:	O

The	O
birth	O
weight	O
was	O
1,770	O
grams	O
.	O

The	O
patient	O
was	O
in	O
mild	B-problem
to	I-problem
moderate	I-problem
respiratory	I-problem
distress	I-problem
.	O

He	O
was	O
a	O
nondysmorphic	O
male	O
.	O

Anterior	O
fontanel	O
was	O
soft	O
,	O
open	O
and	O
flat	O
.	O

The	O
ears	O
and	O
eyes	O
were	O
normally	O
placed	O
.	O

The	O
palate	O
was	O
intact	O
.	O

The	O
oropharynx	O
was	O
benign	O
.	O

Neck	O
was	O
supple	O
without	O
masses	B-problem
or	O
defects	B-problem
.	O

The	O
lungs	O
were	O
coarse	B-problem
bilaterally	I-problem
with	O
moderate	B-problem
retractions	I-problem
.	O

The	B-test
cardiovascular	I-test
examination	I-test
revealed	O
S1	B-test
and	O
S2	B-test
regular	O
,	O
no	O
murmurs	B-problem
,	O
2+	B-test
femoral	I-test
pulses	I-test
.	O

He	O
was	O
warm	O
and	O
well	O
perfused	O
.	O

The	O
abdomen	O
was	O
benign	O
,	O
flat	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
,	O
no	O
hepatosplenomegaly	B-problem
.	O

He	O
had	O
a	O
normal	O
male	O
phallus	O
and	O
bilaterally	O
descended	O
testes	O
.	O

The	O
anus	O
was	O
patent	O
and	O
normally	O
placed	O
.	O

Hips	O
were	O
stable	O
without	O
clunk	B-problem
.	O

The	O
extremities	O
were	O
normal	O
in	O
appearance	O
.	O

The	O
skin	O
was	O
without	O
lesions	B-problem
.	O

The	B-test
neurological	I-test
examination	I-test
was	O
appropriate	O
for	O
age	O
with	O
normal	O
tone	O
and	O
strength	O
and	O
appropriate	O
reflexes	O
.	O

HOSPITAL	O
COURSE	O
:	O

1.	O
Cardiovascular	O
:	O

The	O
patient	O
remained	O
cardiovascularly	O
stable	O
throughout	O
the	O
admission	O
.	O

He	O
was	O
noted	O
to	O
have	O
some	B-problem
apnea	I-problem
and	O
bradycardic	B-problem
spells	I-problem
of	I-problem
prematurity	I-problem
and	O
was	O
therefore	O
started	O
on	O
caffeine	B-treatment
.	O

With	O
the	O
initiation	O
of	O
caffeine	B-treatment
therapy	I-treatment
the	O
patient	O
has	O
had	O
no	O
more	O
apnea	B-problem
or	O
bradycardic	B-problem
events	I-problem
.	O

2.	O
Respiratory	O
:	O

The	O
patient	O
was	O
initially	O
started	O
on	O
nasal	B-treatment
prong	I-treatment
CPAP	I-treatment
at	O
6	O
and	O
required	O
additional	B-treatment
oxygen	I-treatment
to	O
35%	O
.	O

However	O
by	O
24	O
hours	O
he	O
transitioned	O
to	O
low-flow	B-treatment
nasal	I-treatment
cannula	I-treatment
and	O
on	O
day	O
of	O
life	O
five	O
transitioned	O
to	O
room	O
air	O
where	O
he	O
currently	O
remains	O
.	O

3.	O
Fluids	O
,	O
electrolytes	O
and	O
nutrition	O
:	O

The	O
patient	O
was	O
initially	O
maintained	O
on	O
intravenous	B-treatment
fluids	I-treatment
only	O
and	O
when	O
his	B-problem
respiratory	I-problem
distress	I-problem
resolved	O
he	O
was	O
transitioned	O
to	O
enteral	B-treatment
feeds	I-treatment
.	O

The	O
morning	O
of	O
transfer	O
his	B-treatment
IV	I-treatment
came	O
out	O
so	O
he	O
has	O
just	O
been	O
advanced	O
to	O
120	O
cc	O
per	O
kg	O
per	O
day	O
of	O
PE-20	B-treatment
and	O
his	O
tolerating	O
these	B-treatment
PG	I-treatment
feedings	I-treatment
without	O
difficulty	O
.	O

Last	B-test
set	I-test
of	I-test
electrolytes	I-test
on	O
06-08	O
,	O
DOL3	O
:	O

Na	B-test
145	O
,	O
K	B-test
4.3	O
,	O
Cl	B-test
110	O
,	O
tCO2	B-test
25	O
.	O

Discharge	O
Wt	O
1645	O
gms	O
.	O

4.	O
Hematology	O
:	O

His	B-test
admission	I-test
complete	I-test
blood	I-test
count	I-test
was	O
notable	O
for	O
a	B-test
white	I-test
count	I-test
of	O
11.8	O
,	O
25	B-test
polys	I-test
and	O
no	O
bands	B-problem
.	O

Hematocrit	B-test
was	O
45	O
,	O
platelet	B-test
count	I-test
270	O
.	O

He	O
developed	O
physiologic	B-problem
hyperbilirubinemia	I-problem
(	O
peak	B-test
bili	I-test
8.6/0.3	O
on	O
06-08	O
,	O
DOL3	O
)	O
for	O
which	O
he	O
was	O
treated	O
with	O
a	B-treatment
single	I-treatment
phototherapy	I-treatment
.	O

His	B-test
most	I-test
recent	I-test
bilirubin	I-test
was	O
6.6	O
on	O
day	O
of	O
life	O
six	O
,	O
the	O
day	O
of	O
discharge	O
,	O
and	O
his	B-treatment
phototherapy	I-treatment
was	O
discontinued.	O
He	O
will	O
need	O
a	B-test
rebound	I-test
bilirubin	I-test
level	I-test
in	O
am	O
.	O

5.	O
Infectious	O
disease	O
:	O

Blood	B-test
culture	I-test
was	O
sent	O
but	O
he	O
was	O
never	O
started	O
on	O
antibiotics	B-treatment
.	O

The	B-test
blood	I-test
culture	I-test
remained	O
sterile	O
.	O

He	O
was	O
noted	O
to	O
have	O
an	B-problem
erythematous	I-problem
perianal	I-problem
rash	I-problem
and	O
for	O
this	O
was	O
started	O
on	O
Nystatin	B-treatment
powder	I-treatment
.	O

The	O
parents	O
were	O
updated	O
throughout	O
the	O
admission	O
and	O
a	O
family	O
meeting	O
was	O
held	O
on	O
2015-06-09	O
.	O

6.	O
Sensory	O
:	O

The	O
patient	O
has	O
not	O
had	O
an	O
CMED	B-test
examination	I-test
or	O
hearing	B-test
test	I-test
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Good	O
.	O

DISPOSITION	O
:	O

To	O
Kindred	O
Hospital	O
Special	O
Care	O
Nursery	O
.	O

NAME	O
OF	O
PEDIATRICIAN	O
:	O

Hale	O
Air	O
Force	O
Base	O
Pediatrics	O
.	O

CARE	O
AND	O
RECOMMENDATIONS	O
:	O

Feeds	B-treatment
at	O
discharge	O
are	O
PE-20	B-treatment
currently	O
at	O
120	O
cc	O
per	O
kg	O
per	O
day	O
due	O
to	O
advance	O
15	O
cc	O
per	O
kg	O
per	O
day	O
to	O
a	O
total	O
of	O
150	O
cc	O
per	O
kg	O
per	O
day	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Caffeine	B-treatment
12	O
mg	O
pg	O
q	O
day.	O
He	O
has	O
not	O
had	O
his	O
06-10	O
dose	O
.	O

STATE	O
NEWBORN	O
SCREENING	O
STATUS	O
:	O

He	O
is	O
due	O
to	O
have	O
his	B-test
state	I-test
screen	I-test
sent	O
today	O
.	O

IMMUNIZATIONS	O
:	O

Not	O
yet	O
received	O
.	O

Synagis	B-treatment
RSV	I-treatment
prophylaxis	I-treatment
should	O
be	O
considered	O
from	O
October	O
through	O
April	O
for	O
infants	O
who	O
meet	O
any	O
of	O
the	O
following	O
criteria	O
:	O

1.	O
Born	O
at	O
less	O
than	O
32	O
weeks	O
.	O

2.	O
Born	O
at	O
32-35	O
weeks	O
with	O
plans	O
for	O
day	O
care	O
during	O
RSV	O
season	O
with	O
a	O
smoker	O
in	O
the	O
household	O
,	O
or	O
with	O
preschool	O
age	O
siblings	O
.	O

3.	O
With	O
chronic	B-problem
lung	I-problem
disease	I-problem
.	O

Influenza	B-treatment
vaccination	I-treatment
should	O
be	O
considered	O
annually	O
in	O
the	O
fall	O
for	O
preterm	O
infants	O
with	O
chronic	B-problem
lung	I-problem
disease	I-problem
once	O
they	O
reach	O
six	O
months	O
of	O
age	O
.	O

Before	O
this	O
age	O
,	O
the	O
family	O
and	O
other	O
caregivers	O
should	O
be	O
considered	O
for	O
immunization	B-treatment
against	O
influenza	B-problem
to	O
protect	O
the	O
infant	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Prematurity	B-problem
at	O
30-6/7	O
weeks	O
.	O

2.	O
Rule	O
out	O
sepsis	B-problem
,	O
off	O
antibiotics	B-treatment
.	O

3.	O
Apnea	B-problem
and	O
bradycardia	B-problem
of	O
prematurity	B-problem
.	O

4.	O
Hyperbilirubinemia	B-problem
.	O

5.	O
Feeding	B-problem
immaturity	I-problem
.	O

Freddy	O
Stephen	O
,	O
M.D.	O

55-454	O

Dictated	O
By:Nathan	O
D.	O
Delgadillo	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O

2015-06-10	O

09:35	O

T	O
:	O

2015-06-10	O

09:51	O

JOB#	O
:	O

53951	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Freddy	O
King	O
on	O
:	O

WED	O
2015-06-10	O
11:54	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2018-03-04	O

Discharge	O
Date	O
:	O

2018-03-09	O

Date	O
of	O
Birth	O
:	O

1957-08-17	O

Sex	O
:	O

M	O

Service	O
:	O

UROLOGY	O

Allergies	O
:	O

Sulfonamides	B-treatment
/	O
Penicillins	B-treatment
/	O
Tetracyclines	B-treatment
/	O
Azithromycin	B-treatment
/	O
Iodine	B-treatment
/	O
Shellfish	O
/	O
Ace	B-treatment
Inhibitors	I-treatment
/	O
Ciprofloxacin	B-treatment

Attending	O
:	O

Donald	O
E.	O
Jacquet	O
,	O
M.D.	O

Chief	O
Complaint:	O

Chronic	B-problem
prostatitis	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O

TURP	B-treatment

History	O
of	O
Present	O
Illness:	O

Justin	O
Searle	O
a	O
60-year-old	O
man	O
with	O
a	O
long	O
history	O
of	O
chronic	B-problem
prostatitis	I-problem
status	O
post	O
two	B-treatment
transurethral	I-treatment
resection	I-treatment
of	I-treatment
the	I-treatment
prostate	I-treatment
procedures	O
in	O
2007	O
and	O
1998	O
.	O

He	O
also	O
has	O
a	O
diagnosis	O
of	O
interstitial	B-problem
cystitis	I-problem
and	O
more	O
significantly	O
has	O
a	O
history	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
with	O
a	B-test
recent	I-test
catheterization	I-test
,	O
supraventricular	B-problem
tachycardia	I-problem
,	O
and	O
a	B-problem
progressive	I-problem
mitochondrial	I-problem
myopathy	I-problem
.	O

He	O
has	O
had	O
symptoms	B-problem
of	O
dribbling	B-problem
,	O
stress	B-problem
incontinence	I-problem
,	O
hematuria	B-problem
,	O
but	O
has	O
no	O
dysuria	B-problem
.	O

He	O
was	O
preadmitted	O
for	O
cardiac	O
clearance	O
by	O
Dr.	O
Lair	O
,	O
his	O
cardiologist	O
.	O

Past	O
Medical	O
History:	O

1.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
(	O
s/p	O
stents	B-treatment
to	I-treatment
LAD	I-treatment
and	I-treatment
3rd	I-treatment
OM	I-treatment
)	O

2.	O
Supraventricular	B-problem
tachycardia	I-problem
(	O
on	O
a	B-treatment
beta	I-treatment
blocker	I-treatment
)	O
.	O

3.	O
Mitochondrial	B-problem
myopathy	I-problem
.	O

4.	O
History	O
of	O
orthostasis	B-problem
with	O
tilt	B-test
table	I-test
testing	I-test
done	O
in	O
the	O
past	O
.	O

5.	O
Status	O
post	O
transurethral	B-treatment
resection	I-treatment
of	I-treatment
prostate	I-treatment
times	O
two	O
(	O
in	O
2007	O
and	O
1998	O
)	O
.	O

6.	O
Interstitial	B-problem
cystitis	I-problem
.	O

7.	O
Pericarditis	B-problem
.	O

8.	O
Hypertension	B-problem
.	O

9.	O
Hypercholesterolemia	B-problem
.	O

10.	O
Gastrointestinal	B-problem
bleed	I-problem

Social	O
History	O
:	O

denies	O
any	O
tobacco.	O
Divorced	O
,	O
lives	O
in	O
Wisconsin	O

Family	O
History	O
:	O

Father	O
had	O
MI	B-problem
at	O
42	O

Mother	O
died	O
of	O
MI	B-problem
at	O
76	O

Physical	O
Exam	O
:	O

Gen	O
:	O

NAD	B-problem

HEENT	O
:	O

MMM	O

CV	O
:	O

RRR	O
,	O
no	O
m/r/g	B-problem

Lungs	O
:	O

CTAB	O

Abd	O
:	O
soft	O
,	O
+distension	B-problem
with	O
tympany	B-problem
,	O
no	O
HSM	B-problem
,	O
hyperactive	B-problem
BS	I-problem

Ext	O
:	O
no	O
c/c/e	B-problem

Neuro	O
:	O

A&O	O
x3	O
.	O

ECG	B-test
:	O

NSR	B-test
at	O
62	O
,	O
nl	O
axis	O
,	O
nl	O
intervals	O
,	O
Q	B-problem
waves	I-problem
in	I-problem
III	I-problem
,	O
avR	B-test
,	I-test
V1	B-test
.	O

TWI	B-problem
's	O
in	O
III	O
,	O
V1	O
.	O

Pertinent	O
Results:	O

2018-03-04	O
01:02PM	O

GLUCOSE	B-test
-	O
94	O
UREA	B-test
N	I-test
-	O
22*	O
CREAT	B-test
-	O
1.4*	O
SODIUM	B-test
-	O
142	O

POTASSIUM	B-test
-	O
5.9*	O
CHLORIDE	B-test
-	O
108	O
TOTAL	B-test
CO2	I-test
-	O
23	O
ANION	B-test
GAP	I-test
-	O
17	O

2018-03-04	O
01:02PM	O

CALCIUM	B-test
-	O
9.7	O
PHOSPHATE	B-test
-	O
3.9	O
MAGNESIUM	B-test
-	O
1.9	O

2018-03-04	O
01:02PM	O

WBC	B-test
-	O
7.5	O
RBC	B-test
-	O
5.09	O
HGB	B-test
-	O
15.4	O
HCT	B-test
-	O
43.7	O
MCV	B-test
-	O
86	O

MCH	B-test
-	O
30.2	O
MCHC	B-test
-	O
35.2*	O
RDW	B-test
-	O
13.6	O

2018-03-04	O
01:02PM	O

PLT	B-test
COUNT	I-test
-	O
257#	O

2018-03-04	O
01:02PM	O

PT	B-test
-	O
12.2	O
PTT	B-test
-	O
23.8	O
INR	B-test
(	I-test
PT	I-test
)	I-test
-	O
0.9	O

Brief	O
Hospital	O
Course:	O

On	O
HD2	O
,	O
cardiac	B-test
clearance	I-test
was	O
obtained	O
by	O
Dr.	O
Sanchez	O
.	O

Patient	O
tolerated	O
procedure	B-treatment
on	O
2018-03-05	O
and	O
was	O
transferred	O
to	O

ICU	O
for	O
24hr	O
post-op	O
cardiac	B-test
monitoring	I-test
.	O

Stay	O
was	O
uneventful	O
.	O

On	O
POD1	O
,	O
patient	O
was	O
transferred	O
out	O
of	O
FICU	O
to	O
12R	O
.	O

Catheter	B-treatment
was	O
removed	O
.	O

He	O
was	O
started	O
on	O
Pyridium	B-treatment
.	O

On	O
POD2	O
,	O
patient	O
was	O
deemed	O
suitable	O
and	O
stable	O
for	O
discharge	O
.	O

On	O
POD4	O
,	O
patient	O
was	O
discharged	O
.	O

Discharge	O
Medications	O
:	O

1.	O
Hydroxyzine	B-treatment
HCl	I-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

2.	O
Atorvastatin	B-treatment
Calcium	I-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

3.	O
Ezetimibe	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

4.	O
Simethicone	B-treatment
80	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
0.5-1	O
Tablet	O
,	O
Chewable	O
PO	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
indigestion/gas	B-problem
pain	I-problem
.	O

5.	O
Aluminum-Magnesium	B-treatment
Hydroxide	I-treatment
225-200	O
mg/5	O
mL	O
Suspension	O
Sig	O
:	O
15-30	O
MLs	O
PO	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
indigestion	B-problem
.	O

6.	O
Atenolol	B-treatment
100	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

7.	O
Hyoscyamine	B-treatment
Sulfate	I-treatment
0.125	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
.	O

8.	O
Phenazopyridine	B-treatment
HCl	I-treatment
100	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
for	O
3	O
days	O
.	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

Chronic	B-problem
prostatitis	I-problem

Interstitial	B-problem
cystitis	I-problem

Discharge	O
Condition	O
:	O

Good	O

Discharge	O
Instructions	O
:	O

Go	O
to	O
an	O
Emergency	O
Room	O
if	O
you	O
experience	O
symptoms	B-problem
including	O
,	O
but	O
not	O
necessarily	O
limited	O
to	O
:	O
new	B-problem
and	I-problem
continuing	I-problem
nausea	I-problem
,	O
vomiting	B-problem
,	O
fevers	B-problem
(	O
>101.5	O
F	O
)	O
,	O
chills	B-problem
,	O
or	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

Proceed	O
to	O
the	O
ER/EW/Monica	O
if	O
your	B-problem
wound	I-problem
becomes	O
red	B-problem
,	O
swollen	B-problem
,	O
warm	B-problem
,	O
or	O
produces	O
pus	B-problem
.	O

You	O
may	O
remove	O
your	B-treatment
dressings	I-treatment
2	O
days	O
after	O
your	B-treatment
surgery	I-treatment
if	O
they	O
were	O
not	O
removed	O
in	O
the	O
hospital	O
.	O

Leave	O
the	B-treatment
steri	I-treatment
strips	I-treatment
on	O
until	O
they	O
begin	O
to	O
peel	O
,	O
then	O
you	O
may	O
remove	O
them.	O
Staples	B-treatment
and	O
stitches	B-treatment
will	O
remain	O
until	O
your	O
follow-up	O
appointment	O
.	O

If	O
you	O
experience	O
clear	B-problem
drainage	I-problem
from	O
your	B-problem
wounds	I-problem
,	O
cover	O
them	O
with	O
a	B-treatment
clean	I-treatment
dressing	I-treatment
and	O
stop	O
showering	O
until	O
the	B-problem
drainage	I-problem
subsides	O
for	O
at	O
least	O
2	O
days	O
.	O

No	O
heavy	O
lifting	O
or	O
exertion	O
for	O
at	O
least	O
6	O
weeks	O
.	O

No	O
driving	O
while	O
taking	O
pain	B-treatment
medications	I-treatment
.	O

Narcotics	B-treatment
can	O
cause	O
constipation	B-problem
.	O

Please	O
take	O
an	B-treatment
over	I-treatment
the	I-treatment
counter	I-treatment
stool	I-treatment
softener	I-treatment
such	O
as	O
Colace	B-treatment
or	O
a	B-treatment
gentle	I-treatment
laxative	I-treatment
such	O
as	O
Milk	B-treatment
of	I-treatment
Magnesia	I-treatment
if	O
you	O
experience	O
constipation	B-problem
.	O

You	O
may	O
resume	O
your	O
regular	O
diet	O
as	O
tolerated	O
.	O

You	O
may	O
take	O
showers	O
(	O
no	O
baths	O
)	O
after	O
your	B-treatment
dressings	I-treatment
have	O
been	O
removed	O
from	O
your	B-problem
wounds	I-problem
.	O

Continue	O
taking	O
your	B-treatment
home	I-treatment
medications	I-treatment
unless	O
otherwise	O
contraindicated	O
and	O
follow	O
up	O
with	O
PCP	O
.	O

Followup	O
Instructions	O
:	O

F/U	O
with	O
Rau	O
.	O

Call	O
for	O
appointment	O

F/U	O
with	O
Dr.	O
Ross	O
in	O
2-3	O
weeks	O
.	O

Michael	O
Morgan	O
MD	O
43-508	O

Completed	O
by	O
:	O

Justin	O
RAO	O
MD	O
71-039	O
2018-03-09	O
@	O
0842	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Freddy	O
Darr	O
on	O
:	O

FRI	O
2018-03-23	O
9:45	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2016-11-21	O

Discharge	O
Date	O
:	O

2016-11-30	O

Date	O
of	O
Birth	O
:	O

1953-10-19	O

Sex	O
:	O

M	O

Service	O
:	O

CMED	O
CCU	O

CHIEF	O
COMPLAINT	O
AND	O
HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Jackson	O
is	O
a	O
63-year-old	O
male	O
with	O
squamous	B-problem
cell	I-problem
carcinoma	I-problem
of	O
the	O
floor	O
of	O
mouth	O
(	O
stage	B-problem
T2	I-problem
N0	I-problem
)	O
that	O
was	O
biopsied	O
by	O
his	O
dentist	O
.	O

Pathology	B-test
was	O
reviewed	O
revealing	O
invasive	B-problem
squamous	I-problem
cell	I-problem
carcinoma	I-problem
.	O

He	O
presented	O
on	O
2016-11-21	O
for	O
resection	B-treatment
.	O

He	O
was	O
admitted	O
on	O
2016-11-21	O
following	O
his	B-treatment
surgery	I-treatment
.	O

He	O
underwent	O
a	B-treatment
joint	I-treatment
procedure	I-treatment
by	O
Otolaryngology	O
and	O
Plastic	O
Surgery	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Includes	O
hypertension	B-problem
and	O
chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Polypectomy	B-treatment
in	O
2011	O
,	O
tooth	B-treatment
extraction	I-treatment
(	O
all	O
)	O
in	O
1980	O
,	O
and	O
hernia	B-problem
in	O
1977	O
.	O

ALLERGIES	O
:	O

TOMATO	O
(	O
causing	O
anaphylaxis	B-problem
)	O
and	O
TETANUS	B-treatment
SHOT	I-treatment
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Triamterene/hydrochlorothiazide	B-treatment
37.5/25	O
mg	O
one	O
tablet	O
by	O
mouth	O
once	O
daily	O
and	O
lorazepam	B-treatment
1	O
mg	O
three	O
times	O
daily	O
as	O
needed	O
(	O
for	O
anxiety	B-problem
)	O
.	O

SOCIAL	O
HISTORY	O
:	O

He	O
has	O
a	O
half-pack	O
per	O
day	O
smoking	O
history	O
and	O
drinks	O
approximately	O
three	O
to	O
four	O
alcoholic	O
beverages	O
per	O
day	O
.	O

PROCEDURES	O
PERFORMED:	O

1.	O
Tracheostomy	B-treatment
.	O

2.	O
Diagnostic	B-test
laryngoscopy	I-test
and	O
biopsy	B-test
.	O

3.	O
Bilateral	B-treatment
supraomohyoid	I-treatment
neck	I-treatment
dissection	I-treatment
.	O

4.	O
Resection	B-treatment
of	O
floor	O
of	O
mouth	B-problem
tumor	I-problem
.	O

SUMMARY	O
OF	O
HOSPITAL	O
COURSE	O
:	O

Surgeon	O
was	O
Dr.	O
Kelsey	O
K	O
Sanchez	O
.	O

Assistant	O
was	O
Dr.	O
Justin	O
K..	O
Velez	O
.	O

Frozen	B-test
section	I-test
sent	O
to	O
pathology	O
revealing	O
invasive	B-problem
squamous	I-problem
cell	I-problem
carcinoma	I-problem
.	O

No	O
complications	B-problem
.	O

The	O
Plastic	O
Team	O
then	O
took	O
over	O
for	O
reconstruction	B-treatment
consisting	O
of	O
radial	B-treatment
forearm	I-treatment
free	I-treatment
flap	I-treatment
to	O
floor	O
of	O
mouth	O
.	O

Surgeon	O
was	O
Dr.	O
Jude.	O
Christopher	O
Swinney	O
.	O

Total	B-treatment
intravenous	I-treatment
fluids	I-treatment
of	O
7300	O
cc	O
.	O

Estimated	B-problem
blood	I-problem
loss	I-problem
of	O
300	O
cc	O
.	O

Urine	B-test
output	I-test
of	O
900	O
cc	O
.	O

No	O
complications	B-problem
.	O

In	O
addition	O
,	O
the	O
patient	O
was	O
prepared	O
for	O
an	B-treatment
attempted	I-treatment
percutaneous	I-treatment
endoscopic	I-treatment
gastrostomy	I-treatment
tube	I-treatment
.	O

The	B-treatment
percutaneous	I-treatment
endoscopic	I-treatment
gastrostomy	I-treatment
was	O
unsuccessful	O
,	O
and	O
the	B-treatment
procedure	I-treatment
was	O
converted	O
to	O
an	B-treatment
open	I-treatment
gastrostomy	I-treatment
tube	I-treatment
which	O
then	O
proceeded	O
without	O
complications	B-problem
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
postoperatively	O
.	O

He	O
was	O
sedated	O
and	O
ventilated	O
by	O
his	B-treatment
tracheostomy	I-treatment
6	I-treatment
cuff	I-treatment
Shiley	I-treatment
tube	I-treatment
.	O

He	O
had	O
three	O
Westwood-Pocasset	B-treatment
drains	I-treatment
-	O
two	O
in	O
the	O
neck	O
and	O
one	O
in	O
his	O
right	O
arm	O
.	O

G-tube	B-treatment
was	O
to	O
gravity	O
,	O
Foley	B-treatment
to	O
gravity	O
,	O
left	B-treatment
radial	I-treatment
A-line	I-treatment
.	O

The	B-treatment
flap	I-treatment
was	O
pink	O
with	O
a	B-test
strong	I-test
Doppler	I-test
signal	I-test
.	O

He	O
underwent	O
flap	B-test
checks	I-test
every	O
15	O
minutes	O
initially	O
with	O
a	B-treatment
dextran	I-treatment
infusion	I-treatment
.	O

He	O
was	O
placed	O
on	O
Unasyn	B-treatment
3	O
grams	O
IV	B-treatment
q.6h.	O

Nothing	O
by	O
mouth	O
initially	O
with	O
morphine	B-treatment
as	O
needed	O
for	O
pain	B-problem
and	O
Ativan	B-treatment
around	O
the	O
clock	O
for	O
delirium	B-treatment
tremens	I-treatment
prophylaxis	I-treatment
.	O

In	O
addition	O
,	O
he	O
received	O
metoprolol	B-treatment
q.4.h.	O
,	O
a	B-treatment
regular	I-treatment
insulin	I-treatment
sliding	I-treatment
scale	I-treatment
,	O
and	O
adequate	O
gastrointestinal	O
prophylaxis	O
with	O
Protonix	B-treatment
.	O

Postoperative	B-test
laboratories	I-test
revealed	O
sodium	B-test
was	O
134	O
,	O
potassium	B-test
was	O
4.1	O
,	O
chloride	B-test
was	O
102	O
,	O
bicarbonate	B-test
was	O
28	O
,	O
blood	B-test
urea	I-test
nitrogen	I-test
was	O
18	O
,	O
creatinine	B-test
was	O
0.8	O
,	O
and	O
glucose	B-test
was	O
148	O
.	O

Calcium	B-test
was	O
7.6	O
.	O

Magnesium	B-test
was	O
2.2	O
.	O

Complete	B-test
blood	I-test
count	I-test
revealed	O
white	B-test
count	I-test
was	O
5.4	O
,	O
hematocrit	B-test
was	O
31.3	O
,	O
and	O
platelets	B-test
were	O
160	O
.	O

ALT	B-test
was	O
14	O
,	O
AST	B-test
was	O
31	O
,	O
alkaline	B-test
phosphatase	I-test
was	O
42	O
,	O
total	B-test
bilirubin	I-test
was	O
0.9	O
,	O
albumin	B-test
was	O
2.2	O
.	O

A	B-test
chest	I-test
x-ray	I-test
postoperatively	O
showed	O
clear	O
lung	O
fields	O
.	O

Tracheostomy	B-treatment
tube	I-treatment
in	O
good	O
position	O
.	O

No	O
pneumothorax	B-problem
.	O

By	O
systems	O
:	O

CMED	O
CSRU	O
and	O
Plastic	O
Surgery	O
flap	B-test
checks	I-test
,	O
tracheostomy	B-treatment
care	I-treatment
,	O
and	O
Westwood-Pocasset	B-treatment
management.	I-treatment

Cardiovascular	O
:	O

Lopressor	B-treatment
5	O
intravenously	O
q.4.h.	O

Respiratory	O
:	O

Nebulizers	B-treatment
as	O
needed	O
,	O
weaning	O
from	O
ventilation	B-treatment
.	O

Gastrointestinal	O
:	O

Medications	B-treatment
per	O
gastrostomy	B-treatment
tube	I-treatment
on	O
postoperative	O
day	O
one	O
.	O

Genitourinary	O
:	O

Foley	B-treatment
catheter	I-treatment
for	O
strict	B-test
monitoring	I-test
of	I-test
ins	I-test
and	I-test
outs	I-test
.	O

Hematologic	O
:	O

Hematocrit	B-test
stable	O
.	O

Infectious	O
Disease	O
:	O

Unasyn	B-treatment
for	O
antibiotic	B-treatment
coverage	I-treatment
.	O

Flap	B-test
checks	I-test
carried	O
out	O
q.2h.	O
initially	O
in	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
showing	O
positive	B-problem
biphasic	I-problem
Doppler	I-problem
signals	I-problem
.	O

Pink	O
flap	O
with	O
good	O
refill	O
.	O

Right	O
arm	O
neurovascularly	O
intact	O
.	O

He	O
was	O
weaned	O
from	O
ventilation	B-treatment
on	O
postoperative	O
day	O
one	O
to	O
pressure	B-treatment
support	I-treatment
ventilation	I-treatment
and	O
then	O
to	O
spontaneous	O
breathing	O
on	O
postoperative	O
day	O
two	O
.	O

His	B-test
Westwood-Pocasset	I-test
output	I-test
for	O
postoperative	O
day	O
one	O
on	O
the	O
left	O
was	O
60	O
,	O
right	O
neck	O
93	O
,	O
in	O
the	O
arm	O
20	O
.	O

Tube	B-treatment
feedings	I-treatment
were	O
started	O
48	O
hours	O
after	O
the	B-treatment
procedure	I-treatment
.	O

The	O
cuff	O
on	O
his	B-treatment
tracheostomy	I-treatment
tube	I-treatment
was	O
put	O
down	O
on	O
11-23	O
,	O
postoperative	O
day	O
two	O
which	O
he	O
tolerated	O
well	O
with	O
minimal	B-problem
secretions	I-problem
and	O
a	O
strong	O
adequate	O
cough	O
.	O

Due	O
to	O
bed	O
issues	O
,	O
he	O
was	O
transferred	O
from	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
to	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
on	O
postoperative	O
day	O
three	O
.	O

His	B-treatment
tube	I-treatment
feedings	I-treatment
were	O
advanced	O
.	O

He	O
was	O
out	O
of	O
bed	O
to	O
a	O
chair	O
.	O

He	O
continued	O
with	O
pulmonary	B-treatment
toilet	I-treatment
and	O
q.2h.	B-test
flap	I-test
checks	I-test
.	O

The	B-treatment
Westwood-Pocasset	I-treatment
in	I-treatment
his	I-treatment
right	I-treatment
arm	I-treatment
was	O
removed	O
on	O
2016-11-25	O
.	O

His	B-treatment
tracheostomy	I-treatment
was	O
changed	O
to	O
a	B-treatment
6	I-treatment
cuffless	I-treatment
Shiley	I-treatment
on	O
2016-11-26	O
and	O
sutures	B-treatment
in	O
place	O
with	O
a	B-treatment
3-0	I-treatment
silk	I-treatment
.	O

The	O
patient	O
tolerated	O
this	B-treatment
procedure	I-treatment
well	O
.	O

This	O
is	O
the	O
end	O
of	O
part	O
1	O
of	O
this	O
dictation	O
summary	O
for	O
Patricia	O
Jackson	O
.	O

To	O
be	O
continued	O
in	O
a	O
separate	O
dictation	O
.	O

Nola	O
Daniel	O
,	O
Hawaii	O
31699	O

Dictated	O
By:Joe	O
C.	O
Roa	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O

2016-11-30	O
10:56:11	O

T	O
:	O

2016-11-30	O
11:44:01	O

Job#	O
:	O

77004	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Michael	O
Z	O
Waldroup	O
on	O
:	O

MON	O
2016-12-19	O
10:13	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2009-12-28	O

Discharge	O
Date	O
:	O

2009-12-31	O

Date	O
of	O
Birth	O
:	O

1964-03-23	O

Sex	O
:	O

F	O

Service	O
:	O

NEUROMEDIC	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mrs.	O
Wisniewski	O
is	O
a	O
45-year-old	O
woman	O
with	O
multiple	B-problem
familial	I-problem
cavernous	I-problem
hemangiomas	I-problem
.	O

She	O
is	O
right-handed	O
.	O

She	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
one	O
and	O
a	O
half	O
weeks	O
prior	O
to	O
admission	O
.	O

She	O
developed	O
an	B-problem
ear	I-problem
ache	I-problem
,	O
for	O
which	O
she	O
saw	O
her	O
primary	O
care	O
physician	O
,	O
Evelyn	O
was	O
prescribed	O
cortisone	B-treatment
drops	I-treatment
.	O

A	O
few	O
days	O
later	O
she	O
complained	O
of	O
dizziness	B-problem
.	O

This	O
was	O
mostly	O
described	O
as	O
feeling	O
unsteady	B-problem
on	I-problem
her	I-problem
feet	I-problem
.	O

She	O
stated	O
that	O
she	O
had	O
trouble	O
knowing	O
if	O
her	O
feet	O
were	O
touching	O
the	O
ground	O
.	O

She	O
was	O
seen	O
again	O
by	O
primary	O
care	O
physician	O
,	O
Roderick	O
since	O
she	O
had	O
complaints	O
of	O
dizziness	B-problem
,	O
as	O
well	O
as	O
a	O
new	O
complaint	O
of	O
decreased	B-problem
hearing	I-problem
and	O
the	O
sensation	O
of	O
static	B-problem
in	I-problem
her	I-problem
ears	I-problem
,	O
meniere	B-problem
's	I-problem
disease	I-problem
was	O
considered	O
.	O

She	O
was	O
given	O
an	B-treatment
oral	I-treatment
prednisone	I-treatment
taper	I-treatment
.	O

This	B-problem
unsteady	I-problem
gait	I-problem
progressed	O
,	O
and	O
then	O
she	O
subsequently	O
started	O
to	O
develop	O
a	B-problem
pins	I-problem
and	I-problem
needle	I-problem
feeling	I-problem
in	I-problem
the	I-problem
face	I-problem
,	I-problem
hands	I-problem
and	I-problem
feet	I-problem
bilaterally	I-problem
.	O

Her	O
hearing	O
got	O
progressively	B-problem
worse	I-problem
and	O
the	B-problem
sound	I-problem
of	I-problem
static	I-problem
increased	O
.	O

She	O
was	O
very	B-problem
fatigued	I-problem
.	O

At	O
an	O
outside	O
hospital	O
,	O
head	B-test
CT	I-test
revealed	O
a	B-problem
1.5	I-problem
cm	I-problem
diameter	I-problem
hyperdense	I-problem
mass	I-problem
in	I-problem
the	I-problem
pons	I-problem
,	O
slightly	O
off	O
center	O
to	O
the	O
right	O
.	O

She	O
was	O
transferred	O
here	O
for	O
further	O
care	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Notable	O
for	O
multiple	B-problem
cavernous	I-problem
hemangiomas	I-problem
.	O

She	O
has	O
had	O
at	B-problem
least	I-problem
two	I-problem
bleeding	I-problem
episodes	I-problem
in	O
the	O
past	O
,	O
mostly	O
described	O
as	O
being	O
accompanied	O
by	O
generalized	B-problem
weakness	I-problem
.	O

She	O
has	O
had	O
at	B-problem
least	I-problem
two	I-problem
generalized	I-problem
seizures	I-problem
in	O
the	O
past	O
,	O
but	O
she	O
has	O
not	O
had	O
one	O
since	O
she	O
was	O
26	O
years	O
old	O
.	O

She	O
was	O
never	O
on	O
an	B-treatment
anticonvulsant	I-treatment
due	O
to	O
her	O
former	O
beliefs	O
as	O
N.	O
Derk	O
Scientist	O
.	O

She	O
no	O
longer	O
observes	O
that	O
belief	O
system	O
.	O

MEDICATIONS	O
:	O

Prednisone	B-treatment
taper	I-treatment
as	O
above	O
.	O

ALLERGIES	O
:	O

None	O
.	O

FAMILY	O
HISTORY	O
:	O

Strong	O
maternal	O
history	O
of	O
hemangiomas	B-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Temperature	B-test
99.2	O
.	O

Pulse	B-test
60	O
.	O

Blood	B-test
pressure	I-test
120/80	O
.	O

Respiratory	B-test
rate	I-test
14	O
.	O

In	O
general	O
,	O
she	O
was	O
a	O
thin	O
well-appearing	O
woman	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Sclera	O
were	O
anicteric	B-problem
.	O

Neck	O
was	O
supple	O
.	O

Chest	O
was	O
clear	O
.	O

Cardiovascular	B-test
exam	I-test
revealed	O
a	O
regular	O
rate	O
and	O
rhythm	O
with	O
no	O
murmurs	B-problem
,	O
rubs	B-problem
or	O
gallops	B-problem
.	O

Abdomen	O
soft	O
,	O
nontender	B-problem
and	O
distended	B-problem
.	O

Extremities	O
showed	O
no	O
edema	B-problem
.	O

Neurologically	O
,	O
she	O
was	O
awoken	O
from	O
sleep	O
by	O
voice	O
,	O
cooperative	O
,	O
but	O
mildly	B-problem
drowsy	I-problem
.	O

She	O
became	O
more	O
alert	O
during	O
the	O
remainder	O
of	O
the	B-test
exam	I-test
.	O

Speech	O
was	O
fluent	O
but	O
slow	B-problem
,	O
and	O
there	O
was	O
long	B-problem
response	I-problem
latencies	I-problem
before	O
she	O
would	O
initiate	O
speech	O
.	O

She	O
otherwise	O
had	O
normal	O
spontaneous	O
movements	O
and	O
facial	O
expression	O
and	O
did	O
not	O
appear	O
to	O
be	O
abulic	B-problem
.	O

She	O
had	O
normal	O
comprehension	O
.	O

She	O
was	O
able	O
to	O
give	O
a	O
detailed	O
history	O
in	O
an	O
organized	O
manner	O
.	O

There	O
was	O
no	O
dysarthria	B-problem
.	O

Language	O
was	O
normal	O
.	O

There	O
was	O
no	O
evidence	O
of	O
any	B-problem
special	I-problem
neglect	I-problem
.	O

Pupils	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
.	O

Visual	O
fields	O
were	O
full	O
.	O

Extraocular	O
movements	O
were	O
full	O
with	O
normal	O
smooth	O
pursuit	O
to	O
the	O
left	O
.	O

Pursuit	O
was	O
interrupted	O
by	O
>.....<	O
when	O
tracking	O
from	O
left	O
to	O
right	O
.	O

She	O
had	O
sustained	B-problem
gaze	I-problem
holding	I-problem
nystagmus	I-problem
in	O
both	O
horizontal	O
directions	O
.	O

There	O
was	O
no	O
rotary	B-problem
component	I-problem
.	O

She	O
had	O
a	B-problem
mildly	I-problem
widened	I-problem
right	I-problem
palpable	I-problem
fissure	I-problem
.	O

There	O
was	O
decreased	B-problem
excursion	I-problem
of	I-problem
the	I-problem
right	I-problem
mouth	I-problem
and	O
flattening	B-problem
of	I-problem
the	I-problem
right	I-problem
nasolabial	I-problem
fold	I-problem
(	I-problem
mild	I-problem
)	I-problem
.	O

Light	O
touch	O
was	O
subjectively	B-problem
abnormal	I-problem
on	O
both	O
sides	O
of	O
the	O
face	O
.	O

Hearing	O
was	O
diminished	B-problem
for	O
conversational	O
speech	O
.	O

Palate	O
and	O
tongue	O
moved	O
normally	O
in	O
the	O
midline	O
.	O

There	O
was	O
a	B-problem
mild	I-problem
left	I-problem
pronator	I-problem
drift	I-problem
.	O

Finger	B-test
tapping	I-test
and	O
rapid	B-test
alternating	I-test
movements	I-test
were	O
slow	B-problem
on	I-problem
the	I-problem
left	I-problem
and	O
she	O
had	O
trouble	B-problem
isolating	I-problem
individual	I-problem
finger	I-problem
movements	I-problem
.	O

There	O
was	O
mild	B-problem
finger-to-nose	I-problem
dysmetria	I-problem
on	I-problem
the	I-problem
left	I-problem
.	O

Power	O
was	O
mildly	B-problem
diminished	I-problem
in	I-problem
the	I-problem
finger	I-problem
extensors	I-problem
and	O
hand	O
intrinsics	O
on	O
the	O
left	O
,	O
otherwise	O
,	O
power	O
was	O
full	O
throughout	O
.	O

Reflexes	B-test
were	O
brisk	O
in	O
the	O
legs	O
with	O
4-5	O
beats	O
of	O
clonus	B-problem
at	I-problem
the	I-problem
ankles	I-problem
bilaterally	I-problem
.	O

She	O
had	O
bilateral	B-problem
upgoing	I-problem
toes	I-problem
.	O

She	O
made	O
mistakes	B-problem
with	I-problem
position	I-problem
sense	I-problem
,	O
roughly	O
at	O
chance	O
level	O
with	O
both	O
great	O
toes	O
and	O
the	O
left	O
first	O
finger	O
,	O
position	O
sense	O
in	O
the	O
right	O
limb	O
seems	O
preserved	O
.	O

Gait	O
was	O
wide	B-problem
based	I-problem
,	O
very	B-problem
unsteady	I-problem
,	O
veering	O
to	O
the	O
left	O
and	O
to	O
the	O
right	O
.	O

She	O
retropulsed	B-problem
and	O
would	O
have	O
pitched	O
backwards	O
without	O
the	O
assistance	O
of	O
the	O
examiner	O
.	O

LABORATORIES	O
:	O

White	B-test
blood	I-test
cell	I-test
count	I-test
7.8	O
with	O
86%	O
polymorphonuclear	B-test
cells	I-test
,	O
11.1	O
lymphocytes	B-test
,	O
hemoglobin	B-test
14.3	O
,	O
hematocrit	B-test
40.5	O
,	O
MCV	B-test
88	O
,	O
INR	B-test
1.0	O
,	O
PTT	B-test
24.7	O
,	O
PT	B-test
12.3	O
,	O
platelet	B-test
count	I-test
295,000	O
,	O
glucose	B-test
81	O
,	O
BUN	B-test
15	O
,	O
creatinine	B-test
0.8	O
,	O
sodium	B-test
142	O
,	O
potassium	B-test
4.2	O
,	O
chloride	B-test
104	O
,	O
CO2	B-test
26	O
,	O
calcium	B-test
9.3	O
,	O
phosphate	B-test
4.8	O
,	O
magnesium	B-test
2.3	O
.	O

MRI	B-test
of	I-test
the	I-test
brain	I-test
revealed	O
multiple	B-problem
foci	I-problem
susceptibility	I-problem
artifact	I-problem
within	I-problem
the	I-problem
brain	I-problem
.	O

These	O
were	O
seen	O
best	O
in	O
gradient	B-test
echocardiogram	I-test
images	I-test
.	O

There	O
was	O
a	O
large	O
focus	O
of	O
subacute	B-problem
blood	I-problem
products	I-problem
in	I-problem
the	I-problem
mid	I-problem
to	I-problem
low	I-problem
pons	I-problem
suggesting	O
recent	B-problem
hemorrhage	I-problem
into	I-problem
a	I-problem
cavernous	I-problem
angioma	I-problem
.	O

There	O
was	O
some	B-problem
mild	I-problem
surrounding	I-problem
edema	I-problem
.	O

There	O
are	O
also	O
tiny	B-problem
foci	I-problem
artifact	I-problem
within	I-problem
the	I-problem
cerebellum	I-problem
and	I-problem
base	I-problem
of	I-problem
the	I-problem
pons	I-problem
.	O

There	O
was	O
a	O
larger	O
area	O
of	O
susceptibility	B-problem
artifact	I-problem
in	I-problem
the	I-problem
left	I-problem
temporal	I-problem
lobe	I-problem
,	I-problem
right	I-problem
frontal	I-problem
lobe	I-problem
,	I-problem
and	I-problem
the	I-problem
splenius	I-problem
of	I-problem
the	I-problem
corpus	I-problem
collasum	I-problem
.	O

The	O
brain	O
parenchyma	O
was	O
otherwise	O
normal	O
.	O

There	O
was	O
mild	B-problem
enhancement	I-problem
of	I-problem
the	I-problem
pontine	I-problem
hemorrhagic	I-problem
mass	I-problem
but	O
none	O
elsewhere	O
.	O

There	O
was	O
no	O
areas	B-problem
of	I-problem
restricted	I-problem
diffusion	I-problem
to	O
indicate	O
infarction	B-problem
.	O

MRA	B-test
of	I-test
the	I-test
brain	I-test
was	O
unremarkable	O
.	O

There	O
was	O
no	O
communication	O
>.......<	O
in	O
the	O
visualized	O
vessels	O
and	O
the	O
angiomas	B-problem
.	O

Follow-up	B-test
CT	I-test
was	O
obtained	O
the	O
second	O
day	O
of	O
admission	O
.	O

There	O
was	O
no	O
evidence	O
of	O
developing	B-problem
hydrocephalus	I-problem
,	O
which	O
was	O
a	O
concern	O
due	O
to	O
the	B-problem
surrounding	I-problem
edema	I-problem
,	O
and	O
possible	O
suppression	B-problem
of	I-problem
the	I-problem
fourth	I-problem
ventricle	I-problem
.	O

There	O
was	O
no	O
significant	B-problem
change	I-problem
in	I-problem
size	I-problem
of	O
the	B-problem
subacute	I-problem
pontine	I-problem
hemorrhage	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

Mrs.	O
Wisniewski	O
is	O
a	O
45	O
-	O
year-old	O
woman	O
with	O
a	O
strong	O
family	O
history	O
of	O
cavernous	B-problem
angiomas	I-problem
.	O

She	O
has	O
had	O
several	B-problem
prior	I-problem
bleeding	I-problem
events	I-problem
and	O
presented	O
with	O
a	B-problem
subacute	I-problem
bleed	I-problem
in	I-problem
the	I-problem
mid	I-problem
to	I-problem
lower	I-problem
pons	I-problem
.	O

There	O
was	O
relatively	O
central	O
in	O
location	O
,	O
with	O
only	O
a	B-problem
slight	I-problem
right-sided	I-problem
predominance	I-problem
.	O

Her	B-test
physical	I-test
examination	I-test
remained	O
relatively	O
unchanged	O
,	O
with	O
resolution	O
of	O
the	B-problem
subtle	I-problem
left	I-problem
hand	I-problem
weakness	I-problem
and	O
right	B-problem
facial	I-problem
weakness	I-problem
.	O

Her	O
gait	O
remained	O
severely	B-problem
ataxic	I-problem
,	O
likely	O
secondary	O
to	O
sensory	B-problem
deafferentation	I-problem
,	O
as	O
well	O
as	O
involvement	O
of	O
crossing	B-problem
pontine	I-problem
cerebellar	I-problem
fibers	I-problem
.	O

Therefore	O
,	O
it	O
was	O
recommended	O
that	O
she	O
have	O
aggressive	B-treatment
Physical	I-treatment
Therapy	I-treatment
at	O
an	O
Acute	O
Rehabilitation	O
Center	O
.	O

The	O
case	O
was	O
discussed	O
with	O
Dr.	O
Harold	O
from	O
the	O
Falmouth	O
Hospital	O
.	O

He	O
has	O
followed	O
this	O
family	O
in	O
the	O
past	O
and	O
will	O
see	O
her	O
in	O
follow-up	O
.	O

We	O
will	O
arrange	O
to	O
have	O
a	O
copy	O
of	O
the	B-test
MRI	I-test
scans	I-test
sent	O
to	O
him	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Familial	B-problem
cavernous	I-problem
hemangiomas	I-problem
,	O
status	O
post	O
a	B-problem
subacute	I-problem
pontine	I-problem
hemorrhage	I-problem
.	O

2.	O
Severe	B-problem
gait	I-problem
ataxia	I-problem
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Gabapentin	B-treatment
100	O
mg	O
po	O
t.i.d.	O
for	O
paresthesias	B-problem
.	O

2.	O
Colace	B-treatment
100	O
mg	O
po	O
b.i.d.	O

3.	O
Zantac	B-treatment
150	O
mg	O
po	O
b.i.d.	O

4.	O
Prednisone	B-treatment
taper	I-treatment
completed	O
.	O

Andre	O
R.	O
RATAN	O
,	O
M.D.	O

23-397	O

Dictated	O
By	O
:	O
Maria	O
A	O
Singler	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2009-12-31	O
14:05	O

T	O
:	O
2009-12-31	O
14:57	O

JOB	O
#:	O
71678	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Juan	O
R.	O
RATAN	O
on	O
:	O
TUE	O
2010-03-02	O
8:13	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2016-03-04	O

Discharge	O
Date	O
:	O

2016-03-22	O

Date	O
of	O
Birth	O
:	O

1930-03-23	O

Sex	O
:	O

M	O

Service	O
:	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
an	O
85	O
year	O
old	O
man	O
initially	O
admitted	O
to	O
the	O
Plastic	O
Surgery	O
Service	O
for	O
evaluation	B-test
of	O
a	B-problem
left	I-problem
facial	I-problem
mass	I-problem
.	O

Subsequently	O
,	O
CMED	O
CCU	O
was	O
consulted	O
and	O
he	O
was	O
transferred	O
to	O
our	O
Service	O
postoperatively	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

His	O
past	O
medical	O
history	O
is	O
significant	O
for	O
prostate	B-problem
cancer	I-problem
,	O
benign	B-problem
prostatic	I-problem
hypertrophy	I-problem
,	O
hypothyroidism	B-problem
,	O
status	O
post	O
radiation	B-treatment
for	O
non	B-problem
Hodgkin	I-problem
's	I-problem
lymphoma	I-problem
,	O
chronic	B-problem
painless	I-problem
hematuria	I-problem
,	O
degenerative	B-problem
joint	I-problem
disease	I-problem
and	O
history	O
of	O
a	B-problem
murmur	I-problem
.	O

Last	O
colonoscopy	B-test
,	O
five	O
years	O
ago	O
.	O

Dementia	B-problem
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
:	O

1.	O
Levothyroxine	B-treatment
.	O

2.	O
Lasix	B-treatment
.	O

3.	O
Proscar	B-treatment
.	O

4.	O
Aeroseb	B-treatment
.	O

5.	O
Ancef	B-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
examination	B-test
,	O
he	O
is	O
afebrile	B-problem
.	O

Vital	B-test
signs	I-test
,	O
stable	O
.	O

Elderly	O
man	O
,	O
somewhat	B-problem
cachectic	I-problem
.	O

Head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
and	O
throat	O
,	O
polypoid	B-problem
lesion	I-problem
just	O
inferior	O
to	O
the	O
left	O
zygoma	O
,	O
elevated	O
superiorly	O
,	O
with	O
visible	B-problem
bone	I-problem
.	O

No	O
exudate	B-problem
.	O

Minimal	B-problem
bleeding	I-problem
.	O

Regular	O
rate	O
and	O
rhythm	O
.	O

Clear	O
to	O
auscultation	B-test
.	O

Nontender	B-problem
,	O
nondistended	B-problem
.	O

HOSPITAL	O
COURSE	O
:	O

He	O
was	O
initially	O
admitted	O
to	O
CMED	O
for	O
resection	B-treatment
and	O
repair	B-treatment
of	O
this	B-problem
left	I-problem
facial	I-problem
lesion	I-problem
.	O

He	O
also	O
had	O
consults	O
from	O
Urology	O
for	O
his	B-problem
hematuria	I-problem
as	O
well	O
as	O
Medicine	O
preoperatively	O
and	O
CMED	O
CCU	O
.	O

He	O
went	O
to	O
the	O
Operating	O
Room	O
on	O
2016-03-10	O
with	O
Urology	O
for	O
hematuria	B-problem
where	O
he	O
had	O
a	B-treatment
cystoscopy	I-treatment
transurethral	I-treatment
resection	I-treatment
of	I-treatment
prostate	I-treatment
placement	I-treatment
.	O

He	O
then	O
went	O
to	O
the	O
Operating	O
Room	O
on	O
2016-03-14	O
where	O
he	O
had	O
resection	B-treatment
of	O
the	B-problem
left	I-problem
face	I-problem
squamous	I-problem
cell	I-problem
cancer	I-problem
by	O
Dr.	O
Langhorne	O
and	O
split	B-treatment
thickness	I-treatment
and	I-treatment
full	I-treatment
thickness	I-treatment
skin	I-treatment
grafting	I-treatment
of	O
the	B-problem
defects	I-problem
on	O
2016-03-14	O
.	O

He	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
with	O
no	O
complications	B-problem
except	O
postoperatively	O
,	O
his	O
voice	O
was	O
hoarse	B-problem
.	O

On	O
scoping	B-test
him	O
he	O
had	O
significant	B-problem
supraglottic	I-problem
edema	I-problem
.	O

He	O
was	O
kept	O
in	O
the	O
Unit	O
for	O
observation	B-test
of	I-test
his	I-test
airway	I-test
and	O
b.i.d.	O
laryngoscopy	B-test
.	O

This	O
revealed	O
some	B-problem
supraglottic	I-problem
edema	I-problem
which	O
revealed	O
with	O
time	O
,	O
without	O
further	B-treatment
intervention	I-treatment
.	O

He	O
was	O
followed	O
by	O
Plastic	O
Surgery	O
for	O
his	B-treatment
split	I-treatment
thickness	I-treatment
skin	I-treatment
graft	I-treatment
and	O
his	B-treatment
bolster	I-treatment
was	O
discontinued	O
on	O
postoperative	O
day	O
#5	O
with	O
good	O
take	O
up	O
of	O
his	B-treatment
skin	I-treatment
graft	I-treatment
.	O

Urology	O
also	O
followed	O
him	O
and	O
kept	O
him	O
on	O
antibiotics	B-treatment
until	O
postoperative	O
day	O
#7	O
at	O
which	O
point	O
antibiotics	B-treatment
were	O
discontinued	O
.	O

His	O

Foley	B-treatment
was	O
also	O
discontinued	O
.	O

He	O
is	O
being	O
discharged	O
to	O
rehabilitation	O
to	O
follow	O
up	O
for	O
XRT	B-treatment
given	O
the	O
fact	O
that	O
his	B-test
pathology	I-test
revealed	O
squamous	B-problem
cell	I-problem
cancer	I-problem
extending	O
deep	O
to	O
the	O
margin	O
as	O
well	O
as	O
positive	B-problem
level	I-problem
II	I-problem
nodes	I-problem
.	O

Dr.	O
Navarrete	O
has	O
been	O
e-mailed	O
and	O
his	O
secretary	O
contacted	O
for	O
as	O
soon	O
as	O
possible	O
appointment	O
for	O
XRT	B-treatment
follow	O
up	O
.	O

He	O
should	O
also	O
follow	O
up	O
with	O
Dr.	O
Rankin	O
and	O
Dr.	O
Langhorne	O
.	O

He	O
is	O
being	O
discharged	O
,	O
most	O
likely	O
,	O
to	O
Falmouth	O
Hospital	O
.	O

John	O
P	O
Friend	O
,	O
M.D.	O

11-466	O

Dictated	O
By	O
:	O
Frances	O
P	O
Sheets	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2016-03-22	O
12:20	O

T	O
:	O
2016-03-22	O
12:23	O

JOB	O
#	O
:	O
80013	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Jermaine	O
X	O
Reynolds	O
on	O
:	O
Andrea	O
2016-06-30	O
3:46	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2018-05-24	O

Discharge	O
Date	O
:	O

2018-05-29	O

Date	O
of	O
Birth	O
:	O

1964-03-11	O

Sex	O
:	O

M	O

Service	O
:	O

CARDIOTHORACIC	O

Allergies	O
:	O

Keflex	B-treatment
/	O
Heparin	B-treatment
Agents	I-treatment

Attending	O
:	O
James	O
F.	O
Bard	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O
pt	O
sent	O
to	O
ER	O
after	O
routine	O
F/U	O
for	O
UE	B-problem
DVT	I-problem
with	O
vascular	O
surgery	O
.	O

In	O
ER	O
c/o	O
dyspnea	B-problem
and	O
was	O
noted	O
to	O
have	O
mental	B-problem
status	I-problem
changes	I-problem
.	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O
none	O
this	O
admission	O

AVR	B-treatment
(	I-treatment
tissue	I-treatment
)	I-treatment
05-14	O

History	O
of	O
Present	O
Illness	O
:	O

s/p	O
AVR	B-treatment
05-14	O
.	O

Postop	O
course	O
c/b	O
right	B-problem
upper	I-problem
extremity	I-problem
DVT	I-problem
and	O
postop	B-problem
Afib	I-problem
.	O

Discharged	O
home	O
05-19	O
with	O
instructions	O
to	O
f/u	O
in	O
vascular	O
clinic	O
.	O

Had	O
vascular	O
clinic	O
f/u	O
on	O
day	O
of	O
admission	O
.	O

At	O
that	O
time	O
had	O
UE	B-test
duplex	I-test
which	O
revealed	O
RUE	B-problem
DVT	I-problem
involving	O
IJ	O
,	O
Axillary	O
,	O
subclav	O
,	O
brachial	O
,	O
and	O
basilic	O
veins	O
.	O

Then	O
referred	O
to	O
ER	O
for	O
Tx	B-treatment

Past	O
Medical	O
History	O
:	O

s/p	O
AVR	B-treatment
(	O
#27	O
pericardial	O
)	O

post-op	B-problem
Afib	I-problem

HTN	B-problem

renal	B-problem
calculi	I-problem

?	O
sleep	B-problem
apnea	I-problem

seasonal	B-problem
allergies	I-problem

s/p	O
2	B-treatment
surgs.	I-treatment
for	O
spermatocele	B-problem

s/p	O
oral	B-treatment
surgery	I-treatment

Social	O
History	O
:	O
lives	O
with	O
partner	O

professor	O
/	O
Kyra	O
social	O
worker	O

quit	O
smoking	O
20	O
years	O
ago	O

occasional	O
ETOH	O

Family	O
History	O
:	O

non-contributory	O
for	O
premature	B-problem
CAD	I-problem
;	O
father	O
had	O
MI	B-problem
in	O
his	O
70	O
's	O

Physical	O
Exam	O
:	O

admission	B-test
PE	I-test

VS	B-test
:	O
HR	B-test
103	O
BP	B-test
162/69	O
RR	B-test
14	O
Sat	B-test
92%	O
RA	O

Neuro	O
:	O
MAE	O
,	O
Follows	O
commands	O
,	O
slightly	B-problem
confused	I-problem

Heent	O
:	O
PERRL/EOMI	O
,	O
no	O
JVD	B-problem

Resp	O
:	O
CTAB	O

CV	O
:	O
RRR	O
S1-S2	O
,	O
no	O
murmur	B-problem
.	O

Sternum	O
stable	O

Abdm	O
:	O
soft	O
NT	B-problem
/	O
ND	B-problem
/	O
NABS	O

Ext	O
:	O
+	O
distal	B-test
pulses	I-test
,	O
no	O
edema	B-problem

Discharge	B-test
PE	I-test

VS	B-test
:	O
T	B-test
99	O
HR	B-test
68	O
BP	B-test
113/72	O
RR	B-test
18	O
Sat	B-test
98%	O
RA	O

Gen	O
:	O
comforable	O

Neuro	O
:	O
A&Ox3	O
,	O
MAE	O
,	O
Follows	O
Commands	O

Resp	O
:	O
CTA-bilat	O

CV:RRR	O
S1-S2	O
,	O
no	O
MRG	B-problem

Resp:CTA-bilat	O

Abdm	O
:	O
soft	O
,	O
NT/ND/NABS	B-problem

Ext	O
:	O
warm	O
well	O
perfused	O
No	O
CCE	B-problem

Pertinent	O
Results	O
:	O

2018-05-24	O
08:55	O
PM	O

GLUCOSE	B-test
-	O
193	O
*	O
UREA	B-test
N	I-test
-	O
23	O
*	O
CREAT	B-test
-	O
1.2	O
SODIUM	B-test
-	O
138	O
POTASSIUM	B-test
-	O
4.6	O
CHLORIDE	B-test
-	O
101	O
TOTAL	B-test
CO2	I-test
-	O
21	O
*	O
ANION	B-test
GAP	I-test
-	O
21	O
*	O

2018-05-24	O
08:55	O
PM	O

CALCIUM	B-test
-	O
8.8	O
PHOSPHATE	B-test
-	O
3.9	O
MAGNESIUM	B-test
-	O
2.4	O

2018-05-24	O
08:55	O
PM	O

PT	B-test
-	O
15.0	O
*	O
PTT	B-test
-	O
107.1	O
*	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
1.3	O
*	O

2018-05-24	O
01:25	O
PM	O

WBC	B-test
-	O
13.3	O
*#	O
RBC	B-test
-	O
3.45	O
*	O
HGB	B-test
-	O
10.6	O
*	O
HCT	B-test
-	O
30.5	O
*	O
MCV	B-test
-	O
88	O
MCH	B-test
-	O
30.6	O
MCHC	B-test
-	O
34.7	O
RDW	B-test
-	O
12.7	O

2018-05-28	O
01:40	O
PM	O

BLOOD	B-test
WBC	I-test
-	O
12.9	O
*	O
RBC	B-test
-	O
3.37	O
*	O
Hgb	B-test
-	O
10.4	O
*	O
Hct	B-test
-	O
29.4	O
*	O
MCV	B-test
-	O
87	O
MCH	B-test
-	O
30.8	O
MCHC	B-test
-	O
35.3	O
*	O
RDW	B-test
-	O
13.3	O
Plt	B-test
Ct	I-test
-	O
345	O

2018-05-29	O
11:34	O
AM	O

BLOOD	B-test
PT	I-test
-	O
39.1	O
*	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
4.4	O
*	O

2018-05-25	O
09:00	O
AM	O

BLOOD	B-test
HEPARIN	I-test
DEPENDENT	I-test
ANTIBODIES	I-test
-	O
positive	O

Brief	O
Hospital	O
Course	O
:	O

Pt	O
admitted	O
05-24	O
from	O
ER	O
after	O
positive	B-problem
RUE	I-problem
DVT	I-problem
finding	O
in	O
vascular	O
lab	O
.	O

During	O
ER	B-test
evaluation	I-test
pt	O
was	O
noted	O
to	O
have	O
some	O
degree	O
of	O
dyspnea	B-problem
as	O
well	O
as	O
mental	B-problem
status	I-problem
changes	I-problem
,	O
including	O
loss	B-problem
of	I-problem
short	I-problem
term	I-problem
memory	I-problem
and	O
brief	B-problem
unresponsive	I-problem
period	I-problem
after	O
one	O
dose	O
of	O
IV	B-treatment
Benadry	I-treatment
and	O
steroids	B-treatment
prior	O
to	O
CT	B-test
scan	I-test
.	O

The	B-test
CT	I-test
was	O
negative	O
for	O
CVA	B-problem
but	O
positive	O
for	O
Pulmonary	B-problem
embolism	I-problem
.	O

He	O
was	O
transferred	O
to	O
CSRU	O
for	O
evaluation	B-test
.	O

Neurology	O
was	O
consulted	O
and	O
the	O
pt	O
also	O
had	O
MRI	B-test
which	O
was	O
negative	O
.	O

The	O
pt	O
was	O
begun	O
on	O
heparin	B-treatment
gtt	I-treatment
and	O
was	O
noted	O
to	O
have	O
platelet	B-problem
drop	I-problem
>	O
50%	O
after	O
infusion	B-treatment
began	O
,	O
hepain	B-treatment
was	O
d/c	O
'd.	O

Argatroban	B-treatment
was	O
started	O
abd	O
a	B-test
HIT	I-test
panel	I-test
was	O
sent	O
,	O
HIT	B-test
panel	I-test
was	O
positive	B-problem
.	O

Hematology	O
was	O
consulted	O
.	O

By	O
the	O
following	O
mornig	O
all	B-problem
mental	I-problem
status	I-problem
changes	I-problem
had	O
cleared	O
and	O
the	O
pt	O
was	O
transferred	O
to	O
the	O
floors	O
for	O
continued	O
care	O
.	O

Over	O
the	O
next	O
several	O
days	O
the	O
patient	O
was	O
maintained	O
on	O
Argatrobanwhile	B-treatment
coumadin	B-treatment
therapy	I-treatment
was	O
initiated	O
.	O

On	O
HD#6	O
the	O
pt	O
had	O
a	B-test
therapeudic	I-test
INR	I-test
(	O
4.4	O
)	O
off	O
Argatroban	B-treatment
and	O
wad	O
discharged	O
home	O
.	O

He	O
was	O
to	O
have	O
f/u	O
INR	B-test
check	I-test
with	O
Dr	O
Lewis	O
on	O
05-31	O
.	O

Additionally	O
the	O
pt	O
should	O
f/u	O
with	O
the	O
hematology	O
clinic	O
.	O

Medications	O
on	O
Admission	O
:	O

ASA	B-treatment
81	O
'	O

Atorvastatin	B-treatment
10	O
'	O

Lisinopril	B-treatment
5	O
'	O

Lopressor	B-treatment
50	O
"	O

Amiodarone	B-treatment
200	O
'	O

Discharge	O
Medications	O
:	O

1.	O
Aspirin	B-treatment
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

2.	O
Atorvastatin	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

3.	O
Metoprolol	B-treatment
Tartrate	I-treatment
50	O
mg	O
Tablet	O
Sig	O
:One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

4.	O
Amoxicillin-Pot	B-treatment
Clavulanate	I-treatment
875-125	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
for	O
10	O
days	O
.	O

Disp	O
:*	O
20	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

5.	O
Amiodarone	B-treatment
200	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

6.	O
Warfarin	B-treatment
2	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
as	O
directed	O
:	O
3	O
mg	O
1943-05-29	O
and	O
6/1	O
then	O
as	O
directed	O
by	O
Dr	O
Mace	O
.	O

Disp	O
:*	O
100	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O
s/p	O
AVR	B-treatment
05-14	O
(	O
tissue	O
)	O
readmitted	O
05-24	O
w/	O
pulmonary	B-problem
embolism	I-problem
,	O
RUE	B-problem
DVT	I-problem
,	O
HIT	B-problem
positive	I-problem

PMH	O
:	O
HTN	B-problem
,	O
Renal	B-problem
calculi	I-problem
,	O
sleep	B-problem
apnea	I-problem
,	O

Discharge	O
Condition	O
:	O
good	O

Discharge	O
Instructions	O
:	O
keep	O
wounds	B-problem
clean	O
and	O
dry	O
.	O

OK	O
to	O
shower	O
,	O
no	O
bathing	O
or	O
swimming	O
.	O

Take	O
all	B-treatment
medications	I-treatment
as	O
prescribed	O
.	O

Follow-up	B-test
INR	I-test
to	O
be	O
drawn	O
06-01	O
,	O
by	O
Dr	O
Lewis	O
@	O
597-4427	O

Followup	O
Instructions	O
:	O

Dr	O
Pessolano	O
in	O
3	O
days	O

Dr	O
Arnold	O
in	O
3	O
weeks	O

Hematology	O
clinic	O
in	O
1-2	O
weeks	O

Messersmith	O
della	O
Blore	O
MD	O
27-337	O

Completed	O
by	O
:	O
MARK	O
Yvonne	O
NP	O
80-AUO	O
2018-05-29	O
@	O
1552	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Edward	O
von	O
der	O
Torros	O
on	O
:	O
WED	O
2018-06-20	O
2:58	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2013-12-24	O

Discharge	O
Date	O
:	O

2014-01-13	O

Date	O
of	O
Birth	O
:	O

1959-12-16	O

Sex	O
:	O

F	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Haldol	B-treatment
/	O
Compazine	B-treatment
/	O
Phenergan	B-treatment
/	O
Tigan	B-treatment
/	O
Flagyl	B-treatment

Attending	O
:	O
David	O
U.	O
Johnson	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Chest	B-problem
Pain	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Removal	B-treatment
of	I-treatment
tunneled	I-treatment
cath	I-treatment
(	O
previously	O
used	O
for	O
tPN	B-treatment
)	O

History	O
of	O
Present	O
Illness	O
:	O

54	O
yo	O
F	O
with	O
Crohn	B-problem
's	I-problem
s/p	O
ileostomy	B-treatment
and	O
subsequent	O
short	B-problem
gut	I-problem
syndrome	I-problem
with	O
port-a-cath	B-treatment
placement	I-treatment
for	O
TPN	B-treatment
who	O
presents	O
with	O
progressive	B-problem
right	I-problem
sided	I-problem
chest	I-problem
pain	I-problem
that	O
comes	O
in	O
waves	O
.	O

The	O
pt	O
reports	O
sharp	B-problem
10/10	I-problem
chest	I-problem
pain	I-problem
under	I-problem
the	I-problem
right	I-problem
breast	I-problem
which	O
is	O
getting	O
progressively	O
worse	O
.	O

The	B-problem
pain	I-problem
is	O
worsened	O
with	O
deep	O
inspiration	O
or	O
movement	O
.	O

It	O
initially	O
started	O
one	O
day	O
previously	O
but	O
has	O
gotten	O
significantly	O
worse	O
over	O
last	O
12	O
hours	O
.	O

It	O
is	O
associated	O
with	O
SOB	B-problem
as	O
well	O
as	O
fevers	B-problem
,	O
chills	B-problem
.	O

The	O
pt	O
denies	O
abd	B-problem
pain	I-problem
,	O
n/v	B-problem
or	O
increased	B-problem
ostomy	I-problem
output	I-problem
.	O

Given	O
her	B-problem
fever	I-problem
,	O
sx	B-problem
of	I-problem
chest	I-problem
pain	I-problem
and	O
SOB	B-problem
as	O
well	O
as	O
an	B-problem
elevated	I-problem
WBC	I-problem
count	I-problem
,	O
she	O
was	O
initially	O
thought	O
to	O
have	O
a	B-problem
PNA	I-problem
.	O

She	O
was	O
therefore	O
given	O
ceftriaxone	B-treatment
1	O
g	O
IV	O
x1	O
and	O
azithromycin	B-treatment
500	O
mg	O
PO	O
x1	O
in	O
the	O
Deanna	O
.	O

As	O
the	B-test
CXR	I-test
was	O
without	O
any	O
evidence	O
of	O
PNA	B-problem
,	O
or	O
PTX	B-problem
,	O
the	O
pt	O
subsequently	O
received	O
a	B-test
CTA	I-test
to	O
evaluate	O
for	O
PE	B-problem
which	O
revealed	O
multifocal	B-problem
bilateral	I-problem
PNA	I-problem
but	O
no	O
PE	B-problem
.	O

At	O
this	O
time	O
,	O
she	O
was	O
given	O
Vancomycin	B-treatment
1	O
g	O
IV	O
x1	O
.	O

She	O
was	O
also	O
given	O
morphine	B-treatment
2	O
mg	O
x3	O
,	O
4	O
mg	O
IV	O
x2	O
,	O
dolasetron	B-treatment
12.5	O
mg	O
x2	O
and	O
ativan	B-treatment
1	O
mg	O
IV	O
x1	O
.	O

Past	O
Medical	O
History	O
:	O

1.	O
Crohn	B-problem
's	I-problem
disease	I-problem
,	O
dx	O
1974	O
s/p	O
three	B-treatment
bowel	I-treatment
resections	I-treatment
and	O
eventual	B-treatment
ileostomy	I-treatment
,	O
resulting	O
in	O
short	B-problem
gut	I-problem
syndrome	I-problem

2.	O
Restless	B-problem
leg	I-problem
syndrome	I-problem

3.	O
?	O
Parkinsons	B-problem
vs.	O
EPS	B-problem
side	I-problem
effects	I-problem
from	O
risperdal	B-treatment

4.	O
Chronic	B-problem
idiopathic	I-problem
pancreatitis	I-problem
,	O
as	O
demonstrated	O
on	O
CT	B-test
in	O
09-01	O

5.	O
Arthritis	B-problem
s/p	O
"	B-treatment
pin	I-treatment
placement	I-treatment
"	I-treatment
in	I-treatment
left	I-treatment
foot	I-treatment
05-01	O

6.	O
Degenerative	B-problem
disc	I-problem
disease	I-problem
s/p	O
two	B-treatment
back	I-treatment
surgeries	I-treatment
in	O
80	O
's	O

7.	O
Benzo	B-treatment
and	O
opiod	B-treatment
addiction	O

8.	O
Paranoia	B-problem
/	O
Depression	B-problem
,	O
h/o	O
auditory	B-problem
hallucinations	I-problem
,	O
?	O
mania	B-problem

9.	O
Port-a-Cath	B-treatment
placement	I-treatment
for	O
IV	B-treatment
hydration	I-treatment
in	O
setting	O
of	O
short	B-problem
gut	I-problem
syndrome	I-problem
,	O
complicated	O
by	O
clotting	B-problem
x	O
4	O
,	O
requiring	O
replacement	B-treatment

Abd	B-test
CT	I-test
performed	O
09-01	O
showed	O
multiple	B-problem
calcifications	I-problem
in	I-problem
the	I-problem
body	I-problem
and	I-problem
tail	I-problem
of	I-problem
the	I-problem
pancreas	I-problem
with	O
a	B-problem
larger	I-problem
cystic	I-problem
lesion	I-problem
in	I-problem
the	I-problem
tail	I-problem
of	I-problem
the	I-problem
pancreas	I-problem
.	O

A	B-problem
second	I-problem
9	I-problem
mm	I-problem
cystic	I-problem
lesion	I-problem
is	O
seen	O
in	O
the	O
head	O
of	O
the	O
pancreas	O
.	O

These	O
findings	O
are	O
consistent	O
with	O
chronic	B-problem
pancreatitis	I-problem
with	O
pseudocyst	B-problem
formation	I-problem

Social	O
History:	O
lives	O
w/	O
her	O
husband	O
in	O
John	O
area	O
;	O
smokes	O
05-04	O
cig	O
/d	O
(	O
30	O
pack	O
year	O
history	O
);	O
no	O
alcohol	O
or	O
recreational	O
drug	O
use	O
,	O
has	O
had	O
addiction	O
to	O
benzodiazepines	B-treatment
and	O
opioids	B-treatment
in	O
the	O
past	O

Family	O
History	O
:	O

Mother-Crohn	B-problem
's	I-problem
;	O
Daugher-IBS	B-problem
,	O
colitis	B-problem
;	O
Mother	O
--	O
breast	B-problem
CA	I-problem
,;	O

Father	O
-	O
Stephanie	B-problem
tumor	I-problem
,	O
no	O
DM	B-problem
,	O
no	O
CAD	B-problem

Physical	O
Exam	O
:	O

V	B-test
:	O
101.4	O
,	O
102	O
,	O
167/54	O
->	O
159/77	O
,	O
24	O
->	O
16	O
,	O
98%	O
RA	O
->	O
96%	O
RA	O

Gen	O
:	O
middle	O
aged	O
obese	O
female	O
lying	O
in	O
bed	O
on	O
her	O
left	O
side	O
asleep	O
,	O
speaking	O
slowly	O
.	O

appears	O
younger	O
than	O
stated	O
age	O

HEENT	O
:	O
PERRL	O
,	O
OP	O
clear	O
,	O
MMM	O

CV	O
:	O
RRR	O
,	O
s1	O
,	O
s2	B-problem
distant	I-problem

Chest	O
:	O
crackles	B-problem
at	I-problem
right	I-problem
base	I-problem
with	O
dec.	B-problem
air	I-problem
movement	I-problem
.	O

tender	B-problem
over	I-problem
right	I-problem
chest	I-problem

Abd	O
:	O
obese	B-problem
,	O
multiple	B-problem
surgical	I-problem
scars	I-problem
.	O

Ileostomy	B-treatment
bag	I-treatment
present	O
with	O
gas	O
and	O
stool	O
.	O

absomen	O
soft	O
,	O
tender	B-problem
to	O
palpation	B-test
over	I-test
RUQ	I-test
,	O
but	O
no	O
guarding	B-problem
or	O
rebound	B-problem

Ext	O
:	O
tr	B-problem
edema	I-problem
,	O
2+	O
DP	B-test
bilaterally	I-test

Pertinent	O
Results	O
:	O

2013-12-24	O
01:30	O
AM	O

GLUCOSE	B-test
-	O
208	O
*	O
UREA	B-test
N	I-test
-	O
21	O
*	O
CREAT	B-test
-	O
1.3	O
*	O
SODIUM	B-test
-	O
138	O
POTASSIUM	B-test
-	O
4.2	O
CHLORIDE	B-test
-	O
104	O
TOTAL	B-test
CO2	I-test
-	O
23	O
ANION	B-test
GAP	I-test
-	O
15	O

2013-12-24	O
01:30	O
AM	O

CK	B-test
(	I-test
CPK	I-test
)-	I-test
31	O

2013-12-24	O
01:30	O
AM	O

cTropnT	B-test
-<	O
0.01	O

2013-12-24	O
01:30	O
AM	O

WBC	B-test
-	O
14.4	O
*#	O
RBC	B-test
-	O
3.82	O
*	O
HGB	B-test
-	O
11.5	O
*	O
HCT	B-test
-	O
33.5	O
*	O
MCV	B-test
-	O
88	O
MCH	B-test
-	O
30.2	O
MCHC	B-test
-	O
34.5	O
RDW	B-test
-	O
14.7	O

2013-12-24	O
01:30	O
AM	O

NEUTS	B-test
-	O
78.0	O
*	O
LYMPHS	B-test
-	O
17.0	O
*	O
MONOS	B-test
-	O
4.6	O
EOS	B-test
-	O
0.3	O
BASOS	B-test
-	O
0.1	O

2013-12-24	O
01:30	O
AM	O

PLT	B-test
COUNT	I-test
-	O
128	O
*	O

2013-12-24	O
01:30	O
AM	O

PT	B-test
-	O
12.3	O
PTT	B-test
-	O
26.1	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
1.0	O

CTA	B-test
2013-12-24	O
-	O
IMPRESSION	O
:	O

1.	O
No	O
definite	B-problem
pulmonary	I-problem
embolism	I-problem
is	O
identified	O
.	O

2.	O
Peripheral	B-problem
patchy	I-problem
opacities	I-problem
are	O
seen	O
bilaterally	O
,	O
most	O
consistent	O
with	O
multifocal	B-problem
pneumonia	I-problem
.	O

CXR	B-test
2013-12-24	O
-	O
There	O
are	O
faint	B-problem
ill-defined	I-problem
opacities	I-problem
within	O
the	O
right	O
lower	O
lung	O
zone	O
and	O
left	O
upper	O
lung	O
zone	O
could	O
represent	O
a	B-problem
multifocal	I-problem
pneumonic	I-problem
process	I-problem
.	O

CXR	B-test
2014-01-02	O
-	O
IMPRESSION	O
:	O

Multilobar	B-problem
pneumonia	I-problem
with	O
interval	B-problem
worsening	I-problem
in	I-problem
the	I-problem
left	I-problem
lung	I-problem
but	O
slight	O
improvement	O
in	O
the	O
right	O
lower	O
lobe	O
.	O

Head	B-test
CT	I-test
2014-01-09	O
-	O
Ordered	O
to	O
evaluate	O
for	O
changes	O
to	O
explain	O
delta	B-problem
MS	I-problem

CONCLUSION	O
:	O

Left	B-problem
parietal	I-problem
subcortical	I-problem
hypodensity	I-problem
,	O
likely	O
ischemic	B-problem
.	O

No	O
definite	B-problem
changes	I-problem
since	O
the	B-test
MR	I-test
of	O
in	O
2011-05-15	O
.	O

CXR	B-test
2014-01-09	O

IMPRESSION	O
:	O

Marked	O
improvement	O
.	O

Brief	O
Hospital	O
Course	O
:	O

54	O
yo	O
F	O
with	O
Crohn	B-problem
's	I-problem
disease	I-problem
s/p	O
ileostomy	B-treatment
with	O
subsequent	O
short	B-problem
gut	I-problem
syndrome	I-problem
with	O
port-o-cath	B-treatment
for	O
TPN	B-treatment
presents	O
with	O
acute	B-problem
onset	I-problem
pleuritic	I-problem
chest	I-problem
pain	I-problem
with	O
fever	B-problem
,	O
chills	B-problem
,	O
and	O
sob	B-problem
.	O

1.	O
Chest	B-problem
pain	I-problem
/	O
Fever	B-problem
/	O
Chills	B-problem
:	O

The	B-problem
acute	I-problem
onset	I-problem
of	I-problem
chest	I-problem
pain	I-problem
was	O
initially	O
very	O
concerning	O
for	O
a	B-problem
PE	I-problem
,	O
however	O
the	B-test
Chest	I-test
CT	I-test
demonstrated	O
multifocal	B-problem
consolidation	I-problem
consistent	O
with	O
a	B-problem
bacterial	I-problem
PNA	I-problem
.	O

This	O
is	O
consistent	O
with	O
the	O
remainder	O
of	O
the	O
pt	O
's	O
history	O
including	O
fever	B-problem
,	O
chills	B-problem
,	O
sob	B-problem
and	O
an	B-problem
elevated	I-problem
WBC	I-problem
count	I-problem
.	O

The	O
pt	O
was	O
given	O
ceftriaxone	B-treatment
/	O
azithromycin	B-treatment
/	O
vancomycin	B-treatment
in	O
Deanna	O
.	O

Blood	B-test
,	I-test
urine	I-test
and	I-test
sputum	I-test
culutres	I-test
were	O
sent	O
.	O

Pt	B-test
's	I-test
blood	I-test
cultures	I-test
came	O
back	O
positive	O
for	O
Staph	B-problem
Aureus	I-problem
and	O
Enterococcus	B-problem
,	O
both	O
were	O
pansensitive	O
.	O

Sputum	B-test
culture	I-test
also	O
returned	O
with	O
Staph.	B-problem
Aureus	I-problem
.	O

Ceftriaxone	B-treatment
and	O
azithro	B-treatment
were	O
discontinued	O
,	O
and	O
Vacomycin	B-treatment
was	O
continued	O
.	O

Pt	O
initially	O
was	O
hypoxic	B-problem
requiring	O
NRB	B-treatment
for	O
O2	B-test
sat	I-test
of	O
94%	O
,	O
with	O
any	O
attempt	O
to	O
wean	O
she	O
would	O
desat	O
.	O

Pt	O
was	O
intubated	O
prior	O
to	O
tunneled	B-treatment
catheter	I-treatment
removal	I-treatment
,	O
see	O
below	O
.	O

(	O
The	B-treatment
tunneled	I-treatment
catheter	I-treatment
later	O
came	O
back	O
for	O
negative	O
for	O
culture.	B-test
)	O

Earlier	O
that	O
day	O
pt	O
had	O
a	B-test
chest	I-test
x	I-test
ray	I-test
which	O
showed	O
diffuse	B-problem
infiltrative	I-problem
process	I-problem
concerning	O
for	O
ARDS	B-problem
.	O

Post	O
procedure	B-treatment
pt	O
remained	O
intubated	B-treatment
on	O
ARDSnet	B-treatment
protocol	I-treatment
.	O

She	O
self	O
extubated	O
the	O
first	O
day	O
and	O
was	O
reintubated	O
without	O
any	B-problem
complications	I-problem
.	O

Her	B-problem
O2	I-problem
requirement	I-problem
improved	O
on	O
the	B-treatment
vent	I-treatment
over	O
the	O
next	O
few	O
days	O
and	O
she	O
was	O
weaned	O
off	O
the	B-treatment
vent	I-treatment
on	O
2013-01-01	O
.	O

After	O
extubation	O
her	B-problem
o2	I-problem
requirement	I-problem
was	O
down	O
to	O
1L	B-treatment
NC	I-treatment
with	O
sats	B-test
in	O
mid	O
90s	O
.	O

She	O
was	O
transferred	O
to	O
the	O
floor	O
for	O
further	O
managment	O
.	O

The	O
patient	O
remained	O
afebrile	B-problem
when	O
she	O
transferred	O
to	O
the	O
medicine	O
service	O
.	O

She	O
was	O
weaned	O
off	O
the	B-treatment
oxygen	I-treatment
and	O
for	O
the	O
remainder	O
of	O
her	O
course	O
her	B-test
O2sats	I-test
were	O
stable	O
on	O
room	O
air	O
.	O

The	O
patient	O
had	O
completed	O
her	B-treatment
antibiotic	I-treatment
course	I-treatment
while	O
in	O
house	O
.	O

2.	O
Hx	O
of	O
multiple	B-problem
port-o-cath	I-problem
clots	I-problem
:	O

Although	O
the	O
pt	O
is	O
on	O
warfarin	B-treatment
chronically	O
,	O
her	B-test
INR	I-test
was	O
subtherapeutic	O
.	O

Goal	O
INR	B-test
01-31	O
.	O

Initially	O
coumadin	B-treatment
was	O
increased	O
,	O
however	O
given	O
concern	O
for	O
infected	B-problem
line	I-problem
,	O
general	O
surgery	O
was	O
consulted	O
who	O
removed	O
the	B-treatment
line	I-treatment
in	O
the	O
ICU	O
.	O

3.	O
ARF	B-problem
:	O

Pt	O
initially	O
with	O
mild	B-problem
ARI	I-problem
,	O
this	O
was	O
thought	O
to	O
be	O
due	O
to	O
dehydration	B-problem
,	O
after	O
initial	B-treatment
volume	I-treatment
repletion	I-treatment
her	O
renal	O
function	O
improved	O
to	O
her	O
baseline	O
.	O

4.	O
CMED	O
:	O

The	O
pt	O
has	O
a	O
history	O
of	O
paranoia	B-problem
/	O
depression	B-problem
.	O

ON	O
admission	O
she	O
was	O
taking	O
Quetiapine	B-treatment
300	O
mg	O
QHS	O
and	O
Clonazepam	B-treatment
1	O
mg	O
QAM	O
,	O
1	O
mg	O
Q3PM	O
,	O
2	O
mg	O
PO	O
QHS	O
.	O

Quetiapine	B-treatment
was	O
continued	O
however	O
clonipin	B-treatment
was	O
initially	O
held	O
when	O
she	O
was	O
intubated	B-treatment
on	O
fentynyl	B-treatment
/	O
versed	B-treatment
.	O

This	O
was	O
restarted	O
post	O
extubation	B-treatment
.	O

Intially	O
after	O
being	O
transferred	O
from	O
the	O
ICU	O
to	O
the	O
medicine	O
service	O
the	O
patient	O
was	O
mentating	O
appropriately	O
.	O

Her	O
course	O
later	O
became	O
complicated	O
by	O
visual	B-problem
and	I-problem
auditory	I-problem
hallucinations	I-problem
.	O

She	O
made	O
disturbing	O
comments	O
to	O
the	O
hospital	O
personnel	O
.	O

She	O
was	O
unable	B-problem
to	I-problem
sleep	I-problem
at	O
night	O
,	O
often	O
pacing	O
the	O
halls	O
.	O

She	O
required	O
a	B-treatment
1:1	I-treatment
sitter	I-treatment
.	O

Psychiatry	O
was	O
consulted	O
.	O

They	O
felt	O
that	O
her	O
presentation	O
was	O
secondary	O
to	O
delirium	B-problem
and	O
was	O
multifactorial	O
.	O

They	O
attributed	O
it	O
to	O
polypharmacy	B-problem
,	O
recent	B-problem
infection	I-problem
(	I-problem
pneumonia	I-problem
)	I-problem
and	O
insomnia	B-problem
.	O

A	B-test
head	I-test
CT	I-test
was	O
done	O
which	O
ruled	O
out	O
any	B-problem
acute	I-problem
processes	I-problem
.	O

The	O
patient	O
refused	O
an	B-test
LP	I-test
.	O

They	O
made	O
recommendations	O
for	O
adjustments	O
to	O
her	B-treatment
anti-psychotic	I-treatment
medications	I-treatment
.	O

At	O
discharge	O
the	O
patient	O
was	O
on	O
clonazepam	B-treatment
1	O
mg	O
tid	O
,	O
seroquel	B-treatment
300	O
BID	O
and	O
neurontin	B-treatment
600	O
QAM	O
,	O
1200	O
QPM	O
and	O
1200	O
QHS	O
.	O

The	O
Kindred	O
Hospital	O
hospital	O
course	O
was	O
prolonged	O
because	O
of	O
her	B-problem
delirium	I-problem
.	O

Once	O
her	O
mental	O
status	O
improved	O
she	O
was	O
discharged	O
.	O

5.	O
?	O
Parkinson	B-problem
's	I-problem
Disease	I-problem
/	O
Akithesia	B-problem
:	O

The	O
patient	O
was	O
maintained	O
Sinemet	B-treatment
.	O

6.	O
Pain	B-problem
:	O

In	O
addition	O
to	O
her	B-problem
usual	I-problem
neuropathy	I-problem
pain	I-problem
,	O
the	O
pt	O
initially	O
appeared	O
to	O
have	O
significant	B-problem
pain	I-problem
from	O
the	B-problem
multi-focal	I-problem
PNA	I-problem
as	O
well	O
.	O

(	O
Home	B-treatment
regimen	I-treatment
,	O
Gabapentin	B-treatment
800	O
mg	O
PO	O
QAM	O
,	O
1600	O
mg	O
PO	O
Q3PM	O
,	O
1600	O
mg	O
PO	O
QHS	O
.	O

This	O
was	O
held	O
in	O
the	O
ICU	O
and	O
she	O
was	O
given	O
diluadid	B-treatment
prn	O
for	O
pain	B-treatment
control	I-treatment
.	O

The	B-treatment
patient	B-test
's	I-treatment
narcotic	I-treatment
and	O
CMED	B-treatment
CCU	I-treatment
regimen	I-treatment
was	O
evaluated	O
by	O
psychiatry	O
during	O
her	B-problem
delirium	I-problem
.	O

Please	O
see	O
above	O
for	O
their	O
recommendations	O
.	O

7.	O
FEN	O
:	O

Given	O
her	O
hx	O
of	O
ileostomy	B-treatment
secondary	O
to	O
crohn	B-problem
's	I-problem
disease	I-problem
and	O
resultant	O
short	B-problem
gut	I-problem
syndrome	I-problem
,	O
the	O
pt	O
requires	O
nutritional	B-treatment
support	I-treatment
via	O
TPN	B-treatment
.	O

After	O
removal	O
of	O
tunneled	B-treatment
line	I-treatment
pt	O
was	O
given	O
tube	B-treatment
feeds	I-treatment
while	O
she	O
was	O
intubated	B-treatment
.	O

The	O
patient	O
was	O
transitioned	O
to	O
a	B-treatment
low	I-treatment
fat	I-treatment
,	I-treatment
low	I-treatment
residue	I-treatment
diet	I-treatment
.	O

8	O
.	O

PPX	O
:	O
PPI	B-treatment
and	O
heparin	B-treatment
SC	I-treatment

9.	O
Dispo	O
:	O

The	O
patient	O
was	O
discharged	O
home	O
and	O
instructed	O
to	O
follow	O
up	O
with	O
her	O
PCP	O
.	O

Louis	O
follow	O
up	O
scheduled	O
with	O
psychiatry	O
.	O

Medications	O
on	O
Admission	O
:	O

1.	O
Quetiapine	B-treatment
300	O
mg	O
QHS	O

2.	O
Clonazepam	B-treatment
1	O
mg	O
QAM	O
,	O
1	O
mg	O
Q3PM	O
,	O
2	O
mg	O
PO	O
QHS	O

3.	O
Ferrous	B-treatment
Sulfate	I-treatment
325	O
PO	O
Daily	O

4.	O
Carbidopa-Levodopa	B-treatment
25-250	O
mg	O
PO	O
5	O
TIMES	O
PER	O
DAY	O
.	O

5.	O
Gabapentin	B-treatment
800	O
mg	O
PO	O
QAM	O
,	O
1600	O
mg	O
PO	O
Q3PM	O
,	O
1600	O
mg	O
PO	O
QHS	O

6.	O
Heparin	B-treatment
Lock	I-treatment
Flush	I-treatment
10	O
unit	O
/	O
mL	O
Daily	O
as	O
needed	O
.	O

7.	O
Saline	B-treatment
Flush	I-treatment

8.	O
Prevacid	B-treatment
30	O
mg	O
PO	O
twice	O
a	O
day	O
.	O

9.	O
Vistaril	B-treatment
50	O
mg	O
once	O
a	O
day	O
as	O
needed	O
for	O
nausea	B-problem
.	O

10.	O
Zofran	B-treatment
4	O
mg	O
PO	O
once	O
a	O
day	O
as	O
needed	O
for	O
nausea	B-problem
.	O

11.	O
Vitamin	B-treatment
B-12	I-treatment
1,000	O
mcg	O
/	O
mL	O
One	O
Injection	O
every	O
other	O
week	O
.	O

12.	O
Vicodin	B-treatment
5-500	O
mg	O
1-2	O
Tablets	O
PO	O
every	O
six	O
(	O
6	O
)	O
hours	O
PRN	O

13.	O
Warfarin	B-treatment
1	O
mg	O
PO	O
HS	O
.	O

14.	O
TPN	B-treatment

Discharge	O
Medications	O
:	O

1.	O
Amylase-Lipase-Protease	B-treatment
33,200	O
-	O
10,000	O
-	O
37,500	O
unit	O
Capsule	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
Four	O
(	O
4	O
)	O
Cap	O
PO	O
W/	O
MEALS	O
AND	O
SNACKS	O
(	O
)	O
.	O

Disp	O
:*	O
120	O
Cap	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

2.	O
Carbidopa-Levodopa	B-treatment
25	O
-	O
250	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
5	O
TIMES	O
A	O
DAY	O
(	O
)	O
.	O

Disp	O
:*	O
150	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

3.	O
Pramipexole	B-treatment
0.125	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
90	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

4.	O
Clonazepam	B-treatment
1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
90	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

5.	O
Ferrous	B-treatment
Sulfate	I-treatment
300	O
mg	O
/	O
5	O
mL	O
Liquid	O
Sig	O
:	O
One	O
(	O
1	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
5	O
bottles	O
*	O
Refills	O
:*	O
2	O
*	O

6.	O
Nystatin	B-treatment
100,000	O
unit	O
/	O
g	O
Cream	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
3	O
tubes	O
*	O
Refills	O
:*	O
2	O
*	O

7.	O
Lansoprazole	B-treatment
30	O
mg	O
Capsule	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
60	O
Capsule	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

8.	O
Quetiapine	B-treatment
100	O
mg	O
Tablet	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
180	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

9.	O
Propranolol	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
60	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

10.	O
Neurontin	B-treatment
300	O
mg	O
Capsule	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Capsule	O
PO	O
three	O
times	O
a	O
day	O
:	O
take	O
2	O
tabs	O
in	O
the	O
morining	O
,	O
4	O
tabs	O
in	O
the	O
afternoon	O
,	O
and	O
4	O
tabs	O
in	O
the	O
evening	O
.	O

Disp	O
:*	O
100	O
Capsule	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

Pneumonia	B-problem

Discharge	O
Condition	O
:	O

Good	O

Discharge	O
Instructions	O
:	O

You	O
are	O
to	O
return	O
to	O
the	O
hospital	O
immediately	O
if	O
you	O
should	O
experience	O
any	B-problem
chest	I-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
fevers	B-problem
or	O
any	B-problem
other	I-problem
worrisome	I-problem
symptom	I-problem
.	O

Please	O
continue	O
taking	O
your	B-treatment
medications	I-treatment
as	O
prescribed	O
.	O

Followup	O
Instructions	O
:	O

Provider	O
:	O

Joyce	O
,	O
Catherine	O
PSYCHIATRY	O
CMED	O
CSRU	O
Phone	O
:(	O
405	O
)	O
582-6811	O

Date	O
/	O
Time	O
:	O
2014-01-21	O
3:30	O

Please	O
followup	O
with	O
your	O
primary	O
care	O
physician	O
Todd	O
12-30	O
weeks	O
of	O
discharge	O
.	O

Donna	O
Mcguire	O
MD	O
19-274	O

Completed	O
by	O
:	O

Mark	O
Joseph	O
MD	O
04-104	O
2014-05-18	O
@	O
2128	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Donna	O
Nance	O
on	O
:	O
WED	O
2014-06-04	O
2:21	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2018-10-25	O

Discharge	O
Date	O
:	O

2018-10-31	O

Date	O
of	O
Birth	O
:	O

1951-06-15	O

Sex	O
:	O

M	O

Service	O
:	O

CARDIOTHORACIC	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O
Michael	O
D.	O
Christensen	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Shortness	B-problem
of	I-problem
Breath	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Coronary	B-treatment
Artery	I-treatment
Bypass	I-treatment
Graft	I-treatment
x3	O
(	O
Left	B-treatment
internal	I-treatment
mammary	I-treatment
->	I-treatment
left	I-treatment
anterior	I-treatment
descending	I-treatment
,	O
saphaneous	B-treatment
vein	I-treatment
graft	I-treatment
->	I-treatment
obtuse	I-treatment
marginal	I-treatment
,	O
saphaneous	B-treatment
vein	I-treatment
graft	I-treatment
->	I-treatment
posterior	I-treatment
descending	I-treatment
artery	I-treatment
)	O
2018-10-25	O

History	O
of	O
Present	O
Illness	O
:	O

67	O
y/o	O
male	O
with	O
worsening	B-problem
shortness	I-problem
of	I-problem
breath.	I-problem
Had	O
abnormal	B-problem
ETT	I-problem
and	O
referred	O
for	O
cath	B-test
.	O

Cath	B-test
revealed	O
severe	B-problem
3	I-problem
vessel	I-problem
disease	I-problem
.	O

Then	O
referred	O
for	O
surgical	B-treatment
intervention	I-treatment
.	O

Past	O
Medical	O
History	O
:	O

Carpal	B-problem
tunnel	I-problem
syndrome	I-problem
,	O
Hypertension	B-problem
,	O
Hyperlipidemia	B-problem
,	O
Arthritis	B-problem
,	O
h/o	O
Bell's	B-problem
Palsy	I-problem
,	O
HOH	B-problem
,	O
s/p	O
Tonsillectomy	B-treatment

Social	O
History	O
:	O

Denies	O
ETOH	O
,	O
rare	O
Tobacco	O
.	O

Electrician	O
.	O

Family	O
History	O
:	O

Father	O
with	O
MI	B-problem
in	O
50	O
's	O
and	O
underwent	O
CABG	B-treatment
.	O

Physical	O
Exam	O
:	O

VS	B-test
:	O
65	O
20	O
160/100	O
5	O
'	O
7	O
"	O
180	O
#	O

General	O
:	O
WD/WN	O
male	O
in	O
NAD	B-problem

HEENT	O
:	O
EOMI	O
,	O
PERRL	O
,	O
NC/AT	B-problem

Neck	O
:	O
Supple	O
,	O
FROM	O
,	O
-	O
JVD	B-problem
,	O
-	O
carotid	B-problem
bruits	I-problem

Chest	O
:	O
CTAB	O
-	O
w/r/r	B-problem

Heart	O
:	O
RRR	O
-	O
c/r/m/g	B-problem

Abd	O
:	O
Soft	O
,	O
NT/ND	B-problem
+BS	O

Ext	O
:	O
Warm	O
,	O
well-perfused	O
-	O
edema	B-problem
,	O
-	O
varicosities	B-problem

Neuro	O
:	O
A&Ox3	O
,	O
MAE	O
,	O
non-focal	O

Pertinent	O
Results	O
:	O

Echo	B-test
10-25	O
:	O
PRE-BYPASS	O
:	O
Left	B-test
ventricular	I-test
wall	I-test
thicknesses	I-test
are	O
normal	O
.	O

The	B-test
left	I-test
ventricular	I-test
cavity	I-test
size	I-test
is	O
normal	O
.	O

There	O
is	O
mild	B-problem
inferior	I-problem
wall	I-problem
hypokinesis	I-problem
.	O

There	O
is	O
akinesis	B-problem
/	O
dyskinesis	B-problem
and	O
thinning	B-problem
of	I-problem
the	I-problem
mid	I-problem
to	I-problem
distal	I-problem
inferior	I-problem
septum	I-problem
and	O
the	O
apex	O
.	O

Overall	B-test
left	I-test
ventricular	I-test
systolic	I-test
function	I-test
is	O
mildly	B-problem
depressed	I-problem
.	O

Right	B-test
ventricular	I-test
chamber	I-test
size	I-test
and	O
free	B-test
wall	I-test
motion	I-test
are	O
normal	O
.	O

The	O
descending	O
thoracic	O
aorta	O
is	O
mildly	B-problem
dilated	I-problem
.	O

There	O
are	O
simple	B-problem
atheroma	I-problem
in	I-problem
the	I-problem
descending	I-problem
thoracic	I-problem
aorta	I-problem
.	O

There	O
are	O
three	O
aortic	O
valve	O
leaflets	O
.	O

There	O
is	O
no	O
aortic	B-problem
valve	I-problem
stenosis	I-problem
.	O

No	O
aortic	B-problem
regurgitation	I-problem
is	O
seen	O
.	O

The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	B-problem
thickened	I-problem
.	O

Trivial	B-problem
mitral	I-problem
regurgitation	I-problem
is	O
seen	O
.	O

POST-BYPASS	B-treatment
:	O
LV	B-test
and	I-test
RV	I-test
function	I-test
is	O
unchanged	O
.	O

Aorta	O
is	O
unchanged	O
.	O

Other	O
findings	O
are	O
unchanged	O
.	O

CXR	B-test
10-30	O
:	O
Left	B-problem
lower	I-problem
lobe	I-problem
atelectasis	I-problem
has	O
partially	O
cleared	O
.	O

Upper	O
lungs	O
are	O
clear	O
.	O

Mild	B-problem
postoperative	I-problem
widening	I-problem
of	I-problem
the	I-problem
cardiomediastinal	I-problem
silhouette	I-problem
is	O
stable	O
.	O

No	O
pneumothorax	B-problem
.	O

2018-10-25	O
11:15	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
18.3	O
*#	O
RBC	B-test
-	O
3.42	O
*	O
Hgb	B-test
-	O
10.9	O
*	O
Hct	B-test
-	O
31.6	O
*	O
MCV	B-test
-	O
92	O
MCH	B-test
-	O
31.7	O
MCHC	B-test
-	O
34.4	O
RDW	B-test
-	O
13.3	O
Plt	B-test
Ct	I-test
-	O
134	O
*	O

2018-10-31	O
06:25	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
13.6	O
*	O
RBC	B-test
-	O
2.72	O
*	O
Hgb	B-test
-	O
8.6	O
*	O
Hct	B-test
-	O
24.6	O
*	O
MCV	B-test
-	O
91	O
MCH	B-test
-	O
31.7	O
MCHC	B-test
-	O
35.0	O
RDW	B-test
-	O
14.0	O
Plt	B-test
Ct	I-test
-	O
314	O

2018-10-25	O
11:15	O
AM	O
BLOOD	B-test
PT	B-test
-	O
13.3	O
*	O
PTT	B-test
-	O
30.0	O
INR(PT)	B-test
-	O
1.2	O
*	O

2018-10-29	O
06:50	O
AM	O
BLOOD	B-test
PT	B-test
-	O
11.9	O
INR(PT)	B-test
-	O
1.0	O

2018-10-25	O
12:36	O
PM	O
BLOOD	B-test
UreaN	B-test
-	O
17	O
Creat	B-test
-	O
0.7	O
Cl	B-test
-	O
111	O
*	O
HCO3	B-test
-	O
23	O

2018-10-31	O
06:25	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
91	O
UreaN	B-test
-	O
19	O
Creat	B-test
-	O
0.8	O
Na	B-test
-	O
134	O
K	B-test
-	O
4.0	O
Cl	B-test
-	O
98	O
HCO3	B-test
-	O
26	O
AnGap	B-test
-	O
14	O

Brief	O
Hospital	O
Course	O
:	O

Mr.	O
Kammerer	O
was	O
a	O
same	O
day	O
admit	O
and	O
on	O
10-25	O
was	O
brought	O
to	O
the	O
operating	O
room	O
where	O
he	O
underwent	O
a	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
x	O
3	O
.	O

Please	O
see	O
operative	O
report	O
for	O
surgical	O
details	O
.	O

He	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
and	O
was	O
transferred	O
to	O
the	O
CSRU	O
for	O
invasive	B-test
monitoring	I-test
in	O
stable	O
condition	O
.	O

Later	O
on	O
op	O
day	O
he	O
was	O
weaned	O
from	O
sedation	B-treatment
,	O
awoke	O
neurologically	O
intact	O
,	O
and	O

extubated	O
.	O

Beta	B-treatment
blockers	I-treatment
and	O
diuretics	B-treatment
were	O
initiated	O
on	O
post-op	O
day	O
one	O
.	O

He	O
was	O
diuresed	B-treatment
towards	O
his	B-test
pre-op	I-test
weight	I-test
.	O

He	O
appeared	O
to	O
be	O
doing	O
well	O
and	O
was	O
transferred	O
to	O
the	O
SDU	O
on	O
this	O
day	O
.	O

He	O
did	O
have	O
burst	B-problem
of	I-problem
atrial	I-problem
fibrillation	I-problem
and	O
was	O
started	O
on	O
a	B-treatment
Amiodarone	I-treatment
gtt	I-treatment
.	O

His	B-treatment
beta	I-treatment
blockers	I-treatment
were	O
also	O
titrated	O
for	O
maximal	B-treatment
BP	I-treatment
and	I-treatment
HR	I-treatment
control	I-treatment
.	O

Chest	B-treatment
tubes	I-treatment
were	O
removed	O
on	O
post-op	O
day	O
two	O
and	O
epicardial	B-treatment
pacing	I-treatment
wires	I-treatment
on	O
post-op	O
day	O
three	O
.	O

Over	O
the	O
next	O
several	O
days	O
he	O
continued	O
to	O
improve	O
his	O
ambulation	O
and	O
mobility	O
with	O
physical	B-treatment
therapy	I-treatment
.	O

He	O
had	O
no	O
further	B-problem
episodes	I-problem
of	I-problem
AFIB	I-problem
while	O
on	O
po	B-treatment
Amiodarone	I-treatment
.	O

On	O
post-op	O
day	O
five	O
he	O
appeared	O
to	O
have	O
left	B-problem
arm	I-problem
phlebitis	I-problem
and	O
was	O
started	O
on	O
antibiotics	B-treatment
.	O

He	O
was	O
discharged	O
home	O
on	O
post-op	O
day	O
six	O
with	O
antibiotics	B-treatment
and	O
appropriate	B-treatment
meds	I-treatment
.	O

He	O
will	O
have	O
VNA	B-treatment
services	I-treatment
and	O
make	O
the	O
appropriate	O
follow-up	O
appointments	O
.	O

Medications	O
on	O
Admission	O
:	O

Aspirin	B-treatment
81	O
mg	O
qd	O
,	O
Toprol	B-treatment
XL	O
50	O
mg	O
qd	O
,	O
MVI	B-treatment
,	O
Flexeril	B-treatment
10	O
mg	O
qhs	O
,	O
Plavix	B-treatment
75	O
mg	O
qd	O
(	O
last	O
on	O
10-18	O
)	O

Discharge	O
Medications	O
:	O

1.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
60	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O

2.	O
Aspirin	B-treatment
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
0	O
*	O

3.	O
Ranitidine	B-treatment
HCl	I-treatment
150	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

4.	O
Oxycodone	B-treatment
-	I-treatment
Acetaminophen	I-treatment
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-problem
.	O

Disp	O
:*	O
40	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

5.	O
Atorvastatin	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

6.	O
Amiodarone	B-treatment
200	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
):	O
please	O
take	O
400	O
mg	O
twice	O
a	O
day	O
until	O
11-02	O
then	O
decrease	O
to	O
400	O
mg	O
once	O
a	O
day	O
for	O
1	O
week	O
and	O
then	O
decrease	O
to	O
200	O
mg	O
once	O
a	O
day	O
.	O

Disp	O
:*	O
40	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

7.	O
Metoprolol	B-treatment
Succinate	I-treatment
50	O
mg	O
Tablet	O
Sustained	O
Release	O
24	O
HR	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
Sustained	O
Release	O
24	O
HR	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
Sustained	O
Release	O
24	O
HR	O
(s)*	O
Refills	O
:*	O
0	O
*	O

8.	O
Ferrous	B-treatment
Gluconate	I-treatment
300	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

9.	O
Ascorbic	B-treatment
Acid	I-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

10.	O
Cephalexin	B-treatment
500	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
for	O
6	O
days	O
:	O
please	O
complete	O
full	O
course	O
.	O

Disp	O
:*	O
24	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O

11.	O
Furosemide	B-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
for	O
2	O
weeks	O
.	O

Disp	O
:*	O
14	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

12.	O
Potassium	B-treatment
Chloride	I-treatment
10	O
mEq	O
Capsule	O
,	O
Sustained	O
Release	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Sustained	O
Release	O
PO	O
DAILY	O
(	O
Daily	O
)	O
for	O
2	O
weeks	O
.	O

Disp	O
:*	O
14	O
Capsule	O
,	O
Sustained	O
Release	O
(s)*	O
Refills	O
:*	O
0	O
*	O

13.	O
Lisinopril	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
15	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

Coronary	B-problem
artery	I-problem
disease	I-problem
s/p	O
Coronary	B-treatment
Artery	I-treatment
Bypass	I-treatment
Graft	I-treatment
x3	O

PMH	O
:	O
Carpal	B-problem
tunnel	I-problem
syndrome	I-problem
,	O
Hypertension	B-problem
,	O
Hyperlipidemia	B-problem
,	O
Arthritis	B-problem

Discharge	O
Condition	O
:	O

good	O

Discharge	O
Instructions	O
:	O

May	O
shower	O
,	O
no	O
baths	O
or	O
swimming	O

Monitor	O
wounds	B-problem
for	O
infection	B-problem
-	O
redness	B-problem
,	O
drainage	B-problem
,	O
or	O
increased	B-problem
pain	I-problem

Report	O
any	B-problem
fever	I-problem
greater	I-problem
than	I-problem
101	I-problem

Report	O
any	B-problem
weight	I-problem
gain	I-problem
of	O
greater	O
than	O
2	O
pounds	O
in	O
24	O
hours	O
or	O
5	O
pounds	O
in	O
a	O
week	O

No	O
creams	B-treatment
,	O
lotions	B-treatment
,	O
powders	B-treatment
,	O
or	O
ointments	B-treatment
to	O
incisions	B-problem

No	O
driving	O
for	O
approximately	O
one	O
month	O

No	O
lifting	O
more	O
than	O
10	O
pounds	O
for	O
10	O
weeks	O

Please	O
call	O
with	O
any	O
questions	O
or	O
concerns	O

Left	O
Arm	O
continue	O
with	O
elevation	B-treatment
,	O
ice	B-treatment
,	O
and	O
complete	O
all	B-treatment
antibiotics	I-treatment

Followup	O
Instructions	O
:	O

Dr	O
Day	O
in	O
4	O
weeks	O
((	O
469	O
)	O
587-0462	O
)	O
please	O
call	O
for	O
appointment	O

Dr	O
Miller	O
in	O
1	O
week	O
(	O
262-575-0600	O
)	O
please	O
call	O
for	O
appointment	O

Dr	O
Scott	O
Raines	O
in	O
2-3	O
weeks	O
please	O
call	O
for	O
appointment	O

Wound	O
check	O
appointment	O
4	O
East	O
as	O
instructed	O
by	O
nurse	O
(	O
280-5326	O
)	O

For	O
surgical	B-problem
incision	I-problem
and	O
left	O
arm	O

Craig	O
Douglas	O
MD	O
10-898	O

Completed	O
by	O
:	O
Reyes	O
Marengo	O
PA	O
80	O
-	O
BMD	O
2018-11-19	O
@	O
1536	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Jeffrey	O
Collins	O
on	O
:	O
WED	O
2018-11-21	O
9:28	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2011-03-10	O

Discharge	O
Date	O
:	O

2011-03-15	O

Date	O
of	O
Birth	O
:	O

1927-10-26	O

Sex	O
:	O

F	O

Service	O
:	O

Medford	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
an	O
83	O
year	O
old	O
woman	O
with	O
a	O
history	O
of	O
hypertension	B-problem
who	O
presents	O
with	O
slurred	B-problem
speech	I-problem
when	O
dehydrated	B-problem
.	O

She	O
has	O
paraplegia	B-problem
secondary	O
to	O
HTLV	B-problem
exposure	I-problem
while	O
on	O
vacation	O
in	O
the	O
Bahamas	O
six	O
years	O
ago	O
.	O

She	O
presented	O
with	O
three	O
days	O
of	O
general	B-problem
malaise	I-problem
,	O
nausea	B-problem
,	O
vomiting	B-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
cough	B-problem
productive	O
of	O
white	B-problem
sputum	I-problem
.	O

She	O
awoke	O
with	O
nausea	B-problem
on	O
the	O
day	O
of	O
admission	O
and	O
pleuritic	B-problem
chest	I-problem
pain	I-problem
.	O

She	O
reports	O
no	O
sick	O
contacts.	O

The	O
patient	O
has	O
some	B-problem
difficulty	I-problem
talking	O
and	O
grasping	O
right	O
hand	O
.	O

She	O
came	O
to	O
the	O
Emergency	O
Department	O
on	O
the	O
2011-03-10	O
,	O
with	O
temperature	B-test
of	O
99.0	O
F	O
.;	O
blood	B-test
pressure	I-test
of	O
97/50	O
;	O
heart	B-test
rate	I-test
100	O
;	O
respirations	B-test
27	O
;	O
O2	B-test
saturation	I-test
84%	O
on	O
room	O
air	O
and	O
94%	O
on	O
two	O
liters	O
.	O

The	O
patient	O
had	O
coarse	B-problem
rhonchi	I-problem
on	O
examination	B-test
.	O

Chest	B-test
x-ray	I-test
revealed	O
mild	B-problem
pulmonary	I-problem
edema	I-problem
.	O

Chest	B-test
CT	I-test
scan	I-test
was	O
negative	O
for	O
pulmonary	B-problem
embolism	I-problem
but	O
positive	O
for	O
consolidation	B-problem
.	O

She	O
was	O
started	O
on	O
Levofloxacin	B-treatment
but	O
the	O
patient	O
became	O
hypotensive	B-problem
at	O
that	O
point	O
with	O
blood	B-test
pressure	I-test
of	O
70/45	O
and	O
received	O
a	B-treatment
normal	I-treatment
saline	I-treatment
bolus	I-treatment
to	O
boost	O
her	B-test
blood	I-test
pressure	I-test
to	O
99/60	O
;	O
however	O
the	O
patient	O
was	O
admitted	O
to	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
for	O
overnight	B-test
observation	I-test
because	O
of	O
her	B-problem
somnolence	I-problem
and	O
hypotension	B-problem
.	O

She	O
was	O
transferred	O
to	O
the	O
Everett	O
Firm	O
on	O
the	O
2011-03-11	O
and	O
was	O
mentating	O
well	O
and	O
was	O
stable	O
for	O
transfer	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Positive	B-problem
lupus	I-problem
anti-coagulant	I-problem
.	O

2.	O
Basilar	B-problem
stenosis	I-problem
.	O

3.	O
Prior	B-problem
transient	I-problem
ischemic	I-problem
attacks	I-problem
.	O

4.	O
Right	B-treatment
medial	I-treatment
malleolus	I-treatment
repair	I-treatment
in	O
2004-08-05	O
.	O

5.	O
Paraplegia	B-problem
secondary	O
to	O
HTLV	B-problem
from	O
a	O
trip	O
to	O
the	O
Bahamas	O
five	O
to	O
six	O
years	O
ago	O
.	O

6.	O
Hypertension	B-problem
.	O

7.	O
Chronic	B-problem
diarrhea	I-problem
with	O
multiple	O
admissions	O
for	O
dehydration	B-problem
with	O
most	O
recent	O
one	O
on	O
2011-02-26	O
.	O

8.	O
Venous	B-problem
stasis	I-problem
.	O

9.	O
Depression	B-problem
.	O

10.	O
Seizure	B-problem
history	I-problem
on	O
Neurontin	B-treatment
.	O

11.	O
Left	B-treatment
CMED	I-treatment
cataract	I-treatment
surgery	I-treatment
in	O
2009-10-05	O
.	O

12.	O
Chronic	B-problem
muscle	I-problem
spasms	I-problem
.	O

ALLERGIES	O
:	O

Penicillin	B-treatment
for	O
which	O
she	O
reports	O
a	B-problem
rash	I-problem
and	O
dyspepsia	B-problem
when	O
taking	O
uncoated	B-treatment
aspirin	I-treatment
.	O

She	O
has	O
a	O
questionable	O
sensitivity	B-problem
to	O
iodine	B-treatment
.	O

MEDICATIONS	O
AS	O
OUTPATIENT	O
:	O

1.	O
Enteric-coated	B-treatment
aspirin	I-treatment
.	O

2.	O
Aggrenox	B-treatment
.	O

3.	O
Zanaflex	B-treatment
.	O

4.	O
Neurontin	B-treatment
300	O
mg	O
three	O
times	O
a	O
day	O
.	O

5.	O
Celexa	B-treatment
10	O
mg	O
daily	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	B-test
examination	I-test
she	O
was	O
a	O
well	O
developed	O
,	O
well	O
nourished	O
female	O
in	O
no	O
apparent	B-problem
distress	I-problem
.	O

She	O
was	O
alert	O
and	O
oriented	O
times	O
three	O
.	O

Speech	O
was	O
fluent	O
.	O

Her	O
lungs	O
revealed	O
coarse	B-problem
bilateral	I-problem
rhonchi	I-problem
from	O
base	O
to	O
midline	O
.	O

Cardiovascular	B-test
examination	I-test
is	O
notable	O
for	O
a	O
regular	O
rate	O
and	O
rhythm	O
;	O
no	O
murmurs	B-problem
,	O
rubs	B-problem
or	O
gallops	B-problem
.	O

Abdomen	O
is	O
soft	O
and	O
obese	B-problem
,	O
nontender	B-problem
.	O

Normal	O
bowel	O
sounds	O
present	O
.	O

Extremities	O
notable	O
for	O
two	B-problem
plus	I-problem
lower	I-problem
extremity	I-problem
edema	I-problem
and	O
the	O
ankles	O
were	O
noted	O
to	O
be	O
in	O
pressure	B-treatment
stockings	I-treatment
.	O

LABORATORY	O
:	O

White	B-test
blood	I-test
cell	I-test
count	I-test
were	O
11.8	O
,	O
hematocrit	B-test
31.5	O
,	O
platelets	B-test
151	O
.	O

Chem-7	B-test
was	O
a	B-test
sodium	I-test
of	O
140	O
,	O
potassium	B-test
of	O
3.0	O
,	O
chloride	B-test
108	O
,	O
bicarbonate	B-test
24	O
,	O
BUN	B-test
22	O
,	O
creatinine	B-test
1.0	O
and	O
glucose	B-test
117	O
.	O

The	O
patient	O
also	O
had	O
a	B-test
head	I-test
CT	I-test
scan	I-test
in	O
the	O
Emergency	O
Department	O
before	O
coming	O
to	O
the	O
Unit	O
which	O
reported	O
no	O
recent	B-problem
bleed	I-problem
and	O
no	O
change	B-problem
from	O
a	B-test
prior	I-test
CT	I-test
scan	I-test
done	O
on	O
2011-03-04	O
.	O

EKG	B-test
is	O
notable	O
for	O
sinus	B-problem
tachycardia	I-problem
at	O
100	O
beats	O
per	O
minute	O
,	O
normal	O
axis	O
.	O

.....	O
done	O
on	O
02-24	O
,	O
notable	O
for	O
mid-basilar	B-problem
artery	I-problem
high-grade	I-problem
stenosis	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

After	O
transfer	O
to	O
the	O
Floor	O
,	O
the	O
patient	O
was	O
continued	O
on	O
Levofloxacin	B-treatment
for	O
a	O
ten	O
to	O
14	O
day	O
course	O
for	O
presumptive	O
pneumonia	B-problem
.	O

Due	O
to	O
her	B-problem
chronic	I-problem
diarrhea	I-problem
she	O
was	O
repleted	O
with	O
intravenous	B-treatment
fluids	I-treatment
.	O

For	O
her	B-problem
depression	I-problem
,	O
continued	O
on	O
Citalopram	B-treatment
10	O
mg	O
daily	O
.	O

For	O
her	B-problem
paraplegia	I-problem
and	O
associated	O
muscle	B-problem
spasticity	I-problem
she	O
was	O
continued	O
on	O
her	B-treatment
Zanaflex	I-treatment
.	O

For	O
deep	B-treatment
vein	I-treatment
thrombosis	I-treatment
prophylaxis	I-treatment
she	O
was	O
treated	O
with	O
subcutaneous	B-treatment
heparin	I-treatment
and	O
for	O
gastrointestinal	B-treatment
prophylaxis	I-treatment
she	O
was	O
treated	O
with	O
Protonix	B-treatment
.	O

She	O
was	O
also	O
evaluated	O
by	O
Physical	B-treatment
Therapy	I-treatment
and	O
Speech	B-treatment
and	O
Swallow	B-treatment
because	O
of	O
some	O
report	O
of	O
dysphagia	B-problem
.	O

Physical	B-treatment
Therapy	I-treatment
felt	O
that	O
the	O
patient	O
was	O
cleared	O
for	O
transfer	O
home	O
with	O
services	O
.	O

Occupational	B-treatment
Therapy	I-treatment
was	O
also	O
in	O
agreement	O
with	O
the	O
patient	O
's	O
disposition	O
home	O
with	O
services	O
.	O

The	O
patient	O
was	O
able	O
to	O
advance	O
her	O
diet	O
well	O
from	O
liquids	O
to	O
solids	O
,	O
however	O
,	O
she	O
was	O
plagued	O
with	O
a	B-problem
persistent	I-problem
cough	I-problem
and	O
some	B-problem
low	I-problem
grade	I-problem
fevers	I-problem
to	O
99.0	O
F	O
.	O

Speech	B-treatment
and	O
Swallow	B-treatment
evaluated	O
the	O
patient	O
at	O
bedside	O
and	O
recommended	O
advancing	O
to	O
regular	O
diet	O
with	O
regular	O
consistency	O
and	O
saw	O
no	O
evidence	O
of	O
any	B-problem
dysphagia	I-problem
.	O

There	O
was	O
some	O
question	O
regarding	O
restarting	O
of	O
the	B-treatment
patient	I-treatment
's	I-treatment
Coumadin	I-treatment
given	O
her	B-problem
positive	I-problem
lupus	I-problem
anti-coagulant	I-problem
status	I-problem
as	O
well	O
as	O
the	O
presence	O
of	O
her	B-problem
basilar	I-problem
artery	I-problem
stenosis	I-problem
.	O

The	O
patient	O
was	O
discharged	O
on	O
the	O
2011-03-15	O
on	O
the	B-treatment
following	I-treatment
medications	I-treatment
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Levofloxacin	B-treatment
250	O
mg	O
q.	O
day	O
for	O
ten	O
days	O
.	O

2.	O
Aspirin	B-treatment
/	O
dipyridamole	B-treatment
25/200	O
mg	O
capsules	O
taken	O
two	O
times	O
a	O
day	O
.	O

3.	O
Neurontin	B-treatment
300	O
mg	O
taken	O
three	O
times	O
a	O
day	O
.	O

4.	O
Subcutaneous	B-treatment
heparin	I-treatment
taken	O
5000	O
units	O
twice	O
a	O
day	O
.	O

5.	O
Albuterol	B-treatment
multiple	I-treatment
dose	I-treatment
inhalers	I-treatment
,	O
one	O
to	O
two	O
puffs	O
q.	O
six	O
hours	O
as	O
needed	O
.	O

6.	O
Atrovent	B-treatment
multiple	I-treatment
dose	I-treatment
inhalers	I-treatment
,	O
one	O
to	O
two	O
puffs	O
q.	O
six	O
hours	O
as	O
needed	O
.	O

7.	O
Citalopram	B-treatment
10	O
mg	O
q.	O
day	O
.	O

8.	O
Lisinopril	B-treatment
2.5	O
mg	O
once	O
a	O
day	O
.	O

9.	O
Trazodone	B-treatment
25	O
mg	O
q.	O
h.s.	O
p.r.n.	O

10.	O
Protonix	B-treatment
40	O
mg	O
q.	O
day	O
.	O

11.	O
Zanaflex	B-treatment
2	O
mg	O
twice	O
a	O
day	O
.	O

12.	O
Tylenol	B-treatment
325	O
mg	O
,	O
one	O
to	O
two	O
tablets	O
q.	O
four	O
to	O
six	O
hours	O
p.r.n.	O

13.	O
The	O
patient	O
was	O
also	O
discharged	O
with	O
the	O
restarting	O
of	O
warfarin	B-treatment
2	O
mg	O
daily	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

1.	O
She	O
was	O
instructed	O
to	O
have	O
blood	B-test
drawn	O
by	O
the	O
Visiting	O
Nurses	O
Association	O
the	O
day	O
after	O
discharge	O
and	O
then	O
a	O
few	O
days	O
after	O
discharge	O
the	O
same	O
week	O
to	O
have	O
INR	B-test
.	O

Will	O
also	O
have	O
INR	B-test
checked	O
at	O
once	O
weekly	O
until	O
target	O
of	O
INR	B-test
of	O
2.0	O
to	O
3.0	O
is	O
reached	O
.	O

2.	O
The	O
patient	O
was	O
instructed	O
to	O
contact	O
Dr.	O
Ralph	O
at	O
(	O
428	O
)	O
678-6930	O
,	O
who	O
is	O
covering	O
for	O
her	O
primary	O
care	O
physician	O
,	O
Dr.	O
Erika	O
Witt	O
,	O
to	O
adjust	O
her	B-treatment
dosages	I-treatment
based	O
on	O
the	B-test
INR	I-test
levels	I-test
.	O

3.	O
The	O
patient	O
also	O
had	O
a	O
Gastrointestinal	O
Clinic	O
follow-up	O
on	O
2011-03-28	O
.	O

She	O
is	O
to	O
follow-up	O
with	O
Dr.	O
Geraldo	O
Davis	O
.	O

4.	O
She	O
was	O
also	O
instructed	O
to	O
follow-up	O
with	O
Dr.	O
Reid	O
from	O
Neurology	O
within	O
a	O
month	O
at	O
(	O
382	O
)	O
716	O
4151	O
,	O
given	O
her	B-problem
neurological	I-problem
deficits	I-problem
during	O
this	O
presentation	O
.	O

Brenda	O
L.	O
Nelson	O
,	O
M.D.	O

Dictated	O
By	O
:	O
Rodolfo	O
X	O
Gifford	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2011-04-18	O
16:17	O

T	O
:	O
2011-04-18	O
22:11	O

JOB	O
#:	O

46153	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Dorothy	O
Donahue	O
on	O
:	O
TUE	O
2011-04-19	O
3:15	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2012-11-06	O

Discharge	O
Date	O
:	O

2012-11-11	O

Date	O
of	O
Birth	O
:	O

1965-09-22	O

Sex	O
:	O

M	O

Service	O
:	O

CCU	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
47	O
-	O
year-old	O
male	O
with	O
a	O
past	O
medical	O
history	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
status	B-treatment
post	I-treatment
2-vessel	I-treatment
percutaneous	I-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
in	O
2005	O
,	O
3-vessel	B-treatment
percutaneous	I-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
in	O
2009	O
,	O
hypertension	B-problem
,	O
new	B-problem
onset	I-problem
type	I-problem
2	I-problem
diabetes	I-problem
,	O
and	O
hypercholesterolemia	B-problem
who	O
presents	O
with	O
the	O
sudden	O
onset	O
of	O
substernal	B-problem
chest	I-problem
pain	I-problem
status	O
post	O
exercise	O
.	O

The	O
patient	O
presented	O
to	O
Bournewood	O
Hospital	O
on	O
the	O
morning	O
of	O
admission	O
with	O
a	O
chief	O
complaint	O
of	O
substernal	B-problem
burning	I-problem
without	O
radiation	O
which	O
developed	O
while	O
doing	O
exercise	O
.	O

Of	O
note	O
,	O
this	O
is	O
the	O
second	O
time	O
the	O
patient	O
has	O
exercised	O
in	O
many	O
months	O
.	O

The	B-problem
pain	I-problem
became	O
worse	O
over	O
the	O
next	O
few	O
minutes	O
to	O
07-12	O
and	O
increased	O
to	O
10-12	O
while	O
he	O
was	O
in	O
the	O
ambulance	O
.	O

His	B-treatment
nitroglycerin	I-treatment
patch	I-treatment
did	O
not	O
help	O
,	O
and	O
he	O
only	O
had	O
slight	O
relief	O
with	O
sublingual	B-treatment
nitroglycerin	I-treatment
times	O
three	O
.	O

In	O
addition	O
,	O
he	O
had	O
slight	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
but	O
denies	O
headache	B-problem
,	O
change	B-problem
in	I-problem
vision	I-problem
,	O
dizziness	B-problem
,	O
nausea	B-problem
,	O
vomiting	B-problem
,	O
abdominal	B-problem
pain	I-problem
,	O
change	B-problem
in	I-problem
bowel	I-problem
or	I-problem
urinary	I-problem
habits	I-problem
,	O
or	O
fevers	B-problem
,	O
chills	B-problem
,	O
and	O
sweats	B-problem
.	O

Of	O
note	O
,	O
he	O
had	O
a	O
negative	O
stress	O
test	O
in	O
2012-07-03	O
.	O

He	O
was	O
sent	O
to	O
Bournewood	O
Hospital	O
via	O
ambulance	O
.	O

In	O
the	O
Emergency	O
Department	O
he	O
received	O
aspirin	B-treatment
,	O
nitroglycerin	B-treatment
drip	I-treatment
,	O
heparin	B-treatment
drip	I-treatment
,	O
Dilaudid	B-treatment
,	O
and	O
TNK	B-treatment
with	O
decreased	O
in	O
his	B-problem
pain	I-problem
but	O
without	O
resolution	O
of	O
symptoms	B-problem
.	O

Electrocardiogram	B-test
at	O
that	O
time	O
showed	O
ST	B-problem
elevations	I-problem
and	O
J	B-problem
point	I-problem
elevations	I-problem
in	I-problem
V2	I-problem
through	I-problem
V4	I-problem
.	O

The	O
patient	O
was	O
transferred	O
to	O
Sturdy	O
Memorial	O
where	O
he	O
underwent	O
catheterization	B-test
.	O

Catheterization	B-test
results	I-test
showed	O
100%	B-problem
occlusion	I-problem
of	I-problem
the	I-problem
proximal	I-problem
left	I-problem
anterior	I-problem
descending	I-problem
artery	I-problem
and	O
50%	B-problem
stenosis	I-problem
of	I-problem
first	I-problem
diagonal	I-problem
.	O

Angio-Jet	B-treatment
percutaneous	I-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
and	O
stenting	B-treatment
was	O
performed	O
on	O
proximal	O
left	O
anterior	O
descending	O
artery	O
and	O
the	B-treatment
percutaneous	I-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
was	O
performed	O
on	O
first	O
diagonal	O
with	O
good	O
results	O
.	O

An	B-treatment
intra-aortic	I-treatment
balloon	I-treatment
pump	I-treatment
was	O
placed	O
at	O
this	O
time	O
as	O
well	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
;	O
the	O
patient	O
is	O
status	B-treatment
post	I-treatment
percutaneous	I-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
times	O
three	O
in	O
2009	O
at	O
Clinton	O
Hospital	O
;	O
the	O
patient	O
is	O
status	B-treatment
post	I-treatment
percutaneous	I-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
times	O
two	O
in	O
2005	O
at	O
Waltham/Weston	O
Hospital	O
.	O

2.	O
Type	B-problem
2	I-problem
diabetes	I-problem
.	O

3.	O
Hypercholesterolemia	B-problem
.	O

4.	O
Hypertension	B-problem
.	O

FAMILY	O
HISTORY	O
:	O

The	O
patient	O
's	O
father	O
died	O
of	O
a	B-problem
myocardial	I-problem
infarction	I-problem
at	O
age	O
40	O
,	O
and	O
a	O
brother	O
who	O
died	O
of	O
a	B-problem
myocardial	I-problem
infarction	I-problem
at	O
age	O
40	O
.	O

SOCIAL	O
HISTORY	O
:	O

No	O
ethanol	O
use	O
.	O

No	O
tobacco	O
at	O
this	O
time	O
;	O
he	O
quit	O
20	O
years	O
ago	O
.	O

The	O
patient	O
is	O
married	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Diltiazem	B-treatment
180	O
mg	O
p.o.	O
q.d.	O
,	O
Lipitor	B-treatment
10	O
mg	O
p.o.	O
q.d.	O
,	O
Glyset	B-treatment
25	O
mg	O
p.o.	O
q.d.	O
,	O
Prevacid	B-treatment
30	O
mg	O
p.o.	O
q.d.	O
,	O
metoprolol	B-treatment
50	O
mg	O
p.o.	O
b.i.d.	O
,	O
Glucophage	B-treatment
500	O
mg	O
p.o.	O
q.d.	O

ALLERGIES	O
:	O

Allergies	B-problem
included	O
PENICILLIN	B-treatment
and	O
IODINE	B-treatment
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION	O
:	O

Temperature	B-test
maximum	I-test
98.7	O
,	O
temperature	B-test
current	I-test
98.3	O
,	O
pulse	B-test
ranged	O
from	O
82	O
to	O
92	O
,	O
blood	B-test
pressure	I-test
104	O
to	O
124/67	O
to	O
74	O
with	O
a	O
mean	O
of	O
86	O
to	O
99	O
,	O
respiratory	B-test
rate	I-test
of	O
11	O
to	O
16	O
,	O
oxygen	B-test
saturation	I-test
94%	O
to	O
98%	O
on	O
2	O
liters	O
.	O

Pulmonary	B-test
artery	I-test
pressure	I-test
was	O
29/15	O
with	O
a	O
mean	O
of	O
22	O
.	O

Cardiac	B-test
output	I-test
was	O
7	O
(	O
that	O
was	O
on	O
6	O
of	O
dopamine	B-treatment
)	O
.	O

Intra-aortic	B-test
balloon	I-test
pump	I-test
augmented	I-test
systole	I-test
was	O
109	O
,	O
augmented	B-test
diastole	I-test
was	O
111	O
.	O

The	O
patient	O
was	O
lying	O
flat	O
in	O
no	O
apparent	B-problem
distress	I-problem
.	O

HEENT	O
revealed	O
extraocular	O
movements	O
were	O
intact	O
.	O

Pupils	O
were	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
and	O
accommodation	O
.	O

The	O
oropharynx	O
was	O
clear	O
with	O
moist	O
mucosa	O
.	O

Neck	O
was	O
supple	O
.	O

No	O
lymphadenopathy	B-problem
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	B-test
bilaterally	O
,	O
anteriorly	O
and	O
laterally	O
.	O

Cardiovascular	O
revealed	O
jugular	B-problem
venous	I-problem
distention	I-problem
not	O
appreciated	O
.	O

Carotids	O
had	O
normal	O
upstroke	O
and	O
normal	O
volume	O
with	O
bilateral	B-problem
bruits	I-problem
.	O

A	O
regular	O
rate	O
.	O

Normal	O
S1	O
and	O
S2	O
.	O

No	O
S3	B-problem
or	O
S4	B-problem
.	O

No	O
murmurs	B-problem
,	O
rubs	B-problem
or	O
gallops	B-problem
.	O

Abdomen	O
had	O
decreased	B-problem
bowel	I-problem
sounds	I-problem
,	O
soft	O
,	O
nontender	B-problem
,	O
and	O
nondistended	B-problem
.	O

No	O
hepatosplenomegaly	B-problem
.	O

Liver	O
was	O
about	O
5	O
cm	O
.	O

Extremities	O
had	O
no	O
edema	B-problem
.	O

The	O
right	O
groin	O
revealed	O
intra-aortic	B-treatment
balloon	I-treatment
pump	I-treatment
site	O
and	O
pulmonary	B-treatment
artery	I-treatment
catheterization	I-treatment
site	O
were	O
clean	O
,	O
dry	O
and	O
intact	O
without	O
tenderness	B-problem
.	O

Dorsalis	B-test
pedis	I-test
pulses	I-test
were	O
2+	O
bilaterally	O
.	O

Neurologic	B-test
examination	I-test
revealed	O
alert	O
and	O
oriented	O
times	O
three	O
.	O

Cranial	O
nerves	O
II	O
through	O
XII	O
were	O
intact	O
.	O

LABORATORY	O
DATA	O
ON	O
ADMISSION	O
:	O

Laboratories	B-test
on	O
admission	O
revealed	O
white	B-test
count	I-test
7.8	O
,	O
hematocrit	B-test
was	O
41.7	O
,	O
platelets	B-test
of	O
252	O
,	O
MCV	B-test
89	O
,	O
RDW	B-test
12.7	O
.	O

Chem-7	B-test
revealed	O
sodium	B-test
of	O
136	O
,	O
potassium	B-test
4.7	O
,	O
chloride	B-test
103	O
,	O
bicarbonate	B-test
22	O
,	O
BUN	B-test
16	O
,	O
creatinine	B-test
0.8	O
,	O
glucose	B-test
284	O
.	O

PT	B-test
14.2	O
,	O
PTT	B-test
108.5	O
,	O
INR	B-test
1.3	O
.	O

Creatine	B-test
kinase	I-test
at	O
11	O
a.m.	O
was	O
83	O
,	O
at	O
5	O
p.m.	O
was	O
3021	O
.	O

Arterial	B-test
blood	I-test
gas	I-test
at	O
11	O
a.m.	O
was	O
7.33/46/115	O
.	O

Creatine	B-test
kinases	I-test
trended	O
from	O
11:15	O
on	O
the	O
day	O
of	O
admission	O
from	O
83	O
to	O
3021	O
at	O
5	O
p.m.	O
to	O
3450	O
at	O
11	O
p.m.	O
,	O
to	O
1734	O
at	O
5:30	O
a.m.	O
on	O
11-07	O
,	O
to	O
1277	O
at	O
11:30	O
a.m.	O
on	O
11-07	O
,	O
to	O
83	O
at	O
9:30	O
a.m.	O
on	O
11-11	O
.	O

RADIOLOGY	O
/	O
IMAGING	O
:	O

Electrocardiogram	B-test
post	O
catheterization	B-test
showed	O
continued	B-problem
ST	I-problem
elevations	I-problem
and	O
J	B-problem
point	I-problem
elevations	I-problem
in	I-problem
V2	I-problem
through	I-problem
V3	I-problem
.	O

Post	B-test
catheterization	I-test
echocardiogram	I-test
showed	O
an	B-test
ejection	I-test
fraction	I-test
of	O
30%	O
,	O
moderate	B-problem
systolic	I-problem
dysfunction	I-problem
,	O
basal	B-problem
anterior	I-problem
hypokinesis	I-problem
,	O
mid	B-problem
anterior	I-problem
akinesis	I-problem
,	O
basal	B-problem
anteroseptal	I-problem
hypokinesis	I-problem
,	O
mid	B-problem
anteroseptal	I-problem
akinesis	I-problem
.	O

Anterior	B-problem
apex	I-problem
akinesis	I-problem
,	O
inferior	B-problem
apex	I-problem
akinesis	I-problem
,	O
and	O
apex	B-problem
akinesis	I-problem
.	O

The	O
was	O
trace	B-problem
mitral	I-problem
regurgitation	I-problem
and	O
trace	B-problem
tricuspid	I-problem
regurgitation	I-problem
.	O

IMPRESSION	O
:	O

This	O
is	O
a	O
47	O
-	O
year-old	O
male	O
with	O
a	O
past	O
medical	O
history	O
of	O
type	B-problem
2	I-problem
diabetes	I-problem
,	O
high	B-problem
cholesterol	I-problem
,	O
hypertension	B-problem
,	O
and	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
status	B-treatment
post	I-treatment
percutaneous	I-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
times	O
two	O
,	O
who	O
presented	O
with	O
acute	B-problem
coronary	I-problem
syndrome	I-problem
refractory	O
to	O
medical	B-treatment
treatment	I-treatment
and	O
TNK	B-treatment
,	O
now	O
status	B-treatment
post	I-treatment
Angio-Jet	I-treatment
percutaneous	I-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
and	O
stent	B-treatment
of	I-treatment
proximal	I-treatment
left	I-treatment
anterior	I-treatment
descending	I-treatment
artery	I-treatment
and	O
percutaneous	B-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
of	O
first	O
diagonal	O
with	O
intra-aortic	B-treatment
balloon	I-treatment
pump	I-treatment
placement	I-treatment
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
Mass.	O
Mental	O
Health	O
Center	O
hospital	O
course	O
was	O
unremarkable	O
.	O

Dopamine	B-treatment
was	O
discontinued	O
on	O
day	O
one	O
.	O

The	B-treatment
intra-aortic	I-treatment
balloon	I-treatment
pump	I-treatment
was	O
discontinued	O
on	O
day	O
two	O
.	O

The	O
patient	O
was	O
continued	O
on	O
heparin	B-treatment
throughout	O
his	O
hospital	O
course	O
and	O
transitioned	O
to	O
Coumadin	B-treatment
on	O
hospital	O
day	O
four	O
.	O

The	O
patient	O
was	O
continued	O
on	O
Lipitor	B-treatment
and	O
aspirin	B-treatment
,	O
and	O
Plavix	B-treatment
was	O
added	O
and	O
will	O
be	O
continued	O
for	O
30	O
days	O
post	O
catheterization	B-test
.	O

The	O
patient	O
was	O
continued	O
on	O
Lopressor	B-treatment
and	O
captopril	B-treatment
throughout	O
his	O
hospital	O
course	O
,	O
and	O
changed	O
to	O

Zestril	B-treatment
10	O
mg	O
q.d.	O
and	O
atenolol	B-treatment
25	O
mg	O
q.d.	O
at	O
discharge	O
.	O

The	O
patient	O
was	O
discharged	O
to	O
the	O
medical	O
floor	O
on	O
hospital	O
day	O
three	O
and	O
discharged	O
from	O
the	O
hospital	O
once	O
his	B-test
INR	I-test
was	O
within	O
the	O
2	O
to	O
2.5	O
range	O
.	O

CONDITION	O
AT	O
DISCHARGE	O
:	O

The	O
patient	O
's	O
condition	O
on	O
discharge	O
was	O
stable	O
.	O

DISCHARGE	O
STATUS	O
:	O

He	O
was	O
discharged	O
home	O
.	O

DISCHARGE	O
FOLLOWUP	O
:	O

Instructions	O
to	O
follow	O
up	O
with	O
his	O
primary	O
care	O
physician	O
on	O
the	O
Heather	O
after	O
discharge	O
.	O

Primary	O
care	O
physician	O
was	O
to	O
check	O
INR	B-test
and	O
titrate	O
Zestril	B-treatment
up	O
and	O
atenolol	B-treatment
as	O
tolerated	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Lipitor	B-treatment
10	O
mg	O
p.o.	O
q.d.	O

2.	O
Aspirin	B-treatment
325	O
mg	O
p.o.	O
q.d.	O

3.	O
Plavix	B-treatment
75	O
mg	O
p.o.	O
q.d.	O
times	O
30	O
days	O
.	O

4.	O
Prevacid	B-treatment
30	O
mg	O
p.o.	O
q.d.	O

5.	O
Atenolol	B-treatment
25	O
mg	O
p.o.	O
q.d.	O

6.	O
Zestril	B-treatment
10	O
mg	O
p.o.	O
q.d.	O

7.	O
Glyset	B-treatment
25	O
mg	O
p.o.	O
q.d.	O

8.	O
Glucophage	B-treatment
500	O
mg	O
p.o.	O
q.d.	O

9.	O
Coumadin	B-treatment
5	O
mg	O
p.o.	O
q.d.	O

Tina	O
Squillace	O
,	O
M.D.	O
30-977	O

Dictated	O
By	O
:	O
Lloyd	O
U.	O
King	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2012-11-12	O
21:57	O

T	O
:	O
2012-11-15	O
14:05	O

JOB	O
#	O
:	O
15711	O

cc	O
:	O
Beau	O
J.	O
Box	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2017-09-03	O

Discharge	O
Date	O
:	O

2017-10-10	O

Date	O
of	O
Birth	O
:	O

1946-12-27	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	B-treatment

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	I-problem
Drugs	I-problem

Attending	O
:	O
Donald	O
R	O
Virgil	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Shortness	B-problem
of	I-problem
Breath	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Endotracheal	B-treatment
Intubation	I-treatment

Central	B-treatment
Venous	I-treatment
Catheter	I-treatment
and	O
Swan	B-treatment
Ganz	I-treatment
catheter	I-treatment
placement	I-treatment

Arterial	B-treatment
Line	I-treatment
Placement	I-treatment

Right	B-treatment
sided	I-treatment
thoracentesis	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

70	O
y/o	O
male	O
with	O
h/o	O
CAD	B-problem
s/p	B-treatment
LAD	I-treatment
PTCA	I-treatment
33	O
yrs	O
ago	O
,	O
COPD	B-problem
,	O
T2DM	B-problem
,	O
and	O
AICD	B-problem
pocket	I-problem
infection	I-problem
who	O
presented	O
to	O
the	O
Juan	O
on	O
2017-09-03	O
with	O
worsening	B-problem
SOB	I-problem
x	O
5	O
days	O
and	O
feeling	O
"	O
cloudy	O
."	O

The	O
patient	O
was	O
currently	O
at	O
Hubbard	O
Regional	O
Hospital	O
and	O
began	O
to	O
develop	O
worsening	B-problem
SOB	I-problem
for	O
the	O
past	O
5	O
days	O
.	O

This	O
AM	O
while	O
talking	O
with	O
his	O
daughter	O
on	O
the	O
phone	O
,	O
he	O
was	O
noted	O
to	O
desaturate	O
into	O
the	O
high	O
80s	O
and	O
he	O
was	O
brought	O
to	O
the	O
The	O
Hospital	O
for	O
Orthopedics	O
Juan	O
for	O
further	B-test
evaluation	I-test
.	O

The	O
patient	O
states	O
that	O
he	O
has	O
felt	O
"	O
cloudy	B-problem
"	O
of	O
late	O
which	O
seems	O
to	O
relate	O
to	O
his	B-problem
worsening	I-problem
SOB	I-problem
.	O

He	O
is	O
not	O
ambulatory	O
and	O
is	O
very	B-problem
deconditioned	I-problem
secondary	O
to	O
several	B-problem
complications	I-problem
within	O
the	O
past	O
two	O
months	O
related	O
to	O
an	B-problem
AICD	I-problem
pocket	I-problem
infection	I-problem
.	O

He	O
denies	O
any	B-problem
CP	I-problem
,	O
N/V/D	B-problem
,	O
abdominal	B-problem
pain	I-problem
,	O
or	O
HA	B-problem
.	O

He	O
states	O
that	O
he	O
only	O
uses	O
one	O
pillow	O
to	O
sleep	O
but	O
admits	O
to	O
sleeping	O
at	O
about	O
30	O
degrees	O
at	O
rehab	O
.	O

In	O
the	O
Juan	O
,	O
his	B-test
VS	I-test
were	O
97.8	O
150/80	O
88	O
12	O
89-94%	O
3L	B-treatment
NC	I-treatment
.	O

He	O
was	O
given	O
Percocet	B-treatment
for	O
back	B-problem
pain	I-problem
,	O
Lasix	B-treatment
80	O
mg	O
IV	O
,	O
and	O
Combivent	B-treatment
neb	I-treatment
.	O

For	O
unclear	O
reasons	O
,	O
he	O
was	O
placed	O
on	O
a	B-treatment
NRB	I-treatment
in	O
the	O
Juan	O
.	O

Upon	O
arrival	O
to	O
the	O
CCU	O
,	O
he	O
was	O
hemodynamically	O
stable	O
.	O

He	O
was	O
quickly	O
weaned	O
to	O
3L	B-treatment
O2	I-treatment
via	O
NC	B-treatment
,	O
O2	B-test
sats	I-test
100%	O
.	O

Past	O
Medical	O
History	O
:	O

-	O
AICD	B-problem
Pocket	I-problem
infection	I-problem
c/b	O
MSSA	B-problem
bacteremia	I-problem
,	O
pericardial	B-problem
effusion	I-problem
s/p	B-test
mediastinal	I-test
exploration	I-test
,	O
evacuation	B-treatment
of	O
pericardial	B-problem
effusion	I-problem
&	O
hematoma	B-problem
(	O
2017-07-24	O
)	O

-	O
Ischemic	B-problem
colitis	I-problem
and	O
ischemic	B-problem
liver	I-problem
2017-06-22	O
(	O
post	O
air	B-problem
embolism	I-problem
from	O
post	O
mediastinal	B-test
exploration	I-test
)	O

-	O
CAD	B-problem
s/p	B-treatment
LAD	I-treatment
PTCA	I-treatment
33	O
years	O
ago	O

-	O
T2DM	B-problem
c/b	O
neuropathy	B-problem
and	O
nephropathy	B-problem

-	O
COPD	B-problem

-	O
Hypothyroidism	B-problem

-	O
CVA	B-problem

-	O
s/p	B-treatment
Bovine	I-treatment
AVR	I-treatment
1999	O

-	O
Hyperlipidemia	B-problem

-	O
GERD	B-problem

-	O
Chronic	B-problem
LBP	I-problem

-	O
Lumbar	B-problem
sympathectomy	I-problem

Social	O
History	O
:	O

The	O
patient	O
is	O
a	O
retired	O
truck	O
driver	O
.	O

He	O
is	O
currently	O
married	O
,	O
has	O
10	O
children	O
.	O

No	O
smoking	O
for	O
last	O
5	O
years	O
.	O

Prior	O
to	O
that	O
smoked	O
2	O
packs	O
a	O
day	O
.	O

No	O
EtOH	O
or	O
IVDU	O
.	O

Family	O
History	O
:	O

Sister	O
with	O
diabetes	B-problem
.	O

No	O
other	O
known	O
family	O
hx	O
.	O

Physical	O
Exam	O
:	O

Vitals	O
:	O

97.6	O
95/48	O
71	O
98%	O
4L	B-treatment
NC	I-treatment

General	O
:	O

Oriented	O
to	O
person	O
and	O
time	O
.	O

Slight	B-problem
confustion	I-problem
with	O
place	O
but	O
oriented	O
with	O
some	O
re-direction	O
.	O

HEENT	O
:	O

NC/AT	O
.	O

MM	O
dry	O
.	O

OP	O
clear	O
.	O

PERRLA	O
.	O

EOMI	O
.	O

Neck	O
:	O

JVD	B-problem
difficult	O
to	O
access	O
02-23	O
increased	B-problem
neck	I-problem
girth	I-problem
.	O

CV	O
:	O

S1	O
,	O
S2	O
with	O
Grade	B-problem
II/VI	I-problem
SEM	I-problem
.	O
+S3	B-problem
.	O

Pulm	O
:	O

Crackles	B-problem
halfway	I-problem
up	I-problem
lung	I-problem
fields	I-problem
B/L	I-problem
.	O

Abd	O
:	O

Soft	O
,	O
NT/ND	B-problem
with	O
normoactive	O
BS	O
.	O

Ext	O
:	O

2+	O
pitting	B-problem
edema	I-problem
to	I-problem
knees	I-problem
B/L	I-problem
.	O

Pertinent	O
Results	O
:	O

Admission	O
Labs	O
:	O

2017-09-03	O
PT	B-test
-	O
13.8	O
*	O
PTT	B-test
-	O
33.1	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
1.2	O
*	O

2017-09-03	O
PLT	B-test
COUNT	I-test
-	O
124	O
*	O

2017-09-03	O
HYPOCHROM	B-test
-	O
2+	O
ANISOCYT	B-test
-	O
1+	O
MACROCYT	B-test
-	O
2+	O

2017-09-03	O
NEUTS	B-test
-	O
79.5	O
*	O
LYMPHS	B-test
-	O
9.9	O
*	O
MONOS	B-test
-	O
4.9	O
EOS	B-test
-	O
5.4	O
*	O
BASOS	B-test
-	O
0.2	O

2017-09-03	O
WBC	B-test
-	O
9.1	O
RBC	B-test
-	O
2.77	O
*	O
HGB	B-test
-	O
8.8	O
*	O
HCT	B-test
-	O
27.2	O
*	O
MCV	B-test
-	O
99	O
*	O
MCH	B-test
-	O
31.9	O
MCHC	B-test
-	O
32.4	O
RDW	B-test
-	O
18.0	O
*	O

2017-09-03	O
CK	B-test
-	I-test
MB	I-test
-	O
Not	O
Done	O
proBNP	B-test
-	O
2656	O
*	O

2017-09-03	O
CK	B-test
(	I-test
CPK	I-test
)-	I-test
16	O
*	O

2017-09-03	O
GLUCOSE	B-test
-	O
206	O
*	O
UREA	B-test
N	I-test
-	O
28	O
*	O
CREAT	B-test
-	O
1.8	O
*	O
SODIUM	B-test
-	O
135	O
POTASSIUM	B-test
-	O
4.1	O
CHLORIDE	B-test
-	O
85	O
*	O
TOTAL	B-test
CO2	I-test
-	O
42	O
*	O
ANION	B-test
GAP	I-test
-	O
12	O

2017-09-03	O
CK	B-test
-	I-test
MB	I-test
-	O
Not	O
Done	O
cTropnT	B-test
-	O
0.22	O
*	O

2017-09-03	O
CK	B-test
(	I-test
CPK	I-test
)-	I-test
38	O

Discharge	O
Labs	O
:	O

2017-10-10	O
:	O

INR	B-test
3.5	O
,	O
PT	B-test
32.5	O
,	O
PTT	B-test
41	O

Imaging	O
Studies	O
:	O

1.	O
CXR	B-test
(	I-test
PA/Lateral	I-test
)	I-test
2017-09-03	O

Congestive	B-problem
heart	I-problem
failure	I-problem
with	O
bilateral	B-problem
effusions	I-problem
(	O
R	O
>	O
L	O
)	O
,	O
with	O
possible	O
underlying	B-problem
consolidation	I-problem
in	I-problem
the	I-problem
RLL	I-problem
and	O
to	O
a	O
lesser	O
degree	O
the	O
RML	O
and	O
LLL	O
.	O

2.	O
CXR	B-test
2017-09-04	O

Compared	O
to	O
PA	B-test
and	I-test
lateral	I-test
chest	I-test
of	O
the	O
prior	O
day	O
.	O

Right-sided	B-treatment
PICC	I-treatment
line	I-treatment
with	O
its	O
tip	O
in	O
the	O
distal	O
SVC	O
.	O

The	O
heart	O
is	O
markedly	B-problem
enlarged	I-problem
.	O

There	O
remains	O
a	B-problem
large	I-problem
right	I-problem
and	I-problem
small	I-problem
left	I-problem
pleural	I-problem
effusion	I-problem
,	O
not	O
significantly	O
changed	O
.	O

Patient	O
remains	O
in	O
congestive	B-problem
heart	I-problem
failure	I-problem
,	O
though	O
it	O
may	O
be	O
slightly	O
improved	O
compared	O
to	O
the	B-test
prior	I-test
study	I-test
.	O

Underlying	B-problem
infectious	I-problem
consolidation	I-problem
in	I-problem
the	I-problem
right	I-problem
lower	I-problem
lobe	I-problem
not	O
excluded	O
.	O

3.	O
Echo	B-test
2017-09-04	O

The	O
left	O
atrium	O
is	O
mildly	B-problem
dilated	I-problem
.	O

There	O
is	O
mild	B-problem
symmetric	I-problem
left	I-problem
ventricular	I-problem
hypertrophy	I-problem
.	O

The	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

LV	B-test
systolic	I-test
function	I-test
appears	O
depressed	B-problem
.	O

Resting	B-problem
regional	I-problem
wall	I-problem
motion	I-problem
abnormalities	I-problem
include	O
inferior	B-problem
and	I-problem
inferolateral	I-problem
hypokinesis	I-problem
.	O

Right	O
ventricular	O
chamber	O
size	O
is	O
normal	O
and	O
free	O
wall	O
motion	O
may	O
be	O
mildly	B-problem
impaired	I-problem
.	O

The	O
aortic	O
root	O
is	O
mildly	B-problem
dilated	I-problem
.	O

The	O
ascending	O
aorta	O
is	O
mildly	B-problem
dilated	I-problem
.	O

The	O
aortic	O
valve	O
leaflets	O
are	O
mildly	B-problem
thickened	I-problem
.	O

A	B-treatment
bioprosthetic	I-treatment
aortic	I-treatment
valve	I-treatment
prosthesis	I-treatment
is	O
present	O
.	O

The	B-treatment
aortic	I-treatment
prosthesis	I-treatment
leaflets	I-treatment
appear	O
to	O
move	O
normally	O
.	O

The	O
transaortic	O
gradient	O
is	O
normal	O
for	O
this	B-treatment
prosthesis	I-treatment
.	O

The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	B-problem
thickened	I-problem
.	O

The	B-test
left	I-test
ventricular	I-test
inflow	I-test
pattern	I-test
suggests	O
a	B-problem
restrictive	I-problem
filling	I-problem
abnormality	I-problem
,	O
with	O
elevated	B-problem
left	I-problem
atrial	I-problem
pressure	I-problem
.	O

Transmitral	B-test
Doppler	I-test
and	O
tissue	B-test
velocity	I-test
imaging	I-test
are	O
consistent	O
with	O
Grade	B-problem
III/IV	I-problem
(	I-problem
severe	I-problem
)	I-problem
left	I-problem
ventricular	I-problem
diastolic	I-problem
dysfunction	I-problem
.	O

The	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	B-problem
thickened	I-problem
.	O

There	O
is	O
mild	B-problem
pulmonary	I-problem
artery	I-problem
systolic	I-problem
hypertension	I-problem
.	O

There	O
is	O
no	O
pericardial	B-problem
effusion	I-problem
.	O

Compared	O
with	O
the	B-test
prior	I-test
study	I-test
(	O
images	O
reviewed	O
)	O
of	O
2017-08-14	O
,	O
ventricular	O
function	O
is	O
now	O
similar.	O

EF	B-test
35-40%	O
.	O

4.	O
Echo	B-test
2017-09-14	O

The	O
left	O
atrium	O
is	O
mildly	B-problem
dilated	I-problem
.	O

The	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

Overall	B-test
left	I-test
ventricular	I-test
systolic	I-test
function	I-test
cannot	O
be	O
reliably	O
assessed	O
.	O

3l	O
.	O

The	O
aortic	O
valve	O
leaflets	O
are	O
mildly	B-problem
thickened	I-problem
.	O

The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	B-problem
thickened	I-problem
.	O

There	O
is	O
no	O
pericardial	B-problem
effusion	I-problem
.	O

Compared	O
with	O
the	B-test
prior	I-test
study	I-test
(	O
images	O
reviewed	O
)	O
of	O
2017-09-04	O
,	O
there	O
is	O
probably	O
no	O
significant	O
change	O
.	O

All	B-test
cultures	I-test
,	O
including	O
BCx	B-test
,	O
UCx	B-test
,	O
pleural	B-test
fluid	I-test
culture	I-test
,	O
and	O
wound	B-test
culture	I-test
have	O
been	O
negative	O
.	O

5.	O
CT	B-test
Chest	I-test
2017-09-16	O
:	O

1.	O
Increasing	B-problem
large	I-problem
right-sided	I-problem
pleural	I-problem
effusion	I-problem
and	O
pulmonary	B-problem
edema	I-problem
.	O

Scattered	B-problem
parenchymal	I-problem
opacities	I-problem
in	I-problem
the	I-problem
left	I-problem
lower	I-problem
lobe	I-problem
represent	O
superimposed	B-problem
infection	I-problem
vs	O
atelectasis	B-problem
.	O

There	O
is	O
no	O
evidence	O
of	O
abscess	B-problem
.	O

6.	O
2017-09-28	O
Chest	B-test
X	I-test
Ray	I-test
:	O

SINGLE	B-test
AP	I-test
VIEW	I-test
OF	I-test
THE	I-test
CHEST	I-test
.	O

There	O
has	O
been	O
almost	O
complete	O
resolution	O
of	O
pulmonary	B-problem
edema	I-problem
.	O

A	B-problem
small	I-problem
right	I-problem
pleural	I-problem
effusion	I-problem
has	O
decreased	O
in	O
size	O
.	O

Mild	B-problem
cardiomegaly	I-problem
is	O
stable	O
.	O

There	O
is	O
no	O
pneumothorax	B-problem
.	O

Right	B-treatment
PIC	I-treatment
catheter	I-treatment
tip	I-treatment
ends	O
in	O
the	O
lower	O
SVC	O
.	O

Patient	O
is	O
post	O
median	B-treatment
sternotomy	I-treatment
.	O

IMPRESSION	O
:	O

Almost	O
complete	O
resolution	O
of	O
pulmonary	B-problem
edema	I-problem
.	O

7.	O
2017-09-29	O
CT	B-test
Head	I-test
:	O

FINDINGS	O
:	O

There	O
is	O
no	O
evidence	O
of	O
intraaxial	B-problem
or	I-problem
extraaxial	I-problem
hemorrhage	I-problem
,	O
mass	B-problem
effect	I-problem
,	O
shift	B-problem
of	I-problem
normally	I-problem
midline	I-problem
structures	I-problem
,	O
or	O
acute	B-problem
major	I-problem
or	I-problem
minor	I-problem
vascular	I-problem
territorial	I-problem
infarction	I-problem
.	O

The	O
ventricles	O
and	O
sulci	O
are	O
mildly	B-problem
prominent	I-problem
,	O
but	O
stable	O
in	O
size	O
and	O
appearance	O
.	O

The	O
gray-white	O
matter	O
differentiation	O
is	O
preserved	O
.	O

Again	O
seen	O
are	O
subtle	B-problem
hypodensities	I-problem
within	I-problem
the	I-problem
periventricular	I-problem
white	I-problem
matter	I-problem
which	O
is	O
an	O
indication	O
of	O
chronic	B-problem
microvascular	I-problem
ischemic	I-problem
changes	I-problem
,	O
stable	O
.	O

Extensive	B-problem
carotid	I-problem
artery	I-problem
calcifications	I-problem
are	O
identified	O
.	O

The	O
visualized	O
paranasal	O
sinuses	O
are	O
clear	O
.	O

The	O
surrounding	O
osseous	O
and	O
soft	O
tissue	O
structures	O
are	O
unremarkable	O
.	O

IMPRESSION	O
:	O

No	O
evidence	O
of	O
acute	B-problem
or	I-problem
chronic	I-problem
infarction	I-problem
.	O

Stable	B-problem
microvascular	I-problem
ischemic	I-problem
changes	I-problem
in	I-problem
the	I-problem
periventricular	I-problem
white	I-problem
matter	I-problem
.	O

8.	O
2017-09-30	O
EEG	B-test
:	O

IMPRESSION	O
:	O

Abnormal	B-problem
EEG	I-problem
due	O
to	O
the	B-problem
moderately	I-problem
slow	I-problem
posterior	I-problem
background	I-problem
and	O
occasional	O
bursts	O
of	O
generalized	B-problem
slowing	I-problem
.	O

These	O
findings	O
indicate	O
a	B-problem
widespread	I-problem
encephalopathic	I-problem
condition	I-problem
affecting	O
both	O
cortical	O
and	O
subcortical	O
structures	O
.	O

Medications	B-treatment
,	O
metabolic	B-problem
disturbances	I-problem
,	O
and	O
infection	B-problem
are	O
among	O
the	O
most	O
common	O
causes	O
.	O

No	O
prominent	B-problem
focal	I-problem
abnormalities	I-problem
were	O
evident	O
,	O
and	O
there	O
were	O
no	O
epileptiform	B-problem
features	I-problem
.	O

The	B-test
cardiac	I-test
monitor	I-test
showed	O
occasional	B-problem
irregularities	I-problem
in	O
a	B-treatment
PACED	I-treatment
rhythm	I-treatment
.	O

Brief	O
Hospital	O
Course	O
:	O

A/P	O
:	O

70	O
y/o	O
male	O
with	O
h/o	O
CAD	B-problem
,	O
T2DM	B-problem
,	O
hyperlipidemia	B-problem
,	O
and	O
COPD	B-problem
who	O
presented	O
to	O
the	O
Juan	O
on	O
2017-09-03	O
with	O
worsening	B-problem
SOB	I-problem
x	O
5	O
days	O
from	O
Morton	O
Hospital	O
&	O
Medical	O
Center	O
.	O

Pt.	O
was	O
initially	O
admitted	O
to	O
CCU	O
on	O
2017-09-03	O
,	O
transferred	O
to	O
Pendleton	O
on	O
2017-09-05	O
,	O
triggered	O
on	O
2017-09-10	O
for	O
hypotension	B-problem
with	O
BP	B-test
67/38	O
and	O
transferred	O
back	O
to	O
CCU	O
on	O
2017-09-10	O
.	O

He	O
remained	O
fluid	B-problem
overloaded	I-problem
and	O
a	B-treatment
swan	I-treatment
catheter	I-treatment
was	O
placed	O
.	O

The	O
following	O
issues	O
were	O
addressed	O
during	O
this	O
hospital	O
admission	O
:	O

1#	O
Cardiac	O
:	O

Pump	B-treatment

The	O
patient	O
was	O
initially	O
admitted	O
for	O
likely	O
CHF	B-problem
exacerbation	I-problem
.	O

He	O
was	O
started	O
on	O
a	B-treatment
lasix	I-treatment
gtt	I-treatment
the	O
night	O
of	O
admission	O
with	O
a	O
good	O
response	O
.	O

He	O
continued	O
to	O
diurese	O
and	O
he	O
was	O
moved	O
to	O
the	O
floor	O
since	O
he	O
no	O
longer	O
required	O
intensive	O
level	O
care	O
.	O

While	O
on	O
the	O
floor	O
,	O
he	O
continued	O
to	O
be	O
diuresed	O
.	O

After	O
several	O
days	O
,	O
he	O
became	O
hypotensive	B-problem
and	O
triggered	O
for	O
BPs	B-test
60s/30s	O
.	O

He	O
was	O
given	O
IVF	B-treatment
without	O
an	O
adequate	O
response	O
in	O
his	B-test
pressures	I-test
.	O

He	O
was	O
transferred	O
back	O
to	O
the	O
CCU	O
and	O
started	O
on	O
a	B-treatment
dopamine	I-treatment
gtt	I-treatment
.	O

He	O
diuresed	O
well	O
on	O
the	B-treatment
dopamine	I-treatment
gtt	I-treatment
and	O
his	B-test
BP	I-test
was	O
supported	O
.	O

Gradually	O
,	O
the	B-treatment
dopamine	I-treatment
gtt	I-treatment
was	O
weaned	O
.	O

However	O
,	O
he	O
still	O
appeared	O
volume	B-problem
overloaded	I-problem
with	O
minimal	O
improvement	O
in	O
his	B-problem
oxygen	I-problem
requirement	I-problem
.	O

A	B-test
swan	I-test
was	O
placed	O
for	O
a	O
more	O
accurate	O
picture	O
of	O
his	O
volume	O
status	O
and	O
he	O
was	O
volume	B-problem
overloaded	I-problem
by	O
swan	B-test
numbers	I-test
with	O
an	B-problem
elevated	I-problem
PAD	I-problem
and	O
elevated	B-problem
CVP	I-problem
without	O
an	B-test
obtainable	I-test
wedge	I-test
pressure	I-test
.	O

He	O
also	O
had	O
a	B-problem
high	I-problem
CO	I-problem
and	O
low	B-problem
SVR	I-problem
suggestive	O
of	O
sepsis	B-problem
,	O
but	O
he	O
never	O
had	O
an	B-problem
elevated	I-problem
WBC	I-problem
and	O
was	O
afebrile	B-problem
during	O
his	O
entire	O
hospital	O
admission	O
with	O
negative	O
blood	B-test
,	I-test
urine	I-test
,	I-test
wound	I-test
,	I-test
and	I-test
pleural	I-test
fluid	I-test
cultures	I-test
.	O

The	B-treatment
Lasix	I-treatment
drip	I-treatment
was	O
eventually	O
changed	O
to	O
IV	B-treatment
Lasix	I-treatment
boluses	I-treatment
,	O
with	O
a	B-treatment
net	I-treatment
diuresis	I-treatment
of	O
over	O
36	O
liters	O
for	O
the	O
hospital	O
stay	O
.	O

He	O
was	O
then	O
transitioned	O
to	O
oral	B-treatment
Lasix	I-treatment
for	O
maintainence	O
.	O

The	O
patient	O
had	O
an	B-test
echo	I-test
on	O
2017-09-04	O
with	O
the	O
results	O
above	O
in	O
detail	O
.	O

It	O
was	O
unchanged	O
in	O
comparison	O
to	O
2017-08-14	O
with	O
similar	O
ventricular	B-test
function	I-test
and	O
inferior	B-problem
and	I-problem
inferolateral	I-problem
hypokinesis	I-problem
.	O

The	O
patient	O
had	O
another	B-test
echo	I-test
on	O
2017-09-14	O
with	O
no	O
new	O
changes	O
.	O

At	O
discharge	O
the	O
patient	O
was	O
thought	O
to	O
be	O
euvolemic	O
,	O
satting	O
well	O
on	O
room	O
air	O
and	O
without	O
peripheral	B-problem
edema	I-problem
.	O

His	B-test
dry	I-test
weight	I-test
is	O
70.4	O
kg	O
.	O

Ischemia	B-problem

The	O
patient	O
had	O
an	B-problem
initial	I-problem
troponin	I-problem
bump	I-problem
on	O
admission	O
which	O
was	O
most	O
likely	O
secondary	O
to	O
CHF	B-problem
exacerbation	I-problem
.	O

He	O
was	O
continued	O
on	O
Aspirin	B-treatment
,	O
Metoprolol	B-treatment
and	O
Lipitor	B-treatment
with	O
no	O
further	B-problem
issues	I-problem
.	O

Rhythm	B-test

The	O
patient	O
is	O
completely	B-problem
pacer-dependent	I-problem
,	O
being	O
epicardially	B-treatment
paced	I-treatment
at	O
70	O
.	O

He	O
is	O
on	O
Amiodarone	B-treatment
for	O
post-op	B-problem
afib	I-problem
and	O
this	O
was	O
continued	O
this	O
entire	O
admission	O
.	O

His	B-test
underlying	I-test
rhythm	I-test
is	O
atrial	B-problem
flutter	I-problem
;	O
it	O
was	O
unclear	O
whether	O
he	O
had	O
previously	O
been	O
cardioverted	O
.	O

Anti-coagulation	B-treatment
was	O
started	O
with	O
Warfarin	B-treatment
5	O
mg	O
with	O
a	O
goal	O
of	O
2-3	O
and	O
a	O
plan	O
for	O
cardioversion	B-treatment
in	O
6	O
weeks	O
.	O

The	B-test
patient	I-test
's	I-test
INR	I-test
became	O
supratherapeutic	B-problem
and	O
Coumadin	B-treatment
was	O
held	O
.	O

His	B-treatment
coumadin	I-treatment
was	O
transitioned	O
to	O
2	O
mg	O
and	O
then	O
1	O
mg	O
.	O

His	B-test
INR	I-test
continued	O
to	O
flucuate	O
.	O

He	O
was	O
discharged	O
on	O
1	O
mg	O
,	O
but	O
a	O
stable	O
regimen	O
had	O
not	O
been	O
achieved	O
.	O

His	B-test
INR	I-test
will	O
have	O
to	O
be	O
monitored	O
closely	O
unitl	O
his	B-test
levels	I-test
are	O
stable	O
.	O

His	O
INR	B-test
goal	O
is	O
02-24	O
.	O

2#	O
SOB	B-problem
on	O
admission	O
:	O

Likely	O
due	O
to	O
CHF	B-problem
exacerbation	I-problem
,	O
with	O
diuresis	B-treatment
of	O
over	O
36	O
L	O
during	O
his	O
admission	O
.	O

He	O
had	O
4	B-treatment
surgeries	I-treatment
(	O
3	B-treatment
cardiac	I-treatment
surgeries	I-treatment
)	O
earlier	O
in	O
the	O
summer	O
,	O
so	O
it	O
is	O
likely	O
that	O
he	O
required	O
copious	B-treatment
IVF	I-treatment
hydration	I-treatment
surrounding	O
these	B-treatment
procedures	I-treatment
which	O
may	O
have	O
been	O
the	O
cause	O
of	O
his	B-problem
massive	I-problem
fluid	I-problem
overload	I-problem
.	O

It	O
appears	O
that	O
his	O
diet	O
was	O
regulated	O
at	O
rehab	O
but	O
there	O
is	O
concern	O
for	O
medication	B-problem
non-compliance	I-problem
at	O
rehab	O
,	O
per	O
previous	O
discharge	O
summaries	O
.	O

On	O
discharge	O
,	O
the	O
patient	O
was	O
maintained	O
on	O
standing	B-treatment
diuretics	I-treatment
as	O
well	O
as	O
PRN	B-treatment
nebs	I-treatment
and	O
INH	B-treatment
COPD	I-treatment
meds	I-treatment
.	O

3#	O
Metabolic	B-problem
Alkalosis	I-problem
/	O
Hypochloremia	B-problem
:	O

Etiology	O
most	O
likely	O
a	O
combination	O
of	O
contraction	B-problem
alkalosis	I-problem
and	O
/	O
or	O
post-hypercapnia	B-problem
.	O

This	O
acutely	O
worsened	O
on	O
2017-09-18	O
,	O
when	O
the	O
patient	O
was	O
found	O
to	O
have	O
mental	B-problem
status	I-problem
changes	I-problem
and	O
an	B-test
ABG	I-test
revealed	O
a	B-test
CO2	I-test
of	O
over	O
100	O
,	O
likley	O
due	O
to	O
a	B-problem
depressed	I-problem
respiratory	I-problem
drive	I-problem
secondary	O
to	O
sedatives	B-treatment
given	O
for	O
agitation	B-problem
on	O
top	O
of	O
a	B-problem
preexisting	I-problem
alkalosis	I-problem
.	O

The	O
patient	O
was	O
therefore	O
intubated	B-treatment
for	O
ventilation	B-treatment
,	O
and	O
continued	O
to	O
be	O
diuresed	O
.	O

His	B-test
CO2	I-test
improved	O
and	O
he	O
was	O
extubated	B-treatment
after	O
a	O
few	O
days	O
.	O

All	B-treatment
sedating	I-treatment
medications	I-treatment
were	O
held	O
and	O
serial	B-test
ABGs	I-test
were	O
trended	O
to	O
follow	O
the	O
resolution	O
of	O
the	B-problem
metabolic	I-problem
alkalosis	I-problem
.	O

4#	O
Pleural	B-problem
effusions	I-problem
:	O
s/p	B-treatment
right	I-treatment
thoracentesis	I-treatment
on	O
2017-09-06	O
,	O
1600	O
mL	O
of	O
serosanguinous	B-problem
fluid	I-problem
removed	O
from	O
right	O
pleural	O
space	O
.	O

Gram	B-test
stain	I-test
and	O
cultures	B-test
were	O
negative	O
,	O
cytology	B-test
was	O
negative	O
.	O

The	B-problem
right	I-problem
pleural	I-problem
effusion	I-problem
slowly	O
re-accumulated	O
after	O
tap	B-treatment
but	O
resolved	O
after	O
continued	B-treatment
diuresis	I-treatment
.	O

Repeat	B-test
CXR	I-test
showed	O
improvement	O
of	O
the	B-problem
effusion	I-problem
and	O
on	O
discharge	O
he	O
had	O
been	O
breathing	O
well	O
on	O
room	O
air	O
without	O
complications	B-problem

5#	O
T2DM	B-problem
:	O

The	O
patient	O
was	O
started	O
on	O
Glargine	B-treatment
for	O
tighter	O
glycemic	O
control	O
and	O
was	O
covered	O
with	O
an	B-treatment
insulin	I-treatment
sliding	I-treatment
scale	I-treatment
.	O

He	O
was	O
monitored	O
with	O
QID	B-test
fingersticks	I-test
.	O

His	B-test
blood	I-test
sugars	I-test
were	O
in	O
the	O
100s	O
on	O
discharge	O
.	O

6#	O
Hyperlipidemia	B-problem
:	O

The	O
patient	O
was	O
continued	O
on	O
his	B-treatment
statin	I-treatment
.	O

7#	O
COPD	B-problem
:	O

The	O
patient	O
was	O
continued	O
on	O
nebs	B-treatment

8#	O
MS	B-problem
changes	I-problem
:	O

The	O
patient	O
has	O
a	O
history	O
of	O
baseline	B-problem
dementia	I-problem
which	O
was	O
confounded	O
by	O
delerium	B-problem
in	O
the	O
face	O
of	O
metabolic	B-problem
abnormalities	I-problem
.	O

His	O
mental	O
status	O
improved	O
as	O
his	O
metabolic	O
process	O
was	O
resolved	O
as	O
detailed	O
above	O
.	O

Neurology	O
was	O
also	O
consulted	O
and	O
a	B-test
head	I-test
CT	I-test
showed	O
old	B-problem
lacunar	I-problem
infarcts	I-problem
but	O
no	O
acute	O
causes	O
for	O
a	B-problem
change	I-problem
in	I-problem
mental	I-problem
status	I-problem
.	O

An	B-test
EEG	I-test
showed	O
mild	B-problem
encephalopathy	I-problem
,	O
but	O
no	O
other	O
findings	O
.	O

His	O
mental	O
status	O
did	O
clear	O
somewhat	O
with	O
the	O
addition	O
of	O
standing	B-treatment
lactulose	I-treatment
;	O
he	O
was	O
discharged	O
on	O
this	B-treatment
medication	I-treatment
.	O

9#	O
Hypothyroidism	B-problem
:	O

The	O
patient	O
was	O
continued	O
on	O
his	O
outpatient	O
dose	O
of	O
Levothyroxine	B-treatment
.	O

10#	O
?	O
UTI	B-problem
:	O

The	O
patient	O
was	O
started	O
on	O
levofloxacin	B-treatment
at	O
Newton-Wellesley	O
Hospital	O
for	O
a	O
question	O
of	O
UTI	B-problem
based	O
on	O
U/A	B-test
positive	O
for	O
WBC	B-test
.	O

UCx	B-test
during	O
this	O
hospitalization	O
were	O
negative	O
and	O
Levofloxacin	B-treatment
was	O
d/c	O
'd	O
.	O

11#	O
Chronic	B-problem
lower	I-problem
back	I-problem
pain	I-problem
:	O

The	O
patient	O
was	O
treated	O
with	O
a	B-treatment
Lidocaine	I-treatment
patch	I-treatment
and	O
Percocet	B-treatment
prn	O
.	O

Stronger	B-treatment
narcotics	I-treatment
were	O
avoided	O
given	O
somnolence	B-problem
and	O
MS	B-problem
changes	I-problem
.	O

12#	O
Wound	B-treatment
Care	I-treatment
:	O

The	O
patient	O
has	O
left	B-problem
chest	I-problem
wound	I-problem
and	O
left	B-problem
gluteal	I-problem
pressure	I-problem
ulcer	I-problem
.	O

Wound	O
care	O
was	O
consulted	O
on	O
2017-09-05	O
and	O
they	O
made	O
several	O
recommendations	O
.	O

For	O
the	B-problem
left	I-problem
gluteal	I-problem
pressure	I-problem
ulcer	I-problem
,	O
they	O
recommended	O
gentle	B-treatment
cleansing	I-treatment
with	O
normal	B-treatment
saline	I-treatment
or	O
commercial	B-treatment
wound	I-treatment
cleaner	I-treatment
,	O
thin	O
layer	O
of	O
Duoderm	B-treatment
gel	I-treatment
,	O
air	O
dry	O
,	O
allevyn	B-treatment
foam	I-treatment
adhesive	I-treatment
over	O
the	O
site	O
,	O
and	O
change	O
every	O
2	O
days	O
or	O
prn	O
.	O

For	O
the	B-problem
left	I-problem
chest	I-problem
wound	I-problem
,	O
they	O
recommended	O
cleansing	O
with	O
commercial	B-treatment
wound	I-treatment
cleanser	I-treatment
,	O
pat	O
dry	O
,	O
pack	B-treatment
aquacel	I-treatment
AG	I-treatment
rope	I-treatment
and	O
moisten	O
with	O
saline	B-treatment
,	O
cover	O
with	O
dry	B-treatment
gauze	I-treatment
and	O
change	O
daily	O
.	O

These	O
recommendations	O
were	O
followed	O
throughout	O
the	O
admission	O
.	O

13#	O
Voiding	O
:	O

Pt.	O
failed	O
multiple	O
attempts	O
to	O
void	O
on	O
his	O
own	O
.	O

Case	O
was	O
discussed	O
with	O
neurology	O
.	O

He	O
was	O
started	O
on	O
finsateride	B-treatment
on	O
the	O
day	O
prior	O
to	O
admission	O
.	O

He	O
is	O
scheduled	O
to	O
follow	O
up	O
with	O
urology	O
to	O
address	O
this	O
issue	O
.	O

Until	O
then	O
,	O
his	B-treatment
foley	I-treatment
should	O
remain	O
in	O
place	O
.	O

14#	O
Code	O
:	O

The	O
patient	O
was	O
full	O
code	O
during	O
admission	O
.	O

Medications	O
on	O
Admission	O
:	O

Levothyroxine	B-treatment
100	O
mcg	O
PO	O
daily	O

Duloxetine	B-treatment
20	O
mg	O
PO	O
QHS	O

Ondansetron	B-treatment
PRN	O

Percocet	B-treatment
1	O
tab	O
PRN	O

Senna	B-treatment
PRN	O

Colace	B-treatment
PRN	O

Lasix	B-treatment
80	O
mg	O
PO	O
BID	O

Lactulose	B-treatment
PRN	O

Lidocaine	B-treatment
patch	I-treatment

Nystatin	B-treatment
powder	I-treatment

Gabapentin	B-treatment
300	O
mg	O
PO	O
TID	O

Alb	B-treatment
nebs	I-treatment

Fluticasone	B-treatment
/	O
Salmeterol	B-treatment

Tiotropium	B-treatment
Bromide	I-treatment

Spironolactone	B-treatment
25	O
mg	O
PO	O
daily	O

Epoetin	B-treatment
4000	O
units	O
MWF	O

RISS	B-treatment

Amiodarone	B-treatment
200	O
mg	O
PO	O
daily	O

Calcium	B-treatment
Acetate	I-treatment
667	O
mg	O
PO	O
TID	O

SubQ	B-treatment
Heparin	I-treatment

Pantoprazole	B-treatment
40	O
mg	O
PO	O
daily	O

Simvastatin	B-treatment
40	O
mg	O
PO	O
QHS	O

ASA	B-treatment
81	O
mg	O
PO	O
daily	O

MVI	B-treatment

Tylenol	B-treatment
PRN	O

Discharge	O
Medications	O
:	O

1.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
Constipation	B-problem
.	O

Disp	O
:*	O
90	O
Capsule	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

2.	O
Levothyroxine	B-treatment
100	O
mcg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

3.	O
Duloxetine	B-treatment
20	O
mg	O
Capsule	O
,	O
Delayed	O
Release(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
QHS	O
(	O
once	O
a	O
day	O
(	O
at	O
bedtime	O
)	O
)	O
.	O

4.	O
Lactulose	B-treatment
10	O
g	O
/	O
15	O
mL	O
Syrup	O
Sig	O
:	O
Thirty	O
(	O
30	O
)	O
ML	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

5.	O
Fluticasone	B-treatment
-	O
Salmeterol	B-treatment
100-50	O
mcg	O
/	O
Dose	O
Disk	O
with	O
Device	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Disk	O
with	O
Device	O
Inhalation	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
qs	O
Disk	O
with	O
Device	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

6.	O
Tiotropium	B-treatment
Bromide	I-treatment
18	O
mcg	O
Capsule	O
,	O
w/	O
Inhalation	B-treatment
Device	I-treatment
Sig	O
:	O
One	O
(	O
1	O
)	O
Cap	O
Inhalation	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
qs	O
*	O
Refills	O
:*	O
2	O
*	O

7.	O
Amiodarone	B-treatment
200	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

8.	O
Calcium	B-treatment
Acetate	I-treatment
667	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
TID	O
W/MEALS	O
(	O
3	O
TIMES	O
A	O
DAY	O
WITH	O
MEALS	O
)	O
.	O

Disp	O
:*	O
90	O
Capsule	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

9.	O
Oxycodone	B-treatment
-	O
Acetaminophen	B-treatment
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-problem
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

10.	O
Multivitamin	B-treatment
Capsule	I-treatment
Sig	O
:	O
One	O
(	O
1	O
)	O
Cap	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
30	O
tablets	O
*	O
Refills	O
:*	O
2	O
*	O

11.	O
Miconazole	B-treatment
Nitrate	I-treatment
2	O
%	O
Powder	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

12.	O
Aspirin	B-treatment
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

13.	O
Simvastatin	B-treatment
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
QHS	O
(	O
once	O
a	O
day	O
(	O
at	O
bedtime	O
)	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

14.	O
Pantoprazole	B-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

15.	O
Lidocaine	B-treatment
5	O
%(	O
700	O
mg	O
/	O
patch	O
)	O
Adhesive	O
Patch	O
,	O
Medicated	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Adhesive	O
Patch	O
,	O
Medicated	O
Topical	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
qs	O
Adhesive	O
Patch	O
,	O
Medicated	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

16.	O
Furosemide	B-treatment
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
60	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

17.	O
Ferrous	B-treatment
Sulfate	I-treatment
325	O
(	O
65	O
)	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

18.	O
Epoetin	B-treatment
Alfa	I-treatment
4,000	O
unit/mL	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Injection	O
QMOWEFR	O
(	O
Monday	O
-	O
Wednesday	O
-	O
Friday	O
)	O
.	O

Disp	O
:*	O
qs	O
*	O
Refills	O
:*	O
2	O
*	O

19.	O
Spironolactone	B-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
60	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

20.	O
Albuterol	B-treatment
90	O
mcg/Actuation	O
Aerosol	O
Sig	O
:	O
4-6	O
Puffs	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
.	O

Disp	O
:*	O
qs	O
*	O
Refills	O
:*	O
2	O
*	O

21.	O
Metoprolol	B-treatment
Succinate	I-treatment
25	O
mg	O
Tablet	O
Sustained	O
Release	O
24HR	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
Sustained	O
Release	O
24HR	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

22.	O
Finasteride	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

23.	O
Gabapentin	B-treatment
300	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
60	O
Capsule	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

24.	O
Warfarin	B-treatment
1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
at	O
bedtime	O
:	O
Please	O
monitor	O
INR	B-test
with	O
goal	O
02-24	O
.	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

Primary	O
:	O

Congestive	B-problem
Heart	I-problem
Failure	I-problem
exacerbation	I-problem

Secondary	O
:	O

Coronary	B-problem
Artery	I-problem
Disease	I-problem

Hypertension	B-problem

Type	B-problem
2	I-problem
Diabetes	I-problem
Mellitus	I-problem

Chronic	B-problem
Obstructive	I-problem
Pulmonary	I-problem
Disease	I-problem

Discharge	O
Condition	O
:	O

The	O
patient	O
was	O
discharged	O
hemodynamicallly	O
stable	O
,	O
afebrile	B-problem
with	O
appropriate	O
follow	O
up	O
.	O

Discharge	O
Instructions	O
:	O

During	O
this	O
admission	O
you	O
have	O
been	O
treated	O
for	O
a	B-problem
CHF	I-problem
exacerbation	I-problem
.	O

Weigh	O
yourself	O
every	O
morning	O
,	O
call	O
MD	O
if	O
weight	O
increases	O
by	O
>	O
3	O
lbs	O
in	O
2	O
days	O
.	O

Adhere	O
to	O
2	O
gm	O
sodium	O
diet	O

Fluid	O
Restriction	O
:	O

1500	O
mL	O

1.	O
Please	O
take	O
all	B-treatment
medications	I-treatment
as	O
prescribed	O
.	O

2.	O
Please	O
keep	O
all	O
follow	O
up	O
appointments	O
.	O

3.	O
Please	O
call	O
your	O
PCP	O
C.	O
Lettinga	O
or	O
seek	O
medical	O
attention	O
in	O
the	O
Juan	O
if	O
you	O
experience	O
worsening	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
,	O
chest	B-problem
pain	I-problem
,	O
dizziness	B-problem
,	O
passing	B-problem
out	I-problem
,	O
or	O
any	B-problem
other	I-problem
concerning	I-problem
symptom	I-problem
.	O

Followup	O
Instructions	O
:	O

Please	O
follow	O
up	O
with	O
your	O
PCP	O
C.	O
Lettinga	O
(	O
572	O
8343	O
)	O
on	O
10-10	O
at	O
1:00	O
PM	O

Please	O
follow	O
up	O
with	O
Dr.	O
Parker	O
in	O
cardiology	O
(	O
(	O
216	O
)	O
660-0019	O
)	O
on	O
10-17	O
at	O
4:45	O
PM	O

Please	O
follow	O
up	O
with	O
Dr.	O
Frye	O
in	O
cardiololgy	O
(	O
(	O
216	O
)	O
660-0019	O
)	O
on	O
10-09	O
at	O
2:15	O
PM	O
.	O

Please	O
follow	O
up	O
with	O
Urology	O
on	O
10-16	O
@	O
1:50	O
PM	O
on	O
the	O
3rd	O
floor	O
of	O
the	O
Maricle	O
Building	O
,	O
east	O
campus	O
of	O
Lahey	O
Clinic	O
-	O
North	O
Shore	O

Ronald	O
Lyman	O
MD	O
77-979	O

Completed	O
by	O
:	O
Bristol	O
MD	O
47-191	O
2017-10-10	O
@	O
1058	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Ronald	O
G.	O
Elston	O
on	O
:	O
WED	O
2017-10-11	O
5:03	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2017-08-14	O

Discharge	O
Date	O
:	O

2017-08-23	O

Date	O
of	O
Birth	O
:	O

1943-08-23	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	B-treatment

Allergies	O
:	O

Sulfonamides	B-treatment

Attending	O
:	O
Marcus	O
W.	O
Kelley	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Transfer	O
from	O
Athol	O
Memorial	O
Hospital	O
for	O
acute	O
on	O
chronic	B-problem
respiratory	I-problem
distress	I-problem
.	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Lumbar	B-test
puncture	I-test
on	O
08-16	O

History	O
of	O
Present	O
Illness	O
:	O

Mr.	O
Lockley	O
is	O
a	O
73	O
yo	O
male	O
with	O
a	O
complicated	O
past	O
medical	O
history	O
,	O
recently	O
discharged	O
from	O
St.	O
Margaret	O
's	O
Center	O
for	O
Women	O
&	O
Infants	O
on	O
08-02	O
following	O
a	O
prolonged	O
admission	O
for	O
STEMI	B-problem
,	O
respiratory	B-problem
failure	I-problem
felt	O
secondary	O
to	O
pulmonary	B-problem
edema	I-problem
requiring	O
intubation	O
and	O
subsequent	B-treatment
tracheostomy	I-treatment
02-22	O
failure	B-problem
to	I-problem
wean	I-problem
,	O
sepsis	B-problem
and	O
C.difficile	B-problem
colitis	I-problem
treated	O
with	O
Vancomycin	B-treatment
and	O
Flagyl	B-treatment
with	O
a	O
course	O
of	O
Levophed	B-treatment
.	O

He	O
was	O
discharged	O
to	O
Athol	O
Memorial	O
Hospital	O
for	O
continued	B-treatment
weaning	I-treatment
.	O

Per	O
Dr.	O
John	O
C.	O
Corrigan	O
Mental	O
Health	O
Center	O
,	O
patient	O
remained	O
ventilator	B-problem
dependent	I-problem
,	O
intermittently	O
on	O
PS	B-treatment
20/5	O
and	O
back	O
on	O
AC	B-treatment
15/5/500/0.35	O
on	O
08-08	O
.	O

At	O
OSH	O
,	O
sputum	B-test
cultures	I-test
grew	O
Pseudomonas	B-problem
and	O
MRSA	B-problem
,	O
and	O
he	O
was	O
restarted	O
on	O
Zosyn	B-treatment
(	O
08-08	O
)	O
and	O
Vancomycin	B-treatment
(	O
08-09	O
).	O

He	O
completed	O
his	O
course	O
of	O
Vancomycin	B-treatment
on	O
2017-08-10	O
.	O

However	O
,	O
today	O
around	O
17:45	O
,	O
while	O
being	O
moved	O
by	O
the	O
nursing	O
staff	O
,	O
Mr.	O
Lockley	O
Bosche	O
started	O
coughing	B-problem
.	O

Suctioned	O
X	O
1	O
,	O
mucus	O
not	O
cleared	O
.	O

He	O
then	O
became	O
dusky	B-problem
and	O
cyanotic	B-problem
,	O
and	O
stopped	B-problem
breathing	I-problem
on	O
his	O
own	O
.	O

A	O
code	O
was	O
called	O
,	O
+	O
pulse	B-test
.	O

Patient	O
placed	O
on	O
FiO2	B-treatment
100%	O
.	O

Vitals	B-test
reportedly	O
HR	B-test
88-98	O
,	O
BP	B-test
150/80	O
.	O

ABG	B-test
done	O
on	O
FiO2	B-treatment
100%	O
7.36/66/417/98%	O
.	O

At	O
Vencor	O
Hospital	O
,	O
BP	B-problem
dropped	I-problem
to	O
90	O
,	O
and	O
patient	O
was	O
started	O
on	O
NS	B-treatment
IVF	I-treatment
,	O
with	O
improvement	O
in	O
BP	B-test
.	O

EKG	B-test
without	O
acute	B-problem
changes	I-problem
.	O

He	O
was	O
transferred	O
to	O
St.	O
Margaret	O
's	O
Center	O
for	O
Women	O
&	O
Infants	O
John	O
for	O
further	B-treatment
management	I-treatment
on	O
AC	B-test
,	O
RR	B-test
15	O
,	O
PEEP	B-test
5	O
,	O
Vt	B-test
500	O
,	O
Fi02	B-test
1.0	O
.	O

In	O
John	O
,	O
BP	B-test
80/60	O
,	O
HR	B-test
80	O
.	O

Continued	O
on	O
IVF	B-treatment
(	O
received	O
total	O
2300	O
cc	O
)	O
,	O
with	O
improved	O
BP	B-test
to	O
SBP	B-test
105-118	O
.	O

Stool	B-test
sent	O
for	O
C.diff	B-problem
and	O
given	O
Flagyl	B-treatment
500	O
mg	O
PO	O
X	O
1	O
dose	O
.	O

Past	O
Medical	O
History	O
:	O

1.	O
Non-small	B-problem
cell	I-problem
lung	I-problem
cancer	I-problem
s/p	B-treatment
XRT	I-treatment
and	O
chemotherapy	B-treatment
in	O
French	O
Guiana	O
,	O
s/p	B-treatment
right	I-treatment
pneumonectomy	I-treatment
in	O
2016-09-21	O
for	O
recurrence	B-problem
.	O

Chronic	B-problem
left	I-problem
pleural	I-problem
effusion	I-problem
.	O

2.	O
SSS	B-problem
status	B-treatment
post	I-treatment
PM/ICD	I-treatment
placement	I-treatment

3.	O
COPD/bronchiectasis	B-problem

4.	O
Hypertension	B-problem

5.	O
CAD	B-problem
,	O
with	O
known	O
TO	O
RCA	O
.	O

6.	O
CHF	B-problem
with	O
EF	B-test
25%	O
on	O
last	B-test
echo	I-test
on	O
2017-07-19	O

7.	O
BPH	B-problem

8.	O
Depression	B-problem

9.	O
Left	B-problem
femoral	I-problem
AV	I-problem
fistula	I-problem
2017-04-19	O

10.	O
Recent	B-problem
MRSA	I-problem
pneumonia	I-problem
and	O
sepsis	B-problem
2017-07-21	O
,	O
treated	O
with	O
Vancomycin	B-treatment

11.	O
C.	B-problem
difficile	I-problem
colitis	I-problem
treated	O
with	O
Flagyl	B-treatment
(	O
completed	O
08-10	O
)	O

12.	O
Status	B-treatment
post	I-treatment
PEG	I-treatment
tube	I-treatment
placement	I-treatment
2017-07-21	O

13.	O
Status	B-treatment
post	I-treatment
tracheostomy	I-treatment
2017-07-21	O
02-22	O
failure	B-problem
to	I-problem
wean	I-problem

14.	O
Status	B-treatment
post	I-treatment
partial	I-treatment
colectomy	I-treatment
1972	O

Social	O
History	O
:	O

Son	O
is	O
next	O
of	O
kin	O
.	O

See	O
below	O
for	O
contact	O
information	O
.	O

He	O
has	O
been	O
living	O
at	O
The	O
Cooley	O
Dickinson	O
Hospital	O
House	O
since	O
2017-08-02	O
.	O

Per	O
Dr.	O
John	O
C.	O
Corrigan	O
Mental	O
Health	O
Center	O
,	O
at	O
baseline	O
,	O
patient	O
not	O
interactive	O
.	O

Opens	O
eyes	O
spontaneously	O
,	O
withdraws	O
to	O
painful	B-test
stimulus	I-test
.	O

Family	O
History	O
:	O

Non-contributory	O

Physical	O
Exam	O
:	O

PHYSICAL	O
EXAM	O
on	O
admission	O
:	O

VITALS	O
:	O

BP	B-test
90s-118/47-59	O
,	O
HR	B-test
80-90s	O
.	O

Vent	O
:	O

AC	B-test
,	O
RR	B-test
15	O
,	O
PEEP	B-test
5	O
,	O
Vt	B-test
500	O
cc	O
,	O
FiO2	B-test
1.0	O
.	O

GEN	O
:	O

Intubated	B-treatment
,	O
opens	O
eyes	O
,	O
responds	O
to	O
painful	B-test
stimulus	I-test
.	O

HEENT	O
:	O

Pupils	B-problem
minimally	I-problem
reactive	I-problem
.	O

Sclera	B-problem
anicteric	I-problem
.	O

NECK	O
:	O

Unable	O
to	O
assess	O
JVP	B-test
.	O

RESP	O
:	O

Bronchial	B-problem
breathing	I-problem
over	I-problem
right	I-problem
hemithorax	I-problem
.	O

Ronchorous	B-problem
breath	I-problem
sounds	I-problem
left	I-problem
chest	I-problem
.	O

Limited	B-test
examination	I-test
.	O

CVS	O
:	O

RRR	O
.	O

Normal	O
S1	O
,	O
S2	O
.	O

+	O
S4	B-problem
.	O

No	O
murmur	B-problem
appreciated	O
.	O

GI	O
:	O

PEG	B-treatment
in	O
place	O
,	O
site	O
without	O
drainage	B-problem
.	O

BS	O
present	O
,	O
hypoactive	B-problem
.	O

Abdomen	O
soft	O
.	O

No	O
grimacing	B-problem
with	O
palpation	B-test
.	O

CMED	O
:	O

Foley	B-treatment
in	O
place	O
.	O

EXT	O
:	O

2+	B-problem
edema	I-problem
both	I-problem
upper	I-problem
extremities	I-problem
,	O
sacral	B-problem
edema	I-problem
.	O

Cool	B-problem
extremities	I-problem
.	O

Good	O
pedal	O
pulses	O
peripherally	O
.	O

NEURO	O
:	O

Limited	B-test
examination	I-test
.	O

Withdraws	O
to	O
painful	B-test
stimulus	I-test
.	O

Moves	O
all	O
4	O
extremities	O
.	O

Pertinent	O
Results	O
:	O

LABS	O
:	O

WBC	B-test
-	O
4.9	O
RBC	B-test
-	O
2.92	O
*	O
HGB	B-test
-	O
8.8	O
*	O
HCT	B-test
-	O
26.2	O
*	O
MCV	B-test
-	O
90	O
MCH	B-test
-	O
30.1	O
MCHC	B-test
-	O
33.5	O
RDW	B-test
-	O
18.5	O
*	O
NEUTS	B-test
-	O
86.5	O
*	O
LYMPHS	B-test
-	O
7.5	O
*	O
MONOS	B-test
-	O
4.7	O
EOS	B-test
-	O
1.2	O
BASOS	B-test
-	O
0.1	O
PLT	B-test
COUNT	I-test
-	O
145	O
*	O
GLUCOSE	B-test
-	O
91	O
UREA	B-test
N	I-test
-	O
21	O
*	O
CREAT	B-test
-	O
0.6	O
SODIUM	B-test
-	O
143	O
POTASSIUM	B-test
-	O
4.2	O
CHLORIDE	B-test
-	O
106	O
TOTAL	B-test
CO2	I-test
-	O
32	O
ANION	B-test
GAP	I-test
-	O
9	O
LACTATE	B-test
-	O
1.4	O
K+	B-test
-	O
3.9	O

ABG	B-test
:	O

2017-08-14	O
07:30	O
PM	O
TYPE	O
-	O
ART	B-test
PO2	I-test
-	O
468	O
*	O
PCO2	B-test
-	O
44	O
PH	B-test
-	O
7.50	O
*	O
TOTAL	B-test
CO2	I-test
-	O
36	O
*	O
BASE	B-test
XS	I-test
-	O
10	O
INTUBATED	B-treatment
-	O
INTUBATED	B-treatment

EKG	B-test
(	O
at	O
Athol	O
Memorial	O
Hospital	O
,	O
17:11	O
)	O
:	O

Atrial	B-problem
fibrillation	I-problem
,	O
occasional	B-treatment
V-paced	I-treatment
,	O
rate	B-test
74	O
.	O

Normal	O
axis	O
.	O

Old	B-problem
TWI	I-problem
V4-6	I-problem
.	O

EKG	B-test
in	O
John	O
:	O

Afib	B-problem
,	O
occasional	B-treatment
V-paced	I-treatment
,	O
rate	B-test
83	O
bpm	O
.	O

Normal	O
axis	O
.	O

Long	B-problem
QT	I-problem
interval	I-problem
(	O
QTc	B-test
462	O
ms	O
).	O

ST	B-problem
depressions	I-problem
V4	I-problem
,	I-problem
5	I-problem
.	O

Mild	B-problem
ST	I-problem
elevation	I-problem
in	I-problem
V3	I-problem
.	O

Old	B-problem
TWI	I-problem
V4-6	I-problem
.	O

****************	O

IMAGING	O
:	O

2017-08-14	O
CXR	B-test
:	O

ETT	B-treatment
in	O
correct	O
position	O
.	O

PM	B-treatment
wires	I-treatment
in	O
good	O
position	O
.	O

S/p	B-treatment
right	I-treatment
pneumonectomy	I-treatment
.	O

Blunting	B-problem
of	I-problem
left	I-problem
CPA	I-problem
likely	O
effusion	B-problem
.	O

New	B-problem
lower	I-problem
left	I-problem
lateral	I-problem
CW	I-problem
opacity	I-problem
,	O
likely	O
loculated	B-problem
pleural	I-problem
fluid	I-problem
.	O

2017-07-19	O
ECHO	B-test
:	O

Left-to-right	B-problem
shunt	I-problem
across	I-problem
the	I-problem
interatrial	I-problem
septum	I-problem
.	O

LVEF	B-test
25%	O
.	O

Resting	B-test
WMA	I-test
include	O
mid	B-problem
to	I-problem
distal	I-problem
septal	I-problem
akinesis	I-problem
,	O
apical	B-problem
akinesis	I-problem
,	O
inferior	B-problem
akinesis/hypokinesis	I-problem
,	O
and	O
mid	B-problem
to	I-problem
distal	I-problem
anterolateral	I-problem
hypokinesis	I-problem
/	O
akinesis	B-problem
.	O

No	O
definite	O
apical	B-problem
thrombus	I-problem
seen	O
(	O
cannot	O
exclude	O
).	O

01-22+	O
AR	B-problem
.	O

Trivial	B-problem
MR	I-problem
.	O

1+	O
TR	B-problem
.	O

2017-08-16	O
CT	B-test
head	I-test
:	O

New	B-problem
rounded	I-problem
low-density	I-problem
area	I-problem
measuring	O
2.5	O
cm	O
in	O
left	O
basal	O
ganglia	O
,	O
which	O
partially	O
extends	O
to	O
the	O
left	O
thalamus	O
,	O
probably	O
representing	O
subacute	B-problem
infarction	I-problem
.	O

On	O
this	B-test
head	I-test
CT	I-test
without	O
contrast	O
,	O
the	B-test
evaluation	I-test
is	O
limited	O
.	O

2017-08-16	O
CTA	B-test
chest	I-test
:	O

No	O
evidence	O
for	O
pulmonary	B-problem
embolism	I-problem
.	O

Findings	O
consistent	O
with	O
failure	B-problem
or	O
fluid	B-problem
overload	I-problem
.	O

Development	O
of	O
small	B-problem
loculated	I-problem
pleural	I-problem
fluid	I-problem
collection	I-problem
along	I-problem
the	I-problem
periphery	I-problem
of	O
the	O
left	O
major	O
fissure	O
or	O
so-called	B-problem
pseudotumor	I-problem
,	O
consistent	O
with	O
the	B-test
recent	I-test
chest	I-test
x-ray	I-test
.	O

Unchanged	O
appearance	O
of	O
right	B-treatment
pneumonectomy	I-treatment
.	O

2017-08-16	O
ECHO	B-test
:	O

The	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

Overall	B-test
LVEF	I-test
is	O
difficult	O
to	O
assess	O
due	O
to	O
poor	O
echo	B-test
windows	I-test
although	O
the	B-test
basal	I-test
LV	I-test
appeas	O
hyperdynamic	B-problem
without	O
regional	B-problem
contraction	I-problem
abnormality	I-problem
(	O
suspect	O
significant	O
improvement	O
compared	O
to	O
prior	B-test
study	I-test
dated	O
2017-07-18	O
).	O

No	O
masses	B-problem
or	O
thrombi	B-problem
are	O
seen	O
in	O
the	O
left	O
ventricle	O
(	O
due	O
to	O
poor	O
echo	B-test
windows	I-test
cannot	O
fully	O
exclude	O
).	O

The	O
ascending	O
aorta	O
is	O
mildly	B-problem
dilated	I-problem
.	O

There	O
is	O
no	O
aortic	B-problem
valve	I-problem
stenosis	I-problem
.	O

Mild	B-problem
(	I-problem
1+	I-problem
)	I-problem
aortic	I-problem
regurgitation	I-problem
is	O
seen	O
.	O

Trivial	B-problem
mitral	I-problem
regurgitation	I-problem
is	O
seen	O
.	O

The	B-test
left	I-test
ventricular	I-test
inflow	I-test
pattern	I-test
suggests	O
impaired	B-problem
relaxation	I-problem
.	O

There	O
is	O
a	B-problem
small	I-problem
pericardial	I-problem
effusion	I-problem
.	O

There	O
are	O
no	O
echocardiographic	B-test
signs	I-test
of	O
tamponade	B-problem

2017-08-17	O
EEG	B-test
:	O

Markedly	B-problem
abnormal	I-problem
portable	I-problem
EEG	I-problem
due	O
to	O
the	B-problem
voltage	I-problem
suppression	I-problem
over	I-problem
the	I-problem
left	I-problem
hemisphere	I-problem
and	O
due	O
to	O
the	B-problem
bursts	I-problem
of	I-problem
generalized	I-problem
slowing	I-problem
and	O
right	B-problem
hemisphere	I-problem
slowing	I-problem
.	O

The	B-problem
first	I-problem
abnormality	I-problem
raises	O
the	O
possibility	O
of	O
material	B-problem
(	I-problem
such	I-problem
as	I-problem
subdural	I-problem
fluid	I-problem
)	I-problem
interposed	I-problem
between	I-problem
the	I-problem
brain	I-problem
and	O
recording	O
electrodes	O
or	O
widespread	B-problem
cortical	I-problem
dysfunction	I-problem
on	I-problem
that	I-problem
side	I-problem
.	O

Anatomic	O
correlation	O
would	O
be	O
of	O
interest	O
if	O
clinically	O
indicated	O
.	O

The	B-problem
generalized	I-problem
slowing	I-problem
indicates	O
a	B-problem
non	I-problem
specific	I-problem
dysfunction	I-problem
in	I-problem
midline	I-problem
structures	I-problem
.	O

There	O
was	O
also	O
evidence	O
of	O
subcortical	B-problem
dysfunction	I-problem
on	I-problem
the	I-problem
right	I-problem
side	I-problem
.	O

No	O
epileptiform	B-problem
features	I-problem
were	O
seen	O
.	O

MICRO	O
DATA	O
:	O

2017-08-17	O
STOOL	B-test
CLOSTRIDIUM	I-test
DIFFICILE	I-test
TOXIN	I-test
ASSAY	I-test
-	O
PENDING	O

2017-08-16	O
CSF	O
;	O
SPINAL	B-test
FLUID	I-test
GRAM	I-test
STAIN	I-test
-	O
neg	O
FLUID	B-test
CULTURE	I-test
-	O
neg	O
;	O
FUNGAL	B-test
CULTURE	I-test
-	O
PENDING	O
;	O
ACID	B-test
FAST	I-test
CULTURE	I-test
-	O
PENDING	O
;	O
VIRAL	B-test
CULTURE	I-test
-	O
PENDING	O

2017-08-15	O
SPUTUM	B-test
CULTURE	I-test
-	O
PRELIMINARY	O
{	O
PSEUDOMONAS	B-problem
AERUGINOSA	I-problem
}	O

2017-08-15	O
BLOOD	B-test
CULTURE	I-test
NGTD	O

2017-08-15	O
URINE	B-test
CULTURE	I-test
-	O
FINAL	O

2017-08-15	O
BLOOD	B-test
CULTURE	I-test
NGTD	O

Brief	O
Hospital	O
Course	O
:	O

Mr.	O
Lockley	O
was	O
admitted	O
with	O
respiratory	B-problem
failure	I-problem
,	O
thought	O
to	O
be	O
related	O
to	O
mucus	B-problem
plugging	I-problem
as	O
well	O
as	O
a	B-problem
pseudomonal	I-problem
pneumonia	I-problem
.	O

Both	O
of	O
these	O
etiologies	O
were	O
treated	O
,	O
and	O
he	O
continued	O
to	O
oxygenate	O
and	O
ventilate	O
well	O
on	O
his	O
usual	O
ventilator	O
settings	O
.	O

However	O
,	O
the	O
issue	O
that	O
dominated	O
the	O
admission	O
was	O
his	B-problem
recent	I-problem
acute	I-problem
decline	I-problem
in	I-problem
mental	I-problem
status	I-problem
.	O

He	O
was	O
thoroughly	O
evaluated	O
by	O
neurology	O
and	O
underwent	O
head	B-test
CT	I-test
,	O
MRI	B-test
,	O
LP	B-test
,	O
and	O
EEG	B-test
.	O

This	B-test
work-up	I-test
demonstrated	O
a	B-problem
small	I-problem
left	I-problem
basal	I-problem
ganglia	I-problem
infarct	I-problem
,	O
likely	O
cardioembolic	B-problem
.	O

However	O
,	O
they	O
felt	O
this	O
event	O
could	O
not	O
account	O
for	O
his	B-problem
new	I-problem
,	I-problem
severe	I-problem
global	I-problem
deficit	I-problem
;	O
this	O
was	O
thought	O
to	O
be	O
secondary	O
to	O
a	B-problem
more	I-problem
pervasive	I-problem
process	I-problem
,	O
likely	O
anoxic	B-problem
encephalopathy	I-problem
,	O
for	O
which	O
the	O
prognosis	O
is	O
extremely	O
grim	O
.	O

This	O
was	O
discussed	O
at	O
length	O
in	O
several	O
family	O
meetings	O
involving	O
the	O
patient	O
's	O
wife	O
,	O
son	O
,	O
primary	O
care	O
doctor	O
,	O
ICU	O
attending	O
,	O
and	O
neurology	O
consultant	O
in	O
the	O
presence	O
of	O
a	O
Asian	O
interpreter	O
.	O

The	O
end	O
result	O
of	O
these	O
discussion	O
was	O
that	O
the	O
patient	O
's	O
wishes	O
would	O
not	O
be	O
consistent	O
with	O
this	O
new	O
level	O
of	O
functioning	O
from	O
which	O
he	O
had	O
little	O
hope	O
of	O
recovery	O
;	O
the	O
family	O
decided	O
to	O
make	O
him	O
comfort	B-treatment
measures	I-treatment
only	I-treatment
.	O

He	O
was	O
disconnected	O
from	O
the	B-treatment
ventilator	I-treatment
and	O
all	B-treatment
medications	I-treatment
beyond	O
a	B-treatment
morphine	I-treatment
drip	I-treatment
were	O
stopped	O
,	O
and	O
he	O
expired	O
shortly	O
thereafter	O
.	O

The	O
family	O
was	O
present	O
.	O

Medications	O
on	O
Admission	O
:	O

Jevity	B-treatment
1.2	O
65	O
mL	O
/	O
hour	O
continuous	O
with	O
water	O
240	O
cc	O
q	O
8	O
hours	O

Lasix	B-treatment
40	O
mg	O
IV	O
QAM	O
(	O
given	O
08-14	O
)	O

Vancomycin	B-treatment
1	O
gm	O
IV	O
q	O
36	O
hours	O
(	O
last	O
dose	O
at	O
2000	O
on	O
08-13	O
)	O
.	O

Started	O
on	O
08-09	O
)	O

ASA	B-treatment
325	O
mg	O
PO	O
QD	O

Lansoprazole	B-treatment
30	O
mg	O
PO	O
QAM	O

Heparin	B-treatment
5000	O
units	O
SC	O
TID	O

Zosyn	B-treatment
4.5	O
gm	O
IV	O
q	O
8	O
hours	O
(	O
last	O
dose	O
on	O
08-14	O
at	O
1400	O
)	O
,	O
started	O
08-08	O
.	O

Metoprolol	B-treatment
37.5	O
mg	O
q	O
12	O
hours	O
(	O
last	O
dose	O
07/25	O
in	O
AM	O
)	O

Protein	B-treatment
/	I-treatment
Soy	I-treatment
supplement	I-treatment
2	O
scoops	O
q	O
12	O
hours	O

Ipratropium	B-treatment
/	O
Albuterol	B-treatment
inhaler	I-treatment
4	O
puffs	O
QID	O

Completed	O
course	O
of	O
Flagyl	B-treatment
07-25	O
-->	O
08-10	O
.	O

Discharge	O
Disposition	O
:	O

Expired	O

Discharge	O
Diagnosis	O
:	O

Anoxic	B-problem
encephalopathy	I-problem

Acute	B-problem
respiratory	I-problem
failure	I-problem

Chronic	B-problem
respiratory	I-problem
failure	I-problem

Pseudomonal	B-problem
pneumonia	I-problem

Volume	B-problem
overload	I-problem

Chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem

Bronchiectasis	B-problem

Hyponatremia	B-problem

Anemia	B-problem
of	I-problem
chronic	I-problem
disease	I-problem

Secondary	O
:	O

1.	O
Non-small	B-problem
cell	I-problem
lung	I-problem
cancer	I-problem
s/p	B-treatment
XRT	I-treatment
and	O
chemotherapy	B-treatment
in	O
Western	O
Sahara	O
,	O
s/p	B-treatment
right	I-treatment
pneumonectomy	I-treatment
in	O
2016-09-21	O
for	O
recurrence	B-problem
.	O

Chronic	B-problem
left	I-problem
pleural	I-problem
effusion	I-problem
.	O

2.	O
Sick	B-problem
Sinus	I-problem
Syndrome	I-problem
status	B-treatment
post	I-treatment
PM/ICD	I-treatment
placement	I-treatment

3.	O
COPD/bronchiectasis	B-problem

4.	O
Hypertension	B-problem

5.	O
CAD	B-problem
,	O
with	O
known	O
TO	O
RCA	O
.	O

6.	O
CHF	B-problem
with	O
EF	B-test
25%	O
on	O
last	B-test
echo	I-test
on	O
2017-07-19	O

7.	O
BPH	B-problem

8.	O
Depression	B-problem

9.	O
Left	B-problem
femoral	I-problem
AV	I-problem
fistula	I-problem
2017-04-19	O

10.	O
Recent	B-problem
MRSA	I-problem
pneumonia	I-problem
and	O
sepsis	B-problem
2017-07-21	O
,	O
treated	O
with	O
Vancomycin	B-treatment

11.	O
C.	B-problem
difficile	I-problem
colitis	I-problem
treated	O
with	O
Flagyl	B-treatment
(	O
completed	O
08-10	O
)	O

12.	O
Status	B-treatment
post	I-treatment
PEG	I-treatment
tube	I-treatment
placement	I-treatment
2017-07-21	O

13.	O
Status	B-treatment
post	I-treatment
tracheostomy	I-treatment
2017-07-21	O
02-22	O
failure	B-problem
to	I-problem
wean	I-problem

14.	O
Status	B-treatment
post	I-treatment
partial	I-treatment
colectomy	I-treatment
1972	O

Discharge	O
Condition	O
:	O

Expired	O

Johnnie	O
Callez	O
MD	O
61-750	O

Completed	O
by	O
:	O
Opal	O
Anne	O
MD	O
40-158	O
2017-08-23	O
@	O
2054	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Teresa	O
Loper	O
on	O
:	O
FRI	O
2017-09-22	O
4:29	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2018-12-26	O

Discharge	O
Date	O
:	O

2019-01-10	O

Date	O
of	O
Birth	O
:	O

1949-02-09	O

Sex	O
:	O

F	O

Service	O
:	O

MEDICINE	B-treatment

Allergies	O
:	O

Losartan	B-treatment
/	O
Aspirin	B-treatment
/	O
Lisinopril-Hctz	B-treatment

Attending	O
:	O
Donald	O
I	O
Patrick	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O
fever	B-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Intubation	B-treatment
for	O
airway	B-treatment
protection	I-treatment
tunneled	B-treatment
line	I-treatment
change	I-treatment
over	I-treatment
wire	I-treatment
2019-01-08	O

History	O
of	O
Present	O
Illness	O
:	O

69	O
y/o	O
female	O
wtih	O
PMH	O
significant	O
for	O
ESRD	B-problem
on	O
HD	B-treatment
,	O
type	B-problem
2	I-problem
DM	I-problem
,	O
and	O
recent	B-problem
PE	I-problem
resulting	O
in	O
PEA	B-problem
arrest	I-problem
admitted	O
through	O
the	O
Juan	O
with	O
sepsis	B-problem
of	O
unknown	O
etiology	O
.	O

Pt	O
was	O
recently	O
admitted	O
to	O
The	O
Hospital	O
for	O
Orthopedics	O
from	O
12-07	O
thorugh	O
12-14	O
with	O
hypotension	B-problem
thought	O
to	O
be	O
secondary	O
to	O
overdiuresis	B-problem
at	O
HD.	B-treatment

However	O
,	O
a	B-problem
septic	I-problem
component	I-problem
to	O
the	B-problem
hypotension	I-problem
was	O
also	O
considered	O
as	O
the	O
pt	O
was	O
found	O
to	O
have	O
citrobacter	B-problem
in	I-problem
her	I-problem
urine	I-problem
and	O
C	B-problem
diff	I-problem
in	I-problem
her	I-problem
stool	I-problem
.	O

Pt	O
was	O
then	O
discharged	O
to	O
Arbour-Fuller	O
Hospital	O
Senior	O
Life	O
where	O
she	O
was	O
in	O
her	O
normal	O
state	O
of	O
health	O
until	O
three	O
days	O
ago	O
.	O

Her	O
son	O
reports	O
that	O
she	O
then	O
developed	O
a	B-problem
headache	I-problem
and	O
fevers	B-problem
started	O
three	O
days	O
ago	O
which	O
were	O
treated	O
with	O
tylenol	B-treatment
.	O

Then	O
,	O
this	O
morning	O
she	O
developed	O
fatigue	B-problem
and	O
did	O
not	O
eat	O
well	O
.	O

He	O
son	O
also	O
notes	O
that	O
she	O
appeared	O
to	O
be	O
working	B-problem
hard	I-problem
to	I-problem
breath	I-problem
.	O

She	O
was	O
found	O
to	O
be	O
febrile	B-problem
to	O
101.9	O
and	O
received	O
levoflox	B-treatment
and	O
vancomycin	B-treatment
.	O

Pt	O
was	O
then	O
sent	O
to	O
the	O
The	O
Hospital	O
for	O
Orthopedics	O
Juan	O
for	O
further	B-test
evaluation	I-test
.	O

Per	O
notes	O
,	O
pt	O
denied	O
SOB	B-problem
,	O
CP	B-problem
,	O
and	O
abdominal	B-problem
pain	I-problem
prior	O
to	O
intubation	B-treatment
.	O

She	O
did	O
complain	O
of	O
a	B-problem
left	I-problem
frontal	I-problem
headache	I-problem
.	O

In	O
the	O
Juan	O
,	O
the	B-test
pt	I-test
's	I-test
VS	I-test
were	O
singificant	O
for	O
a	B-problem
fever	I-problem
of	O
103.8	O
,	O
tachycardia	B-problem
in	O
the	O
130s-150s	O
,	O
and	O
initial	B-problem
hypertensive	I-problem
in	O
the	O
140s	O
.	O

Her	B-test
oxygen	I-test
saturation	I-test
was	O
96%	O
on	O
RA	O
but	O
she	O
was	O
tachypneic	B-problem
to	O
31	O
.	O

She	O
was	O
obtunded	B-problem
and	O
was	O
thus	O
intubated	B-treatment
for	O
airway	B-treatment
protection	I-treatment
.	O

Post-intubation	O
,	O
the	B-test
pt	I-test
's	I-test
BP	I-test
acutely	O
dropped	O
to	O
58/19	O
in	O
the	O
setting	O
of	O
propofol	B-treatment
.	O

When	O
this	B-treatment
medication	I-treatment
was	O
discontinued	O
,	O
her	B-test
BP	I-test
came	O
back	O
up	O
to	O
the	O
70s-90s	O
/	O
30s-50s	O
.	O

Pt	O
was	O
then	O
initiated	O
on	O
the	B-treatment
sepsis	I-treatment
protocol	I-treatment
.	O

In	O
the	O
Juan	O
,	O
she	O
received	O
vancomycin	B-treatment
,	O
levofloxacin	B-treatment
,	O
flagyl	B-treatment
,	O
and	O
cefepime	B-treatment
(	O
2	O
gm	O
).	O

She	O
received	O
a	O
total	O
of	O
4	O
liters	O
of	O
NS	B-treatment
then	O
was	O
started	O
on	O
levophed	B-treatment
for	O
continued	B-problem
hypotension	I-problem
.	O

Pt	O
is	O
now	O
transferred	O
to	O
the	O
FICU	O
for	O
further	B-treatment
care	I-treatment
.	O

Per	O
pt	O
's	O
son	O
,	O
she	O
is	O
bedbound	B-problem
at	O
baseline	O
due	O
to	O
her	B-problem
multiple	I-problem
LE	I-problem
femur	I-problem
fractures	I-problem
.	O

Past	O
Medical	O
History	O
:	O

1.	O
Type	B-problem
2	I-problem
diabetes	I-problem
mellitus	I-problem

2.	O
Diabetic	B-problem
nephropathy	I-problem
resulting	O
in	O
ESRD	B-problem
for	O
which	O
she	O
is	O
on	O
HD	B-treatment
.	O

Pt	O
was	O
due	O
for	O
HD	B-treatment
but	O
missed	O
it	O
secondary	O
to	O
her	B-problem
illness	I-problem
.	O

She	O
normally	O
receives	O
HD	B-treatment
on	O
Mon	O
,	O
Wed	O
,	O
and	O
Fri	O
.	O

3.	O
Status	B-problem
post	I-problem
left	I-problem
femur	I-problem
fracture	I-problem

4.	O
Hyponatremia	B-problem

5.	O
Hypercholesterolemia	B-problem

6.	O
Unsteady	B-problem
gait	I-problem

7.	O
Cataracts	B-problem

8.	O
Back	B-problem
pain	I-problem

9.	O
Hypertension	B-problem

10.	O
Anemia	B-problem
of	I-problem
chronic	I-problem
disease	I-problem

11.	O
S/P	B-treatment
L	I-treatment
shoulder	I-treatment
hemiarthroplasty	I-treatment
following	O
a	B-problem
left	I-problem
humeral	I-problem
fracuture	I-problem
in	O
2018-11-10-	O
Dumas	O
was	O
complicated	O
by	O
a	B-problem
PEA	I-problem
arrest	I-problem
secondary	O
to	O
PE	B-problem
.	O

12.	O
PE	B-problem
2018-11-17	O
leading	O
to	O
PEA	B-problem
arrest	I-problem

Social	O
History	O
:	O

Lives	O
with	O
son	O
who	O
is	O
very	O
involved	O
and	O
well	O
informed	O
regarding	O
her	O
care	O
needs	O
.	O

Non	O
smoker	O
.	O

No	O
EtOH	O

Family	O
History	O
:	O

Noncontributory	O

Physical	O
Exam	O
:	O

94.5	O

132/50	O

108	O

15	O

100%	O

AC	O
500	O
/	O
15	O
/	O
.50	O
/	O
PEEP	B-treatment
5	O

Gen	O
-	O
Sedated	B-treatment
and	O
intubated	B-treatment
.	O

Grimaces	O
eyes	O
when	O
they	O
are	O
opened	O
.	O

HEENT	O
-	O
NC	O
AT	O
.	O

Right	O
pupil	O
ERRL	O
.	O

Surgical	O
left	O
pupil	O
.	O

Anicteric	B-problem
sclera	I-problem
.	O

MMM	O
.	O

Cardiac	O
-	O
RRR	O
.	O

S1	O
S2	O
.	O

No	O
m,r,g	B-problem
.	O

Pulm	O
-	O
CTA	O
anteriorlly	O
.	O

Abdomen	O
-	O
Obese	B-problem
.	O

Soft	O
.	O

NT	B-problem
.	O

ND	B-problem
.	O

Positive	O
bowel	O
sounds	O
.	O

Extremities	O
-	O
Feet	B-problem
mildly	I-problem
cool	I-problem
.	O

2+	B-test
DP	I-test
pulses	I-test
bilaterally	I-test
.	O

2+	B-problem
pitting	I-problem
edema	I-problem
bilateral	I-problem
LE	I-problem
.	O

Skin	B-problem
breakdown	I-problem
between	I-problem
toes	I-problem
.	O

Pressure	B-problem
ulcers	I-problem
under	I-problem
bilateral	I-problem
LE	I-problem
right	O
above	O
the	O
ankles	O
.	O

Do	O
not	O
appear	O
infected	B-problem
.	O

Question	O
mild	B-problem
erythema	I-problem
and	O
warmth	B-problem
of	I-problem
left	I-problem
LE	I-problem
.	O

Neuro	O
-	O
Sedated	B-problem
.	O

Downgoing	O
toes	O
bilaterally	O
.	O

Scruntches	O
eyes	O
closed	O
when	O
try	O
to	O
open	O
them	O
.	O

Pertinent	O
Results	O
:	O

2018-12-26	O
11:10	O
PM	O

LACTATE	B-test
-	O
1.8	O

2018-12-26	O
10:53	O
PM	O

CRP	B-test
-	O
46.2	O
*	O

2018-12-26	O
10:53	O
PM	O

SED	B-test
RATE	I-test
-	O
33	O
*	O

2018-12-26	O
09:54	O
PM	O

TYPE	O
-	O
MIX	B-test
TEMP	I-test
-	O
35.6	O
RATES	B-test
-/	O
15	O
TIDAL	B-test
VOL	I-test
-	O
500	O
PEEP	B-treatment
-	O
5	O
O2	B-test
-	O
50	O
PO2	B-test
-	O
34	O
*	O
PCO2	B-test
-	O
39	O
PH	B-test
-	O
7.32	O
*	O
TOTAL	B-test
CO2	I-test
-	O
21	O
BASE	B-test
XS	I-test
-	O
-6	O

-	O
ASSIST	O
/	O
CON	O
INTUBATED	B-treatment
-	O
INTUBATED	B-treatment

2018-12-26	O
09:54	O
PM	O

LACTATE	B-test
-	O
1.6	O

2018-12-26	O
09:44	O
PM	O

GLUCOSE	B-test
-	O
210	O
*	O
UREA	B-test
N	I-test
-	O
29	O
*	O
CREAT	B-test
-	O
3.2	O
*	O
SODIUM	B-test
-	O
139	O
POTASSIUM	B-test
-	O
3.9	O
CHLORIDE	B-test
-	O
112	O
*	O
TOTAL	B-test
CO2	I-test
-	O
17	O
*	O
ANION	B-test
GAP	I-test
-	O
14	O

2018-12-26	O
09:44	O
PM	O

CALCIUM	B-test
-	O
6.2	O
*	O
PHOSPHATE	B-test
-	O
1.7	O
*	O
MAGNESIUM	B-test
-	O
0.9	O
*	O

2018-12-26	O
09:44	O
PM	O

CORTISOL	B-test
-	O
10.3	O

2018-12-26	O
09:44	O
PM	O

WBC	B-test
-	O
9.0	O
RBC	B-test
-	O
2.93	O
*	O
HGB	B-test
-	O
9.0	O
*	O
HCT	B-test
-	O
29.7	O
*	O
MCV	B-test
-	O
101	O
*	O
MCH	B-test
-	O
30.8	O
MCHC	B-test
-	O
30.4	O
*	O
RDW	B-test
-	O
24.1	O
*	O

2018-12-26	O
09:44	O
PM	O

NEUTS	B-test
-	O
65.2	O
LYMPHS	B-test
-	O
25.2	O
MONOS	B-test
-	O
6.0	O
EOS	B-test
-	O
3.3	O
BASOS	B-test
-	O
0.4	O

2018-12-26	O
09:44	O
PM	O

HYPOCHROM	B-test
-	O
3+	O
ANISOCYT	B-test
-	O
3+	O
POIKILOCY	B-test
-	O
1+	O
MACROCYT	B-test
-	O
3+	O
MICROCYT	B-test
-	O
1+	O

2018-12-26	O
09:44	O
PM	O

PLT	B-test
COUNT	I-test
-	O
177	O

2018-12-26	O
08:28	O
PM	O

CORTISOL	B-test
-	O
9.3	O

2018-12-26	O
08:28	O
PM	B-test
URINE	I-test

COLOR	B-test
-	O
Yellow	O
APPEAR	B-test
-	O
SlHazy	O
SP	O
Barajas	O
-	O
1.005	O

2018-12-26	O
08:28	O
PM	B-test
URINE	I-test

BLOOD	B-test
-	O
LGE	B-test
NITRITE	I-test
-	O
NEG	O
PROTEIN	B-test
-	O
500	O
GLUCOSE	B-test
-	O
TR	O
KETONE	B-test
-	O
NEG	O
BILIRUBIN	B-test
-	O
NEG	O
UROBILNGN	B-test
-	O
NEG	O
PH	B-test
-	O
7.0	O
LEUK	B-test
-	O
NEG	O

2018-12-26	O
08:28	O
PM	B-test
URINE	I-test

RBC	B-test
-	O
225	O
*	O
WBC	B-test
-	O
8	O
*	O
BACTERIA	B-test
-	O
NONE	O
YEAST	B-test
-	O
NONE	O
EPI	B-test
-	O
<	O
1	O

2018-12-26	O
02:40	O
PM	O

CK	B-test
(	I-test
CPK	I-test
)-	I-test
350	O
*	O

2018-12-26	O
02:40	O
PM	O

CK	B-test
-	O
MB	B-test
-	O
3	O
cTropnT	B-test
-	O
0.40	O
*	O

MICRO	O
:	O
sputum	B-test
12-27	O
:	O
grm	B-test
stn	I-test
and	O
cx	B-test
negative	O

infl	B-test
A	I-test
and	I-test
B	I-test
12-27	O
:	O
negative	O

CSF	B-test
grm	I-test
stn	I-test
/	O
cx	B-test
:	O
negative	O

urine	B-test
cx	I-test
12-26	O
:	O
>	O
100K	O
VRE	B-problem
likely	O
colonized	O
,	O
01-03	O
yest	O
and	O
VRE	B-problem

c	B-test
diff	I-test
neg	O
:	O
12-28	O
,	O
12-31	O
,	O
01-01	O
,	O
01-02	O
.	O

bld	B-test
cx	I-test
12-26	O
,	O
12-27	O
,	O
12-28	O
,	O
12-31	O
-	O
NG	O
.	O

01-01	O
,	O
01-02	O
X	O
3	O
,	O
01-03	O
,	O
01-04	O
,	O
11/27X	O
2	O
NGTD	O
.	O

Catheter	B-treatment
tip	I-treatment
01-05	O
,	O
NG	B-treatment
.	O

C.	B-test
Diff	I-test
B	I-test
-	O
negative	O

Tunnled	B-treatment
catheter	I-treatment
tip	I-treatment
01-08	O
-	O
ngtd	O

HERPES	B-test
SIMPLEX	I-test
VIRUS	I-test
PCR	I-test
-	O
PND	O

Brief	O
Hospital	O
Course	O
:	O

A/P	O
:	O

69	O
y/o	O
female	O
wtih	O
PMH	B-problem
significant	O
for	O
ESRD	B-problem
on	O
HD	B-treatment
,	O
type	B-problem
2	I-problem
DM	I-problem
,	O
and	O
recent	B-problem
PE	I-problem
resulting	O
in	O
PEA	B-problem
arrest	I-problem
admitted	O
through	O
the	O
Juan	O
with	O
sepsis	B-problem
of	O
unknown	O
etiology	O
.	O

1.	O
Sepsis	B-problem
/	O
ID-	O
Started	O
on	O
sepsis	B-treatment
protocol	I-treatment
.	O

Unclear	O
etiology	O
headache	B-problem
over	O
the	O
three	O
days	O
prior	O
to	O
admission	O
in	O
association	O
with	O
fever	B-problem
was	O
concerning	O
for	O
a	O
CNS	O
etiology	O
.	O

Covered	O
broadly	O
with	O
vancomycin	B-treatment
,	O
flagyl	B-treatment
,	O
and	O
cefipime	B-treatment
.	O

Given	O
stress	B-treatment
dose	I-treatment
steroids	I-treatment
empirically	O
and	O
Sanchez	B-test
stim	I-test
showed	O
cortisol	B-test
of	O
9.3	O
-->	O
10.3	O
therefore	O
steroids	B-treatment
continued	O
.	O

CXR	B-test
,	O
LP	B-test
,	O
UA	B-test
and	O
abdominal	B-test
CT	I-test
showed	O
no	O
sign	O
of	O
infection	B-problem
.	O

PICC	B-treatment
line	I-treatment
was	O
removed	O
empirically	O
.	O

Tip	B-treatment
could	O
not	O
be	O
cultured	O
due	O
to	O
contamination	B-problem
.	O

Cultures	B-test
drawn	O
off	O
the	B-treatment
HD	I-treatment
cath	I-treatment
are	O
negative	O
to	O
date	O
.	O

Patient	B-problem
's	I-problem
LE	I-problem
ulcers	I-problem
appear	O
chronic	O
and	O
do	O
not	O
appear	O
to	O
be	O
the	O
source	O
of	O
infection	B-problem
.	O

Her	O
left	O
knee	O
is	O
slightly	B-problem
erythematous	I-problem
compared	O
to	O
the	O
right	O
but	O
not	O
impressive	O
.	O

Joint	O
is	O
mobile	O
.	O

Nasal	B-test
washings	I-test
for	O
influenza	B-problem
were	O
negative	O
;	O
culture	B-test
pending	O
.	O

Patient	O
improved	O
over	O
the	O
next	O
few	O
days	O
.	O

Steroids	B-treatment
were	O
discontinued	O
.	O

On	O
12-18	O
flagyl	B-treatment
and	O
cefepime	B-treatment
were	O
discontinued	O
as	O
all	B-test
culture	I-test
data	I-test
negative	O
to	O
date	O
.	O

Plan	O
to	O
continue	O
vancomycin	B-treatment
for	O
08-19	O
day	O
course	O
to	O
treat	O
empiric	B-problem
line	I-problem
infection	I-problem
.	O

Urine	B-test
culture	I-test
came	O
back	O
positive	O
for	O
VRE	B-problem
,	O
however	O
,	O
since	O
patient	O
improved	O
without	O
treatement	B-treatment
(	O
ie	O
Linezolid	B-treatment
)	O
initially	O
.	O

After	O
transfer	O
to	O
the	O
floor	O
when	O
she	O
was	O
stable	O
.	O

On	O
the	O
floor	O
the	B-treatment
Vancomycin	I-treatment
was	O
discontinued	O
as	O
the	B-test
catheter	I-test
tip	I-test
culture	I-test
was	O
negative	O
.	O

ID	O
was	O
consulted	O
who	O
suggested	O
broad	B-treatment
spectrum	I-treatment
antibiotics	I-treatment
if	O
she	O
were	O
to	O
spike	B-problem
.	O

When	O
pt	O
spiked	O
a	B-problem
temperature	I-problem
and	O
became	O
hypotensive	B-problem
she	O
was	O
started	O
on	O
Linezolid	B-treatment
was	O
started	O
for	O
presumed	O
VRE	B-problem
infection	I-problem
in	I-problem
the	I-problem
urine	I-problem
.	O

She	O
will	O
be	O
treated	O
for	O
total	O
14	O
day	O
course	O
.	O

She	O
was	O
also	O
started	O
on	O
fluconazole	B-treatment
for	O
yeast	B-problem
in	I-problem
the	I-problem
urine	I-problem
,	O
to	O
be	O
treated	O
with	O
fluconazole	B-treatment
for	O
total	O
7	O
days	O
.	O

She	O
was	O
given	O
Flagyl	B-treatment
for	O
presumed	O
C.	B-problem
Diff.	I-problem
Colitis	I-problem
,	O
however	O
this	O
was	O
stopped	O
when	O
C.	B-test
Diff	I-test
B	I-test
toxin	I-test
came	O
back	O
negative	O
on	O
2019-01-10	O
.	O

The	B-treatment
tunneled	I-treatment
catheter	I-treatment
line	I-treatment
was	O
changed	O
over	O
a	B-treatment
wire	I-treatment
and	O
the	B-test
tip	I-test
was	O
also	O
negative	O
.	O

2.	O
Respiratory	O
-	O
Intubated	B-treatment
for	O
airway	B-treatment
protection	I-treatment
due	O
to	O
change	B-problem
in	I-problem
mental	I-problem
status	I-problem
.	O

Extubated	B-treatment
12-28	O
with	O
no	O
incident	O
.	O

3.	O
ECG	B-problem
changes	I-problem
-	O
Patient	O
had	O
an	O
episode	O
of	O
chest	B-problem
pain	I-problem
during	O
her	O
hospital	O
stay	O
that	O
was	O
both	O
right	O
and	O
left	O
sided	O
with	O
no	O
radiation	O
and	O
no	O
associated	B-problem
symptoms	I-problem
.	O

ECG	B-test
showed	O
new	B-problem
diffuse	I-problem
TWI	I-problem
in	I-problem
all	I-problem
leads	I-problem
.	O

Cardiac	B-test
enzymes	I-test
were	O
cycled	O
and	O
were	O
normal	O
.	O

Echo	B-test
was	O
obtained	O
which	O
showed	O
WMA	B-problem
and	O
EF	B-test
of	O
35-40%	O
.	O

Pt	O
was	O
note	O
started	O
on	O
ASA	B-treatment
as	O
she	O
does	O
not	O
tolerate	O
this	O
well	O
,	O
BB	B-treatment
was	O
also	O
not	O
started	O
given	O
SBPs	B-test
in	O
the	O
110s	O
.	O

Statin	B-treatment
was	O
also	O
deffered	O
.	O

She	O
may	O
be	O
started	O
on	O
ASA	B-treatment
,	O
BB	B-treatment
,	O
statin	B-treatment
by	O
PCP	O
as	O
Stephen	O
.	O

4.	O
Shoulder	B-problem
fracture	I-problem
-	O
Patient	O
is	O
s/p	B-problem
a	I-problem
left	I-problem
hip	I-problem
fracture	I-problem
(	O
decision	O
not	O
to	O
operate	O
)	O
and	O
a	B-problem
left	I-problem
shoulder	I-problem
fracture	I-problem
with	O
hemiarthroplasty	B-treatment
11-14	O
.	O

Patient	O
was	O
found	O
to	O
have	O
a	B-problem
new	I-problem
humerus	I-problem
fracture	I-problem
distal	I-problem
to	I-problem
the	I-problem
hardware	I-problem
on	O
film	B-test
this	O
admission	O
.	O

Assumed	O
to	O
be	O
secondary	O
to	O
trauma	B-problem
when	O
moving	O
patient	O
into	O
ambulance	O
.	O

CMED	O
service	O
was	O
consulted	O
and	O
recommended	O
wtd	B-treatment
woulnd	I-treatment
care	I-treatment
and	O
sling	B-treatment
at	O
all	O
times	O
.	O

Wound	B-treatment
care	I-treatment
should	O
be	O
continued	O
as	O
described	O
after	O
discharge	O
.	O

5.	O
Type	B-problem
2	I-problem
DM	I-problem
-	O
Patient	O
was	O
initially	O
covered	O
with	O
an	B-treatment
insulin	I-treatment
drip	I-treatment
while	O
septic	B-problem
and	O
then	O
transitioned	O
back	O
to	O
insulin	B-treatment
sliding	I-treatment
scale	I-treatment
.	O

6.	O
ESRD	B-problem
on	O
HD	B-treatment
-	O
Pt	O
has	O
ESRD	B-problem
secondary	O
to	O
her	B-problem
DM	I-problem
and	O
is	O
on	O
HD	B-treatment
.	O

She	O
was	O
dialysed	O
but	O
was	O
slightly	B-problem
limited	I-problem
by	O
hypotension	B-problem
.	O

Dialyzed	O
12-28	O
with	O
plan	O
to	O
dialyze	O
again	O
12-31	O
.	O

Her	B-treatment
dialysis	I-treatment
was	O
managed	O
by	O
renal	O
service	O
in	O
house	O
.	O

7.	O
PE	B-problem
(	O
11-14	O
)-	O
On	O
heparin	B-treatment
drip	I-treatment
.	O

Restared	O
coumadin	B-treatment
on	O
12-29	O
.	O

Heparin	B-treatment
discontinued	O
on	O
01-01	O
when	O
INR	B-test
was	O
2.0	O
.	O

Coumadin	B-treatment
was	O
stopped	O
and	O
she	O
received	O
fFP	B-treatment
for	O
tunneled	B-treatment
line	I-treatment
change	I-treatment
over	I-treatment
a	I-treatment
wire	I-treatment
.	O

Coumadin	B-treatment
was	O
restarted	O
at	O
a	O
dose	O
of	O
2	O
mg	O
qhs	O
.	O

This	O
should	O
be	O
titrated	O
after	O
discharge	O
for	O
INR	B-test
goal	I-test
of	O
2-3	O
.	O

8.	O
PVD	B-problem
:	O

Dry	B-problem
gangrene	I-problem
of	I-problem
toes	I-problem
bilaterally	I-problem
w/	O
necrosis	B-problem
of	I-problem
the	I-problem
heels	I-problem
and	I-problem
posterior	I-problem
calf	I-problem
.	O

Continue	O
to	O
monitor	B-test
for	O
sign	O
of	O
infection	B-problem
.	O

On	O
vit	B-treatment
C.	I-treatment
and	O
zinc	B-treatment
as	O
well	O
to	O
aid	O
w/	O
wound	O
healing	O
.	O

Wound	O
care	O
consult	O
given	O
anasarca	B-treatment
to	O
prevent	O
decub	B-problem
.	O

9.	O
Left	O
UE	O
markedly	O
more	B-problem
edematous	I-problem
than	O
right	O
UE	O
,	O
this	O
could	O
be	O
from	O
fracture	B-problem
,	O
or	O
there	O
could	O
be	O
a	B-problem
clot	I-problem
,	O
an	B-problem
abscess	I-problem
in	I-problem
the	I-problem
area	I-problem
also	O
a	O
possiblity	O
.	O

Ultrasound	B-test
without	O
clot	B-problem
.	O

Continue	O
elevation	B-treatment
and	O
tight	B-treatment
dressing	I-treatment
to	I-treatment
LUE	I-treatment
>	O

10.	O
Access	O
-	O
Left	B-treatment
IJ	I-treatment
placed	O
12-26	O
in	O
Juan	O
was	O
discontinued	O
during	O
the	O
hospitilization	O
.	O

Right	B-treatment
dialysis	I-treatment
catheter	I-treatment
(	O
2018-11-05	O
)	O
was	O
changed	O
over	O
a	B-treatment
wire	I-treatment
2019-01-08	O
.	O

PICC	B-treatment
line	I-treatment
placed	O
2019-01-08	O
,	O
this	O
should	O
be	O
discontinued	O
immediately	O
after	O
pt	O
finishes	O
the	B-treatment
linezolid	I-treatment
course	I-treatment
.	O

11.	O
Code	O
status	O
-	O
Initially	O
full	O
code	O
then	O
made	O
DNR	O
/	O
DNI	O
after	O
family	O
meeting	O
on	O
02-27	O
.	O

Made	O
full	O
code	O
again	O
on	O
12-30	O
after	O
family	O
meeting	O
with	O
son	O
.	O

Larry	O
would	O
like	O
everything	O
done	O
.	O

12.	O
Communication	O
-	O
With	O
pt	O
's	O
son	O
.	O

His	O
name	O
is	O
Andrea	O
and	O
his	O
phone	O
number	O
is	O
794	O
1029	O
x.	O
1385	O
.	O

Medications	O
on	O
Admission	O
:	O

1.	O
Ascorbic	B-treatment
acid	I-treatment
500	O
mg	O
BID	O

2.	O
Folic	B-treatment
acid	I-treatment
1	O
mg	O
daily	O

3.	O
Humulin	B-treatment
insulin	I-treatment
2	O
units	O
QAM	O

4.	O
RISS	B-treatment

5.	O
Pantoprazole	B-treatment
40	O
mg	O
BID	O

6.	O
Neutra	B-treatment
phos	I-treatment
2	O
tabs	O
BID	O

7.	O
Vitamin	B-treatment
B	I-treatment
complex	I-treatment
1	O
tab	O
daily	O

8.	O
Coumadin	B-treatment
-	O
Dose	O
unknown	O

9.	O
Tylenol	B-treatment
650	O
mg	O
Q4H	O
PRN	O

10.	O
Ondansetron	B-treatment
4	O
mg	O
Q6H	O
PRN	O

Discharge	O
Medications	O
:	O

1.	O
Ascorbic	B-treatment
Acid	I-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

2.	O
Folic	B-treatment
Acid	I-treatment
1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

3.	O
Zinc	B-treatment
Sulfate	I-treatment
220	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

4.	O
Acetaminophen	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

5.	O
Papain	B-treatment
-	I-treatment
Urea	I-treatment
544	O
287	O
0616	O
unit	O
-	O
mg	O
/	O
g	O
Ointment	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
DAILY	O
(	O
Daily	O
)	O
.	O

6.	O
Ipratropium	B-treatment
Bromide	I-treatment
0.02	O
%	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Inhalation	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
.	O

7.	O
Calcium	B-treatment
Acetate	I-treatment
667	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
W/	O
MEALS	O
(	O
3	O
TIMES	O
A	O
DAY	O
WITH	O
MEALS	O
)	O
.	O

8.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
:	O
Hold	O
for	O
SBP	O
<	O
100	O
,	O
HR	O
<	O
60	O
.	O

9.	O
Fluconazole	B-treatment
200	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
for	O
2	O
days	O
.	O

10.	O
Insulin	B-treatment
Regular	I-treatment
Human	I-treatment
300	O
unit	O
/	O
3	O
mL	O
Insulin	O
Pen	O
Sig	O
:	O
as	O
directed	O
Subcutaneous	O
four	O
times	O
a	O
day	O
:	O
Please	O
administer	O
8	O
units	O
glargine	B-treatment
at	O
dinner	O
and	O
regular	B-treatment
insulin	I-treatment
sliding	I-treatment
scale	I-treatment
as	O
prescribed	O
.	O

11.	O
Warfarin	B-treatment
2	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
)	O
:	O
Titrate	O
dose	O
to	O
Goal	O
INR	B-test
03-15	O
.	O

Tablet	O
(	O
s	O
)	O

12.	O
Linezolid	B-treatment
600	O
mg	O
IV	O
Q12H	O

13.	O
Heparin	B-treatment
Flush	I-treatment
PICC	I-treatment
(	O
100	O
units	O
/	O
ml	O
)	O
2	O
ml	O
IV	O
DAILY	O
:	O
PRN	O
10	O
ml	O
NS	O
followed	O
by	O
2	O
ml	O
of	O
100	O
Units	O
/	O
ml	O
heparin	B-treatment
(	O
200	O
units	O
heparin	B-treatment
)	O
each	O
lumen	B-treatment
Daily	O
and	O
PRN	O
.	O

Inspect	O
site	O
every	O
shift	O
.	O

14.	O
Heparin	B-treatment
Flush	I-treatment
CVL	I-treatment
(	O
100	O
units	O
/	O
ml	O
)	O
1	O
ml	O
IV	O
DAILY	O
:	O
PRN	O

10ml	O
NS	B-treatment
followed	O
by	O
1ml	O
of	O
100	O
units/ml	O
heparin	B-treatment
(	O
100	O
units	O
heparin	B-treatment
)	O
each	O
lumen	B-treatment
QD	O
and	O
PRN	O
.	O

Inspect	O
site	O
every	O
shift	O

15.	O
Dolasetron	B-treatment
Mesylate	I-treatment
12.5	O
mg	O
IV	O
Q8H	O
:	O
PRN	O

16.	O
medication	B-treatment

Please	O
complete	O
a	O
total	O
14	O
day	O
course	O
of	O
linezolid	B-treatment
.	O

Stop	O
linezolid	B-treatment
on	O
2019-01-17	O
.	O

The	B-treatment
PICC	I-treatment
line	I-treatment
should	O
be	O
discontinued	O
promptly	O
after	O
the	B-treatment
linezolid	I-treatment
course	I-treatment
is	O
completed	O
.	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Facility	O
:	O

Newton-Wellesley	O
Hospital	O
for	O
the	O
Aged	O
-	O
Acute	O
Rehab	O

Discharge	O
Diagnosis	O
:	O

Sepsis	B-problem
-?	O
source	O

Chronic	B-problem
Kidney	I-problem
disease	I-problem
-	O
on	O
hemodialysis	B-treatment
type	B-problem
2	I-problem
diabetes	I-problem
hypercholestrolemia	B-problem
anemia	B-problem
of	I-problem
chornic	I-problem
disease	I-problem
h/o	O
PE	B-problem
,	O
s/p	B-problem
PEA	I-problem
arrest	I-problem
11-14	O

Discharge	O
Condition	O
:	O

Stable	O

Discharge	O
Instructions	O
:	O

You	O
were	O
admitted	O
with	O
low	B-problem
blood	I-problem
pressure	I-problem
and	O
fevers	B-problem
likely	O
due	O
to	O
an	B-problem
infection	I-problem
.	O

Although	O
there	O
was	O
never	O
any	B-problem
bacteria	I-problem
isolated	O
from	O
the	B-test
blood	I-test
you	O
had	O
some	B-problem
bacteria	I-problem
in	I-problem
the	I-problem
urine	I-problem
which	O
you	O
are	O
being	O
treated	O
for	O
.	O

It	O
is	O
important	O
that	O
you	O
complete	O
the	B-treatment
antibiotic	I-treatment
course	I-treatment
as	O
prescribed	O
.	O

Please	O
continue	O
to	O
take	O
all	B-treatment
medications	I-treatment
as	O
prescirbed	O
and	O
follow	O
up	O
with	O
all	O
your	O
appointments	O
.	O

If	O
you	O
have	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
diahrrea	B-problem
or	O
fevers	B-problem
please	O
contact	O
your	O
PCP	O
.	O

Robert	O
the	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
gets	O
worse	O
please	O
return	O
to	O
emergency	O
room	O
.	O

If	O
you	O
have	O
fevers	B-problem
please	O
contact	O
your	O
PCP	O
or	O
return	O
to	O
the	O
emergency	O
room	O
.	O

Followup	O
Instructions	O
:	O

Please	O
call	O
(	O
664	O
)	O
369-9786	O
to	O
set	O
up	O
an	O
appointment	O
with	O
your	O
primary	O
care	O
doctor	O
Dr.	O
Andrew	O
Shelton	O
in	O
1-2	O
wks	O
after	O
discharge	O
.	O

Cleveland	O
Barbara	O
MD	O
00-732	O

Completed	O
by	O
:	O
Sharon	O
Frank	O
MD	O
75-572	O
2019-01-10	O
@	O
1333	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Janice	O
Oconnell	O
on	O
:	O
Kent	O
2019-01-10	O
3:28	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2012-04-20	O

Discharge	O
Date	O
:	O

2012-05-01	O

Date	O
of	O
Birth	O
:	O

1952-06-24	O

Sex	O
:	O

M	O

Service	O
:	O

Medicine	B-treatment

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
59	O
year	O
old	O
male	O
with	O
a	O
past	O
medical	O
history	O
significant	O
for	O
an	B-treatment
atrioseptal	I-treatment
defect	I-treatment
repair	I-treatment
at	O
age	O
18	O
,	O
congestive	B-problem
heart	I-problem
failure	I-problem
with	O
an	B-test
ejection	I-test
fraction	I-test
of	O
45%	O
and	O
a	B-problem
recent	I-problem
cardiac	I-problem
myocardial	I-problem
infarction	I-problem
,	O
pulmonary	B-problem
hypertension	I-problem
and	O
mitral	B-problem
regurgitation	I-problem
,	O
and	O
atrial	B-problem
fibrillation	I-problem
.	O

He	O
was	O
seen	O
by	O
his	O
primary	O
care	O
physician	O
the	O
day	O
before	O
admission	O
and	O
complained	O
of	O
two	O
weeks	O
of	O
increasing	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
and	O
fatigue	B-problem
,	O
weight	B-problem
gain	I-problem
and	O
abdominal	B-problem
fullness	I-problem
.	O

He	O
was	O
sent	O
to	O
the	O
Emergency	O
Department	O
for	O
further	B-test
evaluation	I-test
.	O

The	O
patient	O
reported	O
feeling	O
at	O
his	O
baseline	O
with	O
chronic	B-problem
mild	I-problem
dyspnea	I-problem
on	O
exertion	O
until	O
two	O
weeks	O
prior	O
to	O
admission	O
.	O

During	O
this	O
period	O
he	O
had	O
also	O
been	O
weaned	O
off	O
of	O
his	B-treatment
Digoxin	I-treatment
starting	O
early	O
in	O
February	O
.	O

Over	O
the	O
two	O
weeks	O
prior	O
to	O
admission	O
he	O
had	O
noticed	O
an	B-problem
increasing	I-problem
heart	I-problem
rate	I-problem
from	O
his	O
baseline	O
in	O
the	O
60s	O
to	O
a	B-test
heart	I-test
rate	I-test
in	O
the	O
120s	O
.	O

He	O
had	O
also	O
some	B-problem
increased	I-problem
shortness	I-problem
of	I-problem
breath	I-problem
and	O
a	B-problem
10	I-problem
pound	I-problem
weight	I-problem
gain	I-problem
and	O
new	O
three	O
to	O
four	O
pillow	B-problem
orthopnea	I-problem
with	O
a	B-problem
dry	I-problem
cough	I-problem
.	O

He	O
denied	O
fevers	B-problem
,	O
chills	B-problem
,	O
nausea	B-problem
or	O
vomiting	B-problem
,	O
chest	B-problem
pain	I-problem
or	O
diaphoresis	B-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Atrioseptal	B-treatment
defect	I-treatment
repair	I-treatment
in	O
1970	O
,	O
cardiomyopathy	B-problem
,	O
right-sided	B-problem
congestive	I-problem
heart	I-problem
failure	I-problem
,	O
pulmonary	B-problem
hypertension	I-problem
,	O
history	O
of	O
atrial	B-problem
fibrillation	I-problem
and	O
atrial	B-problem
flutter	I-problem
,	O
history	O
of	O
prostate	B-problem
cancer	I-problem
,	O
status	B-treatment
post	I-treatment
brachytherapy	I-treatment
,	O
history	O
of	O
rectal	B-problem
bleeding	I-problem
,	O
obstructive	B-problem
sleep	I-problem
apnea	I-problem
on	O
CPAP	B-treatment
.	O

ALLERGIES	O
:	O

ACE	B-treatment
inhibitors	I-treatment
,	O
possible	O
allergy	B-problem
to	O
barium	B-treatment
reported	O
by	O
the	O
patient	O
during	O
a	B-treatment
barium	I-treatment
swallow	I-treatment
25	O
years	O
ago	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Digoxin	B-treatment
0.125	O
,	O
discontinued	O
one	O
month	O
prior	O
to	O
admission	O
,	O
Toprol	B-treatment
XL	I-treatment
100	O
mg	O
daily	O
,	O
Trazodone	B-treatment
50	O
mg	O
once	O
daily	O
,	O
Lipitor	B-treatment
10	O
mg	O
daily	O
,	O
Diovan	B-treatment
40	O
mg	O
daily	O
,	O
Atrovent	B-treatment
/	O
Albuterol	B-treatment
prn	O
,	O
Pulmicort	B-treatment
,	O
Coumadin	B-treatment
2.5	O
mg	O
daily	O
,	O
Vitamin	B-treatment
E	I-treatment
,	O
Vitamin	B-treatment
C	I-treatment
,	O
iron	B-treatment
supplement	I-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

Remote	O
history	O
of	O
tobacco	O
,	O
occasional	O
alcohol	O
use	O
.	O

He	O
is	O
a	O
retired	O
fire	O
fighter	O
.	O

LABORATORY	O
DATA	O
:	O

White	B-test
blood	I-test
cell	I-test
count	I-test
10.5	O
,	O
hematocrit	B-test
38.1	O
,	O
platelets	B-test
254	O
,	O
INR	B-test
1.8	O
.	O

Sodium	B-test
140	O
,	O
potassium	B-test
5.2	O
,	O
BUN	B-test
38	O
,	O
creatinine	B-test
.7	O
,	O
TSH	B-test
1.8	O
,	O
Digoxin	B-test
level	I-test
less	O
than	O
0.2	O
.	O

Serial	B-test
cardiac	I-test
enzymes	I-test
negative	O
.	O

ALT	B-test
14	O
,	O
AST	B-test
31	O
,	O
alkaline	B-test
phosphatase	I-test
283	O
,	O
total	B-test
bilirubin	I-test
1.0	O
,	O
amylase	B-test
71	O
,	O
glucose	B-test
tolerance	I-test
test	I-test
317	O
.	O

Electrocardiogram	B-test
showed	O
atrial	B-problem
fibrillation	I-problem
with	O
rapid	B-problem
ventricular	I-problem
response	I-problem
and	O
atrial	B-problem
flutter	I-problem
.	O

Echocardiogram	B-test
showed	O
moderate	B-problem
dilated	I-problem
left	I-problem
atrium	I-problem
,	O
no	O
atrioseptal	B-problem
defect	I-problem
,	O
severe	B-problem
global	I-problem
left	I-problem
ventricular	I-problem
hypokinesis	I-problem
with	O
severe	B-problem
left	I-problem
ventricular	I-problem
systolic	I-problem
function	I-problem
and	O
moderately	B-problem
dilated	I-problem
right	I-problem
ventricle	I-problem
.	O

There	O
was	O
global	B-problem
hypokinesis	I-problem
apical	I-problem
throughout	I-problem
the	I-problem
right	I-problem
ventricle	I-problem
and	O
abnormal	B-problem
septal	I-problem
motion	I-problem
consistent	O
with	O
right	B-problem
ventricular	I-problem
volume	I-problem
overload	I-problem
.	O

Moderate	B-problem
to	I-problem
severe	I-problem
3+	I-problem
mitral	I-problem
regurgitation	I-problem
and	O
3+	B-problem
tricuspid	I-problem
regurgitation	I-problem
along	O
with	O
moderate	B-problem
pulmonary	I-problem
early	I-problem
systolic	I-problem
hypertension	I-problem
.	O

Of	O
note	O
,	O
this	B-test
echocardiogram	I-test
was	O
performed	O
when	O
the	O
patient	O
was	O
tachycardiac	B-problem
.	O

HOSPITAL	O
COURSE	O
:	O

1.	O
Hypotension	B-problem
-	O
The	O
patient	O
was	O
initially	O
mildly	B-problem
hypotensive	I-problem
with	O
systolic	B-test
blood	I-test
pressures	I-test
in	O
the	O
80s	O
.	O

Upon	O
admission	O
it	O
was	O
unclear	O
whether	O
or	O
not	O
the	O
patient	O
was	O
volume	B-problem
overloaded	I-problem
or	O
volume	B-problem
depleted	I-problem
.	O

Initially	O
he	O
was	O
treated	O
with	O
intravenous	B-treatment
fluids	I-treatment
with	O
a	O
dramatic	O
response	O
in	O
his	B-test
systolic	I-test
blood	I-test
pressure	I-test
.	O

However	O
,	O
subsequent	O
it	O
was	O
determined	O
that	O
the	B-problem
patient	I-problem
's	I-problem
hypotension	I-problem
may	O
have	O
been	O
related	O
to	O
his	B-problem
rapid	I-problem
ventricular	I-problem
response	I-problem
and	O
right	B-problem
heart	I-problem
failure	I-problem
.	O

Therefore	O
the	O
focus	O
of	O
treatment	B-treatment
was	O
changed	O
to	O
controlling	O
his	B-test
rate	I-test
.	O

2.	O
Atrial	B-problem
fibrillation	I-problem
-	O
The	B-treatment
patient	I-treatment
's	I-treatment
Digoxin	I-treatment
had	O
been	O
weaned	O
off	O
prior	O
to	O
his	O
admission	O
.	O

It	O
was	O
felt	O
that	O
this	O
potentially	O
had	O
lead	O
to	O
his	B-problem
atrial	I-problem
flutter	I-problem
and	O
atrial	B-problem
fibrillation	I-problem
with	O
rapid	B-problem
ventricular	I-problem
response	I-problem
.	O

The	O
patient	O
was	O
loaded	O
once	O
again	O
with	O
Digoxin	B-treatment
and	O
his	B-treatment
beta	I-treatment
blocker	I-treatment
was	O
increased	O
to	O
100	O
mg	O
of	O
Lopressor	B-treatment
,	O
three	O
times	O
a	O
day	O
.	O

In	O
addition	O
the	O
patient	O
was	O
started	O
on	O
Verapamil	B-treatment
since	O
his	B-test
heart	I-test
rate	I-test
had	O
remained	O
mildly	B-problem
tachycardiac	I-problem
in	O
the	O
low	O
100s	O
.	O

3.	O
Congestive	B-problem
heart	I-problem
failure	I-problem
-	O
During	O
the	O
initial	O
course	O
of	O
the	O
patient	O
's	O
admission	O
,	O
it	O
was	O
unclear	O
as	O
to	O
whether	O
or	O
not	O
he	O
was	O
volume	B-problem
overloaded	I-problem
or	O
volume	B-problem
depleted	I-problem
.	O

The	O
patient	O
was	O
initially	O
treated	O
with	O
intravenous	B-treatment
fluids	I-treatment
,	O
however	O
,	O
subsequently	O
he	O
was	O
diuresed	O
when	O
he	O
became	O
symptomatic	B-problem
and	O
short	B-problem
of	I-problem
breath	I-problem
.	O

Chest	B-test
x-rays	I-test
revealed	O
evidence	O
of	O
congestive	B-problem
heart	I-problem
failure	I-problem
.	O

The	O
decision	O
was	O
made	O
to	O
have	O
the	O
patient	O
undergo	O
a	B-test
cardiac	I-test
catheterization	I-test
to	O
fully	O
evaluate	O
the	O
hemodynamics	O
to	O
determine	O
the	O
etiology	O
of	O
the	B-problem
patient	I-problem
's	I-problem
heart	I-problem
failure	I-problem
.	O

In	O
addition	O
,	O
plans	O
were	O
made	O
to	O
evaluate	O
the	O
patient	O
's	O
cardiac	O
arteries	O
to	O
determine	O
if	O
he	O
had	O
any	O
component	O
of	O
ischemic	B-problem
cardiomyopathy	I-problem
.	O

4.	O
Abnormal	B-test
liver	I-test
function	I-test
tests	I-test
-	O
The	O
patient	O
had	O
an	B-problem
isolated	I-problem
,	I-problem
elevated	I-problem
alkaline	I-problem
phosphatase	I-problem
with	O
a	B-problem
confirmatory	I-problem
elevation	I-problem
in	O
his	B-test
gamma	I-test
glutamyl	I-test
transferase	I-test
.	O

An	B-test
ultrasound	I-test
of	I-test
the	I-test
right	I-test
upper	I-test
quadrant	I-test
did	O
not	O
reveal	O
any	B-problem
cholelithiasis	I-problem
or	O
cholecystitis	B-problem
,	O
however	O
,	O
an	B-problem
irregular	I-problem
hepatic	I-problem
contour	I-problem
was	O
seen	O
which	O
is	O
suggestive	O
of	O
underlying	B-problem
chronic	I-problem
liver	I-problem
disease	I-problem
.	O

There	O
was	O
some	O
concern	O
that	O
the	O
patient	O
may	O
have	O
a	B-problem
partial	I-problem
biliary	I-problem
obstruction	I-problem
and	O
the	O
patient	O
was	O
sent	O
for	O
an	B-test
magnetic	I-test
resonance	I-test
cholangiopancreatography	I-test
to	O
further	O
evaluate	O
the	O
biliary	O
system	O
.	O

Magnetic	B-test
resonance	I-test
cholangiopancreatography	I-test
did	O
not	O
reveal	O
any	O
evidence	O
of	O
biliary	B-problem
dilatation	I-problem
or	O
of	O
any	B-problem
obstructing	I-problem
pancreatic	I-problem
mass	I-problem
.	O

Again	O
seen	O
was	O
a	B-problem
slightly	I-problem
irregular	I-problem
contour	I-problem
of	I-problem
the	I-problem
liver	I-problem
with	O
dilated	B-problem
hepatic	I-problem
veins	I-problem
suggesting	O
chronic	B-problem
hepatic	I-problem
vascular	I-problem
congestion	I-problem
.	O

The	O
patient	O
also	O
revealed	O
a	O
prior	O
history	O
of	O
heavy	O
alcohol	O
use	O
for	O
approximately	O
20	O
years	O
,	O
during	O
the	O
mid	O
1950s	O
to	O
mid	O
1970s	O
.	O

It	O
was	O
felt	O
that	O
he	O
may	O
have	O
had	O
some	O
component	O
of	O
vascular	B-problem
congestion	I-problem
from	O
his	B-problem
congestive	I-problem
heart	I-problem
failure	I-problem
as	O
well	O
as	O
possibly	O
some	B-problem
mild	I-problem
cirrhotic	I-problem
changes	I-problem
secondary	O
to	O
his	O
previous	O
alcohol	O
use	O
.	O

5.	O
Fall	O
-	O
The	O
patient	O
had	O
a	O
mechanical	O
fall	O
during	O
his	O
admission	O
.	O

He	O
did	O
not	O
sleep	O
at	O
all	O
the	O
night	O
before	O
and	O
was	O
extremely	B-problem
fatigued	I-problem
.	O

He	O
was	O
walking	O
in	O
the	O
hall	O
,	O
dragging	O
his	B-treatment
intravenous	I-treatment
pole	I-treatment
when	O
he	O
tripped	O
over	O
the	O
foot	O
of	O
the	O
pole	O
and	O
lost	O
his	O
balance	O
.	O

He	O
fell	O
backwards	O
,	O
landing	O
on	O
his	O
buttocks	O
and	O
bumped	O
his	O
head	O
.	O

His	B-test
neurological	I-test
examination	I-test
at	O
that	O
time	O
was	O
nonfocal	O
and	O
the	O
head	O
was	O
atraumatic	B-problem
without	O
any	O
evidence	O
of	O
a	B-problem
hematoma	I-problem
.	O

A	B-test
computerized	I-test
axial	I-test
tomography	I-test
scan	I-test
of	I-test
his	I-test
head	I-test
at	O
that	O
time	O
did	O
not	O
reveal	O
any	B-problem
extra	I-problem
or	I-problem
intracranial	I-problem
hemorrhage	I-problem
.	O

6.	O
Rectal	B-problem
bleeding	I-problem
-	O
The	O
patient	O
has	O
a	O
history	O
of	O
rectal	B-problem
bleeding	I-problem
,	O
ever	O
since	O
his	B-treatment
brachytherapy	I-treatment
for	O
his	B-problem
prostate	I-problem
cancer	I-problem
.	O

The	O
patient	O
has	O
been	O
treated	O
with	O
Argon	B-treatment
laser	I-treatment
therapy	I-treatment
in	O
the	O
past	O
for	O
his	B-problem
rectal	I-problem
bleeding	I-problem
and	O
it	O
is	O
recommended	O
that	O
he	O
follow	O
up	O
with	O
his	O
gastroenterologist	O
for	O
repeat	B-treatment
Argon	I-treatment
laser	I-treatment
therapy	I-treatment
.	O

The	O
remainder	O
of	O
the	O
hospital	O
course	O
will	O
be	O
dictated	O
by	O
the	O
covering	O
intern	O
.	O

Sheila	O
Providence	O
,	O
M.D.	O
50-442	O

Dictated	O
By	O
:	O
Marjorie	O
I.	O
Taylor	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2012-05-01	O
22:34	O

T	O
:	O
2012-05-02	O
06:55	O

JOB	O
#:	O
79270	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Jane	O
Nix	O
on	O
:	O
MON	O
2012-05-07	O
9:28	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

Discharge	O
Date	O
:	O

2014-01-24	O

Date	O
of	O
Birth	O
:	O

1928-11-23	O

Sex	O
:	O

F	O

Service	O
:	O

Internal	B-treatment
Medicine	I-treatment

During	O
the	O
last	O
four	O
hospital	O
days	O
,	O
the	O
continued	O
to	O
do	O
relatively	O
well	O
.	O

Her	O
renal	O
function	O
significantly	O
improved	O
,	O
and	O
her	B-test
discharge	I-test
creatinine	I-test
was	O
3.1	O
.	O

Of	O
note	O
,	O
her	B-test
blood	I-test
pressure	I-test
significantly	O
improved	O
in	O
the	O
120s-130s	O
which	O
assured	O
better	O
perfusion	O
in	O
her	O
kidneys	O
.	O

She	O
received	O
intermittent	O
doses	O
of	O
Lasix	B-treatment
to	O
assure	O
overall	O
negative	O
intakes	O
and	O
outputs	O
.	O

She	O
progressed	O
beautifully	O
with	O
physical	B-treatment
therapy	I-treatment
and	O
occupational	B-treatment
therapy	I-treatment
and	O
was	O
able	O
to	O
ambulate	O
with	O
assistance	O
.	O

She	O
has	O
very	B-problem
mild	I-problem
left	I-problem
lower	I-problem
extremity	I-problem
pain	I-problem
which	O
is	O
largely	O
unchanged	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
.	O

2.	O
Congestive	B-problem
heart	I-problem
failure	I-problem
.	O

3.	O
Acute	B-problem
renal	I-problem
failure	I-problem
.	O

4.	O
Acute	B-problem
myocardial	I-problem
infarction	I-problem
.	O

5.	O
Osteomyelitis	B-problem
.	O

6.	O
Diabetes	B-problem
mellitus	I-problem
.	O

DISPOSITION	O
:	O

Discharged	O
to	O
a	O
rehabilitation	O
facility	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Amiodarone	B-treatment
200	O
mg	O
p.o.	O
q	O
day	O
.	O

2.	O
Warfarin	B-treatment
3	O
mg	O
p.o.	O
q	O
h.s.	O

3.	O
Renagel	B-treatment
1600	O
mg	O
p.o.	O
t.i.d.	O

4.	O
Aspirin	B-treatment
325	O
mg	O
p.o.	O
q	O
day	O
.	O

5.	O
Miconazole	B-treatment
powder	I-treatment
2%	O
t.i.d.	O

6.	O
Levofloxacin	B-treatment
250	O
mg	O
p.o.	O
q48	O
hours	O
for	O
the	O
next	O
five	O
weeks	O
for	O
osteomyelitis	B-problem
.	O

7.	O
Flagyl	B-treatment
500	O
mg	O
p.o.	O
t.i.d.	O
for	O
the	O
next	O
five	O
weeks	O
for	O
osteomyelitis	B-problem
.	O

8.	O
Protonix	B-treatment
40	O
mg	O
p.o.	O
q	O
day	O
.	O

9.	O
Magnesium	B-treatment
Oxide	I-treatment
800	O
mg	O
p.o.	O
b.i.d.	O

10.	O
Epogen	B-treatment
5000	O
units	O
two	O
times	O
weekly	O
,	O
on	O
Monday	O
and	O
Thursday	O
.	O

11.	O
Colace	B-treatment
100	O
mg	O
p.o.	O
b.i.d.	O

12.	O
Lasix	B-treatment
80	O
mg	O
p.o.	O
b.i.d.	O

13.	O
NPH	B-treatment
insulin	I-treatment
7	O
units	O
in	O
the	O
morning	O
and	O
5	O
units	O
at	O
night	O
.	O

14.	O
Regular	B-treatment
insulin	I-treatment
sliding	I-treatment
scale	I-treatment
.	O

Richard	O
U.	O
Walker	O
,	O
M.D.	O

36-781	O

Dictated	O
By	O
:	O
Levi	O
G.	O
Savage	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2014-01-24	O
13:13	O

T	O
:	O
2014-01-24	O
13:45	O

JOB	O
#:	O

12151	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Kelly	O
Hunter	O
YANG	O
on	O
:	O
FRI	O
2014-01-31	O
2:04	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2015-10-28	O

Discharge	O
Date	O
:	O

2015-11-13	O

Date	O
of	O
Birth	O
:	O

1941-08-30	O

Sex	O
:	O

F	O

Service	O
:	O
CARDIOTHORACIC	O

Allergies	O
:	O

Tape	O
/	O
Benadryl	B-treatment

Attending	O
:Jordan	O
U	O
Kostohryz	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Chest	B-problem
discomfort	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

2015-10-30	O
Left	B-treatment
Carotid	I-treatment
Stenting	I-treatment

2015-11-02	O
Coronary	B-treatment
Artery	I-treatment
Bypass	I-treatment
Graft	I-treatment
x	O
2	O
(	O
Lima	B-treatment
to	I-treatment
LAD	I-treatment
,	O
SVG	B-treatment
to	I-treatment
OM	I-treatment
)	O

History	O
of	O
Present	O
Illness	O
:	O

Ms.	O
Bridge	O
is	O
a	O
74	O
y/o	O
female	O
admitted	O
to	O
outside	O
hospital	O
on	O
2015-10-21	O
with	O
chest	B-problem
discomfort	I-problem
,	O
vomiting	B-problem
and	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

Initial	B-test
EKG	I-test
showed	O
ST	B-problem
depressions	I-problem
,	O
but	O
cardiac	B-test
enzymes	I-test
were	O
not	O
elevated	B-problem
.	O

She	O
eventually	O
underwent	O
a	B-test
cardiac	I-test
cath	I-test
to	O
assess	O
coronary	B-problem
disease	I-problem
which	O
revealed	O
three	B-problem
vessel	I-problem
coronary	I-problem
artery	I-problem
disease	I-problem
.	O

She	O
was	O
then	O
transferred	O
to	O
The	O
Hospital	O
for	O
Orthopedics	O
for	O
surgical	B-treatment
intervention	I-treatment
.	O

Past	O
Medical	O
History	O
:	O

Coronary	B-problem
Artery	I-problem
Disease	I-problem
,	O
Hypertension	B-problem
,	O
Hyperlipidemia	B-problem
,	O
Diabetes	B-problem
Mellitus	I-problem
,	O
Hypothyroid	B-problem
,	O
h/o	O
Bilateral	B-problem
DVT	I-problem
's	I-problem
(	O
on	O
chronic	B-treatment
coumadin	I-treatment
therapy	I-treatment
),	O
Pleural	B-problem
disorder	I-problem
?	O
Sarcoidosis	B-problem
,	O
Gastritis	B-problem
,	O
B12	B-problem
deficiency	I-problem
,	O
Chronic	B-problem
renal	I-problem
insufficiency	I-problem
,	O
s/p	O
Appendectomy	B-treatment
,	O
s/p	O
Lap	B-treatment
cholectomy	I-treatment
,	O
s/p	O
Total	B-treatment
abdominal	I-treatment
hysterectomy	I-treatment

Social	O
History	O
:	O

Denies	O
tobacco	O
or	O
ETOH	O
use	O
.	O

Lives	O
wth	O
husband	O
.	O

Family	O
History	O
:	O

Mother	O
died	O
of	O
MI	B-problem
at	O
age	O
55	O
.	O

Brother	O
w/	O
CAD	B-problem
since	O
age	O
40	O
and	O
died	O
in	O
70	O
's	O
after	O
cardiac	B-treatment
surgery	I-treatment
.	O

Son	O
died	O
at	O
14	O
d/t	O
ASD	B-problem
.	O

Physical	O
Exam	O
:	O

Gen	O
:	O
NAD	B-problem

Neck	O
:	O
Supple	O
,	O
-	O
JVD	B-problem
,	O
-	O
Bruits	B-problem

Heart	O
:	O
RRR	O
-	O
c/r/m/g	B-problem

Lungs	O
:	O
CTAB	O
,	O
coarse	B-problem

Abd	O
:	O
Soft	O
,	O
NT/NT	B-problem
+	O
BS	O

Ext	O
:	O
Cool	O
,	O
1	O
+	O
pedal	B-test
pulses	I-test
,	O
-	O
varicosities	B-problem
,	O
-	O
edema	B-problem

Neuro	O
:	O
A&O	O
x	O
3	O
,	O
MAE	O
,	O
non-focal	O

Some	B-problem
rashes	I-problem
on	I-problem
ACW	I-problem
around	O
EKG	B-treatment
leads	I-treatment

Pertinent	O
Results	O
:	O

CNIS	B-test
10-29	O
:	O

1.	O
60-69%	B-problem
stenosis	I-problem
of	I-problem
the	I-problem
right	I-problem
internal	I-problem
carotid	I-problem
artery	I-problem
.	O

2.	O
80-99%	B-problem
stenosis	I-problem
of	I-problem
the	I-problem
left	I-problem
internal	I-problem
carotid	I-problem
artery	I-problem
.	O

Echo	B-test
11-02	O
:	O
PRE-BYPASS	O
:	O
Left	O
ventricular	O
wall	O
thickness	O
,	O
cavity	O
size	O
,	O
and	O
systolic	O
function	O
are	O
normal	O
(	O
LVEF>55%	B-test
).	O

Resting	B-problem
regional	I-problem
wall	I-problem
motion	I-problem
abnormalities	I-problem
include	O
mild	B-problem
apical	I-problem
hypokinesis	I-problem
.	O

The	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B-problem
regurgitation	I-problem
.	O

The	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	B-problem
mitral	I-problem
regurgitation	I-problem
.	O

There	O
are	O
complex	B-problem
(>	I-problem
4	I-problem
mm	I-problem
)	I-problem
atheroma	I-problem
in	I-problem
the	I-problem
descending	I-problem
thoracic	I-problem
aorta	I-problem
.	O

Mild	B-problem
tricuspid	I-problem
regurgitation	I-problem
.	O

POST-BYPASS	O
:	O
Preserved	O
Kindred	O
/	O
North	O
Shore	O
-	O
ventricular	O
systolic	O
fxn	O
.	O

Trivial	B-problem
MR	I-problem
.	O

Edith	O
AI	O
.	O

Aorta	O
intact	O
.	O

CT	B-test
11-04	O
:	O
No	O
acute	B-problem
intracranial	I-problem
hemorrhage	I-problem
.	O

Findings	O
consistent	O
with	O
small	B-problem
vessel	I-problem
ischemic	I-problem
changes	I-problem
.	O

MRI	B-test
would	O
be	O
more	O
sensitive	O
for	O
the	O
detection	O
of	O
acute	B-problem
infarction	I-problem
.	O

CT	B-test
angiogram	I-test
demonstrates	O
no	O
stenosis	B-problem
or	O
aneurysm	B-problem
in	I-problem
the	I-problem
intracranial	I-problem
circulation	I-problem
.	O

Slight	B-problem
irregularity	I-problem
of	O
the	O
origin	O
of	O
the	O
right	O
vertebral	O
artery	O
may	O
be	O
atherosclerotic	B-problem
in	O
nature	O
.	O

Normal	O
contrast	O
enhancement	O
seen	O
in	O
the	B-treatment
left	I-treatment
common/internal	I-treatment
carotid	I-treatment
artery	I-treatment
stent	I-treatment
.	O

Mild	B-problem
stenosis	I-problem
of	I-problem
the	I-problem
proximal	I-problem
right	I-problem
internal	I-problem
carotid	I-problem
artery	I-problem
.	O

4	B-problem
mm	I-problem
left	I-problem
upper	I-problem
lobe	I-problem
lung	I-problem
nodule	I-problem
.	O

In	O
the	O
absence	O
of	O
history	O
of	O
malignancy	B-problem
,	O
this	O
is	O
statistically	O
benign	O
.	O

One-year	O
followup	O
may	O
be	O
considered	O
.	O

CXR	B-test
11-06	O
:	O
Allowing	O
for	O
technical	O
changes	O
,	O
no	O
major	B-problem
adverse	I-problem
interval	I-problem
change	I-problem
has	O
occurred	O
.	O

Bibasilar	B-problem
subsegmental	I-problem
atelectasis	I-problem
together	O
with	O
bilateral	B-problem
pleural	I-problem
effusions	I-problem
appear	O
relatively	O
unchanged	O
.	O

The	O
mediastinum	O
appears	O
unchanged	O
.	O

Left-sided	B-treatment
subclavian	I-treatment
line	I-treatment
is	O
unchanged	O
in	O
position	O
.	O

There	O
is	O
evidence	O
of	O
prior	B-treatment
cardiac	I-treatment
surgery	I-treatment
.	O

2015-11-13	O
06:15	O
AM	O
BLOOD	O
WBC	B-test
-	O
8.8	O
RBC	B-test
-	O
2.79	O
*	O
Hgb	B-test
-	O
8.6	O
*	O
Hct	B-test
-	O
25.4	O
*	O
MCV	B-test
-	O
91	O
MCH	B-test
-	O
30.9	O
MCHC	B-test
-	O
33.8	O
RDW	B-test
-	O
15.6	O
*	O
Plt	B-test
Ct	I-test
-	O
583	O
*	O

2015-11-12	O
06:00	O
AM	O
BLOOD	O
WBC	B-test
-	O
7.7	O
RBC	B-test
-	O
2.73	O
*	O
Hgb	B-test
-	O
8.3	O
*	O
Hct	B-test
-	I-test
25.1	O
*	O
MCV	B-test
-	O
92	O
MCH	B-test
-	O
30.4	O
MCHC	B-test
-	O
33.1	O
RDW	B-test
-	O
15.5	O
Plt	B-test
Ct	I-test
-	O
528	O
*	O

2015-11-13	O
06:15	O
AM	O
BLOOD	O
Plt	B-test
Ct	I-test
-	O
583	O
*	O

2015-11-13	O
06:15	O
AM	O
BLOOD	O
PT	B-test
-	O
18.0	O
*	O
PTT	B-test
-	O
62.3	O
*	O
INR(PT)	B-test
-	O
1.7	O
*	O

2015-11-12	O
06:00	O
AM	O
BLOOD	O
PT	B-test
-	O
15.5	O
*	O
PTT	B-test
-	O
62.4	O
*	O
INR(PT)	B-test
-	O
1.4	O
*	O

2015-11-11	O
05:45	O
AM	O
BLOOD	O
PT	B-test
-	O
14.5	O
*	O
PTT	B-test
-	O
51.4	O
*	O
INR(PT)	B-test
-	O
1.3	O
*	O

2015-11-13	O
06:15	O
AM	O
BLOOD	O
Glucose	B-test
-	O
96	O
UreaN	B-test
-	O
20	O
Creat	B-test
-	O
1.6	O
*	O
Na	B-test
-	O
141	O
K	B-test
-	O
4.3	O
Cl	B-test
-	O
106	O
HCO3	B-test
-	O
24	O
AnGap	B-test
-	O
15	O

2015-11-12	O
06:00	O
AM	O
BLOOD	O
Glucose	B-test
-	O
85	O
UreaN	B-test
-	O
19	O
Creat	B-test
-	O
1.6	O
*	O
Na	B-test
-	O
140	O
K	B-test
-	I-test
4.4	O
Cl	B-test
-	O
105	O
HCO3	B-test
-	O
24	O
AnGap	B-test
-	I-test
15	O

2015-11-11	O
05:45	O
AM	O
BLOOD	O
Creat	B-test
-	O
1.6	O
*	O
K	B-test
-	O
4.7	O

2015-10-28	O
03:30	O
PM	O
BLOOD	O
Glucose	B-test
-	O
98	O
UreaN	B-test
-	O
26	O
*	O
Creat	B-test
-	O
1.6	O
*	O
Na	B-test
-	O
140	O
K	B-test
-	O
4.6	O
Cl	B-test
-	O
104	O
HCO3	B-test
-	O
27	O
AnGap	B-test
-	O
14	O

Brief	O
Hospital	O
Course	O
:	O

Ms.	O
Bridge	O
was	O
admitted	O
from	O
OSH	O
for	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
surgery	I-treatment
.	O

She	O
underwent	O
usual	B-test
pre-operative	I-test
testing	I-test
along	O
with	O
carotid	B-test
ultrasound	I-test
.	O

CNIS	B-test
revealed	O
carotid	B-problem
stenosis	I-problem
and	O
she	O
ultimately	O
underwent	O
left	B-treatment
carotid	I-treatment
stenting	I-treatment
by	O
vascular	O
surgery	O
on	O
10-30	O
.	O

Please	O
see	O
report	O
for	O
details	O
.	O

On	O
11-02	O
she	O
was	O
brought	O
to	O
the	O
operating	O
room	O
where	O
she	O
underwent	O
a	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
x	O
2	O
.	O

Please	O
see	O
operative	O
report	O
for	O
surgical	O
details	O
.	O

She	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
and	O
was	O
transferred	O
to	O
the	O
CSRU	O
for	O
invasive	B-test
monitoring	I-test
in	O
stable	O
condition	O
.	O

Later	O
on	O
op	O
day	O
sedation	B-treatment
was	O
weaned	O
,	O
she	O
awoke	O
neurologically	O
intact	O
and	O
was	O
extubated	B-treatment
.	O

On	O
post-op	O
day	O
one	O
chest	B-treatment
tubes	I-treatment
were	O
removed	O
and	O
beta	B-treatment
blockers	I-treatment
and	O
diuretics	B-treatment
were	O
initiated	O
.	O

She	O
was	O
gently	O
diuresed	O
towards	O
her	O
pre-op	O
weight	O
.	O

Also	O
on	O
this	O
day	O
she	O
was	O
transferred	O
to	O
the	O
SDU	O
.	O

Early	O
on	O
post-op	O
day	O
two	O
Ms.	O
Bridge	O
had	O
an	O
episode	O
of	O
aphasia	B-problem
.	O

She	O
underwent	O
an	B-test
immediate	I-test
head	I-test
CT	I-test
and	O
Neuro	O
consult	O
and	O
was	O
transferred	O
back	O
to	O
the	O
CSRU	O
.	O

CT	B-test
was	O
negative	O
and	O
she	O
returned	O
to	O
baseline	O
neuro	O
status	O
without	O
deficits	B-problem
by	O
arrival	O
to	O
CSRU	O
.	O

Neurology	O
concluded	O
episode	B-problem
was	O
most	O
concerning	O
for	O
TIA	B-problem
.	O

Epicardial	B-treatment
pacing	I-treatment
wires	I-treatment
were	O
removed	O
on	O
post-op	O
day	O
four	O
.	O

After	O
remaining	O
stable	O
in	O
the	O
CSRU	O
for	O
several	O
days	O
without	O
change	B-problem
in	I-problem
neuro	I-problem
status	I-problem
she	O
was	O
transferred	O
back	O
to	O
the	O
SDU	O
on	O
post-op	O
day	O
four	O
.	O

She	O
was	O
then	O
started	O
on	O
Heparin	B-treatment
with	O
transition	O
to	O
Coumadin	B-treatment
(	O
goal	O
INR	B-test
of	O
2-3	O
secondary	O
to	O
h/o	O
bilateral	B-problem
DVT	I-problem
's).	O

During	O
entire	O
post-op	O
course	O
she	O
was	O
followed	O
by	O
physical	O
therapy	O
for	O
strength	O
and	O
mobility	O
.	O

She	O
continued	O
to	O
improve	O
steadily	O
over	O
the	O
next	O
several	O
days	O
without	O
any	O
other	O
post-op	O

complications	B-problem
.	O

She	O
was	O
discharged	O
on	O
post-op	O
day	O
11	O
.	O

Medications	O
on	O
Admission	O
:	O

Meds	B-treatment
at	O
home	O
:	O
Coumadin	B-treatment
,	O
Levoxyl	B-treatment
,	O
Folate	B-treatment
,	O
Colace	B-treatment
,	O
Byetta	B-treatment
,	O
Verapamil	B-treatment
,	O
Lisinopril	B-treatment
,	O
Pravachol	B-treatment
,	O
Nexium	B-treatment
,	O
Lasix	B-treatment
,	O
Celexa	B-treatment

Meds	B-treatment
at	O
transfer	O
:	O
Levoxyl	B-treatment
,	O
Celexa	B-treatment
,	O
Folate	B-treatment
,	O
Lopressor	B-treatment
,	O
Colace	B-treatment
,	O
RISS	B-treatment
,	O
B12	B-treatment
,	O
Protonix	B-treatment
,	O
Lasix	B-treatment
,	O
Zocor	B-treatment
,	O
Verapamil	B-treatment
,	O
Lovenox	B-treatment
,	O
Lisinopril	B-treatment

Discharge	O
Medications	O
:	O

1.	O
Aspirin	B-treatment
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
0	O
*	O

2.	O
Pantoprazole	B-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
).	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
0	O
*	O

3.	O
Levothyroxine	B-treatment
125	O
mcg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

4.	O
Simvastatin	B-treatment
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

5.	O
Citalopram	B-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

6.	O
Clopidogrel	B-treatment
75	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

7.	O
Ferrous	B-treatment
Gluconate	I-treatment
300	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

8.	O
Ascorbic	B-treatment
Acid	I-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

9.	O
Folic	B-treatment
Acid	I-treatment
1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

10.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

11.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
30	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O

12.	O
Coumadin	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
:	O
Check	O
INR	B-test
11-15	O
with	O
results	O
called	O
to	O
Dr.	O
Lynn	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

13.	O
Tramadol	B-treatment
50	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

Disp	O
:*	O
50	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

14.	O
Lasix	B-treatment
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
:	O
40	O
mg	O
daily	O
x	O
1	O
week	O
then	O
40	O
mg	O
every	O
other	O
day	O
as	O
prior	O
to	O
surgery	B-treatment
.	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

Coronary	B-problem
Artery	I-problem
Disease	I-problem
s/p	O
Coronary	B-treatment
Artery	I-treatment
Bypass	I-treatment
Graft	I-treatment
x	O
2	O

Post-operative	B-problem
Transient	I-problem
Ischemic	I-problem
Attack	I-problem

Carotid	B-problem
Stenosis	I-problem
s/p	O
Left	B-treatment
Carotid	I-treatment
Stenting	I-treatment

PMH	O
:	O
Hypertension	B-problem
,	O
Hyperlipidemia	B-problem
,	O
Diabetes	B-problem
Mellitus	I-problem
,	O
Hypothyroid	B-problem
,	O
h/o	O
Bilateral	B-problem
DVT	I-problem
's,	I-problem
Pleural	B-problem
disorder	I-problem
?	O
Sarcoidosis	B-problem
,	O
Gastritis	B-problem
,	O
B12	B-problem
deficiency	I-problem
,	O
Chronic	B-problem
renal	I-problem
insufficiency	I-problem
,	O
s/p	O
Appendectomy	B-treatment
,	O
s/p	O
Lap	B-treatment
cholectomy	I-treatment
,	O
s/p	O
Total	B-treatment
abdominal	I-treatment
hysterectomy	I-treatment

Discharge	O
Condition	O
:	O

good	O

Discharge	O
Instructions	O
:	O

Patient	O
may	O
shower	O
,	O
no	O
baths	O
.	O

No	O
creams	B-treatment
,	O
lotions	B-treatment
or	O
ointments	B-treatment
to	O
incisions	B-problem
.	O

No	O
driving	O
for	O
at	O
least	O
one	O
month	O
.	O

No	O
lifting	O
more	O
than	O
10	O
lbs	O
for	O
at	O
least	O
10	O
weeks	O
from	O
the	O
date	O
of	O
surgery	B-treatment
.	O

Monitor	O
wounds	B-problem
for	O
signs	B-problem
of	I-problem
infection	I-problem
.	O
Please	O
call	O
with	O
any	O
concerns	O
or	O
questions	O
.	O

VVp	O
Instructions	O
:	O

Dr.	O
von	O
Sampson	O
in	O
4	O
weeks	O

Dr	O
Royer	O
in	O
2-3	O
weeks	O

Dr.	O
Lynn	O
in	O
1-2	O
weeks	O

Peterson	O
ver	O
Vasquez	O
MD	O
07-506	O

Completed	O
by	O
:	O
Theresa	O
Leonore	O
NP	O
80-BXH	O
2015-11-13	O
@	O
1100	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Ruby	O
von	O
der	O
Smith	O
on:	O
WED	O
2015-12-09	O
3:34	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date:	O

2011-02-08	O

Discharge	O
Date	O
:	O

2011-02-14	O

Date	O
of	O
Birth	O
:	O

1953-05-15	O

Sex	O
:	O

M	O

Service	O
:	O

CMED	O

HISTORY	O
OF	O
THE	O
PRESENT	O
ILLNESS	O
:	O

Briefly	O
,	O
this	O
is	O
a	O
57-year-old	O
gentleman	O
with	O
a	O
history	O
of	O
COPD	B-problem
,	O
status	O
post	O
intubation	B-treatment
six	O
years	O
ago	O
but	O
not	O
on	O
home	B-treatment
02	I-treatment
with	O
recent	O
FEV1	B-test
27%	O
of	O
predicted	O
value	O
,	O
and	O
FEV1/FVC	B-test
ratio	I-test
56%	O
of	O
hypercholesterolemia	B-problem
,	O
who	O
was	O
admitted	O
for	O
COPD	B-problem
exacerbation	I-problem
and	O
worsening	O
of	O
upper	B-problem
respiratory	I-problem
tract	I-problem
infection	I-problem
symptoms	I-problem
for	O
a	O
week	O
prior	O
to	O
admission	O
.	O

He	O
was	O
afebrile	B-problem
with	O
stable	O
vital	O
signs	O
on	O
presentation	O
to	O

HOSPITAL	O
COURSE	O
:	O

He	O
was	O
started	O
on	O
p.o.	B-treatment
steroids	I-treatment
and	O
to	O
CMED	O
for	O
management	B-treatment
of	O
COPD	B-problem
exacerbation	I-problem
but	O
he	O
appeared	O
in	O
more	B-problem
respiratory	I-problem
distress	I-problem
overnight	O
and	O
was	O
started	O
on	O
IV	B-treatment
Solu-Medrol	I-treatment
and	O
more	B-treatment
frequent	I-treatment
nebulizers	I-treatment
for	O
COPD	B-problem
.	O

He	O
was	O
also	O
started	O
on	O
antibiotics	B-treatment
for	O
possible	O
bronchitis	B-problem
or	O
community-acquired	B-problem
pneumonia	I-problem
.	O

Given	O
his	B-problem
tenuous	I-problem
respiratory	I-problem
status	I-problem
,	O
he	O
was	O
transferred	O
to	O
the	O
FICU	O
with	O
closer	B-test
observation	I-test
.	O

He	O
did	O
not	O
require	O
intubation	B-treatment
and	O
improved	O
with	O
q.	O
two	O
hour	O
nebulizers	B-treatment
and	O
chest	B-treatment
PT	I-treatment
.	O

He	O
was	O
again	O
transferred	O
to	O
the	O
CMED	O
Service	O
for	O
further	B-treatment
management	I-treatment
of	O
his	B-problem
COPD	I-problem
exacerbation	I-problem
.	O

He	O
was	O
continued	O
on	O
p.o.	B-treatment
prednisone	I-treatment
and	O
frequent	B-treatment
nebulizers	I-treatment
for	O
COPD	B-problem
.	O

He	O
was	O
evaluated	O
by	O
the	O
physical	O
therapist	O
in	O
the	O
hospital	O
and	O
was	O
found	O
to	O
desaturate	B-problem
to	O
84%	O
with	O
ambulating	O
on	O
room	O
air	O
.	O

Therefore	O
,	O
home	B-treatment
02	I-treatment
was	O
recommended	O
on	O
discharge	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
.	O

DISCHARGE	O
STATUS	O
:	O

To	O
home	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
Chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
exacerbation	I-problem
.	O

2.	O
Bronchitis	B-problem
.	O

3.	O
Community-acquired	B-problem
pneumonia	I-problem
.	O

4.	O
Rule	O
out	O
myocardial	B-problem
infarction	I-problem
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Flovent	B-treatment
two	O
puffs	O
b.i.d.	O

2.	O
Levofloxacin	B-treatment
500	O
mg	O
p.o.	O
q.d.	O
for	O
another	O
11	O
days	O
for	O
a	O
total	O
of	O
a	O
14	O
day	O
course	O
.	O

3.	O
Albuterol	B-treatment
inhaler	I-treatment
one	O
to	O
two	O
puffs	O
q.	O
four	O
to	O
six	O
hours	O
p.r.n.	O

4.	O
Aspirin	B-treatment
81	O
mg	O
p.o.	O
q.d.	O

5.	O
Salmeterol	B-treatment
one	O
to	O
two	O
puffs	O
b.i.d.	O

6.	O
Oxygen	B-treatment
2	I-treatment
liters	I-treatment
nasal	I-treatment
cannula	I-treatment
with	O
ambulating	O
as	O
needed	O
.	O

7.	O
Prednisone	B-treatment
taper	I-treatment
with	O
40	O
mg	O
p.o.	O
q.d.	O
for	O
two	O
days	O
,	O
30	O
mg	O
p.o.	O
q.d.	O
for	O
two	O
days	O
,	O
20	O
mg	O
p.o.	O
q.d.	O
for	O
two	O
days	O
,	O
10	O
mg	O
p.o.	O
q.d.	O
for	O
two	O
days	O
.	O

DISCHARGE	O
FOLLOW-UP	O
:	O

The	O
patient	O
will	O
see	O
his	O
PCP	O
in	O
one	O
to	O
two	O
weeks	O
.	O

The	O
patient	O
will	O
also	O
see	O
his	O
pulmonologist	O
,	O
Dr.	O
Daniel	O
Bell	O
,	O
appointment	O
was	O
made	O
on	O
discharge	O
.	O

John	O
C	O
Stalnaker	O
,	O
M.D.	O

35-693	O

Dictated	O
By	O
:	O
Margaret	O
BT	O
Mahaffey	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2011-02-19	O
10:21	O

T	O
:	O
2011-02-21	O
18:42	O

JOB	O
#:	O

74873	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Kate	O
Gentry	O
on	O
:	O
MON	O
2011-03-07	O
4:08	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2013-05-09	O

Discharge	O
Date	O
:	O

2013-06-02	O

Date	O
of	O
Birth	O
:	O

1966-03-19	O

Sex	O
:	O

M	O

Service	O
:	O

Scott	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
47	O
year	O
old	O
male	O
,	O
with	O
end	B-problem
stage	I-problem
liver	I-problem
disease	I-problem
secondary	O
to	O
hepatitis	B-problem
C	I-problem
cirrhosis	I-problem
diagnosed	O
about	O
5	O
years	O
prior	O
to	O
admission	O
.	O

The	O
patient	O
had	O
undergone	O
treatment	B-treatment
with	O
interferon	B-treatment
and	O
Ribavirin	B-treatment
.	O

He	O
had	O
been	O
admitted	O
to	O
the	O
St.	O
Margaret	O
's	O
Center	O
for	O
Women	O
&	O
Infants	O
multiple	O
times	O
early	O
in	O
2013	O
for	O
management	B-treatment
of	O
encephalopathy	B-problem
and	O
ascites	B-problem
.	O

The	O
patient	O
had	O
been	O
discharged	O
from	O
the	O
St.	O
Margaret	O
's	O
Center	O
for	O
Women	O
&	O
Infants	O
on	O
2013-05-06	O
,	O
but	O
was	O
readmitted	O
on	O
2013-05-09	O
when	O
noted	O
to	O
have	O
worsening	B-problem
renal	I-problem
function	I-problem
.	O

The	B-test
patient	I-test
's	I-test
serum	I-test
creatinine	I-test
on	O
the	O
day	O
of	O
discharge	O
,	O
on	O
2013-05-06	O
,	O
was	O
1.9	O
,	O
but	O
was	O
noted	O
to	O
increase	O
to	O

3.2	O
on	O
2013-05-08	O
,	O
and	O
was	O
further	B-problem
elevated	I-problem
to	O
3.6	O
on	O
2013-05-09	O
.	O

The	O
patient	O
was	O
admitted	O
with	O
concern	O
for	O
hepatorenal	B-problem
syndrome	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Hepatitis	B-problem
C	I-problem
cirrhosis	I-problem
for	O
which	O
the	O
patient	O
was	O
on	O
the	O
liver	O
transplant	O
list	O
.	O

2.	O
Hypertension	B-problem
.	O

3.	O
Nephrolithiasis	B-problem
.	O

4.	O
Hemorrhoids	B-problem
.	O

5.	O
Knee	B-treatment
surgeries	I-treatment
.	O

6.	O
Back	B-treatment
surgery	I-treatment
.	O

MEDICATIONS	O
:	O

1.	O
Miconazole	B-treatment
nitrate	I-treatment
powder	I-treatment
tid	O
prn	O
for	O
groin	B-problem
rash	I-problem
.	O

2.	O
Protonix	B-treatment
40	O
mg	O
po	O
bid	O
.	O

3.	O
Lactulose	B-treatment
30	O
ml	O
tid	O
(	O
titrated	O
to	O
4	O
to	O
5	O
bowel	O
movements	O
qd	O
)	O
.	O

4.	O
Vancomycin	B-treatment
1	O
gm	O
IV	O
bid	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
married	O
with	O
no	O
children	O
.	O

He	O
works	O
as	O
a	O
counselor	O
at	O
an	O
alcohol	O
and	O
drug	O
treatment	O
facility	O
for	O
teenagers	O
.	O

The	O
patient	O
was	O
previously	O
a	O
heavy	O
alcohol	O
user	O
,	O
but	O
had	O
been	O
sober	O
since	O
1996	O
.	O

The	O
patient	O
had	O
also	O
used	O
cocaine	O
in	O
the	O
past	O
,	O
but	O
had	O
also	O
stopped	O
in	O
1996	O
.	O

HOSPITAL	O
COURSE	O
:	O

(	O
Part	O
of	O
the	O
patient	O
's	O
chart	O
from	O
the	O
period	O
2013-05-09	O
to	O
2013-05-23	O
is	O
currently	O
unavailable	O
,	O
and	O
this	O
dictation	O
will	O
mainly	O
cover	O
the	O
period	O
from	O
2013-05-23	O
to	O
2013-06-02	O
)	O

As	O
previously	O
mentioned	O
,	O
the	B-test
patient	I-test
's	I-test
creatinine	I-test
at	O
the	O
time	O
of	O
admission	O
was	O
up	O
to	O
3.6	O
from	O
1.9	O
at	O
the	O
time	O
of	O
his	O
discharge	O
3	O
days	O
prior	O
.	O

Over	O
the	O
following	O
5	O
days	O
,	O
the	B-test
patient	I-test
's	I-test
creatinine	I-test
improved	O
marginally	O
to	O
2.7	O
.	O

Optimization	O
of	O
his	B-test
fluid	I-test
balance	I-test
was	O
managed	O
by	O
the	O
medical	O
service	O
in	O
consultation	O
with	O
hepatology	O
and	O
renal	O
.	O

The	B-test
patient	I-test
's	I-test
INR	I-test
on	O
admission	O
was	O
2.4	O
,	O
with	O
his	B-test
PT	I-test
level	I-test
being	O
18.9	O
.	O

The	O
patient	O
periodically	O
required	O
transfusions	B-treatment
of	O
fresh	B-treatment
frozen	I-treatment
plasma	I-treatment
,	O
as	O
well	O
as	O
platelets	B-treatment
and	O
red	B-treatment
cells	I-treatment
.	O

The	O
patient	O
was	O
thrombocytopenic	B-problem
with	O
a	B-test
platelet	I-test
count	I-test
of	O
49	O
on	O
the	O
23	O
.	O

The	O
patient	O
was	O
continued	O
on	O
vancomycin	B-treatment
therapy	I-treatment
for	O
his	B-problem
previously	I-problem
diagnosed	I-problem
Methicillin	I-problem
resistant	I-problem
,	I-problem
coagulase	I-problem
negative	I-problem
Staph	I-problem
bacteremia	I-problem
.	O

The	O
patient	O
's	O
nutrition	O
was	O
suboptimal	O
,	O
and	O
the	O
patient	O
was	O
started	O
on	O
tube	B-treatment
feeding	I-treatment
.	O

The	O
patient	O
underwent	O
diagnostic	O
and	O
therapeutic	B-treatment
paracentesis	I-treatment
on	O
2013-05-16	O
,	O
2013-05-21	O
,	O
and	O
2013-05-24	O
.	O

He	O
had	O
no	O
evidence	O
of	O
spontaneous	B-problem
bacterial	I-problem
peritonitis	I-problem
.	O

On	O
2013-05-25	O
,	O
a	O
liver	O
became	O
available	O
for	O
transplant	B-treatment
to	O
the	O
patient	O
.	O

The	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
and	O
underwent	O
an	B-treatment
orthotopic	I-treatment
liver	I-treatment
transplant	I-treatment
.	O

In	O
order	O
to	O
aid	O
in	O
optimization	O
of	O
the	B-test
patient	I-test
's	I-test
fluid	I-test
status	I-test
,	O
the	O
patient	O
was	O
on	O
continuous	B-treatment
Baker	I-treatment
Baker	I-treatment
dialysis	I-treatment
during	O
the	B-treatment
procedure	I-treatment
.	O

His	B-problem
estimated	I-problem
blood	I-problem
loss	I-problem
was	O
2	O
liters	O
.	O

The	O
patient	O
received	O
5	O
liters	O
of	O
crystalloid	B-treatment
,	O
9	O
units	O
of	O
fresh	B-treatment
frozen	I-treatment
plasma	I-treatment
,	O
9	O
units	O
of	O
red	B-treatment
cells	I-treatment
,	O
6	O
units	O
of	O
platelets	B-treatment
,	O
as	O
well	O
as	O
1	O
liter	O
of	O
Cell	B-treatment
Saver	I-treatment
.	O

The	B-treatment
procedure	I-treatment
proceeded	O
without	O
complications	B-problem
,	O
and	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
intensive	O
care	O
unit	O
while	O
still	O
intubated	B-treatment
following	O
the	B-treatment
procedure	I-treatment
.	O

The	O
patient	O
underwent	O
an	O
uncomplicated	O
recovery	O
in	O
the	O
intensive	O
care	O
unit	O
.	O

By	O
postop	O
day	O
1	O
,	O
the	O
patient	O
was	O
awake	O
,	O
in	O
no	O
distress	B-problem
,	O
and	O
appeared	O
lucid	O
prior	O
to	O
extubation	O
.	O

The	O
patient	O
was	O
extubated	O
on	O
postop	O
day	O
1	O
without	O
any	B-problem
problems	I-problem
.	O

The	O
patient	O
was	O
on	O
a	B-treatment
Lasix	I-treatment
drip	I-treatment
to	O
aid	O
in	O
diuresis	B-treatment
,	O
and	O
was	O
ultimately	O
converted	O
to	O
oral	B-treatment
Lasix	I-treatment
on	O
postop	O
day	O
1	O
.	O

The	B-treatment
patient	I-treatment
's	I-treatment
pain	I-treatment
control	I-treatment
was	O
with	O
morphine	B-treatment
.	O

The	O
patient	O
required	O
2	O
units	O
of	O
fresh	B-treatment
frozen	I-treatment
plasma	I-treatment
on	O
the	O
night	O
following	O
surgery	B-treatment
,	O
and	O
1	O
unit	O
of	O
platelets	B-treatment
on	O
postop	O
day	O
1	O
,	O
but	O
otherwise	O
required	O
no	O
blood	B-treatment
products	I-treatment
following	O
the	B-treatment
liver	I-treatment
transplant	I-treatment
.	O

The	O
patient	O
was	O
started	O
on	O
sips	O
on	O
postop	O
day	O
2	O
,	O
and	O
advanced	O
to	O
clear	O
liquids	O
on	O
postop	O
day	O
3	O
.	O

He	O
was	O
advanced	O
to	O
a	O
regular	O
house	O
diet	O
later	O
on	O
postop	O
day	O
3	O
.	O

The	O
patient	O
was	O
advanced	O
per	O
protocol	O
to	O
an	B-treatment
immunosuppressive	I-treatment
regimen	I-treatment
of	O
prednisone	B-treatment
,	O
Neoral	B-treatment
,	O
and	O
CellCept	B-treatment
.	O

The	O
patient	O
's	O
mental	O
status	O
remained	O
essentially	O
clear	O
throughout	O
the	O
entire	O
postoperative	O
period	O
.	O

The	O
patient	O
started	O
ambulating	O
with	O
the	O
assistance	O
of	O
physical	B-treatment
therapy	I-treatment
following	O
transfer	O
to	O
the	O
surgical	O
floor	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
the	O
patient	O
was	O
independent	O
,	O
ambulating	O
,	O
and	O
functioning	O
well	O
.	O

The	O
patient	O
's	O
appetite	O
improved	O
significantly	O
,	O
and	O
at	O
the	O
time	O
of	O
discharge	O
the	O
patient	O
was	O
on	O
a	O
regular	O
diet	O
with	O
no	O
tube	B-treatment
feed	I-treatment
supplements	I-treatment
deemed	O
necessary	O
.	O

The	B-test
patient	I-test
's	I-test
liver	I-test
function	I-test
tests	I-test
all	O
improved	O
appropriately	O
by	O
the	O
time	O
of	O
discharge	O
.	O

The	B-problem
patient	I-problem
's	I-problem
surgical	I-problem
incision	I-problem
was	O
also	O
healing	O
well	O
by	O
the	O
time	O
of	O
discharge	O
with	O
no	O
evidence	O
of	O
infection	B-problem
.	O

The	O
patient	O
was	O
ultimately	O
deemed	O
ready	O
for	O
discharge	O
on	O
postoperative	O
day	O
8	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Bactrim	B-treatment
single	I-treatment
strength	I-treatment
1	O
tablet	O
po	O
qd	O
.	O

2.	O
Protonix	B-treatment
40	O
mg	O
po	O
qd	O
.	O

3.	O
Metoprolol	B-treatment
25	O
mg	O
po	O
bid	O
.	O

4.	O
Fluconazole	B-treatment
200	O
mg	O
po	O
qd	O
.	O

5.	O
CellCept	B-treatment
1	O
gm	O
po	O
bid	O
.	O

6.	O
Prednisone	B-treatment
20	O
mg	O
po	O
qd	O
.	O

7.	O
Dilaudid	B-treatment
prn	O
.	O

8.	O
Neoral	B-treatment
500	O
mg	O
po	O
bid	O
.	O

9.	O
Valcyte	B-treatment
450	O
mg	O
po	O
qod	O
.	O

10.	O
Lasix	B-treatment
40	O
mg	O
bid	O
x	O
21	O
days	O
.	O

11.	O
Colace	B-treatment
100	O
mg	O
po	O
bid	O
.	O

FOLLOW	O
UP	O
:	O

1.	O
The	O
patient	O
was	O
to	O
follow-up	O
with	O
Dr.	O
Ronald	O
in	O
the	O
Transplant	O
Center	O
3	O
days	O
following	O
discharge	O
.	O

2.	O
The	O
patient	O
was	O
to	O
follow-up	O
with	O
Dr.	O
Lueras	O
of	O
hepatology	O
following	O
discharge	O
.	O

MAJOR	O
SURGICAL	O
PROCEDURES	O
:	O

Liver	B-treatment
transplant	I-treatment
on	O
2013-05-25	O
.	O

Elinor	O
Nicole	O
,	O
New	O
York	O
12428	O

Dictated	O
By	O
:	O
Elizabeth	O
F.	O
Wells	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2013-06-05	O
08:29:54	O

T	O
:	O
2013-06-06	O
10:40:21	O

Job	O
#	O
:	O
34705	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Charles	O
Y.S.	O
Warnock	O
on	O
:	O
Maxine	O
2013-06-20	O
5:29	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2016-08-08	O

Discharge	O
Date	O
:	O

2016-08-15	O

Date	O
of	O
Birth	O
:	O

1978-08-02	O

Sex	O
:	O

F	O

Service:	O

PROCEDURE	O
:	O

Cadaveric	B-treatment
pancreas	I-treatment
transplantation	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
37	O
year	O
old	O
lady	O
with	O
type	B-problem
1	I-problem
diabetes	I-problem
mellitus	I-problem
,	O
who	O
is	O
four	O
months	O
postcadaveric	B-treatment
kidney	I-treatment
transplantation	I-treatment
and	O
now	O
has	O
good	O
graft	O
function	O
.	O

She	O
presents	O
for	O
cadaveric	B-treatment
pancreas	I-treatment
transplantation	I-treatment
.	O

Her	B-problem
diabetes	I-problem
mellitus	I-problem
has	O
been	O
complicated	O
by	O
retinopathy	B-problem
and	O
nephropathy	B-problem
as	O
well	O
as	O
peripheral	B-problem
neuropathy	I-problem
.	O

She	O
takes	O
14	O
units	O
of	O
NPH	B-treatment
insulin	I-treatment
twice	O
a	O
day	O
supplementing	O
with	O
a	B-treatment
sliding	I-treatment
scale	I-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
examination	B-test
,	O
she	O
is	O
in	O
no	O
apparent	B-problem
distress	I-problem
and	O
is	O
alert	O
and	O
oriented	O
.	O

Her	B-test
chest	I-test
and	I-test
cardiovascular	I-test
examinations	I-test
are	O
unremarkable	O
.	O

She	O
is	O
afebrile	B-problem
with	O
stable	O
vital	O
signs	O
.	O

Her	O
abdomen	O
is	O
soft	O
and	O
nontender	B-problem
with	O
a	B-problem
well	I-problem
healed	I-problem
left	I-problem
lower	I-problem
quadrant	I-problem
incision	I-problem
from	O
her	B-treatment
kidney	I-treatment
transplantation	I-treatment
.	O

She	O
has	O
good	O
femoral	O
pulses	O
bilaterally	O
.	O

HOSPITAL	O
COURSE	O
:	O

She	O
underwent	O
cadaveric	B-treatment
pancreas	I-treatment
transplantation	I-treatment
without	O
complication	B-problem
.	O

She	O
received	O
induction	B-treatment
therapy	I-treatment
with	O
thymoglobulin	B-treatment
intraoperative	O
and	O
postoperatively	O
for	O
five	O
days	O
.	O

She	O
was	O
kept	O
on	O
a	B-treatment
similar	I-treatment
immunosuppressive	I-treatment
regimen	I-treatment
as	O
with	O
her	B-treatment
kidney	I-treatment
transplant	I-treatment
.	O

She	O
had	O
excellent	O
pancreas	O
graft	O
function	O
immediately	O
.	O

Her	O
renal	O
function	O
also	O
remained	O
stable	O
in	O
the	O
perioperative	O
period	O
.	O

She	O
was	O
quickly	O
placed	O
on	O
a	O
diet	O
and	O
advanced	O
to	O
regular	O
diet	O
.	O

She	O
was	O
discharged	O
home	O
in	O
stable	O
condition	O
on	O
postoperative	O
day	O
six	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

She	O
will	O
begin	O
weekly	O
follow-up	O
in	O
the	O
Transplant	O
Center	O
.	O

She	O
is	O
to	O
not	O
lift	O
anything	O
greater	O
than	O
ten	O
pounds	O
for	O
six	O
weeks	O
.	O

She	O
is	O
to	O
continue	O
monitoring	O
her	B-test
blood	I-test
sugar	I-test
twice	O
a	O
day	O
.	O

She	O
has	O
undergone	O
full	O
teaching	O
in	O
regards	O
to	O
immunosuppressant	B-treatment
medications	I-treatment
.	O

In	O
addition	O
,	O
she	O
will	O
take	O
Valganciclovir	B-treatment
for	O
three	O
months	O
posttransplant	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Status	O
post	O
cadaveric	B-treatment
pancreas	I-treatment
transplant	I-treatment
.	O

2.	O
Type	B-problem
1	I-problem
diabetes	I-problem
mellitus	I-problem
.	O

3.	O
End	B-problem
stage	I-problem
renal	I-problem
disease	I-problem
,	O
status	O
post	O
kidney	B-treatment
transplantation	I-treatment
.	O

Dictated	O
By	O
:	O
Jon	O
O	O
Shappy	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2016-11-10	O
18:28	O

T	O
:	O
2016-11-12	O
11:51	O

JOB	O
#	O
:	O
63429	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Jacob	O
Butler	O
on	O
:	O
WED	O
2016-11-16	O
7:45	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2014-04-23	O

Discharge	O
Date	O
:	O

2014-04-28	O

Date	O
of	O
Birth	O
:	O

1980-02-05	O

Sex	O
:	O

F	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Penicillins	B-treatment
/	O
Sulfonamides	B-treatment

Attending	O
:	O
Louie	O
A.	O
Keith	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Benzo	B-problem
overdose	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Intubation	B-treatment
for	I-treatment
airway	I-treatment
protection	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

HPI	O
:	O

Ms.	O
Franklin	O
is	O
a	O
34	O
-	O
year-old	O
woman	O
with	O
Bipolar	B-problem
disorder	I-problem
and	O
group	O
home	O
resident	O
who	O
by	O
way	O
of	O
EMS	O
for	O
apparent	B-problem
alprazolam	I-problem
overdose	I-problem
.	O

In	O
the	O
St.	O
Margaret	O
's	O
Center	O
for	O
Women	O
&	O
Infants	O
,	O
the	O
patient	O
was	O
lethargic	B-problem
and	O
unable	O
to	O
give	O
a	O
history	O
.	O

She	O
was	O
promptly	O
intubated	O
for	O
airway	O
protection	O
and	O
in	O
order	O
to	O
administer	O
charcoal	B-treatment
.	O

Patient	O
was	O
found	O
at	O
group	O
home	O
in	O
am	O
laying	O
on	O
floor	O
by	O
bed	O
unresponsive	B-problem
,	O
last	O
seen	O
awake	O
8	O
hours	O
prior	O
at	O
dinner	O
.	O

Group	O
home	O
states	O
that	O
patient	O
"	O
may	O
have	O
taken	O
too	O
many	O
Xanax	B-treatment
.	O

Patient	O
has	O
a	O
history	O
of	O
suicidal	B-problem
ideations	I-problem
and	O
self	B-problem
mutilation	I-problem
.	O

Later	O
patient	O
told	O
CMED	O
CCU	O
that	O
she	O
was	O
feeling	O
down	O
and	O
impulsively	O
ingested	O
5	O
days	O
worth	O
of	O
medications	B-treatment
,	O
she	O
states	O
that	O
her	O
intent	O
at	O
that	O
time	O
was	O
to	O
end	O
her	O
life	O
.	O

Past	O
Medical	O
History	O
:	O

1.	O
Bipolar	B-problem
disorder	I-problem
.	O

2.	O
Asthma	B-problem
.	O

3.	O
Posttraumatic	B-problem
stress	I-problem
disorder	I-problem
.	O

4.	O
GERD	B-problem

5.	O
Chronic	B-problem
constipation	I-problem
from	O
laxative	B-problem
abuse	I-problem
.	O

Social	O
History	O
:	O

Denies	O
any	O
recent	O
use	O
of	O
EtOH	O
or	O
illicit	O
drugs	O
.	O

Per	O
OMR	O
,	O
h/o	O
sporadic	O
marijuana	O
use	O
.	O

Now	O
living	O
at	O
the	O
DBT	O
House	O
on	O
Treva	O
Williamson	O
in	O
Westborough	O
.	O

In	O
currently	O
in	O
a	O
relationship	O
with	O
a	O
man	O
whom	O
she	O
met	O
during	O
a	O
previous	O
inpt	O
admission	O
.	O

Per	O
OMR	O
,	O
the	O
patient	O
is	O
currently	O
not	O
in	O
contact	O
with	O
her	O
family	O
.	O

She	O
was	O
raised	O
in	O
multiple	O
foster	O
care	O
homes	O
because	O
her	O
mother	O
could	O
not	O
care	O
for	O
her	O
.	O

She	O
was	O
physically	O
abused	O
and	O
severely	O
neglected	O
as	O
a	O
child	O
and	O
been	O
sexually	O
assaulted	O
.	O

She	O
has	O
no	O
current	O
romantic	O
relationship	O
.	O

She	O
has	O
never	O
been	O
married	O
.	O

She	O
has	O
completed	O
up	O
to	O
the	O
tenth	O
grade	O
of	O
high	O
school	O
.	O

She	O
has	O
no	O
current	O
legal	O
issues	O
.	O

Family	O
History	O
:	O

Substance	O
abuse	O
in	O
mother	O
and	O
brother	O
.	O

Two	O
sisters	O
with	O
h/o	O
depression	B-problem
and	O
suicidality	B-problem
.	O

Physical	O
Exam	O
:	O

VS	B-test
95.4	O
HR	B-test
62	O
BP	B-test
99/70	O
RR	B-test
20	O
O2Sat	B-test
100%	O

Gen	O
:	O

Intubated	B-treatment
and	O
sedated	B-treatment

HEENT	O
:	O

ATNC	B-problem
,	O
Pupils	O
dialted	O
at	O
5	O
mm	O
but	O
minimally	B-problem
reactive	I-problem
,	O
anicteric	B-problem

Chest	O
:	O

CTA	O
ant/lat	O

Cor	O
:	O

RR	O
nl	O
S1	O
S2	O
no	O
m	B-problem

Abd	O
:	O

Soft	O
,	O
nd	B-problem
,	O
hypoactive	B-problem
bowel	I-problem
sounds	I-problem

Ext	O
:	O

WWP	B-problem
,	O
multiple	B-problem
linear	I-problem
scars	I-problem
and	O
burns	B-problem
on	I-problem
hands	I-problem
and	I-problem
arms	I-problem

Neuro	O
:	O

Sedated	B-treatment
,	O
DTRs	B-test
:	O

Skin	O
:	O

No	O
rashes	B-problem
or	O
petechiae	B-problem
,	O
linear	B-problem
and	I-problem
burn	I-problem
scars	I-problem
as	O
above	O

Pertinent	O
Results	O
:	O

2014-04-23	O
07:56	O
AM	O

WBC	B-test
-	O
9.4	O
#	O
RBC	B-test
-	O
4.75	O
HGB	B-test
-	O
14.7	O
HCT	B-test
-	O
42.2	O
MCV	B-test
-	O
89	O
MCH	B-test
-	O
30.9	O
MCHC	B-test
-	O
34.8	O
RDW	B-test
-	O
13.6	O

2014-04-23	O
07:56	O
AM	O

PLT	B-test
COUNT	I-test
-	O
330	O

2014-04-23	O
07:56	O
AM	O

NEUTS	B-test
-	O
73.0	O
*	O
LYMPHS	B-test
-	O
21.8	O
MONOS	B-test
-	O
3.8	O
EOS	B-test
-	O
1.1	O
BASOS	B-test
-	O
0.3	O

2014-04-23	O
07:56	O
AM	O

ASA	B-test
-	O
NEG	O
ETHANOL	B-test
-	O
NEG	O
ACETMNPHN	B-test
-	O
NEG	O
bnzodzpn	B-test
-	O
NEG	O
barbitrt	B-test
-	O
NEG	O
tricyclic	B-test
-	O
POS	O

2014-04-23	O
07:56	O
AM	O

LITHIUM	B-test
-	O
LESS	O
THAN	O

2014-04-23	O
07:56	O
AM	O

DIGOXIN	B-test
-<	O
0.2	O
*	O

2014-04-23	O
07:56	O
AM	O

GLUCOSE	B-test
-	O
116	O
*	O
UREA	B-test
N	I-test
-	O
14	O
CREAT	B-test
-	O
1.0	O
SODIUM	B-test
-	O
137	O
POTASSIUM	B-test
-	O
4.5	O
CHLORIDE	B-test
-	O
105	O
TOTAL	B-test
CO2	I-test
-	O
20	O
*	O
ANION	B-test
GAP	I-test
-	O
17	O

2014-04-23	O
07:56	O
AM	O

CALCIUM	B-test
-	O
9.7	O
PHOSPHATE	B-test
-	O
3.7	O
MAGNESIUM	B-test
-	O
2.1	O

2014-04-23	O
07:56	O
AM	O

ALT	B-test
(	I-test
SGPT	I-test
)-	I-test
21	O
AST	B-test
(	I-test
SGOT	I-test
)-	O
40	O
ALK	B-test
PHOS	I-test
-	O
70	O
AMYLASE	B-test
-	O
59	O
TOT	B-test
BILI	I-test
-	O
0.4	O

2014-04-23	O
07:56	O
AM	O

LIPASE	B-test
-	O
66	O
*	O

2014-04-23	O
08:00	O
AM	O
URINE	B-test

BLOOD	B-test
-	O
NEG	O
NITRITE	B-test
-	O
NEG	O
PROTEIN	B-test
-	O
NEG	O
GLUCOSE	B-test
-	O
NEG	O
KETONE	B-test
-	O
TR	O
BILIRUBIN	B-test
-	O
NEG	O
UROBILNGN	B-test
-	O
NEG	O
PH	B-test
-	O
6.5	O
LEUK	B-test
-	O
NEG	O

2014-04-23	O
08:13	O
AM	O
URINE	B-test
bnzodzpn	B-test
-	O
POS	O
barbitrt	B-test
-	O
NEG	O
opiates	B-test
-	O
NEG	O
cocaine	B-test
-	O
NEG	O
amphetmn	B-test
-	O
NEG	O
mthdone	B-test
-	O
NEG	O

2014-04-23	O
01:38	O
PM	O

CK	B-test
(	I-test
CPK	I-test
)-	I-test
4713	O
*	O

2014-04-23	O
03:45	O
PM	O
URINE	B-test

UCG	B-test
-	O
NEGATIVE	O

2014-04-23	O
03:56	O
PM	O

D-DIMER	B-test
-	O
7998	O
*	O

CXR	B-test
:	O

Probable	O
ateletasis	B-problem
of	I-problem
lingula	I-problem
,	O
consistent	O
with	O
pneumonitis	B-problem

EKG	B-test
:	O

NSR	O
R	B-test
60	O
Normal	O
axis	O
,	O
intervals	O
,	O
incomplete	B-problem
RBBB	I-problem
,	O
flat	B-problem
T	I-problem
aVL	I-problem
,	O
V2	O
,	O
TWI	B-problem
V1	I-problem

CT	B-test
Chest	I-test
-	O
shows	O
bilateral	B-problem
segmental	I-problem
,	I-problem
subsegmental	I-problem
PEs	I-problem

B/L	B-test
LE	I-test
LENIs	I-test
-	O
negative	O

Brief	O
Hospital	O
Course	O
:	O

CMED	O
CSRU	O
Course	O
:	O

Patient	O
was	O
intubated	O
in	O
John	O
for	O
airway	O
protection	O
and	O
administation	O
of	O
charcoal	B-treatment
.	O

Toxicology	O
consulted	O
and	O
felt	O
that	O
patient	O
most	O
likely	O
had	O
benzo	B-problem
overdose	I-problem
.	O

ABG	B-test
revealed	O
widened	B-problem
A-a	I-problem
gradient	I-problem
so	O
a	B-test
d-dimer	I-test
was	O
sent	O
which	O
was	O
elevated	B-problem
.	O

Patient	O
had	O
CTA	B-test
which	O
showed	O
bilateral	B-problem
pulmonary	I-problem
embolisms	I-problem
.	O

Patient	O
was	O
started	O
on	O
heparin	B-treatment
drip	I-treatment
and	O
bilateral	B-test
lower	I-test
extremeties	I-test
were	O
done	O
which	O
were	O
negative	O
for	O
DVT	B-problem
.	O

Patient	O
was	O
exubated	O
after	O
1	O
day	O
in	O
ICU	O
after	O
waking	O
up	O
.	O

Overnight	O
in	O
the	O
ICU	O
patient	O
was	O
noticed	O
to	O
have	O
painful	B-problem
bullae	I-problem
on	I-problem
hands	I-problem
and	I-problem
arm	I-problem
along	O
with	O
swelling	B-problem
.	O

Dermatology	O
and	O
plastic	O
surgery	O
were	O
consulted	O
who	O
felt	O
that	O
symptoms	B-problem
were	O
due	O
to	O
trauma	B-problem
;	O
it	O
was	O
not	O
felt	O
that	O
patient	O
had	O
compartment	B-problem
syndrome	I-problem
.	O

Patient	O
was	O
splinted	O
and	O
UE	O
were	O
kept	O
elevated	O
.	O

Patient	O
was	O
gradually	O
put	O
back	O
on	O
her	B-treatment
outpatient	I-treatment
xanax	I-treatment
dose	I-treatment
of	O
1	O
mg	O
qid	O
and	O
clozaril	B-treatment
was	O
restarted	O
.	O

Patient	O
was	O
transferred	O
to	O
floor	O
after	O
spending	O
1	O
day	O
in	O
the	O
ICU	O
.	O

Once	O
on	O
the	O
floor	O
patient	O
stable	O
.	O

Plastic	O
did	O
not	O
feel	O
that	O
patient	O
had	O
any	B-problem
compartment	I-problem
syndrome	I-problem
and	O
recommended	O
aggresive	B-treatment
upper	I-treatment
extremity	I-treatment
elevation	I-treatment
for	O
swelling	B-treatment
reduction	I-treatment
.	O

While	O
on	O
the	O
floor	O
patient	O
's	O
hands	O
improved	O
with	O
good	O
range	O
of	O
motion	O
of	O
left	O
hand	O
,	O
however	O
Jones	O
some	B-problem
poor	I-problem
range	I-problem
of	I-problem
motion	I-problem
of	O
right	O
.	O

X-ray	B-test
of	I-test
the	I-test
hands	I-test
and	I-test
wrist	I-test
were	O
obtained	O
which	O
were	O
negative	O
.	O

Patient	O
seen	O
by	O
PT	O
and	O
OT	O
who	O
recommended	O
hand	B-treatment
exercises	I-treatment
and	O
splints	B-treatment
for	O
patient	O
.	O

Patient	O
was	O
put	O
on	O
coumadin	B-treatment
that	O
was	O
bridged	O
with	O
lovenox	B-treatment
unti	O
lINR	B-treatment
theraputic	I-treatment
01-23	O
.	O

Patient	O
conitnued	O
to	O
have	O
SI	B-problem
while	O
on	O
floor	O
and	O
was	O
transferred	O
to	O
psychiatry	O
.	O

While	O
on	O
the	O
floor	O
patient	B-test
's	I-test
urinalysis	I-test
suggestive	O
of	O
UTI	B-problem
and	O
was	O
put	O
on	O
6	O
day	O
course	O
of	O
levofloxacin	B-treatment
.	O

Medications	O
on	O
Admission	O
:	O

Propanolol	B-treatment
XL	I-treatment
80	O
mg	O
qd	O

Modifinal	B-treatment
100	O
mg	O
po	O
qd	O

Lamictal	B-treatment
100	O
mg	O
po	O
bid	O

Alprazolam	B-treatment
1	O
mg	O
po	O
qid	O

Senna	B-treatment

Trazadone	B-treatment
200	O
mg	O
po	O
qhs	O

Clomipramine	B-treatment
100	O
mg	O
po	O
qhs	O

Pantopraozle	B-treatment
40	O
mg	O
po	O
qd	O

Clozapine	B-treatment
300	O
mg	O
po	O
qhs	O

Folate	B-treatment
1	O
mg	O
po	O
qd	O

Multivitamin	B-treatment

Discharge	O
Medications	O
:	O

1.	O
Acetaminophen	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

2.	O
Lamotrigine	B-treatment
100	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

3.	O
Pantoprazole	B-treatment
Sodium	I-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
.	O

4.	O
Folic	B-treatment
Acid	I-treatment
1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

5.	O
Multivitamin	B-treatment
Capsule	I-treatment
Sig	O
:	O
One	O
(	O
1	O
)	O
Cap	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

6.	O
Senna	B-treatment
8.6	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

7.	O
Clozapine	B-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
)	O
.	O

8.	O
Warfarin	B-treatment
Sodium	I-treatment
3	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
at	O
bedtime	O
.	O

9.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

10.	O
Trazodone	B-treatment
HCl	I-treatment
100	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
)	O
as	O
needed	O
.	O

11.	O
Alprazolam	B-treatment
1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
.	O

12.	O
Levofloxacin	B-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
for	O
3	O
days	O
.	O

13.	O
Bisacodyl	B-treatment
5	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
as	O
needed	O
.	O

14.	O
Nicotine	B-treatment
14	O
mg	O
/	O
24	O
hr	O
Patch	O
24	O
HR	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Patch	O
24	O
HR	O
Transdermal	O
DAILY	O
(	O
Daily	O
)	O
.	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

Benzodiazapine	B-problem
Overdose	I-problem

Traumatic	B-problem
/	I-problem
pressure	I-problem
bullae	I-problem

Bipolar	B-problem
Disorder	I-problem

Discharge	O
Condition	O
:	O

Stable	O
-	O
Swelling	B-problem
in	I-problem
hands	I-problem
reduced	O
and	O
range	O
of	O
motion	O
continue	O
to	O
improve	O
.	O

Discharge	O
Instructions	O
:	O

Please	O
continue	O
to	O
take	O
coumadin	B-treatment
as	O
directed	O
by	O
your	O
doctors	O
until	O
told	O
to	O
stop	O
for	O
clots	B-problem
found	O
in	O
your	O
lungs	O
.	O

Please	O
continue	O
to	O
take	O
antibiotics	B-treatment
as	O
directed	O
for	O
urinary	B-problem
tract	I-problem
infection	I-problem
for	O
3	O
more	O
days	O
.	O

Please	O
conitnue	O
to	O
keep	O
hands	O
elevated	O
in	O
bed	O
until	O
follow	O
up	O
appointment	O
with	O
plastic	O
surgery	O
.	O

Followup	O
Instructions	O
:	O

Patient	O
will	O
be	O
admitted	O
to	O
psychiatry	O
service	O

Patient	O
should	O
follow	O
up	O
with	O
at	O
plastic	O
surgery	O
clinic	O
in	O
2	O
weeks	O
.	O

Appointment	O
setup	O
for	O
Tues.	O
05-13	O
at	O
10	O
am	O
.	O

3rd	O
floor	O
Henderson	O
Building	O
with	O
Dr.	O
Black	O
(	O
650	O
)	O
866-1361	O

Raymond	O
William	O
MD	O
50-154	O

Completed	O
by	O
:	O
Simon	O
Claudine	O
Audrey	O
MD	O
82-812	O
2014-04-28	O
@	O
1227	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Tracey	O
Mccourtney	O
on	O
:	O
MON	O
2014-05-05	O
10:26	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2012-04-30	O

Discharge	O
Date	O
:	O

2012-05-14	O

Date	O
of	O
Birth	O
:	O

1956-11-04	O

Sex	O
:	O

M	O

Service	O
:	O

O-CMED	O
CCU	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
55	O
-	O
year-old	O
male	O
with	O
recently	B-problem
diagnosed	I-problem
abdominal	I-problem
carcinomatosis	I-problem
.	O

The	O
patient	O
presented	O
with	O
abdominal	B-problem
pain	I-problem
and	O
bloating	B-problem
and	O
was	O
found	O
to	O
have	O
a	B-problem
large	I-problem
omental	I-problem
mass	I-problem
.	O

Biopsy	B-test
revealed	O
adenocarcinoma	B-problem
.	O

Histochemical	B-test
stains	I-test
are	O
consistent	O
with	O
hepatobiliary	O
origin	O
.	O

Endoscopies	B-test
were	O
negative	O
except	O
for	O
an	B-problem
extrinsic	I-problem
mass	I-problem
present	I-problem
on	I-problem
the	I-problem
stomach	I-problem
.	O

The	O
patient	O
presents	O
with	O
increased	B-problem
abdominal	I-problem
pain	I-problem
and	O
poor	B-problem
oral	I-problem
intake	I-problem
as	O
well	O
as	O
generalized	B-problem
weakness	I-problem
.	O

On	O
presentation	O
,	O
the	O
patient	O
denied	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
and	O
cough	B-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Benign	B-problem
prostatic	I-problem
hypertrophy	I-problem
.	O

2.	O
Osteoarthritis	B-problem
.	O

3.	O
Gastrointestinal	B-problem
adenocarcinoma	I-problem
(	O
as	O
noted	O
in	O
History	O
of	O
Present	O
Illness	O
)	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Colace	B-treatment
,	O
Senna	B-treatment
,	O
Dulcolax	B-treatment
,	O
Tylenol	B-treatment
,	O
oxycodone	B-treatment
as	O
needed	O
,	O
Ambien	B-treatment
,	O
and	O
Protonix	B-treatment
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

FAMILY	O
HISTORY	O
:	O

Mother	O
had	O
adrenal	B-problem
cancer	I-problem
.	O

Father	O
had	O
coronary	B-problem
artery	I-problem
disease	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
was	O
employed	O
as	O
a	O
salesman	O
.	O

He	O
denied	O
the	O
use	O
of	O
tobacco	O
and	O
drugs	O
.	O

He	O
uses	O
alcohol	O
occasionally	O
.	O

The	O
patient	O
is	O
married	O
with	O
two	O
children	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Review	B-test
of	I-test
systems	I-test
was	O
significant	O
for	O
progressive	B-problem
abdominal	I-problem
discomfort	I-problem
,	O
decreased	B-problem
oral	I-problem
intake	I-problem
,	O
and	O
weakness	B-problem
in	O
the	O
past	O
nine	O
weeks	O
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
PRESENTATION	O
:	O

Physical	B-test
examination	I-test
revealed	O
temperature	B-test
was	O
96.9	O
,	O
heart	B-test
rate	I-test
was	O
121	O
,	O
blood	B-test
pressure	I-test
was	O
122/86	O
,	O
respiratory	B-test
rate	I-test
was	O
22	O
,	O
and	O
oxygen	B-test
saturation	I-test
was	O
96%	O
on	O
room	O
air	O
.	O

In	O
general	O
,	O
the	O
patient	O
looked	O
acutely	B-problem
and	I-problem
chronically	I-problem
ill	I-problem
.	O

Head	B-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
,	I-test
and	I-test
throat	I-test
examination	I-test
revealed	O
the	O
oropharynx	O
was	O
clear	O
.	O

Sclerae	O
were	O
anicteric	B-problem
.	O

Mucous	O
membranes	O
were	O
moist	O
.	O

Cardiovascular	B-test
examination	I-test
revealed	O
tachycardic	B-problem
first	I-problem
heart	I-problem
sound	I-problem
and	I-problem
second	I-problem
heart	I-problem
sound	I-problem
.	O

No	O
murmurs	B-problem
,	O
rubs	B-problem
,	O
or	O
gallops	B-problem
.	O

Lungs	O
revealed	O
decreased	B-problem
breath	I-problem
sounds	I-problem
and	O
dullness	B-problem
to	O
percussion	B-test
in	O
the	O
left	O
lung	O
base	O
.	O

The	O
abdomen	O
was	O
distended	B-problem
and	O
firm	B-problem
.	O

Positive	O
bowel	O
sounds	O
.	O

Extremity	B-test
examination	I-test
revealed	O
no	O
clubbing	B-problem
,	O
cyanosis	B-problem
,	O
or	O
edema	B-problem
.	O

IMPRESSION	O
:	O

This	O
was	O
a	O
55	O
-	O
year-old	O
gentleman	O
with	O
recently	B-problem
diagnosed	I-problem
abdominal	I-problem
carcinomatosis	I-problem
admitted	O
with	O
increased	B-problem
abdominal	I-problem
pain	I-problem
and	O
poor	B-problem
oral	I-problem
intake	I-problem
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
O-CMED	O
Service	O
for	O
further	B-treatment
management	I-treatment
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
O-CMED	O

Service	O
.	O

He	O
was	O
placed	O
on	O
a	B-treatment
patient-controlled	I-treatment
analgesia	I-treatment
for	O
pain	B-treatment
control	I-treatment
.	O

He	O
was	O
administered	O
intravenous	B-treatment
fluids	I-treatment
and	O
oral	O
diet	O
as	O
tolerated	O
.	O

On	O
the	O
night	O
of	O
05-01	O
,	O
the	O
patient	O
complained	O
of	O
increased	B-problem
vomiting	I-problem
.	O

He	O
also	O
complained	O
of	O
increased	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
and	O
"	O
difficulty	B-problem
catching	I-problem
his	I-problem
breath	I-problem
."	O

On	O
room	O
air	O
,	O
the	B-test
patient	I-test
's	I-test
oxygen	I-test
saturation	I-test
was	O
80%	O
.	O

His	B-test
saturation	I-test
increased	O
to	O
87%	O
on	O
a	B-treatment
nonrebreather	I-treatment
.	O

A	B-test
chest	I-test
x-ray	I-test
disclosed	O
a	B-problem
left	I-problem
pleural	I-problem
effusion	I-problem
.	O

The	O
patient	O
was	O
bolused	O
with	O
intravenous	B-treatment
heparin	I-treatment
due	O
to	O
concern	O
for	O
pulmonary	B-problem
embolism	I-problem
.	O

The	O
patient	O
expressed	O
a	O
desire	O
to	O
be	O
full	O
code	O
,	O
so	O
he	O
was	O
transferred	O
to	O
the	O
Intensive	O
Care	O
Unit	O
.	O

The	O
patient	O
became	O
more	O
comfortable	O
being	O
seated	O
upright	O
with	O
nebulizer	B-treatment
treatments	I-treatment
.	O

An	B-test
angiogram	I-test
was	O
done	O
which	O
disclosed	O
possible	O
subsegmental	B-problem
pulmonary	I-problem
emboli	I-problem
of	I-problem
the	I-problem
upper	I-problem
lobes	I-problem
as	O
well	O
as	O
infiltrates	B-problem
consistent	O
with	O
aspiration	B-problem
pneumonia	I-problem
.	O

The	O
patient	O
was	O
placed	O
on	O
Flagyl	B-treatment
and	O
Levaquin	B-treatment
for	O
treatment	B-treatment
of	O
pneumonia	B-problem
.	O

He	O
was	O
continued	O
on	O
heparin	B-treatment
for	O
treatment	B-treatment
of	O
the	B-problem
pulmonary	I-problem
emboli	I-problem
.	O

While	O
in	O
the	O
Intensive	O
Care	O
Unit	O
,	O
the	O
patient	O
was	O
noted	O
to	O
have	O
increasing	B-problem
abdominal	I-problem
distention	I-problem
.	O

On	O
05-03	O
the	O
patient	O
underwent	O
an	B-test
abdominal	I-test
ultrasound	I-test
with	O
paracentesis	B-treatment
,	O
and	O
5	O
liters	O
of	O
fluid	B-problem
were	O
removed	O
.	O

On	O
05-04	O
,	O
the	O
patient	O
was	O
transferred	O
back	O
to	O
the	O
O-CMED	O
CSRU	O

Service	O
.	O

Due	O
to	O
persistent	B-problem
gastric	I-problem
secretions	I-problem
,	O
an	B-treatment
nasogastric	I-treatment
tube	I-treatment
was	O
placed	O
for	O
decompression	B-treatment
.	O

The	O
patient	O
was	O
noted	O
to	O
have	O
a	O
functional	O
ileus	O
.	O

Octreotide	B-treatment
was	O
initiated	O
in	O
an	O
attempt	O
to	O
decrease	O
the	B-problem
gastric	I-problem
secretions	I-problem
.	O

On	O
05-13	O
,	O
the	O
patient	O
's	O
respiratory	O
status	O
declined	O
further	O
.	O

He	O
was	O
noted	O
not	O
have	O
an	B-problem
increasing	I-problem
left-sided	I-problem
pleural	I-problem
effusion	I-problem
.	O

A	B-treatment
thoracentesis	I-treatment
was	O
done	O
with	O
removal	B-treatment
of	O
1.5	O
liters	O
of	O
fluid	B-problem
.	O

A	B-treatment
paracentesis	I-treatment
was	O
repeated	O
with	O
removal	B-treatment
of	O
2.5	O
liters	O
of	O
fluid	B-problem
.	O

On	O
the	O
night	O
of	O
05-13	O
,	O
the	O
patient	O
continued	O
to	O
decline	O
.	O

The	O
family	O
decided	O
to	O
pursue	O
comfort	B-treatment
measures	I-treatment
.	O

Morphine	B-treatment
was	O
administered	O
to	O
insure	O
patient	O
's	O
comfort	O
.	O

The	O
patient	O
expired	O
at	O
6	O
p.m.	O
on	O
05-14	O
.	O

FINAL	O
DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Gastrointestinal	B-problem
adenocarcinoma	I-problem
;	O
primary	O
unknown	O
(	O
likely	O
hepatobiliary	O
)	O
.	O

2.	O
Aspiration	B-problem
pneumonia	I-problem
.	O

3.	O
Pulmonary	B-problem
emboli	I-problem
.	O

4.	O
Hypoxia	B-problem
.	O

5.	O
Dehydration	B-problem
.	O

6.	O
Ileus	B-problem
.	O

Pearl	O
Y.	O
Simmons	O
,	O
M.D.	O
68-957	O

Dictated	O
By	O
:	O
Lynn	O
J	O
Crump	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2012-05-14	O
19:24	O

T	O
:	O
2012-05-19	O
05:00	O

JOB	O
#	O
:	O
79196	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Catherine	O
GOLDSTEIN	O
on	O
:	O
Andrea	O
2012-06-07	O
8:18	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2019-01-09	O

Discharge	O
Date	O
:	O

2019-01-15	O

Date	O
of	O
Birth	O
:	O

1973-11-18	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Erythromycin	B-treatment
Base	I-treatment

Attending	O
:	O
Stephanie	O
I	O
Sept	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Syncope	B-problem
.	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

None	O
.	O

History	O
of	O
Present	O
Illness	O
:	O

45M	O
w/no	O
PMH	O
presented	O
to	O
Chelseahospital	O
after	O
a	B-problem
syncopal	I-problem
episode	I-problem
on	O
the	O
morning	O
of	O
admission	O
.	O

Pt	O
was	O
preparing	O
lunch	O
when	O
suddenly	O
felt	O
lightheaded	B-problem
/	O
faint	B-problem
and	O
immediately	O
fell	O
to	O
the	O
kitchen	O
floor	O
face	O
first	O
.	O

He	O
denies	O
LOC	B-problem
.	O

Immediately	O
there	O
after	O
he	O
was	O
very	B-problem
short	I-problem
of	I-problem
breath	I-problem
,	O
felt	O
lightheaded	B-problem
again	O
and	O
called	O
911	O
.	O

At	O
Springfield	O
,	O
CT	B-test
chest	I-test
was	O
positive	O
for	O
saddle	B-problem
PE	I-problem
.	O

VS	B-test
were	O
with	O
stable	O
BPs	O
,	O
tachy	B-problem
to	O
110-120	O
,	O
sat	B-test
98%	O
RA	O
.	O

He	O
received	O
Lovenox	B-treatment
91	O
mg	O
SC	O
prior	O
to	O
transport	O
and	O
was	O
transferred	O
to	O
Arbour	O
Hospital	O
for	O
further	O
care	O
.	O

Mr.	O
Anders	O
states	O
that	O
2	O
weeks	O
prior	O
to	O
his	O
presentation	O
he	O
hurt	O
his	O
left	O
knee	O
.	O

He	O
was	O
sitting	O
on	O
the	O
floor	O
legs	O
crossed	O
and	O
stood	O
up	O
when	O
he	O
heard	O
his	O
knee	O
CMED	O
CCU	O
.	O

Then	O
again	O
on	O
Sunday	O
,	O
3	O
days	O
PTA	O
,	O
again	O
from	O
sitting	O
to	O
standing	O
heard	O
his	O
knee	O
CMED	O
CCU	O
.	O

He	O
was	O
essentially	B-problem
bed	I-problem
bound	I-problem
for	O
3	O
days	O
prior	O
to	O
admission	O
,	O
unable	B-problem
to	I-problem
ambulate	I-problem
.	O

He	O
started	O
to	O
notice	O
inflammation	B-problem
of	I-problem
his	I-problem
L	I-problem
calf	I-problem
/	I-problem
leg	I-problem
worse	O
2	O
days	O
prior	O
to	O
presentation	O
.	O

In	O
this	O
2	O
week	O
interval	O
he	O
denied	O
having	O
CP	B-problem
/	O
chest	B-problem
discomfort	I-problem
or	O
difficulty	B-problem
breathing	I-problem
,	O
no	O
cough	B-problem
or	O
hemoptysis	B-problem
.	O

No	O
f/c/	B-problem
sweats	B-problem
.	O

Pt	O
denied	O
any	B-problem
bleeding	I-problem
or	I-problem
clotting	I-problem
disorders	I-problem
and	O
has	O
never	O
had	O
a	B-problem
clot	I-problem
in	O
the	O
past	O
.	O

Past	O
Medical	O
History	O
:	O

Left	B-problem
knee	I-problem
injury	I-problem
.	O

Seasonal	B-problem
allergies	I-problem
.	O

Social	O
History	O
:	O

-	O
Lives	O
w/	O
wife	O
&	O
son	O
in	O
Jose	O
,	O
MA	O

-	O
Denies	O
TOB	O
use	O
,	O
occasional	O
ETOH	O
use	O

Family	O
History	O
:	O

-	O
M	O
:	O

HTN	B-problem
,	O
DM	B-problem

-	O
F	O
:	O

COPD	B-problem
,	O
Prostate	B-problem
CA	I-problem

-	O
Grandfather	O
died	O
of	O
MI	B-problem
at	O
age	O
75	O

Physical	O
Exam	O
:	O

VS	B-test
:	O
99.4	O
HR	B-test
111	O
BP	B-test
110/64	O
RR16	B-test
97%	O
2LNC	B-treatment

GEN	O
:	O
NAD	B-problem
,	O
pleasant	O
speaking	O
in	O
full	O
sentences	O

HEENT	O
:	O
MMM	O
,	O
OP	O
clear	O
,	O
dried	B-problem
blood	I-problem
in	I-problem
nasal	I-problem
mucosa	I-problem

RESP	O
:	O
CTABL	O
,	O
no	O
crackles	B-problem
,	O
no	O
wheezing	B-problem
or	O
rhonchi	B-problem

CV	O
:	O
Reg	O
,	O
tachy	B-problem
Nml	O
S1	O
,	O
S2	O
,	O
no	O
M/R/G	B-problem

ABD	O
:	O
soft	O
ND/NT	B-problem
+BS	O

EXT	O
:	O
L	B-problem
leg/calf	I-problem
swollen	I-problem
,	O
+	O
Johnson	B-test
sign	I-test
,	O
not	O
tense	B-problem
,	O
no	O
cord	O
palpable	O
,	O
L	O
knee	O
w/	O
medial	B-problem
meniscus	I-problem
area	I-problem
inflammed	I-problem
,	O
not	O
warm	B-problem
,	O
no	O
crepitus	B-problem
,	O
feet-2+DP	B-test
pulses	I-test
b/l	O

Pertinent	O
Results	O
:	O

1.	O
CT	B-test
OF	I-test
HEAD	I-test
WITHOUT	I-test
CONTRAST	I-test
:	O

No	O
evidence	O
of	O
acute	B-problem
intracranial	I-problem
hemorrhage	I-problem
or	O
fractures	B-problem
.	O

2.	O
ECHO	B-test

Conclusions	O
:	O

The	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

The	B-test
estimated	I-test
right	I-test
atrial	I-test
pressure	I-test
is	O
16-20	O
mmHg	O
.	O

Left	B-test
ventricular	I-test
wall	I-test
thicknesses	I-test
are	O
normal	O
.	O

The	B-test
left	I-test
ventricular	I-test
cavity	I-test
is	O
small	O
.	O

Left	B-test
ventricular	I-test
systolic	I-test
function	I-test
is	O
hyperdynamic	B-problem
(	O
EF	B-test
>	O
75%	O
)	O
.	O

There	O
is	O
no	O
ventricular	B-problem
septal	I-problem
defect	I-problem
.	O

The	O
right	O
ventricular	O
cavity	O
is	O
mildly	B-problem
dilated	I-problem
.	O

Right	B-test
ventricular	I-test
systolic	I-test
function	I-test
is	O
borderline	O
normal	O
.	O

The	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B-problem
regurgitation	I-problem
.	O

The	O
mitral	O
valve	O
leaflets	O
are	O
structurally	O
normal	O
.	O

There	O
is	O
no	O
mitral	B-problem
valve	I-problem
prolapse	I-problem
.	O

There	O
is	O
moderate	B-problem
pulmonary	I-problem
artery	I-problem
systolic	I-problem
hypertension	I-problem
.	O

There	O
is	O
no	O
pericardial	B-problem
effusion	I-problem
.	O

Impression	O
:	O
mildly	B-problem
dilated	I-problem
right	I-problem
ventricle	I-problem
;	O
small	B-problem
,	I-problem
hyperdynamic	I-problem
left	I-problem
ventricle	I-problem
;	O
at	O
least	O
moderate	B-problem
pulmonary	I-problem
hypertension	I-problem

3.	O
BILATERAL	B-test
LENI	I-test
's	I-test

IMPRESSION	O
:	O

No	O
evidence	O
of	O
DVT	B-problem
in	I-problem
either	I-problem
lower	I-problem
limb	I-problem
.	O

OSH	B-test
IMAGING	I-test
:	O

-	O
saddle	B-problem
PE	I-problem
,	O
no	O
CD	O
or	O
report	O
sent	O

EKG	B-test
:	O

-	O
Sinus	B-problem
Tach	I-problem
,	O
normal	O
axis	O
HR	B-test
119	O
ST	B-problem
Depression	I-problem
V3-V5	I-problem
;	O
S1Q3T3	B-problem
,	O
p-pulmonale	B-problem
.	O

01-11	O
MRI	B-test
Left	I-test
Knee	I-test
w/o	I-test
Contrast	I-test

1.	O
Bucket	B-problem
handle	I-problem
medial	I-problem
meniscal	I-problem
tear	I-problem
with	O
flipped	B-problem
fragment	I-problem
in	I-problem
the	I-problem
intercondylar	I-problem
notch	I-problem
.	O

Complex	B-problem
tear	I-problem
involving	O
the	O
posterior	O
Ellison	O
and	O
body	O
.	O

2.	O
Moderate	B-problem
knee	I-problem
joint	I-problem
effusion	I-problem
with	O
possible	O
ganglion	B-problem
cyst	I-problem
at	I-problem
the	I-problem
insertion	I-problem
of	I-problem
the	I-problem
PCL	I-problem
.	O

3.	O
Discoid	B-problem
lateral	I-problem
meniscus	I-problem
.	O

Brief	O
Hospital	O
Course	O
:	O

Mr.	O
Anders	O
was	O
admitted	O
for	O
anticoagulation	B-treatment
and	O
hemodynamic	B-test
monitoring	I-test
in	O
the	O
setting	O
of	O
saddle	B-problem
pulmonary	I-problem
embolus	I-problem
and	O
left	B-problem
knee	I-problem
injury	I-problem
.	O

#.	O
PE	B-problem
:	O

Given	O
no	O
other	O
risk	O
factors	O
or	O
likely	O
causes	O
,	O
the	O
most	O
likely	O
etiology	O
for	O
his	B-problem
embolus	I-problem
is	O
DVT	B-problem
from	I-problem
the	I-problem
left	I-problem
leg	I-problem
.	O

He	O
has	O
no	O
known	B-problem
clotting	I-problem
disorder	I-problem
but	O
did	O
have	O
trauma	B-problem
to	I-problem
leg	I-problem
prompting	O
immobility	B-problem
and	O
stasis	B-problem
.	O

He	O
remained	O
hemodynmically	O
stable	O
throughout	O
his	O
hospitalization	O
and	O
did	O
not	O
have	O
an	B-problem
oxygen	I-problem
requirement	I-problem
upon	O
discharge	O
.	O

Given	O
no	O
evidence	O
of	O
hemodynamic	B-problem
instability	I-problem
,	O
lysis	B-treatment
was	O
not	O
required	O
.	O

He	O
was	O
anticoagulated	O
with	O
heparin	B-treatment
and	O
coumadin	B-treatment
.	O

He	O
will	O
need	O
to	O
follow	O
up	O
with	O
hematology	O
for	O
an	B-test
outpatient	I-test
thrombophilia	I-test
work-up	I-test
(	O
not	O
done	O
as	O
inpatient	O
as	O
results	O
would	O
not	O
change	O
acute	B-treatment
management	I-treatment
of	O
PE	B-problem
).	O

He	O
will	O
also	O
require	O
close	O
follow	O
up	O
with	O
his	O
primary	O
care	O
provider	O
for	O
coumadin	B-treatment
management	I-treatment
.	O

Duration	O
of	O
his	B-treatment
coumadin	I-treatment
therapy	I-treatment
to	O
be	O
determined	O
by	O
hematology	O
,	O
but	O
likely	O
to	O
be	O
at	O
least	O
6	O
months	O
in	O
duration	O
.	O

#.	O
Syncope	B-problem
:	O

In	O
setting	O
of	O
PE	B-problem
.	O

Remainder	O
of	O
his	B-test
cardiac	I-test
workup	I-test
was	O
negative	O
.	O

He	O
did	O
have	O
a	B-problem
small	I-problem
troponin	I-problem
leak	I-problem
,	O
felt	O
to	O
be	O
related	O
to	O
right	B-problem
heart	I-problem
strain	I-problem
in	O
the	O
setting	O
of	O
P-pulmonale	B-problem
related	O
to	O
clot	B-problem
burden	I-problem
.	O

His	B-test
tronponin	I-test
quickly	O
trended	O
down	O
and	O
he	O
did	O
not	O
have	O
EKG	B-test
evidence	O
of	O
ischemia	B-problem
.	O

An	B-test
ECHO	I-test
did	O
not	O
reveal	O
any	B-problem
wall	I-problem
motion	I-problem
abnormalities	I-problem
related	O
to	O
ischemia	B-problem
.	O

#.	O
Hematocrit	B-test
:	O

Dropped	O
from	O
42.7	O
to	O
36	O
in	O
setting	O
of	O
anticoagulation	B-treatment
for	O
saddle	B-problem
PE	I-problem
and	O
IV	B-treatment
fluids	I-treatment
.	O

No	O
active	B-problem
bleeding	I-problem
noted	O
.	O

Pt	O
asymptomatic	B-problem
.	O

#.	O
L	B-problem
knee	I-problem
injury	I-problem
:	O

Given	O
his	O
history	O
and	O
physical	B-test
exam	I-test
,	O
Mr.	O
Anders	O
presented	O
with	O
an	B-problem
injury	I-problem
most	O
consistent	O
with	O
meniscal	B-problem
tear	I-problem
.	O

In	O
order	O
to	O
facilitate	O
therapy	B-treatment
and	O
to	O
promote	O
mobility	O
,	O
an	B-test
MRI	I-test
of	I-test
the	I-test
knee	I-test
was	O
done	O
.	O

He	O
was	O
seen	O
by	O
physical	O
therapy	O
and	O
will	O
need	O
to	O
follow	O
up	O
with	O
orthopaedics	O
upon	O
discharge	O
for	O
repeat	B-test
evaluation	I-test
.	O

#.	O
CODE	O
:	O

FULL	O
CODE	O
.	O

Medications	O
on	O
Admission	O
:	O

-	O
Claritin	B-treatment
prn	O

-	O
Flonase	B-treatment
prn	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

Pulmonary	B-problem
embolus	I-problem

Left	B-problem
knee	I-problem
meniscal	I-problem
tear	I-problem

Discharge	O
Condition	O
:	O

Stable	O

Discharge	O
Instructions	O
:	O

You	O
were	O
admitted	O
to	O
the	O
hospital	O
for	O
a	B-problem
pulmonary	I-problem
embolism	I-problem
.	O

You	O
were	O
treated	O
with	O
blood	B-treatment
thinners	I-treatment
.	O

You	O
have	O
been	O
started	O
on	O
an	B-treatment
oral	I-treatment
blood	I-treatment
thinner	I-treatment
called	O
Coumadin	B-treatment
(	I-treatment
Warfarin	I-treatment
).	O

Please	O
continue	O
to	O
take	O
this	B-treatment
medication	I-treatment
as	O
prescribed	O
.	O

You	O
must	O
have	O
your	B-test
INR	I-test
(	O
blood	B-test
levels	I-test
)	O
checked	O
on	O
a	O
regular	O
basis	O
until	O
your	B-test
INR	I-test
levels	I-test
remain	O
01-19	O
.	O

The	B-test
MRI	I-test
of	I-test
your	I-test
knee	I-test
showed	O
a	B-problem
meniscal	I-problem
tear	I-problem
.	O

Please	O
schedule	O
an	O
appointment	O
with	O
your	O
orthopedic	O
surgeon	O
to	O
determine	O
a	O
plan	O
for	O
treatment	B-treatment
.	O

Please	O
follow-up	O
with	O
your	O
Primary	O
Care	O
doctor	O
Marion	O
Bock	O
as	O
below	O
.	O

Please	O
return	O
to	O
the	O
hospital	O
if	O
you	O
experience	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
lightheadedness	B-problem
or	O
dizziness	B-problem
.	O

Followup	O
Instructions	O
:	O

Please	O
follow-up	O
with	O
your	O
Primary	O
care	O
doctor	O
Larry	O
Bock	O
2019-01-16	O
at	O
8:30	O
AM	O
.	O

At	O
this	O
appointment	O
,	O
you	O
should	O
confirm	O
orthopedic	O
follow-up	O
and	O
request	O
a	O
hematology	O
referral	O
.	O

Call	O
to	O
reschedule	O
.	O

Heidi	O
Laura	O
MD	O
44-725	O

Completed	O
by	O
:	O
Daniel	O
Tapaha	O
MD	O
73-060	O
2019-01-15	O
@	O
0918	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Steven	O
W.	O
Weekley	O
on	O
:	O
Sandra	O
2019-01-15	O
10:22	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2012-05-21	O

Discharge	O
Date	O
:	O

2012-05-25	O

Date	O
of	O
Birth	O
:	O

1957-01-05	O

Sex	O
:	O

F	O

Service	O
:	O

CMED	O
CCU	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
55-year-old	O
female	O
with	O
multiple	O
prior	O
admissions	O
for	O
pneumonia	B-problem
,	O
COPD	B-problem
,	O
asthma	B-problem
exacerbation	I-problem
,	O
over	O
3	O
weeks	O
of	O
upper	B-problem
respiratory	I-problem
like	I-problem
infection	I-problem
unremitting	O
with	O
increased	B-treatment
nebulizer	I-treatment
treatments	I-treatment
at	O
home	O
.	O

The	O
patient	O
saw	O
her	O
PCP	O
and	O
was	O
known	O
to	O
have	O
an	B-test
oxygen	I-test
saturation	I-test
of	O
82	O
to	O
85	O
percent	O
on	O
room	O
air	O
.	O

She	O
was	O
referred	O
to	O
the	O
Emergency	O
Department	O
.	O

In	O
the	O
Emergency	O
Department	O
,	O
the	O
patient	O
received	O
Zithromax	B-treatment
,	O
ceftriaxone	B-treatment
,	O
and	O
Flagyl	B-treatment
.	O

Chest	B-test
x-ray	I-test
was	O
remarkable	O
for	O
a	O
questionable	O
left	B-problem
lower	I-problem
lobe	I-problem
infiltrate	I-problem
.	O

The	O
patient	O
received	O
nebulizer	B-treatment
treatment	I-treatment
with	O
oxygen	B-test
saturations	I-test
increasing	O
up	O
to	O
98	O
percent	O
on	O
room	O
air	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Asthma	B-problem
/	O
COPD	B-problem
on	O
BiPAP	B-treatment
,	O
history	O
of	O
intubation	B-treatment
.	O

Restrictive	B-problem
lung	I-problem
disease	I-problem
.	O

Chronic	B-problem
inflammatory	I-problem
demyelinating	I-problem
polyradiculopathy	I-problem
.	O

Gastritis	B-problem
and	O
duodenitis	B-problem
.	O

Question	O
of	O
Tyrone	B-problem
esophagus	I-problem
.	O

Chronic	B-problem
abdominal	I-problem
pain	I-problem
.	O

Neurogenic	B-problem
bladder	I-problem
.	O

Chronic	B-problem
muscle	I-problem
spasms	I-problem
.	O

Coronary	B-problem
artery	I-problem
disease	I-problem
status	O
post	O
negative	O
stress	B-test
echo	I-test
on	O
10-12	O
.	O

History	O
of	O
syncope	B-problem
.	O

Adrenal	B-problem
insufficiency	I-problem
.	O

Hypercholesterolemia	B-problem
.	O

Depression	B-problem
and	O
anxiety	B-problem
.	O

Hyperthyroidism	B-problem
.	O

IgG	B-problem
deficiency	I-problem
.	O

Status	O
post	O
cholecystectomy	B-treatment
and	O
appendectomy	B-treatment
.	O

Anemia	B-problem
of	O
chronic	B-problem
disease	I-problem
.	O

ALLERGIES	O
:	O

AZMACORT	B-treatment
,	O
CLINDAMYCIN	B-treatment
,	O
VERSED	B-treatment
,	O
FENTANYL	B-treatment
,	O
and	O
MORPHINE	B-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

History	O
of	O
20-to-30-pack-year	O
smoking	O
,	O
quit	O
approximately	O
15	O
years	O
ago	O
.	O

She	O
denies	O
any	O
alcohol	O
or	O
drug	O
use	O
.	O

Married	O
with	O
children	O
,	O
wheelchair	B-problem
bound	I-problem
mostly	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

From	O
admission	O
,	O
vital	B-test
signs	I-test
98.3	O
,	O
blood	B-test
pressure	I-test
128/74	O
,	O
68	O
to	O
112	O
is	O
her	B-test
heart	I-test
rate	I-test
,	O
respiratory	B-test
rate	I-test
24	O
,	O
100	O
percent	O
on	O
room	O
air	O
.	O

General	O
:	O

She	O
is	O
a	O
chronically	O
ill-appearing	O
female	O
,	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

HEENT	O
:	O

Benign	O
.	O

Cardiac	B-test
exam	I-test
:	O

Normal	O
.	O

Pulmonary	B-test
exam	I-test
:	O

Diffuse	B-problem
bronchial	I-problem
breath	I-problem
sounds	I-problem
,	O
no	O
wheezes	B-problem
.	O

Abdominal	B-test
exam	I-test
:	O

Benign	O
.	O

Extremity	B-test
exam	I-test
:	O

No	O
edema	B-problem
.	O

Left	B-problem
lower	I-problem
extremity	I-problem
and	I-problem
left	I-problem
upper	I-problem
extremity	I-problem
weaker	I-problem
at	O
3/5	O
compared	O
to	O
right	O
upper	O
extremity	O
and	O
right	O
lower	O
extremity	O
,	O
chronic	O
according	O
to	O
the	O
patient	O
.	O

MEDICATIONS	O
:	O

On	O
admission	O

1.	O
Vitamin	B-treatment
D	I-treatment
400	O
mg	O
q.d.	O

2.	O
Levoxyl	B-treatment
50	O
mcg	O
q.d.	O

3.	O
Baclofen	B-treatment
20	O
mg	O
p.o.	O
t.i.d.	O

4.	O
Florinef	B-treatment
0.1	O
mg	O
p.o.	O
q.a.m.	O

5.	O
Klonopin	B-treatment
2	O
mg	O
t.i.d.	O

6.	O
BuSpar	B-treatment
10	O
mg	O
t.i.d.	O

7.	O
Zanaflex	B-treatment
8	O
mg	O
q.4	O
h.	O

8.	O
Oxazepam	B-treatment
30	O
mg	O
p.r.n.	O

9.	O
Singulair	B-treatment
10	O
mg	O
q.p.m.	O

10.	O
Lipitor	B-treatment
10	O
mg	O
q.p.m.	O

11.	O
Ativan	B-treatment
2	O
mg	O
p.r.n.	O

12.	O
Protonix	B-treatment
20	O
mg	O
p.o.	O
b.i.d.	O

13.	O
Sucralfate	B-treatment
2	O
mg	O
b.i.d.	O

14.	O
Albuterol	B-treatment
nebulizer	I-treatment
q.03-14	O
h.	O
p.r.n.	O

15.	O
Pamidronate	B-treatment
30	O
mg	O
IV	O
every	O
month	O
.	O

HOSPITAL	O
COURSE	O
:	O

Shortness	B-problem
of	I-problem
breath	I-problem
.	O

The	O
patient	O
was	O
maintained	O
on	O
albuterol	B-treatment
nebulizer	I-treatment
treatments	I-treatment
and	O
Ipratropium	B-treatment
nebulizer	I-treatment
treatments	I-treatment
,	O
as	O
this	O
was	O
apparently	O
thought	O
to	O
be	O
related	O
to	O
her	B-problem
chronic	I-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
.	O

Given	O
the	O
presence	O
of	O
consolidation	B-problem
on	O
chest	B-test
x-ray	I-test
,	O
however	O
,	O
and	O
previous	O
history	O
of	O
pneumonia	B-problem
,	O
the	O
patient	O
was	O
maintained	O
on	O
antibiotics	B-treatment
of	O
Zithromax	B-treatment
500	O
mg	O
daily	O
and	O
ceftriaxone	B-treatment
.	O

The	O
patient	O
was	O
also	O
started	O
on	O
Solu-Medrol	B-treatment
IV	I-treatment
for	O
active	B-problem
airway	I-problem
disease	I-problem
component	I-problem
of	O
her	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
.	O

The	O
patient	O
was	O
maintained	O
on	O
supplemental	B-treatment
oxygen	I-treatment
and	O
sputum	O
production	O
was	O
maximized	O
with	O
the	O
help	O
of	O
an	B-treatment
Acapella	I-treatment
device	I-treatment
and	O
respiratory	B-treatment
therapy	I-treatment
.	O

Mucomyst	B-treatment
was	O
also	O
considered	O
as	O
a	B-treatment
mucolytic	I-treatment
component	I-treatment
towards	O
secretions	B-problem
.	O

Adrenal	B-problem
insufficiency	I-problem
.	O

The	O
patient	O
was	O
maintained	O
on	O
IV	B-treatment
Solu	I-treatment
-	I-treatment
Medrol	I-treatment
60	O
mg	O
q.	O
8	O
h.	O

Chest	B-problem
soreness	I-problem
.	O

The	O
patient	O
describes	O
chest	B-problem
discomfort	I-problem
without	O
any	B-problem
significant	I-problem
EKG	I-problem
changes	I-problem
.	O

The	O
patient	O
was	O
maintained	O
on	O
Percocet	B-treatment
p.r.n.	O
for	O
pain	B-treatment
relief	I-treatment
.	O

This	O
was	O
thought	O
to	O
be	O
related	O
to	O
musculoskeletal	O
.	O

There	O
was	O
no	O
evidence	O
of	O
acute	B-problem
rib	I-problem
factors	I-problem
on	O
her	B-test
chest	I-test
x-ray	I-test
.	O

GI	O
.	O

The	O
patient	O
was	O
maintained	O
on	O
PPI	B-treatment
for	O
reflux	B-problem
disease	I-problem
and	O
known	B-problem
gastritis	I-problem
.	O

CMED	O
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
neurogenic	B-problem
bladder	I-problem
and	O
,	O
therefore	O
,	O
she	O
required	O
a	B-treatment
Foley	I-treatment
catheterization	I-treatment
.	O

Endocrine	O
.	O

The	O
patient	O
was	O
on	O
Levoxyl	B-treatment
at	O
home	O
as	O
her	O
home	O
dose	O
for	O
hyperthyroidism	B-problem
.	O

CMED	O
CSRU	O
transfer	O
.	O

The	O
patient	O
was	O
transferred	O
on	O
the	O
evening	O
of	O
2012-05-22	O
to	O
the	O
ICU	O
given	O
persistent	B-problem
carbon	I-problem
dioxide	I-problem
retention	I-problem
and	O
respiratory	B-problem
acidosis	I-problem
and	O
the	B-problem
intermittent	I-problem
mental	I-problem
status	I-problem
changes	I-problem
.	O

The	O
patient	O
had	O
had	O
ABG	B-test
on	O
the	O
floor	O
,	O
which	O
prompted	O
her	O
to	O
transfer	O
to	O
the	O
ICU	O
.	O

Her	B-test
pH	I-test
was	O
7.23	O
,	O
PCO2	B-test
73	O
,	O
PO2	B-test
146	O
on	O
a	B-treatment
nonrebreather	I-treatment
.	O

The	O
patient	O
had	O
BiPAP	B-treatment
initiated	O
once	O
she	O
reached	O
the	O
unit	O
,	O
but	O
did	O
not	O
tolerate	O
it	O
,	O
becoming	O
apneic	B-problem
and	O
obstructing	B-problem
.	O

The	O
patient	O
was	O
switched	O
to	O
2	B-treatment
liters	I-treatment
nasal	I-treatment
cannula	I-treatment
and	O
oxygen	O
saturating	O
at	O
98	O
to	O
100	O
percent	O
.	O

After	O
BiPAP	B-treatment
was	O
initiated	O
,	O
the	O
patient	O
became	O
hypotensive	B-problem
down	O
to	O
75/28	O
and	O
bradycardiac	B-problem
,	O
responding	O
to	O
3	B-treatment
fluid	I-treatment
boluses	I-treatment
over	O
the	O
course	O
of	O
the	O
night	O
.	O

The	O
patient	O
was	O
started	O
on	O
Florinef	B-treatment
for	O
concern	O
of	O
adrenal	B-problem
insufficiency	I-problem
;	O
however	O
,	O
she	O
was	O
hemodynamically	O
stable	O
that	O
morning	O
and	O
was	O
transferred	O
back	O
out	O
to	O
the	O
floor	O
.	O

It	O
was	O
thought	O
that	O
the	O
patient	O
may	O
have	O
been	O
mucous	B-problem
plugging	I-problem
during	O
her	O
stay	O
in	O
the	O
ICU	O
.	O

Hematologic	O
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
high	B-problem
MCV	I-problem
and	O
megaloblastic	B-problem
cells	I-problem
on	O
smear	B-test
in	O
the	O
setting	O
of	O
anemia	B-problem
;	O
question	O
B12	B-problem
deficiency	I-problem
,	O
the	O
patient	O
also	O
has	O
a	O
history	O
of	O
borderline	B-problem
low	I-problem
B12	I-problem
levels	I-problem
.	O

The	O
patient	O
was	O
diagnosed	O
for	O
B12	B-problem
deficiency	I-problem
due	O
to	O
her	O
long	O
history	O
of	O
poor	B-problem
p.o.	I-problem
intake	I-problem
.	O

Methylmalonic	B-test
acid	I-test
levels	I-test
were	O
sent	O
,	O
the	O
results	O
are	O
pending	O
at	O
the	O
time	O
of	O
discharge	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Asthma	B-problem
flare	I-problem
and	O
bronchitis	B-problem
.	O

Chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
.	O

Demyelinating	B-problem
polyradiculopathy	I-problem
.	O

Anxiety	B-problem
disorder	I-problem
.	O

Chronic	B-problem
abdominal	I-problem
pain	I-problem
.	O

DISCHARGE	O
STATUS	O
:	O

The	O
patient	O
will	O
be	O
discharged	O
to	O
home	O
.	O

DISCHARGE	O
CONDITION	O
:	O

The	O
patient	O
is	O
stable	O
without	O
an	B-problem
oxygen	I-problem
requirement	I-problem
.	O

DISCHARGE	O
FOLLOWUP	O
:	O

The	O
patient	O
is	O
instructed	O
to	O
followup	O
with	O
her	O
doctor	O
in	O
1	O
to	O
2	O
weeks	O
of	O
discharge	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Cholecalciferol	B-treatment
.	O

2.	O
Vitamin	B-treatment
D	I-treatment
.	O

3.	O
Levothyroxine	B-treatment
50	O
mcg	O
p.o.	O
q.d.	O

4.	O
Baclofen	B-treatment
10	O
mg	O
p.o.	O
t.i.d.	O

5.	O
Clonazepam	B-treatment
1	O
mg	O
p.o.	O
t.i.d.	O

6.	O
Buspirone	B-treatment
10	O
mg	O
p.o.	O
t.i.d.	O

7.	O
Montelukast	B-treatment
sodium	I-treatment
10	O
mg	O
p.o.	O
q.h.s.	O

8.	O
Atorvastatin	B-treatment
10	O
mg	O
p.o.	O
q.h.s.	O

9.	O
Protonix	B-treatment
40	O
mg	O
p.o.	O
q.d.	O

10.	O
Albuterol	B-treatment
sulfate	I-treatment
solution	I-treatment
q.05-15	O
h.	O
p.r.n.	O
for	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

11.	O
Tizanidine	B-treatment
8	O
mg	O
p.o.	O
q.6	O
h.	O

12.	O
Acetaminophen	B-treatment
p.r.n.	O

13.	O
Prednisone	B-treatment
taper	I-treatment
for	O
3	O
days	O
.	O

14.	O
Levofloxacin	B-treatment
500	O
mg	O
p.o.	O
q.d.	O
for	O
10	O
more	O
days	O
.	O

15.	O
Florinef	B-treatment
Acetate	I-treatment
0.1	O
mg	O
p.o.	O
q.d.	O

James	O
Grunow	O
,	O
M.D.	O
53-506	O

Dictated	O
By	O
:	O
Elizabeth	O
A	O
Eaton	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2012-08-01	O
12:27:33	O

T	O
:	O
2012-08-01	O
20:27:59	O

Job	O
#:	O

33698	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Kenneth	O
Wilford	O
on	O
:	O
Maxine	O
2012-08-16	O
12:22	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2019-06-14	O

Discharge	O
Date	O
:	O

2019-06-19	O

Date	O
of	O
Birth	O
:	O

1968-01-21	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	B-treatment

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O
Michael	O
A.E.	O
Adkins	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Shortness	B-problem
of	I-problem
breath	I-problem
,	O
fever	B-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

None	O

History	O
of	O
Present	O
Illness	O
:	O

Mr.	O
Mcelveen	O
is	O
a	O
51	O
year-old	O
male	O
with	O
metastatic	B-problem
RCC	I-problem
status	O
post	O
left	B-treatment
radical	I-treatment
nephrectomy	I-treatment
in	O
2018-03-21	O
,	O
status	O
post	O
Avastin	B-treatment
and	O
sorafenib	B-treatment
,	O
most	O
recently	O
on	O
Sutent	B-treatment
monotherapy	I-treatment
since	O
2018-12-21	O
,	O
with	O
mild	B-problem
renal	I-problem
insufficiency	I-problem
,	O
who	O
presented	O
from	O
home	O
on	O
2019-06-14	O
with	O
shortness	B-problem
of	I-problem
breath	I-problem
and	O
fever	B-problem
.	O

Of	O
note	O
,	O
he	O
was	O
hospitalized	O
at	O
Dana-Farber	O
Cancer	O
Institute	O
from	O
9/25-10/6	O
with	O
chest	B-problem
pain	I-problem
,	O
at	O
which	O
time	O
he	O
reportedly	O
had	O
cardiac	B-test
enzymes	I-test
,	O
an	B-test
echocardiogram	I-test
and	O
a	B-test
pharmacological	I-test
stress	I-test
test	I-test
performed	O
.	O

It	O
is	O
unclear	O
from	O
history	O
what	O
these	B-test
studies	I-test
revealed	O
.	O

He	O
reports	O
that	O
he	O
felt	O
fatigued	B-problem
during	O
the	O
week	O
prior	O
to	O
the	O
current	O
admission	O
.	O

On	O
the	O
day	O
of	O
admission	O
,	O
he	O
felt	O
"	O
congested	B-problem
"	O
in	O
his	O
chest	O
,	O
and	O
had	O
a	B-problem
new	I-problem
fever	I-problem
.	O

He	O
was	O
taken	O
to	O
the	O
Deanna	O
by	O
his	O
wife	O
.	O

Patrick	O
reports	O
a	B-problem
mild	I-problem
cough	I-problem
for	O
2	O
days	O
PTA	O
,	O
non-productive	B-problem
.	O

He	O
denies	O
a	O
history	O
of	O
aspiration	B-problem
events	I-problem
or	O
choking	B-problem
with	O
food	O
intake	O
.	O

He	O
describes	O
mild	B-problem
reflux	I-problem
symptoms	I-problem
at	O
night	O
.	O

Further	B-test
ROS	I-test
reveals	O
mild	B-problem
SOB	I-problem
in	O
the	O
days	O
preceding	O
admission	O
,	O
but	O
he	O
tells	O
me	O
that	O
he	O
was	O
surprised	O
to	O
find	O
out	O
about	O
his	B-problem
low	I-problem
oxygen	I-problem
saturation	I-problem
because	O
he	O
did	O
not	O
feel	O
that	O
bad	O
.	O

He	O
denies	O
chills	B-problem
,	O
no	O
chest	B-problem
pain	I-problem
,	O
no	O
LE	B-problem
swelling	I-problem
.	O

In	O
the	O
Deanna	O
,	O
Tmax	B-test
102.8	O
,	O
BP	B-test
100	O
-	O
140/60	O
s,	O
HR	B-test
80	O
s,	O
RR	B-test
20	O
s,	O
Sat	B-test
75%	O
on	O
RA	B-treatment
in	O
triage	O
,	O
up	O
to	O
100%	O
on	O
NRB	B-treatment
.	O

CXR	B-test
with	O
bibasilar	B-problem
consolidations	I-problem
.	O

He	O
was	O
given	O
Levo	B-treatment
750	O
mg	O
PO	O
X1	O
,	O
and	O
Flagyl	B-treatment
500	O
mg	O
PO	O
X1	O
.	O

His	B-test
BP	I-test
decreased	O
to	O
100	O
systolic	O
despite	O
hydration	B-treatment
with	O
2L	O
of	O
NS	B-treatment
.	O

He	O
was	O
subsquently	O
admitted	O
to	O
the	O
ICU	O
for	O
further	B-treatment
care	I-treatment
.	O

He	O
was	O
placed	O
on	O
Levo	B-treatment
and	O
Ceftriaxone	B-treatment
.	O

A	B-test
cosyntropin	I-test
stimulation	I-test
test	I-test
revealed	O
cortisol	B-test
32.1	O
-->	O
36.4	O
.	O

His	B-problem
oxygen	I-problem
requirement	I-problem
decreased	O
,	O
and	O
his	O
overall	O
status	O
improved	O
quickly	O
.	O

He	O
is	O
being	O
transferred	O
to	O
the	O
floor	O
for	O
ongoing	B-treatment
care	I-treatment
.	O

Past	O
Medical	O
History	O
:	O

1.	O
Metastatic	B-problem
renal	I-problem
cell	I-problem
carcinoma	I-problem
,	O
diagnosed	O
in	O
2018-03-21	O
,	O
status	O
post	O
left	B-treatment
radical	I-treatment
nephrectomy	I-treatment
at	O
St.	O
Margaret's	O
Center	O
for	O
Women	O
&	O
Infants	O
in	O
03/2006	O
.	O

Path	O
consistent	O
with	O
renal	B-problem
cell	I-problem
carcinoma	I-problem
of	I-problem
chromophobe	I-problem
type	I-problem
with	O
Carter	B-problem
nuclear	I-problem
grade	I-problem
of	O
4/4	O
.	O

Lymphovascular	B-problem
invasion	I-problem
was	O
present	O
.	O

He	O
later	O
presented	O
with	O
increasing	B-problem
back	I-problem
pain	I-problem
,	O
and	O
metastatic	B-problem
disease	I-problem
was	O
documented	O
.	O

He	O
is	O
status	O
post	O
Avastin	B-treatment
plus	O
sorafenib	B-treatment
,	O
protocol	O
#04-393	O
,	O
discontinued	O
in	O
the	O
setting	O
of	O

ongoing	B-problem
grade	I-problem
III	I-problem
rash	I-problem
,	O
involving	O
the	O
hands	O
and	O
feet	O
in	O
addition	O
proteinuria	B-problem
secondary	O
to	O
the	O
Avastin	B-treatment
.	O

He	O
has	O
been	O
maintained	O
on	O
single	B-treatment
Timlin	I-treatment
therapy	I-treatment
with	O
Sutent	B-treatment
50	O
mg	O
daily	O
as	O
of	O
2018-12-21	O
and	O
has	O
completed	O
nearly	O
6	O
cycles	O
.	O

He	O
has	O
mild	B-problem
renal	I-problem
insufficiency	I-problem
in	O
the	O
setting	O
of	O
Sutent	B-treatment
.	O

2.	O
Seasonal	B-problem
allergies	I-problem

Social	O
History	O
:	O

He	O
lives	O
at	O
home	O
with	O
his	O
wife	O
and	O
son	O
,	O
who	O
is	O
7	O
years	O
old	O
.	O

He	O
works	O
in	O
real	O
estate	O
development	O
and	O
invests	O
in	O
stockmarket	O
.	O

HE	O
is	O
a	O
lifelong	O
non-smoker	O
.	O

Family	O
History	O
:	O

Not	O
reviewed	O
with	O
patient	O
.	O

Physical	O
Exam	O
:	O

VITALS	B-test
:	O
T	B-test
96.9	O
,	O
BP	B-test
110/70	O
,	O
HR	B-test
84	O
,	O
RR	B-test
20	O
,	O
Sat	B-test
97%	O
on	O
4L	O
.	O

GEN	O
:	O
In	O
NAD	B-problem
.	O

HEENT	O
:	O
Flushed	B-problem
cheeks	I-problem
.	O

Slightly	B-problem
dry	I-problem
MM	I-problem
.	O

NECK	O
:	O
JVP	B-test
not	O
elevated	B-problem
.	O

RESP	O
:	O
Decreased	B-problem
air	I-problem
entry	I-problem
and	O
crackles	B-problem
at	I-problem
both	I-problem
lung	I-problem
bases	I-problem
.	O

+	O
Egophony	B-problem
.	O

CVS	O
:	O
RRR	O
.	O
Normal	O
S1	O
,	O
S2	O
.	O

No	O
S3	B-problem
,	O
S4	B-problem
.	O

No	O
murmur	B-problem
or	O
rub	B-problem
.	O

GI	O
:	O
BS	O
NA	O
.	O

Abdomen	O
soft	O
and	O
non-tender	B-problem
.	O

EXT	O
:	O
Without	O
edema	B-problem
.	O

Good	O
pedal	O
pulses	O
.	O

Pertinent	O
Results	O
:	O

Laboratory	O
results	O
:	O

2019-06-14	O
10:30	O
AM	O
BLOOD	O
WBC	B-test
-	O
8.0	O
RBC	B-test
-	O
4.22	O
*	O
Hgb	B-test
-	O
12.9	O
*	O
Hct	B-test
-	O
41.7	O
MCV	B-test
-	O
99	O
*	O
MCH	B-test
-	O
30.5	O
MCHC	B-test
-	O
30.8	O
*	O
RDW	B-test
-	O
16.8	O
*	O
Plt	B-test
Ct	I-test
-	O
797	O
*#	O

2019-06-19	O
07:20	O
AM	O
BLOOD	O
WBC	B-test
-	O
11.1	O
*	O
RBC	B-test
-	O
3.47	O
*	O
Hgb	B-test
-	O
10.9	O
*	O
Hct	B-test
-	O
34.1	O
*	O
MCV	B-test
-	O
98	O
MCH	B-test
-	O
31.3	O
MCHC	B-test
-	O
31.9	O
RDW	B-test
-	O
16.7	O
*	O
Plt	B-test
Ct	I-test
-	O
604	O
*	O

2019-06-14	O
10:30	O
AM	O
BLOOD	O
PT	B-test
-	O
11.2	O
PTT	B-test
-	O
23.9	O
INR(PT)	B-test
-	O
0.9	O

2019-06-14	O
10:30	O
AM	O
BLOOD	O
Plt	B-test
Ct	I-test
-	O
797	O
*#	O

2019-06-14	O
10:30	O
AM	O
BLOOD	O
Glucose	B-test
-	O
134	O
*	O
UreaN	B-test
-	O
39	O
*	O
Creat	B-test
-	O
2.1	O
*	O
Na	B-test
-	O
133	O
K	B-test
-	O
7.9	O
*	O
Cl	B-test
-	O
94	O
*	O
HCO3	B-test
-	O
28	O
AnGap	B-test
-	O
19	O

2019-06-19	O
07:20	O
AM	O
BLOOD	O
Glucose	B-test
-	O
73	O
UreaN	B-test
-	O
20	O
Creat	B-test
-	O
1.1	O
Na	B-test
-	O
136	O
K	B-test
-	O
5.0	O
Cl	B-test
-	O
101	O
HCO3	B-test
-	O
27	O
AnGap	B-test
-	O
13	O

2019-06-14	O
10:30	O
AM	O
BLOOD	O
ALT	B-test
-	O
34	O
AST	B-test
-	O
167	O
*	O
CK(CPK)	B-test
-	O
313	O
*	O
AlkPhos	B-test
-	O
383	O
*	O
Amylase	B-test
-	O
44	O
TotBili	B-test
-	O
0.7	O

2019-06-14	O
06:03	O
PM	O
BLOOD	O
CK(CPK)	B-test
-	O
194	O
*	O

2019-06-14	O
10:30	O
AM	O
BLOOD	O
CK-MB	B-test
-	O
3	O
cTropnT	B-test
-	O
0.05	O
*	O

2019-06-14	O
06:03	O
PM	O
BLOOD	O
CK-MB	B-test
-4	O
cTropnT	B-test
-	O
0.03	O
*	O

2019-06-17	O
05:30	O
AM	O
BLOOD	O
proBNP	B-test
-	O
258	O
*	O

2019-06-14	O
06:03	O
PM	O
BLOOD	O
Calcium	B-test
-	O
8.3	O
*	O
Phos	B-test
-	O
4.3	O
Mg	B-test
-	O
1.9	O

2019-06-18	O
07:55	O
AM	O
BLOOD	O
calTIBC	B-test
-	O
229	O
Ferritn	B-test
-	O
GREATER	O
TH	O
TRF	O
-	O
176	O
*	O

2019-06-16	O
07:35	O
AM	O
BLOOD	O
TSH	B-test
-	O
43	O
*	O

2019-06-16	O
07:35	O
AM	O
BLOOD	O
Free	B-test
T4	I-test
-	O
0.36	O
*	O

2019-06-19	O
07:20	O
AM	O
BLOOD	O
WBC	B-test
-	O
11.1	O
*	O
RBC	B-test
-	O
3.47	O
*	O
Hgb	B-test
-	O
10.9	O
*	O
Hct	B-test
-	O
34.1	O
*	O
MCV	B-test
-	O
98	O
MCH	B-test
-	O
31.3	O
MCHC	B-test
-	O
31.9	O
RDW	B-test
-	O
16.7	O
*	O
Plt	B-test
Ct	I-test
-	O
604	O
*	O

2019-06-19	O
07:20	O
AM	O
BLOOD	O
Neuts	B-test
-	O
77.0	O
*	O
Bands	B-test
-	O
5.0	O
Lymphs	B-test
-	O
11.0	O
*	O
Monos	B-test
-	O
3.0	O
Eos	B-test
-	O
0	O
Baso	B-test
-	O
0	O
Atyps	B-test
-	O
1.0	O
*	O
Metas	B-test
-	O
2.0	O
*	O
Myelos	B-test
-	O
1.0	O
*	O

2019-06-18	O
07:55	O
AM	O
BLOOD	O
PT	B-test
-	O
11.5	O
INR(PT)	B-test
-	O
1.0	O

2019-06-19	O
07:20	O
AM	O
BLOOD	O
Glucose	B-test
-	O
73	O
UreaN	B-test
-	O
20	O
Creat	B-test
-	O
1.1	O
Na	B-test
-	O
136	O
K	B-test
-	O
5.0	O
Cl	B-test
-	O
101	O
HCO3	B-test
-	O
27	O
AnGap	B-test
-	O
13	O

2019-06-19	O
07:20	O
AM	O
BLOOD	O
Calcium	B-test
-	O
8.0	O
*	O
Phos	B-test
-	O
3.3	O
Mg	B-test
-	O
2.0	O

Relevant	O
Imaging	O
:	O

1)	O
Bilateral	B-test
LE	I-test
doppler	I-test
(	O
06-14	O
):	O
No	O
evidence	O
of	O
deep	B-problem
venous	I-problem
thrombosis	I-problem
in	I-problem
the	I-problem
lower	I-problem
extremities	I-problem
bilaterally	I-problem
.	O

2)	O
Cxray	B-test
(	O
06-14	O
):	O
New	B-problem
bibasilar	I-problem
consolidations	I-problem
are	O
demonstrated	O
accompanied	O
by	O
bilateral	B-problem
small	I-problem
pleural	I-problem
effusion	I-problem
.	O

The	O
lung	O
volumes	O
are	O
slightly	B-problem
increased	I-problem
.	O

There	O
is	O
no	O
pneumothorax	B-problem
identified	O
.	O

3)	O
CT	B-test
Torso	I-test
(	O
06-17	O
):	O

1.	O
Marked	B-problem
interval	I-problem
enlargement	I-problem
of	I-problem
the	I-problem
cardiac	I-problem
silhouette	I-problem
.	O

Together	O
with	O
the	O
interval	O
development	O
of	O
bilateral	B-problem
pleural	I-problem
effusions	I-problem
,	O
this	O
indicates	O
cardiac	B-problem
insufficiency	I-problem
(	O
or	O
alternatively	O
volume	B-problem
overload	I-problem
)	O
and	O
an	B-test
echocardiogram	I-test
may	O
be	O
indicated	O
for	O
further	B-test
evaluation	I-test
.	O

2.	O
Bilateral	B-problem
basilar	I-problem
compressive	I-problem
atelectasis	I-problem
.	O

Superimposed	B-problem
infectious	I-problem
consolidation	I-problem
is	O
likely	O
.	O

3.	O
Interval	O
development	O
of	O
tree-in-Eric	B-problem
nodular	I-problem
opacities	I-problem
and	O
scattered	B-problem
ground	I-problem
glass	I-problem
opacities	I-problem
involving	I-problem
the	I-problem
right	I-problem
lung	I-problem
,	O
concerning	O
for	O
an	B-problem
infectious	I-problem
process	I-problem
.	O

The	O
differential	O
diagnosis	O
of	O
this	O
is	O
wide	O
including	O
viral	B-problem
,	I-problem
fungal	I-problem
and	I-problem
atypical	I-problem
mycobacterial	I-problem
infections	I-problem
.	O

Drug	B-problem
toxicity	I-problem
would	O
be	O
a	O
consideration	O
,	O
although	O
somewhat	O
less	O
likely	O
given	O
the	O
unilaterality	O
of	O
the	O
findings	O
.	O

4.	O
New	B-problem
jejunal	I-problem
wall	I-problem
thickening	I-problem
with	O
persistent	B-problem
distal	I-problem
ileal	I-problem
wall	I-problem
thickening	I-problem
and	O
diffuse	B-problem
mesenteric	I-problem
stranding	I-problem
,	O
most	O
likely	O
reflecting	O
an	B-problem
infectious	I-problem
etiology	I-problem
.	O

5.	O
Overall	O
stability	O
in	O
metastatic	B-problem
burden	I-problem
.	O

4)	O
ECHO	B-test
(	O
06-18	O
):	O
Mild	B-problem
symmetric	I-problem
left	I-problem
ventricular	I-problem
hypertrophy	I-problem
with	O
preserved	O
biventricular	O
systolic	O
function	O
.	O

Mild	B-problem
posterior	I-problem
mitral	I-problem
valve	I-problem
prolapse	I-problem
with	O
mild	B-problem
mitral	I-problem
regurgitation	I-problem
.	O

Small	B-problem
(	I-problem
0.6	I-problem
cm	I-problem
)	I-problem
circumferential	I-problem
pericardial	I-problem
effusion	I-problem
,	O
largest	O
around	O
the	O
left	O
atrium	O
.	O

5)	O
L	B-test
femur	I-test
xray	I-test
(	O
06-18	O
):	O
Predominantly	B-problem
sclerotic	I-problem
lesion	I-problem
with	O
interval	B-problem
periosteal	I-problem
new	I-problem
bone	I-problem
formation	I-problem
involving	O
the	O
intertrochanteric	O
and	O
subtrochanteric	O
regions	O
.	O

No	O
displaced	B-problem
fracture	I-problem
is	O
demonstrated	O
.	O

Brief	O
Hospital	O
Course	O
:	O

Mr.	O
Mcelveen	O
51	O
year-old	O
male	O
with	O
metastatic	B-problem
RCC	I-problem
on	O
Sutent	B-treatment
since	O
2018-12-21	O
,	O
admitted	O
with	O
fever	B-problem
,	O
hypoxemia	B-problem
,	O
and	O
bibasilar	B-problem
pneumonia	I-problem
.	O

1)	O
Bibasilar	B-problem
pneumonia	I-problem
:	O
Patient	O
was	O
treated	O
for	O
community-acquired	B-problem
pneumonia	I-problem
.	O

He	O
was	O
initially	O
placed	O
on	O
Ceftriaxone	B-treatment
,	O
Levaquin	B-treatment
,	O
and	O
Flagyl	B-treatment
in	O
the	O
ICU	O
but	O
then	O
changed	O
to	O

Azithromycin	B-treatment
&	O
CTX	B-treatment
at	O
time	O
of	O
transfer	O
to	O
the	O
oncology	O
service	O
.	O

He	O
continued	O
to	O
have	O
an	B-problem
oxygen	I-problem
requirement	I-problem
and	O
CT	B-test
scan	I-test
suggested	O
ground	B-problem
glass	I-problem
opacities	I-problem
,	O
suggestive	O
of	O
an	B-problem
underlying	I-problem
infectious	I-problem
process	I-problem
.	O

ECHO	B-test
was	O
done	O
and	O
confirmed	O
normal	O
ejection	O
fraction	O
.	O

His	O
respiratory	O
status	O
improved	O
slowly	O
,	O
oxygen	B-treatment
was	O
weaned	O
off	O
,	O
and	O
he	O
was	O
discharged	O
on	O
course	O
of	O
Levaquin	B-treatment
.	O

2)	O
Metastatic	B-problem
RCC	I-problem
:	O
Sutent	B-treatment
was	O
held	O
on	O
admission	O
in	O
light	O
of	O
acute	B-problem
infection	I-problem
.	O

He	O
underwent	O
a	B-test
staging	I-test
CT	I-test
scan	I-test
torso	I-test
which	O
suggested	O
no	O
significant	B-problem
increase	I-problem
in	I-problem
tumor	I-problem
burden	I-problem
.	O

Patient	O
was	O
also	O
found	O
to	O
have	O
abnormal	B-problem
TFTs	I-problem
on	O
Sutent	B-treatment
and	O
was	O
started	O
on	O
replacement	B-treatment

therapy	B-treatment
.	O

He	O
will	O
need	O
follow-up	B-test
bloodwork	I-test
as	O
an	O
outpatient	O
.	O

Recent	B-test
CT	I-test
scan	I-test
showed	O
destruction	B-problem
of	I-problem
L	I-problem
femoral	I-problem
neck	I-problem
.	O

He	O
underwent	O
an	B-test
xray	I-test
of	I-test
the	I-test
L	I-test
femur	I-test
which	O
did	O
not	O
suggest	O
an	B-problem
acute	I-problem
fracture	I-problem
.	O

No	O
limitations	O
were	O
placed	O
in	O
regards	O
to	O
weightbearing	O
status	O
.	O

Patient	O
was	O
instructed	O
to	O
restart	O
Sutent	B-treatment
next	O
Monday	O
.	O

3)	O
Renal	B-problem
insufficiency	I-problem
:	O
Creatinine	B-test
improved	O
from	O
2.1	O
to	O
1.3	O
at	O
time	O
of	O
discharge	O
.	O

Likely	O
related	O
to	O
underlying	B-problem
malignancy	I-problem
as	O
well	O
as	O
prerenal	B-problem
component	I-problem
given	O
improvement	O
with	O
gentle	B-treatment
hydration	I-treatment
.	O

Medications	O
on	O
Admission	O
:	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O
He	O
takes	O
Imodium	B-treatment
and	O
Lomotil	B-treatment
while	O
on	O
Sutent	B-treatment
for	O
diarrhea	B-problem
.	O

He	O
has	O
not	O
had	O
a	O
BM	O
in	O
3	O
days	O
now	O
.	O

He	O
is	O
also	O
on	O
MS	B-treatment
Contin	I-treatment
45	O
mg	O
PO	O
q12	O
hours	O
(	O
confirmed	O
with	O
wife	O
)	O
and	O
MSIR	B-treatment
15	O
mg	O
every	O
4	O
hours	O
as	O
needed	O
.	O

MEDICATIONS	O
ON	O
TRANSFER	O
:	O

Heparin	B-treatment
5000	O
UNIT	O
SC	O
TID	O

Albuterol	B-treatment
0.083%	O
Neb	O
Soln	O
1	O
NEB	O
IH	O
Q6H	O

Ipratropium	B-treatment
Bromide	I-treatment
Neb	I-treatment
1	O
NEB	O
IH	O
Q6H	O

CeftriaXONE	B-treatment
1	O
gm	O
IV	O
Q24H	O

Levofloxacin	B-treatment
500	O
mg	O
PO	O
Q24H	O

Morphine	B-treatment
Sulfate	I-treatment
2-4	O
mg	O
IV	O
Q4H	O
:	O
PRN	O

Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
PO	O
BID	O

Pantoprazole	B-treatment
40	O
mg	O
PO	O
Q24H	O

Fluticasone	B-treatment
Propionate	I-treatment
110mcg	O
2	O
PUFF	O
IH	O
BID	O

Discharge	O
Medications	O
:	O

1.	O
Levothyroxine	B-treatment
50	O
mcg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

2.	O
Levofloxacin	B-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
for	O
4	O
days	O
:	O
last	O
dose	O
will	O
be	O
Nolen	O
,	O
06-23	O
.	O

Disp	O
:*	O
4	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

3.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
):	O
Take	O
as	O
necessary	O
for	O
constipation	B-problem
.	O

4.	O
SUTENT	B-treatment
50	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
Every	O
other	O
day	O
:	O
Please	O
restart	O
on	O
Wallace	O
,	O
06-24	O
.	O

5.	O
Morphine	B-treatment
15	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
for	O
Pain	B-problem
.	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

6.	O
Morphine	B-treatment
15	O
mg	O
Tablet	O
Sustained	O
Release	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Tablet	O
Sustained	O
Release	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
).	O

Disp	O
:*	O
90	O
Tablet	O
Sustained	O
Release	O
(s)*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

Primary	O
diagnoses	O
:	O

1)	O
Pneumonia	B-problem

2)	O
Acute	B-problem
renal	I-problem
failure	I-problem

3)	O
Metastatic	B-problem
renal	I-problem
cell	I-problem
carcinoma	I-problem

4)	O
Hypoxemia	B-problem

Discharge	O
Condition	O
:	O

Stable	O

Discharge	O
Instructions	O
:	O

1)	O
Please	O
take	O
all	B-treatment
medications	I-treatment
as	O
listed	O
in	O
the	O
discharge	O
instructions	O
.	O

2)	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
and	O
started	O
on	O
an	B-treatment
antibiotic	I-treatment
called	O
Levaquin	B-treatment
for	O
a	B-problem
pneumonia	I-problem
.	O

You	O
should	O
continue	O
taking	O
this	B-treatment
medication	I-treatment
and	O
your	O
last	O
day	O
will	O
be	O
Nolen	O
,	O
06-23	O
.	O

3)	O
When	O
you	O
were	O
admitted	O
to	O
the	O
hospital	O
your	B-treatment
Sutent	I-treatment
was	O
stopped	O
.	O

You	O
should	O
resume	O
this	B-treatment
medication	I-treatment
starting	O
Wallace	O
,	O
06-24	O
.	O

You	O
should	O
take	O
this	B-treatment
medication	I-treatment
every	O
other	O
day	O
.	O

4)	O
During	O
your	O
hospital	O
stay	O
you	O
were	O
also	O
found	O
to	O
have	O
low	B-problem
thyroid	I-problem
hormone	I-problem
levels	I-problem
.	O

As	O
a	O
result	O
,	O
you	O
were	O
started	O
on	O
thyroid	B-treatment
supplements	I-treatment
.	O

You	O
should	O
have	O
follow-up	B-test
blood	I-test
tests	I-test
by	O
your	O
primary	O
care	O
physician	O
B	O
3	O
months	O
.	O

5)	O
Please	O
attend	O
all	O
appointments	O
as	O
listed	O
below	O
.	O

6)	O
If	O
you	O
experience	O
any	O
fevers	B-problem
,	O
chills	B-problem
,	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
dizziness	B-problem
or	O
any	B-problem
other	I-problem
concerning	I-problem
symptoms	I-problem
please	O
return	O
to	O
the	O
emergency	O
department	O
.	O

Followup	O
Instructions	O
:	O

1)	O
Provider	O
:	O
Yolanda	O
Joyce	O
,	O
MD	O
Phone	O
:	O
337	O
2567	O

Date	O
/	O
Time	O
:	O
2019-07-03	O
3:30	O

2)	O
Provider	O
:	O
Peter	O
Helen	O
Braddy	O
,	O
MD	O
Phone	O
:	O
337	O
2567	O

Date	O
/	O
Time	O
:	O
2019-07-03	O
3:30	O

Philip	O
Glenn	O
MD	O
60-385	O

Completed	O
by	O
:	O
Eva	O
Susan	O
MD	O
54-940	O
2019-07-27	O
@	O
1700	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Patrick	O
B	O
Santiago	O
on	O
:	O
MON	O
2019-07-29	O
9:27	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2013-06-12	O

Discharge	O
Date	O
:	O

2013-06-25	O

Date	O
of	O
Birth	O
:	O

1943-03-31	O

Sex	O
:	O

M	O

Service	O
:	O

TRA	O

ADDENDUM	O
:	O

This	O
is	O
a	O
discharge	O
summary	O
addendum	O
for	O
Discharge	O
Summary	O
number	O
554108	O
.	O

As	O
follows	O
.	O

Patient	O
was	O
discharged	O
to	O
rehabilitation	B-treatment
on	O
2013-06-25	O
.	O

Discharge	O
was	O
delayed	O
by	O
one	O
day	O
to	O
ensure	O
patient	O
could	O
tolerate	O
P.O.	O
which	O
patient	O
did	O
without	O
difficulty	B-problem
.	O

Please	O
see	O
original	O
Discharge	O
Summary	O
for	O
discharge	B-treatment
medications	I-treatment
.	O

Josh	O
Harry	O
,	O
Missouri	O
43478	O

Dictated	O
By	O
:	O
Joe	O
J.	O
T.	O
Gochenour	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2013-06-25	O
07:58:05	O

T	O
:	O
2013-06-25	O
08:07:03	O

Job	O
#:	O

79141	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Clara	O
M.	O
Odell	O
on	O
:	O
WED	O
2013-06-26	O
9:58	O
AM	O

(	O
End	O
of	O
Report	O
)	O

01909607	O

Admission	O
Date	O
:	O

2010-06-28	O

Discharge	O
Date	O
:	O

2010-07-01	O

Date	O
of	O
Birth	O
:	O

1990-02-01	O

Sex	O
:	O

F	O

Service	O
:	O

ORTHOPEDIC	O

HISTORY	O
OF	O
THE	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
20-year-old	O
female	O
with	O
no	O
significant	O
past	O
medical	O
history	O
,	O
who	O
was	O
the	O
unrestrained	O
passenger	O
in	O
a	O
high	O
speed	O
rollover	O
motor	O
vehicle	O
accident	O
on	O
2010-06-27	O
.	O

By	O
report	O
,	O
the	O
patient	O
was	O
ejected	O
from	O
the	O
vehicle	O
on	O
impact	O
and	O
found	O
curled	O
in	O
the	O
fetal	O
position	O
at	O
the	O
rear	O
of	O
the	O
vehicle	O
at	O
the	O
scene	O
.	O

The	O
vehicle	O
was	O
noted	O
to	O
be	O
extensively	O
damaged	O
.	O

By	O
report	O
,	O
the	O
patient	O
was	O
noted	O
to	O
be	O
awake	O
,	O
but	O
confused	B-problem
at	O
the	O
scene	O
of	O
the	O
accident	O
with	O
no	O
memory	O
of	O
the	O
incident	O
.	O

She	O
was	O
immobilized	O
in	O
the	B-treatment
C-spine	I-treatment
collar	I-treatment
at	O
the	O
scene	O
of	O
the	O
accident	O
and	O
subsequently	O
transported	O
by	O
EMS	O
to	O
the	O
New	O
England	O
Sinai	O
Hospital	O
&	O
Rehab	O
Center	O
Emergency	O
Department	O
for	O
further	B-treatment
management	I-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Examination	B-test
on	O
presentation	O
to	O
the	O
emergency	O
room	O
revealed	O
the	O
following	O
:	O

Temperature	B-test
35.4	O
Celsius	O
,	O
blood	B-test
pressure	I-test
116/63	O
,	O
pulse	B-test
105	O
,	O
respiratory	B-test
rate	I-test
18	O
,	O
oxygen	B-test
saturation	I-test
98%	O
on	O
room	O
air	O
.	O

The	O
patient	O
was	O
alert	O
and	O
oriented	O
times	O
three	O
in	O
no	O
apparent	B-problem
distress	I-problem
.	O

Boston	B-test
Coma	I-test
Scale	I-test
of	O
15	O
.	O

Tympanic	O
membranes	O
were	O
noted	O
to	O
be	O
clear	O
.	O

Pupils	O
were	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
at	O
approximately	O
4	O
mm	O
.	O

The	O
patient	O
's	O
trachea	O
was	O
noted	O
to	O
be	O
midline	O
.	O

The	B-test
patient	I-test
's	I-test
lung	I-test
examination	I-test
revealed	O
the	O
lungs	O
to	O
be	O
clear	O
to	O
auscultation	B-test
bilaterally	O
,	O
no	O
crepitus	B-problem
,	O
and	O
a	B-problem
left	I-problem
clavicular	I-problem
deformity	I-problem
was	O
grossly	O
apparent	O
on	O
examination	B-test
.	O

CARDIAC	O
:	O

Cardiac	B-test
examination	I-test
demonstrated	O
regular	O
rate	O
and	O
rhythm	O
,	O
no	O
murmurs	B-problem
,	O
rubs	B-problem
,	O
or	O
gallops	B-problem
.	O

ABDOMEN	O
:	O

Soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
.	O

RECTAL	O
:	O

Examination	B-test
was	O
guaiac	B-test
negative	O
with	O
good	O
rectal	O
tone	O
.	O

The	O
patient	O
's	O
pelvis	O
was	O
stable	O
to	O
AP	B-test
and	I-test
lateral	I-test
compression	I-test
.	O

A	B-problem
5	I-problem
cm	I-problem
laceration	I-problem
was	O
noted	O
over	O
the	O
patient	O
's	O
occiput	O
on	O
further	B-test
inspection	I-test
with	O
no	O
exposed	B-problem
underlying	I-problem
bone	I-problem
.	O

Right	B-test
upper	I-test
extremity	I-test
examination	I-test
demonstrated	O
intact	O
motor	O
,	O
sensory	O
,	O
and	O
vascular	O
function	O
.	O

Left	B-test
upper	I-test
extremity	I-test
examination	I-test
demonstrated	O
no	O
gross	B-problem
deformities	I-problem
,	O
tenderness	B-problem
to	O
palpation	B-test
in	I-test
the	I-test
mid	I-test
forearm	I-test
,	O
intact	O
motor	O
function	O
in	O
the	O
median	O
,	O
radial	O
,	O
and	O
ulnar	O
nerve	O
distributions	O
,	O
intact	O
sensation	O
to	O
light	B-test
touch	I-test
in	O
the	O
median	O
and	O
radial	O
nerve	O
distributions	O
,	O
decreased	B-problem
sensation	I-problem
in	I-problem
the	I-problem
ulnar-nerve	I-problem
distribution	I-problem
,	O
warm	O
and	O
well	O
perfused	O
limb	O
with	O
2+	O
radial	B-test
pulses	I-test
.	O

Right	B-test
lower	I-test
extremity	I-test
examination	I-test
demonstrated	O
mild	B-problem
swelling	I-problem
and	O
ecchymosis	B-problem
of	I-problem
the	I-problem
right	I-problem
posterior	I-problem
thigh	I-problem
and	O
approximately	O
a	B-problem
3	I-problem
cm	I-problem
laceration	I-problem
in	I-problem
the	I-problem
lower	I-problem
leg	I-problem
,	O
expressive	O
of	O
moderate	O
amounts	O
of	O
standard	O
sterile	O

fashion	O
.	O

No	O
gross	B-problem
deformities	I-problem
.	O

Motor	B-test
,	I-test
sensory	I-test
,	I-test
and	I-test
vascular	I-test
examinations	I-test
were	O
intact	O
in	O
all	O
distributions	O
.	O

Left	B-test
lower	I-test
extremity	I-test
examination	I-test
demonstrated	O
no	O
gross	B-problem
deformities	I-problem
and	O
intact	O
motor	O
,	O
sensory	O
,	O
and	O
vascular	O
examinations	O
in	O
all	O
distributions	O
.	O

Radiographic	B-test
studies	I-test
demonstrated	O
an	B-problem
inferior	I-problem
displaced	I-problem
left	I-problem
midclavicular	I-problem
fracture	I-problem
,	O
no	O
evidence	O
of	O

pneumothorax	B-problem
.	O

Trauma	B-test
series	I-test
demonstrated	O
no	O
evidence	O
of	O
a	B-problem
pelvic	I-problem
fracture	I-problem
.	O

Head	B-test
CT	I-test
demonstrated	O
no	O
evidence	O
of	O
intracranial	B-problem
bleeding	I-problem
.	O

Trauma	B-test
CT	I-test
demonstrated	O
mild	B-problem
pulmonary	I-problem
contusions	I-problem
,	O
but	O
no	O
pelvic	B-problem
fracture	I-problem
.	O

Cervical	B-test
spine	I-test
imaging	I-test
demonstrated	O
no	O
evidence	O
of	O
cervical	B-problem
spine	I-problem
injury	I-problem
.	O

Right	B-test
tibial-fibular	I-test
film	I-test
series	I-test
demonstrated	O
no	O
evidence	O
of	O
fracture	B-problem
displacement	I-problem
.	O

Left	B-test
humerus	I-test
film	I-test
series	I-test
demonstrated	O
no	O
evidence	O
of	O
fracture	B-problem
or	O
displacement	B-problem
.	O

Right	B-test
foot	I-test
and	I-test
femur	I-test
series	I-test
demonstrated	O
no	O
evidence	O
of	O
fracture	B-problem
displacement	I-problem
.	O

Left	B-test
forearm	I-test
and	I-test
wrist	I-test
series	I-test
demonstrated	O
transverse	B-problem
mid	I-problem
shaft	I-problem
radial	I-problem
fracture	I-problem
with	O
ulnar	B-problem
displacement	I-problem
.	O

Diagnosis	B-test
peritoneum	I-test
lavage	I-test
times	O
two	O
was	O
negative	O
for	O
any	O
signs	O
of	O
intra-abdominal	B-problem
bleeding	I-problem
.	O

LABORATORY	O
DATA	O
:	O

Studies	B-test
on	O
admission	O
revealed	O
the	O
following	O
:	O

White	B-test
blood	I-test
cell	I-test
12.9	O
,	O
hemoglobin	B-test
11.5	O
,	O
hematocrit	B-test
32.8	O
,	O
platelet	B-test
count	I-test
197,000	O
,	O
sodium	B-test
141	O
,	O
potassium	B-test
3.6	O
,	O
chloride	B-test
110	O
,	O
bicarbonate	B-test
21	O
,	O
BUN	B-test
20	O
,	O
creatinine	B-test
0.7	O
,	O
glucose	B-test
189	O
,	O
PT	B-test
13.3	O
,	O
INR	B-test
1.2	O
,	O
PTT	B-test
30.0	O
,	O
amylase	B-test
57	O
,	O
arterial	B-test
blood	I-test
gas	I-test
7.32	O
,	O
35	O
,	O
159	O
,	O
19	O
,	O
-7	O
.	O

Urinalysis	B-test
was	O
within	O
normal	O
limits	O
with	O
6	O
to	O
10	O
red	B-test
blood	I-test
cells	I-test
.	O

Toxicology	B-test
screen	I-test
was	O
negative	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
evaluated	O
by	O
the	O
Trauma	O
Service	O
in	O
the	O
emergency	O
room	O
,	O
where	O
she	O
received	O
four	O
liters	O

crystalloid	B-treatment
and	O
four	O
units	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
with	O
good	O
response	O
.	O

In	O
addition	O
,	O
the	O
patient	O
received	O
the	O
above-described	O
diagnostic	B-test
procedures	I-test
,	O
which	O
demonstrated	O
injuries	B-problem
limited	O
to	O
a	B-problem
posterior	I-problem
scalp	I-problem
laceration	I-problem
,	O
left	B-problem
fractured	I-problem
clavicle	I-problem
,	O
left	B-problem
fractured	I-problem
radius	I-problem
,	O
right	B-problem
thigh	I-problem
hematoma	I-problem
,	O
and	O
right	B-problem
leg	I-problem
laceration	I-problem
.	O

The	O
patient	O
was	O
subsequently	O
admitted	O
to	O
the	O
Trauma	O
Service	O
on	O
2010-06-28	O
under	O
the	O
direction	O
of	O
Dr.	O
Lowery	O
.	O

Given	O
the	B-problem
patient	I-problem
's	I-problem
right	I-problem
thigh	I-problem
hematoma	I-problem
,	O
a	B-test
duplex	I-test
evaluation	I-test
of	I-test
the	I-test
right	I-test
lower	I-test
extremity	I-test
was	O
performed	O
on	O
2010-06-28	O
and	O
demonstrated	O
no	O
evidence	O
of	O
major	B-problem
arterial	I-problem
or	I-problem
venous	I-problem
injury	I-problem
in	O
the	O
level	O
of	O

the	O
right	O
inguinal	O
region	O
.	O

On	O
06-28	O
,	O
the	O
patient	O
was	O
also	O
cleared	O
for	O
removal	O
of	O
her	B-treatment
C-spine	I-treatment
collar	I-treatment
and	O
deemed	O
stable	O
for	O
transfer	O
to	O
the	O
Orthopedic	O
Service	O
under	O
the	O
direction	O
of	O
Dr.	O
Ronda	O
Lopez	O
.	O

The	O
patient	O
remained	O
stable	O
through	O
2010-06-29	O
at	O
which	O
point	O
she	O
was	O
sent	O
to	O
the	O
operating	O
room	O
to	O
undergo	O
a	B-treatment
left	I-treatment
radial	I-treatment
fracture	I-treatment
open	I-treatment
reduction	I-treatment
and	O
internal	B-treatment
fixation	I-treatment
procedure	I-treatment
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
and	O
demonstrated	O
a	B-test
postoperative	I-test
hematocrit	I-test
of	O
40.9	O
.	O

Of	O
note	O
,	O
the	B-problem
scalp	I-problem
and	I-problem
right	I-problem
lower	I-problem
leg	I-problem
lacerations	I-problem
were	O
closed	O
primarily	O
by	O
the	O
trauma	O
team	O
on	O
admission	O
and	O
on	O
hospital	O
day	O
#1	O
were	O
noted	O
to	O
be	O
clean	O
,	O
dry	O
,	O
and	O
intact	O
.	O

Nonoperative	B-treatment
treatment	I-treatment
was	O
elected	O
for	O
the	B-problem
patient	I-problem
's	I-problem
left	I-problem
clavicular	I-problem
fracture	I-problem
.	O

On	O
postoperative	O
day	O
#1	O
,	O
2010-06-30	O
,	O
the	O
patient	O
was	O
noted	O
to	O
be	O
clinically	O
stable	O
,	O
tolerating	O
oral	O
intake	O
,	O
and	O
expressive	O
of	O
adequate	O
amounts	O
of	O
urine	O
independent	O
of	O
a	B-treatment
Foley	I-treatment
catheter	I-treatment
.	O

The	B-problem
patient	I-problem
's	I-problem
head	I-problem
wound	I-problem
laceration	I-problem
was	O
noted	O
to	O
be	O
clean	O
and	O
dry	O
with	O
intact	B-treatment
staples	I-treatment
.	O

There	O
was	O
no	O
erythema	B-problem
or	O
purulence	B-problem
.	O

The	O
left	O
clavicle	O
was	O
noted	O
to	O
have	O
continued	B-problem
ecchymosis	I-problem
decreased	O
from	O
prior	B-test
examination	I-test
with	O
a	B-problem
minor	I-problem
stepoff	I-problem
and	O
mild	B-problem
tenderness	I-problem
to	O
palpation	B-test
decreased	O
from	O
prior	B-test
examinations	I-test
.	O

The	B-treatment
left	I-treatment
forearm	I-treatment
dressing	I-treatment
was	O
noted	O
to	O
be	O
in	O
place	O
,	O
clean	O
,	O
dry	O
,	O
and	O
intact	O
with	O
no	O
saturation	B-problem
.	O

The	O
patient	O
was	O
noted	O
to	O
be	O
able	O
to	O
wiggle	O
her	O
fingers	O
with	O
intact	O
flexor	O
,	O
extensor	O
,	O
abductor	O
,	O
and	O
adductor	O
function	O
.	O

Mild	B-problem
swelling	I-problem
was	O
noted	O
in	O
the	O
left	O
hand	O
.	O

Sensation	O
was	O
intact	O
in	O
the	O
median	O
,	O
radius	O
,	O
and	O
ulnar-nerve	O
distributions	O
.	O

Fingers	O
were	O
warm	O
and	O
well	O
perfused	O
with	O
capillary	B-test
refill	I-test
less	O
than	O
3	O
seconds	O
.	O

The	B-problem
patient	I-problem
's	I-problem
right	I-problem
anterior	I-problem
tibial	I-problem
wound	I-problem
was	O
noted	O
to	O
be	O
clean	O
,	O
dry	O
,	O
and	O
intact	O
with	O
sutures	B-treatment
intact	O
and	O
no	O
erythema	B-problem
or	O
purulence	B-problem
noted	O
.	O

On	O
06-30	O
,	O
the	O
patient	O
was	O
evaluated	O
by	O
Occupational	O
Therapy	O
and	O
fitted	O
for	O
a	B-treatment
left	I-treatment
upper	I-treatment
extremity	I-treatment
splint	I-treatment
.	O

The	O
patient	O
was	O
also	O
administered	O
adaptive	B-treatment
training	I-treatment
for	O
activities	B-treatment
of	I-treatment
daily	I-treatment
life	I-treatment
and	O
advised	O
regarding	O
wound	B-treatment
care	I-treatment
.	O

In	O
addition	O
,	O
the	O
patient	O
was	O
also	O
fitted	O
with	O
a	B-treatment
figure-of-eight	I-treatment
clavicular	I-treatment
splint	I-treatment
and	O
instructed	O
in	O
its	O

proper	O
use	O
.	O

On	O
2010-07-01	O
,	O
the	O
patient	O
was	O
discharged	O
from	O
the	O
hospital	O
with	O
instructions	O
for	O
follow	O
up	O
care	O
on	O
return	O
to	O
the	O
United	O
Kingdom	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

The	O
patient	O
is	O
to	O
be	O
discharged	O
to	O
home	O
.	O

DISCHARGE	O
STATUS	O
:	O

Stable	O
.	O

DIAGNOSIS	O
:	O

1.	O
Left	B-problem
transverse	I-problem
mid	I-problem
shaft	I-problem
radial	I-problem
fracture	I-problem
with	O
ulnar	B-problem
displacement	I-problem
status	O
post	O
left	B-treatment
radial	I-treatment
open	I-treatment
reduction	I-treatment
and	O
internal	B-treatment
fixation	I-treatment
.	O

2.	O
Left	B-problem
midclavicular	I-problem
fracture	I-problem
managed	O
nonoperatively	O
.	O

3.	O
Occipital	B-problem
scalp	I-problem
laceration	I-problem
.	O

4.	O
Right	B-problem
anterior	I-problem
tibial	I-problem
laceration	I-problem
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Percocet	B-treatment
one	O
to	O
two	O
tablets	O
PO	O
q.4h.	O
to	O
6h.p.r.n.	O
pain	B-problem
.	O

FOLLOW-UP	O
CARE	O
:	O

The	O
patient	O
is	O
medically	O
cleared	O
for	O
a	O
flight	O
to	O
return	O
to	O
her	O
home	O
in	O
the	O
United	O
Kingdom	O
.	O

The	O
patient	O
is	O
to	O
maintain	O
her	B-treatment
figure-of-eight	I-treatment
clavicular	I-treatment
splint	I-treatment
and	O
left	B-treatment
posterior	I-treatment
forearm	I-treatment
splint	I-treatment
in	O
place	O
for	O
fourteen	O
days	O
following	O
discharge	O
.	O

The	B-problem
left	I-problem
forearm	I-problem
and	I-problem
right	I-problem
lower	I-problem
leg	I-problem
wound	I-problem
should	O
be	O
kept	O
clean	O
and	O
dry	O
with	O
regular	B-treatment
dressing	I-treatment
changes	I-treatment
with	O
dry	B-treatment
gauze	I-treatment
once	O
per	O
day	O
.	O

Scalp	B-problem
laceration	I-problem
should	O
be	O
kept	O
clean	O
and	O
dry	O
for	O
five	O
days	O
following	O
discharge	O
after	O
which	O
point	O
the	O
patient	O
may	O
once	O
wash	O
her	O
hair	O
.	O

Percocet	B-treatment
for	O
pain	B-problem
as	O
needed	O
.	O

The	O
patient	O
is	O
to	O
followup	O
with	O
an	O
orthopedist	O
in	O
the	O
United	O
Kingdom	O
fourteen	O
days	O
following	O
discharge	O
at	O
which	O
point	O
repeat	B-test
x-rays	I-test
of	I-test
her	I-test
left	I-test
forearm	I-test
should	O
be	O
obtained	O
and	O
her	B-treatment
left	I-treatment
forearm	I-treatment
scalp	I-treatment
and	I-treatment
right	I-treatment
lower	I-treatment
leg	I-treatment
sutures	I-treatment
and	O
staples	B-treatment
may	O
be	O
removed	O
.	O

Questions	O
regarding	O
follow	O
up	O
may	O
be	O
referred	O
to	O
Dr.	O
Ronda	O
Lopez	O
at	O
the	O
Ayer	O
Orthopedic	O
Group	O
.	O

Telephone	O
#:	O

(	O
658	O
)	O
842-8661	O
.	O

Ortiz	O
V	O
Baugher	O
,	O
M.D.	O

75-285	O

Dictated	O
By	O
:	O
Catherine	O
K	O
Thomas	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2010-06-30	O
17:18	O

T	O
:	O
2010-06-30	O
17:39	O

JOB	O
#:	O

03326	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Kisha	O
Jones	O
on	O
:	O
Jose	O
2010-07-01	O
8:27	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2018-10-25	O

Discharge	O
Date	O
:	O

2018-11-01	O

Date	O
of	O
Birth	O
:	O

1943-11-06	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	I-problem
Drugs	I-problem

Attending	O
:	O
Kelly	O
L.	O
Bradley	O
,	O
M.D.	O

Addendum	O
:	O

Explained	O
to	O
pt	O
which	O
of	O
the	B-treatment
meds	I-treatment
he	O
should	O
no	O
longer	O
take	O
that	O
he	O
was	O
taking	O
pre-admission	O
.	O

Also	O
,	O
explained	O
which	O
meds	B-treatment
are	O
new	O
.	O

Wife	O
verbally	O
agrees	O
to	O
understanding	O
.	O

Discharge	O
Medications	O
:	O

1.	O
Diltiazem	B-treatment
HCl	O
240	O
mg	O
Capsule	O
,	O
Sustained	O
Release	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Sustained	O
Release	O
PO	O
DAILY	O
(	O
Daily	O
).	O

2.	O
Simvastatin	B-treatment
40	O
mg	O
Tablet	O
Sig:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

3.	O
Albuterol-Ipratropium	B-treatment
103-18	O
mcg	O
/	O
Actuation	O
Aerosol	O
Sig	O
:	O
02-26	O
Puffs	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

4.	O
Fluticasone-Salmeterol	B-treatment
250-50	O
mcg	O
/	O
Dose	O
Disk	O
with	O
Device	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Disk	O
with	O
Device	O
Inhalation	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

5.	O
Terazosin	B-treatment
1	O
mg	O
Capsule	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Capsule	O
PO	O
HS	O
(	O
at	O
bedtime	O
).	O

6.	O
Acetaminophen	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

7.	O
Nimodipine	B-treatment
30	O
mg	O
Capsule	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Capsule	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
for	O
2	O
weeks	O
.	O

Disp	O
:*	O
168	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O

8.	O
Ferrous	B-treatment
Sulfate	I-treatment
325	O
(	O
65	O
)	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

9.	O
Aspirin	B-treatment
81	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Chewable	O
PO	O
DAILY	O
(	O
Daily	O
).	O

10.	O
Ipratropium	B-treatment
Bromide	I-treatment
0.02	O
%	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
).	O

11.	O
Simvastatin	B-treatment
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

12.	O
Hydralazine	B-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
135	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

13.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
90	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

14.	O
Isosorbide	B-treatment
Dinitrate	I-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
90	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

15.	O
Clopidogrel	B-treatment
75	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

16.	O
Glipizide	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Jacob	O
Montegut	O
MD	O
71-786	O

Completed	O
by	O
:	O
Oscar	O
Jerome	O
Julian	O
MD	O
39-824	O
2018-11-01	O
@	O
1610	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Joyce	O
Arney	O
on	O
:	O
MON	O
2018-12-03	O
10:55	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2012-01-07	O

Discharge	O
Date	O
:	O

2012-03-10	O

Date	O
of	O
Birth	O
:	O

Sex	O
:	O

M	O

Service	O
:	O

Since	O
2012-02-26	O
,	O
the	O
patient	O
has	O
been	O
stable	O
.	O

The	O
Whidden	O
Memorial	O
Hospital	O
hospital	O
course	O
has	O
been	O
smooth	O
with	O
the	O
patient	O
progressively	O
improving	O
.	O

The	O
patient	O
was	O
initially	O
on	O
several	B-treatment
antibiotics	I-treatment
included	O
Cefepime	B-treatment
,	O
Vancomycin	B-treatment
,	O
Ciprofloxacin	B-treatment
,	O
Ambazone	B-treatment
and	O
Flagyl	B-treatment
.	O

The	B-test
patient	I-test
's	I-test
HSV	I-test
antibody	I-test
titer	I-test
was	O
found	O
to	O
be	O
negative	O
and	O
the	O
patient	O
's	O
Acyclovir	B-treatment
was	O
not	O
restarted	O
.	O

Infectious	O
disease	O
continued	O
to	O
follow	O
and	O
on	O
2012-02-29	O
,	O
the	O
patient	O
spiked	O
again	O
which	O
at	O
that	O
time	O
was	O
felt	O
to	O
be	O
due	O
to	O
his	B-treatment
central	I-treatment
line	I-treatment
and	O
the	B-treatment
central	I-treatment
line	I-treatment
was	O
resited	O
on	O
the	O
left	O
side	O
and	O
the	O
patient	O
was	O
started	O
on	O
intravenous	B-treatment
Vancomycin	I-treatment
.	O

Over	O
the	O
following	O
days	O
until	O
discharge	O
,	O
the	O
patient	O
remained	O
afebrile	B-problem
and	O
on	O
2012-03-09	O
,	O
in	O
fact	O
all	O
the	B-treatment
patient	I-treatment
's	I-treatment
antibiotics	I-treatment
were	O
discontinued	O
.	O

As	O
for	O
the	O
patient	O
's	O
ALL	B-problem
and	O
AML	B-problem
,	O
the	O
patient	O
was	O
started	O
on	O
a	B-treatment
new	I-treatment
chemotherapy	I-treatment
protocol	I-treatment
called	O
hyper-CVAD	B-treatment
on	O
2012-03-06	O
.	O

After	O
the	O
patient	O
began	O
on	O
this	B-treatment
protocol	I-treatment
,	O
his	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
steadily	O
began	O
to	O
climb	O
.	O

The	O
patient	O
became	O
no	O
longer	O
neutropenic	B-problem
.	O

The	O
patient	O
's	O
also	O
began	O
to	O
climb	O
and	O
the	B-test
percent	I-test
blasts	I-test
in	O
his	B-test
differential	I-test
decreased	O
significantly	O
.	O

The	O
patient	O
had	O
no	O
further	B-problem
complaints	I-problem
and	O
on	O
2012-03-10	O
,	O
his	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
was	O
2.3	O
,	O
neutrophils	B-test
50%	O
,	O
bands	B-test
2%	O
,	O
lymphocytes	B-test
5%	O
,	O
monocytes	B-test
40%	O
,	O
and	O
blasts	B-test
1%	O
.	O

Platelet	B-test
count	I-test
was	O
759,000	O
.	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
with	O
instructions	O
to	O
return	O
to	O
the	O
hospital	O
on	O
Monday	O
,	O
2012-03-12	O
,	O
for	O
follow-up	O
and	O
laboratory	B-test
checks	I-test
.	O

The	O
patient	O
was	O
also	O
given	O
instructions	O
to	O
be	O
prudent	O
and	O
stay	O
away	O
from	O
public	O
places	O
as	O
well	O
as	O
small	O
children	O
.	O

The	O
patient	O
was	O
also	O
told	O
to	O
continue	O
on	O
a	B-treatment
neutropenic	I-treatment
diet	I-treatment
.	O

The	O
patient	O
was	O
also	O
told	O
that	O
he	O
would	O
have	O
to	O
be	O
admitted	O
for	O
several	O
days	O
during	O
his	B-treatment
next	I-treatment
cycle	I-treatment
of	I-treatment
CVAD	I-treatment
.	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
in	O
good	O
condition	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Bactrim	B-treatment
double	I-treatment
strength	I-treatment
one	O
tablet	O
q.	O
Monday	O
,	O
Wednesday	O
and	O
Friday	O
.	O

2.	O
Compazine	B-treatment
10	O
mg	O
p.o.	O
q	O
6hours	O
p.r.n.	O
nausea	B-problem
.	O

3.	O
Anzemet	B-treatment
100	O
mg	O
p.o.	O
once	O
daily	O
p.r.n.	O
nausea	B-problem
.	O

The	O
patient	O
is	O
to	O
return	O
to	O
the	O
hospital	O
on	O
Monday	O
for	O
follow-up	O
.	O

DR.	O
Esparza	O
,	O
Gail	O
18-714	O

Dictated	O
By	O
:	O
Cristobal	O
C.	O
Reid	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2012-03-10	O
22:44	O

T	O
:	O
2012-03-11	O
10:08	O

JOB	O
#:	O

24313	O

1	O

1	O

1	O

OMR	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Brenda	O
C.	O
Massey	O
on	O
:	O
MON	O
2012-04-23	O
1:02	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2010-08-26	O

Discharge	O
Date	O
:	O

2010-09-02	O

Date	O
of	O
Birth	O
:	O

1961-06-26	O

Sex	O
:	O

M	O

Service	O
:	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Robert	O
Mackey	O
is	O
a	O
49	O
year	O
old	O
gentleman	O
with	O
a	O
22	O
year	O
history	O
of	O
diabetes	B-problem
mellitus	I-problem
.	O

He	O
has	O
a	O
history	O
of	O
peripheral	B-problem
neuropathy	I-problem
,	O
kidney	B-treatment
transplantation	I-treatment
in	O
2003	O
secondary	O
to	O
diabetic	B-problem
nephropathy	I-problem
,	O
as	O
well	O
as	O
throat	B-problem
cancer	I-problem
in	O
2004	O
treated	O
with	O
local	B-treatment
resection	I-treatment
and	O
radical	B-treatment
neck	I-treatment
dissection	I-treatment
on	I-treatment
the	I-treatment
left	I-treatment
as	O
well	O
as	O
postoperative	B-treatment
radiation	I-treatment
.	O

Mr.	O
Mackey	O
also	O
had	O
signs	B-problem
and	I-problem
symptoms	I-problem
consistent	O
with	O
cervical	B-problem
myelopathy	I-problem
;	O
a	B-test
cervical	I-test
MRI	I-test
scan	I-test
showed	O
very	O
impressive	B-problem
disc	I-problem
herniations	I-problem
at	I-problem
C5-C6	I-problem
,	O
less	O
so	O
at	O
C4-C5	O
,	O
with	O
clear	B-problem
cut	I-problem
cord	I-problem
compression	I-problem
,	O
particularly	O
on	O
the	O
right	O
side	O
C5-C6	O
.	O

Therefore	O
,	O
he	O
was	O
admitted	O
for	O
C4-C5	B-treatment
and	I-treatment
C5-C6	I-treatment
anterior	I-treatment
diskectomy	I-treatment
with	O
autologous	B-treatment
bone	I-treatment
graft	I-treatment
and	O
instrumented	B-treatment
fusion	I-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Postoperative	B-test
physical	I-test
examination	I-test
demonstrated	O
that	O
he	O
was	O
afebrile	B-problem
at	O
97	O
degrees	O
;	O
blood	B-test
pressure	I-test
145/80	O
;	O
pulse	B-test
60	O
;	O
respiratory	B-test
rate	I-test
10	O
;	O
100%	O
on	O
a	B-treatment
non-rebreather	I-treatment
.	O

He	O
was	O
awake	O
,	O
alert	O
,	O
uncomfortable	B-problem
secondary	O
to	O
incisional	B-problem
tenderness	I-problem
at	O
neck	B-problem
site	I-problem
as	O
well	O
as	O
right	B-problem
iliac	I-problem
graft	I-problem
site	I-problem
.	O

The	B-problem
wounds	I-problem
were	O
clean	O
,	O
dry	O
and	O
intact	O
,	O
and	O
flat	O
.	O

HOSPITAL	O
COURSE	O
:	O

While	O
in	O
the	O
PACU	O
,	O
Anesthesia	O
was	O
called	O
because	O
the	O
patient	O
became	O
dyspneic	B-problem
and	O
tachypneic	B-problem
and	O
his	B-test
SAO2	I-test
dropped	O
to	O
89%	O
.	O

His	B-test
respiratory	I-test
rate	I-test
was	O
30	O
on	O
face	B-treatment
mask	I-treatment
.	O

Interoperatively	O
,	O
he	O
was	O
positive	O
two	O
liters	O
with	O
a	O
stable	O
blood	O
pressure	O
and	O
heart	B-test
rate	I-test
,	O
although	O
requiring	O
some	B-treatment
neo-synephrine	I-treatment
interoperatively	O
.	O

He	O
responded	O
to	O
intravenous	B-treatment
Lasix	I-treatment
with	O
3.2	O
liters	O
of	O
urine	B-test
output	I-test
as	O
well	O
as	O
marked	O
clinical	O
improvement	O
.	O

The	O
etiology	O
for	O
his	B-problem
congestive	I-problem
heart	I-problem
failure	I-problem
was	O
determined	O
likely	O
to	O
be	O
diastolic	B-problem
dysfunction	I-problem
from	O
increased	B-problem
heart	I-problem
rate	I-problem
as	O
well	O
as	O
excess	B-problem
volume	I-problem
.	O

No	O
definite	O
evidence	O
for	O
significant	B-problem
myocardial	I-problem
ischemia	I-problem
,	O
although	O
cardiac	B-test
enzymes	I-test
were	O
sent	O
and	O
he	O
ruled	O
out	O
for	O
myocardial	B-problem
infarction	I-problem
.	O

He	O
was	O
admitted	O
to	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
where	O
his	O
respiratory	O
and	O
cardiac	O
status	O
was	O
monitored	O
carefully	O
.	O

He	O
was	O
given	O
Lasix	B-treatment
to	O
continue	O
to	O
diurese	O
the	B-problem
excess	I-problem
volume	I-problem
.	O

He	O
was	O
also	O
put	O
on	O
Lopressor	B-treatment
150	O
mg	O
twice	O
a	O
day	O
.	O

Also	O
in	O
the	O
Intensive	O
Care	O
Unit	O
,	O
O2	B-test
saturation	I-test
was	O
closely	O
monitored	O
.	O

The	O
patient	O
became	O
agitated	B-problem
with	O
both	O
tent	B-treatment
and	O
Bi-PAP	B-treatment
machine	I-treatment
,	O
although	O
continued	O
to	O
saturate	O
well	O
.	O

He	O
was	O
transferred	O
to	O
Medicine	O
the	O
morning	O
of	O
2010-08-30	O
,	O
for	O
continued	B-treatment
medical	I-treatment
management	I-treatment
post	O
surgery	O
.	O

On	O
the	O
day	O
of	O
transfer	O
,	O
the	O
patient	O
was	O
noted	O
to	O
be	O
confused	B-problem
with	O
waxing	B-problem
and	I-problem
waning	I-problem
sensorium	I-problem
;	O
thus	O
,	O
a	B-test
delirium	I-test
work-up	I-test
was	O
initiated	O
looking	O
for	O
precipitants	O
.	O

1.	O
When	O
his	B-test
O2	I-test
saturation	I-test
was	O
monitored	O
,	O
his	B-test
pulse	I-test
oximetry	I-test
remained	O
in	O
the	O
90s	O
during	O
his	O
stay	O
.	O

2.	O
His	B-treatment
non-essential	I-treatment
medications	I-treatment
that	O
may	O
have	O
been	O
contributing	O
to	O
his	B-problem
change	I-problem
in	I-problem
mental	I-problem
status	I-problem
were	O
discontinued	O
;	O
those	O
included	O
Temocillin	B-treatment
,	O
Nortriptyline	B-treatment
,	O
Haldol	B-treatment
,	O
Lorazepam	B-treatment
,	O
Venlafaxine	B-treatment
,	O
Bupropion	B-treatment
,	O
and	O
Gabapentin	B-treatment
.	O

In	O
addition	O
,	O
his	B-test
cyclosporin	I-test
levels	I-test
were	O
checked	O
.	O

3.	O
Hypo	B-problem
or	I-problem
hyperglycemia	I-problem
:	O

Mahoney	O
had	O
been	O
following	O
with	O
their	O
appreciated	O
recommendations	O
on	O
glucose	B-treatment
control	I-treatment
.	O

Finger	B-test
sticks	I-test
were	O
in	O
the	O
150	O
s	O
when	O
acutely	B-problem
agitated	I-problem
,	O
therefore	O
,	O
it	O
was	O
not	O
determined	O
that	O
glucose	B-test
levels	I-test
were	O
contributory	O
.	O

4.	O
Infectious	B-problem
causes	I-problem
were	O
evaluated	O
.	O

He	O
was	O
febrile	B-problem
in	O
the	O
Intensive	O
Care	O
Unit	O
to	O
101.0	O
F.	O
;	O
yet	O
,	O
chest	B-test
x-ray	I-test
,	O
blood	B-test
cultures	I-test
,	O
urinalysis	B-test
and	O
urine	B-test
cultures	I-test
were	O
all	O
negative	O
for	O
sources	O
.	O

A	B-test
lumbar	I-test
puncture	I-test
was	O
considered	O
,	O
although	O
not	O
performed	O
due	O
to	O
the	O
fact	O
that	O
the	O
cerebrospinal	O
fluid	O
was	O
not	O
breached	O
during	O
the	B-treatment
procedure	I-treatment
.	O

5.	O
Mass	B-problem
effect	I-problem
was	O
considered	O
,	O
although	O
no	O
focal	B-problem
deficits	I-problem
were	O
ever	O
noted	O
on	O
examination	B-test
and	O
due	O
to	O
the	B-problem
fluctuating	I-problem
sensorium	I-problem
,	O
it	O
was	O
determined	O
that	O
there	O
was	O
no	O
severe	B-problem
underlying	I-problem
structural	I-problem
abnormality	I-problem
.	O

A	B-test
head	I-test
and	I-test
neck	I-test
CT	I-test
scan	I-test
,	I-test
non-contrast	I-test
,	O
were	O
ordered	O
though	O
to	O
evaluate	O
for	O
such	B-problem
processes	I-problem
.	O

No	O
acute	B-problem
intracranial	I-problem
hemorrhages	I-problem
or	O
midline	B-problem
shifts	I-problem
were	O
noted	O
,	O
although	O
a	B-problem
soft	I-problem
tissue	I-problem
mass	I-problem
was	O
noted	O
at	O
the	O
level	O
of	O
C2	O
.	O

This	O
was	O
determined	O
to	O
be	O
within	O
the	O
normal	O
expected	O
changes	O
post	O
surgery	O
.	O

6.	O
Trauma	B-problem
was	O
also	O
considered	O
.	O

The	O
patient	O
was	O
found	O
out	O
of	O
bed	O
but	O
no	O
signs	O
of	O
head	B-problem
trauma	I-problem
,	O
no	O
loss	B-problem
of	I-problem
consciousness	I-problem
.	O

Throughout	O
his	O
stay	O
,	O
Chem-10	B-test
was	O
monitored	O
.	O

There	O
were	O
no	O
electrolytes	B-problem
or	I-problem
mineral	I-problem
abnormalities	I-problem
that	O
could	O
explain	O
his	B-problem
delirium	I-problem
.	O

Liver	B-test
function	I-test
tests	I-test
were	O
checked	O
,	O
only	O
total	B-test
bilirubin	I-test
was	O
slightly	B-problem
elevated	I-problem
at	O
1.6	O
.	O

TSH	B-test
was	O
within	O
normal	O
limits	O
as	O
was	O
B12	B-test
and	O
folate	B-test
.	O

RPR	B-test
evaluating	I-test
for	O
possible	O
neurologic	B-problem
syphilis	I-problem
was	O
also	O
checked	O
.	O

The	B-test
assay	I-test
was	O
nonreactive	O
.	O

An	B-test
EEG	I-test
was	O
also	O
considered	O
to	O
rule	O
out	O
non-convulsive	B-problem
status	I-problem
epilepticus	I-problem
,	O
although	O
again	O
this	O
did	O
not	O
seem	O
to	O
be	O
a	O
likely	O
cause	O
.	O

On	O
the	O
evening	O
of	O
the	O
22nd	O
,	O
the	O
patient	O
became	O
acutely	B-problem
agitated	I-problem
,	O
threatening	O
to	O
leave	O
,	O
and	O
also	O
threatening	O
to	O
harm	O
those	O
nurses	O
and	O
physicians	O
that	O
were	O
attempting	O
to	O
prevent	O
him	O
from	O
leaving	O
.	O

Security	O
was	O
notified	O
who	O
then	O
arrived	O
to	O
the	O
room	O
and	O
helped	O
to	O
place	O
the	O
patient	O
in	O
four-point	O

restraints	B-treatment
,	O
for	O
the	O
safety	O
of	O
both	O
the	O
patient	O
and	O
the	O
staff	O
of	O
the	O
hospital	O
.	O

The	B-treatment
restraints	I-treatment
were	O
weaned	O
off	O
overnight	O
although	O
he	O
became	O
acutely	B-problem
agitated	I-problem
and	O
they	O
were	O
replaced	O
early	O
on	O
08-31	O
.	O

Later	O
in	O
the	O
morning	O
on	O
08-31	O
,	O
the	O
patient	O
was	O
more	O
oriented	O
and	O
alert	O
,	O
and	O
asked	O
to	O
have	O
the	B-treatment
restraints	I-treatment
removed	O
.	O

They	O
were	O
taken	O
off	O
two	O
at	O
a	O
time	O
.	O

The	O
patient	O
continued	O
to	O
do	O
well	O
and	O
did	O
not	O
require	O
restraints	B-treatment
after	O
that	B-problem
event	I-problem
.	O

Intramuscular	B-treatment
as	O
well	O
as	O
intravenous	B-treatment
Haldol	I-treatment
were	O
ordered	O
p.r.n.	O
for	O
emergency	O
use	O
should	O
he	O
become	O
acutely	B-problem
agitated	I-problem
.	O

haldol	B-treatment
as	O
well	O
as	O
the	B-treatment
restraints	I-treatment
were	O
not	O
required	O
after	O
the	O
morning	O
of	O
the	O
23rd	O
.	O

Each	O
progressive	O
day,	O
Mr.	O
Donald	O
delirium	B-problem
abated	O
with	O
return	O
to	O
baseline	O
mental	O
status	O
early	O
on	O
09-01	O
.	O

The	O
likely	O
cause	O
of	O
the	B-problem
delirium	I-problem
was	O
a	O
combination	O
of	O
surgery	B-treatment
and	O
Intensive	O
Care	O
Unit	O
stay	O
in	O
addition	O
to	O
poly-pharmacy	B-treatment
.	O

Other	O
concerns	O
during	O
his	O
stay	O
was	O
his	B-test
kidney	I-test
function	I-test
,	O
due	O
to	O
his	B-treatment
renal	I-treatment
transplant	I-treatment
in	O
2003	O
.	O

His	B-treatment
immunosuppressive	I-treatment
therapy	I-treatment
was	O
continued	O
throughout	O
his	O
stay	O
;	O
his	B-test
creatinine	I-test
remained	O
approximately	O
2.3	O
to	O
2.4	O
;	O
he	O
has	O
a	B-problem
baseline	I-problem
renal	I-problem
insufficiency	I-problem
.	O

With	O
this	O
in	O
mind	O
,	O
when	O
obtaining	O
a	B-test
CT	I-test
scan	I-test
it	O
was	O
determined	O
that	O
contrast	B-treatment
would	O
not	O
be	O
the	O
best	O
option	O
.	O

While	O
the	O
patient	O
was	O
in	O
restraints	B-treatment
,	O
gentle	B-treatment
hydration	I-treatment
was	O
initiated	O
since	O
p.o.	B-test
intake	I-test
was	O
not	B-problem
adequate	I-problem
.	O

As	O
for	O
his	B-problem
diabetes	I-problem
mellitus	I-problem
,	O
the	O
Mahoney	O
Team	O
provided	O
updated	O
recommendations	O
each	O
day	O
,	O
adjusting	O
for	O
the	O
changing	O
p.o.	O
intake	O
.	O

The	O
only	O
other	B-problem
complaints	I-problem
from	O
Mr.	O
Mackey	O
during	O
his	O
stay	O
were	O
:	O

Soreness	B-problem
at	O
his	B-problem
operative	I-problem
sites	I-problem
,	O
for	O
which	O
he	O
was	O
given	O
p.r.n.	B-treatment
Tylenol	I-treatment
once	O
his	B-problem
delirium	I-problem
had	O
resolved	O
.	O

In	O
addition	O
,	O
he	O
also	O
complained	O
of	O
difficulty	B-problem
with	I-problem
swallowing	I-problem
,	O
necessitating	O
only	O
soft	B-treatment
and	I-treatment
liquid	I-treatment
diet	I-treatment
.	O

This	O
was	O
attributed	O
to	O
postoperative	B-problem
swelling	I-problem
and	O
changes	O
from	O
his	B-treatment
diskectomy	I-treatment
performed	O
2010-08-27	O
.	O

DISPOSITION	O
:	O

The	O
patient	O
was	O
discharged	O
on	O
09-02	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

1.	O
Follow-up	O
with	O
Dr.	O
Williams	O
on	O
Tuesday	O
,	O
09-07	O
,	O
at	O
noon	O
.	O

2.	O
Follow-up	O
with	O
Dr.	O
Michael	O
,	O
his	O
psychiatrist	O
,	O
on	O
Wednesday	O
,	O
09-08	O
.	O

3.	O
He	O
was	O
also	O
discharged	O
home	O
with	O
Visiting	O
Nurse	O
Association	O
for	O
Physical	B-test
Therapy	I-test
evaluation	I-test
of	O
home	O
safety	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Venlafaxine	B-treatment
XR	I-treatment
75	O
mg	O
q.	O
a.m.	O

2.	O
Furosemide	B-treatment
20	O
mg	O
q.o.d.	O

3.	O
Metoprolol	B-treatment
100	O
mg	O
twice	O
a	O
day	O
.	O

4.	O
Nitroglycerin	B-treatment
sublingual	I-treatment
0.3	O
mg	O
p.r.n.	O

5.	O
Cyclosporin	B-treatment
microemulsion	I-treatment
.	O

6.	O
Neoral	B-treatment
100	O
mg	O
twice	O
a	O
day	O
.	O

7.	O
Zithropren	B-treatment
50	O
mg	O
q.	O
day	O
.	O

8.	O
Prednisone	B-treatment
10	O
mg	O
q.	O
day	O
.	O

9.	O
Minoxidil	B-treatment
10	O
mg	O
twice	O
a	O
day	O
.	O

10.	O
Prilosec	B-treatment
20	O
mg	O
q.	O
day	O
.	O

11.	O
NPH	B-treatment
30	O
units	O
q.	O
a.m.	O
,	O
5	O
to	O
6	O
units	O
q.	O
p.m.	O

12.	O
Regular	B-treatment
insulin	I-treatment
5	O
units	O
q.	O
a.m.	O
and	O
3	O
to	O
5	O
units	O
q.	O
p.m.	O

13.	O
Wellbutrin	B-treatment
100	O
mg	O
q.	O
day	O
.	O

14.	O
Zocor	B-treatment
60	O
mg	O
q.	O
day	O
.	O

15.	O
Nitroglycerin	B-treatment
SR	I-treatment
2.5	O
mg	O
twice	O
a	O
day	O
.	O

He	O
was	O
instructed	O
to	O
hold	O
the	O
following	O
three	O
medications	B-treatment
that	O
he	O
took	O
prior	O
to	O
admission	O
:	O

Nortriptyline	B-treatment
10	O
mg	O
q.	O
h.s.	O
;	O
Flomax	B-treatment
0.4	O
mg	O
q.	O
h.s.	O
;	O
Neurontin	B-treatment
600	O
mg	O
three	O
times	O
a	O
day	O
.	O

He	O
was	O
instructed	O
not	O
to	O
restart	O
these	O
until	O
seen	O
by	O
Dr.	O
Ercek	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
C4-C5	B-treatment
,	I-treatment
C5-C6	I-treatment
,	I-treatment
anterior	I-treatment
microdiscectomy	I-treatment
and	I-treatment
fusion	I-treatment
with	O
right	B-treatment
iliac	I-treatment
bone	I-treatment
graft	I-treatment
.	O

For	O
completeness	O
,	O
the	O
patient	O
's	O
complete	O
past	O
medical	O
history	O
:	O

1.	O
End-stage	B-problem
renal	I-problem
disease	I-problem
secondary	O
to	O
type	B-problem
1	I-problem
diabetes	I-problem
mellitus	I-problem
;	O
status	O
post	O
renal	B-treatment
transplant	I-treatment
in	O
2003	O
.	O

2.	O
History	O
of	O
multiple	B-problem
urinary	I-problem
tract	I-problem
infections	I-problem
.	O

3.	O
Pyelonephritis	B-problem
.	O

4.	O
Creatinine	B-test
2.2	O
to	O
2.5	O
.	O

5.	O
Right	B-treatment
coronary	I-treatment
artery	I-treatment
stent	I-treatment
in	O
2008	O
;	O
ejection	B-test
fraction	I-test
60	O
to	O
65%	O
.	O

6.	O
Type	B-problem
1	I-problem
diabetes	I-problem
mellitus	I-problem
with	O
triopathy	B-problem
,	O
retinopathy	B-problem
,	O
neuropathy	B-problem
,	O
nephropathy	B-problem
.	O

7.	O
Benign	B-problem
prostatic	I-problem
hypertrophy	I-problem
status	O
post	O
transurethral	B-treatment
resection	I-treatment
of	I-treatment
the	I-treatment
prostate	I-treatment
;	O
self	B-treatment
catheterization	I-treatment
.	O

8.	O
Hypertension	B-problem
.	O

9.	O
Hypercholesterolemia	B-problem
.	O

10.	O
Hepatitis	B-problem
B	I-problem
.	O

11.	O
Throat	B-problem
cancer	I-problem
status	O
post	O
right	B-treatment
neck	I-treatment
dissection	I-treatment
and	O
XRT	B-treatment
in	O
2004	O
.	O

12.	O
Cerebral	B-problem
aneurysm	I-problem
.	O

13.	O
Left	B-treatment
prosthetic	I-treatment
CMED	O
CCU	O
.	O

ALLERGIES	O
:	O

Gentamicin	B-treatment
,	O
and	O
ibuprofen	B-treatment
.	O

Kenneth	O
Jeffrey	O
,	O
MD	O
89-808	O

Dictated	O
By	O
:	O
Michael	O
S	O
Bonham	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2010-09-02	O
18:23	O

T	O
:	O
2010-09-07	O
16:04	O

JOB	O
#:	O

36814	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Victoria	O
Williams	O
on	O
:	O
MON	O
2010-11-08	O
3:18	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2009-08-17	O

Discharge	O
Date	O
:	O

2009-09-10	O

Date	O
of	O
Birth	O
:	O

1951-04-02	O

Sex	O
:	O

M	O

Service	O
:	O

BLUE	O
GENERAL	O
SURGERY	O

Attending	O
:	O
Terry	O
U	O
Cheatom	O
,	O
M.D.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Cordano	O
is	O
a	O
58-year-old	O
gentlemen	O
with	O
a	O
past	O
medical	O
history	O
significant	O
for	O
primary	B-problem
sclerosing	I-problem
cholangitis	I-problem
who	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
endoscopic	B-test
retrograde	I-test
cholangiopancreatography	I-test
endoscopic	B-test
retrograde	I-test
cholangiopancreatography	I-test
and	O
percutaneous	B-test
transhepatic	I-test
cholangiogram	I-test
.	O

The	B-treatment
most	I-treatment
recent	I-treatment
percutaneous	I-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
was	O
done	O
in	O
2009-07-25	O
.	O

At	O
the	O
time	O
an	B-treatment
8	I-treatment
Caucasian	I-treatment
catheter	I-treatment
was	O
placed	O
in	O
the	O
common	O
hepatic/bioduct	O
for	O
external	B-treatment
drainage	I-treatment
.	O

The	B-test
endoscopic	I-test
retrograde	I-test
cholangiopancreatography	I-test
also	O
showed	O
the	O
presence	O
proximal	O
common	O
bile	O
duct	O
.	O

Nodularities	B-problem
in	I-problem
the	I-problem
common	I-problem
bile	I-problem
duct	I-problem
visualized	O
by	O
endoscopic	B-test
retrograde	I-test
cholangiopancreatography	I-test
was	O
also	O
worrisome	O
for	O
cholangiocarcinoma	B-problem
and	O
the	O
patient	O
was	O
admitted	O
to	O
the	O
Blue	O
General	O
Surgery	O
Service	O
for	O
possible	O
surgical	B-treatment
interventions	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Ulcerative	B-problem
colitis	I-problem
,	O
primary	B-problem
sclerosing	I-problem
cholangitis	I-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Status	O
post	O
placement	B-treatment
of	I-treatment
percutaneous	I-treatment
transhepatic	I-treatment
biliary	I-treatment
drainage	I-treatment
with	O
placement	B-treatment
of	I-treatment
8	I-treatment
Caucasian	I-treatment
nephrostomy	I-treatment
catheter	I-treatment
in	O
the	O
common	O
bile	O
duct	O
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Ursodiol	B-treatment
600	O
mg	O
t.i.d.	O

2.	O
Ambien	B-treatment
5	O
mg	O
q.h.s.	O

PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION	O
:	O

The	O
patient	O
is	O
a	O
jaundiced	O
looking	O
gentlemen	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

The	O
head	O
is	O
normocephalic	O
,	O
atraumatic	B-problem
and	O
eyes	O
are	O
icteric	B-problem
.	O

The	O
neck	O
is	O
supple	O
with	O
no	O
lymphadenopathy	B-problem
.	O

The	O
chest	O
is	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

The	O
heart	O
has	O
a	O
regular	O
rate	O
and	O
rhythm	O
with	O
normal	O
S1	O
,	O
S2	O
.	O

There	O
is	O
no	O
murmurs	B-problem
.	O

The	O
abdomen	O
was	O
soft	O
,	O
nontender	B-problem
,	O
no	O
masses	B-problem
and	O
nondistended	B-problem
.	O

There	O
is	O
no	O
hepatosplenomegaly	B-problem
.	O

Rectal	B-test
exam	I-test
showed	O
no	O
masses	B-problem
and	O
is	O
guaiac	B-test
negative	O
.	O

The	O
extremities	O
have	O
distal	O
pulses	O
and	O
were	O
warm	O
and	O
well	O
perfused	O
.	O

Neurological	B-test
exam	I-test
was	O
grossly	O
intact	O
.	O

LABORATORY	O
STUDIES	O
AT	O
ADMISSION	O
:	O

A	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
of	O
14.2	O
,	O
hematocrit	B-test
of	O
35.3	O
,	O
platelet	B-test
count	I-test
of	O
449,000	O
.	O

Sodium	B-test
of	O
130	O
,	O
potassium	B-test
3.5	O
,	O
chloride	B-test
93	O
,	O
bicarbonate	B-test
28	O
,	O
BUN	B-test
15	O
,	O
creatinine	B-test
1.1,	O
prothrombin	B-test
time	I-test
14.1	O
,	O
partial	B-test
thrombin	I-test
time	I-test
29.7	O
.	O

INR	B-test
1.4	O
.	O

ALT	B-test
106	O
,	O
AST	B-test
149	O
,	O
alkaline	B-test
phosphatase	I-test
242	O
.	O

Total	B-test
bilirubin	I-test
10.1	O
,	O
amylase	B-test
90	O
and	O
lipase	B-test
112	O
.	O

RADIOLOGICAL	O
STUDIES	O
AT	O
TIME	O
OF	O
ADMISSION	O
:	O

Chest	B-test
x-ray	I-test
revealed	O
minimal	B-problem
left	I-problem
base	I-problem
atelectasis	I-problem
and	O
elevation	B-problem
of	I-problem
left	I-problem
hemidiaphragm	I-problem
.	O

A	B-test
CT	I-test
scan	I-test
with	I-test
po	I-test
contrast	I-test
showed	O
dilation	B-problem
of	I-problem
intrahepatic	I-problem
common	I-problem
bile	I-problem
duct	I-problem
which	O
is	O
improved	O
from	O
previous	B-test
studies	I-test
.	O

It	O
is	O
also	O
noted	O
that	O
there	O
was	O
splenomegaly	B-problem
.	O

HOSPITAL	O
COURSE	O
:	O

Mr.	O
Cordano	O
was	O
admitted	O
on	O
2009-08-17	O
for	O
a	B-treatment
replacement	I-treatment
of	I-treatment
transhepatic	I-treatment
biliary	I-treatment
drainage	I-treatment
catheter	I-treatment
.	O

At	O
that	O
time	O
,	O
cholangiogram	B-test
confirmed	O
that	O
there	O
was	O
a	B-problem
distal	I-problem
stricture	I-problem
of	I-problem
the	I-problem
common	I-problem
bile	I-problem
duct	I-problem
.	O

An	B-test
endoscopic	I-test
retrograde	I-test
cholangiopancreatography	I-test
also	O
demonstrated	O
similar	O
findings	O

and	O
it	O
is	O
noted	O
there	O
was	O
nodularity	B-problem
in	I-problem
the	I-problem
common	I-problem
bile	I-problem
duct	I-problem
which	O
is	O
worrisome	O
for	O
cholangiocarcinoma	B-problem
.	O

Therefore	O
,	O
the	O
patient	O
was	O
taken	O
to	O
the	O
Operating	O
Room	O
on	O
2009-08-24	O
for	O
a	B-treatment
Whipple	I-treatment
procedure	I-treatment
versus	O
hepaticojejunostomy	B-treatment
.	O

On	O
exploration	B-test
of	I-test
the	I-test
abdomen	I-test
revealed	O
significant	B-problem
nodularity	I-problem
of	I-problem
the	I-problem
liver	I-problem
indicating	O
of	O
advanced	B-problem
cirrhosis	I-problem
.	O

Intraoperative	O
frozen	O
section	O
of	O
the	O
distal	O
and	O
proximal	O
common	O
bile	O
duct	O
in	O
the	O

region	B-problem
nodularity	I-problem
,	O
which	O
is	O
identified	O
previously	O
by	O
endoscopic	B-test
retrograde	I-test
cholangiopancreatography	I-test
,	O
and	O
regional	O
lymph	O
nodes	O
were	O
all	O
sent	O
to	O
pathology	B-test
.	O

They	O
were	O
all	O
negative	O
for	O
malignancy	B-problem
and	O
therefore	O
a	B-treatment
hepaticojejunostomy	I-treatment

was	O
performed	O
.	O

Cholangiogram	B-test
on	O
postoperative	O
day	O
number	O
two	O
showed	O
no	O
evidence	O
of	O
leakage	B-problem
at	I-problem
the	I-problem
anastomosis	I-problem
site	I-problem
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
and	O
he	O
was	O
sent	O
to	O
the	O
floor	O
in	O
stable	O
condition	O
.	O

The	O
patient	O
's	O
postoperative	O
course	O
was	O
notable	O
for	O
an	B-problem
elevation	I-problem
in	O
white	B-test
blood	I-test
cell	I-test
count	O
peaking	O
at	O
30.0	O
on	O
postoperative	O
day	O
number	O
two	O
.	O

He	O
was	O
given	O
Unasyn	B-treatment
for	O
empiric	B-treatment
antibiotic	I-treatment
treatment	I-treatment
.	O

At	O
the	O
time	O
,	O
blood	O
,	O
urine	O
and	O
bile	O
was	O
sent	O
for	O
culture	B-test
,	O
which	O
were	O
all	O
negative	O
.	O

A	B-test
chest	I-test
x-ray	I-test
was	O
also	O
negative	O
for	O
any	B-problem
pneumonia	I-problem
.	O

Postoperatively	O
,	O
Mr.	O
Cordano	O
also	O
suffered	O
from	O
low	B-problem
urine	I-problem
output	I-problem
ranges	O
between	O
25	O
to	O
30	O
cc	O
per	O
hour	O
.	O

Fractional	B-test
excretion	I-test
of	I-test
sodium	I-test
was	O
less	O
than	O
1%	O
suggesting	O
a	B-problem
prerenal	I-problem
etiology	I-problem
.	O

The	B-test
sodium	I-test
creatinine	I-test
peaked	O
at	O
2.0	O
and	O
the	O
patient	O
was	O
treated	O
with	O
boluses	B-treatment
of	I-treatment
intravenous	I-treatment
fluid	I-treatment
and	O
intravenous	B-treatment
albumin	I-treatment
infusion	I-treatment
was	O
also	O
administered	O
.	O

He	O
responded	O
well	O
to	O
this	B-treatment
regimen	I-treatment
and	O
made	O
adequate	O
urine	O
output	O
.	O

At	O
the	O
same	O
time	O
,	O
the	O
patient	O
also	O
developed	O
distentions	B-problem
of	I-problem
the	I-problem
abdomen	I-problem
consistent	O
with	O
accumulation	B-problem
of	I-problem
ascitic	I-problem
fluid	I-problem
.	O

He	O
also	O
had	O
significant	B-problem
lower	I-problem
extremity	I-problem
and	I-problem
scrotum	I-problem
edema	I-problem
.	O

On	O
postoperative	O
day	O
number	O
eight	O
,	O
the	B-test
patient	I-test
's	I-test
oxygen	I-test
saturation	I-test
dropped	O
to	O
85%	O
on	O
room	O
air	O
and	O
he	O
was	O
transferred	O
to	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
for	O
fluid	B-treatment
management	I-treatment
.	O

Chest	B-test
x-ray	I-test
and	O
sputum	B-test
culture	I-test
obtained	O
at	O
the	O
time	O
were	O
negative	O
and	O
the	O
patient	O
was	O
treated	O
with	O
100%	B-treatment
nonrebreather	I-treatment
which	O
improved	O
his	B-test
oxygenation	I-test
.	O

While	O
he	O
is	O
in	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
,	O
paracentesis	B-test
was	O
performed	O
and	O
it	O

revealed	O
greater	O
than	O
24,000	O
white	B-test
blood	I-test
cell	I-test
count	I-test
in	O
the	B-problem
ascites	I-problem
which	O
is	O
consistent	O
with	O
SVT	B-problem
.	O

He	O
was	O
given	O
Zosyn	B-treatment
for	O
empiric	B-treatment
treatment	I-treatment
.	O

Gram	B-test
stain	I-test
and	O
culture	B-test
of	O
the	B-problem
ascites	I-problem
failed	O
to	O
identify	O
any	B-problem
organism	I-problem
.	O

He	O
was	O
weaned	O
from	O
oxygen	B-problem
requirement	I-problem
and	O
was	O
continued	O
on	O
normal	B-treatment
saline	I-treatment
boluses	I-treatment
and	O

intravenous	B-treatment
albumin	I-treatment
for	O
treatment	O
of	O
prerenal	B-problem
azotemia	I-problem
.	O

Somatostatin	B-treatment
and	O
midodrine	B-treatment
were	O
also	O
given	O
for	O
this	B-problem
condition	I-problem
and	O
he	O
also	O
received	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
.	O

On	O
postoperative	O
day	O
number	O
ten	O
,	O
the	O
patient	O
returned	O
to	O
the	O
floor	O
with	O
improved	O
renal	O
function	O
and	O
without	O
oxygen	B-problem
requirement	I-problem
.	O

The	B-treatment
somatostatin	I-treatment
and	O
the	B-treatment
midodrine	I-treatment
were	O
discontinued	O
and	O
the	O
regimen	O
of	O
Lasix	B-treatment
and	O
spironolactone	B-treatment
was	O
started	O
for	O
diuresis	B-treatment
.	O

His	B-test
creatinine	I-test
levels	I-test
trended	O
toward	O
normal	O
and	O
the	B-test
fractional	I-test
excretion	I-test
of	I-test
sodium	I-test
also	O
increased	O
indicating	O
a	O
resolution	O
of	O
the	B-problem
prerenal	I-problem
kidney	I-problem
failure	I-problem
.	O

On	O
postoperative	O
day	O
number	O
17	O
,	O
the	O
patient	O
was	O
discharged	O
.	O

At	O
the	O
time	O
he	O
took	O
good	O
po	O
.	O

He	O
has	O
a	B-treatment
PICC	I-treatment
line	I-treatment
in	O
place	O
for	O
continued	O
treatment	O
with	O
Rocephin	B-treatment
and	O
he	O
will	O
have	O
a	O
visiting	O
nurse	O
to	O
help	O
him	O
to	O
administer	O
these	B-treatment
medications	I-treatment
.	O

While	O
in	O
the	O
hospital	O
,	O
the	O
patient	O
received	O
initial	B-test
work-up	I-test
including	O
echocardiogram	B-test
,	O
electrocardiogram	B-test
and	O
serology	B-test
studies	I-test
to	O
be	O
listed	O
for	O
liver	B-treatment
transplant	I-treatment
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Rocephin	B-treatment
1	O
gram	O
q.d.	O

2.	O
Furosemide	B-treatment
10	O
mg	O
q.d.	O

3.	O
Spironolactone	B-treatment
100	O
mg	O
q.d.	O

4.	O
Ursodiol	B-treatment
600	O
mg	O
po	O
t.i.d.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
STATUS	O
:	O

To	O
home	O
with	O
services	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

PSC	B-problem
,	O
status	O
post	O
hepaticojejunostomy	B-treatment
.	O

Hope	O
Raymond	O
,	O
M.D.	O
,	O
Ph.D.	O

02-366	O

Dictated	O
By	O
:	O
Alden	O
B.	O
Edwards	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2009-10-02	O
09:08	O

T	O
:	O
2009-10-02	O
09:08	O

JOB	O
#:	O

86749	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Mary	O
Jones	O
on	O
:	O
SUN	O
2009-10-04	O
1:08	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2016-12-30	O

Discharge	O
Date	O
:	O

2017-01-13	O

Date	O
of	O
Birth	O
:	O

1960-09-05	O

Sex	O
:	O

M	O

Service	O
:	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
56	O
year	O
old	O
man	O
with	O
history	O
of	O
hypercholesterolemia	B-problem
and	O
type	B-problem
II	I-problem
diabetes	I-problem
mellitus	I-problem
.	O

He	O
has	O
a	O
recent	O
history	O
of	O
dyspnea	B-problem
on	O
exertion	O
on	O
exertional	B-problem
chest	I-problem
pain	I-problem
which	O
has	O
increased	O
over	O
the	O
last	O
several	O
weeks	O
and	O
is	O
relieved	O
by	O
sublingual	B-treatment
nitroglycerin	I-treatment
.	O

On	O
2016-06-26	O
,	O
he	O
had	O
a	B-problem
positive	I-problem
exercise	I-problem
tolerance	I-problem
test	I-problem
.	O

Cardiac	B-test
catheterization	I-test
at	O
the	O
end	O
of	O
October	O
revealed	O
a	B-problem
dilated	I-problem
aortic	I-problem
root	I-problem
to	O
4.4	O
cm	O
and	O
80%	B-problem
stenosis	I-problem
of	I-problem
the	I-problem
mid	I-problem
left	I-problem
anterior	I-problem
descending	I-problem
at	O
the	O
bifurcation	O
involving	O
the	O
diagonal	O
branch	O
,	O
70%	B-problem
stenoses	I-problem
of	I-problem
the	I-problem
left	I-problem
circumflex	I-problem
and	I-problem
oblique	I-problem
marginal	I-problem
artery	I-problem
and	O
90%	B-problem
stenosis	I-problem
of	I-problem
the	I-problem
posterior	I-problem
descending	I-problem
artery	I-problem
.	O

His	B-test
atrioventricular	I-test
valve	I-test
gradient	I-test
was	O
27	O
with	O
an	B-test
AV	I-test
surface	I-test
area	I-test
of	O
.91	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Review	B-test
of	I-test
systems	I-test
shows	O
that	O
the	O
patient	O
denies	O
any	B-problem
orthopnea	I-problem
,	O
paroxysmal	B-problem
nocturnal	I-problem
dyspnea	I-problem
.	O

He	O
has	O
no	O
bleeding	B-problem
or	O
clotting	B-problem
problems	I-problem
.	O

Juanita	O
does	O
not	O
feel	O
any	B-problem
palpitations	I-problem
.	O

He	O
does	O
not	O
have	O
wheezing	B-problem
,	O
claudication	B-problem
or	O
gastrointestinal	B-problem
bleeding	I-problem
.	O

Nor	O
does	O
he	O
have	O
any	O
history	O
of	O
stroke	B-problem
like	I-problem
symptoms	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Hypercholesterolemia	B-problem
.	O

Type	B-problem
II	I-problem
diabetes	I-problem
.	O

Recent	B-problem
pneumonia	I-problem
.	O

Remote	O
tobacco	O
use	O
.	O

Recent	B-problem
weight	I-problem
loss	I-problem
associated	O
with	O
the	B-problem
pneumonia	I-problem
.	O

Gastroesophageal	B-problem
reflux	I-problem
disease	I-problem
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

One	O
aspirin	B-treatment
a	O
day	O
.	O

Nexium	B-treatment
40	O
mg	O
a	O
day	O
.	O

Carvedilol	B-treatment
6.125	O
mg	O
a	O
day	O
.	O

Glucophage	B-treatment
25	O
mg	O
once	O
a	O
day	O
.	O

Lipitor	B-treatment
10	O
mg	O
once	O
a	O
day	O
.	O

SOCIAL	O
HISTORY	O
:	O

He	O
lives	O
with	O
his	O
wife	O
and	O
works	O
as	O
a	O
drug	O
representative	O
for	O
Carvedilol	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
physical	B-test
examination	I-test
,	O
the	O
patient	O
is	O
afebrile	B-problem
.	O

Weight	B-test
is	O
82	O
kilograms	O
.	O

Blood	B-test
pressure	I-test
126/66	O
.	O

General	O
:	O

Active	O
,	O
well-developed	O
,	O
well-nourished	O
male	O
.	O

Head	B-test
and	I-test
neck	I-test
examination	I-test
:	O

No	O
bruits	B-problem
appreciated	O
.	O

Lungs	O
are	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Heart	O
was	O
regular	O
rate	O
and	O
rhythm	O
.	O

S1	O
and	O
S2	O
.	O

3/6	B-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
throughout	O
his	O
precordium	O
.	O

His	O
abdomen	O
is	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
.	O

No	O
hepatosplenomegaly	B-problem
and	O
no	O
CVA	B-problem
tenderness	I-problem
.	O

Extremities	O
are	O
warm	O
,	O
well	O
perfused	O
,	O
no	O
cyanosis	B-problem
,	O
clubbing	B-problem
or	O

edema	B-problem
.	O

Palpable	O
dorsalis	O
pedis	O
pulses	O
.	O

No	O
varicosities	B-problem
noted	O
.	O

The	O
patient	O
was	O
also	O
noted	O
to	O
be	O
right	O
handed	O
.	O

HOSPITAL	O
COURSE	O
:	O

He	O
was	O
admitted	O
to	O
the	O
cardiac	O
surgery	O
service	O
for	O
an	B-treatment
elected	I-treatment
Bental	I-treatment
procedure	I-treatment
with	O
homograft	B-treatment
and	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
.	O

Once	O
consent	O
and	O
preoperative	B-test
evaluation	I-test
was	O
complete	O
,	O
he	O
was	O
taken	O
to	O
the	O
operating	O
room	O
.	O

Please	O
refer	O
to	O
the	O
previously	O
dictated	O
operative	O
note	O
of	O
2016-12-30	O
by	O
Dr.	O
Lawrence	O
.	O

Briefly	O
,	O
the	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
to	O
repair	B-treatment
his	B-problem
critical	I-problem
aortic	I-problem
stenosis	I-problem
,	O
his	B-problem
coronary	I-problem
artery	I-problem
disease	I-problem
and	O
his	B-problem
significantly	I-problem
dilated	I-problem
ascending	I-problem
aortic	I-problem
aneurysm	I-problem
.	O

The	B-treatment
procedure	I-treatment
was	O
an	B-treatment
aortic	I-treatment
valve	I-treatment
replacement	I-treatment
with	O
a	B-treatment
tissue	I-treatment
valve	I-treatment
,	O
a	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
procedure	I-treatment
where	O
five	B-treatment
grafts	I-treatment
were	O
performed	O
.	O

The	O
left	O
internal	O
mammary	O
artery	O
was	O
connected	O
to	O
the	O
proximal	O
left	O
anterior	O
descending	O
and	O
saphenous	B-treatment
vein	I-treatment
grafts	I-treatment
were	O
connected	O
to	O
the	O
posterior	O
descending	O
artery	O
,	O
diagonal	O
branch	O
,	O
obtuse	O
marginal	O
and	O
distal	O
left	O
anterior	O
descending	O
.	O

Finally	O
,	O
a	B-treatment
super	I-treatment
coronary	I-treatment
arch	I-treatment
graft	I-treatment
was	O
implanted	O
.	O

This	O
was	O
a	B-treatment
....................	I-treatment
graft	I-treatment
.	O

Cardiopulmonary	B-treatment
bypass	I-treatment
time	O
was	O
234	O
minutes	O
.	O

His	O
aorta	O
was	O
cross	B-treatment
clamped	I-treatment
for	O
168	O
minutes	O
.	O

He	O
had	O
pharmacologic	B-treatment
circulatory	I-treatment
arrest	I-treatment
for	O
18	O
minutes	O
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
and	O
was	O
transferred	O
to	O
the	O
unit	O
,	O
intubated	B-treatment
on	O
Milrinone	B-treatment
,	O
Levophed	B-treatment
and	O
Propofol	B-treatment
drips	I-treatment
.	O

The	O
rest	O
of	O
the	O
hospital	O
stay	O
can	O
be	O
discussed	O
in	O
terms	O
of	O
system	O
based	O
approach	O
.	O

Pulmonary	O
:	O

The	O
patient	O
remained	O
intubated	B-treatment
until	O
postoperative	O
day	O
number	O
five	O
.	O

After	O
that	O
,	O
the	O
patient	O
had	O
no	O
major	B-problem
problems	I-problem
with	I-problem
his	I-problem
lungs	I-problem
.	O

His	B-test
oxygen	I-test
saturations	I-test
remained	O
good	O
and	O
he	O
did	O
not	O
require	O
supplemental	B-treatment
oxygen	I-treatment
more	O
than	O
a	O
couple	O
of	O
days	O
after	O
his	O
extubation	O
.	O

He	O
was	O
sent	O
to	O
the	O
floor	O
from	O
the	O
cardiac	O
surgery	O
recovery	O
unit	O
on	O
postoperative	O
day	O
number	O
seven	O
.	O

After	O
an	O
extended	O
stay	O
for	O
hemodynamic	B-test
monitoring	I-test
and	O
pressor	B-treatment
support	I-treatment
to	O
maintain	O
his	O
perfusion	O
.	O

Neurologic	O
:	O

The	B-problem
major	I-problem
neurologic	I-problem
event	I-problem
of	O
this	O
hospital	O
course	O
was	O
that	O
the	O
patient	O
was	O
slow	B-problem
to	I-problem
awake	I-problem
after	O
his	B-treatment
Propofol	I-treatment
drip	I-treatment
was	O
discontinued	O
.	O

Because	O
of	O
his	B-problem
confusion	I-problem
,	O
a	O
neurology	O
consult	O
was	O
obtained	O
and	O
subsequent	B-test
radiographic	I-test
imaging	I-test
revealed	O
chronic	B-problem
appearing	I-problem
infarcts	I-problem
in	I-problem
the	I-problem
right	I-problem
occipital	I-problem
lobe	I-problem
as	O
well	O
as	O
both	O
cerebellar	O
hemispheres	O
,	O
suggestive	O
of	O
more	B-problem
chronic	I-problem
infarcts	I-problem
,	O
as	O
well	O
as	O
an	O
area	O
in	O
the	O
left	O
corona	O
radiata	O
,	O
adjacent	O
to	O
the	O
left	O
lateral	O
ventricle	O
which	O
may	O
or	O
may	O
not	O
be	O
an	B-problem
acute	I-problem
infarct	I-problem
.	O

This	O
was	O
seen	O
on	O
the	B-test
CAT	I-test
scan	I-test
on	O
postoperative	O
day	O
number	O
one	O
,	O
12-31	O
.	O

As	O
the	O
patient	O
became	O
more	O
awake	O
,	O
he	O
still	O
remained	O
somewhat	B-problem
confused	I-problem
and	O
a	B-problem
little	I-problem
bit	I-problem
out	I-problem
of	I-problem
it	I-problem
.	O

In	O
addition	O
,	O
he	O
was	O
noted	O
to	O
have	O
a	B-problem
right	I-problem
sided	I-problem
hemiplegia	I-problem
.	O

Over	O
his	O
postoperative	O
course	O
,	O
Mr.	O
Douglass	O
has	O
gradually	O
been	O
able	O
to	O
utilize	O
more	O
and	O
more	O
of	O
his	O
right	O
side	O
and	O
with	O
the	O
assistance	O
of	O
physical	B-treatment
therapy	I-treatment
and	O
occupational	B-treatment
therapy	I-treatment
,	O
he	O
has	O
4	O
to	O
5	O
+	O
strength	O
in	O
his	O
right	O
hand	O
and	O
arm	O
and	O
about	O
4	O
+	O
strength	O
in	O
his	O
right	O
leg	O
.	O

He	O
is	O
able	O
to	O
walk	O
about	O
the	O
floor	O
on	O
the	O
days	O
prior	O
to	O
discharge	O
,	O
with	O
the	O
assistance	O
of	O
the	O
physical	O
therapist	O
and	O
nurses	O
.	O

In	O
addition	O
,	O
Mr.	O
Douglass	O
is	O
given	O
Trazodone	B-treatment
to	O
help	O
him	O
sleep	O
at	O
night	O
.	O

A	O
psychiatric	O
consult	O
was	O
also	O
obtained	O
due	O
to	O
his	O
mental	O
status	O
and	O
confusion	B-problem
postoperatively	O
but	O
his	B-problem
psychiatric	I-problem
issues	I-problem
are	O
mostly	O
related	O
to	O
his	B-problem
neurologic	I-problem
insults	I-problem
and	O
he	O
has	O
no	O
distinctive	B-problem
psychiatric	I-problem
disorder	I-problem
,	O
except	O
for	O
perhaps	O
postoperative	B-problem
delirium	I-problem
.	O

Cardiovascularly	O
,	O
the	O
patient	O
did	O
extremely	O
well	O
following	O
the	B-treatment
surgery	I-treatment
.	O

The	B-treatment
Levophed	I-treatment
drip	I-treatment
was	O
continued	O
until	O
postoperative	O
day	O
number	O
one	O
.	O

Milrinone	B-treatment
was	O
continued	O
until	O
postoperative	O
day	O
number	O
three	O
,	O
at	O
which	O
point	O
he	O
was	O
having	O
good	O
enough	O
cardiac	O
output	O
that	O
he	O
did	O
not	O
need	O
these	B-treatment
drips	I-treatment
to	O
help	O
maintain	O
his	B-test
blood	I-test
pressure	I-test
anymore	O
.	O

He	O
has	O
remained	O
without	O
any	B-problem
chest	I-problem
pain	I-problem
following	O
this	B-treatment
procedure	I-treatment
and	O
his	B-problem
sternal	I-problem
wound	I-problem
is	O
clean	O
,	O
dry	O
and	O
intact	O
at	O
the	O
end	O
of	O
the	B-treatment
procedure	I-treatment
.	O

In	O
addition	O
,	O
he	O
has	O
hypertension	B-problem
,	O
for	O
which	O
he	O
receives	O
Metoprolol	B-treatment
and	O
he	O
has	O
hypercholesterolemia	B-problem
,	O
for	O
which	O
he	O
receives	O
nothing	O
at	O
this	O
time	O
.	O

Pulmonary	O
:	O

The	O
patient	O
remained	O
intubated	B-treatment
until	O
postoperative	O
day	O
number	O
five	O
.	O

He	O
was	O
diuresed	O
and	O
was	O
soon	O
saturating	O
very	O
well	O
on	O
room	O
air	O
.	O

Gastrointestinal	O
:	O

The	O
patient	O
has	O
gastroesophageal	B-problem
reflux	I-problem
disease	I-problem
,	O
for	O
which	O
he	O
has	O
been	O
receiving	O
Zantac	B-treatment
as	O
an	O
inpatient	O
.	O

We	O
will	O
put	O
him	O
back	O
on	O
his	B-treatment
Nexium	I-treatment
.	O

In	O
addition	O
,	O
over	O
the	O
last	O
couple	O
of	O
days	O
prior	O
to	O
discharge	O
,	O
the	O
patient	O
did	O
appear	O
a	B-problem
little	I-problem
bit	I-problem
icteric	I-problem
.	O

Liver	B-test
function	I-test
tests	I-test
were	O
obtained	O
and	O
they	O
were	O
slightly	B-problem
elevated	I-problem
liver	I-problem
function	I-problem
tests	I-problem
and	O
ALT	B-test
was	O
44	O
,	O
AST	B-test
was	O
34	O
;	O
alkaline	B-test
phosphatase	I-test
was	O
199	O
,	O
within	O
normal	O
limits	O
.	O

Total	B-test
bilirubin	I-test
was	O
2.8	O
.	O

Amylase	B-test
was	O
108	O
and	O
lipase	B-test
was	O
213	O
.	O

A	B-test
right	I-test
upper	I-test
quadrant	I-test
ultrasound	I-test
did	O
not	O
reveal	O
any	B-problem
gallstones	I-problem
or	O
common	B-problem
bile	I-problem
duct	I-problem
dilatation	I-problem
indicative	O
of	O
cholecystitis	B-problem
or	O
cholelithiasis	B-problem
.	O

In	O
addition	O
,	O
the	O
patient	O
did	O
have	O
slightly	B-problem
elevated	I-problem
blood	I-problem
sugars	I-problem
over	O
the	O
last	O
couple	O
of	O
days	O
and	O
has	O
required	O
an	B-treatment
insulin	I-treatment
sliding	I-treatment
scale	I-treatment
and	O
basal	B-treatment
insulin	I-treatment
to	O
maintain	O
his	B-test
blood	I-test
sugars	I-test
at	O
a	O
more	O
appropriate	O
level	O
.	O

The	O
ideal	O
blood	O
sugar	O
levels	O
for	O
Mr.	O
Douglass	O
in	O
this	O
postoperative	O
period	O
should	O
be	O
less	O
than	O
140	O
.	O

Please	O
stay	O
on	O
top	O
of	O
the	B-treatment
sliding	I-treatment
scale	I-treatment
so	O
that	O
the	O
patient	O
can	O
keep	O
a	O
euglycemic	O
level	O
.	O

Hematologic	O
:	O

The	O
patient	O
,	O
during	O
this	O
admission	O
,	O
required	O
transfusion	O
of	O
three	O
units	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
to	O
maintain	O
adequate	O
hematocrit	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
Mr.	O
Norman	O
hematocrit	B-test
is	O
at	O
40.7	O
.	O

Fluids	O
,	O
electrolytes	O
and	O
nutrition	O
:	O

The	O
patient	O
did	O
receive	O
a	O
significant	O
amount	O
of	O
diuresis	B-treatment
postoperatively	O
and	O
is	O
well	O
below	O
his	O
baseline	O
with	O
weight	B-test
,	O
most	O
likely	O
because	O
of	O
his	B-problem
inability	I-problem
to	I-problem
eat	I-problem
because	O
of	O
his	B-problem
stroke	I-problem
.	O

Once	O
he	O
was	O
coherent	O
enough	O
,	O
the	O
patient	O
was	O
evaluated	O
by	O
the	O
swallow	O
team	O
who	O

declared	O
him	O
at	O
first	O
an	B-problem
aspiration	I-problem
risk	I-problem
.	O

As	O
Mr.	O
Douglass	O
has	O
improved	O
from	O
his	B-problem
initial	I-problem
stroke	I-problem
,	O
he	O
has	O
become	O
more	O
lucid	O

and	O
is	O
less	O
of	O
an	B-problem
aspiration	I-problem
risk	I-problem
.	O

On	O
01-12	O
,	O
one	O
day	O
prior	O
to	O
discharge	O
,	O
he	O
was	O
cleared	O
by	O
the	O
swallow	O
team	O
to	O
eat	O

a	O
diet	O
as	O
he	O
wishes	O
.	O

He	O
is	O
going	O
out	O
on	O
a	B-treatment
cardiac	I-treatment
healthy	I-treatment
,	I-treatment
diabetic	I-treatment
diet	I-treatment
,	O
as	O
tolerated	O
with	O
Boost	B-treatment
supplements	I-treatment
.	O

Infectious	O
disease	O
:	O

The	O
patient	O
had	O
positive	B-problem
blood	I-problem
and	I-problem
urine	I-problem
cultures	I-problem
on	O
01-05	O
for	O
history	O
of	O
Methicillin	B-problem
resistant	I-problem
Staphylococcus	I-problem
aureus	I-problem
,	O
which	O
was	O
pan	B-test
sensitive	I-test
.	O

He	O
was	O
started	O
on	O
Oct.	O
25	O
for	O
this	B-problem
bug	I-problem
.	O

On	O
01-08	O
,	O
the	B-treatment
patient	I-treatment
's	I-treatment
central	I-treatment
venous	I-treatment
line	I-treatment
was	O
discontinued	O
.	O

The	B-test
catheterization	I-test
tip	I-test
also	O
grew	O
out	O
Serratia	B-problem
.	O

On	O
the	O
16th	O
,	O
a	B-test
urine	I-test
culture	I-test
was	O
obtained	O
and	O
did	O
grow	O
out	O
greater	O
than	O
100,000	O
colonies	O
of	O
E.	B-problem
coli	I-problem
which	O
was	O
intermittently	B-problem
resistant	I-problem
to	O
Ciprofloxacin	B-treatment
.	O

He	O
was	O
started	O
on	O
Bactrim	B-treatment
for	O
that	O
.	O

Please	O
continue	O
Mr.	O
David	O
Montero	O
for	O
one	O
month	O
to	O
fight	O
his	B-problem
blood	I-problem
borne	I-problem
infection	I-problem
,	O
to	O
prevent	O
seeding	O
of	O
his	B-treatment
aortic	I-treatment
graft	I-treatment
and	O
continue	O
Bactrim	B-treatment
for	O
ten	O
days	O
after	O
discharge	O
to	O
treat	O
the	B-problem
E.	I-problem
coli	I-problem
in	I-problem
his	I-problem
urine	I-problem
.	O

DISPOSITION	O
:	O

Mr.	O
Douglass	O
is	O
being	O
discharged	O
on	O
2017-01-13	O
to	O
a	O
rehabilitation	O
facility	O
in	O
good	O
condition	O
.	O

FOLLOW-UP	O
:	O

One	O
to	O
two	O
weeks	O
with	O
his	O
primary	O
care	O
physician	O
and	O
two	O
to	O
three	O
weeks	O
with	O
his	O
cardiologist	O
and	O
at	O
one	O
month	O
with	O
Dr.	O
Costello	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Coronary	B-problem
artery	I-problem
disease	I-problem
,	O
status	O
post	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
.	O

Critical	B-problem
aortic	I-problem
stenosis	I-problem
,	O
status	O
post	O
aortic	B-treatment
valve	I-treatment
replacement	I-treatment
.	O

Aortic	B-problem
arch	I-problem
aneurysm	I-problem
,	O
status	O
post	O
aortic	B-treatment
arch	I-treatment
graft	I-treatment
.	O

Acute	B-problem
postoperative	I-problem
delirium	I-problem
.	O

Perioperative	B-problem
stroke	I-problem
.	O

Chronic	B-problem
blood	I-problem
loss	I-problem
anemia	I-problem
and	O
chronic	B-treatment
RBC	I-treatment
transfusion	I-treatment
.	O

Urinary	B-problem
tract	I-problem
infection	I-problem
.	O

Hypercholesterolemia	B-problem
.	O

Type	B-problem
II	I-problem
diabetes	I-problem
.	O

Gastroesophageal	B-problem
reflux	I-problem
disease	I-problem
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Metoprolol	B-treatment
75	O
mg	O
p.o.	O
twice	O
a	O
day	O
.	O

Captopril	B-treatment
12.5	O
mg	O
p.o.	O
three	O
times	O
a	O
day	O
.	O

Aspirin	B-treatment
81	O
mg	O
p.o.	O
q.	O
day	O
.	O

Plavix	B-treatment
75	O
mg	O
p.o.	O
q.	O
day	O
.	O

Heparin	B-treatment
5000	O
units	O
subcutaneous	O
twice	O
a	O
day	O
.	O

Metformin	B-treatment
1000	O
mg	O
extended	O
release	O
p.o.	O
q.	O
day	O
.	O

Humalog	B-treatment
Max	I-treatment
75/25	O
,	O
20	O
units	O
subcutaneous	O
once	O
a	O
day	O
in	O
the	O
morning	O
.	O

Levofloxacin	B-treatment
500	O
mg	O
p.o.	O
q.	O
day	O
.	O

Bactrim	B-treatment
DS	I-treatment
tabs	I-treatment
,	O
one	O
tablet	O
p.o.	O
q.	O
day	O
for	O
ten	O
days	O
.	O

Colace	B-treatment
100	O
mg	O
p.o.	O
twice	O
a	O
day	O
.	O

Hold	O
for	O
loose	B-problem
stools	I-problem
.	O

Nexium	B-treatment
40	O
mg	O
p.o.	O
q.	O
day	O
.	O

Trazodone	B-treatment
25	O
mg	O
p.o.	O
q	O
h.s.	O
as	O
needed	O
for	O
sleep	O
.	O

Lasix	B-treatment
20	O
mg	O
p.o.	O
q.	O
day	O
for	O
one	O
week	O
.	O

KCl	B-treatment
20	O
mg	O
p.o.	O
q.	O
day	O
for	O
one	O
week	O
.	O

Dolly	O
V	O
Blevins	O
,	O
M.D.	O

04-100	O

Dictated	O
By	O
:	O
Kenneth	O
O.	O
Hogan	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2017-01-12	O
11:35	O

T	O
:	O
2017-01-13	O
05:30	O

JOB	O
#:	O

92344	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Dolly	O
D.F.	O
Sipes	O
on:	O
Roxane	O
2017-02-21	O
11:52	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2014-02-21	O

Discharge	O
Date	O
:	O

2014-03-25	O

Date	O
of	O
Birth	O
:	O

1928-07-25	O

Sex	O
:	O

F	O

Service	O
:	O

SURGERY	O

Allergies	O
:	O

Sulfa	B-treatment
(	I-treatment
Sulfonamides	I-treatment
)	I-treatment

Attending	O
:	O
Mattie	O
R.	O
A.	O
Hamilton	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Nausea	B-problem
,	O
vomiting	B-problem
,	O
Abdominal	B-problem
pain	I-problem
,	O
distention	B-problem
.	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

1.	O
Subtotal	B-treatment
colectomy	I-treatment
,	O
end	B-treatment
ileostomy	I-treatment
,	O
Hartmann's	B-treatment
pouch	I-treatment
,	O
G-tube	B-treatment

2.	O
Completion	B-treatment
sigmoid	I-treatment
colectomy	I-treatment
,	O
repair	B-treatment
of	O
colovesicular	B-problem
fistula	I-problem
,	O
small	B-treatment
bowel	I-treatment
repair	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

Ms	O
Crossman	O
is	O
an	O
84	O
year	O
old	O
female	O
with	O
complaints	O
of	O
abdominal	B-problem
pain	I-problem
,	O
diarrhea	B-problem
,	O
nausea	B-problem
and	O
vomiting	B-problem
x	O
1	O
week	O
,	O
who	O
presented	O
to	O
an	O
outside	O
hospital	O
.	O

She	O
was	O
transferred	O
to	O
Arbour	O
Hospital	O
on	O
2015-02-21	O
for	O
bowel	B-problem
obstruction	I-problem
,	O
ischemia	B-problem
and	O
worsening	B-problem
abdominal	I-problem
distention	I-problem
and	O
pain	B-problem
.	O

Past	O
Medical	O
History	O
:	O

CAD	B-problem
s/p	O
MI	B-problem
,	O
HTN	B-problem
,	O
DMII	B-problem

Social	O
History	O
:	O

Lives	O
independently	O
,	O
but	O
in	O
the	O
same	O
building	O
with	O
daughter	O
.	O

Amy	O
3	O
children	O
,	O
2	O
daughters	O
and	O
1	O
son	O
.	O

Daughter	O
Lurline	O
is	O
Durable	O
Power	O
of	O
Attorney	O
.	O

The	O
other	O
daughter	O
was	O
recently	O
in	O
a	O
car	O
accident	O
and	O
underwent	O
surgery	B-treatment
at	O
Saint	O
Vincent	O
Hospital	O
.	O

Family	O
History	O
:	O

NC	O

Physical	O
Exam	O
:	O

At	O
time	O
of	O
discharge	O
:	O

Afebrile	B-problem
,	O
VSS	O

A&O	O
X	O
3	O
,	O
NAD	B-problem

RRR	O

CTAB	O
,	O
mildly	B-problem
decreased	I-problem
breath	I-problem
sounds	I-problem
b/l	I-problem

Abd	O
soft	O
,	O
NT/ND	B-problem
,	O
+	O
bs	O
,	O
no	O
masses	B-problem
,	O
ostomy	B-treatment
in	I-treatment
RLQ	I-treatment
pink	O
,	O
with	O
stool	O

G-tube	B-treatment
in	O
place	O

LE	B-problem
trace	I-problem
edema	I-problem

Pertinent	O
Results	O
:	O

2014-02-21	O
12:20	O
PM	O
BLOOD	B-test
WBC	B-test
-	O
10.2	O
RBC	B-test
-	O
5.32	O
Hgb	B-test
-	O
14.9	O
Hct	B-test
-	O
43.4	O
MCV	B-test
-	O
82	O
MCH	B-test
-	O
28.0	O
MCHC	B-test
-	O
34.4	O
RDW	B-test
-	O
16.0	O
*	O
Plt	B-test
Ct	I-test
-	O
204	O

2014-02-21	O
12:20	O
PM	O
BLOOD	B-test
PT	B-test
-	O
12.9	O
PTT	B-test
-	O
32.5	O
INR(PT)	B-test
-	O
1.1	O

2014-02-21	O
12:20	O
PM	O
BLOOD	B-test
Glucose	B-test
-	O
345	O
*	O
UreaN	B-test
-	O
34	O
*	O
Creat	B-test
-	O
1.0	O
Na	B-test
-	O
137	O
K	B-test
-	O
4.3	O
Cl	B-test
-	O
99	O
HCO3	B-test
-	O
24	O
AnGap	B-test
-	O
18	O

2014-02-21	O
12:20	O
PM	O
BLOOD	B-test
ALT	B-test
-	O
17	O
AST	B-test
-	O
27	O
AlkPhos	B-test
-	O
119	O
*	O
Amylase	B-test
-	O
27	O
TotBili	B-test
-	O
0.9	O

2014-02-21	O
12:20	O
PM	O
BLOOD	B-test
Lipase	B-test
-	O
11	O

2014-02-21	O
12:20	O
PM	O
BLOOD	B-test
CK-MB	B-test
-	O
7	O
cTropnT	B-test
-<	O
0.01	O

2014-03-09	O
02:59	O
AM	O
BLOOD	B-test
cTropnT	B-test
-	O
0.21	O
*	O

2014-03-09	O
11:29	O
AM	O
BLOOD	B-test
CK-MB	B-test
-	O
35	O
*	O
MB	B-test
Indx	I-test
-	O
25.5	O
*	O
cTropnT	B-test
-	O
0.45	O
*	O

2014-03-09	O
07:52	O
PM	O
BLOOD	B-test
CK-MB	B-test
-	O
NotDone	O
cTropnT	B-test
-	O
0.55	O
*	O

2014-03-10	O
05:25	O
PM	O
BLOOD	B-test
cTropnT	B-test
-	O
0.42	O
*	O

2014-03-11	O
02:00	O
AM	O
BLOOD	B-test
cTropnT	B-test
-	O
0.45	O
*	O

2014-03-19	O
07:13	O
AM	O
BLOOD	B-test
CK-MB	B-test
-	O
3	O
cTropnT	B-test
-	O
0.19	O
*	O

2014-03-19	O
01:33	O
PM	O
BLOOD	B-test
CK-MB	B-test
-	O
NotDone	O
cTropnT	B-test
-	O
0.17	O
*	O

2014-03-21	O
09:58	O
AM	O
BLOOD	B-test
CK-MB	B-test
-	O
NotDone	O
cTropnT	B-test
-	O
0.06	O
*	O

03-07	O
wound	B-test
swab	I-test
:	O
VRE	B-problem

CT	B-test
Abd	I-test
02-21	O
:	O

1.	O
Markedly	B-problem
dilated	I-problem
colon	I-problem
throughout	O
ascending	O
,	O
transverse	O
,	O
and	O
descending	O
colon	O
with	O
air-fluid	B-problem
levels	I-problem
,	O
overall	O
unchanged	O
since	O
prior	B-test
study	I-test
performed	O
on	O
the	O
same	O
day	O
with	O
pneumatosis	B-problem
in	I-problem
the	I-problem
ascending	I-problem
colon	I-problem
.	O

Sigmoid	B-problem
diverticulosis	I-problem
with	O
focal	B-problem
narrowing	I-problem
of	I-problem
the	I-problem
sigmoid	I-problem
colon	I-problem
just	O
distal	O
to	O
the	B-problem
dilatation	I-problem
with	O
wall	B-problem
thickening	I-problem
,	O
due	O
to	O
diverticulitis	B-problem
.	O

This	O
area	O
can	O
be	O
a	O
leading	O
point	O
of	O
obstruction	B-problem
.	O

An	B-problem
underlying	I-problem
mass	I-problem
lesion	I-problem
or	O
cancer	B-problem
cannot	O
be	O
excluded	O
in	O
this	O
area	O
,	O
and	O
further	B-test
clinical	I-test
investigation	I-test
is	O
recommended	O
.	O

2.	O
Limited	B-test
evaluation	I-test
for	O
known	B-problem
sigmoid-vesicle	I-problem
fistula	I-problem
.	O

3.	O
Small	B-problem
amount	I-problem
of	I-problem
ascites	I-problem
,	O
somewhat	O
increased	O
anterior	O
to	O
the	O
liver	O
.	O

4.	O
Bilateral	B-problem
renal	I-problem
cysts	I-problem
.	O

5.	O
Heavy	B-problem
calcification	I-problem
of	I-problem
the	I-problem
aorta	I-problem
and	I-problem
SMA	I-problem
and	I-problem
its	I-problem
branches	I-problem
.	O

Due	O
to	O
atherosclerosis	B-problem
,	O
assessment	B-test
of	I-test
the	I-test
intraluminal	I-test
process	I-test
of	O
these	O
branches	O
is	O
limited	O
.	O

CTA/CT	B-test
abd	I-test
03-07	O
:	O

1.	O
No	O
evidence	O
of	O
pulmonary	B-problem
embolism	I-problem
.	O

Small	B-problem
bilateral	I-problem
pleural	I-problem
effusions	I-problem
with	O
compressive	B-problem
atelectasis	I-problem
.	O

2.	O
Left	B-problem
lower	I-problem
quadrant	I-problem
thick-walled	I-problem
peripherally	I-problem
enhancing	I-problem
fluid	I-problem
collection	I-problem
,	O
which	O
appears	O
to	O
communicate	O
with	O
the	O
sutured	O
end	O
of	O
the	O
proximal	O
sigmoid	O
colon	O
via	O
a	B-problem
small	I-problem
collection	I-problem
of	I-problem
extraluminal	I-problem
gas	I-problem
.	O

In	O
the	O
correct	O
clincial	O
setting	O
,	O
this	O
could	O
be	O
consistent	O
with	O
an	B-problem
abscess	I-problem
.	O

3.	O
Moderate	B-problem
intraabdominal	I-problem
ascites	I-problem
.	O

4.	O
Status	O
post	O
ileostomy	B-treatment
without	O
evidence	O
of	O
small-bowel	B-problem
obstruction	I-problem
.	O

5.	O
Distended	B-problem
gallbladder	I-problem
.	O

6.	O
Diverticulosis	B-problem
within	I-problem
the	I-problem
right	I-problem
remnant	I-problem
sigmoid	I-problem
colon	I-problem
.	O

03-21	O
VCUG	B-test
-	O
no	O
leak	B-problem

Brief	O
Hospital	O
Course	O
:	O

Ms	O
Crossman	O
was	O
admitted	O
on	O
2015-02-21	O
from	O
an	O
outside	O
hospital	O
to	O
the	O
ICU	O
.	O

Neuro	O
:	O
Developed	O
confusion	B-problem
during	O
her	O
first	O
5	O
days	O
in	O
the	O
ICU	O
.	O

Post-operatively	O
mental	O
status	O
improved	O
.	O

Intermitent	B-problem
delirium	I-problem
throughout	O
admission	O
.	O

Required	O
restraints	B-treatment
to	O
prevent	O
DC	O
of	O
pertinent	B-treatment
therapies	I-treatment
while	O
in	O
the	O
ICU	O
.	O

Currently	O
AAOx3	O
.	O

Cardiovascular	O
:	O
Complained	O
of	O
chest	B-problem
pain	I-problem
during	O
first	O
few	O
days	O
of	O
admission	O
,	O
a	O
cardiology	O
consult	O
was	O
obtained	O
.	O

She	O
recieved	O
serial	B-test
enzymes	I-test
and	O
EKGs	B-test
.	O

Troponins	B-test
remained	O
mildly	B-problem
elevated	I-problem
as	O
high	O
as	O
0.6	O
throughout	O
her	O
admission	O
,	O
and	O
most	O
recent	O
result	O
now	O
0.1	O
.	O

She	O
was	O
treated	O
in	O
IUC	O
for	O
unstable	B-problem
angina	I-problem
with	O
nitroglycerin	B-treatment
.	O

It	O
was	O
recommended	O
to	O
maximize	O
her	B-treatment
medical	I-treatment
treatment	I-treatment
with	O
Beta	B-treatment
blockers	I-treatment
,	O
aspirin	B-treatment
,	O
a	B-treatment
statin	I-treatment
and	O
an	B-treatment
ACE	I-treatment
Inhibitor	I-treatment
.	O

Required	O
diuresis	B-treatment
of	O
>	O
9	O
L	O
while	O
in	O
the	O
ICU	O
,	O
after	O
2nd	B-treatment
surgery	I-treatment
.	O

Continues	O
to	O
have	O
trace	B-problem
lower	I-problem
extremity	I-problem
edema	I-problem
,	O
and	O
recieves	O
lasix	B-treatment
po	I-treatment
.	O

Respiratory	O
:	O
She	O
was	O
intubated	B-treatment
briefly	O
post-op	O
subtotal	B-treatment
colectomy	I-treatment
and	O
again	O
for	O
several	O
days	O
after	O
second	B-treatment
surgery	I-treatment
.	O

Recieved	O
nebulizer	B-treatment
treatments	I-treatment
post-op	O
in	O
the	O
ICU	O
,	O
after	O
successfully	O
extubated	O
.	O

Gastrointestinal	O
:	O
Her	B-test
initial	I-test
CT	I-test
scan	I-test
showed	O
dilated	B-problem
Turner	I-problem
colon	I-problem
,	O
wall	B-problem
thickening	I-problem
and	O
pneumatosis	B-problem
see	O
pertinent	O
results	O
.	O

She	O
was	O
initially	O
treated	O
nonoperatively	O
with	O
IV	B-treatment
fluids	I-treatment
,	O
antibiotics	B-treatment
,	O
serial	B-test
exams	I-test
and	O
NGT	B-treatment
decompression	I-treatment
.	O

On	O
HD#5	O
flexible	B-test
sigmoidoscopy	I-test
was	O
performed	O
for	O
colonic	B-treatment
decompression	I-treatment
.	O

On	O
HD#6	O
,	O
colonscopy	B-test
was	O
performed	O
for	O
decompression	B-treatment
,	O
and	O
revealed	O
pseudomembrane	B-problem
and	O
friable	B-problem
colonic	I-problem
tissue	I-problem
.	O

Her	O
abdomen	O
remained	O
tender	B-problem
and	O
distended	B-problem
despite	O
attempted	O
decompression	B-treatment
.	O

She	O
was	O
taken	O
to	O
the	O
OR	O
for	O
Subtotal	B-treatment
Colectomy	I-treatment
,	O
G	B-treatment
tube	I-treatment
and	O
ileostomy	B-treatment
due	O
to	O
unresponsiveness	B-problem
to	O
non-operative	B-treatment
treatment	I-treatment
.	O

Ileostomy	B-treatment
remains	O
pink	O
and	O
intact	O
,	O
draining	O
green-brown	O
soft	O
stool	O
.	O

Her	O
post-operative	O
course	O
continued	O
uneventfully	O
in	O
the	O
ICU	O
,	O
and	O
she	O
was	O
transferred	O
to	O
the	O
floor	O
POD#6	O
.	O

She	O
developed	O
additional	B-problem
abdominal	I-problem
tenderness	I-problem
and	O
distention	B-problem
.	O

Her	B-test
HCT	I-test
dropped	O
and	O
she	O
recieved	O
1	B-treatment
unit	I-treatment
PRBCs	I-treatment
.	O

Geriatric	O
consult	O
was	O
obtained	O
to	O
assist	O
with	O
management	O
.	O

On	O
POD#8	O
a	B-test
CT	I-test
scan	I-test
was	O
obtained	O
which	O
revealed	O
an	B-problem
abcess	I-problem
with	O
a	B-problem
colovesicular	I-problem
fistula	I-problem
.	O

She	O
was	O
taken	O
to	O
the	O
OR	O
for	O
exploration	B-test
and	O
drainage	B-treatment
.	O

She	O
recieved	O
further	B-treatment
resection	I-treatment
of	I-treatment
remaining	I-treatment
colon	I-treatment
,	O
repair	B-treatment
of	O
a	B-problem
leak	I-problem
from	I-problem
Relaford	I-problem
pouch	I-problem
and	O
repair	B-treatment
of	O
colovesicular	B-problem
fistula	I-problem
.	O

After	O
her	B-treatment
2nd	I-treatment
surgery	I-treatment
she	O
returned	O
to	O
the	O
ICU	O
and	O
improved	O
steadily	O
.	O

Abdomen	O
remained	O
soft	O
and	O
nontender	B-problem
.	O

She	O
remained	O
on	O
IV	B-treatment
antibiotics	I-treatment
x	O
14	O
days	O
and	O
required	O
pressors	B-treatment
for	O
the	O
first	O
few	O
days	O
post-op	O
.	O

Her	B-problem
incision	I-problem
has	O
remained	O
clean	O
,	O
dry	O
,	O
intact	O
,	O
with	O
staples	B-treatment
removed	O
on	O
POD#	O
27/18	O
.	O

Genitourinary	O
:	O
She	O
had	O
a	B-treatment
foley	I-treatment
catheter	I-treatment
from	O
the	O
time	O
of	O
admission	O
.	O

POD#	O
23/14	O
she	O
recieved	O
a	B-test
cystoscopy	I-test
which	O
revealed	O
no	O
leak	B-problem
.	O

Her	B-treatment
foley	I-treatment
was	O
subsequently	O
dc	O
'd	O
.	O

Musculoskeletal	O
:	O
Has	O
suffered	O
significant	B-problem
deconditioning	I-problem
since	O
admission	O
,	O
but	O
has	O
consisitently	O
recieved	O
PT	B-treatment
.	O

See	O
PT	O
note	O
for	O
further	B-test
assessment	I-test
and	O
discussion	O
.	O

Nutrition	O
:	O
She	O
was	O
held	O
NPO	B-treatment
at	O
admission	O
,	O
and	O
initiated	O
on	O
TPN	B-treatment
by	O
HD#3	O
.	O

Post-operatively	O
she	O
began	O
on	O
TF	B-treatment
s,	I-treatment
and	O
the	B-treatment
TPN	I-treatment
was	O
weaned	O
down	O
.	O

By	O
POD#	O
05-29	O
she	O
was	O
having	O
high	B-problem
residuals	I-problem
on	O
TF	B-treatment
s,	I-treatment
so	O
TPN	B-treatment
was	O
reinitiated	O
.	O

Tf	B-treatment
's	I-treatment
were	O
dc	O
'ed	O
prior	O
to	O
second	B-treatment
surgery	I-treatment
.	O

POD#	O
15/6	O
,	O
she	O
resumed	O
TF	B-treatment
's	I-treatment
and	O
TPN	B-treatment
was	O
tapered	O
again	O
.	O

TF	O
goals	O
were	O
achieved	O
and	O
TPN	B-treatment
dc	O
'ed.	O

A	O
diet	O
by	O
mouth	O
was	O
initiated	O
.	O

At	O
time	O
of	O
discharge	O
she	O
is	O
tolerating	O
a	O
regular	O
diet	O
with	O
TF	B-treatment
's	I-treatment
at	O
goal	O
.	O

Patient	O
is	O
an	B-problem
insulin	I-problem
dependent	I-problem
diabetic	I-problem
.	O

She	O
was	O
followed	O
by	O
Cape	O
Cod	O
Hospital	O
Clinic	O
for	O
treatment	B-treatment
of	O
persistent	B-problem
hyperglycemia	I-problem
.	O

Pain	B-problem
:	O
Her	B-problem
pain	I-problem
was	O
controlled	O
with	O
IV	B-treatment
pain	I-treatment
medicines	I-treatment
while	O
in	O
ICU	O
.	O

She	O
has	O
been	O
adequately	O
controlled	O
with	O
Tylenol	B-treatment
,	O
Motrin	B-treatment
&	O
Oxycodone	B-treatment
by	O
mouth	O
,	O
per	O
recommendations	O
by	O
Geriatrics	O
.	O

POD#	O
22/15	O
Ms	O
Crossman	O
was	O
transferred	O
to	O
3	O
North	O
where	O
she	O
continued	O
to	O
progress	O
well	O
with	O
PT	B-treatment
,	O
increasing	O
PO	O
intake	O
,	O
tolerating	O
TF	B-treatment
s,	I-treatment
and	O
weaning	O
from	O
nasal	B-treatment
cannula	I-treatment
oxygen	I-treatment
.	O

She	O
has	O
remained	O
stable	O
with	O
no	O
acute	B-problem
events	I-problem
.	O

She	O
is	O
discharged	O
to	O
rehab	O
on	O
POD#	O
27/18	O
.	O

Medications	O
on	O
Admission	O
:	O

Norvasc	B-treatment

Atenolol	B-treatment

Isosorbide	B-treatment

Lasix	B-treatment

Insulin	B-treatment

Discharge	O
Medications	O
:	O

1.	O
Heparin	B-treatment
(	I-treatment
Porcine	I-treatment
)	I-treatment
5,000	O
unit	O
/	O
mL	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
mL	O
Injection	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

2.	O
Acetaminophen	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

3.	O
Polyvinyl	B-treatment
Alcohol	I-treatment
-	O
Povidone	B-treatment
1.4-0.6	O
%	O
Dropperette	O
Sig	O
:	O
02-25	O
Drops	O
Ophthalmic	O
PRN	O
(	O
as	O
needed	O
).	O

4.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

5.	O
Aspirin	B-treatment
81	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Chewable	O
PO	O
DAILY	O
(	O
Daily	O
).	O

6.	O
Atorvastatin	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

7.	O
Lisinopril	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

8.	O
Furosemide	B-treatment
40	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

9.	O
Ipratropium	B-treatment
Bromide	I-treatment
17	O
mcg	O
/	O
Actuation	O
Aerosol	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Puff	O
Inhalation	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

10.	O
Albuterol	B-treatment
90	O
mcg	O
/	O
Actuation	O
Aerosol	O
Sig	O
:	O
1-2	O
Puffs	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

11.	O
Oxycodone	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-problem
.	O

12.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

13.	O
Potassium	B-treatment
Chloride	I-treatment
20	O
mEq	O
Tab	O
Sust	O
.	O
Rel	O
.	O
Particle	O
/	O
Crystal	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tab	O
Sust	O
.	O
Rel	O
.	O
Particle	O
/	O
Crystal	O
PO	O
once	O
a	O
day	O
.	O

14.	O
Glargine	B-treatment
Sig	O
:	O
Twenty	O
Two	O
(	O
22	O
)	O
units	O
at	O
bedtime	O
.	O

15.	O
Miconazole	B-treatment
Nitrate	I-treatment
2	O
%	O
Powder	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

16.	O
Miconazole	B-treatment
Nitrate	I-treatment
2	O
%	O
Cream	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

17.	O
Ibuprofen	B-treatment
100	O
mg/5	O
mL	O
Suspension	O
Sig	O
:	O
Twenty	O
(	O
20	O
)	O
mL	O
PO	O
Q8H	O
(	O
every	O
8	O
hours	O
)	O
as	O
needed	O
.	O

18.	O
Debrox	B-treatment
6.5	O
%	O
Drops	O
Sig	O
:	O
Five	O
(	O
5	O
)	O
Drop	O
Otic	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
for	O
5	O
days	O
:	O
both	O
ears	O
.	O

19.	O
Trazodone	B-treatment
50	O
mg	O
Tablet	O
Sig	O
:	O
1	O
/	O
2-1	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
).	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

Hurtado	B-problem
Colon	I-problem

Diverticulitis	B-problem

S/P	O
Subtotal	B-treatment
Colectomy	I-treatment
,	O
Ileostomy	B-treatment
,	O
Gastrostomy	B-treatment
tube	I-treatment

S/P	O
Exploratory	B-test
laparotomy	I-test
,	O
resection	B-treatment
of	I-treatment
small	I-treatment
intestine	I-treatment
with	O
primary	B-treatment
anastomosis	I-treatment
,	O
Sigmoid	B-treatment
colectomy	I-treatment
,	O
repair	B-treatment
of	O
colovesicular	B-problem
fistula	I-problem

Unstable	B-problem
Angina	I-problem

Discharge	O
Condition	O
:	O

stable	O

Discharge	O
Instructions	O
:	O

Please	O
call	O
the	O
surgeon	O
or	O
return	O
to	O
the	O
Emergency	O
Department	O
if	O
you	O
develop	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
fever	B-problem
greater	I-problem
than	I-problem
101.5	I-problem
,	O
foul	B-problem
smelling	I-problem
or	I-problem
colorful	I-problem
drainage	I-problem
from	O
your	B-problem
incisions	I-problem
,	O
redness	B-problem
or	O
swelling	B-problem
,	O
severe	B-problem
abdominal	I-problem
pain	I-problem
or	O
distention	B-problem
,	O
persistent	B-problem
nausea	I-problem
or	O
vomiting	B-problem
,	O
inability	B-problem
to	I-problem
eat	I-problem
or	I-problem
drink	I-problem
,	O
or	O
any	O

other	B-problem
symptoms	I-problem
which	O
are	O
concerning	O
to	O
you	O
.	O

No	O
tub	O
baths	O
or	O
swimming	O
.	O

You	O
may	O
shower	O
.	O

If	O
there	O
is	O
clear	B-problem
drainage	I-problem
from	O
your	B-problem
incisions	I-problem
,	O
cover	O
with	O
a	B-treatment
dry	I-treatment
dressing	I-treatment
.	O

Leave	O
white	B-treatment
strips	I-treatment
above	O
your	B-problem
incisions	I-problem
in	O
place	O
,	O
allow	O
them	O
to	O
fall	O
off	O
on	O
their	O
own	O
.	O

Activity	O
:	O
No	O
heavy	O
lifting	O
of	O
items	O
12-08	O
pounds	O
until	O
the	O
follow	O
up	O
appointment	O
with	O
your	O
doctor	O
.	O

Medications	O
:	O
Resume	O
your	O
home	B-treatment
medications	I-treatment
.	O

You	O
should	O
take	O
a	B-treatment
stool	I-treatment
softener	I-treatment
,	O
Colace	B-treatment
100	O
mg	O
twice	O
daily	O
as	O
needed	O
for	O
constipation	B-problem
.	O

You	O
will	O
be	O
given	O
pain	B-treatment
medication	I-treatment
which	O
may	O
make	O
you	O
drowsy	B-problem
.	O

Followup	O
Instructions	O
:	O

Provider	O
:	O
Joe	O
Kari	O
,	O
MD	O
Phone	O
:(	O
625	O
)	O
747-8259	O

Date	O
/	O
Time	O
:	O
2014-04-11	O
1:15	O

Joe	O
Kari	O
MD	O
09-697	O

Completed	O
by	O
:	O
Carol	O
Robert	O
NP	O
80-CIY	O
2014-03-25	O
@	O
0837	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Marion	O
SCHNEIDER	O
on	O
:	O
Sandra	O
2014-03-25	O
12:56	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2012-06-07	O

Discharge	O
Date	O
:	O

2012-06-09	O

Date	O
of	O
Birth	O
:	O

1963-12-03	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	I-problem
Drugs	I-problem

Attending	O
:	O
Christopher	O
KJ	O
Cater	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Overdose	B-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

NG	B-treatment
tube	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

Mr.	O
Vazquez	O
is	O
a	O
48	O
year	O
old	O
man	O
with	O
a	O
history	O
of	O
hepatitis	B-problem
C	I-problem
,	O
bipolar	B-problem
disorder	I-problem
with	O
suicide	O
attempts	O
in	O
the	O
past	O
,	O
recent	O
CMED	O
admit	O
earlier	O
in	O
4/05	O
who	O
was	O
found	O
alert	O
approximately	O
one	O
hour	O
after	O
taking	O
an	O
unspecified	O
number	O
of	O
pills	B-treatment
.	O

Per	O
report	O
,	O
there	O
were	O
empty	O
bottles	O
of	O
Inderal	B-treatment
and	O
Klonopin	B-treatment
found	O
at	O
bedside	O
,	O
as	O
well	O
as	O
02-26	O
full	O
bottles	O
of	O
geodon	B-treatment
,	O
gabapentin	B-treatment
,	O
Lescol	B-treatment
and	O
paroxitine	B-treatment
.	O

The	O
patient	O
was	O
reportedly	O
alert	O
at	O
scene	O
,	O
and	O
then	O
became	O
unresponsive	B-problem
in	O
route	O
to	O
the	O
hospital	O
.	O

In	O
the	O
Rita	O
,	O
the	O
patient	O
was	O
intubated	O
and	O
given	O
activated	B-treatment
charcoal	I-treatment
.	O

His	B-test
initial	I-test
BP	I-test
was	O
60/P	O
with	O
a	B-test
pulse	I-test
in	O
the	O
60	O
s.	O

He	O
was	O
given	O
4	O
amps	O
of	O
calcium	B-treatment
gluconate	I-treatment
,	O
and	O
started	O
on	O
a	B-treatment
Calcium	I-treatment
gtt	I-treatment
.	O

He	O
was	O
also	O
given	O
5mg	O
of	O
glucagon	B-treatment
and	O
started	O
on	O
a	B-treatment
glucagon	I-treatment
drip	I-treatment
with	O
good	O
response	O
.	O

His	B-test
urine	I-test
and	O
serum	B-test
tox	I-test
screens	I-test
were	O
notable	O
only	O
for	O
benzos	B-treatment
,	O
otherwise	O
negative	O
.	O

He	O
was	O
seen	O
by	O
cardiology	O
,	O
and	O
toxicology	O
was	O
consulted	O
via	O
telephone	O
.	O

He	O
was	O
admitted	O
to	O
the	O
CMED	O
,	O
intubated	O
for	O
airway	B-treatment
protection	I-treatment
and	O
started	O
on	O
both	O
a	B-treatment
calcium	I-treatment
and	I-treatment
glucagon	I-treatment
drip	I-treatment
.	O

There	O
was	O
evidence	O
of	O
possible	O
aspiration	B-problem
pneumonia	I-problem
on	O
CXR	B-test
,	O
though	O
he	O
was	O
extubated	O
without	O
incident	O
on	O
the	O
AM	O
of	O
transfer	O
to	O
the	O
medicine	O
floor	O
.	O

CMED	O
was	O
made	O
aware	O
,	O
and	O
they	O
are	O
actively	O
involved	O
in	O
his	O
care	O
.	O

Past	O
Medical	O
History	O
:	O

Hep	B-problem
C	I-problem

Bipolar	B-problem
D/O	I-problem
with	O
one	O
suicide	O
attempt	O
by	O
overdose	B-problem
several	O
years	O
ago	O

Agoraphobia	B-problem

Panic	B-problem
disorder	I-problem

Narcissism	B-problem

No	O
history	O
of	O
head	B-problem
trauma	I-problem
or	O
seizure	B-problem
disorder	I-problem

Social	O
History	O
:	O

Denies	O
alcohol	O
use	O
.	O

Has	O
a	O
history	O
of	O
cocaine	O
abuse	O
-	O
in	O
remission	O
for	O
6	O
years	O
,	O
with	O
one	O
relapse	O
2.5	O
years	O
ago	O
.	O

Has	O
a	O
history	O
of	O
qualude	O
use	O
since	O
high	O
school	O
,	O
also	O
in	O
remission	O
.	O

Denies	O
use	O
of	O
AA/NA	O
.	O
Smokes	O
1ppd	O
.	O

Patient	O
lives	O
at	O
home	O
with	O
his	O
mother	O
,	O
father	O
and	O
brother	O
.	O

Reports	O
that	O
he	O
has	O
suffered	O
from	O
anxiety	B-problem
since	O
childhood	O
and	O
needed	O
to	O
drop	O
out	O
of	O
college	O
.	O

Unemployed	O
and	O
on	O
disability	O
.	O

Waiting	O
for	O
a	O
subsidized	O
apartment	O
.	O

No	O
current	O
relationship	O
.	O

Family	O
History	O
:	O

Denies	O
.	O

Physical	O
Exam	O
:	O

Vitals	B-test
:	O
99.3	O
67	O
(	O
60-70	O
)	O
99/53	O
(	O
90-100	O
s)	O
96%	O
on	O
RA	O
3.7L	O
+	O
LOS	O

Gen	O
:	O
caucasian	O
man	O
lying	O
in	O
bed	O
,	O
NAD	B-problem

HEENT	O
:	O
NCAT	O
,	O
PERRL	O
,	O
EOMI	O
,	O
no	O
icterus	B-problem
,	O
OP	O
clear	O
,	O
MMM	O
,	O
no	O
tongue	B-problem
fasciculations	I-problem

Neck	O
:	O
supple	O
,	O
no	O
LAD	B-problem
,	O
no	O
JVD	B-problem

CV	O
:	O
RRR	O
,	O
nl	O
s1	O
s2	O
,	O
no	O
m/g/r	B-problem

Lungs	O
:	O
?	O
decreased	B-problem
BS	I-problem
over	I-problem
left	I-problem
middle	I-problem
lung	I-problem
,	O
otherwise	O
CTA	O

Abd	O
:	O
normal	O
size	O
,	O
nd	B-problem
,	O
no	O
scars	B-problem
,	O
nl	O
bs	O
,	O
soft	O
,	O
nt	B-problem
,	O
palp	O
liver	O

Ext	O
:	O
no	O
c/c/e	B-problem
,	O
no	O
edema	B-problem

Neuro	O
:	O
no	O
asterixis	B-problem
,	O
CN	O
II-XII	O
intact	O
,	O
5/5	O
strength	O
throughout	O
,	O
sensation	O
to	O
LT	B-test
intact	O
throughout	O
,	O
gait	O
deferred	O

CMED	O
:	O
A+Ox3	O
,	O
mood	O
"	O
great	O
,"	O
affect	O
approp	O
,	O
speech	B-problem
stuttering	I-problem
,	O
linear	O
TP	O
,	O
no	O
SI	B-problem
or	O
HI	B-problem

Pertinent	O
Results	O
:	O

Labs	O
on	O
admit	O
:	O

2012-06-07	O
09:55	O
PM	O
BLOOD	B-test
WBC	B-test
-	O
8.9	O
RBC	B-test
-	O
4.94	O
Hgb	B-test
-	O
15.8	O
Hct	B-test
-	O
45.3	O
MCV	B-test
-	O
92	O
MCH	B-test
-	O
31.9	O
MCHC	B-test
-	O
34.8	O
RDW	B-test
-	O
12.4	O
Plt	B-test
Ct	I-test
-	O
175	O

2012-06-07	O
09:55	O
PM	O
BLOOD	B-test
Neuts	B-test
-	O
49.9	O
*	O
Lymphs	B-test
-	O
42.4	O
*	O
Monos	B-test
-	O
5.5	O
Eos	B-test
-	O
1.6	O
Baso	B-test
-	O
0.6	O

2012-06-07	O
09:55	O
PM	O
BLOOD	B-test
Plt	B-test
Ct	I-test
-	O
175	O

2012-06-07	O
09:55	O
PM	O
BLOOD	B-test
PT	B-test
-	O
12.8	O
PTT	B-test
-	O
25.7	O
INR(PT)	B-test
-	O
1.0	O

2012-06-07	O
09:55	O
PM	O
BLOOD	B-test
Glucose	B-test
-	O
108	O
*	O
UreaN	B-test
-	O
13	O
Creat	B-test
-	O
0.7	O
Na	B-test
-	O
146	O
*	O
K	B-test
-	O
3.7	O
Cl	B-test
-	O
109	O
*	O
HCO3	B-test
-	O
30	O
*	O
AnGap	B-test
-	O
11	O

2012-06-07	O
09:55	O
PM	O
BLOOD	B-test
Albumin	B-test
-	O
3.9	O
Calcium	B-test
-	O
8.5	O
Phos	B-test
-	O
4.2	O
Mg	B-test
-	O
2.0	O

2012-06-07	O
09:55	O
PM	O
BLOOD	B-test
ALT	B-test
-	O
44	O
*	O
AST	B-test
-	O
31	O
AlkPhos	B-test
-	O
36	O
*	O
TotBili	B-test
-	O
0.2	O

2012-06-07	O
09:55	O
PM	O
BLOOD	B-test
ASA	B-test
-	O
NEG	O
Ethanol	B-test
-	O
NEG	O
Acetmnp	B-test
-	O
NEG	O
Bnzodzp	B-test
-	O
NEG	O
Barbitr	B-test
-	O
NEG	O
Tricycl	B-test
-	O
NEG	O

Labs	O
today	O
:	O

2012-06-08	O
09:30	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
10.1	O
RBC	B-test
-	O
4.35	O
*	O
Hgb	B-test
-	O
14.2	O
Hct	B-test
-	O
39.9	O
*	O
MCV	B-test
-	O
92	O
MCH	B-test
-	O
32.6	O
*	O
MCHC	B-test
-	O
35.6	O
*	O
RDW	B-test
-	O
12.4	O
Plt	B-test
Ct	I-test
-	O
151	O

2012-06-08	O
09:30	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
115	O
*	O
UreaN	B-test
-	O
14	O
Creat	B-test
-	O
0.8	O
Na	B-test
-	O
142	O
K	B-test
-	O
4.1	O
Cl	B-test
-	O
112	O
*	O
HCO3	B-test
-	O
26	O
AnGap	B-test
-	O
8	O

2012-06-08	O
09:30	O
AM	O
BLOOD	B-test
Calcium	B-test
-	O
10.4	O
*	O
Phos	B-test
-	O
2.8	O
Mg	B-test
-	O
1.8	O

2012-06-08	O

CXR	B-test
:	O

An	B-treatment
endotracheal	I-treatment
tube	I-treatment
terminates	O
just	O
above	O
the	O
thoracic	O
inlet	O
approximately	O
6.5	O
cm	O
above	O
the	O
carina	O
.	O

The	B-treatment
nasogastric	I-treatment
tube	I-treatment
terminates	O
within	O
the	O
stomach	O
.	O

Cardiac	O
and	O
mediastinal	O
contours	O
are	O
within	O
normal	O
limits	O
.	O

There	O
is	O
a	B-problem
patchy	I-problem
area	I-problem
of	I-problem
increased	I-problem
opacity	I-problem
in	O
the	O
left	O
retrocardiac	O
region	O
,	O
which	O
was	O
not	O
seen	O
on	O
the	B-test
earlier	I-test
study	I-test
.	O

Right	O
lung	O
is	O
clear	O
.	O

Left	O
costophrenic	O
angle	O
has	O
been	O
excluded	O
from	O
the	B-test
study	I-test
and	O
cannot	O
be	O
assessed	O
.	O

There	O
is	O
no	O
evidence	O
of	O
right	B-problem
pleural	I-problem
effusion	I-problem
or	O
right	B-problem
pneumothorax	I-problem
.	O

IMPRESSION	O
:	O

1)	O
Endotracheal	B-treatment
tube	I-treatment
is	O
slightly	O
proximal	O
in	O
location	O
,	O
and	O
could	O
be	O
advanced	O
approximately	O
1.5	O
cm	O
for	O
more	O
optimal	O
placement	O
.	O

2)	O
Patchy	B-problem
left	I-problem
retrocardiac	I-problem
opacity	I-problem
which	O
may	O
be	O
due	O
to	O
patchy	B-problem
atelectasis	I-problem
,	O
aspiration	B-problem
,	O
or	O
early	B-problem
pneumonia	I-problem
.	O

Followup	B-test
radiograph	I-test
suggested	O

Brief	O
Hospital	O
Course	O
:	O

A/P	O
:	O
48yo	O
man	O
with	O
h/o	O
HCV	B-problem
,	O
bipolar	B-problem
DO	I-problem
,	O
h/o	O
suicide	O
attempts	O
,	O
a/w	O
overdose	B-problem
of	O
Inderal	B-treatment
,	O
Klonopin	B-treatment
,	O
Geodon	B-treatment
,	O
s/T	O
Jackson	O
stay	O
with	O
intubation	B-treatment
for	O
airway	B-treatment
protection	I-treatment
,	O
with	O
question	O
of	O
L	B-problem
retrocardiac	I-problem
infiltrate	I-problem
,	O
now	O
doing	O
well	O
.	O

Overdose	O
:	O

-	O
monitor	O
on	O
tele	B-test
overnight	O

-	O
if	O
HR	B-test
drops	O
,	O
restart	O
glucagon	B-treatment
gtt	I-treatment

-	O
watch	O
for	O
BZD	B-problem
withdrawal	I-problem
,	O
agitation	B-problem

Bipolar	B-problem
disorder	I-problem
:	O

-	O
appreciate	O
CMED	O
consult	O
;	O
patient	O
to	O
be	O
discharged	O
to	O
inpatient	O
CMED	O
facility	O
once	O
stable	O

-	O
suicide	B-treatment
precautions	I-treatment

Activity	O
:	O
OOB	O
with	O
assist	O

FEN	O
:	O
house	O
diet	O

PPX	O
:	O
SC	B-treatment
heparin	I-treatment
,	O
bowel	B-treatment
regimen	I-treatment
,	O
nicotine	B-treatment
patch	I-treatment

CODE	O
:	O
full	O

DISPO	O
:	O
transfer	O
to	O
inpatient	O
CMED	O
likely	O
tomorrow	O

Medications	O
on	O
Admission	O
:	O

Neurontin	B-treatment
800	O
mg	O
tid	O

Ziprasidone	B-treatment
bid	O

Propanolol	B-treatment
20	O
mg	O
tid	O

Klonopin	B-treatment
2	O
mg	O
tid	O

Paxil	B-treatment
30	O
mg	O
qd	O

Protonix	B-treatment
40	O
mg	O
qd	O

Folate	B-treatment
1	O
mg	O
qd	O

Lescol	B-treatment
40	O
qd	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

Depression	B-problem

Discharge	O
Condition	O
:	O

Depressed	B-problem

Discharge	O
Instructions	O
:	O

Going	O
to	O
UMass	O
Memorial	O
Medical	O
Center	O
4	O
.	O

Followup	O
Instructions	O
:	O

Please	O
f	O
/	O
u	O
with	O
PCP	O
D	O
2	O
weeks	O
.	O

Joseph	O
Judy	O
MD	O
35-943	O

Completed	O
by	O
:	O
John	O
Konderla	O
MD	O
01-196	O
2012-06-09	O
@	O
1707	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Felix	O
Garcia	O
on	O
:	O
FRI	O
2012-06-15	O
4:29	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2013-02-12	O

Discharge	O
Date	O
:	O

2013-02-16	O

Date	O
of	O
Birth	O
:	O

1937-03-25	O

Sex	O
:	O

F	O

Service	O
:	O

CARDIOTHORACIC	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
was	O
referred	O
from	O
an	O
outside	O
hospital	O
with	O
a	O
chief	O
complaint	O
of	O
increasing	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
and	O
tires	B-problem
easily	I-problem
with	O
exertion	O
.	O

Admitted	O
to	O
Bay	O
State	O
Medical	O
Center	O
Hospital	O
in	O
2012-10-22	O
in	O
congestive	B-problem
heart	I-problem
failure	I-problem
at	O
that	O
time	O
.	O

Via	O
echocardiogram	B-test
,	O
found	O
to	O
have	O
aortic	B-problem
stenosis	I-problem
.	O

Referred	O
to	O
Memorial	O
Hospital	O
(	O
Worcester	O
)	O
for	O
cardiac	B-test
catheterization	I-test
to	O
further	O
evaluate	O
her	B-problem
aortic	I-problem
stenosis	I-problem
.	O

Cardiac	B-test
catheterization	I-test
done	O
on	O
01-07	O
showed	O
an	B-test
aortic	I-test
valve	I-test
area	I-test
of	O
.38	O
cm.sq.	O
,	O
with	O
a	B-test
mean	I-test
gradient	I-test
of	O
62	O
,	O
and	O
a	B-test
peak	I-test
gradient	I-test
of	O
85	O
.	O

Moderate	B-problem
pulmonary	I-problem
hypertension	I-problem
,	O
PA	B-test
pressure	I-test
48/24	O
,	O
1+	B-problem
mitral	I-problem
regurgitation	I-problem
,	O
severe	B-problem
aortic	I-problem
stenosis	I-problem
with	O
an	B-test
LVEDP	I-test
of	O
19	O
and	O
an	B-test
ejection	I-test
fraction	I-test
of	O
43%	O
.	O

She	O
was	O
then	O
referred	O
to	O
Cardiothoracic	O
Surgery	O
for	O
aortic	B-treatment
valve	I-treatment
replacement	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Aortic	B-problem
stenosis	I-problem

2.	O
Diabetes	B-problem
mellitus	I-problem
Type	I-problem
2	I-problem

3.	O
Right	B-treatment
hip	I-treatment
replacement	I-treatment

4.	O
Noninsulin	B-problem
dependent	I-problem
diabetes	I-problem
mellitus	I-problem

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Include	O
Glucovance	B-treatment
5/500	O
one	O
tablet	O
twice	O
a	O
day	O
,	O
Univasc	B-treatment
7.5	O
mg	O
once	O
daily	O
,	O
lasix	B-treatment
20	O
mg	O
every	O
other	O
day	O
,	O
and	O
aspirin	B-treatment
325	O
mg	O
once	O
daily	O
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

FAMILY	O
HISTORY	O
:	O

Significant	O
for	O
her	O
father	O
,	O
who	O
died	O
at	O
50	O
years	O
from	O
myocarditis	B-problem
.	O

SOCIAL	O
HISTORY	O
:	O

She	O
lives	O
alone	O
in	O
Methuen	O
with	O
five	O
stairs	O
.	O

She	O
has	O
a	O
remote	O
tobacco	O
history	O
,	O
quit	O
in	O
October	O
,	O
one	O
pack	O
per	O
day	O
for	O
50	O
years	O
.	O

No	O
alcohol	O
use	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Vital	O
signs	O
:	O

Heart	B-test
rate	I-test
108	O
and	O
regular	O
,	O
blood	B-test
pressure	I-test
145/76	O
,	O
respiratory	B-test
rate	I-test
20	O
,	O
height	B-test
5'2"	O
,	O
weight	B-test
141	O
pounds	O
.	O

General	O
:	O

Healthy-appearing	O
woman	O
,	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Skin	O
:	O

No	O
lesions	B-problem
or	O
rashes	B-problem
.	O

Head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
and	O
throat	O
:	O

Pupils	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
,	O
extraocular	O
movements	O
intact	O
,	O
anicteric	B-problem
,	O
not	O
injected	B-problem
.	O

Oropharynx	O
:	O

Mucous	O
membranes	O
moist	O
.	O

Neck	O
:	O

Supple	O
,	O
no	O
lymphadenopathy	B-problem
,	O
no	O
jugular	B-problem
venous	I-problem
distention	I-problem
,	O
no	O
thyromegaly	B-problem
.	O

Chest	O
:	O

Clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Heart	O
:	O

Regular	O
rate	O
and	O
rhythm	O
,	O
S1	O
,	O
S2	O
,	O
with	O
III/VI	B-problem
blowing	I-problem
murmur	I-problem
.	O

Abdomen	O
:	O

Soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
,	O
normal	O
active	O
bowel	O
sounds	O
,	O
no	O
hepatosplenomegaly	B-problem
.	O

Extremities	O
:	O

Warm	O
and	O
well	O
perfused	O
,	O
with	O
no	O
cyanosis	B-problem
,	O
clubbing	B-problem
or	O
edema	B-problem
,	O
no	O
varicosities	B-problem
.	O

Neurological	O
:	O

Cranial	O
nerves	O
II	O
through	O
XII	O
grossly	O
intact	O
.	O

Moves	O
all	O
extremities	O
.	O

Strength	B-test
5/5	O
in	O
upper	O
and	O
lower	O
extremities	O
.	O

Sensation	O
intact	O
in	O
all	O
dermatomes	O
.	O

Pulses	B-test
:	O

Femoral	B-test
2	O
+	O
bilaterally	O
,	O
dorsalis	B-test
pedis	I-test
1	O
+	O
bilaterally	O
,	O
posterior	B-test
tibial	I-test
1	O
+	O
bilaterally	O
,	O
and	O
radial	B-test
2	O
+	O
bilaterally	O
.	O

No	O
carotid	B-problem
bruits	I-problem
were	O
noted	O
.	O

LABORATORY	O
DATA	O
:	O

White	B-test
count	I-test
5.3	O
,	O
hematocrit	B-test
43	O
,	O
platelets	B-test
200	O
.	O

Sodium	B-test
138	O
,	O
potassium	B-test
4.9	O
,	O
chloride	B-test
102	O
,	O
CO2	B-test
25	O
,	O
BUN	B-test
24	O
,	O
creatinine	B-test
0.9	O
,	O
glucose	B-test
309	O
.	O

Electrocardiogram	B-test
:	O

Rate	B-test
of	O
91	O
,	O
first	B-problem
degree	I-problem
AV	I-problem
block	I-problem
,	O
intervals	B-test
.22	O
,	O
.92	O
,	O
.36	O
,	O
with	O
left	B-problem
ventricular	I-problem
hypertrophy	I-problem
.	O

Chest	B-test
x-ray	I-test
is	O
pending	O
at	O
the	O
time	O
of	O
physical	B-test
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
a	O
direct	O
admission	O
to	O
the	O
operating	O
room	O
on	O
02-12	O
,	O
at	O
which	O
time	O
she	O
underwent	O
an	O

aortic	B-treatment
valve	I-treatment
replacement	I-treatment
.	O

Please	O
see	O
the	O
operative	O
report	O
for	O
full	O
details	O
.	O

In	O
summary	O
,	O
she	O
had	O
an	B-treatment
aortic	I-treatment
valve	I-treatment
replacement	I-treatment
with	O
a	B-treatment
#21	I-treatment
mosaic	I-treatment
porcine	I-treatment
valve	I-treatment
.	O

She	O
tolerated	O
the	B-treatment
operation	I-treatment
well	O
,	O
and	O
was	O
transferred	O
from	O
the	O
operating	O
room	O
to	O
the	O
Cardiothoracic	O
Intensive	O
Care	O
Unit	O
.	O

The	O
patient	O
did	O
well	O
in	O
the	O
immediate	O
postoperative	O
period	O
,	O
however	O
,	O
her	B-test
blood	I-test
pressure	I-test
remained	O
somewhat	B-problem
labile	I-problem
.	O

Therefore	O
,	O
she	O
was	O
continued	O
on	O
a	B-treatment
Neo-Synephrine	I-treatment
drip	I-treatment
to	O
maintain	O
a	B-test
systolic	I-test
blood	I-test
pressure	I-test
greater	O
than	O
110	O
.	O

In	O
addition	O
,	O
she	O
was	O
slow	O
to	O
awaken	O
after	O
her	B-treatment
anesthesia	I-treatment
was	O
reversed	O
,	O
and	O
in	O
several	O
attempts	O
to	O
wean	O
from	O
the	B-treatment
ventilator	I-treatment
,	O
she	O
developed	O
a	B-problem
respiratory	I-problem
acidosis	I-problem
.	O

She	O
therefore	O
remained	O
on	O
the	B-treatment
ventilator	I-treatment
throughout	O
the	O
day	O
of	O
postoperative	O
day	O
one	O
.	O

On	O
postoperative	O
day	O
two	O
,	O
the	O
patient	O
remained	O
hemodynamically	O
stable	O
.	O

Her	B-treatment
Neo-Synephrine	I-treatment
drip	I-treatment
was	O
weaned	O
to	O
off	O
.	O

She	O
was	O
again	O
weaned	O
from	O
the	B-treatment
ventilator	I-treatment
,	O
and	O
successfully	O
extubated	O
.	O

Her	B-treatment
chest	I-treatment
tubes	I-treatment
were	O
discontinued	O
and	O
,	O
at	O
the	O
end	O
of	O
the	O
day	O
,	O
she	O
was	O
transferred	O
from	O
the	O
Cardiothoracic	O
Intensive	O
Care	O
Unit	O
to	O
the	O
floor	O
for	O
continuing	B-treatment
postoperative	I-treatment
care	I-treatment
and	O
cardiac	B-treatment
rehabilitation	I-treatment
.	O

After	O
being	O
transferred	O
to	O
the	O
floor	O
,	O
the	O
patient	O
did	O
well	O
.	O

Over	O
the	O
next	O
several	O
days	O
,	O
her	O
activity	O
level	O
was	O
increased	O
with	O
the	O
assistance	O
of	O
Physical	O
Therapy	O
and	O
the	O
nursing	O
staff	O
.	O

She	O
remained	O
hemodynamically	O
stable	O
.	O

Her	O
respiratory	O
condition	O
remained	O
stable	O
and	O
,	O
on	O
postoperative	O
day	O
four	O
,	O
she	O
was	O
deemed	O
stable	O
and	O
ready	O
to	O
be	O
transferred	O
to	O
rehabilitation	O
for	O
continuing	B-treatment
postoperative	I-treatment
care	I-treatment
and	O
physical	O

therapy	B-treatment
.	O

At	O
the	O
time	O
of	O
transfer	O
,	O
the	B-test
patient	I-test
's	I-test
physical	I-test
examination	I-test
is	O
as	O
follows	O
:	O

Vital	O
signs	O
:	O

Temperature	B-test
98.4	O
,	O
heart	B-test
rate	I-test
78	O
and	O
sinus	B-test
rhythm	I-test
,	O
blood	B-test
pressure	I-test
106/50	O
,	O
respiratory	B-test
rate	I-test
18	O
,	O
oxygen	B-test
saturation	I-test
97%	O
on	O
room	O
air	O
.	O

Weight	B-test
preoperatively	O
was	O
67	O
kg	O
,	O
at	O
discharge	O
is	O
70.9	O
kg	O
.	O

Laboratory	B-test
data	I-test
on	O
02-15	O
:	O

White	B-test
count	I-test
4.1	O
,	O
hematocrit	B-test
23	O
,	O
platelets	B-test
144	O
.	O

Sodium	B-test
141	O
,	O
potassium	B-test
4.3	O
,	O
chloride	B-test
108	O
,	O
CO2	B-test
25	O
,	O
BUN	B-test
24	O
,	O
creatinine	B-test
0.8	O
,	O
glucose	B-test
140	O
.	O

Physical	O
examination	O
:	O

Alert	O
and	O
oriented	O
x	O
3	O
,	O
moves	O
all	O
extremities	O
,	O
conversant	O
.	O

Respiratory	O
:	O

Scattered	B-problem
rhonchi	I-problem
with	O
diminished	B-problem
breath	I-problem
sounds	I-problem
in	I-problem
the	I-problem
bases	I-problem
.	O

Cor	O
:	O

Regular	O
rate	O
and	O
rhythm	O
,	O
S1	O
,	O
S2	O
,	O
with	O
soft	B-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
.	O

Sternum	O
is	O
stable	O
.	O

Incision	B-problem
with	O
staples	B-treatment
,	O
open	O
to	O
air	O
,	O
clean	O
and	O
dry	O
.	O

Abdomen	O
:	O

Soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
,	O
normal	O
active	O
bowel	O
sounds	O
.	O

Extremities	O
:	O

Warm	O
and	O
well	O
perfused	O
,	O
with	O
no	O
cyanosis	B-problem
,	O
clubbing	B-problem
or	O
edema	B-problem
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Ranitidine	B-treatment
150	O
mg	O
twice	O
a	O
day	O
,	O
enteric-coated	B-treatment
aspirin	I-treatment
325	O
mg	O
once	O
daily	O
,	O
Glucovance	B-treatment
5/500	O
one	O
tablet	O
twice	O
a	O
day	O
,	O
metoprolol	B-treatment
25	O
mg	O
twice	O
a	O
day	O
,	O
Furosemide	B-treatment
20	O
mg	O
once	O
daily	O
for	O
14	O
days	O
,	O
potassium	B-treatment
chloride	I-treatment
20	O
mEq	O
once	O
daily	O
for	O
14	O
days	O
,	O
Colace	B-treatment
100	O
mg	O
twice	O
a	O
day	O
,	O
Niferex	B-treatment
150	O
mg	O
once	O
daily	O
,	O
Percocet	B-treatment
5/325	O
one	O
to	O
two	O
tablets	O
every	O
four	O
hours	O
as	O
needed	O
,	O
ibuprofen	B-treatment
400	O
mg	O
every	O
six	O
hours	O
as	O
needed	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
Aortic	B-problem
stenosis	I-problem
status	O
post	O
aortic	B-treatment
valve	I-treatment
replacement	I-treatment
with	O
a	B-treatment
#21	I-treatment
mosaic	I-treatment
porcine	I-treatment
valve	I-treatment

2.	O
Diabetes	B-problem
mellitus	I-problem
Type	I-problem
2	I-problem

3.	O
Right	B-treatment
hip	I-treatment
replacement	I-treatment

CONDITION	O
ON	O
TRANSFER	O
:	O

Stable	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

She	O
is	O
to	O
have	O
follow	O
up	O
with	O
Dr.	O
Bloomfield	O
in	O
one	O
month	O
,	O
and	O
follow	O
up	O
in	O
the	O
Wound	O
Clinic	O
in	O
two	O

weeks	O
.	O

Alice	O
S.	O
Shadle	O
,	O
M.D.	O

37-538	O

Dictated	O
By	O
:	O
James	O
F.	O
Buchanan	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2013-02-15	O
18:35	O

T	O
:	O
2013-02-16	O
01:03	O

JOB	O
#:	O

59205	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Richard	O
Gray	O
on	O
:	O
Tommy	O
2013-02-17	O
12:05	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2015-09-16	O

Discharge	O
Date	O
:	O

2015-09-21	O

Date	O
of	O
Birth	O
:	O

1962-09-26	O

Sex	O
:	O

M	O

Service	O
:	O

CARDIOTHOR	O

REASON	O
FOR	O
ADMISSION	O
:	O

Mitral	B-treatment
valve	I-treatment
repair	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
52	O
year	O
old	O
Czech	O
speaking	O
gentleman	O
with	O
a	O
history	O
of	O
severe	B-problem
mitral	I-problem
regurgitation	I-problem
.	O

For	O
the	O
past	O
several	O
years	O
,	O
the	O
patient	O
has	O
continued	O
to	O
have	O
significant	B-problem
exercise	I-problem
intolerance	I-problem
which	O
has	O
limited	O
his	O
ability	O
to	O
work	O
.	O

He	O
reports	O
severe	B-problem
dyspnea	I-problem
on	O
exertion	O
.	O

The	O
patient	O
had	O
a	O
recent	O
admission	O
earlier	O
in	O
the	O
month	O
and	O
he	O
was	O
discharged	O
on	O
2015-09-10	O
,	O
after	O
undergoing	O
cardiac	B-test
catheterization	I-test
.	O

This	O
was	O
significant	O
for	O
demonstrating	O
no	O
flow-limited	B-problem
disease	I-problem
in	I-problem
the	I-problem
coronaries	I-problem
but	O
several	B-problem
fistulae	I-problem

from	O
the	O
left	O
anterior	O
descending	O
to	O
the	O
PA	O
.	O

Several	O
of	O
these	O
were	O
coil	B-treatment
embolized	I-treatment
during	O
this	O
admission	O
.	O

He	O
tolerated	O
this	O
well	O
,	O
was	O
sent	O
home	O
,	O
and	O
now	O
returns	O
for	O
his	B-treatment
mitral	I-treatment
valve	I-treatment
repair	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Mitral	B-problem
valve	I-problem
regurgitation	I-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

None	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Atenolol	B-treatment
25	O
mg	O
p.o.	O
q.	O
day	O
.	O

2.	O
Enteric-coated	B-treatment
aspirin	I-treatment
325	O
mg	O
p.o.	O
q.	O
day	O
.	O

3.	O
Nitroglycerin	B-treatment
sublingual	I-treatment
p.r.n.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
currently	O
on	O
Disability	O
and	O
lives	O
at	O
home	O
with	O
his	O
wife	O
.	O

Kimberly	O
was	O
born	O
in	O
Great	O
Britain	O
.	O

He	O
denies	O
any	O
ETOH	O
or	O
tobacco	O
use	O
.	O

FAMILY	O
HISTORY	O
:	O

Negative	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
is	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Temperature	B-test
is	O
98.3	O
F.	O
;	O
pulse	B-test
is	O
76	O
;	O
blood	B-test
pressure	I-test
113/52	O
;	O
breathing	B-test
18	O
;	O
98%	O
on	O
room	O
air	O
.	O

HEENT	O
:	O

The	O
patient	O
is	O
missing	B-problem
many	I-problem
teeth	I-problem
.	O

Oropharynx	O
is	O
clear	O
.	O

There	O
is	O
no	O
cervical	B-problem
lymphadenopathy	I-problem
.	O

Supple	O
neck	O
.	O

Heart	O
is	O
regular	O
rate	O
and	O
rhythm	O
with	O
a	B-problem
III/VI	I-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
.	O

His	O
lungs	O
are	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Abdomen	O
is	O
soft	O
and	O
nontender	B-problem
.	O

The	O
patient	O
has	O
no	O
cyanosis	B-problem
,	O
clubbing	B-problem
or	O
edema	B-problem
in	I-problem
extremities	I-problem
.	O

LABORATORY	O
:	O

On	O
admission	O
include	O
a	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
of	O
5.6	O
,	O
hematocrit	B-test
of	O
32.5	O
,	O
platelets	B-test
of	O
202	O
.	O

Sodium	B-test
of	O
140	O
,	O
potassium	B-test
of	O
3.5	O
,	O
BUN	B-test
of	O
4	O
,	O
creatinine	B-test
of	O
0.6	O
,	O
glucose	B-test
of	O
137	O
.	O

Chest	B-test
x-ray	I-test
shows	O
no	O
infiltrate	B-problem
or	O
pneumothorax	B-problem
.	O

Cardiac	B-test
catheterization	I-test
demonstrates	O
no	O
significant	B-problem
disease	I-problem
in	I-problem
the	I-problem
coronary	I-problem
arteries	I-problem
.	O

Two	O
branches	O
of	O
an	B-problem
left	I-problem
anterior	I-problem
descending	I-problem
to	I-problem
PA	I-problem
fistula	I-problem
which	O
was	O
successfully	O
coiled	O
.	O

There	O
is	O
a	B-problem
persistent	I-problem
flow	I-problem
through	O
an	O
inferior	O
branch	O
of	O
the	O
left	O
anterior	O
descending	O
to	O
PA	B-problem
fistula	I-problem
and	O
a	O
persistent	O
branch	O
of	O
the	B-problem
circumflex	I-problem
to	I-problem
PA	I-problem
branch	I-problem
fistula	I-problem
which	O
anatomically	O
were	O
not	O
suitable	O
for	O
coil	B-treatment
embolization	I-treatment
.	O

Ejection	B-test
fraction	I-test
was	O
60%	O
.	O

HOSPITAL	O
COURSE	O
:	O

On	O
the	O
day	O
of	O
admission	O
,	O
the	O
patient	O
went	O
to	O
the	O
Operating	O
Room	O
and	O
underwent	O
a	O
minimally	O
invasive	O

mitral	B-treatment
valve	I-treatment
repair	I-treatment
.	O

He	O
tolerated	O
this	B-treatment
procedure	I-treatment
well	O
.	O

The	O
patient	O
was	O
brought	O
to	O
the	O
cardiothoracic	O
Intensive	O
Care	O
Unit	O
in	O
stable	O
condition	O
on	O
minimal	B-treatment
pressor	I-treatment
support	I-treatment
.	O

He	O
was	O
successfully	O
weaned	O
off	O
this	B-treatment
support	I-treatment
.	O

The	O
patient	O
was	O
fully	O
weaned	O
from	O
ventilatory	B-treatment
support	I-treatment
secondary	O
to	O
a	B-problem
persistent	I-problem
acidemia	I-problem
.	O

This	O
was	O
treated	O
with	O
sodium	B-treatment
bicarbonate	I-treatment
and	O
a	B-treatment
Swan-Ganz	I-treatment
was	O
placed	O
to	O
provide	O
close	B-test
hemodynamic	I-test
monitoring	I-test
.	O

The	O
patient	O
was	O
found	O
to	O
have	O
stable	O
hemodynamics	O
with	O
appropriate	O
mixed	O
venous	B-test
saturations	I-test
in	O
the	O
70%	O
range	O
.	O

The	O
patient	O
was	O
corrected	O
to	O
a	O
normal	O
pH	O
of	O
7.41	O
by	O
the	O
first	O
postoperative	O
night	O
and	O
remained	O
stable	O
.	O

He	O
was	O
then	O
weaned	O
off	O
of	O
ventilatory	B-treatment
support	I-treatment
and	O
was	O
successfully	O
extubated	O
.	O

The	O
patient	O
did	O
have	O
a	B-problem
slight	I-problem
bit	I-problem
of	I-problem
confusion	I-problem
early	O
in	O
post-extubation	O
course	O
which	O
cleared	O
.	O

This	O
was	O
also	O
compounded	O
by	O
a	O
language	O
barrier	O
since	O
the	O
patient	O
cannot	O
speak	O
English	O
.	O

In	O
addition	O
,	O
the	O
patient	O
's	O
early	O
postoperative	O
course	O
had	O
a	O
tremendous	O
urine	B-test
output	I-test
.	O

It	O
was	O
equally	O
up	O
to	O
700	O
cc.	O
an	O
hour	O
and	O
a	B-test
renal	I-test
consultation	I-test
was	O
obtained	O
.	O

He	O
underwent	O
a	B-test
head	I-test
CT	I-test
scan	I-test
to	O
rule	O
out	O
intracranial	B-problem
pathology	I-problem
leading	O
to	O
diabetes	B-problem
insipidus	I-problem
.	O

This	O
was	O
negative	O
.	O

The	B-test
patient	I-test
's	I-test
serum	I-test
and	O
urine	B-test
electrolytes	I-test
indicated	O
that	O
this	B-treatment
diuresis	I-treatment
was	O
appropriate	O
.	O

The	B-test
patient	I-test
's	I-test
urine	I-test
output	I-test
has	O
decreased	O
and	O
his	B-test
BUN	I-test
and	O
creatinine	B-test
remained	O
normal	O
.	O

The	B-treatment
patient	I-treatment
's	I-treatment
Foley	I-treatment
was	O
discontinued	O
.	O

He	O
had	O
developed	O
some	B-problem
hematuria	I-problem
which	O
has	O
resolved	O
.	O

The	O
patient	O
has	O
remained	O
stable	O
and	O
is	O
now	O
ready	O
for	O
discharge	O
to	O
home	O
with	O
follow-up	O
in	O
approximately	O
four	O
weeks	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Mitral	B-problem
regurgitation	I-problem
status	O
post	O
minimally	B-treatment
invasive	I-treatment
mitral	I-treatment
valve	I-treatment
repair	I-treatment
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Lopressor	B-treatment
75	O
mg	O
p.o.	O
twice	O
a	O
day	O
.	O

2.	O
Colace	B-treatment
100	O
mg	O
p.o.	O
twice	O
a	O
day	O
.	O

3.	O
Percocet	B-treatment
one	O
to	O
two	O
p.o.	O
q.	O
four	O
hours	O
p.r.n.	O

4.	O
Aspirin	B-treatment
325	O
mg	O
p.o.	O
q.	O
day	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DIGibsonE	O
INSTRUCTIONS	O
:	O

1.	O
The	O
patient	O
will	O
follow-up	O
with	O
Dr.	O
de	O
las	O
Grau	O
in	O
four	O
weeks	O
.	O

2.	O
He	O
will	O
follow-up	O
with	O
his	O
primary	O
care	O
physician	O
,	O
Dr.	O
Blake	O
,	O
in	O
two	O
weeks	O
.	O

3.	O
The	O
patient	O
will	O
call	O
for	O
any	B-problem
fevers	I-problem
or	O
difficulties	B-problem
with	I-problem
the	I-problem
wound	I-problem
care	I-problem
,	O
and	O
will	O
be	O
instructed	O
with	O
an	O
interpreter	O
present	O
.	O

Bruce	O
lou	O
Murphy	O
,	O
M.D.	O

07-760	O

Dictated	O
By	O
:	O
Ellen	O
V	O
Wise	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2015-09-21	O
08:34	O

T	O
:	O
2015-09-26	O
15:44	O

JO	O
B#:	O

18430	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Mary	O
van	O
den	O
Mosley	O
on	O
:	O
WED	O
2015-10-14	O
7:16	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2013-10-29	O

Discharge	O
Date	O
:	O

2013-11-04	O

Date	O
of	O
Birth	O
:	O

1943-01-06	O

Sex	O
:	O

M	O

Service	O
:	O

CARDIOTHORACIC	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	I-problem
Drugs	I-problem

Attending	O
:	O
Angie	O
CM	O
Johnson	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Coronary	B-problem
artery	I-problem
disease	I-problem
requiring	O
surgical	B-treatment
intervention	I-treatment

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

CABG	B-treatment
x	O
5	O

History	O
of	O
Present	O
Illness	O
:	O

Mr.	O
Andersen	O
is	O
a	O
71-year-old	O
male	O
with	O
worsening	B-problem
anginal	I-problem
symptoms	I-problem
who	O
underwent	O
catheterization	B-test
that	O
showed	O
severe	B-problem
three-vessel	I-problem
disease	I-problem
.	O

He	O
is	O
presenting	O
for	O
revascularization	B-treatment
.	O

Past	O
Medical	O
History	O
:	O

DM2	B-problem
-	O
dx	O
'd	O
at	O
the	O
age	O
of	O
48	O

Arthritis	B-problem

HTN	B-problem

Tonsillectomy	B-treatment
around	O
the	O
age	O
of	O
10	O

Social	O
History	O
:	O

Quit	O
smoking	O
23	O
years	O
ago	O
,	O
occasional	O
ETOH	O
,	O
denies	O
illicit	O
drug	O
use	O
.	O

Lives	O
with	O
wife	O
,	O
retired	O
12	O
years	O
ago	O
after	O
working	O
as	O
electrician	O
for	O
Attleboro	O
Donald	O

Family	O
History	O
:	O

Father	O
died	O
of	O
colon	B-problem
cancer	I-problem
.	O

Mother	O
with	O
pacemaker	B-treatment
,	O
alive	O
at	O
91	O
years	O
old	O
.	O

Physical	O
Exam	O
:	O

Awake	O
and	O
alert	O
,	O
NAD	B-problem

HEENT	O
:	O
PERRLA	O
,	O
no	O
carotid	B-problem
bruits	I-problem

CV	O
:	O
RRR	O
,	O
no	O
M/R/G	B-problem

Lungs	O
:	O
CTA	O
b/l	O

Abd	O
:	O
Soft	O
,	O
NT/ND	B-problem
,	O
NABS	O

Ext	O
:	O
cool	O
,	O
no	O
varicosities	B-problem
,	O
1+	O
pedal	B-test
pulses	I-test

Pertinent	O
Results	O
:	O

2013-10-29	O
11:37	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
11.4	O
*#	O
RBC	B-test
-	O
3.09	O
*#	O
Hgb	B-test
-	O
9.1	O
*#	O
Hct	B-test
-	O
27.5	O
*#	O
MCV	B-test
-	O
89	O
MCH	B-test
-	O
29.5	O
MCHC	B-test
-	O
33.3	O
RDW	B-test
-	O
14.6	O
Plt	B-test
Ct	I-test
-	O
180	O

2013-10-29	O
11:37	O
AM	O
BLOOD	B-test
PT	B-test
-	O
16.2	O
*	O
PTT	B-test
-	O
29.0	O
INR(PT)	B-test
-	O
1.7	O

2013-10-29	O
11:37	O
AM	O
BLOOD	B-test
Plt	B-test
Ct	I-test
-	O
180	O

2013-10-29	O
01:09	O
PM	O
BLOOD	B-test
Glucose	B-test
-	O
172	O
*	O
UreaN	B-test
-	O
11	O
Creat	B-test
-	O
0.9	O
Na	B-test
-	O
142	O
Cl	B-test
-	O
111	O
*	O
HCO3	B-test
-	O
22	O

2013-10-29	O
01:09	O
PM	O
BLOOD	B-test
Mg	B-test
-	O
2.6	O

Brief	O
Hospital	O
Course	O
:	O

The	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
on	O
2013-10-29	O
for	O
a	B-treatment
CABG	I-treatment
x5	O
.	O

Please	O
see	O
operative	O
note	O
for	O
full	O
details	O
.	O

The	O
patient	O
tolerated	O
this	B-treatment
procedure	I-treatment
well	O
.	O

He	O
was	O
taken	O
immediately	O
post-operatively	O
to	O
the	O
CSRU	O
.	O

He	O
was	O
extubated	O
that	O
night	O
.	O

The	O
did	O
well	O
in	O
the	O
ICU	O
.	O

His	B-treatment
central	I-treatment
line	I-treatment
and	O
chest	B-treatment
tubes	I-treatment
were	O
removed	O
on	O
post-op	O
day	O
#2	O
and	O
was	O
transferred	O
to	O
the	O
floor	O
in	O
stable	O
condition	O
.	O

On	O
post-op	O
day	O
#3	O
,	O
the	B-treatment
patient	I-treatment
's	I-treatment
pacing	I-treatment
wires	I-treatment
were	O
removed	O
,	O
and	O
his	B-treatment
lopressor	I-treatment
was	O
started	O
.	O

On	O
post-op	O
day	O
#4	O
,	O
the	O
patient	O
failed	O
the	O
first	O
of	O
his	B-test
void	I-test
trials	I-test
.	O

He	O
was	O
seen	O
and	O
cleared	O
by	O
physical	O
therapy	O
.	O

He	O
was	O
discharged	O
home	O
on	O
post-op	O
day	O
#6	O
in	O
stable	O
condition	O
with	O
a	B-treatment
foley	I-treatment
catheter	I-treatment
and	O
leg	B-treatment
bag	I-treatment
.	O

Medications	O
on	O
Admission	O
:	O

Avandia	B-treatment
8	O
mg	O
daily	O

Glipizide	B-treatment
10	O
mg	O
bid	O

Diovan	B-treatment
160	O
mg	O
daily	O

Metformin	B-treatment
500	O
mg	O
two	O
tabs	O
bid	O

Omeprazole	B-treatment
20	O
mg	O
q	O
PM	O

Discharge	O
Medications	O
:	O

1.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
constipation	B-problem
.	O

Disp	O
:*	O
60	O
Capsule	O
(s)*	O
Refills	O
:*	O
2	O
*	O

2.	O
Aspirin	B-treatment
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
2	O
*	O

3.	O
Oxycodone	B-treatment
-	O
Acetaminophen	B-treatment
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-problem
for	O
30	O
doses	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

4.	O
Atorvastatin	B-treatment
Calcium	I-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

5.	O
Rosiglitazone	B-treatment
Maleate	I-treatment
8	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

6.	O
Glipizide	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

7.	O
Tamsulosin	B-treatment
0.4	O
mg	O
Capsule	O
,	O
Sust.	O
Release	O
24	O
HR	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Sust	O
.	O
Release	O
24	O
HR	O
PO	O
HS	O
(	O
at	O
bedtime	O
).	O

Disp	O
:*	O
30	O
Capsule	O
,	O
Sust.	O
Release	O
24	O
HR	O
(s)*	O
Refills	O
:*	O
0	O
*	O

8.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

9.	O
Furosemide	B-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
every	O
twelve	O
(	O
12	O
)	O
hours	O
.	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

10.	O
Pantoprazole	B-treatment
Sodium	I-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
).	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
2	O
*	O

11.	O
Potassium	B-treatment
Chloride	I-treatment
10	O
mEq	O
Capsule	O
,	O
Sustained	O
Release	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Capsule	O
,	O
Sustained	O
Release	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
).	O

Disp	O
:*	O
120	O
Capsule	O
,	O
Sustained	O
Release	O
(s)*	O
Refills	O
:*	O
2	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

Coronary	B-problem
artery	I-problem
disease	I-problem

Discharge	O
Condition	O
:	O

Stable	O

Discharge	O
Instructions	O
:	O

Please	O
return	O
to	O
the	O
hospital	O
or	O
call	O
Dr.	O
Alvarado	O
's	O
office	O
if	O
you	O
experience	O
chills	B-problem
or	O
fever	B-problem
greater	I-problem
than	I-problem
101	I-problem
degrees	I-problem
F.	I-problem

Please	O
call	O
if	O
you	O
notice	O
redness	B-problem
,	O
swelling	B-problem
,	O
or	O
tenderness	B-problem
of	O
your	B-problem
chest	I-problem
wound	I-problem
,	O
or	O
if	O
it	O
begins	O
to	O
drain	O
pus	B-problem
.	O

No	O
heavy	O
lifting	O
or	O
driving	O
until	O
follow	O
up	O
with	O
Dr.	O
Mullins	O
.	O

You	O
may	O
shower	O
.	O

Wash	O
incision	B-problem
with	O
mild	O
soap	O
and	O
water	O
,	O
then	O
pat	O
dry	O
.	O

You	O
will	O
need	O
to	O
follow	O
up	O
with	O
your	O
primary	O
care	O
physician	O
/	O
urologist	O
prior	O
to	O
removal	O
of	O
your	B-treatment
urinary	I-treatment
catheter	I-treatment
.	O

Followup	O
Instructions	O
:	O

Provider	O
:	O
Mary	O
,	O
Francis	O
Z.	O
739-488-1975	O
Call	O
to	O
schedule	O
appointment	O
.	O

Please	O
follow	O
up	O
in	O
1	O
month	O
.	O

Provider	O
:	O
Laurie	O
,	O
Paul	O
G.	O
(	O
858	O
)	O
481-2816	O
Call	O
to	O
schedule	O
appointment	O
.	O

Please	O
follow	O
up	O
in	O
1	O
week	O
.	O

Bernice	O
Jessica	O
MD	O
95-512	O

Completed	O
by	O
:	O
Carol	O
Lydia	O
MD	O
27-960	O
2013-11-05	O
@	O
0029	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Elizabeth	O
GS	O
Vega	O
on	O
:	O
FRI	O
2013-12-06	O
12:28	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2020-03-11	O

Discharge	O
Date	O
:	O

2020-03-23	O

Date	O
of	O
Birth	O
:	O

1946-04-03	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Penicillins	B-treatment

Attending	O
:	O
Ross	O
Z	O
Kenmore	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Transfer	O
from	O
Newton-Wellesley	O
Hospital	O
hospital	O
for	O
epidural	B-problem
abscess	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

1.	O
Partial	B-treatment
vertebrectomy	I-treatment
of	I-treatment
L3	I-treatment
and	I-treatment
L4	I-treatment
.	O

2.	O
Fusion	B-treatment
at	I-treatment
L3-L4	I-treatment
.	O

3.	O
Vertebral	B-treatment
Spacer	I-treatment
at	I-treatment
L3-L4	I-treatment
.	O

4.	O
Anterior	B-treatment
instrumentation	I-treatment
L3-L4	I-treatment
.	O

5.	O
Autograft	B-treatment
,	O
bone	B-treatment
morphogenic	I-treatment
protein	I-treatment
,	O
and	O
allograft	B-treatment
.	O

6.	O
Debridement	B-treatment

7.	O
Incision	B-treatment
and	O
drainage	B-treatment

8.	O
Echocardiogram	B-test

History	O
of	O
Present	O
Illness	O
:	O

73	O
yo	O
M	O
transferred	O
from	O
Newton-Wellesley	O
Hospital	O
hospital	O
for	O
epidural	B-problem
abscess	I-problem
.	O

Pt	O
has	O
h/o	O
colon	B-problem
can	I-problem
to	I-problem
liver	I-problem
,	O
s/p	O
resxn	B-treatment
with	O
serosal	B-problem
implants	I-problem
in	O
9/03	O
.	O

Pt	O
states	O
he	O
has	O
been	O
receiving	O
chemotherapy	B-treatment
up	O
until	O
1	O
week	O
ago	O
.	O

States	O
he	O
first	O
developed	O
back	B-problem
pain	I-problem
5	O
weeks	O
ago	O
but	O
was	O
still	O
able	O
to	O
ambulate	O
with	O
his	B-treatment
cane	I-treatment
.	O

Last	O
week	O
it	O
was	O
worse	O
and	O
he	O
was	O
seen	O
in	O
clinic	O
.	O

An	B-test
MRI	I-test
was	O
done	O
and	O
this	O
showed	O
a	B-problem
signal	I-problem
abno	I-problem
in	I-problem
L3	I-problem
L4	I-problem
?	O
disciitis	B-problem
vs	O
osteo	B-problem
without	O
a	B-problem
definitive	I-problem
epidural	I-problem
abscess	I-problem
.	O

Initially	O
on	O
Vanc	B-treatment
and	O
Cipro	B-treatment
on	O
Friday	O
but	O
then	O
seen	O
by	O
ID	O
who	O
reccommended	O
no	O
abx	B-treatment
but	O
a	B-test
bone	I-test
biopsy	I-test
,	O
blood	B-test
cx	I-test
.	O

He	O
was	O
also	O
seen	O
by	O
spine	O
who	O
repeated	O
the	B-test
MRI	I-test
and	O
this	O
showed	O
L3-4	B-problem
osteomyelitis	I-problem
and	O
discitis	B-problem
and	O
an	B-problem
epidural	I-problem
abscess	I-problem
,	O
5cm	O
.	O

He	O
was	O
subsequently	O
restared	O
on	O
Vancomycin	B-treatment
for	O
Corynebacterium	B-problem
in	O
blood	B-test
cx	I-test
from	O
Fri	O
;	O
Followup	B-test
cx	I-test
has	O
been	O
NGTD	O
.	O

CXR	B-test
also	O
showed	O
small	B-problem
pleural	I-problem
effusion	I-problem
and	O
attempt	O
was	O
made	O
to	O
tap	B-treatment
it	O
,	O
but	O
pt	O
did	O
not	O
tolerate	O
the	B-treatment
procedure	I-treatment
and	O
asked	O
that	O
it	O
be	O
deferred	O
.	O

He	O
did	O
undergo	O
a	B-test
CT-guided	I-test
aspiration	I-test
/	I-test
biopsy	I-test
at	I-test
the	I-test
L3-4	I-test
disc	I-test
space	I-test
on	O
2020-03-11	O
and	O
the	O
pt	O
was	O
transferred	O
to	O
Mediplex	O
Rehab	O
Hospital	O
immediately	O
following	O
this	O
.	O

No	O
results	O
from	O
this	O
were	O
sent	O
.	O

Currently	O
pt	O
denies	O
sensory	B-problem
deficits	I-problem
or	O
weakness	B-problem
.	O

States	O
he	O
is	O
not	O
able	O
to	O
walk	O
because	O
of	O
severe	B-problem
pain	I-problem
.	O

States	O
pain	B-problem
is	O
worst	O
when	O
he	O
sits	O
up	O
or	O
twists	O
his	O
back	O
.	O

No	O
bowel	B-problem
or	I-problem
bladder	I-problem
incontinence	I-problem
.	O

Past	O
Medical	O
History	O
:	O

-	O
epidural	B-problem
abscess	I-problem

-	O
colon	B-problem
cancer	I-problem
with	O
mets	B-problem
to	I-problem
liver	I-problem
s/p	O
resection	B-treatment
09-07	O
.	O

Oncologist	O
is	O
Dr.	O
Rowles	O
.	O

-	O
CAD	B-problem
s/p	O
CABG	B-treatment
x4	O
in	O
'	O
03	O
.	O

-	O
hypercholesterolemia	B-problem

-	O
DM	B-problem
with	O
neuropathy	B-problem
.	O

-	O
persistent	B-problem
R	I-problem
foot	I-problem
ulcer	I-problem

Social	O
History	O
:	O

Lives	O
alone	O
in	O
apartment	O
in	O
Boston	O
.	O

Is	O
married	O
but	O
"	O
separated	O
"	O
from	O
his	O
wife	O
,	O
although	O
they	O
still	O
help	O
each	O
other	O
-	O

he	O
states	O
he	O
gives	O
her	O
one	O
of	O
his	O
pensions	O
and	O
she	O
helps	O
him	O
with	O
medicines	B-treatment
etc	O
.	O

Quit	O
tobacco	O
in	O
2003	O
after	O
smoking	O
1	O
ppd	O
for	O
"	O
a	O
very	O
long	O
time	O
".	O

Drank	O
ETOH	O
heavily	O
until	O
8	O
years	O
ago	O
when	O
he	O
quit	O
.	O

Denies	O
IVDU	O
.	O

Has	O
children	O
but	O
they	O
are	O
not	O
nearby	O
.	O

Family	O
History	O
:	O

NC	O

Physical	O
Exam	O
:	O

98.6	O
,	O
104/50	O
,	O
96	O
,	O
20	O
,	O
96%	O
RA	O

Gen	O
:	O
in	O
NAD	B-problem
,	O
but	O
winces	O
in	O
pain	B-problem
with	O
movements	O
of	O
his	O
back	O
.	O

HEENT	O
:	O
Clear	O
OP	O
,	O
MM	B-problem
very	I-problem
dry	I-problem
.	O

NECK	O
:	O
Supple	O
,	O
No	O
LAD	B-problem
,	O
No	O
JVD	B-problem

CHEST	O
:	O
Port	B-treatment
a	I-treatment
cath	I-treatment
in	I-treatment
R	I-treatment
chest	I-treatment
,	O
no	O
erythema	B-problem
or	O
tenderness	B-problem
.	O

CV	O
:	O
RR	O
,	O
NL	O
rate	O
.	O

NL	O
S1	O
,	O
S2	O
.	O

II/VI	B-problem
SEM	I-problem
at	I-problem
LSB	I-problem
with	O
radiation	B-problem
to	I-problem
apex	I-problem
.	O

LUNGS	O
:	O
+	O
crackles	B-problem
at	I-problem
L	I-problem
base	I-problem
>	O
R	O
base	O
.	O

ABD	O
:	O
Pt	O
very	B-problem
tense	I-problem
in	I-problem
abdomen	I-problem
(	O
states	O
belly	O
is	O
fine	O
,	O
but	O
he	O
is	O
weary	O
of	O
his	O
back	O
).	O

Well	B-problem
healed	I-problem
midline	I-problem
scar	I-problem
from	O
chest	O
down	O
to	O
pubis	O
.	O

No	O
HSM	B-problem
.	O

EXT	O
:	O
No	O
edema	B-problem
.	O

Dressing	B-treatment
c/d/i	O
over	O
R	B-problem
LE	I-problem
ulcer	I-problem
.	O

1	O
+	O
DP	B-test
pulses	I-test
BL	O

NEURO	O
:	O
A&Ox3	O
.	O

Appropriate	O
.	O

CN	O
02-17	O
grossly	O
intact	O
.	O

Preserved	O
sensation	O
throughout	O
.	O

5/5	O
strength	O
throughout	O
,	O
though	O
weary	O
of	O
moving	O
back	O
.	O

Back	O
:	O
+	O
ttp	B-problem
of	I-problem
lumbar	I-problem
spine	I-problem
and	I-problem
paraspinal	I-problem
muscles	I-problem
,	O
R	O
>	O
L	O
.	O

No	O
erythema	B-problem
or	O
swelling	B-problem
noted	O
.	O

CMED	O
CSRU	O
:	O
Listens	O
and	O
responds	O
to	O
questions	O
appropriately	O
,	O
pleasant	O

Pertinent	O
Results	O
:	O

Na	B-test
:	O
135	O
,	O
K	B-test
4.5	O
,	O
Cl	B-test
96	O
,	O
CO2	B-test
27	O
,	O
BUN	B-test
12	O
,	O
Cr	B-test
0.7	O
,	O
Glu	B-test
167	O
,	O
Ca	B-test
8.4	O
,	O
Vanco	B-test
trough	I-test
13	O
,	O
WBC	B-test
5.3	O
,	O
Hct	B-test
32.0	O
,	O
plt	B-test
330	O
,	O
INR	B-test
1.0	O
.	O

No	O
culture	B-test
data	I-test
was	O
sent	O
.	O

STUDIES	O
:	O

MRI	B-test
lumbar	I-test
spine	I-test
(	O
Youville	O
Hospital	O
2020-03-10	O
):	O
L3-4	B-problem
osteomyelitis	I-problem
,	O
discitis	B-problem
,	O
and	O
epidural	B-problem
abscess	I-problem
.	O

Degenerative	B-problem
changes	I-problem
including	O
multilevel	B-problem
central	I-problem
spinal	I-problem
stenosis	I-problem
.	O

Impression	B-problem
on	I-problem
the	I-problem
anterior	I-problem
aspect	I-problem
of	I-problem
the	I-problem
lower	I-problem
spinal	I-problem
cord	I-problem
at	I-problem
T11-12	I-problem
by	O
disc	B-problem
bulge	I-problem
.	O

Addendum	O
:	O
Findings	O
are	O
c/w	O
paraspinous	B-problem
extension	I-problem
of	I-problem
infection	I-problem
anteriorly	O
and	O
laterally	O
into	O
the	O
medial	O
aspects	O
of	O
the	O
psoas	O
muscles	O
bilaterally	O
at	O
the	O
L3	O
and	O
L4	O
levels	O
.	O

CXR	B-test
(	O
Youville	O
Hospital	O
2020-03-09	O
):	O
Persistent	B-problem
unchanged	I-problem
L	I-problem
mid	I-problem
and	I-problem
lower	I-problem
lung	I-problem
field	I-problem
airspace	I-problem
disease	I-problem
with	O
moderate	B-problem
L	I-problem
pleural	I-problem
effusion	I-problem
.	O

Brief	O
Hospital	O
Course	O
:	O

73	O
yo	O
M	O
transferred	O
from	O
Youville	O
Hospital	O
with	O
h/o	O
colon	B-problem
cancer	I-problem
with	O
known	B-problem
liver	I-problem
mets	I-problem
now	O
with	O
epidural	B-problem
abscess	I-problem
and	O
corynebacterium	B-problem
bacteremia	I-problem
:	O

#	O
Epidural	B-problem
abscess	I-problem
:	O
The	O
patient	O
was	O
evaluated	O
by	O
orthopedic	O
spine	O
consult	O
service	O
and	O
ID	O
.	O

He	O
was	O
continued	O
on	O
IV	B-treatment
vancomycin	I-treatment
throughout	O
his	O
course	O
and	O
had	O
therapeutic	O
troughs	B-test
.	O

The	O
patient	O
was	O
taken	O
to	O
the	O
OR	O
twice	O
with	O
orthopaedics	O
.	O

Please	O
see	O
the	O
operation	O
notes	O
for	O
details	O
about	O
the	B-treatment
surgeries	I-treatment
.	O

The	O
patient	O
was	O
briefly	O
admitted	O
to	O
the	O
ICU	O
for	O
low	B-problem
hematocrit	I-problem
and	O
hyponatremia	B-problem
immediately	O
following	O
the	B-treatment
surgery	I-treatment
but	O
was	O
then	O
transferred	O
back	O
to	O
the	O
floor	O
in	O
stable	O
condition	O
.	O

The	O
patient	O
had	O
a	B-treatment
PICC	I-treatment
line	I-treatment
placed	O
and	O
will	O
continue	O
a	B-treatment
8	I-treatment
week	I-treatment
course	I-treatment
of	I-treatment
antibiotics	I-treatment
.	O

The	O
patient	O
will	O
also	O
wear	O
a	B-treatment
back	I-treatment
brace	I-treatment
at	O
all	O
times	O
while	O
out	O
of	O
bed	O
.	O

#	O
Candidemia	B-problem
:	O
The	O
patient	O
was	O
noted	O
to	O
have	O
a	O
positive	O
blood	B-test
culture	I-test
from	O
03-12	O
.	O

The	O
patient	O
was	O
started	O
on	O
Diflucan	B-treatment
.	O

Ophthalmology	O
was	O
consulted	O
and	O
ruled	O
out	O
ocular	B-problem
spread	I-problem
.	O

The	B-treatment
patient	I-treatment
's	I-treatment
portocath	I-treatment
was	O
removed	O
.	O

The	O
tip	O
was	O
culture	B-test
negative	O
.	O

The	O
patient	O
will	O
get	O
a	O
total	O
of	O
a	B-treatment
two	I-treatment
week	I-treatment
course	I-treatment
of	I-treatment
Diflucan	I-treatment
.	O

#	O
Corynebacterium	B-problem
bacteremia	I-problem
:	O
presumably	O
Corynebacterium	B-problem
in	O
epidural	B-problem
abscess	I-problem
as	O
well	O
.	O

The	O
patient	O
had	O
no	O
blood	B-test
cultures	I-test
to	O
grow	O
corynebacterium	B-problem
while	O
hospitalized	O
.	O

#	O
Pleural	B-problem
effusion	I-problem
:	O
The	O
patient	O
was	O
noted	O
have	O
an	B-problem
effusion	I-problem
on	O
CXR	B-test
.	O

IP	O
was	O
consulted	O
and	O
did	O
a	B-test
thoracentesis	I-test
.	O

The	B-test
tap	I-test
was	O
negative	O
for	O
malignant	B-problem
cells	I-problem
.	O

A	B-test
repeat	I-test
CT	I-test
was	O
done	O
showing	O
nodular	B-problem
thickening	I-problem
along	O
the	O
right	O
major	O
and	O
minor	O
fissure	O
,	O
concerning	O
for	O
intrapleural	B-problem
tumor	I-problem
implants	I-problem
.	O

IP	O
reviewed	O
the	B-test
films	I-test
and	O
recommended	O
continue	O
oncologic	B-treatment
care	I-treatment
according	O
to	O

outpatient	O
course	O
and	O
pleurodesis	B-treatment
if	O
the	O
pt	O
becomes	O
symptomatic	B-problem
02-07	O
fluid	B-problem
accumulation	I-problem
.	O

The	O
patient	O
will	O
follow	O
up	O
with	O
his	O
oncologist	O
.	O

#	O
Foot	B-problem
ulcer	I-problem
:	O
diabetic	B-problem
ulcer	I-problem
s/p	O
surgery	B-treatment
but	O
never	O
healed	O
.	O

Wound	O
care	O
was	O
consulted	O
and	O
made	O
recommendations	O
for	O
ulcer	B-treatment
care	I-treatment
.	O

His	B-treatment
dressings	I-treatment
were	O
changed	O
by	O
the	O
nursing	O
staff	O
accordingly	O
.	O

#	O
Anemia	B-problem
:	O
His	B-test
HCT	I-test
remained	O
stable	O
post-surgery	O
.	O

The	O
patient	O
was	O
continued	O
on	O
his	B-treatment
iron	I-treatment
supplements	I-treatment
.	O

Medications	O
on	O
Admission	O
:	O

-	O
Iron	B-treatment
Sulfate	I-treatment
300	O
mg	O
po	O
tid	O

-	O
Procrit	B-treatment
40,000	O
units	O
SC	O
q	O
Friday	O

-	O
Lovenox	B-treatment
40	O
mg	O
SC	O
q24	O
for	O
DVT	O
ppx	O

-	O
Albuterol	B-treatment
/	O
Atrovent	B-treatment
nebs	O
q4	O

-	O
Morphine	B-treatment
2-4	O
mg	O
IV	O
q3-4	O
prn	O

-	O
Mylanta	B-treatment
30	O
cc	O
po	O
q6	O
prn	O

-	O
Pepcid	B-treatment
20	O
mg	O
po	O
daily	O

-	O
insulin	B-treatment
sliding	I-treatment
scale	I-treatment

-	O
glipizide	B-treatment
5	O
mg	O
po	O
bid	O

-	O
metformin	B-treatment
500	O
mg	O
po	O
bid	O

-	O
metoprolol	B-treatment
50	O
mg	O
po	O
daily	O

-	O
Vancomycin	B-treatment
1.5	O
gm	O
q	O
12	O
hours	O

Discharge	O
Medications	O
:	O

1.	O
Albuterol	B-treatment
Sulfate	I-treatment
0.083	O
%	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Inhalation	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
.	O

2.	O
Ipratropium	B-treatment
Bromide	I-treatment
0.02	O
%	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

3.	O
Aluminum-Magnesium	B-treatment
Hydroxide	I-treatment
225-200	O
mg	O
/	O
5	O
mL	O
Suspension	O
Sig	O
:	O
15-30	O
MLs	O
PO	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

4.	O
Glipizide	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

5.	O
Miconazole	B-treatment
Nitrate	I-treatment
2	O
%	O
Powder	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

6.	O
Acetaminophen	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
for	O
fever	B-problem
or	O
pain	B-problem
.	O

7.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

8.	O
Cepacol	B-treatment
2	O
mg	O
Lozenge	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Lozenge	O
Mucous	O
membrane	O
PRN	O
(	O
as	O
needed	O
).	O

9.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

10.	O
Senna	B-treatment
8.6	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

11.	O
Oxycodone	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
every	O
4-6	O
hours	O
as	O
needed	O
for	O
pain	B-problem
for	O
14	O
days	O
.	O

12.	O
Fluconazole	B-treatment
200	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
for	O
7	O
days	O
.	O

13.	O
Oxycodone	B-treatment
10	O
mg	O
Tablet	O
Sustained	O
Release	O
12	O
HR	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
Sustained	O
Release	O
12HR	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
).	O

14.	O
Bisacodyl	B-treatment
5	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

15.	O
Aspirin	B-treatment
81	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Chewable	O
PO	O
DAILY	O
(	O
Daily	O
).	O

16.	O
Vancomycin	B-treatment
in	I-treatment
Dextrose	I-treatment
1	O
g	O
/	O
200	O
mL	O
Piggyback	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Intravenous	O
Q	O
12H	O
(	O
Every	O
12	O
Hours	O
):	O
To	O
finish	O
on	O
2020-05-12	O
.	O

17.	O
Pepcid	B-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
.	O

18.	O
Heparin	B-treatment
Lock	I-treatment
Flush	I-treatment
(	I-treatment
Porcine	I-treatment
)	I-treatment
100	O
unit	O
/	O
mL	O
Syringe	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
ML	O
Intravenous	O
DAILY	O
(	O
Daily	O
)	O
as	O
needed	O
:	O
10	O
ml	O
NS	B-treatment
followed	O
by	O
2	O
ml	O
of	O
100	O
Units	O
/	O
ml	O
heparin	B-treatment
(	O
200	O
units	O
heparin	B-treatment
)	O
each	O
lumen	O
Daily	O
and	O
PRN	O
.	O

Inspect	O
site	O
every	O
shift	O
.	O

19.	O
Insulin	B-treatment
Glargine	I-treatment
100	O
unit	O
/	O
mL	O
Solution	O
Sig	O
:	O
Four	O
(	O
4	O
)	O
units	O
Subcutaneous	O
at	O
dinner	O
time	O
.	O

20.	O
Insulin	B-treatment
Lispro	I-treatment
(	I-treatment
Human	I-treatment
)	I-treatment
100	O
unit	O
/	O
mL	O
Cartridge	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Subcutaneous	O
four	O
times	O
a	O
day	O
:	O
As	O
directed	O
by	O
sliding	B-treatment
scale-please	I-treatment
see	O
attached	O
scale	O
.	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

Primary	O
diagnosis	O
:	O
Epidural	B-problem
abscess	I-problem

Secondary	O
diagnosis	O
:	O

-	O
colon	B-problem
cancer	I-problem
with	O
mets	B-problem
to	I-problem
liver	I-problem
s/p	O
resection	B-treatment
09-07	O
.	O

-	O
CAD	B-problem
s/p	O
CABG	B-treatment
x4	O
in	O
'	O
03	O
.	O

-	O
hypercholesterolemia	B-problem

-	O
DM	B-problem
with	O
neuropathy	B-problem
.	O

-	O
persistent	B-problem
R	I-problem
foot	I-problem
ulcer	I-problem

Discharge	O
Condition	O
:	O

Stable	O
,	O
afebrile	B-problem

Discharge	O
Instructions	O
:	O

You	O
were	O
diagnosed	O
with	O
an	B-problem
epidural	I-problem
abscess	I-problem
.	O

Continue	O
to	O
take	O
the	B-treatment
antibiotics	I-treatment
as	O
directed	O
.	O

Take	O
the	B-treatment
pain	I-treatment
medication	I-treatment
as	O
directed	O
and	O
do	O
not	O
drive	O
while	O
taking	O
this	B-treatment
medication	I-treatment
.	O

Call	O
the	O
doctor	O
or	O
return	O
to	O
the	O
Thomas	O
for	O
:	O

-	O
fever	B-problem
>	O
102	O

-	O
chest	B-problem
pain	I-problem
or	O
shortness	B-problem
of	I-problem
breath	I-problem

-	O
worsening	B-problem
pain	I-problem
or	O
weakness	B-problem
in	I-problem
your	I-problem
legs	I-problem
,	O
loss	B-problem
of	I-problem
bowel	I-problem
or	I-problem
bladder	I-problem
function	I-problem
or	O
any	B-problem
other	I-problem
concerning	I-problem
symptoms	I-problem
.	O

Followup	O
Instructions	O
:	O

Please	O
follow	O
up	O
with	O
Dr.	O
Scott	O
Ann	O
,	O
MD	O
Phone	O
:(	O
921	O
)	O
538	O
8079	O
on	O
2020-04-30	O
at	O
11:00am	O
.	O

Please	O
follow	O
up	O
with	O
Dr	O
Erb	O
-	O
3/30/07	O
at	O
10:00am	O
.	O

Please	O
follow	O
up	O
with	O
Dr.	O
Rowles	O
,	O
your	O
oncologist	O
,	O
in	O
2-3	O
weeks	O

Brooke	O
Donna	O
MD	O
37-421	O

Completed	O
by	O
:	O
Jessica	O
POPE	O
MD	O
58-704	O
2020-03-23	O
@	O
1515	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Maryjane	O
WS	O
Hammond	O
on	O
:	O
FRI	O
2020-05-01	O
12:36	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2015-03-26	O

Discharge	O
Date	O
:	O

2015-03-30	O

Date	O
of	O
Birth	O
:	O

1967-03-08	O

Sex	O
:	O

F	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Morphine	B-treatment
/	O
Histamine	B-treatment
H2	I-treatment
Inhibitors	I-treatment
/	O
Heparin	B-treatment
Agents	I-treatment

Attending	O
:	O
Terry	O
T	O
Trott	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Increasing	B-problem
abdominal	I-problem
girth	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

4u	B-treatment
FFP	I-treatment

Paracentesis	B-treatment

History	O
of	O
Present	O
Illness	O
:	O

47	O
female	O
with	O
h/o	O
HCV	B-problem
cirrhosis	I-problem
compocated	O
by	O
encephalopathy	B-problem
,	O
ascites	B-problem
,	O
and	O
h/o	O
portal	B-problem
vein	I-problem
thrombosis	I-problem
(	O
right	O
anterior	O
portal	O
vein	O
)	O
and	O
portalcaval	B-treatment
shunt	I-treatment
(	O
reversed	O
flow	O
in	O
main	O
portal	O
vein	O
)	O
presents	O
from	O
liver	O
clinic	O
with	O
increasing	B-problem
abdominal	I-problem
girth	I-problem
.	O

She	O
also	O
described	O
sob	B-problem
,	O
nausea	B-problem
,	O
worsening	B-problem
lower	I-problem
ext	I-problem
edema	I-problem
.	O

She	O
denied	O
abd	B-problem
pain	I-problem
,	O
fevers	B-problem
,	O
chills	B-problem
.	O

She	O
was	O
admitted	O
for	O
a	B-treatment
large	I-treatment
volume	I-treatment
paracentesis	I-treatment
but	O
her	B-test
INR	I-test
on	O
admission	O
was	O
3.8	O
.	O

She	O
received	O
4units	O
of	O
FFP	B-treatment
which	O
decreased	O
her	B-test
INR	I-test
to	O
2.2	O
and	O
then	O
2	O
more	O
units	O
during	O
the	B-treatment
tap	I-treatment
.	O

She	O
then	O
had	O
6L	O
of	O
non-bloody	B-problem
ascitic	I-problem
fluid	I-problem
removed	O
without	O
complication	B-problem
.	O

She	O
received	O
36gm	O
of	O
albumin	B-treatment
following	O
the	B-treatment
tap	I-treatment
.	O

Her	B-test
BP	I-test
on	O
admission	O
was	O
120/70	O
and	O
remained	O
stable	O
following	O
the	B-treatment
tap	I-treatment
.	O

Over	O
the	O
next	O
several	O
hours	O
,	O
pt	O
complained	O
of	O
abd	B-problem
pain	I-problem
but	O
this	O
resolved	O
on	O
its	O
own	O
without	O
medication	B-treatment
.	O

In	O
the	O
am	O
,	O
she	O
was	O
found	O
to	O
have	O
a	B-test
hct	I-test
of	O
24	O
,	O
down	O
from	O
32	O
and	O
plts	B-test
35	O
,	O
down	O
from	O
72	O
.	O

She	O
received	O
2	O
units	O
of	O
plts	B-treatment
and	O
1	O
unit	O
of	O
PRBC	B-treatment
s.	I-treatment

Her	B-test
BP	I-test
was	O
then	O
noted	O
to	O
be	O
decreased	B-problem
at	O
80/40	O
which	O
improved	O
mildly	O
to	O
90/30	O
with	O
1.5L	O
of	O
NS	B-treatment
.	O

Temp	B-test
noted	O
to	O
be	O
low	B-problem
at	O
94	O
and	O
she	O
was	O
placed	O
on	O
bear	B-treatment
hugger	I-treatment
which	O
improved	O
temp	B-test
to	O
96.7	O
.	O

Her	O
mental	O
status	O
also	O
had	O
decreased	B-problem
from	O
admission	O
and	O
her	B-test
urine	I-test
output	I-test
was	O
minimal	B-problem
,	O
225cc	O
over	O
the	O
past	O
12	O
hours	O
.	O

Creatinine	B-test
this	O
am	O
was	O
1.9	O
from	O
0.9	O
yesterday	O
.	O

Previous	O
hospital	O
course	O
(	O
per	O
H&P	O
):	O

She	O
was	O
recently	O
hospitalised	O
from	O
02-23	O
/	O
03-04	O
for	O
abdominal	B-problem
discomfort	I-problem
at	O
which	O
time	O
she	O
underwent	O
paracentesis	B-treatment
that	O
ruled	O
out	O
SBP	B-problem
and	O
relieved	O
her	B-problem
abdominal	I-problem
pain	I-problem
.	O

She	O
also	O
underwent	O
US	B-test
that	O
revealed	O
patent	O
portal	O
and	O
hepatic	O
vessels	O
.	O

While	O
her	O
discharge	O
summary	O
maintains	O
that	O
she	O
was	O
continued	O
on	O
Furosemide	B-treatment
/	O
Spirinolactone	B-treatment
/	O
Propranolol	B-treatment
,	O
the	O
patient	O
did	O
not	O
receive	O
any	O
scripts	O
on	O
discharge	O
and	O
as	O
a	O
result	O
did	O
not	O
take	O
these	B-treatment
medications	I-treatment
.	O

Also	O
,	O
due	O
to	O
worsening	B-problem
renal	I-problem
function	I-problem
,	O
she	O
was	O
started	O
on	O
octreotide	B-treatment
/	O
midodrine	B-treatment
/	O
albumin	B-treatment
for	O
hepatorenal	O

syndrome	B-problem
(	O
Cr	B-test
3.3	O
at	O
its	O
worst	O
)	O
which	O
resolved	O
prior	O
to	O
her	O
discharge	O
.	O

The	O
hospitalisation	O
was	O
also	O
significant	O
for	O
mild	B-problem
DIC	I-problem
for	O
which	O
she	O
received	O
cryoglobulins	B-treatment
and	O
UTI	B-problem
(+	O
Enterococcus	B-problem
and	O
+	O
Klebsiella	B-problem
).	O

She	O
received	O
a	O
7	O
day	O
course	O
of	O
amoxicillin	B-treatment
for	O
which	O
Enterococcus	B-problem
was	O
sensitive	O
but	O
Klebsiella	B-problem
unknown	O
.	O

Past	O
Medical	O
History	O
:	O

HCV	B-problem
cirrhosis	I-problem
c/b	O
esophageal	B-problem
varices	I-problem
,	O
ascites	B-problem
,	O
partial	B-problem
portal	I-problem
vein	I-problem
thrombosis	I-problem

h/o	O
gastritis	B-problem

morbid	B-problem
obesity	I-problem

recent	O
cholecystitis	B-problem
08-10	O

h/o	O
EtOH	O
abuse	O

sickle	B-problem
cell	I-problem
trait	I-problem

Social	O
History	O
:	O

Patient	O
denies	O
etoh	O
and	O
tobacco	O
use	O
.	O

She	O
has	O
a	O
history	O
of	O
heavy	O
alcohol	O
use	O
.	O

Lives	O
alone	O
second	O
floor	O
apartment	O
;	O
son	O
and	O
mother	O
nearby	O

Family	O
History	O
:	O

None	O

Physical	O
Exam	O
:	O

Physical	O
Exam	O
:	O
T	B-test
95	O
,	O
BP	B-test
120/70	O
,	O
HR	B-test
82	O
,	O
RR	B-test
20	O
,	O
96%	O
RA	O
Wt	B-test
301.6	O
lb	O

HEENT	O
:	O
+	O
scleral	B-problem
icterus	I-problem
.	O

No	O
thrush	B-problem
.	O

Neck	O
:	O
No	O
Donna	O
,	O
normal	O
thyroid	O
contour	O

Lungs	O
:	O
CTAB	O

Cardiac	O
:	O
RRR	O
,	O
no	O
murmurs	B-problem

Abdomen	O
:	O
obese	B-problem
,	O
soft	O
,	O
mildly	B-problem
distended	I-problem
dull	B-problem
to	O
percussion	B-test
throughout	O
,	O
no	O
tenderness	B-problem
,	O
liver	B-problem
non-palpable	I-problem
due	O
to	O
large	B-problem
volume	I-problem
of	I-problem
ascited	I-problem

Extremities	O
:	O
05-09	O
+	O
pretibial	B-problem
edema	I-problem
extending	O
above	O
knee	O
R	O
>	O
L	O
,	O
no	O
asterixis	B-problem
.	O

No	O
palmar	B-problem
erythema	I-problem

Pertinent	O
Results	O
:	O

2015-03-26	O
10:10	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
8.1	O
RBC	B-test
-	O
3.69	O
*	O
Hgb	B-test
-	O
11.0	O
*	O
Hct	B-test
-	O
32.4	O
*	O
MCV	B-test
-	O
88	O
MCH	B-test
-	O
29.8	O
MCHC	B-test
-	O
33.9	O
RDW	B-test
-	O
26.0	O
*	O
Plt	B-test
Ct	I-test
-	O
72	O
*#	O

2015-03-26	O
10:10	O
AM	O
BLOOD	B-test
Neuts	B-test
-	O
68.3	O
Bands	B-test
-	O
0	O
Lymphs	B-test
-	O
19.8	O
Monos	B-test
-	O
10.6	O
Eos	B-test
-	O
1.1	O
Baso	B-test
-	O
0.2	O

2015-03-26	O
10:10	O
AM	O
BLOOD	B-test
Hypochr	B-test
-	O
1	O
+	O
Anisocy	B-test
-	O
2	O
+	O
Poiklo	B-test
-	O
2	O
+	O
Macrocy	B-test
-	O
2	O
+	O
Microcy	B-test
-	O
NORMAL	O
Polychr	B-test
-	O
NORMAL	O
Ovalocy	B-test
-	O
OCCASIONAL	O
Target	B-test
-	O
OCCASIONAL	O
Schisto	B-test
-	O
OCCASIONAL	O
Tear	O
Dr	O
Clark	O

2015-03-26	O
10:10	O
AM	O
BLOOD	B-test
PT	B-test
-	O
23.0	O
*	O
PTT	B-test
-	O
63.2	O
*	O
INR(PT)	B-test
-	O
3.8	O

2015-03-26	O
10:10	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
76	O
UreaN	B-test
-	O
17	O
Creat	B-test
-	O
0.8	O
Na	B-test
-	O
129	O
*	O
K	B-test
-	O
3.9	O
Cl	B-test
-	O
101	O
HCO3	B-test
-	O
19	O
*	O
AnGap	B-test
-	O
13	O

2015-03-26	O
10:10	O
AM	O
BLOOD	B-test
ALT	B-test
-	O
33	O
AST	B-test
-	O
65	O
*	O
AlkPhos	B-test
-	O
70	O
TotBili	B-test
-	O
30.3	O
*	O
DirBili	B-test
-	O
20.8	O
*	O
IndBili	B-test
-	O
9.5	O

2015-03-26	O
10:10	O
AM	O
BLOOD	B-test
Albumin	B-test
-	O
3.1	O
*	O

2015-03-26	O
10:10	O
AM	O
BLOOD	B-test
Ammonia	B-test
-	O
39	O

RADIOLOGY	O

1.	O
Small	B-problem
cirrhotic	I-problem
liver	I-problem
with	O
what	O
appears	O
to	O
be	O
a	B-treatment
portocaval	I-treatment
shunt	I-treatment
.	O

2.	O
Moderate	B-problem
ascites	I-problem
.	O

3.	O
Cholelithiasis	B-problem
without	O
evidence	O
of	O
acute	B-problem
cholecystitis	I-problem
.	O

4.	O
No	O
hydronephrosis	B-problem
.	O

5.	O
Borderline	B-problem
splenomegaly	I-problem
.	O

Brief	O
Hospital	O
Course	O
:	O

A/P	O
:	O
48	O
yo	O
morbidly	O
obese	O
woman	O
with	O
HCV	B-problem
cirrhosis	I-problem
c/b	O
encephalopathy	B-problem
,	O
esophageal	B-problem
varices	I-problem
and	O
partial	B-problem
vein	I-problem
thrombosis	I-problem
(	O
but	O
no	O
hx	O
of	O
SBP	B-problem
)	O
presents	O
with	O
increasing	B-problem
abdominal	I-problem
girth	I-problem
likely	O
secondary	O
to	O
ascites	B-problem
.	O

Admitted	O
for	O
diagnostic	B-treatment
/	I-treatment
therapeutic	I-treatment
paracentesis	I-treatment
and	O
then	O
transferred	O
to	O
the	O
ICU	O
for	O
hypotension	B-problem
,	O
confusion	B-problem
and	O
anemia	B-problem
.	O

#	O
Liver	B-problem
cirrhosis	I-problem
:	O
MELD	B-test
score	I-test
of	O
34	O
on	O
admission	O
.	O

Pt	O
became	O
more	B-problem
encephalopathic	I-problem
during	O
her	O
hospital	O
course	O
.	O

She	O
was	O
not	O
a	O
transplant	O
candidate	O
due	O
to	O
her	B-problem
obesity	I-problem
.	O

A	O
family	O
meeting	O
was	O
held	O
on	O
hospital	O
day	O
#4	O
which	O
included	O
the	O
pt	O
's	O
closest	O
family	O
members	O
,	O
her	O
hepatologist	O
,	O
Dr.	O
Steidl	O
,	O
her	O
PCP	O
,	O
Dr.	O
Popoff	O
and	O
the	O
ICU	O
team	O
.	O

After	O
it	O
was	O
explained	O
that	O
the	B-problem
pt	I-problem
's	I-problem
prognosis	I-problem
was	O
very	O
poor	O
given	O
that	O
she	O
was	O
not	O
a	B-treatment
transplant	I-treatment
candidate	O
,	O
the	O

decision	O
was	O
made	O
by	O
the	O
family	O
and	O
the	O
medical	O
team	O
to	O
withdraw	O
care	B-treatment
.	O

The	O
pt	O
was	O
made	O
comfortable	O
and	O
she	O
expired	O
several	O
hours	O
later	O
.	O

#	O
Recurrent	B-problem
ascites	I-problem
:	O
On	O
the	O
medical	O
floor	O
,	O
pt	O
had	O
a	B-treatment
large	I-treatment
volume	I-treatment
paracentesis	I-treatment
(	O
6	O
liters	O
)	O
followed	O
by	O
replacement	B-treatment
with	I-treatment
albumin	I-treatment
.	O

She	O
had	O
no	O
evidence	O
of	O
SBP	B-problem
.	O

#	O
Hypotension	B-problem
:	O
Pt	O
became	O
hypotensive	B-problem
following	O
the	B-treatment
large	I-treatment
volume	I-treatment
paracentesis	I-treatment
despite	O
replacement	B-treatment
with	I-treatment
albumin	I-treatment
.	O

This	O
was	O
thought	O
to	O
be	O
04-09	O
the	B-treatment
large	I-treatment
volume	I-treatment
tap	I-treatment
verses	O
sepsis	B-problem
though	O
she	O
had	O
no	O
other	O
evidence	O
of	O
sepsis	B-problem
.	O

She	O
was	O
placed	O
on	O
pressors	B-treatment
to	O
maintain	O
a	B-test
MAP	I-test
>	O
55	O
.	O

Once	O
the	O
decision	O
was	O
made	O
to	O
withdraw	O
care	O
,	O
the	B-treatment
pressors	I-treatment
were	O
discontinued	O
.	O

#	O
Anemia	B-problem
:	O
Hct	B-problem
dropped	I-problem
following	O
the	B-treatment
tap	I-treatment
and	O
there	O
was	O
concern	O
for	O
bleed	B-problem
into	I-problem
her	I-problem
abdomen	I-problem
.	O

She	O
received	O
one	O
unit	O
of	O
PRBC	B-treatment
s.	I-treatment

CT	B-test
of	I-test
the	I-test
abdomen	I-test
and	I-test
pelvis	I-test
showed	O
no	O
evidence	O
of	O
bleed	B-problem
.	O

Her	B-test
hematocrit	I-test
remained	O
stable	O
at	O
24-26	O
following	O
the	B-problem
acute	I-problem
drop.	I-problem

#	O
ARF	B-problem
:	O
Creatinine	B-test
has	O
increased	O
from	O
0.9	O
on	O
admission	O
to	O
1.9	O
on	O
admission	O
to	O
ICU	O
.	O

Urine	B-test
lytes	I-test
with	O
Na	B-test
of	O
10	O
indicating	O
either	O
pre-renal	B-problem
or	O
hepatorenal	B-problem
.	O

Fluid	B-test
challenge	I-test
with	O
36gm	O
of	O
albumin	B-treatment
,	O
one	O
unit	O
of	O
PRBCs	B-treatment
and	O
2L	O
of	O
NS	B-treatment
.	O

Will	O
check	O
creatinine	B-test
this	O
afternoon	O
.	O

Pt	O
previously	O
diagnosed	O
with	O
hepatorenal	B-problem
and	O
was	O
started	O
on	O
midodrine	B-treatment
,	O
octreotide	B-treatment
and	O
albumin	B-treatment
;	O
these	O
were	O

continued	O
.	O

Her	B-test
creatinine	I-test
continued	O
to	O
increase	O
,	O
likely	O
due	O
to	O
her	B-problem
worsening	I-problem
liver	I-problem
failure	I-problem
.	O

Pt	O
expired	O
during	O
this	O
admission	O
after	O
family	O
discussion	O
to	O
make	O
her	O
comfort	O
care	O
only	O
.	O

Medications	O
on	O
Admission	O
:	O

Rifaximine	B-treatment
200	O
mg	O
tid	O

Lactulose	B-treatment
30	O
cc	O
qid	O
titrated	O
to	O
3-4	O
BM	O
/	O
day	O

Protonix	B-treatment
40	O
mg	O
po	O
qd	O

Discharge	O
Medications	O
:	O

none	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

none	O

Discharge	O
Condition	O
:	O

expired	B-problem

Discharge	O
Instructions	O
:	O

none	O

Followup	O
Instructions	O
:	O

none	O

Tracy	O
Doris	O
MD	O
79-274	O

Completed	O
by	O
:	O
Melvin	O
Thomas	O
MD	O
50-805	O
2015-06-22	O
@	O
1413	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Micheal	O
J.	O
Rozzi	O
on	O
:	O
MON	O
2015-07-20	O
1:53	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2008-12-24	O

Discharge	O
Date	O
:	O

2009-02-06	O

Date	O
of	O
Birth	O
:	O

2008-12-24	O

Sex	O
:	O

F	O

Service	O
:	O

Neonatology	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Gerardo	O
is	O
the	O
1400	O
gm	O
product	O
of	O
a	O
32	O
05-03	O
week	O
twin	O
gestation	O
born	O
to	O
a	O
37	O
year	O
old	O
gravida	O
1	O
,	O
para	O
0	O
mother	O
.	O

Prenatal	O
laboratory	O
values	O
:	O

Maternal	B-test
blood	I-test
type	I-test
0-positive	O
,	O
DAT	B-test
negative	O
,	O
negative	O
,	O
RPR	B-test
nonreactive	O
.	O

The	O
mother	O
's	O
past	O
medical	O
history	O
is	O
significant	O
for	O
:	O

1.	O
Tuberculosis	B-problem
,	O
mother	O
was	O
treated	O
in	O
2001	O
according	O
to	O
chart	O
with	O
subsequent	O
negative	O
chest	B-test
x-ray	I-test
,	O
and	O

2.	O
Infertility	B-problem
.	O

The	O
pregnancy	O
was	O
complicated	O
by	O
twin	B-problem
gestation	I-problem
and	O
by	O
polyhydramnios	B-problem
with	O
apparent	O
duodenal	B-problem
atresia	I-problem
and	O
nuchal	O

thickening	B-problem
consistent	O
with	O
Trisomy	B-problem
21	I-problem
in	O
the	O
B	O
co-twin	O
.	O

Amniocentesis	B-test
was	O
not	O
performed	O
.	O

Maternal	B-problem
hypertension	I-problem
was	O
noted	O
in	O
the	O
doctor	O
's	O
office	O
and	O
Mom	O
was	O
referred	O
to	O
nonreassuring	B-test
fetal	I-test
tracing	I-test
,	O
necessitating	O
an	B-treatment
urgent	I-treatment
cesarean	I-treatment
section	I-treatment
.	O

Twin	O
#1	O
cried	O
spontaneously	O
at	O
birth	O
,	O
was	O
bulb	B-treatment
suctioned	I-treatment
and	O
received	O
Blow-by	B-treatment
oxygen	I-treatment
.	O

Apgars	B-test
were	O
8	O
at	O
one	O
minute	O
and	O
8	O
at	O
five	O
minutes	O
.	O

Twin	O
#1	O
was	O
noted	O
to	O
be	O
in	O
a	B-problem
breech	I-problem
presentation	I-problem
.	O

Sepsis	B-problem
risk	I-problem
factors	I-problem
:	O

No	O
fever	B-problem
,	O
no	O
fetal	B-problem
tachycardia	I-problem
,	O
rupture	B-problem
of	I-problem
membranes	I-problem
at	O
delivery	O
.	O

Group	B-test
B	I-test
Streptococcus	I-test
status	I-test
unknown	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Well-appearing	O
female	O
without	O
distress	B-problem
on	O
admission	O
to	O
the	O
Newborn	O
Intensive	O
Care	O
Unit	O
.	O

The	O
patient	O
had	O
a	B-test
weight	I-test
of	O
1400	O
gm	O
,	O
length	B-test
41.5	O
cm	O
and	O
head	B-test
circumference	I-test
of	O
29.25	O
cm	O
.	O

Anterior	O
fontanelle	O
,	O
soft	O
and	O
flat	O
,	O
palate	O
intact	O
,	O
nondysmorphic	B-problem
features	I-problem
.	O

Lungs	O
:	O
breath	B-test
sounds	I-test
clear	O
and	O
equal	O
bilaterally	O
,	O
no	O
retractions	B-problem
.	O

Heart	O
:	O
regular	O
rate	O
and	O
rhythm	O
,	O
no	O
murmur	B-problem
,	O
normal	O
S1	O
and	O
S2	O
,	O
pulses	B-test
2	O
+.	O

Abdomen	O
:	O
soft	O
,	O
nondistended	B-problem
.	O

Without	O
hepatosplenomegaly	B-problem
,	O
without	O
masses	B-problem
.	O

Normal	O
female	O
genitalia	O
.	O

Anus	O
patent	O
.	O

Positive	O
suck	B-test
,	O
positive	O
grasp	B-test
.	O

Skin	O
intact	O
.	O

Size	O
appropriate	O
for	O
gestational	O
age	O
,	O
32	O
week	O
female	O
.	O

SUMMARY	O
OF	O
HOSPITAL	O
COURSE	O
:	O

1.	O
Respiratory	O
-	O
Gerardo	O
was	O
initially	O
placed	O
in	O
nasal	B-treatment
cannula	I-treatment
oxygen	I-treatment
to	O
maintain	O
oxygen	B-test
saturation	I-test
greater	O
than	O
94	O
.	O

On	O
day	O
of	O
life	O
#1	O
,	O
caffeine	B-treatment
was	O
started	O
.	O

Gerardo	O
weaned	O
to	O
room	O
air	O
on	O
day	O
of	O
life	O
#6	O
.	O

Caffeine	B-treatment
was	O
discontinued	O
on	O
day	O
of	O
life	O
#19	O
.	O

Breath	B-test
sounds	I-test
,	O
clear	O
and	O
equal	O
,	O
without	O
retractions	B-problem
,	O
respiratory	B-test
rate	I-test
30	O
s	O
to	O
60	O
s.	O

2.	O
Cardiovascular	O
-	O
The	O
patient	O
has	O
been	O
cardiovascularly	O
stable	O
without	O
murmur	B-problem
.	O

3.	O
Fluids	O
,	O
electrolytes	O
and	O
nutrition	O
-	O
Birthweight	B-test
was	O
1400	O
gm	O
,	O
25th	O
percentile	O
.	O

The	O
patient	O
was	O
initially	O
started	O
on	O
D10	B-treatment
/	I-treatment
W	I-treatment
at	O
80	O
cc	O
/	O
kg	O
/	O
day	O
.	O

She	O
began	O
enteral	B-treatment
feeds	I-treatment
on	O
day	O
of	O
life	O
#2	O
advancing	O
to	O
mother	O
's	O
breastmilk	O
30	O
with	O
ProMod	B-treatment
at	O
150	O
cc	O
/	O
kg	O
/	O
day	O
.	O

Baby	O
received	O
parenteral	B-treatment
nutrition	I-treatment
and	O
lipids	B-treatment
for	O
four	O
days	O
.	O

No	O
hypoglycemia	B-problem
issues	I-problem
noted	O
.	O

Baby	O
is	O
presently	O
tolerating	O
mother	O
's	O
breastmilk	O
with	O
Enfamil	B-treatment
powder	I-treatment
to	O
make	O
24	O
cal	O
/	O
oz	O
at	O
130	O
cc	O
/	O
kg	O
/	O
day	O
.	O

The	O
baby	O
is	O
breastfeeding	O
well	O
.	O

The	O
plan	O
is	O
for	O
alternating	O
feeds	O
.	O

4.	O
Gastrointestinal	O
,	O
genitourinary	O
-	O
Peak	B-test
bilirubin	I-test
8.5	O
,	O
phototherapy	B-treatment
times	O
24	O
hours	O
.	O

Rebound	B-test
bilirubin	I-test
6.4	O
.	O

5.	O
Hematology	O
-	O
Most	O
recent	O
hematocrit	B-test
was	O
42.8	O
on	O
50-05-25	O
.	O

The	O
baby	O
received	O
no	O
blood	B-treatment
products	I-treatment
.	O

6.	O
Infectious	O
disease	O
-	O
No	O
sepsis	B-problem
risk	I-problem
factors	I-problem
.	O

Initial	B-test
complete	I-test
blood	I-test
count	I-test
with	O
white	B-test
blood	I-test
cell	I-test
count	I-test
14	O
,	O
hemoglobin	B-test
21.6	O
,	O
hematocrit	B-test
62.9	O
,	O
65	O
neutrophils	B-test
,	O
no	O
bands	B-test
,	O
28	O
lymphocytes	B-test
.	O

Blood	B-test
cultures	I-test
negative	O
.	O

7.	O
Neurology	O
-	O
Normal	O
head	O
ultrasound	O
on	O
2009-01-08	O
.	O

8.	O
Sensory	O
-	O
Audiology	O
,	O
hearing	B-test
screening	I-test
was	O
performed	O
with	O
automated	O
auditory	O
brain	O
stem	O
responses	O
.	O

Baby	O
passed	O
hearing	B-test
test	I-test
on	O
2009-01-21	O
.	O

Follow	O
up	O
recommended	O
in	O
eight	O
months	O
.	O

Ophthalmology	O
:	O
eyes	O
were	O
examined	O
most	O
recently	O
on	O
2009-01-14	O
,	O
revealing	O
mature	O
retinal	O
vessels	O
.	O

A	B-test
follow	I-test
up	I-test
examination	I-test
is	O
recommended	O
in	O
six	O
to	O
eight	O
months	O
.	O

9.	O
Psychosocial	O
-	O
Bridgewater	O
State	O
Hospital	O
Center	O
's	O
social	O
work	O
involved	O
with	O
family	O
.	O

The	O
contact	O
social	O
worker	O
is	O
Barbara	O
Cole	O
and	O
she	O
can	O
be	O
reached	O
at	O
(	O
972	O
)	O
433-8086	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O
Home	O
.	O

PRIMARY	O
PEDIATRICIAN	O
:	O

Dr.	O
Vito	O
Dotzler	O
,	O
phone	O
(	O
259	O
)	O
579-8396	O
,	O
fax	O
898-3942	O
.	O

RECOMMENDATIONS	O
:	O

1.	O
Feeds	O
-	O
Breastfeeding	O
ad	O
lib	O
,	O
supplementing	O
with	O
Enfamil	B-treatment
24	O
or	O
breastmilk	O
24	O
cal	O
/	O
oz	O
made	O
with	O
1	O
tsp	O
of	O
Enfamil	B-treatment
powder	I-treatment
per	O
100	O
cc	O
of	O
breastmilk	O
.	O

2.	O
Medications	B-treatment
-	O
Poly-Vi-James	B-treatment
1	O
cc	O
p.o.	O
q.	O
day	O
;	O
Iron	B-treatment
or	O
Fer-In-James	B-treatment
0.2	O
cc	O
p.o.	O
q.	O
day	O
to	O
give	O
2	O
mg	O
/	O
kg	O
/	O
day	O

3.	O
Car	B-test
seat	I-test
screening	I-test
-	O
Passed	O
.	O

4.	O
State	B-test
newborn	I-test
screening	I-test
-	O
Last	O
on	O
2009-01-07	O
,	O
all	O
within	O
normal	O
range	O
.	O

5.	O
Immunizations	B-treatment
received	O
-	O
Hepatitis	B-treatment
B	I-treatment
vaccine	I-treatment
given	O
2009-01-22	O
.	O

6.	O
Immunizations	B-treatment
recommended	O
-	O

Synagis	B-treatment
respiratory	I-treatment
syncytial	I-treatment
virus	I-treatment
prophylaxis	I-treatment
should	O
be	O
considered	O
from	O
October	O
through	O
April	O
for	O
infants	O
who	O
meet	O

any	O
of	O
the	O
following	O
three	O
criteria	O
-	O

1.	O
Born	O
at	O
less	O
than	O
32	O
weeks	O
;	O

2.	O
Born	O
between	O
32	O
and	O
35	O
weeks	O
with	O
plans	O
for	O
daycare	O
during	O
respiratory	O
syncytial	O
virus	O
season	O
,	O
with	O
a	O
smoker	O
in	O
the	O
household	O
or	O
with	O
preschool	O
siblings	O
;	O
or	O

3.	O
With	O
chronic	B-problem
lung	I-problem
disease	I-problem
.	O

After	O
some	O
debate	O
,	O
we	O
concluded	O
that	O
Vetrano	O
was	O
not	O
at	O
unusually	O
high	O
risk	O
from	O
RSV	B-problem
,	O
but	O
that	O
her	O
sister	O
might	O
be	O
.	O

Vetrano	O
probably	O
does	O
not	O
need	O
Synagis	B-treatment
at	O
least	O
until	O
her	O
sibling	O
is	O
discharged	O
from	O
the	O
hospital	O
.	O

It	O
may	O
then	O
be	O
reasonable	O
to	O
treat	O
both	O
for	O
the	O
balance	O
of	O
the	O
RSV	O
season	O
.	O

Influenza	B-treatment
immunization	I-treatment
should	O
be	O
considered	O
annually	O
in	O
the	O
fall	O
for	O
preterm	O
infants	O
with	O
chronic	B-problem
lung	I-problem
disease	I-problem
once	O
they	O

reach	O
six	O
months	O
of	O
age	O
,	O
before	O
this	O
age	O
the	O
family	O
and	O
other	O
caregivers	O
should	O
be	O
considered	O
for	O
immunization	B-treatment
against	O

influenza	B-problem
to	O
protect	O
the	O
infant	O
.	O

7.	O
Follow	O
up	O
-	O
Follow	O
up	O
appointment	O
with	O
primary	O
pediatrician	O
within	O
five	O
days	O
of	O
discharge	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
Prematurity	B-problem
,	O
former	O
32	O
4/7	O
weeks	O
,	O
Twin	O
#1	O

2.	O
Rule	O
out	O
sepsis	B-problem

Beverly	O
Q.	O
Bailey	O
,	O
M.D.	O
02-131	O

Dictated	O
By	O
:	O
Carmen	O
Y.R.	O
Martinez	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2009-02-05	O
18:20	O

T	O
:	O
2009-02-05	O
18:39	O

JOB	O
#:	O

17371	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Lizzie	O
Calkins	O
on	O
:	O
Adeline	O
2009-02-06	O
10:27	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2009-03-27	O

Discharge	O
Date	O
:	O

2009-04-03	O

Date	O
of	O
Birth	O
:	O

1960-03-06	O

Sex	O
:	O

F	O

Service	O
:	O

GYNECOLOGY	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
49-year-old	O
gravida	O
III	O
,	O
para	O
II	O
,	O
who	O
was	O
sent	O
from	O
her	O
primary	O
care	O
physician	O
's	O
office	O
secondary	O
to	O
lower	B-problem
abdominal	I-problem
pain	I-problem
.	O

The	O
patient	O
is	O
status	O
post	O
uterine	B-treatment
artery	I-treatment
embolization	I-treatment
on	O
2009-01-07	O
secondary	O
to	O
fibroids	B-problem
.	O

She	O
has	O
had	O
continuing	B-problem
vaginal	I-problem
discharge	I-problem
,	O
and	O
was	O
diagnosed	O
with	O
bacterial	B-problem
vaginosis	I-problem
one	O
day	O
prior	O
to	O
admission	O
,	O
and	O
was	O
given	O
a	O
prescription	O
for	O
Flagyl	B-treatment
.	O

She	O
noted	O
increasing	B-problem
abdominal	I-problem
pain	I-problem
two	O
days	O
prior	O
to	O
admission	O
,	O
which	O
became	O
more	O
severe	O
on	O
the	O
day	O
prior	O
to	O
admission	O
.	O

She	O
went	O
to	O
her	O
primary	O
care	O
physician	O
's	O
office	O
on	O
the	O
day	O
of	O
admission	O
complaining	O
of	O
abdominal	B-problem
pain	I-problem
,	O
which	O
she	O
stated	O
was	O
constant	O
but	O
intermittently	O
sharper	O
at	O
times	O
.	O

The	O
location	O
was	O
variable	O
.	O

She	O
also	O
complained	O
of	O
some	B-problem
loose	I-problem
stools	I-problem
on	O
the	O
day	O
of	O
admission	O
,	O
no	O
nausea	B-problem
or	O
vomiting	B-problem
.	O

Her	B-test
temperature	I-test
was	O
100.4	O
in	O
the	O
office	O
,	O
and	O
she	O
had	O
no	O
chills	B-problem
.	O

She	O
was	O
sent	O
for	O
a	B-test
CT	I-test
scan	I-test
of	I-test
her	I-test
abdomen	I-test
,	O
which	O
revealed	O
fluid	B-problem
and	O
question	O
of	O
gas	B-problem
in	I-problem
the	I-problem
endometrial	I-problem
cavity	I-problem
,	O
and	O
she	O
was	O
sent	O
to	O
Pinewood	O
,	O
Norfolk	O
for	O
treatment	B-treatment
and	O
admission	B-treatment
.	O

PAST	O
OBSTETRICAL	O
HISTORY	O
:	O

Cesarean	B-treatment
section	I-treatment
x	O
2	O
,	O
spontaneous	B-problem
abortion	I-problem
x	O
1	O
.	O

PAST	O
GYNECOLOGIC	O
HISTORY	O
:	O

Last	O
menstrual	O
period	O
2009-02-21	O
.	O

Some	B-problem
spotting	I-problem
on	O
the	O
day	O
prior	O
to	O
admission	O
,	O
but	O
not	O
a	O
normal	O
period	O
.	O

Periods	O
regular	O
.	O

Lupron	B-treatment
x	O
three	O
months	O
prior	O
to	O
embolization	B-treatment
.	O

Fibroid	B-problem
uterus	I-problem
status	O
post	O
embolization	B-treatment
on	O
2009-01-07	O
.	O

Dilatation	B-treatment
and	I-treatment
curettage	I-treatment
x	O
1	O
for	O
SAB	B-problem
.	O

History	O
of	O
herpes	B-problem
simplex	I-problem
virus	I-problem
,	O
last	O
outbreak	O
in	O
2000	O
.	O

No	O
history	O
of	O
abnormal	B-problem
Pap	I-problem
smears	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

None	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Cesarean	B-treatment
section	I-treatment
x	O
2	O
,	O
dilatation	B-treatment
and	I-treatment
curettage	I-treatment
x	O
1	O
,	O
neck	B-treatment
fusion	I-treatment
after	O
motor	O
vehicle	O
accident	O
,	O
shoulder	B-treatment
surgery	I-treatment
after	O
motor	O
vehicle	O
accident	O
.	O

MEDICATIONS	O
:	O

Flagyl	B-treatment
.	O

ALLERGIES	O
:	O

None	O
.	O

SOCIAL	O
HISTORY	O
:	O

No	O
smoking	O
,	O
alcohol	O
or	O
drugs	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Temperature	B-test
100.4	O
,	O
pulse	B-test
108	O
,	O
respirations	B-test
20	O
,	O
blood	B-test
pressure	I-test
110/70	O
,	O
oxygen	B-test
saturation	I-test
100%	O
on	O
room	O
air	O
.	O

In	O
general	O
,	O
she	O
was	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Her	O
abdomen	O
was	O
notable	O
for	O
voluntary	B-problem
guarding	I-problem
but	O
no	O
involuntary	B-problem
guarding	I-problem
or	O
rebound	B-problem
,	O
mild	B-problem
right	I-problem
lower	I-problem
quadrant	I-problem
tenderness	I-problem
greater	O
than	O
left	O
lower	O
quadrant	O
,	O
nondistended	B-problem
.	O

Her	B-test
pelvic	I-test
examination	I-test
was	O
notable	O
for	O
some	B-problem
brownish	I-problem
discharge	I-problem
.	O

Her	O
uterus	O
and	O
adnexa	O
were	O
difficult	O
to	O
assess	O
secondary	O
to	O
voluntary	B-problem
tensing	I-problem
of	I-problem
her	I-problem
abdomen	I-problem
.	O

ASSESSMENT	O
:	O

This	O
is	O
a	O
49-year-old	O
gravida	O
III	O
,	O
para	O
II	O
,	O
status	B-treatment
post	I-treatment
uterine	I-treatment
artery	I-treatment
embolization	I-treatment
on	O
2009-01-07	O
due	O
to	O
uterine	B-problem
fibroids	I-problem
,	O
with	O
continued	B-problem
abdominal	I-problem
pain	I-problem
and	O
CT	B-test
scan	I-test
revealing	O
fluid	B-problem
and	I-problem
gas	I-problem
in	I-problem
the	I-problem
endometrial	I-problem
cavity	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
and	O
was	O
initially	O
started	O
on	O
intravenous	B-treatment
ampicillin	I-treatment
,	O
gentamicin	B-treatment
and	O
clindamycin	B-treatment
.	O

Her	B-test
initial	I-test
white	I-test
blood	I-test
cell	I-test
count	I-test
was	O
11.3	O
,	O
with	O
a	O
normal	O
differential	O
.	O

Her	B-test
sedimentation	I-test
rate	I-test
was	O
elevated	B-problem
at	O
110	O
.	O

Her	B-test
electrolytes	I-test
were	O
within	O
normal	O
limits	O
.	O

She	O
was	O
maintained	O
on	O
intravenous	B-treatment
antibiotics	I-treatment
.	O

On	O
hospital	O
day	O
number	O
three	O
,	O
her	B-test
blood	I-test
cultures	I-test
came	O
back	O
positive	B-problem
in	O
the	B-test
anaerobic	I-test
culture	I-test
for	O
gram-positive	B-problem
cocci	I-problem
in	I-problem
pairs	I-problem
and	I-problem
clusters	I-problem
.	O

Further	B-test
identification	I-test
revealed	O
staphylococcus	B-problem
coag-negative	I-problem
,	O
which	O
was	O
sensitive	O
to	O
gentamicin	B-treatment
and	O
clindamycin	B-treatment
.	O

She	O
was	O
continued	O
on	O
her	B-treatment
antibiotics	I-treatment
,	O
and	O
was	O
afebrile	B-problem
until	O
hospital	O
day	O
number	O
five	O
,	O
when	O
she	O
had	O
a	B-problem
temperature	I-problem
spike	I-problem
to	O
102.3	O
.	O

Repeat	B-test
blood	I-test
cultures	I-test
were	O
sent	O
.	O

Her	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
was	O
12.8	O
,	O
with	O
a	O
normal	O
differential	O
.	O

At	O
this	O
time	O
,	O
an	O
Infectious	O
Disease	O
consult	O
was	O
obtained	O
,	O
and	O
the	O
recommendation	O
was	O
to	O
discontinue	O
the	B-treatment
ampicillin	I-treatment
,	O
gentamicin	B-treatment
and	O
clindamycin	B-treatment
,	O
and	O
start	O
her	O
on	O
intravenous	B-treatment
Unasyn	I-treatment
.	O

She	O
underwent	O
a	B-test
pelvic	I-test
ultrasound	I-test
and	O
an	B-test
abdomen	I-test
and	I-test
pelvis	I-test
CT	I-test
,	O
which	O
revealed	O
continued	B-problem
air	I-problem
in	I-problem
the	I-problem
endometrial	I-problem
cavity	I-problem
vs.	O
in	O
the	B-problem
fundal	I-problem
fibroid	I-problem
.	O

Discussion	O
was	O
had	O
at	O
this	O
time	O
with	O
the	O
patient	O
regarding	O
whether	O
or	O
not	O
this	O
represented	O
an	B-problem
infected	I-problem
abscess	I-problem
vs.	O
post-surgical	B-problem
change	I-problem
.	O

Extensive	O
discussion	O
was	O
held	O
,	O
and	O
second	O
opinion	O
was	O
obtained	O
regarding	O
the	O
need	O
for	O

possible	O
drainage	B-treatment
of	O
the	B-problem
abscess	I-problem
vs.	O
hysterectomy	B-treatment
.	O

The	O
patient	O
requested	O
an	O
outside	O
second	O
opinion	O
,	O
as	O
she	O
was	O
reluctant	O
to	O
undergo	O
hysterectomy	B-treatment
at	O
this	O
time	O
.	O

She	O
was	O
discharged	O
to	O
home	O
on	O
hospital	O
day	O
number	O
eight	O
,	O
on	O
oral	B-treatment
antibiotics	I-treatment
.	O

The	O
patient	O
was	O
to	O
have	O
a	B-test
repeat	I-test
CT	I-test
scan	I-test
in	O
one	O
week	O
.	O

She	O
was	O
also	O
to	O
obtain	O
a	O
second	O
opinion	O
regarding	O
the	O
question	O
of	O
possible	O
surgical	B-treatment
management	I-treatment
.	O

Claude	O
U	O
Bolanos	O
,	O
M.D.	O

95-182	O

Dictated	O
By	O
:	O
William	O
MP	O
Lajoie	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2009-04-02	O
22:09	O

T	O
:	O
2009-04-03	O
01:26	O

JOB	O
#:	O

61261	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Suzanne	O
Simpson	O
on	O
:	O
FRI	O
2009-04-24	O
12:48	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2013-11-21	O

Discharge	O
Date	O
:	O

2013-11-26	O

Date	O
of	O
Birth	O
:	O

1949-07-18	O

Sex	O
:	O

F	O

Service	O
:	O

PLASTIC	O

Allergies	O
:	O

Trazodone	B-treatment
/	O
Ambien	B-treatment
/	O
Sinequan	B-treatment

Attending	O
:	O
Bobby	O
Z.S.	O
Ruiz	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

ACQUIRED	B-problem
DEFECT	I-problem
FROM	O
BASAL	B-treatment
CELL	I-treatment
CARCINOMA	I-treatment
RESECTION	I-treatment

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

RIGHT	B-treatment
NOSE	I-treatment
/	I-treatment
ALA	I-treatment
RECONSTRUCTION	I-treatment
USING	O
RIGHT	B-treatment
CHEEK	I-treatment
ADVANCEMENT	I-treatment
AND	O
FOREHEAD	B-treatment
LOCAL	I-treatment
FLAP	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

MS.	O
Marshall	O
IS	O
A	O
64-YEAR	O
OLD	O
,	O
MENTALLY	B-problem
RETARDED	I-problem
,	O
FEMALE	O
WHO	O
PRESENTED	O
WITH	O
AN	B-problem
AQUIRED	I-problem
DEFECT	I-problem
OF	I-problem
THE	I-problem
RIGHT	I-problem
NASAL	I-problem
ALA	I-problem
AND	I-problem
MEDIAL	I-problem
CHEEK	I-problem
REGION	I-problem
AFTER	O
BASAL	B-problem
CELL	I-problem
CARCINOMA	I-problem
WAS	O
RESECTED	O
BY	O
DERMATOLOGY	O
.	O

Past	O
Medical	O
History	O
:	O

MENTAL	B-problem
RETARDATION	I-problem

DIABETES	B-problem

BIPOLAR	B-problem
DISORDER	I-problem

Social	O
History	O
:	O

LIVES	O
IN	O
A	O
NURSING	O
HOME	O
,	O
HAS	O
A	O
BROTHER	O
WHO	O
IS	O
THE	O
HEALTH	O
CARE	O
PROXY	O
.	O

NO	O
Tifany	O
,	O
ETOH	O
,	O
OR	O
REC	O
DRUG	O
USE	O
.	O

Physical	O
Exam	O
:	O

ON	O
PRESENTATION	O
,	O
PT	O
WAS	O
AFEBRILE	B-problem
WITH	O
NORMAL	O
VITAL	O
SIGNS	O

GEN	O
:	O
NO	O
ACUTE	B-problem
DISTRESS	I-problem
,	O
ABLE	O
TO	O
COMMUNICATE	O
AND	O
FOLLOW	O
ORDERS	O

HEAD	O
AND	O
NECK	O
:	O
5	B-problem
CM	I-problem
CIRCULAR	I-problem
FULL	I-problem
THICKNESS	I-problem
DEFECT	I-problem
AT	O
THE	O
JUNCTION	O
OF	O
THE	O
RIGHT	O
ALA	O
AND	O
CHEEK	O

HEART	O
:	O
REGULAR	O
RATE	O
AND	O
RHYTHM	O

LUNGS	O
:	O
CLEAR	O
TO	O
ASCULATION	B-test

ABDOMEN	O
:	O
SOFT	O
,	O
NON-TENDER	B-problem
,	O
NON-DISTENDED	B-problem

EXTREMITIES	O
:	O
NO	O
EDEMA	B-problem
,	O
CYANOSIS	B-problem
,	O
FULL	O
RANGE	O
OF	O
MOTION	O

Brief	O
Hospital	O
Course	O
:	O

UPON	O
ADMISSION	O
,	O
THE	O
PATIENT	O
WAS	O
PRE-OP	O
'D	O
AND	O
MADE	O
NPO	B-treatment
/	O
IVF	B-treatment
.	O

SHE	O
WENT	O
TO	O
SURGERY	B-treatment
THE	O
NEXT	O
MORNING	O
AND	O
TOLERATED	O
THE	B-treatment
SURGERY	I-treatment
WELL	O
.	O

HOWEVER	O
,	O
SHE	O
WAS	O
SLOW	O
TO	O
AWAKE	O
FROM	O
ANESTHESIA	B-treatment
,	O
AND	O
WAS	O
ADMITTED	O
TO	O
THE	O
CMED	O
CCU	O
OBSERVATION	B-test
.	O

SHE	O
WAS	O
TRANSFERED	O
TO	O
THE	O
FLOOR	O
POST-OP	O
DAY	O
2	O
WHERE	O
SHE	O
HAD	O
BEEN	O
AFEBRILE	B-problem
WITH	O
NORMAL	O
VITALS	O
,	O
MAKING	O
GOOD	O
URINE	O
,	O
AND	O
TOLERATING	O
A	O
REGULAR	O
DIET	O
.	O

HER	B-problem
WOUND	I-problem
HAS	O
REMAIND	O
DRY	O
AND	O
CLOSED	O
,	O
WITHOUT	O
EVIDENCE	O
OF	O
INFECTION	B-problem
OR	O
BREAKDOWN	B-problem
.	O

SHE	O
HAS	O
BEEN	O
WATCHED	O
BY	O
A	O
SITTER	O
AT	O
ALL	O
TIMES	O
.	O

SHE	O
WILL	O
BE	O
DISCHARGED	O
TODAY	O
BACK	O
TO	O
HER	O
NURSING	O
HOME	O
IN	O
GOOD	O
CONDITION	O
,	O
ON	O
PAIN	B-treatment
MEDS	I-treatment
,	O
ANTIBIOTICS	B-treatment
,	O
AND	O
WITH	O
ANTICIPATED	O
1:1	O
WATCH	O
.	O

SHE	O
WILL	O
FOLLOW	O
UP	O
WITH	O
DR.	O
Karen	O
IN	O
1	O
WEEK	O
.	O

STAGE	O
TWO	O
OF	O
HER	B-treatment
SURGERY	I-treatment
WILL	O
BE	O
DONE	O
IN	O
3	O
WEEKS	O
.	O

Discharge	O
Medications	O
:	O

1.	O
Paroxetine	B-treatment
HCl	I-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
AM	O
().	O

2.	O
Multivitamin	B-treatment
Capsule	I-treatment
Sig	O
:	O
One	O
(	O
1	O
)	O
Cap	O
PO	O
QAM	O
(	O
once	O
a	O
day	O
(	O
in	O
the	O
morning	O
)).	O

3.	O
Divalproex	B-treatment
Sodium	I-treatment
500	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
QAM	O
(	O
once	O
a	O
day	O
(	O
in	O
the	O
morning	O
)).	O

4.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
:	O
constipation	B-problem
.	O

Disp	O
:*	O
30	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O

5.	O
Triamcinolone	B-treatment
Acetonide	I-treatment
0.1	O
%	O
Cream	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

6.	O
Divalproex	B-treatment
Sodium	I-treatment
Oral	O

7.	O
Atorvastatin	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
).	O

8.	O
Oxybutynin	B-treatment
Chloride	I-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
QPM	O
(	O
once	O
a	O
day	O
(	O
in	O
the	O
evening	O
)).	O

9.	O
Hydrocodone-Acetaminophen	B-treatment
5-500	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
).	O

Disp	O
:*	O
40	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

10.	O
Bacitracin-Polymyxin-Neosp	B-treatment
HC	I-treatment
Ointment	I-treatment
Sig	O
:	O
One	O
(	O
1	O
)	O
Topical	O
three	O
times	O
a	O
day	O
.	O

Disp	O
:*	O
1	O
500	O
/	O
gram	O
*	O
Refills	O
:*	O
2	O
*	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

AQUIRED	B-problem
DEFORMITY	I-problem
OF	I-problem
THE	I-problem
RIGHT	I-problem
ALA	I-problem
/	I-problem
NOSE	I-problem
AND	I-problem
MEDIAL	I-problem
CHEEK	I-problem
FROM	O
BASAL	B-treatment
CELL	I-treatment
CARCINOMA	I-treatment
RESECTION	I-treatment

Discharge	O
Condition	O
:	O

GOOD	O

Discharge	O
Instructions	O
:	O

PLEASE	O
GIVE	O
PATIENT	O
MEDICATIONS	B-treatment
AS	O
PRESCRIBED	O
AND	O
READ	O
WARNING	O
LABELS	O
CAREFULLY	O
.	O

IF	O
SIGNS	B-problem
AND	I-problem
SYMPTOMS	I-problem
OF	O
INFECTION	B-problem
,	O
SUCH	O
AS	O
FEVERS	B-problem
/	O
CHILLS	B-problem
,	O
PURULENT	B-problem
DISCHARGE	I-problem
FROM	I-problem
WOUND	I-problem
/	I-problem
INCISION	I-problem
SITE	I-problem
,	O
INCREASED	B-problem
REDNESS	I-problem
,	O
INCREASED	B-problem
PAIN	I-problem
,	O
PLEASE	O
CALL	O
OR	O
GO	O
TO	O
THE	O
EMERGENCY	O
ROOM	O
.	O

REMEMBER	O
TO	O
CALL	O
TO	O
SCHEDULE	O
HER	O
FOLLOW	O
UP	O
APPOINTMENT	O
(	O
BELOW	O
).	O

LIGHT	O
ACTIVITIES	O
UNTIL	O
SEEN	O
IN	O
CLINIC	O
.	O

STAGE	O
2	O
OF	O
THE	B-treatment
SURGERY	I-treatment
WILL	O
BE	O
DONE	O
IN	O
3	O
WEEKS	O
.	O

MAY	O
SHOWER	O
--	O
DAB	O
DRY	O
,	O
DO	O
NOT	O
SCRUB	O
.	O

PLEASE	O
CLEAN	O
INCISION	B-problem
SITE	I-problem
WITH	O
NORMAL	B-treatment
SALINE	I-treatment
OR	O
CLEAN	O
WATER	O
THREE	O
TIMES	O
A	O
DAY	O
AND	O
PLACE	O
ANTIBIOTIC	B-treatment
OINTMENT	I-treatment
(	O
GIVEN	O
)	O
ON	O
TOP	O
OF	O
WOUND	B-problem
.	O

PLEASE	O
KEEP	O
PATIENT	O
AWAY	O
FROM	O
THE	O
SUN	O
.	O

MOST	O
IMPORTANTLY	O
,	O
THE	O
PATIENT	O
MUST	O
BE	O
WATCH	O
ONE-ON-ONE	O
SO	O
THAT	O
SHE	O
DOES	O
NOT	O
PICK	O
AT	O
HER	B-problem
WOUND	I-problem
.	O

Followup	O
Instructions	O
:	O

PLEASE	O
CALL	O
DR.Parson	O
OFFICE	O
FOR	O
A	O
FOLLOW	O
UP	O
(	O
989-5361	O
Mauricio	O
(	O
540-4644	O

Nancy	O
Lois	O
MD	O
88-449	O

Completed	O
by	O
:	O
Mary	O
Lisa	O
MD	O
53-914	O
2013-11-26	O
@	O
1134	O

Signed	O
electronically	O
by	O
:	O
DR.	O
David	O
Randazzo	O
on	O
:	O
MON	O
2013-12-16	O
7:25	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2013-05-18	O

Discharge	O
Date	O
:	O

2013-05-24	O

Date	O
of	O
Birth	O
:	O

1811-08-19	O

Sex	O
:	O

F	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	I-problem
Drugs	I-problem

Attending	O
:	O
Sarah	O
Q.	O
George	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Hip	B-problem
fracture	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

OPERATIVE	O
PROCEDURE	O
:	O

1.	O
Closed	B-treatment
reduction	I-treatment
of	I-treatment
right	I-treatment
hip	I-treatment
with	O
open	B-treatment
placement	I-treatment
of	I-treatment
dynamic	I-treatment
hip	I-treatment
screw	I-treatment
,	I-treatment
right	I-treatment
hip	I-treatment
.	O

2.	O
Examination	B-test
under	I-test
anesthesia	I-test
with	O
placement	B-treatment
of	I-treatment
splint	I-treatment
,	I-treatment
right	I-treatment
elbow	I-treatment
.	O

PROCEDURE	O
#2	O
:	O

1.	O
Exploratory	B-test
laparotomy	I-test
with	O
drainage	B-treatment
of	O
intra-abdominal	B-problem
abscess	I-problem
and	O
peritonitis	B-problem
with	O
gross	B-problem
soilage	I-problem
with	I-problem
bile	I-problem
and	I-problem
gastric	I-problem
contents	I-problem
.	O

2.	O
Exposure	B-treatment
and	O
wide	B-treatment
drainage	I-treatment
of	O
perforated	B-problem
posterior	I-problem
duodenal	I-problem
ulcer	I-problem
with	O
internal	B-treatment
and	I-treatment
external	I-treatment
drainage	I-treatment
.	O

3.	O
Feeding	B-treatment
jejunostomy	I-treatment
.	O

4.	O
Tube	B-treatment
gastrostomy	I-treatment
.	O

5.	O
Placement	O
of	O
a	B-treatment
right	I-treatment
femoral	I-treatment
arterial	I-treatment
line	I-treatment
.	O

History	O
of	O
Present	O
Illness	O
:	O

90	O
yo	O
F	O
with	O
MMP	B-problem
(	O
see	O
below	O
)	O
who	O
sustained	O
a	B-problem
mechanical	I-problem
fall	I-problem
down	O
stairs	O
resulting	O
in	O
a	B-problem
hip	I-problem
and	I-problem
arm	I-problem
fracture	I-problem
.	O

Fall	B-problem
was	O
witnessed	O
by	O
daughter	O
.	O

Nicholas	B-problem
seizures	I-problem
,	O
no	O
LOC	B-problem
,	O
no	O
head	B-problem
or	I-problem
neck	I-problem
trauma	I-problem
.	O

Patient	O
denies	O
CP	B-problem
,	O
SOB	B-problem
,	O
light	B-problem
headedness	I-problem
,	O
or	O
dizziness	B-problem
prior	O
to	O
of	O
after	O
the	B-problem
fall	I-problem
.	O

She	O
fell	O
on	O
her	O
R	O
side	O
and	O
had	O
a	O
great	O
deal	O
of	O
pain	B-problem
in	I-problem
her	I-problem
R	I-problem
arm	I-problem
and	I-problem
hip	I-problem
.	O

Presented	O
to	O
Taunton	O
and	O
found	O
to	O
have	O
R	B-problem
humerus	I-problem
and	I-problem
R	I-problem
hip	I-problem
fx	I-problem
.	O

Ct	B-test
of	I-test
head	I-test
and	I-test
neck	I-test
neg	O
for	O
fx	B-problem
,	O
bleed	B-problem
,	O
and	O
dislocation	B-problem
.	O

Past	O
Medical	O
History	O
:	O

1.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
status	O
post	O
non-ST-elevation	B-problem
myocardial	I-problem
infarction	I-problem
in	O
2009-05-05	O
,	O
status	O
post	O
cardiac	B-test
catheterization	I-test
with	O
left	B-treatment
anterior	I-treatment
descending	I-treatment
artery	I-treatment
stent	I-treatment
placement	I-treatment
in	O
05/2001	O
.	O

2.	O
CHF	B-problem
with	O
an	B-test
ejection	I-test
fraction	I-test
of	O
40-45%	O
02-09	O

3.	O
Diabetes	B-problem
type	I-problem
2	I-problem
.	O

4.	O
Anemia	B-problem
,	O
transfusion	B-problem
dependent	I-problem
every	O
three	O
months	O
.	O

Hct	B-test
28	O
b/l	O

5.	O
Polymyalgia	B-problem
rheumatica	I-problem
.	O

6.	O
Hypertension	B-problem
.	O

7.	O
Hypothyroidism	B-problem
.	O

8.	O
Chronic	B-problem
renal	I-problem
insufficiency	I-problem
with	O
a	B-test
b/l	I-test
creatinine	I-test
of	O
1.4	O
.	O

9.	O
History	O
of	O
syncope	B-problem
and	O
first	B-problem
degree	I-problem
A-V	I-problem
heart	I-problem
block	I-problem
with	O
beta	B-treatment
blocker	I-treatment
therapy	I-treatment
.	O

10.	O
History	O
of	O
lower	B-problem
gastrointestinal	I-problem
bleed	I-problem
in	O
2009-06-05	O
.	O

11.	O
spinal	B-problem
stenosis	I-problem

12.	O
Pacemaker	B-treatment
-	O
DDD	B-treatment
dual	I-treatment
chamber	I-treatment
rate	I-treatment
response	I-treatment
pacemaker	I-treatment
2011-08-22	O
for	O
symptomatic	B-problem
bradycardia	I-problem

Social	O
History	O
:	O

Lives	O
alone	O
in	O
elderly	O
housing	O
,	O
a	O
daughter	O
in	O
the	O
area	O
,	O
two	O
children	O
and	O
exercises	O
two	O
times	O
a	O
week	O
by	O
walking	O
and	O
stretching	O
.	O

no	O
,	O
tob	O
,	O
no	O
etoh	O
,	O
no	O
drugs	O

Family	O
History	O
:	O

Noncontributory	O

Physical	O
Exam	O
:	O

at	O
admission	O

T	B-test
96.0	O
BP	B-test
177/61	O
P	B-test
70	O
R	B-test
18	O
O2	B-test
97	O
on	O
RA	O

Gen	O
-	O
somnolent	B-problem
,	O
confused	B-problem

HEENT	O
-	O
PERRL	O
,	O
OP	O
clear	O
,	O
EOMI	O

Cor	O
-	O
rrr	O
,	O
no	O
m/r/g	B-problem

Chest	O
-	O
CTAB	O
anteriorly	O

Abd	O
-	O
s/nt/nd	B-problem
+BS	O

Ext	O
-	O
2	O
+	O
edema	B-problem
to	I-problem
knees	I-problem
,	O
warm	O
2	O
+	O
pulses	B-test
,	O
pain	B-problem
in	I-problem
R	I-problem
arm	I-problem
and	I-problem
R	I-problem
hip	I-problem

Pertinent	O
Results	O
:	O

2013-05-18	O
06:00	O
PM	O
GLUCOSE	B-test
-	O
188	O
*	O
UREA	B-test
N	I-test
-	O
48	O
*	O
CREAT	B-test
-	O
1.3	O
*	O
SODIUM	B-test
-	O
138	O
POTASSIUM	B-test
-	O
4.0	O
CHLORIDE	B-test
-	O
106	O
TOTAL	B-test
CO2	I-test
-	O
21	O
*	O
ANION	B-test
GAP	I-test
-	O
15	O

2013-05-18	O
06:00	O
PM	O
CK(CPK)	B-test
-	O
32	O

2013-05-18	O
06:00	O
PM	O
CK-MB	B-test
-	O
NotDone	O

2013-05-18	O
06:00	O
PM	O
WBC	B-test
-	O
14.9	O
*#	O
RBC	B-test
-	O
2.91	O
*	O
HGB	B-test
-	O
8.5	O
*	O
HCT	B-test
-	O
24.7	O
*	O
MCV	B-test
-	O
85	O
MCH	B-test
-	O
29.3	O
MCHC	B-test
-	O
34.5	O
RDW	B-test
-	O
14.6	O

2013-05-18	O
06:00	O
PM	O
NEUTS	B-test
-	O
87.9	O
*	O
BANDS	B-test
-	O
0	O
LYMPHS	B-test
-	O
6.3	O
*	O
MONOS	B-test
-	O
5.7	O
EOS	B-test
-	O
0.1	O
BASOS	B-test
-	O
0	O

2013-05-18	O
06:00	O
PM	O
HYPOCHROM	B-test
-	O
1	O
+	O
ANISOCYT	B-test
-	O
NORMAL	O
POIKILOCY	B-test
-	O
NORMAL	O
MACROCYT	B-test
-	O
NORMAL	O
MICROCYT	B-test
-	O
NORMAL	O
POLYCHROM	B-test
-	O
NORMAL	O

2013-05-18	O
06:00	O
PM	O
PLT	B-test
SMR	I-test
-	O
NORMAL	O
PLT	B-test
COUNT	I-test
-	O
216	O

2013-05-18	O
06:00	O
PM	O
PT	B-test
-	O
13.3	O
PTT	B-test
-	O
26.4	O
INR(PT)	B-test
-	O
1.2	O
EKG	B-test
-	O
NSR	O
64	O
,	O
1st	B-problem
deg	I-problem
block	I-problem
,	O
LAD	B-problem
,	O
new	B-problem
TWI	I-problem
inf/lat	I-problem
leads	I-problem
,	O
new	B-problem
ST	I-problem
depressions	I-problem
V4-6	I-problem

Echo	B-test
02-09	O

1.	O
The	O
left	O
atrium	O
is	O
moderately	B-problem
dilated	I-problem
.	O

The	O
left	O
atrium	O
is	O
elongated	B-problem
.	O

2.	O
The	B-test
left	I-test
ventricular	I-test
wall	I-test
thicknesses	I-test
are	O
normal	O
.	O

The	B-test
left	I-test
ventricular	I-test
cavity	I-test
size	I-test
is	O
normal	O
.	O

There	O
is	O
mild	B-problem
regional	I-problem
left	I-problem
ventricular	I-problem
systolic	I-problem
dysfunction	I-problem
.	O

Overall	O
left	B-test
ventricular	I-test
systolic	I-test
function	I-test
is	O
mildly	B-problem
depressed	I-problem
.	O

Resting	B-problem
regional	I-problem
wall	I-problem
motion	I-problem
abnormalities	I-problem
include	O
inferolateral	B-problem
,	I-problem
inferior	I-problem
and	I-problem
mid	I-problem
septal	I-problem
hypokinesis	I-problem
.	O

3.	O
Right	B-test
ventricular	I-test
chamber	I-test
size	I-test
is	O
normal	O
.	O

Right	B-test
ventricular	I-test
systolic	I-test
function	I-test
is	O
normal	O
.	O

4.	O
The	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	B-problem
thickened	I-problem
.	O

No	O
aortic	B-problem
regurgitation	I-problem
present	O
.	O

5.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	B-problem
thickened	I-problem
.	O

Moderate	B-problem
(	I-problem
2	I-problem
+)	I-problem
mitral	I-problem
regurgitation	I-problem
is	O
seen	O
.	O

6.	O
There	O
is	O
moderate	B-problem
pulmonary	I-problem
artery	I-problem
systolic	I-problem
hypertension	I-problem
.	O

7.	O
There	O
is	O
no	O
pericardial	B-problem
effusion	I-problem
.	O

Compared	O
with	O
the	O
findings	O
of	O
the	B-test
prior	I-test
study	I-test
(	O
tape	O
reviewed	O
)	O
of	O
2009-06-05	O
,	O
the	B-test
LV	I-test
function	I-test
has	O
improved	O
with	O
an	O
improvementt	O
in	O
function	O
of	O
the	O
apex	O
,	O
septal	O
and	O
anterior	O
walls	O
.	O

New	B-problem
inferior	I-problem
and	I-problem
inferolateral	I-problem
wall	I-problem
motion	I-problem
abnormalities	I-problem
with	O
more	B-problem
severe	I-problem
mitral	I-problem
regurgitation	I-problem
present	O
.	O

Cath	B-test
2001	O

1.	O
Coronary	B-test
angiography	I-test
demonstrated	O
single	B-problem
vessel	I-problem
disease	I-problem
in	I-problem
a	I-problem
right	I-problem
dominant	I-problem
system	I-problem
.	O

The	O
left	O
main	O
was	O
normal	O
.	O

The	O
LAD	O
had	O
serial	B-problem
90%	I-problem
lesions	I-problem
proximally	I-problem
,	O
involving	O
the	O
origin	O
of	O
the	O
first	O
diagonal	O
,	O
which	O
was	O
occluded	B-problem
and	O
filled	O
via	O
left	O
to	O
left	O
collaterals	O
.	O

The	O
mid-distal	O
LAD	O
was	O
underfilled	B-problem
initially	O
but	O
was	O
without	O
obstructive	B-problem
disease	I-problem
.	O

The	O
non-dominant	O
circumflex	O
system	O
had	O
no	O
hemodynamically	B-problem
significant	I-problem
stenoses	I-problem
.	O

The	O
dominant	O
RCA	O
was	O
a	O
large	O
vessel	O
with	O
no	O
significant	B-problem
disease	I-problem
.	O

2.	O
Resting	B-test
hemodynamics	I-test
revealed	O
elevated	B-problem
right	I-problem
and	I-problem
left	I-problem
sided	I-problem
filling	I-problem
pressures	I-problem
with	O
a	B-test
mean	I-test
RA	I-test
pressure	I-test
of	O
12	O
mm	O
Hg	O
and	O
a	B-test
mean	I-test
wedge	I-test
pressure	I-test
24	O
mm	O
Hg	O
.	O

Moderate	B-problem
pulmonary	I-problem
hypertension	I-problem
was	O
present	O
with	O
a	B-test
PA	I-test
of	O
52/28	O
.	O

The	B-test
cardiac	I-test
index	I-test
was	O
preserved	O
at	O
3.0	O
L	O
/	O
min	O
/	O
m2	O
.	O

3.	O
Left	B-test
ventriculography	I-test
was	O
not	O
performed	O
due	O
to	O
the	O
presence	O
of	O
moderate	B-problem
renal	I-problem
insufficiency	I-problem
(	O
creatinine	B-test
1.6	O
).	O

4.	O
Successful	B-treatment
PTCA	I-treatment
and	O
stenting	B-treatment
of	I-treatment
the	I-treatment
proximal	I-treatment
LAD	I-treatment
with	O
overlapping	B-treatment
2.25	I-treatment
x	I-treatment
13	I-treatment
mm	I-treatment
and	I-treatment
2.25	I-treatment
x	I-treatment
18	I-treatment
mm	I-treatment
Hepacoat	I-treatment
stents	I-treatment
with	O
no	O
residual	B-problem
stenosis	I-problem
or	O
dissection	B-problem
and	O
normal	O
flow	O
(	O
see	O
PTCA	B-treatment
comments	O
).	O

FINAL	O
DIAGNOSIS	O
:	O

1.	O
One	B-problem
vessel	I-problem
coronary	I-problem
artery	I-problem
disease	I-problem
.	O

2.	O
Moderately	B-problem
elevated	I-problem
right	I-problem
and	I-problem
left	I-problem
sided	I-problem
filling	I-problem
pressures	I-problem
.	O

3.	O
Successful	B-treatment
stenting	I-treatment
of	I-treatment
the	I-treatment
proximal	I-treatment
LAD	I-treatment
.	O

Hematology	O

COMPLETE	B-test
BLOOD	I-test
COUNT	I-test
WBC	B-test
RBC	B-test
Hgb	B-test
Hct	B-test
MCV	B-test
MCH	B-test
MCHC	B-test
RDW	B-test
Plt	B-test
Ct	I-test

2013-05-24	O
09:40	O
AM	O
19.3	O
*	O
4.46	O
13.1	O
39.2	O
88	O
29.4	O
33.5	O
14.4	O
159	O

2013-05-24	O
12:52	O
AM	O
19.8	O
*#	O
4.73	O
13.8	O
42.1	O
#	O
89	O
29.3	O
32.9	O
14.3	O
147	O
*	O

DIFFERENTIAL	B-test
Neuts	B-test
Bands	B-test
Lymphs	B-test
Monos	B-test
Eos	B-test
Baso	B-test
Atyps	B-test
Metas	B-test

2013-05-22	O
06:15	O
AM	O
90.0	O
*	O
0	O
5.6	O
*	O
4.2	O
0.1	O
0.2	O

RED	B-test
CELL	I-test
MORPHOLOGY	I-test
Hypochr	B-test
Anisocy	B-test
Poiklo	B-test
Macrocy	B-test
Microcy	B-test
Polychr	B-test

2013-05-22	O
06:15	O
AM	O
NORMAL	O
NORMAL	O
NORMAL	O
NORMAL	O
NORMAL	O
NORMAL	O

BASIC	B-test
COAGULATION	I-test
(	O
PT	B-test
,	O
PTT	B-test
,	O
PLT	B-test
,	O
INR	B-test
)	O
PT	B-test
PTT	B-test
Plt	B-test
Smr	I-test
Plt	B-test
Ct	I-test
INR(PT)	B-test
LPlt	B-test

2013-05-24	O
09:40	O
AM	O
159	O
1	O
+	O

2013-05-24	O
09:40	O
AM	O
14.9	O
*	O
1	O
31.9	O
1.5	O

1	O
NOTE	O
NEW	O
NORMAL	O
RANGE	O
AS	O
OF	O
12	O
AM	O
2013-05-04	O

2013-05-24	O
12:52	O
AM	O
147	O
*	O

2013-05-24	O
12:52	O
AM	O
14.6	O
*	O
1	O
33.8	O
1.4	O

1	O
NOTE	O
NEW	O
NORMAL	O
RANGE	O
AS	O
OF	O
12	O
AM	O
2013-05-04	O

Chemistry	B-test

RENAL	O
&	O
GLUCOSE	O
Glucose	B-test
UreaN	B-test
Creat	B-test
Na	B-test
K	B-test
Cl	B-test
HCO3	B-test
AnGap	B-test

2013-05-24	O
09:40	O
AM	O
192	O
*	O
87	O
*	O
2.4	O
*	O
146	O
*	O
5.1	O
114	O
*	O
16	O
*	O
21	O
*	O

2013-05-24	O
12:52	O
AM	O
160	O
*	O
86	O
*	O
2.6	O
*	O
148	O
*	O
4.4	O
115	O
*	O
14	O
*	O
1	O
23	O
*	O

1	O
VERIFIED	O
BY	O
DILUTION	O

NOTIFIED	O
Y.	O
Welch	O
-	O
TSICU	O
140	O
AM	O
2013-05-24	O

ENZYMES	B-test
&	O
BILIRUBIN	B-test
ALT	B-test
AST	B-test
LD(LDH)	B-test
CK(CPK)	B-test
AlkPhos	B-test
Amylase	B-test
TotBili	B-test
DirBili	B-test

2013-05-24	O
07:40	O
AM	O
628	O
*	O

2013-05-24	O
12:52	O
AM	O
22	O
65	O
*	O
739	O
*	O
52	O
81	O
1.0	O

OTHER	B-test
ENZYMES	I-test
&	O
BILIRUBINS	B-test
Lipase	B-test

2013-05-24	O
12:52	O
AM	O
17	O

CPK	B-test
ISOENZYMES	B-test
CK-MB	B-test
MB	B-test
Indx	I-test
cTropnT	B-test

2013-05-24	O
07:40	O
AM	O
15	O
*	O
2.4	O

2013-05-24	O
12:52	O
AM	O
14	O
*	O
1.9	O
0.12	O
*	O
1	O

1	O
CTROPNT	B-test
>	O
0.10	O
NG/ML	O
SUGGESTS	O
ACUTE	B-problem
MI	I-problem

CHEMISTRY	B-test
TotProt	B-test
Albumin	B-test
Globuln	B-test
Calcium	B-test
Phos	B-test
Mg	B-test
UricAcd	B-test
Iron	B-test
Cholest	B-test

2013-05-24	O
09:40	O
AM	O
8.3	O
*	O
5.4	O
*	O
2.1	O

2013-05-24	O
12:52	O
AM	O
2.1	O
*	O
7.7	O
*	O
5.1	O
*#	O
1.6	O

LIPID	B-test
/	O
CHOLESTEROL	B-test
Triglyc	B-test
HDL	B-test
CHOL/HD	B-test
LDLcalc	B-test

2013-05-19	O
09:20	O
AM	O
1603	O
-	O
5419	O
LDL(CALC)	B-test
INVALID	O
IF	O
TRIG	B-test
>	O
400	O
OR	O
NON-FASTING	O
SAMPLE	O
LAB	O
USE	O
ONLY	O
GreenHd	O

2013-05-18	O
06:00	O
PM	O
HOLD1	O

1	O
HOLD	O

DISCARD	O
GREATER	O
THAN	O
4	O
HOURS	O
OLD	O

Blood	B-test
Gas	I-test

BLOOD	B-test
GASES	I-test
Type	B-test
Temp	B-test
Rates	B-test
Tidal	B-test
V	I-test
PEEP	B-test
FiO2	B-test
O2	B-test
Flow	B-test
pO2	B-test
pCO2	B-test
pH	B-test
calHCO3	B-test
Base	B-test
XS	I-test
AADO2	B-test
REQ	B-treatment
O2	I-treatment
Intubat	B-treatment
Vent	B-treatment

2013-05-24	O
07:58	O
AM	O
ART	B-test
102	O
36	O
7.26	O
*	O
17	O
*	O
-9	O

2013-05-24	O
04:31	O
AM	O
ART	B-test
36.4	O
16	O
/	O
662-15484	O
*	O
7.26	O
*	O
16	O
*	O
-10	O

ASSIST	O
/	O
CON1	O
INTUBATED	B-treatment

1	O
ASSIST	O
/	O
CONTROL	O

2013-05-24	O
12:58	O
AM	O
ART	O
147	O
*	O
39	O
7.22	O
*	O
1	O
17	O
*	O
-11	O

1	O
VERIFIED	O

PROVIDER	O
NOTIFIED	O
PER	O
CURRENT	O
LAB	O
POLICY	O

WHOLE	O
BLOOD	O
,	O
MISCELLANEOUS	B-test
CHEMISTRY	I-test
Glucose	B-test
Lactate	B-test
Na	B-test
K	B-test
Cl	B-test
calHCO3	B-test

2013-05-24	O
07:58	O
AM	O
4.5	O
*	O
1	O

1	O
VERIFIED	O

2013-05-24	O
04:31	O
AM	O
5.1	O
*	O
1	O

1	O
VERIFIED	O

2013-05-24	O
12:58	O
AM	O
6.2	O
*	O
1	O

1	O
VERIFIED	O

HEMOGLOBLIN	B-test
FRACTIONS	I-test
(	O
COOXIMETRY	B-test
)	O
Hgb	B-test
calcHCT	B-test
O2	B-test
Sat	I-test
COHgb	B-test
MetHgb	B-test

2013-05-23	O
09:36	O
PM	O
11.4	O
*	O
34	O
73	O
1	O
1	O

2013-05-23	O
01:08	O
PM	O
10.9	O
*	O
33	O
96	O

CALCIUM	B-test
freeCa	B-test

2013-05-23	O
09:36	O
PM	O
1.00	O
*	O

2013-05-23	O
01:08	O
PM	O
1.22	O

RADIOLOGY	O
Final	O
Report	O

CT	B-test
ABDOMEN	I-test
W/O	I-test
CONTRAST	I-test
2013-05-23	O
5:46	O
PM	O

CT	B-test
ABDOMEN	I-test
W/O	I-test
CONTRAST	I-test
;	O
CT	B-test
PELVIS	I-test
W/O	I-test
CONTRAST	I-test

Reason	O
:	O
Please	O
eval	O
for	O
perf	B-problem
/	I-problem
ischemic	I-problem
bowel	I-problem

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

92	O
year	O
old	O
woman	O
with	O
MS	B-problem
changes	I-problem
,	O
abd	B-problem
pain	I-problem
hypotension	B-problem
and	O
bloody	B-problem
lavage	I-problem
on	O
Lovenox+ASA	B-treatment

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

Please	O
eval	O
for	O
perf	B-problem
/	I-problem
ischemic	I-problem
bowel	I-problem

CONTRAINDICATIONS	O
for	O
IV	B-test
CONTRAST	I-test
:	O
renal	B-problem
failure	I-problem

INDICATION	O
:	O
94-year-old	O
woman	O
with	O
mental	B-problem
status	I-problem
changes	I-problem
,	O
now	O
with	O
abdominal	B-problem
pain	I-problem
and	O
hypertension	B-problem
.	O

TECHNIQUE	O
:	O
A	O
multidetector	O
scanner	O
was	O
used	O
to	O
obtain	O
contiguous	B-test
axial	I-test
images	I-test
from	O
the	O
lung	O
bases	O
to	O
the	O
pubic	O
symphysis	O
.	O

Neither	O
IV	B-test
nor	I-test
oral	I-test
contrast	I-test
were	O
used	O
.	O

CT	B-test
OF	I-test
THE	I-test
ABDOMEN	I-test
WITHOUT	I-test
IV	I-test
CONTRAST	I-test
:	O
There	O
are	O
bilateral	B-problem
pleural	I-problem
effusions	I-problem
,	O
right	O
greater	O
the	O
left	O
;	O
there	O
is	O
compressive	B-problem
atelectasis	I-problem
at	I-problem
the	I-problem
left	I-problem
lung	I-problem
base	I-problem
.	O

There	O
are	O
coronary	B-problem
vascular	I-problem
calcifications	I-problem
.	O

A	B-treatment
nasogastric	I-treatment
tube	I-treatment
is	O
seen	O
coiling	O
in	O
the	O
stomach	O
.	O

A	B-treatment
dual	I-treatment
chamber	I-treatment
pacemaker	I-treatment
is	O
seen	O
with	O
leads	O
terminating	O
in	O
the	O
right	O
atrium	O
and	O
right	O
ventricle	O
.	O

Nasogastric	B-treatment
tube	I-treatment
is	O
seen	O
coiling	O
in	O
the	O
stomach	O
,	O
with	O
its	O
tip	O
at	O
the	O
pylorus	O
.	O

Allowing	O
for	O
the	O
limitations	O
of	O
this	B-test
noncontrast	I-test
study	I-test
,	O
the	O
liver	O
,	O
pancreas	O
,	O
adrenals	O
,	O
stomach	O
are	O
unremarkable	O
.	O

A	B-problem
1.8	I-problem
cm	I-problem
exophytic	I-problem
renal	I-problem
cyst	I-problem
is	O
seen	O
on	O
the	O
left	O
.	O

A	B-problem
similar	I-problem
lesion	I-problem
is	O
seen	O
on	O
the	O
right	O
,	O
measuring	O
2.2	O
cm	O
.	O

The	O
aorta	O
is	O
normal	O
in	O
caliber	O
,	O
with	O
vascular	B-problem
calcifications	I-problem
.	O

A	B-problem
small	I-problem
amount	I-problem
of	I-problem
free	I-problem
fluid	I-problem
is	O
seen	O
tracking	O
around	O
the	O
liver	O
,	O
right	O
pericolic	O
gutter	O
,	O
along	O
the	O
mesentery	O
and	O
surrounding	O
the	O
right	O
colon	O
,	O
which	O
is	O
collapsed	O
.	O

A	B-problem
small	I-problem
amount	I-problem
of	I-problem
nondependent	I-problem
free	I-problem
air	I-problem
is	O
seen	O
in	O
the	O
anterior	O
aspect	O
of	O
the	O
abdomen	O
.	O

The	O
remainder	O
of	O
the	O
bowel	O
loops	O
are	O
fluid	O
filled	O
,	O
and	O
nondilated	B-problem
.	O

CT	B-test
OF	I-test
THE	I-test
PELVIS	I-test
WITHOUT	I-test
IV	I-test
CONTRAST	I-test
:	O
As	O
previously	O
noted	O
,	O
there	O
is	O
a	B-problem
small	I-problem
amount	I-problem
of	I-problem
free	I-problem
fluid	I-problem
surrounding	O
the	O
right	O
colon	O
,	O
tracking	O
along	O
the	O
mesentery	O
and	O
into	O
the	O
pelvis	O
.	O

A	B-problem
small	I-problem
amount	I-problem
of	I-problem
free	I-problem
air	I-problem
is	O
seen	O
in	O
the	O
nondependent	O
portion	O
of	O
the	O
pelvis	O
.	O

Vascular	B-problem
calcifications	I-problem
are	O
seen	O
in	O
the	O
abdominal	O
aorta	O
and	O
iliac	O
arteries	O
.	O

Subcutaneous	B-problem
edema	I-problem
is	O
noted	O
in	O
the	O
lower	O
abdomen	O
and	O
pelvis	O
.	O

A	B-treatment
catheter	I-treatment
is	O
seen	O
entering	O
the	O
left	O
inguinal	O
region	O
and	O
coursing	O
along	O
the	O
iliac	O
vessels	O
,	O
terminating	O
in	O
the	O
left	O
pelvis	O
.	O

Osseous	O
structures	O
are	O
remarkable	O
for	O
degenerative	B-problem
changes	I-problem
of	I-problem
the	I-problem
spine	I-problem
,	O
and	O
a	B-problem
fracture	I-problem
of	I-problem
the	I-problem
proximal	I-problem
right	I-problem
humerus	I-problem
,	O
with	O
orthopedic	B-treatment
hardware	I-treatment
causing	O
beam	B-problem
hardening	I-problem
artifact	I-problem
.	O

IMPRESSION	O
:	O

1.	O
A	O
small	O
amount	O
of	O
free	B-problem
air	I-problem
and	I-problem
free	I-problem
fluid	I-problem
in	I-problem
the	I-problem
pelvis	I-problem
and	I-problem
abdomen	I-problem
,	O
mostly	O
along	O
the	O
right	O
pericolic	O
gutter	O
and	O
surrounding	O
the	O
ascending	O
colon	O
,	O
concerning	O
for	O
perforation	B-problem
.	O

Other	O
bowel	O
loops	O
are	O
unremarkable	O
on	O
this	B-test
limited	I-test
study	I-test
.	O

This	O
was	O
discussed	O
with	O
Dr.	O
Jason	O
Long	O
at	O
approximately	O
6:30	O
p.m.	O
,	O
2013-05-23	O
.	O

2.	O
Bilateral	B-problem
pleural	I-problem
effusions	I-problem
,	O
right	O
greater	O
than	O
left	O
,	O
with	O
left-sided	B-problem
compressive	I-problem
atelectasis	I-problem
.	O

3.	O
Right	B-problem
proximal	I-problem
humeral	I-problem
fracture	I-problem
status	O
post	O
fixation	B-treatment
.	O

The	B-test
study	I-test
and	O
the	O
report	O
were	O
reviewed	O
by	O
the	O
staff	O
radiologist	O
.	O

DR.	O
Billy	O
L.	O
Boender	O

DR.	O
Pat	O
K.	O
Walton	O

Approved	O
:	O
FRI	O
2013-05-24	O
4:01	O
PM	O

Brief	O
Hospital	O
Course	O
:	O

95	O
yo	O
F	O
with	O
MMP	B-problem
who	O
sustained	O
a	B-problem
mechanical	I-problem
fall	I-problem
down	O
stairs	O
resulting	O
in	O
a	B-problem
hip	I-problem
and	I-problem
arm	I-problem
fracture	I-problem
.	O

1)	O
s/p	O
Fall	B-problem
-	O
unlikely	O
to	O
be	O
mechanical	O
in	O
nature	O
.	O

Patient	O
has	O
injuries	B-problem
to	I-problem
her	I-problem
shoulder	I-problem
and	I-problem
hip	I-problem
.	O

2)	O
CV	O
-	O
Patient	O
has	O
CAD	B-problem
and	O
CHF	B-problem
with	O
a	B-problem
low	I-problem
hct	I-problem
and	O
major	B-problem
trauma	I-problem
.	O

She	O
also	O
has	O
new	B-problem
changes	I-problem
on	I-problem
EKG	I-problem
.	O

On	O
pressor	B-treatment
to	O
hold	O
mean	O
60	O
.	O

3)	O
Anemia	B-problem
-	O
patient	O
transfusion	B-problem
dependant	I-problem
with	O
a	O
baseline	O
of	O
28	O
.	O

-	O
transfuse	O
2	O
units	O
today	O
,	O
with	O
lasix	B-treatment

4)	O
GERD	B-problem
-	O
PPI	B-treatment

5)	O
DM	B-problem
-	O
glipizide	B-treatment
,	O
ISS	B-treatment

6)	O
PMR	B-problem
-	O
cont	O
prednisone	B-treatment

7)	O
GI	O
:	O
Ms.	O
Pimental	O
is	O
an	O
unfortunate	O
95	O
year	O
old	O
woman	O
,	O
status	O
post	O
a	B-problem
recent	I-problem
fall	I-problem
necessitating	O
right	B-treatment
ORIF	I-treatment
of	I-treatment
the	I-treatment
hip	I-treatment
and	O
right	B-problem
wrist	I-problem
fracture	I-problem
ORIF	B-treatment
,	O
who	O
was	O
in	O
the	O
hospital	O
for	O
this	O
event	O
,	O
when	O
it	O
was	O
noted	O
that	O
she	O
had	O
abdominal	B-problem
pain	I-problem
,	O
distention	B-problem
and	O
coffee	B-problem
ground	I-problem
emesis	I-problem
with	O
worsening	B-problem
mental	I-problem
status	I-problem
and	O
renal	B-problem
failure	I-problem
.	O

CT	B-test
scan	I-test
was	O
obtained	O
and	O
this	O
revealed	O
free	B-problem
air	I-problem
and	O
massive	B-problem
ascites	I-problem
.	O

Pt	O
underwent	O
surgery	B-treatment
on	O
05-23	O

1.	O
Exploratory	B-test
laparotomy	I-test
with	O
drainage	B-treatment
of	O
intra-abdominal	B-problem
abscess	I-problem
and	O
peritonitis	B-problem
with	O
gross	B-problem
soilage	I-problem
with	I-problem
bile	I-problem
and	I-problem
gastric	I-problem
contents	I-problem
.	O

2.	O
Exposure	B-treatment
and	O
wide	B-treatment
drainage	I-treatment
of	O
perforated	B-problem
posterior	I-problem
duodenal	I-problem
ulcer	I-problem
with	O
internal	B-treatment
and	I-treatment
external	I-treatment
drainage	I-treatment
.	O

3.	O
Feeding	B-treatment
jejunostomy	I-treatment
.	O

4.	O
Tube	B-treatment
gastrostomy	I-treatment
.	O

Continue	O
to	O
deteriorate	O
spiking	B-problem
fevers	I-problem
with	O
ventilatory	B-treatment
support	I-treatment
on	O
pressors	B-treatment
to	O
hold	O
the	B-test
bp.	I-test
with	O
no	O
improvement	O
in	O
mental	O
staus	O
was	O
made	O
CMO	O
5/20/5	O
.	O

Expired	O
at	O
5	O
pm	O

Medications	O
on	O
Admission	O
:	O

lasix	B-treatment
alt	O
40	O
mg	O
and	O
20	O
mg	O
qday	O

levothyrox	B-treatment
50	O
mcg	O
qday	O

lisinopril	B-treatment
5	O
mg	O
qday	O

famotidine	B-treatment
20	O
mg	O
qday	O

fe	B-treatment
so4	I-treatment
325	O
mg	O
qday	O

asa	B-treatment
325	O
mg	O
qday	O

toprol	B-treatment
xl	I-treatment
25	O
mg	O
qday	O

glipizide	B-treatment
5	O
mg	O
qday	O

imdur	B-treatment
60	O
mg	O
qdau	O

prednisone	B-treatment
5	O
mg	O
qday	O

tylenol	B-treatment

Discharge	O
Disposition	O
:	O

Expired	B-problem

Discharge	O
Diagnosis	O
:	O

MULTIORGAN	B-problem
FAILURE	I-problem

DUODENAL	B-problem
PERFORATION	I-problem

MULTIPLE	B-problem
TRAUMA	I-problem

Discharge	O
Condition	O
:	O

deceased	O

Followup	O
Instructions	O
:	O

none	O

Frank	O
Linda	O
MD	O
44-897	O

Completed	O
by	O
:	O
Deanna	O
Patague	O
MD	O
48-130	O
2013-05-24	O
@	O
1820	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Marta	O
Keever	O
on	O
:	O
FRI	O
2013-06-21	O
9:40	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2013-05-14	O

Discharge	O
Date	O
:	O

2013-05-18	O

Date	O
of	O
Birth	O
:	O

1953-07-27	O

Sex	O
:	O

F	O

Service	O
:	O

CMED	O
CSRU	O

CHIEF	O
COMPLAINT	O
:	O

The	O
patient	O
was	O
admitted	O
originally	O
for	O
airway	B-test
monitoring	I-test
status	O
post	O
endoscopic	O
retrograde	O

cholangiopancreatography	B-test
with	O
adverse	B-problem
reaction	I-problem
to	O
Fentanyl	B-treatment
and	O
tongue	B-problem
injury	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
59	O
year-old	O
female	O
status	O
post	O
endoscopic	B-test
retrograde	I-test
cholangiopancreatography	I-test
on	O
the	O
day	O
of	O
admission	O
,	O
which	O
had	O
been	O
done	O
to	O
evaluate	O
for	O
possible	O
bile	B-problem
leak	I-problem
after	O
cholecystectomy	B-treatment
was	O
performed	O
four	O
days	O
ago	O
.	O

The	O
patient	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
four	O
days	O
prior	O
to	O
admission	O
when	O
she	O
had	O
a	B-treatment
cholecystectomy	I-treatment
.	O

Her	O
postop	O
course	O
was	O
uneventful	O
until	O
one	O
day	O
prior	O
to	O
admission	O
when	O
she	O
developed	O
abdominal	B-problem
pain	I-problem
.	O

She	O
went	O
to	O
an	O
outside	O
hospital	O
Emergency	O
Room	O
and	O
was	O
reassured	O
and	O
sent	O
home	O
.	O

On	O
the	O
day	O
of	O
admission	O
she	O
returned	O
to	O
the	O
outside	O
hospital	O
Emergency	O
Room	O
where	O
an	B-test
abdominal	I-test
CT	I-test
was	O
performed	O
,	O
which	O
showed	O
"	O
thickened	B-problem
stomach	I-problem
and	O
free	B-problem
air	I-problem
."	O

She	O
was	O
sent	O
to	O
New	O
England	O
Sinai	O
Hospital	O
&	O
Rehab	O
Center	O
for	O
an	B-test
endoscopic	I-test
retrograde	I-test
cholangiopancreatography	I-test
and	O
possible	O
stent	B-treatment
placement	I-treatment
.	O

She	O
had	O
a	B-test
successful	I-test
endoscopic	I-test
retrograde	I-test
cholangiopancreatography	I-test
,	O
which	O
showed	O
a	B-problem
bile	I-problem
leak	I-problem
at	I-problem
the	I-problem
duct	I-problem
of	I-problem
Luschka	I-problem
.	O

A	B-treatment
stent	I-treatment
was	O
placed	O
successfully	O
.	O

After	O
her	B-test
endoscopic	I-test
retrograde	I-test
cholangiopancreatography	I-test
the	O
patient	O
developed	O
"	O
jaw	B-problem
clenching	I-problem
,	O
biting	B-problem
tongue	I-problem
,	O
rigidity	B-problem
and	O
cold	B-problem
/	I-problem
chills	I-problem
."	O

The	O
patient	O
received	O
ampicillin	B-treatment
,	O
Gentamycin	B-treatment
and	O
Flagyl	B-treatment
empirically	O
as	O
well	O
as	O
Narcan	B-treatment
to	O
reverse	O
fentanyl	B-treatment
.	O

Because	O
of	O
the	B-problem
tongue	I-problem
injury	I-problem
and	O
tachycardia	B-problem
as	O
well	O
as	O
possible	O
infection	B-problem
given	O
her	B-problem
fevers	I-problem
or	O
chills	B-problem
the	O
GI	O
Service	O
transferred	O
the	O
patient	O
to	O
the	O
CMED	O
CCU	O
for	O
close	O
observation	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Hiatal	B-problem
hernia	I-problem
.	O

2.	O
Status	O
post	O
cholecystectomy	B-treatment
four	O
days	O
prior	O
to	O
admission	O
.	O

3.	O
Urinary	B-problem
frequency	I-problem
secondary	O
to	O
interstitial	B-problem
cystitis	I-problem
.	O

4.	O
Mitral	B-problem
valve	I-problem
prolapse	I-problem
.	O

5.	O
Tubal	B-treatment
ligation	I-treatment
many	O
years	O
ago	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Prempro	B-treatment
.	O

2.	O
CMED	B-treatment
CCU	I-treatment
drops	I-treatment
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
at	O
the	O
time	O
of	O
admission	O
,	O
however	O
,	O
it	O
is	O
assumed	O
that	O
her	B-problem
rigidity	I-problem
and	O
jaw	B-problem
clenching	I-problem
was	O
secondary	O
to	O
Fentanyl	B-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
married	O
.	O

She	O
works	O
as	O
a	O
teacher	O
's	O
aid	O
in	O
Cambridge	O
.	O

She	O
denies	O
tobacco	O
or	O
alcohol	O
use	O
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION	O
TO	O
THE	O
CMED	O
CCU	O
:	O

Vital	B-test
signs	I-test
temperature	B-test
100.6	O
.	O

Heart	B-test
rate	I-test
105	O
.	O

Blood	B-test
pressure	I-test
162/76	O
.	O

Respiratory	B-test
rate	I-test
18	O
.	O

Sating	B-test
98%	O
on	O
3	O
liters	O
.	O

In	O
general	O
,	O
the	O
patient	O
was	O
groggy	B-problem
status	O
post	O
anesthesia	B-treatment
,	O
shivering	B-problem
,	O
but	O
awake	O
.	O

HEENT	O
showed	O
tongue	O
with	O
laceration	B-problem
on	I-problem
the	I-problem
right	I-problem
edge	I-problem
.	O

Mucous	O
membranes	O
are	O
moist	O
.	O

Pupils	O
are	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
.	O

Extraocular	O
movements	O
intact	O
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Heart	O
regular	O
rate	O
and	O
rhythm	O
.	O

No	O
murmurs	B-problem
,	O
rubs	B-problem
or	O
gallops	B-problem
.	O

Abdomen	O
was	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
.	O

There	O
were	O
normoactive	O
bowel	O
sounds	O
.	O

There	O
was	O
no	O
rebound	B-problem
or	O
guarding	B-problem
.	O

There	O
were	O
post	B-problem
laparoscopic	I-problem
incisions	I-problem
without	O
erythema	B-problem
with	O
Steri-Strips	B-treatment
in	O
place	O
.	O

The	O
extremities	O
were	O
without	O
edema	B-problem
.	O

Dorsalis	B-test
pedis	I-test
pulses	I-test
were	O
intact	O
bilaterally	O
.	O

There	O
were	O
no	O
rashes	B-problem
.	O

LABORATORIES	O
ON	O
ADMISSION	O
:	O

White	B-test
blood	I-test
cell	I-test
count	I-test
9.0	O
,	O
hematocrit	B-test
39.3	O
,	O
platelets	B-test
296	O
,	O
neutrophil	B-test
count	I-test
82	O
,	O
lymphocytes	B-test
14	O
,	O
4	O
monocytes	B-test
,	O
troponin	B-test
was	O
less	O
then	O
0.3	O
.	O

Sodium	B-test
139	O
,	O
potassium	B-test
3.8	O
,	O
chloride	B-test
101	O
,	O
bicarb	B-test
26	O
,	O
BUN	B-test
9	O
,	O
creatinine	B-test
0.7	O
,	O
glucose	B-test
141	O
,	O
albumin	B-test
4.1	O
,	O
calcium	B-test
8.9	O
,	O
LDH	B-test
665	O
,	O
AST	B-test
44	O
,	O
ALT	B-test
of	O
57	O
,	O
amylase	B-test
41	O
,	O
CK	B-test
32	O
.	O

Electrocardiogram	B-test
showed	O
normal	O
sinus	O
rhythm	O
at	O
73	O
beats	O
per	O
minute	O
.	O

There	O
was	O
normal	O
axis	O
.	O

Normal	O
intervals	O
.	O

There	O
were	O
no	O
ST	B-problem
or	I-problem
T	I-problem
wave	I-problem
changes	I-problem
.	O

Abdominal	B-test
CT	I-test
showed	O
inflammation	B-problem
in	I-problem
the	I-problem
right	I-problem
upper	I-problem
quadrant	I-problem
,	O
small	B-problem
fluid	I-problem
in	I-problem
the	I-problem
circumferential	I-problem
thickening	I-problem
of	I-problem
the	I-problem
distal	I-problem
stomach	I-problem
.	O

There	O
was	O
a	O
question	O
of	O
a	B-problem
small	I-problem
ulcer	I-problem
.	O

There	O
was	O
a	O
tiny	O
amount	O
of	O
free	B-problem
air	I-problem
.	O

This	O
was	O
per	O
report	O
of	O
Vencor	O
Hospital	O
.	O

HOSPITAL	O
COURSE	O
:	O

In	O
summary	O
the	O
patient	O
is	O
a	O
59	O
year-old	O
female	O
who	O
was	O
admitted	O
to	O
Quincy	O
Medical	O
Center	O
for	O
an	B-test
endoscopic	I-test
retrograde	I-test
cholangiopancreatography	I-test
for	O
possible	O
stent	B-treatment
placement	I-treatment
for	O
a	B-problem
bile	I-problem
leak	I-problem
secondary	O
to	O
cholecystectomy	B-treatment
performed	O
four	O
days	O
prior	O
to	O
admission	O
.	O

She	O
then	O
suffered	O
rigidity	B-problem
with	O
jaw	B-problem
clenching	I-problem
and	O
tongue	B-problem
biting	I-problem
secondary	O
to	O
Fentanyl	B-treatment
administration	O
and	O
was	O
transferred	O
to	O
the	O
CMED	O
CCU	O
for	O
close	O
observation	O
.	O

She	O
did	O
well	O
overnight	O
in	O
the	O
CMED	O
CCU	O
.	O

She	O
was	O
started	O
on	O
Ampicillin	B-treatment
,	O
Gentamycin	B-treatment
and	O
Flagyl	B-treatment
.	O

Her	B-test
liver	I-test
function	I-test
tests	I-test
and	O
amylase	B-test
and	O
lipase	B-test
were	O
followed	O
closely	O
.	O

On	O
the	O
second	O
hospital	O
day	O
the	O
patient	O
was	O
doing	O
much	O
better	O
and	O
was	O
stable	O
from	O
an	O
airway	O
perspective	O
,	O
so	O
she	O
was	O
transferred	O
to	O
the	O
General	O
Medical	O
Floor	O
.	O

1.	O
Gastrointestinal	O
:	O

As	O
stated	O
the	O
patient	O
was	O
status	O
post	O
endoscopic	B-test
retrograde	I-test
cholangiopancreatography	I-test
with	O
stent	O

placement	B-treatment
for	O
a	B-problem
bile	I-problem
leak	I-problem
from	I-problem
the	I-problem
duct	I-problem
of	I-problem
Luschka	I-problem
.	O

The	O
patient	O
was	O
continued	O
on	O
Ampicillin	B-treatment
,	O
Gentamycin	B-treatment
and	O
Flagyl	B-treatment
,	O
which	O
had	O
been	O
started	O
at	O
the	O
time	O
of	O
transfer	O
to	O
the	O
CMED	O
CCU	O
.	O

She	O
had	O
waxing	B-problem
and	I-problem
waning	I-problem
fevers	I-problem
.	O

However	O
,	O
her	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
was	O
never	O
really	B-problem
elevated	I-problem
and	O
she	O
did	O
not	O
have	O
a	B-problem
bandemia	I-problem
.	O

On	O
the	O
day	O
of	O
transfer	O
to	O
the	O
General	O
Medical	O
Floor	O
the	O
patient	O
had	O
received	O
clear	B-treatment
liquids	I-treatment
.	O

She	O
did	O
not	O
tolerate	O
this	O
very	O
well	O
.	O

Her	B-test
amylase	I-test
and	O
lipase	B-test
on	O
the	O
day	O
following	O
the	B-test
endoscopic	I-test
retrograde	I-test
cholangiopancreatography	I-test

were	O
elevated	B-problem
.	O

Amylase	B-test
was	O
2304	O
with	O
lipase	B-test
being	O
7116	O
.	O

Therefore	O
she	O
was	O
made	O
NPO	B-treatment
and	O
given	O
aggressive	B-treatment
intravenous	I-treatment
hydration	I-treatment
.	O

On	O
the	O
second	O
hospital	O
day	O
on	O
the	O
General	O
Medical	O
Floor	O
the	O
patient	O
had	O
marked	B-problem
rebound	I-problem
to	O
palpation	B-test
of	I-test
her	I-test
abdomen	I-test
.	O

She	O
was	O
followed	O
closely	O
with	O
serial	B-test
abdominal	I-test
examinations	I-test
.	O

Her	B-test
amylase	I-test
and	O
lipase	B-test
were	O
trending	O
down	O
,	O
however	O
.	O

An	B-test
abdominal	I-test
CT	I-test
was	O
obtained	O
,	O
which	O
showed	O
only	O
mild	B-problem
pancreatitis	I-problem
.	O

There	O
were	O
no	O
intra-abdominal	B-problem
fluid	I-problem
collections	I-problem
,	O
which	O
required	O
any	B-treatment
drainage	I-treatment
.	O

On	O
the	O
third	O
hospital	O
day	O
the	B-problem
patient	I-problem
's	I-problem
pain	I-problem
was	O
improving	O
and	O
the	B-problem
rebound	I-problem
was	O
decreasing	O
.	O

Her	B-test
enzymes	I-test
continued	O
to	O
trend	O
down	O
.	O

She	O
received	O
clear	B-treatment
liquids	I-treatment
in	O
the	O
evening	O
and	O
tolerated	O
these	O
well	O
.	O

On	O
the	O
day	O
of	O
discharge	O
the	O
patient	O
was	O
tolerating	O
a	B-treatment
BRAT	I-treatment
diet	I-treatment
without	O
significant	O
abdominal	O

pain	B-problem
.	O

She	O
had	O
no	O
further	B-problem
rebound	I-problem
.	O

She	O
had	O
no	O
temperature	B-problem
spikes	I-problem
in	O
greater	O
then	O
24	O
hours	O
at	O
the	O
time	O
of	O
discharge	O
.	O

2.	O
Hematology	O
:	O

The	B-test
patient	I-test
's	I-test
hematocrit	I-test
was	O
34.8	O
at	O
the	O
time	O
of	O
admission	O
.	O

It	O
decreased	O
to	O
30	O
in	O
the	O
setting	O
of	O
aggressive	B-treatment
hydration	I-treatment
.	O

It	O
remained	O
stable	O
at	O
the	O
time	O
of	O
discharge	O
and	O
it	O
was	O
29.5	O
on	O
the	O
day	O
of	O
discharge	O
.	O

3.	O
FEN	O
:	O

The	O
patient	O
was	O
aggressively	B-treatment
hydrated	I-treatment
given	O
that	O
she	O
was	O
NPO	B-treatment
.	O

She	O
required	O
periodic	B-treatment
repletion	I-treatment
of	I-treatment
her	I-treatment
potassium	I-treatment
.	O

Her	B-test
bicarb	I-test
began	O
to	O
drop	O
and	O
she	O
developed	O
an	B-problem
anion	I-problem
gap	I-problem
acidosis	I-problem
.	O

This	O
was	O
most	O
likely	O
secondary	O
to	O
ketoacidosis	B-problem
as	O
she	O
had	O
no	O
dextrose	B-treatment
in	O
her	B-treatment
intravenous	I-treatment
fluids	I-treatment
.	O

This	O
was	O
added	O
on	O
the	O
evening	O
prior	O
to	O
discharge	O
and	O
on	O
the	O
day	O
of	O
discharge	O
her	B-problem
anion	I-problem
gap	I-problem
acidosis	I-problem
had	O
resolved	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Levaquin	B-treatment
500	O
mg	O
one	O
po	O
q	O
day	O
times	O
seven	O
days	O
.	O

2.	O
Protonix	B-treatment
40	O
mg	O
po	O
q	O
day	O
.	O

3.	O
Percocet	B-treatment
one	O
to	O
two	O
tablets	O
po	O
q	O
4	O
to	O
6	O
hours	O
prn	O
.	O

The	O
patient	O
was	O
given	O
a	B-treatment
prescription	I-treatment
for	I-treatment
ten	I-treatment
pills	I-treatment
.	O

4.	O
Prempro	B-treatment
as	O
the	O
patient	O
was	O
formerly	O
taking	O
.	O

5.	O
Trazodone	B-treatment
at	O
bedtime	O
.	O

DISCHARGE	O
FOLLOW	O
UP	O
:	O

The	O
patient	O
was	O
to	O
make	O
an	O
appointment	O
with	O
Dr.	O
Nicholson	O
within	O
one	O
to	O
two	O
months	O
after	O
discharge	O
for	O
removal	B-treatment
of	I-treatment
the	I-treatment
stent	I-treatment
.	O

In	O
addition	O
,	O
she	O
would	O
follow	O
up	O
with	O
her	O
primary	O
care	O
physician	O
within	O
one	O
to	O
two	O
weeks	O
following	O
discharge	O
.	O

She	O
was	O
to	O
continue	O
on	O
a	B-treatment
BRAT	I-treatment
diet	I-treatment
over	O
the	O
weekend	O
and	O
two	O
days	O
after	O
discharge	O
she	O
could	O
advance	O
to	O
a	B-treatment
low	I-treatment
fat	I-treatment
no	I-treatment
dairy	I-treatment
diet	I-treatment
.	O

She	O
could	O
slowly	O
advance	O
back	O
to	O
a	O
normal	O
diet	O
over	O
the	O
next	O
week	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Post	B-problem
endoscopic	I-problem
retrograde	I-problem
cholangiopancreatography	I-problem
pancreatitis	I-problem
.	O

2.	O
Anemia	B-problem
.	O

3.	O
Hypokalemia	B-problem
.	O

4.	O
Anion	B-problem
gap	I-problem
acidosis	I-problem
.	O

5.	O
Bile	B-problem
leak	I-problem
.	O

Thompson	O
MING	O
LI	O
,	O
M.D.	O

44-725	O

Dictated	O
By	O
:	O
Marcelene	O
R.	O
Brennan	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2013-05-18	O
13:49	O

T	O
:	O
2013-05-20	O
08:16	O

JOB	O
#:	O

23220	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Ruth	O
O.	O
Black	O
on	O
:	O
WED	O
2013-05-22	O
7:10	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2011-10-28	O

Discharge	O
Date	O
:	O

2011-12-01	O

Date	O
of	O
Birth	O
:	O

1964-04-14	O

Sex	O
:	O

F	O

Service	O
:	O

Bone	O
marrow	O
transplant	O
service	O

Again	O
,	O
this	O
was	O
a	O
47-year-old	O
female	O
admitted	O
with	O
Berkitt's	B-problem
lymphoma	I-problem
.	O

HOSPITAL	O
COURSE	O
OVER	O
THESE	O
PREVIOUS	O
DAYS	O
:	O

1.	O
Liver	B-problem
lesions	I-problem
:	O

The	O
patient	O
went	O
for	O
a	B-test
repeat	I-test
MRI	I-test
which	O
showed	O
no	O
change	O
in	O
the	B-problem
previously	I-problem
noted	I-problem
enumerable	I-problem
hepatic	I-problem
cyst	I-problem
in	I-problem
her	I-problem
liver	I-problem
.	O

A	O
Hepatology	O
consult	O
was	O
obtained	O
who	O
felt	O
that	O
the	O
most	O
likely	O
etiology	O
of	O
these	B-problem
cysts	I-problem
were	O
from	O
hepatic	B-problem
candidiasis	I-problem
,	O
although	O
one	O
could	O
not	O
rule	O
out	O
lymphoma	B-problem
involving	O
from	O
Burkitt's	B-problem
.	O

She	O
will	O
be	O
discharged	O
on	O
AmBisome	B-treatment
300	O
mg	O
IV	O
q.d.	O
for	O
treatment	O
of	O
her	B-problem
hepatic	I-problem
candidiasis	I-problem
.	O

This	O
regimen	O
,	O
that	O
being	O
AmBisome	B-treatment
,	O
was	O
recommended	O
by	O
the	O
Infectious	O
Disease	O
physicians	O
,	O
who	O
felt	O
that	O
AmBisome	B-treatment
was	O
a	O
better	O
drug	O
of	O
choice	O
as	O
compared	O
to	O
fluconazole	B-treatment
.	O

2.	O
Heme	O
:	O

The	B-test
patient	I-test
's	I-test
platelets	I-test
,	O
white	B-test
count	I-test
,	O
and	O
hematocrit	B-test
have	O
all	O
been	O
stable	O
.	O

Her	B-test
white	I-test
count	I-test
remained	O
elevated	B-problem
despite	O
discontinuing	O
her	B-treatment
G-CSF	I-treatment
.	O

However	O
,	O
the	O
patient	O
is	O
not	O
febrile	B-problem
and	O
her	B-test
white	I-test
count	I-test
should	O
be	O
continued	O
to	O
be	O
watched	O
.	O

3.	O
On	O
the	O
morning	O
of	O
12-01	O
,	O
the	O
patient	O
had	O
some	O
transient	O
episodes	O
of	O
hypotension	B-problem
with	O
SBP	B-test
s	I-test
in	O
the	O
70	O
s.	O

Her	B-treatment
captopril	I-treatment
was	O
discontinued	O
,	O
and	O
she	O
was	O
given	O
two	B-treatment
IV	I-treatment
fluid	I-treatment
boluses	I-treatment
with	O
appropriate	O
response	O
.	O

Her	B-test
blood	I-test
pressures	I-test
and	O
all	O
of	O
her	B-test
vital	I-test
signs	I-test
are	O
stable	O
.	O

4.	O
FEN	O
:	O

The	O
patient	O
was	O
continued	O
on	O
TPN	B-treatment
over	O
the	O
past	O
couple	O
days	O
.	O

She	O
is	O
also	O
started	O
on	O
marinol	B-treatment
2.5	O
mg	O
p.o.	O
b.i.d.	O
and	O
encouraged	O
p.o.	O
intake	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Guarded	B-problem
,	O
but	O
stable	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Burkitt's	B-problem
lymphoma	I-problem
.	O

2.	O
Hepatic	B-problem
candidiasis	I-problem
.	O

DISCHARGE	O
STATUS	O
:	O

The	O
patient	O
will	O
be	O
discharged	O
to	O
an	O
outside	O
hospital	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
AmBisome	B-treatment
300	O
mg	O
IV	O
q.d.	O

2.	O
Marinol	B-treatment
2.5	O
mg	O
p.o.	O
b.i.d.	O
before	O
breakfast	O
and	O
dinner	O
.	O

3.	O
Atarax	B-treatment
25	O
mg	O
IV	O
/	O
p.o.	O
q.	O
4-6	O
h.	O
prn	O
for	O
itching	B-problem
.	O

4.	O
Colace	B-treatment
100	O
mg	O
p.o.	O
b.i.d.	O

5.	O
Protonix	B-treatment
40	O
mg	O
p.o.	O
/	O
IV	O
q.d.	O

6.	O
Nystatin	B-treatment
06-18	O
mL	O
swish	O
and	O
swallow	O
q.6.	O
prn	O
.	O

7.	O
Peridex	B-treatment
15	O
mL	O
swish	O
and	O
swallow	O
prn	O
.	O

Maria	O
Scheer	O
,	O
M.D.12.699	O

Dictated	O
By	O
:	O
Inez	O
Q	O
Hubbard	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2011-12-01	O
13:09	O

T	O
:	O
2011-12-01	O
13:20	O

JOB	O
#:	O

66182	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Richard	O
Blakey	O
on	O
:	O
FRI	O
2011-12-23	O
9:54	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2011-01-19	O

Discharge	O
Date	O
:	O

2011-01-25	O

Date	O
of	O
Birth	O
:	O

1943-01-22	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	O

INDICATION	O
FOR	O
ADMISSION	O
:	O

Transfer	O
from	O
Rehab	O
Hospital	O
of	O
the	O
Cape	O
&	O
Islands	O
Hospital	O
for	O
an	B-test
endoscopic	I-test
retrogram	I-test
cholangiopancreatography	I-test
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Eugene	O
is	O
a	O
67	O
year	O
old	O
male	O
with	O
a	O
remote	O
history	O
of	O
chronic	B-problem
pancreatitis	I-problem
due	O
to	O
alcohol	O
abuse	O
30	O
years	O
ago	O
,	O
who	O
is	O
transferred	O
now	O
from	O
Rehab	O
Hospital	O
of	O
the	O
Cape	O
&	O
Islands	O
Hospital	O
for	O
an	B-test
ERCP	I-test
and	O
work-up	B-test
for	O
a	B-problem
cystic	I-problem
lesion	I-problem
at	O
the	O
head	O
of	O
his	O
pancreas	O
on	O
CT	B-test
scan	I-test
shown	O
at	O
the	O
outside	O
hospital	O
.	O

The	O
patient	O
presented	O
initially	O
to	O
Rehab	O
Hospital	O
of	O
the	O
Cape	O
&	O
Islands	O
Hospital	O
at	O
the	O
end	O
of	O
December	O
for	O
abdominal	B-problem
pain	I-problem
,	O
and	O
was	O
found	O
to	O
have	O
pancreatitis	B-problem
.	O

During	O
this	O
admission	O
,	O
two	B-test
CT	I-test
scans	I-test
had	O
shown	O
a	O
question	O
of	O
an	B-problem
enlargement	I-problem
of	I-problem
the	I-problem
head	I-problem
of	I-problem
his	I-problem
pancreas	I-problem

versus	O
early	B-problem
pseudocyst	I-problem
.	O

The	O
patient	O
was	O
discharged	O
home	O
early	O
from	O
this	O
admission	O
due	O
to	O
family	O
needs	O
.	O

While	O
at	O
home	O
,	O
the	O
patient	O
did	O
not	O
do	O
well	O
and	O
could	O
tolerate	O
minimal	O
food	O
intake	O
and	O
lost	O
about	O
20	O
pounds	O
in	O
one	O
month	O
.	O

On	O
an	O
office	O
visit	O
on	O
01-14	O
,	O
the	O
patient	O
was	O
found	O
to	O
have	O
significantly	B-problem
elevated	I-problem
alkaline	I-problem
phosphatase	I-problem
.	O

That	O
evening	O
,	O
the	O
patient	O
again	O
developed	O
abdominal	B-problem
pain	I-problem
"	O
like	O
his	B-problem
pancreatitis	I-problem
"	O
with	O
nausea	B-problem
and	O
vomiting	B-problem
,	O
for	O
which	O
he	O
was	O
admitted	O
to	O
the	O
Rehab	O
Hospital	O
of	O
the	O
Cape	O
&	O
Islands	O
Hospital	O
.	O

In	O
the	O
Emergency	O
Department	O
at	O
the	O
Rehab	O
Hospital	O
of	O
the	O
Cape	O
&	O
Islands	O
Hospital	O
,	O
the	O
patient	O
was	O
noted	O
to	O
have	O
vomited	O
some	O
heme	O
positive	O
material	O
.	O

His	B-test
complete	I-test
blood	I-test
count	I-test
showed	O
11%	B-problem
bandemia	I-problem
with	O
a	B-test
total	I-test
white	I-test
count	I-test
of	O
10	O
.	O

A	B-test
HIDA	I-test
scan	I-test
showed	O
no	B-problem
flow	I-problem
,	O
question	O
of	O
pancreatitis	B-problem
versus	O
common	B-problem
bile	I-problem
duct	I-problem
obstruction	I-problem
.	O

His	B-test
electrocardiogram	I-test
showed	O
a	O
normal	O
sinus	O
rhythm	O
.	O

A	B-test
chest	I-test
x-ray	I-test
was	O
unremarkable	O
.	O

During	O
his	O
admission	O
to	O
Rehab	O
Hospital	O
of	O
the	O
Cape	O
&	O
Islands	O
Hospital	O
,	O
the	O
patient	O
had	O
dropped	O
his	B-test
hematocrit	I-test
to	O
the	O
30	O
s	O
with	O
recorded	B-problem
melena	I-problem
.	O

He	O
received	O
an	B-test
MRCP	I-test
which	O
was	O
negative	O
for	O
evidence	O
of	O
stones	B-problem
.	O

An	B-test
ultrasound	I-test
showed	O
normal	O
gallbladder	O
with	O
no	O
wall	B-problem
thickening	I-problem
but	O
a	B-problem
dilated	I-problem
common	I-problem
bile	I-problem
duct	I-problem
of	O
8	O
mm	O
measured	O
on	O
CT	B-test
scan	I-test
.	O

The	O
patient	O
had	O
an	B-test
attempted	I-test
ERCP	I-test
on	O
01-18	O
,	O
which	O
was	O
unsuccessful	O
due	O
to	O
a	B-problem
long	I-problem
nipple	I-problem
like	I-problem
papilla	I-problem
.	O

He	O
was	O
therefore	O
transferred	O
to	O
Saints	O
Medical	O
Center	O
for	O
endoscopic	B-test
retrogram	I-test
cholangiopancreatography	I-test
.	O

The	B-test
patient	I-test
's	I-test
blood	I-test
cultures	I-test
at	O
outside	O
hospital	O
grew	O
out	O
Streptococcus	B-problem
sanguis-gordonii	I-problem
on	O
01-18	O
.	O

This	O
was	O
sensitive	O
to	O
Clindamycin	B-treatment
,	O
Erythromycin	B-treatment
,	O
penicillin	B-treatment
S	I-treatment
and	O
Vancomycin	B-treatment
.	O

Prior	O
to	O
this	O
result	O
,	O
the	O
patient	O
had	O
already	O
been	O
on	O
Ampicillin	B-treatment
,	O
Sulbactam	B-treatment
and	O
Gentamycin	B-treatment
.	O

It	O
appears	O
from	O
the	O
Discharge	O
summary	O
that	O
the	O
patient	O
was	O
placed	O
on	O
Unasyn	B-treatment
3	O
grams	O
intravenously	O
every	O
six	O
hours	O
after	O
his	B-test
ERCP	I-test
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Type	B-problem
2	I-problem
diabetes	I-problem
mellitus	I-problem
.	O

2.	O
Right	B-problem
rotator	I-problem
cuff	I-problem
injury	I-problem
.	O

3.	O
Gastroesophageal	B-problem
reflux	I-problem
disease	I-problem
with	O
esophageal	B-treatment
dilatation	I-treatment
for	O
stricture	B-problem
.	O

4.	O
Recent	B-problem
pancreatitis	I-problem
;	O
prior	O
history	O
for	O
recurrent	B-problem
pancreatitis	I-problem
30	O
years	O
ago	O
from	O
alcohol	O
.	O

5.	O
History	O
of	O
Streptococcemia	B-problem
in	O
the	O
year	O
2008	O
;	O
source	O
was	O
unclear	O
but	O
presumed	O
to	O
be	O
urinary	O
.	O

6.	O
Status	O
post	O
tonsillectomy	B-treatment
as	O
a	O
child	O
.	O

MEDICATIONS	O
AT	O
HOME	O
:	O

1.	O
Prilosec	B-treatment
20	O
mg	O
p.o.	O
q.	O
day	O
.	O

2.	O
Flomax	B-treatment
4	O
mg	O
p.o.	O
q.	O
day	O
.	O

3.	O
Humalog	B-treatment
75/25	O
,	O
subcutaneously	O
.	O

4.	O
Regular	B-treatment
insulin	I-treatment
15	O
units	O
q.	O
a.m.	O
and	O
14	O
units	O
q.	O
p.m.	O

MEDICATIONS	O
ON	O
ADMISSION	O
FROM	O
TRANSFER	O
:	O

1.	O
Unasyn	B-treatment
3	O
grams	O
intravenous	O
every	O
six	O
hours	O
.	O

2.	O
NPH	B-treatment
10	O
units	O
subcutaneously	O
every	O
morning	O
and	O
8	O
units	O
subcutaneously	O
every	O
evening	O
.	O

3.	O
Flomax	B-treatment
0.4	O
mg	O
p.o.	O
q.	O
day	O
.	O

4.	O
Prilosec	B-treatment
30	O
mg	O
p.o.	O
q.	O
day	O
.	O

5.	O
Regular	B-treatment
insulin	I-treatment
sliding	I-treatment
scale	I-treatment
.	O

6.	O
Tylenol	B-treatment
.	O

ALLERGIES	O
:	O

The	O
patient	O
is	O
allergic	B-problem
to	O
Ciprofloxacin	B-treatment
,	O
morphine	B-treatment
sulfate	I-treatment
and	O
Droperidol	B-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
with	O
his	O
disabled	O
wife	O
who	O
has	O
a	B-problem
psychiatric	I-problem
condition	I-problem
.	O

He	O
had	O
a	O
history	O
of	O
alcohol	O
abuse	O
but	O
has	O
been	O
sober	O
for	O
30	O
years	O
.	O

He	O
is	O
a	O
retired	O
painter	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
showed	O
a	B-test
temperature	I-test
of	O
97.1	O
F.	O
;	O
heart	B-test
rate	I-test
of	O
65	O
;	O
blood	B-test
pressure	I-test
of	O
146/74	O
;	O
respiratory	B-test
rate	I-test
of	O
20	O
;	O
oxygen	B-test
saturation	I-test
98%	O
on	O
three	O
liters	O
and	O
95%	O
on	O
room	O
air	O
.	O

The	O
patient	O
was	O
alert	O
,	O
awake	O
and	O
oriented	O
,	O
pleasant	O
,	O
and	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Head	B-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
and	I-test
throat	I-test
examination	I-test
revealed	O
mucous	O
membranes	O
that	O
were	O
moist	O
.	O

The	O
patient	O
has	O
two	O
teeth	O
.	O

He	O
has	O
fine	O
dental	O
hygiene	O
.	O

He	O
had	O
no	O
icterus	B-problem
.	O

Cardiovascular	O
system	O
revealed	O
normal	O
S1	O
and	O
S2	O
,	O
no	O
murmurs	B-problem
or	O
gallops	B-problem
and	O
regular	O
rate	O
and	O
rhythm	O
.	O

Pulmonary	B-test
examination	I-test
revealed	O
lungs	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Abdominal	B-test
examination	I-test
revealed	O
an	O
abdomen	O
that	O
is	O
nondistended	B-problem
,	O
nontender	B-problem
.	O

He	O
had	O
normoactive	O
bowel	O
sounds	O
.	O

His	B-test
liver	I-test
span	I-test
was	O
8	O
cm	O
.	O

The	O
antrum	O
was	O
palpable	O
3	O
cm	O
below	O
the	O
costal	O
margin	O
.	O

The	O
spleen	O
tip	O
was	O
palpable	O
.	O

There	O
was	O
no	O
rebound	B-problem
;	O
no	O
Munos	B-problem
sign	I-problem
.	O

Extremities	O
reveal	O
no	O
edema	B-problem
,	O
no	O
swelling	B-problem
.	O

Neurologic	B-test
examination	I-test
revealed	O
an	O
alert	O
and	O
oriented	O
individual	O
.	O

His	O
face	O
was	O
symmetric	O
;	O
tongue	O
was	O
midline	O
.	O

His	O
language	O
was	O
fluent	O
and	O
normal	O
.	O

The	O
patient	O
was	O
moving	O
all	O
four	O
extremities	O
with	O
ease	O
.	O

There	O
was	O
no	O
formal	B-test
strength	I-test
test	I-test
done	O
.	O

LABORATORY	O
:	O

Studies	O
revealed	O
a	B-test
hematocrit	I-test
of	O
32.6	O
,	O
white	B-test
count	I-test
of	O
6.0	O
.	O

His	B-test
platelet	I-test
count	I-test
was	O
267	O
.	O

His	B-test
MCV	I-test
was	O
88	O
,	O
red	B-test
cell	I-test
distribution	I-test
was	O
13.4	O
.	O

Chemistry	O
on	O
admission	O
showed	O
a	B-test
sodium	I-test
of	O
141	O
,	O
potassium	B-test
of	O
4.3	O
,	O
chloride	B-test
of	O
107	O
,	O
bicarbonate	B-test
of	O
25	O
,	O
BUN	B-test
of	O
4	O
,	O
creatinine	B-test
of	O
0.6	O
and	O
a	B-test
sugar	I-test
of	O
177	O
.	O

Liver	B-test
function	I-test
tests	I-test
revealed	O
an	B-test
ALT	I-test
of	O
31	O
,	O
AST	B-test
of	O
36	O
,	O
alkaline	B-test
phosphatase	I-test
of	O
509	O
.	O

Total	B-test
bilirubin	I-test
was	O
0.8	O
.	O

Albumin	B-test
was	O
2.6	O
.	O

His	B-test
blood	I-test
cultures	I-test
were	O
drawn	O
and	O
pending	O
.	O

Urinalysis	B-test
revealed	O
trace	B-problem
glucose	I-problem
,	O
no	O
ketones	B-problem
,	O
no	O
red	B-problem
cells	I-problem
,	O
no	O
white	B-problem
cells	I-problem
and	O
less	O
than	O
one	O
epithelial	O
cells	O
.	O

COURSE	O
IN	O
HOSPITAL	O
:	O

The	O
patient	O
was	O
taken	O
down	O
to	O
the	B-test
endoscopic	I-test
retrogram	I-test
cholangiopancreatogram	I-test
upon	O
admission	O
.	O

On	O
this	B-test
examination	I-test
,	O
the	O
patient	O
was	O
found	O
to	O
have	O
mild	B-problem
biliary	I-problem
stricture	I-problem
most	O
likely	O
secondary	O
to	O
chronic	B-problem
pancreatitis	I-problem
.	O

Cytology	B-test
was	O
obtained	O
.	O

He	O
was	O
also	O
found	O
to	O
have	O
dilated	B-problem
pancreatic	I-problem
ducts	I-problem
with	O
calcifications	B-problem
consistent	O
with	O
chronic	B-problem
pancreatitis	I-problem
.	O

The	O
patient	O
underwent	O
a	B-treatment
percutaneous	I-treatment
sphincterotomy	I-treatment
extended	O
to	O
a	B-treatment
full	I-treatment
sphincterectomy	I-treatment
.	O

He	O
also	O
had	O
successful	B-treatment
extraction	I-treatment
of	O
stone	B-problem
fragments	I-problem
.	O

The	O
patient	O
tolerated	O
this	B-treatment
procedure	I-treatment
well	O
and	O
had	O
no	O
complications	B-problem
.	O

The	O
patient	O
subsequently	O
underwent	O
a	B-test
CT	I-test
scan	I-test
angiogram	I-test
with	O
Pancreas	B-test
protocol	I-test
to	O
assess	O
the	O
pseudocyst	B-problem
versus	O
enlarged	B-problem
pancreas	I-problem
head	I-problem
.	O

The	O
results	O
of	O
this	B-test
study	I-test
indicated	O
that	O
this	O
structure	O
at	O
the	O
head	O
of	O
his	O
pancreas	O
is	O
most	O
likely	O
a	B-problem
forming	I-problem
pseudocyst	I-problem
;	O
however	O
,	O
the	O
suspicion	O
of	O
malignancy	B-problem
is	O
still	O
possible	O
and	O
the	O
patient	O
underwent	O
an	B-test
ultrasound	I-test
guided	I-test
biopsy	I-test
of	O
this	B-problem
mass	I-problem
on	O
2011-01-20	O
.	O

The	O
cytology	O
for	O
this	B-test
biopsy	I-test
is	O
still	O
pending	O
.	O

The	O
patient	O
recovered	O
well	O
status	O
post	O
these	B-test
two	I-test
procedures	I-test
.	O

He	O
had	O
no	O
complications	B-problem
and	O
no	O
subsequently	B-problem
pancreatitis	I-problem
.	O

His	B-test
alkaline	I-test
phosphatase	I-test
and	O
all	B-problem
the	I-problem
other	I-problem
abnormal	I-problem
liver	I-problem
function	I-problem
tests	I-problem
were	O
resolving	O
.	O

He	O
had	O
no	O
pain	B-problem
and	O
did	O
not	O
require	O
any	B-treatment
pain	I-treatment
medications	I-treatment
.	O

He	O
was	O
tolerating	O
food	O
very	O
well	O
and	O
was	O
afebrile	B-problem
throughout	O
admission	O
.	O

With	O
regards	O
to	O
the	B-problem
patient	I-problem
's	I-problem
documented	I-problem
Strep	I-problem
septicemia	I-problem
in	O
the	O
outside	O
hospital	O
,	O
the	O
Infectious	O
Disease	O
Team	O
was	O
formally	O
consulted	O
.	O

Upon	O
obtaining	O
more	O
information	O
from	O
Rehab	O
Hospital	O
of	O
the	O
Cape	O
&	O
Islands	O
Hospital	O
,	O
it	O
appears	O
that	O
the	O
patient	O
had	O
two	O
out	O
of	O
four	O
bottles	O
growing	O
out	O
Streptococcus	B-problem
sanguis	I-problem
in	O
the	O
outside	O
hospital	O
.	O

The	O
patient	O
appeared	O
to	O
have	O
been	O
covered	O
by	O
Ampicillin	B-treatment
,	O
Gentamycin	B-treatment
and	O
then	O
Unasyn	B-treatment
in	O
the	O
outside	O
hospital	O
.	O

The	O
patient	O
,	O
on	O
admission	O
,	O
was	O
placed	O
on	O
Ampicillin	B-treatment
,	O
Gentamycin	B-treatment
and	O
Flagyl	B-treatment
.	O

With	O
repeated	B-test
blood	I-test
cultures	I-test
that	O
were	O
negative	O
,	O
the	O
patient	O
was	O
reduced	O
to	O
single	O
Mckenzie	O
of	O
intravenous	B-treatment
Ampicillin	I-treatment
.	O

For	O
this	B-problem
documented	I-problem
septicemia	I-problem
,	O
this	O
patient	O
went	O
for	O
a	B-test
endocarditis	I-test
work-up	I-test
.	O

He	O
had	O
a	B-test
transthoracic	I-test
echocardiogram	I-test
which	O
revealed	O
no	O
vegetations	B-problem
.	O

On	O
this	B-test
echocardiogram	I-test
,	O
he	O
was	O
found	O
to	O
have	O
mildly	B-problem
dilated	I-problem
left	I-problem
atrium	I-problem
,	O
mild	B-problem
symmetric	I-problem
left	I-problem
ventricular	I-problem
hypertrophy	I-problem
,	O
and	O
a	O
normal	O
ejection	O
fraction	O
of	O
greater	O
than	O
55%	O
.	O

There	O
were	O
no	O
other	B-problem
abnormalities	I-problem
noted	O
on	O
this	B-test
study	I-test
.	O

The	O
patient	O
then	O
underwent	O
a	B-test
transesophageal	I-test
echocardiogram	I-test
on	O
01-24	O
.	O

On	O
this	B-test
echocardiogram	I-test
,	O
he	O
was	O
again	O
noted	O
to	O
not	O
have	O
any	O
evidence	O
for	O
valvular	B-problem
vegetations	I-problem
.	O

A	B-problem
complex	I-problem
plaque	I-problem
was	O
found	O
in	O
the	O
aortic	O
arch	O
in	O
the	O
descending	O
thoracic	O
aorta	O
,	O
although	O
this	B-problem
plaque	I-problem
is	O
non-mobile	O
.	O

There	O
was	O
focal	B-problem
mitral	I-problem
valve	I-problem
prolapse	I-problem
noted	O
without	O
pathologic	B-problem
mitral	I-problem
regurgitation	I-problem
.	O

The	O
patient	O
was	O
noted	O
to	O
have	O
trace	B-problem
aortic	I-problem
regurgitation	I-problem
.	O

A	B-test
Panorex	I-test
x-ray	I-test
of	O
his	O
two	O
teeth	O
were	O
obtained	O
and	O
a	B-test
Dental	I-test
Consultation	I-test
was	O
done	O
.	O

The	O
patient	O
was	O
thought	O
to	O
have	O
normal	O
dental	O
hygiene	O
and	O
low	O
suspicion	O
for	O
a	O
source	O
of	O
his	B-problem
alpha	I-problem
septicemia	I-problem
from	I-problem
his	I-problem
mouth	I-problem
.	O

Infectious	O
Disease	O
Department	O
as	O
well	O
as	O
Cardiology	O
had	O
recommended	O
a	O
formal	O
14	O
-	O
day	O
course	O
of	O
intravenous	B-treatment
antibiotics	I-treatment
to	O
treat	O
a	B-problem
documented	I-problem
alpha	I-problem
Streptococcal	I-problem
septicemia	I-problem
from	O
outside	O
hospital	O
blood	B-test
cultures	I-test
.	O

The	O
patient	O
's	O
insurance	O
company	O
,	O
however	O
,	O
would	O
not	O
pay	O
for	O
home	B-treatment
antibiotics	I-treatment
.	O

After	O
much	O
discussion	O
with	O
the	O
patient	O
,	O
the	O
patient	O
was	O
informed	O
of	O
the	O
risks	O
of	O
not	O
finishing	O
a	O
14	O
day	O
course	O
of	O
intravenous	B-treatment
antibiotics	I-treatment
and	O
chose	O
to	O
go	O
home	O
.	O

He	O
had	O
three	O
days	O
of	O
antibiotics	B-treatment
remaining	O
at	O
the	O
time	O
of	O
discharge	O
.	O

It	O
was	O
discussed	O
with	O
the	O
patient	O
to	O
send	O
him	O
out	O
on	O
Augmentin	B-treatment
500	O
mg	O
three	O
times	O
a	O
day	O
for	O
ten	O
more	O
days	O
.	O

He	O
was	O
to	O
follow-up	O
with	O
his	O
primary	O
care	O
physician	O
within	O
two	O
to	O
three	O
days	O
for	O
repeat	B-test
laboratory	I-test
studies	I-test
and	O
blood	B-test
cultures	I-test
.	O

He	O
was	O
to	O
return	O
to	O
the	O
hospital	O
with	O
any	O
signs	O
of	O
shaking	B-problem
chills	B-problem
or	O
fever	B-problem
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Pancreatitis	B-problem
status	O
post	O
endoscopic	B-test
retrogram	I-test
cholangiopancreatography	I-test
and	O
sphincterotomy	B-treatment
.	O

2.	O
Alpha	B-problem
Streptococcus	I-problem
septicemia	I-problem
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Augmentin	B-treatment
500	O
mg	O
p.o.	O
three	O
times	O
a	O
day	O
times	O
ten	O
days	O
.	O

2.	O
Flomax	B-treatment
0.4	O
mg	O
p.o.	O
q.	O
day	O
.	O

3.	O
Prilosec	B-treatment
20	O
mg	O
p.o.	O
q.	O
day	O
.	O

4.	O
Humalog	B-treatment
and	O
Regular	B-treatment
insulin	I-treatment
subcutaneously	O
.	O

Hallo	O
MING	O
LI	O
,	O
M.D.	O

40-963	O

Dictated	O
By	O
:	O
Annie	O
D.	O
Martinez	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2011-01-25	O
14:08	O

T	O
:	O
2011-01-26	O
11:30	O

JOB	O
#:	O

09167	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Dorothy	O
L.	O
Brennan	O
on	O
:	O
Russell	O
2011-01-27	O
11:38	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2010-10-04	O

Discharge	O
Date	O
:	O

2010-10-17	O

Date	O
of	O
Birth	O
:	O

1929-11-09	O

Sex	O
:	O

F	O

Service	O
:	O

There	O
will	O
be	O
further	O
addendum	O
.	O

Respiratory	B-problem
distress	I-problem
-	O
On	O
10-12	O
,	O
the	O
patient	O
was	O
transferred	O
to	O
Medicine	O
Intensive	O
Care	O
Unit	O
secondary	O
to	O
respiratory	B-problem
distress	I-problem
.	O

In	O
the	O
Medicine	O
Intensive	O
Care	O
Unit	O
,	O
the	O
patient	O
was	O
initially	O
placed	O
on	O
high-flow	B-treatment
60%	I-treatment
oxygen	I-treatment
face	I-treatment
mask	I-treatment
and	O
they	O
diuresed	O
approximately	O
5	O
liters	O
off	O
into	O
the	B-treatment
intravenous	I-treatment
Lasix	I-treatment
.	O

The	O
patient	O
actually	O
was	O
improved	O
.	O

She	O
came	O
back	O
to	O
the	O
floor	O
on	O
10-14	O
.	O

Since	O
then	O
the	O
patient	O
's	O
oxygenation	O
has	O
been	O
improving	O
and	O
today	O
,	O
10-17	O
,	O
she	O
is	O
requiring	O
.5	O
liters	O
of	O
keep	O
her	B-test
saturations	I-test
above	O
94	O
.	O

The	O
patient	O
continues	O
to	O
be	O
diuresed	O
with	O
approximately	O
20	O
mg	O
of	O
Lasix	B-treatment
a	O
day	O
and	O
she	O
has	O
had	O
good	O
urine	O
output	O
.	O

Anemia	B-problem
-	O
The	B-test
patient	I-test
's	I-test
hematocrit	I-test
dropped	O
in	O
the	O
Intensive	O
Care	O
Unit	O
to	O
the	O
mid	O
20s	O
and	O
she	O
received	O
one	O
unit	O
of	O
packed	O

red	B-treatment
blood	I-treatment
cells	I-treatment
with	O
a	O
good	O
response	O
up	O
to	O
30	O
.	O

Hypotension	B-problem
-	O
On	O
the	O
night	O
of	O
10-16	O
,	O
the	O
patient	O
was	O
diuresed	O
with	O
20	O
mg	O
of	O
intravenous	B-treatment
Lasix	I-treatment
.	O

This	O
is	O
the	O
normal	O
dose	O
that	O
she	O
puts	O
out	O
too	O
.	O

The	O
patient	O
became	O
hypotensive	B-problem
into	O
the	O
70	O
s	O
without	O
any	B-problem
symptoms	I-problem
.	O

Her	B-test
oxygen	I-test
saturations	I-test
were	O
greater	O
than	O
94%	O
at	O
the	O
time	O
.	O

The	O
patient	O
was	O
given	O
250	O
cc	O
of	O
normal	B-treatment
saline	I-treatment
and	O
her	B-test
blood	I-test
pressure	I-test
responded	O
coming	O
back	O
up	O
to	O
the	O
high	O
90	O
s.	O

No	O
further	O
episodes	O
of	O
hypotension	B-problem
were	O
noted	O
.	O

As	O
of	O
the	O
time	O
of	O
this	O
dictation	O
,	O
on	O
2010-10-17	O
,	O
the	O
patient	O
appears	O
to	O
be	O
getting	O
better	O
.	O

Recent	B-test
chest	I-test
x-ray	I-test
shows	O
resolving	B-problem
right	I-problem
lower	I-problem
lobe	I-problem
pneumonia	I-problem
.	O

She	O
continues	O
on	O
her	B-treatment
Prednisone	I-treatment
taper	I-treatment
for	O
her	B-problem
asthma	I-problem
and	O
this	O
is	O
day	O
#	O
14	O
of	O
antibiotics	B-treatment
.	O

MARK	O
Shorter	O
,	O
M.D.	O

94-264	O

Dictated	O
By	O
:	O
Donna	O
Q	O
Fisher	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2010-10-17	O
12:22	O

T	O
:	O
2010-10-17	O
17:21	O

JOB	O
#:	O

33371	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2019-01-19	O

Discharge	O
Date	O
:	O

2019-01-24	O

Date	O
of	O
Birth	O
:	O

1981-03-17	O

Sex	O
:	O

M	O

Service	O
:	O
MEDICINE	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O
Antonio	O
I	O
Staples	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

nausea	B-problem
and	O
vomiting	B-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

01-23	O
PORT	B-treatment
line	I-treatment
removal	I-treatment
.	O

01-23	O
PICC	B-treatment
placement	I-treatment
.	O

01-24	O
PICC	B-treatment
removal	I-treatment
.	O

History	O
of	O
Present	O
Illness	O
:	O

This	O
is	O
a	O
37	O
y/o	O
male	O
patient	O
with	O
PMH	O
Type	B-problem
I	I-problem
DM	I-problem
,	O
HTN	B-problem
,	O
gastroparesis	B-problem
,	O
ESRD	B-problem
on	O
HD	B-treatment
(	O
last	O
in	O
12/26	O
per	O
patient	O
)	O
who	O
presents	O
to	O
CMED	O
CCU	O
with	O
hypertensive	B-problem
urgency	I-problem
unable	O
from	O
the	O
Larry	O
.	O

The	O
patient	O
early	O
this	O
morning	O
to	O
the	O
Ruthie	O
with	O
his	B-problem
usual	I-problem
nausea	I-problem
,	O
vomiting	B-problem
,	O
abdominal	B-problem
pain	I-problem
and	O
was	O
found	O
to	O
be	O
hypertensive	B-problem
to	O
256/110	O
,	O
HR	B-test
102	O
,	O
T	B-test
99.2	O
,	O
RR	B-test
22	O
,	O
92%	O
RA	O
.	O

History	O
is	O
difficult	O
to	O
obtain	O
from	O
patient	O
d/t	O
somnolence	B-problem
and	O
lack	B-problem
of	I-problem
desire	I-problem
to	O
participate	O
in	O
interview	O
,	O
but	O
per	O
Frank	O
note	O
he	O
was	O
diaphoretic	B-problem
and	O
'	O
writing	O
in	O
pain	B-problem
',	O
vomiting	O
clear	O
substance	O
.	O

He	O
was	O
given	O
ativan	B-treatment
a	O
total	O
of	O
4	O
mg	O
of	O
ativan	B-treatment
,	O
6	O
mg	O
of	O
dilaudid	B-treatment
,	O
labetolol	B-treatment
20	O
mg	O
IV	O
x	O
1	O
and	O
hydralazine	B-treatment
10	O
mg	O
IV	O
x	O
1	O
without	O
good	O
response	O
(	O
200/99	O
).	O

He	O
recieved	O
2L	B-treatment
NS	I-treatment
and	O
was	O
started	O
on	O
labetolol	B-treatment
gtt	I-treatment
and	O
BP	B-test
decreased	O
to	O
161/79	O
.	O

Tranferred	O
to	O
CMED	O
CCU	O
for	O
further	O
management	O
while	O
on	O
labetolol	B-treatment
gtt	I-treatment
.	O

Of	O
note	O
,	O
the	O
patient	O
is	O
admitted	O
to	O
hospital	O
3	O
times	O
every	O
month	O
for	O
similar	O
complaints	O
with	O
last	O
admission	O
1/20-2/1/07	O
.	O

At	O
that	O
time	O
BP	B-test
was	O
attributed	O
to	O
abdominal	B-problem
pain	I-problem
and	O
inability	O
to	O
take	O
PO	O
meds	O
d/t	O
nausea	B-problem
/	O
vomiting	B-problem
.	O

Also	O
had	O
labile	B-problem
blood	I-problem
sugars	I-problem
with	O
repeated	O
episodes	O
of	O
hypoglycemia	B-problem
,	O
and	O
Strickland	O
recommended	O
sugars	B-test
in	O
the	O
range	O
of	O
150-200	O
.	O

He	O
eloped	O
prior	O
to	O
formal	O
discharge	O
when	O
his	B-test
FS	I-test
was	O
found	O
to	O
be	O
critically	B-problem
high	I-problem
-	O
recommended	O
to	O
patient	O
that	O
he	O
stay	O
for	O
repeat	O
,	O
but	O
left	O
AMA	O
without	O
signing	O
any	O
forms	O
.	O

Upon	O
transfer	O
to	O
the	O
CMED	O
CCU	O
the	O
patient	O
appears	O
somewhat	B-problem
uncomfortable	I-problem
,	O
reporting	O
nausea	B-problem
and	O
abdominal	B-problem
pain	I-problem
,	O
but	O
when	O
questioned	O
he	O
was	O
unable	O
/	O
unwilling	O
to	O
participate	O
in	O
HPI	O
or	O
exam	B-test
d/t	O
sleepiness	B-problem
.	O

He	O
denied	O
CP	B-problem
,	O
SOB	B-problem
,	O
HA	B-problem
,	O
vision	B-problem
changes	I-problem
,	O
neck	B-problem
stiffness	I-problem
,	O
dysuria	B-problem
,	O
or	O
other	B-problem
symptoms	I-problem
.	O

In	O
the	O
CMED	O
CCU	O
he	O
became	O
hypotensive	B-problem
to	O
SBP	B-test
80	O
s.	O

Labetalol	B-treatment
was	O
stopped	O
and	O
he	O
received	O
a	B-treatment
500	I-treatment
cc	I-treatment
fluid	I-treatment
bolus	I-treatment
and	O
his	B-test
blood	I-test
pressure	I-test
rose	O
to	O
SBP	B-test
90	O
s.	O

Cardiac	O
and	O
infectious	O
sources	O
of	O
hypotension	B-problem
were	O
considered	O
,	O
but	O
cardiac	B-test
enzymes	I-test
were	O
not	O
changed	O
from	O
prior	O
studies	O
and	O
he	O
had	O
no	O
localizing	B-problem
signs	I-problem
of	I-problem
infection	I-problem
;	O
blood	B-test
cultures	I-test
were	O
sent	O
and	O
a	B-test
ultrasound	I-test
of	O
the	B-treatment
L	I-treatment
arm	I-treatment
AVF	I-treatment
ordered	O
to	O
rule	O
out	O
abscess	B-problem
at	I-problem
the	I-problem
site	I-problem
.	O

He	O
received	O
a	B-treatment
partial	I-treatment
HD	I-treatment
session	I-treatment
,	O
limited	O
by	O
hypotension	B-problem
.	O

Over	O
night	O
,	O
his	B-test
blood	I-test
pressure	I-test
trended	O
up	O
to	O
130	O
s	O
systolic	O
.	O

He	O
was	O
restarted	O
on	O
his	B-treatment
home	I-treatment
blood	I-treatment
pressure	I-treatment
regimen	I-treatment
.	O

Renal	O
consult	O
team	O
saw	O
him	O
2019-01-20	O
and	O
plan	O
to	O
next	O
dialyze	O
him	O
on	O
2019-01-21	O
.	O

He	O
was	O
to	O
be	O
called	O
out	O
to	O
the	O
medical	O
floor	O
on	O
2019-01-20	O
but	O
became	O
somnolent	B-problem
after	O
receiving	O
pain	B-treatment
and	I-treatment
anti-nausea	I-treatment
meds	I-treatment
,	O
so	O
he	O
stayed	O
in	O
the	O
ICU	O
for	O
closer	O
monitoring	O
of	O
respiratory	O
status	O
,	O
which	O
spontaneously	O
improved	O
.	O

His	B-test
blood	I-test
sugar	I-test
at	O
10	O
pm	O
was	O
low	O
at	O
22	O
and	O
he	O
was	O
disoriented	B-problem
,	O
which	O
resolved	O
with	O
two	O
glasses	O
of	O
juice	O
;	O
he	O
did	O
not	O
receive	O
his	O
standing	O
dose	O
of	O
NPH	B-treatment
that	O
evening	O
.	O

Blood	B-test
cultures	I-test
returned	O
positive	O
with	O
GPC	B-problem
in	I-problem
pairs	I-problem
and	I-problem
clusters	I-problem
,	O
so	O
a	B-test
TTE	I-test
and	O
surveillance	B-test
cultures	I-test
were	O
ordered	O
and	O
vancomycin	B-treatment
was	O
started	O
.	O

He	O
was	O
then	O
called	O
out	O
to	O
the	O
medical	O
floor	O
on	O
01-21	O
.	O

Past	O
Medical	O
History	O
:	O

1.	O
DM	B-problem
type	I-problem
I	O

2.	O
ESRD	B-problem
on	O
hemodialysis	B-treatment
started	O
2017-01-07	O
on	O
Tu	O
,	O
Th	O
,	O
Sat	O

3.	O
Severe	B-problem
autonomic	I-problem
dysfunction	I-problem
with	O
multiple	O
hospitalizations	O
for	O
hypertensive	B-problem
emergency	I-problem
,	O
gastroparesis	B-problem
,	O
and	O
orthostatic	B-problem
hypotension	I-problem
.	O

4.	O
History	O
of	O
esophageal	B-problem
erosion	I-problem
,	O
MW	B-problem
tear	I-problem

5.	O
CAD	B-problem
with	O
1-vessel	B-problem
disease	I-problem
(	O
50%	B-problem
stenosis	I-problem
D1	I-problem
in	O
2014-06-07	O
),	O
normal	O
stress	O

2015-10-07	O

6.	O
hx	O
of	O
Foot	B-problem
Ulcer	I-problem

7.	O
h/o	O
clot	B-problem
in	O
AV	B-treatment
graft	I-treatment
x2	O
(	O
March	O
and	O
2018-07-07	O
)	O

Social	O
History	O
:	O

Denies	O
alcohol	O
or	O
tobacco	O
use	O
.	O

Endorses	O
occassional	O
marijuana	O
use	O
.	O

Lives	O
with	O
his	O
Carney	O
Hospital	O
mother	O
and	O
their	O
three	O
children	O
.	O

Family	O
History	O
:	O

His	O
father	O
recently	O
died	O
of	O
ESRD	B-problem
and	O
diabetes	B-problem
.	O

His	O
mother	O
is	O
in	O
her	O
50	O
s	O
and	O
has	O
hypertension	B-problem
.	O

He	O
has	O
two	O
sisters	O
,	O
one	O
with	O
diabetes	B-problem
,	O
and	O
six	O
brothers	O
,	O
one	O
with	O
diabetes	B-problem
.	O

Physical	O
Exam	O
:	O

Vitals	B-test
:	O
97.4	O
,	O
164/90	O
,	O
102	O
,	O
10	O
,	O
97%	O
4L	O

General	O
:	O
sleepy	B-problem
,	O
arouses	O
to	O
voice	O
but	O
limited	O
participation	O
with	O
physical	B-test
exam	I-test

HEENT	O
:	O
PERRL	O
,	O
left	B-problem
pupil	I-problem
smaller	I-problem
than	I-problem
right	I-problem
,	O
pt	O
will	O
not	O
participate	O
in	O
EOMI	O
,	O
sclera	O
anicteric	B-problem
,	O
MM	B-problem
dry	I-problem
,	O
No	O
OP	B-problem
lesions	I-problem

Neck	O
:	O
Supple	O
,	O
no	O
JVD	B-problem

CV	O
:	O
RRR	O
,	O
nl	O
S1	O
,	O
S2	O
,	O
2/6	B-problem
systolic	I-problem
murmur	I-problem
at	I-problem
LUSB	I-problem

Lungs	O
:	O
CTAB	O
post	O

Chest	O
:	O
HD	B-treatment
line	I-treatment
in	O
place	O
without	O
erythema	B-problem

Abd	O
:	O
Soft	O
,	O
ND	B-problem
,	O
nontender	B-problem
,	O
+	O
BS	O
,	O
no	O
guarding	B-problem
,	O
no	O
rebound	B-problem
,	O
multiple	B-problem
well	I-problem
healed	I-problem
scars	I-problem

Ext	O
:	O
no	O
c/c/e	B-problem
,	O
left	B-problem
arm	I-problem
with	I-problem
fistula	I-problem
with	O
good	O
thrill	O

Skin	O
:	O
no	O
rashes	B-problem

Brief	O
Hospital	O
Course	O
:	O

Pt	O
admitted	O
to	O
medical	O
floor	O
in	O
hemodynamically	O
stable	O
condition	O
without	O
specific	B-problem
complaints	I-problem
.	O

#	O
hypertensive	B-problem
urgency	I-problem
:	O

Upon	O
presentation	O
it	O
was	O
unclear	O
when	O
last	O
time	O
was	O
that	O
patient	O
took	O
meds	B-treatment
,	O
but	O
hypertension	B-problem
likely	O
d/t	O
inability	B-problem
to	I-problem
take	I-problem
meds	I-problem
in	O
setting	O
of	O
N/V	B-problem
.	O

Also	O
contribution	O
of	O
autonomic	B-problem
dysfunction	I-problem
.	O

No	O
evidence	O
of	O
active	B-problem
end	I-problem
organ	I-problem
damage	I-problem
.	O

Pt	O
was	O
treated	O
with	O
labetalol	B-treatment
gtt	I-treatment
in	O
CMED	O
CCU	O
which	O
was	O
weaned	O
off	O
on	O
01-20	O
.	O

carduac	B-problem
enzymes	I-problem
mildly	I-problem
elevated	I-problem
,	O
felt	O
02-08	O
demand	B-problem
ischemia	I-problem
in	O
setting	O
of	O
hypertensive	B-problem
urgency	I-problem
,	O
CK	B-test
and	O
MB	B-test
trended	O
Mcewen	O
at	O
time	O
of	O
admission	O
to	O
medical	O
floor	O
.	O

Pt	B-problem
's	I-problem
hypertensive	I-problem
urgency	I-problem
was	O
resolved	O
upon	O
admission	O
to	O
the	O
medical	O
floor	O
.	O

His	B-test
SBP	I-test
s	I-test
ranged	O
140	O
s-	O
170	O
s	O
.	O

He	O
was	O
restarted	O
on	O
his	O
home	O
regimen	O
of	O
antihypertensives	B-treatment
without	O
difficulty	O
(	O
metoprolol	B-treatment
75	O
tid	O
,	O
clonidine	B-treatment
patch	I-treatment
and	I-treatment
oral	I-treatment
,	O
nifedipine	B-treatment
30	O
SR	O
q	O
daily	O
).	O

he	O
was	O
discharged	O
home	O
with	O
change	O
in	O
his	O
regimen	O
.	O

#	O
bacteremia	B-problem
:	O

pt	O
with	O
2/4	O
bottles	O
coag	B-problem
neg	I-problem
staph	I-problem
on	O
01-19	O
and	O
again	O
on	O
01-20	O
.	O

PORT	B-treatment
was	O
felt	O
most	O
likely	O
source	O
,	O
and	O
pt	O
has	O
had	O
at	O
least	O
2	O
sets	O
of	O
+	B-problem
blood	I-problem
cultures	I-problem
since	O
it	O
was	O
placed	O
.	O

TTE	B-test
was	O
obtained	O
which	O
was	O
not	O
concerning	O
for	O
endocarditis	B-problem
.	O

pt	O
without	O
stigmata	B-problem
of	I-problem
SBE	I-problem
.	O

ID	O
consult	O
obtained	O
which	O
recommended	O
removal	B-treatment
of	I-treatment
PORT	I-treatment
,	O
which	O
was	O
taken	O
out	O
on	O
01-23	O
.	O

Pt	O
will	O
compelete	O
a	O
2	O
week	O
course	O
of	O
vancomycin	B-treatment
at	O
hemodialysis	B-treatment
,	O
which	O
has	O
been	O
arranged	O
by	O
renal	O
service	O
.	O

A	B-treatment
PICC	I-treatment
was	O
breifly	O
placed	O
,	O
however	O
removed	O
as	O
it	O
is	O
unclear	O
if	O
pt	O
can	O
reliably	O
flush	O
this	O
.	O

PORT	B-treatment
will	O
be	O
replaced	O
on	O
2019-02-11	O
per	O
IR	O
(	O
Dr.	O
Welsh	O
placed	O
last	O
PORT	B-treatment
,	O
then	O
removed	O
it	O
on	O
01-23	O
),	O
ordered	O
placed	O
in	O
OMR	O
.	O

Indication	O
:	O

diabetic	B-problem
gastropathy	I-problem
causing	O
inability	B-problem
to	I-problem
toleral	I-problem
oral	I-problem
antihypertensive	I-problem
medication	I-problem
prompting	O
repeated	O
Donald	O
presentation	O
for	O
hypertensive	B-problem
urgency	I-problem
.	O

Pt	O
with	O
surveillance	B-test
cultures	I-test
and	O
port	B-test
tip	I-test
cultures	I-test
showing	O
NGTD	O
on	O
01-24	O
,	O
he	O
will	O
have	O
futher	B-test
surveillance	I-test
cultures	I-test
drawn	O
at	O
hemodialysis	B-treatment
and	O
followed	O
by	O
his	O
nephrologist	O
.	O

#	O
n/v/	B-problem
abdominal	B-problem
pain	I-problem
:	O
pt	O
with	O
multiple	O
admissions	O
with	O
similar	B-problem
complaints	I-problem
,	O
etiology	O
02-08	O
gastroparesis	B-problem
,	O
improves	O
considerably	O
with	O
ativan	B-treatment
,	O
dilaudid	B-treatment
,	O
reglan	B-treatment
,	O
pt	O
was	O
tolerating	O
PO	B-treatment
meds	I-treatment
/	O
diet	O
at	O
time	O
of	O
admission	O
to	O
medical	O
service	O
and	O
was	O
restarted	O
on	O
oral	B-treatment
reglan	I-treatment
.	O

#	O
DMI	B-problem
:	O
Pt	O
on	O
sliding	B-treatment
scale	I-treatment
as	O
inpatient	O
and	O
taking	O
NPH	B-treatment
2	O
units	O
BID	O
at	O
home	O
.	O

pt	O
with	O
two	O
episodes	O
of	O
hypoglycemia	B-problem
(	O
FSBS	B-test
22	O
and	O
27	O
),	O
etiology	O
unclear	O
,	O
pt	O
followed	O
by	O
Strickland	O
,	O
who	O
recommend	O
no	O
changes	O
to	O
current	B-treatment
insulin	I-treatment
regimen	I-treatment
.	O

will	O
discharge	O
pt	O
with	O
instructions	O
to	O
continue	O
NPH	B-treatment
2	O
UNITS	O
BID	O
as	O
Frederick	O
Tracey	O
recs	O
.	O

#	O
CAD	B-problem
-	O
pt	O
denied	O
cp	B-problem
/	O
sob	B-problem
throughout	O
hospitalization	O
.	O

Troponins	B-test
rose	O
at	O
admission	O
,	O
however	O
CK	B-test
and	O
MB	B-test
trending	O
Mcewen	O
wat	O
time	O
of	O
admission	O
to	O
medical	O
service	O
.	O

Etiology	O
felt	O
most	O
likely	O
demand	B-problem
ischemia	I-problem
in	O
setting	O
of	O
original	B-problem
hypertensive	I-problem
urgency	I-problem
with	O
persistent	B-problem
elevation	I-problem
of	I-problem
trop	I-problem
02-08	O
ESRD	B-problem
.	O

Pt	O
was	O
continued	O
on	O
aspirin	B-treatment
,	O
metoprolol	B-treatment
,	O
nifedipine	B-treatment
.	O

#	O
ESRD	B-problem
:	O
etiology	O
likely	O
02-08	O
DM	B-problem
and	O
HTN	B-problem
,	O
pt	O
tolerating	O
HD	B-treatment
well	O
,	O
and	O
underwent	O
dialysis	B-treatment
without	O
difficulty	B-problem
on	O
01-24	O
.	O

pt	O
will	O
be	O
discharged	O
home	O
with	O
plan	O
to	O
continue	O
current	B-treatment
dialysis	I-treatment
schedule	I-treatment
(	O
Tue	O
/	O
Th	O
/	O
Sat	O
).	O

In	O
addition	O
pt	O
will	O
be	O
given	O
vancomycin	B-treatment
at	O
dialysis	O
x	O
2	O
week	O
course	O
(	O
last	O
day	O
2019-02-05	O
)	O
given	O
his	B-problem
PORT	I-problem
line	I-problem
infection	I-problem
.	O

He	O
will	O
have	O
levels	B-test
drawn	O
at	O
dialysis	B-treatment
and	O
be	O
dosed	O
with	O
vancomycin	B-treatment
as	O
appropriate	O
.	O

Plan	O
is	O
for	O
surveillance	B-test
cultures	I-test
to	O
be	O
drawn	O
at	O
dialysis	B-treatment
.	O

If	O
negative	O
,	O
pt	O
is	O
scheduled	O
for	O
presumptively	B-treatment
replacement	I-treatment
of	I-treatment
PORT	I-treatment
on	O
2019-02-11	O
with	O
interventional	B-treatment
radiology	I-treatment
(	O
dr.	O
Arevalo	O
).	O

Pt	O
continued	O
on	O
home	O
regimen	O
of	O
calcium	B-treatment
acetate	I-treatment
667	O
mg	O
,	O
3	O
capsules	O
TID	O
.	O

#	O
AV	B-treatment
fistula	I-treatment
:	O
pt	O
with	O
h/o	O
numerous	B-problem
clots	I-problem
in	O
AV	B-treatment
fistula	I-treatment
.	O

No	O
signs	O
of	O
infection	B-problem
presently	O
,	O
and	O
tolerating	O
dialysis	B-treatment
without	O
difficulty	B-problem
.	O

Pt	O
was	O
subtherapeuticon	B-problem
INR	I-problem
on	O
admission	O
,	O
thus	O
treated	O
with	O
heparin	B-treatment
gtt	I-treatment
.	O

coumadin	B-treatment
held	O
on	O
01-22	O
for	O
PORT	B-treatment
removal	I-treatment
,	O
and	O
restarted	O
on	O
01-24	O
.	O

Pt	O
discharged	O
with	O
instructions	O
to	O
continue	O
coumadin	B-treatment
1.5	O
mg	O
po	O
q	O
daily	O
with	O
goal	B-test
INR	I-test
02-09	O
.	O

#	O
DISPO	O
:	O

pt	O
discharged	O
home	O
on	O
01-24	O
with	O
instructions	O
to	O
complete	O
2	O
week	O
course	O
of	O
vancomycin	B-treatment
at	O
hemodialysis	B-treatment
for	O
his	B-problem
PORT	I-problem
line	I-problem
infection	I-problem
.	O

an	O
appointment	O
was	O
made	O
with	O
interventional	O
radiology	O
on	O
2019-02-11	O
to	O
replace	O
his	B-treatment
PORT	I-treatment
,	O
under	O
the	O
assumption	O
that	O
his	B-test
surveillance	I-test
cultures	I-test
from	O
dialysis	B-treatment
remain	O
negative	O
.	O

discussed	O
this	O
plan	O
with	O
renal	O
service	O
(	O
Anthony	O
Mcknight	O
)	O
who	O
will	O
communicate	O
with	O
pt	O
's	O
outpatient	O
dialysis	O
service	O
.	O

Medications	O
on	O
Admission	O
:	O

Metoclopramide	B-treatment
10	O
mg	O
PO	O
Q6	O

Metoprolol	B-treatment
Tartrate	I-treatment
75	O
mg	O
PO	O
TID	O

Calcium	B-treatment
Acetate	I-treatment
1340	O
mg	O
tid	O
with	O
meals	O

Anzemet	B-treatment
12.5	O
IV	O
prn	O

Prochlorperazine	B-treatment
10	O
mg	O
IV	O
Q6H	O
prn	O

Ativan	B-treatment
1	O
mg	O
PO	O
Q6H	O
prn	O

Dilaudid	B-treatment
4mg	O
PO	O
Q3-4H	O
prn	O

Insulin	B-treatment
NPH	I-treatment
2	O
units	O
Subcutaneous	O
twice	O
a	O
day	O
.	O

Clonidine	B-treatment
0.3	O
mg	O
/	O
24	O
hr	O
Patch	O
Weekly	O
Transdermal	O
QTHUR	O

Clonidine	B-treatment
0.2	O
mg	O
PO	O
TID	O

Prochlorperazine	B-treatment
10	O
mg	O
q	O
6	O
h	O

Coumadin	B-treatment
1.5	O
mg	O
PO	O
QHS	O

Nifedipine	B-treatment
30	O
SR	O
mg	O
PO	O
QD	O

Bisacodyl	B-treatment
prn	O

Protonix	B-treatment
40	O
QD	O

Discharge	O
Medications	O
:	O

1.	O
Metoclopramide	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
).	O

2.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

3.	O
Calcium	B-treatment
Acetate	I-treatment
667	O
mg	O
Capsule	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Capsule	O
PO	O
TID	O
W/	O
MEALS	O
(	O
3	O
TIMES	O
A	O
DAY	O
WITH	O
MEALS	O
).	O

4.	O
Ativan	B-treatment
1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
q6h	O
prn	O
.	O

5.	O
Dilaudid	B-treatment
4	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
q3-4hr	O
prn	O
.	O

6.	O
Clonidine	B-treatment
0.3	O
mg	O
/	O
24	O
hr	O
Patch	O
Weekly	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Patch	O
Weekly	O
Transdermal	O
Q	O
WED	O
(	O
every	O
Wednesday	O
).	O

7.	O
Clonidine	B-treatment
0.2	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

8.	O
Warfarin	B-treatment
1	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
DAILY	O
(	O
Daily	O
).	O

9.	O
Nifedipine	B-treatment
30	O
mg	O
Tablet	O
Sustained	O
Release	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
Sustained	O
Release	O
PO	O
DAILY	O
(	O
Daily	O
).	O

10.	O
Pantoprazole	B-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
).	O

11.	O
Bisacodyl	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
as	O
needed	O
for	O
constipation	B-problem
.	O

12.	O
Vancomycin	B-treatment
in	I-treatment
Dextrose	I-treatment
1	O
g	O
/	O
200	O
mL	O
Piggyback	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Intravenous	O
QHD	O
(	O
each	O
hemodialysis	B-treatment
):	O
2	O
week	O
course	O
to	O
be	O
given	O
at	O
dialysis	O
,	O
last	O
day	O
2019-02-05	O
.	O

Disp	O
:*	O
qs	O
*	O
Refills	O
:*	O
2	O
*	O

13.	O
Aspirin	B-treatment
81	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
.	O

14.	O
Humalog	B-treatment
100	O
unit	O
/	O
mL	O
Solution	O
Sig	O
:	O
USE	O
AS	O
DIRECTED	O
Subcutaneous	O
four	O
times	O
a	O
day	O
:	O
please	O
use	O
attached	O
sliding	B-treatment
scale	I-treatment
.	O

Disp	O
:*	O
qs	O
*	O
Refills	O
:*	O
2	O
*	O

15.	O
Insulin	B-treatment
NPH	I-treatment
Human	I-treatment
Recomb	I-treatment
100	O
unit	O
/	O
mL	O
Suspension	O
Sig	O
:	O
2	O
UNITS	O
Subcutaneous	O
twice	O
a	O
day	O
.	O

Disp	O
:*	O
qs	O
*	O
Refills	O
:*	O
2	O
*	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

primary	O
:	O

bacteremia	B-problem
02-08	O
PORT	B-problem
line	I-problem
infection	I-problem

hypertensive	B-problem
urgency	I-problem

diabetic	B-problem
gastropathy	I-problem

Discharge	O
Condition	O
:	O

stable	O
.	O

Discharge	O
Instructions	O
:	O

please	O
continue	O
to	O
take	O
all	O
of	O
your	B-treatment
medications	I-treatment
as	O
prescribed	O
.	O

you	O
were	O
started	O
on	O
a	O
2	O
week	O
course	O
of	O
vancomycin	B-treatment
to	O
be	O
given	O
at	O
hemodialysis	B-treatment
for	O
your	B-problem
line	I-problem
infection	I-problem
.	O

you	O
will	O
have	O
your	B-treatment
PORT	I-treatment
replaced	O
after	O
2	O
weeks	O
of	O
antibiotics	B-treatment
if	O
your	B-test
blood	I-test
cultures	I-test
remain	O
negative	O
.	O

if	O
you	O
have	O
recurrent	B-problem
fevers	I-problem
,	O
chills	B-problem
,	O
naseau	B-problem
,	O
vomitting	B-problem
,	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
or	O
other	B-problem
worrisome	I-problem
symptoms	I-problem
,	O
please	O
contact	O
your	O
primary	O
care	O
physician	O
or	O
the	O
emergency	O
department	O
.	O

Followup	O
Instructions	O
:	O

please	O
follow	O
up	O
with	O
your	O
primary	O
care	O
doctor	O
within	O
4	O
weeks	O
.	O

please	O
follow-up	O
with	O
your	O
dialysis	O
physician	O
regarding	O
replacing	O
your	B-treatment
PORT	I-treatment
.	O

please	O
follow-up	O
with	O
dr.	O
Lillian	O
becker	O
in	O
gastroenterology	O
within	O
1-2	O
weeks	O
,	O
an	O
appointment	O
has	O
been	O
made	O
for	O
on	O
you	O
2019-02-11	O
at	O
3PM	O
.	O

(	O
447	O
)	O
671-2034	O
(	O
Caldwell	O
building	O
,	O
1st	O
floor	O
,	O
1718	O
S.	O
Sixth	O
Blvd.	O
).	O

upon	O
arriving	O
home	O
please	O
contact	O
the	O
King	O
and	O
arrange	O
to	O
be	O
seen	O
within	O
1-2	O
weeks	O
.	O

Adam	O
Ruth	O
MD	O
61-358	O

Completed	O
by	O
:	O
Elwood	O
Edmond	O
MD	O
68-884	O
2019-01-31	O
@	O
1141	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Pamula	O
Pugh	O
on	O
:	O
Russell	O
2019-01-31	O
12:12	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2011-12-26	O

Discharge	O
Date	O
:	O

2012-01-26	O

Date	O
of	O
Birth	O
:	O

1958-04-03	O

Sex	O
:	O

F	O

Service	O
:	O

NOTE	O
:	O

This	O
is	O
an	O
addendum	O
to	O
the	O
discharge	O
summary	O
for	O
the	O
admission	O
starting	O
2012-01-05	O
.	O

The	O
patient	O
was	O
discharged	O
on	O
2012-01-26	O
.	O

ADDENDUM	O
HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
had	O
stage	B-problem
1	I-problem
sacral	I-problem
decubitus	I-problem
on	I-problem
her	I-problem
buttocks	I-problem
.	O

This	O
was	O
treated	O
with	O
wound	B-treatment
care	I-treatment
using	O
Eucerin	B-treatment
cream	I-treatment
and	O
also	O
patient	O
was	O
treated	O
with	O
lidocaine	B-treatment
jelly	I-treatment
for	O
pain	B-treatment
control	I-treatment
.	O

The	O
patient	O
was	O
seen	O
by	O
the	O
wound	O
care	O
nurse	O
and	O
the	B-problem
decubitus	I-problem
ulcer	I-problem
was	O
felt	O
to	O
be	O
mild	O
,	O
but	O
was	O
causing	O
the	O
patient	O
a	O
lot	O
of	O
discomfort	B-problem
and	O
the	O
wound	O
care	O
nurse	O
Ivy	O
Rose	O
lidocaine	B-treatment
jelly	I-treatment
.	O

With	O
regard	O
to	O
the	B-problem
patient	I-problem
's	I-problem
chronic	I-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
,	O
the	O
patient	O
's	O
respiratory	O
status	O
improved	O
throughout	O
the	O
remainder	O
of	O
her	O
hospital	O
course	O
.	O

The	O
patient	O
had	O
no	O
shortness	B-problem
of	I-problem
breath	I-problem
or	O
cough	B-problem
on	O
discharge	O
.	O

The	O
patient	O
was	O
oxygenating	O
well	O
on	O
her	B-treatment
home	I-treatment
O2	I-treatment
dose	I-treatment
of	O
2	O
liters	O
per	O
minute	O
.	O

The	O
patient	O
overall	O
continued	O
to	O
improve	O
,	O
but	O
remained	O
physically	B-problem
decompensated	I-problem
and	O
the	O
patient	O
was	O
transferred	O
to	O
Waltham/Weston	O
Hospital	O
Rehabilitation	O
Hospital	O
for	O
intensive	B-treatment
physical	I-treatment
therapy	I-treatment
.	O

DISCHARGE	B-treatment
MEDICATIONS	I-treatment
are	O
the	O
same	O
with	O
the	O
addition	O
of	O
viscous	B-treatment
lidocaine	I-treatment
jelly	I-treatment
to	O
be	O
applied	O
to	O
buttock	O
prn	O
and	O
viscous	B-treatment
lidocaine	I-treatment
swish	I-treatment
and	I-treatment
swallow	I-treatment
tid	O
prn	O
before	O
meals	O
.	O

Timothy	O
E	O
Woolfolk	O
,	O
M.D.	O

18-858	O

Dictated	O
By	O
:	O
Robert	O
C.	O
Warren	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2012-01-26	O
09:56	O

T	O
:	O
2012-01-26	O
09:58	O

JOB	O
#:	O

48146	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Kevin	O
Arthur	O
on	O
:	O
Tony	O
2012-01-27	O
6:52	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2010-05-17	O

Discharge	O
Date	O
:	O

2010-05-29	O

Date	O
of	O
Birth	O
:	O

1923-11-09	O

Sex	O
:	O

F	O

Service	O
:	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
an	O
86-year-old	O
female	O
with	O
a	O
past	O
medical	O
history	O
of	O
diabetes	B-problem
and	O
hypertension	B-problem
who	O
presented	O
to	O
the	O
Emergency	O
Department	O
with	O
a	O
two	O
day	O
history	O
of	O
shortness	B-problem
of	I-problem
breath	I-problem
and	O
easy	B-problem
fatigability	I-problem
.	O

She	O
also	O
noted	O
increased	B-problem
dyspnea	I-problem
on	O
exertion	O
.	O

Prior	O
to	O
this	O
patient	O
could	O
walk	O
upstairs	O
but	O
now	O
cannot	O
.	O

She	O
denies	O
chest	B-problem
pain	I-problem
,	O
orthopnea	B-problem
,	O
paroxysmal	B-problem
nocturnal	I-problem
dyspnea	I-problem
.	O

However	O
,	O
the	O
patient	O
has	O
noted	O
some	B-problem
abdominal	I-problem
pain	I-problem
,	O
intermittent	O
times	O
a	O
couple	O
of	O
days	O
,	O
none	O
on	O
the	O
day	O
of	O
admission	O
.	O

Denied	O
nausea	B-problem
,	O
vomiting	B-problem
,	O
diaphoresis	B-problem
,	O
bowel	B-problem
movement	I-problem
changes	I-problem
.	O

She	O
has	O
noted	O
increased	B-problem
urinary	I-problem
frequency	I-problem
.	O

Denies	O
fever	B-problem
or	O
chills	B-problem
.	O

Of	O
note	O
,	O
she	O
has	O
had	O
recent	B-treatment
medication	I-treatment
changes	I-treatment
which	O
included	O
discontinuing	O
Diovan	B-treatment
and	O
starting	O
terazosin	B-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Diabetes	B-problem
mellitus	I-problem
.	O

2.	O
Hypertension	B-problem
.	O

3.	O
Osteoarthritis	B-problem
.	O

4.	O
_______________	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

HOME	O
MEDICATIONS	O
:	O

1.	O
Aspirin	B-treatment
325	O
mg	O
p.o.	O
q.	O
day	O
.	O

2.	O
Norvasc	B-treatment
10	O
mg	O
p.o.	O
q.	O
day	O
.	O

3.	O
Isosorbide	B-treatment
mononitrate	I-treatment
30	O
q.	O
day	O
.	O

4.	O
Terazosin	B-treatment
1	O
mg	O
p.o.	O
q.	O
day	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
alone	O
.	O

Has	O
a	O
remote	O
tobacco	O
history	O
.	O

No	O
ethanol	O
.	O

FAMILY	O
HISTORY	O
:	O

Positive	O
for	O
diabetes	B-problem
.	O

No	O
coronary	B-problem
artery	I-problem
disease	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
,	O
blood	B-test
pressure	I-test
151/61	O
,	O
heart	B-test
rate	I-test
75	O
,	O
SaO2	B-test
93%	O
on	O
room	O
air	O
.	O

In	O
general	O
,	O
patient	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Speaks	O
in	O
full	O
sentences	O
.	O

Neck	O
:	O

Jugular	B-test
venous	I-test
pressure	I-test
notable	O
at	O
the	O
mid	O
neck	O
upright	O
about	O
80	O
degree	O
angles	O
.	O

Cardiovascular	O
regular	O
rate	O
and	O
rhythm	O
with	O
a	B-problem
1-2/6	I-problem
holosystolic	I-problem
murmur	I-problem
.	O

Pulmonary	O
:	O

Crackles	B-problem
bilaterally	I-problem
one-third	O
to	O
one-half	O
the	O
way	O
up	O
.	O

Abdomen	O
:	O

Bowel	B-test
sounds	I-test
positive	O
,	O
soft	O
,	O
non-tender	B-problem
,	O
non-distended	B-problem
.	O

Extremities	O
:	O

1+	B-problem
lower	I-problem
extremity	I-problem
edema	I-problem
.	O

LABORATORIES	O
ON	O
ADMISSION	O
:	O

Included	O
normal	O
CBC	O
,	O
BUN	B-test
47	O
,	O
creatinine	B-test
2.4	O
up	O
from	O
baseline	O
of	O
about	O
1.5	O
.	O

Troponin	B-test
4.7	O
,	O
CK	B-test
101	O
,	O
MB	B-test
3	O
.	O

RADIOLOGY	O
:	O

Chest	B-test
x-ray	I-test
showed	O
patient	O
was	O
in	O
congestive	B-problem
heart	I-problem
failure	I-problem
.	O

ELECTROCARDIOGRAM	B-test
:	O

Showed	O
normal	O
sinus	O
rhythm	O
at	O
107	O
beats	O
per	O
minute	O
with	O
left	B-problem
axis	I-problem
deviation	I-problem
and	O
poor	B-problem
R-wave	I-problem
progression	I-problem
.	O

However	O
,	O
no	O
acute	B-problem
changes	I-problem
were	O
apparent	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Cardiac	O
Medicine	O
Service	O
and	O
treated	O
for	O
presumed	O
diastolic	B-problem
and	I-problem
systolic	I-problem
dysfunction	I-problem
.	O

Echocardiogram	B-test
was	O
obtained	O
which	O
showed	O
moderately	B-problem
depressed	I-problem
left	I-problem
ventricular	I-problem
systolic	I-problem
function	I-problem
as	O
well	O
as	O
hypokinesis	B-problem
of	I-problem
the	I-problem
lower	I-problem
half	I-problem
of	I-problem
septum	I-problem
and	I-problem
apex	I-problem
.	O

Also	O
of	O
note	O
was	O
the	B-problem
distal	I-problem
lateral	I-problem
wall	I-problem
hypokinesis	I-problem
.	O

The	B-problem
wall	I-problem
motion	I-problem
abnormalities	I-problem
were	O
noted	O
to	O
be	O
new	O
.	O

It	O
was	O
believed	O
that	O
a	B-test
troponin	I-test
on	O
admission	O
in	O
addition	O
to	O
the	B-problem
wall	I-problem
motion	I-problem
abnormalities	I-problem
she	O
underwent	O
a	B-problem
non-Q	I-problem
wave	I-problem
myocardial	I-problem
infarction	I-problem
prior	O
to	O
resulted	O
in	O
her	B-problem
current	I-problem
cardiac	I-problem
failure	I-problem
.	O

Throughout	O
hospital	O
course	O
patient	B-test
's	I-test
troponin	I-test
trended	O
down	O
to	O
less	O
than	O
0.3	O
.	O

Heart	O
Failure	O
Service	O
was	O
involved	O
.	O

She	O
was	O
continued	O
with	O
aggressive	B-treatment
diuresis	I-treatment
.	O

She	O
was	O
started	O
on	O
_________	O
with	O
excellent	O
diuresis	O
,	O
however	O
,	O
her	B-problem
renal	I-problem
functioning	I-problem
worsening	I-problem
.	O

A	B-test
cardiac	I-test
catheterization	I-test
was	O
deferred	O
until	O
the	B-problem
renal	I-problem
issue	I-problem
could	O
be	O
resolved	O
.	O

However	O
,	O
her	B-test
creatinine	I-test
continued	O
to	O
increase	O
.	O

Diuresis	B-treatment
was	O
halted	O
and	O
without	O
improvement	O
in	O
creatinine	B-test
.	O

Renal	O
was	O
consulted	O
.	O

A	B-test
renal	I-test
ultrasound	I-test
was	O
obtained	O
.	O

It	O
showed	O
a	B-test
right	I-test
kidney	I-test
size	I-test
of	O
6.3	O
cm	O
and	O
a	B-test
left	I-test
kidney	I-test
size	I-test
of	O
8.4	O
cm	O
.	O

Given	O
her	B-problem
hypertension	I-problem
which	O
was	O
very	O
difficult	O
to	O
control	O
,	O
it	O
was	O
felt	O
that	O
she	O
had	O
renal	B-problem
artery	I-problem
stenosis	I-problem
and	O
thus	O
she	O
underwent	O
MRA	B-test
of	I-test
the	I-test
kidney	I-test
which	O
showed	O
severe	B-problem
right	I-problem
renal	I-problem
artery	I-problem
stenosis	I-problem
at	I-problem
its	I-problem
origin	I-problem
.	O

There	O
was	O
also	O
moderate	B-problem
to	I-problem
severe	I-problem
focal	I-problem
stenosis	I-problem
of	I-problem
the	I-problem
left	I-problem
renal	I-problem
artery	I-problem
approximately	O
1.3	O
cm	O
from	O
its	O
origin	O
.	O

Dr.	O
______________	O
consulted	O
on	O
the	O
case	O
.	O

She	O
was	O
transferred	O
to	O
the	O
unit	O
overnight	O
to	O
assess	O
volume	B-test
which	O
was	O
noted	O
to	O
be	O
optimal	O
.	O

On	O
05-25	O
she	O
underwent	O
catheterization	B-test
and	O
subsequent	B-treatment
stenting	I-treatment
of	I-treatment
the	I-treatment
left	I-treatment
renal	I-treatment
artery	I-treatment
.	O

Due	O
to	O
dye	B-treatment
load	I-treatment
required	O
to	O
assess	O
the	B-problem
coronary	I-problem
disease	I-problem
were	O
not	O
visualized	O
.	O

After	O
the	B-treatment
procedure	I-treatment
the	O
patient	O
did	O
well	O
.	O

However	O
,	O
her	B-test
creatinine	I-test
has	O
worsened	B-problem
up	O
to	O
4.2	O
.	O

However	O
,	O
her	B-test
urine	I-test
output	I-test
has	O
improved	O
.	O

She	O
has	O
not	O
required	O
hemodialysis	B-treatment
at	O
this	O
time	O
.	O

She	O
will	O
need	O
close	O
follow	O
up	O
of	O
her	O
renal	O
functioning	O
.	O

The	O
patient	O
is	O
discharged	O
to	O
an	O
extended	O
discharge	O
facility	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Non-Q	B-problem
wave	I-problem
myocardial	I-problem
infarction	I-problem
.	O

2.	O
Systolic	B-problem
and	I-problem
diastolic	I-problem
congestive	I-problem
heart	I-problem
failure	I-problem
.	O

3.	O
Bilateral	B-problem
renal	I-problem
artery	I-problem
stenosis	I-problem
status	O
post	O
stent	B-treatment
left	I-treatment
renal	I-treatment
artery	I-treatment
.	O

4.	O
Acute	B-problem
renal	I-problem
failure	I-problem
.	O

5.	O
Hypertension	B-problem
.	O

FOLLOW	O
UP	O
:	O

She	O
is	O
to	O
follow	O
up	O
with	O
her	O
primary	O
care	O
physician	O
in	O
one	O
week	O
.	O

She	O
is	O
to	O
follow	O
up	O
Heart	O
Failure	O
and	O
Cardiology	O
in	O
one	O
week	O
as	O
well	O
.	O

In	O
addition	O
,	O
patient	O
is	O
to	O
have	O
her	O
own	O
appointment	O
with	O
Podiatry	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Aspirin	B-treatment
325	O
mg	O
p.o.	O
q.	O
day	O
.	O

2.	O
Norvasc	B-treatment
10	O
mg	O
p.o.	O
q.	O
day	O
.	O

3.	O
Atorvastatin	B-treatment
10	O
mg	O
p.o.	O
q.	O
day	O
.	O

4.	O
Protonix	B-treatment
20	O
mg	O
p.o.	O
q.	O
day	O
.	O

5.	O
Multivitamin	B-treatment
one	O
p.o.	O
q.	O
day	O
.	O

6.	O
Carvedilol	B-treatment
3.125	O
p.o.	O
b.i.d.	O

7.	O
___________	O
dinitrate	B-treatment
20	O
mg	O
p.o.	O
t.i.d.	O

8.	O
Erythropoietin	B-treatment
10,000	O
units	O
two	O
times	O
a	O
week	O
Tuesday	O
and	O
Saturday	O
.	O

9.	O
Calcium	B-treatment
acetate	I-treatment
Tums	I-treatment
one	O
p.o.	O
t.i.d.	O
with	O
meals	O
.	O

10.	O
Tylenol	B-treatment
325	O
mg	O
p.o.	O
q.	O
4-6	O
h.	O
p.r.n.	O

11.	O
Iron	B-treatment
sulfate	I-treatment
325	O
mg	O
p.o.	O
q.	O
day	O
.	O

12.	O
Colace	B-treatment
100	O
mg	O
p.o.	O
b.i.d.	O

13.	O
Hydralazine	B-treatment
10	O
mg	O
p.o.	O
q.	O
6h.	O

14.	O
Plavix	B-treatment
75	O
mg	O
p.o.	O
q.	O
day	O
times	O
30	O
days	O
.	O

Kathy	O
Tillis	O
,	O
M.D.	O

85-987	O

Dictated	O
By	O
:	O
John	O
V.E.	O
Jameson	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2010-05-27	O
14:29	O

T	O
:	O
2010-05-27	O
14:10	O

JOB	O
#:	O

80987	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Kathy	O
Tillis	O
on	O
:	O
MON	O
2010-06-07	O
4:00	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2017-08-12	O

Discharge	O
Date	O
:	O

2017-08-16	O

Date	O
of	O
Birth	O
:	O

1995-02-03	O

Sex	O
:	O

F	O

Service	O
:	O
SURGERY	O

Allergies	O
:	O

Shellfish	O

Attending	O
:	O
Maria	O
X	O
White	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Motor	O
vehicle	O
accident	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

None	O

History	O
of	O
Present	O
Illness	O
:	O

22	O
year	O
old	O
female	O
transfer	O
from	O
outside	O
hospital	O
after	O
a	O
motor	O
vehicle	O
accident	O
with	O
diagnosed	B-problem
liver	I-problem
laceration	I-problem
by	O
CT	B-test
scan	I-test
.	O

Past	O
Medical	O
History	O
:	O

None	O

Social	O
History	O
:	O

Social	O
alcohol	O

Family	O
History	O
:	O

Non	O
pertinent	O
to	O
admission	O

Physical	O
Exam	O
:	O

Patient	O
was	O
alert	O
,	O
oriented	O
x3	O
.	O

Neck	O
with	O
cervical	B-treatment
collar	I-treatment
.	O

Left	B-problem
forarm	I-problem
and	I-problem
right	I-problem
knee	I-problem
abrasions	I-problem
.	O

Chest	O
clear	O
to	O
auscultation	B-test
bilateral	O
,	O
S1	O
S2	O
normal	O
and	O
with	O
no	O
murmors	B-problem
.	O

Abdominal	B-problem
pain	I-problem
predominally	O
on	O
the	O
right	O
upper	O
quadrant	O
,	O
no	O
signs	O
of	O
peritoneal	B-problem
irritation	I-problem
.	O

Pertinent	O
Results	O
:	O

2017-08-12	O
11:41	O
PM	O

GLUCOSE	B-test
-	O
74	O
UREA	B-test
N	I-test
-	O
9	O
CREAT	B-test
-	O
0.7	O
SODIUM	B-test
-	O
139	O
POTASSIUM	B-test
-	O
3.5	O
CHLORIDE	B-test
-	O
106	O
TOTAL	B-test
CO2	I-test
-	O
23	O
ANION	B-test
GAP	I-test
-	O
14	O

2017-08-12	O
11:41PM	O

ALT(SGPT)	B-test
-	O
241	O
*	O
AST(SGOT)	B-test
-	O
207	O
*	O
ALK	B-test
PHOS	I-test
-	O
51	O
TOT	B-test
BILI	I-test
-	O
0.8	O

2017-08-12	O
11:41	O
PM	O

CALCIUM	B-test
-	O
8.2	O
*	O
PHOSPHATE	B-test
-	O
3.1	O
MAGNESIUM	B-test
-	O
2.2	O

2017-08-12	O
03:15	O
PM	O

GLUCOSE	B-test
-	O
75	O
UREA	B-test
N	I-test
-	O
10	O
CREAT	B-test
-	O
0.6	O
SODIUM	B-test
-	O
137	O
POTASSIUM	B-test
-	O
3.7	O
CHLORIDE	B-test
-	O
103	O
TOTAL	B-test
CO2	I-test
-	O
23	O
ANION	B-test
GAP	I-test
-	O
15	O

2017-08-12	O
03:15	O
PM	O

ALT(SGPT)	B-test
-	O
318	O
*	O
AST(SGOT)	B-test
-	O
307	O
*	O
ALK	B-test
PHOS	I-test
-	O
61	O
TOT	B-test
BILI	I-test
-	O
0.9	O

2017-08-12	O
03:15	O
PM	O

WBC	B-test
-	O
8.3	O
RBC	B-test
-	O
3.64	O
*	O
HGB	B-test
-	O
12.6	O
HCT	B-test
-	O
36.1	O
MCV	B-test
-	O
99	O
*	O
MCH	B-test
-	O
34.7	O
*	O
MCHC	B-test
-	O
35.0	O
RDW	B-test
-	O
12.4	O

2017-08-12	O
03:15	O
PM	O

PT	B-test
-	O
11.6	O
PTT	B-test
-	O
26.0	O
INR(PT)	B-test
-	O
0.9	O

Brief	O
Hospital	O
Course	O
:	O

Patient	O
was	O
admited	O
,	O
pain	B-problem
was	O
managed	O
with	O
a	B-treatment
PCA	I-treatment
and	O
later	O
with	O
PO	B-treatment
medication	I-treatment
.	O

The	B-problem
liver	I-problem
laceration	I-problem
was	O
stable	O
,	O
no	O
sign	O
of	O
rupture	B-problem
or	O
further	B-problem
complication	I-problem
,	O
did	O
not	O
required	O
surgical	B-treatment
managment	I-treatment
.	O

The	B-test
liver	I-test
enzimes	I-test
come	O
down	O
,	O
no	O
signs	O
of	O
biliary	B-problem
stasis	I-problem
.	O

She	O
was	O
able	O
to	O
tolerate	O
diet	O
,	O
ambulate	O
,	O
having	O
a	O
bowel	O
movement	O
and	O
dischargo	O
home	O
in	O
good	O
conditions	O
.	O

Medications	O
on	O
Admission	O
:	O

None	O

Discharge	O
Medications	O
:	O

1.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
for	O
4	O
days	O
.	O

Disp	O
:*	O
8	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O

2.	O
Hydromorphone	B-treatment
2	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q2H	O
(	O
every	O
2	O
hours	O
)	O
as	O
needed	O
for	O
Pain	B-problem
for	O
4	O
days	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

Motor	O
vehicle	O
accident	O

Discharge	O
Condition	O
:	O

Good	O

Discharge	O
Instructions	O
:	O

-	O
Follow	O
up	O
with	O
Trauma	O
Surgery	O
Clinic	O
with	O
the	O
Result	O
from	O
the	B-test
CT	I-test
scan	I-test
abdomen	I-test

-	O
Call	O
for	O
appointment	O
to	O
(	O
289	O
)	O
411-5387	O
for	O
the	O
Trauma	O
Clinic	O
and	O
Abdominal	B-test
CT	I-test
scan	I-test
of	I-test
the	I-test
Abdomen	I-test
in	O
4	O
weeks	O

-	O
If	O
any	B-problem
abdominal	I-problem
pain	I-problem
,	O
fever	B-problem
or	O
dizziness	B-problem
,	O
go	O
to	O
the	O
Emergency	O
Room	O

-	O
Avoid	O
contact	O
sport	O
until	O
seen	O
in	O
the	O
Clinic	O

-	O
Analgesic	B-treatment
(	I-treatment
Percocet	I-treatment
)	I-treatment
as	O
needed	O

Followup	O
Instructions	O
:	O

-	O
Trauma	O
Surgery	O
Clinic	O
in	O
four	O
weeks	O
with	O
CT	B-test
abdomen	I-test
results	O
.	O

Call	O
Trauma	O
Clinic	O
to	O
coordinate	O
the	B-test
study	I-test
,	O
result	O
and	O
appointment	O
dates	O
((	O
289	O
)	O
411-5387	O
).	O

Ida	O
Doris	O
MD	O
79-274	O

Completed	O
by	O
:	O
Jane	O
Ashmore	O
MD	O
50-063	O
2017-08-16	O
@	O
0950	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Jennifer	O
Green	O
on	O
:	O
FRI	O
2017-09-01	O
1:04	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2009-05-01	O

Discharge	O
Date	O
:	O

Date	O
of	O
Birth	O
:	O

1969-05-19	O

Sex	O
:	O

M	O

Service	O
:	O

Surgery	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
39	O
year-old	O
gentleman	O
admitted	O
on	O
2009-05-01	O
to	O
the	O
Jewish	O
Memorial	O
Hospital	O
referred	O
from	O
South	O
Cove	O
Community	O
Health	O
Center	O
.	O

He	O
is	O
a	O
39	O
year-old	O
gentleman	O
with	O
hyperlipidemia	B-problem
and	O
smoking	O
who	O
presented	O
with	O
acute	O
onset	O
of	O
chest	B-problem
pain	I-problem
since	O
five	O
in	O
the	O
morning	O
with	O
radiation	O
to	O
the	O
left	O
arm	O
and	O
nausea	B-problem
.	O

Symptoms	B-problem
resolved	O
spontaneously	O
.	O

He	O
was	O
taken	O
to	O
the	O

Cath	O
Lab	O
at	O
the	O
Pinewood	O
,	O
Norfolk	O
that	O
evening	O
where	O
a	B-treatment
stent	I-treatment
procedure	I-treatment
to	I-treatment
the	I-treatment
RCA	I-treatment
was	O
complicated	O
by	O
guidewire	O
entrapment	O
inside	O
of	O
a	B-treatment
stent	I-treatment
requiring	O
CT	B-treatment
surgery	I-treatment
to	O
do	O
a	B-treatment
thoracotomy	I-treatment
with	O
bypass	B-treatment
and	O
excision	B-treatment
of	I-treatment
the	I-treatment
wire	I-treatment
.	O

The	O
case	O
was	O
complicated	O
by	O
an	O
episode	O
of	O
coffee	B-problem
ground	I-problem
emesis	I-problem
and	O
a	B-problem
bleed	I-problem
from	I-problem
femoral	I-problem
access	I-problem
site	I-problem
prior	O
to	O
CT	B-treatment
surgery	I-treatment
.	O

Gastroenterology	O
was	O
consulted	O
and	O
they	O
recommended	O
Protonix	B-treatment
and	O
felt	O
it	O
was	O
due	O
to	O
peptic	B-problem
ulcer	I-problem
disease	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Hepatitis	B-problem
B	I-problem
.	O

2.	O
Hypercholesterolemia	B-problem
.	O

3.	O
Fatty	B-problem
liver	I-problem
resolved	O
.	O

MEDICATIONS	O
AT	O
HOME	O
:	O

Relatively	O
unknown	O
other	O
than	O
Lipitor	B-treatment
.	O

ALLERGIES	O
:	O
He	O
had	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

He	O
smokes	O
one	O
pack	O
per	O
day	O
.	O

He	O
works	O
as	O
a	O
jeweler	O
.	O

He	O
lives	O
at	O
home	O
with	O
his	O
wife	O
.	O

FAMILY	O
HISTORY	O
:	O
Not	O
significant	O
for	O
coronary	B-problem
artery	I-problem
disease	I-problem
.	O

Please	O
note	O
the	O
patient	O
is	O
only	O
Caucasian	O
speaking	O
and	O
information	O
is	O
second	O
hand	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
diagnosed	O
as	O
having	O
an	B-problem
acute	I-problem
myocardial	I-problem
infarction	I-problem
.	O

The	O
patient	O
was	O
taken	O
emergently	O
to	O
the	O
operating	O
room	O
on	O
2009-05-02	O
for	O
his	B-treatment
CABG	I-treatment
,	O
right	B-treatment
coronary	I-treatment
endarterectomy	I-treatment
,	O
removal	B-treatment
of	I-treatment
RCA	I-treatment
stents	I-treatment
and	O
retrieval	B-treatment
of	I-treatment
the	I-treatment
aortic	I-treatment
guidewire	I-treatment
.	O

Postoperatively	O
he	O
did	O
well	O
and	O
was	O
transferred	O
to	O
the	O
Cardiac	O
Surgery	O
Intensive	O
Care	O
Unit	O
where	O
he	O
was	O
on	O
pressor	B-treatment
support	I-treatment
of	O
Neo-Synephrine	B-treatment
and	O
he	O
was	O
extubated	O
.	O

The	O
patient	O
slowly	O
weaned	O
off	O
Neo-Synephrine	B-treatment
as	O
tolerated	O
.	O

He	O
was	O
transferred	O
to	O
the	O
floor	O
on	O
2009-05-04	O
.	O

His	B-treatment
chest	I-treatment
tube	I-treatment
had	O
been	O
discontinued	O
.	O

Upon	O
arrival	O
to	O
the	O
floor	O
the	B-treatment
patient	I-treatment
's	I-treatment
wires	I-treatment
were	O
discontinued	O
on	O
2009-05-05	O
and	O
his	B-treatment
Foley	I-treatment
catheter	I-treatment
was	O
discontinued	O
.	O

The	O
patient	O
was	O
seen	O
by	O
Physical	O
Therapy	O
.	O

His	B-test
electrolytes	I-test
were	O
repleted	O
and	O
the	O
patient	O
was	O
discharged	O
home	O
on	O
2009-05-06	O
after	O
tolerating	O
a	O
level	O
V	O
.	O

MEDICATIONS	O
:	O
His	B-treatment
prescriptions	I-treatment
shall	O
include	O

1.	O
Lopressor	B-treatment
25	O
milligrams	O
po	O
bid	O
.	O

2.	O
Lipitor	B-treatment
20	O
milligrams	O
po	O
q	O
HS	O
.	O

3.	O
Niferex	B-treatment
150	O
milligrams	O
caplet	O
one	O
cap	O
per	O
day	O
.	O

4.	O
Protonix	B-treatment
40	O
milligrams	O
po	O
q	O
day	O
.	O

5.	O
Colace	B-treatment
100	O
milligrams	O
po	O
bid	O
.	O

6.	O
Percocet	B-treatment
one	O
to	O
two	O
tablets	O
q	O
four	O
H	O
prn	O
for	O
pain	B-problem
.	O

He	O
will	O
get	O
60	O
of	O
those	O
.	O

7.	O
Plavix	B-treatment
75	O
milligrams	O
po	O
q	O
day	O
times	O
three	O
months	O
.	O

8.	O
Aspirin	B-treatment
325	O
milligrams	O
po	O
q	O
day	O
.	O

9.	O
Lasix	B-treatment
20	O
milligrams	O
po	O
times	O
30	O
days	O
.	O

10.	O
KCL	B-treatment
20	O
milliequivalents	O
po	O
q	O
d	O
times	O
three	O
days	O
.	O

DISCHARGE	O
FOLLOW	O
UP	O
:	O
The	O
patient	O
is	O
to	O
follow	O
up	O
with	O
Dr.	O
Debra	O
Oneal	O
,	O
his	O
PCP	O
and	O
his	O
cardiologist	O
in	O
3	O
weeks	O
.	O

Saul	O
N.	O
Keehne	O
,	O
M.D.	O

Dictated	O
By	O
:	O
Shirley	O
Y	O
Waler	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2009-05-06	O
11:12	O

T	O
:	O
2009-05-06	O
11:34	O

JOB	O
#:	O

20629	O

Signed	O
electronically	O
by	O
:	O
DR.	O
William	O
Spencer	O
on	O
:	O
WED	O
2009-05-06	O
12:20	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2012-01-20	O

Discharge	O
Date	O
:	O

2012-01-23	O

Date	O
of	O
Birth	O
:	O

1947-09-21	O

Sex	O
:	O

M	O

Service	O
:	O

UROLOGY	O

PREOPERATIVE	O
DIAGNOSIS	O
:	O

Prostate	B-problem
cancer	I-problem
.	O

ADMITTING	O
DIAGNOSIS	O
:	O

Status	O
post	O
radical	B-treatment
retropubic	I-treatment
prostatectomy	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
64	O
year	O
old	O
gentleman	O
with	O
a	O
history	O
of	O
elevated	B-problem
PSA	I-problem
,	O
prostate	B-problem
cancer	I-problem
.	O

He	O
was	O
diagnosed	O
with	O
needle	B-test
biopsy	I-test
on	O
either	O
side	O
of	O
the	O
prostate	O
with	O
3+3	O
equals	O
6	O
on	O
the	O
right	O
side	O
and	O
3+4	O
equals	O
7	O
on	O
the	O
left	O
side	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
underwent	O
radical	B-treatment
retropubic	I-treatment
prostatectomy	I-treatment
on	O
2012-01-20	O
.	O

Dr.	O
Marie	O
Anderson	O
performed	O
the	B-treatment
surgery	I-treatment
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
.	O

On	O
postoperative	O
day	O
number	O
one	O
,	O
he	O
was	O
administered	O
1	B-treatment
mg	I-treatment
Coumadin	I-treatment
per	O
protocol	O
as	O
well	O
as	O
on	O
the	O
operative	O
day	O
1	O
mg	O
of	O
Coumadin	B-treatment
.	O

The	O
patient	O
was	O
advanced	O
to	O
regular	O
diet	O
on	O
postoperative	O
day	O
one	O
.	O

His	B-test
laboratories	I-test
were	O
checked	O
and	O
his	B-test
hematocrit	I-test
was	O
noted	O
to	O
be	O
stable	O
.	O

He	O
was	O
made	O
to	O
ambulate	O
on	O
postoperative	O
day	O
one	O
.	O

His	B-problem
pain	I-problem
was	O
well	O
controlled	O
with	O
oral	B-treatment
medication	I-treatment
at	O
this	O
time	O
.	O

On	O
postoperative	O
day	O
two	O
,	O
he	O
continued	O
to	O
convalesce	O
as	O
planned	O
.	O

His	B-treatment
intravenous	I-treatment
fluids	I-treatment
were	O
discontinued	O
at	O
this	O
time	O
.	O

He	O
was	O
on	O
a	O
house	O
diet	O
and	O
tolerating	O
it	O
well	O
at	O
this	O
time	O
as	O
well	O
.	O

His	B-treatment
Penrose	I-treatment
drain	I-treatment
was	O
discontinued	O
at	O
this	O
time	O
.	O

He	O
was	O
ready	O
for	O
discharge	O
home	O
on	O
postoperative	O
day	O
three	O
.	O

He	O
was	O
discharged	O
home	O
with	O
a	B-treatment
Foley	I-treatment
catheter	I-treatment
and	O
he	O
will	O
follow-up	O
with	O
Dr.	O
Ross	O
in	O
one	O
to	O
two	O
weeks	O
.	O

COMPLICATIONS	O
DURING	O
STAY	O
:	O

None	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
STATUS	O
:	O

To	O
home	O
.	O

Terry	O
CR	O
Dennis	O
,	O
M.D.	O

68-233	O

Dictated	O
By	O
:	O
Tracy	O
C	O
Rea	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2012-04-28	O
17:18	O

T	O
:	O
2012-05-01	O
20:32	O

JOB	O
#:	O

21454	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Antonio	O
Hall	O
on	O
:	O
FRI	O
2012-05-04	O
7:48	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2014-10-21	O

Discharge	O
Date	O
:	O

2014-11-21	O

Date	O
of	O
Birth	O
:	O

1942-03-10	O

Sex	O
:	O

M	O

Service	O
:	O
SURGERY	O

Allergies	O
:	O

Iodine	B-treatment
;	O
Iodine	B-treatment
Containing	I-treatment

Attending	O
:	O
Dona	O
J.	O
O.	O
Anderson	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

s/p	O
Fall	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Tracheostomy	B-treatment
2014-11-11	O

Bronchoscopy	B-test
2014-11-05	O

Past	O
Medical	O
History	O
:	O

Atrial	B-problem
fibrillation	I-problem
(	O
on	O
Coumadin	B-treatment
)	O

Coronary	B-problem
Artery	I-problem
Disease	I-problem

Ulcerative	B-problem
Colitis	I-problem
w/	O
colostomy	B-treatment

Hypertension	B-problem

Pacemaker	B-treatment

CVA	B-problem
2012	O
w/	O
right	B-problem
sided	I-problem
weakness	I-problem

Cataracts	B-problem
,	O
s/p	O
cataract	B-treatment
surgery	I-treatment

s/p	O
TURP	B-treatment

Social	O
History	O
:	O

Lives	O
with	O
wife	O
;	O
+ETOH	O
use	O

Family	O
History	O
:	O

Noncontributory	O

Pertinent	O
Results	O
:	O

2014-10-21	O
08:10	O
PM	O

GLUCOSE	B-test
-	O
126	O
*	O
UREA	B-test
N	I-test
-	O
9	O
CREAT	B-test
-	O
0.8	O
SODIUM	B-test
-	O
135	O
POTASSIUM	B-test
-	O
3.4	O
CHLORIDE	B-test
-	O
99	O
TOTAL	B-test
CO2	I-test
-	O
25	O
ANION	B-test
GAP	I-test
-	O
14	O

2014-10-21	O
08:10	O
PM	O

CALCIUM	B-test
-	O
8.2	O
*	O
PHOSPHATE	B-test
-	O
2.1	O
*	O
MAGNESIUM	B-test
-	O
1.9	O

2014-10-21	O
08:10	O
PM	O

WBC	B-test
-	O
6.5	O
RBC	B-test
-	O
3.68	O
*	O
HGB	B-test
-	O
11.6	O
*	O
HCT	B-test
-	O
32.5	O
*	O
MCV	B-test
-	O
88	O
MCH	B-test
-	O
31.5	O
MCHC	B-test
-	O
35.6	O
*	O
RDW	B-test
-	O
13.6	O

2014-10-21	O
08:10	O
PM	O

PLT	B-test
COUNT	I-test
-	O
207	O

2014-10-21	O
08:10	O
PM	O

PT	B-test
-	O
15.0	O
*	O
PTT	B-test
-	O
31.3	O
INR(PT)	B-test
-	O
1.5	O

2014-10-21	O
02:56	O
PM	O

TYPE	O
-	O
ART	O
TEMP	B-test
-	O
36.6	O
RATES	B-test
-	O
14	O
/	O
TIDAL	B-test
VOL	I-test
-	O
550	O
PEEP	B-treatment
-	O
5	O
O2	B-treatment
-	O
100	O
PO2	B-test
-	O
416	O
*	O
PCO2	B-test
-	O
39	O
PH	B-test
-	O
7.41	O
TOTAL	B-test
CO2	I-test
-	O
26	O
BASE	B-test
XS	I-test
-	O
0	O
AADO2	B-test
-	O
279	O
REQ	B-test
O2	I-test
-	O
52	O
-	O
ASSIST	O
/	O
CON	O
INTUBATED	O
-	O
INTUBATED	O

2014-10-21	O
09:35	O
AM	O

ASA	B-test
-	O
NEG	O
ETHANOL	B-test
-	O
NEG	O
ACETMNPHN	B-test
-	O
NEG	O
bnzodzpn	B-test
-	O
NEG	O
barbitrt	B-test
-	O
NEG	O
tricyclic	B-test
-	O
NEG	O

2014-10-21	O
09:35	O
AM	O
URINE	B-test

bnzodzpn	B-test
-	O
NEG	O
barbitrt	B-test
-	O
NEG	O
opiates	B-test
-	O
NEG	O
cocaine	B-test
-	O
NEG	O
amphetmn	B-test
-	O
NEG	O
mthdone	B-test
-	O
NEG	O

CT	B-test
C	I-test
-	I-test
SPINE	I-test
W/O	I-test
CONTRAST	I-test

2014-10-21	O
9:59	O
AM	O

CT	B-test
C	I-test
-	I-test
SPINE	I-test
W/O	I-test
CONTRAST	I-test
;	O
CT	O
RECONSTRUCTION	O

Reason	O
:	O
72	O
male	O
s/p	O
fall	O
down	O
20	O
stairs	O

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

72	O
year	O
old	O
man	O
with	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

72	O
male	O
s/p	O
fall	O
down	O
20	O
stairs	O

CONTRAINDICATIONS	O
for	O
IV	O
CONTRAST	O
:	O
None	O
.	O

INDICATIONS	O
:	O
Fall	O
down	O
20	O
stairs	O
.	O

TECHNIQUE	O
:	O
Noncontrast	B-test
cervical	I-test
spine	I-test
CT	I-test
.	O

COMPARISON	O
:	O
None	O
.	O

NOTE	O
:	O
This	B-test
study	I-test
was	O
initially	O
performed	O
on	O
2014-10-21	O
.	O

Findings	O
were	O
discussed	O
with	O
Dr.	O
Leanne	O
Vazquez	O
at	O
the	O
time	O
this	B-test
study	I-test
was	O
performed	O
,	O
but	O
the	B-test
study	I-test
was	O
not	O
dictated	O
until	O
the	O
morning	O
of	O
2014-10-22	O
,	O
due	O
to	O
PACS	O
malfunction	O
.	O

NONCONTRAST	B-test
CERVICAL	I-test
SPINE	I-test
CT	I-test
:	O
There	O
are	O
minimally	B-problem
displaced	I-problem
and	I-problem
comminuted	I-problem
fractures	I-problem
through	I-problem
the	I-problem
left	I-problem
C7	I-problem
and	I-problem
T1	I-problem
transverse	I-problem
processes	I-problem
.	O

The	O
margins	O
do	O
not	O
appear	O
to	O
extend	O
into	O
the	O
foramina	O
transversaria	O
.	O

Positioning	O
limits	O
assessment	B-test
of	I-test
alignment	I-test
due	O
to	O
extreme	B-problem
head	I-problem
tilting	I-problem
to	I-problem
the	I-problem
right	I-problem
,	O
but	O
this	O
is	O
likely	O
the	O
best	O
obtainable	O
secondary	O
to	O
intubation	B-treatment
and	O
nasogastric	B-treatment
tube	I-treatment
placement	I-treatment
.	O

Allowing	O
for	O
the	O
limitations	O
,	O
the	O
vertebral	O
bodies	O
are	O
normal	O
in	O
height	O
and	O
normally	O
aligned	O
.	O

There	O
is	O
no	O
atlantoaxial	B-problem
subluxation	I-problem
.	O

The	O
lateral	O
masses	O
of	O
C1	O
articulate	O
normally	O
about	O
the	O
odontoid	O
process	O
.	O

Prevertebral	B-problem
soft	I-problem
tissue	I-problem
swelling	I-problem
cannot	O
be	O
excluded	O
secondary	O
to	O
intubation	B-treatment
.	O

Extensive	B-problem
carotid	I-problem
arterial	I-problem
calcifications	I-problem
are	O
present	O
in	O
the	O
bulb	O
regions	O
bilaterally	O
.	O

Biapical	B-problem
lung	I-problem
scarring	I-problem
and	O
mild	B-problem
bronchiectasis	I-problem
are	O
present	O
.	O

Also	O
noted	O
is	O
sclerosis	B-problem
and	O
opacification	B-problem
of	I-problem
the	I-problem
visualized	I-problem
left	I-problem
mastoid	I-problem
air	I-problem
cells	I-problem
and	I-problem
mastoid	I-problem
tip	I-problem
,	O
likely	O
chronic	O
inflammatory	O

disease	B-problem
.	O

IMPRESSION	O
:	O
Minimally	B-problem
displaced	I-problem
,	I-problem
comminuted	I-problem
fractures	I-problem
of	I-problem
the	I-problem
left	I-problem
C7	I-problem
and	I-problem
T1	I-problem
transverse	I-problem
processes	I-problem
.	O

No	O
evidence	O
of	O
extension	B-problem
into	I-problem
the	I-problem
foramina	I-problem
transversaria	I-problem
.	O

CT	B-test
HEAD	I-test
W/O	I-test
CONTRAST	I-test

2014-10-21	O
9:42	O
AM	O

CT	B-test
HEAD	I-test
W/O	I-test
CONTRAST	I-test

Reason	O
:	O
bleed	B-problem
?	O

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

72	O
year	O
old	O
man	O
with	O
intraparenchymal	B-problem
bleed	I-problem
s/p	O
fall	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

bleed	B-problem
?	O

CONTRAINDICATIONS	O
for	O
IV	O
CONTRAST	O
:	O
None	O
.	O

INDICATION	O
:	O
Intraparenchymal	B-problem
hemorrhage	I-problem
after	O
fall	O
.	O

Assess	O
for	O
hemorrhage	B-problem
.	O

TECHNIQUE	O
:	O
Non-contrast	B-test
head	I-test
CT	I-test
.	O

COMPARISON	O
:	O
No	O
prior	B-test
studies	I-test
are	O
available	O
.	O

By	O
report	O
,	O
the	O
patient	O
has	O
an	B-test
outside	I-test
study	I-test
.	O

Should	O
this	O
become	O
available	O
,	O
an	O
addendum	O
will	O
be	O
issued	O
to	O
this	O
report	O
following	O
the	O
comparison	O
with	O
the	B-test
outside	I-test
examination	I-test
.	O

NOTE	O
:	O
This	B-test
study	I-test
was	O
initially	O
performed	O
on	O
the	O
morning	O
of	O
10-21	O
,	O
and	O
is	O
being	O
dictated	O
on	O
the	O
morning	O
of	O
10-22	O
due	O
to	O
PACS	O
malfunction	O
.	O

Findings	O
were	O
called	O
to	O
Dr.	O
Leanne	O
Vazquez	O
on	O
the	O
morning	O
of	O
10-21	O
.	O

NON-CONTRAST	B-test
HEAD	I-test
CT	I-test
:	O
There	O
is	O
a	B-problem
small	I-problem
amount	I-problem
of	I-problem
hemorrhage	I-problem
within	O
the	O
occipital	O
horns	O
of	O
both	O
lateral	O
ventricles	O
,	O
right	O
greater	O
than	O
left	O
.	O

Located	O
within	O
the	O
atrium	O
of	O
the	O
right	O
lateral	O
ventricle	O
is	O
an	B-problem
18	I-problem
x	I-problem
10	I-problem
mm	I-problem
nodular	I-problem
area	I-problem
of	I-problem
increased	I-problem
density	I-problem
which	O
is	O
separate	O
from	O
the	O
choroid	O
plexus	O
.	O

There	O
is	O
no	O
evidence	O
of	O
surrounding	B-problem
edema	I-problem
.	O

There	O
is	O
diffuse	B-problem
brain	I-problem
atrophy	I-problem
and	O
chronic	B-problem
microvascular	I-problem
infarction	I-problem
throughout	I-problem
the	I-problem
white	I-problem
matter	I-problem
.	O

There	O
is	O
a	B-problem
remote	I-problem
right	I-problem
frontal	I-problem
infarct	I-problem
.	O

There	O
is	O
no	O
evidence	O
of	O
subarachnoid	B-problem
hemorrhage	I-problem
or	O
acute	B-problem
major	I-problem
vascular	I-problem
territorial	I-problem
infarction	I-problem
.	O

The	O
ventricles	O
do	O
not	O
appear	O
dilated	O
relative	O
to	O
the	O
sulci	O
,	O
and	O
there	O
is	O
no	O
shift	B-problem
of	I-problem
normally	I-problem
midline	I-problem
structures	I-problem
.	O

There	O
is	O
no	O
skull	B-problem
fracture	I-problem
.	O

There	O
is	O
opacification	B-problem
of	I-problem
the	I-problem
posterior	I-problem
nasal	I-problem
cavity	I-problem
and	I-problem
nasopharynx	I-problem
but	O
an	B-treatment
NG	I-treatment
tube	I-treatment
is	O
present	O
,	O
and	O
the	O
patient	O
is	O
intubated	O
.	O

Opacified	B-problem
and	I-problem
sclerotic	I-problem
left	I-problem
mastoid	I-problem
air	I-problem
cells	I-problem
are	O
noted	O
.	O

IMPRESSION	O
:	O

1.	O
Small	O
amount	O
of	O
intraventricular	B-problem
hemorrhage	I-problem
.	O

2.	O
Ovoid	B-problem
18	I-problem
-	I-problem
mm	I-problem
density	I-problem
within	I-problem
the	I-problem
atrium	I-problem
of	O
the	O
right	O
lateral	O
ventricle	O
.	O

This	O
could	O
represent	O
either	O
an	B-problem
atypically	I-problem
located	I-problem
blood	I-problem
clot	I-problem
or	O
an	B-problem
intraventricular	I-problem
mass	I-problem
,	O
and	O
further	O
evaluation	O
with	O
contrast	B-test
-	I-test
enhanced	I-test
MRI	I-test
of	I-test
the	I-test
brain	I-test
,	O
when	O
clinically	O
feasible	O
,	O
is	O
recommended	O
.	O

Results	O
were	O
discussed	O
with	O
Dr.	O
Leanne	O
Vazquez	O
in	O
the	O
early	O
afternoon	O
on	O
2014-10-21	O
.	O

CT	B-test
HEAD	I-test
W/O	I-test
CONTRAST	I-test

2014-11-14	O
12:34	O
PM	O

CT	B-test
HEAD	I-test
W/O	I-test
CONTRAST	I-test

Reason	O
:	O
altered	B-problem
mental	I-problem
status	I-problem

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

72	O
year	O
old	O
man	O
with	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

altered	B-problem
mental	I-problem
status	I-problem

CONTRAINDICATIONS	O
for	O
IV	O
CONTRAST	O
:	O
None	O
.	O

INDICATION	O
:	O
72-year-old	O
male	O
with	O
altered	B-problem
mental	I-problem
status	I-problem
.	O

TECHNIQUE	O
:	O
Axial	B-test
noncontrast	I-test
CT	I-test
scans	I-test
of	I-test
the	I-test
brain	I-test
were	O
obtained	O
.	O

Comparison	O
is	O
made	O
to	O
a	B-test
previous	I-test
study	I-test
from	O
2014-10-27	O
.	O

FINDINGS	O
:	O

There	O
are	O
numerous	O
areas	O
of	O
decreased	B-problem
attenuation	I-problem
in	I-problem
the	I-problem
periventricular	I-problem
and	I-problem
subcortical	I-problem
white	I-problem
matter	I-problem
of	O
both	O
cerebral	O
hemispheres	O
,	O
indicating	O
chronic	B-problem
microvascular	I-problem
infarction	I-problem
.	O

There	O
is	O
also	O
an	B-problem
old	I-problem
right	I-problem
frontal	I-problem
lobe	I-problem
cortical	I-problem
infarction	I-problem
.	O

A	B-problem
small	I-problem
right	I-problem
occipital	I-problem
lobe	I-problem
chronic	I-problem
infarction	I-problem
is	O
also	O
evident	O
.	O

There	O
is	O
a	B-problem
small	I-problem
amount	I-problem
of	I-problem
blood	I-problem
layering	I-problem
in	I-problem
both	I-problem
lateral	I-problem
ventricles	I-problem
,	O
and	O
this	O
has	O
decreased	O
since	O
the	B-test
previous	I-test
study	I-test
.	O

The	O
size	O
and	O
shape	O
of	O
the	O
ventricles	O
is	O
unchanged	O
.	O

No	O
new	B-problem
hemorrhage	I-problem
is	O
observed	O
.	O

There	O
is	O
opacification	B-problem
of	I-problem
the	I-problem
mastoid	I-problem
air	I-problem
cells	I-problem
,	O
greater	O
on	O
the	O
left	O
than	O
the	O
right	O
.	O

There	O
is	O
some	B-problem
fluid	I-problem
or	O
mucosal	B-problem
thickening	I-problem
in	I-problem
the	I-problem
ethmoid	I-problem
and	I-problem
sphenoid	I-problem
sinuses	I-problem
.	O

IMPRESSION	O
:	O
No	O
new	B-problem
cortical	I-problem
territorial	I-problem
infarction	I-problem
or	O
hemorrhage	B-problem
is	O
identified	O
.	O

There	O
is	O
decreased	B-problem
intraventricular	I-problem
blood	I-problem
,	O
compared	O
to	O
the	B-test
previous	I-test
study	I-test
,	O
and	O
there	O
are	O
no	O
signs	O
of	O
hydrocephalus	B-problem
.	O

CHEST	B-test
(	I-test
PORTABLE	I-test
AP	I-test
)	I-test

2014-11-12	O
9:10	O
AM	O

CHEST	B-test
(	I-test
PORTABLE	I-test
AP	I-test
)	I-test

Reason	O
:	O
Fever	B-problem
,	O
f/u	O
infiltrte	B-problem

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

72	O
yo	O
M	O
with	O
rib	B-problem
fx	I-problem
s/p	O
trauma	B-problem
,	O
failure	O
on	O
previous	B-test
CXR	I-test
,	O
now	O
with	O
fever	B-problem
.	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

Fever	B-problem
,	O
f/u	O
infiltrte	B-problem

HISTORY	O
:	O
Trauma	B-problem
,	O
congestive	B-problem
heart	I-problem
failure	I-problem
,	O
fever	B-problem
,	O
pneumonia	B-problem
.	O

Portable	B-test
supine	I-test
chest	I-test
radiograph	I-test
shows	O
improvement	O
in	O
edema	B-problem
compared	O
to	O
studies	B-test
from	O
four	O
and	O
five	O
days	O
earlier	O
with	O
no	O
significant	B-problem
radiographic	I-problem
change	I-problem
in	O
right	B-problem
upper	I-problem
lobe	I-problem
consolidation	I-problem
consistent	O
with	O
pneumonia	B-problem
.	O

Some	B-problem
interstitial	I-problem
edema	I-problem
still	O
persists	O
,	O
but	O
there	O
is	O
no	O
central	B-problem
pulmonary	I-problem
vascular	I-problem
congestion	I-problem
.	O

Cardiac	B-test
size	I-test
is	O
unchanged	O
.	O

The	O
amount	O
of	O
fluid	B-problem
layering	I-problem
at	I-problem
the	I-problem
apices	I-problem
and	I-problem
the	I-problem
pleural	I-problem
spaces	I-problem
appear	O
slightly	O
decreased	O
.	O

Multiple	B-problem
left-sided	I-problem
rib	I-problem
fractures	I-problem
are	O
seen	O
.	O

Supporting	B-treatment
tubes	I-treatment
and	I-treatment
lines	I-treatment
are	O
in	O
unchanged	O
position	O
and	O
the	O
patient	O
has	O
a	B-treatment
single	I-treatment
lead	I-treatment
pacemaker	I-treatment
projected	O
on	O
the	O
left	O
.	O

Calcification	B-problem
is	O
seen	O
at	O
both	O
carotid	O
bifurcations	O
.	O

CONCLUSION	O
:	O
Improvement	O
in	O
congestion	B-problem
from	O
edema	B-problem
with	O
no	O
worsening	O
,	O
but	O
no	O
significant	O
improvement	O
,	O
in	O
the	B-problem
right	I-problem
upper	I-problem
lobe	I-problem
pneumonia	I-problem
.	O

Supporting	B-treatment
lines	I-treatment
and	I-treatment
tubes	I-treatment
in	O
unchanged	O
position	O
.	O

Brief	O
Hospital	O
Course	O
:	O

Admitted	O
to	O
TSICU	O
for	O
subarachnoid	B-problem
hemorrhage	I-problem
and	O
multiple	B-problem
spinal	I-problem
fractures	I-problem
.	O

Intubated	B-treatment
and	O
sedated	B-treatment
for	O
desats	B-problem
on	O
2014-10-27	O
.	O

Evaluated	O
by	O
neurosurgery	O
and	O
deemed	O
stable	O
on	O
2014-10-22	O
.	O

CT	B-test
head	I-test
remained	O
stable	O
for	O
SAH	B-problem
.	O

Evaluated	O
by	O
orthopedic	O
spine	O
surgeons	O
with	O
recommendations	O
for	O
soft	B-treatment
c-collar	I-treatment
for	O
comfort	O
.	O

In	O
TSICU	O
,	O
developed	O
MRSA	B-problem
pneumonia	I-problem
with	O
question	O
of	O
aspiration	B-problem
,	O
treated	O
Zosyn	B-treatment
-->	O
vanc	B-treatment
/	O
levo	B-treatment
-->	O
then	O
2	O
week	O
course	O
of	O
Linazolid	B-treatment
with	O
resolution	O
of	O
fevers	B-problem
and	O
decreased	B-problem
pulmonary	I-problem
secretions	I-problem
.	O

2014-11-11	O
:	O
Tracheostomy	B-treatment
performed	O
without	O
complication	B-problem
.	O

Patient	O
tolerated	O
decreasing	B-treatment
ventillary	I-treatment
support.	I-treatment

Mental	O
status	O
improved	O
with	O
the	O
discontinuation	O
of	O
his	B-treatment
bensodiazapines	I-treatment
.	O

Failed	B-problem
swallow	I-problem
study	I-problem
x	O
2	O
in	O
early	O
November	O
.	O

Decision	O
to	O
continue	O
Dobhoff	B-treatment
at	O
rehab	O
given	O
continued	O
clinical	O
improvement	O
and	O
his	O
poor	O
candidacy	O
for	O
G/J	B-treatment
tube	I-treatment
.	O

Communicating	O
by	O
speech	O
s/p	O
PMV	B-treatment
placement	I-treatment
.	O

Continued	O
in	O
Melrose-J	O
for	O
comfort	O
per	O
orthopedics	O
.	O

Stable	O
during	O
his	O
course	O
on	O
the	O
surgical	O
Beth	O
Israel	O
Deaconess	O
Hospital-Needham	O
.	O

Occasionally	O
required	O
Haldol	B-treatment
/	O
ativan	B-treatment
at	O
night	O
for	O
agitation	B-problem
.	O

Progressed	O
adequately	O
with	O
physical	B-treatment
/	I-treatment
occupational	I-treatment
therapy	I-treatment
,	O
however	O
was	O
noted	O
to	O
develop	O
an	B-problem
early	I-problem
bilateral	I-problem
upper	I-problem
extermity	I-problem
contracture	I-problem
at	I-problem
the	I-problem
elbows	I-problem
and	I-problem
wrists	I-problem
.	O

Serial	B-test
CT	I-test
head	I-test
revealed	O
decreased	B-problem
blood	I-problem
through	O
2014-11-14	O
.	O

Discharge	O
Medications	O
:	O

1.	O
Heparin	B-treatment
(	I-treatment
Porcine	I-treatment
)	I-treatment
5,000	O
unit/mL	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Injection	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

2.	O
Lisinopril	B-treatment
15	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

3.	O
Lansoprazole	B-treatment
30	O
mg	O
Susp	O
,	O
Delayed	O
Release	O
for	O
Recon	O
Sig	O
:	O
One	O
(	O
1	O
)	O
PO	O
DAILY	O
(	O
Daily	O
).	O

4.	O
Linezolid	B-treatment
600	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
):	O
Last	O
dose	O
2014-11-20	O
.	O

5.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

6.	O
Digoxin	B-treatment
125	O
mcg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

7.	O
Docusate	B-treatment
Sodium	I-treatment
150	O
mg	O
/	O
15	O
mL	O
Liquid	O
Sig	O
:	O
One	O
(	O
1	O
)	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

8.	O
Bisacodyl	B-treatment
5	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
as	O
needed	O
for	O
constipation	B-problem
.	O

9.	O
Magnesium	B-treatment
Hydroxide	I-treatment
400	O
mg	O
/	O
5	O
mL	O
Suspension	O
Sig	O
:	O
Thirty	O
(	O
30	O
)	O
ML	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
for	O
consitpation	B-problem
.	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Facility	O
:	O

Children	O
's	O
Hospital	O
of	O
Waltham	O

Discharge	O
Diagnosis	O
:	O

s/p	O
Fall	O

Subarachnoid	B-problem
hemorrhage	I-problem
w/	O
bilateral	B-problem
intraventricular	I-problem
hemorrhage	I-problem

Left	B-problem
T1	I-problem
transverse	I-problem
process	I-problem
fracture	I-problem

C7	B-problem
&	I-problem
T1	I-problem
mimimally	I-problem
displaced	I-problem
transverse	I-problem
process	I-problem
fracture	I-problem

Left	B-problem
rib	I-problem
fractures	I-problem
05-22	O

Discharge	O
Condition	O
:	O

Stable	O

Discharge	O
Instructions	O
:	O

You	O
must	O
continue	O
to	O
wear	O
your	B-treatment
cervical	I-treatment
collar	I-treatment
for	O
the	O
next	O
4	O
weeks	O
(	O
through	O
12-11	O
).	O

Follow	O
up	O
with	O
Trauma	O
in	O
3-4	O
weeks	O
after	O
your	O
discharge	O
.	O

Follow	O
up	O
Instructions	O
:	O

Call	O
(	O
909	O
)	O
566-1185	O
to	O
schedule	O
appointment	O
in	O
Trauma	O
Clinic	O
in	O
3-4	O
weeks	O
.	O

Follow	O
up	O
with	O
Dr.	O
Topping	O
after	O
your	O
discharge	O
from	O
rehabilitation	O

Call	O
887	O
415	O
4220	O
to	O
schedule	O
an	O
appointment	O
with	O
Orthopedics	O
for	O
late	O
November	O
.	O

David	O
Thomas	O
MD	O
60-008	O

Completed	O
by	O
:	O
Russell	O
Anthony	O
Conner	O
MD	O
87-672	O
2014-11-21	O
@	O
1110	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Melissa	O
Higuera	O
on	O
:	O
SUN	O
2014-11-23	O
6:13	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2015-10-26	O

Discharge	O
Date	O
:	O

2015-10-30	O

Date	O
of	O
Birth	O
:	O

1998-01-05	O

Sex	O
:	O

M	O

Service	O
:	O

SURGERY	B-treatment

Allergies	O
:	O

Sulfa	B-treatment
(	I-treatment
Sulfonamides	I-treatment
)	I-treatment
/	O
Penicillins	B-treatment

Attending	O
:	O
Mary	O
T	O
Davis	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

s/p	O
Pedestrian	O
struck	O
by	O
auto	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

2015-10-27	O
Open	B-treatment
reduction	I-treatment
and	O
internal	B-treatment
fixation	I-treatment
of	O
right	B-problem
tib/fib	I-problem
fractures	I-problem

History	O
of	O
Present	O
Illness	O
:	O

17	O
yo	O
male	O
pedestrian	O
who	O
was	O
struck	O
by	O
auto	O
at	O
unknown	O
speed	O
;	O
+LOC	B-problem
.	O

He	O
was	O
medflighted	O
to	O
The	O
Hospital	O
for	O
Orthopedics	O
for	O
ongoing	B-treatment
trauma	I-treatment
care	I-treatment
.	O

Upon	O
arrival	O
GCS	B-test
15	O
,	O
alert	O
and	O
oriented	O
x3	O
.	O

Past	O
Medical	O
History	O
:	O

Attention	B-problem
deficit	I-problem
disorder	I-problem
(	O
diagnosed	O
@	O
14	O
yrs	O
of	O
age	O
)	O

Social	O
History	O
:	O

High	O
school	O
student	O

Resides	O
with	O
parents	O
and	O
siblings	O

Family	O
History	O
:	O

Noncontributory	O

Pertinent	O
Results	O
:	O

2015-10-26	O
08:48	O
PM	O

GLUCOSE	B-test
-	O
101	O
LACTATE	B-test
-	O
2.9	O
*	O
NA+	B-test
-	O
142	O
K+	B-test
-	O
3.6	O
CL-	B-test
-	O
102	O
TCO2	B-test
-	O
26	O

2015-10-26	O
08:34	O
PM	O

UREA	B-test
N	I-test
-	O
12	O
CREAT	B-test
-	O
1.0	O

2015-10-26	O
08:34	O
PM	O

AMYLASE	B-test
-	O
44	O

2015-10-26	O
08:34	O
PM	O

ASA	B-test
-	O
NEG	O
ETHANOL	B-test
-	O
NEG	O
ACETMNPHN	B-test
-	O
NEG	O
bnzodzpn	B-test
-	O
NEG	O
barbitrt	B-test
-	O
NEG	O
tricyclic	B-test
-	O
NEG	O

2015-10-26	O
08:34	O
PM	O

WBC	B-test
-	O
16.0	O
*	O
RBC	B-test
-	O
4.89	O
HGB	B-test
-	O
14.5	O
HCT	B-test
-	O
40.4	O
MCV	B-test
-	O
83	O
MCH	B-test
-	O
29.7	O
MCHC	B-test
-	O
35.9	O
*	O
RDW	B-test
-	O
13.4	O

2015-10-26	O
08:34	O
PM	O

PLT	B-test
COUNT	I-test
-	O
247	O

2015-10-26	O
08:34	O
PM	O

PT	B-test
-	O
12.7	O
PTT	B-test
-	O
23.8	O
INR(PT)	B-test
-	O
1.1	O

CT	B-test
HEAD	I-test
W/O	I-test
CONTRAST	I-test

Reason	O
:	O
STUCK	O
BY	O
AUTO	O

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

56	O
year	O
old	O
man	O
s/p	O
struck	O
by	O
auto	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

eval	B-test
for	O
bleed	B-problem

CONTRAINDICATIONS	O
for	O
IV	O
CONTRAST	O
:	O
None	O
.	O

INDICATION	O
:	O
Struck	O
by	O
car	O
.	O

COMPARISONS	O
:	O
None	O
.	O

TECHNIQUE	O
:	O
Axial	B-test
MDCT	I-test
images	I-test
of	I-test
the	I-test
brain	I-test
without	O
IV	O
contrast	O
.	O

FINDINGS	O
:	O
There	O
is	O
a	B-problem
linear	I-problem
nondepressed	I-problem
right	I-problem
temporal	I-problem
calvarial	I-problem
fracture	I-problem
extending	O
into	O
the	O
mastoid	O
process	O
.	O

There	O
is	O
a	B-problem
small	I-problem
subdural	I-problem
hematoma	I-problem
with	O
components	O
of	O
pneumocephalus	B-problem
tracking	O
from	O
the	O
mastoid	O
air	O
cells	O
.	O

There	O
is	O
no	O
shift	B-problem
of	I-problem
normally	I-problem
midline	I-problem
structures	I-problem
.	O

There	O
is	O
also	O
a	B-problem
left	I-problem
occipital	I-problem
scalp	I-problem
contusion	I-problem
but	O
no	O
associated	B-problem
skull	I-problem
fracture	I-problem
.	O

Prominent	B-treatment
sutures	I-treatment
in	O
this	O
young	O
patient	O
,	O
the	B-treatment
right	I-treatment
calvarial	I-treatment
suture	I-treatment
extending	O
into	O
the	O
right	O
temporal	O
bones	O
appears	O
more	O
prominent	O
than	O
its	O
counterpart	O
on	O
the	O
left	O
,	O
however	O
,	O
does	O
not	O
appear	O
to	O
represent	O
an	B-problem
acute	I-problem
fracture	I-problem
.	O

No	O
other	B-problem
acute	I-problem
fractures	I-problem
are	O
appreciated	O
.	O

There	O
is	O
small	O
amount	O
of	O
mucosal	B-problem
thickening	I-problem
in	I-problem
the	I-problem
sphenoid	I-problem
sinuses	I-problem
.	O

No	O
air-fluid	B-test
levels	I-test
to	O
suggest	O
occult	B-problem
facial	I-problem
fractures	I-problem
.	O

Orbits	O
are	O
unremarkable	O
.	O

IMPRESSION	O
:	O
Linear	B-problem
right	I-problem
temporal	I-problem
calvarial	I-problem
fracture	I-problem
extending	O
into	O
the	O
mastoid	O
process	O
with	O
small	B-problem
associated	I-problem
right	I-problem
posterior	I-problem
convexity	I-problem
subdural	I-problem
hematoma	I-problem
and	O
pneumocephalus	B-problem
.	O

Discussed	O
with	O
trauma	O
team	O
during	O
the	B-test
study	I-test
.	O

CT	B-test
C-SPINE	I-test
W/O	O
CONTRAST	O

Reason	O
:	O
STUCK	O
BY	O
AUTO	O

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

56	O
year	O
old	O
man	O
s/p	O
struck	O
by	O
auto	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

eval	B-test
for	O
fx	B-problem

CONTRAINDICATIONS	O
for	O
IV	O
CONTRAST	O
:	O
None	O
.	O

INDICATION	O
:	O
18-year-old	O
hit	O
by	O
car	O
.	O

Head	B-problem
injury	I-problem
to	I-problem
the	I-problem
occiput	I-problem
.	O

COMPARISONS	O
:	O
None	O
.	O

TECHNIQUE	O
:	O
Axial	B-test
MDCT	I-test
images	I-test
of	I-test
the	I-test
cervical	I-test
spine	I-test
with	O
coronal	O
and	O
sagittal	O
reformats	O
without	O
IV	O
contrast	O
.	O

FINDINGS	O
:	O
C1	O
through	O
T1	O
are	O
well	O
visualized	O
.	O

There	O
is	O
normal	O
alignment	O
of	O
the	O
cervical	O
vertebral	O
bodies	O
without	O
acute	B-problem
fracture	I-problem
or	O
traumatic	B-problem
malalignment	I-problem
.	O

The	O
posterior	O
elements	O
are	O
intact	O
.	O

There	O
is	O
no	O
significant	B-problem
prevertebral	I-problem
soft	I-problem
tissue	I-problem
swelling	I-problem
.	O

The	O
C1-C2	O
relationship	O
is	O
within	O
normal	O
limits	O
.	O

The	O
dens	O
is	O
intact	O
.	O

The	O
lung	O
apices	O
are	O
clear	O
without	O
pneumothorax	B-problem
.	O

The	O
upper	O
ribs	O
are	O
intact	O
.	O

There	O
is	O
a	B-problem
linear	I-problem
right	I-problem
temporal	I-problem
calvarial	I-problem
fracture	I-problem
extending	O
into	O
the	O
right	O
temporal	O
bones	O
.	O

This	O
appears	O
to	O
stop	O
short	O
of	O
the	O
carotid	O
canal	O
.	O

Multiple	O
posterior	O
right	O
-	O
sided	O
mastoid	O
air	O
cells	O
are	O
opacified	B-problem
with	I-problem
blood	I-problem
.	O

IMPRESSION	O
:	O

1)	O
No	O
acute	B-problem
cervical	I-problem
spine	I-problem
fracture	I-problem
.	O

2)	O
Linear	B-problem
right	I-problem
temporal	I-problem
calvarial	I-problem
fracture	I-problem
extending	O
into	O
the	O
mastoid	O
with	O
a	B-problem
small	I-problem
right	I-problem
posterior	I-problem
convexity	I-problem
subdural	I-problem
hematoma	I-problem
and	O
pneumocephalus	B-problem
;	O
see	O
head	B-test
CT	I-test
report	O
.	O

CHEST	B-test
(	I-test
PA	I-test
&	I-test
LAT	I-test
)	I-test

Reason	O
:	O
Please	O
r/o	O
acute	B-problem
process	I-problem
.	O

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

17	O
year	O
old	O
man	O
with	O
post-op	B-problem
fever	I-problem
.	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

Please	O
r/o	O
acute	B-problem
process	I-problem
.	O

INDICATION	O
:	O
Postoperative	B-problem
fever	I-problem
.	O

COMPARISONS	O
:	O
Comparison	O
is	O
made	O
to	O
2015-10-27	O
.	O

TECHNIQUE	O
:	O
PA	B-test
and	I-test
lateral	I-test
views	I-test
of	I-test
the	I-test
chest	I-test
.	O

FINDINGS	O
:	O
The	O
heart	O
is	O
of	O
normal	O
size	O
.	O

Mediastinal	O
and	O
hilar	O
contours	O
are	O
within	O
normal	O
limits	O
.	O

The	O
lung	O
fields	O
are	O
clear	O
.	O

There	O
are	O
no	O
pleural	B-problem
effusions	I-problem
or	O
focal	B-problem
consolidations	I-problem
.	O

There	O
is	O
no	O
evidence	O
of	O
CHF	B-problem
.	O

IMPRESSION	O
:	O
No	O
evidence	O
of	O
significant	B-problem
abnormality	I-problem
.	O

TIB	B-test
/	I-test
FIB	I-test
(	I-test
AP	I-test
&	I-test
LAT	I-test
)	I-test
SOFT	O
TISSUE	O

Reason	O
:	O
eval	B-test
for	I-test
alignment	I-test
,	I-test
post	I-test
op	I-test
changes	I-test

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

56	O
year	O
old	O
man	O
with	O
open	B-problem
RLE	I-problem
fx	I-problem
now	O
s/p	B-treatment
fixation	I-treatment

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

eval	B-test
for	I-test
alignment	I-test
,	I-test
post	I-test
op	I-test
changes	I-test

INDICATION	O
:	O
Fracture	B-problem
.	O
Assess	O
for	O
alignment	O
.	O

RIGHT	B-test
TIBIA	I-test
/	I-test
FIBULA	I-test
,	I-test
AP	I-test
AND	I-test
LATERAL	I-test
VIEWS	I-test
:	O
An	B-treatment
intramedullary	I-treatment
rod	I-treatment
is	O
seen	O
fixating	O
a	B-problem
proximal	I-problem
diaphyseal	I-problem
comminuted	I-problem
tibial	I-problem
fracture	I-problem
with	O
six	B-treatment
proximal	I-treatment
and	I-treatment
two	I-treatment
distal	I-treatment
screws	I-treatment
.	O

Additionally	O
,	O
a	B-treatment
side	I-treatment
plate	I-treatment
is	O
seen	O
medially	O
fixating	O
the	B-problem
fracture	I-problem
.	O

There	O
is	O
a	B-problem
non-displaced	I-problem
comminuted	I-problem
fracture	I-problem
of	I-problem
the	I-problem
proximal	I-problem
fibular	I-problem
diaphysis	I-problem
.	O

There	O
is	O
surrounding	O
soft	B-problem
tissue	I-problem
swelling	I-problem
.	O

Os	O
trigonum	O
is	O
visualized	O
.	O

IMPRESSION	O
:	O
Comminuted	B-problem
proximal	I-problem
tibiofibular	I-problem
fractures	I-problem
status	B-treatment
post	I-treatment
ORIF	I-treatment
of	I-treatment
the	I-treatment
tibia	I-treatment
with	O
an	B-treatment
intramedullary	I-treatment
rod	I-treatment
and	I-treatment
side	I-treatment
plate	I-treatment
.	O

No	O
evidence	O
of	O
immediate	B-problem
hardware	I-problem
complication	I-problem
.	O

CT	B-test
HEAD	I-test
W/O	O
CONTRAST	O

Reason	O
:	O
follow	B-test
up	I-test
ct	I-test

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

17	O
year	O
old	O
man	O
with	O
pneumocephalus	B-problem
s/p	O
CMED	O
CCU	O
v.	O
mvc	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

follow	B-test
up	I-test
ct	I-test

CONTRAINDICATIONS	O
for	O
IV	O
CONTRAST	O
:	O
None	O
.	O

CLINICAL	O
HISTORY	O
:	O
History	O
of	O
pneumocephalus	B-problem
status	O
post	O
pedestrian	O
versus	O
motor	O
vehicle	O
collision	O
.	O

Follow	B-test
up	I-test
CT	I-test
scan	I-test
.	O

COMPARISON	O
:	O
Non-contrast	B-test
head	I-test
CT	I-test
from	O
2015-10-27	O
.	O

TECHNIQUE	O
:	O
Non-contrast	B-test
head	I-test
CT	I-test
.	O

FINDINGS	O
:	O
The	O
previously	O
noted	O
subdural	B-problem
hemorrhage	I-problem
in	I-problem
the	I-problem
right	I-problem
posterior	I-problem
fossa	I-problem
appears	O
less	O
conspicuous	O
.	O

The	O
pneumocephalus	B-problem
adjacent	O
to	O
the	B-problem
linear	I-problem
skull	I-problem
fracture	I-problem
appears	O
to	O
have	O
decreased	O
in	O
size	O
.	O

There	O
are	O
persistent	B-problem
bifrontal	I-problem
and	I-problem
right	I-problem
parietal	I-problem
hemorrhagic	I-problem
contusions	I-problem
with	O
surrounding	B-problem
edema	I-problem
and	O
possible	O
small	B-problem
left	I-problem
frontal	I-problem
subarachnoid	I-problem
hemorrhage	I-problem
(	O
adjacent	O
to	O
falx	O
)	O
which	O
are	O
largely	O
unchanged	O
.	O

There	O
is	O
no	O
shift	B-problem
of	I-problem
normally	I-problem
midline	I-problem
structures	I-problem
or	O
hydrocephalus	B-problem
.	O

The	O
ventricles	O
,	O
cisterns	O
and	O
sulci	O
are	O
normal	O
.	O

The	B-test
air-	I-test
fluid	I-test
level	I-test
in	I-test
the	I-test
right	I-test
sphenoid	I-test
sinus	I-test
and	O
bilateral	B-problem
opacification	I-problem
of	I-problem
the	I-problem
mastoid	I-problem
air	I-problem
cells	I-problem
are	O
unchanged	O
.	O

IMPRESSION	O
:	O

1.	O
Decreased	O
size	O
of	O
right	B-problem
posterior	I-problem
subdural	I-problem
hemorrhage	I-problem
.	O

2.	O
Multifocal	B-problem
hemorrhagic	I-problem
contusions	I-problem
and	O
surrounding	B-problem
edema	I-problem
are	O
largely	O
unchanged	O
.	O

Brief	O
Hospital	O
Course	O
:	O

He	O
was	O
admitted	O
to	O
the	O
trauma	O
service	O
.	O
Orthopedics	O
and	O
Neurosurgery	O
were	O
consulted	O
because	O
of	O
his	B-problem
injuries	I-problem
.	O

His	B-problem
Neurosurgical	I-problem
issues	I-problem
were	O
nonoperative	O
;	O
he	O
was	O
loaded	O
with	O
Dilantin	B-treatment
;	O
serial	B-test
head	I-test
CT	I-test
scans	I-test
were	O
performed	O
and	O
were	O
stable	O
.	O

He	O
will	O
need	O
to	O
follow	O
up	O
with	O
Dr.	O
Mckinney	O
in	O
4	O
weeks	O
for	O
repeat	B-test
head	I-test
imaging	I-test
and	O
continue	O
with	O
Dilantin	B-treatment
for	O
one	O
month	O
.	O

His	B-problem
right	I-problem
tib	I-problem
/	I-problem
fib	I-problem
fracture	I-problem
was	O
repaired	O
by	O
Orthopedics	O
on	O
10-27	O
;	O
postoperatively	O
there	O
were	O
no	O
complications	B-problem
.	O

Weight	O
bearing	O
status	O
was	O
increased	O
to	O
weight	O
bearing	O
as	O
tolerated	O
.	O

He	O
was	O
fitted	O
with	O
a	B-treatment
hinged	I-treatment
Mcdonald	I-treatment
brace	I-treatment
for	O
his	B-problem
LLE	I-problem
.	O

He	O
will	O
need	O
to	O
continue	O
on	O
Lovenox	B-treatment
injections	I-treatment
for	O
at	O
least	O
4-6	O
weeks	O
.	O

He	O
was	O
transfused	O
with	O
3	B-treatment
u	I-treatment
packed	I-treatment
cells	I-treatment
for	O
a	B-test
hematocrit	I-test
of	O
21	O
,	O
post	B-test
transfusion	I-test
HCT	I-test
was	O
26.1	O
;	O
there	O
was	O
a	O
questionable	O
transfusion	B-problem
reaction	I-problem
at	O
the	O
end	O
of	O
his	B-treatment
first	I-treatment
unit	I-treatment
of	I-treatment
packed	I-treatment
cells	I-treatment
;	O
he	O
did	O
subsequently	O
receive	O
the	B-treatment
remaining	I-treatment
2	I-treatment
units	I-treatment
without	O
any	B-problem
further	I-problem
reaction	I-problem
.	O

Physical	O
and	O
Occupational	O
therapy	O
were	O
consulted	O
and	O
have	O
recommended	O
home	O
with	O
services	O
.	O

Medications	O
on	O
Admission	O
:	O

None	O

Allergic	B-problem
to	O
PCN	B-treatment
and	O
Sulfa	B-treatment

Discharge	O
Medications	O
:	O

1.	O
Phenytoin	B-treatment
50	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
,	O
Chewable	O
PO	O
three	O
times	O
a	O
day	O
for	O
1	O
months	O
.	O

Disp	O
:*	O
180	O
Tablet	O
,	O
Chewable	O
(s)*	O
Refills	O
:*	O
0	O
*	O

2.	O
Oxycodone	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-problem
.	O

Disp	O
:*	O
75	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

3.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

4.	O
Magnesium	B-treatment
Hydroxide	I-treatment
400	O
mg	O
/	O
5	O
mL	O
Suspension	O
Sig	O
:	O
Thirty	O
(	O
30	O
)	O
ML	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
for	O
constipation	B-problem
.	O

5.	O
Lovenox	B-treatment
40	O
mg	O
/	O
0.4	O
mL	O
Syringe	O
Sig	O
:	O
0.4	O
ML	O
's	O
Subcutaneous	O
once	O
a	O
day	O
for	O
30	O
days	O
.	O

Disp	O
:*	O
30	O
*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

s/p	O
Pedestrian	O
Struck	O
by	O
Auto	O

Subdural	B-problem
hematoma	I-problem

Skull	B-problem
fracture	I-problem

Right	B-problem
comminuted	I-problem
tibia	I-problem
/	I-problem
fibula	I-problem
fracture	I-problem

Discharge	O
Condition	O
:	O

Good	O

Discharge	O
Instructions	O
:	O

Return	O
to	O
the	O
emergency	O
room	O
if	O
you	O
develop	O
fevers	B-problem
,	O
chills	B-problem
,	O
severe	B-problem
headaches	I-problem
,	O
visual	B-problem
disturbances	I-problem
,	O
nause	B-problem
,	O
vomiting	B-problem
and	O
/	O
or	O
any	B-problem
other	I-problem
symptoms	I-problem
that	O
are	O
concerning	O
to	O
you	O
.	O

You	O
will	O
need	O
to	O
conrtinue	O
with	O
your	B-treatment
Lovenox	I-treatment
injections	I-treatment
for	O
at	O
least	O
4-6	O
weeks	O
as	O
instructed	O
by	O
Orthopedics	O

Followup	O
Instructions	O
:	O

Follow	O
up	O
with	O
Dr.	O
Garza	O
,	O
Orthopaedics	O
in	O
10-14	O
days	O
,	O
call	O
953	O
6923	O
for	O
an	O
appointment	O
.	O

Follow	O
up	O
with	O
Dr.	O
Melendez	O
,	O
Neurosurgery	O
in	O
4	O
weeks	O
;	O
call	O
745	O
8256	O
ext	O
-	O
6468	O
for	O
an	O
appointment	O
.	O

Inform	O
the	O
office	O
that	O
you	O
will	O
need	O
a	B-test
repeat	I-test
head	I-test
CT	I-test
scan	I-test
for	O
this	O
appointment	O
.	O

Lori	O
Dorothy	O
MD	O
79-290	O

Completed	O
by	O
:	O
Christopher	O
Sandy	O
NP	O
80-BYL	O
2015-11-03	O
@	O
1526	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Muriel	O
Zech	O
on	O
:	O
WED	O
2015-11-04	O
11:30	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2014-03-31	O

Discharge	O
Date	O
:	O

2014-04-09	O

Date	O
of	O
Birth	O
:	O

1964-04-26	O

Sex	O
:	O

M	O

Service	O
:	O

Liver	B-treatment
Transplant	I-treatment
Surgery	I-treatment
Service	O

ADMISSION	O
DIAGNOSIS	O
:	O

Hepatitis	B-problem
C	I-problem
cirrhosis	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
49	O
year-old	O
man	O
with	O
hepatitis	B-problem
C	I-problem
cirrhosis	I-problem
complicated	O
by	O
encephalopathy	B-problem
,	O
positive	B-problem
esophageal	I-problem
varices	I-problem
,	O
now	O
with	O
worsening	B-problem
confusion	I-problem
and	O
lethargy	B-problem
.	O

The	O
patient	O
has	O
been	O
admitted	O
5	O
x	O
in	O
the	O
past	O
to	O
Nantucket	O
Cottage	O
Hospital	O
since	O
11-30	O
for	O
encephalopathy	B-problem
.	O

Most	O
recently	O
admitted	O
on	O
2014-03-19	O
to	O
2014-03-22	O
.	O

Infectious	B-test
work-up	I-test
was	O
negative	O
.	O

Trazodone	B-treatment
stopped	O
.	O

Patient	O
was	O
started	O
on	O
Lactulose	B-treatment
and	O
Rifaximine	B-treatment
which	O
improved	O
his	O
mental	O
status	O
.	O

Today	O
,	O
on	O
2014-03-03	O
,	O
the	O
patient	O
was	O
seen	O
in	O
clinic	O
with	O
increased	B-problem
lethargy	I-problem
,	O
confusion	B-problem
.	O

Wife	O
reports	O
that	O
the	O
patient	O
has	O
a	O
history	O
of	O
lethargy	B-problem
and	O
confusion	B-problem
,	O
similar	O
to	O
the	B-problem
symptoms	I-problem
for	O
which	O
the	O
patient	O
was	O
recently	O
admitted	O
.	O

The	O
patient	O
also	O
reports	O
that	O
he	O
has	O
had	O
"	O
yellowish	B-problem
eyes	I-problem
,	O
some	B-problem
shaking	I-problem
and	O
his	O
breath	O
smelled	O
more	O
like	O
ammonia	O
over	O
the	O
past	O
3	O
days	O
."	O

The	O
patient	O
has	O
been	O
compliant	O
with	O
his	B-treatment
medications	I-treatment
.	O

He	O
has	O
had	O
one	O
bowel	O
movement	O
today	O
which	O
is	O
on	O
2014-03-31	O
.	O

He	O
has	O
had	O
night	B-problem
sweats	I-problem
for	O
the	O
past	O
2	O
weeks	O
.	O

He	O
denies	O
any	B-problem
abdominal	I-problem
pain	I-problem
.	O

He	O
gets	O
cold	B-problem
easily	O
but	O
denies	O
fevers	B-problem
.	O

His	O
stools	O
have	O
been	O
brown	O
to	O
green	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

HCV	B-problem
cirrhosis	I-problem
.	O

Underwent	O
treatment	B-treatment
with	O
Interferon	B-treatment
10	O
years	O
ago	O
.	O

He	O
stopped	O
secondary	O
to	O
aggressive	B-problem
behavior	I-problem
.	O

History	O
of	O
hepatic	B-problem
encephalopathy	I-problem
.	O

Esophageal	B-problem
varices	I-problem
.	O

EGD	B-test
on	O
2013-12-08	O
demonstrated	O
5	B-problem
cores	I-problem
of	I-problem
varices	I-problem
,	O
grade	O
1	O
to	O
2	O
at	O
the	O
lower	O
third	O
of	O
the	O
esophagus	O
.	O

Four	B-treatment
bands	I-treatment
were	O
placed	O
without	O
difficulty	O
.	O

Also	O
,	O
the	O
patient	O
has	O
a	O
past	O
medical	O
history	O
of	O
hypertension	B-problem
,	O
glucose	B-problem
intolerance	I-problem
,	O
peripheral	B-problem
neuropathy	I-problem
.	O

The	O
patient	O
was	O
taken	O
off	O
of	O
Neurontin	B-treatment
because	O
it	O
started	O
to	O
worsen	O
his	O
mental	O
status	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Nadolol	B-treatment
20	O
mg	O
q.	O
Day	O
.	O

Protonix	B-treatment
20	O
mg	O
q.	O
24	O
hours	O
.	O

Osamine	B-treatment
200	O
mg	O
t.i.d.	O

Lactulose	B-treatment
30	O
mg	O
q.i.d.	O

Lasix	B-treatment
40	O
mg	O
q.	O
Day	O
.	O

Insulin	B-treatment
regular	I-treatment
.	O

Amlodipine	B-treatment
5	O
mg	O
q.	O
Day	O
.	O

Retazepine	B-treatment
50	O
mg	O
q	O
h.s.	O

Testosterone	B-treatment
4	O
mg	O
q.	O
24	O
hours	O
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
married	O
and	O
lives	O
with	O
his	O
wife	O
.	O

Previously	O
employed	O
as	O
a	O
security	O
guard	O
at	O
a	O
nuclear	O
power	O
plant	O
.	O

Quit	O
tobacco	O
20	O
years	O
ago	O
and	O
currently	O
denies	O
any	O
cigarette	O
.	O

Alcohol	O
:	O
No	O
alcohol	O
use	O
.	O

The	O
patient	O
contracted	O
HCV	B-problem
20	O
years	O
ago	O
secondary	O
to	O
IV	O
drug	O
use	O
.	O

FAMILY	O
HISTORY	O
:	O
Father	O
died	O
of	O
metastatic	B-problem
colon	I-problem
cancer	I-problem
.	O

Mother	O
died	O
of	O
end	B-problem
stage	I-problem
renal	I-problem
disease	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Vital	B-test
signs	I-test
were	O
stable	O
.	O

Weight	B-test
was	O
122.5	O
.	O

General	O
:	O
Patient	O
is	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Lethargic	B-problem
,	O
occasionally	O
falling	O
asleep	O
.	O

HEENT	O
:	O
Pupils	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
.	O

Sclera	B-problem
mildly	I-problem
icteric	I-problem
.	O

Neck	O
:	O
No	O
LAD	B-problem
.	O

Lungs	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

CV	O
:	O
Regular	O
rate	O
and	O
rhythm	O
.	O

Normal	O
S1	O
and	O
S2	O
without	O
murmurs	B-problem
or	O
rubs	B-problem
.	O

Positive	B-problem
gynecomastia	I-problem
.	O

Abdomen	O
:	O
Positive	O
bowel	O
sounds	O
,	O
soft	O
,	O
nondistended	B-problem
,	O
nontender	B-problem
.	O

Obvious	B-problem
ascites	I-problem
.	O

1+	B-problem
edema	I-problem
bilaterally	I-problem
.	O

Neurologic	O
:	O
Awake	O
,	O
alert	O
and	O
oriented	O
x3	O
.	O

Cranial	O
nerves	O
2	O
through	O
12	O
intact	O
.	O

There	O
was	O
mild	B-problem
asterixis	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
.	O

Patient	O
continued	O
on	O
Lactulose	B-treatment
.	O

The	O
goal	O
was	O
3	O
to	O
4	O
stools	O
per	O
day	O
.	O

Continue	O
on	O
Rifaximine	B-treatment
.	O

Continue	O
Lasix	B-treatment
.	O

Physical	O
therapy	O
was	O
consulted	O
on	O
2014-04-01	O
.	O

On	O
2014-04-02	O
,	O
the	O
patient	O
was	O
awake	O
,	O
alert	O
and	O
oriented	O
,	O
taking	O
Lactulose	B-treatment
.	O

Difficulty	B-problem
with	I-problem
word	I-problem
finding	I-problem
at	O
times	O
.	O

Denies	O
any	B-problem
pain	I-problem
or	O
discomfort	B-problem
.	O

Abdomen	O
:	O
Slightly	B-problem
distended	I-problem
,	O
nontender	B-problem
.	O

Positive	O
bowel	O
sounds	O
.	O

Positive	O
flatus	O
.	O

Good	O
op	O
site	O
.	O

Ultrasound	B-test
was	O
performed	O
on	O
2014-04-01	O
demonstrating	O
severe	B-problem
portal	I-problem
hypertension	I-problem
with	O
massive	B-problem
peri	I-problem
splenic	I-problem
varices	I-problem
and	O
splenorenal	B-treatment
shunt	I-treatment
.	O

Portal	O
vein	O
was	O
fully	O
patent	O
.	O

Repeat	B-problem
hepato	I-problem
fungal	I-problem
flare	I-problem
.	O

On	O
2014-04-04	O
,	O
the	O
transplant	O
service	O
was	O
consulted	O
because	O
the	O
patient	O
was	O
possibly	O
going	O
to	O
the	O
operating	O
room	O
for	O
transplant	B-treatment
on	O
2014-04-04	O
.	O

The	O
patient	O
did	O
go	O
to	O
operating	O
room	O
on	O
2014-04-04	O
and	O
the	O
patient	O
had	O
cadaveric	B-treatment
liver	I-treatment
transplant	I-treatment
performed	O
by	O
Dr.	O
Michael	O
Sanders	O
.	O

Please	O
see	O
detailed	O
operative	O
note	O
for	O
more	O
information	O
about	O
the	B-treatment
procedure	I-treatment
.	O

Postoperatively	O
,	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
ICU	O
.	O

The	O
patient	O
received	O
MMF	B-treatment
1	O
gram	O
b.i.d.	O
,	O
Flagyl	B-treatment
500	O
mg	O
IV	O
x1	O
.	O

The	O
patient	O
also	O
received	O
Unasyn	B-treatment
for	O
2	O
days	O
,	O
Fluconazole	B-treatment
,	O
heparin	B-treatment
,	O
Protonix	B-treatment
,	O
insulin	B-treatment
,	O
morphine	B-treatment
,	O
Bactrim	B-treatment
.	O

The	O
patient	O
was	O
on	O
Propofol	B-treatment
for	O
2	O
days	O
.	O

LABORATORY	O
DATA	O
:	O

On	O
2014-04-04	O
,	O
labs	B-test
were	O
as	O
follows	O
:	O

WBC	B-test
of	O
8.3	O
;	O
hematocrit	B-test
of	O
30.6	O
;	O
platelets	B-test
69	O
;	O
sodium	B-test
132	O
;	O
3.9	O
,	O
102	O
,	O
22	O
,	O
serum	B-test
creatinine	I-test
of	O
13	O
and	O
1.1	O
.	O

Glucose	B-test
114	O
.	O

AST	B-test
87	O
.	O

ALT	B-test
44	O
.	O

Alkaline	B-test
phosphatase	I-test
169	O
.	O

PT	B-test
of	O
20.6	O
.	O

PTT	B-test
of	O
38.7	O
.	O

INR	B-test
of	O
2.0	O
.	O

On	O
postoperative	O
day	O
number	O
1	O
,	O
duplex	B-test
ultrasound	I-test
of	I-test
the	I-test
patient	I-test
's	I-test
liver	I-test
was	O
performed	O
demonstrating	O
normal	O
appearing	O
portal	O
veins	O
and	O
hepatic	O
arteries	O
.	O

There	O
was	O
normal	O
flow	O
within	O
the	O
middle	O
hepatic	O
vein	O
.	O

There	O
appears	O
to	O
be	O
a	B-problem
decreased	I-problem
and	I-problem
sluggish	I-problem
flow	I-problem
within	I-problem
the	I-problem
right	I-problem
and	I-problem
left	I-problem
hepatic	I-problem
veins	I-problem
with	O
loss	B-problem
of	I-problem
normal	I-problem
respiratory	I-problem
variations	I-problem
,	I-problem
wave	I-problem
forms	I-problem
and	I-problem
the	I-problem
intrahepatic	I-problem
portion	I-problem
.	O

Additionally	O
,	O
there	O
is	O
diminished	B-problem
color	I-problem
flow	I-problem
with	O
confluence	O
of	O
the	O
hepatic	O
veins	O
.	O

These	O
findings	O
may	O
reflect	O
thrombus	B-problem
within	I-problem
the	I-problem
left	I-problem
and	I-problem
right	I-problem
hepatic	I-problem
veins	I-problem
.	O

Caval	B-problem
narrowing	I-problem
is	O
seen	O
,	O
most	O
likely	O
correlation	O
to	O
clinical	O
history	O
is	O
recommended	O
and	O
further	O
evaluation	O
of	O
the	B-test
CT	I-test
or	O
short-term	B-test
ultrasounds	I-test
for	O
follow-up	O
was	O
recommended	O
.	O

The	B-treatment
Feeney	I-treatment
Gann-Burlington	I-treatment
drain	I-treatment
on	O
postoperative	O
day	O
number	O
demonstrated	O
medial	B-test
output	I-test
of	O
780	O
with	O
lateral	B-test
output	I-test
of	O
150	O
.	O

Patient	O
went	O
to	O
the	O
floor	O
and	O
patient	O
was	O
on	O
the	O
floor	O
on	O
2014-04-07	O
.	O

Patient	O
continued	O
getting	O
Acyclovir	B-treatment
,	O
Prednisone	B-treatment
,	O
MMF	B-treatment
one	O
gram	O
b.i.d	O
.	O

The	O
patient	O
was	O
on	O
FK	B-treatment
2	I-treatment
and	O
2	O
that	O
was	O
started	O
on	O
postoperative	O
day	O
number	O
2	O
.	O

Diet	O
was	O
advanced	O
.	O

Patient	O
was	O
ambulating	O
.	O

Waltham-Ludlow	B-treatment
drains	I-treatment
put	O
out	O
on	O
the	O
13th	O
620	O
and	O
380	O
.	O

Physical	O
therapy	O
was	O
re	O
consulted	O
.	O

Omalley	O
was	O
consulted	O
on	O
2014-04-08	O
for	O
better	O
glucose	B-treatment
control	I-treatment
since	O
the	O
patient	O
was	O
on	O
steroids	B-treatment
.	O

Social	O
work	O
was	O
consulted	O
.	O

Patient	O
continued	O
to	O
do	O
very	O
well	O
,	O
ambulating	O
,	O
following	O
the	O
diet	O
.	O

Patient	O
was	O
transfused	O
1	B-treatment
unit	I-treatment
of	I-treatment
platelets	I-treatment
on	O
2014-04-08	O
for	O
platelet	B-test
count	I-test
of	O
66	O
.	O

A	B-test
heparin	I-test
independent	I-test
antibody	I-test
was	O
sent	O
off	O
on	O
2014-04-07	O
which	O
was	O
unremarkable	O
.	O

On	O
2014-04-09	O
,	O
patient	O
continued	O
to	O
do	O
very	O
well	O
,	O
ambulating	O
,	O
tolerating	O
a	O
diet	O
,	O
urinating	O
without	O
difficulty	B-problem
.	O

Drains	B-treatment
continued	O
to	O
put	O
out	O
significant	O
amount	O
of	O
fluid	O
.	O

Patient	B-test
's	I-test
labs	I-test
from	O
2014-04-10	O
were	O
the	O
following	O
:	O

7.1	O
,	O
hematocrit	B-test
of	O
30.8	O
,	O
platelets	B-test
90	O
.	O

Sodium	B-test
of	O
138	O
;	O
potassium	B-test
3.5	O
;	O
106	O
,	O
28	O
,	O
31	O
,	O
1.0	O
,	O
glucose	B-test
134	O
.	O

AST	B-test
82	O
.	O

ALT	B-test
176	O
.	O

Alkaline	B-test
phosphatase	I-test
78	O
which	O
all	O
have	O
significantly	O
decreased	O
since	O
postoperative	O
day	O
number	O
1	O
.	O

Total	B-test
bilirubin	I-test
was	O
0.9	O
.	O

On	O
2014-04-09	O
,	O
FK	B-test
level	I-test
was	O
10.3	O
.	O

Patient	O
left	O
on	O
2014-04-09	O
with	O
VNA	O
to	O
home	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Protonix	B-treatment
40	O
mg	O
q.	O
24	O
.	O

Moltipine	B-treatment
5	O
mg	O
q.	O
Day	O
.	O

Fluconazole	B-treatment
400	O
mg	O
q.	O
24	O
hours	O
.	O

Prednisone	B-treatment
20	O
mg	O
q.	O
Day	O
.	O

MMF	B-treatment
1000	O
mg	O
b.i.d.	O
.	O

Lopressor	B-treatment
50	O
m	O
b.i.d.	O

Percocet	B-treatment
1	O
to	O
2	O
tabs	O
q.	O
4	O
to	O
6	O
hours	O
prn	O
.	O

Colace	B-treatment
100	O
mg	O
b.i.d.	O

Bactrim	B-treatment
SS	O
1	O
tab	O
q.	O
Day	O
.	O

Tacrolimus	B-treatment
3	O
mg	O
b.i.d.	O

Lasix	B-treatment
20	O
mg	O
b.i.d.	O

Valcyte	B-treatment
900	O
mg	O
q.	O
Day	O
.	O

Patient	O
is	O
on	O
insulin	B-treatment
sliding	I-treatment
scale	I-treatment
with	O
fixed	O
dose	O
.	O

FOLLOW	O
UP	O
:	O

The	O
patient	O
is	O
to	O
follow-up	O
with	O
Dr.	O
Amanda	O
Pepper	O
on	O
the	O
following	O
dates	O
:	O

2014-04-14	O
at	O
9	O
a.m.	O
,	O
2014-04-24	O
at	O
10:20	O
a.m.	O
and	O
2014-05-01	O
at	O
10:20	O
a.m.	O

If	O
the	O
patient	O
can	O
not	O
make	O
those	O
appointments	O
or	O
has	O
any	O
questions	O
about	O
the	O
appointments	O
,	O
please	O
call	O
787-984-9608	O
.	O

The	O
patient	O
is	O
to	O
call	O
787-984-9608	O
if	O
any	O
fevers	B-problem
,	O
chills	B-problem
,	O
nausea	B-problem
and	O
vomiting	B-problem
,	O
abdominal	B-problem
pain	I-problem
,	O
inability	B-problem
to	I-problem
take	I-problem
medications	I-problem
,	O
inability	B-problem
to	I-problem
eat	I-problem
or	I-problem
drink	I-problem
.	O

Patient	O
needs	O
to	O
have	O
labs	B-test
every	O
Monday	O
and	O
Thursday	O
including	O
a	B-test
CBC	I-test
,	O
chem-10	B-test
,	O
AST	B-test
,	O
ALT	B-test
,	O
alkaline	B-test
phosphatase	I-test
,	O
albumin	B-test
,	O
total	B-test
bilirubin	I-test
and	O
Prograf	B-test
level	I-test
need	O
to	O
be	O
obtained	O
.	O

Please	O
fax	O
results	O
to	O
(	O
728	O
)	O
250-3265	O
.	O

All	B-test
cultures	I-test
have	O
been	O
unremarkable	O
.	O

Cultures	B-test
were	O
obtained	O
on	O
2014-03-31	O
.	O

Urine	B-test
culture	I-test
and	O
blood	B-test
culture	I-test
have	O
been	O
unremarkable	O
on	O
2014-04-03	O
.	O

Hepatitis	B-test
viral	I-test
load	I-test
was	O
76,500	O
.	O

Pathology	O
demonstrates	O
that	O
the	B-test
pathology	I-test
results	I-test
of	I-test
the	I-test
liver	I-test
were	O
not	O
finalized	O
.	O

Darrell	O
Diiorio	O
,	O
MD	O
,	O
PHD	O
02-366	O

Dictated	O
By	O
:	O
Deborah	O
JP	O
Allen	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2014-04-11	O
14:30:39	O

T	O
:	O
2014-04-11	O
15:05:40	O

Job	O
#:	O

88167	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Greg	O
Jones	O
on	O
:	O
FRI	O
2014-04-25	O
2:37	O
PM	O

(	O
End	O
of	O
Report	O
)	O

242460787	O
DH	O

5950242	O

67766054	O

86004855	O

09/26/2004	O
12:00:00	O
AM	O

Face	O
Sheet	O
/	O
Discharge	O
Order	O

SIGNED	O

DIS	O

[	O
report	O
_	O
end	O
]	O

Admission	O
Date	O
:	O

2015-11-09	O

Discharge	O
Date	O
:	O

2015-11-16	O

Date	O
of	O
Birth	O
:	O

2015-11-09	O

Sex	O
:	O

F	O

Service	O
:	O

CMED	O
CCU	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Baby	O
girl	O
Fritsche	O
is	O
the	O
1670	O
gram	O
product	O
of	O
a	O
31	O
and	O
06-17	O
week	O
gestation	O
born	O
to	O
a	O
34	O
-	O
year-old	O
G2	O
P1	O
now	O
2	O
woman	O
.	O

Fetal	B-test
screens	I-test
,	O
O	O
positive	O
,	O
antibody	B-test
negative	O
,	O
RPR	B-test
nonreactive	O
,	O
rubella	B-test
immune	O
,	O
hepatitis	B-test
surface	I-test
antigen	I-test
negative	O
,	O
GBS	B-test
unknown	O
.	O

IVF	B-problem
pregnancy	I-problem
complicated	O
by	O
IUGR	B-problem
,	O
2	B-problem
vessel	I-problem
cord	I-problem
,	O
normal	O
fetal	O
echo	O
reverse	O
diastolic	O
flow	O
and	O
demise	B-problem
of	I-problem
twin	I-problem
A	I-problem
at	O
27	O
weeks	O
.	O

Twin	O
B	O
with	O
normal	O
fetal	O
survey	O
was	O
transferred	O
to	O
Boston	O
Medical	O
Center	O
at	O
26	O
and	O
2/7	O
weeks	O
with	O
IUGR	B-problem
of	I-problem
twin	I-problem
A	I-problem
was	O
first	O
noted	O
,	O
presented	O
with	O
preterm	B-problem
labor	I-problem
at	O
31	O
weeks	O
.	O

Betamethasone	B-treatment
complete	O
at	O
approximately	O
26	O
weeks	O
and	O
31	O
weeks	O
.	O

Mother	O
was	O
on	O
clindamycin	B-treatment
since	O
11-04	O
.	O

PPROM	B-problem
with	O
bleeding	B-problem
and	O
transverse	B-problem
lie	I-problem
prompted	O
cesarean	B-treatment
section	I-treatment
.	O

Abruption	B-problem
noted	O
.	O

Apgars	B-test
were	O
6	O
and	O
9	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
weight	B-test
1670	O
grams	O
approximately	O
50	O
th	O
percentile	O
,	O
length	B-test
43	O
cm	O
50	O
th	O
percentile	O
,	O
head	B-test
circumference	I-test
not	O
done	O
.	O

Anterior	O
fontanel	O
soft	O
,	O
flat	O
,	O
cap	O
and	O
prong	B-treatment
CPAP	I-treatment
in	O
place	O
.	O

Nondysmorphic	B-problem
intact	O
Veliz	O
.	O

Comfortable	O
with	O
good	O
aeration	O
,	O
clear	O
breath	O
sounds	O
,	O
does	O
grunt	O
intermittently	O
when	O
disturbed	O
.	O

No	O
murmur	B-problem
.	O

Normal	O
pulses	O
.	O

Soft	O
abdomen	O
,	O
3	O
vessel	O
cord	O
.	O

No	O
hepatosplenomegaly	B-problem
.	O

Normal	O
female	O
genitalia	O
.	O

Positive	O
vaginal	B-problem
tag	I-problem
.	O

Patent	O
anus	O
.	O

No	O
hip	B-problem
click	I-problem
.	O

No	O
sacral	B-problem
dimple	I-problem
.	O

Moves	O
all	O
extremities	O
.	O

Decrease	B-problem
tone	I-problem
,	O
ruddy	O
,	O
warm	O
,	O
well	O
perfused	O
with	O
peripheral	B-treatment
IV	I-treatment
in	I-treatment
left	I-treatment
hand	I-treatment
.	O

HOSPITAL	O
COURSE	O
:	O

Respiratory	O
.	O

Mills	O
was	O
admitted	O
to	O
the	O
newborn	O
intensive	O
care	O
unit	O
with	O
moderate	B-problem
respiratory	I-problem
distress	I-problem
.	O

Infant	O
placed	O
on	O
CPAP	B-treatment
.	O

X-ray	B-test
revealed	O
mild	B-problem
respiratory	I-problem
distress	I-problem
syndrome	I-problem
.	O

She	O
remained	O
on	O
CPAP	B-treatment
for	O
a	O
total	O
of	O
24	O
hours	O
at	O
which	O
time	O
she	O
transitioned	O
to	O
room	O
air	O
and	O
continues	O
to	O
be	O
stable	O
in	O
room	O
air	O
.	O

Caffeine	B-treatment
citrate	I-treatment
was	O
initiated	O
on	O
11-14	O
for	O
apnea	B-problem
and	O
bradycardia	B-problem
of	I-problem
prematurity	I-problem
.	O

She	O
is	O
currently	O
receiving	O
11	O
mg	O
po	O
every	O
day	O
.	O

Cardiovascular	O
.	O

Has	O
been	O
cardiovascular	O
stable	O
throughout	O
hospital	O
course	O
.	O

Heart	B-test
ranges	I-test
130	O
s	O
to	O
160	O
s.	O

Blood	B-test
pressure	I-test
most	O
recently	O
60/37	O
with	O
a	O
mean	O
of	O
44	O
.	O

Fluid	O
and	O
electrolyte	O
.	O

Birth	B-test
weight	I-test
was	O
1670	O
grams	O
50	O
th	O
percentile	O
,	O
length	B-test
43	O
cm	O
50	O
th	O
percentile	O
.	O

Head	B-test
circumference	I-test
not	O
done	O
.	O

Infant	O
was	O
initially	O
started	O
on	O
80	O
cc	O
per	O
kilo	O
per	O
day	O
of	O
D10W	B-treatment
.	O

Enteral	B-treatment
feedings	I-treatment
were	O
initiated	O
on	O
day	O
of	O
life	O
#1	O
.	O

Infant	O
achieved	O
full	B-treatment
enteral	I-treatment
feedings	I-treatment
by	O
day	O
of	O
life	O
6	O
.	O

She	O
is	O
currently	O
receiving	O
150	O
cc	O
per	O
kilo	O
per	O
day	O
of	O
Special	B-treatment
Care	I-treatment
20	I-treatment
.	O

Her	B-test
discharge	I-test
weight	I-test
is	O
1477	O
gm	O
.	O

Her	O
most	O
recent	O
set	O
of	O
electrolytes	O
were	O
on	O
2015-11-13	O
with	O
a	B-test
sodium	I-test
of	O
143	O
,	O
a	B-test
potassium	I-test
of	O
6.3	O
hemolyzed	O
,	O
a	B-test
chloride	I-test
of	O
113	O
and	O
a	B-test
total	I-test
CO2	I-test
of	O
17	O
.	O

She	O
will	O
need	O
advance	B-treatment
calorie	I-treatment
density	I-treatment
for	O
better	O
growth	O
.	O

GI	B-test
.	I-test
Bilirubin	I-test
peaked	O
on	O
day	O
of	O
life	O
#2	O
of	O
9.0	O
/	O
0.3	O
.	O

Infant	O
is	O
under	O
phototherapy	B-treatment
,	O
which	O
was	O
discontinued	O
on	O
11-13	O
.	O

Most	B-test
recent	I-test
bilirubin	I-test
was	O
on	O
11-14	O
of	O
4.8	O
/	O
0.3	O
.	O

Hematology	O
.	O

Hematocrit	B-test
on	O
admission	O
was	O
53.7	O
.	O

She	O
has	O
not	O
required	O
any	B-treatment
blood	I-treatment
transfusions	I-treatment
.	O

Infectious	O
disease	O
.	O

A	B-test
CBC	I-test
and	O
blood	B-test
culture	I-test
obtained	O
on	O
admission	O
.	O

CBC	B-test
had	O
a	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
of	O
9	O
,	O
17	O
polys	B-test
,	O
0	O
bands	B-test
,	O
platelets	B-test
of	O
326	O
.	O

She	O
received	O
48	O
hours	O
of	O
ampicillin	B-treatment
and	O
gentamycin	B-treatment
with	O
negative	O
blood	B-test
cultures	I-test
and	O
antibiotics	B-treatment
were	O
discontinued	O
.	O

Neurological	O
.	O

She	O
has	O
been	O
appropriate	O
for	O
gestational	O
age	O
.	O

Head	B-test
ultrasound	I-test
was	O
performed	O
on	O
2015-11-16	O
and	O
was	O
normal	O
.	O

Sensory	B-test
,	I-test
hearing	I-test
screen	I-test
has	O
not	O
yet	O
been	O
performed	O
,	O
but	O
should	O
be	O
done	O
prior	O
to	O
discharge	O
.	O

CONDITION	O
AT	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

To	O
Boston	O
Medical	O
Center	O
.	O

PRIMARY	O
PEDIATRICIAN	O
:	O

Dr.	O
Kim	O
Adams	O
.	O

Telephone	O
number	O
is	O
(	O
261	O
)	O
564-6894	O
.	O

CARE	O
AND	O
RECOMMENDATIONS	O
:	O

Continue	O
150	O
cc	O
per	O
kilo	O
per	O
day	O
of	O
Special	B-treatment
Care	I-treatment
20	I-treatment
calories	I-treatment
advancing	O
caloric	O
intake	O
as	O
required	O
to	O
maintain	O
weight	O
gain	O
of	O
3	O
grams	O
per	O
kilogram	O
per	O
day	O
.	O

Medications	B-treatment
,	O
continue	O
caffeine	B-treatment
citrate	I-treatment
of	O
11	O
mg	O
po	O
every	O
day	O
.	O

Car	B-test
seat	I-test
position	I-test
screening	I-test
has	O
not	O
yet	O
been	O
done	O
.	O

State	B-test
newborn	I-test
screen	I-test
was	O
sent	O
on	O
day	O
of	O
life	O
#3	O
and	O
at	O
discharge	O
.	O

Initial	O
results	O
were	O
within	O
normal	O
limits	O
.	O

Immunizations	B-treatment
received	O
,	O
infant	O
has	O
not	O
received	O
any	B-treatment
immunizations	I-treatment
to	O
date	O
.	O

State	B-test
newborn	I-test
screen	I-test
was	O
sent	O
on	O
2015-11-12	O
.	O

Immunizations	B-treatment
:	O
recommended	O
Synagis	B-treatment
RSV	I-treatment
prophylaxis	I-treatment
should	O
be	O
considered	O
from	O
November	O
through	O
March	O
for	O
infants	O
who	O
meet	O
any	O
of	O
the	O
following	O
3	O
criteria	O
,	O
born	O
at	O
less	O
than	O
32	O
weeks	O
,	O
born	O
between	O
32	O
and	O
35	O
weeks	O
with	O
2	O
of	O
the	O
following	O
,	O
daycare	O
during	O
RSV	O
season	O
,	O
a	O
smoker	O
in	O
the	O
household	O
,	O
neuromuscular	B-problem
disease	I-problem
and	O
weight	B-problem
abnormalities	I-problem
or	O
school	O
age	O
siblings	O
with	O
chronic	B-problem
lung	I-problem
disease	I-problem
.	O

Influenza	B-treatment
immunization	I-treatment
is	O
recommended	O
annually	O
in	O
the	O
fall	O
for	O
all	O
infants	O
once	O
they	O
reach	O
6	O
months	O
of	O
age	O
.	O

Before	O
this	O
age	O
and	O
for	O
the	O
first	O
24	O
months	O
of	O
the	B-treatment
child	I-treatment
's	I-treatment
life	I-treatment
immunizations	I-treatment
against	O
influenza	B-problem
is	O
recommended	O
for	O
household	O
contacts	O
and	O
out	O
of	O
home	O
care	O
givers	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Premature	B-problem
infant	I-problem
born	O
at	O
31	O
and	O
6/7	O
weeks	O
gestation	O
,	O
resolved	O
respiratory	B-problem
distress	I-problem
syndrome	I-problem
.	O

Rule	O
out	O
sepsis	B-problem
with	O
antibiotic	B-treatment
.	O

Hyperbilirubinemia	B-problem
resolving	O
.	O

Apnea	B-problem
and	O
bradycardia	B-problem
of	I-problem
prematurity	I-problem
.	O

Tai	O
Pamela	O
Wendell	O
,	O
Oklahoma	O
05158	O

Dictated	O
By	O
:	O
Kurt	O
S	O
Imperato	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2015-11-15	O
21:17:13	O

T	O
:	O
2015-11-16	O
06:38:42	O

Job	O
#:	O

82694	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Debbie	O
TRAN	O
on	O
:	O
MON	O
2015-11-16	O
9:57	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2018-05-26	O

Discharge	O
Date	O
:	O

2018-05-31	O

Date	O
of	O
Birth	O
:	O

1935-11-10	O

Sex	O
:	O

F	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Codeine	B-treatment
/	O
Iodine	B-treatment

Attending	O
:	O
Derrick	O
L.	O
Mayo	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

large	B-problem
pericardial	I-problem
effusion	I-problem
,	O
transfer	O
from	O
OSH	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Thoracentesis	B-treatment
2018-05-27	O

History	O
of	O
Present	O
Illness	O
:	O

82	O
F	O
with	O
h/o	O
COPD	B-problem
,	O
CAD	B-problem
,	O
pafib	B-problem
and	O
SSS	B-problem
s/p	O
pacer	B-treatment
on	O
05-08	O
for	O
symptomatic	B-problem
pauses	I-problem
is	O
transferred	O
for	O
large	B-problem
pericardial	I-problem
effusion	I-problem
?	O
needing	O
drainage	B-treatment
and	O
CHF	B-problem
.	O

She	O
was	O
admitted	O
to	O
Cambridge	O
Hospital	O
2018-05-24	O
with	O
ARF	B-problem
(	O
Cr	B-test
3.5	O
up	O
from	O
0.9	O
)	O
and	O
SOB	B-problem
.	O

According	O
to	O
her	O
guardian	O
she	O
was	O
discharged	O
to	O
her	O
NH	O
for	O
a	O
few	O
days	O
after	O
her	B-treatment
pacer	I-treatment
was	O
placed	O
05-08	O
,	O
which	O
was	O
complicated	O
by	O
a	B-problem
PTX	I-problem
requiring	O
CT	B-treatment
placement	I-treatment
which	O
had	O
been	O
d/c	O
'd	O
in	O
the	O
hospital	O
after	O
resolution	O
of	O
her	B-problem
PTX	I-problem
.	O

She	O
had	O
some	O
nausea	B-problem
/	O
vomiting	B-problem
and	O
generally	O
was	O
taking	O
poor	O
pos	O
at	O
her	O
NH	O
.	O

There	O
had	O
been	O
some	O
concern	O
her	B-problem
nausea	I-problem
was	O
due	O
to	O
her	B-treatment
amiodarone	I-treatment
which	O
had	O
been	O
discontinued	O
about	O
1	O
week	O
ago	O
.	O

She	O
was	O
then	O
sent	O
to	O
Franklin	O
Medical	O
Center	O
05-24	O
with	O
lethargy	B-problem
and	O
n/v	B-problem
.	O

At	O
Erich	O
Lindemann	O
Mental	O
Health	O
Center	O
she	O
was	O
discovered	O
to	O
have	O
ARF	B-problem
,	O
a	B-problem
large	I-problem
pericardial	I-problem
effusion	I-problem
,	O
and	O
bilateral	B-problem
pleural	I-problem
effusions	I-problem
.	O

She	O
was	O
treated	O
with	O
IVF	B-treatment
for	O
her	B-problem
ARF	I-problem
.	O

She	O
underwent	O
a	B-test
TTE	I-test
at	O
Erich	O
Lindemann	O
Mental	O
Health	O
Center	O
today	O
(	O
05-26	O
)	O
showing	O
mod-lg	B-problem
circumferential	I-problem
pericardial	I-problem
effusion	I-problem
without	O
evidence	O
of	O
RV	B-problem
diastolic	I-problem
collapse	I-problem
and	O
no	O
MV	O
inflow	O
evidence	O
of	O
tamponade	B-problem
,	O
pacer	B-treatment
wire	I-treatment
located	O
in	O
RV	O
apex	O
.	O

There	O
was	O
still	O
concern	O
for	O
her	B-problem
effusion	I-problem
contributing	O
to	O
her	B-problem
SOB	I-problem
at	O
the	O
OSH	O
so	O
she	O
was	O
transferred	O
for	O
drainage	B-treatment
and	O
treatment	B-treatment
of	O
CHF	B-problem
.	O

Today	O
she	O
only	O
complains	O
of	O
some	B-problem
SOB	I-problem
,	O
which	O
she	O
says	O
remains	O
largely	O
unchanged	O
over	O
the	O
past	O
few	O
days	O
.	O

She	O
denies	O
any	B-problem
CP	I-problem
/	O
cough	B-problem
/	O
fever	B-problem
/	O
abd	B-problem
pain	I-problem
/	O
diarrhea	B-problem
/	O
black	B-problem
or	I-problem
bloody	I-problem
stools	I-problem
/	O
headache	B-problem
.	O

Past	O
Medical	O
History	O
:	O

htn	B-problem

afib	B-problem
,	O
SSS	B-problem

COPD	B-problem

CAD	B-problem

pacer	B-treatment
DDDR	I-treatment
(	I-treatment
Vitatron	I-treatment
CL860	I-treatment
)	I-treatment
placed	O
05-08	O
for	O
SSS	B-problem
with	O
symptomatic	B-problem
bradycardia	I-problem
,	O
c/b	O
R	B-problem
PTX	I-problem
requiring	O
chest	B-treatment
tube	I-treatment

GERD	B-problem

CVA	B-problem

hypothyroidism	B-problem

legally	B-problem
blind	I-problem

Social	O
History	O
:	O

NH	O
resident	O
,	O
guardian	O
Robert	O
Murrell	O

Family	O
History	O
:	O

NC	O

Physical	O
Exam	O
:	O

Exam	O
:	O
T	B-test
96.2	O
HR	B-test
70	O
BP	B-test
118/46	O
R	B-test
24	O
sat	B-test
90%	O
on	O
60%FM	B-treatment

pulsus	B-problem
parodoxus	I-problem
=	O
6-8	O
mm	O

gen	O
:	O
mild	B-problem
resp	I-problem
distress	I-problem
speaking	O
in	O
full	O
sentences	O
but	O
using	O
accessory	O
muscles	O

HEENT	O
:	O
mmm	O
,	O
JVP	B-test
at	O
14	O
cm	O
,	O
no	O
bruits	B-problem
,	O
supple	O

CV	O
:	O
RRR	O
,	O
02-19	O
sys	O
m	O
at	O
RUSB	O

pulm	O
:	O
no	O
BS	B-test
01-15	O
way	O
up	O
bilat	O
,	O
no	O
consolidation	B-problem

abd	O
:	O
s/nt/slightly	O
distended	B-problem
,	O
dec	B-problem
BS	I-problem
,	O
no	O
CVA	B-problem
tenderness	I-problem

ext	O
:	O
1+	B-problem
LE	I-problem
edema	I-problem

Pertinent	O
Results	O
:	O

ECG	B-test
:	O
a	O
paced	O
at	O
70	O
bpm	O
/	O
nml	O
axis	O
,	O
LBBB	B-problem
,	O
no	O
ST	B-problem
or	I-problem
TW	I-problem
changes	I-problem

CXR	B-test
at	O
Erich	O
Lindemann	O
Mental	O
Health	O
Center	O
05-26	O
:	O
bilateral	B-problem
pleural	I-problem
eff	I-problem
and	O
pericardial	B-problem
eff	I-problem

CT	B-test
chest	I-test
at	O
Erich	O
Lindemann	O
Mental	O
Health	O
Center	O
05-25	O
:	O
large	B-problem
pericardial	I-problem
effusion	I-problem
,	O
bilat	B-problem
pleural	I-problem
eff	I-problem
with	O
underlying	B-problem
consolidation	I-problem
which	O
could	O
represent	O
PNA	B-problem
vs.	O
atelectasis	B-problem

TTE	B-test
at	O
Erich	O
Lindemann	O
Mental	O
Health	O
Center	O
05-26	O
:	O
mod-lg	B-problem
circumferential	I-problem
pericardial	I-problem
eff	I-problem
,	O
no	O
evidence	O
of	O
RV	B-problem
diastolic	I-problem
collapse	I-problem
,	O
no	O
MV	O
inflow	O
evidence	O
of	O
tamponade	B-problem
,	O
pacer	B-treatment
lead	I-treatment
located	O
in	O
RV	O
apex	O

head	B-test
CT	I-test
at	O
Erich	O
Lindemann	O
Mental	O
Health	O
Center	O
05-24	O
:	O
atrophy	B-problem
,	O
dense	B-problem
calcification	I-problem
of	I-problem
the	I-problem
tentorium	I-problem
,	O
most	O
likely	O
of	O
metabolic	O
etiology	O

IMAGING	B-test
AT	O
Providence	O
Behavioral	O
Health	O
Hospital	O
:	O

ECHO	B-test
2018-05-28	O

IMPRESSION	O
:	O
Moderate	B-problem
to	I-problem
large	I-problem
pericardial	I-problem
effusion	I-problem
(	O
minimal	B-problem
fluid	I-problem
anteriorly	I-problem
(	O
1cm	O
),	O
?	O
bloody	B-problem
).	O

No	O
definite	B-problem
tamponade	I-problem
physiology	I-problem
.	O

Pacer	B-treatment
seen	O
in	O
RV	O
apex	O
,	O
but	O
cannot	O
exclude	O
perforation	B-problem
.	O

CXR	B-test
2018-05-30	O

FINDINGS	O
:	O
The	B-test
lung	I-test
volumes	I-test
are	O
Moderate	O
bilateral	B-problem
pleural	I-problem
effusions	I-problem
are	O
unchanged	O
.	O

Mild	B-problem
pulmonary	I-problem
edema	I-problem
is	O
unchanged	O
.	O

Lung	B-test
volumes	I-test
are	O
low	B-problem
.	O

Bibasilar	B-problem
atelectasis	I-problem
is	O
unchanged	O
.	O

IMPRESSION	O
:	O
Unchanged	B-problem
moderate	I-problem
bilateral	I-problem
pleural	I-problem
effusions	I-problem
and	O
mild	B-problem
CHF	I-problem
.	O

RENAL	B-test
US	I-test
2018-05-28	O

FINDINGS	O
:	O
The	O
right	O
kidney	O
measures	O
11	O
cm	O
in	O
length	B-test
,	O
the	O
left	O
kidney	O
measures	O
9.7	O
cm	O
in	O
length	B-test
.	O

No	O
hydronephrosis	B-problem
is	O
seen	O
.	O

No	O
urinary	B-problem
calculi	I-problem
are	O
seen	O
.	O

The	O
bladder	O
appears	O
unremarkable	O
and	O
contains	O
a	B-treatment
Foley	I-treatment
catheter	I-treatment
.	O

IMPRESSION	O
:	O
No	O
evidence	O
of	O
hydronephrosis	B-problem
.	O

Brief	O
Hospital	O
Course	O
:	O

A/P	O
:	O

82	O
y/o	O
f	O
w	O
h/o	O
afib	B-problem
,	O
SSS	B-problem
s/p	O
pacer	B-treatment
05-08	O
c/b	O
PTX	B-problem
requiring	O
CT	B-treatment
,	O
CAD	B-problem
,	O
who	O
was	O
readmitted	O
05-24	O
with	O
ARF	B-problem
and	O
lethargy	B-problem
,	O
found	O
to	O
have	O
a	B-problem
large	I-problem
pericardial	I-problem
effusion	I-problem
and	O
bilateral	B-problem
pleural	I-problem
effusions	I-problem
,	O
with	O
echo	B-test
showing	O
no	O
evidence	O
of	O
tamponade	B-problem
,	O
who	O
is	O
transferred	O
for	O
possible	O
pericardial	B-treatment
effusion	I-treatment
drainage	I-treatment
and	O
treatment	B-treatment
of	O
CHF	B-problem
,	O
as	O
well	O
as	O
drainage	B-treatment
of	O
bilateral	B-problem
pleural	I-problem
effusions	I-problem
.	O

She	O
had	O
a	B-test
BNP	I-test
of	O
>	O
5000	O
on	O
admission	O
.	O

Since	O
admission	O
,	O
she	O
ruled	O
out	O
for	O
MI	B-problem
by	O
enzymes	B-test
,	O
and	O
had	O
a	B-test
right	I-test
sided	I-test
thoracentesis	I-test
which	O
yielded	O
transudative	B-problem
fluid	I-problem
.	O

WBC	B-test
s	I-test
since	O
admission	O
were	O
as	O
high	O
as	O
14,000	O
but	O
normalized	O
.	O

She	O
also	O
had	O
2	B-test
echocardiograms	I-test
which	O
revealed	O
persistent	B-problem
pericardial	I-problem
effusions	I-problem
.	O

She	O
has	O
been	O
gently	O
diuresed	O
but	O
has	O
worsening	B-problem
ARF	I-problem
.	O

Her	B-problem
O2	I-problem
requirement	I-problem
has	O
increased	O
despite	O
diuresis	B-treatment
.	O

She	O
denies	O
any	O
CP	B-problem
/	O
cough	B-problem
/	O
fever	B-problem
,	O
abdominal	B-problem
pain	I-problem
/	O
diarrhea	B-problem
,	O
black	B-problem
or	I-problem
bloody	I-problem
stools	I-problem
or	O
headache	B-problem
.	O

Her	B-test
urine	I-test
output	I-test
decreased	B-problem
to	O
nearly	O
zero	O
.	O

In	O
the	O
setting	O
of	O
her	B-problem
ongoing	I-problem
pericardial	I-problem
effusion	I-problem
,	O
she	O
was	O
transferred	O
for	O
closer	O
observation	O
to	O
the	O
CCU	O
.	O

The	O
CCU	O
fellow	O
and	O
team	O
declined	O
to	O
do	O
pericardial	B-treatment
drainage	I-treatment
,	O
as	O
the	O
pt	O
was	O
hemodynamically	O
stable	O
,	O
without	O
change	B-problem
in	I-problem
appearance	I-problem
of	I-problem
effusion	I-problem
by	O
echo	B-test
performed	O
at	O
bedside	O
by	O
cards	O
fellow	O
.	O

As	O
she	O
was	O
felt	O
by	O
the	O
CCU	O
to	O
be	O
a	O
poor	O
candidate	O
for	O
right	B-test
heart	I-test
cath	I-test
,	O
was	O
hemodynamically	O
stable	O
with	O
blood	B-test
pressure	I-test
110	O
s-	O
120	O
s	O
systolic	B-test
and	O
pulse	B-test
70	O
s-	O
80	O
s	O
,	O
she	O
was	O
called	O
out	O
of	O
the	O
CCU	O
and	O
back	O
to	O
the	O
cardiac	O
floor	O
without	O
intervention	B-treatment
.	O

The	O
procedure	O
team	O
was	O
called	O
to	O
consider	O
doing	O
a	B-treatment
left	I-treatment
thoracentesis	I-treatment
,	O
but	O
she	O
was	O
declined	O
because	O
it	O
was	O
felt	O
that	O
her	B-problem
effusions	I-problem
were	O
transudative	B-problem
,	O
secondary	O
to	O
CHF	B-problem
,	O
and	O
it	O
was	O
recommended	O
to	O
treat	O
CHF	B-problem
.	O

The	O
pt	O
continued	O
to	O
have	O
low	B-problem
urine	I-problem
output	I-problem
.	O

She	O
was	O
given	O
a	B-treatment
lasix	I-treatment
drip	I-treatment
IV	I-treatment
upon	O
call-out	O
of	O
the	O
ICU	O
,	O
and	O
additional	O
boluses	B-treatment
of	I-treatment
IV	I-treatment
lasix	I-treatment
,	O
200	O
mg	O
then	O
300	O
mg	O
IV	O
were	O
given	O
with	O
a	O
good	O
response	O
,	O
however	O
,	O
she	O
remained	O
net	B-problem
positive	I-problem
fluid	I-problem
balance	I-problem
.	O

Renal	O
consultants	O
did	O
not	O
feel	O
there	O
was	O
an	O
emergent	O
need	O
for	O
dialysis	B-treatment
.	O

A	B-treatment
nitro	I-treatment
drip	I-treatment
was	O
started	O
in	O
an	O
effort	O
to	O
decrease	O
her	O
preload	B-test
and	O
afterload	B-test
.	O

On	O
call	O
out	O
from	O
the	O
CCU	O
,	O
the	O
pt	O
was	O
satting	B-test
93%	O
on	O
4-5L	O
NC	B-treatment
,	O
and	O
through	O
the	O
following	O
night	O
,	O
her	B-problem
oxygen	I-problem
requirement	I-problem
increased	O
to	O
NRB	B-treatment
,	O
wherein	O
she	O
was	O
satting	B-test
upper	O
80	O
s-	O
low	O
90	O
s.	O

ABG	B-test
that	O
evening	O
was	O
7.29/51/56	O
on	O
4L	O
NC	B-treatment
and	O
early	O
the	O
next	O
morning	O
,	O
was	O
7.25/62/64	O
on	O
NRB	B-treatment
.	O

A	B-test
CXR	I-test
was	O
performed	O
the	O
evening	O
of	O
5/16	O
,	O
showing	O
moderate	B-problem
sized	I-problem
bilateral	I-problem
pleural	I-problem
effusions	I-problem
,	O
stable	B-problem
cardiomegaly	I-problem
and	O
a	O
possible	O
RLL	B-problem
infiltrate	I-problem
.	O

Vancomycin	B-treatment
and	O
Zosyn	B-treatment
were	O
started	O
.	O

She	O
was	O
afebrile	B-problem
.	O

The	O
morning	O
of	O
5/17	O
,	O
her	B-test
pulsus	I-test
parodoxicus	I-test
was	O
12	O
.	O

Because	O
of	O
her	B-test
ABG	I-test
,	O
and	O
declining	O
clinical	O
status	O
,	O
the	O
CCU	O
was	O
notified	O
for	O
possible	O
transfer	O
.	O

The	O
CMED	O
CSRU	O
Intern	O
called	O
the	O
Murphy	O
,	O
Robert	O
Leigh	O
,	O
to	O
give	O
her	O
the	O
update	O
with	O
regards	O
to	O
the	O
pt	O
's	O
deteriorating	O
clinical	O
status	O
.	O

It	O
was	O
felt	O
that	O
given	O
her	O
age	O
,	O
multiple	B-problem
co-morbidities	I-problem
,	O
that	O
her	O
prognosis	O
was	O
poor	O
even	O
prior	O
to	O
CCU	O
admission	O
,	O
possible	O
pericardial	B-treatment
drainage	I-treatment
or	O
repeat	B-treatment
thoracenteses	I-treatment
.	O

Goals	O
of	O
care	O
were	O
clarified	O
with	O
her	O
Murphy	O
,	O
Robert	O
Sanchez	O
.	O

Explained	O
to	O
Lewin	O
that	O
pt	O
will	O
likely	O
need	O
to	O
be	O
intubated	O
,	O
as	O
she	O
cannot	O
lie	O
flat	O
,	O
and	O
most	O
likely	O
cannot	O
undergo	O
pericardial	B-treatment
drainage	I-treatment
,	O
thoracentesis	B-treatment
,	O
or	O
right	B-treatment
heart	I-treatment
cath	I-treatment
with	O
BiPAP	B-treatment
(	O
which	O
would	O
have	O
been	O
the	O
next	O
measure	O
after	O
NRB	B-treatment
,	O
and	O
prior	O
to	O
intubation	B-treatment
).	O

Explained	O
that	O
despite	O
these	B-treatment
invasive	I-treatment
measures	I-treatment
,	O
she	O
still	O
has	O
a	O
very	O
poor	O
prognosis	O
.	O

Odell	O
stated	O
she	O
had	O
been	O
thinking	O
about	O
this	O
all	O
night	O
of	O
2018-05-30	O
,	O
and	O
agreed	O
that	O
this	O
is	O
not	O
what	O
the	O
pt	O
would	O
have	O
wanted	O
.	O

Odell	O
does	O
not	O
believe	O
the	O
pt	O
would	O
want	O
to	O
be	O
intubated	O
,	O
with	O
central	B-treatment
line	I-treatment
,	O
right	B-treatment
heart	I-treatment
cath	I-treatment
,	O
in	O
the	O
CCU	O
.	O

She	O
requested	O
the	O
patient	O
be	O
made	O
Comfort	B-treatment
Measures	I-treatment
Only	O
.	O

She	O
was	O
DNR/DNI	O
on	O
admission	O
.	O

This	O
was	O
documented	O
in	O
the	O
computer	O
,	O
confirmed	O
with	O
Cardiology	O
attending	O
and	O
fellow	O
,	O
and	O
conveyed	O
to	O
the	O
CCU	O
staff	O
,	O
who	O
were	O
informed	O
she	O
may	O
need	O
to	O
go	O
for	O
transfer	O
(	O
which	O
was	O
subsequently	O
cancelled	O
).	O

The	O
pt	O
will	O
be	O
made	O
comfortable	O
,	O
with	O
goals	O
of	O
care	O
shifted	O
towards	O
suppressing	O
her	B-problem
air	I-problem
hunger	I-problem
and	O
pain	B-problem
.	O

#.	O
SOB	B-problem
:	O
Most	O
consistent	O
with	O
CHF	B-problem
by	O
exam	B-test
,	O
although	O
unknown	O
what	O
the	O
severity	O
of	O
her	B-problem
COPD	I-problem
is	O
currently	O
.	O

TTE	B-test
revealed	O
large	B-problem
pericardial	I-problem
effusion	I-problem
.	O

Pt	O
is	O
now	O
s/p	O
drainage	B-treatment
of	O
right	B-problem
pleural	I-problem
effusion	I-problem
,	O
diagnostic	O
and	O
therapeutic	O
,	O
with	O
studies	B-test
consistent	O
with	O
transudate	B-problem
,	O
etiology	O
most	O
likely	O
02-15	O
CHF	B-problem
.	O

We	O
continued	O
her	B-treatment
albuterol	I-treatment
/	O
atrovent	B-treatment
nebs	I-treatment
,	O
diuresis	B-treatment
with	O
IV	B-treatment
lasix	I-treatment
drip	I-treatment
and	O
boluses	B-treatment
.	O

Her	B-test
05-27	I-test
CXR	I-test
post	O
procedure	O
w/o	O
PNX	B-problem
,	O
effusion	B-problem
much	O
improved	O
,	O
yet	O
her	B-test
05-28	I-test
CXR	I-test
worse	O
than	O
05-27	O
with	O
some	O
reaccumulation	O
of	O
right	B-problem
pleural	I-problem
effusion	I-problem
.	O

Then	O
,	O
on	O
05-29	O
,	O
she	O
demonstrated	O
bilateral	B-problem
pleural	I-problem
effusions	I-problem
(	O
reaccumulated	O
),	O
right	B-problem
lower	I-problem
lobe	I-problem
infiltrate	I-problem
(	O
started	O
on	O
vanco	B-treatment
/	O
zosyn	B-treatment
)->	O
put	O
on	O
face	B-treatment
mask	I-treatment
,	O
given	O
lasix	B-treatment
x	O
1	O
bolus	O
100	O
mg	O
,	O
responded	O
somewhat	O
and	O
o2	B-test
sat	I-test
stable	O
in	O
low	O
90	O
s.	O

She	O
was	O
given	O
200	B-treatment
mg	I-treatment
IV	I-treatment
lasix	I-treatment
X	O
1	O
with	O
an	O
additional	O
100	O
cc	O
of	O
urine	B-test
output	I-test
the	O
evening	O
of	O
5/16	O
.	O

Her	B-treatment
lasix	I-treatment
gtt	I-treatment
continued	O
during	O
this	O
time	O
.	O

Her	B-test
oxygen	I-test
sats	I-test
did	O
not	O
improve	O
.	O

She	O
was	O
then	O
made	O
CMO	O
.	O

See	O
above	O
.	O

#.	O
Pericardial	B-problem
effusion	I-problem
:	O
unclear	O
etiology	O
,	O
OSH	O
had	O
raised	O
question	O
of	O
RV	B-problem
perforation	I-problem
from	O
pacer	B-treatment
,	O
however	O
she	O
had	O
a	O
normal	O
echo	O
appearance	O
of	O
lead	O
,	O
no	O
tamponade	B-problem
by	O
exam	B-test
.	O

This	O
has	O
still	O
be	O
known	O
to	O
occur	O
during	O
the	B-treatment
placement	I-treatment
of	I-treatment
pacemaker	I-treatment
.	O

It	O
was	O
felt	O
posthumously	O
that	O
her	B-problem
large	I-problem
pericardial	I-problem
effusion	I-problem
was	O
most	O
likely	O
secondary	O
to	O
a	B-problem
complication	I-problem
of	O
pacer	B-treatment
placement	I-treatment
,	O
although	O
this	O
was	O
not	O
seen	O
on	O
imaging	B-test
.	O

In	O
the	O
last	O
12	O
hours	O
of	O
her	O
life	O
,	O
her	B-test
pulsus	I-test
was	O
12	O
,	O
and	O
she	O
was	O
felt	O
to	O
likely	O
to	O
have	O
aspect	O
of	O
tamponade	B-problem
physiology	I-problem
,	O
since	O
her	B-test
preload	I-test
was	O
reduced	O
.	O

#.	O
CHF	B-problem
:	O
normal	O
EF	O
on	O
TTE	B-test
so	O
possibly	O
with	O
diastolic	B-problem
dysfunction	I-problem
,	O
ruled	O
out	O
for	O
MI	B-problem

-	O
See	O
course	O
of	O
diuresis	B-treatment
above	O
.	O

-	O
We	O
continued	O
ASA	B-treatment
/	O
imdur	B-treatment
/	O
CCB	B-treatment
/	O
hold	O
diovan	B-treatment
until	O
pt	O
was	O
made	O
CMO	O
.	O

#.	O
Pleural	B-problem
effusions	I-problem
:	O
Likely	O
due	O
to	O
CHF	B-problem
although	O
had	O
some	B-problem
leukocytosis	I-problem
at	O
admission	O
to	O
OSH	O
.	O

Mary	B-test
studies	I-test
c/w	O
transudate	B-problem
.	O

-	O
After	O
she	O
was	O
made	O
CMO	O
,	O
the	O
pt	O
was	O
started	O
on	O
Morphine	B-treatment
gtt	I-treatment
to	O
maximize	O
comfort	O
and	O
minimize	O
air	B-problem
hunger	I-problem
.	O

#.	O
Afib/SSS	B-problem
:	O
She	O
was	O
A-paced	B-treatment
,	O
pacer	B-treatment
placed	O
05-08	O
in	O
DDDR	B-treatment
mode	I-treatment
,	O
complicated	O
by	O
PTX	B-problem
requiring	O
chest	B-treatment
tube	I-treatment
which	O
resolved	O
and	O
tube	B-treatment
was	O
removed	O
during	O
admit	O
for	O
pacer	B-treatment
,	O
no	O
evidence	O
of	O
PTX	B-problem
on	O
most	B-test
recent	I-test
CXR	I-test
.	O

Her	B-treatment
pacer	I-treatment
wires	I-treatment
in	O
correct	O
position	O
.	O

We	O
continued	O
amiodarone	B-treatment
until	O
pt	O
was	O
made	O
CMO	O
.	O

Anticoagulation	B-treatment
has	O
not	O
been	O
given	O
this	O
admission	O
.	O

She	O
was	O
a	O
poor	O
anticoagulation	O
candidate	O
.	O

We	O
started	O
her	O
on	O
dilt	B-treatment
for	O
additional	B-treatment
a	I-treatment
fib	I-treatment
control	I-treatment
(	O
revert	O
back	O
to	O
a	B-problem
fib	I-problem
on	O
05-29	O
),	O
which	O
was	O
stopped	O
when	O
the	O
pt	O
was	O
made	O
CMO	O
.	O

#.	O
Oliguric	B-problem
ARF	I-problem
:	O
likely	O
prerenal	O
due	O
to	O
n/v	B-problem
poor	B-problem
po	I-problem
intake	I-problem
and	O
poor	B-problem
forward	I-problem
flow	I-problem
,	O
However	O
,	O
need	O
to	O
continue	O
diuresis	B-treatment
.	O

Her	B-test
urine	I-test
lytes	I-test
consistent	O
with	O
ATN	B-problem
,	O
FENA	B-test
4%	O
.	O

Renal	B-test
u/s	I-test
negative	O
for	O
hydronephrosis	B-problem
.	O

Renal	O
consultants	O
did	O
not	O
feel	O
that	O
there	O
was	O
an	O
indication	O
for	O
urgent	B-treatment
hemodialysis	I-treatment
.	O

She	O
continued	O
to	O
put	O
out	O
low	B-problem
amounts	I-problem
of	I-problem
urine	I-problem
throughout	O
the	O
admission	O
,	O
despite	O
aggressive	B-treatment
diuresis	I-treatment
with	O
IV	B-treatment
lasix	I-treatment
gtt	I-treatment
and	O
boluses	B-treatment
.	O

See	O
above	O
.	O

#.	O
ID	O
:	O
initially	O
had	O
leukocytosis	B-problem
at	O
admission	O
,	O
with	O
chest	B-test
CT	I-test
showing	O
possible	O
underlying	B-problem
consolidations	I-problem
vs.	O
atelectasis	B-problem
,	O
levoflox	B-treatment
started	O
05-24	O
and	O
subsequently	O
stopped	O
(	O
no	O
consolidations	B-problem
on	O
CXR	B-test
and	O
afebrile	B-problem
).	O

U/A	B-test
on	O
05-27	O
c/w	O
UTI	B-problem
.	O

Pt	O
now	O
on	O
IV	B-treatment
Ceftriaxone	I-treatment
(	O
was	O
on	O
levoflox	B-treatment
since	O
05-24	O
however	O
UA	B-test
now	O
floridly	B-problem
positive	I-problem
(	O
more	O
so	O
than	O
UA	B-test
at	O
OSH	O
)	O
so	O
felt	O
possibly	O
levo-resistant	B-problem
.	O

Pt	O
started	O
on	O
CTX	B-treatment
05-27	O
.	O

She	O
was	O
empirically	O
started	O
on	O
vanco/zosyn	B-treatment
for	O
empiric	B-treatment
hosp	I-treatment
acquired	I-treatment
pna	I-treatment
coverage	I-treatment

-	O
possible	O
opacity	B-problem
on	O
CXR	B-test
-	O
along	O
w/	O
leukocytosis	B-problem
.	O

#.	O
Anemia	B-problem
:	O
Unclear	O
source	O
.	O

She	O
was	O
guiaic	B-test
negative	O
.	O

-	O
no	O
transfusions	B-treatment
,	O
CMO/DNR/DNI	O

#.	O
FEN	O
:	O
check	O
lytes	B-test
,	O
most	O
recently	O
normal	O
.	O

cardiac/renal	B-treatment
diet	I-treatment

#.	O
Access	O
:	O
PIV	B-treatment

#.	O
Code	O
:	O
DNR/DNI/CMO	O
verified	O
with	O
Robert	O
Marks	O
2018-05-29	O

#.	O
Communication	O
:	O
Guardian	O
Robert	O
Fitzgerald	O
(	O
520	O
)	O
328	O
5499	O
.	O

Medications	O
on	O
Admission	O
:	O

aranesp	B-treatment
100	O
mcg	O
(	O
X1	O
05-26	O
)	O

diltiazem	B-treatment
CD	I-treatment
240	O
mg	O

paxil	B-treatment
20	O
mg	O
daily	O

detrol	B-treatment
LA	I-treatment
4	O
mg	O
daily	O

EC	B-treatment
ASA	I-treatment
81	O
mg	O
daily	O

pepcid	B-treatment
20	O
mg	O
daily	O

amiodarone	B-treatment
200	O
mg	O
daily	O

levofloxacin	B-treatment
250	O
mg	O
IV	O
daily	O
(	O
started	O
05-24	O
)	O

levothyroxine	B-treatment
50	O
mcg	O
daily	O

diovan	B-treatment
160	O
mg	O
daily	O

imdur	B-treatment
60	O
mg	O
daily	O

albuterol-ipratroprium	B-treatment
INH	O
2	O
sprays	O
tid	O
prn	O

Discharge	O
Disposition	O
:	O

Expired	O

Discharge	O
Diagnosis	O
:	O

1.	O
Pulmonary	B-problem
Edema	I-problem
and	O
Hypoxic	B-problem
Respiratory	I-problem
Failure	I-problem

2.	O
Large	B-problem
pericardial	I-problem
effusion	I-problem

3.	O
Moderate	B-problem
bilateral	I-problem
pleural	I-problem
effusions	I-problem

4.	O
Congestive	B-problem
Heart	I-problem
Failure	I-problem

5.	O
Paroxysmal	B-problem
Atrial	I-problem
Fibrillation	I-problem

6.	O
Sick	B-problem
sinus	I-problem
syndrome	I-problem
status	O
post	O
pacer	B-treatment
placement	I-treatment

7.	O
Coronary	B-problem
Artery	I-problem
Disease	I-problem

Discharge	O
Condition	O
:	O

Expired	O

Discharge	O
Instructions	O
:	O

Not	O
applicable	O

Followup	O
Instructions	O
:	O

Not	O
applicable	O

Jessica	O
Ashley	O
MD	O
19-617	O

Completed	O
by	O
:	O
James	O
Weishaar	O
MD	O
01-503	O
2018-05-31	O
@	O
1428	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Barry	O
Smith	O
on	O
:	O
FRI	O
2018-06-01	O
8:26	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2016-07-18	O

Discharge	O
Date	O
:	O

2016-07-21	O

Date	O
of	O
Birth	O
:	O

1969-11-05	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Penicillins	B-treatment

Attending	O
:	O
Daniel	O
Z.	O
H.	O
Walton	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Dyspnea	B-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

None	O

History	O
of	O
Present	O
Illness	O
:	O

46	O
-	O
yo-man	O
w/	O
active	O
cocaine	O
use	O
presents	O
w/	O
LE	B-problem
edema	I-problem
.	O

10	O
days	O
ago	O
,	O
he	O
developed	O
b/l	B-problem
LE	I-problem
edema	I-problem
that	O
has	O
gotten	O
progressively	O
worse	O
until	O
now	O
.	O

Three	O
days	O
ago	O
,	O
he	O
developed	O
dyspnea	B-problem
on	O
exertion	O
when	O
climbing	O
stairs	O
,	O
assoc	O
w/	O
2-pillow	B-problem
orthopnea	I-problem
and	O
PND	B-problem
.	O

He	O
denies	O
any	B-problem
recent	I-problem
chest	I-problem
pain	I-problem
,	O
palpitations	B-problem
,	O
headache	B-problem
,	O
confusion	B-problem
,	O
weakness	B-problem
,	O
numbness	B-problem
,	O
abd	B-problem
pain	I-problem
,	O
or	O
hematuria	B-problem
.	O

No	O
recent	B-problem
viral	I-problem
syndromes	I-problem
or	O
URI	B-problem
s.	I-problem

He	O
does	O
admit	O
to	O
cocaine	O
use	O
last	O
night	O
.	O

Today	O
,	O
his	O
wife	O
convinced	O
him	O
to	O
present	O
to	O
the	O
Deanna	O
for	O
evaluation	B-test
.	O

In	O
the	O
Deanna	O
,	O
his	B-test
BP	I-test
was	O
230/170	O
.	O

BNP	B-test
was	O
elevated	O
at	O
7500	O
.	O

CXR	B-test
revealed	O
evidence	O
of	O
cardiomegaly	B-problem
and	O
pulm	B-problem
edema	I-problem
.	O

He	O
was	O
treated	O
w/	O
ASA	B-treatment
325	O
mg	O
,	O
lasix	B-treatment
10	O
mg	O
IV	O
,	O
and	O
hydralazine	B-treatment
10	O
mg	O
IV	O
x	O
2	O
.	O

He	O
responded	O
well	O
to	O
lasix	B-treatment
w/	O
good	O
UOP	B-test
,	O
but	O
diastolic	B-test
BP	I-test
remained	O
elevated	B-problem
at	O
170	O
,	O
prompting	O
initiation	O
of	O
nitroprusside	B-treatment
gtt	I-treatment
.	O

He	O
is	O
now	O
admitted	O
to	O
the	O
CCU	O
for	O
further	O
care	O
.	O

Past	O
Medical	O
History	O
:	O

none	O

Social	O
History	O
:	O

significant	O
for	O
current	O
tobacco	O
use	O
.	O

Drinks	O
3-4	O
beers	O
a	O
few	O
times	O
weekly	O
,	O
no	O
h/o	O
withdrawal	B-problem
symptoms	I-problem
,	O
seizures	B-problem
or	O
DT	B-problem
s.	I-problem

Snorts	O
cocaine	O
1-2	O
times	O
monthly	O
.	O

Never	O
injected	O
drugs	O
.	O

Family	O
History	O
:	O

There	O
is	O
no	O
family	O
history	O
of	O
premature	B-problem
coronary	I-problem
artery	I-problem
disease	I-problem
or	O
sudden	B-problem
death	I-problem
.	O

Physical	O
Exam	O
:	O

VS	B-test
:	O
T,	B-test
BP	B-test
181/122	O
,	O
HR	B-test
84	O
,	O
RR	B-test
12	O
,	O
O2	B-test
98%	O
2L/m	O

Gen	O
:	O
lying	O
flat	O
in	O
bed	O
,	O
pleasant	O
and	O
conversational	O
,	O
NAD	B-problem

HEENT	O
:	O
NCAT	B-problem
.	O

Sclera	B-problem
anicteric	I-problem
.	O

PERRL	O
,	O
EOMI	O
.	O

OP	O
clear	O
w/	O
MMM	O
.	O

Neck	O
:	O
Supple	O
with	O
JVP	B-test
of	O
8	O
cm	O
.	O

CV	O
:	O
reg	O
s1	O
,	O
loud	B-problem
s2	I-problem
,	O
+	O
2/6	B-problem
systolic	I-problem
murmur	I-problem
radiating	I-problem
to	I-problem
axilla	I-problem
,	O
no	O
s3/s4/r	B-problem

Pulm	O
:	O
CTA	O
b/l	O
w/	O
no	O
crackles	B-problem
or	O
wheezing	B-problem

Abd	O
:	O
obese	B-problem
,	O
+BS	O
,	O
soft	O
,	O
NTND	B-problem
.	O

Ext	O
:	O
warm	O
,	O
2+	O
DP	B-test
b/l	O
,	O
2+	B-problem
pitting	I-problem
edema	I-problem
to	I-problem
knees	I-problem
b/l	I-problem

Neuro	O
:	O
a/o	O
x	O
3	O
,	O
CN	O
04-04	O
intact	O

Pertinent	O
Results	O
:	O

2016-07-18	O
05:30	O
PM	O

WBC	B-test
-	O
7.7	O
RBC	B-test
-	O
5.00	O
HGB	B-test
-	O
15.0	O
HCT	B-test
-	O
42.8	O
MCV	B-test
-	O
86	O
MCH	B-test
-	O
30.0	O
MCHC	B-test
-	O
35.0	O
RDW	B-test
-	O
14.6	O

2016-07-18	O
05:30	O
PM	O

PLT	B-test
COUNT	I-test
-	O
315	O

2016-07-18	O
05:30	O
PM	O

CK-MB	B-test
-	O
4	O
proBNP	B-test
-	O
7489	O
*	O

2016-07-18	O
05:30	O
PM	O

cTropnT	B-test
-	O
0.02	O
*	O

2016-07-18	O
05:30	O
PM	O

ALT(SGPT)	B-test
-	O
77	O
*	O
AST(SGOT)	B-test
-	O
60	O
*	O
CK(CPK)	B-test
-	O
195	O
*	O
ALK	B-test
PHOS	I-test
-	O
104	O
AMYLASE	B-test
-	O
100	O
TOT	B-test
BILI	I-test
-	O
0.4	O

EKG	B-test
demonstrated	O
NSR	O
at	O
87	O
bpm	O
,	O
nl	O
axis	O
,	O
nl	O
int	O
,	O
LVH	B-problem
w/	O
strain	B-problem
pattern	I-problem
,	O
no	O
ischemic	B-problem
changes	I-problem
.	O

CXR	B-test
:	O

Moderate	B-problem
to	I-problem
severe	I-problem
enlargement	I-problem
of	I-problem
the	I-problem
cardiac	I-problem
silhouette	I-problem
,	O
and	O
particularly	O
the	O
left	O
atrium	O
accompanied	O
by	O
pulmonary	B-problem
vascular	I-problem
congestion	I-problem
and	O
mild	B-problem
pulmonary	I-problem
edema	I-problem
consistent	O
with	O
heart	B-problem
failure	I-problem
.	O

Conclusions	O
:	O

The	O
left	O
atrium	O
is	O
moderately	B-problem
dilated	I-problem
.	O

There	O
is	O
moderate	B-problem
symmetric	I-problem
left	I-problem
ventricular	I-problem
hypertrophy	I-problem
with	O
mild	B-problem
cavity	I-problem
dilation	I-problem
and	O
severe	B-problem
global	I-problem
hypokinesis	I-problem
.	O

No	O
left	B-problem
ventricular	I-problem
thrombus	I-problem
is	O
seen	O
.	O

Tissue	B-test
Doppler	I-test
imaging	I-test
suggests	O
an	B-problem
increased	I-problem
left	I-problem
ventricular	I-problem
filling	I-problem
pressure	I-problem
(	O
PCWP	B-test
>	O
18	O
mmHg	O
).	O

The	O
right	O
ventricular	O
cavity	O
is	O
mildly	B-problem
dilated	I-problem
with	O
severe	B-problem
free	I-problem
wall	I-problem
hypokinesis	I-problem
.	O

The	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
minimally	B-problem
thickened	I-problem
.	O

No	O
aortic	B-problem
stenosis	I-problem
or	O
aortic	B-problem
regurgitation	I-problem
is	O
seen	O
.	O

The	O
mitral	O
valve	O
leaflets	O
are	O
structurally	O
normal	O
.	O

There	O
is	O
no	O
mitral	B-problem
valve	I-problem
prolapse	I-problem
.	O

Mild	B-problem
(	I-problem
1+	I-problem
)	I-problem
mitral	I-problem
regurgitation	I-problem
is	O
seen	O
.	O

There	O
is	O
moderate	B-problem
pulmonary	I-problem
artery	I-problem
systolic	I-problem
hypertension	I-problem
.	O

There	O
is	O
a	B-problem
very	I-problem
small	I-problem
circumferential	I-problem
pericardial	I-problem
effusion	I-problem
.	O

IMPRESSION	O
:	O
Moderate	B-problem
symmetric	I-problem
eft	I-problem
ventricular	I-problem
hypertrophy	I-problem
with	O
severe	B-problem
global	I-problem
biventricular	I-problem
hypokinesis	I-problem
c/w	O
diffuse	B-problem
process	I-problem
(	O
toxin	B-problem
,	O
metabolic	O
,	O
cannot	O
exclude	O
myocarditis	B-problem
;	O
in	O
the	O
absence	O
of	O
LVH	B-problem
on	O
ECG	B-test
,	O
an	B-problem
infiltrative	I-problem
process	I-problem
should	O
also	O
be	O
considered	O
).	O

Mild	B-problem
mitral	I-problem
regurgitation	I-problem
.	O

Moderate	B-problem
pulmonary	I-problem
arterial	I-problem
hypertension	I-problem
.	O

Very	B-problem
small	I-problem
circumferential	I-problem
pericardial	I-problem
effusion	I-problem
.	O

Possible	O
abnormality	B-problem
on	I-problem
the	I-problem
aortic	I-problem
valve	I-problem
as	O
described	O
above	O
without	O
aortic	B-problem
regurgitation	I-problem
.	O

If	O
clinically	O
indicated	O
a	B-test
TEE	I-test
would	O
be	O
better	O
able	O
to	O
define	O
an	B-problem
abnormality	I-problem
of	I-problem
the	I-problem
aortic	I-problem
valve	I-problem
.	O

Brief	O
Hospital	O
Course	O
:	O

46	O
-	O
yo-man	O
w/	O
cocaine	O
abuse	O
presents	O
w/	O
LE	B-problem
edema	I-problem
and	O
DOE	B-problem
likely	O
from	O
diastolic	B-problem
heart	I-problem
failure	I-problem
in	O
the	O
setting	O
of	O
cocaine	O
use	O
complicated	O
by	O
hypertensive	B-problem
urgency	I-problem
.	O

Hypertensive	B-problem
urgency	I-problem
:	O

BP	B-test
230/170	O
on	O
presentation	O
,	O
most	O
likely	O
from	O
chronic	B-problem
HTN	I-problem
exacerbated	O
by	O
cocaine	O
use	O
.	O

No	O
signs	O
of	O
end-organ	B-problem
damage	I-problem
at	O
present	O
except	O
for	O
elevated	B-problem
creatinine	I-problem
,	O
which	O
is	O
more	O
likely	O
a	B-problem
chronic	I-problem
problem	I-problem
.	O

The	O
patient	O
was	O
started	O
on	O
labetalol	B-treatment
and	O
Lisinopril	B-treatment
.	O

His	B-test
blood	I-test
pressure	I-test
was	O
taken	O
down	O
from	O
230	O
systolic	B-test
to	O
approx	O
160	O
systolic	B-test
/	O
100	O
diastolic	B-test
on	O
discharge	O
.	O

His	B-problem
lower	I-problem
extremity	I-problem
edema	I-problem
improved	O
with	O
diuresis	B-treatment
.	O

An	B-test
echo	I-test
performed	O
on	O
admission	O
showed	O
an	B-test
LF	I-test
EF	I-test
of	O
25%	O
.	O

It	O
is	O
hoped	O
with	O
good	B-treatment
blood	I-treatment
pressure	I-treatment
control	I-treatment
and	O
use	O
of	O
an	B-treatment
ACE-I	I-treatment
with	O
follow	O
up	O
in	O
addition	O
to	O
cocaine	O
abstaining	O
will	O
improved	O
his	O
cardiac	O
function	O
.	O

Renal	B-problem
Failure	I-problem
:	O
creatinine	B-test
on	O
admission	O
was	O
1.6	O
Likely	O
acute	B-problem
hypertensive	I-problem
nephropathy	I-problem
plus	O
probalbe	O
long-standing	B-problem
hypertensive	I-problem
disease	I-problem
.	O

discharged	O
on	O
ACE-I	B-treatment
.	O

Substance	O
Use	O
:	O
Social	O
work	O
saw	O
patient	O
and	O
counceled	O
him	O
regarding	O
substance	O
abuse	O
.	O

Discharged	O
with	O
Margaret	O
Hallock	O
,	O
cardiology	O
follow	O
up	O
as	O
well	O
as	O
scheduled	O
appointment	O
with	O
a	O
new	O
PCP	O
@	O
Newton	O
Health	O
Center	O
.	O

Medications	O
on	O
Admission	O
:	O

none	O

Discharge	O
Medications	O
:	O

1.	O
Aspirin	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

2.	O
Hydrochlorothiazide	B-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

3.	O
Labetalol	B-treatment
200	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
120	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

4.	O
Lisinopril	B-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

Primary	O
:	O

-	O
hypertensive	B-problem
emergency	I-problem

-	O
ARF	B-problem

-	O
mild	B-problem
transaminitis	I-problem
likely	O
03-25	O
etoh	O
and	O
cocaine	O
abuse	O

-	O
cocaine	O
abuse	O

-	O
lower	B-problem
extremity	I-problem
edema	I-problem
improved	O

Discharge	O
Condition	O
:	O

well	O

Discharge	O
Instructions	O
:	O

You	O
came	O
in	O
with	O
hypertensive	B-problem
emergency	I-problem
.	O

You	O
were	O
treated	O
with	O
medications	B-treatment
to	O
improve	O
your	B-test
blood	I-test
pressure	I-test
.	O

Notably	O
you	O
were	O
discharged	O
on	O
:	O

1.	O
Lisinopril	B-treatment
20	O
mg	O
daily	O

2.	O
HCTZ	B-treatment
25	O
mg	O
daily	O

3.	O
Labetalol	B-treatment
400	O
mg	O
bid	O

4.	O
ASA	B-treatment
162mg	O
daily	O

It	O
is	O
extremely	O
important	O
for	O
you	O
to	O
take	O
these	B-treatment
medications	I-treatment
.	O

It	O
is	O
very	O
important	O
that	O
you	O
followup	O
with	O
your	O
cardiology	O
.	O

Please	O
return	O
to	O
the	O
Deanna	O
if	O
you	O
experience	O
SOB	B-problem
,	O
chest	B-problem
pain	I-problem
,	O
fevers	B-problem
,	O
chills	B-problem
,	O
dizziness	B-problem
,	O
decreased	B-problem
urine	I-problem
output	I-problem
.	O

It	O
is	O
also	O
very	O
important	O
that	O
you	O
abstain	O
from	O
cocaine	O
use	O
.	O

Followup	O
Instructions	O
:	O

Please	O
see	O
Dr.	O
Villani	O
on	O
Monday	O
2016-07-25	O
at	O
10:00	O
in	O
Smith	O
7th	O
.	O

It	O
is	O
extremely	O
important	O
for	O
you	O
to	O
keep	O
this	O
appointment	O
.	O

You	O
have	O
a	O
Primary	O
Care	O
Physician	O
B.	O
Schumacher	O
on	O
07-29	O
@	O
1:45	O
pm	O
.	O

Please	O
arrive	O
1	O
hour	O
prior	O
to	O
the	O
appointment	O
to	O
complete	O
the	O
Free	O
Care	O
Application	O
there	O
.	O

You	O
need	O
to	O
bring	O
a	O
picture	O
ID	O
,	O
proof	O
of	O
citizenship	O
,	O
proof	O
of	O
address	O
.	O

The	O
Clinci	O
phone	O
number	O
is	O
(	O
754	O
)	O
280-1011	O

Please	O
followup	O
with	O
Dr.	O
Lesha	O
Lefebvre	O
on	O
08-15	O
at	O
10:30	O
am	O
.	O

His	O
number	O
is	O
(	O
532-803-1162	O
.	O

His	O
secretary	O
can	O
help	O
you	O
clarify	O
your	O
insurance	O
.	O

Ralph	O
Katherine	O
MD	O
31-164	O

Completed	O
by	O
:	O
Terry	O
Smith	O
MD	O
12-201	O
2016-07-21	O
@	O
1848	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Jennifer	O
Applebee	O
on	O
:	O
Sandra	O
2016-07-21	O
9:54	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2011-09-23	O

Discharge	O
Date	O
:	O

2011-10-06	O

Date	O
of	O
Birth	O
:	O

2011-09-23	O

Sex	O
:	O

M	O

Service	O
:	O

NEONATOLOGY	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Ken	O
Nansteel-Miller	O
is	O
the	O
triplet	O
#3	O
of	O
a	B-problem
spontaneous	I-problem
triamniotic-trichorionic	I-problem
triplet	I-problem
pregnancy	I-problem
born	O
to	O
a	O
39-year-old	O
G4	O
P1	O
spontaneous	O
abortion	O
2	O
woman	O
.	O

Prenatal	O
screens	O
:	O

Blood	B-test
type	I-test
A	O
positive	O
,	O
antibody	B-test
negative	O
,	O
rubella	B-test
immune	O
,	O
RPR	B-test
nonreactive	O
,	O
hepatitis	B-test
B	I-test
surface	I-test
antigen	I-test
negative	O
,	O
group	B-test
beta	I-test
Strep	I-test
status	I-test
unknown	O
.	O

The	O
mother	O
was	O
followed	O
closely	O
and	O
received	O
betamethasone	B-treatment
2011-08-22	O
.	O

She	O
was	O
admitted	O
on	O
2011-08-25	O
for	O
nausea	B-problem
,	O
vomiting	B-problem
,	O
and	O
a	B-problem
shortened	I-problem
cervix	I-problem
.	O

She	O
was	O
treated	O
with	O
bed	B-treatment
rest	I-treatment
and	O
prn	O
terbutaline	B-treatment
.	O

Other	B-treatment
medications	I-treatment
including	O
Prozac	B-treatment
.	O

The	O
babies	O
were	O
born	O
by	O
elective	B-treatment
cesarean	I-treatment
section	I-treatment
at	O
34	O
weeks	O
gestation	O
.	O

This	O
triplet	O
#3	O
emerged	O
with	O
spontaneous	O
respirations	O
,	O
and	O
required	O
blow-by	B-treatment
oxygen	I-treatment
in	O
the	O
delivery	O
room	O
.	O

Apgars	B-test
were	O
seven	O
at	O
one	O
minute	O
and	O
eight	O
at	O
five	O
minutes	O
.	O

He	O
was	O
admitted	O
to	O
the	O
Neonatal	O
Intensive	O
Care	O
Unit	O
for	O
treatment	B-treatment
of	O
prematurity	B-problem
.	O

PHYSICAL	O
EXAM	O
UPON	O
ADMISSION	O
TO	O
THE	O
NEONATAL	O
INTENSIVE	O
CARE	O
UNIT	O
:	O

Weight	B-test
1.7	O
kg	O
,	O
length	B-test
41.5	O
cm	O
,	O
head	B-test
circumference	I-test
29	O
cm	O
,	O
all	O
10th-25th	O
percentile	O
for	O
34	O
weeks	O
.	O

General	O
:	O
Nondysmorphic	B-problem
preterm	O
male	O
in	O
mild	B-problem
respiratory	I-problem
distress	I-problem
.	O

Head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
,	O
and	O
throat	O
:	O

Anterior	O
fontanel	O
open	O
and	O
flat	O
.	O

Symmetric	O
facial	O
features	O
.	O

Positive	O
red	B-test
reflex	I-test
bilaterally	O
.	O

Palate	O
intact	O
.	O

Chest	O
:	O
Mild	B-problem
intercostal	I-problem
and	I-problem
sternal	I-problem
retractions	I-problem
.	O

Breath	B-test
sounds	I-test
equal	O
with	O
fair	O
aeration	O
.	O

Cardiovascular	O
:	O
Regular	O
,	O
rate	O
,	O
and	O
rhythm	O
,	O
no	O
murmur	B-problem
.	O

Femoral	B-test
pulses	I-test
+2	O
.	O

Abdomen	O
is	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
,	O
no	O
masses	B-problem
,	O
positive	O
bowel	O
sounds	O
.	O

Genitourinary	O
:	O
Normal	O
preterm	O
male	O
.	O

Testes	O
descended	O
bilaterally	O
.	O

Spine	O
straight	O
with	O
normal	O
sacrum	O
.	O

Hips	O
stable	O
.	O

Neurologic	O
:	O
Appropriate	O
tone	O
and	O
reflexes	O
.	O

HOSPITAL	O
COURSE	O
BY	O
SYSTEMS	O
INCLUDING	O
PERTINENT	O
LABORATORY	O
DATA	O
:	O

1.	O
Respiratory	O
:	O
Lincoln	O
required	O
nasal	B-treatment
cannula	I-treatment
O2	I-treatment
for	O
approximately	O
the	O
first	O
8-12	O
hours	O
of	O
life	O
.	O

He	O
weaned	O
to	O
room	O
air	O
and	O
remained	O
on	O
room	O
air	O
the	O
rest	O
of	O
his	O
Neonatal	O
Intensive	O
Care	O
Unit	O
admission	O
.	O

He	O
has	O
had	O
no	O
episodes	O
of	O
spontaneous	B-problem
apnea	I-problem
during	O
admission	O
.	O

2.	O
Cardiovascular	O
:	O
Falmouth	O
has	O
maintained	O
normal	O
heart	O
rates	O
and	O
blood	B-test
pressures	I-test
.	O

No	O
murmurs	B-problem
have	O
been	O
noted	O
.	O

3.	O
Fluids	O
,	O
electrolytes	O
,	O
and	O
nutrition	O
:	O

Beverly	O
was	O
initially	O
NPO	B-treatment
and	O
maintained	O
on	O
intravenous	B-treatment
fluids	I-treatment
.	O

Enteral	B-treatment
feeds	I-treatment
were	O
started	O
on	O
day	O
of	O
life	O
#1	O
,	O
and	O
gradually	O
advanced	O
to	O
full	O
volume	O
.	O

His	O
maximum	O
caloric	O
intake	O
was	O
24	O
calories	O
per	O
ounce	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
he	O
is	O
breastfeeding	O
or	O
taking	O
Enfamil	O
fortified	O
to	O
24	O
calories	O
/	O
ounce	O
with	O
intake	O
approximately	O
150	O
cc	O
/	O
kg	O
/	O
day	O
.	O

Discharge	B-test
weight	I-test
is	O
1.89	O
kg	O
.	O

4.	O
Gastrointestinal	O
:	O
Boston	O
required	O
treatment	B-treatment
for	O
unconjungated	B-problem
hyperbilirubinemia	I-problem
with	O
phototherapy	B-treatment
.	O

His	B-test
peak	I-test
serum	I-test
bilirubin	I-test
occurred	O
on	O
day	O
of	O
life	O
three	O
with	O
a	O
total	O
of	O
8.3	O
/	O
0.2	O
direct	O
,	O
8.1	O
indirect	O
mg/dl	O
.	O

He	O
received	O
phototherapy	B-treatment
for	O
approximately	O
72	O
hours	O
.	O

Rebound	B-test
bilirubin	I-test
on	O
day	O
of	O
life	O
#7	O
was	O
6.6	O
,	O
and	O
total	O
was	O
0.2	O
direct	O
.	O

5.	O
Neurological	O
:	O
Wellesley	O
has	O
maintained	O
a	O
normal	O
neurological	O
examination	O
.	O

Throughout	O
admission	O
,	O
there	O
are	O
no	O
neurological	B-problem
concerns	I-problem
at	O
the	O
time	O
of	O
discharge	O
.	O

6.	O
Sensory	O
:	O

Audiology	O
:	O
Hearing	B-test
screening	I-test
was	O
performed	O
with	O
automated	O
auditory	O
brain	O
stem	O
responses	O
.	O

Nantucket	O
passed	O
in	O
both	O
ears	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O
Good	O
.	O

DISCHARGE	O
/	O
DISPOSITION	O
:	O
Home	O
with	O
parents	O
.	O

PRIMARY	O
PEDIATRICIAN	O
:	O
Dr.	O
Penny	O
Scott	O
,	O
8400	O
S.	O
Maple	O
Blvd.	O
,	O
Arbour-Fuller	O
Hospital	O
,	O
New	O
Hampshire	O
25344	O
,	O
phone	O
number	O
617-6198	O
.	O

Fax	O
number	O
(	O
317	O
)	O
497-7408	O
.	O

CARE	O
AND	O
RECOMMENDATIONS	O
AT	O
THE	O
TIME	O
OF	O
DISCHARGE	O
:	O

1.	O
Feeding	O
:	O
Breast	O
feeding	O
or	O
Enfamil	O
24	O
calories	O
/	O
ounce	O
.	O

2.	O
Medications	B-treatment
:	O
Ferrous	B-treatment
sulfate	I-treatment
0.15	O
cc	O
po	O
q	O
day	O
25	O
mg	O
/	O
ml	O
dilution	O
.	O

3.	O
Car	B-test
seat	I-test
position	I-test
screening	I-test
was	O
performed	O
.	O

Waltham	O
was	O
monitored	O
for	O
90	O
minutes	O
without	O
any	O
episodes	O
of	O
apnea	B-problem
or	O
oxygen	B-problem
desaturation	I-problem
.	O

4.	O
State	B-test
Newborn	I-test
Screens	I-test
were	O
sent	O
on	O
09-27	O
and	O
2011-10-05	O
with	O
no	O
notification	O
of	O
abnormal	B-problem
results	I-problem
to	O
date	O
.	O

5.	O
No	O
immunizations	B-treatment
administered	O
.	O

Plan	O
is	O
to	O
receive	O
hepatitis	B-treatment
B	I-treatment
in	O
the	O
pediatrician	O
's	O
office	O
,	O
once	O
he	O
reaches	O
a	O
weight	O
of	O
2	O
kg	O
.	O

6.	O
Immunizations	B-treatment
recommended	O
:	O
Synagis	B-treatment
RSV	I-treatment
prophylaxis	I-treatment
should	O
be	O
considered	O
from	O
October	O
through	O
April	O
for	O
infants	O
who	O
meet	O
any	O
of	O
the	O
following	O
three	O
criteria	O
:	O

1)	O
Born	O
at	O
less	O
than	O
32	O
weeks	O
,	O

2)	O
born	O
between	O
32	O
and	O
35	O
weeks	O
with	O
plans	O
for	O
daycare	O
during	O
RSV	O
season	O
,	O
with	O
a	O
smoker	O
in	O
the	O
household	O
,	O
or	O
with	O
preschool	O
siblings	O
,	O
or	O

3)	O
with	O
chronic	B-problem
lung	I-problem
disease	I-problem
.	O

Influenza	B-treatment
immunization	I-treatment
should	O
be	O
considered	O
annually	O
in	O
the	O
fall	O
for	O
preterm	O
infants	O
with	O
chronic	B-problem
lung	I-problem
disease	I-problem
once	O
they	O
reach	O
six	O
months	O
of	O
age	O
.	O

Before	O
this	O
age	O
,	O
the	O
family	O
and	O
other	O
caregivers	O
should	O
be	O
considered	O
for	O
immunization	B-treatment
against	O
influenza	B-problem
to	O
protect	O
the	O
infant	O
.	O

FOLLOW-UP	O
APPOINTMENTS	O
:	O
Dr.	O
Parramore	O
on	O
10-10	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Prematurity	B-problem
at	I-problem
34	I-problem
weeks	I-problem
gestation	I-problem
.	O

2.	O
Triplet	O
#3	O
of	O
triplet	O
gestation	O
.	O

3.	O
Unconjugated	B-problem
hyperbilirubinemia	I-problem
.	O

Reviewed	O
By	O
:	O
Janna	O
L.	O
Desorbo	O
,	O
M.D.	O

00-112	O

Dictated	O
By	O
:	O
Jeannette	O
D.	O
Rede	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2011-10-06	O
04:03	O

T	O
:	O
2011-10-06	O
06:19	O

JOB	O
#:	O

02566	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Bernice	O
Jenkins	O
on	O
:	O
FRI	O
2011-10-07	O
4:01	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2019-09-27	O

Discharge	O
Date	O
:	O

2019-10-07	O

Date	O
of	O
Birth	O
:	O

1959-01-27	O

Sex	O
:	O

M	O

Service	O
:	O

CARDIOTHORACIC	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	I-problem
Drugs	I-problem

Attending	O
:	O
Luis	O
JG	O
Lavoie	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

exertional	B-problem
angina	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

10-01	O
CABG	B-treatment
x	O
3	O

History	O
of	O
Present	O
Illness	O
:	O

60	O
yo	O
M	O
with	O
exertional	B-problem
angina	I-problem
->	O
positive	B-problem
ETT	I-problem
->	O
cath	B-test
with	O
severe	B-problem
3VD	I-problem

Past	O
Medical	O
History	O
:	O

HTN	B-problem

DM	B-problem

cataracts	B-problem
s/p	O
removal	B-treatment
of	O
in	O
Mayotte	O
c/b	O
enucleated	O
CMED	O
CSRU	O

urinary	B-problem
incontinence	I-problem

Social	O
History	O
:	O

farmer	O
in	O
Mayotte	O

-	O
tob	O

-	O
etoh	O

lives	O
with	O
wife	O
and	O
oldest	O
son	O

Family	O
History	O
:	O

father	O
with	O
?	O
Mi	B-problem
at	O
unknown	O
age	O

Physical	O
Exam	O
:	O

NAD	B-test
76	O
184/87	O
18	O

Teeth	B-problem
in	I-problem
poor	I-problem
repair	I-problem

lungs	O
ctab	O
ant	O
/	O
lat	O

distant	B-problem
heart	I-problem
sounds	I-problem
,	O
RRR	O

Abdomen	O
benign	O

extrem	B-problem
warm	I-problem
,	O
no	O
edema	B-problem
,	O
no	O
varicosities	B-problem
,	O
2+	O
pedal	B-test
pulses	I-test

Pertinent	O
Results	O
:	O

2019-10-07	O
05:30	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
6.5	O
RBC	B-test
-	O
3.23	O
*	O
Hgb	B-test
-	O
9.5	O
*	O
Hct	B-test
-	O
27.6	O
*	O
MCV	B-test
-	O
86	O
MCH	B-test
-	O
29.4	O
MCHC	B-test
-	O
34.4	O
RDW	B-test
-	O
14.0	O
Plt	B-test
Ct	I-test
-	O
356	O
#	O

2019-10-07	O
05:30	O
AM	O
BLOOD	B-test
Plt	B-test
Ct	I-test
-	O
356	O
#	O

2019-10-04	O
06:50	O
AM	O
BLOOD	B-test
PT	B-test
-	O
13.2	O
*	O
PTT	B-test
-	O
32.1	O
INR(PT)	B-test
-	O
1.2	O
*	O

2019-10-07	O
05:30	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
156	O
*	O
UreaN	B-test
-	O
20	O
Creat	B-test
-	O
1.0	O
Na	B-test
-	O
140	O
K	B-test
-	O
3.8	O
Cl	B-test
-	O
99	O
HCO3	B-test
-	O
31	O
AnGap	B-test
-	O
14	O

Brief	O
Hospital	O
Course	O
:	O

He	O
was	O
taken	O
to	O
the	O
operating	O
room	O
on	O
2019-10-01	O
where	O
he	O
underwent	O
a	B-treatment
CABG	I-treatment
x	O
3	O
.	O

He	O
was	O
transferred	O
to	O
the	O
CMED	O
CCU	O
in	O
critical	O
but	O
stable	O
condition	O
.	O

He	O
was	O
extubated	O
by	O
POD	O
#1	O
.	O

He	O
was	O
weaned	O
from	O
his	B-treatment
vasoactive	I-treatment
drips	I-treatment
and	O
transferred	O
to	O
the	O
floor	O
on	O
POD	O
#2	O
.	O

He	O
was	O
seen	O
by	O
speech	O
and	O
swallowing	O
who	O
recommended	O
NPO	B-treatment
,	O
he	O
then	O
underwent	O
a	B-test
video	I-test
swallow	I-test
after	O
which	O
he	O
was	O
changed	O
to	O
a	B-treatment
diet	I-treatment
of	I-treatment
thin	I-treatment
liquids	I-treatment
and	I-treatment
soft	I-treatment
solids	I-treatment
,	O
and	O
felt	O
that	O
his	O
eeating	O
may	O
be	O
limited	O
by	O
his	B-problem
loose	I-problem
teeth	I-problem
.	O

Dentistry	O
and	O
OMFS	O
were	O
consulted	O
,	O
and	O
he	O
had	O
four	O
front	O
teeth	O
removed	O
on	O
10-04	O
.	O

He	O
did	O
well	O
post	O
operatively	O
and	O
he	O
was	O
ready	O
for	O
discharge	O
on	O
2019-10-07	O
.	O

Medications	O
on	O
Admission	O
:	O

lisinopril	B-treatment
,	O
protonix	B-treatment
,	O
glipizide	B-treatment
,	O
metformin	B-treatment
,	O
asa	B-treatment

Discharge	O
Medications	O
:	O

1.	O
Aspirin	B-treatment
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
0	O
*	O

2.	O
Pantoprazole	B-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
).	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
0	O
*	O

3.	O
Metoprolol	B-treatment
Tartrate	I-treatment
50	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

4.	O
Docusate	B-treatment
Sodium	I-treatment
150	O
mg	O
/	O
15	O
mL	O
Liquid	O
Sig	O
:	O
One	O
(	O
1	O
)	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
QS	O
1	O
month	O
*	O
Refills	O
:*	O
0	O
*	O

5.	O
Oxycodone	B-treatment
-	O
Acetaminophen	B-treatment
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
every	O
4-6	O
hours	O
as	O
needed	O
for	O
pain	B-problem
.	O

Disp	O
:*	O
50	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

6.	O
Clopidogrel	B-treatment
75	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

7.	O
Atorvastatin	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

8.	O
Glipizide	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

9.	O
Lisinopril	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

10.	O
Hydrochlorothiazide	B-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

CAD	B-problem

HTN	B-problem

DM	B-problem

cataracts	B-problem
s/p	O
removal	B-treatment
c/b	O
enucleated	O
left	O
CMED	O
CSRU	O

urinary	B-problem
incontinence	I-problem

?	O
TIA	B-problem

Discharge	O
Condition	O
:	O

Good	O
.	O

Discharge	O
Instructions	O
:	O

Call	O
with	O
fever	B-problem
,	O
redness	B-problem
or	O
drainage	B-problem
from	I-problem
incision	I-problem
or	O
weight	B-problem
gain	I-problem
more	O
than	O
2	O
pounds	O
in	O
one	O
day	O
or	O
five	O
in	O
one	O
week	O
.	O

Shower	O
,	O
no	O
baths	O
,	O
no	O
lotions	B-treatment
,	O
creams	B-treatment
or	O
powders	B-treatment
to	O
incisions	B-problem
.	O

No	O
lifting	O
more	O
than	O
10	O
pounds	O
or	O
driving	O
until	O
follow	O
up	O
with	O
surgeon	O
.	O

Followup	O
Instructions	O
:	O

Dr.	O
Dewhurst	O
2	O
weeks	O

Dr.	O
Burns	O
4	O
weeks	O

Chad	O
Barbara	O
MD	O
49-703	O

Completed	O
by	O
:	O
Theresa	O
Leonore	O
NP	O
80-BXH	O
2019-10-07	O
@	O
1229	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Eugene	O
Offutt	O
on	O
:	O
MON	O
2019-10-07	O
12:44	O
PM	O

(	O
End	O
of	O
Report	O
)	O

655488444	O

BH	O

7432347	O

065055	O

2/10/2000	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

FREIREKOTE	O
,	O
SONYLA	O

MRN	O
:	O

7432347	O

Age	O
:	O

35y	O

REGISTRATION	O
DATE	O
:	O

02/10/2000	O
03:19	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
FREIREKOTE	O
,	O
SONYLA	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Bri	O
Health	O
on	O
02/10/2000	O
03:19	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
FOUND	B-problem
DOWN	I-problem
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
's	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
BRI	O
HEALTH	O
.	O

Your	O
patient	O
was	O
admitted	O
under	O
the	O
care	O
of	O
REEFRAUP	O
,	O
JA	O
Y	O
with	O
a	O
preliminary	O
diagnosis	O
of	O
SYNCOPE	B-problem
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
442-025-0303	O
.	O

[	O
report	O
_	O
end	O
]	O

Admission	O
Date	O
:	O

2015-06-04	O

Discharge	O
Date	O
:	O

2015-06-08	O

Date	O
of	O
Birth	O
:	O

1958-03-17	O

Sex	O
:	O

F	O

Service	O
:	O

CCU	O

HISTORY	O
OF	O
THE	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
57	O
-	O
year-old	O
female	O
with	O
a	O
history	O
of	O
hypertension	B-problem
and	O
hypercholesterolemia	B-problem
but	O
no	O
prior	B-problem
coronary	I-problem
artery	I-problem
disease	I-problem
history	I-problem
who	O
presented	O
with	O
chest	B-problem
pain	I-problem
.	O

The	O
patient	O
reports	O
the	B-problem
pain	I-problem
began	O
at	O
4:00	O
p.m.	O
on	O
the	O
day	O
of	O
admission	O
.	O

She	O
reports	O
that	O
it	O
had	O
essentially	O
started	O
earlier	O
in	O
the	O
day	O
with	O
some	B-problem
GERD-like	I-problem
symptoms	I-problem
.	O

She	O
had	O
taken	O
Maalox	B-treatment
but	O
had	O
no	O
relief	O
with	O
this	O
.	O

The	B-problem
pain	I-problem
was	O
intermittent	O
through	O
the	O
day	O
and	O
then	O
at	O
4:00	O
p.m.	O
increased	O
and	O
was	O
also	O
associated	O
with	O
nausea	B-problem
and	O
diaphoresis	B-problem
.	O

She	O
reports	O
that	O
the	B-problem
pain	I-problem
shot	O
through	O
her	O
back	O
.	O

The	O
patient	O
has	O
never	O
had	O
these	B-problem
symptoms	I-problem
in	O
the	O
past	O
.	O

She	O
arrived	O
in	O
the	O
Emergency	O
Room	O
at	O
8:00	O
p.m.	O

At	O
that	O
time	O
,	O
the	B-problem
pain	I-problem
was	O
unremitting	O
.	O

In	O
the	O
Emergency	O
Room	O
,	O
the	O
patient	O
was	O
given	O
Lopressor	B-treatment
,	O
nitroglycerin	B-treatment
,	O
and	O
aspirin	B-treatment
.	O

A	B-treatment
TP3A	I-treatment
inhibitor	I-treatment
was	O
not	O
given	O
for	O
concern	O
for	O
dissection	B-problem
.	O

The	O
patient	O
was	O
found	O
to	O
have	O
5057	O
E.	O
Sixth	O
Blvd.	O
elevations	B-problem
in	I-problem
I	I-problem
,	I-problem
aVL	I-problem
,	I-problem
and	I-problem
V1	I-problem
through	I-problem
V2	I-problem
and	O
ST	B-problem
depressions	I-problem
in	I-problem
II	I-problem
,	I-problem
III	I-problem
,	I-problem
and	I-problem
aVF	I-problem
.	O

The	O
patient	O
was	O
taken	O
emergently	O
to	O
the	O
Cardiac	O
Catheterization	O
Laboratory	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Hypertension	B-problem
.	O

2.	O
Hypercholesterolemia	B-problem
.	O

3.	O
Chondrocalcinosis	B-problem
.	O

4.	O
Carpal	B-problem
tunnel	I-problem
syndrome	I-problem
.	O

5.	O
GERD	B-problem
.	O

ADMISSION	O
MEDICATIONS	O
:	O

1.	O
Atenolol	B-treatment
25	O
.	O

2.	O
Crestor	B-treatment
10	O
q.d.	O

3.	O
Uniretic	B-treatment
15/25	O
.	O

ALLERGIES	O
:	O
The	O
patient	O
has	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O
The	O
patient	O
denied	O
tobacco	O
.	O

The	O
patient	O
denied	O
alcohol	O
or	O
other	O
drug	O
use	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O
Vital	O
signs	O
:	O

On	O
admission	O
,	O
the	O
patient	O
was	O
afebrile	B-problem
,	O
blood	B-test
pressure	I-test
146/88	O
,	O
pulse	B-test
71	O
,	O
respirations	B-test
18	O
.	O

General	O
:	O
The	O
patient	O
was	O
a	O
well	O
appearing	O
female	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Cardiac	O
:	O
Regular	O
rate	O
and	O
rhythm	O
,	O
normal	O
S1	O
,	O
S2	O
.	O

No	O
murmurs	B-problem
were	O
appreciated	O
.	O

Lungs	O
:	O
Clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Abdomen	O
:	O
Soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
,	O
good	O
bowel	O
sounds	O
.	O

Extremities	O
:	O
There	O
was	O
no	O
edema	B-problem
in	I-problem
the	I-problem
extremities	I-problem
.	O

The	B-test
dorsalis	I-test
pedis	I-test
pulses	I-test
were	O
2+	O
bilaterally	O
.	O

LABORATORY	O
AND	O
RADIOLOGIC	O
DATA	O
:	O
On	O
admission	O
,	O
white	B-test
count	I-test
10.8	O
,	O
hematocrit	B-test
38.2	O
,	O
platelets	B-test
324,000	O
.	O

HOSPITAL	O
COURSE	O
:	O

1.	O
CORONARY	B-problem
ARTERY	I-problem
DISEASE	I-problem
:	O
The	O
patient	O
was	O
taken	O
to	O
Cardiac	B-test
Catheterization	I-test
where	O
she	O
was	O
found	O
to	O
have	O
two	B-problem
vessel	I-problem
disease	I-problem
.	O

The	O
proximal	O
LAD	O
was	O
found	O
to	O
have	O
a	B-problem
90%	I-problem
lesion	I-problem
with	O
a	O
septal	O
branch	O
with	O
a	B-problem
95%	I-problem
stenosis	I-problem
and	O
a	O
diagonal	O
branch	O
with	O
99%	B-problem
stenosis	I-problem
.	O

The	O
patient	O
had	O
twin	B-treatment
LAD	I-treatment
stents	I-treatment
to	O
the	O
LAD	O
diagonal	O
and	O
LAD	O
septal	O
branches	O
with	O
Taxus	B-treatment
stents	I-treatment
.	O

This	O
restored	O
flow	O
appropriately	O
.	O

The	O
patient	O
also	O
had	O
proximal	B-problem
RCA	I-problem
lesion	I-problem
of	I-problem
80%	I-problem
and	O
a	B-problem
mid	I-problem
RCA	I-problem
lesion	I-problem
of	I-problem
80-90%	I-problem
which	O
were	O
not	O
intervened	O
upon	O
.	O

The	O
patient	O
was	O
given	O
an	B-treatment
aspirin	I-treatment
and	O
Plavix	B-treatment
and	O
in	O
addition	O
started	O
on	O
a	B-treatment
beta	I-treatment
Elmore	I-treatment
,	O
Maxine	B-treatment
ACE	I-treatment
inhibitor	I-treatment
,	O
and	O
these	O
were	O
titrated	O
up	O
as	O
her	B-test
blood	I-test
pressure	I-test
tolerated	O
.	O

Given	O
the	O
fact	O
that	O
the	O
patient	O
had	O
issues	O
with	O
muscle	B-problem
cramping	I-problem
with	O
Atorvastatin	B-treatment
in	O
the	O
past	O
,	O
she	O
was	O
started	O
on	O
Pravastatin	B-treatment
which	O
should	O
give	O
less	O
of	O
these	B-problem
side	I-problem
effects	I-problem
.	O

The	O
patient	O
will	O
follow-up	O
with	O
Cardiology	O
in	O
one	O
months	O
time	O
for	O
further	B-treatment
management	I-treatment
of	O
her	B-problem
coronary	I-problem
artery	I-problem
disease	I-problem
and	O
further	B-test
evaluation	I-test
of	O
her	B-problem
remaining	I-problem
RCA	I-problem
lesions	I-problem
.	O

2.	O
PUMP	O
:	O
The	O
patient	O
had	O
an	B-test
echocardiogram	I-test
to	O
assess	O
her	O
LV	O
function	O
.	O

She	O
was	O
found	O
to	O
have	O
an	B-test
ejection	I-test
fraction	I-test
of	O
30-35%	O
as	O
well	O
as	O
an	B-problem
akinetic	I-problem
apex	I-problem
and	O
apical	B-problem
mid	I-problem
and	I-problem
septal	I-problem
akinesis	I-problem
.	O

Given	O
the	O
fact	O
that	O
the	O
patient	O
had	O
significant	B-problem
apical	I-problem
akinesis	I-problem
,	O
she	O
was	O
started	O
on	O
heparin	B-treatment
with	O
a	O
transition	O
to	O
Coumadin	B-treatment
for	O
anticoagulation	B-treatment
for	O
stroke	B-treatment
prevention	I-treatment
in	O
the	O
setting	O
of	O
apical	B-problem
akinesis	I-problem
.	O

On	O
discharge	O
,	O
the	O
patient	O
was	O
given	O
Lovenox	B-treatment
injections	I-treatment
which	O
should	O
be	O
continued	O
until	O
the	O
patient	O
reaches	O
a	O
therapeutic	O
dose	O
of	O
Coumadin	B-treatment
.	O

3.	O
RHYTHM	O
:	O
The	O
patient	O
was	O
monitored	O
on	O
telemetry	B-test
throughout	O
her	O
hospitalization	O
with	O
no	O
significant	B-problem
events	I-problem
.	O

The	O
patient	O
had	O
an	B-test
EP	I-test
evaluation	I-test
and	O
will	O
be	O
followed-up	O
by	O
Dr.	O
Welch	O
.	O

14-087	O
,	O
the	O
patient	O
had	O
a	B-test
signal-averaged	I-test
EKG	I-test
.	O

She	O
will	O
follow-up	O
with	O
Dr.	O
Welch	O
with	O
an	B-test
echocardiogram	I-test
on	O
2015-07-24	O
in	O
a	O
meeting	O
to	O
discuss	O
risk	O
stratification	O
for	O
sudden	B-problem
cardiac	I-problem
death	I-problem
and	O
possible	O
ICD	B-treatment
placement	I-treatment
.	O

4.	O
NEUROLOGY	O
:	O
The	O
patient	O
complained	O
of	O
left	B-problem
lower	I-problem
extremity	I-problem
weakness	I-problem
with	O
ambulation	O
two	O
days	O
after	O
her	B-test
cardiac	I-test
catheterization	I-test
.	O

The	O
patient	O
had	O
no	O
evidence	O
for	O
weakness	B-problem
on	O
examination	B-test
with	O
good	O
proximal	O
and	O
distal	O
strength	O
in	O
the	O
lower	O
extremities	O
as	O
well	O
as	O
intact	O
sensation	O
.	O

The	O
patient	O
worked	O
with	O
Physical	O
Therapy	O
and	O
was	O
able	O
to	O
ambulate	O
without	O
difficulty	O
.	O

She	O
was	O
also	O
able	O
to	O
ascend	O
stairs	O
without	O
difficulty	B-problem
.	O

The	O
patient	O
was	O
already	O
on	O
an	B-treatment
aspirin	I-treatment
and	O
Plavix	B-treatment
should	O
this	O
represent	O
a	B-problem
small	I-problem
stroke	I-problem
.	O

However	O
,	O
there	O
was	O
no	O
evidence	O
for	O
neurologic	B-problem
deficit	I-problem
on	O
examination	B-test
and	O
this	O
will	O
be	O
followed-up	O
by	O
her	O
primary	O
care	O
physician	O
.	O

5.	O
HEMATOLOGY	O
:	O
The	O
patient	O
was	O
discharged	O
on	O
Coumadin	B-treatment
for	O
apical	B-problem
akinesis	I-problem
and	O
stroke	B-problem
risk	I-problem
.	O

This	O
will	O
be	O
further	O
monitored	O
by	O
her	O
primary	O
care	O
physician	O
,	O
Dr.	O
Banks	O
,	O
who	O
will	O
adjust	O
her	B-treatment
Coumadin	I-treatment
dose	I-treatment
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O
Stable	O
.	O

DISCHARGE	O
STATUS	O
:	O
To	O
home	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O
ST	B-problem
elevation	I-problem
myocardial	I-problem
infarction	I-problem
,	O
status	O
post	O
left	B-treatment
anterior	I-treatment
descending	I-treatment
artery	I-treatment
stent	I-treatment
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Aspirin	B-treatment
325	O
q.d.	O

2.	O
Lisinopril	B-treatment
5	O
q.d.	O

3.	O
Toprol	B-treatment
XL	I-treatment
100	O
q.d.	O

4.	O
Coumadin	B-treatment
5	O
q.d.	O

5.	O
Plavix	B-treatment
75	O
q.d.	O

6.	O
Lovenox	B-treatment
60	O
mg	O
b.i.d.	O
until	O
therapeutic	O
on	O
Coumadin	B-treatment
.	O

7.	O
Pravastatin	B-treatment
80	O
q.d.	O

FOLLOW-UP	O
PLANS	O
:	O
The	O
patient	O
will	O
follow-up	O
with	O
her	O
primary	O
care	O
physician	O
in	O
the	O
week	O
following	O
discharge	O
for	O
further	O
monitoring	O
of	O
her	B-test
INR	I-test
and	O
adjustment	O
of	O
her	B-treatment
Coumadin	I-treatment
dose	I-treatment
.	O

The	O
patient	O
will	O
also	O
follow-up	O
with	O
Electrophysiology	O
with	O
Dr.	O
Welch	O
on	O
2015-07-24	O
.	O

In	O
addition	O
to	O
this	O
,	O
the	O
patient	O
will	O
follow-up	O
with	O
Cardiology	O
,	O
Dr.	O
Foster	O
,	O
and	O
Dr.	O
Upshaw	O
,	O
on	O
2015-07-06	O
for	O
further	B-test
monitoring	I-test
.	O

Joshua	O
PINTO	O
,	O
M.D.	O
12.932	O

Dictated	O
By	O
:	O
Greg	O
E.	O
Riordan	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2015-06-10	O
09:17	O

T	O
:	O
2015-06-12	O
16:28	O

JOB	O
#:	O

74717	O

Signed	O
electronically	O
by	O
:	O
DR.	O
David	O
PINTO	O
on	O
:	O
FRI	O
2015-06-19	O
5:36	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2013-04-24	O

Discharge	O
Date	O
:	O

2013-05-11	O

Date	O
of	O
Birth	O
:	O

2013-04-24	O

Sex	O
:	O

F	O

Service	O
:	O

NEONATOLOGY	O

HISTORY	O
:	O

Richard	O
Williams	O
,	O
Twin	O
number	O
II	O
,	O
was	O
born	O
at	O
31-6/7	O
weeks	O
gestation	O
by	O
cesarean	B-treatment
section	I-treatment
for	O
rupture	B-problem
of	I-problem
membranes	I-problem
of	O
Twin	O
number	O
I	O
and	O
progressive	B-problem
preterm	I-problem
labor	I-problem
.	O

Mother	O
is	O
a	O
37	O
year	O
old	O
Gravida	O
1	O
,	O
Para	O
0	O
now	O
2	O
woman	O
whose	O
blood	B-test
type	I-test
is	O
A	O
negative	O
,	O
antibody	B-test
negative	O
,	O
rubella	B-test
immune	O
,	O
RPR	B-test
nonreactive	O
,	O
hepatitis	B-test
B	I-test
surface	I-test
antigen	I-test
negative	O
and	O
Group	B-test
B	I-test
Streptococcus	I-test
unknown	O
.	O

The	O
mother	O
had	O
received	O
a	O
complete	O
course	O
of	O
betamethasone	B-treatment
prior	O
to	O
delivery	O
.	O

This	O
pregnancy	O
was	O
achieved	O
with	O
in	O
Bartley	B-treatment
fertilization	I-treatment
.	O

A	B-treatment
cerclage	I-treatment
was	O
placed	O
at	O
18	O
weeks	O
gestation	O
.	O

Cesarean	B-treatment
section	I-treatment
was	O
performed	O
under	O
spinal	B-treatment
anesthesia	I-treatment
.	O

This	O
infant	O
emerged	O
with	O
Apgars	B-test
of	O
8	O
at	O
one	O
minute	O
and	O
8	O
at	O
five	O
minutes	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
,	O
revealed	O
a	O
vigorous	O
non-dysmorphic	O
premature	O
infant	O
,	O
with	O
moderate	B-problem
subcostal	I-problem
retractions	I-problem
and	O
some	B-problem
occasional	I-problem
grunting	I-problem
,	O
normal	O
S1	O
,	O
S2	O
heart	O
sounds	O
,	O
no	O
murmur	B-problem
.	O

Pink	O
and	O
well	O
perfused	O
.	O

Normal	O
hip	O
examination	O
and	O
age	O
appropriate	O
tone	O
and	O
reflexes	O
.	O

The	B-test
birth	I-test
weight	I-test
was	O
1,980	O
grams	O
,	O
80th	O
percentile	O
.	O

The	B-test
birth	I-test
length	I-test
was	O
44	O
centimeters	O
,	O
the	O
75th	O
percentile	O
and	O
the	B-test
birth	I-test
head	I-test
circumference	I-test
was	O
30.6	O
centimeters	O
,	O
in	O
the	O
65th	O
percentile	O

HOSPITAL	O
COURSE	O
BY	O
SYSTEMS	O
:	O

1.	O
Respiratory	O
Status	O
:	O

The	O
infant	O
was	O
intubated	O
soon	O
after	O
admission	O
to	O
the	O
CMED	O
CSRU	O
and	O
received	O
two	O
doses	O
of	O
surfactant	B-treatment
.	O

She	O
weaned	O
to	O
room	O
air	O
on	O
day	O
of	O
life	O
one	O
where	O
she	O
has	O
remained	O
since	O
that	O
time	O
.	O

Her	B-test
respirations	I-test
are	O
comfortable	O
.	O

Her	B-test
lung	I-test
sounds	I-test
are	O
clear	O
and	O
equal	O
.	O

She	O
has	O
had	O
no	O
apnea	B-problem
,	O
bradycardia	B-problem
or	O
desaturation	B-problem
.	O

2.	O
Cardiovascular	O
Status	O
:	O

She	O
had	O
remained	O
normotensive	O
throughout	O
her	O
CMED	O
CSRU	O
stay	O
.	O

She	O
has	O
a	O
normal	O
S1	O
,	O
S2	O
heart	O
sound	O
and	O
no	O
murmur	B-problem
.	O

She	O
is	O
pink	O
and	O
well	O
perfused	O
.	O

3.	O
Fluids	O
,	O
Electrolytes	O
and	O
Nutrition	O
Status	O
:	O

She	O
started	O
on	O
enteral	B-treatment
feeds	I-treatment
on	O
day	O
of	O
life	O
number	O
two	O
and	O
progressed	O
without	O
difficulty	O
to	O
full	B-treatment
volume	I-treatment
feedings	I-treatment
by	O
day	O
of	O
life	O
five	O
and	O
then	O
was	O
advanced	O
to	O
calorie	B-treatment
enhanced	I-treatment
breast	I-treatment
milk	I-treatment
of	O
24	O
calories	O
per	O
ounce	O
.	O

She	O
has	O
been	O
taking	O
from	O
130	O
to	O
160	O
cc.	O
per	O
kilo	O
per	O
day	O
on	O
an	B-treatment
ad	I-treatment
lib	I-treatment
feeding	I-treatment
plan	I-treatment
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
her	B-test
weight	I-test
is	O
2,200	O
grams	O
;	O
her	B-test
length	I-test
is	O
49.5	O
centimeters	O
(	O
19.5	O
inches	O
)	O
and	O
her	B-test
head	I-test
circumference	I-test
is	O
30.5	O
centimeters	O
.	O

4.	O
Gastrointestinal	O
Status	O
:	O

Her	B-test
peak	I-test
bilirubin	I-test
occurred	O
on	O
day	O
of	O
life	O
five	O
and	O
was	O
total	B-test
12.1	O
,	O
direct	B-test
0.3	O
;	O
the	B-test
last	I-test
bilirubin	I-test
on	O
day	O
of	O
life	O
six	O
was	O
total	B-test
11.1	O
,	O
direct	B-test
0.4	O
.	O

She	O
never	O
required	O
phototherapy	B-treatment
.	O

5.	O
Hematological	O
Status	O
:	O

Her	B-test
hematocrit	I-test
at	O
the	O
time	O
of	O
admission	O
was	O
45.4	O
,	O
platelets	B-test
were	O
360,000	O
.	O

She	O
is	O
receiving	O
supplemental	B-treatment
iron	I-treatment
to	O
provide	O
2	O
mg	O
per	O
kilo	O
per	O
day	O
as	O
elemental	B-treatment
iron	I-treatment
.	O

She	O
has	O
never	O
received	O
any	O
blood	B-treatment
products	I-treatment
during	O
this	O
CMED	O
CSRU	O
stay	O
.	O

6.	O
Infectious	O
Disease	O
Status	O
:	O

The	O
infant	O
was	O
started	O
on	O
Ampicillin	B-treatment
and	O
Gentamycin	B-treatment
at	O
the	O
time	O
of	O
admission	O
for	O
sepsis	B-problem
risk	I-problem
factor	I-problem
.	O

The	B-treatment
antibiotics	I-treatment
were	O
discontinued	O
after	O
48	O
hours	O
when	O
the	O
infant	O
was	O
clinically	O
well	O
and	O
the	B-test
blood	I-test
cultures	I-test
remained	O
negative	O
.	O

7.	O
Neurological	O
Status	O
:	O

She	O
had	O
a	B-test
head	I-test
ultrasound	I-test
on	O
2013-05-02	O
,	O
that	O
was	O
completely	O
within	O
normal	O
limits	O
.	O

8.	O
Psychosocial	O
:	O

The	O
parents	O
have	O
been	O
very	O
involved	O
in	O
the	O
infant	O
's	O
care	O
throughout	O
her	O
CMED	O
CSRU	O
stay	O
.	O

She	O
is	O
the	O
first	O
twin	O
to	O
go	O
home	O
.	O

The	O
infant	O
's	O
first	O
name	O
is	O
Ralph	O
and	O
after	O
discharge	O
the	O
infant	O
's	O
last	O
name	O
will	O
be	O
Neoma	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Good	O
.	O

DISPOSITION	O
:	O

The	O
infant	O
is	O
being	O
discharged	O
home	O
with	O
her	O
parents	O
.	O

Primary	O
pediatric	O
care	O
will	O
be	O
provided	O
by	O
Dr.	O
Hortencia	O
Conner	O
of	O
Milton	O
Hospital	O
Pediatric	O
Group	O
,	O
3408	O
E.	O
Fifth	O
Rd.	O
,	O
Bridgewater	O
State	O
Hospital	O
,	O
Tennessee	O
06546	O
,	O
telephone	O
number	O
is	O
433-0531	O
.	O

CARE	O
AND	O
RECOMMENDATIONS	O
:	O

1.	O
Feedings	O
:	O

The	O
infant	O
is	O
on	O
breast	B-treatment
milk	I-treatment
with	I-treatment
Enfamil	I-treatment
Powder	I-treatment
to	O
provide	O
24	O
calories	O
per	O
ounce	O
and	O
on	O
an	B-treatment
ad	I-treatment
lib	I-treatment
feeding	I-treatment
schedule	I-treatment
.	O

2.	O
Medications	O
:	O

Ferinsol	B-treatment
0.2	O
cc.	O
to	O
provide	O
5	O
mg	O
a	O
day	O
.	O

3.	O
The	O
infant	O
passed	O
a	B-test
car	I-test
seat	I-test
positioning	I-test
test	I-test
on	O
2013-05-11	O
.	O

4.	O
State	B-test
Screens	I-test
were	O
sent	O
on	O
04-27	O
and	O
2013-05-08	O
.	O

5.	O
The	O
infant	O
received	O
the	B-treatment
hepatitis	I-treatment
B	I-treatment
vaccine	I-treatment
on	O
2013-05-09	O
,	O
and	O
Synagis	B-treatment
on	O
2013-05-11	O
.	O

Immunization	O
recommended	O
:	O

1)	O
Synagis	B-treatment
RSV	I-treatment
prophylaxis	I-treatment
should	O
be	O
considered	O
from	O
October	O
through	O
April	O
for	O
infants	O
who	O
meet	O
any	O
of	O
the	O
following	O
three	O
criteria	O
:	O

Born	O
at	O
less	O
than	O
32	O
weeks	O
;	O
born	O
between	O
32	O
and	O
35	O
weeks	O
with	O
plans	O
for	O
day	O
care	O
during	O
the	O
RSV	O
season	O
,	O
with	O
a	O

smoker	O
in	O
the	O
household	O
,	O
with	O
preschool	O
siblings	O
,	O
or	O
with	O
chronic	B-problem
lung	I-problem
disease	I-problem
;	O

2)	O
Influenza	B-treatment
immunization	I-treatment
should	O
be	O
considered	O
annually	O
in	O
the	O
Fall	O
for	O
preterm	O
infants	O
with	O
chronic	B-problem
lung	I-problem
disease	I-problem
once	O
they	O
reach	O
six	O
months	O
of	O
age	O
.	O

Before	O
this	O
age	O
,	O
the	O
family	O
and	O
other	O
care	O
givers	O
should	O
be	O
considered	O
for	O
immunization	B-treatment
against	O
influenza	B-problem
to	O
protect	O
the	O
infant	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

1.	O
Follow-up	O
appointments	O
,	O
the	O
parents	O
have	O
an	O
appointment	O
with	O
Dr.	O
Avon	O
on	O
Tuesday	O
,	O
05-14	O
.	O

2.	O
Visiting	O
Nurses	O
Association	O
of	O
the	O
L.F.	O
Quigley	O
Memorial	O
Hospital	O
will	O
visit	O
on	O
Sunday	O
,	O
2013-05-12	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Prematurity	B-problem
at	O
31-6/7	O
weeks	O
gestation	O
.	O

2.	O
Twin	O
II	O
.	O

3.	O
Sepsis	B-problem
,	O
ruled	O
out	O
.	O

4.	O
Status	O
post	O
respiratory	B-problem
distress	I-problem
syndrome	I-problem
.	O

Brian	O
LT	O
Wentzel	O
,	O
M.D.	O

96-131	O

Dictated	O
By	O
:	O
Tammy	O
T.K.	O
Farless	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2013-05-11	O
17:49	O

T	O
:	O
2013-05-11	O
18:43	O

JOB	O
#:	O

06197	O

Signed	O
electronically	O
by	O
:	O
DR.	O
John	O
Bonilla	O
on	O
:	O
MON	O
2013-05-13	O
4:49	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2015-12-03	O

Discharge	O
Date	O
:	O

2015-12-08	O

Date	O
of	O
Birth	O
:	O

1960-04-22	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O
Geoffrey	O
F	O
Corney	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

bright	B-problem
red	I-problem
blood	I-problem
per	I-problem
rectum	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Colonoscopy	B-treatment

Virtual	B-treatment
colonoscopy	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

55	O
yo	O
M	O
w/	O
h/o	O
recurrent	B-problem
bladder	I-problem
ca	I-problem
s/p	O
cystectomy	B-treatment
w/	O
ileal	B-treatment
conduit	I-treatment
p/w	O
BRBPR	B-problem
to	O
OSH	O
.	O

Hct	B-test
dropped	O
34	O
->	O
22	O
.	O

EGD	B-test
normal	O
.	O

Cscope	B-test
unable	O
to	O
complete	O
due	O
to	O
blood	B-problem
but	O
tics	B-problem
seen	O
.	O

Tagged	O
RBC	B-test
+	O
activity	O
in	O
RLQ	O
.	O

Transferred	O
to	O
Mediplex	O
Rehab	O
Hospital	O
ICU	O
where	O
Hct	B-test
has	O
remained	O
stable	O
.	O

Seen	O
by	O
GI	O
and	O
plan	O
is	O
to	O
continue	O
holding	O
anticoagulation	B-treatment
and	O
repeat	B-test
scope	I-test
on	O
Monday	O
.	O

Pt	O
feeling	O
well	O
,	O
denies	O
abd	B-problem
pain	I-problem
,	O
N/V	B-problem
,	O
LH	B-problem
,	O
SOB	B-problem
,	O
CP	B-problem
.	O

Past	O
Medical	O
History	O
:	O

Metastatic	B-problem
bladder	I-problem
CA	I-problem
now	O
in	O
remission	O
s/p	O
chemo/xrt	B-treatment
s/p	O
cystectomy	B-treatment
and	O
ileal	B-treatment
loop	I-treatment
urinary	I-treatment
diversion	I-treatment
and	O
also	O
radical	B-treatment
prstatectomy	I-treatment
with	O
bilateral	B-treatment
pelvic	I-treatment
lymph	I-treatment
node	I-treatment
dissection	I-treatment
.	O

b/l	B-problem
DVT	I-problem
s,	O
most	O
recent	O
seen	O
in	O
IVC	O
to	O
right	O
femoral	O
vein	O
s/p	O
IVC	B-treatment
filter	I-treatment
2015-01-15	O

Nephrolithiasis	B-problem
.	O

Anemia	B-problem
-	O
baseline	O
mid	O
30	O
s.	O

Social	O
History	O
:	O

From	O
Sao	O
Tome	O
originally	O
.	O

denies	O
smoking	O

works	O
at	O
a	O
deli	O
in	O
beaconhill	O
.	O

Family	O
History	O
:	O

denies	O
fh	O
of	O
bleeding	B-problem
or	O
clotting	B-problem
disorders	I-problem
.	O

Physical	O
Exam	O
:	O

per	O
admitting	O
resident	O
:	O

T	B-test
97.4	O
BP	B-test
100/62	O
P	B-test
56	O
RR	B-test
16	O

Mid	O
aged	O
man	O
in	O
NAD	B-problem

sclera	B-problem
anicteric	I-problem
,	O
MMM	O

supple	O
,	O
no	O
LAD	B-problem

CTAB	O

RRR	O
S1/S2	O
no	O
M	B-problem

soft	O
,	O
+BS	O
,	O
NT	B-problem
,	O
Midline	B-problem
surgical	I-problem
scar	I-problem
,	O
nephrostomy	B-treatment
bag	I-treatment
draining	O

yellowish	B-problem
urine	I-problem
in	I-problem
RLQ	I-problem

no	O
edema	B-problem
,	O
no	O
clubbing	B-problem

Pertinent	O
Results	O
:	O

2015-12-03	O
10:27	O
PM	O
GLUCOSE	B-test
-	O
88	O
UREA	B-test
N	I-test
-	O
12	O
CREAT	B-test
-	O
1.0	O
SODIUM	B-test
-	O
138	O
POTASSIUM	B-test
-	O
3.3	O
CHLORIDE	B-test
-	O
107	O
TOTAL	B-test
CO2	I-test
-	O
25	O
ANION	B-test
GAP	I-test
-	O
9	O

2015-12-03	O
10:27	O
PM	O
estGFR	B-test
-	O
Using	O
this	O

2015-12-03	O
10:27	O
PM	O
CALCIUM	B-test
-	O
8.7	O
PHOSPHATE	B-test
-	O
2.4	O
*	O
MAGNESIUM	B-test
-	O
1.5	O
*	O

2015-12-03	O
10:27	O
PM	O
WBC	B-test
-	O
8.4	O
RBC	B-test
-	O
2.98	O
*	O
HGB	B-test
-	O
9.3	O
*	O
HCT	B-test
-	O
26.3	O
*	O
MCV	B-test
-	O
88	O
MCH	B-test
-	O
31.1	O
MCHC	B-test
-	O
35.3	O
*	O
RDW	B-test
-	O
14.4	O

2015-12-03	O
10:27	O
PM	O
PLT	B-test
COUNT	I-test
-	O
164	O

2015-12-03	O
10:27	O
PM	O
PT	B-test
-	O
11.4	O
PTT	B-test
-	O
27.5	O
INR(PT)	B-test
-	O
1.0	O

Brief	O
Hospital	O
Course	O
:	O

55	O
year	O
old	O
man	O
with	O
history	O
of	O
metastatic	B-problem
bladder	I-problem
cancer	I-problem
and	O
recurrent	B-problem
DVT	I-problem
s	I-problem
on	O
Lovenox	B-treatment
admitted	O
with	O
lower	B-problem
GI	I-problem
bleeding	I-problem
.	O

Right	B-problem
lower	I-problem
quadrant	I-problem
source	I-problem
of	I-problem
bleed	I-problem
on	O
red	B-test
blood	I-test
cell	I-test
scan	I-test
.	O

Attempts	O
to	O
visualize	O
colon	O
by	O
conventional	B-test
and	I-test
CT	I-test
virtual	I-test
colonoscopy	I-test
failed	O
because	O
of	O
sigmoid	B-problem
angulation	I-problem
and	O
inadequate	O
preparation	O
,	O
respectively	O
.	O

On	O
Ct	B-test
scan	I-test
,	O
a	B-problem
right	I-problem
psoas	I-problem
mass	I-problem
,	O
most	O
consistent	O
with	O
a	B-problem
hematoma	I-problem
,	O
was	O
seen	O
.	O

Since	O
the	B-test
hematocrit	I-test
of	O
the	O
patient	O
was	O
stable	O
and	O
outside	O
records	O
from	O
2015-03-28	O
mentioned	O
a	B-problem
mass	I-problem
in	I-problem
the	I-problem
right	I-problem
pelvis	I-problem
,	O
the	O
patient	O
was	O
discharged	O
.	O

Lovenox	B-treatment
was	O
held	O
until	O
follow-up	O
with	O
primary	O
care	O
doctor	O
.	O

Also	O
,	O
a	B-test
repeat	I-test
outpatient	I-test
CT	I-test
colonoscopy	I-test
with	O
better	O
preparation	O
should	O
be	O
considered	O
.	O

Medications	O
on	O
Admission	O
:	O

Lovenox	B-treatment
0.6	O
mg	O
/	O
kg	O
SC	O
BID	O

Discharge	O
Medications	O
:	O

1.	O
Pantoprazole	B-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
once	O
a	O
day	O
.	O

2.	O
Outpatient	O
Lab	O
Work	O

cbc	B-test
,	O
creatinine	B-test

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

Primary	O
diagnosis	O
:	O

GIB	B-problem

Secondary	O
diagnosis	O
:	O

Metastatic	B-problem
,	I-problem
recurrent	I-problem
bladder	I-problem
cancer	I-problem

h/o	O
DVT	B-problem
s	I-problem

Discharge	O
Condition	O
:	O

Good	O
.	O

Stable	O
Hct	O
of	O
31	O
.	O

Discharge	O
Instructions	O
:	O

We	O
recommend	O
that	O
you	O
do	O
NOT	O
resume	O
your	B-treatment
lovenox	I-treatment
until	O
talking	O
to	O
your	O
PCP	O
,	O
Dr.	O
Jessie	O
.	O

You	O
likely	O
have	O
a	B-problem
bleeding	I-problem
source	I-problem
in	I-problem
your	I-problem
colon	I-problem
that	O
we	O
have	O
been	O
unable	O
to	O
visualize	O
.	O

The	B-problem
bleeding	I-problem
has	O
stopped	O
and	O
you	O
have	O
remained	O
hemodynamically	O
stable	O
and	O
your	B-test
hematocrit	I-test
is	O
stable	O
,	O
but	O
you	O
are	O
at	O
risk	O
of	O
bleeding	B-problem
from	O
this	O
source	O
again	O
with	O
anticoagulation	B-treatment
.	O

A	B-test
CT	I-test
scan	I-test
of	I-test
your	I-test
abdomen	I-test
showed	O
a	B-problem
right	I-problem
pelvic	I-problem
mass	I-problem
,	O
most	O
likely	O
a	B-problem
hematoma	I-problem
,	O
which	O
had	O
been	O
described	O
previously	O
in	O
2015-03-28	O
.	O

Please	O
continue	O
to	O
take	O
your	B-treatment
other	I-treatment
medications	I-treatment
as	O
prescribed	O
.	O

Please	O
follow	O
up	O
with	O
your	O
PCP	O
as	O
scheduled	O
.	O

Please	O
bring	O
your	O
outpatient	O
lab	O
results	O
to	O
your	O
PCP	O
(	O
Dr.	O
Hemler	O
)	O

Please	O
see	O
a	O
doctor	O
if	O
you	O
feel	O
dizzy	B-problem
,	O
or	O
have	O
blood	B-problem
in	I-problem
your	I-problem
stool	I-problem
again	O
.	O

Followup	O
Instructions	O
:	O

Please	O
follow	O
up	O
with	O
your	O
PCP	O
S.	O
Saracino	O
on	O
2015-12-30	O
at	O
8:00	O
AM	O
.	O

Her	O
number	O
is	O
(	O
512	O
)	O
677-6547	O
.	O

Please	O
go	O
to	O
Dr.	O
Colombo	O
office	O
later	O
this	O
week	O
to	O
have	O
your	B-test
labs	I-test
drawn	O
and	O
sent	O
to	O
Dr.	O
Powell	O
.	O

James	O
Jennifer	O
MD	O
,	O
PHD	O
12-944	O

Completed	O
by	O
:	O
Kimberly	O
Sarah	O
MD	O
97-625	O
2015-12-08	O
@	O
1543	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Joanne	O
Gilbert	O
YANG	O
on	O
:	O
MON	O
2016-02-08	O
9:27	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2016-04-05	O

Discharge	O
Date	O
:	O

2016-04-11	O

Date	O
of	O
Birth	O
:	O

1948-10-18	O

Sex	O
:	O

M	O

Service	O
:	O

Cardiothoracic	B-treatment
Surgery	I-treatment

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
67	O
-	O
year-old	O
male	O
with	O
a	O
history	O
of	O
high	B-problem
cholesterol	I-problem
who	O
was	O
in	O
his	O
usual	O
state	O
of	O
health	O
until	O
2016-04-03	O
.	O

He	O
was	O
raking	O
leaves	O
on	O
04-02	O
and	O
then	O
developed	O
episodes	O
of	O
mid	B-problem
chest	I-problem
pain	I-problem
and	O
burning	B-problem
which	O
radiated	O
to	O
the	O
left	O
arm	O
.	O

That	O
night	O
he	O
reportedly	O
stopped	O
breathing	B-problem
and	O
was	O
unresponsive	B-problem
.	O

His	O
wife	O
gave	O
him	O
mouth-to-mouth	B-treatment
resuscitation	I-treatment
and	O
he	O
regained	O
consciousness	O
.	O

He	O
presented	O
to	O
an	O
outside	O
hospital	O
with	O
an	B-problem
acute	I-problem
inferior	I-problem
myocardial	I-problem
infarction	I-problem
and	O
was	O
treated	O
with	O
thrombolytic	B-treatment
therapy	I-treatment
.	O

His	B-test
troponin	I-test
was	O
20	O
and	O
he	O
had	O
EKG	B-problem
changes	I-problem
.	O

He	O
underwent	O
catheterization	B-test
on	O
2016-04-05	O
which	O
revealed	O
a	B-test
left	I-test
ventricular	I-test
ejection	I-test
fraction	I-test
of	O
50%	O
,	O
no	O
mitral	B-problem
regurgitation	I-problem
,	O
insufficiency	B-problem
or	O
hypokinesis	B-problem
.	O

Left	O
main	O
coronary	O
artery	O
was	O
narrowed	B-problem
50-60%	O
,	O
left	O
anterior	O
descending	O
coronary	O
artery	O
70%	O
proximally	O
,	O
right	B-problem
coronary	I-problem
artery	I-problem
dominant	I-problem
diseased	I-problem
up	O
to	O
90%	O
proximally	O
in	O
the	O
midportion	O
,	O
70%	O
distally	O
.	O

The	O
left	O
circumflex	O
coronary	O
artery	O
was	O
50%	O
proximally	O
,	O
90%	O
obtuse	O
marginal	O
#3	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
History	O
of	O
high	B-problem
cholesterol	I-problem
.	O

2.	O
Hemorrhoidectomy	B-treatment
.	O

3.	O
Carotid	B-problem
disease	I-problem
.	O

MEDICATIONS	O
AT	O
HOME	O
:	O

1.	O
Lipitor	B-treatment
20	O
mg	O
p.o.	O
q.d.	O

2.	O
Aspirin	B-treatment
325	O
mg	O
p.o.	O
q.d.	O

3.	O
Lopressor	B-treatment
25	O
mg	O
p.o.	O
b.i.d.	O

4.	O
Plavix	B-treatment
75	O
mg	O
p.o.	O
q.d.	O
which	O
has	O
been	O
discontinued	O
prior	O
to	O
surgery	B-treatment
.	O

FAMILY	O
HISTORY	O
:	O

Positive	O
for	O
coronary	B-problem
artery	I-problem
disease	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

No	O
cigarettes	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

In	O
general	O
the	O
patient	O
was	O
in	O
no	O
acute	B-problem
distress	I-problem
,	O
afebrile	B-problem
,	O
vital	B-test
signs	I-test
stable	O
.	O

HEENT	O
:	O
Normocephalic	O
,	O
atraumatic	B-problem
.	O

Pupils	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
.	O

Extraocular	O
movements	O
intact	O
.	O

Nasopharynx	O
benign	O
.	O

Neck	O
:	O
Supple	O
with	O
full	O
range	O
of	O
motion	O
,	O
no	O
lymphadenopathy	B-problem
nor	O
thyromegaly	B-problem
.	O

Carotids	B-test
were	O
1+	O
bilaterally	O
.	O

Positive	O
right	B-problem
carotid	I-problem
bruits	I-problem
.	O

Lungs	O
:	O
Clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Cardiovascular	O
:	O
Regular	O
rate	O
and	O
rhythm	O
,	O
no	O
murmurs	B-problem
.	O

Abdomen	O
:	O
Positive	O
bowel	O
sounds	O
,	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
,	O
no	O
masses	B-problem
,	O
no	O
hepatosplenomegaly	B-problem
.	O

Extremities	O
:	O
Without	O
cyanosis	B-problem
,	O
clubbing	B-problem
or	O
edema	B-problem
.	O

Pulses	B-test
were	O
2+	O
bilaterally	O
throughout	O
.	O

Neurologic	O
:	O
Nonfocal	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
hospital	O
and	O
on	O
2016-04-06	O
the	O
patient	O
underwent	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
x	O
4	O
with	O
left	O
internal	O
mammary	O
artery	O
to	O
the	O
left	O
anterior	O
descending	O
coronary	O
artery	O
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
the	I-treatment
diagonal	I-treatment
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
obtuse	I-treatment
marginal	I-treatment
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
right	I-treatment
coronary	I-treatment
artery	I-treatment
,	O
posterior	O
descending	O
coronary	O
artery	O
.	O

The	O
patient	O
appeared	O
to	O
have	O
tolerated	O
the	B-treatment
procedure	I-treatment
and	O
was	O
transferred	O
to	O
the	O
cardiac	O
intensive	O
care	O
unit	O
for	O
postoperative	B-treatment
management	I-treatment
.	O

He	O
was	O
started	O
on	O
beta	B-treatment
blockers	I-treatment
.	O

The	O
patient	O
had	O
pacing	B-treatment
wires	I-treatment
and	O
chest	B-treatment
tubes	I-treatment
in	O
place	O
,	O
both	O
of	O
which	O
over	O
the	O
course	O
of	O
his	O
stay	O
were	O
removed	O
successfully	O
.	O

The	O
patient	O
did	O
well	O
postoperatively	O
and	O
was	O
transported	O
to	O
the	O
regular	O
cardiac	O
surgery	O
floor	O
where	O
he	O
tolerated	O
a	O
regular	O
diet	O
,	O
ambulated	O
well	O
,	O
did	O
well	O
with	O
his	O
activities	O
of	O
daily	O
living	O
.	O

He	O
was	O
seen	O
by	O
physical	O
therapy	O
and	O
cleared	O
.	O

They	O
requested	O
that	O
he	O
follow	O
up	O
in	O
three	O
to	O
five	O
weeks	O
for	O
endurance	B-treatment
training	I-treatment
,	O
however	O
then	O
physical	O
therapy	O
followed	O
him	O
a	O
number	O
of	O
times	O
afterward	O
and	O
decided	O
that	O
he	O
was	O
in	O
good	O
condition	O
and	O
did	O
not	O
need	O
further	O
physical	B-treatment
therapy	I-treatment
.	O

On	O
2016-04-11	O
the	O
patient	O
was	O
in	O
good	O
condition	O
and	O
he	O
is	O
being	O
discharged	O
on	O
a	O
regular	O
heart-healthy	O
diet	O
.	O

He	O
may	O
observe	O
regular	O
activity	O
although	O
he	O
should	O
avoid	O
strenuous	O
activity	O
and	O
should	O
not	O
drive	O
while	O
on	O
pain	B-treatment
medications	I-treatment
.	O

He	O
should	O
follow	O
up	O
with	O
Dr.	O
Dushaj	O
in	O
four	O
weeks	O
.	O

He	O
should	O
follow	O
up	O
with	O
his	O
cardiologist	O
in	O
two	O
to	O
three	O
weeks	O
and	O
he	O
should	O
follow	O
up	O
with	O
his	O
primary	O
care	O
physician	O
in	O
one	O
to	O
two	O
weeks	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Lasix	B-treatment
20	O
mg	O
p.o.	O
q.	O
12	O
.	O

2.	O
Potassium	B-treatment
20	O
mEq	O
p.o.	O
q.	O
12	O
.	O

3.	O
Colace	B-treatment
100	O
mg	O
p.o.	O
b.i.d.	O

4.	O
Aspirin	B-treatment
325	O
mg	O
p.o.	O
q.d.	O

5.	O
Percocet	B-treatment
1-2	O
tablets	O
p.o.	O
q.	O
4	O
p.r.n.	O
pain	B-problem
.	O

6.	O
Lopressor	B-treatment
12.5	O
mg	O
p.o.	O
b.i.d.	O

Alexander	O
S.	O
Young	O
,	O
M.D.	O
29-418	O

Dictated	O
By	O
:	O
Lila	O
I	O
Morgan	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2016-04-11	O
10:48	O

T	O
:	O
2016-04-11	O
10:59	O

JOB	O
#:	O
75073	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Jose	O
Kines	O
on	O
:	O
TUE	O
2016-04-12	O
7:03	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2017-09-22	O

Discharge	O
Date	O
:	O

2017-09-27	O

Date	O
of	O
Birth	O
:	O

2017-09-22	O

Sex	O
:	O

M	O

Service	O
:	O

CMED	O
CSRU	O

HISTORY	O
:	O

Peggy	O
Hammock	O
is	O
a	O
full	O
term	O
baby	O
boy	O
born	O
at	O
38	O
1/7	O
weeks	O
by	O
repeat	B-treatment
cesarean	I-treatment
section	I-treatment
to	O
a	O
34	O
year	O
old	O
gravida	O
III	O
,	O
now	O
para	O
II	O
mother	O
.	O

Serologies	B-test
include	O
blood	B-test
type	I-test
O	O
negative	O
,	O
antibody	B-test
negative	O
,	O
RPR	B-test
nonreactive	O
.	O

Hepatitis	B-test
B	I-test
surface	I-test
antigen	I-test
negative	O
,	O
rubella	B-test
immune	O
.	O

Group	B-test
B	I-test
strep	I-test
screening	I-test
was	O
negative	O
.	O

Pregnancy	O
was	O
uncomplicated	B-problem
until	O
an	O
occurrence	O
of	O
HSV	B-problem
outbreak	I-problem
occurred	O
on	O
2017-09-13	O
approximately	O
one	O
week	O
prior	O
to	O
delivery	B-treatment
.	O

Pregnancy	O
was	O
also	O
complicated	O
by	O
maternal	O
history	O
of	O
depression	B-problem
for	O
which	O
mother	O
received	O
Zoloft	B-treatment
.	O

On	O
day	O
of	O
delivery	B-treatment
mother	O
presented	O
in	O
spontaneous	B-problem
labor	I-problem
.	O

There	O
were	O
no	O
sepsis	B-problem
risk	I-problem
factors	I-problem
.	O

GBS	B-test
negative	O
.	O

No	O
maternal	B-problem
fever	I-problem
.	O

Rupture	B-problem
of	I-problem
membranes	I-problem
at	O
time	O
of	O
delivery	B-treatment
.	O

Delivery	B-treatment
was	O
by	O
repeat	B-treatment
cesarean	I-treatment
section	I-treatment
and	O
Apgars	B-test
of	O
8	O
and	O
9	O
were	O
given	O
at	O
one	O
and	O
five	O
minutes	O
respectively	O
.	O

Baby	O
appeared	O
well	O
and	O
went	O
to	O
the	O
newborn	O
nursery	O
and	O
was	O
breast	O
feeding	O
and	O
undergoing	O
routine	B-treatment
newborn	I-treatment
care	I-treatment
.	O

On	O
the	O
newborn	O
nursery	O
the	O
mother	O
called	O
the	O
nurse	O
for	O
concern	O
of	O
baby	O
turning	O
dusky	B-problem
while	O
feeding	O
.	O

She	O
called	O
the	O
nurses	O
and	O
patted	O
the	O
infant	O
on	O
the	O
back	O
.	O

This	B-problem
episode	I-problem
was	O
also	O
accompanied	O
by	O
gagging	B-problem
motions	I-problem
noted	O
of	O
the	O
infant	O
.	O

A	B-problem
second	I-problem
episode	I-problem
occurred	O
where	O
the	O
baby	O
turned	O
pale	B-problem
.	O

Mother	O
thought	O
the	O
baby	O
just	O
did	O
not	O
look	O
right	O
.	O

The	O
baby	O
did	O
not	O
turn	O
blue	B-problem
at	O
that	O
time	O
.	O

The	O
Neonatal	O
Intensive	O
Care	O
Unit	O
was	O
notified	O
and	O
the	O
baby	O
was	O
transferred	O
to	O
the	O
Newborn	O
Intensive	O
Care	O
Unit	O
for	O
further	B-test
evaluation	I-test
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
to	O
the	O
Neonatal	O
Intensive	O
Care	O
Unit	O
:	O

Full	O
term	O
well	O
appearing	O
infant	O
with	O
some	B-problem
facial	I-problem
jaundice	I-problem
,	O
overall	O
pink	O
,	O
warm	O
and	O
well	O
perfused	O
,	O
alert	O
and	O
responsive	O
.	O

Anterior	O
fontanelle	O
is	O
soft	O
,	O
open	O
and	O
flat	O
.	O

Ears	O
are	O
normally	O
set	O
.	O

Red	B-test
reflexes	I-test
noted	O
bilaterally	O
.	O

He	O
had	O
a	O
left	O
pupil	O
that	O
was	O
in	O
unequal	B-problem
in	I-problem
size	I-problem
with	O
a	B-problem
keyhole	I-problem
appearance	I-problem
consistent	O
with	O
a	B-problem
coloboma	I-problem
.	O

The	O
nares	O
were	O
patent	O
.	O

Palate	O
was	O
intact	O
.	O

Mucous	O
membranes	O
were	O
moist	O
and	O
pink	O
.	O

His	O
neck	O
was	O
supple	O
without	O
masses	B-problem
or	O
bruits	B-problem
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	B-test
and	O
equal	O
.	O

Comfortable	O
respiratory	O
pattern	O
.	O

Cardiovascular	O
:	O

Regular	O
rate	O
and	O
rhythm	O
,	O
no	O
murmur	B-problem
.	O

2	O
plus	O
femoral	B-test
pulses	I-test
were	O
noted	O
.	O

Abdomens	O
oft	O
with	O
positive	O
bowel	O
sounds	O
.	O

Genitourinary	O
:	O

Infant	O
was	O
circumcised	B-treatment
in	O
the	O
newborn	O
nursery	O
which	O
was	O
healing	O
well	O
.	O

Testes	O
were	O
descended	O
bilaterally	O
.	O

Extremities	O
were	O
pink	O
and	O
well	O
perfused	O
.	O

Neurologic	O
:	O

Tone	B-test
was	O
appropriate	O
for	O
gestational	O
age	O
with	O
equal	O
strength	B-test
,	O
symmetric	O
reflexes	B-test
.	O

HOSPITAL	O
COURSE	O
BY	O
SYSTEMS	O
:	O

Respiratory	O
:	O

The	O
infant	O
was	O
placed	O
on	O
a	B-test
cardiopulmonary	I-test
monitor	I-test
upon	O
admission	O
to	O
the	O
Newborn	O
Intensive	O
Care	O
Unit	O
with	O
pulse	B-test
oximetry	I-test
.	O

He	O
was	O
noted	O
to	O
have	O
an	O
episode	O
of	O
desaturation	B-problem
related	O
to	O
feeding	O
with	O
desaturations	B-problem
in	O
the	O
70	O
percent	O
.	O

This	O
resolved	O
spontaneously	O
when	O
the	O
bottle	O
was	O
pulled	O
from	O
the	O
baby	O
's	O
mouth	O
.	O

Jule	O
remained	O
in	O
room	O
air	O
without	O
any	O
evidence	O
of	O
respiratory	B-problem
distress	I-problem
and	O
was	O
without	O
any	B-problem
further	I-problem
dusky	I-problem
spells	I-problem
or	O
pale	B-problem
episodes	I-problem
in	O
the	O
48	O
hours	O
prior	O
to	O
discharge	O
.	O

Cardiovascular	O
:	O

Renee	O
remained	O
cardiovascularly	O
stable	O
with	O
AP	B-test
s	I-test
noted	O
to	O
be	O
120	O
to	O
130	O
s.	O

Blood	B-test
pressure	I-test
84/43	O
with	O
a	B-test
mean	I-test
of	O
59	O
.	O

Fluid	O
,	O
electrolytes	O
and	O
nutritions	O
:	O

The	O
baby	O
had	O
been	O
breast	O
feeding	O
ad	O
lib	O
in	O
the	O
Newborn	O
Nursery	O
.	O

He	O
continued	O
to	O
feed	O
ad	O
lib	O
while	O
a	O
patient	O
in	O
the	O
Newborn	O
Intensive	O
Care	O
Unit	O
.	O

He	O
was	O
fed	O
with	O
a	O
bottle	O
occasionally	O
by	O
his	O
dad	O
and	O
had	O
a	O
vigorous	O
suck	O
and	O
was	O
noted	O
to	O
have	O
some	B-problem
discoordination	I-problem
of	I-problem
his	I-problem
suck	I-problem
while	O
breathing	O
at	O
the	O
initial	O
onset	O
of	O
feeding	O
time	O
.	O

This	O
resolved	O
with	O
removal	O
of	O
the	O
bottle	O
from	O
the	O
baby	O
's	O
mouth	O
.	O

Breast	O
feeding	O
was	O
limited	O
to	O
four	O
to	O
five	O
minutes	O
on	O
each	O
side	O
per	O
recommendation	O
of	O
neurology	O
after	O
their	B-test
evaluation	I-test
to	O
try	O
and	O
minimize	O
incidence	O
of	O
gastroesophageal	B-problem
reflux	I-problem
.	O

Weight	B-test
at	O
time	O
of	O
discharge	O
is	O
3.13	O
kilograms	O
.	O

Birth	B-test
weight	I-test
was	O
3.29	O
kilograms	O
in	O
the	O
75th	O
percentile	O
.	O

Head	B-test
circumference	I-test
was	O
34.5	O
cm	O
,	O
75th	O
percentile	O
,	O
and	O
length	B-test
was	O
50.7	O
cm	O
,	O
also	O
the	O
75th	O
percentile	O
.	O

Gastrointestinal	O
:	O

Baby	O
was	O
noted	O
to	O
have	O
frequent	B-problem
spitting	I-problem
episodes	I-problem
.	O

This	O
was	O
minimized	O
with	O
limitation	B-treatment
of	I-treatment
volume	I-treatment
at	I-treatment
each	I-treatment
feed	I-treatment
with	O
frequent	B-treatment
feeding	I-treatment
.	O

He	O
had	O
normal	O
voiding	O
and	O
stooling	O
patterns	O
.	O

The	O
baby	O
demonstrated	O
mild	B-problem
physiologic	I-problem
jaundice	I-problem
with	O
a	B-test
serum	I-test
bilirubin	I-test
obtained	O
on	O
day	O
of	O
life	O
three	O
which	O
was	O
6.7	O
with	O
a	O
direct	O
of	O
0.2	O
.	O

Mother	B-test
's	I-test
blood	I-test
type	I-test
is	O
O	O
negative	O
.	O

Infant	B-test
's	I-test
blood	I-test
type	I-test
was	O
O	O
positive	O
and	O
Coombs	B-test
was	O
noted	O
to	O
be	O
negative	O
.	O

Hematologic	O
:	O

In	O
addition	O
a	B-test
complete	I-test
blood	I-test
count	I-test
was	O
obtained	O
on	O
admission	O
with	O
a	B-test
white	I-test
count	I-test
of	O
10.1	O
with	O
43	O
polys	B-test
and	O
0	O
bands	B-test
.	I-test

Hematocrit	B-test
was	O
noted	O
to	O
47.5	O
with	O
platelets	B-test
of	O
257,000	O
.	O

There	O
were	O
no	O
blood	B-treatment
products	I-treatment
received	O
during	O
hospitalization	O
.	O

Infectious	O
disease	O
:	O

A	B-test
blood	I-test
culture	I-test
was	O
obtained	O
upon	O
admission	O
and	O
Ampicillin	B-treatment
and	O
Gentamicin	B-treatment
were	O
given	O
for	O
48	O
hours	O
with	O
blood	B-test
cultures	I-test
remaining	O
sterile	O
.	O

Antibiotics	B-treatment
were	O
discontinued	O
on	O
day	O
of	O
life	O
three	O
and	O
infant	O
has	O
remained	O
clinically	O
well	O
off	O
antibiotics	B-treatment
.	O

Neurology	O
:	O

Neurology	O
was	O
consulted	O
due	O
to	O
the	O
concern	O
for	O
seizures	B-problem
in	O
the	O
setting	O
of	O
dusky	B-problem
episodes	I-problem
.	O

Neurology	O
evaluated	O
the	O
baby	O
and	O
found	O
the	O
baby	O
to	O
have	O
a	O
normal	O
neurological	O
examination	O
.	O

An	B-test
EEG	I-test
was	O
performed	O
.	O

The	B-test
EEG	I-test
showed	O
transient	B-problem
sharp	I-problem
waves	I-problem
in	I-problem
the	I-problem
left	I-problem
front	I-problem
,	O
left	O
occipital	O
and	O
right	O
parietal	O
regions	O
.	O

There	O
was	O
no	O
electrographic	B-test
evidence	I-test
of	O
seizure	B-problem
activity	I-problem
noted	O
.	O

Sensory	O
:	O

Hearing	B-test
screening	I-test
was	O
performed	O
with	O
automated	O
auditory	O
brain	O
stem	O
responses	O
.	O

Baby	O
passed	O
in	O
both	O
ears	O
on	O
09-23	O
.	O

Ophthalmology	O
:	O

Ophthalmology	O
was	O
consulted	O
due	O
to	O
the	O
presence	O
of	O
a	B-problem
coloboma	I-problem
into	O
the	O
left	O
CMED	O
.	O

Ophthalmology	O
noted	O
that	O
this	B-problem
left	I-problem
Martha	I-problem
coloboma	I-problem
was	O
likely	O
an	B-problem
isolated	I-problem
anomaly	I-problem
in	O
the	O
absence	O
of	O
other	B-problem
pathology	I-problem
.	O

Follow	O
up	O
as	O
below	O
.	O

Psychosocial	O
:	O

Cambridge	O
Health	O
Alliance	O
social	O
worker	O
was	O
involved	O
with	O
this	O
family	O
.	O

She	O
may	O
be	O
reached	O
at	O
(	O
756	O
)	O
599-4849	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Good	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

To	O
home	O
with	O
parents	O
.	O

Primary	O
pediatrician	O
is	O
Dr.	O
Satterlund	O
of	O
Westborough	O
Pediatrics	O
.	O

Telephone	O
number	O
is	O
(	O
739	O
)	O
520-0347	O
.	O

Fax	O
number	O
is	O
(	O
617	O
)	O
455-4585	O
.	O

Appointment	O
is	O
on	O
Lyon	O
,	O
10-30	O
.	O

CARE	O
AND	O
RECOMMENDATIONS	O
:	O

Feeds	O
are	O
breast	O
feeding	O
P.O.	O
ad	O
lib	O
.	O

Medications	B-treatment
are	O
Tri-Vi-Michael	B-treatment
1	O
cc	O
by	O
mouth	O
each	O
day	O
.	O

Newborn	B-test
state	I-test
screen	I-test
was	O
sent	O
on	O
day	O
of	O
life	O
three	O
.	O

Results	O
are	O
pending	O
.	O

Immunizations	B-treatment
received	O
are	O
hepatitis	B-treatment
B	I-treatment
vaccine	I-treatment
given	O
on	O
09-26	O
.	O

Follow	O
up	O
appointments	O
scheduled	O
:	O

Neurology	O
follow	O
up	O
with	O
Dr.	O
Workman	O
is	O
scheduled	O
for	O
2017-10-20	O
at	O
12:30	O
pm	O
at	O
the	O
Addison	O
Gilbert	O
Hospital	O
of	O
Oak	O
Bluffs	O
,	O
Ison	O
11	O
.	O

Phone	O
number	O
is	O
209-604-1402	O
.	O

Follow	O
up	O
ophthalmology	O
appointment	O
is	O
with	O
Dr.	O
Jundt	O
on	O
Ison	O
4	O
at	O
the	O
Addison	O
Gilbert	O
Hospital	O
of	O
Oak	O
Bluffs	O
in	O
three	O
months	O
.	O

Appointment	O
to	O
be	O
scheduled	O
by	O
mom	O
.	O

Telephone	O
number	O
is	O
444	O
7700	O
.	O

Boston	O
Regional	O
Medical	O
Centerr	O
Visiting	O
Nurse	O
Association	O
has	O
been	O
asked	O
to	O
visit	O
this	O
family	O
at	O
home	O
to	O
follow	O
up	O
on	O
feeding	O
and	O

parenting	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Full	O
term	O
male	O
infant	O
with	O
cyanosis	B-problem
episodes	I-problem
.	O

Rule	O
out	O
sepsis	B-problem
.	O

Left	B-problem
coloboma	I-problem
.	O

Rule	O
out	O
seizures	B-problem
.	O

Lucile	O
Virgina	O
,	O
MD	O
50AAD	O

Dictated	O
By	O
:	O
Sherry	O
G	O
Christie	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2017-09-27	O
17:51:44	O

T	O
:	O
2017-09-27	O
18:26:21	O

Job	O
#:	O
75510	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Marcus	O
N	O
Schartz	O
on	O
:	O
Maxine	O
2017-09-28	O
9:34	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2011-02-06	O

Discharge	O
Date	O
:	O

2011-02-08	O

Date	O
of	O
Birth	O
:	O

Sex	O
:	O

M	O

Service	O
:	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Pohl	O
is	O
a	O
53	O
-	O
year-old	O
male	O
with	O
history	O
of	O
alcohol	O
use	O
and	O
hypertension	B-problem
.	O

He	O
was	O
found	O
in	O
his	O
apartment	O
lobby	O
"	O
shouting	O
"	O
and	O
very	B-problem
agitated	I-problem
.	O

The	O
patient	O
states	O
that	O
he	O
recalls	O
going	O
out	O
alone	O
to	O
a	O
cafe	O
the	O
evening	O
prior	O
to	O
admission	O
.	O

There	O
he	O
recalls	O
having	O
pizza	O
and	O
two	O
glasses	O
of	O
red	O
wine	O
.	O

The	O
patient	O
told	O
other	O
staff	O
that	O
he	O
had	O
a	O
few	O
cocktails	O
and	O
drinking	O
a	O
few	O
more	O
glasses	O
of	O
wine	O
when	O
he	O
ran	O
into	O
some	O
friends	O
at	O
a	O
bar	O
.	O

He	O
denies	O
any	O
other	O
drug	O
or	O
toxin	O
ingestion	O
.	O

He	O
does	O
not	O
recall	O
walking	O
home	O
,	O
but	O
he	O
states	O
that	O
the	O
way	O
is	O
well	O
known	O
to	O
him	O
.	O

He	O
has	O
no	O
further	O
recollection	O
,	O
until	O
he	O
presented	O
to	O
the	O
emergency	O
room	O
.	O

He	O
by	O
emergency	O
room	O
report	O
,	O
was	O
found	O
in	O
his	O
apartment	O
lobby	O
agitated	B-problem
.	O

EMS	O
was	O
called	O
and	O
the	O
patient	O
was	O
taken	O
to	O
the	O
emergency	O
room	O
.	O

Blood	B-test
alcohol	I-test
level	I-test
was	O
383	O
.	O

Agitated	B-problem
in	O
emergency	O
room	O
requiring	O
4	B-treatment
leather	I-treatment
restraints	I-treatment
,	O
received	O
5	O
mg	O
of	O
Haldol	B-treatment
,	O
2	O
mg	O
of	O
Ativan	B-treatment
.	O

He	O
became	O
hypotensive	B-problem
in	O
the	O
emergency	O
room	O
with	O
a	B-test
systolic	I-test
blood	I-test
pressure	I-test
in	O
the	O
80	O
's	O
and	O
had	O
decreased	B-problem
respiratory	I-problem
rate	I-problem
.	O

He	O
received	O
a	B-treatment
normal	I-treatment
saline	I-treatment
bolus	I-treatment
of	O
2	O
liters	O
of	O
good	O
blood	O
pressure	O
response	O
.	O

The	O
patient	O
was	O
then	O
admitted	O
to	O
the	O
medical	O
Intensive	O
Care	O
Unit	O
for	O
observation	O
of	O
his	B-test
blood	I-test
pressure	I-test
and	O
then	O
transferred	O
to	O
our	O
service	O
on	O
medicine	O
when	O
the	B-test
blood	I-test
pressures	I-test
remained	O
stable	O
overnight	O
.	O

The	O
patient	O
denies	O
any	B-problem
chest	I-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
dysuria	B-problem
,	O
diarrhea	B-problem
,	O
bright	B-problem
red	I-problem
blood	I-problem
per	I-problem
rectum	I-problem
.	O

He	O
does	O
complain	O
of	O
cold	B-problem
symptoms	I-problem
times	O
one	O
week	O
.	O

The	O
patient	O
states	O
in	O
the	O
past	O
that	O
he	O
has	O
participated	O
in	O
several	O
alcohol	B-treatment
treatment	I-treatment
programs	I-treatment
,	O
most	O
recently	O
Star	O
which	O
is	O
similar	O
Alcoholics	O
Anonymous	O
.	O

The	O
patient	O
admits	O
that	O
he	O
has	O
had	O
many	O
stressors	O
in	O
his	O
life	O
lately	O
.	O

His	O
job	O
as	O
a	O
computer	O
programmer	O
is	O
unstable	O
.	O

His	O
brother	O
is	O
mentally	B-problem
handicapped	I-problem
and	O
might	O
be	O
sent	O
away	O
from	O
his	O
instate	O
institution	O
.	O

He	O
is	O
also	O
concerned	O
about	O
the	O
threat	O
of	O
war	O
and	O
is	O
ready	O
to	O
"	O
move	O
to	O
Madagascar	O
".	O

He	O
states	O
that	O
he	O
primarily	O
relies	O
on	O
friends	O
.	O

In	O
the	O
past	O
,	O
he	O
has	O
been	O
very	B-problem
depressed	I-problem
and	O
has	O
seen	O
a	B-treatment
counselor	I-treatment
at	O
Greenfield	O
Community	O
College	O
Community	O
Health	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Hypertension	B-problem
.	O

2.	O
History	O
of	O
colonic	B-problem
polyps	I-problem
times	O
3	O
,	O
benign	O
in	O
2007	O
,	O
repeat	B-test
colonoscopy	I-test
due	O
to	O
in	O
2010	O
.	O

3.	O
History	O
of	O
right	B-problem
inguinal	I-problem
hernia	I-problem
in	O
2002	O
.	O

FAMILY	O
HISTORY	O
:	O

Noncontributory	O
.	O

SOCIAL	O
HISTORY	O
:	O

Positive	O
tobacco	O
,	O
10	O
pack	O
year	O
history	O
,	O
quit	O
for	O
8	O
years	O
in	O
his	O
40	O
's	O
and	O
now	O
no	O
cigarettes	O
for	O
one	O
week	O
using	O
no	O
pharmacal	B-treatment
therapy	I-treatment
.	O

Positive	O
for	O
ETOH	O
(	O
10	O
glasses	O
a	O
week	O
),	O
positive	O
for	O
drugs	O
,	O
marijuana	O
in	O
college	O
.	O

He	O
denies	O
any	O
IV	O
drug	O
use	O
.	O

The	O
patient	O
currently	O
lives	O
lone	O
in	O
Malden	O
.	O

He	O
came	O
out	O
here	O
for	O
college	O
at	O
BU	O
and	O
works	O
as	O
a	O
computer	O
programmer	O
.	O

Primarily	O
the	O
family	O
lives	O
in	O
Wisconsin	O
.	O

The	O
patient	O
has	O
only	O
male	O
sexual	O
partners	O
and	O
in	O
the	O
last	O
six	O
months	O
has	O
two	O
regular	O
partners	O
who	O
reportedly	O
are	O
human	B-problem
immunodeficiency	I-problem
virus	I-problem
negative	O
and	O
no	O
IV	O
drug	O
use	O
.	O

He	O
uses	O
condoms	B-treatment
consistently	O
.	O

Major	O
stressors	O
in	O
his	O
life	O
include	O
unstable	O
job	O
,	O
brother	O
is	O
mentally	B-problem
handicapped	I-problem
,	O
war	O
.	O

ALLERGIES	O
:	O
No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
AT	O
HOME	O
:	O

1.	O
Lisinopril	B-treatment
5	O
mg	O
p.o.	O
q.d.	O

2.	O
Mavik	B-treatment
question	O
of	O
dosage	O
.	O

3.	O
Hydrochlorothiazide	B-treatment
question	O
of	O
dosage	O
.	O

MEDICATIONS	O
ON	O
TRANSFER	O
:	O

1.	O
Ranitidine	B-treatment
150	O
mg	O
b.i.d.	O

2.	O
Thiamine	B-treatment
100	O
mg	O
q.d.	O

3.	O
Folic	B-treatment
acid	I-treatment
1	O
mg	O
q.	O
d.	O

4.	O
Multivitamin	B-treatment

PHYSICAL	O
EXAMINATION	O
:	O

Vitals	B-test
on	I-test
admission	I-test
:	O
Please	O
refer	O
to	O
addendum	O
.	O

Vital	B-test
signs	I-test
were	O
stable	O
.	O

Systolic	B-test
blood	I-test
pressure	I-test
in	O
the	O
120	O
's	O
to	O
130	O
's.	O

Pulse	B-test
in	O
the	O
60	O
's	O
to	O
70	O
's.	O

The	O
patient	O
was	O
a	O
thin	O
well-appearing	O
man	O
who	O
was	O
visibly	B-problem
restless	I-problem
in	O
bed	O
.	O

Neurological	O
:	O

He	O
was	O
alert	O
and	O
oriented	O
times	O
3	O
and	O
with	O
slightly	B-problem
pressured	I-problem
speech	I-problem
.	O

He	O
states	O
that	O
mood	O
is	O
depressed	B-problem
.	O

He	O
denies	O
auditory	B-problem
,	I-problem
visual	I-problem
or	I-problem
tactile	I-problem
hallucinations	I-problem
.	O

Cranial	B-test
nerves	I-test
II-XII	I-test
are	O
grossly	O
intact	O
,	O
5/5	O
strength	B-test
in	I-test
all	I-test
extremities	I-test
,	O
sensation	B-test
is	O
intact	O
in	O
all	O
extremities	O
.	O

Head	B-test
,	I-test
ears	I-test
,	I-test
eyes	I-test
,	I-test
nose	I-test
and	I-test
throat	I-test
:	O
Atraumatic	B-problem
and	O
normocephalic	O
.	O

Sclerae	O
were	O
anicteric	B-problem
.	O

Oropharynx	O
was	O
benign	O
without	O
exudate	B-problem
.	O

Neck	O
:	O

Supple	O
.	O

Cardiovascular	O
:	O

Regular	O
rate	O
and	O
rhythm	O
with	O
normal	O
S1	O
and	O
S2	O
.	O

NO	O
murmurs	B-problem
,	O
rubs	B-problem
or	O
gallops	B-problem
.	O

Chest	O
:	O

Rare	B-problem
crackles	I-problem
on	I-problem
the	I-problem
right	I-problem
base	I-problem
,	O
otherwise	O
clear	O
to	O
auscultation	B-test
bilaterally	I-test
.	O

Abdomen	O
:	O

Positive	O
bowel	O
sounds	O
,	O
nontender	B-problem
and	O
nondistended	B-problem
.	O

No	O
hepatosplenomegaly	B-problem
.	O

Extremities	O
:	O

He	O
had	O
Dorsalis	B-test
pedis	I-test
in	O
radial	B-test
pulses	I-test
,	O
hands	B-problem
and	I-problem
feet	I-problem
notably	I-problem
tremulous	I-problem
without	O
asterixis	B-problem
.	O

No	O
stigmata	B-problem
of	O
IV	O
drug	O
use	O
.	O

LABORATORY	O
DATA	O
:	O

CBC	B-test
:	O
White	B-test
blood	I-test
cell	I-test
count	I-test
is	O
8.8	O
,	O
hematocrit	B-test
35.5	O
platelets	B-test
266	O
,	O
PT	B-test
13	O
,	O
PT-T	B-test
23.3	O
,	O
INR	B-test
was	O
1.1	O
.	O

Chem-7	B-test
:	O
Sodium	B-test
145	O
,	O
potassium	B-test
3.4	O
,	O
chloride	B-test
116	O
,	O
bicarb	B-test
21	O
,	O
BUN	B-test
12	O
,	O
creatinine	B-test
0.6	O
,	O
glucose	B-test
96	O
,	O
calcium	B-test
7.2	O
,	O
phos	B-test
3.6	O
,	O
magnesium	B-test
1.7	O
.	O

Liver	B-test
function	I-test
tests	I-test
:	O
ALT	B-test
38	O
,	O
AST	B-test
34	O
,	O
alk	B-test
phos	I-test
is	I-test
107	O
,	O
albumin	B-test
is	O
3.2	O
,	O
peak	B-test
bili	I-test
is	I-test
0.3	O
,	O
amylase	B-test
31	O
,	O
and	O
lipase	B-test
is	O
32	O
.	O

UA	B-test
was	O
negative	O
.	O

Urine	B-test
tox	I-test
was	O
negative	O
.	O

Serum	B-test
tox	I-test
was	O
positive	O
for	O
ETOH	B-test
at	O
383	O
,	O
otherwise	O
negative	O
.	O

Serum	B-test
osmolality	I-test
was	O
38397	O
,	O
calculated	B-test
osmolality	I-test
gap	I-test
was	O
21	O
.	O

Radiology	O
:	O

chest	B-test
x-ray	I-test
from	O
02-07	O
had	O
linear	B-problem
atelectasis	I-problem
in	I-problem
right	I-problem
lower	I-problem
lobe	I-problem
with	O
no	O
evidence	O
of	O
a	B-problem
band-like	I-problem
opacity	I-problem
in	I-problem
the	I-problem
left	I-problem
lower	I-problem
lobe	I-problem
which	O
was	O
evident	O
on	O
the	B-test
chest	I-test
x-ray	I-test
on	O
02-06	O
.	O

CT	B-test
of	I-test
the	I-test
head	I-test
on	O
02-06	O
was	O
negative	O
for	O
hemorrhage	B-problem
.	O

There	O
was	O
bran	B-problem
atrophy	I-problem
and	O
right	B-problem
temporal	I-problem
encephalomalacia	I-problem
.	O

ASSESSMENT	O
AND	O
PLAN	O
:	O

Mr.	O
Pohl	O
is	O
a	O
53	O
-	O
year-old	O
male	O
with	O
a	O
history	O
of	O
ETOH	O
,	O
hypertension	B-problem
who	O
presented	O
int	O
he	O
emergency	O
room	O
with	O
increased	B-problem
agitation	I-problem
,	O
like	O
secondary	O
to	O
ETOH	B-problem
intoxication	I-problem
and	O
developed	O
subsequent	B-problem
hypotension	I-problem
,	O
systolic	B-test
blood	I-test
pressures	I-test
in	O
the	O
80	O
's,	O
status	O
post	O
Ativan	B-treatment
and	O
Haldol	B-treatment
,	O
but	O
was	O
responsive	O

to	O
fluid	B-treatment
resuscitation	I-treatment
at	O
4	O
liters	O
and	O
was	O
admitted	O
to	O
the	O
CMED	O
CCU	O
for	O
hemodynamic	B-test
monitoring	I-test
.	O

On	O
hospital	O
day	O
#2	O
,	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
Medicine	O
Ludlow	O
Team	O
.	O

Plan	O
for	O
patient	O
regarding	O
cardiac	O
,	O
unlike	O
hypotension	B-problem
of	I-problem
cardiac	I-problem
origin	I-problem
.	O

The	O
patient	O
responded	O
well	O
to	O
fluid	B-treatment
resuscitation	I-treatment
.	O

Elevated	B-problem
CK	I-problem
on	O
02-07	O
is	O
likely	O
secondary	O
to	O
mild	B-problem
rhabdomyolysis	I-problem
.	O

The	O
patient	O
was	O
hemodynamically	O
stable	O
overnight	O
in	O
the	O
CMED	O
CCU	O
.	O

We	O
decided	O
to	O
discontinue	O
telemetry	B-test
and	O
held	O
all	B-treatment
hypertension	I-treatment
medications	I-treatment
including	O
Lisinopril	B-treatment
,	O
Mavik	B-treatment
,	O
hydrochlorothiazide	B-treatment
.	O

2.	O
For	O
pulmonary	O
,	O
the	O
patient	O
had	O
a	O
good	O
O2	B-test
saturations	I-test
on	O
room	O
air	O
.	O

He	O
had	O
atelectasis	B-problem
in	I-problem
the	I-problem
right	I-problem
lower	I-problem
lobe	I-problem
by	O
chest	B-test
x-ray	I-test
.	O

We	O
encouraged	O
activity	O
and	O
patient	O
out	O
of	O
bed	O
.	O

3.	O
Gastrointestinal	O
:	O

The	O
patient	O
on	O
ranitidine	B-treatment
150	O
mg	O
p.o.	O
b.i.d.	O
for	O
gastrointestinal	B-treatment
prophylaxis	I-treatment
.	O

4.	O
Urology	O
:	O
Foley	B-treatment
was	O
discontinued	O
in	O
the	O
CMED	O
CCU	O
at	O
12	O
p.m.	O

The	O
patient	O
was	O
urinating	O
without	O
difficulty	B-problem
.	O

We	O
gave	O
the	O
patient	O
bathroom	O
privileges	O
.	O

5.	O
FEN	O
:	O

We	O
continued	O
IV	B-treatment
fluids	I-treatment
at	O
100	O
cc	O
per	O
hour	O
for	O
one	O
liter	O
secondary	O
to	O
a	O
concern	O
for	O
rhabdomyolysis	B-problem
plus	O
kidney	B-treatment
protective	I-treatment
effects	I-treatment
.	O

K	B-test
was	O
3.4	O
,	O
repleted	O
,	O
potassium	B-treatment
chloride	I-treatment
40	O
mEq	O
times	O
1	O
dose	O
p.o.	O

Calcium	B-test
with	O
7.2	O
corrected	O
to	O
less	O
than	O
8.0,	O
completed	O
calcium	B-treatment
carbonate	I-treatment
at	O
500	O
mg	O
blood	B-test
pressure.o.	I-test
t.i.d.	O
while	O
in	O
the	O
hospital	O
.	O

Mag	B-test
was	O
1.7	O
,	O
repleted	O
with	O
magnesium	B-treatment
oxide	I-treatment
with	O
400	O
mg	O
p.o.	O
times	O
one	O
dose	O
.	O

Diet	O
as	O
tolerated	O
.	O

6.	O
Substance	O
use	O
and	O
psychiatry	O
:	O

The	O
patient	O
states	O
that	O
he	O
was	O
willing	O
to	O
speak	O
with	O
someone	O
from	O
addiction	O
services	O
.	O

We	O
were	O
concerned	O
regarding	O
possibly	O
binge	O
drinking	O
or	O
ETOH	O
abuse	O
.	O

The	O
patient	O
seemed	O
notably	B-problem
anxious	I-problem
and	O
depressed	B-problem
.	O

It	O
is	O
possible	O
that	O
the	O
patient	O
is	O
self	O
medicating	O
for	O
underlying	B-problem
psychiatric	I-problem
disorder	I-problem
.	O

We	O
will	O
monitor	B-test
for	O
signs	O
of	O
alcohol	B-problem
withdrawal	I-problem
according	O
to	O
the	B-test
CIWA	I-test
scale	I-test
.	O

We	O
will	O
given	O
valium	B-treatment
5	O
mg	O
p.o.	O
q.	O
3	O
hours	O
for	O
withdrawal	B-problem
.	O

We	O
will	O
consult	O
addiction	O
service	O
in	O
the	O
a.m.	O

We	O
will	O
consider	O
psychiatry	O
consult	O
in	O
the	O
future	O
to	O
assess	O
for	O
underlying	B-problem
anxiety	I-problem
disorder	I-problem
or	O
depression	B-problem
.	O

DISPOSITION	O
:	O

The	O
patient	O
may	O
be	O
discharge	O
Harry	O
02-08	O
pending	O
observations	B-test
for	O
delirium	B-problem
tremens	I-problem
after	O
discussion	O
with	O
primary	O
care	O
physician	O
,	O
Dr.	O
Blue	O
who	O
knows	O
the	O
patient	O
well	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
transferred	O
to	O
medicine	O
service	O
on	O
hospital	O
day	O
#2	O
after	O
remaining	O
hemodynamically	O
stable	O
in	O
the	O
CMED	O
CCU	O
overnight	O
.	O

1.	O
Blood	B-test
pressure	I-test
:	O

The	B-test
patient	I-test
's	I-test
blood	I-test
pressure	I-test
remained	O
stable	O
on	O
hospital	O
day	O
#2	O
through	O
hospital	O
day	O
#3	O
status	O
post	O
IV	B-treatment
hydration	I-treatment
with	O
systolic	B-test
blood	I-test
pressures	I-test
in	O
the	O
120	O
's	O
to	O
130	O
's.	O

We	O
continued	O
to	O
hold	O
the	O
patient	O
's	O
home	B-treatment
blood	I-treatment
pressure	I-treatment
medications	I-treatment
.	O

The	O
patient	O
was	O
asymptomatic	B-problem
without	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
and	O
no	O
mental	B-problem
status	I-problem
changes	I-problem
.	O

2.	O
Substance	O
abuse	O
:	O

On	O
Hospital	O
day	O
#2	O
through	O
hospital	O
day	O
#3	O
,	O
the	O
patient	O
had	O
mild	B-problem
tremor	I-problem
on	I-problem
hands	I-problem
,	O
but	O
improved	O
over	O
hospital	O
course	O
.	O

The	O
patient	O
became	O
notably	B-problem
less	I-problem
anxious	I-problem
throughout	O
hospital	O
stay	O
.	O

CIWA	B-test
scale	I-test
over	O
night	O
was	O
1	O
for	O
tremor	B-problem
and	O
the	O
patient	O
did	O
not	O
require	O
any	O
Valium	B-treatment
for	O
alcohol	B-problem
withdrawal	I-problem
.	O

We	O
believe	O
that	O
the	O
patient	O
is	O
able	O
to	O
be	O
discharged	O
and	O
to	O
follow	O
up	O
with	O
Dr.	O
Sandra	O
Rose	O
,	O
addiction	O
services	O
as	O
an	O
outpatient	O
.	O

Call	O
for	O
further	O
referral	O
.	O

3.	O
FEN	O
:	O

Calcium	B-treatment
carbonate	I-treatment
500	O
mg	O
p.o.	O
t.i.d.	O
,	O
Mag	B-treatment
oxide	I-treatment
400	O
mg	O
p.o.	O
times	O
one	O
dose	O
,	O
potassium	B-treatment
chloride	I-treatment
repleted	O
40	O
mEq	O
times	O
one	O
dose	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
ETOH	B-problem
intoxication	I-problem
.	O

2.	O
Hypertension	B-problem
.	O

3.	O
History	O
of	O
colonic	B-problem
polyp	I-problem
times	O
3	O
,	O
benign	O
in	O
2007	O
,	O
repeat	B-test
colonoscopy	I-test
due	O
in	O
2010	O
.	O

4.	O
History	B-problem
of	I-problem
right	I-problem
inguinal	I-problem
hernia	I-problem
in	O
2002	O
.	O

DISCHARGE	O
STATUS	O
:	O

Home	O
.	O

FOLLOW	O
UP	O
:	O

Follow	O
up	O
with	O
Dr.	O
Marcia	O
Bender	O
to	O
be	O
arranged	O
by	O
the	O
patient	O
.	O

The	O
patient	O
will	O
also	O
call	O
clinical	O
nurse	O
specialist	O
,	O
Sandra	O
Rose	O
at	O
(	O
968	O
)	O
347-9868	O
for	O
further	O
referral	O
to	O
addiction	O
services	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Return	O
to	O
home	B-treatment
medications	I-treatment
:	O

1.	O
Lisinopril	B-treatment
5	O
mg	O
p.o.q.d.	O

2.	O
Mavik	B-treatment
unknown	O
dosage	O
.	O

3.	O
Hydrochlorothiazide	B-treatment
unknown	O
dosage	O
.	O

MARK	O
T	O
Ragin	O
,	O
M.D.	O
34-329	O

Dictated	O
By	O
:	O
Alice	O
T.	O
Mahoney	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2011-02-08	O
12:05	O

T	O
:	O
2011-02-08	O
12:15	O

JOB	O
#:	O
77892	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Richard	O
Carlson	O
on	O
:	O
SUN	O
2011-02-20	O
1:40	O
PM	O

(	O
End	O
of	O
Report	O
)	O

7901625	O

Admission	O
Date	O
:	O

2015-03-16	O

Discharge	O
Date	O
:	O

2015-03-19	O

Date	O
of	O
Birth	O
:	O

Sex	O
:	O

Service	O
:	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
an	O
82	O
-	O
year-old	O
male	O
with	O
a	O
history	O
of	O
hypertension	B-problem
,	O
remote	O
tobacco	O
abuse	O
,	O
chronic	B-problem
renal	I-problem
insufficiency	I-problem
,	O
and	O
a	O
history	O
of	O
a	B-problem
TIA	I-problem
who	O
was	O
in	O
his	O
usual	O
state	O
of	O
health	O
until	O
five	O
nights	O
prior	O
to	O
admission	O
when	O
he	O
awoke	O
at	O
midnight	O
with	O
severe	B-problem
epigastric	I-problem
pain	I-problem
radiating	O
to	O
both	O
arms	O
.	O

He	O
also	O
had	O
bilateral	B-problem
arm	I-problem
numbness	I-problem
.	O

The	B-problem
symptoms	I-problem
were	O
associated	O
with	O
diaphoresis	B-problem
and	O
shortness	B-problem
of	I-problem
breath	I-problem
but	O
no	O
nausea	B-problem
or	O
vomiting	B-problem
.	O

After	O
approximately	O
one	O
hour	O
,	O
he	O
presented	O
to	O
the	O
Bristol	O
County	O
Tuberculosis	O
Hospital	O
Dana-Farber	O
Cancer	O
Institute	O
Campus	O
where	O
he	O
ruled	O
in	O
for	O
a	B-problem
non-ST	I-problem
elevation	I-problem
MI	I-problem
with	O
a	B-test
CK	I-test
of	O
438	O
with	O
a	B-test
peak	I-test
CK	I-test
MB	I-test
of	O
19.8	O
and	O
troponin	B-test
that	O
peaked	O
at	O
10.2	O
.	O

He	O
was	O
started	O
on	O
nitrates	B-treatment
there	O
as	O
well	O
as	O
heparin	B-treatment
and	O
Integrelin	B-treatment
and	O
remained	O
pain-free	B-problem
.	O

He	O
denied	O
any	O
history	O
of	O
similar	B-problem
symptoms	I-problem
in	O
the	O
past	O
and	O
has	O
had	O
no	O
prior	O
history	O
of	O
angina	B-problem
or	O
myocardial	B-problem
infarction	I-problem
.	O

The	O
patient	O
was	O
subsequently	O
transferred	O
to	O
Youville	O
Hospital	O
for	O
cardiac	B-test
catheterization	I-test
.	O

At	O
the	O
time	O
of	O
transfer	O
,	O
he	O
was	O
initially	O
admitted	O
to	O
the	O
CMI	O
Service	O
after	O
undergoing	O
cardiac	B-test
catheterization	I-test
which	O
revealed	O
a	B-problem
long	I-problem
LAD	I-problem
lesion	I-problem
that	O
was	O
angioplastied	O
without	O
stent	B-treatment
placement	I-treatment
,	O
and	O
a	B-problem
total	I-problem
occlusion	I-problem
of	I-problem
the	I-problem
RCA	I-problem
with	O
collaterals	O
.	O

He	O
subsequently	O
became	O
hypotensive	B-problem
and	O
bradycardiac	B-problem
in	O
the	O
Catheterization	O
Laboratory	O
which	O
responded	O
to	O
IV	B-treatment
fluids	I-treatment
,	O
dopamine	B-treatment
,	O
Atropine	B-treatment
,	O
and	O
he	O
was	O
then	O
transferred	O
to	O
the	O
CCU	O
for	O
further	B-test
monitoring	I-test
.	O

He	O
had	O
a	B-test
bedside	I-test
transthoracic	I-test
echocardiogram	I-test
done	O
in	O
the	O
Cardiac	O
Catheterization	O
laboratory	O
without	O
evidence	O
of	O
an	B-problem
effusion	I-problem
.	O

A	B-treatment
Swan	I-treatment
was	O
also	O
placed	O
.	O

There	O
were	O
no	O
stents	B-treatment
deployed	O
at	O
all	O
throughout	O
the	B-test
catheterization	I-test
.	O

By	O
the	O
time	O
he	O
was	O
admitted	O
,	O
he	O
was	O
off	O
pressors	B-treatment
and	O
hemodynamically	O
stable	O
and	O
pain-free	B-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

TIA	B-problem
in	O
1998	O
.	O

COPD	B-problem
with	O
2	O
liters	O
dependence	O
of	O
home	B-treatment
02	I-treatment
.	O

BPH	B-problem
.	O

Chronic	B-problem
renal	I-problem
insufficiency	I-problem
.	O

Gastritis	B-problem
.	O

Asthma	B-problem
.	O

SOCIAL	O
HISTORY	O
:	O

He	O
lis	O
currently	O
widowed	O
.	O

He	O
lives	O
in	O
senior	O
apartment	O
housing	O
in	O
Cambridge	O
on	O
the	O
second	O
floor	O
.	O

He	O
is	O
very	O
active	O
.	O

He	O
uses	O
a	B-treatment
cane	I-treatment
p.r.n.	O
for	O
walking	O
.	O

He	O
denied	O
any	O
falls	O
at	O
home	O
.	O

His	O
only	O
family	O
member	O
is	O
a	O
niece	O
in	O
Missouri	O
.	O

He	O
is	O
currently	O
retired	O
.	O

He	O
has	O
a	O
remote	O
tobacco	O
history	O
and	O
reports	O
occasional	O
alcohol	O
use	O
.	O

He	O
denied	O
any	O
other	O
drug	O
use	O
.	O

FAMILY	O
HISTORY	O
:	O

Noncontributory	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
has	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Aspirin	B-treatment
325	O
mg	O
q.d.	O

2.	O
Metoprolol	B-treatment
50	O
mg	O
b.i.d.	O

3.	O
Lipitor	B-treatment
10	O
mg	O
q.d.	O

4.	O
MDI	B-treatment
p.r.n.	O

5.	O
Heparin	B-treatment
drip	I-treatment
on	O
transfer	O
.	O

6.	O
Integrelin	B-treatment
drip	I-treatment
on	O
transfer	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Vital	B-test
signs	I-test
:	O

Heart	B-test
rate	I-test
91	O
,	O
regular	O
,	O
blood	B-test
pressure	I-test
169/81	O
from	O
a	B-treatment
right	I-treatment
groin	I-treatment
A	I-treatment
line	I-treatment
,	O
respirations	B-test
12	O
,	O
oxygen	B-test
saturation	I-test
of	O
97	O
percent	O
on	O
2	B-treatment
liters	I-treatment
nasal	I-treatment
cannula	I-treatment
.	O

General	O
:	O

He	O
was	O
a	O
well	O
appearing	O
male	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

HEENT	O
:	O

Crusting	B-problem
around	I-problem
the	I-problem
right	I-problem
eyelid	I-problem
but	O
the	O
pupils	O
were	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

He	O
was	O
edentulous	B-problem
.	O

Neck	O
:	O

The	O
neck	O
was	O
supple	O
without	O
lymphadenopathy	B-problem
or	O
thyromegaly	B-problem
.	O

Cardiovascular	O
:	O

His	O
heart	O
was	O
regular	O
with	O
a	O
normal	O
S1	O
and	O
S2	O
.	O

He	O
had	O
no	O
murmurs	B-problem
,	O
rubs	B-problem
,	O
or	O
gallops	B-problem
.	O

Lungs	O
:	O

His	O
lungs	O
were	O
clear	O
to	O
auscultation	B-test
bilaterally	O
Anteriorly	O
and	O
laterally	O
.	O

Abdomen	O
:	O

Soft	O
,	O
obese	B-problem
,	O
nontender	B-problem
,	O
nondistended	B-problem
.	O

He	O
had	O
normoactive	O
bowel	B-test
sounds	I-test
.	O

Extremities	O
:	O

There	O
was	O
a	B-treatment
right	I-treatment
groin	I-treatment
A	I-treatment
line	I-treatment
and	O
a	B-treatment
left	I-treatment
groin	I-treatment
venous	I-treatment
sheath	I-treatment
with	O
a	B-treatment
Swan	I-treatment
.	O

He	O
had	O
no	O
evident	B-problem
edema	I-problem
.	O

He	O
had	O
2+	O
dorsalis	B-test
pedis	I-test
and	O
posterior	B-test
tibial	I-test
pulses	I-test
bilaterally	O
.	O

Neurologic	O
:	O

He	O
was	O
alert	O
and	O
oriented	O
times	O
three	O
,	O
moving	O
all	O
extremities	O
.	O

LABORATORY	O
DATA	O
:	O

On	O
admission	O
,	O
the	B-test
CBC	I-test
revealed	O
a	B-test
white	I-test
count	I-test
of	O
7.4	O
,	O
hematocrit	B-test
39.7	O
,	O
and	O
platelets	B-test
of	O
217,000	O
.	O

Serum	B-test
chemistries	I-test
revealed	O
a	B-test
sodium	I-test
of	O
135,	O
potassium	B-test
4.0	O
,	O
chloride	B-test
102	O
,	O
bicarbonate	B-test
26	O
,	O
BUN	B-test
29	O
,	O
creatinine	B-test
1.6	O
,	O
and	O
glucose	B-test
of	O
111	O
.	O

The	B-test
initial	I-test
EKG	I-test
showed	O
normal	O
sinus	B-test
rhythm	I-test
at	O
a	B-test
rate	I-test
of	O
71	O
with	O
a	O
normal	O
axis	B-test
and	O
evidence	O
of	O
first-degree	B-problem
AV	I-problem
block	I-problem
with	O
prolonged	B-problem
PR	I-problem
interval	I-problem
of	O
238	O
milliseconds	O
.	O

He	O
also	O
had	O
a	B-problem
widened	I-problem
QRS	I-problem
of	O
153	O
milliseconds	O
,	O
an	B-problem
old	I-problem
right	I-problem
bundle	I-problem
branch	I-problem
block	I-problem
,	O
and	O
no	O
acute	B-problem
ST	I-problem
or	I-problem
T	I-problem
wave	I-problem
changes	I-problem
.	O

The	B-test
EKG	I-test
was	O
prior	O
to	O
catheterization	B-test
and	O
the	O
one	O
post	O
PTCA	B-treatment
was	O
no	O
different	O
.	O

He	O
had	O
a	B-test
bedside	I-test
echocardiogram	I-test
done	O
in	O
the	O
Catheterization	O
Laboratory	O
which	O
showed	O
normal	O
LV	O
wall	O
thickness	O
and	O
normal	O
LV	O
cavity	O
size	O
.	O

There	O
was	O
no	O
evidence	O
of	O
effusion	B-problem
.	O

It	O
was	O
difficult	O
to	O
assess	O
free	O
wall	O
motion	O
.	O

Cardiac	B-test
catheterization	I-test
revealed	O
a	B-problem
totally	I-problem
occluded	I-problem
RCA	I-problem
with	O
collaterals	O
,	O
an	B-problem
80	I-problem
percent	I-problem
LAD	I-problem
lesion	I-problem
extending	O
distally	O
which	O
was	O
angioplastied	O
but	O
no	O
stent	B-treatment
was	O
placed	O
.	O

Hemodynamics	O
:	O

The	B-test
right	I-test
heart	I-test
catheterization	I-test
revealed	O
pulmonary	B-test
capillary	I-test
wedge	I-test
pressure	I-test
of	O
4	O
,	O
cardiac	B-test
output	I-test
of	O
8	O
,	O
and	O
cardiac	B-test
index	I-test
of	O
3.8	O
,	O
he	O
had	O
an	B-test
RA	I-test
pressure	I-test
of	O
10	O
,	O
RV	B-test
pressure	I-test
of	O
43/4	O
,	O
PA	B-test
pressure	I-test
of	O
37/10	O
.	O

ASSESSMENT	O
:	O

This	O
is	O
an	O
82	O
-	O
year-old	O
male	O
with	O
a	O
history	O
of	O
prior	O
tobacco	O
use	O
,	O
hypertension	B-problem
,	O
chronic	B-problem
renal	I-problem
insufficiency	I-problem
,	O
COPD	B-problem
,	O
gastritis	B-problem
,	O
and	O
TIA	B-problem
who	O
initially	O
presented	O
to	O
Braintree	O
with	O
a	B-problem
non-ST	I-problem
elevation	I-problem
MI	I-problem
and	O
Guaiac	B-problem
positive	I-problem
stools	I-problem
,	O
transferred	O
to	O
St.	O
Margaret's	O
Center	O
for	O
Women	O
&	O
Infants	O
for	O
cardiac	B-test
catheterization	I-test
with	O
PTCA	B-treatment
to	O
mid	B-problem
LAD	I-problem
lesion	I-problem
complicated	O
by	O
hypotension	B-problem
and	O
bradycardia	B-problem
requiring	O
Atropine	B-treatment
,	O
IV	B-treatment
fluids	I-treatment
and	O
transient	B-treatment
dopamine	I-treatment
possibly	O
secondary	O
to	O
vagal	B-problem
reaction	I-problem
,	O
subsequently	O
transferred	O
to	O
CCU	O
for	O
close	B-test
monitoring	I-test
,	O
hemodynamically	O
stable	O
at	O
the	O
time	O
of	O
admission	O
to	O
the	O
CCU	O
.	O

HOSPITAL	O
COURSE	O
:	O

1.	O
CARDIOVASCULAR	O
:	O

As	O
summarized	O
above	O
,	O
the	O
patient	O
had	O
a	B-problem
non-ST	I-problem
elevation	I-problem
MI	I-problem
with	O
evidence	O
of	O
an	B-problem
80	I-problem
percent	I-problem
mid	I-problem
LAD	I-problem
lesion	I-problem
for	O
which	O
he	O
underwent	O
angioplasty	B-treatment
without	O
stent	B-treatment
placement	I-treatment
.	O

He	O
was	O
initially	O
continued	O
on	O
aspirin	B-treatment
,	O
Plavix	B-treatment
,	O
beta	B-treatment
blocker	I-treatment
,	O
statin	B-treatment
,	O
and	O
ACE	B-treatment
inhibitor	I-treatment
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
his	B-treatment
Plavix	I-treatment
was	O
held	O
due	O
to	O
Guaiac	B-problem
positive	I-problem
stools	I-problem
and	O
hematocrit	B-problem
drop	I-problem
throughout	O
admission	O
.	O

He	O
had	O
a	B-test
transthoracic	I-test
echocardiogram	I-test
the	O
day	O
after	O
admission	O
showing	O
an	B-test
ejection	I-test
fraction	I-test
of	O
greater	O
than	O
60	O
percent	O
.	O

No	O
focal	B-problem
wall	I-problem
motion	I-problem
abnormalities	I-problem
.	O

He	O
had	O
no	O
recurrent	B-problem
chest	I-problem
pain	I-problem
or	O
shortness	B-problem
of	I-problem
breath	I-problem
throughout	O
admission	O
.	O

In	O
regards	O
to	O
his	O
rhythm	O
,	O
he	O
has	O
an	B-problem
underlying	I-problem
right	I-problem
bundle	I-problem
branch	I-problem
block	I-problem
and	O
first-degree	B-problem
AV	I-problem
block	I-problem
which	O
were	O
stable	O
throughout	O
this	O
admission	O
.	O

He	O
will	O
be	O
followed-up	O
by	O
his	O
cardiologist	O
after	O
discharge	O
.	O

1.	O
PULMONARY	O
:	O

He	O
had	O
a	O
history	O
of	O
COPD	B-problem
for	O
which	O
he	O
is	O
on	O
baseline	O
2	O
liters	O
of	O
02	B-treatment
by	O
nasal	B-treatment
cannula	I-treatment
at	O
home	O
and	O
Albuterol	B-treatment
and	O
Atrovent	B-treatment
MDI	I-treatment
s	O
p.r.n.	O
at	O
home	O
.	O

He	O
is	O
also	O
on	O
Flovent	B-treatment
MDI	I-treatment
at	O
home	O
as	O
well	O
.	O

He	O
was	O
continued	O
on	O
his	B-treatment
MDI	I-treatment
and	O
was	O
at	O
his	B-problem
baseline	I-problem
02	I-problem
requirement	I-problem
throughout	O
admission	O
.	O

1.	O
RENAL	O
:	O

He	O
has	O
a	O
history	O
of	O
chronic	B-problem
renal	I-problem
insufficiency	I-problem
likely	O
secondary	O
to	O
hypertension	B-problem
and	O
was	O
admitted	O
with	O
a	B-test
creatinine	I-test
of	O
1.6	O
.	O

His	B-treatment
ACE	I-treatment
inhibitor	I-treatment
post	O
MI	B-problem
was	O
initially	O
held	O
due	O
to	O
his	B-test
creatinine	I-test
.	O

However	O
,	O
this	O
responded	O
to	O
IV	B-treatment
fluids	I-treatment
and	O
his	B-treatment
ACE	I-treatment
inhibitor	I-treatment
was	O
restarted	O
at	O
the	O
time	O
of	O
discharge	O
.	O

He	O
will	O
need	O
close	B-test
monitoring	I-test
of	O
his	B-test
creatinine	I-test
post	O
discharge	O
in	O
the	O
setting	O
of	O
reinstitution	O
of	O
his	B-treatment
ACE	I-treatment
inhibitor	I-treatment
.	O

1.	O
GASTROINTESTINAL	O
:	O

His	O
stools	O
were	O
noted	O
to	O
be	O
Guaiac	B-problem
positive	I-problem
at	O
the	O
outside	O
hospital	O
and	O
there	O
was	O
still	O
concern	O
for	O
possible	O
GI	B-problem
bleed	I-problem
given	O
continued	O
Guaiac	B-problem
positive	I-problem
stools	I-problem
during	O
this	O
admission	O
and	O
a	B-problem
slight	I-problem
drop	I-problem
in	I-problem
his	I-problem
hematocrit	I-problem
from	O
39	O
to	O
33	O
.	O

It	O
was	O
felt	O
most	O
appropriate	O
for	O
him	O
to	O
have	O
an	B-test
outpatient	I-test
GI	I-test
workup	I-test
,	O
and	O
his	O
PCP	O
was	O
contacted	O
and	O
will	O
arrange	O
for	O
outpatient	B-test
colonoscopy	I-test
.	O

His	B-treatment
Plavix	I-treatment
was	O
held	O
at	O
the	O
time	O
of	O
discharge	O
due	O
to	O
a	O
question	O
of	O
GI	B-problem
bleed	I-problem
and	O
in	O
the	O
setting	O
of	O
not	O
having	O
a	B-treatment
stent	I-treatment
placed	O
at	O
the	O
time	O
of	O
catheterization	B-test
.	O

He	O
was	O
continued	O
on	O
his	B-treatment
aspirin	I-treatment
,	O
however	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Coronary	B-problem
artery	I-problem
disease	I-problem
,	O
status	O
post	O
non-ST	B-problem
elevation	I-problem
myocardial	I-problem
infarction	I-problem
with	O
80	B-problem
percent	I-problem
mid	I-problem
LAD	I-problem
lesion	I-problem
,	O
now	O
status	O
post	O
angioplasty	B-treatment
.	O

Hypertension	B-problem
.	O

Chronic	B-problem
renal	I-problem
insufficiency	I-problem
.	O

Chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
.	O

Guaiac	B-problem
positive	I-problem
stools	I-problem
.	O

Anemia	B-problem
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Lipitor	B-treatment
10	O
mg	O
q.d.	O

2.	O
Lisinopril	B-treatment
2.5	O
mg	O
q.d.	O

3.	O
Flovent	B-treatment
110	O
micrograms	O
aerosol	O
two	O
puffs	O
b.i.d.	O

4.	O
Aspirin	B-treatment
325	O
mg	O
q.d.	O

5.	O
Combivent	B-treatment
MDI	O
p.r.n.	O

6.	O
Toprol	B-treatment
XL	I-treatment
100	O
mg	O
q.d.	O

DISPOSITION	O
:	O

At	O
the	O
time	O
of	O
discharge	O
,	O
the	B-test
patient	I-test
's	I-test
vital	I-test
signs	I-test
were	O
stable	O
and	O
he	O
was	O
without	O
complaints	B-problem
.	O

DISCHARGE	O
STATUS	O
:	O

He	O
will	O
be	O
discharged	O
to	O
home	O
and	O
was	O
cleared	O
by	O
Physical	O
Therapy	O
.	O

FOLLOW	O
UP	O
:	O

He	O
has	O
been	O
scheduled	O
for	O
follow-up	O
with	O
Dr.	O
Martha	O
on	O
2015-03-25	O
at	O
11:00	O
a.m.	O

It	O
was	O
discussed	O
with	O
him	O
the	O
need	O
to	O
schedule	O
follow-up	O
for	O
colonoscopy	B-test
with	O
his	O
PCP	O
as	O
well	O
.	O

He	O
will	O
call	O
the	O
Cardiology	O
Division	O
at	O
Addison	O
Gilbert	O
Hospital	O
Greenfield	O
to	O
schedule	O
a	O
follow-up	O
with	O
his	O
cardiologist	O
there	O
within	O
the	O
next	O
week	O
.	O

Lucile	O
Minor	O
Etta	O
,	O
MD	O

12ADA	O

Dictated	O
By	O
:	O
Emily	O
M.	O
Cassidy	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2015-07-29	O
17:03:53	O

T	O
:	O
2015-07-29	O
22:08:30	O

Job	O
#:	O
81504	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Brenda	O
JM.	O
Espinosa	O
on	O
:	O
Maxine	O
2015-09-10	O
1:57	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2013-11-04	O

Discharge	O
Date	O
:	O

2013-11-16	O

Date	O
of	O
Birth	O
:	O

1930-12-19	O

Sex	O
:	O

F	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Sulfa	B-treatment
(	I-treatment
Sulfonamides	I-treatment
)	O
/	O
Penicillins	B-treatment
/	O
Macrodantin	B-treatment
/	O
Ivp	B-treatment
Dye	I-treatment
,	O
Iodine	B-treatment
Containing	I-treatment

Attending	O
:	O
Robert	O
E	O
Goldschmidt	O
,	O
M.D.	O

Addendum	O
:	O

Just	O
prior	O
to	O
discharge	O
on	O
11-14	O
,	O
pt	B-test
's	I-test
BP	I-test
was	O
found	O
to	O
be	O
70/40	O
P70	O
s	O
just	O
after	O
receiving	O
her	B-treatment
am	I-treatment
BP	I-treatment
meds	I-treatment
.	O

She	O
was	O
asymptomatic	B-problem
.	O

The	O
patient	O
was	O
kept	O
in	O
the	O
hospital	O
and	O
the	O
following	O
issues	O
were	O
addressed	O
:	O

1.	O
Hypotension	B-problem
:	O
The	B-treatment
patient	I-treatment
'd	I-treatment
pm	I-treatment
BP	I-treatment
meds	I-treatment
were	O
held	O
11-14	O
and	O
she	O
was	O
administered	O
1.5L	O
NS	B-treatment
over	O
the	O
course	O
of	O
the	O
day	O
with	O
subsequent	O
SBP	B-test
s	I-test
in	O
the	O
high	O
90	O
s,	O
low	O
100	O
s,.	O

The	B-problem
hypotension	I-problem
was	O
likely	O
due	O
to	O
volume	B-problem
depletion	I-problem
caused	O
by	O
her	B-problem
diarrhea	I-problem
/	O
loose	B-problem
stools	I-problem
in	O
addition	O
to	O
decreased	B-problem
PO	I-problem
intake	I-problem
secondary	O
to	O
her	B-problem
GERD	I-problem
and	O
thrush	B-problem
.	O

All	O
of	O
this	O
occurred	O
in	O
the	O
setting	O
of	O
aggressive	B-treatment
BP	I-treatment
management	I-treatment
with	O
metoprolol	B-treatment
25	O
BID	O
,	O
HCTZ	B-treatment
/	O
Triampterene	B-treatment
(	O
as	O
a	O
replacment	O
for	O
lasix	B-treatment
due	O
to	O
recurrent	B-problem
hypokalemia	I-problem
),	O
Benicar	B-treatment
20	O
mg	O
QD	O
,	O
and	O
Imdur	B-treatment
30	O
mg	O
QD	O
.	O

Infection	B-problem
/	O
sepsis	B-problem
was	O
not	O
likely	O
given	O
she	O
was	O
afebrile	B-problem
and	O
had	O
no	O
localizing	B-problem
sx	I-problem
with	O
an	O
improving	O
lung	B-test
exam	I-test
and	O
02	B-problem
requirement	I-problem
.	O

Given	O
the	B-problem
patient	I-problem
's	I-problem
recent	I-problem
RP	I-problem
bleed	I-problem
,	O
there	O
was	O
concern	O
for	O
a	B-problem
recurrent	I-problem
bleed	I-problem
.	O

Her	B-test
groin	I-test
exam	I-test
was	O
unchanged	O
.	O

Her	B-test
Hct	I-test
dropped	O
from	O
Hct	B-test
38.9	O
before	O
fluids	B-treatment
to	O
35.5	O
s/p	O
1.5L	O
NS	B-treatment
and	O
was	O
thought	O
to	O
be	O
dilutional	O
.	O

Repeat	B-test
hcts	I-test
were	O
stable	O
.	O

The	O
patient	O
was	O
kept	O
an	O
additional	O
two	O
days	O
to	O
follow	O
her	B-test
hcts	I-test
and	O
titrate	O
her	B-treatment
BP	I-treatment
meds	I-treatment
.	O

As	O
volume	B-problem
depletion	I-problem
was	O
thought	O
to	O
be	O
the	O
cause	O
of	O
her	B-problem
low	I-problem
BP	I-problem
,	O
only	O
the	B-treatment
BBlocker	I-treatment
was	O
restarted	O
.	O

She	O
was	O
also	O
placed	O
on	O
on	O
low	B-treatment
dose	I-treatment
spironolactone	I-treatment
as	O
a	B-treatment
K	I-treatment
sparing	I-treatment
diuretic	I-treatment
and	O
for	O
BP	B-treatment
control	I-treatment
in	O
addition	O
to	O
Toprol	B-treatment
XL	I-treatment
25	O
mg	O
QD	O
for	O
her	B-problem
coronary	I-problem
disease	I-problem
.	O

She	O
tolerated	O
these	B-treatment
meds	I-treatment
with	O
SBP	B-test
s	I-test
in	O
the	O
high	O
90	O
s	O
to	O
100	O
s	O
and	O
was	O
therefore	O
discharged	O
on	O
this	B-treatment
regimen	I-treatment
.	O

She	O
will	O
need	O
follow	O
up	O
with	O
her	O
PCP	O
within	O
B	O
week	O
after	O
discharge	O
from	O
the	O
extended	O
care	O
facility	O
for	O
further	B-treatment
BP	I-treatment
titration	I-treatment
and	O
monitoring	B-test
of	I-test
her	I-test
electrolytes	I-test
.	O

2.	O
Thrush	B-problem
:	O
This	O
is	O
likely	O
secondary	O
to	O
her	B-treatment
steroid	I-treatment
inhalers	I-treatment
and	O
PO	B-treatment
prednisone	I-treatment
for	O
COPD	B-problem
exacerbation	I-problem
.	O

She	O
was	O
started	O
on	O
nystatin	B-treatment
swish	O
and	O
swallow	O
QID	O
.	O

The	O
patient	O
was	O
encouraged	O
to	O
take	B-treatment
PO	I-treatment
liquids	I-treatment
to	O
prevent	O
volume	B-problem
depletion	I-problem
.	O

3.	O
diarrhea	B-problem
:	O
The	O
patient	O
has	O
been	O
having	O
loose	B-problem
stools	I-problem
at	O
night	O
and	O
was	O
guiac	B-problem
pos	I-problem
x	O
2	O
.	O

Stool	B-test
for	I-test
C.diff	I-test
toxin	I-test
was	O
sent	O
x	O
1	O
and	O
was	O
negative	O
.	O

Her	B-treatment
bowel	I-treatment
regimen	I-treatment
is	O
prn	O
.	O

Gastroenteritis	B-problem
is	O
possible	O
but	O
she	O
has	O
no	O
vomiting	B-problem
and	O
only	O
occ	B-problem
nausea	I-problem
with	O
meds	B-treatment
.	O

There	O
is	O
no	O
evidence	O
of	O
obstruction	B-problem
on	O
AXR	B-test
.	O

Therefore	O
,	O
the	O
cause	O
of	O
her	B-problem
mild	I-problem
diarrhea	I-problem
(	O
few	B-problem
loose	I-problem
BM	I-problem
/	O
liquid	B-problem
stool	I-problem
/	O
night	O
)	O
may	O
be	O
either	O
viral	B-problem
or	O
secondary	O
to	O
resolving	B-problem
abdominal	I-problem
hematoma	I-problem
with	O
resultant	O
irritation	B-problem
of	I-problem
GI	I-problem
system	I-problem
.	O

We	O
have	O
advised	O
a	B-treatment
BRAT	I-treatment
diet	I-treatment
.	O

4.	O
guiac	B-problem
pos	I-problem
stool	I-problem
:	O
Given	O
the	O
patient	O
's	O
sx	O
of	O
GERD	B-problem
,	O
current	O
PO	B-treatment
steroid	I-treatment
regimen	I-treatment
,	O
and	O
ASA	B-treatment
for	O
her	B-treatment
stents	I-treatment
,	O
the	O
ddx	O
for	O
her	B-problem
guiac	I-problem
positive	I-problem
stools	I-problem
would	O
include	O
gastritis	B-problem
/	O
gastric	B-problem
ulcer	I-problem
in	O
addition	O
to	O
lower	B-problem
GI	I-problem
pathology	I-problem
.	O

However	O
,	O
she	O
has	O
no	O
vomiting	B-problem
and	O
only	B-problem
mild	I-problem
nausea	I-problem
with	O
medications	B-treatment
.	O

She	O
also	O
has	O
no	O
gross	B-problem
blood	I-problem
per	I-problem
rectum	I-problem
and	O
her	B-test
hct	I-test
is	O
stable	O
.	O

Upon	O
discharge	O
the	O
patient	O
was	O
changed	O
to	O
a	B-treatment
BID	I-treatment
protonix	I-treatment
regimen	I-treatment
.	O

Dr.	O
Valerio	O
office	O
was	O
notified	O
about	O
the	O
patient	O
's	O
discharge	O
plans	O
and	O
status	O
.	O

She	O
will	O
need	O
outpatient	O
follow	O
up	O
for	O
her	B-problem
guiac	I-problem
pos	I-problem
stools	I-problem
with	O
endoscopy	B-test
vs	O
EGD	B-test
+/-	O
H.pylori	B-test
serologies	I-test
.	O

A	O
copy	O
of	O
this	O
dc	O
summary	O
will	O
be	O
faxed	O
to	O
her	O
PCP	O
to	O
ensure	O
proper	O
follow	O
up	O
.	O

Discharge	O
Medications	O
:	O

1.	O
Atorvastatin	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

2.	O
Pantoprazole	B-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
twice	O
a	O
day	O
.	O

3.	O
Acetaminophen	B-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
).	O

Disp	O
:*	O
240	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

4.	O
Oxycodone	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-problem
.	O

Disp	O
:*	O
90	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

5.	O
Fluticasone	B-treatment
50	O
mcg	O
/	O
Actuation	O
Aerosol	O
,	O
Spray	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Spray	O
Nasal	O
DAILY	O
(	O
Daily	O
).	O

6.	O
Fluticasone	B-treatment
110	O
mcg	O
/	O
Actuation	O
Aerosol	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Puff	O
Inhalation	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

7.	O
Tiotropium	B-treatment
Bromide	I-treatment
18	O
mcg	O
Capsule	O
,	O
w/	O
Inhalation	O
Device	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Cap	O
Inhalation	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Cap	O
(s)*	O
Refills	O
:*	O
2	O
*	O

8.	O
Clopidogrel	B-treatment
75	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

9.	O
Albuterol	B-treatment
Sulfate	I-treatment
0.083	O
%	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
puff	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
for	O
shortness	B-problem
of	I-problem
breath	I-problem
or	O
wheezing	B-problem
.	O

Disp	O
:*	O
1	O
inhaler	O
*	O
Refills	O
:*	O
1	O
*	O

10.	O
Aluminum	B-treatment
-	I-treatment
Magnesium	I-treatment
Hydroxide	I-treatment
225-200	O
mg	O
/	O
5	O
mL	O
Suspension	O
Sig	O
:	O
15-30	O
ML	O
s	O
PO	O
PRN	O
(	O
as	O
needed	O
).	O

11.	O
Senna	B-treatment
8.6	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

12.	O
Prednisone	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
DAILY	O
(	O
Daily	O
)	O
for	O
4	O
days	O
:	O
Please	O
take	O
two	O
pills	O
for	O
one	O
day	O
starting	O
11-17	O
,	O
then	O
take	O
one	O
pill	O
for	O
three	O
days	O
.	O

Disp	O
:*	O
5	O
Tablet	O
(s)*	O
Refills	O
:	O
*	O
0	O
*	O

13.	O
oxygen	B-treatment
continue	O
02	B-treatment
at	O
1L/min	O
continuous	O
to	O
keep	O
sats	B-test
in	O
90	O
's.	O

14.	O
Spironolactone	B-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

15.	O
Metoprolol	B-treatment
Succinate	I-treatment
25	O
mg	O
Tablet	O
Sustained	O
Release	O
24HR	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
Sustained	O
Release	O
24HR	O
PO	O
DAILY	O
(	O
Daily	O
).	O

16.	O
Nystatin	B-treatment
100,000	O
unit	O
/	O
mL	O
Suspension	O
Sig	O
:	O
Ten	O
(	O
10	O
)	O
ML	O
PO	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
for	O
7	O
days	O
.	O

17.	O
Aspirin	B-treatment
325	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Facility	O
:	O

3133	O
W.	O
Third	O
Ave.	O
Rehab	O
&	O
Nursing	O
Center	O
-	O
Westwood	O
Lodge	O
Hospital	O

Discharge	O
Diagnosis	O
:	O

1)	O
Rapid	B-problem
atrial	I-problem
fibrillation	I-problem
with	O
demand	B-problem
ischemia	I-problem

2)	O
Retroperitoneal	B-problem
bleed	I-problem

Discharge	O
Condition	O
:	O

Stable	O

Discharge	O
Instructions	O
:	O

Please	O
follow	O
up	O
with	O
your	O
PCP	O
Richard	O
,	O
Kevin	O
Robinson	O
(	O
771	O
)	O
937-5400	O
upon	O
discharge	O
.	O

If	O
you	O
experience	O
CP	B-problem
,	O
SOB	B-problem
,	O
dizzyness	B-problem
,	O
or	O
any	B-problem
other	I-problem
symptoms	I-problem
that	O
concern	O
you	O
please	O
call	O
your	O
PCP	O
or	O
return	O
to	O
the	O
ER	O
.	O

Note	O
:	O
you	O
have	O
had	O
a	B-treatment
cardiac	I-treatment
stent	I-treatment
placed	O
during	O
this	O
admission	O
.	O

You	O
must	O
take	O
your	B-treatment
aspirin	I-treatment
and	O
plavix	B-treatment
every	O
day	O
to	O
prevent	O
failure	B-problem
of	I-problem
these	I-problem
stents	I-problem
which	O
could	O
be	O
life	O
threatening	O
.	O

Please	O
take	O
all	B-treatment
medications	I-treatment
as	O
prescribed	O
.	O

Followup	O
Instructions	O
:	O

1)	O
Please	O
follow	O
up	O
with	O
your	O
PCP	O
and	O
cardiologist	O
,	O
David	O
,	O
Larry	O
Robinson	O
(	O
771	O
)	O
937-5400	O
,	O
upon	O
discharge	O
.	O

2)	O
You	O
are	O
scheduled	O
to	O
have	O
your	B-treatment
staples	I-treatment
removed	O
on	O
2013-11-20	O
3:00	O
with	O
provider	O
:	O
Leah	O
,	O
Paula	O
G.	O
Wilson	O
SURGERY	O
(	O
NHB	O
)	O

Date	O
/	O
Time	O
:	O
2013-11-20	O
3:00	O
.	O

Lashonda	O
Christopher	O
MD	O
48-669	O

Completed	O
by	O
:	O
Jill	O
Kelly	O
MD	O
47-482	O
2013-11-16	O
@	O
1550	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Lee	O
V.	O
Young	O
on	O
:	O
FRI	O
2013-12-20	O
4:59	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2014-10-14	O

Discharge	O
Date	O
:	O

2014-10-17	O

Date	O
of	O
Birth	O
:	O

1959-12-09	O

Sex	O
:	O

M	O

Service	O
:	O

CCU	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
55	O
-	O
year-old	O
Caucasian	O
speaking	O
male	O
who	O
is	O
a	O
smoker	O
and	O
has	O
a	O
family	O
history	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
as	O
well	O
as	O
a	O
personal	O
history	O
of	O
hypertension	B-problem
,	O
who	O
experienced	O
multiple	O
episodes	O
of	O
10/10	B-problem
substernal	I-problem
chest	I-problem
pain	I-problem
radiating	O
down	O
his	O
left	O
arm	O
last	O
night	O
with	O
his	O
daily	O
activities	O
.	O

Each	B-problem
episode	I-problem
lasted	O
approximately	O
15	O
minutes	O
in	O
duration	O
and	O
resolved	O
on	O
their	O
own	O
.	O

This	O
morning	O
while	O
landscaping	O
the	O
patient	O
had	O
unremitting	B-problem
12-05	I-problem
pain	I-problem
with	O
shortness	B-problem
of	I-problem
breath	I-problem
and	O
diaphoresis	B-problem
.	O

He	O
presented	O
to	O
Deaconess-Nashoba	O
Hospital	O
Hospital	O
and	O
the	B-test
first	I-test
EKG	I-test
was	O
found	O
to	O
have	O
ST	B-problem
elevations	I-problem
in	I-problem
V1-V3	I-problem
of	O
1-2	O
mm	O
with	O
T	B-problem
wave	I-problem
inversions	I-problem
in	O
V4-6	O
,	O
I	O
and	O
L	O
,	O
which	O
progressed	O
to	O
3-0167	O
W.	O
Seventh	O
Ave.	O
elevations	O
within	O
20	O
minutes	O
.	O

Heparin	B-treatment
and	O
nitroglycerin	B-treatment
drip	I-treatment
were	O
started	O
with	O
10	O
mg	O
of	O
IV	B-treatment
Retavase	I-treatment
half	O
dose	O
.	O

He	O
was	O
transferred	O
to	O
the	O
North	O
Adams	O
Regional	O
Hospital	O
for	O
catheterization	B-test
.	O

Once	O
at	O
Hahnemann	O
General	O
Hospital	O
he	O
received	O
heparin	B-treatment
and	O
Integrilin	B-treatment
.	O

Coronary	B-test
angiography	I-test
revealed	O
left	O
main	O
,	O
left	O
circumflex	O
and	O
RCA	O
normal	O
and	O
left	B-problem
LAD	I-problem
with	I-problem
99%	I-problem
midstenosis	I-problem
.	O

A	B-treatment
Hepacoat	I-treatment
stent	I-treatment
was	O
placed	O
with	O
no	O
residuals	B-test
but	O
good	O
flow	O
after	O
nitroglycerin	B-treatment
and	O
diltiazem	B-treatment
.	O

The	B-problem
chest	I-problem
pain	I-problem
persisted	O
afterwards	O
and	O
a	B-test
relook	I-test
catheterization	I-test
was	O
performed	O
that	O
revealed	O
no	O
occlusions	B-problem
.	O

The	B-test
right	I-test
heart	I-test
catheterization	I-test
revealed	O
a	B-test
cardiac	I-test
output	I-test
index	I-test
of	O
4.11	O
and	O
2.15	O
respectively	O
.	O

RA	B-test
pressure	I-test
was	O
13	O
,	O
RV	B-test
pressure	I-test
45/7	O
,	O
wedge	B-test
27	O
and	O
PA	B-test
pressures	I-test
of	O
42/21	O
.	O

He	O
was	O
transferred	O
to	O
the	O
CC	O
for	O
monitoring	B-test
and	O
he	O
denied	O
having	O
further	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
nausea	B-problem
or	O
vomiting	B-problem
.	O

At	O
baseline	O
the	O
patient	O
denies	O
any	O
previous	B-problem
chest	I-problem
pain	I-problem
,	O
pressure	B-problem
,	O
dyspnea	B-problem
on	O
exertion	O
,	O
orthopnea	B-problem
,	O
PND	B-problem
or	O
palpitations	B-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Only	O
hypertension	B-problem
.	O

MEDICATIONS	O
:	O

Antihypertensive	B-treatment
medications	I-treatment
that	O
the	O
patient	O
could	O
not	O
identify	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
denies	O
having	O
any	B-problem
drug	I-problem
allergies	I-problem
.	O

FAMILY	O
HISTORY	O
:	O

Significant	O
for	O
a	O
brother	O
who	O
had	O
an	B-problem
MI	I-problem
at	O
age	O
61	O
.	O

SOCIAL	O
HISTORY	O
:	O

He	O
has	O
two	O
kids	O
,	O
works	O
as	O
a	O
landscaper	O
and	O
as	O
a	O
school	O
custodian	O
in	O
Ware	O
.	O

He	O
has	O
a	O
15	O
to	O
20	O
pack-year	O
history	O
.	O

Smokes	O
1	O
pack-per-day	O
for	O
15	O
years	O
but	O
had	O
quit	O
for	O
20	O
years	O
and	O
recently	O
restarted	O
.	O

He	O
drinks	O
two	O
glasses	O
of	O
wine	O
per	O
day	O
and	O
denies	O
any	O
use	O
of	O
illicit	O
substances	O
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION	O
:	O

The	O
patient	O
was	O
afebrile	B-problem
.	O

Blood	B-test
pressure	I-test
156/67	O
,	O
pulse	B-test
80	O
and	O
respiratory	B-test
rate	I-test
14	O
.	O

Appearance	O
:	O

He	O
was	O
laying	O
flat	O
,	O
very	B-problem
tense	I-problem
.	O

Skin	O
was	O
strong	O
build	O
and	O
was	O
in	O
no	O
apparent	B-problem
distress	I-problem
.	O

HEENT	O
:	O

He	O
was	O
anicteric	B-problem
with	O
moist	O
mucous	O
membranes	O
.	O

No	O
JVD	B-problem
or	O
increased	B-problem
JVP	I-problem
was	O
appreciated	O
at	O
0	O
degrees	O
.	O

The	O
patient	O
did	O
not	O
have	O
any	B-problem
carotid	I-problem
bruits	I-problem
,	O
abdominal	B-problem
bruits	I-problem
or	O
femoral	B-problem
bruits	I-problem
.	O

His	B-test
PMI	I-test
was	O
two	O
finger	B-test
breath	I-test
width	I-test
in	O
the	O
fifth	O
intercostal	O
space	O
lateral	O
to	O
the	O
midclavicular	O
line	O
.	O

There	O
were	O
no	O
lifts	B-problem
or	O
heaves	B-problem
on	O
examination	B-test
.	O

His	O
heart	O
was	O
regular	O
with	O
no	O
murmurs	B-problem
,	O
rubs	B-problem
or	O
gallops	B-problem
and	O
his	B-test
radial	I-test
and	I-test
DP	I-test
pulses	I-test
were	O
both	O
2+	O
bilaterally	O
and	O
equal	O
.	O

His	O
lungs	O
were	O
clear	O
to	O
auscultation	B-test
.	O

His	O
abdomen	O
was	O
scaphoid	B-problem
,	O
nondistended	B-problem
,	O
nontender	B-problem
with	O
positive	O
bowel	O
sounds	O
.	O

His	O
extremities	O
were	O
warm	O
,	O
pink	O
with	O
no	O
edema	B-problem
.	O

The	O
right	O
calf	O
site	O
had	O
minimal	B-problem
ooze	I-problem
and	O
no	O
hematomas	B-problem
or	O
bruits	B-problem
.	O

ELECTROCARDIOGRAM	O
:	O

Significant	O
for	O
what	O
was	O
stated	O
in	O
the	O
HPI	O
.	O

OVERALL	O
IMPRESSION	O
:	O

This	O
is	O
a	O
54	O
-	O
year-old	O
man	O
with	O
significant	B-problem
coronary	I-problem
artery	I-problem
disease	I-problem
risk	I-problem
factors	I-problem
,	O
positive	O
family	O
history	O
,	O
smoking	O
history	O
,	O
hypertension	B-problem
and	O
gender	O
who	O
presented	O
with	O
an	B-problem
ST	I-problem
elevation	I-problem
MI	I-problem
status	O
post	O
LAD	B-treatment
stent	I-treatment
,	O
complicated	O
by	O
no	O
residuals	B-problem
requiring	O
nitroglycerin	B-treatment
and	O
diltiazem	B-treatment
for	O
good	O
flow	O
.	O

The	O
patient	O
was	O
pain	B-problem
free	O
and	O
doing	O
well	O
.	O

HOSPITAL	O
COURSE	O
:	O

For	O
his	B-problem
coronary	I-problem
artery	I-problem
disease	I-problem
,	O
aspirin	B-treatment
was	O
started	O
at	O
325	O
.	O

Plavix	B-treatment
was	O
started	O
at	O
75	O
mg	O
a	O
day	O
,	O
Lipitor	B-treatment
20	O
mg	O
per	O
day	O
,	O
metoprolol	B-treatment
25	O
mg	O
twice	O
a	O
day	O
to	O
be	O
titrated	O
up	O
as	O
tolerated	O
and	O
on	O
day	O
two	O
of	O
admission	O
an	B-treatment
ACE	I-treatment
inhibitor	I-treatment
was	O
started	O
.	O

Captopril	B-treatment
6.2	O
3	O
x	O
a	O
day	O
and	O
titrated	O
up	O
.	O

A	B-test
lipid	I-test
panel	I-test
was	O
checked	O
and	O
found	O
to	O
be	O
within	O
normal	O
limits	O
,	O
although	O
it	O
was	O
noted	O
this	O
was	O
in	O
the	O
post	O
MI	O
setting	O
and	O
the	B-test
lipid	I-test
panel	I-test
could	O
be	O
falsely	O
low	O
.	O

Serial	B-test
CK	I-test
s	I-test
were	O
followed	O
with	O
a	B-test
CK	I-test
peak	I-test
of	O
433	O
.	O

Hypertension	B-problem
was	O
managed	O
with	O
beta	B-treatment
blocker	I-treatment
and	O
ACE	B-treatment
inhibitor	I-treatment
and	O
Integrilin	B-treatment
was	O
continued	O
post	O
MI	B-problem
for	O
18	O
hours	O
.	O

Rhythm	O
was	O
maintained	O
at	O
normal	O
sinus	O
,	O
monitored	O
on	O
telemetry	B-test
without	O
ectopy	B-problem
.	O

EKG	B-test
s	I-test
were	O
followed	O
for	O
normalization	O
.	O

The	O
patient	O
had	O
an	B-test
echocardiogram	I-test
on	O
day	O
two	O
of	O
admission	O
,	O
which	O
revealed	O
a	B-problem
mildly	I-problem
dilated	I-problem
left	I-problem
atrium	I-problem
,	O
mild	B-problem
symmetric	I-problem
LVH	I-problem
,	O
normal	O
LV	O
cavity	O
size	O
,	O
mild	B-problem
region	I-problem
LV	I-problem
systolic	I-problem
dysfunction	I-problem
,	O
arresting	B-problem
regional	I-problem
wall	I-problem
motion	I-problem
abnormality	I-problem
including	O
focal	B-problem
apical	I-problem
hypokinesis	I-problem
,	O
a	O
normal	O
right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
,	O
a	B-problem
moderately	I-problem
dilated	I-problem
aortic	I-problem
root	I-problem
,	O
a	B-problem
mildly	I-problem
dilated	I-problem
ascending	I-problem
aorta	I-problem
,	O
normal	O
aortic	O
valve	O
leaflet	O
,	O
normal	O
mitral	O
valve	O
leaflet	O
and	O
no	O
pericardial	B-problem
effusions	I-problem
.	O

The	O
patient	O
was	O
normal	O
volume	O
and	O
displayed	O
no	O
evidence	O
CHF	B-problem
signs	I-problem
or	I-problem
symptoms	I-problem
.	O

The	B-problem
risk	I-problem
factors	I-problem
were	O
addressed	O
.	O

The	O
patient	O
was	O
told	O
repeatedly	O
that	O
he	O
needed	O
to	O
stop	O
smoking	O
and	O
was	O
given	O
a	B-treatment
nicotine	I-treatment
patch	I-treatment
and	O
his	O
primary	O
care	O
provider	O
was	O
called	O
to	O
discuss	O
outpatient	O
plans	O
to	O
help	O
the	O
patient	O
stop	O
smoking	O
.	O

The	O
patient	O
was	O
advised	O
to	O
have	O
a	B-treatment
low	I-treatment
fat	I-treatment
/	I-treatment
low	I-treatment
cholesterol	I-treatment
diet	I-treatment
,	O
was	O
cleared	O
by	O
PT	O
and	O
advised	O
to	O
do	O
cardiac	B-treatment
rehabilitation	I-treatment
.	O

He	O
was	O
advised	O
the	O
importance	O
of	O
each	O
of	O
his	O
and	O
compliance	O
with	O
each	O
of	O
these	B-treatment
medications	I-treatment
and	O
was	O
told	O
he	O
needed	O
close	O
followup	O
with	O
a	O
cardiologist	O
.	O

For	O
renal	O
,	O
his	B-test
creatinine	I-test
was	O
monitored	O
and	O
the	B-test
dye	I-test
load	I-test
and	O
the	B-test
catheterization	I-test
.	O

It	O
was	O
normal	O
and	O
did	O
not	O
increase	O
.	O

Gastrointestinal	O
:	O

The	O
patient	O
was	O
given	O
a	B-treatment
low	I-treatment
fat	I-treatment
/	I-treatment
low	I-treatment
cholesterol	I-treatment
diet	I-treatment
.	O

His	B-test
electrolytes	I-test
were	O
monitored	O
and	O
repleted	O
carefully	O
.	O

He	O
had	O
normal	O
bowel	O
movements	O
and	O
had	O
GI	B-treatment
prophylaxis	I-treatment
throughout	O
his	O
stay	O
.	O

For	O
hematology	O
,	O
the	B-test
patient	I-test
's	I-test
hematocrit	I-test
and	O
platelets	B-test
were	O
monitored	O
after	O
the	B-test
catheterization	I-test
.	O

They	O
were	O
normal	O
and	O
did	O
not	O
change	O
and	O
the	O
patient	O
received	O
pneumatic	B-treatment
boots	I-treatment
for	O
DVT	B-treatment
prophylaxis	I-treatment
.	O

On	O
day	O
two	O
of	O
admission	O
,	O
the	O
patient	O
ambulated	O
with	O
PT	B-treatment
and	O
was	O
moved	O
to	O
the	O
regular	O
floor	O
.	O

On	O
day	O
three	O
of	O
admission	O
,	O
the	O
patient	O
felt	O
that	O
his	O
strength	O
was	O
back	O
to	O
baseline	O
.	O

He	O
denied	O
ever	O
having	O
any	B-problem
chest	I-problem
pain	I-problem
,	O
chest	B-problem
pressure	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
dyspnea	B-problem
on	O
exertion	O
and	O
he	O
was	O
discharged	O
to	O
home	O
.	O

He	O
was	O
told	O
to	O
return	O
to	O
the	O
emergency	O
department	O
if	O
he	O
had	O
any	B-problem
chest	I-problem
pain	I-problem
,	O
pressure	B-problem
,	O
difficulty	B-problem
breathing	I-problem
,	O
nausea	B-problem
,	O
light-headiness	B-problem
or	O
dizziness	B-problem
.	O

He	O
was	O
advised	O
to	O
take	O
all	O
of	O
his	B-treatment
medications	I-treatment
.	O

An	O
appointment	O
was	O
established	O
for	O
him	O
to	O
see	O
his	O
primary	O
care	O
doctor	O
,	O
Dr.	O
Stella	O
Booth	O
on	O
Maynard	O
,	O
2014-10-20	O
and	O
the	O
patient	O
was	O
referred	O
to	O
Dr.	O
Granville	O
Hamers	O
,	O
at	O
Ware	O
in	O
cardiology	O
to	O
be	O
seen	O
in	O
two	O
weeks	O
.	O

Dr	O
Marcus	O
assistant	O
was	O
called	O
and	O
she	O
stated	O
that	O
she	O
would	O
call	O
the	O
patient	O
with	O
an	O
appointment	O
.	O

FINAL	O
DIAGNOSES	O
:	O

1.	O
ST	B-problem
elevation	I-problem
myocardial	I-problem
infarction	I-problem
.	O

2.	O
Hypertension	B-problem
.	O

MAJOR	O
SURGICAL	O
AND	O
INVASIVE	O
PROCEDURES	O
:	O

Cardiac	B-test
catheterization	I-test
and	O
stent	B-treatment
placement	I-treatment
in	I-treatment
the	I-treatment
mid	I-treatment
left	I-treatment
anterior	I-treatment
descending	I-treatment
artery	I-treatment
.	O

DISCHARGE	O
CONDITION	O
:	O

Good	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Aspirin	B-treatment
325	O
mg	O
q.d.	O
,	O
Plavix	B-treatment
75	O
mg	O
q.d.	O
,	O
Lipitor	B-treatment
20	O
mg	O
q.d.	O
,	O
nitroglycerin	B-treatment
0.3	O
mg	O
sublingually	O
p.r.n.	O
chest	B-problem
pain	I-problem
or	O
pressure	B-problem
or	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
lisinopril	B-treatment
hydrochlorothiazide	B-treatment
20	O
/	O
12.5	O
mg	O
q.d.	O
,	O
atenolol	B-treatment
25	O
mg	O
q.d.	O

The	O
patient	O
was	O
told	O
he	O
could	O
return	O
to	O
work	O
after	O
two	O
weeks	O
of	O
rest	B-treatment
,	O
given	O
that	O
his	O
work	O
required	O
a	O
high	O
level	O
of	O
exertion	O
and	O
the	O
patient	O
was	O
also	O
given	O
a	O
prescription	O
for	O
a	B-treatment
transdermal	I-treatment
nicotine	I-treatment
patch	I-treatment
14	O
mg	O
the	O
be	O
used	O
for	O
up	O
to	O
2	O
weeks	O
until	O
cravings	B-problem
remitted	O
.	O

Antonio	O
PINTO	O
,	O
M.D.	O
52-057	O

Dictated	O
By	O
:	O
Salvador	O
BX	O
Hernandez	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2014-10-18	O
12:39	O

T	O
:	O
2014-10-21	O
12:42	O

JOB	O
#:	O
78572	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Steve	O
PINTO	O
on	O
:	O
SUN	O
2014-11-02	O
8:39	O
PM	O

(	O
End	O
of	O
Report	O
)	O

